PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Renny-Byfield, S; Kovarik, A; Chester, M; Nichols, RA; Macas, J; Novak, P; Leitch, AR				Renny-Byfield, Simon; Kovarik, Ales; Chester, Michael; Nichols, Richard A.; Macas, Jiri; Novak, Petr; Leitch, Andrew R.			Independent, Rapid and Targeted Loss of Highly Repetitive DNA in Natural and Synthetic Allopolyploids of Nicotiana tabacum	PLOS ONE			English	Article							RESYNTHESIZED BRASSICA-NAPUS; GENOME EVOLUTION; CONCERTED EVOLUTION; RIBOSOMAL DNA; GENE-EXPRESSION; PARENTAL RDNA; COPY NUMBER; ELIMINATION; POLYPLOIDY; REPEATS	Allopolyploidy (interspecific hybridisation and polyploidy) has played a significant role in the evolutionary history of angiosperms and can result in genomic, epigenetic and transcriptomic perturbations. We examine the immediate effects of allopolyploidy on repetitive DNA by comparing the genomes of synthetic and natural Nicotiana tabacum with diploid progenitors N. tomentosiformis (paternal progenitor) and N. sylvestris (maternal progenitor). Using next generation sequencing, a recently developed graph-based repeat identification pipeline, Southern blot and fluorescence in situ hybridisation (FISH) we characterise two highly repetitive DNA sequences (NicCL3 and NicCL7/30). Analysis of two independent high-throughput DNA sequencing datasets indicates NicCL3 forms 1.6-1.9% of the genome in N. tomentosiformis, sequences that occur in multiple, discontinuous tandem arrays scattered over several chromosomes. Abundance estimates, based on sequencing depth, indicate NicCL3 is almost absent in N. sylvestris and has been dramatically reduced in copy number in the allopolyploid N. tabacum. Surprisingly elimination of NicCL3 is repeated in some synthetic lines of N. tabacum in their forth generation. The retroelement NicCL7/30, which occurs interspersed with NicCL3, is also under-represented but to a much lesser degree, revealing targeted elimination of the latter. Analysis of paired-end sequencing data indicates the tandem component of NicCL3 has been preferentially removed in natural N. tabacum, increasing the proportion of the dispersed component. This occurs across multiple blocks of discontinuous repeats and based on the distribution of nucleotide similarity among NicCL3 units, was concurrent with rounds of sequence homogenisation.	[Renny-Byfield, Simon; Chester, Michael; Nichols, Richard A.; Leitch, Andrew R.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Kovarik, Ales] Acad Sci Czech Republ, Inst Biophys, CS-61265 Brno, Czech Republic; [Chester, Michael] Univ Florida, Florida Museum Nat Hist, Lab Mol Systemat & Evolutionary Genet, Gainesville, FL 32611 USA; [Macas, Jiri; Novak, Petr] ASCR, Ctr Biol, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic	University of London; Queen Mary University London; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; State University System of Florida; University of Florida; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Renny-Byfield, S (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	a.r.leitch@qmul.ac.uk	Macas, Jiri/G-8618-2014; Leitch, Andrew R/J-6385-2014; Novak, Petr/A-3059-2013; Kovarik, Ales/H-1952-2014; Nichols, Richard Alan/T-4773-2019	Macas, Jiri/0000-0003-0829-1570; Leitch, Andrew R/0000-0001-8574-302X; Novak, Petr/0000-0002-5068-9681; Nichols, Richard Alan/0000-0002-4801-9312; Kovarik, Ales/0000-0003-2896-0698	Natural Environment Research Council, UK; Academy of Sciences of the Czech Republic [AVOZ50510513, OC10037]; NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, NE/C511964/1] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Natural Environment Research Council, UK and the Academy of Sciences of the Czech Republic (AVOZ50510513, OC10037) funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennett MD, 2005, ANGIOSPERM DNA C VAL; BURK LG, 1973, J HERED, V64, P348, DOI 10.1093/oxfordjournals.jhered.a108438; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chester M, 2010, CYTOGENET GENOME RES, V129, P35, DOI 10.1159/000312959; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GOODSPEED T. H., 1954, Chronica botanica, V16, P1; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jones RN, 2009, CYTOGENET GENOME RES, V126, P376, DOI 10.1159/000266171; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kelly LJ, 2010, MOL BIOL EVOL, V27, P781, DOI 10.1093/molbev/msp267; Khasdan V, 2010, GENETICS, V185, P387, DOI 10.1534/genetics.110.116178; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; Koukalova B, 2010, NEW PHYTOL, V186, P148, DOI 10.1111/j.1469-8137.2009.03101.x; Kovarik A, 2000, CHROMOSOME RES, V8, P527, DOI 10.1023/A:1009223823327; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Langdon T, 2000, GENETICS, V154, P869; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Lim KY, 2006, PLANT J, V48, P907, DOI 10.1111/j.1365-313X.2006.02930.x; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lim KY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003353; Lim KY, 2000, CHROMOSOMA, V109, P161; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Lim KY, 1998, THEOR APPL GENET, V97, P1027, DOI 10.1007/s001220050987; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; Matzke M, 2004, BIOL J LINN SOC, V82, P627, DOI 10.1111/j.1095-8312.2004.00347.x; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; R Core Team, 2021, R LANGUAGE ENV STAT; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Salina EA, 2004, GENOME, V47, P860, DOI 10.1139/G04-044; Sambrook J., 2001, MOL CLONING LAB MANU; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Skalicka K, 2005, NEW PHYTOL, V166, P291, DOI 10.1111/j.1469-8137.2004.01297.x; Skalicka K, 2003, AM J BOT, V90, P988, DOI 10.3732/ajb.90.7.988; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swaminathan K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-132; Szadkowski E, 2010, NEW PHYTOL, V186, P102, DOI 10.1111/j.1469-8137.2010.03182.x; Tek AL, 2005, GENETICS, V170, P1231, DOI 10.1534/genetics.105.041087; VERSHININ AV, 1995, PLANT CELL, V7, P1823, DOI 10.1105/tpc.7.11.1823; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x	59	57	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36963	10.1371/journal.pone.0036963	http://dx.doi.org/10.1371/journal.pone.0036963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606317	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400047
J	Goulet, GM; Moreau, P; Robitaille, N; Peretz, I				Goulet, Genevieve Mignault; Moreau, Patricia; Robitaille, Nicolas; Peretz, Isabelle			Congenital Amusia Persists in the Developing Brain after Daily Music Listening	PLOS ONE			English	Article							PITCH DISCRIMINATION; TONE-DEAFNESS; RESPONSES; IDENTIFICATION; PLASTICITY; CHILDREN; RECOVERY; DEFICITS; NETWORK; ENHANCE	Congenital amusia is a neurodevelopmental disorder that affects about 3% of the adult population. Adults experiencing this musical disorder in the absence of macroscopically visible brain injury are described as cases of congenital amusia under the assumption that the musical deficits have been present from birth. Here, we show that this disorder can be expressed in the developing brain. We found that (10-13 year-old) children exhibit a marked deficit in the detection of fine-grained pitch differences in both musical and acoustical context in comparison to their normally developing peers comparable in age and general intelligence. This behavioral deficit could be traced down to their abnormal P300 brain responses to the detection of subtle pitch changes. The altered pattern of electrical activity does not seem to arise from an anomalous functioning of the auditory cortex, because all early components of the brain potentials, the N100, the MMN, and the P200 appear normal. Rather, the brain and behavioral measures point to disrupted information propagation from the auditory cortex to other cortical regions. Furthermore, the behavioral and neural manifestations of the disorder remained unchanged after 4 weeks of daily musical listening. These results show that congenital amusia can be detected in childhood despite regular musical exposure and normal intellectual functioning.	[Goulet, Genevieve Mignault; Moreau, Patricia; Robitaille, Nicolas; Peretz, Isabelle] Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Goulet, GM (corresponding author), Univ Montreal, Dept Psychol, Int Lab Brain Mus & Sound Res BRAMS, CP 6128, Montreal, PQ H3C 3J7, Canada.	isabelle.peretz@umontreal.ca			Canadian Institutes of Health Research (CIHR); Canada Research Chair; CIHR; Fonds de Recherche du Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and from a Canada Research Chair to I. P., and by fellowships from the CIHR to P. M., from the Fonds de Recherche du Quebec to G.M.G. and from the Collaborative Research and Training Experience Program (CREATE) from the Natural Sciences and Engineering Research Council of Canada (NSERC) to N.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelucci F, 2007, BEHAV PHARMACOL, V18, P491, DOI 10.1097/FBP.0b013e3282d28f50; Avidan G, 2009, CURR BIOL, V19, P1146, DOI 10.1016/j.cub.2009.04.060; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Engineer ND, 2004, J NEUROPHYSIOL, V92, P73, DOI 10.1152/jn.00059.2004; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Hyde KL, 2011, CEREB CORTEX, V21, P292, DOI 10.1093/cercor/bhq094; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lebrun MA, 2011, CORTEX IN PRESS; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2011, FRONTIERS PSYCHOL, P2; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Luo Yuejia, 1999, Chinese Medical Sciences Journal, V14, P75; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Merrett DW, 2012, LIFELONG ENGAGEMENT; Moreau P, 2009, ANN NY ACAD SCI, V1169, P191, DOI 10.1111/j.1749-6632.2009.04775.x; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Raven J.C., 1998, ADV PROGR MATRICES; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rentfrow PJ, 2006, PSYCHOL SCI, V17, P236, DOI 10.1111/j.1467-9280.2006.01691.x; Sarkamo T, 2008, BRAIN, V131, P866, DOI 10.1093/brain/awn013; Sarkamo T, 2010, J COGNITIVE NEUROSCI, V22, P2716, DOI 10.1162/jocn.2009.21376; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Shahin A, 2003, J NEUROSCI, V23, P5545; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Williamson VJ, 2010, MEMORY, V18, P657, DOI 10.1080/09658211.2010.501339; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	50	28	28	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36860	10.1371/journal.pone.0036860	http://dx.doi.org/10.1371/journal.pone.0036860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606299	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200050
J	Ferreira, GEM; dos Santos, BN; Dorval, MEC; Ramos, TPB; Porrozzi, R; Peixoto, AA; Cupolillo, E				Melim Ferreira, Gabriel Eduardo; dos Santos, Barbara Neves; Cavalheiros Dorval, Maria Elizabeth; Bastos Ramos, Tereza Pompilio; Porrozzi, Renato; Peixoto, Alexandre Afranio; Cupolillo, Elisa			The Genetic Structure of Leishmania infantum Populations in Brazil and Its Possible Association with the Transmission Cycle of Visceral Leishmaniasis	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS LUTZ; MATO-GROSSO; MICROSATELLITE POLYMORPHISM; DONOVANI STRAINS; CRUZI MANGABEIRA; CLONAL DIPLOIDS; DO-SUL; STATE; EPIDEMIOLOGY; PSYCHODIDAE	Leishmania infantum is the etiologic agent of visceral leishmaniasis (VL) in the Americas, Mediterranean basin and West and Central Asia. Although the geographic structure of L. infantum populations from the Old World have been described, few studies have addressed the population structure of this parasite in the Neotropical region. We employed 14 microsatellites to analyze the population structure of the L. infantum strains isolated from humans and dogs from most of the Brazilian states endemic for VL and from Paraguay. The results indicate a low genetic diversity, high inbreeding estimates and a depletion of heterozygotes, which together indicate a predominantly clonal breeding system, but signs of sexual events are also present. Three populations were identified from the clustering analysis, and they were well supported by F statistics inferences and partially corroborated by distance-based. POP1 (111 strains) was observed in all but one endemic area. POP2 (31 strains) is also well-dispersed, but it was the predominant population in Mato Grosso (MT). POP3 (31 strains) was less dispersed, and it was observed primarily in Mato Grosso do Sul (MS). Strains originated from an outbreak of canine VL in Southern Brazil were grouped in POP1 with those from Paraguay, which corroborates the hypothesis of dispersal from Northeastern Argentina and Paraguay. The distribution of VL in MS seems to follow the west-east construction of the Bolivia-Brazil pipeline from Corumba municipality. This may have resulted in a strong association of POP3 and Lutzomyia cruzi, which is the main VL vector in Corumba, and a dispersion of this population in this region that was shaped by human interference. This vector also occurs in MT and may influence the structure of POP2. This paper presents significant advances in the understanding of the population structure of L. infantum in Brazil and its association with eco-epidemiological aspects of VL.	[Melim Ferreira, Gabriel Eduardo; dos Santos, Barbara Neves; Porrozzi, Renato; Cupolillo, Elisa] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil; [Melim Ferreira, Gabriel Eduardo; Peixoto, Alexandre Afranio] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Insetos, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Ferreira, GEM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Pesquisa Leishmaniose, Rio De Janeiro, Brazil.	gmelim@ioc.fiocruz.br	Porrozzi, Renato/U-2166-2019; Porrozzi, Renato/U-2059-2019; Ferreira, Gabriel EM/M-6028-2018; Cupolillo, Elisa/U-1667-2019	Porrozzi, Renato/0000-0003-2167-316X; Ferreira, Gabriel EM/0000-0002-3514-3031; Cupolillo, Elisa/0000-0002-0620-3250; Ferreira, Evandro/0000-0002-1057-5508	Howard Hughes Medical Institute; FINEP (Research Projects and Financing); CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology); Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ); European Commission [INCO-CT2005-015407]; CNPq	Howard Hughes Medical Institute(Howard Hughes Medical Institute); FINEP (Research Projects and Financing); CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology); Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); European Commission(European CommissionEuropean Commission Joint Research Centre); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Howard Hughes Medical Institute, FINEP (Research Projects and Financing) and CNPq (National Council for Scientific and Technological Development) of the Ministry of Science and Technology), the Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ) and The European Commission (INCO-CT2005-015407). Elisa Cupolillo and Gabriel Grimaldi are CNPq fellows. Gabriel Eduardo Melim Ferreira was a Ph.D. student in the Program in Molecular and Cell Biology/Oswaldo Cruz Institute and was sponsored by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Al-Jawabreh A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-183; Alam MZ, 2009, PARASITOLOGY, V136, P981, DOI 10.1017/S0031182009006465; Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Botelho ACA, 2009, REV SOC BRAS MED TRO, V42, P503, DOI 10.1590/S0037-86822009000500006; Amro A, 2009, MICROBES INFECT, V11, P484, DOI 10.1016/j.micinf.2009.02.001; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Balloux F, 2003, GENETICS, V164, P1635; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Brazil R.P., 1991, Parassitologia (Rome), V33, P113; Bruce MC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-38; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Butlin R, 2002, NAT REV GENET, V3, P311, DOI 10.1038/nrg749; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004; Cunha A. M. da, 1938, Memorias do Instituto Oswaldo Cruz, V33, P581, DOI 10.1590/S0074-02761938000400008; Mestre GLD, 2007, REV SOC BRAS MED TRO, V40, P42, DOI 10.1590/S0037-86822007000100008; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; De Meeus T, 2006, INFECT GENET EVOL, V6, P163, DOI 10.1016/j.meegid.2005.02.004; De Meeus T, 2005, MOL ECOL, V14, P2695, DOI 10.1111/j.1365-294X.2005.02643.x; de Oliveira AG, 2006, MEM I OSWALDO CRUZ, V101, P869, DOI 10.1590/S0074-02762006000800008; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; Deane L. M., 1954, Hospital, V45, P703; DESJEUX P, 1983, T ROY SOC TROP MED H, V77, P851, DOI 10.1016/0035-9203(83)90305-X; Dias Flávio de Oliveira Passos, 2003, Cad. Saúde Pública, V19, P1373, DOI 10.1590/S0102-311X2003000500015; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Nascimento João Cezar do, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P119, DOI 10.1590/S0036-46652007000200011; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garcia AL, 2009, AM J TROP MED HYG, V80, P704, DOI 10.4269/ajtmh.2009.80.704; Gelanew T, 2011, MICROBES INFECT, V13, P595, DOI 10.1016/j.micinf.2011.02.003; Gelanew T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000889; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Hennequin C, 2001, J CLIN MICROBIOL, V39, P551, DOI 10.1128/JCM.39.2.551-559.2001; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X; KILLICKKENDRICK R, 1980, ANN TROP MED PARASIT, V74, P563, DOI 10.1080/00034983.1980.11687385; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Lainson R., 1987, LEISHMANIASES BIOL M, P1; Leblois R, 2011, INFECT GENET EVOL, V11, P1091, DOI 10.1016/j.meegid.2011.04.004; de Oliveira ALL, 2006, REV SOC BRAS MED TRO, V39, P446, DOI 10.1590/S0037-86822006000500005; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Ribeiro Ana Lúcia Maria, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P317, DOI 10.1590/S0036-46652007000500008; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Missawa NA, 2006, REV SOC BRAS MED TRO, V39, P337, DOI 10.1590/S0037-86822006000400004; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; MOMEN H, 1987, Memorias do Instituto Oswaldo Cruz, V82, P447, DOI 10.1590/S0074-02761987000300022; Momen Hooman, 1993, Biological Research, V26, P249; Nei M., 2000, MOL EVOLUTION PHYLOG; Nolder D, 2007, AM J TROP MED HYG, V76, P573, DOI 10.4269/ajtmh.2007.76.573; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Oddone R, 2009, J CLIN MICROBIOL, V47, P2818, DOI 10.1128/JCM.00645-09; Oliveira Alessandra Gutierrez de, 2003, Cad. Saúde Pública, V19, P933, DOI 10.1590/S0102-311X2003000400016; Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Pritchard JK, 2000, GENETICS, V155, P945; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Reale S, 2010, TRANSBOUND EMERG DIS, V57, P37, DOI 10.1111/j.1865-1682.2010.01131.x; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584; Rosypal AC, 2003, J EUKARYOT MICROBIOL, V50, P691, DOI 10.1111/j.1550-7408.2003.tb00690.x; Rougeron V, 2008, MOL ECOL RESOUR, V8, P351, DOI 10.1111/j.1471-8286.2007.01953.x; Rougeron V, 2010, PARASITOLOGY, V137, P1879, DOI 10.1017/S0031182010000776; Rougeron V, 2011, MOL ECOL, V20, P3116, DOI 10.1111/j.1365-294X.2011.05162.x; Rougeron V, 2009, P NATL ACAD SCI USA, V106, P10224, DOI 10.1073/pnas.0904420106; Russell R, 1999, MOL BIOCHEM PARASIT, V103, P71, DOI 10.1016/S0166-6851(99)00117-6; Salim B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001196; Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; SHAW JJ, 1994, MEM I OSWALDO CRUZ, V89, P471, DOI 10.1590/S0074-02761994000300033; Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002; Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TRAVI BL, 1990, T ROY SOC TROP MED H, V84, P676, DOI 10.1016/0035-9203(90)90142-2; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Werneck GL, 2010, CAD SAUDE PUBLICA, V26, P645; Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023; WHO, 2010, CONTR LEISHM REP M W, Vxiii, P186	91	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36242	10.1371/journal.pone.0036242	http://dx.doi.org/10.1371/journal.pone.0036242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606248	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200020
J	Cai, H; Huang, JP; Xu, GF; Yang, ZL; Liu, M; Mi, YP; Liu, WS; Wang, HJ; Qian, DR				Cai, Hui; Huang, Jianping; Xu, Guangfei; Yang, Zili; Liu, Ming; Mi, Yaoping; Liu, Weisheng; Wang, Hongjun; Qian, Derong			Prevalence and Determinants of Metabolic Syndrome among Women in Chinese Rural Areas	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; RISK-FACTORS; CARDIOVASCULAR RISK; SMOKING; ADULTS; EXERCISE; DISEASE; EDUCATION	Background and Aims: Metabolic syndrome (MS) is prevalent in recent years but few data is reported in the rural areas in China. The aim of this study was to examine MS prevalence and its risk factors among women in rural China. Methods and Results: The Nantong Metabolic Syndrome Study (NMSS), a population based cross-sectional study, was conducted during 2007-2008 in Nantong, China. In person interviews, blood glucose and lipid measurements were completed for 13,505 female participants aged 18-74 years. The International Diabetes Federation (IDF), the US Third Report of the National Cholesterol Education Program, the Adult Treatment Panel (ATPIII) and modified ATPIII for Asian population has determined three criteria of MS. These criteria for MS were used and compared in this study. The prevalence of MS was 22.0%, 16.9% and 23.3% according to IDF, ATPIII and ATPIII-modified criteria, respectively. Levels of agreement of these criteria for MS were above 0.75. We found that vigorous-intensity of occupational physical activity was associated with a low prevalence of MS with OR of 0.76 (95% confidence interval (CI): 0.63-0.91). Rice wine drinkers (alcohol >12.8 g/day) had about 34% low risks of developing MS with OR of 0.66 (95% CI: 0.48-0.91), compared with non-drinkers. Odds ratio of MS was 1.81 (95% CI: 1.15-2.84) in women who smoked more than 20 pack-years, compared to non-smokers. Odds ratio of MS was 1.56 (95% CI: 1.25-1.95) in women who had familial history of diseases, including hypertension, diabetes and stroke, compared to women without familial history of those diseases. Conclusion: MS is highly prevalent among women in rural China. Both physical activity and rice wine consumption play a protective role, while family history and smoking are risk factors in MS development. Educational programs should be established for promoting healthy lifestyles and appropriate interventions in rural China.	[Cai, Hui; Xu, Guangfei] Nantong Univ, Dept Epidemiol & Med Stat, Nantong, Jiangsu, Peoples R China; [Huang, Jianping; Yang, Zili; Mi, Yaoping] Ctr Dis Control & Prevent Nantong, Dept Chron Dis & Prevent, Nantong, Jiangsu, Peoples R China; [Liu, Ming; Liu, Weisheng; Wang, Hongjun; Qian, Derong] Ctr Dis Control & Prevent Tongzhou, Dept Chron Dis & Prevent, Nantong, Jiangsu, Peoples R China	Nantong University	Cai, H (corresponding author), Nantong Univ, Dept Epidemiol & Med Stat, Nantong, Jiangsu, Peoples R China.	huicai2012@yahoo.com			Ministry of Science and Technology of China [2006BAI 01A 01]; Department of Science and Technology of Nantong [BK2011059, S2010042]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Department of Science and Technology of Nantong	This work was supported by 2006BAI 01A 01, funded from the Ministry of Science and Technology of China, and by BK2011059, S2010042, funded from the Department of Science and Technology of Nantong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anjana RM, 2009, METABOLISM, V58, P344, DOI 10.1016/j.metabol.2008.10.006; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bergstrom G, 2012, ANGIOLOGY, V63, P297, DOI 10.1177/0003319711414867; Botezelli JD, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-35; Chang ST, 2011, INT J IMPOT RES, V23, P87, DOI 10.1038/ijir.2011.9; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Christ M, 2004, INT J CARDIOL, V97, P115, DOI 10.1016/j.ijcard.2004.01.034; Church T, 2011, PROG CARDIOVASC DIS, V53, P412, DOI 10.1016/j.pcad.2011.03.013; Corder R, 2006, NATURE, V444, P566, DOI 10.1038/444566a; da Costa FF, 2011, ARQ BRAS CARDIOL, V97, P485, DOI 10.1590/S0066-782X2011005000113; Das M, 2008, AM J HUM BIOL, V20, P440, DOI 10.1002/ajhb.20757; Djousse L, 2004, OBES RES, V12, P1375, DOI 10.1038/oby.2004.174; Erem C, 2008, ENDOCRINE, V33, P9, DOI 10.1007/s12020-008-9044-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Freiberg MS, 2004, DIABETES CARE, V27, P2954, DOI 10.2337/diacare.27.12.2954; da Silveira VMF, 2010, ARQ BRAS ENDOCRINOL, V54, P390, DOI 10.1590/S0004-27302010000400008; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gayda M, 2008, NUTR METAB CARDIOVAS, V18, P142, DOI 10.1016/j.numecd.2006.07.003; Gomez-Abellan P, 2008, INT J OBESITY, V32, P121, DOI 10.1038/sj.ijo.0803689; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Halldin M, 2007, NUTR METAB CARDIOVAS, V17, P349, DOI 10.1016/j.numecd.2006.01.002; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He Y, 2007, DIABETES CARE, V30, P2128, DOI 10.2337/dc06-2402; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Jesmin S, 2012, DIABETES RES CLIN PR, V95, pE7, DOI 10.1016/j.diabres.2011.09.025; Katano S, 2010, J ATHEROSCLER THROMB, V17, P644, DOI 10.5551/jat.3699; Kristiansson K, 2012, CIRC CARDIOVASC 0307, V7; Lakka TA, 2007, APPL PHYSIOL NUTR ME, V32, P76, DOI [10.1139/H06-113, 10.1139/h06-113]; Lee WY, 2005, DIABETES RES CLIN PR, V67, P70, DOI 10.1016/j.diabres.2004.05.006; Leighton F, 2006, CELL BIOCHEM FUNCT, V24, P291, DOI 10.1002/cbf.1269; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Mendez-Hernandez P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-276; Miccoli R, 2005, NUTR METAB CARDIOVAS, V15, P250, DOI 10.1016/j.numecd.2004.09.002; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Mohebbi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031790; Mozumdar A, 2011, J PHYS ACT HEALTH, V8, P321, DOI 10.1123/jpah.8.3.321; Mukamal KJ, 2006, ARCH INTERN MED, V166, P2145, DOI 10.1001/archinte.166.19.2145; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Oh EG, 2011, BIOL RES NURS; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Onat A, 2007, ATHEROSCLEROSIS, V193, P380, DOI 10.1016/j.atherosclerosis.2006.07.002; Pan JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021515; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Reynolds K, 2005, AM J MED SCI, V330, P273, DOI 10.1097/00000441-200512000-00004; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Sangun O, 2011, J CLIN RES PEDIATR E, V3, P70, DOI 10.4274/jcrpe.v3i2.15; Santos AC, 2007, PREV MED, V44, P328, DOI 10.1016/j.ypmed.2006.11.016; SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005; Wada T, 2007, INTERNAL MED, V46, P1079, DOI 10.2169/internalmedicine.46.0026; Wang HN, 2012, MOL BIOL REP, V39, P5691, DOI 10.1007/s11033-011-1377-y; Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006; Yang WJ, 2007, AM J MED SCI, V334, P184, DOI 10.1097/MAJ.0b013e3180a6ed66; Yoon YS, 2007, INT J OBESITY, V31, P528, DOI 10.1038/sj.ijo.0803442; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Zhang M, 2011, EXP CLIN ENDOCR DIAB, V119, P509, DOI 10.1055/s-0031-1277138	58	46	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36936	10.1371/journal.pone.0036936	http://dx.doi.org/10.1371/journal.pone.0036936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590636	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400046
J	Blount, JR; Burr, AA; Denuc, A; Marfany, G; Todi, SV				Blount, Jessica R.; Burr, Aaron A.; Denuc, Amanda; Marfany, Gemma; Todi, Sokol V.			Ubiquitin-Specific Protease 25 Functions in Endoplasmic Reticulum-Associated Degradation	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME ATAXIN-3; QUALITY-CONTROL; USP25; ERAD; RETROTRANSLOCATION; GENERATION; MUTATIONS; TURNOVER; VCP/P97	Endoplasmic Reticulum (ER)-associated degradation (ERAD) discards abnormal proteins synthesized in the ER. Through coordinated actions of ERAD components, misfolded/anomalous proteins are recognized, ubiquitinated, extracted from the ER and ultimately delivered to the proteasome for degradation. It is not well understood how ubiquitination of ERAD substrates is regulated. Here, we present evidence that the deubiquitinating enzyme Ubiquitin-Specific Protease 25 (USP25) is involved in ERAD. Our data support a model where USP25 counteracts ubiquitination of ERAD substrates by the ubiquitin ligase HRD1, rescuing them from degradation by the proteasome.	[Blount, Jessica R.; Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Blount, Jessica R.; Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Burr, Aaron A.; Todi, Sokol V.] Wayne State Univ, Sch Med, Grad Program Canc Biol, Detroit, MI USA; [Denuc, Amanda; Marfany, Gemma] Univ Barcelona, Fac Med, Dept Genet, Barcelona 7, Spain	Wayne State University; Wayne State University; Wayne State University; University of Barcelona	Blount, JR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Marfany, Gemma/I-5668-2015	Marfany, Gemma/0000-0001-7941-983X; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [R00NS064097]; Albert and Goldye Nelson Fund; Ministerio de Educacion y Cienda [BFU2010-15656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS064097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert and Goldye Nelson Fund; Ministerio de Educacion y Cienda; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant R00NS064097 to S.V.T., a research grant to S.V.T. by the Albert and Goldye Nelson Fund and by BFU2010-15656 (Ministerio de Educacion y Cienda) to G.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Claessen JH, 2011, TRENDS CELL BIOL; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Denuc A, 2010, BIOCHEM SOC T, V38, P34, DOI 10.1042/BST0380034; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Morreale G, 2009, FEBS J, V276, P1208, DOI 10.1111/j.1742-4658.2008.06858.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Todi S.V., 2011, TRENDS NEUROSCI; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Valero R, 1999, GENOMICS, V62, P395, DOI 10.1006/geno.1999.6025; Valero R, 2001, GENOME BIOL, V2; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Williams AJ, 2009, NEUROBIOL DIS, V33, P342, DOI 10.1016/j.nbd.2008.10.016; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	42	47	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36542	10.1371/journal.pone.0036542	http://dx.doi.org/10.1371/journal.pone.0036542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590560	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100035
J	Dheilly, NM; Lelong, C; Huvet, A; Kellner, K; Dubos, MP; Riviere, G; Boudry, P; Favrel, P				Dheilly, Nolwenn M.; Lelong, Christophe; Huvet, Arnaud; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Boudry, Pierre; Favrel, Pascal			Gametogenesis in the Pacific Oyster Crassostrea gigas: A Microarrays-Based Analysis Identifies Sex and Stage Specific Genes	PLOS ONE			English	Article							RNA-BINDING PROTEIN; VASA-LIKE GENE; SUMMER MORTALITY; EXPRESSION; SPERM; GERMLINE; CYCLE; DIFFERENTIATION; TRANSCRIPTOME; SPERMATOGENESIS	Background: The Pacific oyster Crassostrea gigas (Mollusca, Lophotrochozoa) is an alternative and irregular protandrous hermaphrodite: most individuals mature first as males and then change sex several times. Little is known about genetic and phenotypic basis of sex differentiation in oysters, and little more about the molecular pathways regulating reproduction. We have recently developed and validated a microarray containing 31,918 oligomers (Dheilly et al., 2011) representing the oyster transcriptome. The application of this microarray to the study of mollusk gametogenesis should provide a better understanding of the key factors involved in sex differentiation and the regulation of oyster reproduction. Methodology/Principal Findings: Gene expression was studied in gonads of oysters cultured over a yearly reproductive cycle. Principal component analysis and hierarchical clustering showed a significant divergence in gene expression patterns of males and females coinciding with the start of gonial mitosis. ANOVA analysis of the data revealed 2,482 genes differentially expressed during the course of males and/or females gametogenesis. The expression of 434 genes could be localized in either germ cells or somatic cells of the gonad by comparing the transcriptome of female gonads to the transcriptome of stripped oocytes and somatic tissues. Analysis of the annotated genes revealed conserved molecular mechanisms between mollusks and mammals: genes involved in chromatin condensation, DNA replication and repair, mitosis and meiosis regulation, transcription, translation and apoptosis were expressed in both male and female gonads. Most interestingly, early expressed male-specific genes included bindin and a dpy-30 homolog and female-specific genes included foxL2, nanos homolog 3, a pancreatic lipase related protein, cd63 and vitellogenin. Further functional analyses are now required in order to investigate their role in sex differentiation in oysters. Conclusions/Significance: This study allowed us to identify potential markers of early sex differentiation in the oyster C. gigas, an alternative hermaphrodite mollusk. We also provided new highly valuable information on genes specifically expressed by mature spermatozoids and mature oocytes.	[Dheilly, Nolwenn M.; Lelong, Christophe; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Favrel, Pascal] Univ Caen Basse Normandie, IBFA, SFR ICORE, Biol Organismes Marins & Ecosyst Associes BioMEA, Caen, France; [Dheilly, Nolwenn M.; Lelong, Christophe; Kellner, Kristell; Dubos, Marie-Pierre; Riviere, Guillaume; Favrel, Pascal] CNRS INEE, BioMEA, Caen, France; [Dheilly, Nolwenn M.; Huvet, Arnaud; Boudry, Pierre] IFREMER, Lab Sci Environm Marin, Ctr Bretagne, Plouzane, France	Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Dheilly, NM (corresponding author), Univ Caen Basse Normandie, IBFA, SFR ICORE, Biol Organismes Marins & Ecosyst Associes BioMEA, Caen, France.	nolwenn.dheilly@univ-perp.fr	Dheilly, Nolwenn/AAU-9185-2020; Dheilly, Nolwenn Marie M/A-7213-2011; Boudry, Pierre/M-3213-2019; Boudry, Pierre/G-2406-2010	Dheilly, Nolwenn/0000-0002-3675-5013; Dheilly, Nolwenn Marie M/0000-0002-3675-5013; Huvet, Arnaud/0000-0001-6912-881X; Boudry, Pierre/0000-0002-5150-2276; Favrel, Pascal/0000-0002-2504-9957	ANR [ANR-08-GENM-041]; GIS Europole Mer; European program FP7-KBBE-2009-3 "Reproseed'' [245119]; Ifremer and Region Basse-Normandie	ANR(French National Research Agency (ANR)); GIS Europole Mer; European program FP7-KBBE-2009-3 "Reproseed''; Ifremer and Region Basse-Normandie(Region Normandie)	This work was partly supported by the ANR project "Gametogenes'' (contract no ANR-08-GENM-041), the GIS Europole Mer project "OxyGenes'' and the European program FP7-KBBE-2009-3 "Reproseed'' (Proposal nu 245119). NMD was funded by post-doctoral grants provided by Ifremer and Region Basse-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; BERNARDINI G, 1992, J EXP ZOOL, V263, P210, DOI 10.1002/jez.1402630211; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Berthelin C, 2000, MAR BIOTECHNOL, V2, P136; Berthelin Heude C, 2001, STORAGE REPROD STRAT; Boudry P, 2009, BASICS, P87, DOI 10.1533/9781845696474.1.87; Boudry P, 2008, SUMMER MORTALITY PAC, P153; BRANDRIFF B, 1978, GAMETE RES, V1, P89, DOI 10.1002/mrd.1120010202; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Choudhury DR, 2010, BIOL REPROD, V83, P663, DOI 10.1095/biolreprod.110.084889; Chuaqui RF, 2002, NAT GENET; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Degremont L, 2007, AQUACULTURE, V262, P41, DOI 10.1016/j.aquaculture.2006.10.025; Degremont L, 2010, AQUACULTURE, V299, P21, DOI 10.1016/j.aquaculture.2009.11.017; Dheilly NM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-468; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Dridi S, 2007, AQUACULTURE, V263, P238, DOI 10.1016/j.aquaculture.2006.10.028; Eckmann CR, 2004, GENETICS, V168, P147, DOI 10.1534/genetics.104.029264; Eckmann CR, 2002, DEV CELL, V3, P697, DOI 10.1016/S1534-5807(02)00322-2; Enriquez-Diaz M, 2009, AQUACULT INT, V17, P491, DOI 10.1007/s10499-008-9219-1; Ernande B, 2003, J EVOLUTION BIOL, V16, P399, DOI 10.1046/j.1420-9101.2003.00543.x; Evans C, 2008, REPROD DOMEST ANIM, V43, P539; Fabioux C, 2005, AQUACULTURE, V250, P458, DOI 10.1016/j.aquaculture.2005.02.038; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V320, P592, DOI 10.1016/j.bbrc.2004.06.009; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; Fleury E, MARINE BIOT IN PRESS; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franco A, 2008, TISSUE CELL, V40, P251, DOI 10.1016/j.tice.2007.12.006; Franco A, 2010, CELL TISSUE RES, V340, P201, DOI 10.1007/s00441-009-0923-6; Gonzalez M, 2005, BIOCHEM BIOPH RES CO, V338, P1089, DOI 10.1016/j.bbrc.2005.10.075; Grizzi F, 2004, J HISTOCHEM CYTOCHEM, V52, P549, DOI 10.1177/002215540405200414; He X, 2011, FISH SHELLFISH IMMUN, P30; Heyer BS, 1999, DEV DYNAM, V215, P344; HSU DR, 1995, DEVELOPMENT, V121, P3323; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Huvet A, 2010, AQUACULTURE, V304, P95, DOI 10.1016/j.aquaculture.2010.03.022; Itoh N, 2011, COMP BIOCHEM PHYS B, V158, P9, DOI 10.1016/j.cbpb.2010.06.006; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Ibanez AJ, 2008, COMP BIOCHEM PHYS A, V150, P347, DOI 10.1016/j.cbpa.2008.04.598; Jouaux A, 2010, J EXP MAR BIOL ECOL, V395, P162, DOI 10.1016/j.jembe.2010.08.030; Kim KS, 2008, COMP BIOCHEM PHYS B, V151, P52, DOI 10.1016/j.cbpb.2008.05.009; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lango-Reynoso F, 2006, INVERTEBR REPROD DEV, V49, P41, DOI 10.1080/07924259.2006.9652192; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Moy GW, 2008, P NATL ACAD SCI USA, V105, P1993, DOI 10.1073/pnas.0711862105; Moy GW, 2008, GENE, V423, P215, DOI 10.1016/j.gene.2008.07.005; Myrand B, 1995, J SHELLFISH RES, V14, P395; Naimi A, 2009, COMP BIOCHEM PHYS A, V152, P189, DOI 10.1016/j.cbpa.2008.09.019; Naimi A, 2009, COMP BIOCHEM PHYS B, V154, P134, DOI 10.1016/j.cbpb.2009.05.011; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Normand J, 2009, AQUAT BIOL, V7, P229, DOI 10.3354/ab00190; Normand Julien, 2008, COMP HISTOLOGICAL ST; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; PERDUE JA, 1984, AQUACULTURE, V37, P231, DOI 10.1016/0044-8486(84)90156-X; Rezen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-76; Rolland AD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-546; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Samain JF, 2007, AQUACULTURE, V268, P227, DOI 10.1016/j.aquaculture.2007.04.044; Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; SMITH RC, 1988, GENE DEV, V2, P1284, DOI 10.1101/gad.2.10.1284; Soletchnik P, 1997, AQUAT LIVING RESOUR, V10, P177, DOI 10.1051/alr:1997019; Sutovsky P, 2001, J CELL SCI, V114, P1665; Swain A, 2006, CURR BIOL, V16, pR507, DOI 10.1016/j.cub.2006.06.009; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Togo T, 2004, MOL REPROD DEV, V67, P465, DOI 10.1002/mrd.20037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaschenko MA, 1997, HYDROBIOLOGIA, V352, P231, DOI 10.1023/A:1003087610120; Wainman A, 2009, J CELL SCI, V122, P1747, DOI 10.1242/jcs.041798; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; WORRALL CM, 1984, MAR BIOL LETT, V5, P85; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang DC, 2009, FISH SHELLFISH IMMUN, V26, P84, DOI 10.1016/j.fsi.2008.10.009; Zheng DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-553; Zorn AM, 1997, CURR BIOL, V7, pR501, DOI 10.1016/S0960-9822(06)00248-X	84	50	53	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36353	10.1371/journal.pone.0036353	http://dx.doi.org/10.1371/journal.pone.0036353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590533	Green Published, gold			2022-12-27	WOS:000305336100026
J	Henriksson, L; Karvonen, J; Salminen-Vaparanta, N; Railo, H; Vanni, S				Henriksson, Linda; Karvonen, Juha; Salminen-Vaparanta, Niina; Railo, Henry; Vanni, Simo			Retinotopic Maps, Spatial Tuning, and Locations of Human Visual Areas in Surface Coordinates Characterized with Multifocal and Blocked fMRI Designs	PLOS ONE			English	Article							VENTRAL OCCIPITAL CORTEX; RECEPTIVE-FIELD SIZES; CEREBRAL-CORTEX; PARIETAL; OBJECT; ORGANIZATION; REPRESENTATIONS; SUPPRESSION; PREFERENCE; ATTENTION	The localization of visual areas in the human cortex is typically based on mapping the retinotopic organization with functional magnetic resonance imaging (fMRI). The most common approach is to encode the response phase for a slowly moving visual stimulus and to present the result on an individual's reconstructed cortical surface. The main aims of this study were to develop complementary general linear model (GLM)-based retinotopic mapping methods and to characterize the inter-individual variability of the visual area positions on the cortical surface. We studied 15 subjects with two methods: a 24-region multifocal checkerboard stimulus and a blocked presentation of object stimuli at different visual field locations. The retinotopic maps were based on weighted averaging of the GLM parameter estimates for the stimulus regions. In addition to localizing visual areas, both methods could be used to localize multiple retinotopic regions-of-interest. The two methods yielded consistent retinotopic maps in the visual areas V1, V2, V3, hV4, and V3AB. In the higher-level areas IPS0, VO1, LO1, LO2, TO1, and TO2, retinotopy could only be mapped with the blocked stimulus presentation. The gradual widening of spatial tuning and an increase in the responses to stimuli in the ipsilateral visual field along the hierarchy of visual areas likely reflected the increase in the average receptive field size. Finally, after registration to Freesurfer's surface-based atlas of the human cerebral cortex, we calculated the mean and variability of the visual area positions in the spherical surface-based coordinate system and generated probability maps of the visual areas on the average cortical surface. The inter-individual variability in the area locations decreased when the midpoints were calculated along the spherical cortical surface compared with volumetric coordinates. These results can facilitate both analysis of individual functional anatomy and comparisons of visual cortex topology across studies.	[Henriksson, Linda] MRC Cognit & Brain Sci Unit, Cambridge, England; [Henriksson, Linda; Karvonen, Juha; Vanni, Simo] Aalto Univ, Brain Res Unit, OV Lounasmaa Lab, Espoo, Finland; [Henriksson, Linda; Karvonen, Juha; Vanni, Simo] Aalto Univ, Adv Magnet Imaging Ctr, Espoo, Finland; [Salminen-Vaparanta, Niina; Railo, Henry] Univ Turku, Ctr Cognit Neurosci, Turku, Finland; [Salminen-Vaparanta, Niina; Railo, Henry] Univ Turku, Dept Psychol, Turku, Finland	Aalto University; Aalto University; University of Turku; University of Turku	Henriksson, L (corresponding author), MRC Cognit & Brain Sci Unit, Cambridge, England.	henriksson@neuro.hut.fi	Henriksson, Linda/D-2871-2013; Vanni, Simo/B-9590-2013	Henriksson, Linda/0000-0002-7688-1882; Vanni, Simo/0000-0002-6101-4129; Railo, Henry/0000-0002-0779-5008	Finnish Cultural Foundation; Finnish Graduate School of Neuroscience; Academy of Finland [213464, 110957, 111817, 124623, 125175, 124698, 140726, 218054]; MRC [MC_U105597120] Funding Source: UKRI; Medical Research Council [MC_U105597120] Funding Source: researchfish	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Graduate School of Neuroscience; Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Finnish Cultural Foundation; Finnish Graduate School of Neuroscience; and Academy of Finland (National Programme for Centres of Excellence 2006 - 2011 grant 213464, and grants 110957, 111817, 124623, 125175, 124698, 140726, 218054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Bressler DW, 2010, NEUROIMAGE, V53, P526, DOI 10.1016/j.neuroimage.2010.06.063; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Drury HA, 1996, J COGNITIVE NEUROSCI, V8, P1, DOI 10.1162/jocn.1996.8.1.1; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Hansen KA, 2007, J NEUROSCI, V27, P11896, DOI 10.1523/JNEUROSCI.2991-07.2007; Hasnain MK, 1998, HUM BRAIN MAPP, V6, P301, DOI 10.1002/(SICI)1097-0193(1998)6:4<301::AID-HBM8>3.0.CO;2-7; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Henriksson L, 2008, J VISION, V8, DOI 10.1167/8.10.5; Hinds O, 2009, NEUROIMAGE, V46, P915, DOI 10.1016/j.neuroimage.2009.03.036; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Huk AC, 2002, J NEUROSCI, V22, P7195; Jack AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000452; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Kraft A, 2005, NEUROIMAGE, V28, P453, DOI 10.1016/j.neuroimage.2005.05.050; Kravitz DJ, 2010, CEREB CORTEX, V20, P2916, DOI 10.1093/cercor/bhq042; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Pihlaja M, 2008, HUM BRAIN MAPP, V29, P1001, DOI 10.1002/hbm.20442; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Rajimehr R, 2009, J NEUROSCI, V29, P11149, DOI 10.1523/JNEUROSCI.1835-09.2009; Saygin AP, 2008, CEREB CORTEX, V18, P2158, DOI 10.1093/cercor/bhm242; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Sereno MI, 1996, NEUROIMAGE, V3, pS252, DOI DOI 10.1016/S1053-8119(96)80254-0; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Skrandies W., 1987, PROGR SENSORY PHYSL, V8, P1, DOI [DOI 10.1007/978-3-642-71060-5_1, 10.1007/978-3-642-71060-5_1]; Stenbacka L, 2007, CLIN NEUROPHYSIOL, V118, P1303, DOI 10.1016/j.clinph.2007.01.023; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Vanni S, 2005, NEUROIMAGE, V27, P95, DOI 10.1016/j.neuroimage.2005.01.046; Wade AR, 2010, J NEUROSCI, V30, P5008, DOI 10.1523/JNEUROSCI.6260-09.2010; Wade AR, 2002, PHILOS T R SOC B, V357, P963, DOI 10.1098/rstb.2002.1108; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Warnking J, 2002, NEUROIMAGE, V17, P1665, DOI 10.1006/nimg.2002.1304; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Yamamoto H, 2011, HUM BRAIN MAPP	64	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36859	10.1371/journal.pone.0036859	http://dx.doi.org/10.1371/journal.pone.0036859			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590626	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100067
J	Oulion, S; Bertrand, S; Belgacem, MR; Le Petillon, Y; Escriva, H				Oulion, Silvan; Bertrand, Stephanie; Belgacem, Mohamed R.; Le Petillon, Yann; Escriva, Hector			Sequencing and Analysis of the Mediterranean Amphioxus (Branchiostoma lanceolatum) Transcriptome	PLOS ONE			English	Article							FLORIDAE; GENOME; VERTEBRATE; ANNOTATION; GENES; TUNICATES; EVOLUTION; RESOURCE; BLAST2GO; RECEPTOR	Background: The basally divergent phylogenetic position of amphioxus (Cephalochordata), as well as its conserved morphology, development and genetics, make it the best proxy for the chordate ancestor. Particularly, studies using the amphioxus model help our understanding of vertebrate evolution and development. Thus, interest for the amphioxus model led to the characterization of both the transcriptome and complete genome sequence of the American species, Branchiostoma floridae. However, recent technical improvements allowing induction of spawning in the laboratory during the breeding season on a daily basis with the Mediterranean species Branchiostoma lanceolatum have encouraged European Evo-Devo researchers to adopt this species as a model even though no genomic or transcriptomic data have been available. To fill this need we used the pyrosequencing method to characterize the B. lanceolatum transcriptome and then compared our results with the published transcriptome of B. floridae. Results: Starting with total RNA from nine different developmental stages of B. lanceolatum, a normalized cDNA library was constructed and sequenced on Roche GS FLX (Titanium mode). Around 1.4 million of reads were produced and assembled into 70,530 contigs (average length of 490 bp). Overall 37% of the assembled sequences were annotated by BlastX and their Gene Ontology terms were determined. These results were then compared to genomic and transcriptomic data of B. floridae to assess similarities and specificities of each species. Conclusion: We obtained a high-quality amphioxus (B. lanceolatum) reference transcriptome using a high throughput sequencing approach. We found that 83% of the predicted genes in the B. floridae complete genome sequence are also found in the B. lanceolatum transcriptome, while only 41% were found in the B. floridae transcriptome obtained with traditional Sanger based sequencing. Therefore, given the high degree of sequence conservation between different amphioxus species, this set of ESTs may now be used as the reference transcriptome for the Branchiostoma genus.	[Oulion, Silvan; Bertrand, Stephanie; Belgacem, Mohamed R.; Le Petillon, Yann; Escriva, Hector] Univ Paris 06, CNRS, UMR7232, Observ Oceanol, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Oulion, S (corresponding author), Univ Paris 06, CNRS, UMR7232, Observ Oceanol, Banyuls Sur Mer, France.	oulion@obs-banyuls.fr; hescriva@obs-banyuls.fr	Escriva, Hector/K-8325-2013; Bertrand, Stephanie/D-8482-2014	Escriva, Hector/0000-0001-7577-5028; Bertrand, Stephanie/0000-0002-0689-0126	Agence Nationale de la Recherche [ANR-2010-BLAN-1716 01, ANR-2010-BLAN-1234 02]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The laboratory of HE is supported by the Agence Nationale de la Recherche Grants ANR-2010-BLAN-1716 01 and ANR-2010-BLAN-1234 02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Canestro C, 2002, J MOL EVOL, V54, P81, DOI 10.1007/s00239-001-0020-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Jin P, 2010, MAR GENOM, V3, P151, DOI 10.1016/j.margen.2010.09.003; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Langlois MC, 2000, DEV GENES EVOL, V210, P471, DOI 10.1007/s004270000087; Nohara M, 2004, ZOOL SCI, V21, P203, DOI 10.2108/zsj.21.203; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Somorjai I, 2008, DEV GENES EVOL, V218, P703, DOI 10.1007/s00427-008-0256-6; Takatori N, 2008, DEV GENES EVOL, V218, P579, DOI 10.1007/s00427-008-0245-9; Yu JK, 2008, DEV GENES EVOL, V218, P723, DOI 10.1007/s00427-008-0228-x; Yu JK, 2008, DEV GENES EVOL, V218, P629, DOI 10.1007/s00427-008-0229-9	26	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36554	10.1371/journal.pone.0036554	http://dx.doi.org/10.1371/journal.pone.0036554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590565	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100038
J	Emmert-Streib, F; Dehmer, M				Emmert-Streib, Frank; Dehmer, Matthias			Exploring Statistical and Population Aspects of Network Complexity	PLOS ONE			English	Article							INFORMATION; GRAPHS; ENTROPY; ORGANIZATION; MECHANICS; DYNAMICS	The characterization and the definition of the complexity of objects is an important but very difficult problem that attracted much interest in many different fields. In this paper we introduce a new measure, called network diversity score (NDS), which allows us to quantify structural properties of networks. We demonstrate numerically that our diversity score is capable of distinguishing ordered, random and complex networks from each other and, hence, allowing us to categorize networks with respect to their structural complexity. We study 16 additional network complexity measures and find that none of these measures has similar good categorization capabilities. In contrast to many other measures suggested so far aiming for a characterization of the structural complexity of networks, our score is different for a variety of reasons. First, our score is multiplicatively composed of four individual scores, each assessing different structural properties of a network. That means our composite score reflects the structural diversity of a network. Second, our score is defined for a population of networks instead of individual networks. We will show that this removes an unwanted ambiguity, inherently present in measures that are based on single networks. In order to apply our measure practically, we provide a statistical estimator for the diversity score, which is based on a finite number of samples.	[Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Emmert-Streib, Frank] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Queens University Belfast; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health	Emmert-Streib, F (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	School of Medicine, Dentistry and Biomedical Sciences of the Queen's University Belfast; Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	School of Medicine, Dentistry and Biomedical Sciences of the Queen's University Belfast; Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Frank Emmert-Streib is supported by the School of Medicine, Dentistry and Biomedical Sciences of the Queen's University Belfast. Matthias Dehmer is supported by the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], PHYSICA A; [Anonymous], 1988, UNIVERSAL TURING MAC; Badii R, 1997, COMPLEXITY HIERARCHI; BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERTZ SH, 1983, B MATH BIOL, V45, P849, DOI 10.1007/BF02460054; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Boginski V, 2005, COMPUT STAT DATA AN, V48, P431, DOI 10.1016/j.csda.2004.02.004; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; Bonchev D, 1987, GRAPH THEORY TOPOLOG, P125; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 1983, INFORM THEORETIC IND; Bonchev D.G., 1995, BULG CHEM COMMUN, V28, P567; Buckley F., 1990, DISTANCE GRAPHS; CECCATTO HA, 1988, PHYS SCRIPTA, V37, P145, DOI 10.1088/0031-8949/37/1/021; CHAITIN GJ, 1966, J ACM, V13, P547, DOI 10.1145/321356.321363; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Constantine G., 1990, LINEAR MULTILINEAR A, V28, P49, DOI DOI 10.1080/03081089008818029; Cormen Thomas H., 2009, INTRO ALGORITHMS; CRUTCHFIELD JP, 1983, PHYSICA D, V7, P201, DOI 10.1016/0167-2789(83)90127-6; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Dancoff SM, 1953, ESSAYS USE INFORM TH, P263; Dehmer M, 2011, QUANTUM FRONTIERS AT, P479; Dehmer M, 2010, PLOS ONE, V5; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Devillers J., 1999, TOPOLOGICAL INDICES; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Diudea MV., 2001, MOL TOPOLOGY; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Emmert-Streib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002053; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012884; Emmert-Streib F, 2010, COMPLEXITY, V16, P24, DOI 10.1002/cplx.20315; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; Emmert-Streib F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.026103; Feller W., 1968, INTRO PROBABILITY TH, V1; Garey M. R., 1979, Computers and intractability. A guide to the theory of NP-completeness; Gell-Mann M., 1996, Complexity, V2, P44, DOI 10.1002/(SICI)1099-0526(199609/10)2:1<44::AID-CPLX10>3.0.CO;2-X; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; GRASSBERGER P, 1989, HELV PHYS ACTA, V62, P489; Gutman I, 2006, LINEAR ALGEBRA APPL, V414, P29, DOI 10.1016/j.laa.2005.09.008; Gutman I, 1991, CHEM GRAPH THEORY IN, P133; Janezic D, 2009, ENCY COMPLEXITY SYST, V5, P9210; Jukna S, 2006, COMB PROBAB COMPUT, V15, P855, DOI 10.1017/S0963548306007620; Kaiser Marcus, 2010, Front Neuroinform, V4, DOI 10.3389/fninf.2010.00112; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lehman E, 1999, THEORY POINT ESTIMAT; LI M, 1997, INTRO KOLMOGOROV COM; Li X., 2006, MATH CHEM MONOGRAPHS; Linshitz H, 1953, ESSAYS USE INFORM TH; LLOYD S, 1988, ANN PHYS-NEW YORK, V188, P186, DOI 10.1016/0003-4916(88)90094-2; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Minoli D., 1975, Atti della Accademia Nazionale dei Lincei. Rendiconti, Classe di Scienze Fisiche, Matematiche e Naturali, V59, P651; Morowitz H, 1953, B MATH BIOPHYS, V17, P81; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Mowshowitz A., 2009, ANAL COMPLEX NETWORK, P1; Mueller LA, 2010, BIOINFORMATICS; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nicolis G., 1989, EXPLORING COMPLEXITY; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Prokopenko M, 2009, COMPLEXITY, V15, P11, DOI 10.1002/cplx.20249; R Core Team, 2021, R LANGUAGE ENV STAT; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Sagan H, 1989, BOUNDARY EIGENVALUE; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schuster H, 2002, COMPLEX ADAPTIVE SYS; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Solomonoff R., 1960, PRELIMINARY REPORT G; Sporns O., 2011, NETWORKS BRAIN; Todeschini R., 2002, HDB MOL DESCRIPTORS; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; van Dongen S, 2000, THESIS U UTRECHT; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; WOLFRAM S, 1983, REV MOD PHYS, V55, P601, DOI 10.1103/RevModPhys.55.601; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Ziv E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046117; Zurek W., 1990, COMPLEXITY ENTROPY P	97	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e34523	10.1371/journal.pone.0034523	http://dx.doi.org/10.1371/journal.pone.0034523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590495	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500002
J	Mazumder, R; Morampudi, KS; Motwani, M; Vasudevan, S; Goldman, R				Mazumder, Raja; Morampudi, Krishna Sudeep; Motwani, Mona; Vasudevan, Sona; Goldman, Radoslav			Proteome-Wide Analysis of Single-Nucleotide Variations in the N-Glycosylation Sequon of Human Genes	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; LINKED GLYCOSYLATION; HYDRAZIDE CHEMISTRY; PROTEINS; DATABASE; MUTATION; ENVIRONMENT; MECHANISMS; INHIBITION; HEALTH	N-linked glycosylation is one of the most frequent post-translational modifications of proteins with a profound impact on their biological function. Besides other functions, N-linked glycosylation assists in protein folding, determines protein orientation at the cell surface, or protects proteins from proteases. The N-linked glycans attach to asparagines in the sequence context Asn-X-Ser/Thr, where X is any amino acid except proline. Any variation (e.g. non-synonymous single nucleotide polymorphism or mutation) that abolishes the N-glycosylation sequence motif will lead to the loss of a glycosylation site. On the other hand, variations causing a substitution that creates a new N-glycosylation sequence motif can result in the gain of glycosylation. Although the general importance of glycosylation is well known and acknowledged, the effect of variation on the actual glycoproteome of an organism is still mostly unknown. In this study, we focus on a comprehensive analysis of non-synonymous single nucleotide variations (nsSNV) that lead to either loss or gain of the N-glycosylation motif. We find that 1091 proteins have modified N-glycosylation sequons due to nsSNVs in the genome. Based on analysis of proteins that have a solved 3D structure at the site of variation, we find that 48% of the variations that lead to changes in glycosylation sites occur at the loop and bend regions of the proteins. Pathway and function enrichment analysis show that a significant number of proteins that gained or lost the glycosylation motif are involved in kinase activity, immune response, and blood coagulation. A structure-function analysis of a blood coagulation protein, antithrombin III and a protease, cathepsin D, showcases how a comprehensive study followed by structural analysis can help better understand the functional impact of the nsSNVs.	[Mazumder, Raja; Motwani, Mona] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Morampudi, Krishna Sudeep; Goldman, Radoslav] Georgetown Univ, Dept Oncol, Washington, DC USA; [Morampudi, Krishna Sudeep; Vasudevan, Sona; Goldman, Radoslav] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	George Washington University; Georgetown University; Georgetown University	Mazumder, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	mazumder@gwu.edu	Motwani, Mona/AAV-8162-2020	Motwani, Mona/0000-0003-0912-5478; Mazumder, Raja/0000-0001-8823-9945	National Cancer Institute (NCI) [RO1 CA115625, CA135069]; Department of Defense PCRP [PC081609]; National Center for Research Resources (NCRR) [UL1RR031975]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [R01CA135069, R01CA115625] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense PCRP(United States Department of Defense); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by National Cancer Institute (NCI) RO1 CA115625 and CA135069 and Department of Defense PCRP grant PC081609 awarded to RG. The project has been funded in part with Federal funds (Grant # UL1RR031975) from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through the Clinical and Translational Science Awards Program (CTSA), a trademark of the Department of Health and Human Services (DHHS), part of the Roadmap Initiative, "Re-Engineering the Clinical Research Enterprise." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Alavi A, 2008, RHEUMATOLOGY, V47, P760, DOI 10.1093/rheumatology/ken081; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Avanov A Ia, 1991, Mol Biol (Mosk), V25, P293; Bagriacik EU, 1996, GLYCOBIOLOGY, V6, P413, DOI 10.1093/glycob/6.4.413; Bayston TA, 1999, BLOOD, V93, P4242, DOI 10.1182/blood.V93.12.4242.412k02_4242_4247; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Bunkenborg J, 2004, PROTEOMICS, V4, P454, DOI 10.1002/pmic.200300556; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Costantino L, 2009, BREAST CANCER RES TR, V114, P449, DOI 10.1007/s10549-008-0031-4; Cui Y, 2005, CANCER EPIDEM BIOMAR, V14, P1096, DOI 10.1158/1055-9965.EPI-04-0721; Dall' olio F, 1996, CLIN MOL PATHOL, V49, P126; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dutta S, 2010, J APPL CRYSTALLOGR, V43, P1224, DOI 10.1107/S002188981002371X; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Firth SM, 2011, MOL ENDOCRINOL, V25, P307, DOI 10.1210/me.2010-0295; FORTENBERRY SC, 1995, J CELL SCI, V108, P2001; Freeze HH, 2001, BIOCHIMIE, V83, P791, DOI 10.1016/S0300-9084(01)01292-5; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hino M, 2003, ZOOL SCI, V20, P709, DOI 10.2108/zsj.20.709; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; IMBERTY A, 1995, PROTEIN ENG, V8, P699, DOI 10.1093/protein/8.7.699; Kimber SJ, 2000, SEMIN REPROD MED, V18, P237, DOI 10.1055/s-2000-12562; Klein A, 2008, ADV CLIN CHEM, V46, P51, DOI 10.1016/S0065-2423(08)00402-2; Kobata A, 2000, GLYCOCONJUGATE J, V17, P443, DOI 10.1023/A:1011006122704; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; Li S, 2009, PAC S BIOC, P337; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Masson O, 2010, BIOCHIMIE, V92, P1635, DOI 10.1016/j.biochi.2010.05.009; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKAMOTO N, 1993, J INHERIT METAB DIS, V16, P435, DOI 10.1007/BF00710294; Park C, 2011, MOL BIOL EVOL, V28, P2351, DOI 10.1093/molbev/msr055; Peracaula R, 2008, DIS MARKERS, V25, P207, DOI 10.1155/2008/797629; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; Raineri M, 2002, MOL CELL ENDOCRINOL, V189, P135, DOI 10.1016/S0303-7207(01)00725-0; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TYLERCROSS R, 1994, PROTEIN SCI, V3, P620; Vandenborre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016682; Varki A, 2009, GLYCOSYLATION CHANGE; Vogt G, 2005, NAT GENET, V37, P692, DOI 10.1038/ng1581; Vogt G, 2007, CURR OPIN GENET DEV, V17, P245, DOI 10.1016/j.gde.2007.04.008; Waite A, 2011, HUM MUTAT, V32, P1246, DOI 10.1002/humu.21561; Wheatley M, 1999, HUM REPROD UPDATE, V5, P356, DOI 10.1093/humupd/5.4.356; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	66	28	30	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36212	10.1371/journal.pone.0036212	http://dx.doi.org/10.1371/journal.pone.0036212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586465	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000027
J	Simonetta, F; Gestermann, N; Martinet, KZ; Boniotto, M; Tissieres, P; Seddon, B; Bourgeois, C				Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Seddon, Benedict; Bourgeois, Christine			Interleukin-7 Influences FOXP3(+)CD4(+) Regulatory T Cells Peripheral Homeostasis	PLOS ONE			English	Article							IN-VIVO; AUTOIMMUNE-DISEASE; CD127 EXPRESSION; FOXP3 EXPRESSION; DENDRITIC CELLS; IL-7 PROMOTES; CUTTING EDGE; MEMORY CELLS; CD4(+)CD25(+); EXPANSION	Mechanisms governing peripheral CD4+ FOXP3+ regulatory T cells (Treg) survival and homeostasis are multiple suggesting tight and complex regulation of regulatory T cells homeostasis. Some specific factors, such as TGF-beta, interleukin-2 (IL-2) and B7 costimulatory molecules have been identified as essentials for maintenance of the peripheral Treg compartment. Conversely, Treg dependency upon classical T cell homeostatic factors such as IL-7 is still unclear. In this work, we formally investigated the role of IL-7 in Treg homeostasis in vivo in murine models. We demonstrated that IL-7 availability regulated the size of peripheral Treg cell pool and thus paralleled the impact of IL-7 on conventional T cell pool. Moreover, we showed that IL-7 administration increased Treg cell numbers by inducing thymic-independent Treg peripheral expansion. Importantly the impact of IL-7 on Treg expansion was detected whether conventional T cells were present or absent as IL-7 directly participates to the peripheral expansion of Treg after adoptive transfer into lymphopenic hosts. Our results definitively identify IL-7 as a central factor contributing to Treg peripheral homeostasis, thus reassembling Treg to other T cell subsets in respect of their need for IL-7 for their peripheral maintenance.	[Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Bourgeois, Christine] INSERM, F-94275 Le Kremlin Bicetre, France; [Simonetta, Federico; Gestermann, Nicolas; Martinet, Kim Zita; Boniotto, Michele; Tissieres, Pierre; Bourgeois, Christine] Univ Paris, Le Kremlin Bicetre, France; [Seddon, Benedict] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; MRC National Institute for Medical Research	Simonetta, F (corresponding author), INSERM, F-94275 Le Kremlin Bicetre, France.	christine.bourgeois@u-psud.fr	Boniotto, Michele/AAB-4302-2020; Boniotto, Michele/F-1857-2010; Bourgeois, Christine/L-5944-2018; Bourgeois, Christine/ABA-1432-2021; Simonetta, Federico/CAH-2436-2022	Boniotto, Michele/0000-0002-9548-2254; Boniotto, Michele/0000-0002-9548-2254; Bourgeois, Christine/0000-0003-1146-6087; Bourgeois, Christine/0000-0003-1146-6087; Seddon, Benedict/0000-0003-4352-3373; Simonetta, Federico/0000-0002-0399-689X	ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales); Fondation de France; FRM (Fondation pour la recherche medicale); MRC [MC_U117573801] Funding Source: UKRI; Medical Research Council [MC_U117573801] Funding Source: researchfish	ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales)(ANRSFrench National Research Agency (ANR)); Fondation de France(Fondation de France); FRM (Fondation pour la recherche medicale)(Fondation pour la Recherche Medicale); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the ANRS (Agence Nationale de la recherche contre le SIDA et les hepatites virales) and Fondation de France. Federico Simonetta was also supported by the FRM (Fondation pour la recherche medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2006, J IMMUNOL, V177, P192, DOI 10.4049/jimmunol.177.1.192; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2008, J IMMUNOL, V181, P225, DOI 10.4049/jimmunol.181.1.225; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boyman O, 2008, J IMMUNOL, V180, P7265, DOI 10.4049/jimmunol.180.11.7265; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; de Latour RP, 2006, BLOOD, V108, P2300, DOI 10.1182/blood-2006-04-017947; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Grinberg-Bleyer Y, 2010, J CLIN INVEST, V120, P4558, DOI 10.1172/JCI42945; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mazzucchelli R, 2008, BLOOD, V112, P3283, DOI 10.1182/blood-2008-02-137414; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Simonetta F, 2010, EUR J IMMUNOL, V40, P2528, DOI 10.1002/eji.201040531; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wuest TY, 2008, J LEUKOCYTE BIOL, V84, P973, DOI 10.1189/jlb.1107778; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	48	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36596	10.1371/journal.pone.0036596	http://dx.doi.org/10.1371/journal.pone.0036596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586481	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000042
J	Anand, K; Maeda, K; Gavin, AC				Anand, Kanchan; Maeda, Kenji; Gavin, Anne-Claude			Structural Analyses of the Slm1-PH Domain Demonstrate Ligand Binding in the Non-Canonical Site	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; PH DOMAIN; PHOSPHOINOSITIDE BINDING; SACCHAROMYCES-CEREVISIAE; MOLECULAR REPLACEMENT; ACTIN CYTOSKELETON; PROTEINS SLM1; KINASE; SPECIFICITY; YEAST	Background: Pleckstrin homology (PH) domains are common membrane-targeting modules and their best characterized ligands are a set of important signaling lipids that include phosphatidylinositol phosphates (PtdInsPs). PH domains recognize PtdInsPs through two distinct mechanisms that use different binding pockets on opposite sides of the beta-strands 1 and 2: i) a canonical binding site delimited by the beta 1-beta 2 and beta 3-beta 4loops and ii) a non-canonical binding site bordered by the beta 1-beta 2 and beta b5-beta 6loops. The PH domain-containing protein Slm1 from budding yeast Saccharomyces cerevisiae is required for actin cytoskeleton polarization and cell growth. We recently reported that this PH domain binds PtdInsPs and phosphorylated sphingolipids in a cooperative manner. Principal Findings: To study the structural basis for the Slm1-PH domain (Slm1-PH) specificity, we co-crystallized this domain with different soluble compounds that have structures analogous to anionic lipid head groups of reported Slm1 ligands: inositol 4-phosphate, which mimics phosphatidylinositol-4-phosphate (PtdIns(4)P), and phosphoserine as a surrogate for dihydrosphingosine 1-phosphate (DHS1-P). We found electron densities for the ligands within the so-called non-canonical binding site. An additional positively charged surface that contacts a phosphate group was identified next to the canonical binding site. Conclusions: Our results suggest that Slm1-PH utilizes a non-canonical binding site to bind PtdInsPs, similar to that described for the PH domains of beta-spectrin, Tiam1 and ArhGAP9. Additionally, Slm1-PH may have retained an active canonical site. We propose that the presence of both a canonical and a non-canonical binding pocket in Slm1-PH may account for the cooperative binding to PtdInsPs and DHS-1P.	[Anand, Kanchan; Maeda, Kenji; Gavin, Anne-Claude] European Mol Biol Lab Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany; [Anand, Kanchan] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Anand, K (corresponding author), European Mol Biol Lab Heidelberg, Struct & Computat Biol Unit, Heidelberg, Germany.	anand@embl.de; gavin@embl.de		Gavin, Anne-Claude/0000-0003-4917-2340; Maeda, Kenji/0000-0002-9080-5691	Federal Ministry of Education and Research (BMBF) [FKZ0315162]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was partially funded by the Federal Ministry of Education and Research (BMBF; FKZ0315162) in the framework of the BioChancePLUS-4 to ACG. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Edlich C, 2005, STRUCTURE, V13, P277, DOI 10.1016/j.str.2004.11.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FERGUSON KM, 1995, NAT STRUCT BIOL, V2, P715, DOI 10.1038/nsb0995-715; Gallego O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.87; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; Hiestand Peter C., 2008, V66; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Koshiba S, 1997, J MOL BIOL, V269, P579, DOI 10.1006/jmbi.1997.1041; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Parker PJ, 1999, PHARMACOL THERAPEUT, V82, P263, DOI 10.1016/S0163-7258(98)00047-3; PARKER PJ, 1994, TRENDS BIOCHEM SCI, V19, P54, DOI 10.1016/0968-0004(94)90031-0; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; ROSSMANN MG, 1990, ACTA CRYSTALLOGR A, V46, P73, DOI 10.1107/S0108767389009815; SARASTE M, 1995, CURR OPIN STRUC BIOL, V5, P403, DOI 10.1016/0959-440X(95)80104-9; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	39	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36526	10.1371/journal.pone.0036526	http://dx.doi.org/10.1371/journal.pone.0036526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574179	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800076
J	Jiang, JF; Lu, JY; Lu, D; Liang, ZJ; Li, LC; Ouyang, SS; Kong, XQ; Jiang, HL; Shen, BR; Luo, C				Jiang, Junfeng; Lu, Junyan; Lu, Dan; Liang, Zhongjie; Li, Lianchun; Ouyang, Sisheng; Kong, Xiangqian; Jiang, Hualiang; Shen, Bairong; Luo, Cheng			Investigation of the Acetylation Mechanism by GCN5 Histone Acetyltransferase	PLOS ONE			English	Article							CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; COENZYME-A; PROTON-WIRE; TRANSCRIPTIONAL COACTIVATOR; N-ACETYLTRANSFERASES; POSITIVE REGULATION; MOLECULAR-DYNAMICS; KINETIC MECHANISM; GENE-EXPRESSION	The histone acetylation of post-translational modification can be highly dynamic and play a crucial role in regulating cellular proliferation, survival, differentiation and motility. Of the enzymes that mediate post-translation modifications, the GCN5 of the histone acetyltransferase (HAT) proteins family that add acetyl groups to target lysine residues within histones, has been most extensively studied. According to the mechanism studies of GCN5 related proteins, two key processes, deprotonation and acetylation, must be involved. However, as a fundamental issue, the structure of hGCN5/AcCoA/pH3 remains elusive. Although biological experiments have proved that GCN5 mediates the acetylation process through the sequential mechanism pathway, a dynamic view of the catalytic process and the molecular basis for hGCN5/AcCoA/pH3 are still not available and none of theoretical studies has been reported to other related enzymes in HAT family. To explore the molecular basis for the catalytic mechanism, computational approaches including molecular modeling, molecular dynamic (MD) simulation and quantum mechanics/molecular mechanics (QM/MM) simulation were carried out. The initial hGCN5/AcCoA/pH3 complex structure was modeled and a reasonable snapshot was extracted from the trajectory of a 20 ns MD simulation, with considering post-MD analysis and reported experimental results. Those residues playing crucial roles in binding affinity and acetylation reaction were comprehensively investigated. It demonstrated Glu80 acted as the general base for deprotonation of Lys171 from H3. Furthermore, the two-dimensional QM/MM potential energy surface was employed to study the sequential pathway acetylation mechanism. Energy barriers of addition-elimination reaction in acetylation obtained from QM/MM calculation indicated the point of the intermediate ternary complex. Our study may provide insights into the detailed mechanism for acetylation reaction of GCN5, and has important implications for the discovery of regulators against GCN5 enzymes and related HAT family enzymes.	[Jiang, Junfeng; Lu, Dan; Liang, Zhongjie; Li, Lianchun; Ouyang, Sisheng; Kong, Xiangqian; Shen, Bairong; Luo, Cheng] Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China; [Jiang, Junfeng; Lu, Junyan; Jiang, Hualiang; Luo, Cheng] Chinese Acad Med Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai, Peoples R China	Soochow University - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Jiang, JF (corresponding author), Soochow Univ, Ctr Syst Biol, Suzhou, Jiangsu, Peoples R China.	bairong.shen@suda.edu.cn; cluo@mail.shcnc.ac.cn	Liang, Zhongjie/F-2108-2019; Shen, Bairong/E-6431-2012; Shen, Bairong/W-1254-2019; Kong, Xiangqian/J-4500-2017	Liang, Zhongjie/0000-0003-0763-5407; Shen, Bairong/0000-0003-2899-1531; Shen, Bairong/0000-0003-2899-1531; Kong, Xiangqian/0000-0002-9596-7825; Lu, Junyan/0000-0002-9211-0746	State Key Program of Basic Research of China [2009CB918502]; National Natural Science Foundation of China [20972174, 21021063, 20872107, 91029703, 91029704]; Shanghai Committee of Science and Technology [10410703900]; Chinese Academy of Sciences [XDA01040305]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Chinese Academy of Sciences(Chinese Academy of Sciences)	The authors gratefully acknowledge financial support from the State Key Program of Basic Research of China grant (2009CB918502), the National Natural Science Foundation of China grants (20972174, 21021063, 20872107, 91029703 and 91029704), Shanghai Committee of Science and Technology grants (10410703900) and the Chinese Academy of Sciences (XDA01040305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2007, J PHYS CHEM B, V111, P7870, DOI 10.1021/jp071403p; Akiyama T, 2004, MOL REPROD DEV, V69, P222, DOI 10.1002/mrd.20121; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; BRADBURY EM, 1992, BIOESSAYS, V14, P9; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Gao J, 1996, REV COMPUTATIONAL CH, P119; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; HONG L, 1993, J BIOL CHEM, V268, P305; Hu H, 2008, ANNU REV PHYS CHEM, V59, P573, DOI 10.1146/annurev.physchem.59.032607.093618; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jeppesen P, 1997, BIOESSAYS, V19, P67, DOI 10.1002/bies.950190111; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kikuchi H, 2011, J IMMUNOL, V186, P3015, DOI 10.4049/jimmunol.1000364; Kong XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025444; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; LEWENDON A, 1994, BIOCHEMISTRY-US, V33, P1944, DOI 10.1021/bi00173a043; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Lu YX, 2009, J PHYS CHEM B, V113, P12615, DOI 10.1021/jp906352e; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; MEYER E, 1992, PROTEIN SCI, V1, P1543, DOI 10.1002/pro.5560011203; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Riccardi D, 2006, J PHYS CHEM B, V110, P6458, DOI 10.1021/jp056361o; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sarmento OF, 2004, J CELL SCI, V117, P4449, DOI 10.1242/jcs.01328; Schuetz A, 2007, PROTEINS, V68, P403, DOI 10.1002/prot.21407; Senn HM, 2009, ANGEW CHEM INT EDIT, V48, P1198, DOI 10.1002/anie.200802019; Sternglanz R, 1999, P NATL ACAD SCI USA, V96, P8807, DOI 10.1073/pnas.96.16.8807; Svensson M, 1996, J PHYS CHEM-US, V100, P19357, DOI 10.1021/jp962071j; Tanner KG, 2000, J BIOL CHEM, V275, P22048, DOI 10.1074/jbc.M002893200; Tanner KG, 2000, BIOCHEMISTRY-US, V39, P15652, DOI 10.1021/bi005121q; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; Vendrell O, 2008, J PHYS CHEM B, V112, P5500, DOI 10.1021/jp801169z; Verdone L, 2005, BIOCHEM CELL BIOL, V83, P344, DOI 10.1139/o05-041; Warshel A, 2003, ANNU REV BIOPH BIOM, V32, P425, DOI 10.1146/annurev.biophys.32.110601.141807; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Wu RB, 2010, J AM CHEM SOC, V132, P9471, DOI 10.1021/ja103932d; Zhang XD, 2007, BIOCHEMISTRY-US, V46, P5505, DOI 10.1021/bi700119p; Zhang YK, 2006, THEOR CHEM ACC, V116, P43, DOI 10.1007/s00214-005-0008-x; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	65	20	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36660	10.1371/journal.pone.0036660	http://dx.doi.org/10.1371/journal.pone.0036660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574209	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800106
J	Nicolas, V; Schaeffer, B; Missoup, AD; Kennis, J; Colyn, M; Denys, C; Tatard, C; Cruaud, C; Laredo, C				Nicolas, Violaine; Schaeffer, Brigitte; Missoup, Alain Didier; Kennis, Jan; Colyn, Marc; Denys, Christiane; Tatard, Caroline; Cruaud, Corinne; Laredo, Catherine			Assessment of Three Mitochondrial Genes (16S, Cytb, CO1) for Identifying Species in the Praomyini Tribe (Rodentia: Muridae)	PLOS ONE			English	Article							SMALL MAMMALS; LASSA FEVER; MORPHOMETRIC VARIATION; RAIN-FOREST; DNA; PHYLOGENY; PHYLOGEOGRAPHY; DIVERSITY; COMMUNITY; TAXONOMY	The Praomyini tribe is one of the most diverse and abundant groups of Old World rodents. Several species are known to be involved in crop damage and in the epidemiology of several human and cattle diseases. Due to the existence of sibling species their identification is often problematic. Thus an easy, fast and accurate species identification tool is needed for non-systematicians to correctly identify Praomyini species. In this study we compare the usefulness of three genes (16S, Cytb, CO1) for identifying species of this tribe. A total of 426 specimens representing 40 species (sampled across their geographical range) were sequenced for the three genes. Nearly all of the species included in our study are monophyletic in the neighbour joining trees. The degree of intra-specific variability tends to be lower than the divergence between species, but no barcoding gap is detected. The success rate of the statistical methods of species identification is excellent (up to 99% or 100% for statistical supervised classification methods as the k-Nearest Neighbour or Random Forest). The 16S gene is 2.5 less variable than the Cytb and CO1 genes. As a result its discriminatory power is smaller. To sum up, our results suggest that using DNA markers for identifying species in the Praomyini tribe is a largely valid approach, and that the CO1 and Cytb genes are better DNA markers than the 16S gene. Our results confirm the usefulness of statistical methods such as the Random Forest and the 1-NN methods to assign a sequence to a species, even when the number of species is relatively large. Based on our NJ trees and the distribution of all intraspecific and interspecific pairwise nucleotide distances, we highlight the presence of several potentially new species within the Praomyini tribe that should be subject to corroboration assessments.	[Nicolas, Violaine; Missoup, Alain Didier; Denys, Christiane] Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, F-75231 Paris, France; [Schaeffer, Brigitte; Laredo, Catherine] INRA, Math & Informat Appl UR341, Jouy En Josas, France; [Missoup, Alain Didier] Univ Douala, Fac Sci, Dept Anim Biol Organisms, Douala, Cameroon; [Kennis, Jan] Univ Antwerp, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Colyn, Marc] Univ Rennes 1, UMR CNRS Ecobio 6553, Paimpont, France; [Tatard, Caroline] IRD, Ctr Biol & Gest Populat, UMR 022, Montferrier Sur Lez, France; [Cruaud, Corinne] Ctr Natl Sequencage, Evry, France; [Laredo, Catherine] Univ Paris 07, LPMA UMR 7599, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Antwerp; Universite de Rennes; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite	Nicolas, V (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7205, Dept Systemat & Evolut, F-75231 Paris, France.	vnicolas@mnhn.fr	Nicolas, Violaine/N-9991-2017; Denys, Christiane/K-8144-2019; Kennis, Jan/D-4064-2018; Kennis, Jan/AAD-2244-2019	Nicolas, Violaine/0000-0001-5384-7529; Denys, Christiane/0000-0002-1519-1546; Kennis, Jan/0000-0002-6431-1372; Kennis, Jan/0000-0002-6431-1372; Cruaud, Corinne/0000-0002-4752-7278	Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections; 'Consortium National de Recheche en Genomique' (Evry, France); 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France); Genoscope [2005/67]; Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life' [2005/67]	Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections; 'Consortium National de Recheche en Genomique' (Evry, France); 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France); Genoscope; Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life'	This research was supported by the "Action Transversale du Museum: Taxonomie moleculaire, DNA Barcode & gestion durable des collections", the 'Consortium National de Recheche en Genomique' (Evry, France), and the 'Service de Systematique Moleculaire' of the Museum National d'Histoire Naturelle (UMS 2700, Paris, France). It is part of the agreement no. 2005/67 between the Genoscope and the Museum National d'Histoire Naturelle on the project 'Macrophylogeny of life' directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Barriere P, 2008, RAPID BIOL ASSESSMEN, P54; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brouat C, 2009, J BIOGEOGR, V36, P2237, DOI 10.1111/j.1365-2699.2009.02184.x; Bryja J, 2010, MOL ECOL, V19, P4783, DOI 10.1111/j.1365-294X.2010.04847.x; Caro TM, 2001, BIOL CONSERV, V98, P251, DOI 10.1016/S0006-3207(00)00105-1; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Clarke B, 2009, PRINICIPLES THEORY D; Colangelo P, 2007, MOL PHYLOGENET EVOL, V42, P797, DOI 10.1016/j.ympev.2006.10.001; Coulibaly-N'Golo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020893; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; de Queiroz K, 1998, ENDLESS FORMS, P57; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Dobigny G, 2008, J ZOOL, V276, P368, DOI 10.1111/j.1469-7998.2008.00500.x; Ducroz J. F., 2001, Journal of Mammalian Evolution, V8, P173, DOI 10.1023/A:1012277012303; DUPLANTIER JM, 1989, REV ECOL-TERRE VIE, V44, P329; Durnez L, 2008, APPL ENVIRON MICROB, V74, P768, DOI 10.1128/AEM.01193-07; Durnez L, 2010, APPL ENVIRON MICROB, V76, P4574, DOI 10.1128/AEM.00199-10; Fadda C, 2001, BIOCHEM SYST ECOL, V29, P585, DOI 10.1016/S0305-1978(00)00087-9; Fichet-Calvet E, 2005, BELG J ZOOL, V135, P63; Fichet-Calvet E, 2009, BELG J ZOOL, V139, P93; Fix E., 1951, DISCRIMINATORY ANAL; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Goldstein PZ, BIOESSAYS IN PRESS; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kennis J, ZOOL J LINN IN PRESS; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lecompte E, 2005, BIOCHEM SYST ECOL, V33, P681, DOI 10.1016/j.bse.2004.12.015; Lecompte E, 2002, CR BIOL, V325, P827, DOI 10.1016/S1631-0691(02)01488-9; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lecompte F, 2005, MOL PHYLOGENET EVOL, V37, P899, DOI 10.1016/j.ympev.2005.06.018; Makundi RH, 2008, MAMMALIA, V72, P253, DOI 10.1515/MAMM.2008.038; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monadjem A, 2005, RAPID SURVEY BATS N, P20; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Mouline K, 2008, MOL ECOL, V17, P1036, DOI 10.1111/j.1365-294X.2007.03610.x; MUSSER GG, 2005, MAMMAL SPECIES WORLD, V2, P894; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Nicolas V, 2008, MOL ECOL, V17, P5118, DOI 10.1111/j.1365-294X.2008.03974.x; Nicolas V, 2006, MOL PHYLOGENET EVOL, V38, P779, DOI 10.1016/j.ympev.2005.11.024; Nicolas V, 2005, ZOOL J LINN SOC-LOND, V145, P539, DOI 10.1111/j.1096-3642.2005.00196.x; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Nicolas V, 2003, CAN J ZOOL, V81, P1034, DOI 10.1139/Z03-092; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nicolas V, 2008, J MAMMAL, V89, P222, DOI 10.1644/06-MAMM-A-286.1; Nicolas V, 2010, ZOOTAXA, P30, DOI 10.11646/zootaxa.2579.1.2; Nicolas V, 2010, ZOOL J LINN SOC-LOND, V160, P397, DOI 10.1111/j.1096-3642.2009.00602.x; Nicolas V, 2009, BIOL J LINN SOC, V98, P29, DOI 10.1111/j.1095-8312.2009.01273.x; O'Brien C, 2006, B BIOL SOC, V12, P137; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Ogbu O., 2007, Journal of Vector Borne Diseases, V44, P1; Olayemi A, 2008, BIODIVERS CONSERV, V17, P2411, DOI 10.1007/s10531-008-9389-1; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Pages M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-184; Palumbi S.R, 1991, SIMPLE FOOLS GUIDE P; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Querouil S, 2001, MOL PHYLOGENET EVOL, V20, P185, DOI 10.1006/mpev.2001.0974; Robins JH, 2007, MOL ECOL NOTES, V7, P717, DOI 10.1111/j.1471-8286.2007.01752.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sluydts V, 2009, CROP PROT, V28, P647, DOI 10.1016/j.cropro.2009.03.018; Stenseth NC, 2001, J APPL ECOL, V38, P1020, DOI 10.1046/j.1365-2664.2001.00656.x; Swofford D, 2000, APUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; van der Straeten E., 1990, P73; van der Straeten E, 1999, S AFR J ZOOL, V34, P80; Van der Straeten E, 1987, STUTTGARTER BEITRAGE, V402, P1; Van der Straeten E, 2003, BONNER ZOOLOGISCHE B, V50, P329; Van der Straeten Erik, 2008, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V1, P123; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407	88	73	89	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36586	10.1371/journal.pone.0036586	http://dx.doi.org/10.1371/journal.pone.0036586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574186	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800083
J	Qin, XY; Kojima, Y; Mizuno, K; Ueoka, K; Muroya, K; Miyado, M; Zaha, H; Akanuma, H; Zeng, Q; Fukuda, T; Yoshinaga, J; Yonemoto, J; Kohri, K; Hayashi, Y; Fukami, M; Ogata, T; Sone, H				Qin, Xian-Yang; Kojima, Yoshiyuki; Mizuno, Kentaro; Ueoka, Katsuhiko; Muroya, Koji; Miyado, Mami; Zaha, Hiroko; Akanuma, Hiromi; Zeng, Qin; Fukuda, Tomokazu; Yoshinaga, Jun; Yonemoto, Junzo; Kohri, Kenjiro; Hayashi, Yutaro; Fukami, Maki; Ogata, Tsutomu; Sone, Hideko			Identification of Novel Low-Dose Bisphenol A Targets in Human Foreskin Fibroblast Cells Derived from Hypospadias Patients	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; MATRIX-METALLOPROTEINASE STROMELYSIN-3; MESSENGER-RNA EXPRESSION; HUMAN EXPOSURE; CANCER CELLS; IN-VITRO; ABNORMALITIES; GENE; CRYPTORCHIDISM; MECHANISMS	Background/Purpose: The effect of low-dose bisphenol A (BPA) exposure on human reproductive health is still controversial. To better understand the molecular basis of the effect of BPA on human reproductive health, a genome-wide screen was performed using human foreskin fibroblast cells (hFFCs) derived from child hypospadias (HS) patients to identify novel targets of low-dose BPA exposure. Methodology/Principal Findings: Gene expression profiles of hFFCs were measured after exposure to 10 nM BPA, 0.01 nM 17 beta-estradiol (E2) or 1 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) for 24 h. Differentially expressed genes were identified using an unpaired Student's t test with P value cut off at 0.05 and fold change of more than 1.2. These genes were selected for network generation and pathway analysis using Ingenuity Pathways Analysis, Pathway Express and KegArray. Seventy-one genes (42 downregulated and 29 upregulated) were identified as significantly differentially expressed in response to BPA, among which 43 genes were found to be affected exclusively by BPA compared with E2 and TCDD. Of particular interest, real-time PCR analysis revealed that the expression of matrix metallopeptidase 11 (MMP11), a well-known effector of development and normal physiology, was found to be inhibited by BPA (0.47-fold and 0.37-fold at 10 nM and 100 nM, respectively). Furthermore, study of hFFCs derived from HS and cryptorchidism (CO) patients (n = 23 and 11, respectively) indicated that MMP11 expression was significantly lower in the HS group than in the CO group (0.25-fold, P = 0.0027). Conclusions/Significance: This present study suggests that an involvement of BPA in the etiology of HS might be associated with the downregulation of MMP11. Further study to elucidate the function of the novel target genes identified in this study during genital tubercle development might increase our knowledge of the effects of low-dose BPA exposure on human reproductive health.	[Qin, Xian-Yang; Zaha, Hiroko; Akanuma, Hiromi; Zeng, Qin; Yonemoto, Junzo; Sone, Hideko] Natl Inst Environm Studies, Hlth Risk Res Sect, Res Ctr Environm Risk, Tsukuba, Ibaraki, Japan; [Qin, Xian-Yang; Yoshinaga, Jun] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Studies, Kashiwa, Chiba, Japan; [Kojima, Yoshiyuki; Mizuno, Kentaro; Kohri, Kenjiro; Hayashi, Yutaro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephro Urol, Nagoya, Aichi, Japan; [Ueoka, Katsuhiko] Natl Res Ctr Child Hlth & Dev, Dept Surg Subspecialties, Tokyo, Japan; [Muroya, Koji] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Miyado, Mami; Fukami, Maki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Prod Sci, Sendai, Miyagi 980, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Univ Hosp, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Nagoya City University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tohoku University; Hamamatsu University School of Medicine	Qin, XY (corresponding author), Natl Inst Environm Studies, Hlth Risk Res Sect, Res Ctr Environm Risk, Tsukuba, Ibaraki, Japan.	hsone@nies.go.jp	Muroya, Koji/J-1304-2016; Qin, Xian-Yang/AAB-5628-2020; Fukami, Maki/ABE-4694-2020; Mizuno, Kentaro/H-8950-2019; Fukuda, Tomokazu/O-1257-2018	Muroya, Koji/0000-0002-1810-9894; Fukami, Maki/0000-0001-9971-4035; Mizuno, Kentaro/0000-0002-9624-2009; Ogata, Tsutomu/0000-0001-7178-9991; Fukuda, Tomokazu/0000-0001-8456-0483	Ministry of the Environment, Japan; Ministry of Health, Labour and Welfare, Japan [H20-004]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Ministry of the Environment, Japan(Ministry of the Environment, Japan); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of the Environment, Japan, and by a grant for Research on Risk on Chemical Substances (H20-004) from the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/english/index.html). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 2010, P NATL ACAD SCI USA, V107, P20405, DOI 10.1073/pnas.1010386107; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Bronner IF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006826; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Desmedt C, 2012, CLIN CANCER RES, V18, P1004, DOI 10.1158/1078-0432.CCR-11-0383; Garavelli L, 2005, HORM RES, V63, P187, DOI 10.1159/000085894; Gibert Y, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-4; Harada Y, 2010, CANCER RES, V70, P5829, DOI 10.1158/0008-5472.CAN-10-0255; Ishizuya-Oka A, 2000, J CELL BIOL, V150, P1177, DOI 10.1083/jcb.150.5.1177; Jasarevic E, 2011, P NATL ACAD SCI USA, V108, P11715, DOI 10.1073/pnas.1107958108; Jorgensen N, 2010, INT J ANDROL, V33, P298, DOI 10.1111/j.1365-2605.2009.01050.x; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Kojima Y, 2010, J PEDIATR UROL, V6, P346, DOI 10.1016/j.jpurol.2009.11.007; Kojima Y, 2009, UROLOGY, V74, P571, DOI 10.1016/j.urology.2009.04.037; KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Lupo A, 2011, INT J BIOCHEM CELL B, V43, P470, DOI 10.1016/j.biocel.2010.12.020; McCord LA, 2011, BIOL REPROD; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Qiao LA, 2011, J UROLOGY, V185, P1888, DOI 10.1016/j.juro.2010.12.066; Qin XY, 2011, TOXICOL LETT, V206, P152, DOI 10.1016/j.toxlet.2011.07.007; Qin XY, 2012, CANC BIOL THER, P13; Rey RA, 2005, J CLIN ENDOCR METAB, V90, P6035, DOI 10.1210/jc.2005-1306; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sharpe RM, 2010, TOXICOL SCI, V114, P1, DOI 10.1093/toxsci/kfp299; Simian M, 2001, DEVELOPMENT, V128, P3117; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Valdivia A, 2011, INT J CLIN EXP PATHO, V4, P674; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang Z, 2007, J UROLOGY, V177, P1939, DOI 10.1016/j.juro.2007.01.014; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wei L, 2005, HISTOL HISTOPATHOL, V20, P177, DOI 10.14670/HH-20.177; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Zhang XW, 2011, TOXICOL SCI, V121, P320, DOI 10.1093/toxsci/kfr061	44	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36711	10.1371/journal.pone.0036711	http://dx.doi.org/10.1371/journal.pone.0036711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574217	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800114
J	Kisu, I; Banno, K; Mihara, M; Lin, LY; Tsuji, K; Yanokura, M; Hara, H; Araki, J; Iida, T; Abe, T; Kouyama, K; Suganuma, N; Aoki, D				Kisu, Iori; Banno, Kouji; Mihara, Makoto; Lin, Li-Yu; Tsuji, Kosuke; Yanokura, Megumi; Hara, Hisako; Araki, Jun; Iida, Takuya; Abe, Takayuki; Kouyama, Keisuke; Suganuma, Nobuhiko; Aoki, Daisuke			Indocyanine Green Fluorescence Imaging for Evaluation of Uterine Blood Flow in Cynomolgus Macaque	PLOS ONE			English	Article							UTERUS TRANSPLANTATION; RADICAL TRACHELECTOMY; OVARIAN ARTERY; PREGNANCY; FERTILITY; AUTOTRANSPLANTATION; CARCINOMA; SURGERY; SYSTEM; CANCER	Background: Uterine blood flow is an important factor in uterine viability, but the number of blood vessels required to maintain viability is uncertain. In this study, indocyanine green (ICG) fluorescence imaging was used to examine uterine hemodynamics and vessels associated with uterine blood flow in cynomolgus macaque. Methods: The uterus of a female cynomolgus macaque was cut from the vaginal canal to mimic a situation during trachelectomy or uterine transplantation surgery in which uterine perfusion is maintained only with uterine and ovarian vessels. Intraoperative uterine hemodynamics was observed using ICG fluorescence imaging under conditions in which various nutrient vessels were selected by clamping of blood vessels. A time-intensity curve was plotted using imaging analysis software to measure the T-max of uterine perfusion for selected blood vessel patterns. Open surgery was performed with the uterus receiving nutritional support only from uterine vessels on one side. The size of the uterus after surgery was monitored using transabdominal ultrasonography. Results: The resulting time-intensity curves displayed the average intensity in the regions of the uterine corpus and uterine cervix, and in the entire uterus. Analyses of the uterine hemodynamics in the cynomolgus macaque showed that uterine vessels were significantly related to uterine perfusion (P = 0.008), whereas ovarian vessels did not have a significant relationship (P = 0.588). When uterine vessels were clamped, ovarian vessels prolonged the time needed to reach perfusion maximum. Postoperative transabdominal ultrasonography showed that the size of the uterus was not changed 2 months after surgery, with recovery of periodic menstruation. The cynomolgus macaque has got pregnant with favorable fetus wellbeing. Conclusion: Uterine vessels may be responsible for uterine blood flow, and even one uterine vessel may be sufficient to maintain uterine viability in cynomolgus macaque. Our results show that ICG fluorescence imaging is useful for evaluation of uterine blood flow since this method allows real-time observation of uterine hemodynamics.	[Kisu, Iori; Banno, Kouji; Tsuji, Kosuke; Yanokura, Megumi; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Mihara, Makoto; Hara, Hisako; Araki, Jun; Iida, Takuya] Univ Tokyo, Dept Plast & Reconstruct Surg, Grad Sch Med, Tokyo, Japan; [Lin, Li-Yu; Abe, Takayuki; Kouyama, Keisuke] Keio Univ, Sch Med, Clin Res Ctr, Tokyo, Japan; [Suganuma, Nobuhiko] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan	Keio University; University of Tokyo; Keio University; Kyoto University	Banno, K (corresponding author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan.	kbanno@sc.itc.keio.ac.jp	Aoki, Daisuke/E-6650-2014; Abe, Takayuki/L-4348-2013; Yanokura, Megumi/W-2667-2017; Banno, Kouji/C-9638-2014		Graduate School Doctoral Student Grant-in-Aid Program; Training for Oncology Professionals in 9 universities (Integrative Research Program); Keio University	Graduate School Doctoral Student Grant-in-Aid Program; Training for Oncology Professionals in 9 universities (Integrative Research Program); Keio University	This study was supported by the Graduate School Doctoral Student Grant-in-Aid Program 2011, a grant from Training for Oncology Professionals in 9 universities (Integrative Research Program 2011), and a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rustum NR, 2007, GYNECOL ONCOL, V104, pS56, DOI 10.1016/j.ygyno.2006.10.036; Abu-Rustum NR, 2006, GYNECOL ONCOL, V103, P807, DOI 10.1016/j.ygyno.2006.05.044; Al-Niaimi AN, 2011, INT J GYNECOL OBSTET, V112, P76, DOI 10.1016/j.ijgo.2010.07.028; Avison DL, 2009, TRANSPLANTATION, V88, P465, DOI 10.1097/TP.0b013e3181b07666; Azuma R, 2008, PLAST RECONSTR SURG, V122, P1062, DOI 10.1097/PRS.0b013e3181858bd2; BENSON RC, 1978, PHYS MED BIOL, V23, P159, DOI 10.1088/0031-9155/23/1/017; Cibula D, 2008, GYNECOL ONCOL, V111, pS111, DOI 10.1016/j.ygyno.2008.07.028; Cicinelli E, 2004, ANN NY ACAD SCI, V1034, P19, DOI 10.1196/annals.1335.002; Cicinelli E, 2004, HUM REPROD, V19, P1003, DOI 10.1093/humrep/deh171; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; DEZIEGLER D, 1991, FERTIL STERIL, V55, P775; Diaz-Garcia C, 2012, MOL HUM REPROD, V18, P68, DOI 10.1093/molehr/gar055; Diaz-Garcia C, 2010, ACTA OBSTET GYN SCAN, V89, P1491, DOI 10.3109/00016349.2010.520688; Dursun P, 2007, EJSO-EUR J SURG ONC, V33, P933, DOI 10.1016/j.ejso.2006.11.021; Einer-Jensen N, 2001, HUM REPROD, V16, P1329, DOI 10.1093/humrep/16.7.1329; El-Akouri RR, 2006, HUM REPROD, V21, P436, DOI 10.1093/humrep/dei349; El-Akouri RR, 2003, HUM REPROD, V18, P2024, DOI 10.1093/humrep/deg395; El-Akouri RR, 2003, HUM REPROD, V18, P2018, DOI 10.1093/humrep/deg396; Enskog A, 2010, HUM REPROD, V25, P1980, DOI 10.1093/humrep/deq109; Fageeh W, 2002, INT J GYNECOL OBSTET, V76, P245, DOI 10.1016/S0020-7292(01)00597-5; Handa Takemi, 2009, Interact Cardiovasc Thorac Surg, V9, P150, DOI 10.1510/icvts.2008.201418; Hojo T, 2010, BREAST, V19, P210, DOI 10.1016/j.breast.2010.01.014; Ishiyama A, 2011, MED ENG PHYS, V33, P381, DOI 10.1016/j.medengphy.2010.11.006; Kisu I, 2012, ARCH GYNECOL OBSTET, V285, P129, DOI 10.1007/s00404-011-1901-2; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Klemm P, 2005, GYNECOL ONCOL, V96, P283, DOI 10.1016/j.ygyno.2004.09.059; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; Mihara M, 2011, HUM REPROD, V26, P3019, DOI 10.1093/humrep/der276; Miyashiro I, 2008, ANN SURG ONCOL, V15, P1640, DOI 10.1245/s10434-008-9872-7; Noura S, 2010, ANN SURG ONCOL, V17, P144, DOI 10.1245/s10434-009-0711-2; Jaraquemada JMP, 2007, ACTA OBSTET GYN SCAN, V86, P228, DOI 10.1080/00016340601089875; Prantl L, 2008, CLIN HEMORHEOL MICRO, V38, P105; Quinn M, 2006, INT J GYNECOL OBSTET, V95, pS43, DOI 10.1016/S0020-7292(06)60030-1; Ramirez ER, 2011, J MINIM INVAS GYN, V18, P238, DOI 10.1016/j.jmig.2010.11.006; Razavi MK, 2002, RADIOLOGY, V224, P707, DOI 10.1148/radiol.2243011513; Saravelos SH, 2008, HUM REPROD UPDATE, V14, P415, DOI 10.1093/humupd/dmn018; Sieunarine K, 2005, INT J GYNECOL CANCER, V15, P967, DOI 10.1111/j.1525-1438.2005.00161.x; Ungar L, 2006, OBSTET GYNECOL, V108, P811, DOI 10.1097/01.AOG.0000216015.15415.5f; Wranning CA, 2010, HUM REPROD, V25, P1973, DOI 10.1093/humrep/deq130; Wranning C, 2008, ACTA OBSTET GYN SCAN, V87, P1239, DOI 10.1080/00016340802484966; Wranning CA, 2011, HUM REPROD, V26, P553, DOI 10.1093/humrep/deq358; Wranning CA, 2006, J OBSTET GYNAECOL RE, V32, P358, DOI 10.1111/j.1447-0756.2006.00426.x; Yabuki Y, 2005, AM J OBSTET GYNECOL, V193, P7, DOI 10.1016/j.ajog.2005.02.108; Yabuki Y, 2000, GYNECOL ONCOL, V77, P155, DOI 10.1006/gyno.1999.5723; Yamamoto T, 2011, PLAST RECONSTR SURG, V128, P941, DOI 10.1097/PRS.0b013e3182268cd9	45	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2012	7	4							e35124	10.1371/journal.pone.0035124	http://dx.doi.org/10.1371/journal.pone.0035124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UD	22606213	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339200037
J	Bernardo, D; Sanchez, B; Al-Hassi, HO; Mann, ER; Urdaci, MC; Knight, SC; Margolles, A				Bernardo, David; Sanchez, Borja; Al-Hassi, Hafid O.; Mann, Elizabeth R.; Urdaci, Maria C.; Knight, Stella C.; Margolles, Abelardo			Microbiota/Host Crosstalk Biomarkers: Regulatory Response of Human Intestinal Dendritic Cells Exposed to Lactobacillus Extracellular Encrypted Peptide	PLOS ONE			English	Article							PROBIOTIC BACTERIA; LAMINA PROPRIA; PLANTARUM 299V; INFLAMMATION; PROTEINS; ADHESION; IMMUNITY; HOST; TOLERANCE; COMMENSAL	The human gastrointestinal tract is exposed to a huge variety of microorganisms, either commensal or pathogenic; at this site, a balance between immunity and immune tolerance is required. Intestinal dendritic cells (DCs) control the mechanisms of immune response/tolerance in the gut. In this paper we have identified a peptide (STp) secreted by Lactobacillus plantarum, characterized by the abundance of serine and threonine residues within its sequence. STp is encoded in one of the main extracellular proteins produced by such species, which includes some probiotic strains, and lacks cleavage sites for the major intestinal proteases. When studied in vitro, STp expanded the ongoing production of regulatory IL-10 in human intestinal DCs from healthy controls. STp-primed DC induced an immunoregulatory cytokine profile and skin-homing profile on stimulated T-cells. Our data suggest that some of the molecular dialogue between intestinal bacteria and DCs may be mediated by immunomodulatory peptides, encoded in larger extracellular proteins, secreted by commensal bacteria. These peptides may be used for the development of nutraceutical products for patients with IBD. In addition, this kind of peptides seem to be absent in the gut of inflammatory bowel disease patients, suggesting a potential role as biomarker of gut homeostasis.	[Bernardo, David; Al-Hassi, Hafid O.; Mann, Elizabeth R.; Knight, Stella C.] Imperial Coll London, Antigen Presentat Res Grp, Harrow, Middx, England; [Sanchez, Borja; Margolles, Abelardo] CSIC, Dept Microbiol & Bioquim Prod Lacteos, Inst Prod Lacteos Asturias, Villaviciosa, Spain; [Urdaci, Maria C.] Ecole Natl Super Sci Agron Bordeaux, Lab Microbiol & Biochim Appl, Gradignan, France	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Bernardo, D (corresponding author), Imperial Coll London, Antigen Presentat Res Grp, Harrow, Middx, England.	borja.sanchez@csic.es	Bernardo, David/GXH-8727-2022; Margolles, Abelardo/H-3871-2012; Sanchez, Borja/B-7770-2009	Margolles, Abelardo/0000-0003-2278-1816; Sanchez, Borja/0000-0003-1408-8018; Urdaci, Maria C/0000-0002-0868-0050; Bernardo, David/0000-0002-2843-6696	Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion; Marie Curie IntraEuropean Fellowship FP7-people-IEF; St Mark's Hospital Foundation; Brigid Balfour Fund; Spanish Ministerio de 1 Ciencia e Innovacion [AGL2010-14952, RM2010-00012-00-00]; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044446] Funding Source: researchfish; BBSRC [BBS/E/F/00044446] Funding Source: UKRI	Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion; Marie Curie IntraEuropean Fellowship FP7-people-IEF; St Mark's Hospital Foundation; Brigid Balfour Fund; Spanish Ministerio de 1 Ciencia e Innovacion; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Juan de la Cierva postdoctoral contract from the Spanish Ministerio de Ciencia e Innovacion (Borja Sanchez), Marie Curie IntraEuropean Fellowship FP7-people-IEF-2008 (David Bernardo); St Mark's Hospital Foundation, the Brigid Balfour Fund and grants AGL2010-14952 and RM2010-00012-00-00 from the Spanish Ministerio de 1 Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beck HC, 2009, FEMS MICROBIOL LETT, V297, P61, DOI 10.1111/j.1574-6968.2009.01662.x; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; CHEVALLIER B, 1994, FEMS MICROBIOL LETT, V120, P51, DOI 10.1016/0378-1097(94)00174-X; Chirdo FG, 2005, EUR J IMMUNOL, V35, P1831, DOI 10.1002/eji.200425882; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Feng T, 2011, MUCOSAL IMMUNOL, V4, P15, DOI 10.1038/mi.2010.60; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Madsen SM, 2005, J BIOTECHNOL, V118, pS142; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mann ER, 2011, INFLAMM BOWEL DIS, DOI 101002/ibd21893; Molin G, 2001, AM J CLIN NUTR, V73, p380S, DOI 10.1093/ajcn/73.2.380s; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Ng SC, 2009, CLIN EXP IMMUNOL, V158, P205, DOI 10.1111/j.1365-2249.2009.04012.x; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Sanchez B, 2009, J MOL MICROB BIOTECH, V17, P158, DOI 10.1159/000233579; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Stagg AJ, 2003, GUT, V52, P1522, DOI 10.1136/gut.52.10.1522; Tallon R, 2007, J APPL MICROBIOL, V102, P442, DOI 10.1111/j.1365-2672.2006.03086.x; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	33	63	66	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36262	10.1371/journal.pone.0036262	http://dx.doi.org/10.1371/journal.pone.0036262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606249	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400014
J	Chan, KYY; Leung, FWL; Lam, HS; Tam, YH; To, KF; Cheung, HM; Leung, KT; Poon, TCW; Lee, KH; Li, K; Fok, TF; Ng, PC				Chan, Kathy Yuen Yee; Leung, Fiona Wan Lun; Lam, Hugh Simon; Tam, Yuk Him; To, Ka Fai; Cheung, Hon Ming; Leung, Kam Tong; Poon, Terence Chuen Wai; Lee, Kim Hung; Li, Karen; Fok, Tai Fai; Ng, Pak Cheung			Immunoregulatory Protein Profiles of Necrotizing Enterocolitis versus Spontaneous Intestinal Perforation in Preterm Infants	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; TUMOR-NECROSIS-FACTOR; II DECOY RECEPTOR; ENDOTHELIAL-CELLS; CYTOKINE LEVELS; GUT BARRIER; SEPSIS; ANGIOPOIETIN-2; INTERLEUKIN-6; EXPRESSION	Necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP) are the most common acute surgical emergencies associated with high morbidity and mortality in preterm infants. We aimed to compare the profiles of immunoregulatory proteins and identify novel mediators in plasma of NEC and SIP infants. We also investigated the expression of target genes in resected intestinal tissues and an enterocyte cell line. Using Cytokine Antibody Array assay, we reported the first comparative profiles of immunoregulatory proteins in plasma of NEC and SIP infants, and showed that dysregulated proteins belonged to functionally diversified categories, including pro-and anti-inflammation, angiogenesis, cell growth, wound healing, anti-apoptosis, cell adhesion and extracellular matrix reorganization. Validation by ELISA confirmed significantly higher concentrations of interleukin (IL)-6, angiopoietin (Ang)-2, soluble type II interleukin-1 receptor (sIL-1RII), and soluble urokinase-type plasminogen activator receptor (suPAR) in NEC infants compared with gestational age-matched control, and a lower level of an epidermal growth factor receptor, secreted form of receptor tyrosine-protein kinase ErbB3 (sErbB3), compared with SIP infants. mRNA expressions of IL1-RII and uPAR were up-regulated in resected bowel tissues from NEC infants, indicating that immunoregulation also occurred at the cellular level. In FHs-74 Int cells, Ang-2, IL1-RII and uPAR mRNA expressions were significantly induced by the combined treatment with lipopolysaccharide (LPS) and platelet activating factor (PAF). Our study provided plasmatic signatures of immunoregulatory proteins in NEC and SIP infants, and demonstrated involvement of multiple functional pathways. The magnitude of changes in these proteins was significantly more extensive in NEC infants, reflecting the different nature of injury and/or severity of inflammation. We speculate that dysregulation of IL-6, Ang-2, IL-1RII and uPAR occurred at both systemic and cellular levels, and probably mediated via LPS and endogeneous PAF signals. Such exaggerated immunologic responses may account for the high morbidity and mortality in NEC compared with SIP patients.	[Chan, Kathy Yuen Yee; Leung, Fiona Wan Lun; Lam, Hugh Simon; Cheung, Hon Ming; Leung, Kam Tong; Poon, Terence Chuen Wai; Li, Karen; Fok, Tai Fai; Ng, Pak Cheung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Tam, Yuk Him; Lee, Kim Hung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, KYY (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	pakcheungng@cuhk.edu.hk	Chan, Kathy/AAE-8538-2021; Leung, Kam Tong/I-8569-2017; Lam, Hugh Simon/G-8373-2015	Chan, Kathy/0000-0002-6501-9592; Leung, Kam Tong/0000-0002-7695-2513; Lam, Hugh Simon/0000-0001-9912-0544	H.M. Lui Memorial Fund [6901814]; Research Grant Council of the Hong Kong Government [472909/GRF]	H.M. Lui Memorial Fund; Research Grant Council of the Hong Kong Government	This project was partially supported by the donation from the charity organization H.M. Lui Memorial Fund (Project Code 6901814) and the Research Grant Council of the Hong Kong Government (project no. 472909/GRF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bister V, 2005, J PEDIATR GASTR NUTR, V40, P60, DOI 10.1097/00005176-200501000-00011; Buke AC, 2004, MED PRIN PRACT, V13, P273, DOI 10.1159/000079526; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Eras Z, 2011, J CLIN LAB ANAL, V25, P233, DOI 10.1002/jcla.20464; Frost BL, 2008, SEMIN PERINATOL, V32, P100, DOI 10.1053/j.semperi.2008.01.001; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Herbert JM, 1997, J LIPID MEDIAT CELL, V17, P1, DOI 10.1016/S0929-7855(97)00011-4; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Kingsmore SF, 2008, MOL CELL PROTEOMICS, V7, P1863, DOI 10.1074/mcp.M800175-MCP200; Kobayashi M, 2003, ONCOGENE, V22, P1294, DOI 10.1038/sj.onc.1206256; Koutroubakis IE, 2006, EUR J CLIN INVEST, V36, P127, DOI 10.1111/j.1365-2362.2006.01602.x; Lacasse C, 1997, INFLAMMATION, V21, P145, DOI 10.1023/A:1027314103063; Lee H, 2001, CANCER RES, V61, P4467; Lemieux C, 2005, BLOOD, V105, P1523, DOI 10.1182/blood-2004-09-3531; Leveau P, 2005, BIOCHEM PHARMACOL, V69, P1325, DOI 10.1016/j.bcp.2005.01.023; Lodha A, 2010, ACTA PAEDIATR, V99, P338, DOI 10.1111/j.1651-2227.2009.01600.x; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Maurer CA, 1998, HUM PATHOL, V29, P771, DOI 10.1016/S0046-8177(98)90444-0; Molkanen T, 2011, EUR J CLIN MICROBIOL, V30, P1417, DOI 10.1007/s10096-011-1236-8; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Nadler EP, 2001, J PEDIATR SURG, V36, P1122, DOI 10.1053/jpsu.2001.25726; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ng PC, 2007, GASTROENTEROLOGY, V132, P1726, DOI 10.1053/j.gastro.2007.03.043; Ng PC, 2007, PEDIATR RES, V61, P93, DOI 10.1203/01.pdr.0000250207.95723.96; Ng PC, 2006, CLIN CHEM, V52, P1181, DOI 10.1373/clinchem.2005.062075; NG PC, 1991, ARCH DIS CHILD-FETAL, V66, P1164, DOI 10.1136/adc.66.10_Spec_No.1164; Ng PC, 2003, ARCH DIS CHILD-FETAL, V88, P209; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Orlando S, 1997, J IMMUNOL, V158, P3861; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Pourcyrous M, 2005, PEDIATRICS, V116, P1064, DOI 10.1542/peds.2004-1806; PRIGENT SA, 1992, ONCOGENE, V7, P1273; Pruitt JH, 1996, BLOOD, V87, P3282; Pumberger W, 2002, J AM COLL SURGEONS, V195, P796, DOI 10.1016/S1072-7515(02)01344-3; Sharma R, 2010, J PERINATOL, V30, P786, DOI 10.1038/jp.2010.59; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; van Dissel JT, 1998, LANCET, V351, P950, DOI 10.1016/S0140-6736(05)60606-X; van Meurs M, 2009, CRIT CARE, V13, DOI 10.1186/cc7153	45	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36977	10.1371/journal.pone.0036977	http://dx.doi.org/10.1371/journal.pone.0036977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606320	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339400049
J	Fischer, U; Keller, A; Voss, M; Backes, C; Welter, C; Meese, E				Fischer, Ulrike; Keller, Andreas; Voss, Meike; Backes, Christina; Welter, Cornelius; Meese, Eckart			Genome-Wide Gene Amplification during Differentiation of Neural Progenitor Cells In Vitro	PLOS ONE			English	Article							MOUSE EMBRYO; GLIOBLASTOMA; ABERRATIONS; AMPLICONS; 12Q13-21; COMPLEX; GROWTH; SERUM	DNA sequence amplification is a phenomenon that occurs predictably at defined stages during normal development in some organisms. Developmental gene amplification was first described in amphibians during gametogenesis and has not yet been described in humans. To date gene amplification in humans is a hallmark of many tumors. We used array-CGH (comparative genomic hybridization) and FISH (fluorescence in situ hybridization) to discover gene amplifications during in vitro differentiation of human neural progenitor cells. Here we report a complex gene amplification pattern two and five days after induction of differentiation of human neural progenitor cells. We identified several amplified genes in neural progenitor cells that are known to be amplified in malignant tumors. There is also a striking overlap of amplified chromosomal regions between differentiating neural progenitor cells and malignant tumor cells derived from astrocytes. Gene amplifications in normal human cells as physiological process has not been reported yet and may bear resemblance to developmental gene amplifications in amphibians and insects.	[Fischer, Ulrike; Keller, Andreas; Voss, Meike; Backes, Christina; Welter, Cornelius; Meese, Eckart] Univ Saarland, Dept Human Genet, D-6650 Homburg, Germany	Saarland University	Fischer, U (corresponding author), Univ Saarland, Dept Human Genet, D-6650 Homburg, Germany.	ulrike.fischer@uks.eu	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895	Deutsche Forschungsgemeinschaft (DFG) [Fi664/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) grant number Fi664/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Bax DA, 2010, CLIN CANCER RES, V16, P3368, DOI 10.1158/1078-0432.CCR-10-0438; BOSTOCK CJ, 1986, PHILOS T ROY SOC B, V312, P261, DOI 10.1098/rstb.1986.0006; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GRAVES JAM, 1984, CHROMOSOMA, V89, P138, DOI 10.1007/BF00292897; Konopka G, 2012, MOL PSYCHIATR, V17, P202, DOI 10.1038/mp.2011.60; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030098; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Mukamel Z, 2011, J NEUROSCI, V31, P11437, DOI 10.1523/JNEUROSCI.0181-11.2011; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RAWSON C, 1991, EXP CELL RES, V192, P271, DOI 10.1016/0014-4827(91)90186-X; SPRADLING AC, 1980, P NATL ACAD SCI-BIOL, V77, P1096, DOI 10.1073/pnas.77.2.1096; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tower J, 2004, ANNU REV GENET, V38, P273, DOI 10.1146/annurev.genet.37.110801.143851	19	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37422	10.1371/journal.pone.0037422	http://dx.doi.org/10.1371/journal.pone.0037422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606362	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400081
J	Galperin, E; Abdelmoti, L; Sorkin, A				Galperin, Emilia; Abdelmoti, Lina; Sorkin, Alexander			Shoc2 Is Targeted to Late Endosomes and Required for Erk1/2 Activation in EGF-Stimulated Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; KINASE ACTIVATION; SCAFFOLD PROTEINS; NOONAN SYNDROME; RAS; ENDOCYTOSIS; COMPLEX; RESISTANCE	Shoc2 is the putative scaffold protein that interacts with RAS and RAF, and positively regulates signaling to extracellular signal-regulated protein kinases 1 and 2 (ERK1/2). To elucidate the mechanism by which Shoc2 regulates ERK1/2 activation by the epidermal growth factor (EGF) receptor (EGFR), we studied subcellular localization of Shoc2. Upon EGFR activation, endogenous Shoc2 and red fluorescent protein tagged Shoc2 were translocated from the cytosol to a subset of late endosomes containing Rab7. The endosomal recruitment of Shoc2 was blocked by overexpression of a GDP-bound H-RAS (N17S) mutant and RNAi knockdown of clathrin, suggesting the requirement of RAS activity and clathrin-dependent endocytosis. RNAi depletion of Shoc2 strongly inhibited activation of ERK1/2 by low, physiological EGF concentrations, which was rescued by expression of wild-type recombinant Shoc2. In contrast, the Shoc2 (S2G) mutant, that is myristoylated and found in patients with the Noonan-like syndrome, did not rescue ERK1/2 activation in Shoc2-depleted cells. Shoc2 (S2G) was not located in late endosomes but was present on the plasma membrane and early endosomes. These data suggest that targeting of Shoc2 to late endosomes may facilitate EGFR-induced ERK activation under physiological conditions of cell stimulation by EGF, and therefore, may be involved in the spatiotemporal regulation of signaling through the RAS-RAF module.	[Galperin, Emilia; Abdelmoti, Lina] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galperin, E (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	emilia.galperin@uky.edu		Galperin, Emilia/0000-0002-8743-026X; Sorkin, Alexander/0000-0002-4446-1920	National Cancer Institute [R00CA126161, CA112219, CA089151]; NIH from the National Center for Research Resources [2P20 RR020171]; NATIONAL CANCER INSTITUTE [R01CA089151, R01CA112219, R00CA126161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported by grants from the National Cancer Institute (grant number R00CA126161 to EG; CA112219 and CA089151 to AS) and NIH Grant Number 2P20 RR020171 from the National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or the NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brown M. D., 2008, V186, P205, DOI 10.1007/978-3-540-72843-6_9; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cappell SD, 2011, J BIOL CHEM, V286, P14852, DOI 10.1074/jbc.M110.195073; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dohlman HG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.142pe46; Galperin E, 2008, TRAFFIC, V9, P1776, DOI 10.1111/j.1600-0854.2008.00788.x; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; HIRATA Y, 1979, ENDOCRINOLOGY, V105, P1382, DOI 10.1210/endo-105-6-1382; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ikeda K, 2009, J MOL ENDOCRINOL, V42, P479, DOI 10.1677/JME-08-0151; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kobayashi T, 2010, HUM MUTAT, V31, P284, DOI 10.1002/humu.21187; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Li WQ, 2000, GENE DEV, V14, P895; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miaczynska M, 2010, CURR OPIN CELL BIOL, V22, P535, DOI 10.1016/j.ceb.2010.05.007; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Tartaglia M, 2011, BEST PRACT RES CL EN, V25, P161, DOI 10.1016/j.beem.2010.09.002; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; WADA I, 1992, J CELL BIOL, V116, P321, DOI 10.1083/jcb.116.2.321; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765; Yi P, 2010, J CELL SCI, V123, P1060, DOI 10.1242/jcs.059717; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	43	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36469	10.1371/journal.pone.0036469	http://dx.doi.org/10.1371/journal.pone.0036469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606262	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305339400018
J	Martin, B; Chadwick, W; Yi, T; Park, SS; Lu, DY; Ni, B; Gadkaree, S; Farhang, K; Becker, KG; Maudsley, S				Martin, Bronwen; Chadwick, Wayne; Yi, Tie; Park, Sung-Soo; Lu, Daoyuan; Ni, Bin; Gadkaree, Shekhar; Farhang, Kathleen; Becker, Kevin G.; Maudsley, Stuart			VENNTURE-A Novel Venn Diagram Investigational Tool for Multiple Pharmacological Dataset Analysis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; EXCHANGER REGULATORY FACTOR; BETA(2)-ADRENERGIC RECEPTOR; SIGNAL-TRANSDUCTION; WEB APPLICATION; ACTIVATION; COMPLEX; GROWTH; PHOSPHORYLATION; ASSOCIATION	As pharmacological data sets become increasingly large and complex, new visual analysis and filtering programs are needed to aid their appreciation. One of the most commonly used methods for visualizing biological data is the Venn diagram. Currently used Venn analysis software often presents multiple problems to biological scientists, in that only a limited number of simultaneous data sets can be analyzed. An improved appreciation of the connectivity between multiple, highly-complex datasets is crucial for the next generation of data analysis of genomic and proteomic data streams. We describe the development of VENNTURE, a program that facilitates visualization of up to six datasets in a user-friendly manner. This program includes versatile output features, where grouped data points can be easily exported into a spreadsheet. To demonstrate its unique experimental utility we applied VENNTURE to a highly complex parallel paradigm, i.e. comparison of multiple G protein-coupled receptor drug dose phosphoproteomic data, in multiple cellular physiological contexts. VENNTURE was able to reliably and simply dissect six complex data sets into easily identifiable groups for straightforward analysis and data output. Applied to complex pharmacological datasets, VENNTURE's improved features and ease of analysis are much improved over currently available Venn diagram programs. VENNTURE enabled the delineation of highly complex patterns of dose-dependent G protein-coupled receptor activity and its dependence on physiological cellular contexts. This study highlights the potential for such a program in fields such as pharmacology, genomics, and bioinformatics.	[Martin, Bronwen; Yi, Tie] NIA, Metab Unit, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Chadwick, Wayne; Park, Sung-Soo; Lu, Daoyuan; Ni, Bin; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, NIH, Baltimore, MD 21224 USA; [Gadkaree, Shekhar; Farhang, Kathleen] NIA, Diabet Sect, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, B (corresponding author), NIA, Metab Unit, Clin Invest Lab, NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; K., Shekhar/0000-0003-3274-4488; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000917, ZIAAG000319, ZICAG000616, ZIAAG000325, ZIAAG000915, ZIAAG000318, ZIAAG000916] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; Chadwick W, 2011, J SIGNAL TRANSDUCT, V2011; Chadwick WA, 2009, REVOLUTION BIOL TOXI, P95; Chadwick W, 2008, TRENDS NEUROSCI, V31, P504, DOI 10.1016/j.tins.2008.07.005; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Davidson L, 2004, J BIOL CHEM, V279, P11906, DOI 10.1074/jbc.M310784200; de Maturana RL, 2008, MOL ENDOCRINOL, V22, P1711, DOI 10.1210/me.2006-0537; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; Duncan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-100, 10.1186/1471-2105-11-S4-P10]; Edwards AWF, 1989, B INT STAT I, V1, P311; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gatlin CL, 1998, ANAL BIOCHEM, V263, P93, DOI 10.1006/abio.1998.2809; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gesty-Palmer D, 2008, J RECEPT SIG TRANSD, V28, P39, DOI [10.1080/10799890801941921, 10.1080/10799890801941921 ]; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Kestler HA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-67; Krumins AM, 1997, MOL PHARMACOL, V52, P144, DOI 10.1124/mol.52.1.144; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mallee JJ, 2002, J BIOL CHEM, V277, P14294, DOI 10.1074/jbc.M109661200; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Maudsley S, 2004, CANCER RES, V64, P7533, DOI 10.1158/0008-5472.CAN-04-1360; Maudsley S, 2010, ENDOCR REV, V31; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Maudsley S, 2007, CURR ALZHEIMER RES, V4, P3, DOI 10.2174/156720507779939850; MELLER E, 1992, J PHARMACOL EXP THER, V263, P462; Nichols Amy M., 2009, V492, P143, DOI 10.1007/978-1-59745-493-3_8; Nuhse Thomas, 2007, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1813s77; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Park SS, 2011, ANAL BIOCHEM, V409, P81, DOI 10.1016/j.ab.2010.10.003; Perez DM, 1996, MOL PHARMACOL, V49, P112; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scaramellini C, 1998, ANN NY ACAD SCI, V861, P97; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Vaidehi N, 2010, CURR OPIN PHARMACOL, V10, P775, DOI 10.1016/j.coph.2010.09.004; Venn J, 1880, LONDON EDINBURGH DUB, V10, P1, DOI [DOI 10.1080/14786448008626877, 10.1080/14786448008626877]; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Webb TR, 2010, MOL ENDOCRINOL, V24, P475, DOI 10.1210/me.2009-0283; Wootten D, 2011, J PHARMACOL EXP THER, V336, P540, DOI 10.1124/jpet.110.176362; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	50	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36911	10.1371/journal.pone.0036911	http://dx.doi.org/10.1371/journal.pone.0036911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606307	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400041
J	Monforte-Royo, C; Villavicencio-Chavez, C; Tomas-Sabado, J; Mahtani-Chugani, V; Balaguer, A				Monforte-Royo, Cristina; Villavicencio-Chavez, Christian; Tomas-Sabado, Joaquin; Mahtani-Chugani, Vinita; Balaguer, Albert			What Lies behind the Wish to Hasten Death? A Systematic Review and Meta-Ethnography from the Perspective of Patients	PLOS ONE			English	Review							PHYSICIAN-ASSISTED SUICIDE; TERMINALLY ILL PATIENTS; QUALITATIVE RESEARCH; PALLIATIVE CARE; DESIRE; EUTHANASIA; CANCER; LIFE; END; DEPRESSION	Background: There is a need for an in-depth approach to the meaning of the wish to hasten death (WTHD). This study aims to understand the experience of patients with serious or incurable illness who express such a wish. Methods and Findings: Systematic review and meta-ethnography of qualitative studies from the patient's perspective. Studies were identified through six databases (ISI, PubMed, PsycINFO, CINAHL, CUIDEN and the Cochrane Register of Controlled Trials), together with citation searches and consultation with experts. Finally, seven studies reporting the experiences of 155 patients were included. The seven-stage Noblit and Hare approach was applied, using reciprocal translation and line-of-argument synthesis. Six main themes emerged giving meaning to the WTHD: WTHD in response to physical/psychological/spiritual suffering, loss of self, fear of dying, the desire to live but not in this way, WTHD as a way of ending suffering, and WTHD as a kind of control over one's life ('having an ace up one's sleeve just in case'). An explanatory model was developed which showed the WTHD to be a reactive phenomenon: a response to multidimensional suffering, rather than only one aspect of the despair that may accompany this suffering. According to this model the factors that lead to the emergence of WTHD are total suffering, loss of self and fear, which together produce an overwhelming emotional distress that generates the WTHD as a way out, i.e. to cease living in this way and to put an end to suffering while maintaining some control over the situation. Conclusions: The expression of the WTHD in these patients is a response to overwhelming emotional distress and has different meanings, which do not necessarily imply a genuine wish to hasten one's death. These meanings, which have a causal relationship to the phenomenon, should be taken into account when drawing up care plans.	[Monforte-Royo, Cristina; Balaguer, Albert] Univ Int Catalunya, Med & Hlth Sci Sch, Barcelona, Spain; [Villavicencio-Chavez, Christian] Inst Catala Oncol, Barcelona, Spain; [Tomas-Sabado, Joaquin] Univ Autonoma Barcelona, Gimbernat Sch Nursing, E-08193 Barcelona, Spain; [Mahtani-Chugani, Vinita] Hosp Nuestra Senora Candelaria & Primary Hlth Car, Res Unit, Tenerife, Spain; [Mahtani-Chugani, Vinita] CIBERESP, Inst Salud Carlos III, Natl Network Biomed Res Epidemiol & Publ Hlth, Barcelona, Spain; [Monforte-Royo, Cristina; Villavicencio-Chavez, Christian; Balaguer, Albert] Univ Int Catalunya, CREB, Barcelona, Spain	Universitat Internacional de Catalunya (UIC); Catalan Institute of Oncology; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Universitat Internacional de Catalunya (UIC)	Monforte-Royo, C (corresponding author), Univ Int Catalunya, Med & Hlth Sci Sch, Barcelona, Spain.	abalaguer@csc.uic.es	Tomas-Sabado, Joaquin/B-7368-2015; Balaguer, Albert/AAG-8678-2020; Monforte-Royo, Cristina/B-5016-2013; Balaguer, Albert/B-3530-2011	Tomas-Sabado, Joaquin/0000-0002-7156-7843; Balaguer, Albert/0000-0002-5222-8635; Monforte-Royo, Cristina/0000-0001-8334-4623; Balaguer, Albert/0000-0002-5222-8635	Col.legi Oficial d'Infermeria de Barcelona [PR 5177/09]; National Grant from Instituto de Salud Carlos III, Spain [PI11-01353]	Col.legi Oficial d'Infermeria de Barcelona; National Grant from Instituto de Salud Carlos III, Spain	This work was supported by a grant (PR 5177/09) from Col.legi Oficial d'Infermeria de Barcelona and a National Grant from Instituto de Salud Carlos III, Spain (PI11-01353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey JG, 2006, BRIT J HEALTH PSYCH, V11, P173, DOI 10.1348/135910705X36749; Albert SM, 2005, NEUROLOGY, V65, P68, DOI 10.1212/01.wnl.0000168161.54833.bb; Arnold EM, 2004, HEALTH SOC WORK, V29, P17, DOI 10.1093/hsw/29.1.17; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; BLOCK SD, 1995, PSYCHOSOMATICS, V36, P445, DOI 10.1016/S0033-3182(95)71625-5; Brady MJ, 1999, PSYCHO-ONCOLOGY, V8, P417, DOI 10.1002/(SICI)1099-1611(199909/10)8:5<417::AID-PON398>3.0.CO;2-4; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; Breitbart William, 2003, J Palliat Med, V6, P979, DOI 10.1089/109662103322654901; BROWN JH, 1986, AM J PSYCHIAT, V143, P208; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Carmel S, 2001, SOC SCI MED, V52, P949, DOI 10.1016/S0277-9536(00)00198-2; CASP, 1999, CRIT APPR SKILLS PRO; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 2006, CA-CANCER J CLIN, V56, P84, DOI 10.3322/canjclin.56.2.84; Chochinov HM, 2005, PSYCHOSOMATICS, V46, P7, DOI 10.1176/appi.psy.46.1.7; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; Clarke DM, 2002, AUST NZ J PSYCHIAT, V36, P733, DOI 10.1046/j.1440-1614.2002.01086.x; Cohen LM, 2000, PSYCHOSOMATICS, V41, P195, DOI 10.1176/appi.psy.41.3.195; Coyle N, 2004, ONCOL NURS FORUM, V31, P699, DOI 10.1188/04.ONF.699-709; de Casterle BD, 2006, J MED ETHICS, V32, P187, DOI 10.1136/jme.2005.011783; Dixon-Woods M, 2004, QUAL SAF HEALTH CARE, V13, P223, DOI 10.1136/qshc.2003.008714; Dixon-Woods Mary, 2007, J Health Serv Res Policy, V12, P42, DOI 10.1258/135581907779497486; Dixon-Woods Mary, 2005, J Health Serv Res Policy, V10, P45, DOI 10.1258/1355819052801804; Doyal L, 2001, BMJ-BRIT MED J, V323, P1079, DOI 10.1136/bmj.323.7321.1079; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Ganzini L, 2002, J PAIN SYMPTOM MANAG, V24, P312, DOI 10.1016/S0885-3924(02)00496-7; Gourie-Devi M, 2007, NEUROLOGY, V68, P79, DOI 10.1212/01.wnl.0000253018.91975.38; Grzybowska P, 1997, PALLIATIVE MED, V11, P313, DOI 10.1177/026921639701100408; Hannes K, 2001, SUPPLEMENTARY GUIDAN; Hudson PL, 2006, PALLIATIVE MED, V20, P693, DOI 10.1177/0269216306071799; Jones ML, 2004, J ADV NURS, V48, P271, DOI 10.1111/j.1365-2648.2004.03196.x; Kelly B, 2003, PSYCHOL MED, V33, P75, DOI 10.1017/S0033291702006827; Kelly B, 2002, PALLIATIVE MED, V16, P339, DOI 10.1191/0269216302pm538oa; Kelly Brian J, 2004, Palliat Support Care, V2, P163; KINSELLA TD, 1995, CLIN INVEST MED, V18, P406; Kissane DW, 1998, LANCET, V352, P1097, DOI 10.1016/S0140-6736(98)05406-3; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; Kissane DW, 2000, AUST NZ J PSYCHIAT, V34, P325, DOI 10.1046/j.1440-1614.2000.00692.x; Kubler-Ross E., 1969, DEATH DYING; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; Lavin MA, 2005, J MED LIBR ASSOC, V93, P104; Lynn J, 2000, JAMA-J AM MED ASSOC, V284, P2508, DOI 10.1001/jama.284.19.2508; Mahtani Chugani V., 2006, METODOLOGIA INCORPOR; Mak YYW, 2005, PALLIATIVE MED, V19, P343, DOI 10.1191/0269216305pm1019oa; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; McKibbon A, 2002, EVIDENCE BASED FILTE; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Monforte-Royo C, 2011, PSYCHO-ONCOLOGY, V20, P795, DOI 10.1002/pon.1839; Monforte-Royo C, 2011, QUAL LIFE RES, V20, P759, DOI 10.1007/s11136-010-9796-0; Morita T, 2000, PSYCHO-ONCOL, V9, P164, DOI 10.1002/(SICI)1099-1611(200003/04)9:2<164::AID-PON447>3.0.CO;2-S; Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P44, DOI 10.1016/j.jpainsymman.2003.05.001; Morse J. M., 1995, QUALITATIVE RES METH; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muskin PR, 1998, JAMA-J AM MED ASSOC, V279, P323, DOI 10.1001/jama.279.4.323; Nelson CJ, 2002, PSYCHOSOMATICS, V43, P213, DOI 10.1176/appi.psy.43.3.213; Nesbit K., 2002, EVIDENCE BASED FILTE; Nissim R, 2009, SOC SCI MED, V69, P165, DOI 10.1016/j.socscimed.2009.04.021; Noblit G, 1988, METAETHNOGRAPHY SINT; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Pearlman RA, 2005, J GEN INTERN MED, V20, P234, DOI 10.1111/j.1525-1497.2005.40225.x; Pessin H, 2003, GEN HOSP PSYCHIAT, V25, P194, DOI 10.1016/S0163-8343(03)00008-2; Pullman D, 2002, THEOR MED BIOETH, V23, P75, DOI 10.1023/A:1019521923979; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Rodin G, 2007, J PAIN SYMPTOM MANAG, V33, P661, DOI 10.1016/j.jpainsymman.2006.09.034; Rosenfeld B, 2000, CANCER, V88, P2868, DOI 10.1002/1097-0142(20000615)88:12<2868::AID-CNCR30>3.0.CO;2-K; Rosenfeld B, 2000, PSYCHOL PUBLIC POL L, V6, P559, DOI 10.1037//1076-8971.6.2.559; Rosenfeld B, 2006, PSYCHOSOMATICS, V47, P504, DOI 10.1176/appi.psy.47.6.504; Rossi PG, 2007, J EPIDEMIOL COMMUN H, V61, P547, DOI 10.1136/jech.2005.045138; Rowan M, 1997, CAN MED ASSOC J, V157, P1442; Sale JEM, 2005, ARTHRIT RHEUM-ARTHR, V53, P314, DOI 10.1002/art.21088; Sandelowski M, 2003, RES NURS HEALTH, V26, P153, DOI 10.1002/nur.10072; Sandelowski M, 1997, RES NURS HEALTH, V20, P365, DOI 10.1002/(SICI)1098-240X(199708)20:4<365::AID-NUR9>3.0.CO;2-E; SAUNDERS C, 1965, Am J Nurs, V65, P70, DOI 10.2307/3453113; Schreiber R., 1997, COMPLETING QUALITATI, P311; Schroepfer TA, 2006, J GERONTOL B-PSYCHOL, V61, pS129, DOI 10.1093/geronb/61.3.S129; SEALE C, 1994, SOC SCI MED, V39, P647, DOI 10.1016/0277-9536(94)90021-3; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Strohbuecker B, 2011, INT J PALLIAT NURS, V17, P27, DOI 10.12968/ijpn.2011.17.1.27; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thorne S, 2004, QUAL HEALTH RES, V14, P1342, DOI 10.1177/1049732304269888; Tiernan E, 2002, J ROY SOC MED, V95, P386, DOI 10.1258/jrsm.95.8.386; Willems DL, 2000, ARCH INTERN MED, V160, P63, DOI 10.1001/archinte.160.1.63	87	92	93	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37117	10.1371/journal.pone.0037117	http://dx.doi.org/10.1371/journal.pone.0037117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UF	22606338	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339400063
J	Ringe, R; Bhattacharya, J				Ringe, Rajesh; Bhattacharya, Jayanta			Association of Enhanced HIV-1 Neutralization by a Single Y681H Substitution in gp41 with Increased gp120-CD4 Interaction and Macrophage Infectivity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENVELOPE GLYCOPROTEINS; TYPE-1 GP41; ENV CLONES; BINDING-SITES; MEMBRANE; SENSITIVITY; DOMAIN	HIV-1 variants that show unusual sensitivity to autologous antibodies due to presence of critical neutralization signatures would likely contribute towards rational envelope based HIV-1 vaccine design. In the present study, we found that presence of a naturally occurring H681 in gp41 membrane proximal external region (MPER) of a clade C envelope (Env) obtained from a recently infected Indian patient conferred increased sensitivity to autologous and heterologous plasma antibodies. Furthermore, Env-pseudotyped viruses expressing H681 showed increased sensitivity to soluble CD4, b12 and 4E10 monoclonal antibodies both in related and unrelated Envs and was corroborated with increased Env susceptibility and binding to cellular CD4 as well as with prolonged exposure of MPER epitopes. The increased gp120-CD4 interaction was further associated with relative exposure of CD4-induced epitopes and macrophage infectivity. In summary, our data indicate that Y681H substitution exposes neutralizing epitopes in CD4bs and MPER towards comprehensive interference in HIV-1 entry.	[Ringe, Rajesh; Bhattacharya, Jayanta] Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Ringe, R (corresponding author), Indian Council Med Res, Natl AIDS Res Inst, Dept Mol Virol, Pune, Maharashtra, India.	jbhattacharya@nariindia.org			Department of Biotechnology, Government of India [BT/PR7829/MED/14/1133/2006, BT/PR12853/MED/29/141/2009]; Council of Scientific and Industrial Research (CSIR), Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Government of India to JB (BT/PR7829/MED/14/1133/2006 and BT/PR12853/MED/29/141/2009), Government of India to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Georgia Tomaras, Duke University for TND L669 and TND L669S plasmids and Dr Julie Overbaugh, Fred Hutchinson Cancer Research Center, Seattle for HIV-1 clade A envelope clones. We are grateful to NIH AIDS Research Reagent and Reference Program for 183-H12-5C, 4E10, 2F5 and b12 MAbs and TZM-b1 cells. RR is supported by Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), Government of India.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; BACK NKT, 1993, J VIROL, V67, P6897, DOI 10.1128/JVI.67.11.6897-6902.1993; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Brunel FM, 2006, J VIROL, V80, P1680, DOI 10.1128/JVI.80.4.1680-1687.2006; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen SSL, 2009, J VIROL, V83, P870, DOI 10.1128/JVI.01088-08; Davis KL, 2009, J VIROL, V83, P1240, DOI 10.1128/JVI.01743-08; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; GABUZDA DH, 1992, J VIROL, V66, P3306, DOI 10.1128/JVI.66.6.3306-3315.1992; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; KAZAZI F, 1989, J GEN VIROL, V70, P2661, DOI 10.1099/0022-1317-70-10-2661; Kolchinsky P, 1999, J VIROL, V73, P8120, DOI 10.1128/JVI.73.10.8120-8126.1999; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; Morris L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023532; Munoz-Barroso I, 1998, J CELL BIOL, V140, P315, DOI 10.1083/jcb.140.2.315; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Richards KH, 2007, J GEN VIROL, V88, P2780, DOI 10.1099/vir.0.83120-0; Richards KH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-48; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Ringe R, 2011, VIROLOGY, V418, P123, DOI 10.1016/j.virol.2011.07.015; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Saez-Cirion A, 2002, J BIOL CHEM, V277, P21776, DOI 10.1074/jbc.M202255200; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walter BL, 2005, J VIROL, V79, P4828, DOI 10.1128/JVI.79.8.4828-4837.2005; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilen CB, 2011, J VIROL, V85, P8514, DOI 10.1128/JVI.00736-11; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	84	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37157	10.1371/journal.pone.0037157	http://dx.doi.org/10.1371/journal.pone.0037157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606344	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400070
J	Vanha-aho, LM; Kleino, A; Kaustio, M; Ulvila, J; Wilke, B; Hultmark, D; Valanne, S; Ramet, M				Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Ulvila, Johanna; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika			Functional Characterization of the Infection-Inducible Peptide Edin in Drosophila melanogaster	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ANTIMICROBIAL PEPTIDE; NEGATIVE REGULATOR; IMMUNE-RESPONSES; GENE-EXPRESSION; RECOGNITION; ACTIVATION; IMD; IDENTIFICATION; PHAGOCYTOSIS	Drosophila is a well-established model organism for studying innate immunity because of its high resistance against microbial infections and lack of adaptive immunity. In addition, the immune signaling cascades found in Drosophila are evolutionarily conserved. Upon infection, activation of the immune signaling pathways, Toll and Imd, leads to the expression of multiple immune response genes, such as the antimicrobial peptides (AMPs). Previously, we identified an uncharacterized gene edin among the genes, which were strongly induced upon stimulation with Escherichia coli in Drosophila S2 cells. Edin has been associated with resistance against Listeria monocytogenes, but its role in Drosophila immunity remains elusive. In this study, we examined the role of Edin in the immune response of Drosophila both in vitro and in vivo. We report that edin expression is dependent on the Imd-pathway NF-kappa B transcription factor Relish and that it is expressed upon infection both in vitro and in vivo. Edin encodes a pro-protein, which is further processed in S2 cells. In our experiments, Edin did not bind microbes, nor did it possess antimicrobial activity to tested microbial strains in vitro or in vivo. Furthermore, edin RNAi did not significantly affect the expression of AMPs in vitro or in vivo. However, edin RNAi flies showed modestly impaired resistance to E. faecalis infection. We conclude that Edin has no potent antimicrobial properties but it appears to be important for E. faecalis infection via an uncharacterized mechanism. Further studies are still required to elucidate the exact role of Edin in the Drosophila immune response.	[Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika] Univ Tampere, BioMediTech, Tampere, Finland; [Vanha-aho, Leena-Maija; Kleino, Anni; Kaustio, Meri; Wilke, Bettina; Hultmark, Dan; Valanne, Susanna; Ramet, Mika] Univ Tampere, Inst Biomed Technol, Tampere, Finland; [Ulvila, Johanna] Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; [Ulvila, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Hultmark, Dan] Umea Univ, Dept Mol Biol, Umea, Sweden; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Tampere University; Tampere University; University of Oulu; University of Oulu; Umea University; Tampere University; Tampere University Hospital	Vanha-aho, LM (corresponding author), Univ Tampere, BioMediTech, Tampere, Finland.	Mika.Ramet@uta.fi	Valanne, Susanna/GZK-2381-2022; Hultmark, Dan/C-5058-2013	Valanne, Susanna/0000-0003-0898-8423; Hultmark, Dan/0000-0002-6506-5855; Vanha-aho, Leena-Maija/0000-0001-7933-7711	Academy of Finland; Sigrid Juselius Foundation; Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Biocenter Finland	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere Tuberculosis Foundation; Pirkanmaa Hospital District; Tampere Graduate Program in Biomedicine and Biotechnology; Orion-Farmos Research Foundation; Biocenter Finland	This research was supported by grants from the Academy of Finland, the Sigrid Juselius Foundation (to MR), the Tampere Tuberculosis Foundation (to MR and SV), Competitive Research Funding of the Pirkanmaa Hospital District (to MR and SV), the Tampere Graduate Program in Biomedicine and Biotechnology (LMV) and the Orion-Farmos Research Foundation (LMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank other members of our laboratory, Prof. Shoichiro Kurata for the L. monocytogenes strain and VDRC for the edin RNAi line. We are also grateful to Ingrid Dacklin in Umea Fly and Worm Transgene Facility for performing microinjections to fly embryos. The fly work was done at University of Tampere Drosophila Core Facility funded by Biocenter Finland. All authors approved the final version of the text.	Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chung YS, EATERJBIOLCHEM, V286, P26524; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hedengren-Olcott M, 2004, J BIOL CHEM, V279, P21121, DOI 10.1074/jbc.M313856200; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014; Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; Valanne S, 2012, DEV COMP IMMUNOL, V37, P9, DOI 10.1016/j.dci.2011.09.001; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Verleyen P, 2006, J INSECT PHYSIOL, V52, P379, DOI 10.1016/j.jinsphys.2005.12.007; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	32	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37153	10.1371/journal.pone.0037153	http://dx.doi.org/10.1371/journal.pone.0037153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606343	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400069
J	Wu, Q; Henry, JL				Wu, Qi; Henry, James L.			Functional Changes in Muscle Afferent Neurones in an Osteoarthritis Model: Implications for Impaired Proprioceptive Performance	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; ANTERIOR CRUCIATE LIGAMENT; KNEE-JOINT PROPRIOCEPTION; PRIMARY SENSORY NEURONS; ACTION-POTENTIAL SHAPE; LOW-BACK-PAIN; RAT MODEL; GUINEA-PIG; TENDON VIBRATION; POSITION SENSE	Background: Impaired proprioceptive performance is a significant clinical issue for many who suffer osteoarthritis (OA) and is a risk factor for falls and other liabilities. This study was designed to evaluate weight-bearing distribution in a rat model of OA and to determine whether changes also occur in muscle afferent neurones. Methodology/Principal Findings: Intracellular recordings were made in functionally identified dorsal root ganglion neurones in acute electrophysiological experiments on the anaesthetized animal following measurements of hind limb weight bearing in the incapacitance test. OA rats but not naive control rats stood with less weight on the ipsilateral hind leg (P = 0.02). In the acute electrophysiological experiments that followed weight bearing measurements, action potentials (AP) elicited by electrical stimulation of the dorsal roots differed in OA rats, including longer AP duration (P = 0.006), slower rise time (P = 0.001) and slower maximum rising rate (P = 0.03). Depolarizing intracellular current injection elicited more APs in models than in naive muscle afferent neurones (P = 0.01) indicating greater excitability. Axonal conduction velocity in model animals was slower (P = 0.04). Conclusions/Significance: The present study demonstrates changes in hind limb stance accompanied by changes in the functional properties of muscle afferent neurones in this derangement model of OA. This may provide a possible avenue to explore mechanisms underlying the impaired proprioceptive performance and perhaps other sensory disorders in people with OA.	[Wu, Qi; Henry, James L.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada	McMaster University	Wu, Q (corresponding author), Toronto Western Res Inst, Div Brain Imaging & Behav Syst, Toronto, ON, Canada.	jhenry@mcmaster.ca			Canadian Arthritis Network (CAN) [03-OAS-03]; Canadian Institutes of Health Research (CIHR) [NEO 66211]; McMaster University; Canadian Pain Society	Canadian Arthritis Network (CAN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McMaster University; Canadian Pain Society	This work was generously supported by a New Emerging Team grant from the Canadian Arthritis Network (CAN) grant number: 03-OAS-03 and the Canadian Institutes of Health Research (CIHR) grant number: NEO 66211, and funds from McMaster University. JLH was Chair in Central Pain in the Faculty of Health Sciences at McMaster University. QW was a CIHR Strategic Training Fellow in Pain: Molecules to Community, and was also supported by the Canadian Pain Society, CAN and CIHR graduate awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs are as follows: http://www.cihr-irsc.gc.ca/e/193.html; http://www.arthritisnetwork.ca/home/home_en.php; http://www.canadianpainsociety.ca/en/	Albert F, 2006, EXP BRAIN RES, V172, P163, DOI 10.1007/s00221-005-0325-2; Appleton CTG, 2007, ANN NY ACAD SCI, V1117, P165, DOI 10.1196/annals.1402.022; ASSIMAKOPOULOS AP, 1992, CLIN ORTHOP RELAT R, P232; Barton NJ, 2007, J NEUROSCI METH, V163, P67, DOI 10.1016/j.jneumeth.2007.02.012; Bennell KL, 2003, J ORTHOP RES, V21, P792, DOI 10.1016/S0736-0266(03)00054-8; BERNAUER EM, 1994, AVIAT SPACE ENVIR MD, V65, P1110; BOUCHER P, 1995, DIABETES CARE, V18, P638, DOI 10.2337/diacare.18.5.638; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Brumagne S, 1999, SPINE, V24, P1328, DOI 10.1097/00007632-199907010-00010; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2008, GAIT POSTURE, V28, P657, DOI 10.1016/j.gaitpost.2008.04.015; Clarke KA, 1997, PHYSIOL BEHAV, V62, P951, DOI 10.1016/S0031-9384(97)00022-X; CORDO P, 1993, ELECTROEN CLIN NEURO, V89, P45, DOI 10.1016/0168-5597(93)90084-3; Creamer P, 1998, OSTEOARTHR CARTILAGE, V6, P318, DOI 10.1053/joca.1998.0130; De Ciantis Paolo Donato, 2010, J Pain Res, V3, P213, DOI 10.2147/JPR.S14209; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; Djouhri L, 2001, NEUROSCIENCE, V108, P479, DOI 10.1016/S0306-4522(01)00423-7; Fang X, 2005, J PHYSIOL-LONDON, V565, P927, DOI 10.1113/jphysiol.2005.086199; Fang X, 2002, J NEUROSCI, V22, P7425; Felson DT, 2009, ARTHRIT RHEUM-ARTHR, V61, P1070, DOI 10.1002/art.24606; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V480, P395, DOI 10.1113/jphysiol.1994.sp020369; Friden T, 2001, J ORTHOP SPORT PHYS, V31, P567, DOI 10.2519/jospt.2001.31.10.567; Gandevia S. C., 1996, HDB PHYSL 12, P128, DOI DOI 10.1002/CPHY.CP120104; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P47, DOI 10.1113/jphysiol.1985.sp015574; HAUS J, 1990, INT ORTHOP, V14, P293; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; Im HJ, 2010, ARTHRITIS RHEUM-US, V62, P2995, DOI 10.1002/art.27608; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Kars H J J Cojanne, 2009, J Diabetes Sci Technol, V3, P931; Kim YI, 1998, NEUROSCIENCE, V86, P301, DOI 10.1016/S0306-4522(98)00022-0; Knoop J, 2011, OSTEOARTHR CARTILAGE, V19, P381, DOI 10.1016/j.joca.2011.01.003; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Lephart SM, 1997, AM J SPORT MED, V25, P130, DOI 10.1177/036354659702500126; Liu CN, 2002, J NEUROPHYSIOL, V87, P2009, DOI 10.1152/jn.00705.2001; Liu S, 2009, MOL THER, V17, P992, DOI 10.1038/mt.2009.23; Lund H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P391; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; Matre D, 2002, EUR J PAIN, V6, P245, DOI 10.1053/eujp.2002.0332; Michaelis M, 2000, J NEUROSCI, V20, P2742; NANCE PW, 1985, ARCH PHYS MED REHAB, V66, P123; Nardone A, 2006, GAIT POSTURE, V23, P364, DOI 10.1016/j.gaitpost.2005.04.002; Oyelese AA, 1996, J NEUROPHYSIOL, V76, P2383, DOI 10.1152/jn.1996.76.4.2383; Pai YC, 1997, ARTHRITIS RHEUM, V40, P2260, DOI 10.1002/art.1780401223; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Proske U, 2005, MUSCLE NERVE, V31, P780, DOI 10.1002/mus.20330; Ribot-Ciscar E, 2003, EXP BRAIN RES, V149, P512, DOI 10.1007/s00221-003-1384-x; Riskowski J. L., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P379; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Roll JP, 2004, EXP BRAIN RES, V157, P359, DOI 10.1007/s00221-004-1853-x; Salo PT, 1997, J ANAT, V190, P515, DOI 10.1046/j.1469-7580.1997.19040515.x; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; SCHOTT E, 1994, J PHARMACOL TOXICOL, V31, P79, DOI 10.1016/1056-8719(94)90046-9; Schuelert N, 2011, PAIN, V152, P975, DOI 10.1016/j.pain.2010.11.025; Shakoor N, 2008, ARTHRIT RHEUM-ARTHR, V59, P117, DOI 10.1002/art.23241; Sharma L, 1999, RHEUM DIS CLIN N AM, V25, P299, DOI 10.1016/S0889-857X(05)70069-7; Sharma L, 2003, ARTHRITIS RHEUM-US, V48, P3359, DOI 10.1002/art.11420; Sharma Leena, 1997, Current Opinion in Rheumatology, V9, P253, DOI 10.1097/00002281-199705000-00013; SIMONEAU GG, 1994, DIABETES CARE, V17, P1411, DOI 10.2337/diacare.17.12.1411; Song XJ, 1999, J NEUROPHYSIOL, V82, P3347, DOI 10.1152/jn.1999.82.6.3347; Sorensen KL, 2002, EXP BRAIN RES, V143, P24, DOI 10.1007/s00221-001-0962-z; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; UCCIOLI L, 1995, DIABETES CARE, V18, P339, DOI 10.2337/diacare.18.3.339; Vad V, 2002, SPORTS MED, V32, P729, DOI 10.2165/00007256-200232110-00004; van der Esch M, 2007, ARTHRIT RHEUM-ARTHR, V57, P787, DOI 10.1002/art.22779; Villiere V, 1996, J NEUROPHYSIOL, V76, P1924, DOI 10.1152/jn.1996.76.3.1924; Weerakkody NS, 2008, J PHYSIOL-LONDON, V586, P3183, DOI 10.1113/jphysiol.2008.152942; Wright DE, 2004, J PERIPHER NERV SYST, V9, P242, DOI 10.1111/j.1085-9489.2004.09404.x; Wu Q, 2011, PRINCIPLES OSTEOARTH, P429; Wu Q, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-37; Wu Q, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-57; Yakhdani HRF, 2010, CLIN BIOMECH, V25, P230, DOI 10.1016/j.clinbiomech.2009.12.003; Zhang JM, 1999, J NEUROPHYSIOL, V82, P3359, DOI 10.1152/jn.1999.82.6.3359	78	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36854	10.1371/journal.pone.0036854	http://dx.doi.org/10.1371/journal.pone.0036854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606297	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400037
J	Lorenzi, T; Turi, A; Lorenzi, M; Paolinelli, F; Mancioli, F; La Sala, L; Morroni, M; Ciarmela, P; Mantovani, A; Tranquilli, AL; Castellucci, M; Marzioni, D				Lorenzi, Teresa; Turi, Angelo; Lorenzi, Maria; Paolinelli, Francesca; Mancioli, Francesca; La Sala, Lucia; Morroni, Manrico; Ciarmela, Pasquapina; Mantovani, Angelo; Tranquilli, Andrea Luigi; Castellucci, Mario; Marzioni, Daniela			Placental Expression of CD100, CD72 and CD45 Is Dysregulated in Human Miscarriage	PLOS ONE			English	Article							REGULATORY T-CELLS; SPONTANEOUS-ABORTION; RISK-FACTORS; REPRODUCTIVE-PERFORMANCE; SEMAPHORINS; LYMPHOCYTES; SURFACE; DIFFERENTIATION; ALLOANTIGENS; CONSUMPTION	Context and Objective: The etiology of miscarriage is often multifactorial. One major cause, immunological rejection of the fetus, has not been clearly elucidated. Our aim was to establish whether the semaphorin CD100, its natural receptor CD72, and the glycoprotein CD45, implicated in immune mechanisms, are involved in pregnancy loss by examining their placental expression with real-time PCR, immunohistochemistry and western blotting techniques. Patients: Placenta tissue from 72 Caucasian women undergoing surgical uterine evacuation due to early spontaneous pregnancy loss between the 8th and 12th week of gestation was divided into four groups based on miscarriage number. Gestational age-matched placentas from 18 healthy women without a history of miscarriage undergoing voluntary pregnancy termination were the control group. Placenta from 6 Caesarean deliveries performed at 38-40 weeks of gestation was also studied. Results: CD100, CD72 and CD45 were expressed in placenta and exhibited different mRNA and protein levels in normal pregnancy and miscarriage. In particular, protein levels were highly dysregulated around 10 weeks of gestation in first and second miscarriage placentas. The CD100 soluble form was produced and immediately shed from placental tissue in all samples. Conclusions: Fetal CD100, CD72 and CD45 seem to play a role in miscarriage. The present data support the involvement of the fetal immune system in pregnancy maintenance as well as failure.	[Lorenzi, Teresa; Lorenzi, Maria; Paolinelli, Francesca; Morroni, Manrico; Ciarmela, Pasquapina; Castellucci, Mario; Marzioni, Daniela] Univ Politecn Marche, Sch Med, Dept Expt & Clin Med, Div Neurosci & Cell Biol, Ancona, Italy; [Turi, Angelo; Mancioli, Francesca; Tranquilli, Andrea Luigi] Univ Politecn Marche, Dept Clin Sci, G Salesi Hosp, Unit Obstet & Gynecol, Ancona, Italy; [La Sala, Lucia] Univ Politecn Marche, Sch Med, Dept Clin & Mol Sci, Ancona, Italy; [Mantovani, Angelo] San Severino Marche Hosp, Unit Obstet & Gynecol, San Severino Marche, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Lorenzi, T (corresponding author), Univ Politecn Marche, Sch Med, Dept Expt & Clin Med, Div Neurosci & Cell Biol, Ancona, Italy.	t.lorenzi@univpm.it; m.castellucci@univpm.it	La Sala, Lucia/A-4467-2019; La Sala, Lucia/AAC-3458-2022; Ciarmela, Pasquapina/U-8435-2019; La Sala, Lucia/Q-9969-2016	La Sala, Lucia/0000-0002-7580-1377; La Sala, Lucia/0000-0002-7580-1377; Ciarmela, Pasquapina/0000-0002-4400-3786; La Sala, Lucia/0000-0002-7580-1377; Lorenzi, Teresa/0000-0002-3723-5378	Universita Politecnica delle Marche; Fondazione Cassa di Risparmio di Fabriano e Cupramontana	Universita Politecnica delle Marche; Fondazione Cassa di Risparmio di Fabriano e Cupramontana	This study was supported by grants from Universita Politecnica delle Marche 2008-2010 to AT, MM, MC, ALT, DM and a grant from Fondazione Cassa di Risparmio di Fabriano e Cupramontana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Billard C, 2000, BLOOD, V95, P965, DOI 10.1182/blood.V95.3.965.003k39_965_972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; de Wit J, 2003, PROG NEUROBIOL, V71, P249, DOI 10.1016/j.pneurobio.2003.06.001; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Elhabazi A, 1997, J BIOL CHEM, V272, P23515, DOI 10.1074/jbc.272.38.23515; Garcia-Enguidanos A, 2002, EUR J OBSTET GYN R B, V102, P111, DOI 10.1016/S0301-2115(01)00613-3; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; Goffin F, 2003, TISSUE ANTIGENS, V62, P104, DOI 10.1034/j.1399-0039.2003.00085.x; GORDON J, 1994, IMMUNOL TODAY, V15, P411, DOI 10.1016/0167-5699(94)90270-4; Gray RH, 2000, AM J PUBLIC HEALTH, V90, P1452, DOI 10.2105/AJPH.90.9.1452; HAYNES BF, 1995, J EXP MED, V181, P1445, DOI 10.1084/jem.181.4.1445; Herold C, 1996, J IMMUNOL, V157, P5262; Jamin C, 1997, INT IMMUNOL, V9, P1001, DOI 10.1093/intimm/9.7.1001; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li M, 2009, IMMUNOLOGY, V128, P114, DOI 10.1111/j.1365-2567.2009.03098.x; Menzies FM, 2011, IMMUNOLOGY, V134, P281, DOI 10.1111/j.1365-2567.2011.03488.x; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Nkyimbeng-Takwi E, 2011, IMMUNOL RES, V50, P10, DOI 10.1007/s12026-010-8201-y; PLOUFFE L, 1992, AM J OBSTET GYNECOL, V167, P313, DOI 10.1016/S0002-9378(11)91407-0; Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Shao L, 2005, J IMMUNOL, V174, P7539, DOI 10.4049/jimmunol.174.12.7539; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Takegahara N, 2005, PHILOS T R SOC B, V360, P1673, DOI 10.1098/rstb.2005.1696; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Wilamasundera S, 1998, EUR J IMMUNOL, V28, P4374, DOI 10.1002/(SICI)1521-4141(199812)28:12<4374::AID-IMMU4374>3.0.CO;2-P; Windham GC, 1997, EPIDEMIOLOGY, V8, P509, DOI 10.1097/00001648-199709000-00007	40	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35232	10.1371/journal.pone.0035232	http://dx.doi.org/10.1371/journal.pone.0035232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606231	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200009
J	Barros-Becker, F; Romero, J; Pulgar, A; Feijoo, CG				Barros-Becker, Francisco; Romero, Jaime; Pulgar, Alvaro; Feijoo, Carmen G.			Persistent Oxytetracycline Exposure Induces an Inflammatory Process That Improves Regenerative Capacity in Zebrafish Larvae	PLOS ONE			English	Article							IMMUNE-SYSTEM; RAINBOW-TROUT; OXOLINIC ACID; DANIO-RERIO; FISH; MODEL; ANTIBIOTICS; AQUACULTURE; EXPRESSION; RESIDUES	Background: The excessive use of antibiotics in aquaculture can adversely affect not only the environment, but also fish themselves. In this regard, there is evidence that some antibiotics can activate the immune system and reduce their effectiveness. None of those studies consider in detail the adverse inflammatory effect that the antibiotic remaining in the water may cause to the fish. In this work, we use the zebrafish to analyze quantitatively the effects of persistent exposure to oxytetracycline, the most common antibiotic used in fish farming. Methodology: We developed a quantitative assay in which we exposed zebrafish larvae to oxytetracycline for a period of 24 to 96 hrs. In order to determinate if the exposure causes any inflammation reaction, we evaluated neutrophils infiltration and quantified their total number analyzing the Tg(mpx:GFP)(i114) transgenic line by fluorescence stereoscope, microscope and flow cytometry respectively. On the other hand, we characterized the process at a molecular level by analyzing several immune markers (il-1 beta, il-10, lysC, mpx, cyp1a) at different time points by qPCR. Finally, we evaluated the influence of the inflammation triggered by oxytetracycline on the regeneration capacity in the lateral line. Conclusions: Our results suggest that after 48 hours of exposure, the oxytetracycline triggered a widespread inflammation process that persisted until 96 hours of exposure. Interestingly, larvae that developed an inflammation process showed an improved regeneration capacity in the mechanosensory system lateral line.	[Barros-Becker, Francisco; Pulgar, Alvaro; Feijoo, Carmen G.] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Romero, Jaime] Univ Chile, Inst Nutr & Tecnol Alimentos, Santiago 11, Chile	Universidad Andres Bello; Universidad de Chile	Barros-Becker, F (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.	cfeijoo@unab.cl	Romero, Jaime/I-2816-2013; Feijoo, Carmen G/AAF-9003-2019	Romero, Jaime/0000-0001-9614-2393; Feijoo, Carmen G/0000-0003-1128-403X; Barros-Becker, Francisco/0000-0002-4983-110X	Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt) [11090102, 1110253]; Universidad Andres Bello (UNAB) [DI39-11/R]; Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) [79090006]	Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello (UNAB); Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	CGF was supported by Fondo Nacional de Desarrolo Cientifico y Tecnologico (Fondecyt) 11090102, Universidad Andres Bello (UNAB) DI39-11/R, and Comision Nacional de Investigacion Cientifica y Tecnologica (Conicyt) 79090006. JR was supported by Fondecyt 1110253. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2010, FUTURE MICROBIOL, V5, P563, DOI [10.2217/fmb.10.24, 10.2217/FMB.10.24]; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bebak-Williams J, 2002, AQUACULTURE, V205, P221, DOI 10.1016/S0044-8486(01)00690-1; BJORKLUND HV, 1991, AQUACULTURE, V97, P85, DOI 10.1016/0044-8486(91)90281-B; Cabello FC, 2004, REV MED CHILE, V132, P1001; Caipang CMA, 2009, COMP BIOCHEM PHYS C, V150, P459, DOI 10.1016/j.cbpc.2009.07.001; Carson MC, 2002, J AOAC INT, V85, P341; Chen GY, NATURE REV IMMUNOL, V10, P826; d'Alencon CA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-151; Ellett F, 2010, CURR OPIN PHARMACOL, V10, P563, DOI 10.1016/j.coph.2010.05.004; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Froehlicher M, 2009, AQUAT TOXICOL, V95, P307, DOI 10.1016/j.aquatox.2009.04.007; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; GOKSOYR A, 1992, AQUAT TOXICOL, V22, P287, DOI 10.1016/0166-445X(92)90046-P; GRONDEL JL, 1987, J FISH DIS, V10, P35, DOI 10.1111/j.1365-2761.1987.tb00716.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; Hinton DE, 2005, MAR POLLUT BULL, V51, P635, DOI 10.1016/j.marpolbul.2005.07.020; JACOBSEN P, 1988, AQUACULTURE, V70, P365, DOI 10.1016/0044-8486(88)90120-2; KAJITA Y, 1990, FISH PATHOL, V25, P93, DOI 10.3147/jsfp.25.93; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LAALE HW, 1977, CAN J ZOOL, V55, P304, DOI 10.1139/z77-041; Lalumera GM, 2004, CHEMOSPHERE, V54, P661, DOI 10.1016/j.chemosphere.2003.08.001; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Lunden T, 1998, FISH SHELLFISH IMMUN, V8, P217, DOI 10.1006/fsim.1998.0142; Lunden T, 2002, VET IMMUNOL IMMUNOP, V85, P99, DOI 10.1016/S0165-2427(01)00422-6; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Millanao A, 2011, REV MED CHILE, V139, P107, DOI /S0034-98872011000100015; Morgan ET, 2001, DRUG METAB DISPOS, V29, P207; Christensen AM, 2006, ENVIRON TOXICOL CHEM, V25, P2208, DOI 10.1897/05-415R.1; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pouliquen H, 2009, ENVIRON TOXICOL CHEM, V28, P496, DOI 10.1897/08-238.1; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; RIJKERS GT, 1981, VET IMMUNOL IMMUNOP, V2, P281, DOI 10.1016/0165-2427(81)90029-5; Roex EWM, 2001, ECOTOX ENVIRON SAFE, V48, P196, DOI 10.1006/eesa.2000.2029; Rose PE, 2005, ENVIRON TOXICOL CHEM, V24, P40, DOI 10.1897/03-640.1; SAMUELSEN OB, 1992, SCI TOTAL ENVIRON, V114, P25, DOI 10.1016/0048-9697(92)90411-K; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; SIWICKI AK, 1989, VET IMMUNOL IMMUNOP, V23, P195, DOI 10.1016/0165-2427(89)90122-0; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Tafalla C, 1999, J FISH DIS, V22, P271, DOI 10.1046/j.1365-2761.1999.00179.x; THORBURN MA, 1987, DIS AQUAT ORGAN, V2, P167; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Traver D, 2003, ADV IMMUNOL, V81, P253; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; vanderHeijden MHT, 1996, VET IMMUNOL IMMUNOP, V52, P127, DOI 10.1016/0165-2427(95)05532-0; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, DEV BIOL, V226, P220, DOI 10.1006/dbio.2000.9860; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005	55	34	39	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36827	10.1371/journal.pone.0036827	http://dx.doi.org/10.1371/journal.pone.0036827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590621	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400039
J	Savic, D; Bell, GI; Nobrega, MA				Savic, Daniel; Bell, Graeme I.; Nobrega, Marcelo A.			An in vivo cis-Regulatory Screen at the Type 2 Diabetes Associated TCF7L2 Locus Identifies Multiple Tissue-Specific Enhancers	PLOS ONE			English	Article							INCREASED RISK; BONE-FORMATION; GENE; CATENIN; EXPRESSION; CHROMATIN; INSIGHTS; INCREASE; GHRELIN; VARIANT	Genome-wide association studies (GWAS) have repeatedly shown an association between non-coding variants in the TCF7L2 locus and risk for type 2 diabetes (T2D), implicating a role for cis-regulatory variation within this locus in disease etiology. Supporting this hypothesis, we previously localized complex regulatory activity to the TCF7L2 T2D-associated interval using an in vivo bacterial artificial chromosome (BAC) enhancer-trapping reporter strategy. To follow-up on this broad initial survey of the TCF7L2 regulatory landscape, we performed a fine-mapping enhancer scan using in vivo mouse transgenic reporter assays. We functionally interrogated approximately 50% of the sequences within the T2D-associated interval, utilizing sequence conservation within this 92-kb interval to determine the regulatory potential of all evolutionary conserved sequences that exhibited conservation to the non-eutherian mammal opossum. Included in this study was a detailed functional interrogation of sequences spanning both protective and risk alleles of single nucleotide polymorphism (SNP) rs7903146, which has exhibited allele-specific enhancer function in pancreatic beta cells. Using these assays, we identified nine segments regulating various aspects of the TCF7L2 expression profile and that constitute nearly 70% of the sequences tested. These results highlight the regulatory complexity of this interval and support the notion that a TCF7L2 cis-regulatory disruption leads to T2D predisposition.	[Savic, Daniel; Bell, Graeme I.; Nobrega, Marcelo A.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Savic, D (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	dsavic@uchicago.edu; nobrega@uchicago.edu	Savic, Daniel/N-5525-2018	Savic, Daniel/0000-0002-6693-0265	NIH [DK078871, HG004428, DK020595, T32 GM007197]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, R21DK078871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants DK078871 and HG004428 (M.A.N.), DK020595 (G.I.B.), T32 GM007197 (D.S.) and a gift from the Kovler Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlzen M, 2008, BIOCHEM BIOPH RES CO, V370, P49, DOI 10.1016/j.bbrc.2008.03.006; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Figeac F, 2010, AM J PHYSIOL-ENDOC M, V298, pE245, DOI 10.1152/ajpendo.00538.2009; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gough Stephen C L, 2005, J Psychopharmacol, V19, P47, DOI 10.1177/0269881105058380; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hansen T, 2011, BIOL PSYCHIAT, V70, P59, DOI 10.1016/j.biopsych.2011.01.031; Heppner KM, 2011, CURR OPIN ENDOCRINOL, V18, P50, DOI 10.1097/MED.0b013e328341e1d3; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Le Bacquer O, 2011, HUM MOL GENET; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lin PI, 2010, SCHIZOPHR RES, V123, P234, DOI 10.1016/j.schres.2010.08.022; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Norton L, 2011, DIABETOLOGIA, V54, P3132, DOI 10.1007/s00125-011-2289-z; Prokunina-Olsson L, 2010, DIABETOLOGIA, V53, P712, DOI 10.1007/s00125-009-1640-0; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sakabe NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-238; Savic D, 2011, GENOME RES; Savic D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026897; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Sousa AGP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007697; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zhou Y, 2011, HUM MOL GENET	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36501	10.1371/journal.pone.0036501	http://dx.doi.org/10.1371/journal.pone.0036501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590553	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400020
J	Wilkerson, MD; Yin, XY; Walter, V; Zhao, N; Cabanski, CR; Hayward, MC; Miller, CR; Socinski, MA; Parsons, AM; Thorne, LB; Haithcock, BE; Veeramachaneni, NK; Funkhouser, WK; Randell, SH; Bernard, PS; Perou, CM; Hayes, DN				Wilkerson, Matthew D.; Yin, Xiaoying; Walter, Vonn; Zhao, Ni; Cabanski, Christopher R.; Hayward, Michele C.; Miller, C. Ryan; Socinski, Mark A.; Parsons, Alden M.; Thorne, Leigh B.; Haithcock, Benjamin E.; Veeramachaneni, Nirmal K.; Funkhouser, William K.; Randell, Scott H.; Bernard, Philip S.; Perou, Charles M.; Hayes, D. Neil			Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation	PLOS ONE			English	Article							CANCER CELL-LINES; GENE-EXPRESSION; CLASS DISCOVERY; BREAST-CANCER; EGFR MUTATION; THERAPY; TUMORS; CLASSIFICATION; VALIDATION; RECURRENCE	Background: Lung adenocarcinoma (LAD) has extreme genetic variation among patients, which is currently not well understood, limiting progress in therapy development and research. LAD intrinsic molecular subtypes are a validated stratification of naturally-occurring gene expression patterns and encompass different functional pathways and patient outcomes. Patients may have incurred different mutations and alterations that led to the different subtypes. We hypothesized that the LAD molecular subtypes co-occur with distinct mutations and alterations in patient tumors. Methodology/Principal Findings: The LAD molecular subtypes (Bronchioid, Magnoid, and Squamoid) were tested for association with gene mutations and DNA copy number alterations using statistical methods and published cohorts (n = 504). A novel validation (n = 116) cohort was assayed and interrogated to confirm subtype-alteration associations. Gene mutation rates (EGFR, KRAS, STK11, TP53), chromosomal instability, regional copy number, and genomewide DNA methylation were significantly different among tumors of the molecular subtypes. Secondary analyses compared subtypes by integrated alterations and patient outcomes. Tumors having integrated alterations in the same gene associated with the subtypes, e.g. mutation, deletion and underexpression of STK11 with Magnoid, and mutation, amplification, and overexpression of EGFR with Bronchioid. The subtypes also associated with tumors having concurrent mutant genes, such as KRAS-STK11 with Magnoid. Patient overall survival, cisplatin plus vinorelbine therapy response and predicted gefitinib sensitivity were significantly different among the subtypes. Conclusions/Significance: The lung adenocarcinoma intrinsic molecular subtypes co-occur with grossly distinct genomic alterations and with patient therapy response. These results advance the understanding of lung adenocarcinoma etiology and nominate patient subgroups for future evaluation of treatment response.	[Wilkerson, Matthew D.; Yin, Xiaoying; Walter, Vonn; Zhao, Ni; Cabanski, Christopher R.; Hayward, Michele C.; Miller, C. Ryan; Socinski, Mark A.; Thorne, Leigh B.; Funkhouser, William K.; Randell, Scott H.; Perou, Charles M.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Walter, Vonn; Zhao, Ni] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cabanski, Christopher R.] Univ N Carolina, Dept Stat & Operat Res, Chapel Hill, NC USA; [Miller, C. Ryan; Thorne, Leigh B.; Funkhouser, William K.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Socinski, Mark A.; Hayes, D. Neil] Univ N Carolina, Dept Internal Med, Div Med Oncol, Multidisciplinary Thorac Oncol Program, Chapel Hill, NC USA; [Socinski, Mark A.; Parsons, Alden M.; Haithcock, Benjamin E.; Veeramachaneni, Nirmal K.] Univ N Carolina, Dept Surg, Div Cardiothorac Surg, Chapel Hill, NC USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Bernard, Philip S.] Utah Hlth Sci Ctr, Salt Lake City, UT USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilkerson, MD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu	Miller, Ryan/B-9365-2008; Walter, Vonn/AAI-3450-2021; Perou, Charles M/H-9934-2014; , Pathology Services Core/CEZ-2246-2022; Zhao, Ni/P-9086-2014	Miller, Ryan/0000-0002-0096-8762; Walter, Vonn/0000-0001-6114-6714; Perou, Charles M/0000-0001-9827-2247; Zhao, Ni/0000-0002-7762-3949; Hayes, D. Neil/0000-0001-6203-7771	National Cancer Institute (NIH) [NIH F32CA142039]; National Center for Research Resources (NIH) [K12-RR023248]; Thomas G. Labrecque Foundation through Joan's Legacy Foundation; Lineberger Comprehensive Cancer Center; National Heart, Lung, and Blood Institute (NHLBI) [1-RC1-HL100108]; NATIONAL CANCER INSTITUTE [F32CA142039, P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100108] Funding Source: NIH RePORTER	National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Thomas G. Labrecque Foundation through Joan's Legacy Foundation; Lineberger Comprehensive Cancer Center; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MDW was supported by a Ruth L. Kirschstein National Research Service Award Individual Fellowship from the National Cancer Institute (NIH F32CA142039). Additional funding provided by National Center for Research Resources (NIH K12-RR023248), the Thomas G. Labrecque Foundation through Joan's Legacy Foundation, Lineberger Comprehensive Cancer Center Translational Small Grants Program, and the National Heart, Lung, and Blood Institute (NHLBI 1-RC1-HL100108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barletta JA, 2010, CANCER-AM CANCER SOC, V116, P659, DOI 10.1002/cncr.24831; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Dacic S, 2010, MODERN PATHOL, V23, P159, DOI 10.1038/modpathol.2009.154; de Wilde J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-271; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Hastak K, 2010, CANCER RES, V70, P7970, DOI 10.1158/0008-5472.CAN-09-4521; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weigman VJ, 2011, BREAST CANC RES TREA; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Yatabe Y, 2005, AM J SURG PATHOL, V29, P633, DOI 10.1097/01.pas.0000157935.28066.35; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	49	159	166	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36530	10.1371/journal.pone.0036530	http://dx.doi.org/10.1371/journal.pone.0036530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590557	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400022
J	Mazzaglia, A; Studholme, DJ; Taratufolo, MC; Cai, RM; Almeida, NF; Goodman, T; Guttman, DS; Vinatzer, BA; Balestra, GM				Mazzaglia, Angelo; Studholme, David J.; Taratufolo, Maria C.; Cai, Rongman; Almeida, Nalvo F.; Goodman, Tokia; Guttman, David S.; Vinatzer, Boris A.; Balestra, Giorgio M.			Pseudomonas syringae pv. actinidiae (PSA) Isolates from Recent Bacterial Canker of Kiwifruit Outbreaks Belong to the Same Genetic Lineage	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENOME; EVOLUTION; SEQUENCE; HOST; INFECTION; SURVIVAL; SEED	Intercontinental spread of emerging plant diseases is one of the most serious threats to world agriculture. One emerging disease is bacterial canker of kiwi fruit (Actinidia deliciosa and A. chinensis) caused by Pseudomonas syringae pv. actinidiae (PSA). The disease first occurred in China and Japan in the 1980s and in Korea and Italy in the 1990s. A more severe form of the disease broke out in Italy in 2008 and in additional countries in 2010 and 2011 threatening the viability of the global kiwi fruit industry. To start investigating the source and routes of international transmission of PSA, genomes of strains from China (the country of origin of the genus Actinidia), Japan, Korea, Italy and Portugal have been sequenced. Strains from China, Italy, and Portugal have been found to belong to the same clonal lineage with only 6 single nucleotide polymorphisms (SNPs) in 3,453,192 bp and one genomic island distinguishing the Chinese strains from the European strains. Not more than two SNPs distinguish each of the Italian and Portuguese strains from each other. The Japanese and Korean strains belong to a separate genetic lineage as previously reported. Analysis of additional European isolates and of New Zealand isolates exploiting genome-derived markers showed that these strains belong to the same lineage as the Italian and Chinese strains. Interestingly, the analyzed New Zealand strains are identical to European strains at the tested SNP loci but test positive for the genomic island present in the sequenced Chinese strains and negative for the genomic island present in the European strains. Results are interpreted in regard to the possible direction of movement of the pathogen between countries and suggest a possible Chinese origin of the European and New Zealand outbreaks.	[Mazzaglia, Angelo; Taratufolo, Maria C.; Balestra, Giorgio M.] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Studholme, David J.] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Cai, Rongman; Goodman, Tokia; Vinatzer, Boris A.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA; [Almeida, Nalvo F.] Univ Fed Mato Grosso do Sul, Sch Comp, Campo Grande, Brazil; [Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	Tuscia University; University of Exeter; Virginia Polytechnic Institute & State University; Universidade Federal de Mato Grosso do Sul; University of Toronto	Mazzaglia, A (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.	balestra@unitus.it; vinatzer@vt.edu	Almeida, Nalvo/B-5856-2012; Guttman, David S/A-7839-2011; Studholme, David/H-6790-2019; Cai, Rongman/C-5998-2015; Mazzaglia, Angelo/I-4336-2012	Guttman, David S/0000-0001-8479-3869; Studholme, David/0000-0002-3010-6637; Cai, Rongman/0000-0003-2404-4852; Mazzaglia, Angelo/0000-0002-1295-2565; Almeida, Nalvo/0000-0001-5615-1746; BALESTRA, Giorgio/0000-0002-0822-4506	Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia; Italian Minister of Agriculture and Food Polices (MIPAAF) [247]; Department of Agriculture, Regione Lazio, Italy; Fundect [23/200194/2009]; CNPq [305503/2010-3, 474814/2010-6]; National Science Foundation [IOS 0746501]; Division Of Integrative Organismal Systems [0746501] Funding Source: National Science Foundation	Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia; Italian Minister of Agriculture and Food Polices (MIPAAF); Department of Agriculture, Regione Lazio, Italy; Fundect(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Department of Science and Technologies for Agriculture, Forestry, Nature and Energy (DAFNE) at the University of Tuscia, the Italian Minister of Agriculture and Food Polices (MIPAAF), OIGA n. 247, and partially by the Department of Agriculture, Regione Lazio, Italy. Nalvo F. Almeida was supported through Fundect (Award 23/200194/2009) and CNPq (Awards 305503/2010-3 and 474814/2010-6). Research at the Department of Plant Pathology, Physiology, and Weed Science at Virginia Tech was supported by the National Science Foundation (Award IOS 0746501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; [Anonymous], 2011, BACTERIAL CANKER KIW; Australia B, 2011, PEST RISK AN REP PSE; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balestra GM, 2009, AUSTRALAS PLANT DIS, V4, P34, DOI 10.1071/DN09014; Balestra G.M., 2010, NEW DIS REPORTS, V22; Balestra G. M., 2008, INFORM AGRARIO, V38, P75; Balestra GM, 2011, NEW DIS REPORTS, P24; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bos KI, 2011, NATURE; Bull CT, 2011, PHYTOPATHOLOGY; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman J., 2011, 2 REPORT CHARACTERIZ; Cheng H.Y., 1995, J ANHUI AGR U, V22, P219; Deflorian S, 2009, MIGLIORAMENTO GENETI; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Everett KR, 2011, AUSTRALIASIAN PLANT; Fang Y., 1990, SICHUAN FRUIT SCI TE, V18, P28; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Green S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010224; HATTINGH MJ, 1989, PLANT DIS, V73, P784, DOI 10.1094/PD-73-0784; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Li JQ, 2007, ACTA HORTICULTURAE, P753; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang Y, 2000, J NW FORESTRY COLL, V15, P37; MALVICK DK, 1988, PLANT PATHOL, V37, P573, DOI 10.1111/j.1365-3059.1988.tb02117.x; Marcelletti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027297; Mazzaglia A, 2011, CAN J PLANT PATHOL, V33, P8, DOI 10.1080/07060661.2010.538556; MCCARTER SM, 1983, PHYTOPATHOLOGY, V73, P1393, DOI 10.1094/Phyto-73-1393; Ministry of Agriculture Forestry NZ, 2011, PSA PATHW TRAC REP; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Morton F, 1987, FRUITS WARM CLIMATES; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Service ER, 2011, 1 SERV ER; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; TAYLOR JD, 1979, ANN APPL BIOL, V93, P267, DOI 10.1111/j.1744-7348.1979.tb06541.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vanneste JL, 2011, PLANT DIS, V95, P1311, DOI 10.1094/PDIS-03-11-0195; Vanneste J. L., 2011, New Zealand Plant Protection, V64, P246	56	102	115	7	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36518	10.1371/journal.pone.0036518	http://dx.doi.org/10.1371/journal.pone.0036518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590555	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100033
J	Tomczak, A; Sontheimer, J; Drechsel, D; Hausdorf, R; Gentzel, M; Shevchenko, A; Eichler, S; Fahmy, K; Buchholz, F; Pisabarro, MT				Tomczak, Aurelie; Sontheimer, Jana; Drechsel, David; Hausdorf, Rainer; Gentzel, Marc; Shevchenko, Andrej; Eichler, Stefanie; Fahmy, Karim; Buchholz, Frank; Pisabarro, M. Teresa			3D Profile-Based Approach to Proteome-Wide Discovery of Novel Human Chemokines	PLOS ONE			English	Article							FOLD RECOGNITION; SEQUENCE ALIGNMENTS; GENE-EXPRESSION; T-CELLS; PROTEINS; PREDICTION; DATABASE; MODELS; CLASSIFICATION; IDENTIFICATION	Chemokines are small secreted proteins with important roles in immune responses. They consist of a conserved three-dimensional (3D) structure, so-called IL8-like chemokine fold, which is supported by disulfide bridges characteristic of this protein family. Sequence-and profile-based computational methods have been proficient in discovering novel chemokines by making use of their sequence-conserved cysteine patterns. However, it has been recently shown that some chemokines escaped annotation by these methods due to low sequence similarity to known chemokines and to different arrangement of cysteines in sequence and in 3D. Innovative methods overcoming the limitations of current techniques may allow the discovery of new remote homologs in the still functionally uncharacterized fraction of the human genome. We report a novel computational approach for proteome-wide identification of remote homologs of the chemokine family that uses fold recognition techniques in combination with a scaffold-based automatic mapping of disulfide bonds to define a 3D profile of the chemokine protein family. By applying our methodology to all currently uncharacterized human protein sequences, we have discovered two novel proteins that, without having significant sequence similarity to known chemokines or characteristic cysteine patterns, show strong structural resemblance to known anti-HIV chemokines. Detailed computational analysis and experimental structural investigations based on mass spectrometry and circular dichroism support our structural predictions and highlight several other chemokine-like features. The results obtained support their functional annotation as putative novel chemokines and encourage further experimental characterization. The identification of remote homologs of human chemokines may provide new insights into the molecular mechanisms causing pathologies such as cancer or AIDS, and may contribute to the development of novel treatments. Besides, the genome-wide applicability of our methodology based on 3D protein family profiles may open up new possibilities for improving and accelerating protein function annotation processes.	[Tomczak, Aurelie; Sontheimer, Jana; Hausdorf, Rainer; Pisabarro, M. Teresa] BIOTEC TU Dresden, Dresden, Germany; [Drechsel, David; Gentzel, Marc; Shevchenko, Andrej; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Eichler, Stefanie; Fahmy, Karim] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp, Dept Med Syst Biol, Dresden, Germany; [Buchholz, Frank] Med Fac Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Max Planck Society; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Tomczak, A (corresponding author), BIOTEC TU Dresden, Dresden, Germany.	mayte@biotec.tu-dresden.de	Buchholz, Frank/B-4700-2017; Pisabarro, M. Teresa/D-4270-2012; Fahmy, Karim/B-2708-2017	Buchholz, Frank/0000-0002-4577-3344; Fahmy, Karim/0000-0002-8752-5824; Gentzel, Marc/0000-0002-4482-6010	Klaus Tschira Stiftung (Foundation) gGmbH	Klaus Tschira Stiftung (Foundation) gGmbH	This work has been funded by the Klaus Tschira Stiftung (Foundation) gGmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Betts MJ, 2001, EMBO J, V20, P5354, DOI 10.1093/emboj/20.19.5354; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Chong IW, 2000, INFLAMMATION, V24, P505, DOI 10.1023/A:1007021322323; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Colobran R, 2007, CLIN EXP IMMUNOL, V148, P208, DOI 10.1111/j.1365-2249.2007.03344.x; Cozzetto D, 2009, PROTEINS, V77, P18, DOI 10.1002/prot.22561; deJongh HHJ, 1996, ANAL BIOCHEM, V242, P95, DOI 10.1006/abio.1996.0434; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Gille C, 2000, J MOL BIOL, V299, P1147, DOI 10.1006/jmbi.2000.3763; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kinch LN, 2003, PROTEINS, V53, P395, DOI 10.1002/prot.10557; Kumar S, 2006, CHEM BIOL, V13, P69, DOI 10.1016/j.chembiol.2005.10.012; Lata S, 2009, PROTEIN ENG DES SEL, V22, P441, DOI 10.1093/protein/gzp016; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luz JG, 2005, J MOL BIOL, V352, P1019, DOI 10.1016/j.jmb.2005.08.011; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Magistrelli G, 2005, BIOCHEM BIOPH RES CO, V334, P370, DOI 10.1016/j.bbrc.2005.06.091; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Murooka TT, 2006, J BIOL CHEM, V281, P25184, DOI 10.1074/jbc.M603912200; Nibbs RJB, 2003, EXPERT OPIN BIOL TH, V3, P15, DOI 10.1517/14712598.3.1.15; Ottersbach K, 2006, BLOOD, V107, P1284, DOI 10.1182/blood-2005-08-3112; Pasquier C, 1999, PROTEIN ENG, V12, P381, DOI 10.1093/protein/12.5.381; Pease JE, 2006, BRIT J PHARMACOL, V147, pS212, DOI 10.1038/sj.bjp.0706475; Pisabarro MT, 2006, J IMMUNOL, V176, P2069, DOI 10.4049/jimmunol.176.4.2069; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Ruggiero P, 2003, EUR CYTOKINE NETW, V14, P91; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sippl MJ, 2001, PROTEINS, P55; SIPPL MJ, 1992, PROTEINS, V13, P258, DOI 10.1002/prot.340130308; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stine JT, 2000, BLOOD, V95, P1151, DOI 10.1182/blood.V95.4.1151.004k37_1151_1157; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tomczak A, 2011, PROTEINS, V79, P1277, DOI 10.1002/prot.22963; Ueda Y, 2007, MELANOMA RES, V17, P91, DOI 10.1097/CMR.0b013e3280a60888; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wang G, 2005, PROTEINS, V61, P46, DOI 10.1002/prot.20721; Wang GL, 2004, PROTEIN SCI, V13, P1612, DOI 10.1110/ps.03601504; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WIDMER U, 1993, J IMMUNOL, V150, P4996; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	68	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36151	10.1371/journal.pone.0036151	http://dx.doi.org/10.1371/journal.pone.0036151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586462	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000024
J	Belatik, A; Hotchandani, S; Carpentier, R; Tajmir-Riahi, HA				Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert; Tajmir-Riahi, Heidar-Ali			Locating the Binding Sites of Pb(II) Ion with Human and Bovine Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; FLUORESCENCE SPECTROSCOPY; FTIR SPECTROSCOPY; PROTEINS; ACID	Lead is a potent environmental toxin that has accumulated above its natural level as a result of human activity. Pb cation shows major affinity towards protein complexation and it has been used as modulator of protein-membrane interactions. We located the binding sites of Pb(II) with human serum (HSA) and bovine serum albumins (BSA) at physiological conditions, using constant protein concentration and various Pb contents. FTIR, UV-visible, CD, fluorescence and X-ray photoelectron spectroscopic (XPS) methods were used to analyse Pb binding sites, the binding constant and the effect of metal ion complexation on HSA and BSA stability and conformations. Structural analysis showed that Pb binds strongly to HSA and BSA via hydrophilic contacts with overall binding constants of KPb-HSA = 8.2 (+/- 0.8) x 10(4) M-1 and KPb-BSA = 7.5 (+/- 0.7) x 10(4) M-1. The number of bound Pb cation per protein is 0.7 per HSA and BSA complexes. XPS located the binding sites of Pb cation with protein N and O atoms. Pb complexation alters protein conformation by a major reduction of alpha-helix from 57% (free HSA) to 48% (metal-complex) and 63% (free BSA) to 52% (metal-complex) inducing a partial protein destabilization.	[Belatik, Ahmed; Hotchandani, Surat; Carpentier, Robert; Tajmir-Riahi, Heidar-Ali] Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Belatik, A (corresponding author), Univ Quebec Trois Rivieres, Dept Chim Biol, Trois Rivieres, PQ, Canada.	tajmirri@uqtr.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED A, 1995, FEBS LETT, V363, P65, DOI 10.1016/0014-5793(95)00282-E; Ahmed MH, 2011, J PHOTOCH PHOTOBIO A, V222, P123, DOI 10.1016/j.jphotochem.2011.05.011; Ahmed-Ouameur A, 2006, CELL BIOCHEM BIOPHYS, V45, P203, DOI 10.1385/CBB:45:2:203; Barazzouk S, 2011, CELLULOSE, V18, P643, DOI 10.1007/s10570-011-9503-5; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Belatik A, 2012, EUR J MED CHEM, V48, P114, DOI 10.1016/j.ejmech.2011.12.002; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; DOUSSEAU F, 1989, APPL SPECTROSC, V43, P538, DOI 10.1366/0003702894202814; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Eslam E, 2008, J HAZARD MATER, V154, P914; Frateur I, 2007, ELECTROCHIM ACTA, V52, P7660, DOI 10.1016/j.electacta.2006.12.060; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Grdadolnik J, 2003, ACTA CHIM SLOV, V50, P777; He WY, 2005, BIOORGAN MED CHEM, V13, P1837, DOI 10.1016/j.bmc.2004.11.038; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Jiang M, 2004, J MOL STRUCT, V692, P71, DOI 10.1016/j.molstruc.2004.01.003; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kirberger M, 2008, J INORG BIOCHEM, V102, P1901, DOI 10.1016/j.jinorgbio.2008.06.014; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Liang L, 2008, BIOMACROMOLECULES, V9, P50, DOI 10.1021/bm700728k; Ling QF, 2009, BIOL TRACE ELEM RES, V129, P251, DOI 10.1007/s12011-008-8283-8; Mandeville JS, 2010, BIOMACROMOLECULES, V11, P465, DOI 10.1021/bm9011979; Mandeville JS, 2009, J PHARMACEUT BIOMED, V49, P468, DOI 10.1016/j.jpba.2008.11.035; Morales KA, 2011, J AM CHEM SOC, V133, P10599, DOI 10.1021/ja2032772; Painter L, 1998, J CHEM SOC PERK T 1, P3041, DOI 10.1039/a803429j; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Peters T., 1996, BIOCH GENETICS MED A; Qin QD, 2011, CHEM ENG J, V172, P68, DOI 10.1016/j.cej.2011.05.066; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tayeh N, 2009, J PHARMACEUT BIOMED, V50, P107, DOI 10.1016/j.jpba.2009.03.015; Tian J., 2005, ARTIC AM J IMMUNOL, V1, P21, DOI [DOI 10.3844/AJISP.2005.21.23, DOI 10.3844/ajisp.2005.21.23]; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002; Zubavichus Y, 2004, J PHYS CHEM A, V108, P4557, DOI 10.1021/jp049376f	40	76	79	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36723	10.1371/journal.pone.0036723	http://dx.doi.org/10.1371/journal.pone.0036723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574219	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800116
J	Cilingir, G; Broschat, SL; Lau, AOT				Cilingir, Gokcen; Broschat, Shira L.; Lau, Audrey O. T.			ApicoAP: The First Computational Model for Identifying Apicoplast-Targeted Proteins in Multiple Species of Apicomplexa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; SIGNAL PEPTIDES; PREDICTION; SEQUENCE; ORIGIN	Background: Most of the parasites of the phylum Apicomplexa contain a relict prokaryotic-derived plastid called the apicoplast. This organelle is important not only for the survival of the parasite, but its unique properties make it an ideal drug target. The majority of apicoplast-associated proteins are nuclear encoded and targeted post-translationally to the organellar lumen via a bipartite signaling mechanism that requires an N-terminal signal and transit peptide (TP). Attempts to define a consensus motif that universally identifies apicoplast TPs have failed. Methodology/Principal Findings: In this study, we propose a generalized rule-based classification model to identify apicoplast-targeted proteins (ApicoTPs) that use a bipartite signaling mechanism. Given a training set specific to an organism, this model, called ApicoAP, incorporates a procedure based on a genetic algorithm to tailor a discriminating rule that exploits the known characteristics of ApicoTPs. Performance of ApicoAP is evaluated for four labeled datasets of Plasmodium falciparum, Plasmodium yoelii, Babesia bovis, and Toxoplasma gondii proteins. ApicoAP improves the classification accuracy of the published dataset for P. falciparum to 94%, originally 90% using PlasmoAP. Conclusions/Significance: We present a parametric model for ApicoTPs and a procedure to optimize the model parameters for a given training set. A major asset of this model is that it is customizable to different parasite genomes. The ApicoAP prediction software is available at http://code.google.com/p/apicoap/ and http://bcb.eecs.wsu.edu.	[Cilingir, Gokcen; Broschat, Shira L.] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Broschat, Shira L.; Lau, Audrey O. T.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Washington State University	Cilingir, G (corresponding author), Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA.	shira@eecs.wsu.edu		Lau, Audrey/0000-0001-8212-0142	Wellcome Trust [GR075800M]; United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [58-5348-7-528]	Wellcome Trust(Wellcome TrustEuropean Commission); United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors wish to acknowledge the support of GC by the Carl M. Hansen Foundation. Funding was provided by Wellcome Trust GR075800M (AOTL) and United States Department of Agriculture-Agricultural Research Service (USDA-ARS) Cooperative Agreement 58-5348-7-528 (AOTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaydin E., 2010, INTRO MACHINE LEARNI; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Caballero MC, 2012, MOL BIOCHEM PARASIT, V181, P125, DOI 10.1016/j.molbiopara.2011.10.009; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132; Fleige T, 2010, MICROBES INFECT, V12, P253, DOI 10.1016/j.micinf.2009.12.010; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gallagher JR, 2011, TRAFFIC, V12, P1124, DOI 10.1111/j.1600-0854.2011.01232.x; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Holland J. H., 1992, ADAPTATION NATURAL A; HOLLAND JH, 1992, SCI AM, V267, P66, DOI 10.1038/scientificamerican0792-66; Johnson RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020633; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kelly Jr JD, 1991, IJCAI, V91, P645; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kumar A, 2010, MOL MICROBIOL, V75, P942, DOI 10.1111/j.1365-2958.2009.07033.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lim L, 2009, TRENDS PARASITOL, V25, P197, DOI 10.1016/j.pt.2009.02.001; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Mitchell M., 1993, INT C NEURAL INF PRO, V12, P51; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prevelige PE, 1989, PREDICTION PROTEIN S, P1; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Sabine B, 2010, MOL PARASITOLOGY; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Tonkin CJ, 2006, MOL BIOCHEM PARASIT, V150, P192, DOI 10.1016/j.molbiopara.2006.08.001; van Dooren GG, 2000, PARASITOL TODAY, V16, P421, DOI 10.1016/S0169-4758(00)01792-0; van Dooren GG, 2002, J BIOL CHEM, V277, P23612, DOI 10.1074/jbc.M201748200; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	40	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36598	10.1371/journal.pone.0036598	http://dx.doi.org/10.1371/journal.pone.0036598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574192	Green Published, gold			2022-12-27	WOS:000305349800089
J	Ostaszewski, M; Eifes, S; del Sol, A				Ostaszewski, Marek; Eifes, Serge; del Sol, Antonio			Evolutionary Conservation and Network Structure Characterize Genes of Phenotypic Relevance for Mitosis in Human	PLOS ONE			English	Article							PROTEIN-INTERACTION; CELL-CYCLE; REGULATORY NETWORK; POSITIVE FEEDBACK; DYNAMICS; EXPRESSION; GENOME; KINASE; MOTIFS; TOOL	The impact of gene silencing on cellular phenotypes is difficult to establish due to the complexity of interactions in the associated biological processes and pathways. A recent genome-wide RNA knock-down study both identified and phenotypically characterized a set of important genes for the cell cycle in HeLa cells. Here, we combine a molecular interaction network analysis, based on physical and functional protein interactions, in conjunction with evolutionary information, to elucidate the common biological and topological properties of these key genes. Our results show that these genes tend to be conserved with their corresponding protein interactions across several species and are key constituents of the evolutionary conserved molecular interaction network. Moreover, a group of bistable network motifs is found to be conserved within this network, which are likely to influence the network stability and therefore the robustness of cellular functioning. They form a cluster, which displays functional homogeneity and is significantly enriched in genes phenotypically relevant for mitosis. Additional results reveal a relationship between specific cellular processes and the phenotypic outcomes induced by gene silencing. This study introduces new ideas regarding the relationship between genotype and phenotype in the context of the cell cycle. We show that the analysis of molecular interaction networks can result in the identification of genes relevant to cellular processes, which is a promising avenue for future research.	[Ostaszewski, Marek; Eifes, Serge; del Sol, Antonio] Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg	University of Luxembourg	Ostaszewski, M (corresponding author), Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg.	antonio.delsol@uni.lu	del Sol, Antonio/M-7431-2017	del Sol, Antonio/0000-0002-9926-617X; Ostaszewski, Marek/0000-0003-1473-370X	Luxembourg Centre for Systems Biomedicine	Luxembourg Centre for Systems Biomedicine	The work has been funded by the Luxembourg Centre for Systems Biomedicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HS, 2007, BLOOD, V109, P4351, DOI 10.1182/blood-2006-09-047563; Albert I, 2004, BIOINFORMATICS, V20, P3346, DOI 10.1093/bioinformatics/bth402; Alvarez-Ponce D, 2011, GENOME BIOL EVOL, V3, P87, DOI 10.1093/gbe/evq084; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2010, BIOCHEM SOC T, V38, P1155, DOI 10.1042/BST0381155; Bassermann F, 2005, CELL CYCLE, V4, P1515, DOI 10.4161/cc.4.11.2192; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; de Lichtenberg U, 2007, CELL CYCLE, V6, P1819, DOI 10.4161/cc.6.15.4537; Dobrin R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-10; Fasanaro P, 2010, CARDIOVASC RES, V85, P272, DOI 10.1093/cvr/cvp244; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordo AC, 2001, MOL REPROD DEV, V59, P106, DOI 10.1002/mrd.1012; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; He E, 2011, P NATL ACAD SCI USA, V108, P10016, DOI 10.1073/pnas.1102106108; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Jin SK, 2001, J CELL SCI, V114, P4139; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kelley BP, 2004, NUCLEIC ACIDS RES, V32, pW83, DOI 10.1093/nar/gkh411; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Langmead CJ, 2003, J COMPUT BIOL, V10, P521, DOI 10.1089/10665270360688165; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Markowetz F, 2010, PLOS COMPUTATIONAL B, V6; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Montanucci L, 2011, MOL BIOL EVOL, V28, P813, DOI 10.1093/molbev/msq259; Moseley JB, 2009, CURR OPIN CELL BIOL, V21, P82, DOI 10.1016/j.ceb.2008.12.005; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson LF, 2011, LEUKEMIA, V25, P761, DOI 10.1038/leu.2011.7; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Santos SDM, 2008, NATURE, V454, P288, DOI 10.1038/454288a; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schnable JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017855; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vinken M, 2011, BBA-REV CANCER, V1815, P13, DOI 10.1016/j.bbcan.2010.08.004; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wray GA, 1999, NOVART FDN SYMP, V222, P203; Wray Gregory A., 1999, P189; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yamada T, 1998, RES COMMUN MOL PATH, V99, P283; Yang YL, 2007, CELL PROLIFERAT, V40, P397, DOI 10.1111/j.1365-2184.2007.00443.x; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	70	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36488	10.1371/journal.pone.0036488	http://dx.doi.org/10.1371/journal.pone.0036488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22577488	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500079
J	Ho, DWY; Yang, ZF; Yi, K; Lam, CT; Ng, MNP; Yu, WC; Lau, J; Wan, T; Wang, XQ; Yan, ZX; Liu, H; Zhang, Y; Fan, ST				Ho, David W. Y.; Yang, Zhen Fan; Yi, Kang; Lam, Chi Tat; Ng, Michael N. P.; Yu, Wan Ching; Lau, Joyce; Wan, Timothy; Wang, Xiaoqi; Yan, Zhixiang; Liu, Hang; Zhang, Yong; Fan, Sheung Tat			Gene Expression Profiling of Liver Cancer Stem Cells by RNA-Sequencing	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; GLYPICAN-3 EXPRESSION; MICROARRAY ANALYSIS; UP-REGULATION; SUPPRESSION; SURVIVAL; MARKER; SEQ; OVEREXPRESSION; RADIATION	Background: Accumulating evidence supports that tumor growth and cancer relapse are driven by cancer stem cells. Our previous work has demonstrated the existence of CD90(+) liver cancer stem cells (CSCs) in hepatocellular carcinoma (HCC). Nevertheless, the characteristics of these cells are still poorly understood. In this study, we employed a more sensitive RNA-sequencing (RNA-Seq) to compare the gene expression profiling of CD90(+) cells sorted from tumor (CD90(+) CSCs) with parallel non-tumorous liver tissues (CD90(+) NTSCs) and elucidate the roles of putative target genes in hepatocarcinogenesis. Methodology/Principal Findings: CD90(+) cells were sorted respectively from tumor and adjacent non-tumorous human liver tissues using fluorescence-activated cell sorting. The amplified RNAs of CD90(+) cells from 3 HCC patients were subjected to RNA-Seq analysis. A differential gene expression profile was established between CD90(+) CSCs and CD90(+) NTSCs, and validated by quantitative real-time PCR (qRT-PCR) on the same set of amplified RNAs, and further confirmed in an independent cohort of 12 HCC patients. Five hundred genes were differentially expressed (119 up-regulated and 381 down-regulated genes) between CD90(+) CSCs and CD90(+) NTSCs. Gene ontology analysis indicated that the over-expressed genes in CD90(+) CSCs were associated with inflammation, drug resistance and lipid metabolism. Among the differentially expressed genes, glypican-3 (GPC3), a member of glypican family, was markedly elevated in CD90(+) CSCs compared to CD90(+) NTSCs. Immunohistochemistry demonstrated that GPC3 was highly expressed in forty-two human liver tumor tissues but absent in adjacent non-tumorous liver tissues. Flow cytometry indicated that GPC3 was highly expressed in liver CD90(+) CSCs and mature cancer cells in liver cancer cell lines and human liver tumor tissues. Furthermore, GPC3 expression was positively correlated with the number of CD90(+) CSCs in liver tumor tissues. Conclusions/Significance: The identified genes, such as GPC3 that are distinctly expressed in liver CD90(+) CSCs, may be promising gene candidates for HCC therapy without inducing damages to normal liver stem cells.	[Ho, David W. Y.; Yang, Zhen Fan; Lam, Chi Tat; Ng, Michael N. P.; Yu, Wan Ching; Lau, Joyce; Wan, Timothy; Wang, Xiaoqi; Fan, Sheung Tat] Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China; [Yang, Zhen Fan] AstraZeneca Global R&D, Innovat Ctr China, Shanghai, Peoples R China; [Yi, Kang; Yan, Zhixiang; Liu, Hang; Zhang, Yong] BGI, Shenzhen, Peoples R China; [Wang, Xiaoqi; Fan, Sheung Tat] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; AstraZeneca; Beijing Genomics Institute (BGI); University of Hong Kong	Ho, DWY (corresponding author), Univ Hong Kong, Dept Surg, Pokfulam, Hong Kong, Peoples R China.	Pamela.Yang@astrazeneca.com; zhangy@genomics.org.cn; stfan@hku.hk	Wan, Timothy/AAA-2432-2021	Wan, Timothy/0000-0002-9235-2913; /0000-0003-2801-5717	University of Hong Kong, Hong Kong, China	University of Hong Kong, Hong Kong, China(University of Hong Kong)	This study was supported by the Mrs. Li Ka Shing Fund of The University of Hong Kong, Hong Kong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abou-Alfa GK, 2006, SEMIN ONCOL, V33, pS79, DOI 10.1053/j.seminoncol.2006.10.015; Al-Assar O, 2009, INT J RADIAT ONCOL, V75, P1216, DOI 10.1016/j.ijrobp.2009.07.001; Baumhoer D, 2008, AM J CLIN PATHOL, V129, P899, DOI 10.1309/HCQWPWD50XHD2DW6; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099; Casneuf T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-461; Chang HW, 2006, ORAL ONCOL, V42, P979, DOI 10.1016/j.oraloncology.2005.12.016; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Davila JA, 2010, AM J GASTROENTEROL, V105, P632, DOI 10.1038/ajg.2009.715; Farooq M, 2003, MOL CELLS, V15, P356; Feldman AL, 2002, BIOTECHNIQUES, V33, P906, DOI 10.2144/02334mt04; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Haupt LM, 2009, J CELL PHYSIOL, V220, P780, DOI 10.1002/jcp.21825; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Ho M, 2011, EUR J CANCER, V47, P333, DOI 10.1016/j.ejca.2010.10.024; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; KANG YH, 2010, AMINO ACIDS; Kim E, 2008, RNA BIOL, V5, P17, DOI 10.4161/rna.5.1.5944; Kwack MH, 2006, MOL CELLS, V21, P224; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Liu B, 2010, HEPATOLOGY, V52, P1060, DOI 10.1002/hep.23794; Liu N, 2010, ANN SURG ONCOL, V17, P2628, DOI 10.1245/s10434-010-1037-9; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Ma S, 2009, CANC TREAT REV; Masson NM, 2006, AM J PHYSIOL-GASTR L, V291, pG45, DOI 10.1152/ajpgi.00465.2005; Miura K, 2010, CANC SCI; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Nakano K, 2010, ANTI-CANCER DRUG, V21, P907, DOI 10.1097/CAD.0b013e32833f5d68; Ng KTP, 2010, INT J CANCER, V127, P859, DOI 10.1002/ijc.25105; Pettigrew CA, 2008, FRONT BIOSCI-LANDMRK, V13, P1090, DOI 10.2741/2747; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Shirakawa H, 2009, CANCER SCI, V100, P1403, DOI 10.1111/j.1349-7006.2009.01206.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su WP, 2010, LUNG CANC; Sun CK, 2011, NEOPLASIA, V13, P735, DOI 10.1593/neo.11664; Suzuki M, 2010, ANTICANCER RES, V30, P5055; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takano S, 2008, ONCOGENE, V27, P2810, DOI 10.1038/sj.onc.1210951; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuchiya M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-74; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wakamatsu T, 2007, INT J ONCOL, V31, P1465; Wang K, 2010, HEPATOLOGY, V52, P164, DOI 10.1002/hep.23650; Wang Y, 2005, J NANOSCI NANOTECHNO, V5, P1249, DOI 10.1166/jnn.2005.218; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yorita K, 2011, LIVER INT, V31, P120, DOI 10.1111/j.1478-3231.2010.02359.x; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu AXGP, 2011, J CLIN ONCOL, P29	55	68	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37159	10.1371/journal.pone.0037159	http://dx.doi.org/10.1371/journal.pone.0037159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606345	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400071
J	Hyatt, CJ; Assaf, M; Muska, CE; Rosen, RI; Thomas, AD; Johnson, MR; Hylton, JL; Andrews, MM; Reynolds, BA; Krystal, JH; Potenza, MN; Pearlson, GD				Hyatt, Christopher J.; Assaf, Michal; Muska, Christine E.; Rosen, Rivkah I.; Thomas, Andre D.; Johnson, Matthew R.; Hylton, Jennifer L.; Andrews, Melissa M.; Reynolds, Brady A.; Krystal, John H.; Potenza, Marc N.; Pearlson, Godfrey D.			Reward-Related Dorsal Striatal Activity Differences between Former and Current Cocaine Dependent Individuals during an Interactive Competitive Game	PLOS ONE			English	Article							COMPULSIVE DRUG-SEEKING; PREDICTION ERRORS; IMPULSIVITY; ADDICTION; MECHANISMS; ABSTINENCE; DOPAMINE; HABITS; BRAIN; TASK	Cocaine addiction is characterized by impulsivity, impaired social relationships, and abnormal mesocorticolimbic reward processing, but their interrelationships relative to stages of cocaine addiction are unclear. We assessed blood-oxygenation-level dependent (BOLD) signal in ventral and dorsal striatum during functional magnetic resonance imaging (fMRI) in current (CCD; n = 30) and former (FCD; n = 28) cocaine dependent subjects as well as healthy control (HC; n = 31) subjects while playing an interactive competitive Domino game involving risk-taking and reward/punishment processing. Out-of-scanner impulsivity-related measures were also collected. Although both FCD and CCD subjects scored significantly higher on impulsivity-related measures than did HC subjects, only FCD subjects had differences in striatal activation, specifically showing hypoactivation during their response to gains versus losses in right dorsal caudate, a brain region linked to habituation, cocaine craving and addiction maintenance. Right caudate activity in FCD subjects also correlated negatively with impulsivity-related measures of self-reported compulsivity and sensitivity to reward. These findings suggest that remitted cocaine dependence is associated with striatal dysfunction during social reward processing in a manner linked to compulsivity and reward sensitivity measures. Future research should investigate the extent to which such differences might reflect underlying vulnerabilities linked to cocaine-using propensities (e. g., relapses).	[Hyatt, Christopher J.; Assaf, Michal; Muska, Christine E.; Rosen, Rivkah I.; Thomas, Andre D.; Johnson, Matthew R.; Hylton, Jennifer L.; Andrews, Melissa M.; Pearlson, Godfrey D.] Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA; [Assaf, Michal; Krystal, John H.; Potenza, Marc N.; Pearlson, Godfrey D.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Johnson, Matthew R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Reynolds, Brady A.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Hartford Hospital; Yale University; Yale University; Yale University; University System of Ohio; Ohio State University	Hyatt, CJ (corresponding author), Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA.	Chyatt@harthosp.org			National Institute on Drug Abuse (NIDA) [RO1 DA020709, P20 DA027844]; Veteran's Administration, Mohegan Sun Casino; National Center for Responsible Gaming; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020709, P20DA027844] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Veteran's Administration, Mohegan Sun Casino; National Center for Responsible Gaming; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by National Institute on Drug Abuse (NIDA) grant RO1 DA020709 (GDP) and grant P20 DA027844 (MNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Potenza has consulted for and advised Boehringer Ingelheim; has consulted for and has financial interests in Somaxon; has received research support from the Veteran's Administration, Mohegan Sun Casino, the National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, and Forest Laboratories, Psyadon, Ortho-McNeil, Oy-Control/Biotie and Glaxo-SmithKline pharmaceuticals; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for law offices and the federal public defender's office in issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr. Krystal's conflicts of interest are as follows: 1) Consultant for Aisling Capital, LLC, AstraZeneca Pharmaceuticals, Brintnall & Nicolini, Inc., Easton Associates, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Lundbeck Research USA, Merz Pharmaceuticals, MK Medical Communications, Medivation, Inc., Naurex, Inc., Pfizer Pharmaceuticals, and Teva Pharmaceutical Industries, Ltd.; 2) Scientific advisory board/consultant for Abbott Laboratories, Bristol-Myers Squibb, Eli Lilly and Co., Lohocla Research Corporation, SK Holdings Co. Ltd., Takeda Industries, and Transcept Pharmaceuticals; 3) Exercizable warrant options for Tetragenex Pharmaceuticals (value less than $100); 4) Research support to Department of Veterans Affairs for Janssen Research Foundation (provided drug and some study support to the Department of Veterans Affairs); 5) Derives income greater than $10,000 as the Editor of Biological Psychiatry; 6) Board Of Directors for the Coalition for Translational Research in Alcohol and Substance Use Disorders; 7) President-Elect for the American College of Neuropsychopharmacology; and 8) has the following patents and inventions: Seibyl JP, Krystal JH, Charney DS. Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia. Patent #:5,447,948. September 5, 1995; co-inventor with Dr. Gerard Sanacora on a filed patent application by Yale University related to targeting the glutamatergic system for the treatment of neuropsychiatric disorders (PCTWO06108055A1); and Intranasal Administration of ketamine to Treat Depression (pending). These potential competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the research support listed above was used for this particular study.	Admon R., 2012, CEREB CORTE IN PRESS; Ahmed SH, 2004, SCIENCE, V306, P1901, DOI 10.1126/science.1107071; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Anholt GE, 2009, J ANXIETY DISORD, V23, P830, DOI 10.1016/j.janxdis.2009.04.004; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Assaf M, 2009, BRAIN IMAGING BEHAV, V3, P24, DOI 10.1007/s11682-008-9047-y; Balodis IM, 2012, BIOL PSYCHI IN PRESS; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Belin D, 2008, SCIENCE, V320, P1352, DOI 10.1126/science.1158136; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Beveridge TJR, 2009, NEUROPSYCHOPHARMACOL, V34, P1162, DOI 10.1038/npp.2008.135; Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Blum K, 2000, J PSYCHOACTIVE DRUGS, V32; Brewer JA, 2008, BIOCHEM PHARMACOL, V75, P63, DOI 10.1016/j.bcp.2007.06.043; Brody AL, 2007, BIOL PSYCHIAT, V62, P642, DOI 10.1016/j.biopsych.2006.10.026; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Dackis CA, 2005, NEUROPSYCHOPHARMACOL, V30, P2299, DOI 10.1038/sj.npp.1300867; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Garavan H, 2008, PHILOS T R SOC B, V363, P3267, DOI 10.1098/rstb.2008.0106; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Goldstein RZ, 2009, P NATL ACAD SCI USA, V106, P9453, DOI 10.1073/pnas.0900491106; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanlon CA, 2009, DRUG ALCOHOL DEPEN, V102, P88, DOI 10.1016/j.drugalcdep.2009.01.005; Harrison L, 1997, NIDA Res Monogr, V167, P1; Hommer DW, 2011, ANN NY ACAD SCI, V1216, P50, DOI 10.1111/j.1749-6632.2010.05898.x; Huestis MA, 2007, J ANAL TOXICOL, V31, P462, DOI 10.1093/jat/31.8.462; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P486, DOI 10.1176/appi.ajp.158.3.486; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Jia Z, 2011, BIOL PSYCHI IN PRESS; JOHANSON CE, 1989, PHARMACOL REV, V41, P3; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kalivas PW, 2008, NEUROTOX RES, V14, P185, DOI 10.1007/BF03033809; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 1997, PHARMACOL BIOCHEM BE, V57, P513, DOI 10.1016/S0091-3057(96)00438-8; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Little KY, 1999, AM J PSYCHIAT, V156, P238; Lundy A, 1997, J NERV MENT DIS, V185, P459, DOI 10.1097/00005053-199707000-00007; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; Myrick H, 2002, AM J ADDICTION, V11, P255, DOI 10.1080/10550490290088045; Nestor L, 2010, NEUROIMAGE, V49, P1133, DOI 10.1016/j.neuroimage.2009.07.022; Opris I, 2009, NEUROSCIENCE, V163, P40, DOI 10.1016/j.neuroscience.2009.06.002; Pacchioni AM, 2011, BEHAV BRAIN RES, V218, P296, DOI 10.1016/j.bbr.2010.12.014; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Porrino LJ, 2007, PROG NEURO-PSYCHOPH, V31, P1593, DOI 10.1016/j.pnpbp.2007.08.040; Porrino LJ, 2004, NEUROSCI BIOBEHAV R, V27, P813, DOI 10.1016/j.neubiorev.2003.11.013; Potenza MN, 2010, ALCOHOL CLIN EXP RES, V34, P1303, DOI 10.1111/j.1530-0277.2010.01214.x; Reynolds B, 2004, BEHAV PROCESS, V67, P343, DOI 10.1016/j.beproc.2004.06.003; SANAVIO E, 1988, BEHAV RES THER, V26, P169, DOI 10.1016/0005-7967(88)90116-7; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Sobell L.C., 1996, ALCOHOL TIMELINE FOL; Sofuoglu M, 2005, ADDICT BEHAV, V30, P1125, DOI 10.1016/j.addbeh.2004.10.010; Takahashi Y, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.011.2007; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; ZUCKERMAN M, 1979, PSYCHIAT RES, V1, P255, DOI 10.1016/0165-1781(79)90007-6	78	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34917	10.1371/journal.pone.0034917	http://dx.doi.org/10.1371/journal.pone.0034917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606228	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400003
J	Wolff, JN; Shearman, DCA; Brooks, RC; Ballard, JWO				Wolff, Jonci N.; Shearman, Deborah C. A.; Brooks, Rob C.; Ballard, John W. O.			Selective Enrichment and Sequencing of Whole Mitochondrial Genomes in the Presence of Nuclear Encoded Mitochondrial Pseudogenes (Numts)	PLOS ONE			English	Article							DNA-POLYMERASE; AMPLIFICATION; ORIGIN; EVOLUTION; ALIGNMENT; FIDELITY; DENSITY; MONKEYS; GENES; MTDNA	Numts are an integral component of many eukaryote genomes offering a snapshot of the evolutionary process that led from the incorporation of an alpha-proteobacterium into a larger eukaryotic cell some 1.8 billion years ago. Although numt sequence can be harnessed as molecular marker, these sequences often remain unidentified and are mistaken for genuine mtDNA leading to erroneous interpretation of mtDNA data sets. It is therefore indispensable that during the process of amplifying and sequencing mitochondrial genes, preventive measures are taken to ensure the exclusion of numts to guarantee the recovery of genuine mtDNA. This applies to mtDNA analyses in general but especially to studies where mtDNAs are sequenced de novo as the launch pad for subsequent mtDNA-based research. By using a combination of dilution series and nested rolling circle amplification (RCA), we present a novel strategy to selectively amplify mtDNA and exclude the amplification of numt sequence. We have successfully applied this strategy to de novo sequence the mtDNA of the Black Field Cricket Teleogryllus commodus, a species known to contain numts. Aligning our assembled sequence to the reference genome of Teleogryllus emma (GenBank EU557269.1) led to the identification of a numt sequence in the reference sequence. This unexpected result further highlights the need of a reliable and accessible strategy to eliminate this source of error.	[Wolff, Jonci N.; Ballard, John W. O.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wolff, Jonci N.; Shearman, Deborah C. A.; Brooks, Rob C.; Ballard, John W. O.] Univ New S Wales, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Shearman, Deborah C. A.; Brooks, Rob C.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Wolff, JN (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	jonciwolff@yahoo.com	Ballard, John William O./ABB-2743-2020; Brooks, Robert/A-1251-2008; Wolff, Jonci/M-4639-2017	Ballard, John William O./0000-0002-2358-6003; Brooks, Robert/0000-0001-6926-0781; Wolff, Jonci/0000-0002-8809-5010	Discovery Project grant from the Australian Research Council [DP0984240]	Discovery Project grant from the Australian Research Council(Australian Research Council)	This work was funded by a Discovery Project grant to RCB and JWOB from the Australian Research Council (DP0984240) [http://www.arc.gov.au/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 1999, P NATL ACAD SCI USA, V96, P13863, DOI 10.1073/pnas.96.24.13863; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bensasson D, 2000, MOL BIOL EVOL, V17, P406, DOI 10.1093/oxfordjournals.molbev.a026320; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cairns KC, 2009, EVIDENCE RECENT POPU; Cairns KM, 2010, AUSTR J ZOOLOGY, V58, P6; CARR SM, 1987, BIOCHEM GENET, V25, P385, DOI 10.1007/BF00554547; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Drummond AJ, 2011, GENEIOUS V5; Emelyanov VV, 2001, BIOSCIENCE REP, V21, P1, DOI 10.1023/A:1010409415723; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Ibarguchi G, 2006, GENOME, V49, P1438, DOI 10.1139/G06-107; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Karanth KP, 2008, J BIOSCIENCES, V33, P761, DOI 10.1007/s12038-008-0096-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Pamilo P, 2007, MOL BIOL EVOL, V24, P1340, DOI 10.1093/molbev/msm055; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Thangaraj K, 2003, J ANDROL, V24, P388; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wolff JN, 2008, HEREDITY, V101, P429, DOI 10.1038/hdy.2008.74; Woodward, 1994, SCIENCE, V266, P1229; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zischler H, 1998, MOL BIOL EVOL, V15, P463, DOI 10.1093/oxfordjournals.molbev.a025943	40	30	32	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37142	10.1371/journal.pone.0037142	http://dx.doi.org/10.1371/journal.pone.0037142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606342	Green Published, gold			2022-12-27	WOS:000305339400068
J	Dumas, G; Chavez, M; Nadel, J; Martinerie, J				Dumas, Guillaume; Chavez, Mario; Nadel, Jacqueline; Martinerie, Jacques			Anatomical Connectivity Influences both Intra- and Inter-Brain Synchronizations	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SMALL-WORLD; CORTICAL ACTIVITY; OSCILLATIONS; MULTISTABILITY; COMMUNICATION; COMPLEXITY; SYNCHRONY; DYNAMICS; SIGNALS	Recent development in diffusion spectrum brain imaging combined to functional simulation has the potential to further our understanding of how structure and dynamics are intertwined in the human brain. At the intra-individual scale, neurocomputational models have already started to uncover how the human connectome constrains the coordination of brain activity across distributed brain regions. In parallel, at the inter-individual scale, nascent social neuroscience provides a new dynamical vista of the coupling between two embodied cognitive agents. Using EEG hyperscanning to record simultaneously the brain activities of subjects during their ongoing interaction, we have previously demonstrated that behavioral synchrony correlates with the emergence of inter-brain synchronization. However, the functional meaning of such synchronization remains to be specified. Here, we use a biophysical model to quantify to what extent inter-brain synchronizations are related to the anatomical and functional similarity of the two brains in interaction. Pairs of interacting brains were numerically simulated and compared to real data. Results show a potential dynamical property of the human connectome to facilitate inter-individual synchronizations and thus may partly account for our propensity to generate dynamical couplings with others.	[Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] INSERM, U975, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] CNRS, UMR 7225, Paris, France; [Dumas, Guillaume; Chavez, Mario; Martinerie, Jacques] ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Nadel, Jacqueline] CNRS, Ctr Emot, USR 3246, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Dumas, G (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	guillaume.dumas@centraliens.net	Dumas, Guillaume/E-3756-2012; Chavez, Mario/D-8495-2011	Dumas, Guillaume/0000-0002-2253-1844; Chavez, Mario/0000-0003-0390-4833	French National Center for Scientific Research; Direction generale de l'armement (DGA); Computer Neuroscience Program [070005IPAM]	French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); Direction generale de l'armement (DGA); Computer Neuroscience Program	This work was supported in part by funds from the French National Center for Scientific Research (http://www.cnrs.fr/). This work was also supported by a PhD fellowship of the Direction generale de l'armement (DGA) (http://www.defense.gouv.fr/dga/) and the Computer Neuroscience Program no070005IPAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron JA, 2005, REV MODERN PHYS; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Allen M., 2011, CONSCIOUSNESS PLASTI, P8, DOI [10.3389/fpsyg.2011.00020/abstract, DOI 10.3389/FPSYG.2011.00020/ABSTRACT]; Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chavez M, 2010, COMPLEX NETWORKS NEW; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Fernandez A, 2011, NEUROIMAGE, V57, P1300, DOI 10.1016/j.neuroimage.2011.05.079; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Fuchs A, 2010, COORDINATION NEURAL; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2004, INTERSUBJECT SYNCHRO; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hinz RC, 2011, CHAOS, V21, DOI 10.1063/1.3581161; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Ikegami T, 2007, INFANT BEHAV DEV, V30, P278, DOI 10.1016/j.infbeh.2007.02.002; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Izhikevich E, 2008, LARGE SCALE MODEL MA; Jirsa V, 2010, ARCH ITALIENNES BIOL; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kelso J. A. S., 2006, COMPLEMENTARY NATURE; Kelso S., 1995, DYNAMIC PATTERNS SEL; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lachaux JP, 2000, EUR J NEUROSCI, V12, P2608, DOI 10.1046/j.1460-9568.2000.00163.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; LUMER ED, 1992, NEURAL COMPUT, V4, P341, DOI 10.1162/neco.1992.4.3.341; Mahalanobis P. C., 1936, P NATL I SCI; Maturana H., 1987, TREE KNOWLEDGE BIOL; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Mori F, 2009, PHYSICA D, V238, P1180, DOI 10.1016/j.physd.2009.04.002; Nadel J., 1999, IMITATION INFANCY; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Paik SB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000342; Perez T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019900; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rodriguez E, 2010, NAT REV NEUROSCI, V11, P718; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Saito DN, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00127; Santo BA, 2011, P IEEE S SERIES COMP; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Schipul SE, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00010; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tononi G, 1996, P NATL ACAD SCI USA, V93, P3422, DOI 10.1073/pnas.93.8.3422; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wallstrom GL, 2004, INT J PSYCHOPHYSIOL, V53, P105, DOI 10.1016/j.ijpsycho.2004.03.007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yeung M, 1999, TIME DELAY KURAMOTO; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	78	68	68	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36414	10.1371/journal.pone.0036414	http://dx.doi.org/10.1371/journal.pone.0036414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400012
J	Coulombe, F; Fiola, S; Akira, S; Cormier, Y; Gosselin, J				Coulombe, Francois; Fiola, Stephanie; Akira, Shizuo; Cormier, Yvon; Gosselin, Jean			Muramyl Dipeptide Induces NOD2-Dependent Ly6C(high) Monocyte Recruitment to the Lungs and Protects Against Influenza Virus Infection	PLOS ONE			English	Article							TREHALOSE DIMYCOLATE; ADAPTIVE IMMUNITY; DENDRITIC CELLS; HOST-DEFENSE; A VIRUS; MICE; PEPTIDOGLYCAN; MURABUTIDE; NOD2; PEPTIDES	Bacterial peptidoglycan-derived muramyl dipeptide (MDP) and derivatives have long-recognized antiviral properties but their mechanism of action remains unclear. In recent years, the pattern-recognition receptor NOD2 has been shown to mediate innate responses to MDP. Here, we show that MDP treatment of mice infected with Influenza A virus (IAV) significantly reduces mortality, viral load and pulmonary inflammation in a NOD2-dependent manner. Importantly, the induction of type I interferon (IFN) and CCL2 chemokine was markedly increased in the lungs following MDP treatment and correlated with a NOD2-dependent enhancement in circulating monocytes. Mechanistically, the protective effect of MDP could be explained by the NOD2-dependent transient increase in recruitment of Ly6C(high) "inflammatory'' monocytes and, to a lesser extent, neutrophils to the lungs. Indeed, impairment in both Ly6C(high) monocyte recruitment and survival observed in infected Nod2-/- mice treated with MDP was recapitulated in mice deficient for the chemokine receptor CCR2 required for CCL2-mediated Ly6C(high) monocyte migration from the bone marrow into the lungs. MDP-induced pulmonary monocyte recruitment occurred normally in IAV-infected and MDP-treated Ips-1-/- mice. However, IPS-1 was required for improved survival upon MDP treatment. Finally, mycobacterial N-glycolyl MDP was more potent than N-acetyl MDP expressed by most bacteria at reducing viral burden while both forms of MDP restored pulmonary function following IAV challenge. Overall, our work sheds light on the antiviral mechanism of a clinically relevant bacterial-derived compound and identifies the NOD2 pathway as a potential therapeutic target against IAV.	[Coulombe, Francois; Fiola, Stephanie; Gosselin, Jean] Univ Laval, Ctr Hosp Univ, Quebec Res Ctr, Quebec City, PQ, Canada; [Coulombe, Francois; Fiola, Stephanie; Gosselin, Jean] Univ Laval, Dept Mol Med, Fac Med, Quebec City, PQ, Canada; [Akira, Shizuo] Osaka Univ, Host Def Lab, World Premier Int Immunol Frontier Res Ctr, Osaka, Japan; [Akira, Shizuo] Osaka Univ, Dept Host Def, Microbial Dis Res Inst, Osaka, Japan; [Cormier, Yvon] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Cormier, Yvon] Univ Laval, Dept Med, Fac Med, Quebec City, PQ, Canada	Laval University; Laval University; Osaka University; Osaka University; Laval University; Laval University	Coulombe, F (corresponding author), Univ Laval, Ctr Hosp Univ, Quebec Res Ctr, Quebec City, PQ, Canada.	jean.gosselin@crchul.ulaval.ca			F. Banting and C. Best Canada Graduate Scholarship; Canadian Institutes of Health Research [IBF-99052]	F. Banting and C. Best Canada Graduate Scholarship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a F. Banting and C. Best Canada Graduate Scholarship to F.C. and by a grant from the Canadian Institutes of Health Research to J.G. and Y.C. (grant #IBF-99052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Ando K, 2011, EXPERT OPIN PHARMACO, V12, P285, DOI 10.1517/14656566.2011.543129; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; AZUMA I, 1971, JPN J MICROBIOL, V15, P193, DOI 10.1111/j.1348-0421.1971.tb00569.x; AZUMA I, 1994, MED RES REV, V14, P401, DOI 10.1002/med.2610140403; BAHR GM, 1995, INT J IMMUNOPHARMACO, V17, P117, DOI 10.1016/0192-0561(94)00094-5; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P1377, DOI 10.1093/jac/dkg244; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P5, DOI 10.1093/jac/dkg063; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; CHOMEL JJ, 1988, J BIOL RESP MODIF, V7, P581; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; De La Tribonniere Xavier, 2003, Med Sci Monit, V9, pPI43; Dienz O, 2012, MUCOSAL IMMUNOL; Dzierzbicka K, 2011, CURR MED CHEM, V18, P2438, DOI 10.2174/092986711795843173; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hoeve MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029443; IKEDA S, 1985, ANTIVIR RES, V5, P207, DOI 10.1016/0166-3542(85)90025-7; Kim YG, 2011, IMMUNITY; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; MASIHI KN, 1984, J BIOL RESP MODIF, V3, P663; MASIHI KN, 1983, INT J IMMUNOPHARMACO, V5, P403; MCLAUGHLIN CA, 1980, SCIENCE, V208, P415, DOI 10.1126/science.7189295; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seo SU, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001304; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; WYDE PR, 1990, J BIOL RESP MODIF, V9, P98; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	39	50	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36734	10.1371/journal.pone.0036734	http://dx.doi.org/10.1371/journal.pone.0036734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590599	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100056
J	Diederich, A; Swait, J; Wirsik, N				Diederich, Adele; Swait, Joffre; Wirsik, Norman			Citizen Participation in Patient Prioritization Policy Decisions: An Empirical and Experimental Study on Patients' Characteristics	PLOS ONE			English	Article							PERSONAL RESPONSIBILITY; CHOICE EXPERIMENTS; HEALTH; CARE; PREFERENCES; ATTITUDES; CRITERION	Health systems worldwide are grappling with the need to control costs to maintain system viability. With the combination of worsening economic conditions, an aging population and reductions in tax revenues, the pressures to make structural changes are expected to continue growing. Common cost control mechanisms, e. g. curtailment of patient access and treatment prioritization, are likely to be adversely viewed by citizens. It seems therefore wise to include them in the decision making processes that lead up to policy changes. In the context of a multilevel iterative mixed-method design a quantitative survey representative of the German population (N = 2031) was conducted to probe the acceptance of priority setting in medicine and to explore the practicability of direct public involvement. Here we focus on preferences for patients' characteristics (medical aspects, lifestyle and socio-economic status) as possible criteria for prioritizing medical services. A questionnaire with closed response options was fielded to gain insight into attitudes toward broad prioritization criteria of patient groups. Furthermore, a discrete choice experiment was used as a rigorous approach to investigate citizens' preferences toward specific criteria level in context of other criteria. Both the questionnaire and the discrete choice experiment were performed with the same sample. The citizens' own health and social situation are included as explanatory variables. Data were evaluated using corresponding analysis, contingency analysis, logistic regression and a multinomial exploded logit model. The results show that some medical criteria are highly accepted for prioritizing patients whereas socio-economic criteria are rejected.	[Diederich, Adele] Jacobs Univ, Bremen, Germany; [Swait, Joffre] Univ Technol, Ctr Study Choice, Sydney, NSW, Australia; [Wirsik, Norman] BIPS Inst Epidemiol & Prevent Res, Bremen, Germany	Jacobs University; University of Technology Sydney; Leibniz Institute for Prevention Research & Epidemiology (BIPS)	Diederich, A (corresponding author), Jacobs Univ, Bremen, Germany.	a.diederich@jacobs-university.de	Swait, Joffre D/F-7236-2014	Swait, Joffre D/0000-0002-0435-117X; Wirsik, Norman/0000-0002-4799-4722	Deutsche Forschungsgemeinschaft (DFG) [DGF Di506/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG) Grant number: DGF Di506/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Borning A, 2008, INTEGR SER INFORM SY, V17, P439; Burge P, 2010, J HEALTH ECON, V29, P883, DOI 10.1016/j.jhealeco.2010.08.006; Busse R, 2010, INT PROFILES HLTH CA; Buyx AM, 2008, J MED ETHICS, V34, P871, DOI 10.1136/jme.2007.024059; CHAPMAN RG, 1982, J MARKETING RES, V19, P288, DOI 10.2307/3151563; Cookson R, 1999, HEALTH POLICY, V49, P63, DOI 10.1016/S0168-8510(99)00043-3; de Bekker-Grob EW, 2010, HLTH EC; Diederich A, 2010, BUNDESGESUNDHEITSBLA, V53, P896, DOI 10.1007/s00103-010-1113-0; Diederich A, 2009, FOR655, V18; Diederich A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023930; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Flynn TN, 2010, PHARMACOECONOMICS, V28, P711, DOI 10.2165/11535660-000000000-00000; Goddard M., 2004, EC PRIORITY SETTING; Green C, 2009, HEALTH ECON, V18, P951, DOI 10.1002/hec.1414; Green C, 2009, SOC SCI MED, V68, P2247, DOI 10.1016/j.socscimed.2009.03.020; Greenacre Michael, 1984, THEORY APPL CORRES A; Gresswell JW, 2007, DESIGNING CONDUCTING; GRIFFIN A, 1993, MARKET SCI, V12, P1, DOI 10.1287/mksc.12.1.1; HADORN DC, 1991, JAMA-J AM MED ASSOC, V265, P2218, DOI 10.1001/jama.265.17.2218; Ham C, 1997, HEALTH POLICY, V42, P49, DOI 10.1016/S0168-8510(97)00054-7; Heil S, 2010, FOR655, V26; Hoffmeyer-Zlotnik J.H.P, 2003, DEV APPL STAT; Johnson FR, 2011, HEALTH ECON, V20, P323, DOI 10.1002/hec.1591; Kahneman D, 2000, CHOICES VALUES FRAME; KUDER LB, 1995, J AGING HEALTH, V7, P301, DOI 10.1177/089826439500700207; Kuhfeld W.F, 2003, MARKETING RES METHOD; Kuhlmann E, 1998, RATIONIERUNG GESUNDH, P11; Lampert T, 2006, GESUNDHEITLICHE UNGL, P297, DOI DOI 10.1007/978-3-531-90357-6_18; Lancsar E, 2011, J HEALTH ECON, V30, P466, DOI 10.1016/j.jhealeco.2011.01.003; Lees Ann, 2002, Health Expect, V5, P47, DOI 10.1046/j.1369-6513.2002.00157.x; Louviere J. J., 2000, STATED CHOICE METHOD, P418; Mossialos E, 1999, HEALTH POLICY, V49, P75, DOI 10.1016/S0168-8510(99)00044-5; Muhlbacher AC, 2011, EUR J HEALTH ECON, V12, P193, DOI 10.1007/s10198-010-0218-6; Myllykangas Markku, 2003, J Health Organ Manag, V17, P338, DOI 10.1108/14777260310505110; Preusker UK, 2007, DTSCH ARZTEBLATT, V104, P903; ROOK KS, 1987, J APPL SOC PSYCHOL, V17, P533, DOI 10.1111/j.1559-1816.1987.tb00329.x; Ryynanen OP, 1999, SOC SCI MED, V49, P1529, DOI 10.1016/S0277-9536(99)00222-1; Sabik LM, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-4; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; Scuffham PA, 2010, APPL HEALTH ECON HEA, V8, P89, DOI 10.2165/11531170-000000000-00000; Shmueli A, 2000, ISR MED ASSOC J, V2, P746; Strech D, 2008, J MED PHILOS, V33, P80, DOI 10.1093/jmp/jhm007; Ware JE, 2001, SF 36 PHYS MENTAL HL; Ware JE Jr, 2001, SCORE INTERPRET SING; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Winkler J., 1999, GESUNDHEITSWESEN, V61, pS178	47	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36824	10.1371/journal.pone.0036824	http://dx.doi.org/10.1371/journal.pone.0036824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590619	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100064
J	Laorden, ML; Ferenczi, S; Pinter-Kubler, B; Gonzalez-Martin, LL; Lasheras, MC; Kovacs, KJ; Milanes, MV; Nunez, C				Luisa Laorden, M.; Ferenczi, Szilamer; Pinter-Kuebler, Bernadett; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Kovacs, Krisztina J.; Victoria Milanes, M.; Nunez, Cristina			Hypothalamic Orexin-A Neurons Are Involved in the Response of the Brain Stress System to Morphine Withdrawal	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PARAVENTRICULAR NUCLEUS; STRIA TERMINALIS; BED NUCLEUS; OPIATE WITHDRAWAL; RAT-BRAIN; ACTIVATION; DEPENDENCE; NEUROPEPTIDES; HYDROXYLASE	Both the hypothalamus-pituitary-adrenal (HPA) axis and the extrahypothalamic brain stress system are key elements of the neural circuitry that regulates the negative states during abstinence from chronic drug exposure. Orexins have recently been hypothesized to modulate the extended amygdala and to contribute to the negative emotional state associated with dependence. This study examined the impact of chronic morphine and withdrawal on the lateral hypothalamic (LH) orexin A (OXA) gene expression and activity as well as OXA involvement in the brain stress response to morphine abstinence. Male Wistar rats received chronic morphine followed by naloxone to precipitate withdrawal. The selective OX1R antagonist SB334867 was used to examine whether orexins' activity is related to somatic symptoms of opiate withdrawal and alterations in HPA axis and extended amygdala in rats dependent on morphine. OXA mRNA was induced in the hypothalamus during morphine withdrawal, which was accompanied by activation of OXA neurons in the LH. Importantly, SB334867 attenuated the somatic symptoms of withdrawal, and reduced morphine withdrawal-induced c-Fos expression in the nucleus accumbens (NAc) shell, bed nucleus of stria terminalis, central amygdala and hypothalamic paraventricular nucleus, but did not modify the HPA axis activity. These results highlight a critical role of OXA signalling, via OX1R, in activation of brain stress system to morphine withdrawal and suggest that all orexinergic subpopulations in the lateral hypothalamic area contribute in this response.	[Luisa Laorden, M.; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Victoria Milanes, M.; Nunez, Cristina] Fac Med, Cellular & Mol Pharmacol Lab, Murcia, Spain; [Luisa Laorden, M.; Gonzalez-Martin, Laura L.; Carmen Lasheras, M.; Victoria Milanes, M.; Nunez, Cristina] IMIB, Murcia, Spain; [Ferenczi, Szilamer; Pinter-Kuebler, Bernadett; Kovacs, Krisztina J.] Hungarian Acad Sci, Inst Expt Med, Mol Neuroendocrinol Lab, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Laorden, ML (corresponding author), Fac Med, Cellular & Mol Pharmacol Lab, Murcia, Spain.	milanes@um.es	Núñez, Cristina/O-8288-2015; Milanés, M. Victoria/AGB-4075-2022; Milanés, M Victoria/K-6591-2017	Núñez, Cristina/0000-0002-0773-4950; Milanés, M. Victoria/0000-0002-0984-2218; Milanés, M Victoria/0000-0002-0984-2218	Ministerio de Ciencia e Innovacion, Spain [2009-07178, 2010-17907]; Red de Trastornos Adictivos, Spain [RD06/0001/1006, RD06/0001/1001]; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain [15405/PI10]; Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund) [68574, 76697]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Red de Trastornos Adictivos, Spain; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain; Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the following grants: Ministerio de Ciencia e Innovacion (Grant 2009-07178 to MVM, Grant 2010-17907 to MLL), Spain, Red de Trastornos Adictivos (RD06/0001/1006 and RD06/0001/1001 to MLL), Spain, Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia (15405/PI10 to MVM), Spain, and Hungarian Research Fund, OTKA (Hungarian Scientific Research Fund) grants, 68574 and 76697 (International Research Collaboration grant) to KJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Azizi H, 2010, NEUROSCI LETT, V482, P255, DOI 10.1016/j.neulet.2010.07.050; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Bisetti A, 2006, NEUROSCIENCE, V142, P999, DOI 10.1016/j.neuroscience.2006.07.018; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Chang H, 2007, NEUROSCI RES, V57, P462, DOI 10.1016/j.neures.2006.11.009; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Forray MI, 2004, BRAIN RES REV, V47, P145, DOI 10.1016/j.brainresrev.2004.07.011; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Georgescu D, 2003, J NEUROSCI, V23, P3106; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; GUITART X, 1989, J NEUROSCI, V9, P4371; Harris GC, 2007, BEHAV BRAIN RES, V176, P251, DOI 10.1016/j.bbr.2006.10.012; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Kagerer SM, 2010, ACTA PHYSIOL, V198, P361, DOI 10.1111/j.1748-1716.2009.02034.x; Katayama S, 2010, NEUROSCI LETT, V484, P157, DOI 10.1016/j.neulet.2010.08.043; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Kuru M, 2000, NEUROREPORT, V11, P1977, DOI 10.1097/00001756-200006260-00034; Laorden ML, 2000, J PHARMACOL EXP THER, V293, P578; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Li YH, 2011, PHYSIOL BEHAV, V102, P42, DOI 10.1016/j.physbeh.2010.10.006; Lu L, 2000, EUR J NEUROSCI, V12, P4398; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; OWENS MJ, 1991, PHARMACOL REV, V43, P425; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peyron C, 1998, J NEUROSCI, V18, P9996; Sakamoto F, 2004, REGUL PEPTIDES, V118, P183, DOI 10.1016/j.regpep.2003.12.014; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson WK, 2002, REGUL PEPTIDES, V104, P97, DOI 10.1016/S0167-0115(01)00353-6; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Sharf R, 2008, BIOL PSYCHIAT, V64, P175, DOI 10.1016/j.biopsych.2008.03.006; STINUS L, 1990, NEUROSCIENCE, V37, P767, DOI 10.1016/0306-4522(90)90106-E; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Zhou Y, 2010, BRAIN RES, V1314, P235, DOI 10.1016/j.brainres.2009.11.015	42	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36871	10.1371/journal.pone.0036871	http://dx.doi.org/10.1371/journal.pone.0036871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590628	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100069
J	Sheikh, AQ; Hurley, JR; Huang, W; Taghian, T; Kogan, A; Cho, HK; Wang, YG; Narmoneva, DA				Sheikh, Abdul Q.; Hurley, Jennifer R.; Huang, Wei; Taghian, Toloo; Kogan, Andrei; Cho, Hongkwan; Wang, Yigang; Narmoneva, Daria A.			Diabetes Alters Intracellular Calcium Transients in Cardiac Endothelial Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SARCOPLASMIC-RETICULUM; ACTIVITY CONTRIBUTES; HIGH GLUCOSE; CA2+ ATPASE; ACTIVATION; DYSFUNCTION; CARDIOMYOPATHY; MOBILIZATION; CA2+-ATPASE	Diabetic cardiomyopathy (DCM) is a diabetic complication, which results in myocardial dysfunction independent of other etiological factors. Abnormal intracellular calcium ([Ca2+](i)) homeostasis has been implicated in DCM and may precede clinical manifestation. Studies in cardiomyocytes have shown that diabetes results in impaired [Ca2+](i) homeostasis due to altered sarcoplasmic reticulum Ca2+ ATPase (SERCA) and sodium-calcium exchanger (NCX) activity. Importantly, altered calcium homeostasis may also be involved in diabetes-associated endothelial dysfunction, including impaired endothelium-dependent relaxation and a diminished capacity to generate nitric oxide (NO), elevated cell adhesion molecules, and decreased angiogenic growth factors. However, the effect of diabetes on Ca2+ regulatory mechanisms in cardiac endothelial cells (CECs) remains unknown. The objective of this study was to determine the effect of diabetes on [Ca2+](i) homeostasis in CECs in the rat model (streptozotocin-induced) of DCM. DCM-associated cardiac fibrosis was confirmed using picrosirius red staining of the myocardium. CECs isolated from the myocardium of diabetic and wild-type rats were loaded with Fura-2, and UTP-evoked [Ca2+](i) transients were compared under various combinations of SERCA, sarcoplasmic reticulum Ca2+ ATPase (PMCA) and NCX inhibitors. Diabetes resulted in significant alterations in SERCA and NCX activities in CECs during [Ca2+](i) sequestration and efflux, respectively, while no difference in PMCA activity between diabetic and wild-type cells was observed. These results improve our understanding of how diabetes affects calcium regulation in CECs, and may contribute to the development of new therapies for DCM treatment.	[Sheikh, Abdul Q.; Hurley, Jennifer R.; Cho, Hongkwan; Narmoneva, Daria A.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA; [Huang, Wei; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Taghian, Toloo; Kogan, Andrei] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA	University of Cincinnati; University of Cincinnati; University of Cincinnati	Sheikh, AQ (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH 45221 USA.	daira.narmoneva@uc.edu	HUANG, WEI/A-4639-2013	Huang, Wei/0000-0003-3046-4220; Kogan, Andrei/0000-0002-3859-1497	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK) [1R21DK078814-01A1]; University of Cincinnati Nanomedicine Group; University of Cincinnati Research Council; University of Cincinnati Biomedical Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078814] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0804199] Funding Source: National Science Foundation	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Cincinnati Nanomedicine Group; University of Cincinnati Research Council; University of Cincinnati Biomedical Engineering; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK 1R21DK078814-01A1) (www.nih.gov); a Nanomedicine Fellowship, University of Cincinnati Nanomedicine Group (http://www.ceas.uc.edu/); an interdisciplinary faculty research grant, University of Cincinnati Research Council (http://webcentral.uc.edu/urc2/apply/programinfo.cfm); and startup funds from University of Cincinnati Biomedical Engineering (http://www.ceas.uc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Arnalich F, 2011, CYTOKINE; Association AD, 2011, ADA FACT SHEET; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOSSU JL, 1992, FEBS LETT, V299, P239, DOI 10.1016/0014-5793(92)80123-X; Brini M., 2011, COLD SPRING HARBOR P, V3; Chattou S, 1999, ACTA PHYSIOL SCAND, V166, P137; Choi KM, 2002, AM J PHYSIOL-HEART C, V283, pH1398, DOI 10.1152/ajpheart.00313.2002; Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794; Cosentino F, 1998, J CARDIOVASC PHARM, V32, pS54; Dang L, 2005, CLIN EXP PHARMACOL P, V32, P771, DOI 10.1111/j.1440-1681.2005.04266.x; DELAFUENTE PG, 1995, PFLUG ARCH EUR J PHY, V429, P617, DOI 10.1007/BF00373982; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; El Amine M, 2010, Endocr Regul, V44, P17; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 1997, AM J CARDIOL, V80, pA102, DOI 10.1016/S0002-9149(97)00464-5; Goel A, 2007, CARDIOVASC RES, V76, P351, DOI 10.1016/j.cardiores.2007.06.029; Green AK, 1997, CELL CALCIUM, V22, P99, DOI 10.1016/S0143-4160(97)90110-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hattori Y, 2000, J PHYSIOL-LONDON, V527, P85, DOI 10.1111/j.1469-7793.2000.00085.x; Hill BJF, 2003, ATHEROSCLEROSIS, V167, P15, DOI 10.1016/S0021-9150(02)00381-7; Huszka M, 1997, THROMB RES, V86, P173, DOI 10.1016/S0049-3848(97)00060-1; Improta-Brears T, 1999, P NATL ACAD SCI USA, V96, P4686, DOI 10.1073/pnas.96.8.4686; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; Ma L, 2008, CLIN EXP PHARMACOL P, V35, P568, DOI 10.1111/j.1440-1681.2007.04832.x; Moccia F, 2002, BIOCHEM J, V364, P235, DOI 10.1042/bj3640235; Moccia F, 2001, MICROVASC RES, V61, P240, DOI 10.1006/mvre.2001.2306; MORGAN JP, 1990, CIRCULATION, V81, P21; NISHIDA M, 1993, AM J PHYSIOL, V264, pH639, DOI 10.1152/ajpheart.1993.264.2.H639; Obrosova IG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1645, DOI 10.1152/ajpendo.00479.2007; PENPARGKUL S, 1980, CIRC RES, V47, P911, DOI 10.1161/01.RES.47.6.911; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; SIEGL PKS, 1984, P NATL ACAD SCI-BIOL, V81, P3238, DOI 10.1073/pnas.81.10.3238; Tchaikovski V, 2009, CIRCULATION, V120, P150, DOI 10.1161/CIRCULATIONAHA.108.817528; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Van Linthout S, 2008, BASIC RES CARDIOL, V103, P319, DOI 10.1007/s00395-008-0715-2; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; Westermann D, 2007, DIABETES, V56, P1834, DOI 10.2337/db06-1662; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xavier-Vidal Ricardo, 2005, Clinics, V60, P85, DOI 10.1590/S1807-59322005000200003; YAMAMOTO N, 1995, BBA-MOL CELL RES, V1266, P157, DOI 10.1016/0167-4889(95)00011-G; Zhao XY, 2006, J PHYSIOL BIOCHEM, V62, P1, DOI 10.1007/BF03165800	47	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36840	10.1371/journal.pone.0036840	http://dx.doi.org/10.1371/journal.pone.0036840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590623	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100065
J	Soupene, E; Rothschild, J; Kuypers, FA; Dean, D				Soupene, Eric; Rothschild, James; Kuypers, Frans A.; Dean, Deborah			Eukaryotic Protein Recruitment into the Chlamydia Inclusion: Implications for Survival and Growth	PLOS ONE			English	Article							ACYL-COA SYNTHETASE; OBLIGATE INTRACELLULAR PATHOGEN; ENDOCYTIC MULTIVESICULAR BODIES; CYTOPLASMIC LIPID DROPLETS; TRACHOMATIS INCA; GOLGI-APPARATUS; INFECTED CELLS; III SECRETION; APOPTOSIS; TRAFFICKING	Chlamydia trachomatis (Ct) is an obligate intracellular human pathogen that multiplies within a parasitophorous vacuole called an inclusion. We report that the location of several host-cell proteins present in the cytosol, the nucleus, and membranes was altered during Ct development. The acyl-CoA synthetase enzyme ACSL3 and the soluble acyl-CoA binding protein ACBD6 were mobilized from organelle membranes and the nucleus, respectively, into the lumen of the inclusion. The nuclear protein ZNF23, a pro-apoptosis factor, was also translocated into the inclusion lumen. ZNF23, among other proteins, might be targeted by Ct to inhibit host cell apoptosis, thereby enabling bacterial survival. In contrast, the acyl-CoA: lysophosphatidylcholine acyltransferase LPCAT1, an endoplasmic reticulum membrane protein, was recruited to the inclusion membrane. The coordinated action of ACBD6, ACSL3 and LPCAT1 likely supports remodeling and scavenging of host lipids into bacterial-specific moieties essential to Ct growth. To our knowledge, these are the first identified host proteins known to be intercepted and translocated into the inclusion.	[Soupene, Eric; Kuypers, Frans A.] Childrens Hosp, Oakland Res Inst, Ctr Sickle Cell Dis & Thalassemia, Oakland, CA 94609 USA; [Rothschild, James; Dean, Deborah] Childrens Hosp, Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Dean, Deborah] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Dean, Deborah] Univ Calif San Francisco, Grad Program Bioengn, San Francisco, CA 94143 USA; [Dean, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Soupene, E (corresponding author), Childrens Hosp, Oakland Res Inst, Ctr Sickle Cell Dis & Thalassemia, 747 52nd St, Oakland, CA 94609 USA.	esoupene@chori.org			Public Health Service from the National Institutes of Health [R56 AI78419]; National Institutes of Health [R21HL092535]; CHORI Red Blood Cell Laboratory; CHORI Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI078419] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHORI Red Blood Cell Laboratory; CHORI Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Public Health Service grant R56 AI78419 from the National Institutes of Health (to DD), and in part by grant R21HL092535 from the National Institutes of Health as well as funds from the CHORI Red Blood Cell Laboratory and the CHORI Foundation (to FAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Du K, 2011, CURR MICROBIOL, V63, P341, DOI 10.1007/s00284-011-9985-2; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fan JJ, 2010, PROG LIPID RES, V49, P218, DOI 10.1016/j.plipres.2009.12.003; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1997, TRENDS MICROBIOL, V5, P288, DOI 10.1016/S0966-842X(97)01061-5; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hasegawa A, 2009, INFECT IMMUN, V77, P1285, DOI 10.1128/IAI.01062-08; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Huang CX, 2008, CANCER LETT, V266, P135, DOI 10.1016/j.canlet.2008.02.059; Huang CX, 2007, EXP CELL RES, V313, P254, DOI 10.1016/j.yexcr.2006.10.009; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lipinski AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000615; Malhotra KT, 1999, BIOCHEM J, V344, P135, DOI 10.1042/0264-6021:3440135; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pirbhai M, 2006, J BIOL CHEM, V281, P31495, DOI 10.1074/jbc.M602796200; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schwarzenbacher R, 2004, J BIOL CHEM, V279, P29320, DOI 10.1074/jbc.M401268200; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Shi YQ, 2009, MOL CELLS, V27, P199, DOI 10.1007/s10059-009-0024-0; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Soupene E, 2008, J LIPID RES, V49, P1103, DOI 10.1194/jlr.M800007-JLR200; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-21; Soupene E, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-18; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Wissel H, 2003, AM J RESP CELL MOL, V29, P303, DOI 10.1165/rcmb.2002-0246OC; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	66	18	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36843	10.1371/journal.pone.0036843	http://dx.doi.org/10.1371/journal.pone.0036843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590624	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100066
J	Wei, W; Qi, XG; Guo, ST; Zhao, DP; Zhang, P; Huang, K; Li, BG				Wei, Wei; Qi, Xiao-Guang; Guo, Song-Tao; Zhao, Da-Peng; Zhang, Peng; Huang, Kang; Li, Bao-Guo			Market Powers Predict Reciprocal Grooming in Golden Snub-Nosed Monkeys (Rhinopithecus roxellana)	PLOS ONE			English	Article							QINLING MOUNTAINS; FEMALE PRIMATES; JAPANESE MACAQUES; DEMAND DETERMINE; BEHAVIOR; SIZE; INTERCHANGE; PATTERNS; SUPPORT; SEX	Social grooming is a common form of affiliative behavior in primates. Biological market theory suggests that grooming can be traded either for grooming or other social commodities and services. When no other services are exchanged, grooming is predicted to be approximately reciprocated within a dyad. In contrast, the amount of reciprocal grooming should decrease as other offered services increase. We studied grooming patterns between polygamous male and female in golden snub-nosed monkeys (Rhinopithecus roxellana) from the Qinling Mountains of central China and found that about 29.7% of grooming bouts were reciprocated. However, the durations of grooming bouts offered and returned was asymmetrical within dyads. In bisexual dyads, more grooming was initiated by females than males, which became more pronounced as the number of females per one-male unit increased. The rate of copulation per day for each female was positively correlated with the total duration of grooming time females invested in males.. Females without an infant (non-mothers) directed more grooming towards females with an infant (mothers) and were significantly more likely to be non-reciprocated. There was a significant negative relationship between non-mother and mother grooming duration and the rate of infants per female in each one-male unit. High-ranking females also received more grooming from low-ranking females than vice versa. The rate of food-related aggressive interactions was per day for low-ranking females was negatively correlated with the duration of grooming that low-ranking females gave to high-ranking females. Our results showed that grooming reciprocation in R. roxellana was discrepancy. This investment-reciprocity rate could be explained by the exchange of other social services in lieu of grooming.	[Wei, Wei; Qi, Xiao-Guang; Guo, Song-Tao; Zhao, Da-Peng; Huang, Kang; Li, Bao-Guo] Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Coll Life Sci, Xian, Peoples R China; [Zhang, Peng] Sun Yat Sen Univ, Sch Sociol & Anthropol, Guangzhou 510275, Guangdong, Peoples R China; [Li, Bao-Guo] Shaanxi Acad Sci, Inst Zool, Xian, Peoples R China	Northwest University Xi'an; Sun Yat Sen University	Wei, W (corresponding author), Northwest Univ, Key Lab Resource Biol & Biotechnol Western China, Coll Life Sci, Xian, Peoples R China.	baoguoli@nwu.edu.cn		Guo, Songtao/0000-0002-8291-5487	National Nature Science Foundation of China [31130061, 30970444, 30970168, 30970379]; Research Fund for the Doctoral Program of Higher Education of China [20106101110005]; Special Foundation of Shaanxi Academy of Sciences, China [2010K-08]; Natural Science Foundation of Shaanxi Province, China [2009JM3002]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Special Foundation of Shaanxi Academy of Sciences, China; Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province)	This work was supported by the grants from the Key Program of National Nature Science Foundation of China (31130061); the National Nature Science Foundation of China (30970444; 30970168; 30970379); the Research Fund for the Doctoral Program of Higher Education of China (20106101110005); the Special Foundation of Shaanxi Academy of Sciences, China (2010K-08); the Natural Science Foundation of Shaanxi Province, China (2009JM3002); the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeggglen JJ, 1984, SOCIALIZATION HAMADR; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Barrett L, 1999, P ROY SOC B-BIOL SCI, V266, P665, DOI 10.1098/rspb.1999.0687; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; Chancellor RL, 2009, BEHAV ECOL, V20, P79, DOI 10.1093/beheco/arn117; CONNOR RC, 1995, ANIM BEHAV, V49, P528, DOI 10.1006/anbe.1995.0070; Cords M, 2002, BEHAVIOUR, V139, P291, DOI 10.1163/156853902760102681; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Dixson A.F., 1998, PRIMATE SEXUALITY CO; DUNBAR R, 1975, SOCIAL DYNAMICS GELA; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Fruteau C, 2010, BEHAV PROCESS, V83, P113, DOI 10.1016/j.beproc.2009.11.004; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Gould W, 2000, STATA TECHN B REPRIN, V9, P257; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; Guo SG, 2007, PRIMATES, V48, P268, DOI 10.1007/s10329-007-0048-z; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HART BL, 1992, ANIM BEHAV, V44, P615, DOI 10.1016/S0003-3472(05)80290-8; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1991, ANIM BEHAV, V41, P923, DOI 10.1016/S0003-3472(05)80630-X; Hemelrijk CK, 1998, BEHAV ECOL SOCIOBIOL, V42, P207, DOI 10.1007/s002650050432; Henzi SP, 1997, ANIM BEHAV, V54, P1235, DOI 10.1006/anbe.1997.0520; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Henzi SP, 1997, ANIM BEHAV, V53, P525, DOI 10.1006/anbe.1996.0302; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hu Songmei, 2006, Acta Theriologica Sinica, V26, P417; JANSON CH, 1995, BEHAV ECOL, V6, P326, DOI 10.1093/beheco/6.3.326; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; Kutsukake N, 2010, ANIM BEHAV, V79, P271, DOI 10.1016/j.anbehav.2009.10.014; Lazaro-Perea C, 2004, ANIM BEHAV, V67, P627, DOI 10.1016/j.anbehav.2003.06.004; Leinfelder I, 2001, AM J PRIMATOL, V55, P25, DOI 10.1002/ajp.1036; Lewis RJ, 2010, AM J PRIMATOL, V72, P254, DOI 10.1002/ajp.20776; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li BG, 2000, FOLIA PRIMATOL, V71, P375, DOI 10.1159/000052734; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Manson JH, 1999, INT J PRIMATOL, V20, P679, DOI 10.1023/A:1020700718458; MELLER RE, 1980, PHARMACOL BIOCHEM BE, V13, P663, DOI 10.1016/0091-3057(80)90010-6; Mooring MS, 1996, BEHAV ECOL SOCIOBIOL, V39, P259, DOI 10.1007/s002650050288; MORI U, 1979, ECOLOGICAL SOCIOLOGI, P125; Newton-Fisher NE, 2011, ANIM BEHAV, V81, P439, DOI 10.1016/j.anbehav.2010.11.015; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Payne HFP, 2003, BEHAVIOUR, V140, P453, DOI 10.1163/156853903322127931; Perez A, 2000, INT J PRIMATOL, V21, P255, DOI 10.1023/A:1005425520658; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Qi Xiao-Guang, 2004, Acta Zoologica Sinica, V50, P697; Qi XG, 2011, AM J PRIMATOL, V73, P366, DOI 10.1002/ajp.20908; Qi XG, 2009, AM J PRIMATOL, V71, P670, DOI 10.1002/ajp.20702; Qi Xiaoguang, 2010, Acta Theriologica Sinica, V30, P322; Ren R, 2000, FIELD STUDY SOC RHIN; Schino G, 2003, BEHAV ECOL, V14, P887, DOI 10.1093/beheco/arg070; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; Silk JB, 1999, ANIM BEHAV, V57, P1021, DOI 10.1006/anbe.1998.1065; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Smuts B.B., 1987, P385; Stopka P, 2001, ANIM BEHAV, V61, P19; Swedell L, 2002, INT J PRIMATOL, V23, P1205, DOI 10.1023/A:1021170703006; Tiddi B, 2010, ANIM BEHAV, V79, P1115, DOI 10.1016/j.anbehav.2010.02.008; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Zhang P, 2006, PRIMATES, V47, P374, DOI 10.1007/s10329-006-0178-8; Zhao DP, 2008, BEHAV PROCESS, V79, P165, DOI 10.1016/j.beproc.2008.07.006; Zhao DP, 2005, FOLIA PRIMATOL, V76, P172, DOI 10.1159/000084379; Zhao HT, 2011, STUDY CORRELATIONSHI; ZUMPE D, 1986, AM J PRIMATOL, V10, P291, DOI 10.1002/ajp.1350100402	80	16	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36802	10.1371/journal.pone.0036802	http://dx.doi.org/10.1371/journal.pone.0036802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590611	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100061
J	Goffe, AS; Blasse, A; Mundry, R; Leendertz, FH; Calvignac-Spencer, S				Goffe, Adeelia S.; Blasse, Anja; Mundry, Roger; Leendertz, Fabian H.; Calvignac-Spencer, Sebastien			Detection of Retroviral Super-Infection from Non-Invasive Samples	PLOS ONE			English	Article							FOAMY VIRUS-INFECTION; TAI NATIONAL-PARK; PHYLOGENETIC ANALYSIS; GENE GENEALOGIES; COMPUTER-PROGRAM; DUAL INFECTION; VIRAL LOAD; CHIMPANZEES; WILD; TYPE-1	While much attention has been focused on the molecular epidemiology of retroviruses in wild primate populations, the correlated question of the frequency and nature of super-infection events, i.e., the simultaneous infection of the same individual host with several strains of the same virus, has remained largely neglected. In particular, methods possibly allowing the investigation of super-infection from samples collected non-invasively (such as faeces) have never been properly compared. Here, we fill in this gap by assessing the costs and benefits of end-point dilution PCR (EPD-PCR) and multiple bulk-PCR cloning, as applied to a case study focusing on simian foamy virus super-infection in wild chimpanzees (Pan troglodytes). We show that, although considered to be the gold standard, EPD-PCR can lead to massive consumption of biological material when only low copy numbers of the target are expected. This constitutes a serious drawback in a field in which rarity of biological material is a fundamental constraint. In addition, we demonstrate that EPD-PCR results (single/multiple infection; founder strains) can be well predicted from multiple bulk-PCR clone experiments, by applying simple statistical and network analyses to sequence alignments. We therefore recommend the implementation of the latter method when the focus is put on retroviral super-infection and only low retroviral loads are encountered.	[Goffe, Adeelia S.; Blasse, Anja; Leendertz, Fabian H.; Calvignac-Spencer, Sebastien] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Goffe, Adeelia S.] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Robert Koch Institute; University of Oxford; Max Planck Society	Goffe, AS (corresponding author), Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany.	calvignacs@rki.de	Leendertz, Fabian Hubertus/H-8902-2019; Calvignac-Spencer, Sebastien/D-2313-2010	Calvignac-Spencer, Sebastien/0000-0003-4834-0509	Robert Koch-Institut, Berlin, Germany; DFG Africa [LE1813/4-1]; FAZIT Stiftung	Robert Koch-Institut, Berlin, Germany; DFG Africa; FAZIT Stiftung	This study was funded by the Robert Koch-Institut, Berlin, Germany, the DFG Africa Grant (LE1813/4-1) and the FAZIT Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bjork A, 2011, MOL BIOL EVOL, V28, P615, DOI 10.1093/molbev/msq227; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calattini S, 2004, J GEN VIROL, V85, P3313, DOI 10.1099/vir.0.80241-0; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grobler J, 2004, J INFECT DIS, V190, P1355, DOI 10.1086/423940; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kondgen S, 2010, ECOHEALTH, V7, P332, DOI 10.1007/s10393-010-0340-z; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Ling BH, 2003, J VIROL, V77, P2214, DOI 10.1128/JVI.77.3.2214-2226.2003; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meertens L, 2001, VIROLOGY, V287, P275, DOI 10.1006/viro.2001.1018; Morozov VA, 2009, J GEN VIROL, V90, P500, DOI 10.1099/vir.0.003939-0; Mullers E, 2011, J VIROL, V85, P1452, DOI 10.1128/JVI.01731-10; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Pacold M, 2010, AIDS RES HUM RETROV, V26, P1291, DOI 10.1089/aid.2010.0042; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ryland EG, 2010, J VIROL, V84, P12437, DOI 10.1128/JVI.01617-10; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHWEIZER M, 1995, VIROLOGY, V207, P577, DOI 10.1006/viro.1995.1120; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; TEMPLETON AR, 1992, GENETICS, V132, P619; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36570	10.1371/journal.pone.0036570	http://dx.doi.org/10.1371/journal.pone.0036570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590569	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500018
J	Maroun, M; Kavushansky, A; Holmes, A; Wellman, C; Motanis, H				Maroun, Mouna; Kavushansky, Alexandra; Holmes, Andrew; Wellman, Cara; Motanis, Helen			Enhanced Extinction of Aversive Memories by High-Frequency Stimulation of the Rat Infralimbic Cortex	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CONDITIONED TASTE-AVERSION; FEAR EXTINCTION; LONG-TERM; PROTEIN-SYNTHESIS; GABA(A) AGONIST; STRESS; CONSOLIDATION; RECONSOLIDATION; EXPRESSION	Electrical stimulation of the rodent medial prefrontal cortex (mPFC), including the infralimbic cortex (IL), immediately prior to or during fear extinction training facilitates extinction memory. Here we examined the effects of high-frequency stimulation (HFS) of the rat IL either prior to conditioning or following retrieval of the conditioned memory, on extinction of Pavlovian fear and conditioned taste aversion (CTA). IL-HFS applied immediately after fear memory retrieval, but not three hours after retrieval or prior to conditioning, subsequently reduced freezing during fear extinction. Similarly, IL-HFS given immediately, but not three hours after, retrieval of a CTA memory reduced aversion during extinction. These data indicate that HFS of the IL may be an effective method for reducing both learned fear and learned aversion.	[Maroun, Mouna; Kavushansky, Alexandra; Motanis, Helen] Univ Haifa, Fac Nat Sci, Dept Neurobiol, IL-31999 Haifa, Israel; [Holmes, Andrew] NIAAA, Lab Behav & Genom Neurosci, NIH, Bethesda, MD USA; [Wellman, Cara] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Wellman, Cara] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN USA	University of Haifa; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Maroun, M (corresponding author), Univ Haifa, Fac Nat Sci, Dept Neurobiol, IL-31999 Haifa, Israel.	mouna.maroun@gmail.com		Kavushansky, Alexandra/0000-0002-8511-3068; Wellman, Cara/0000-0002-3064-4259	United States-Israel Binational Science Foundation; Ministry of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000411] Funding Source: NIH RePORTER	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ministry of Health; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by the United States-Israel Binational Science Foundation (to AH, CLW and MM) and the Ministry of Health grant (to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2006, EUR J NEUROSCI, V23, P758, DOI 10.1111/j.1460-9568.2006.04603.x; Akirav I, 2007, NEUROPSYCHOPHARMACOL, V32, P542, DOI 10.1038/sj.npp.1301050; Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Akirav I, 2006, LEARN MEMORY, V13, P254, DOI 10.1101/lm.191706; Akirav Irit, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/30873; Akirav I, 2009, LEARN MEMORY, V16, P682, DOI 10.1101/lm.1565109; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Bahar A, 2003, EUR J NEUROSCI, V17, P1527, DOI 10.1046/j.1460-9568.2003.02551.x; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BOUTON ME, 1994, J EXP PSYCHOL ANIM B, V20, P51, DOI 10.1037/0097-7403.20.1.51; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Farrell MR, 2010, NEUROBIOL LEARN MEM, V94, P240, DOI 10.1016/j.nlm.2010.06.001; Fernandez M, 2001, NEUROSCI LETT, V297, P101, DOI 10.1016/S0304-3940(00)01674-8; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2003, BEHAV BRAIN RES, V146, P89, DOI 10.1016/j.bbr.2003.09.017; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2010, EUR J NEUROSCI, V31, P599, DOI 10.1111/j.1460-9568.2010.07101.x; Hikind N, 2008, NEUROBIOL LEARN MEM, V90, P217, DOI 10.1016/j.nlm.2008.03.003; Holmes A, 2010, TRENDS PHARMACOL SCI, V31, P2, DOI 10.1016/j.tips.2009.10.003; Izquierdo A, 2006, J NEUROSCI, V26, P5733, DOI 10.1523/JNEUROSCI.0474-06.2006; Jay TM, 1996, J PHYSIOLOGY-PARIS, V90, P361, DOI 10.1016/S0928-4257(97)87920-X; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Maroun M, 2003, J NEUROSCI, V23, P4406; Maroun M, 2006, EUR J NEUROSCI, V24, P2917, DOI 10.1111/j.1460-9568.2006.05169.x; Mickley GA, 2005, BRAIN RES, V1051, P176, DOI 10.1016/j.brainres.2005.05.033; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Miracle AD, 2006, NEUROBIOL LEARN MEM, V85, P213, DOI 10.1016/j.nlm.2005.10.005; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Pare D, 2004, TRENDS NEUROSCI, V27, P440, DOI 10.1016/j.tins.2004.05.004; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Rescorla RA, 1996, Q J EXP PSYCHOL-B, V49, P245; Richter-Levin G, 2010, CEREB CORTEX, V20, P2433, DOI 10.1093/cercor/bhp311; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Vouimba RM, 2011, NEUROPSYCHOPHARMACOL, V36, P2276, DOI 10.1038/npp.2011.115; Wilber AA, 2011, NEUROSCIENCE, V174, P115, DOI 10.1016/j.neuroscience.2010.10.070; Yasoshima Y, 2000, BRAIN RES, V869, P15, DOI 10.1016/S0006-8993(00)02397-0	55	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35853	10.1371/journal.pone.0035853	http://dx.doi.org/10.1371/journal.pone.0035853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586453	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000015
J	Tagawa, K; Yoshihara, T; Shibata, T; Kitazaki, K; Endo, Y; Fujita, T; Koshiba, T; Kawabata, S				Tagawa, Keisuke; Yoshihara, Toyoki; Shibata, Toshio; Kitazaki, Kazuki; Endo, Yuichi; Fujita, Teizo; Koshiba, Takumi; Kawabata, Shun-ichiro			Microbe-Specific C3b Deposition in the Horseshoe Crab Complement System in a C2/Factor B-Dependent or -Independent Manner	PLOS ONE			English	Article							TACHYPLEUS-TRIDENTATUS; INNATE IMMUNITY; PLASMA LECTINS; PROTEINS; LIPOPOLYSACCHARIDE; HEMOLYMPH	Complement C3 plays an essential role in the opsonization of pathogens in the mammalian complement system, whereas the molecular mechanism underlying C3 activation in invertebrates remains unknown. To understand the molecular mechanism of C3b deposition on microbes, we characterized two types of C2/factor B homologs (designated TtC2/Bf-1 and TtC2/Bf-2) identified from the horseshoe crab Tachypleus tridentatus. Although the domain architectures of TtC2/Bf-1 and TtC2/Bf-2 were identical to those of mammalian homologs, they contained five-repeated and seven-repeated complement control protein domains at their N-terminal regions, respectively. TtC2/Bf-1 and TtC2/Bf-2 were synthesized and glycosylated in hemocytes and secreted to hemolymph plasma, which existed in a complex with C3 (TtC3), and their activation by microbes was absolutely Mg2+-dependent. Flow cytometric analysis revealed that TtC3b deposition was Mg2+-dependent on Gram-positive bacteria or fungi, but not on Gram-negative bacteria. Moreover, this analysis demonstrated that Ca2+-dependent lectins (C-reactive protein-1 and tachylectin-5A) were required for TtC3b deposition on Gram-positive bacteria, and that a Ca2+-independent lectin (Tachypleus plasma lectin-1) was definitely indispensable for TtC3b deposition on fungi. In contrast, a horseshoe crab lipopolysaccharide-sensitive protease factor C was necessary and sufficient to deposit TtC3b on Gram-negative bacteria. We conclude that plasma lectins and factor C play key roles in microbe-specific TtC3b deposition in a C2/factor B-dependent or -independent manner.	[Tagawa, Keisuke; Yoshihara, Toyoki; Kitazaki, Kazuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Shibata, Toshio; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Endo, Yuichi; Fujita, Teizo] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan	Kyushu University; Kyushu University; Fukushima Medical University	Tagawa, K (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	skawascb@kyudai.jp	Koshiba, Takumi/A-3996-2013; Shibata, Toshio/AAE-1694-2020	Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Takeda Science Foundation; Japan Society for the Promotion of Science [23890147]; Grants-in-Aid for Scientific Research [22570144] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Takeda Science Foundation (to SK) and Grant-in-Aid for Research Activity Start-up from Japan Society for the Promotion of Science No. 23890147) (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Chiou ST, 2000, J BIOL CHEM, V275, P1630, DOI 10.1074/jbc.275.3.1630; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gokudan S, 1999, P NATL ACAD SCI USA, V96, P10086, DOI 10.1073/pnas.96.18.10086; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Iwaki D, 1999, EUR J BIOCHEM, V264, P314, DOI 10.1046/j.1432-1327.1999.00588.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kuo TH, 2006, BIOCHEM J, V393, P757, DOI 10.1042/BJ20051108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le GT, 2007, J BIOL CHEM, V282, P34809, DOI 10.1074/jbc.M705646200; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; ROBERTSON JD, 1970, BIOL BULL-US, V138, P157, DOI 10.2307/1540199; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Smith LC, 1998, J IMMUNOL, V161, P6784; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	18	18	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36783	10.1371/journal.pone.0036783	http://dx.doi.org/10.1371/journal.pone.0036783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22611464	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000057
J	Bokony, V; Kulcsar, A; Toth, Z; Liker, A				Bokony, Veronika; Kulcsar, Anna; Toth, Zoltan; Liker, Andras			Personality Traits and Behavioral Syndromes in Differently Urbanized Populations of House Sparrows (Passer domesticus)	PLOS ONE			English	Article							RESPONSES; BIRDS; NOVELTY; TEMPERAMENT; LANDSCAPE; SELECTION; SUCCESS; CITY; FEAR	Urbanization creates novel environments for wild animals where selection pressures may differ drastically from those in natural habitats. Adaptation to urban life involves changes in various traits, including behavior. Behavioral traits often vary consistently among individuals, and these so-called personality traits can be correlated with each other, forming behavioral syndromes. Despite their adaptive significance and potential to act as constraints, little is known about the role of animal personality and behavioral syndromes in animals' adaptation to urban habitats. In this study we tested whether differently urbanized habitats select for different personalities and behavioral syndromes by altering the population mean, inter-individual variability, and correlations of personality traits. We captured house sparrows (Passer domesticus) from four different populations along the gradient of urbanization and assessed their behavior in standardized test situations. We found individual consistency in neophobia, risk taking, and activity, constituting three personality axes. On the one hand, urbanization did not consistently affect the mean and variance of these traits, although there were significant differences between some of the populations in food neophobia and risk taking (both in means and variances). On the other hand, both urban and rural birds exhibited a behavioral syndrome including object neophobia, risk taking and activity, whereas food neophobia was part of the syndrome only in rural birds. These results indicate that there are population differences in certain aspects of personality in house sparrows, some of which may be related to habitat urbanization. Our findings suggest that urbanization and/or other population-level habitat differences may not only influence the expression of personality traits but also alter their inter-individual variability and the relationships among them, changing the structure of behavioral syndromes.	[Bokony, Veronika; Liker, Andras] Univ Pannonia, Dept Limnol, Veszprem, Hungary; [Kulcsar, Anna] Szent Istvan Univ, Fac Vet Sci, Dept Physiol & Biochem, Budapest, Hungary; [Toth, Zoltan] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	University of Pannonia; Hungarian University of Agriculture & Life Sciences; Jagiellonian University	Bokony, V (corresponding author), Univ Pannonia, Dept Limnol, Veszprem, Hungary.	vbokony@almos.uni-pannon.hu	Bókony, Veronika/AAH-7679-2020	Bókony, Veronika/0000-0002-2136-5346; Toth, Zoltan/0000-0002-2634-8393	Hungarian Scientific Research Fund [OTKA K84132, TAMOP -4.2.2/B-10/1-2010-0025]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by the Hungarian Scientific Research Fund (OTKA K84132) and TAMOP -4.2.2/B-10/1-2010-0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TR., 2006, BIOL UBIQUITOUS HOUS; [Anonymous], 2001, AVIAN ECOLOGY CONSER; Arbuckle J.L., 2006, AMOS 7 0 USERS GUIDE; Beckmann JP, 2003, J ZOOL, V261, P207, DOI 10.1017/S0952836903004126; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bokony V, 2012, LANDSCAPE URBAN PLAN, V104, P75, DOI 10.1016/j.landurbplan.2011.10.006; Bokony V, 2010, OIKOS, V119, P437, DOI 10.1111/j.1600-0706.2009.17848.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Crawley M.J., 2007, R BOOK; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2010, ANIM BEHAV, V79, P439, DOI 10.1016/j.anbehav.2009.11.024; Dochtermann NA, 2010, BEHAV ECOL, V21, P437, DOI 10.1093/beheco/arq021; Echeverria AI, 2008, ETHOLOGY, V114, P616, DOI 10.1111/j.1439-0310.2008.01512.x; Edelaar P, 2012, BEHAV ECOL, V23, P619, DOI 10.1093/beheco/ars006; Evans J, 2010, ETHOLOGY, V116, P588, DOI 10.1111/j.1439-0310.2010.01771.x; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Fernandez-Juricic E, 2003, CONDOR, V105, P316, DOI 10.1650/0010-5422(2003)105[0316:TTRHIA]2.0.CO;2; Fleischer AL, 2003, CONDOR, V105, P515, DOI 10.1650/7224; Greenberg Russell, 2003, P175; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Johnson WC, 2004, BIOL CONSERV, V115, P487, DOI 10.1016/S0006-3207(03)00165-4; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Lendvai AZ, 2011, J EXP BIOL, V214, P821, DOI 10.1242/jeb.047712; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McDonnell MJ, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P1, DOI 10.1017/CBO9780511609763; Moller AP, 2008, BEHAV ECOL SOCIOBIOL, V63, P63, DOI 10.1007/s00265-008-0636-y; Moller AP, 2010, BEHAV ECOL, V21, P913, DOI 10.1093/beheco/arq079; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Mutzel A, 2011, ANIM BEHAV, V81, P731, DOI 10.1016/j.anbehav.2011.01.001; Niemela J, 2011, URBAN ECOLOGY: PATTERNS, PROCESSES, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199563562.001.0001; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Scales J, 2011, ETHOLOGY, V117, P887, DOI 10.1111/j.1439-0310.2011.01943.x; Seress G, 2011, ETHOLOGY, V117, P896, DOI 10.1111/j.1439-0310.2011.01944.x; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Snekser JL, 2009, BEHAV ECOL, V20, P124, DOI 10.1093/beheco/arn123; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Valcarcel A, 2009, BEHAV ECOL SOCIOBIOL, V63, P673, DOI 10.1007/s00265-008-0701-6; Vangestel C, 2011, MOL ECOL, V20, P4643, DOI 10.1111/j.1365-294X.2011.05316.x; Yeh PJ, 2007, OIKOS, V116, P1473, DOI 10.1111/j.2007.0030-1299.15910.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zuur Alain F., 2009, P1	56	110	111	2	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36639	10.1371/journal.pone.0036639	http://dx.doi.org/10.1371/journal.pone.0036639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574204	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800101
J	Nellen, A; Heinrichs, D; Berres, ML; Sahin, H; Schmitz, P; Proudfoot, AE; Trautwein, C; Wasmuth, HE				Nellen, Andreas; Heinrichs, Daniel; Berres, Marie-Luise; Sahin, Hacer; Schmitz, Petra; Proudfoot, Amanda E.; Trautwein, Christian; Wasmuth, Hermann E.			Interference with Oligomerization and Glycosaminoglycan Binding of the Chemokine CCL5 Improves Experimental Liver Injury	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPARIN-BINDING; STELLATE CELLS; RANTES; MECHANISMS; FIBROSIS; FIBROGENESIS; INFLAMMATION; RECEPTORS; VARIANTS	Background: The chemokine CCL5 is involved in the recruitment of immune cells and a subsequent activation of hepatic stellate cells (HSC) after liver injury. We here investigate whether inhibition of CCL5 oligomerization and glycosaminoglycan binding by a mutated CCL5 protein ((44)AANA(47)-CCL5) has the potential to ameliorate liver cell injury and fibrosis in vivo. Methodology: Liver injury was induced in C57BL/6 mice by intraperitoneal injection of carbon tetrachloride (CCl4) in an acute and a chronic liver injury model. Simultaneously, mice received either (44)AANA(47)-CCL5 or vehicle. Liver cell necrosis and fibrosis was analyzed by histology, and measurement of serum transaminases and hydroxyproline. Intrahepatic mRNA expression of fibrosis and inflammation related genes were determined by quantitative RT-PCR and infiltration of immune cells was assessed by FACS analysis and immunocytochemistry. In vitro, HSC were stimulated with conditioned media of T-cell enriched splenocytes. Principal Findings: (44)AANA(47)-CCL5 treated mice displayed a significantly reduced degree of acute liver injury (liver cell necrosis, transaminases) and fibrosis (Sirus red positive area and hydroxyproline content) compared to vehicle treated mice. Ameliorated fibrosis by (44)AANA(47)-CCL5 was associated with a decreased expression of fibrosis related genes, decreased alpha-smoth muscle antigen (alpha SMA) and a reduction of infiltrating immune cells. In the acute model, (44)AANA(47)-CCL5 treated mice displayed a reduced immune cell infiltration and mRNA levels of TNF, IL-1 and CCL3 compared to vehicle treated mice. In vitro, conditioned medium of T-cell enriched splenocytes of (44)AANA(47)-CCL5 treated mice inhibited the chemotaxis and proliferation of HSC. Conclusions: The results provide evidence that inhibition of oligomerization and glycosaminoglycan binding of the chemokine CCL5 is a new therapeutic strategy for the treatment of acute and chronic liver injuries and represents an alternative to chemokine receptor antagonism.	[Nellen, Andreas; Heinrichs, Daniel; Berres, Marie-Luise; Sahin, Hacer; Schmitz, Petra; Trautwein, Christian; Wasmuth, Hermann E.] Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Proudfoot, Amanda E.] Merck Serono, Geneva Res Ctr, Geneva, Switzerland	RWTH Aachen University; RWTH Aachen University Hospital; Merck KGaA; EMD Serono Inc.	Nellen, A (corresponding author), Univ Hosp Aachen, Dept Med 3, Aachen, Germany.	hwasmuth@ukaachen.de	Berres, Marie-Luise/AAN-5351-2021		Deutsche Forschungsgemeinschaft [SFB-TRR57, WA2557/2-1]; Else Kroner-Freseniusstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Freseniusstiftung	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB-TRR57, WA2557/2-1) and the Else Kroner-Freseniusstiftung to HEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; BOROJEVIC R, 1985, IN VITRO CELL DEV B, V21, P382, DOI 10.1007/BF02623469; Braunersreuther V, 2010, J MOL CELL CARDIOL, V48, P789, DOI 10.1016/j.yjmcc.2009.07.029; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Colditz IG, 2007, THROMB HAEMOSTASIS, V97, P688, DOI 10.1160/TH07-02-0105; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hellier S, 2003, HEPATOLOGY, V38, P1468, DOI [10.1016/j.hep.2003.09.027, 10.1053/jhep.2003.09027]; Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Nischalke HD, 2004, MEDIAT INFLAMM, V13, P357, DOI 10.1080/09629350400003159; Promrat K, 2003, GASTROENTEROLOGY, V124, P352, DOI 10.1053/gast.2003.50061; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Rot A, 2010, FRONT BIOSCI-LANDMRK, V15, P645, DOI 10.2741/3638; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Wasmuth HE, 2004, HEPATOLOGY, V40, P327, DOI 10.1002/hep.20322; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36614	10.1371/journal.pone.0036614	http://dx.doi.org/10.1371/journal.pone.0036614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574195	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800092
J	Zhang, T; Du, J; Liu, LG; Chen, XL; Yang, F; Jin, Q				Zhang, Ting; Du, Jiang; Liu, Liguo; Chen, Xiaolan; Yang, Fang; Jin, Qi			Inhibitory Effects and Underlying Mechanism of 7-Hydroxyflavone Phosphate Ester in HeLa Cells	PLOS ONE			English	Article							IN-VITRO; CYCLE ARREST; CANCER; APOPTOSIS; PROLIFERATION; EXPRESSION; FLAVONOIDS; PROTEIN; P21(WAF1/CIP1); CHRYSIN	Chrysin and its phosphate ester have previously been shown to inhibit cell proliferation and induce apoptosis in Hela cells; however, the underlying mechanism remains to be characterized. In the present study, we therefore synthesized diethyl flavon-7-yl phosphate (FP, C19H19O6P) by a simplified Atheron-Todd reaction, and explored its anti-tumor characteristics and mechanisms. Cell proliferation, cell cycle progression and apoptosis were measured by MTS, flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling techniques, respectively in human cervical cancer HeLa cells treated with 7-hydroxyflavone (HF) and FP. p21, proliferating cell nuclear antigen (PCNA) and cAMP levels in Hela cells were analyzed by western blot and radioimmunoassay. Both HF and FP inhibited proliferation and induced apoptosis in HeLa cells via induction of PCNA/p21 expression, cleaved caspase-3/poly (ADP-ribose) polymerase (PARP)-1, elevation of cAMP levels, and cell cycle arrest with accumulation of cells in the G0/G1 fraction. The effects of FP were more potent than those of HF. The interactions of FP with Ca2+-calmodulin (CaM) and Ca2+-CaM-phosphodiesterase (PDE)1 were explored by electrospray ionization-mass spectrometry and fluorescence spectra. FP, but not HF, formed non-covalent complexes with Ca2+-CaM-PDE1, indicating that FP is an inhibitor of PDE1, and resulting in elevated cellular cAMP levels. It is possible that the elevated cAMP levels inhibit growth and induce apoptosis in Hela cells through induction of p21 and cleaved caspase-3/PARP-1 expression, and causing down-regulation of PCNA and cell cycle arrest with accumulation of cells in the G0/G1 and G2/M fractions. In conclusion, FP was shown to be a Ca2+-CaM-PDE inhibitor, which might account for its underlying anti-cancer mechanism in HeLa cells. These observations clearly demonstrate the special roles of phosphorylated flavonoids in biological processes, and suggest that FP might represent a potential new drug for the therapy of human cervical carcinoma.	[Zhang, Ting; Du, Jiang; Liu, Liguo; Yang, Fang; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Zhang, Ting; Du, Jiang; Liu, Liguo; Yang, Fang; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Xiaolan] Zhengzhou Univ, Dept Chem, Key Lab Chem Biol, Zhengzhou 450052, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University	Zhang, T (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	chenxl@zzu.edu.cn; ymf129@163.com; jinqi36@yahoo.com.cn	Zhang, Ting/S-8215-2019		National Basic Research Program from the Ministry of Science and Technology of China [2011CB504902]; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' [2009ZX10004-102]; Institute of Pathogen Biology, Chinese Academy of Medical Sciences [2009IPB112]	National Basic Research Program from the Ministry of Science and Technology of China; National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment''; Institute of Pathogen Biology, Chinese Academy of Medical Sciences	The work was supported by the National Basic Research Program (Grant No. 2011CB504902) from the Ministry of Science and Technology of China, National Science and Technology Key Projects on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment'' (2009ZX10004-102), and an intramural grant from the Institute of Pathogen Biology, Chinese Academy of Medical Sciences (2009IPB112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin A, 2007, RECENT PAT ANTI-CANC, V2, P109, DOI 10.2174/157489207780832414; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chen Xiao-lan, 2007, Yaoxue Xuebao, V42, P396; Chen XL, 2004, ANAL CHEM, V76, P211, DOI 10.1021/ac035027q; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Cohausz O, 2009, CELL BIOL TOXICOL, V25, P379, DOI 10.1007/s10565-008-9092-8; Cooke BA, 1999, MOL CELL ENDOCRINOL, V151, P25, DOI 10.1016/S0303-7207(98)00255-X; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Ferreira CG, 2002, CLIN CANCER RES, V8, P2024; Fotsis T, 1997, CANCER RES, V57, P2916; Goyeneche AA, 2007, CLIN CANCER RES, V13, P3370, DOI 10.1158/1078-0432.CCR-07-0164; GUTHRIE JP, 1977, J AM CHEM SOC, V99, P3991, DOI 10.1021/ja00454a018; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; KANDASWAMI C, 1991, CANCER LETT, V56, P147, DOI 10.1016/0304-3835(91)90089-Z; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Lee YK, 2009, EXP MOL MED, V41, P201, DOI 10.3858/emm.2009.41.3.023; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Ma G, 2007, CHEM-BIOL INTERACT, V167, P153, DOI 10.1016/j.cbi.2007.02.006; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; Middleton E, 2000, PHARMACOL REV, V52, P673; Noguera MA, 2001, N-S ARCH PHARMACOL, V363, P612, DOI 10.1007/s002100100397; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Sa F, 2008, CHEM-BIOL INTERACT, V171, P1, DOI 10.1016/j.cbi.2007.08.012; SATO F, 1994, BIOCHEM BIOPH RES CO, V204, P578, DOI 10.1006/bbrc.1994.2498; Sinicrope FA, 1998, CLIN CANCER RES, V4, P1251; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Weng MS, 2005, BIOCHEM PHARMACOL, V69, P1815, DOI 10.1016/j.bcp.2005.03.011; WESTHEIMER FH, 1968, ACCOUNTS CHEM RES, V1, P70, DOI 10.1021/ar50003a002; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Xiang ZL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-176; YANG ZY, 1995, NAT MED, V1, P1052, DOI 10.1038/nm1095-1052; Zhang T, 2004, BIOORGAN MED CHEM, V12, P6097, DOI 10.1016/j.bmc.2004.09.013	35	7	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36652	10.1371/journal.pone.0036652	http://dx.doi.org/10.1371/journal.pone.0036652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574207	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800104
J	Das Gupta, J; Luk, KC; Tang, N; Gaughan, C; Klein, EA; Kandel, ES; Hackett, J; Silverman, RH				Das Gupta, Jaydip; Luk, Ka-Cheung; Tang, Ning; Gaughan, Christina; Klein, Eric A.; Kandel, Eugene S.; Hackett, John, Jr.; Silverman, Robert H.			Absence of XMRV and Closely Related Viruses in Primary Prostate Cancer Tissues Used to Derive the XMRV-Infected Cell Line 22Rv1	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; HUMAN RETROVIRUS XMRV; NO EVIDENCE; BLOOD-CELLS; MULTIPLE; PCR; CONTAMINATION; REPLICATION; GENE	The 22Rv1 cell line is widely used for prostate cancer research and other studies throughout the world. These cells were established from a human prostate tumor, CWR22, that was serially passaged in nude mice and selected for androgen independence. The 22Rv1 cells are known to produce high titers of xenotropic murine leukemia virus-related virus (XMRV). Recent studies suggested that XMRV was inadvertently created in the 1990's when two murine leukemia virus (MLV) genomes (pre-XMRV1 and pre-XMRV-2) recombined during passaging of the CWR22 tumor in mice. The conclusion that XMRV originated from mice and not the patient was based partly on the failure to detect XMRV in early CWR22 xenografts. While that deduction is certainly justified, we examined the possibility that a closely related virus could have been present in primary tumor tissue. Here we report that we have located the original prostate tumor tissue excised from patient CWR22 and have assayed the corresponding DNA by PCR and the tissue sections by fluorescence in situ hybridization for the presence of XMRV or a similar virus. The primary tumor tissues lacked mouse DNA as determined by PCR for intracisternal A type particle DNA, thus avoiding one of the limitations of studying xenografts. We show that neither XMRV nor a closely related virus was present in primary prostate tissue of patient CWR22. Our findings confirm and reinforce the conclusion that XMRV is a recombinant laboratory-generated mouse virus that is highly adapted for human prostate cancer cells.	[Das Gupta, Jaydip; Gaughan, Christina; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Luk, Ka-Cheung; Hackett, John, Jr.] Abbott Diagnost, Emerging Pathogens & Virus Discovery, Abbott Pk, IL USA; [Tang, Ning] Abbott Mol, Des Plaines, IL USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Kandel, Eugene S.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Roswell Park Cancer Institute	Das Gupta, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	silverr@ccf.org			Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories; NCI [CA137708]; Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center [P30 CA43703]; NATIONAL CANCER INSTITUTE [R21CA137708, P30CA043703] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories(Abbott Laboratories); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These investigations were performed with the support of the Charlotte Geyer Foundation, the Maltz Family Foundation and Abbott Laboratories (to RHS and EAK), NCI grant CA137708 (to ESK), and by the Tissue Procurement, Histology and Immunohistochemistry Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). Co-authors at Abbott were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript. The other funding agencies had no such roles.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bacich Dean J, 2011, BMC Res Notes, V4, P457, DOI 10.1186/1756-0500-4-457; BITTNER ML, 1996, Patent No. 5491224; Braun A, 1997, CLIN CHEM, V43, P1151; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; Del Prete GQ, 2012, J VIROL, V86, P3152, DOI 10.1128/JVI.06886-11; Dodd RY, 2012, TRANSFUSION, V52, P298, DOI 10.1111/j.1537-2995.2011.03450.x; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dong BH, 2010, J VIROL, V84, P1648, DOI 10.1128/JVI.01763-09; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Morrison L. E., 2003, METHOD MOL BIOL, P21, DOI DOI 10.1385/1-59259-300-3:21; Nagabhushan M, 1996, CANCER RES, V56, P3042; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Pandhare-Dash J, 2011, PROSTATE; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; PRETLOW TG, 1993, J NATL CANCER I, V85, P394, DOI 10.1093/jnci/85.5.394; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Rodriguez JJ, 2010, J VIROL, V84, P2556, DOI 10.1128/JVI.01969-09; Rusmevichientong A, 2011, J VIROL, V85, P12830, DOI 10.1128/JVI.05624-11; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Silverman RH, 2011, SCIENCE, V334, P176, DOI 10.1126/science.334.6053.176-a; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Stieler K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011738; STOYE JP, 1988, J VIROL, V62, P168, DOI 10.1128/JVI.62.1.168-175.1988; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Tang N, 2012, J VIROL METHODS, V179, P127, DOI 10.1016/j.jviromet.2011.10.010; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Verhaegh GW, 2011, PROSTATE, V71, P415, DOI 10.1002/pros.21255; Yang JW, 2011, ONCOTARGET, V2, P358; YMER S, 1986, NUCLEIC ACIDS RES, V14, P5901, DOI 10.1093/nar/14.14.5901	50	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36072	10.1371/journal.pone.0036072	http://dx.doi.org/10.1371/journal.pone.0036072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615748	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341300010
J	Kim, J; Shin, JM; Jeon, YJ; Chung, HM; Chae, JI				Kim, Jumi; Shin, Jeong Min; Jeon, Young Joo; Chung, Hyung Min; Chae, Jung-Il			Proteomic Validation of Multifunctional Molecules in Mesenchymal Stem Cells Derived from Human Bone Marrow, Umbilical Cord Blood and Peripheral Blood	PLOS ONE			English	Article							ADIPOSE-TISSUE; DIFFERENTIATION; REGENERATION; EXPRESSION; PROTEINS; SYNOVIUM; THERAPY; ADULT	Mesenchymal stem cells (MSCs) are one of the most attractive therapeutic resources in clinical application owing to their multipotent capability, which means that cells can differentiate into various mesenchymal tissues such as bone, cartilage, fat, tendon, muscle and marrow stroma. Depending on the cellular source, MSCs exhibit different application potentials according to their different in vivo functions, despite similar phenotypic and cytological characteristics. To understand the different molecular conditions that govern the different application or differentiation potential of each MSC according to cellular source, we generated a proteome reference map of MSCs obtained from bone marrow (BM), umbilical cord blood (CB) and peripheral blood (PB). We identified approximately 30 differentially regulated (or expressed) proteins. Most upregulated proteins show a cytoskeletal and antioxidant or detoxification role according to their functional involvement. Additionally, these proteins are involved in the increase of cell viability, engraftment and migration in pathological conditions in vivo. In summary, we examined differentially expressed key regulatory factors of MSCs obtained from several cellular sources, demonstrated their differentially expressed proteome profiles and discussed their functional role in specific pathological conditions. With respect to the field of cell therapy, it may be particularly crucial to determine the most suitable cell sources according to target disease.	[Kim, Jumi; Shin, Jeong Min; Chung, Hyung Min] CHA Bio & Diostech Co Ltd, Seoul, South Korea; [Chung, Hyung Min] CHA Univ, Coll Med, CHA Stem Cell Inst, Grad Sch Life Sci, Seoul, South Korea; [Jeon, Young Joo; Chae, Jung-Il] Chonbuk Natl Univ, Brain Korea Project 21, Sch Dent, Dept Oral Pharmacol, Jeonju, South Korea	Pochon Cha University; Jeonbuk National University	Kim, J (corresponding author), CHA Bio & Diostech Co Ltd, Seoul, South Korea.	hmchung@cha.ac.kr; jichae@chonbuk.ac.kr			Industry Sources Development Project [10033642]; Ministry of Knowledge Economy, Republic of Korea; basic Science Research Program [2010-0021532]; Rural Development Administration, Republic of Korea [PJ008116062011]; Chonbuk National University	Industry Sources Development Project; Ministry of Knowledge Economy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of KoreaGeneral Electric); basic Science Research Program; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Chonbuk National University	This research was supported by a grant (10033642) from the Industry Sources Development Project funded by the Ministry of Knowledge Economy, Republic of Korea and by basic Science Research Program (2010-0021532), and by the Next-Generation BioGreen 21 Program (PJ008116062011), Rural Development Administration, Republic of Korea, and by research funds of Chonbuk National University in 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Baharvand H, 2007, STEM CELLS, V25, P1888, DOI 10.1634/stemcells.2007-0107; Ciavarella S, 2009, STEM CELLS DEV, V18, P1211, DOI 10.1089/scd.2008.0340; Cuende N, 2010, CELL STEM CELL, V6, P508, DOI 10.1016/j.stem.2010.05.005; Deb KD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-7; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Jager M, 2009, STEM CELL REV REP, V5, P266, DOI 10.1007/s12015-009-9083-z; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Lanneau D, 2007, PRION, V1, P53, DOI 10.4161/pri.1.1.4059; Leeper NJ, 2010, CIRCULATION, V122, P517, DOI 10.1161/CIRCULATIONAHA.109.881441; LEMIEUX N, 1993, GENOMICS, V15, P169, DOI 10.1006/geno.1993.1024; Levchenko A, 2005, NAT BIOTECHNOL, V23, P828, DOI 10.1038/nbt0705-828; Mareddy S, 2009, J CELL BIOCHEM, V106, P776, DOI 10.1002/jcb.22088; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Miyazaki M, 2008, SPINE, V33, P863, DOI 10.1097/BRS.0b013e31816b45c3; Musina RA, 2006, B EXP BIOL MED+, V141, P147, DOI 10.1007/s10517-006-0115-2; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Shiozawa Y, 2008, J CELL BIOCHEM, V105, P370, DOI 10.1002/jcb.21835; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Ye NS, 2006, STEM CELLS DEV, V15, P665, DOI 10.1089/scd.2006.15.665; Yi W, 2010, MOL CELL BIOCHEM, V341, P9, DOI 10.1007/s11010-010-0432-7; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zenzmaier C, 2005, BIOCHEM BIOPH RES CO, V328, P968, DOI 10.1016/j.bbrc.2005.01.044; Zhan M, 2008, FRONT BIOSCI-LANDMRK, V13, P276, DOI 10.2741/2678	31	30	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e32350	10.1371/journal.pone.0032350	http://dx.doi.org/10.1371/journal.pone.0032350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615730	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341300001
J	Shi, YF; Wang, Y; Cao, XY; Wang, Y; Wang, YN; Zong, JG; Xu, T; Tse, VWS; Hsi, XL; Stone, WS; Lui, SSY; Cheung, EFC; Chan, RCK				Shi, Yan-fang; Wang, Yi; Cao, Xiao-yan; Wang, Ya; Wang, Yu-na; Zong, Ji-gang; Xu, Ting; Tse, Vincent W. S.; Hsi, Xiao-lu; Stone, William S.; Lui, Simon S. Y.; Cheung, Eric F. C.; Chan, Raymond C. K.			Experience of Pleasure and Emotional Expression in Individuals with Schizotypal Personality Features	PLOS ONE			English	Article							SOCIAL ANHEDONIA; SCHIZOPHRENIA; MEMORY; SCALE; DEPRESSION; VALIDATION; BEHAVIOR; DEFICITS; SAMPLES; MODELS	Difficulties in feeling pleasure and expressing emotions are one of the key features of schizophrenia spectrum conditions, and are significant contributors to constricted interpersonal interactions. The current study examined the experience of pleasure and emotional expression in college students who demonstrated high and low levels of schizotypal personality disorder (SPD) traits on self-report questionnaires. One hundred and seventeen subjects with SPD traits and 116 comparison controls were recruited to participate. Cluster analyses conducted in the SPD group identified negative SPD and positive SPD subgroups. The negative SPD group exhibited deficient emotional expression and anticipatory pleasure, but showed intact consummatory pleasure. The positive SPD group reported significantly greater levels of anticipatory, consummatory and total pleasure compared to the control group. Both SPD groups reported significantly more problems in everyday memory and greater levels of depressive and anxiety-related symptoms.	[Shi, Yan-fang; Wang, Yi; Cao, Xiao-yan; Wang, Ya; Wang, Yu-na; Zong, Ji-gang; Xu, Ting; Lui, Simon S. Y.; Chan, Raymond C. K.] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Wang, Yi; Cao, Xiao-yan; Wang, Yu-na; Zong, Ji-gang; Xu, Ting; Lui, Simon S. Y.] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tse, Vincent W. S.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Hsi, Xiao-lu] MIT, Cambridge, MA 02139 USA; [Hsi, Xiao-lu; Stone, William S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Lui, Simon S. Y.; Cheung, Eric F. C.] Castle Peak Hosp, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Shi, YF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China.	rckchan@psych.ac.cn	Chan, Raymond CK/B-6717-2009; wang, yi/AAI-8689-2020	Chan, Raymond CK/0000-0002-3414-450X; wang, yi/0000-0001-6880-5831; Tse, Wai Shing/0000-0001-8059-2111; Wang, Ya/0000-0001-5764-6740; Lui, Simon S. Y./0000-0001-9360-6244	National Key Technologies RD Program [2012BAI36B01]; National Science Fund China [81088001, 91132701]; Chinese Academy of Sciences [KSCX2-EW-J-8]; Key Laboratory of Mental Health, Institute of Psychology	National Key Technologies RD Program(National Key Technology R&D Program); National Science Fund China; Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Mental Health, Institute of Psychology	This study was supported partially by a grant from the National Key Technologies R&D Program (2012BAI36B01), the National Science Fund China (81088001, 91132701), the Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8), and the Key Laboratory of Mental Health, Institute of Psychology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barrantes-Vidal N, 2003, SCHIZOPHR RES, V61, P293, DOI 10.1016/S0920-9964(02)00321-3; Beck AT, 1967, DEPRESSION CAUSES TR; Berenbaum H, 2006, J ABNORM PSYCHOL, V115, P359, DOI 10.1037/0021-843X.115.2.359; Blanchard JJ, 1998, SCHIZOPHRENIA BULL, V24, P413, DOI 10.1093/oxfordjournals.schbul.a033336; BLANCHARD JJ, 1994, J ABNORM PSYCHOL, V103, P719, DOI 10.1037/0021-843X.103.4.719; Blanchard JJ, 2000, J ABNORM PSYCHOL, V109, P87, DOI 10.1037/0021-843X.109.1.87; Bleuler E., 1950, DEMENTIA PRAECOX GRO; CHAN CM, 1984, COGNITIVE THER RES, V8, P501, DOI 10.1007/BF01173287; Chan RCK, 2008, SCHIZOPHR RES, V103, P229, DOI 10.1016/j.schres.2008.02.019; Chan RCK, 2010, PSYCHOLOGIA, V53, P44, DOI 10.2117/psysoc.2010.44; Chan RCK, 2010, PSYCHIAT RES, V175, P181, DOI 10.1016/j.psychres.2009.01.020; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chen WJ, 1997, J ABNORM PSYCHOL, V106, P649, DOI 10.1037/0021-843X.106.4.649; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Gaebel W, 2004, EUR ARCH PSY CLIN N, V254, P335, DOI 10.1007/s00406-004-0510-5; Gard DE, 2006, J RES PERS, V40, P1086, DOI 10.1016/j.jrp.2005.11.001; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Heerey EA, 2007, J ABNORM PSYCHOL, V116, P268, DOI 10.1037/0021-843X.116.2.268; Henry JD, 2007, SCHIZOPHR RES, V95, P197, DOI 10.1016/j.schres.2007.06.002; Henry JD, 2009, PSYCHIAT RES, V166, P116, DOI 10.1016/j.psychres.2008.01.007; Herbener ES, 2008, SCHIZOPHR RES, V98, P239, DOI 10.1016/j.schres.2007.06.025; Herbener ES, 2007, J ABNORM PSYCHOL, V116, P43, DOI 10.1037/0021-843X.116.1.43; Horan WP, 2006, J ABNORM PSYCHOL, V115, P496, DOI 10.1037/0021-843X.115.3.496; Kerns JG, 2005, J ABNORM PSYCHOL, V114, P392, DOI 10.1037/0021-843X.114.3.392; Klein DN., 1984, ANHEDONIA AFFECT DEF, P1; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kraepelin E., 1919, GERMAN EDITION TXB P, P282; KRING AM, 1994, J PERS SOC PSYCHOL, V66, P934, DOI 10.1037/0022-3514.66.5.934; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Leung WW, 2006, DISS ABSTR INT B, P3457; Lewandowski KE, 2006, SCHIZOPHR RES, V83, P225, DOI 10.1016/j.schres.2005.11.024; MEEHL PE, 1962, AM PSYCHOL, V17, P827, DOI 10.1037/h0041029; Meehl PE., 1990, J PERS DISORD, V4, P1, DOI [10.1521/pedi.1990.4.1.1, DOI 10.1521/PEDI.1990.4.1.1]; Phillips LK, 2008, SCHIZOPHRENIA BULL, V34, P888, DOI 10.1093/schbul/sbn085; RADO S, 1953, AM J PSYCHIAT, V110, P406, DOI 10.1176/ajp.110.6.406; Rado S., 1960, OUTPATIENT TREATMENT, P87; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Suhr JA, 2001, SCHIZOPHR RES, V52, P231, DOI 10.1016/S0920-9964(00)00170-5; Tremeau F, 2005, AM J PSYCHIAT, V162, P92, DOI 10.1176/appi.ajp.162.1.92; Tremeau F, 2009, SCHIZOPHRENIA RES; van't Wout M, 2004, SCHIZOPHR RES, V68, P271, DOI 10.1016/j.schres.2003.09.006; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	50	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e34147	10.1371/journal.pone.0034147	http://dx.doi.org/10.1371/journal.pone.0034147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615731	Green Published, Green Submitted			2022-12-27	WOS:000305341300002
J	Maherali, H; Klironomos, JN				Maherali, Hafiz; Klironomos, John N.			Phylogenetic and Trait-Based Assembly of Arbuscular Mycorrhizal Fungal Communities	PLOS ONE			English	Article							PLANT-ROOTS; DIVERSITY; EVOLUTION; SOIL; OVERDISPERSION; GLOMEROMYCOTA; COLONIZATION; PATTERNS; ECOLOGY; PHYLUM	Both competition and environmental filtering are expected to influence the community structure of microbes, but there are few tests of the relative importance of these processes because trait data on these organisms is often difficult to obtain. Using phylogenetic and functional trait information, we tested whether arbuscular mycorrhizal (AM) fungal community composition in an old field was influenced by competitive exclusion and/or environmental filtering. Communities at the site were dominated by species from the most speciose family of AM fungi, the Glomeraceae, though species from two other lineages, the Acaulosporaceae and Gigasporaceae were also found. Despite the dominance of species from a single family, AM fungal species most frequently co-existed when they were distantly related and when they differed in the ability to colonize root space on host plants. The ability of AM fungal species to colonize soil did not influence co-existence. These results suggest that competition between closely related and functionally similar species for space on plant roots influences community assembly. Nevertheless, in a substantial minority of cases communities were phylogenetically clustered, indicating that closely related species could also co-occur, as would be expected if i) the environment restricted community membership to single functional type or ii) competition among functionally similar species was weak. Our results therefore also suggest that competition for niche space between closely related fungi is not the sole influence of mycorrhizal community structure in field situations, but may be of greater relative importance than other ecological mechanisms.	[Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Klironomos, John N.] Univ British Columbia Okanagan, Dept Biol, IK Barber Sch Arts & Sci, Kelowna, BC, Canada	University of Guelph; University of British Columbia; University of British Columbia Okanagan	Maherali, H (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	maherali@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by Discovery grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) to both authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; [Anonymous], 1877, DIFFERENT FORMS FLOW; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brundrett M, 1996, WORKING MYCORRHIZAS; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Gange A, 2000, TRENDS ECOL EVOL, V15, P369, DOI 10.1016/S0169-5347(00)01940-6; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hawkes CV, 2006, PLANT SOIL, V281, P369, DOI 10.1007/s11104-005-4826-3; Helgason T, 2002, J ECOL, V90, P371, DOI 10.1046/j.1365-2745.2001.00674.x; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Ingram T, 2009, ECOLOGY, V90, P2444, DOI 10.1890/08-1841.1; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JOHNSON NC, 1992, ECOLOGY, V73, P2034, DOI 10.2307/1941453; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2009, ECOL LETT, V12, P949, DOI 10.1111/j.1461-0248.2009.01354.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Klironomos JN, 1999, APPL SOIL ECOL, V12, P227, DOI 10.1016/S0929-1393(99)00014-1; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Moles AT, 2005, SCIENCE, V307, P576, DOI 10.1126/science.1104863; Morisita M., 1962, RES POPUL ECOL, V4, P1, DOI [10.1007/BF02533903, DOI 10.1007/BF02533903]; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Purin S, 2008, FEMS MICROBIOL LETT, V279, P8, DOI 10.1111/j.1574-6968.2007.01007.x; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Rosendahl S, 2008, NEW PHYTOL, V178, P253, DOI 10.1111/j.1469-8137.2008.02378.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sherrard ME, 2012, EVOL ECOL, V26, P529, DOI 10.1007/s10682-011-9518-2; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237	65	103	108	0	155	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36695	10.1371/journal.pone.0036695	http://dx.doi.org/10.1371/journal.pone.0036695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606282	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400029
J	Wang, HT; Gao, JX; Li, WJ; Wong, AHH; Hu, KD; Chen, K; Wang, Y; Sang, JL				Wang, Haitao; Gao, Jiaxin; Li, Wanjie; Wong, Ada Hang-Heng; Hu, Kangdi; Chen, Kun; Wang, Yue; Sang, Jianli			Pph3 Dephosphorylation of Rad53 Is Required for Cell Recovery from MMS-Induced DNA Damage in Candida albicans	PLOS ONE			English	Article							REPLICATION PROTEIN-A; BUDDING YEAST RAD9; SACCHAROMYCES-CEREVISIAE; S-PHASE; INDUCED PHOSPHORYLATION; PHOSPHATASE COMPLEX; FILAMENTOUS GROWTH; GENE DISRUPTION; BINDING PROTEIN; P34 SUBUNIT	The pathogenic fungus Candida albicans switches from yeast growth to filamentous growth in response to genotoxic stresses, in which phosphoregulation of the checkpoint kinase Rad53 plays a crucial role. Here we report that the Pph3/Psy2 phosphatase complex, known to be involved in Rad53 dephosphorylation, is required for cellular responses to the DNA-damaging agent methyl methanesulfonate (MMS) but not the DNA replication inhibitor hydroxyurea (HU) in C. albicans. Deletion of either PPH3 or PSY2 resulted in enhanced filamentous growth during MMS treatment and continuous filamentous growth even after MMS removal. Moreover, during this growth, Rad53 remained hyperphosphorylated, MBF-regulated genes were downregulated, and hypha-specific genes were upregulated. We have also identified S461 and S545 on Rad53 as potential dephosphorylation sites of Pph3/Psy2 that are specifically involved in cellular responses to MMS. Therefore, our studies have identified a novel molecular mechanism mediating DNA damage response to MMS in C. albicans.	[Wang, Haitao; Gao, Jiaxin; Li, Wanjie; Hu, Kangdi; Chen, Kun; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China; [Wang, Yue] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Wong, Ada Hang-Heng] Tsinghua Univ, Sch Life Sci, Prot Sci Lab, Beijing 100084, Peoples R China	Beijing Normal University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Tsinghua University	Wang, HT (corresponding author), Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Beijing 100875, Peoples R China.	mcbwangy@imcb.a-star.edu.sg; jlsang@bnu.edu.cn	Wang, Yue/H-2107-2011; Wang, Yue/AGN-6053-2022; wang, haitao/ABH-3669-2020; Haitao, Wang/ABG-4822-2020	Wang, Yue/0000-0002-1211-2822; Haitao, Wang/0000-0001-6910-974X; Li, Wanjie/0000-0001-6439-7535	The National Basic Research Program of China [2007CB914401]; The Fundamental Research Funds for the Central Universities [105566GK]	The National Basic Research Program of China(National Basic Research Program of China); The Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The National Basic Research Program of China (no. 2007CB914401) and The Fundamental Research Funds for the Central Universities (no. 105566GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Andaluz E, 2006, MOL MICROBIOL, V59, P1452, DOI 10.1111/j.1365-2958.2005.05038.x; Atir-Lande A, 2005, MOL BIOL CELL, V16, P2772, DOI 10.1091/mbc.E05-01-0079; Bachewich C, 2005, MOL MICROBIOL, V57, P942, DOI 10.1111/j.1365-2958.2005.04727.x; Bachewich C, 2005, EUKARYOT CELL, V4, P95, DOI 10.1128/EC.4.1.95-102.2005; Bachewich C, 2003, MOL BIOL CELL, V14, P2163, DOI 10.1091/mbc.02-05-0076; Bai C, 2002, MOL MICROBIOL, V45, P31, DOI 10.1046/j.1365-2958.2002.02995.x; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bazzi M, 2010, MOL CELL BIOL, V30, P131, DOI 10.1128/MCB.01000-09; Bean JM, 2005, GENETICS, V171, P49, DOI 10.1534/genetics.105.044560; Bensen ES, 2005, MOL BIOL CELL, V16, P3387, DOI 10.1091/mbc.E04-12-1081; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; BRILL SJ, 1991, GENE DEV, V5, P1589, DOI 10.1101/gad.5.9.1589; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Dotiwala F, 2007, P NATL ACAD SCI USA, V104, P11358, DOI 10.1073/pnas.0609636104; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Foord R, 1999, NAT STRUCT BIOL, V6, P157; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Hastie CJ, 2006, FEBS J, V273, P3322, DOI 10.1111/j.1742-4658.2006.05336.x; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hussein B, 2011, EUKARYOT CELL, V10, P384, DOI 10.1128/EC.00278-10; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kelly MT, 2004, MOL MICROBIOL, V53, P969, DOI 10.1111/j.1365-2958.2004.04185.x; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lazo BCY, 2005, EUKARYOT CELL, V4, P90, DOI 10.1128/EC.4.1.90-94.2005; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Lee SJ, 2003, MOL CELL BIOL, V23, P6300, DOI 10.1128/MCB.23.17.6300-6314.2003; Legrand M, 2008, MICROBIOL-SGM, V154, P2446, DOI 10.1099/mic.0.2008/017616-0; Leroy C, 2003, MOL CELL, V11, P827, DOI 10.1016/S1097-2765(03)00058-3; Liao H, 1999, J MOL BIOL, V294, P1041, DOI 10.1006/jmbi.1999.3313; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Ma JL, 2006, J BIOL CHEM, V281, P3954, DOI 10.1074/jbc.M507508200; Ma NJL, 2008, CELL CYCLE, V7, P808, DOI 10.4161/cc.7.6.5595; Maniar HS, 1997, GENETICS, V145, P891; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Oakley GG, 2001, MOL BIOL CELL, V12, P1199, DOI 10.1091/mbc.12.5.1199; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Shi QM, 2007, MOL BIOL CELL, V18, P815, DOI 10.1091/mbc.E06-05-0442; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Smolka MB, 2005, MOL CELL PROTEOMICS, V4, P1358, DOI 10.1074/mcp.M500115-MCP200; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sun LL, 2011, EUKARYOT CELL; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Sweeney FD, 2009, THESIS, P132; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Truman AW, 2009, MOL CELL BIOL, V29, P6449, DOI 10.1128/MCB.00794-09; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Verma R, 1992, P NATL ACAD SCI USA, P9479; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Vidanes GM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000286; Wightman R, 2004, J CELL BIOL, V164, P581, DOI 10.1083/jcb.200307176; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	75	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37246	10.1371/journal.pone.0037246	http://dx.doi.org/10.1371/journal.pone.0037246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606354	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400077
J	Gough, SM; Chung, YJ; Aplan, PD				Gough, Sheryl M.; Chung, Yang Jo; Aplan, Peter D.			Depletion of Cytotoxic T-Cells Does Not Protect NUP98-HOXD13 Mice from Myelodysplastic Syndrome but Reveals a Modest Tumor Immunosurveillance Effect	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSGENIC MICE; BETHESDA PROPOSALS; ANTIGEN RECEPTOR; MOUSE MODEL; EXPRESSION; APOPTOSIS; CANCER; PAK5	Myelodysplastic syndrome (MDS) and aplastic anemia (AA) patients both present with symptoms of bone marrow failure. In many AA patients, these features are thought to result from an oligoclonal expansion of cytotoxic T-cells that destroy haematopoietic stem or progenitor cells. This notion is supported by the observation that AA patients respond to immunosuppressive therapy. A fraction of MDS patients also respond well to immunosuppressive therapy suggesting a similar role for cytotoxic T-cells in the etiology of MDS, however the role of cytotoxic T-cells in MDS remains unclear. Mice that express a NUP98-HOXD13 (NHD13) transgene develop a MDS that closely mimics the human condition in terms of dysplasia, ineffective hematopoiesis, and transformation to acute myeloid leukemia (AML). We followed a cohort of NHD13 mice lacking the Rag1 protein (NHD13/Rag1KO) to determine if the absence of lymphocytes might 1) delay the onset and/or diminish the severity of the MDS, or 2) effect malignant transformation and survival of the NHD13 mice. No difference was seen in the onset or severity of MDS between the NHD13 and NHD13/Rag1KO mice. However, NHD13/Rag1KO mice had decreased survival and showed a trend toward increased incidence of transformation to AML compared to the NHD13 mice, suggesting protection from AML transformation by a modest immuno-surveillance effect. In the absence of functional Tcrb signaling in the NHD13/Rag1KO T-cell tumors, Pak7 was identified as a potential Tcrb surrogate survival signal.	[Gough, Sheryl M.; Chung, Yang Jo; Aplan, Peter D.] NCI, Leukemia Biol Sect, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gough, SM (corresponding author), NCI, Leukemia Biol Sect, Genet Branch, NIH, Bethesda, MD 20892 USA.	aplanp@mail.nih.gov	Aplan, Peter D/K-9064-2016		Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIASC010378, ZIABC010983] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Calado RT, 2011, SEMIN ONCOL, V38, P667, DOI 10.1053/j.seminoncol.2011.04.006; Caudell D, 2007, CANCER RES, V67, P8022, DOI 10.1158/0008-5472.CAN-06-3749; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen GB, 2004, BLOOD, V104, P4210, DOI 10.1182/blood-2004-01-0103; Chervinsky DS, 2001, CANCER RES, V61, P6382; Choi CW, 2008, HAEMATOL-HEMATOL J, V93, P1394, DOI 10.3324/haematol.13042; Choi CW, 2009, J IMMUNOL, V183, P6227, DOI 10.4049/jimmunol.0901121; Chung YJ, 2008, P NATL ACAD SCI USA, V105, P14088, DOI 10.1073/pnas.0804507105; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Epling-Burnette PK, 2007, LEUKEMIA, V21, P659, DOI 10.1038/sj.leu.2404590; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Fozza C, 2009, EXP HEMATOL, V37, P947, DOI 10.1016/j.exphem.2009.04.009; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hauer J, 2011, BLOOD, V118, P544, DOI 10.1182/blood-2010-09-305383; Heinrichs S, 2005, BRIT J HAEMATOL, V130, P83, DOI 10.1111/j.1365-2141.2005.05555.x; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Jung SW, 2010, CYTOGENETIC CHARACTE; Kameoka J, 2001, CANCER GENET CYTOGEN, V124, P159, DOI 10.1016/S0165-4608(00)00347-2; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Mitelman F., MITELMAN DATABASE CH; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Molldrem JJ, 1998, BRIT J HAEMATOL, V102, P1314, DOI 10.1046/j.1365-2141.1998.00920.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Nepal RM, 2008, ONCOGENE, V27, P4752, DOI 10.1038/onc.2008.111; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; SANCHO J, 1989, J BIOL CHEM, V264, P20760; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Slape Christopher, 2008, J Natl Cancer Inst Monogr, P64, DOI 10.1093/jncimonographs/lgn014; Sloand EM, 2010, HEMATOL ONCOL CLIN N, V24, P331, DOI 10.1016/j.hoc.2010.02.009; Sowter HM, 2001, CANCER RES, V61, P6669; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tiu RV, 2011, UPDATES CYTOGENETICS; Visconte V, 2011, SF3B1 SPLICING FACTO; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470	53	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36876	10.1371/journal.pone.0036876	http://dx.doi.org/10.1371/journal.pone.0036876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606303	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200054
J	Jiang, WW; Jin, GH; Ma, DY; Wang, F; Fu, T; Chen, X; Chen, XW; Jia, KZ; Marikar, FMMT; Hua, ZC				Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Wang, Feng; Fu, Tong; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun			Modification of Cyclic NGR Tumor Neovasculature-Homing Motif Sequence to Human Plasminogen Kringle 5 Improves Inhibition of Tumor Growth	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; AMINOPEPTIDASE N; CHEMOTHERAPEUTIC DRUGS; CARCINOMA GROWTH; NECROSIS-FACTOR; ANGIOGENESIS; CANCER; APOPTOSIS; CISPLATIN; PEPTIDES	Background: Blood vessels in tumors express higher level of aminopeptidase N (APN) than normal tissues. Evidence suggests that the CNGRC motif is an APN ligand which targets tumor vasculature. Increased expression of APN in tumor vascular endothelium, therefore, offers an opportunity for targeted delivery of NGR peptide-linked drugs to tumors. Methods/Principal Findings: To determine whether an additional cyclic CNGRC sequence could improve endothelial cell homing and antitumor effect, human plasminogen kringle 5 (hPK5) was modified genetically to introduce a CNGRC motif (NGR-hPK5) and was subsequently expressed in yeast. The biological activity of NGR-hPK5 was assessed and compared with that of wild-type hPK5, in vitro and in vivo. NGR-hPK5 showed more potent antiangiogenic activity than wild-type hPK5: the former had a stronger inhibitory effect on proliferation, migration and cord formation of vascular endothelial cells, and produced a stronger antiangiogenic response in the CAM assay. To evaluate the tumor-targeting ability, both wild-type hPK5 and NGR-hPK5 were Tc-99 m-labeled, for tracking biodistribution in the in vivo tumor model. By planar imaging and biodistribution analyses of major organs, NGR-hPK5 was found localized to tumor tissues at a higher level than wild-type hPK5 (approximately 3-fold). Finally, the effects of wild-type hPK5 and NGR-modified hPK5 on tumor growth were investigated in two tumor model systems. NGR modification improved tumor localization and, as a consequence, effectively inhibited the growth of mouse Lewis lung carcinoma (LLC) and human colorectal adenocarcinoma (Colo 205) cells in tumor-bearing mice. Conclusions/Significance: These studies indicated that the addition of an APN targeting peptide NGR sequence could improve the ability of hPK5 to inhibit angiogenesis and tumor growth.	[Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China; [Jiang, Weiwei; Jin, Guanghui; Ma, Dingyuan; Chen, Xiao; Chen, Xiwen; Jia, Kunzhi; Marikar, Faiz M. M. T.; Hua, Zichun] Nanjing Univ, Affiliated Stomatol Hosp, Sch Stomatol, Nanjing 210008, Peoples R China; [Jin, Guanghui] Xiamen Univ, Coll Med, Dept Basic Med Sci, Xiamen, Peoples R China; [Wang, Feng; Fu, Tong] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Nucl Med, Nanjing, Peoples R China; [Hua, Zichun] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Peoples R China	Nanjing University; Nanjing University; Xiamen University; Nanjing Medical University; Nanjing University	Jiang, WW (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Peoples R China.	zchua@nju.edu.cn			Chinese Ministry of Science and Technology [2012CB967004, 2011CB933502]; Chinese National Nature Sciences Foundation [81121062, 50973046, J1103512, 31071196, 31070706]; Jiangsu Provincial Nature Science Foundation [BZ2010074, BZ2011048, BK2011228, BK2011573]; Bureau of Science and Technology of Changzhou [CZ20100008, CE20115034, CZ20110028, CJ20115006]; Natural Science Foundation of Fujian Province of China [2007J0114]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Nature Sciences Foundation; Jiangsu Provincial Nature Science Foundation; Bureau of Science and Technology of Changzhou; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This study was supported, in part, by grants from the National Key Basic Research Project from the Chinese Ministry of Science and Technology (2012CB967004, 2011CB933502), the Chinese National Nature Sciences Foundation (81121062, 50973046, J1103512, 31071196, 31070706), the Jiangsu Provincial Nature Science Foundation (BZ2010074, BZ2011048, BK2011228, BK2011573), the Bureau of Science and Technology of Changzhou (CZ20100008, CE20115034, CZ20110028, CJ20115006), and the Natural Science Foundation of Fujian Province of China ( NO. 2007J0114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell PJ, 2010, EUR J CANCER, V46, P966, DOI 10.1016/j.ejca.2009.12.026; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bocci G, 2002, CANCER RES, V62, P6938; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018; Cao Yihai, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P667, DOI 10.2174/1568011023353705; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2004, ANN NY ACAD SCI, V1028, P104, DOI 10.1196/annals.1322.011; Corti A, 2011, CURR PHARM BIOTECHNO, V12, P1128, DOI 10.2174/138920111796117373; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; DeClerck YA, 2004, AM J PATHOL, V164, P1131, DOI 10.1016/S0002-9440(10)63200-2; Dreischaluck J, 2010, INT J ONCOL, V37, P1389, DOI 10.3892/ijo_00000790; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fontijn D, 2006, BRIT J CANCER, V94, P1627, DOI 10.1038/sj.bjc.6603157; FUJII H, 1995, CLIN EXP METASTAS, V13, P337; Gonzalez-Gronow M, 2003, J BIOL CHEM, V278, P27312, DOI 10.1074/jbc.M303172200; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jeyapalan JC, 2006, INT J CANCER, V118, P2727, DOI 10.1002/ijc.21675; Ji WR, 1998, BIOCHEM BIOPH RES CO, V247, P414, DOI 10.1006/bbrc.1998.8825; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jin GH, 2007, INT J CANCER, V121, P2539, DOI 10.1002/ijc.22708; Kessler Torsten, 2008, Curr Drug Discov Technol, V5, P1; Li SF, 2007, MOL THER, V15, P515, DOI 10.1038/sj.mt.6300072; Li YH, 2008, CANCER BIOTHER RADIO, V23, P332, DOI 10.1089/cbr.2007.0437; Lu H, 1999, BIOCHEM BIOPH RES CO, V258, P668, DOI 10.1006/bbrc.1999.0612; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Merchan JR, 2005, INT J CANCER, V113, P490, DOI 10.1002/ijc.20595; Nguyen TMB, 2010, GENE THER, V17, P606, DOI 10.1038/gt.2010.15; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Pasqualini R, 2000, CANCER RES, V60, P722; Pastorino F, 2003, CANCER RES, V63, P7400; Perri SR, 2005, CANCER RES, V65, P8359, DOI 10.1158/0008-5472.CAN-05-0508; Pham CD, 1998, CANCER INVEST, V16, P225, DOI 10.3109/07357909809039771; Polycarpe E, 2004, INT J CANCER, V111, P131, DOI 10.1002/ijc.20202; Schmitz V, 2008, CANCER INVEST, V26, P464, DOI 10.1080/07357900801970927; Schwoppe C, 2010, THROMB RES, V125, pS143, DOI 10.1016/S0049-3848(10)70033-5; Soff GA, 2000, CANCER METAST REV, V19, P97, DOI 10.1023/A:1026525121027; Sun QM, 2005, PROTEIN EXPRES PURIF, V39, P288, DOI 10.1016/j.pep.2004.10.024; Tan GH, 2004, INT J CANCER, V112, P701, DOI 10.1002/ijc.20449; van Hensbergen Y, 2002, BIOCHEM PHARMACOL, V63, P897, DOI 10.1016/S0006-2952(01)00928-5; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Yang X, 2010, J CELL MOL MED, V14, P2519, DOI 10.1111/j.1582-4934.2009.01004.x; Yang Y, 2006, CANCER BIOL THER, V5, P399; Yokoyama Y, 2005, CANCER-AM CANCER SOC, V104, P321, DOI 10.1002/cncr.21149; Zou YF, 2007, CANCER RES, V67, P7295, DOI 10.1158/0008-5472.CAN-06-3920	50	27	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37132	10.1371/journal.pone.0037132	http://dx.doi.org/10.1371/journal.pone.0037132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590653	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400062
J	Karpus, ON; Heutinck, KM; Wijnker, PJM; Tak, PP; Hamann, J				Karpus, Olga N.; Heutinck, Kirstin M.; Wijnker, Paul J. M.; Tak, Paul P.; Hamann, Jorg			Triggering of the dsRNA Sensors TLR3, MDA5, and RIG-I Induces CD55 Expression in Synovial Fibroblasts	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; ACTIVATION ANTIGEN CD97; HUMAN HEPATOMA-CELLS; INDUCIBLE GENE-I; RHEUMATOID-ARTHRITIS; CELLULAR LIGAND; MESSENGER-RNA; UP-REGULATION; STRANDED-RNA; FACTOR DAF	Background: CD55 (decay-accelerating factor) is a complement-regulatory protein highly expressed on fibroblast-like synoviocytes (FLS). CD55 is also a ligand for CD97, an adhesion-type G protein-coupled receptor abundantly present on leukocytes. Little is known regarding the regulation of CD55 expression in FLS. Methods: FLS isolated from arthritis patients were stimulated with pro-inflammatory cytokines and Toll-like receptor (TLR) ligands. Transfection with polyinosinic-polycytidylic acid (poly(I:C)) and 5'-triphosphate RNA were used to activate the cytoplasmic double-stranded (ds)RNA sensors melanoma differentiation-associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I). CD55 expression, cell viability, and binding of CD97-loaded beads were quantified by flow cytometry. Results: CD55 was expressed at equal levels on FLS isolated from patients with rheumatoid arthritis (RA), osteoarthritis, psoriatic arthritis and spondyloarthritis. CD55 expression in RA FLS was significantly induced by IL-1 beta and especially by the TLR3 ligand poly(I:C). Activation of MDA5 and RIG-I also enhanced CD55 expression. Notably, activation of MDA5 dose-dependently induced cell death, while triggering of TLR3 or RIG-I had a minor effect on viability. Upregulation of CD55 enhanced the binding capacity of FLS to CD97-loaded beads, which could be blocked by antibodies against CD55. Conclusions: Activation of dsRNA sensors enhances the expression of CD55 in cultured FLS, which increases the binding to CD97. Our findings suggest that dsRNA promotes the interaction between FLS and CD97-expressing leukocytes.	[Karpus, Olga N.; Heutinck, Kirstin M.; Wijnker, Paul J. M.; Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Heutinck, Kirstin M.] Univ Amsterdam, Acad Med Ctr, Renal Transplant Unit, NL-1105 AZ Amsterdam, Netherlands; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Karpus, ON (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.hamann@amc.uva.nl		Hamann, Jorg/0000-0002-9448-1727	Dutch Arthritis Association [NR 07-01-404]; Academic Medical Center	Dutch Arthritis Association; Academic Medical Center	This work was supported by grant NR 07-01-404 from the Dutch Arthritis Association and by the Academic Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2003, IMMUNOLOGY, V110, P258, DOI 10.1046/j.1365-2567.2003.01733.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Becker J, 2010, CURR OPIN RHEUMATOL, V22, P72, DOI 10.1097/BOR.0b013e328333b9f5; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cha HS, 2006, ARTHRITIS RHEUM-US, V54, P587, DOI 10.1002/art.21631; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Edwards JCW, 1996, J ANAT, V188, P119; Eichler W, 1997, TISSUE ANTIGENS, V50, P429, DOI 10.1111/j.1399-0039.1997.tb02897.x; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Gerlag DM, 2009, BEST PRACT RES CL RH, V23, P221, DOI 10.1016/j.berh.2009.01.006; Halme J, 2009, MOL IMMUNOL, V46, P2284, DOI 10.1016/j.molimm.2009.04.005; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; HAMANN J, 1995, J IMMUNOL, V155, P1942; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Heutinck KM, 2012, KIDNEY INT, V82, P664, DOI 10.1038/ki.2012.206; Heutinck KM, 2012, NEPHROL DIAL TRANSPL, V27, P2746, DOI 10.1093/ndt/gfr690; Hoek RM, 2010, ARTHRITIS RHEUM-US, V62, P1036, DOI 10.1002/art.27347; Hyc A, 2003, INT J MOL MED, V11, P91; Imaizumi T, 2008, CLIN EXP IMMUNOL, V153, P240, DOI 10.1111/j.1365-2249.2008.03685.x; Imaizumi T, 2010, NEPHROL DIAL TRANSPL, V25, P3534, DOI 10.1093/ndt/gfq270; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kop EN, 2005, ARTHRITIS RHEUM-US, V52, P442, DOI 10.1002/art.20788; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nasu J, 1998, CLIN EXP IMMUNOL, V113, P379; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Paone A, 2008, CARCINOGENESIS, V29, P1334, DOI 10.1093/carcin/bgn149; Peng S, 2009, CANCER SCI, V100, P529, DOI 10.1111/j.1349-7006.2008.01062.x; Song WC, 2006, AUTOIMMUNITY, V39, P403, DOI 10.1080/08916930600739647; Spiller OB, 2000, CLIN EXP IMMUNOL, V121, P234, DOI 10.1046/j.1365-2249.2000.01305.x; Stacey M, 2002, J BIOL CHEM, V277, P29283, DOI 10.1074/jbc.M204306200; Stahl HD, 2000, ANN RHEUM DIS, V59, P342, DOI 10.1136/ard.59.5.342; STEVENS CR, 1990, RHEUMATOL INT, V10, P103, DOI 10.1007/BF02274823; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Weber A, 2010, CELL DEATH DIFFER, V17, P942, DOI 10.1038/cdd.2009.190; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zimmermann B, 2012, ANN RHEUM DIS, V71, pA89, DOI 10.1136/annrheumdis-2011-201239.10	57	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35606	10.1371/journal.pone.0035606	http://dx.doi.org/10.1371/journal.pone.0035606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590509	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400005
J	Manna, A; Saha, P; Sarkar, A; Mukhopadhyay, D; Bauri, AK; Kumar, D; Das, P; Chattopadhyay, S; Chatterjee, M				Manna, Alak; Saha, Piu; Sarkar, Avijit; Mukhopadhyay, Debanjan; Bauri, Ajay K.; Kumar, Deepak; Das, Padma; Chattopadhyay, Subrata; Chatterjee, Mitali			Malabaricone-A Induces A Redox Imbalance That Mediates Apoptosis in U937 Cell Line	PLOS ONE			English	Article							LEISHMANIA-DONOVANI PROMASTIGOTES; CANCER-CELLS; NITRIC-OXIDE; MITOCHONDRIAL PATHWAYS; GLUTATHIONE-PEROXIDASE; CYCLE ARREST; DEATH; STRESS; AGENTS; PROLIFERATION	Backround: The 'two-faced' character of reactive oxygen species (ROS) plays an important role in cancer biology by acting both as secondary messengers in intracellular signaling cascades and sustaining the oncogenic phenotype of cancer cells, while on the other hand, it triggers an oxidative assault that causes a redox imbalance translating into an apoptotic cell death. Principal Findings: Using a tetrazolium [{3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl}-2H-tetrazolium] based cell viability assay, we evaluated the cytotoxicity of a plant derived diarylnonanoid, malabaricone-A on leukemic cell lines U937 and MOLT-3. This cytotoxicity hinged on its ability to cause a redox imbalance via its ability to increase ROS, measured by flow cytometry using 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate and by decreasing glutathione peroxidase activity. This redox imbalance mediated apoptosis was evident by an increase in cytosolic [Ca2+], externalization of phosphatidyl serine as also depolarization of the mitochondrial membrane potential as measured by flow cytometry. There was concomitant peroxidation of cardiolipin, release of free cytochrome c to cytosol along with activation of caspases 9, 8 and 3. This led to cleavage of the DNA repair enzyme, poly (ADP-ribose) polymerase that caused DNA damage as proved by labeling with 4',6-diamidino-2-phenylindole (DAPI); furthermore, terminal deoxy ribonucleotide transferase catalysed incorporation of deoxy uridine triphosphate confirmed DNA nicking and was accompanied by arrest of cell cycle progression. Conclusions: Taken together, compounds like MAL-A having pro-oxidant activity mediate their cytotoxicity in leukemic cells via induction of oxidative stress triggering a caspase dependent apoptosis.	[Manna, Alak; Saha, Piu; Sarkar, Avijit; Mukhopadhyay, Debanjan; Chatterjee, Mitali] Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, W Bengal, India; [Bauri, Ajay K.; Chattopadhyay, Subrata] Bhabha Atom Res Ctr, Bioorgan Div, Bombay 400085, Maharashtra, India; [Kumar, Deepak; Das, Padma] Indian Inst Chem Biol, Dept Cell Biol & Physiol, Kolkata, W Bengal, India	Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Bhabha Atomic Research Center (BARC); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Manna, A (corresponding author), Inst Post Grad Med Educ & Res, Dept Pharmacol, Kolkata, W Bengal, India.	ilatim@vsnl.net	Manna, Alak/AAY-1248-2021; Chatterjee, Mitali/AAV-2129-2021; Manna, Alak/AAE-7308-2021; Mukhopadhyay, Debanjan/S-3347-2019; Kumar, Deepak/J-4347-2016	Manna, Alak/0000-0003-3894-3277; Mukhopadhyay, Debanjan/0000-0002-8921-4106; 	Indian Council of Medical Research, Govt. of India	Indian Council of Medical Research, Govt. of India(Indian Council of Medical Research (ICMR))	AM, AS, DM received Senior Research fellowships from Indian Council of Medical Research, Govt. of India, and PS received a Research Associateship from Council of Scientific and Industrial Research, Govt. of India. This study had no external funding source.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Baneljee D, 2008, EUR J PHARMACOL, V578, P300, DOI 10.1016/j.ejphar.2007.09.041; Barbier M, 2004, CYTOM PART B-CLIN CY, V59B, P46, DOI 10.1002/cyto.b.20004; Beck R, 2011, CURR MED CHEM, V18, P2816, DOI 10.2174/092986711796011256; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Brockhaus F, 1998, EXP CELL RES, V238, P33, DOI 10.1006/excr.1997.3778; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Das B, 2010, BIOORG MED CHEM LETT, V20, P6947, DOI 10.1016/j.bmcl.2010.09.126; Doering M, 2010, J MED CHEM, V53, P6954, DOI 10.1021/jm100576z; Ganguly S, 2006, J MICROBIOL METH, V66, P79, DOI 10.1016/j.mimet.2005.10.011; Guha P, 2011, J PHARMACOL EXP THER, V336, P206, DOI 10.1124/jpet.110.171983; Harada Hisashi, 2003, Rev Clin Exp Hematol, V7, P117; Jaeger T, 2006, BIOFACTORS, V27, P109, DOI 10.1002/biof.5520270110; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Laurent A, 2005, CANCER RES, V65, P948; Morita T, 2003, J AGR FOOD CHEM, V51, P1560, DOI 10.1021/jf020946n; Munoz MA, 2011, J PHOTOCH PHOTOBIO B, V103, P57, DOI 10.1016/j.jphotobiol.2011.01.012; Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paris C, 2007, APOPTOSIS, V12, P1257, DOI 10.1007/s10495-007-0052-1; Patro BS, 2010, BIOORGAN MED CHEM, V18, P7043, DOI 10.1016/j.bmc.2010.08.011; Patro BS, 2005, J AGR FOOD CHEM, V53, P6912, DOI 10.1021/jf050861x; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Saha P, 2011, INT IMMUNOPHARMACOL, V11, P1668, DOI 10.1016/j.intimp.2011.08.002; Saha P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018467; Saha P, 2009, FREE RADICAL RES, V43, P1101, DOI 10.1080/10715760903186124; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; Schnelldorfer T, 2000, CANCER-AM CANCER SOC, V89, P1440, DOI 10.1002/1097-0142(20001001)89:7<1440::AID-CNCR5>3.3.CO;2-S; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sen R, 2011, PHYTOMEDICINE, V18, P1056, DOI 10.1016/j.phymed.2011.03.004; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; Yang ES, 2011, TOXICOL IN VITRO, V25, P1803, DOI 10.1016/j.tiv.2011.09.016; Zhou Y, 2003, BLOOD, V101, P4098, DOI 10.1182/blood-2002-08-2512; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	43	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36938	10.1371/journal.pone.0036938	http://dx.doi.org/10.1371/journal.pone.0036938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590637	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400047
J	Krumme, C; Cebrian, M; Pickard, G; Pentland, S				Krumme, Coco; Cebrian, Manuel; Pickard, Galen; Pentland, Sandy			Quantifying Social Influence in an Online Cultural Market	PLOS ONE			English	Article							CHOICE	We revisit experimental data from an online cultural market in which 14,000 users interact to download songs, and develop a simple model that can explain seemingly complex outcomes. Our results suggest that individual behavior is characterized by a two-step process-the decision to sample and the decision to download a song. Contrary to conventional wisdom, social influence is material to the first step only. The model also identifies the role of placement in mediating social signals, and suggests that in this market with anonymous feedback cues, social influence serves an informational rather than normative role.	[Krumme, Coco; Cebrian, Manuel; Pickard, Galen; Pentland, Sandy] MIT, Media Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Krumme, C (corresponding author), MIT, Media Lab, Cambridge, MA 02139 USA.	kak@mit.edu			Department of the Air Force [FA8721-05-C-0002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER	Department of the Air Force; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was sponsored by the Department of the Air Force under contract FA8721-05-C-0002. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Borghesi C, 2007, QUAL QUANT, V41, P557, DOI 10.1007/s11135-007-9074-6; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Elberse A., 2006, SUPERSTARS UNDERDOGS; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Goel Sharad, 2010, P 11 ACM C EL COMM, P357; Hendricks K, 2009, OBSERVATIONAL LEARNI; Salganik MJ, 2009, TOP COGN SCI, V1, P439, DOI 10.1111/j.1756-8765.2009.01030.x; Salganik MJ, 2008, SOC PSYCHOL QUART, V71, P338, DOI 10.1177/019027250807100404; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Senecal S, 2004, J RETAILING, V80, P159, DOI 10.1016/j.jretai.2004.04.001; Smith L, 2000, ECONOMETRICA, V68, P371, DOI 10.1111/1468-0262.00113; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Urban G, 1986, MANAGE SCI, P645; Vany A. de, 1999, Journal of Cultural Economics, V23, P285, DOI 10.1023/A:1007608125988	16	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e33785	10.1371/journal.pone.0033785	http://dx.doi.org/10.1371/journal.pone.0033785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590493	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100001
J	Weiss, LC; Kruppert, S; Laforsch, C; Tollrian, R				Weiss, Linda C.; Kruppert, Sebastian; Laforsch, Christian; Tollrian, Ralph			Chaoborus and Gasterosteus Anti-Predator Responses in Daphnia pulex Are Mediated by Independent Cholinergic and Gabaergic Neuronal Signals	PLOS ONE			English	Article							LIFE-HISTORY SHIFTS; VERTICAL MIGRATION; PREDATOR; KAIROMONES; DEFENSE; COSTS	Many prey species evolved inducible defense strategies that protect effectively against predation threats. Especially the crustacean Daphnia emerged as a model system for studying the ecology and evolution of inducible defenses. Daphnia pulex e. g. shows different phenotypic adaptations against vertebrate and invertebrate predators. In response to the invertebrate phantom midge larvae Chaoborus (Diptera) D. pulex develops defensive morphological defenses (neckteeth). Cues originating from predatory fish result in life history changes in which resources are allocated from somatic growth to reproduction. While there are hints that responses against Chaoborus cues are transmitted involving cholinergic neuronal pathways, nothing is known about the neurophysiology underlying the transmission of fish related cues. We investigated the neurophysiological basis underlying the activation of inducible defenses in D. pulex using induction assays with the invertebrate predator Chaoborus and the three-spined stickleback Gasterosteus aculeatus. Predator-specific cues were combined with neuro-effective substances that stimulated or inhibited the cholinergic and gabaergic nervous system. We show that cholinergic-dependent pathways are involved in the perception and transmission of Chaoborus cues, while GABA was not involved. Thus, the cholinergic nervous system independently mediates the development of morphological defenses in response to Chaoborus cues. In contrast, only the inhibitory effect of GABA significantly influence fish-induced life history changes, while the application of cholinergic stimulants had no effect in combination with fish related cues. Our results show that cholinergic stimulation mediates signal transmission of Chaoborus cues leading to morphological defenses. Fish cues, which are responsible for predator-specific life history adaptations involve gabaergic control. Our study shows that both pathways are independent and thus potentially allow for adjustment of responses to variable predation regimes.	[Weiss, Linda C.; Kruppert, Sebastian; Tollrian, Ralph] Ruhr Univ Bochum, Bochum, Germany; [Laforsch, Christian] Univ Munich, Dept Biol 2, Munich, Germany	Ruhr University Bochum; University of Munich	Weiss, LC (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	linda.weiss@rub.de	Kruppert, Sebastian/AAJ-8746-2020	Kruppert, Sebastian/0000-0001-5932-8455; Weiss, Linda C./0000-0002-7737-5017	Ruhr University Research School; Germany's Excellence Initiative [DFG] [GSC 98/1]	Ruhr University Research School; Germany's Excellence Initiative [DFG](German Research Foundation (DFG))	This work was supported by the Ruhr University Research School, which is funded by Germany's Excellence Initiative [DFG GSC 98/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT J, 1986, BRIT J PHARMACOL, V87, P771, DOI 10.1111/j.1476-5381.1986.tb14596.x; Barry MJ, 2002, PHYSIOL BIOCHEM ZOOL, V75, P179, DOI 10.1086/339389; Boeing WJ, 2005, CAN J FISH AQUAT SCI, V62, P1286, DOI 10.1139/F05-043; Dodson SI, 1997, J PLANKTON RES, V19, P969, DOI 10.1093/plankt/19.8.969; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; LOOSE CJ, 1993, ARCH HYDROBIOL, V126, P329; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Nilsson GE, 2012, NATURE CLIMATE CHANG; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; PIJANOWSKA J, 1992, INT REV GES HYDROBIO, V77, P153, DOI 10.1002/iroh.19920770111; STIBOR H, 1994, FUNCT ECOL, V8, P97, DOI 10.2307/2390117; STIBOR H, 1992, OECOLOGIA, V92, P162, DOI 10.1007/BF00317358; TOLLRIAN R, 1995, ECOLOGY, V76, P1691, DOI 10.2307/1940703; TOLLRIAN R, 1993, J PLANKTON RES, V15, P1309, DOI 10.1093/plankt/15.11.1309; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Wojtal-Frankiewicz A, 2010, AQUAT ECOL, V44, P243, DOI 10.1007/s10452-009-9280-5	17	38	38	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36879	10.1371/journal.pone.0036879	http://dx.doi.org/10.1371/journal.pone.0036879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590631	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100071
J	Yang, RJ; Lacson, RG; Castriota, G; Zhang, XHD; Liu, YP; Zhao, WQ; Einstein, M; Camargo, LM; Qureshi, S; Wong, KK; Zhang, BB; Ferrer, M; Berger, JP				Yang, Ruojing; Lacson, Raul G.; Castriota, Gino; Zhang, Xiaohua D.; Liu, Yaping; Zhao, Wenqing; Einstein, Monica; Camargo, Luiz Miguel; Qureshi, Sajjad; Wong, Kenny K.; Zhang, Bei B.; Ferrer, Marc; Berger, Joel P.			A Genome-Wide siRNA Screen to Identify Modulators of Insulin Sensitivity and Gluconeogenesis	PLOS ONE			English	Article							GLUCAGON RECEPTOR ANTAGONISTS; BINDING PROTEIN-1 PROMOTER; HEPATIC GLUCOSE-PRODUCTION; TRANSCRIPTION FACTOR FKHR; RESPONSE SEQUENCE; DIABETIC RATS; HYPERGLYCEMIA; PHOSPHORYLATION; METABOLISM; METFORMIN	Background: Hepatic insulin resistance impairs insulin's ability to suppress hepatic glucose production (HGP) and contributes to the development of type 2 diabetes (T2D). Although the interests to discover novel genes that modulate insulin sensitivity and HGP are high, it remains challenging to have a human cell based system to identify novel genes. Methodology/Principal Findings: To identify genes that modulate hepatic insulin signaling and HGP, we generated a human cell line stably expressing beta-lactamase under the control of the human glucose-6-phosphatase (G6PC) promoter (AH-G6PC cells). Both beta-lactamase activity and endogenous G6PC mRNA were increased in AH-G6PC cells by a combination of dexamethasone and pCPT-cAMP, and reduced by insulin. A 4-gene High-Throughput-Genomics assay was developed to concomitantly measure G6PC and pyruvate-dehydrogenase-kinase-4 (PDK4) mRNA levels. Using this assay, we screened an siRNA library containing pooled siRNA targeting 6650 druggable genes and identified 614 hits that lowered G6PC expression without increasing PDK4 mRNA levels. Pathway analysis indicated that siRNA-mediated knockdown (KD) of genes known to positively or negatively affect insulin signaling increased or decreased G6PC mRNA expression, respectively, thus validating our screening platform. A subset of 270 primary screen hits was selected and 149 hits were confirmed by target gene KD by pooled siRNA and 7 single siRNA for each gene to reduce G6PC expression in 4-gene HTG assay. Subsequently, pooled siRNA KD of 113 genes decreased PEPCK and/or PGC1alpha mRNA expression thereby demonstrating their role in regulating key gluconeogenic genes in addition to G6PC. Last, KD of 61 of the above 113 genes potentiated insulin-stimulated Akt phosphorylation, suggesting that they suppress gluconeogenic gene by enhancing insulin signaling. Conclusions/Significance: These results support the proposition that the proteins encoded by the genes identified in our cell-based druggable genome siRNA screen hold the potential to serve as novel pharmacological targets for the treatment of T2D.	[Yang, Ruojing; Castriota, Gino; Einstein, Monica; Camargo, Luiz Miguel; Qureshi, Sajjad; Zhang, Bei B.; Berger, Joel P.] Merck Res Labs, Dept Metebol Disorders Diabet, Rahway, NJ 07055 USA; [Lacson, Raul G.; Liu, Yaping; Ferrer, Marc] Merck Res Labs, Cell Based HTS, N Wales, PA USA; [Zhang, Xiaohua D.] Merck Res Labs, West Point, PA USA; [Zhao, Wenqing] Merck Res Labs, Dept Guided Solut, Rahway, NJ USA; [Wong, Kenny K.] Merck Res Labs, Dept Atherosclerosis, Rahway, NJ USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Yang, RJ (corresponding author), Merck Res Labs, Dept Metebol Disorders Diabet, Rahway, NJ 07055 USA.	ruojing_yang@merck.com; joel_berger@merck.com		Zhang, Xiaohua Douglas/0000-0002-2486-7931	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Cichy SB, 1998, J BIOL CHEM, V273, P6482, DOI 10.1074/jbc.273.11.6482; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang BL, 2002, DIABETES, V51, P276, DOI 10.2337/diabetes.51.2.276; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Kim RM, 2008, BIOORG MED CHEM LETT, V18, P3701, DOI 10.1016/j.bmcl.2008.05.072; Lau J, 2007, J MED CHEM, V50, P113, DOI 10.1021/jm058026u; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang Y, 2005, METABOLISM, V54, P848, DOI 10.1016/j.metabol.2005.01.030; Mang Y, 2004, DIABETES, V53, P410; Martel RR, 2002, ASSAY DRUG DEV TECHN, V1, P61, DOI 10.1089/154065802761001310; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Mithieux G, 2002, DIABETES, V51, P139, DOI 10.2337/diabetes.51.1.139; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qureshi SA, 2004, DIABETES, V53, P3267, DOI 10.2337/diabetes.53.12.3267; Rondinone CM, 2006, ENDOCRINOLOGY, V147, P2650, DOI 10.1210/en.2006-0147; SAAD MJA, 1995, ENDOCRINOLOGY, V136, P1579, DOI 10.1210/en.136.4.1579; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Sloop KW, 2004, J CLIN INVEST, V113, P1571, DOI 10.1172/JCI200420911; STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Yang RJ, 2008, INT J BIOCHEM CELL B, V40, P2702, DOI 10.1016/j.biocel.2008.06.012; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2010, PHARMACOGENOMICS, V11, P199, DOI [10.2217/pgs.09.136, 10.2217/PGS.09.136]; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36384	10.1371/journal.pone.0036384	http://dx.doi.org/10.1371/journal.pone.0036384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590537	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336100028
J	Kam, MKM; Lee, KY; Tam, PKH; Lui, VCH				Kam, Mandy Ka Man; Lee, King Yiu; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang			Generation of NSE-MerCreMer Transgenic Mice with Tamoxifen Inducible Cre Activity in Neurons	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; MOUSE; EXPRESSION; ENOLASE; CELLS; PHENOTYPE; MIGRATION; GENOME; BRAIN; FORM	To establish a genetic tool for conditional deletion or expression of gene in neurons in a temporally controlled manner, we generated a transgenic mouse (NSE-MerCreMer), which expressed a tamoxifen inducible type of Cre recombinase specifically in neurons. The tamoxifen inducible Cre recombinase (MerCreMer) is a fusion protein containing Cre recombinase with two modified estrogen receptor ligand binding domains at both ends, and is driven by the neural-specific rat neural specific enolase (NSE) promoter. A total of two transgenic lines were established, and expression of MerCreMer in neurons of the central and enteric nervous systems was confirmed. Transcript of MerCreMer was detected in several non-neural tissues such as heart, liver, and kidney in these lines. In the background of the Cre reporter mouse strain Rosa26R, Cre recombinase activity was inducible in neurons of adult NSE-MerCreMer mice treated with tamoxifen by intragastric gavage, but not in those fed with corn oil only. We conclude that NSE-MerCreMer lines will be useful for studying gene functions in neurons for the conditions that Cre-mediated recombination resulting in embryonic lethality, which precludes investigation of gene functions in neurons through later stages of development and in adult.	[Kam, Mandy Ka Man; Lee, King Yiu; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, LKS Fac Med, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Kam, MKM (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	vchlui@hkucc.hku.hk	/C-4405-2009; /C-4359-2009	/0000-0001-6231-3035; /0000-0002-1758-8854	Hong Kong SAR Government Research Council	Hong Kong SAR Government Research Council	Funding support came from The Hong Kong SAR Government Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; CASTILLO MB, 1995, ARCH BIOCHEM BIOPHYS, V317, P292, DOI 10.1006/abbi.1995.1165; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Garcia EL, 2002, SEMIN CELL DEV BIOL, V13, P151, DOI 10.1016/S1084-9521(02)00019-8; GILLIES K, 1993, NEUROREPORT, V4, P911, DOI 10.1097/00001756-199307000-00018; HAMILTON DL, 1984, J MOL BIOL, V178, P481, DOI 10.1016/0022-2836(84)90154-2; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hwang DY, 2004, EXP NEUROL, V186, P20, DOI 10.1016/j.expneurol.2003.09.021; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Levers TE, 2001, J NEUROBIOL, V48, P265, DOI 10.1002/neu.1056; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; MARANGOS PJ, 1980, BRAIN RES, V190, P185, DOI 10.1016/0006-8993(80)91168-3; Metzger D, 1999, CURR OPIN BIOTECH, V10, P470, DOI 10.1016/S0958-1669(99)00012-9; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Patzke H, 2003, J NEUROSCI, V23, P2769; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Schmechel DE, 1983, NEURON SPECIFIC ENOL; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Young HM, 2001, ANAT REC, V262, P1; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35799	10.1371/journal.pone.0035799	http://dx.doi.org/10.1371/journal.pone.0035799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586451	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000013
J	Wich, SA; Krutzen, M; Lameira, AR; Nater, A; Arora, N; Bastian, ML; Meulman, E; Morrogh-Bernard, HC; Atmoko, SSU; Pamungkas, J; Perwitasari-Farajallah, D; Hardus, ME; van Noordwijk, M; van Schaik, CP				Wich, Serge A.; Kruetzen, Michael; Lameira, Adriano R.; Nater, Alexander; Arora, Natasha; Bastian, Meredith L.; Meulman, Ellen; Morrogh-Bernard, Helen C.; Atmoko, S. Suci Utami; Pamungkas, Joko; Perwitasari-Farajallah, Dyah; Hardus, Madeleine E.; van Noordwijk, Maria; van Schaik, Carel P.			Call Cultures in Orang-Utans?	PLOS ONE			English	Article							GEOGRAPHIC-VARIATION; WILD CHIMPANZEES; BORNEAN ORANGUTANS; EVOLUTION; SOUND; SONG; VOCALIZATIONS; TRANSMISSION; TRADITIONS; PRODUCE	Background: Several studies suggested great ape cultures, arguing that human cumulative culture presumably evolved from such a foundation. These focused on conspicuous behaviours, and showed rich geographic variation, which could not be attributed to known ecological or genetic differences. Although geographic variation within call types (accents) has previously been reported for orang-utans and other primate species, we examine geographic variation in the presence/absence of discrete call types (dialects). Because orang-utans have been shown to have geographic variation that is not completely explicable by genetic or ecological factors we hypothesized that this will be similar in the call domain and predict that discrete call type variation between populations will be found. Methodology/Principal Findings: We examined long-term behavioural data from five orang-utan populations and collected fecal samples for genetic analyses. We show that there is geographic variation in the presence of discrete types of calls. In exactly the same behavioural context (nest building and infant retrieval), individuals in different wild populations customarily emit either qualitatively different calls or calls in some but not in others. By comparing patterns in call-type and genetic similarity, we suggest that the observed variation is not likely to be explained by genetic or ecological differences. Conclusion/Significance: These results are consistent with the potential presence of 'call cultures' and suggest that wild orang-utans possess the ability to invent arbitrary calls, which spread through social learning. These findings differ substantially from those that have been reported for primates before. First, the results reported here are on dialect and not on accent. Second, this study presents cases of production learning whereas most primate studies on vocal learning were cases of contextual learning. We conclude with speculating on how these findings might assist in bridging the gap between vocal communication in non-human primates and human speech.	[Wich, Serge A.; Kruetzen, Michael; Nater, Alexander; Arora, Natasha; Meulman, Ellen; van Noordwijk, Maria; van Schaik, Carel P.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Wich, Serge A.] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Lameira, Adriano R.] Univ Utrecht, Utrecht, Netherlands; [Bastian, Meredith L.] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Morrogh-Bernard, Helen C.] Univ Cambridge, Wildlife Res Grp, Cambridge, England; [Atmoko, S. Suci Utami] Univ Nas, Fak Biol, Jakarta, Indonesia; [Pamungkas, Joko; Perwitasari-Farajallah, Dyah] Bogor Agr Univ, Primate Res Ctr, Bogor, Indonesia; [Hardus, Madeleine E.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Zurich; Utrecht University; Boston University; University of Cambridge; Universitas Nasional Pionir Perubahan; Bogor Agricultural University; University of Amsterdam	Wich, SA (corresponding author), Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland.	sergewich1@yahoo.com	Nater, Alexander/ABF-5719-2020; Arora, Natasha/L-6579-2014; Perwitasari-Farajallah, Dyah/CAE-9260-2022; Pamungkas, Joko/GPK-3471-2022; Krutzen, Michael C/D-9550-2011	Nater, Alexander/0000-0002-4805-5575; Arora, Natasha/0000-0002-6144-4743; Perwitasari-Farajallah, Dyah/0000-0001-6206-1675; Krutzen, Michael/0000-0003-1055-5299; Lameira, Adriano/0000-0003-3071-4824; Wich, Serge/0000-0003-3954-5174; utami, sri/0000-0002-5138-242X	Netherlands Organisation for Scientific Research (NWO); L.S.B. Leakey Foundation; National Geographic Society; Swiss National Science Foundation; Messerli Foundation; A.H.-Schultz Foundation; PanEco; Claraz-Schenkung; Portuguese Foundation for Science and Technology; Wenner-Gren Foundation for Anthropological Research; Dobberke Foundation; Lucie Burgers Foundation for Comparative Behaviour Research; Schure-Beijerinck-Popping Funds; Royal Anthropological Institute of Great Britain and Ireland; Primate Conservation, Inc.; Fundacao Calouste Gulbenkian	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); L.S.B. Leakey Foundation; National Geographic Society(National Geographic Society); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Messerli Foundation; A.H.-Schultz Foundation; PanEco; Claraz-Schenkung; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Wenner-Gren Foundation for Anthropological Research; Dobberke Foundation; Lucie Burgers Foundation for Comparative Behaviour Research; Schure-Beijerinck-Popping Funds; Royal Anthropological Institute of Great Britain and Ireland; Primate Conservation, Inc.; Fundacao Calouste Gulbenkian(European Commission)	This work was supported by the Netherlands Organisation for Scientific Research (NWO), L.S.B. Leakey Foundation, National Geographic Society, Swiss National Science Foundation, Messerli Foundation, A.H.-Schultz Foundation, PanEco, Claraz-Schenkung, Portuguese Foundation for Science and Technology, Wenner-Gren Foundation for Anthropological Research, Dobberke Foundation, Lucie Burgers Foundation for Comparative Behaviour Research, Schure-Beijerinck-Popping Funds, Ruggles-Gates Fund for Anthropological Scholarship of the Royal Anthropological Institute of Great Britain and Ireland, Primate Conservation, Inc., and Fundacao Calouste Gulbenkian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian ML, 2010, AM J PHYS ANTHROPOL, V143, P175, DOI 10.1002/ajpa.21304; Bertelli S, 2002, BIOL J LINN SOC, V77, P423, DOI 10.1046/j.1095-8312.2002.00112.x; Bluff LA, 2010, BIOL J LINN SOC, V101, P767, DOI 10.1111/j.1095-8312.2010.01527.x; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Crockford C, 2004, ETHOLOGY, V110, P221, DOI 10.1111/j.1439-0310.2004.00968.x; de la Torre S, 2009, AM J PRIMATOL, V71, P333, DOI 10.1002/ajp.20657; Delgado RA, 2007, ETHOLOGY, V113, P487, DOI 10.1111/j.1439-0310.2007.01345.x; Dindo M, 2011, BIOL LETTERS, V7, P181, DOI 10.1098/rsbl.2010.0637; Falconer D. S., 1996, Introduction to quantitative genetics.; Fichtel C, 2006, ETHOLOGY, V112, P839, DOI 10.1111/j.1439-0310.2006.01239.x; Fischer J, 1998, ANIM BEHAV, V56, P623, DOI 10.1006/anbe.1998.0796; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; Hardus ME, 2009, P ROY SOC B-BIOL SCI, V276, P3689, DOI 10.1098/rspb.2009.1027; Hardus Madeleine E., 2009, P49; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Jaeggi AV, 2008, AM J PRIMATOL, V70, P533, DOI 10.1002/ajp.20525; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Krutzen M, 2012, CURRENT BIO IN PRESS; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Lameira AR., 2010, J EVOL PSYCHOL, V8, P309; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P2094, DOI 10.1098/rspb.2011.0391; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lycett SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2091, DOI 10.1098/rspb.2010.2599; M Paul, 2007, NESTING SOUNDS WILD; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; Miles H. Lyn, 1996, P278; Mitani JC, 1999, AM J PRIMATOL, V47, P133, DOI 10.1002/(SICI)1098-2345(1999)47:2<133::AID-AJP4>3.0.CO;2-I; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Muir CC, 2000, J MOL EVOL, V51, P471, DOI 10.1007/s002390010110; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Owren MJ, 2010, AM J PRIMATOL, V71, P1; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell LE, 2003, P ROY SOC B-BIOL SCI, V270, P225, DOI 10.1098/rspb.2002.2239; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Saranathan V, 2007, MOL ECOL, V16, P3689, DOI 10.1111/j.1365-294X.2007.03415.x; Schusterman R.J., 2008, EVOLUTION COMMUNICAT, P41, DOI [10.7551/mitpress/9780262151214.003.0003, DOI 10.7551/MITPRESS/9780262151214.003.0003]; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Slik JWF, 2011, P NATL ACAD SCI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van Schaik CP, 2006, BEHAVIOUR, V143, P839, DOI 10.1163/156853906778017944; Van Schaik Carel P., 2003, P297, DOI 10.1017/CBO9780511584022.012; van Schaik Carel P., 2009, P299; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Wich SA, 2008, AM J PRIMATOL, V70, P566, DOI 10.1002/ajp.20527; Wich SA, 2009, PRIMATES, V50, P56, DOI 10.1007/s10329-008-0117-y; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	60	53	54	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36180	10.1371/journal.pone.0036180	http://dx.doi.org/10.1371/journal.pone.0036180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586464	Green Accepted, gold, Green Published			2022-12-27	WOS:000305335000026
J	Li, N; Hong, WF; Huang, H; Lu, HP; Lin, GY; Hong, M				Li, Nan; Hong, Weifang; Huang, Hong; Lu, Hanping; Lin, Guangyun; Hong, Mei			Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; FUNCTIONAL-CHARACTERIZATION; OATP TRANSPORTERS; HUMAN LIVER; HOAT1; POLYMORPHISMS; SUPERFAMILY; STABILITY; FAMILY	As an important structure in membrane proteins, transmembrane domains have been found to be crucial for properly targeting the protein to cell membrane as well as carrying out transport functions in transporters. Computer analysis of OATP sequences revealed transmembrane domain 2 (TM2) is among those transmembrane domains that have high amino acid identities within different family members. In the present study, we identify four amino acids (Asp70, Phe73, Glu74, and Gly76) that are essential for the transport function of OATP1B1, an OATP member that is specifically expressed in the human liver. A substitution of these four amino acids with alanine resulted in significantly reduced transport activity. Further mutagenesis showed the charged property of Asp70 and Glu74 is critical for proper function of the transporter protein. Comparison of the kinetic parameters indicated that Asp70 is likely to interact with the substrate while Glu74 may be involved in stabilizing the binding site through formation of a salt-bridge. The aromatic ring structure of Phe73 seems to play an important role because substitution of Phe73 with tyrosine, another amino acid with a similar structure, led to partially restored transport function. On the other hand, replacement of Gly76 with either alanine or valine could not recover the function of the transporter. Considering the nature of a transmembrane helix, we proposed that Gly76 may be important for maintaining the proper structure of the protein. Interestingly, when subjected to transport function analysis of higher concentration of esteone-3-sulfate (50 mu M) that corresponds to the low affinity binding site of OATP1B1, mutants of Phe73, Glu74, and Gly76 all showed a transport function that is comparable to that of the wild-type, suggesting these amino acids may have less impact on the low affinity component of esteone-3-sulfate within OATP1B1, while Asp 70 seems to be involved in the interaction of both sites.	[Li, Nan; Hong, Weifang; Hong, Mei] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL USA; [Lu, Hanping; Lin, Guangyun] Zhongshan Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; State University System of Florida; University of South Florida; Sun Yat Sen University	Li, N (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	mh2788@scau.edu.cn	Huang, Hong/G-5957-2016	Huang, Hong/0000-0002-8957-4881; Hong, Mei/0000-0001-9219-2844	Guangdong Province Talent Introduction Project Grant	Guangdong Province Talent Introduction Project Grant	This work was supported by Guangdong Province Talent Introduction Project Grant (2009) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bossuyt X, 1996, J HEPATOL, V25, P733, DOI 10.1016/S0168-8278(96)80246-7; Cai SY, 2002, AM J PHYSIOL-GASTR L, V282, pG702, DOI 10.1152/ajpgi.00458.2001; Glaeser H, 2010, BRIT J PHARMACOL, V159, P698, DOI 10.1111/j.1476-5381.2009.00568.x; Gui CS, 2009, PROTEIN SCI, V18, P2298, DOI 10.1002/pro.240; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hong M, 2007, J PHARMACOL EXP THER, V320, P1209, DOI 10.1124/jpet.106.117663; Hong M, 2010, J PHARMACOL EXP THER, V332, P650, DOI 10.1124/jpet.109.160515; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Miyagawa M, 2009, J PHARMACOL EXP THER, V329, P551, DOI 10.1124/jpet.108.148411; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Poirier A, 2007, CURR OPIN DRUG DISC, V10, P74; Rizwan AN, 2007, J BIOL CHEM, V282, P13402, DOI 10.1074/jbc.M609849200; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Tamai I, 2001, PHARMACEUT RES, V18, P1262, DOI 10.1023/A:1013077609227; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; van Montfoort JE, 2003, CURR DRUG METAB, V4, P185, DOI 10.2174/1389200033489460; Weaver YM, 2010, J MEMBRANE BIOL, V236, P279, DOI 10.1007/s00232-010-9300-3	24	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36647	10.1371/journal.pone.0036647	http://dx.doi.org/10.1371/journal.pone.0036647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574206	Green Published, gold			2022-12-27	WOS:000305349800103
J	Dawson, J; Walters, M; Delles, C; Mischak, H; Mullen, W				Dawson, Jesse; Walters, Matthew; Delles, Christian; Mischak, Harald; Mullen, William			Urinary Proteomics to Support Diagnosis of Stroke	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; VALIDATION; EMERGENCY; PROTEIN; RECOGNITION; BIOMARKERS; UROMODULIN; DISCOVERY; PEPTIDES; TOOL	Accurate diagnosis in suspected ischaemic stroke can be difficult. We explored the urinary proteome in patients with stroke (n = 69), compared to controls (n = 33), and developed a biomarker model for the diagnosis of stroke. We performed capillary electrophoresis online coupled to micro-time-of-flight mass spectrometry. Potentially disease-specific peptides were identified and a classifier based on these was generated using support vector machine-based software. Candidate biomarkers were sequenced by liquid chromatography-tandem mass spectrometry. We developed two biomarker-based classifiers, employing 14 biomarkers (nominal p-value <0.004) or 35 biomarkers (nominal p-value <0.01). When tested on a blinded test set of 47 independent samples, the classification factor was significantly different between groups; for the 35 biomarker model, median value of the classifier was 0.49 (-0.30 to 1.25) in cases compared to -1.04 (IQR -1.86 to -0.09) in controls, p < 0.001. The 35 biomarker classifier gave sensitivity of 56%, specificity was 93% and the AUC on ROC analysis was 0.86. This study supports the potential for urinary proteomic biomarker models to assist with the diagnosis of acute stroke in those with mild symptoms. We now plan to refine further and explore the clinical utility of such a test in large prospective clinical trials.	[Dawson, Jesse; Walters, Matthew; Delles, Christian; Mischak, Harald; Mullen, William] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Mischak, Harald] Mosaiques Diagnost, Hannover, Germany	University of Glasgow	Dawson, J (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	jesse.dawson@glasgow.ac.uk	Mullen, William/GWC-8078-2022	Mischak, Harald/0000-0003-0323-0306; Mullen, William/0000-0002-5685-1563	Chest Heart Stroke Scotland [ResFell 06]; EU-MASCARA, from the European Union [HEALTH-2011-278249]	Chest Heart Stroke Scotland; EU-MASCARA, from the European Union	Samples were collected during a study funded by a grant from Chest Heart Stroke Scotland (Grant Number ResFell 06). The study was funded in part by grant HEALTH-2011-278249, EU-MASCARA, from the European Union to CD and HM. No additional external funding was received or needed for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Dawson J, 2009, QJM-INT J MED, V102, P43, DOI 10.1093/qjmed/hcn139; Dawson J, 2011, CARDIOVASC THER, V29, P301, DOI 10.1111/j.1755-5922.2010.00188.x; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; Delles C, 2010, J HYPERTENS, V28, P2316, DOI 10.1097/HJH.0b013e32833d81b7; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Gimelreich D, 2001, KIDNEY INT, V59, P1812, DOI 10.1046/j.1523-1755.2001.0590051812.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Haubitz M, 2005, NEPHROL DIAL TRANSPL, V20, pV20; IKONEN E, 1993, CURR BIOL, V3, P635, DOI 10.1016/0960-9822(93)90061-R; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kashyap RS, 2009, CLIN CHIM ACTA, V402, P160, DOI 10.1016/j.cca.2009.01.009; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Ning MM, 2010, TRANSL STROKE RES, V1, P268, DOI 10.1007/s12975-010-0047-z; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Su SJ, 1997, J IMMUNOL, V158, P3449; Sylaja PN, 2008, STROKE, V39, P1898, DOI 10.1161/STROKEAHA.107.497453; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Walther T, 2002, FASEB J, V16, P169, DOI 10.1096/fj.01-0601com; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Yu CH, 2007, EXP NEUROL, V203, P116, DOI 10.1016/j.expneurol.2006.07.023; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	33	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35879	10.1371/journal.pone.0035879	http://dx.doi.org/10.1371/journal.pone.0035879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615742	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305341300009
J	Bittman, EL				Bittman, Eric L.			Does the Precision of a Biological Clock Depend upon Its Period? Effects of the Duper and tau Mutations in Syrian Hamsters	PLOS ONE			English	Article							CIRCADIAN-RHYTHM GENERATION; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; BEHAVIOR; PACEMAKERS; MODEL; SCN; ROBUSTNESS	Mutations which alter the feedback loops that generate circadian rhythms may provide insight into their insensitivity to perturbation robustness) and their consistency of period (precision). I examined relationships between endogenous period, activity and rest (tau(DD), alpha and rho) in Syrian hamsters using two different mutations, duper and tau, both of which speed up the circadian clock. I generated 8 strains of hamsters that are homozygous or heterozygous for the tau, duper, and wild type alleles in all combinations. The endogenous period of activity onsets among these strains ranged from 17.94 +/- 0.04 to 24.13 +/- 0.04 h. Contrary to predictions, the variability of period was unrelated to its absolute value: all strains showed similar variability of tau(DD) when activity onsets and acrophase were used as phase markers. The tau(DD) of activity offsets was more variable than onsets but also differed little between genotypes. Cycle variation and precision were not correlated with tau(DD) within any strain, and only weakly correlated when all strains are considered together. Only in animals homozygous for both mutations (super duper hamsters) were cycle variation and precision reduced. Rhythm amplitude differed between strains and was positively correlated with tau(DD) and precision. All genotypes showed negative correlations between alpha and rho. This confirms the expectation that deviations in the duration of subjective day and night should offset one another in order to conserve circadian period, even though homeostatic maintenance of energy reserves predicts that longer intervals of activity or rest would be followed by longer durations of rest or activity. Females consistently showed greater variability of the period of activity onset and acrophase, and of alpha, but variability of the period of offset differed between sexes only in super duper hamsters. Despite the differences between genotypes in tau(DD), rho was consistently more strongly correlated with the preceding than the succeeding alpha.	[Bittman, Eric L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Bittman, Eric L.] Univ Massachusetts, Neurosci & Behav Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Bittman, EL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	elb@bio.umass.edu			National Institute of Mental Health [RO1MH70019]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070019] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the National Institute of Mental Health award RO1MH70019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschoff J, 1971, P3; Daan S., 2002, P24; Daan S, 2003, CHRONOBIOL INT, V20, P209, DOI 10.1081/CBI-120019309; Dey J, 2005, J BIOL RHYTHM, V20, P99, DOI 10.1177/0748730404274264; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; FITZGERALD KM, 1976, P NATL ACAD SCI USA, V73, P2923, DOI 10.1073/pnas.73.8.2923; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Hague JFE, 2003, PHYSIOL BEHAV, V78, P261, DOI 10.1016/S0031-9384(02)00975-7; Houben T, 2009, J BIOL RHYTHM, V24, P477, DOI 10.1177/0748730409349895; Karatsoreos IN, 2007, ENDOCRINOLOGY, V148, P5487, DOI 10.1210/en.2007-0775; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Krug S, 2011, J BIOL RHYTHM, V26, P293, DOI 10.1177/0748730411411570; Kunz H, 2003, J THEOR BIOL, V224, P63, DOI 10.1016/S0022-5193(03)00141-3; LAKINTHOMAS PL, 1985, GENETICS, V109, P49; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Monecke S, 2011, J BIOL RHYTHM, V26, P283, DOI 10.1177/0748730411411569; MORIN LP, 1977, SCIENCE, V196, P305, DOI 10.1126/science.557840; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oklejewicz M., 2001, THESIS U GRONNINGEN; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; PITTENDRIGH CS, 1973, P NATL ACAD SCI USA, V70, P2697, DOI 10.1073/pnas.70.9.2697; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Rothenfluh A, 2000, GENETICS, V156, P665; Sharma VK, 1999, NATURWISSENSCHAFTEN, V86, P333; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822; Taylor SR, 2008, IEEE T AUTOMAT CONTR, V53, P177, DOI 10.1109/TAC.2007.911364; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36119	10.1371/journal.pone.0036119	http://dx.doi.org/10.1371/journal.pone.0036119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615753	Green Published, gold			2022-12-27	WOS:000305336300007
J	Ban, JJ; Jung, KH; Chu, K; Lee, ST; Jeon, D; Park, KI; Moon, HJ; Kim, H; Kim, S; Lee, SK; Roh, JK				Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Jeon, Daejong; Park, Kyung-Il; Moon, Hye-Jin; Kim, Hyeyun; Kim, Sunghun; Lee, Sang Kun; Roh, Jae-Kyu			Profiles of Multidrug Resistance Protein-1 in the Peripheral Blood Mononuclear Cells of Patients with Refractory Epilepsy	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DRUG EFFLUX TRANSPORTERS; P-GLYCOPROTEIN ACTIVITY; MDR1 GENE-EXPRESSION; ENDOTHELIAL-CELLS; PHARMACORESISTANCE; TRANSCRIPTOME; LYMPHOCYTES; THERAPY; DISEASE	Background: About one third of patients with epilepsy become refractory to therapy despite receiving adequate medical treatment, possibly from multidrug resistance. P-glycoprotein, encoded by multidrug resistance protein-1 (MDR1) gene, at the blood brain barrier is considered as a major factor mediating drug efflux and contributing to resistance. Given that peripheral blood mononuclear cells (PBMNCs) express MDR1, we investigated a MDR1 status of PBMNCs in various subsets of epilepsy patients and demonstrated their association with clinical characteristics. Methodology/Principal Findings: Clinical and MDR1 data were collected from 140 patients with epilepsy, 30 healthy volunteers, and 20 control patients taking anti-epileptic drugs. PBMNCs were isolated, and basal MDR1 levels and MDR1 conformational change levels were measured by flow cytometry. MDR1 profiles were analyzed according to various clinical parameters, including seizure frequency and number of medications used in epilepsy patients. Epilepsy patients had a higher basal MDR1 level than non-epilepsy groups (p < 0.01). Among epilepsy patients, there is a tendency for higher seizure frequency group to have higher basal MDR1 level (p = 0.059). The MDR1 conformational change level was significantly higher in the high-medication-use group than the low-use group (p = 0.028). Basal MDR1 (OR = 1.16 [95% CI: 1.060-1.268]) and conformational change level (OR = 1.11 [95% CI: 1.02-1.20]) were independent predictors for seizure frequency and number of medications, respectively. Conclusions/Significance: The MDR1 profile of PBMNCs is associated with seizure frequency and medication conditions in patients with epilepsy.	[Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Moon, Hye-Jin; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Lab Neurotherapeut, Dept Neurol, Seoul 110744, South Korea; [Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Neurosci Res Inst SNUMRC, Program Neurosci, Seoul, South Korea; [Ban, Jae-Jun; Jung, Keun-Hwa; Chu, Kon; Lee, Soon-Tae; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Comprehens Epilepsy Ctr, Seoul 110744, South Korea; [Jeon, Daejong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Park, Kyung-Il] Inje Univ, Baik Hosp, Dept Neurol, Seoul, South Korea; [Kim, Hyeyun] Kwandong Univ, Myongji Hosp, Goyang, South Korea; [Kim, Sunghun] Gangwon Natl Univ, Coll Med, Chunchon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Korea Advanced Institute of Science & Technology (KAIST); Inje University; Catholic Kwandong University; Myongji Hospital; Kangwon National University	Ban, JJ (corresponding author), Seoul Natl Univ Hosp, Lab Neurotherapeut, Dept Neurol, Seoul 110744, South Korea.	stemcell.snu@gmail.com; sangkun2923@gmail.com	Lee, Sang Kun/J-5578-2012; Roh, Jae Kyu/J-5459-2012; Jeon, Daejong/C-1814-2011	Hess, Christopher/0000-0002-5132-5302; /0000-0002-8008-5539; Jeon, Daejong/0000-0002-6998-7603; Park, Kyung-Il/0000-0001-8064-6749; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	Ministry of Health and Welfare, Republic of Korea [A090538]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by the Ministry of Health and Welfare, Republic of Korea (A090538). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beleza P, 2009, EUR NEUROL, V62, P65, DOI 10.1159/000222775; Callaghan BC, 2007, ANN NEUROL, V62, P382, DOI 10.1002/ana.21166; Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s; Diaz-Borjon A, 2000, JOINT BONE SPINE, V67, P40; Dombrowski SM, 2001, EPILEPSIA, V42, P1501, DOI 10.1046/j.1528-1157.2001.12301.x; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4323, DOI 10.1021/bi001372n; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Grude P, 2002, TRANSPLANTATION, V73, P1824, DOI 10.1097/00007890-200206150-00021; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Karsten SL, 2011, NEUROSCI LETT, V497, P213, DOI 10.1016/j.neulet.2011.03.019; Kwan P, 2009, EPILEPSIA, V51; Langer O, 2007, EPILEPSIA, V48, P1774, DOI 10.1111/j.1528-1167.2007.01116.x; Lazarowski A, 2007, EPILEPSIA, V48, P140, DOI 10.1111/j.1528-1167.2007.01302.x; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lubberink M, 2007, J CEREBR BLOOD F MET, V27, P424, DOI 10.1038/sj.jcbfm.9600349; Luna-Tortos C, 2008, NEUROPHARMACOLOGY, V55, P1364, DOI 10.1016/j.neuropharm.2008.08.032; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Parfenova H, 2010, AM J PHYSIOL-HEART C, V298, pH1687, DOI 10.1152/ajpheart.00032.2010; Robey RW, 2008, MOL PHARMACOL, V73, P1343, DOI 10.1124/mol.108.046680; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Senent L, 1998, HAEMATOLOGICA, V83, P783; TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x; Tsujimura S, 2007, HISTOL HISTOPATHOL, V22, P465, DOI 10.14670/HH-22.465; Turriziani O, 2008, J MED VIROL, V80, P766, DOI 10.1002/jmv.21152; van Vliet EA, 2010, EPILEPSIA, V51, P362, DOI 10.1111/j.1528-1167.2009.02261.x; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; Zhang C, 2011, ADV DRUG DELIV REV; Zimprich F, 2004, NEUROLOGY, V63, P1087, DOI 10.1212/01.WNL.0000141021.42763.F6	30	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36985	10.1371/journal.pone.0036985	http://dx.doi.org/10.1371/journal.pone.0036985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606322	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400051
J	Hesselman, MC; Odoni, DI; Ryback, BM; de Groot, S; van Heck, RGA; Keijsers, J; Kolkman, P; Nieuwenhuijse, D; van Nuland, YM; Sebus, E; Spee, R; de Vries, H; Wapenaar, MT; Ingham, CJ; Schroen, K; dos Santos, VAPM; Spaans, SK; Hugenholtz, F; van Passel, MWJ				Hesselman, Matthijn C.; Odoni, Dorett I.; Ryback, Brendan M.; de Groot, Suzette; van Heck, Ruben G. A.; Keijsers, Jaap; Kolkman, Pim; Nieuwenhuijse, David; van Nuland, Youri M.; Sebus, Erik; Spee, Rob; de Vries, Hugo; Wapenaar, Marten T.; Ingham, Colin J.; Schroen, Karin; dos Santos, Vitor A. P. Martins; Spaans, Sebastiaan K.; Hugenholtz, Floor; van Passel, Mark W. J.			A Multi-Platform Flow Device for Microbial (Co-) Cultivation and Microscopic Analysis	PLOS ONE			English	Article							CULTURE; MICROORGANISMS; POPULATION; RESISTANCE; MEMBRANES; BACTERIA; CHAMBER; SUPPORT; ARRAYS	Novel microbial cultivation platforms are of increasing interest to researchers in academia and industry. The development of materials with specialized chemical and geometric properties has opened up new possibilities in the study of previously unculturable microorganisms and has facilitated the design of elegant, high-throughput experimental set-ups. Within the context of the international Genetically Engineered Machine (iGEM) competition, we set out to design, manufacture, and implement a flow device that can accommodate multiple growth platforms, that is, a silicon nitride based microsieve and a porous aluminium oxide based microdish. It provides control over (co-)culturing conditions similar to a chemostat, while allowing organisms to be observed microscopically. The device was designed to be affordable, reusable, and above all, versatile. To test its functionality and general utility, we performed multiple experiments with Escherichia coli cells harboring synthetic gene circuits and were able to quantitatively study emerging expression dynamics in real-time via fluorescence microscopy. Furthermore, we demonstrated that the device provides a unique environment for the cultivation of nematodes, suggesting that the device could also prove useful in microscopy studies of multicellular microorganisms.	[Hesselman, Matthijn C.; Odoni, Dorett I.; Ryback, Brendan M.; de Groot, Suzette; van Heck, Ruben G. A.; Keijsers, Jaap; Kolkman, Pim; Nieuwenhuijse, David; van Nuland, Youri M.; Sebus, Erik; Spee, Rob; de Vries, Hugo; Wapenaar, Marten T.; Spaans, Sebastiaan K.; Hugenholtz, Floor; van Passel, Mark W. J.] Wageningen Univ, Wageningen UR iGEM Team 2011, Wageningen, Netherlands; [Ingham, Colin J.] MicroDish BV, Utrecht, Netherlands; [Spaans, Sebastiaan K.; Hugenholtz, Floor] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Hugenholtz, Floor] Univ Amsterdam, Netherlands Consortium Syst Biol, Amsterdam, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Amsterdam	Hesselman, MC (corresponding author), Wageningen Univ, Wageningen UR iGEM Team 2011, Wageningen, Netherlands.	Mark.vanPassel@wur.nl	van Passel, Mark WJ/K-5698-2012; schroen, karin/B-9640-2008	schroen, karin/0000-0002-1713-3278; martins dos santos, vitor/0000-0002-2352-9017; Hugenholtz, Floor/0000-0001-8173-197X; Van Heck, Ruben/0000-0001-6787-6830; Odoni, Dorett/0000-0001-9085-3899	Netherlands Organization for Scientific Research (NWO) via a VENI grant; Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative; NWO; MicroDish BV; Aquamarijn; Olympus	Netherlands Organization for Scientific Research (NWO) via a VENI grant; Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative; NWO(Netherlands Organization for Scientific Research (NWO)); MicroDish BV; Aquamarijn; Olympus	MWJvP is funded by the Netherlands Organization for Scientific Research (NWO) via a VENI grant. FH is funded by the Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative and the NWO. The Wageningen UR iGEM team has received general sponsorship in kind from MicroDish BV (cultivation chips), Aquamarijn (microsieves), and Olympus (a 20x microscope objective). Aquamarijn and Olympus had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Microdish had no role in the study design, data collection or decision to publish. CJI (Microdish) has contributed to our experimental set-up, data interpretation, and preparation of the manuscript.	Aoi Y, 2009, APPL ENVIRON MICROB, V75, P3826, DOI 10.1128/AEM.02542-08; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Brans G, 2006, J MEMBRANE SCI, V278, P344, DOI 10.1016/j.memsci.2005.11.018; Carr JA, 2011, LAB CHIP, V11, P2385, DOI 10.1039/c1lc20170k; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Girones M, 2005, J MEMBRANE SCI, V259, P55, DOI 10.1016/j.memsci.2005.03.006; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Ingham CJ, 2008, INT J TUBERC LUNG D, V12, P645; Ingham C, 2010, LAB CHIP, V10, P1410, DOI 10.1039/b925796a; Ingham CJ, 2007, P NATL ACAD SCI USA, V104, P18217, DOI 10.1073/pnas.0701693104; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Ingham CJ, 2012, BIOTECHNOL ADV, V30, P1089, DOI 10.1016/j.biotechadv.2011.08.005; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Krajniak J, 2010, LAB CHIP, V10, P1862, DOI 10.1039/c001986k; Kuiper S, 2002, J MEMBRANE SCI, V196, P149, DOI 10.1016/S0376-7388(01)00552-X; Kuiper S, 1998, J MEMBRANE SCI, V150, P1, DOI 10.1016/S0376-7388(98)00197-5; Leong TG, 2008, LAB CHIP, V8, P1621, DOI 10.1039/b809098j; Lindstrom S, 2009, ELECTROPHORESIS, V30, P4166, DOI 10.1002/elps.200900572; Melamed S, 2011, LAB CHIP, V11, P139, DOI [10.1039/c0lc00243g, 10.1039/c01c00243g]; Mondragon-Palomino O, 2011, SCIENCE, V333, P1315, DOI 10.1126/science.1205369; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smolke CD, 2009, NAT BIOTECHNOL, V27, P1099, DOI 10.1038/nbt1209-1099; van Rijn CJM, 1998, NANOTECHNOLOGY, V9, P343, DOI 10.1088/0957-4484/9/4/007; Vinuselvi P, 2011, INT J MOL SCI, V12, P3576, DOI 10.3390/ijms12063576; Xu LP, 2007, NANO LETT, V7, P2068, DOI 10.1021/nl070983z; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	28	27	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36982	10.1371/journal.pone.0036982	http://dx.doi.org/10.1371/journal.pone.0036982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606321	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400050
J	Ciacci, C; Canonico, B; Bilanicova, D; Fabbri, R; Cortese, K; Gallo, G; Marcomini, A; Pojana, G; Canesi, L				Ciacci, Caterina; Canonico, Barbara; Bilanicova, Dagmar; Fabbri, Rita; Cortese, Katia; Gallo, Gabriella; Marcomini, Antonio; Pojana, Giulio; Canesi, Laura			Immunomodulation by Different Types of N-Oxides in the Hemocytes of Marine Bivalve Mytilus galloprovincialis	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; OXIDATIVE STRESS; IMMUNE-SYSTEM; TOXICITY; NANOMATERIALS; IMMUNOTOXICITY; INVERTEBRATES; CYTOTOXICITY; ECOTOXICITY; RESPONSES	The potential toxicity of engineered nanoparticles (NPs) for humans and the environment represents an emerging issue. Since the aquatic environment represents the ultimate sink for NP deposition, the development of suitable assays is needed to evaluate the potential impact of NPs on aquatic biota. The immune system is a sensitive target for NPs, and conservation of innate immunity represents an useful basis for studying common biological responses to NPs. Suspension-feeding invertebrates, such as bivalves, are particularly at risk to NP exposure, since they have extremely developed systems for uptake of nano and microscale particles integral to intracellular digestion and cellular immunity. Evaluation of the effects of NPs on functional parameters of bivalve immunocytes, the hemocytes, may help understanding the major toxic mechanisms and modes of actions that could be relevant for different NP types in aquatic organisms. In this work, a battery of assays was applied to the hemocytes of the marine bivalve Mytilus galloprovincialis to compare the in vitro effects of different n-oxides (n-TiO2, n-SiO2, n-ZnO, n-CeO2) chosen on the basis of their commercial and environmental relevance. Physico-chemical characterization of both primary particles and NP suspensions in artificial sea water-ASW was performed. Hemocyte lysosomal and mitochondrial parameters, oxyradical and nitric oxide production, phagocytic activity, as well as NP uptake, were evaluated. The results show that different n-oxides rapidly elicited differential responses hemocytes in relation to their chemical properties, concentration, behavior in sea water, and interactions with subcellular compartments. These represent the most extensive data so far available on the effects of NPs in the cells of aquatic organisms. The results indicate that Mytilus hemocytes can be utilized as a suitable model for screening the potential effects of NPs in the cells of aquatic invertebrates, and may provide a basis for future experimental work for designing environmentally safer nanomaterials.	[Ciacci, Caterina; Canonico, Barbara] Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente DISUAN, Urbino, Italy; [Bilanicova, Dagmar; Marcomini, Antonio; Pojana, Giulio] Univ Ca Foscari Venezia, Dipartimento Sci Ambientali Informat & Stat, Venice, Italy; [Fabbri, Rita; Gallo, Gabriella; Canesi, Laura] Univ Genoa, DISTAV, Dipartimento Sci Terra Ambiente & Vita, Genoa, Italy; [Cortese, Katia] Univ Genoa, Dipartimento Med Sperimentale DIMES, Genoa, Italy	University of Urbino; Universita Ca Foscari Venezia; University of Genoa; University of Genoa	Ciacci, C (corresponding author), Univ Urbino Carlo Bo, Dipartimento Sci Terra Vita & Ambiente DISUAN, Urbino, Italy.	Laura.Canesi@unige.it	Ciacci, Caterina/H-1004-2012; Cortese, Katia/AAC-2990-2021	Canesi, Laura/0000-0003-2061-3819; Canonico, Barbara/0000-0003-3383-715X; Cortese, Katia/0000-0001-9218-8933	Italian Ministry of Research (PRIN) [prot. 2009FHHP2W_002]; Fondi Ateneo, University of Genoa	Italian Ministry of Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondi Ateneo, University of Genoa	Funding was provided by the Italian Ministry of Research (PRIN2009) prot. 2009FHHP2W_002, http://prin.miur.it, and Fondi Ateneo 2008, University of Genoa, http://www.unige.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; ASTM International, 2004, STANDARD GUIDE CONDU, P724; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Blaise C, 2008, ENVIRON TOXICOL, V23, P591, DOI 10.1002/tox.20402; Borm PJA, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-11; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Canesi L, 2006, ISJ-INVERT SURVIV J, V3, P40; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Canesi L, 2010, AQUAT TOXICOL, V100, P168, DOI 10.1016/j.aquatox.2010.04.009; Canesi L, 2008, ENVIRON INT, V34, P1114, DOI 10.1016/j.envint.2008.04.002; Canesi L, 2012, MAR ENVIRON RES, V76, P16, DOI 10.1016/j.marenvres.2011.06.005; Canesi L, 2010, AQUAT TOXICOL, V96, P151, DOI 10.1016/j.aquatox.2009.10.017; Cassee FR, 2011, CRIT REV TOXICOL, V41, P213, DOI 10.3109/10408444.2010.529105; CHU FLE, 1989, J INVERTEBR PATHOL, V54, P224, DOI 10.1016/0022-2011(89)90032-3; Crane M, 2008, ECOTOXICOLOGY, V17, P421, DOI 10.1007/s10646-008-0215-z; Dabrunz A, 2011, PLOS ONE; Dhawan A, 2010, ANAL BIOANAL CHEM, V398, P589, DOI 10.1007/s00216-010-3996-x; Dwivedi PD, 2009, NANOTOXICOLOGY, V3, P19, DOI 10.1080/17435390802604276; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Gagne F, 2008, AQUAT TOXICOL, V86, P333, DOI 10.1016/j.aquatox.2007.11.013; Garcia-Garcia E, 2008, DEV COMP IMMUNOL, V32, P637, DOI 10.1016/j.dci.2007.10.004; Gottschalk F, 2011, J ENVIRON MONITOR, V13, P1145, DOI 10.1039/c0em00547a; Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706; Kaloyianni M, 2006, COMP BIOCHEM PHYS C, V144, P93, DOI 10.1016/j.cbpc.2006.07.001; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lowe DM, 1995, MAR ECOL PROG SER, V129, P189, DOI 10.3354/meps129189; Miller RJ, 2012, PLOS ONE; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Moore MN, 2006, ENVIRON INT, V32, P967, DOI 10.1016/j.envint.2006.06.014; Moore MN, 2009, NANOTOXICOLOGY, V3, P40, DOI 10.1080/17435390802593057; Muller KH, 2010, ACS NANO, V4, P6767, DOI 10.1021/nn101192z; Oostingh GJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-8; Pfaller T, 2010, NANOTOXICOLOGY, V4, P52, DOI 10.3109/17435390903374001; Pipe Richard K., 1995, Fish Immunology Technical Communications, V4, P93; Robichaud CO, 2009, ENVIRON SCI TECHNOL, V43, P4227, DOI 10.1021/es8032549; Rodea-Palomares I, 2011, TOXICOL SCI, V119, P135, DOI 10.1093/toxsci/kfq311; Sandra F, 2005, CANCER RES, V65, P8286, DOI 10.1158/0008-5472.CAN-04-1913; Sauve S, 2002, AQUAT TOXICOL, V58, P189, DOI 10.1016/S0166-445X(01)00232-6; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Singh S, 2010, MOL BIOSYST, V6, P1813, DOI 10.1039/c0mb00014k; Soderhall K, 2010, ADV EXP MED BIOL, V708, P1, DOI 10.1007/978-1-4419-8059-5; Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z; Xia T, 2008, ACS NANO, V2, P2121, DOI 10.1021/nn800511k; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	44	106	106	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36937	10.1371/journal.pone.0036937	http://dx.doi.org/10.1371/journal.pone.0036937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606310	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200057
J	Koulmanda, M; Bhasin, M; Awdeh, Z; Qipo, AD; Fan, ZG; Hanidziar, D; Putheti, P; Shi, H; Csizuadia, E; Libermann, TA; Strom, TB				Koulmanda, Maria; Bhasin, Manoj; Awdeh, Zuheir; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Shi, Hang; Csizuadia, Eva; Libermann, Towia A.; Strom, Terry B.			The Role of TNF-alpha in Mice with Type 1-and 2-Diabetes	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; NECROSIS-FACTOR-ALPHA; NOD MICE; BIOCONDUCTOR PACKAGE; T-CELLS; THERAPY; MOUSE; AUTOIMMUNITY; PROGRESSION; TOLERANCE	Background: Previously, we have demonstrated that short-term treatment of new onset diabetic Non-obese diabetic (NOD) mice, mice that are afflicted with both type 1 (T1D) and type 2 (T2D) diabetes with either Power Mix (PM) regimen or alpha1 antitrypsin (AAT) permanently restores euglycemia, immune tolerance to self-islets and normal insulin signaling. Methodology and Principal Findings: To search for relevant therapeutic targets, we have applied genome wide transcriptional profiling and systems biology oriented bioinformatics analysis to examine the impact of the PM and AAT regimens upon pancreatic lymph node (PLN) and fat, a crucial tissue for insulin dependent glucose disposal, in new onset diabetic non-obese diabetic (NOD) mice. Systems biology analysis identified tumor necrosis factor alpha (TNF-alpha) as the top focus gene hub, as determined by the highest degree of connectivity, in both tissues. In PLNs and fat, TNF-alpha interacted with 53% and 32% of genes, respectively, associated with reversal of diabetes by previous treatments and was thereby selected as a therapeutic target. Short-term anti-TNF-alpha treatment ablated a T cell-rich islet-invasive and beta cell-destructive process, thereby enhancing beta cell viability. Indeed anti-TNF-alpha treatment induces immune tolerance selective to syngeneic beta cells. In addition to these curative effects on T1D anti-TNF-alpha treatment restored in vivo insulin signaling resulting in restoration of insulin sensitivity. Conclusions: In short, our molecular analysis suggested that PM and AAT both may act in part by quenching a detrimental TNF-alpha dependent effect in both fat and PLNs. Indeed, short-term anti-TNF-alpha mAb treatment restored enduring euglycemia, self-tolerance, and normal insulin signaling.	[Koulmanda, Maria; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Csizuadia, Eva; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Transplant Inst, Boston, MA 02215 USA; [Koulmanda, Maria; Qipo, Andi; Fan, Zhigang; Hanidziar, Dusan; Putheti, Prabhakar; Csizuadia, Eva; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Bhasin, Manoj; Libermann, Towia A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, BIDMC Genom & Prote Ctr,Med Sch, Boston, MA 02215 USA; [Awdeh, Zuheir] Pulsar Clin Technol Inc, Cambridge, MA USA; [Shi, Hang] Wake Forest Hlth Sci, Dept Internal Med, Winston Salem, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Wake Forest University	Koulmanda, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Transplant Inst, Boston, MA 02215 USA.	mkoulman@bidmc.harvard.edu; tstrom@bidmc.harvard.edu	Hanidziar, Dusan/AAM-3187-2020	Bhasin, Manoj/0000-0001-5172-420X; Libermann, Towia/0000-0002-4006-8179	Juvenile Diabetes Research Foundation; National Institutes of Health (NIH) [JDRF 402004-368 NIH, NIH RO1 AI54976, NIH RO1 DK067632, NIH PO1 AI041521, NIH NIH R37 DK 28082, NIH DK44523, DK 66056]; Medical Research Council [MR/J006742/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054976, P01AI041521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067632, R37DK028082, R01DK044523, R01DK066056] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded both by the Juvenile Diabetes Research Foundation and National Institutes of Health (NIH). Juvenile Diabetes Research Foundation: TS, MK, ZF: JDRF 402004-368 NIH: MK, BH, AQ: NIH RO1 AI54976; MK, TS: NIH RO1 DK067632: TS, PP: NIH PO1 AI041521; JSF, HS: NIH NIH R37 DK 28082: SBW: NIH DK44523 and DK 66056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Ban LQ, 2008, P NATL ACAD SCI USA, V105, P13644, DOI 10.1073/pnas.0803429105; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; Feldmann M, 2009, ANNU REV IMMUNOL, V27, P1, DOI 10.1146/annurev-immunol-082708-100732; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; LEE KU, 1988, DIABETES, V37, P989, DOI 10.2337/diabetes.37.7.989; Mastrandrea L, 2009, DIABETES CARE, V32, P1244, DOI 10.2337/dc09-0054; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; YANG XD, 1994, J EXP MED, V180, P995, DOI 10.1084/jem.180.3.995	27	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33254	10.1371/journal.pone.0033254	http://dx.doi.org/10.1371/journal.pone.0033254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606220	Green Published, gold			2022-12-27	WOS:000305338200002
J	Manske, SL; Good, CA; Zernicke, RF; Boyd, SK				Manske, Sarah L.; Good, Craig A.; Zernicke, Ronald F.; Boyd, Steven K.			High-Frequency, Low-Magnitude Vibration Does Not Prevent Bone Loss Resulting from Muscle Disuse in Mice following Botulinum Toxin Injection	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; MECHANICAL SIGNALS; LOW-LEVEL; MEDIAL GASTROCNEMIUS; POSTMENOPAUSAL WOMEN; INBRED STRAINS; STRENGTH; DENSITY; MASS; ENHANCE	High-frequency, low-magnitude vibration enhances bone formation ostensibly by mimicking normal postural muscle activity. We tested this hypothesis by examining whether daily exposure to low-magnitude vibration (VIB) would maintain bone in a muscle disuse model with botulinum toxin type A (BTX). Female 16-18 wk old BALB/c mice (N = 36) were assigned to BTX-VIB, BTX-SHAM, VIB, or SHAM. BTX mice were injected with BTX (20 mu L; 1 U/100 g body mass) into the left hindlimb posterior musculature. All mice were anaesthetized for 20 min/d, 5 d/wk, for 3 wk, and the left leg mounted to a holder. Through the holder, VIB mice received 45 Hz, =0.6 g sinusoidal acceleration without weight bearing. SHAM mice received no vibration. At baseline and 3 wk, muscle cross-sectional area (MCSA) and tibial bone properties (epiphysis, metaphysis and diaphysis) were assessed by in vivo micro-CT. Bone volume fraction in the metaphysis decreased 12 +/- 9% and 7 +/- 6% in BTX-VIB and BTX-SHAM, but increased in the VIB and SHAM. There were no differences in dynamic histomorphometry outcomes between BTX-VIB and BTX nor between VIB and SHAM. Thus, vibration did not prevent bone loss induced by a rapid decline in muscle activity nor produce an anabolic effect in normal mice. The daily loading duration was shorter than would be expected from postural muscle activity, and may have been insufficient to prevent bone loss. Based on the approach used in this study, vibration does not prevent bone loss in the absence of muscle activity induced by BTX.	[Manske, Sarah L.; Zernicke, Ronald F.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Manske, Sarah L.; Good, Craig A.; Boyd, Steven K.] Univ Calgary, Schulich Sch Engn, Calgary, AB, Canada; [Zernicke, Ronald F.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Zernicke, Ronald F.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Zernicke, Ronald F.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Zernicke, Ronald F.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Calgary; University of Calgary; University of Calgary; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Manske, SL (corresponding author), Univ Calgary, Fac Kinesiol, Calgary, AB, Canada.	zernicke@umich.edu	Boyd, Steven K/E-9595-2010; Manske, Sarah/B-5920-2011; Manske, Sarah/AAF-6917-2020	Boyd, Steven K/0000-0002-2930-5997; Manske, Sarah/0000-0003-0888-9556; Manske, Sarah/0000-0003-0888-9556	Natural Sciences and Engineering Research Council of Canada (NSERC); Alberta Innovates - Health Solutions; Killam Trust	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates - Health Solutions; Killam Trust	Sarah L. Manske was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/), Alberta Innovates - Health Solutions, and the Killam Trust. Steven K. Boyd is a Senior Scholar supported by Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca/). Neither funder is a profit-making organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD EK, 1987, EXP NEUROL, V96, P635, DOI 10.1016/0014-4886(87)90225-1; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Belavy DL, 2009, J MUSCULOSKEL NEURON, V9, P225; Bemben DA, 2010, BONE, V47, P650, DOI 10.1016/j.bone.2010.06.019; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brouwers JEM, 2010, J ORTHOP RES, V28, P62, DOI 10.1002/jor.20951; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Christiansen BA, 2009, BONE, V45, P750, DOI 10.1016/j.bone.2009.06.025; Eleopra R, 1997, MOVEMENT DISORD, V12, P89, DOI 10.1002/mds.870120115; Fritton SP, 2000, J BIOMECH, V33, P317, DOI 10.1016/S0021-9290(99)00210-9; Garman R, 2007, J ORTHOP RES; Garman R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000653; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Huang RP, 1999, J GERONTOL A-BIOL, V54, pB352, DOI 10.1093/gerona/54.8.B352; JANKOVICH JP, 1972, J BIOMECH, V5, P241, DOI 10.1016/0021-9290(72)90038-3; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2005, J CELL BIOCHEM, V94, P982, DOI 10.1002/jcb.20363; Judex S, 2010, J MUSCULOSKEL NEURON, V10, P3; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kang BS, 2007, AM J PHYS MED REHAB, V86, P901, DOI 10.1097/PHM.0b013e3181520449; Kim HS, 2003, DEV MED CHILD NEUROL, V45, P200, DOI 10.1017/S0012162203000380; Lau E, 2010, BONE, V46, P1508, DOI 10.1016/j.bone.2010.02.031; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Manske SL, 2011, J BIOMECH, V44, P637, DOI 10.1016/j.jbiomech.2010.11.011; Manske SL, 2010, CALCIFIED TISSUE INT, V87, P541, DOI 10.1007/s00223-010-9428-2; Manske SL, 2010, BONE, V46, P24, DOI 10.1016/j.bone.2009.10.016; Manske SL, J BIOMECH UNPUB; Misiaszek JE, 2002, J NEUROPHYSIOL, V87, P229, DOI 10.1152/jn.00410.2001; MONSTER AW, 1977, J NEUROPHYSIOL, V40, P1432, DOI 10.1152/jn.1977.40.6.1432; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; ORIZIO C, 1990, J APPL PHYSIOL, V68, P508, DOI 10.1152/jappl.1990.68.2.508; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ozcivici E, 2007, J BIOMECH, V40, P3404, DOI 10.1016/j.jbiomech.2007.05.015; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Poliachik SL, 2010, BONE, V46, P18, DOI 10.1016/j.bone.2009.10.025; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Robling AG, 2009, MED SCI SPORT EXER, V41, P2044, DOI 10.1249/MSS.0b013e3181a8c702; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; RUBIN CT, 1994, CLIN ORTHOP RELAT R, P165; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Russo CR, 2003, ARCH PHYS MED REHAB, V84, P1854, DOI 10.1016/S0003-9993(03)00357-5; Slatkovska L, 2010, J BONE MINER RES; Slatkovska L, 2011, ANN INTERN MED, V155, P668, DOI 10.7326/0003-4819-155-10-201111150-00005; Tabachnick B.G., 2007, EXPT DESIGNS USING A; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; WALMSLEY B, 1978, J NEUROPHYSIOL, V41, P1203, DOI 10.1152/jn.1978.41.5.1203; Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009; Warner SE, 2006, RANKL INHIBITION PRE; Xie LQ, 2008, J APPL PHYSIOL, V104, P1056, DOI 10.1152/japplphysiol.00764.2007; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012	65	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36486	10.1371/journal.pone.0036486	http://dx.doi.org/10.1371/journal.pone.0036486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590551	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400018
J	Yang, FS; Qin, AL; Li, YF; Wang, XQ				Yang, Fu-Sheng; Qin, Ai-Li; Li, Yu-Fei; Wang, Xiao-Quan			Great Genetic Differentiation among Populations of Meconopsis integrifolia and Its Implication for Plant Speciation in the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							HABITAT FRAGMENTATION; PHYLOGENETIC INFERENCE; QUATERNARY CLIMATE; ADJACENT REGIONS; CHLOROPLAST DNA; UPLIFT; PHYLOGEOGRAPHY; CONSEQUENCES; CHINA; DIVERGENCE	The complex tectonic events and climatic oscillations in the Qinghai-Tibetan Plateau (QTP), the largest and highest plateau in the world, are thought to have had great effects on the evolutionary history of the native plants. Of great interest is to investigate plant population genetic divergence in the QTP and its correlation with the geologic and climatic changes. We conducted a range-wide phylogeographical analysis of M. integrifolia based on the chloroplast DNA (cpDNA) trnL-trnF and trnfM-trnS regions, and defined 26 haplotypes that were phylogenetically divided into six clades dated to the late Tertiary. The six clades correspond, respectively, to highly differentiated population groups that do not overlap in geographic distribution, implying that the mountain ranges acting as corridors or barriers greatly affected the evolutionary history of the QTP plants. The older clade of M. integrifolia only occurs in the southwest of the species' range, whereas the distributions of younger clades extend northeastward in the eastern QTP, suggesting that climatic divergence resulting from the uplift of the QTP triggered the initial divergence of M. integrifolia native to the plateau. Also, the nrDNA ITS region was used to clarify the unexpected phylogenetic relationships of cpDNA haplotypes between M. integrifolia and M. betonicifolia. The topological incongruence between the two phylogenies suggests an ancestral hybridization between the two species. Our study indicates that geographic isolation and hybridization are two important mechanisms responsible for the population differentiation and speciation of Meconopsis, a species-rich genus with complex polyploids.	[Yang, Fu-Sheng; Qin, Ai-Li; Li, Yu-Fei; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Yang, FS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yang_fsh@ibcas.ac.cn; xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [30730010]; National Basic Research Program of China [2007CB411602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Grant No. 30730010) and the National Basic Research Program of China (Grant No. 2007CB411602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; CARSON HL, 1990, TRENDS ECOL EVOL, V5, P228, DOI 10.1016/0169-5347(90)90137-3; CHANG DHS, 1983, ANN MO BOT GARD, V70, P564, DOI 10.2307/2992087; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Grant V., 1981, PLANT SPECIATION; Hall T.A., 1999, BIOEDIT USER FRIENDL; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Nylander JAA., 2004, BIOINFORMATICS; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Prain D, 1906, ANN BOT-LONDON, V20, P323, DOI 10.1093/oxfordjournals.aob.a089107; Qian H, 2003, J BIOGEOGR, V30, P129, DOI 10.1046/j.1365-2699.2003.00807.x; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Rambaut A., 2009, TRACER VERSION 1 5; Rambaut A., 2009, FIGTREE VERSION 1 3; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAYLOR G, 1934, ACCOUNT GENUS MECONO; TEMPLETON AR, 1990, ANN MO BOT GARD, V77, P13, DOI 10.2307/2399621; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valtuena FJ, 2012, MOL ECOL, V21, P1423, DOI 10.1111/j.1365-294X.2012.05473.x; WALLACE RB, 1981, GENE, V16, P21, DOI 10.1016/0378-1119(81)90057-3; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025896; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WU C-Y, 1980, Acta Botanica Yunnanica, V2, P371; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Ying M, 2006, CARYOLOGIA, V59, P1; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang ML, 2008, FLORA CHINA, V7, P262; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002	53	73	79	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37196	10.1371/journal.pone.0037196	http://dx.doi.org/10.1371/journal.pone.0037196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590654	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400063
J	Armstrong, NJ; Fagotto, F; Prothmann, C; Rupp, RAW				Armstrong, Neil J.; Fagotto, Francois; Prothmann, Christian; Rupp, Ralph A. W.			Maternal Wnt/beta-Catenin Signaling Coactivates Transcription through NF-kappa B Binding Sites during Xenopus Axis Formation	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; BETA-CATENIN; SPEMANN ORGANIZER; NEURAL INDUCTION; GENE-EXPRESSION; LAEVIS EMBRYOS; ACTIVE REPRESSION; DROSOPHILA EMBRYO; ACTIVATION; PROTEIN	Maternal Wnt/beta-Catenin signaling establishes a program of dorsal-specific gene expression required for axial patterning in Xenopus. We previously reported that a subset of dorsally expressed genes depends not only on Wnt/beta-Catenin stimulation, but also on a MyD88-dependent Toll-like receptor/IL1-receptor (TLR/IL1-R) signaling pathway. Here we show that these two signal transduction cascades converge in the nucleus to coactivate gene transcription in blastulae through a direct interaction between beta-Catenin and NF-kappa B proteins. A transdominant inhibitor of NF-kappa B, Delta NI kappa B alpha, phenocopies loss of MyD88 protein function, implicating Rel/NF-kappa B proteins as selective activators of dorsal-specific gene expression. Sensitive axis formation assays in the embryo demonstrate that dorsalization by Wnt/beta-Catenin requires NF-kappa B protein activity, and vice versa. Xenopus nodal-related 3 (Xnr3) is one of the genes with dual beta-Catenin/NF-kappa B input, and a proximal NF-kappa B consensus site contributes to the regional activity of its promoter. We demonstrate in vitro binding of Xenopus beta-Catenin to several XRel proteins. This interaction is observed in vivo upon Wnt-stimulation. Finally, we show that a synthetic luciferase reporter gene responds to both endogenous and exogenous beta-Catenin levels in an NF-kappa B motif dependent manner. These results suggest that beta-Catenin acts as a transcriptional co-activator of NF-kappa B-dependent transcription in frog primary embryonic cells.	[Armstrong, Neil J.; Prothmann, Christian; Rupp, Ralph A. W.] Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, Munich, Germany; [Fagotto, Francois] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Munich; McGill University	Armstrong, NJ (corresponding author), DNALogic Ltd, Dept Evolutionary Algorithms, Stockton Brook, Staffs, England.	ralph.rupp@med.uni-muenchen.de	Fagotto, Francois/AAA-9983-2021	Fagotto, Francois/0000-0002-1495-2112; rupp, ralph/0000-0002-8068-9957	Deutsche Forschungsgemeinschaft [SPP1027, Ru448/3-3]; Canadian Cancer Research Society; CCSRI [017162]; Cancer Research Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Cancer Research Society; CCSRI; Cancer Research Society	RR received support from the Deutsche Forschungsgemeinschaft (SPP1027/project Ru448/3-3). FF was supported by the Canadian Cancer Research Society and by CCSRI grant #017162. FF was partly supported by a Cancer Research Society Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Armstrong NJ, 1998, MECH DEVELOP, V71, P99, DOI 10.1016/S0925-4773(98)00003-3; BEARER EL, 1994, EUR J CELL BIOL, V63, P255; Bushdid PB, 1998, NATURE, V392, P615, DOI 10.1038/33435; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Combriato G, 2002, J IMMUNOL, V168, P1259, DOI 10.4049/jimmunol.168.3.1259; Correa RG, 2004, MOL CELL BIOL, V24, P5257, DOI 10.1128/MCB.24.12.5257-5268.2004; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; DEMARAIS AA, 1992, DEV BIOL, V153, P337, DOI 10.1016/0012-1606(92)90118-Z; Deng J, 2004, MOL CARCINOGEN, V39, P139, DOI 10.1002/mc.10169; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; DOMINGUEZ I, 1993, MOL CELL BIOL, V13, P1290, DOI 10.1128/MCB.13.2.1290; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hansen CS, 1997, DEVELOPMENT, V124, P483; Haramoto Y, 2004, DEV BIOL, V265, P155, DOI 10.1016/j.ydbio.2003.09.015; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Houston DW, 2002, DEVELOPMENT, V129, P4015; Ishii A, 2007, IMMUNOGENETICS, V59, P281, DOI 10.1007/s00251-007-0193-y; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; KAO KR, 1991, P NATL ACAD SCI USA, V88, P2697, DOI 10.1073/pnas.88.7.2697; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kurth T, 1999, DEV DYNAM, V215, P155, DOI 10.1002/(SICI)1097-0177(199906)215:2<155::AID-DVDY8>3.0.CO;2-S; Laurent MN, 1997, DEVELOPMENT, V124, P4905; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Li QT, 2000, GENE DEV, V14, P1729; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; NIEHRS C, 1994, SCIENCE, V263, P817, DOI 10.1126/science.7905664; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; Prothmann C, 2000, MECH DEVELOP, V97, P85, DOI 10.1016/S0925-4773(00)00447-0; RICHARDSON JC, 1994, MECH DEVELOP, V45, P173, DOI 10.1016/0925-4773(94)90031-0; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schohl A, 2002, DEVELOPMENT, V129, P37; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH WC, 1995, CELL, V82, P37, DOI 10.1016/0092-8674(95)90050-0; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Steinbach OC, 1999, METH MOL B, V127, P41, DOI 10.1385/1-59259-678-9:41; Stoetzel C, 1998, INT J DEV BIOL, V42, P747; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Suzuki K, 1998, GENE, V206, P1, DOI 10.1016/S0378-1119(97)00561-1; SUZUKI K, 1995, NUCLEIC ACIDS RES, V23, P4664, DOI 10.1093/nar/23.22.4664; TANNAHILL D, 1995, INT J DEV BIOL, V39, P549; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; VODICKA MA, 1995, DEVELOPMENT, V121, P3505; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150; Yang SS, 1998, J BIOL CHEM, V273, P13746, DOI 10.1074/jbc.273.22.13746; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	70	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36136	10.1371/journal.pone.0036136	http://dx.doi.org/10.1371/journal.pone.0036136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590521	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336100019
J	Okuda, H; Tsujimura, A; Irie, S; Yamamoto, K; Fukuhara, S; Matsuoka, Y; Takao, T; Miyagawa, Y; Nonomura, N; Wada, M; Tanaka, H				Okuda, Hidenobu; Tsujimura, Akira; Irie, Shinji; Yamamoto, Keisuke; Fukuhara, Shinichiro; Matsuoka, Yasuhiro; Takao, Tetsuya; Miyagawa, Yasushi; Nonomura, Norio; Wada, Morimasa; Tanaka, Hiromitsu			A Single Nucleotide Polymorphism within the Novel Sex-Linked Testis-Specific Retrotransposed PGAM4 Gene Influences Human Male Fertility	PLOS ONE			English	Article							FIBROUS SHEATH; MALE GERMLINE; SUCCINYL-COA; PHOSPHOGLYCERATE; EVOLUTION; ISOZYMES; CLONING; ACID; SPERMATOGENESIS; GLYCOLYSIS	Background: The development of novel fertilization treatments, including in vitro fertilization and intracytoplasmic injection, has made pregnancy possible regardless of the level of activity of the spermatozoa; however, the etiology of male-factor infertility is poorly understood. Multiple studies, primarily through the use of transgenic animals, have contributed to a list of candidate genes that may affect male infertility in humans. We examined single nucleotide polymorphisms (SNPs) as a cause of male infertility in an analysis of spermatogenesis-specific genes. Methods and Finding: We carried out the prevalence of SNPs in the coding region of phosphoglycerate mutase 4 (PGAM4) on the X chromosome by the direct sequencing of PCR-amplified DNA from male patients. Using RT-PCR and western blot analyses, we identified that PGAM4 is a functional retrogene that is expressed predominantly in the testes and is associated with male infertility. PGAM4 is expressed in post-meiotic stages, including spermatids and spermatozoa in the testes, and the principal piece of the flagellum and acrosome in ejaculated spermatozoa. A case-control study revealed that 4.5% of infertile patients carry the G75C polymorphism, which causes an amino acid substitution in the encoded protein. Furthermore, an assay for enzymatic activity demonstrated that this polymorphism decreases the enzyme's activity both in vitro and in vivo. Conclusion: These results suggest that PGAM4, an X-linked retrogene, is a fundamental gene in human male reproduction and may escape meiotic sex chromosome inactivation. These findings provide fresh insight into elucidating the mechanisms of male infertility.	[Okuda, Hidenobu; Tsujimura, Akira; Yamamoto, Keisuke; Fukuhara, Shinichiro; Matsuoka, Yasuhiro; Takao, Tetsuya; Miyagawa, Yasushi; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan; [Irie, Shinji] Toppan Printing Co Ltd, Toppan Tech Res Inst, Life Sci Res Lab, Chiyoda Ku, Tokyo, Japan; [Wada, Morimasa; Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Div Mol Biol, Sasebo, Nagasaki, Japan	Osaka University; Toppan Printing Co Ltd; Nagasaki International University	Okuda, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan.	h-tanaka@niu.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) of Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [22591810] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants for Research and Development to Promote the Creation and Utilization of an Intellectual Infrastructure from the New Energy and Industrial Technology Development Organization (NEDO) of Japan and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betran E, 2002, MOL BIOL EVOL, V19, P654, DOI 10.1093/oxfordjournals.molbev.a004124; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BROCENO C, 1995, EUR J BIOCHEM, V227, P629, DOI 10.1111/j.1432-1033.1995.tb20182.x; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; DIERICK HA, 1995, GENOMICS, V28, P462, DOI 10.1006/geno.1995.1175; Dierick HA, 1997, GENE, V198, P37, DOI 10.1016/S0378-1119(97)00289-8; Disteche CM, 2008, NAT GENET, V40, P689, DOI 10.1038/ng0608-689; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Feiden Sandra, 2007, Reproduction, V134, P81, DOI 10.1530/REP-06-0250; FUNDELE R, 1987, DEV BIOL, V124, P562, DOI 10.1016/0012-1606(87)90510-0; Gonsalves J, 2004, HUM MOL GENET, V13, P2875, DOI 10.1093/hmg/ddh302; Hendriksen PJM, 1997, GENOMICS, V41, P350, DOI 10.1006/geno.1997.4673; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Kamp G, 2007, REPRODUCTION, V133, P29, DOI 10.1530/REP-06-0082; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Koga M, 2000, BIOL REPROD, V63, P1601, DOI 10.1095/biolreprod63.6.1601; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; MCCARREY JR, 1990, NUCLEIC ACIDS RES, V18, P949, DOI 10.1093/nar/18.4.949; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Nakamura N, 2010, BIOL REPROD, V82, P504, DOI 10.1095/biolreprod.109.080580; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nishimune Y, 2006, J ANDROL, V27, P326, DOI 10.2164/jandrol.05162; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Tanaka H, 2002, MOL HUM REPROD, V8, P16, DOI 10.1093/molehr/8.1.16; Tanaka H, 1997, GENE, V204, P159, DOI 10.1016/S0378-1119(97)00537-4; Tanaka Hiromitsu, 2007, Reproductive Medicine and Biology, V6, P1, DOI 10.1111/j.1447-0578.2007.00158.x; Travis AJ, 1998, MOL BIOL CELL, V9, P263, DOI 10.1091/mbc.9.2.263; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Vemuganti SA, 2007, DEV BIOL, V309, P18, DOI 10.1016/j.ydbio.2007.06.010; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; World Health Organization, 1999, WHO LAB MAN EX HUM S; Zhang JX, 2001, GENE, V264, P273, DOI 10.1016/S0378-1119(00)00597-7	38	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35195	10.1371/journal.pone.0035195	http://dx.doi.org/10.1371/journal.pone.0035195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590500	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100006
J	Zhang, XB; Volpe, EA; Gandhi, NB; Schaumburg, CS; Siemasko, KF; Pangelinan, SB; Kelly, SD; Hayday, AC; Li, DQ; Stern, ME; Niederkorn, JY; Pflugfelder, SC; De Paiva, CS				Zhang, Xiaobo; Volpe, Eugene A.; Gandhi, Niral B.; Schaumburg, Chris S.; Siemasko, Karyn F.; Pangelinan, Solherny B.; Kelly, Scott D.; Hayday, Adrian C.; Li, De-Quan; Stern, Michael E.; Niederkorn, Jerry Y.; Pflugfelder, Stephen C.; De Paiva, Cintia S.			NK Cells Promote Th-17 Mediated Corneal Barrier Disruption in Dry Eye	PLOS ONE			English	Article							MUCOSA-SPECIFIC LYMPHOCYTES; NATURAL-KILLER-CELLS; DELTA-T-CELLS; EPITHELIAL-CELLS; DESICCATING STRESS; OCULAR SURFACE; LACRIMAL KERATOCONJUNCTIVITIS; SJOGRENS-SYNDROME; INTERFERON-GAMMA; DENDRITIC CELLS	Background: The conjunctiva contains a specialized population of lymphocytes that reside in the epithelium, named intraepithelial lymphocytes (IEL). Methodology/Principal Findings: Here we characterized the IEL population prior to and after experimental desiccating stress (DS) for 5 or 10 days (DS5, DS10) and evaluated the effect of NK depletion on DS. The frequency of IELs in normal murine conjunctiva was CD3(+)CD103(+) (similar to 22%), CD3(+)gamma delta(+) (similar to 9.6%), CD3(+)NK(+) (2%), CD3(+)NK(+) (similar to 4.4%), CD3(+)CD8 alpha (similar to 0.9%), and CD4 (similar to 0.6%). Systemic depletion of NK cells prior and during DS led to a decrease in the frequency of total and activated DCs, a decrease in T helper-17(+) cells in the cervical lymph nodes and generation of less pathogenic CD4(+)T cells. B6.nude recipient mice of adoptively transferred CD4(+)T cells isolated from NK-depleted DS5 donor mice showed significantly less corneal barrier disruption, lower levels of IL-17A, CCL20 and MMP-3 in the cornea epithelia compared to recipients of control CD4(+)T cells. Conclusions/Significance: Taken together, these results show that the NK IELs are involved in the acute immune response to desiccation-induced dry eye by activating DC, which in turn coordinate generation of the pathogenic Th-17 response.	[Zhang, Xiaobo; Volpe, Eugene A.; Gandhi, Niral B.; Pangelinan, Solherny B.; Kelly, Scott D.; Li, De-Quan; Stern, Michael E.; Pflugfelder, Stephen C.; De Paiva, Cintia S.] Baylor Coll Med, Ocular Surface Ctr, Dept Ophthalmol, Houston, TX 77030 USA; [Zhang, Xiaobo] Wenzhou Med Coll, Dept Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Schaumburg, Chris S.; Siemasko, Karyn F.; Stern, Michael E.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA USA; [Hayday, Adrian C.] Guys Hosp, Kings Coll London, Dept Immunobiol, London SE1 9RT, England; [Niederkorn, Jerry Y.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	Baylor College of Medicine; Wenzhou Medical University; AbbVie; Allergan; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, XB (corresponding author), Baylor Coll Med, Ocular Surface Ctr, Dept Ophthalmol, Houston, TX 77030 USA.	cintiadp@bcm.tmc.edu	De Paiva, Cintia/AAH-8354-2021; Volpe, Eugene A./D-2000-2012	De Paiva, Cintia/0000-0002-9057-5494; Volpe, Eugene A./0000-0002-9128-754X; HAYDAY, ADRIAN/0000-0002-9495-5793	National Institute of Health [EY018888, EY018090, EY11915, P30-EY002520]; Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE [R21EY018888, R01EY011915, P30EY002520, R01EY018090] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oshman Foundation; William Stamps Farish Fund; Hamill Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institute of Health Grants EY018888 (CSDP), EY018090 (SCP, MES, JYN) EY11915 (SCP), NIH Grant RPB, NIH Core Grant P30-EY002520, Oshman Foundation, William Stamps Farish Fund, Hamill Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CEPEK KL, 1993, J IMMUNOL, V150, P3459; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen YH, 2011, J LEUKOCYTE BIOL, V89, P965, DOI 10.1189/jlb.1110611; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; De Paiva CS, 2011, MUCOSAL IMMUNOL, V4, P397, DOI 10.1038/mi.2010.82; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; DUA HS, 1995, EYE, V9, P261, DOI 10.1038/eye.1995.51; DUA HS, 1994, CURR EYE RES, V13, P87, DOI 10.3109/02713689409042401; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hazlett LD, 2007, J IMMUNOL, V179, P1138, DOI 10.4049/jimmunol.179.2.1138; Hingorani M, 1997, EXP EYE RES, V64, P905, DOI 10.1006/exer.1996.0280; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Hornung M, 2006, EUR J IMMUNOL, V36, P1210, DOI 10.1002/eji.200535332; Huber S, 2002, J VIROL, V76, P6487, DOI 10.1128/JVI.76.13.6487-6494.2002; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jung S, 2009, BIOCHEM BIOPH RES CO, V390, P399, DOI 10.1016/j.bbrc.2009.09.008; KOO GC, 1986, J IMMUNOL, V137, P3742; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LIDER O, 1989, J IMMUNOL, V142, P748; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Middendorp S, 2009, MUCOSAL IMMUNOL, V2, P393, DOI 10.1038/mi.2009.99; MILLER A, 1991, J EXP MED, V174, P791, DOI 10.1084/jem.174.4.791; Muhlen KA, 2004, J IMMUNOL, V172, P3034, DOI 10.4049/jimmunol.172.5.3034; NAKATA M, 1992, INT IMMUNOL, V4, P1049, DOI 10.1093/intimm/4.9.1049; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Oh K, 2011, EUR J IMMUNOL, V41, P392, DOI 10.1002/eji.201040569; RAPHAEL M, 1988, HISTOPATHOLOGY, V13, P191, DOI 10.1111/j.1365-2559.1988.tb02024.x; Rojas B, 2005, EXP EYE RES, V81, P313, DOI 10.1016/j.exer.2005.02.004; SACKS EH, 1986, OPHTHALMOLOGY, V93, P1276; Schaumburg CS, 2011, J IMMUNOL, V187, P3653, DOI 10.4049/jimmunol.1101442; SENTMAN CL, 1989, J IMMUNOL, V142, P1847; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Sugita S, 2004, J IMMUNOL, V172, P4184, DOI 10.4049/jimmunol.172.7.4184; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yagi Y, 2007, J GASTROENTEROL, V42, P746, DOI 10.1007/s00535-007-2091-3; Zheng XF, 2010, INVEST OPHTH VIS SCI, V51, P3083, DOI 10.1167/iovs.09-3838	44	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36822	10.1371/journal.pone.0036822	http://dx.doi.org/10.1371/journal.pone.0036822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590618	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335500032
J	Kim, TH; Cho, KH; Jung, WS; Lee, MS				Kim, Tae-Hun; Cho, Ki-Ho; Jung, Woo-Sang; Lee, Myeong Soo			Herbal Medicines for Parkinson's Disease: A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							PREVALENCE; IMPACT	Objective: We conducted systematic review to evaluate current evidence of herbal medicines (HMs) for Parkinson's disease (PD). Methods: Along with hand searches, relevant literatures were located from the electronic databases including CENTRAL, MEDLINE, EMBASE, CINAHL, AMED, PsycInfo, CNKI, 7 Korean Medical Databases and J-East until August, 2010 without language and publication status. Randomized controlled trials (RCTs), quasi-randomized controlled trials and randomized crossover trials, which evaluate HMs for idiopathic PD were selected for this review. Two independent authors extracted data from the relevant literatures and any disagreement was solved by discussion. Results: From the 3432 of relevant literatures, 64 were included. We failed to suggest overall estimates of treatment effects on PD because of the wide heterogeneity of used herbal recipes and study designs in the included studies. When compared with placebo, specific effects were not observed in favor of HMs definitely. Direct comparison with conventional drugs suggested that there was no evidence of better effect for HMs. Many studies compared combination therapy with single active drugs and combination therapy showed significant improvement in PD related outcomes and decrease in the dose of anti-Parkinson's drugs with low adverse events rate. Conclusion: Currently, there is no conclusive evidence about the effectiveness and efficacy of HMs on PD. For establishing clinical evidence of HMs on PD, rigorous RCTs with sufficient statistical power should be promoted in future.	[Kim, Tae-Hun; Cho, Ki-Ho; Jung, Woo-Sang] Kyung Hee Univ, Coll Oriental Med, Dept Cardiovasc & Neurol Dis, Seoul, South Korea; [Kim, Tae-Hun; Lee, Myeong Soo] Korea Inst Oriental Med, Taejon, South Korea	Kyung Hee University; Korea Institute of Oriental Medicine (KIOM)	Kim, TH (corresponding author), Kyung Hee Univ, Coll Oriental Med, Dept Cardiovasc & Neurol Dis, Seoul, South Korea.	johkiho@khmc.or.kr	Lee, Myeong Soo/C-8147-2013; Kim, Tae-Hun/G-8728-2014	Lee, Myeong Soo/0000-0001-6651-7641; Kim, Tae-Hun/0000-0002-8448-3219				Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; ALTMAN DG, 1980, BRIT MED J, V281, P1336, DOI 10.1136/bmj.281.6251.1336; An LZ, 2009, J SICHUAN TRADITIONA, V27, P81; Bao YC, 2001, J ANHUI TRADIT CHIN, V20, P11; Campos HC, 2011, CNS NEUROL DISORD-DR, V10, P239; Carroll CB, 2004, NEUROLOGY, V63, P1245, DOI 10.1212/01.WNL.0000140288.48796.8E; Chang XH, 2008, J NEW CHINESE MED, V4, P62; Chen JZ, 1999, J CHENGDOU U TCM, V22, P14; Chen JZ, 1999, J CHENGDU U TRADITIO, V22, P19; [陈列红 CHEN Lie-hong], 2009, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V25, P472; Cheng CH, 2007, SHANXI J TRADITIONAL, V23, P35; Chung V, 2006, MOVEMENT DISORD, V21, P1709, DOI 10.1002/mds.21008; [崔玲 Cui Ling], 2003, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V23, P504; Cui RT, 2004, CAPITAL MED; DOU YQ, 2006, CHIN J CLIN REHABIL, V10, P6; Dowding CH, 2006, DRUG AGING, V23, P693, DOI 10.2165/00002512-200623090-00001; Egger M, 2003, Health Technol Assess, V7, P1; Ernst E, 2006, DESKTOP GUIDE COMPLE; Ernst E, 2008, OXFORD HDB COMPLEMEN; Fan YP, 2006, CLIN RES TREMOR TYPE; Feng GK, 2002, MODERN REHABILITATIO, V6, P334; Fu WY, 2004, LIAONING J TRADIT CH, V31, P750; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hu Xue-jun, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P811; Jiang SY, 2009, J LIAONING U TRADITI, V11, P118; Jiang XC, 2003, MODERN J INTEGRATED, V12, P934; Kim IK, 2004, EFFICACY UNDERLYING; Li N, 2009, J GERIATRIC CARE, V7, P100; Li Q, 2006, BEHAV PHARMACOL, V17, P403, DOI 10.1097/00008877-200609000-00006; Li XX, 2008, TRADITIONAL CHINESE, V21, P32; Lian XF, 2008, J NEW CHINESE MED, V40, P37; Liang JF, 2008, LIAONING J TRADITION, V35, P82; Liu H, 1994, YELLOW RIVER MED, V3, P72; Lokk J, 2008, EUR J PHYS REHAB MED, V44, P39; Lu Y, 2009, SHANGHAI J TRADITION, V43, P20; Luo ZM, 2001, W CHINA MED J, V16, P40; Lx Ai, 2004, JIANGSU ZHONGYIYAO, V19, P31; Ma L, 2008, TRADITIONAL CHINESE, V21, P39; Ma QM, 2003, CHINESE J INTEGRATIV, V1, P614; Ma YZ, 2008, HENAN TRADITIONAL CH, V27, P73; MA YZ, 2005, XIN ZHONGYI, V37, P55; Manyam B V, 1999, Adv Neurol, V80, P565; Ming KW, 2010, J NEW CHINESE MED, V42, P23; Muangpaisan W, 2009, J EPIDEMIOL, V19, P281, DOI 10.2188/jea.JE20081034; Pan WD, 2009, ACTA U TRADIT MED SI, V23, P29, DOI DOI 10.16306/J.1008-861X.2009.04.024; Qiu CL, 1998, ZHEJIANG J INTEGRATE, V8, P224; Rao SS, 2006, AM FAM PHYSICIAN, V74, P2046; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Schrag A, 2000, BRIT MED J, V321, P21, DOI 10.1136/bmj.321.7252.21; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Serrano-Duenas M., 2001, SCI REV ALTERNATIVE, V5, P127; Shen W, 2006, SHANGHAI J TRADITION, V40, P21; Shen Y, 2008, J ZHEJIANG U TRADITI, V32, P197; Sun YZ, 2005, CLIN RES TREATING HY; Tang XJ, 2005, N J TRADIT CHIN MED, V37, P25; Teng SW, 2000, J ZHEJIANG U TRADIT, V24, P34; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; von Campenhausen S, 2005, EUR NEUROPSYCHOPHARM, V15, P473, DOI 10.1016/j.euroneuro.2005.04.007; Wang D, 2009, PRACTICAL CLIN J INT, V9, P27; Wang EL, 2008, LIAONING ZHONGYI ZAZ, V35, P227; Wang HX, 2010, GUIDING J TRADITIONA, V16, P17; [王文同 Wang Wentong], 2004, [中医杂志, Journal of Traditional Chinese Medicine], V45, P274; Wang XD, 1985, CHINESE J NEUROLOGY, V18, P256; Wang YL, 2008, MODERN TRADITIONAL C, V28, P1; Wang YL, 2009, J SHANDONG U TRADITI, V33, P26; Wang ZY, 2005, CAPITAL MED, V12, P32; Wang ZY, 2005, TRADITIONAL CHINESE, V18, P37; Winter Y, 2010, PARKINSONISM RELAT D, V16, P51, DOI 10.1016/j.parkreldis.2009.07.005; Wu CH, 2008, CHINESE J INTEGRATIV, V6, P397; Wu DH, 2008, GUIDING J TRADITIONA, V14, P24; Yang LJ, 2009, CHINESE J GERONTOLOG, V6, P1554; Yang M.J., 2010, GUANGMING J CHIN MED, V25, P31; YANG MH, 2002, CHINA J INTEGRATED C, V9, P256; Yang YF, 2008, J ANHUI TRADITIONAL, V27, P16; Yang Zhi-min, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P612; Yuan CX, 2010, SHANGHAI J TRADITION, V44, P3; Yuan JP, 2005, JILIN J TRADITIONAL, V25, P47; Zhang H, 2008, ACTA CHINESE MED PHA, V36, P34; Zhang JP, 2009, YUNNAN J TRADITIONAL, V30, P37; Zhang L, 2006, ZHONGGUO LINCHUANG K, V10, P152; Zhang Y, 2008, LIAONING J TRADITION, V35, P728; Zhang Y, 2006, CLIN RES DING ZHEN T; Zhao Guo-Hua, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P590; Zhao Hong, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P780; Zhao XH, 2003, MODERN J INTEGRATED, V12, P1923; [郑春叶 Zheng Chunye], 2006, [中医杂志, Journal of Traditional Chinese Medicine], V47, P516; Zheng GQ, 2009, J ALTERN COMPLEM MED, V15, P1223, DOI 10.1089/acm.2009.0101; Zhu XY, 2009, J NEUROLOGY NEUROREH, V6, P114; 顾锡镇, 2002, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V18, P275	90	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35695	10.1371/journal.pone.0035695	http://dx.doi.org/10.1371/journal.pone.0035695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615738	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300003
J	Gao, JX; Zhang, CW; Yang, B; Sun, L; Zhang, CZ; Westerfield, M; Peng, G				Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Westerfield, Monte; Peng, Gang			Dcc Regulates Asymmetric Outgrowth of Forebrain Neurons in Zebrafish	PLOS ONE			English	Article							FLUORESCENT PROTEIN; C-ELEGANS; EMBRYONIC ZEBRAFISH; AXON TRACTS; POLARITY; EXPRESSION; NEOGENIN; BRAIN; NETRIN-1; ESTABLISHMENT	The guidance receptor DCC (deleted in colorectal cancer) ortholog UNC-40 regulates neuronal asymmetry development in Caenorhabditis elegans, but it is not known whether DCC plays a role in the specification of neuronal polarity in vertebrates. To examine the roles of DCC in neuronal asymmetry regulation in vertebrates, we studied zebrafish anterior dorsal telencephalon (ADt) neuronal axons. We generated transgenic zebrafish animals expressing the photo-convertible fluorescent protein Kaede in ADt neurons and then photo-converted Kaede to label specifically the ADt neuron axons. We found that ADt axons normally project ventrally. Knock down of Dcc function by injecting antisense morpholino oligonucleotides caused the ADt neurons to project axons dorsally. To examine the axon projection pattern of individual ADt neurons, we labeled single ADt neurons using a forebrain-specific promoter to drive fluorescent protein expression. We found that individual ADt neurons projected axons dorsally or formed multiple processes after morpholino knock down of Dcc function. We further found that knock down of the Dcc ligand, Netrin1, also caused ADt neurons to project axons dorsally. Knockdown of Neogenin1, a guidance receptor closely related to Dcc, enhanced the formation of aberrant dorsal axons in embryos injected with Dcc morpholino. These experiments provide the first evidence that Dcc regulates polarized axon initiation and asymmetric outgrowth of forebrain neurons in vertebrates.	[Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Peng, Gang] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Gao, Jingxia; Zhang, Changwen; Yang, Bin; Sun, Liu; Zhang, Cuizhen; Peng, Gang] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Fudan University; Fudan University; University of Oregon	Gao, JX (corresponding author), Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China.	gangpeng@fudan.edu.cn	sun, liu/U-5553-2019	sun, liu/0000-0002-1459-9478; peng, gang/0000-0001-6625-5426	National 985 Program; Ministry of Education of China, National Natural Science Foundation of China [30900861, 30970948]; Innovation Program of Shanghai Education Commission [11ZZ05]; National Institutes of Health [DC004186, HD22486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004186] Funding Source: NIH RePORTER	National 985 Program; Ministry of Education of China, National Natural Science Foundation of China(Ministry of Education, China); Innovation Program of Shanghai Education Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National 985 Program sponsored by the Ministry of Education of China, National Natural Science Foundation of China (Grant 30900861, 30970948), by the Innovation Program of Shanghai Education Commission (Grant 11ZZ05), and by National Institutes of Health grants DC004186 and HD22486 to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; De Vries M, 2008, J NEUROCHEM, V106, P1483, DOI 10.1111/j.1471-4159.2008.05485.x; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Fricke C, 2005, DEV DYNAM, V234, P732, DOI 10.1002/dvdy.20492; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hjorth JT, 2001, MECH DEVELOP, V109, P105, DOI 10.1016/S0925-4773(01)00513-5; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Kuo TY, 2009, MOL CELL NEUROSCI, V42, P195, DOI 10.1016/j.mcn.2009.07.006; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Maves L, 2002, DEVELOPMENT, V129, P3825; Mawdsley DJ, 2004, DEV BIOL, V269, P302, DOI 10.1016/j.ydbio.2004.02.001; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Park KW, 2005, DEV DYNAM, V234, P726, DOI 10.1002/dvdy.20474; Peng G, 2006, DEVELOPMENT, V133, P3191, DOI 10.1242/dev.02485; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shen H, 2002, MECH DEVELOP, V118, P219, DOI 10.1016/S0925-4773(02)00255-1; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Viktorin G, 2009, DEV DYNAM, V238, P1984, DOI 10.1002/dvdy.22031; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wilson NH, 2007, INT J BIOCHEM CELL B, V39, P874, DOI 10.1016/j.biocel.2006.10.023; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; WILSON SW, 1990, DEVELOPMENT, V108, P121; Xu B, 2010, NEUROSCIENCE, V169, P932, DOI 10.1016/j.neuroscience.2010.05.025; Xu ZN, 2009, GENETICS, V183, P941, DOI 10.1534/genetics.109.108654; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	53	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36516	10.1371/journal.pone.0036516	http://dx.doi.org/10.1371/journal.pone.0036516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606267	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400021
J	Kataria, H; Wadhwa, R; Kaul, SC; Kaur, G				Kataria, Hardeep; Wadhwa, Renu; Kaul, Sunil C.; Kaur, Gurcharan			Water Extract from the Leaves of Withania somnifera Protect RA Differentiated C6 and IMR-32 Cells against Glutamate-Induced Excitotoxicity	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; NMDA RECEPTOR ACTIVATION; D-ASPARTATE RECEPTORS; POLYSIALIC ACID; TRANSCRIPTIONAL REGULATION; INDUCED NEUROPROTECTION; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; NERVOUS-SYSTEM; INDIAN GINSENG	Glutamate neurotoxicity has been implicated in stroke, head trauma, multiple sclerosis and neurodegenerative disorders. Search for herbal remedies that may possibly act as therapeutic agents is an active area of research to combat these diseases. The present study was designed to investigate the neuroprotective role of Withania somnifera (Ashwagandha), also known as Indian ginseng, against glutamate induced toxicity in the retinoic acid differentiated rat glioma (C6) and human neuroblastoma (IMR-32) cells. The neuroprotective activity of the Ashwagandha leaves derived water extract (ASH-WEX) was evaluated. Cell viability and the expression of glial and neuronal cell differentiation markers was examined in glutamate challenged differentiated cells with and without the presence of ASH-WEX. We demonstrate that RA-differentiated C6 and IMR-32 cells, when exposed to glutamate, undergo loss of neural network and cell death that was accompanied by increase in the stress protein HSP70. ASH-WEX pre-treatment inhibited glutamate-induced cell death and was able to revert glutamate-induced changes in HSP70 to a large extent. Furthermore, the analysis on the neuronal plasticity marker NCAM (Neural cell adhesion molecule) and its polysialylated form, PSA-NCAM revealed that ASH-WEX has therapeutic potential for prevention of neurodegeneration associated with glutamate-induced excitotoxicty.	[Kataria, Hardeep; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kataria, H (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	renu-wadhwa@aist.go.jp; kgurcharan.neuro@yahoo.com	Kataria, Hardeep/AAI-8411-2020; Kaur, Gurcharan/V-6033-2019; Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Kataria, Hardeep/0000-0001-8413-0600	Department of Biotechnology, Government of India under DBT-AIST, Japan collaboration program; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India under DBT-AIST, Japan collaboration program; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study was supported by grants from the Department of Biotechnology, Government of India to Guru Nanak Dev University, under DBT-AIST, Japan collaboration program. H. K. is supported by a fellowship grant from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Anderson CM, 2000, GLIA, V32, P1; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; Bouzioukh F, 2001, J NEUROSCI, V21, P4721, DOI 10.1523/JNEUROSCI.21-13-04721.2001; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Bruses JL, 1998, J CELL BIOL, V140, P1177, DOI 10.1083/jcb.140.5.1177; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Dobrek L, 2011, POSTEP HIG MED DOSW, V65, P338; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Duveau V, 2007, NEUROBIOL DIS, V26, P385, DOI 10.1016/j.nbd.2007.01.007; El Maarouf A, 2006, P NATL ACAD SCI USA, V103, P16989, DOI 10.1073/pnas.0608036103; Gardoni F, 2006, EUR J PHARMACOL, V545, P2, DOI 10.1016/j.ejphar.2006.06.022; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hoffman KB, 2001, NEUROSCI RES, V39, P167, DOI 10.1016/S0168-0102(00)00214-5; Hughes EG, 2004, MOL BRAIN RES, V124, P114, DOI 10.1016/j.molbrainres.2004.02.021; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kataria H, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep188; Kim K, 2011, J CELL PHYSIOL, V226, P2484, DOI 10.1002/jcp.22609; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni S, 1998, INDIAN DRUGS, P208, DOI DOI 10.1002/(SICI)1099-1573(199809)12:6%3C451::AID-PTR328%3E3.0.CO;2-C; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; LEE MK, 1994, CURR OPIN CELL BIOL, V6, P34, DOI 10.1016/0955-0674(94)90113-9; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Meriin AB, 2005, INT J HYPERTHER, V21, P403, DOI 10.1080/02656730500041871; NIXON RA, 1992, CELL MOTIL CYTOSKEL, V22, P81, DOI 10.1002/cm.970220202; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Panicker AK, 2003, FRONT BIOSCI, V8, pD900, DOI 10.2741/1014; Parihar MS, 2003, J BIOSCIENCES, V28, P121, DOI 10.1007/BF02970142; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pietrzik C, 2005, INT J EXP PATHOL, V86, P173, DOI 10.1111/j.0959-9673.2005.00435.x; Priyandoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019552; RABINOVSKY ED, 1992, J NEUROSCI, V12, P171; RajaSankar S, 2009, J ETHNOPHARMACOL, V125, P369, DOI 10.1016/j.jep.2009.08.003; RajaSankara S, 2009, NEUROSCI LETT, V454, P11, DOI 10.1016/j.neulet.2009.02.044; Rajdev S, 2000, TOXICOL PATHOL, V28, P105, DOI 10.1177/019262330002800113; Ringman John M., 2005, Current Alzheimer Research, V2, P131, DOI 10.2174/1567205053585882; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; RUTISHAUSER U, 1988, PHYSIOL REV, V68, P819, DOI 10.1152/physrev.1988.68.3.819; Saito Y, 2010, FREE RADICAL BIO MED, V49, P1542, DOI 10.1016/j.freeradbiomed.2010.08.016; Sandi C, 2001, NEUROSCIENCE, V102, P329, DOI 10.1016/S0306-4522(00)00484-X; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Shah JS, 2011, J YOUNG PHARM, V3, P119, DOI 10.4103/0975-1483.80296; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shah ZA, 2011, NEUROSCIENCE, V180, P248, DOI 10.1016/j.neuroscience.2011.02.031; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Sherwin AL, 1999, NEUROCHEM RES, V24, P1385, DOI 10.1023/A:1022580506443; Shichi K, 2011, J PHARMACOL EXP THER, V338, P701, DOI 10.1124/jpet.110.178079; Singh J, 2007, BRAIN RES, V1154, P8, DOI 10.1016/j.brainres.2007.04.015; Singh J, 2009, BRAIN RES BULL, V79, P157, DOI 10.1016/j.brainresbull.2009.02.005; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takahashi S, 1997, DEV BRAIN RES, V104, P111, DOI 10.1016/S0165-3806(97)00175-2; Taskinen HS, 1997, ACTA NEUROPATHOL, V93, P252, DOI 10.1007/s004010050611; Tohda C, 2005, NEUROSIGNALS, V14, P34, DOI 10.1159/000085384; Tohda C, 2009, BRIT J PHARMACOL, V157, P1427, DOI 10.1111/j.1476-5381.2009.00313.x; Ueda Y, 2000, EXP BRAIN RES, V135, P199, DOI 10.1007/s002210000509; Wang C, 1996, J CELL BIOL, V135, P1565, DOI 10.1083/jcb.135.6.1565; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; Wermuth CG, 2004, DRUG DISCOV TODAY, V9, P826, DOI 10.1016/S1359-6446(04)03213-1; Wu JQ, 2001, J PHYSIOL-LONDON, V533, P745, DOI 10.1111/j.1469-7793.2001.t01-1-00745.x; Wu PF, 2010, ACTA PHARMACOL SIN, V31, P1523, DOI 10.1038/aps.2010.186; Xu XH, 2006, BRAIN RES, V1102, P154, DOI 10.1016/j.brainres.2006.04.111; Yan D, 2004, CELL STRESS CHAPERON, V9, P378, DOI 10.1379/CSC-51R.1; Yazawa K, 2006, FEBS LETT, V580, P6623, DOI 10.1016/j.febslet.2006.11.011; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x	78	51	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37080	10.1371/journal.pone.0037080	http://dx.doi.org/10.1371/journal.pone.0037080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606332	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339400059
J	Riou, C; Peixoto, BP; Roberts, L; Ronacher, K; Walzl, G; Manca, C; Rustomjee, R; Mthiyane, T; Fallows, D; Gray, CM; Kaplan, G				Riou, Catherine; Peixoto, Blas Perez; Roberts, Lindi; Ronacher, Katharina; Walzl, Gerhard; Manca, Claudia; Rustomjee, Roxana; Mthiyane, Thuli; Fallows, Dorothy; Gray, Clive M.; Kaplan, Gilla			Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPUTUM-CULTURE CONVERSION; NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; DISEASE-ACTIVITY; HIV-INFECTION; SERUM-LEVELS; FOLLOW-UP; IP-10; BIOMARKERS	Background: Sputum Mycobacterium tuberculosis (Mtb) culture is commonly used to assess response to antibiotic treatment in individuals with pulmonary tuberculosis (TB). Such techniques are constrained by the slow growth rate of Mtb, and more sensitive methods to monitor Mtb clearance are needed. The goal of this study was to evaluate changes in plasma cytokines in patients undergoing treatment for TB as a means of identifying candidate host markers associated with microbiologic response to therapy. Methods: Twenty-four plasma cytokines/chemokines were measured in 42 individuals diagnosed with active pulmonary TB, 52% were HIV co-infected. Individuals, undergoing a 26-week standard TB treatment, were followed longitudinally over 18 months and measurements were associated with HIV status and rates of sputum culture conversion. Results: Plasma concentrations of interferon-inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF) were significantly reduced upon TB treatment, regardless of HIV status. By the end of treatment, IP-10 concentrations were significantly lower in HIV negative individuals when compared to HIV-positive individuals (p = 0.02). Moreover, in HIV negative patients, plasma VEGF concentrations, measured as early as 2-weeks post TB treatment initiation, positively correlated with the time of sputum conversion (p = 0.0017). No significant changes were observed in other studied immune mediators. Conclusions: These data suggest that VEGF plasma concentration, measured during early TB treatment, could represent a surrogate marker to monitor sputum culture conversion in HIV uninfected individuals.	[Riou, Catherine; Gray, Clive M.] Univ Cape Town, Div Immunol, IIDMM, Clin Sci Lab, ZA-7925 Cape Town, Western Cape, South Africa; [Peixoto, Blas Perez; Manca, Claudia; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; [Peixoto, Blas Perez; Manca, Claudia; Fallows, Dorothy; Kaplan, Gilla] Univ Med & Dent New Jersey, Publ Hlth Res Inst, TB Res Unit, Newark, NJ 07103 USA; [Roberts, Lindi] Univ Cape Town, Div Med Virol, IIDMM, ZA-7925 Cape Town, Western Cape, South Africa; [Ronacher, Katharina; Walzl, Gerhard] Univ Stellenbosch, Dept Biomed Sci, Dept Sci & Technol, Natl Res Fdn,Ctr Excellence TB Res, Cape Town, Western Cape, South Africa; [Rustomjee, Roxana; Mthiyane, Thuli] MRC, TB Res Unit Clin & Biomed, Durban, Kwazulu Natal, South Africa	University of Cape Town; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Cape Town; National Research Foundation - South Africa; Stellenbosch University	Riou, C (corresponding author), Univ Cape Town, Div Immunol, IIDMM, Clin Sci Lab, ZA-7925 Cape Town, Western Cape, South Africa.	clive.gray@uct.ac.za	Ronacher, Katharina/N-9603-2016; Walzl, Gerhard/N-6371-2016	Ronacher, Katharina/0000-0002-6371-1462; Gray, Clive/0000-0002-9293-901X; Walzl, Gerhard/0000-0003-2487-125X; Mthiyane, Thuli/0000-0002-1782-5485; Masson, Lindi/0000-0002-2539-817X	U.S. National Institutes of Health [RO1-AI080737, contract NO1-AI70022]; Department of Arts and Culture; South African Medical Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080737] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Arts and Culture; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the U.S. National Institutes of Health [RO1-AI080737 and contract NO1-AI70022 for the Tuberculosis Research Unit (TBRU) to GK], the Department of Arts and Culture and the South African Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2001, RESPIRATION, V68, P496, DOI 10.1159/000050557; Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Aliyu MH, 2003, WIEN KLIN WOCHENSCHR, V115, P340, DOI 10.1007/BF03041486; [Anonymous], 2007, SA TUB STRAT PLAN S; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; BAJAJ G, 1989, Indian Pediatrics, V26, P1010; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Bezuidenhout J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004228; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; Columb MO, 2006, CURR ANAESTH CRIT CA, V17, P233, DOI DOI 10.1016/J.CACC.2006.03.005; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Dalhoff A, 2003, LANCET INFECT DIS, V3, P359, DOI 10.1016/S1473-3099(03)00658-3; Demir T, 2002, INT J TUBERC LUNG D, V6, P155; Djoba Siawaya JF, 2009, CLIN EXP IMMUNOL, V156, P69, DOI 10.1111/j.1365-2249.2009.03875.x; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gay C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019617; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Huang WC, 2011, JPN J INFECT DIS, V64, P367; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; John SH, 2011, BIOMARKERS; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; Keating SM, 2011, AIDS; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Matsuyama W, 2000, AM J RESP CRIT CARE, V162, P1120, DOI 10.1164/ajrccm.162.3.9911010; Mendez S, 2009, ANTIMICROB AGENTS CH, V53, P5114, DOI 10.1128/AAC.01146-09; Morikawa K, 1996, ANTIMICROB AGENTS CH, V40, P1366, DOI 10.1128/AAC.40.6.1366; Park HY, 2012, YONSEI MED J, V53, P369, DOI 10.3349/ymj.2012.53.2.369; Ribeiro-Rodrigues R, 2002, CLIN DIAGN LAB IMMUN, V9, P818, DOI 10.1128/CDLI.9.4.818-823.2002; Roach DR, 2002, J IMMUNOL, V168, P4620, DOI 10.4049/jimmunol.168.9.4620; Rose R M, 1991, Bull Int Union Tuberc Lung Dis, V66, P15; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Sakaguchi I, 2000, INFECT IMMUN, V68, P2043, DOI 10.1128/IAI.68.4.2043-2052.2000; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Tammela T, 2005, TRENDS CELL BIOL, V15, P434, DOI 10.1016/j.tcb.2005.06.004; Wallis R, 2005, CURR MED CHEM ANTIIN, V4, P1; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2010, LANCET INFECT DIS, V10, P70, DOI 10.1016/S1473-3099(10)70002-5; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; World Health Organization, 2010, TUB; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793	54	65	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36886	10.1371/journal.pone.0036886	http://dx.doi.org/10.1371/journal.pone.0036886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606304	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400039
J	Schlotter, F; Matsumoto, Y; Mangner, N; Schuler, G; Linke, A; Adams, V				Schlotter, Florian; Matsumoto, Yasuharu; Mangner, Norman; Schuler, Gerhard; Linke, Axel; Adams, Volker			Regular Exercise or Changing Diet Does Not Influence Aortic Valve Disease Progression in LDLR Deficient Mice	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; LOW-DENSITY-LIPOPROTEIN; PHYSICAL-ACTIVITY; STENOSIS; ASSOCIATION; CELLS; TRIAL	Background: The development and progression of calcific aortic valve disease (CAVD) shares a number of similarities with atherosclerosis. Recently we could demonstrate that regular exercise training (ET) as primary prevention prevents aortic valve disease in LDL-receptor deficient (LDLR-/-) mice. We aimed to investigate the impact of exercise training on the progression of CAVD in LDLR-/- mice in the setting of secondary prevention Methods and Results: Sixty-four LDLR-/- mice were fed with high cholesterol diet to induce aortic valve sclerosis. Thereafter the animals were divided into 3 groups: group 1 continuing on high cholesterol diet, group 2 continuing with cholesterol diet plus 1 h ET per day, group 3 continuing with normal mouse chow. After another 16 weeks the animal were sacrificed. Histological analysis of the aortic valve thickness demonstrated no significant difference between the three groups (control 98.3 +/- 4.5 mu m, ET 88.2 +/- 6.6 mu m, change in diet 87.5 +/- 4.0). Immunohistochemical staining for endothelial cells revealed a disrupted endothelial cell layer to the same extend in all groups. Furthermore no difference between the groups was evident with respect to the expression of inflammatory, fibroblastic and osteoblastic markers. Conclusion: Based on the present study we have to conclude that once the development of a CAVD is initiated, exercise training or a change in diet does not have the potential to attenuate the progress of the CAVD.	[Schlotter, Florian; Mangner, Norman; Schuler, Gerhard; Linke, Axel; Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany; [Matsumoto, Yasuharu] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi 980, Japan	Heart Center Leipzig GMBH; Leipzig University; Tohoku University	Schlotter, F (corresponding author), Univ Leipzig, Heart Ctr Leipzig, Dept Internal Med Cardiol, Leipzig, Germany.	adav@medizin.uni-leipzig.de	Schlotter, Florian/AAC-4864-2021; Mangner, Norman/AAN-4673-2020	Mangner, Norman/0000-0003-0793-7923	German Heart Foundation; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad	German Heart Foundation; Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad	The study was supported by a grant from the German Heart Foundation (Dr. Linke). Dr. Matsumoto was a recipient of a research grant of the Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E; Aikawa E, 2007, CIRCULATION, V115, P377, DOI 10.1161/CIRCULATIONAHA.106.654913; Beckmann E, 2010, J HEART VALVE DIS, V19, P441; Ben-Dor I, 2010, CIRCULATION, V122, pS37, DOI 10.1161/CIRCULATIONAHA.109.926873; Butcher JT, 2006, ARTERIOSCL THROM VAS, V26, P69, DOI 10.1161/01.ATV.0000196624.70507.0d; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; El-Hamamsy I, 2009, J AM COLL CARDIOL, V53, P1448, DOI 10.1016/j.jacc.2008.11.056; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Gummert JF, 2010, THORAC CARDIOV SURG, V58, P379, DOI 10.1055/s-0030-1250294; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Matsumoto Y, 2010, CIRCULATION, V121, P759, DOI 10.1161/CIRCULATIONAHA.109.892224; Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Newby DE, 2006, HEART, V92, P729, DOI 10.1136/hrt.2005.066852; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; O'Brien KD, 2002, CIRCULATION, V106, P2224, DOI 10.1161/01.CIR.0000035655.45453.D2; Otto CM, 2008, NEW ENGL J MED, V359, P1395, DOI 10.1056/NEJMe0807001; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Salas MJ, 2011, J CARDIOVASC PH 0809; Sider KL, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/364310; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37298	10.1371/journal.pone.0037298	http://dx.doi.org/10.1371/journal.pone.0037298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606357	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400079
J	Wikstrom, JD; Sereda, SB; Stiles, L; Elorza, A; Allister, EM; Neilson, A; Ferrick, DA; Wheeler, MB; Shirihai, OS				Wikstrom, Jakob D.; Sereda, Samuel B.; Stiles, Linsey; Elorza, Alvaro; Allister, Emma M.; Neilson, Andy; Ferrick, David A.; Wheeler, Michael B.; Shirihai, Orian S.			A Novel High-Throughput Assay for Islet Respiration Reveals Uncoupling of Rodent and Human Islets	PLOS ONE			English	Article							MITOCHONDRIAL PROTON LEAK; OXYGEN-CONSUMPTION RATE; BETA-CELLS; INSULIN; OSCILLATIONS; LANGERHANS; SECRETION	Background: The pancreatic beta cell is unique in its response to nutrient by increased fuel oxidation. Recent studies have demonstrated that oxygen consumption rate (OCR) may be a valuable predictor of islet quality and long term nutrient responsiveness. To date, high-throughput and user-friendly assays for islet respiration are lacking. The aim of this study was to develop such an assay and to examine bioenergetic efficiency of rodent and human islets. Methodology/Principal Findings: The XF24 respirometer platform was adapted to islets by the development of a 24-well plate specifically designed to confine islets. The islet plate generated data with low inter-well variability and enabled stable measurement of oxygen consumption for hours. The F1F0 ATP synthase blocker oligomycin was used to assess uncoupling while rotenone together with myxothiazol/antimycin was used to measure the level of non-mitochondrial respiration. The use of oligomycin in islets was validated by reversing its effect in the presence of the uncoupler FCCP. Respiratory leak averaged to 59% and 49% of basal OCR in islets from C57Bl6/J and FVB/N mice, respectively. In comparison, respiratory leak of INS-1 cells and C2C12 myotubes was measured to 38% and 23% respectively. Islets from a cohort of human donors showed a respiratory leak of 38%, significantly lower than mouse islets. Conclusions/Significance: The assay for islet respiration presented here provides a novel tool that can be used to study islet mitochondrial function in a relatively high-throughput manner. The data obtained in this study shows that rodent islets are less bioenergetically efficient than human islets as well as INS1 cells.	[Wikstrom, Jakob D.; Sereda, Samuel B.; Elorza, Alvaro; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Wikstrom, Jakob D.] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Elorza, Alvaro] Univ Andres Bello, Dept Biol, Fac Ciencias Salud, Santiago, Chile; [Allister, Emma M.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Allister, Emma M.; Wheeler, Michael B.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Neilson, Andy; Ferrick, David A.] Seahorse Biosci, N Billerica, MA USA; [Stiles, Linsey] Tufts Univ, Sch Med, Boston, MA 02111 USA	Boston University; Stockholm University; Universidad Andres Bello; University of Toronto; University of Toronto; Tufts University	Wikstrom, JD (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	shirihai@bu.edu		Shirihai, Orian/0000-0002-9502-2661; Elorza, Alvaro A./0000-0003-1570-9832; Wheeler, Michael B./0000-0002-7480-7267; Wikstrom, Jakob/0000-0002-4287-1774; Stiles, Linsey/0000-0002-1514-458X	National Institute of Health [R01 DK074778, R01 DK56690-11]; Boston University Mitochondria Affinity Research Collaborative (mtARC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056690, R01DK074778] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Mitochondria Affinity Research Collaborative (mtARC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Health, grants R01 DK074778 and R01 DK56690-11, and by the Boston University Mitochondria Affinity Research Collaborative (mtARC). The laboratory has been previously supported by a pilot grant from Seahorse Bioscience (www.seahorsebio.com, http://www.seahorsebio.com), but the organization did not contribute funding to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2000, METH MOL B, V155, P213; Doliba NM, 2006, AM J PHYSIOL-ENDOC M, V291, pE525, DOI 10.1152/ajpendo.00579.2005; Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440; Grover GJ, 2008, INT J BIOCHEM CELL B, V40, P2698, DOI 10.1016/j.biocel.2008.06.013; HELLERSTROM C, 1966, BIOCHEM J, V98, pC7, DOI 10.1042/bj0980007C; Jung SK, 1999, ANAL CHEM, V71, P3642, DOI 10.1021/ac990271w; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Leahy JL, 2008, DIABETES, V57, P2563, DOI 10.2337/db08-0869; LONGO EA, 1991, J BIOL CHEM, V266, P9314; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; MITCHELL P, 1976, BIOCHEM SOC T, V4, P399, DOI 10.1042/bst0040399; Mulder H, 2009, MOL CELL ENDOCRINOL, V297, P34, DOI 10.1016/j.mce.2008.05.015; Ortsater H, 2000, DIABETOLOGIA, V43, P1313, DOI 10.1007/s001250051528; Papas KK, 2007, AM J TRANSPLANT, V7, P707, DOI 10.1111/j.1600-6143.2006.01655.x; Papas KK, 2010, J INVEST SURG, V23, P28, DOI 10.3109/08941930903410825; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	28	90	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e33023	10.1371/journal.pone.0033023	http://dx.doi.org/10.1371/journal.pone.0033023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606219	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400001
J	Arnold, M; Ellwanger, DC; Hartsperger, ML; Pfeufer, A; Stumpflen, V				Arnold, Matthias; Ellwanger, Daniel C.; Hartsperger, Mara L.; Pfeufer, Arne; Stuempflen, Volker			Cis-Acting Polymorphisms Affect Complex Traits through Modifications of MicroRNA Regulation Pathways	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PRIMARY BILIARY-CIRRHOSIS; DNA-REPAIR; INTEGRATIVE ANALYSIS; HUMAN-DISEASE; RNA; DATABASE; EXPRESSION; GENE; IDENTIFICATION	Genome-wide association studies (GWAS) have become an effective tool to map genes and regions contributing to multifactorial human diseases and traits. A comparably small number of variants identified by GWAS are known to have a direct effect on protein structure whereas the majority of variants is thought to exert their moderate influences on the phenotype through regulatory changes in mRNA expression. MicroRNAs (miRNAs) have been identified as powerful posttranscriptional regulators of mRNAs. Binding to their target sites, which are mostly located within the 3'-untranslated region (3'-UTR) of mRNA transcripts, they modulate mRNA expression and stability. Until today almost all human mRNA transcripts are known to harbor at least one miRNA target site with an average of over 20 miRNA target sites per transcript. Among 5,101 GWAS-identified sentinel single nucleotide polymorphisms (SNPs) that correspond to 18,884 SNPs in linkage disequilibrium (LD) with the sentinels (r(2) >= 0.8) we identified a significant overrepresentation of SNPs that affect the 3'-UTR of genes (OR = 2.33, 95% CI = 2.12-2.57, P<10(-52)). This effect was even stronger considering all SNPs in one LD bin a single signal (OR = 4.27, 95% CI = 3.84-4.74, P<10(-114)). Based on crosslinking immunoprecipitation data we identified four mechanisms affecting miRNA regulation by 39-UTR mutations: (i) deletion or (ii) creation of miRNA recognition elements within validated RNA-induced silencing complex binding sites, (iii) alteration of 3'-UTR splicing leading to a loss of binding sites, and (iv) change of binding affinity due to modifications of 3'-UTR folding. We annotated 53 SNPs of a total of 288 trait-associated 3'-UTR SNPs as mediating at least one of these mechanisms. Using a qualitative systems biology approach, we demonstrate how our findings can be used to support biological interpretation of GWAS results as well as to provide new experimentally testable hypotheses.	[Arnold, Matthias; Ellwanger, Daniel C.; Hartsperger, Mara L.; Stuempflen, Volker] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Ellwanger, Daniel C.] Tech Univ Munich, Ctr Life & Food Sci, Chair Genome Oriented Bioinformat, Freising Weihenstephan, Germany; [Pfeufer, Arne] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Pfeufer, Arne] German Natl Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Pfeufer, Arne] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pfeufer, Arne] Univ Lubeck, Affiliated Inst, Lubeck, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; European Academy of Bozen-Bolzano; University of Lubeck	Arnold, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	v.stuempflen@helmholtz-muenchen.de	Pfeufer, Arne/B-6634-2013	Arnold, Matthias/0000-0002-4666-0923; Ellwanger, Daniel/0000-0002-3481-8455	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research (BMBF) in its MedSys initiative [FKZ: 0315494A]; British Foundation for the study of infant deaths FSID [261]; German National Genome Research Network NGFN [01GR0803]; BMBF [01EZ0874]	Helmholtz Alliance on Systems Biology; Federal Ministry of Education and Research (BMBF) in its MedSys initiative(Federal Ministry of Education & Research (BMBF)); British Foundation for the study of infant deaths FSID; German National Genome Research Network NGFN; BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the Helmholtz Alliance on Systems Biology (project CoReNe) and the Federal Ministry of Education and Research (BMBF) in its MedSys initiative (project SysMBo, FKZ: 0315494A). It was also supported by grants by the British Foundation for the study of infant deaths FSID, Grant No. 261 (Pfeufer) and the German National Genome Research Network NGFN 01GR0803 and BMBF 01EZ0874 (Pfeufer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de la Chapelle A, 2009, ONCOGENE, V28, P3345, DOI 10.1038/onc.2009.194; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Heathcote J, 2000, CAN J GASTROENTEROL, V14, P43, DOI 10.1155/2000/989486; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hindorff LA, 2011, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Howel D, 1999, GUT, V45, P756, DOI 10.1136/gut.45.5.756; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kirschner K, 2010, ANTICANCER RES, V30, P3223; Kryston TB, 2011, MUTAT RES; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Li SX, 2010, ENVIRON MOL MUTAGEN, V51, P897, DOI 10.1002/em.20606; Li X, 2010, RNA, V16, P1096, DOI 10.1261/rna.2017210; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mackay IR, 2007, HEPATOL RES, V37, pS357, DOI 10.1111/j.1872-034X.2007.00230.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sage E, 2010, MUTAT RES; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Selmi C, 2008, J HEPATOL, V49, P451, DOI 10.1016/j.jhep.2008.06.006; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Turissini SB, 1997, AM J GASTROENTEROL, V92, P676; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Visscher PM, 2009, JAMA-J AM MED ASSOC, V302, P2028, DOI 10.1001/jama.2009.1643; Waldispuhl J, 2007, J COMPUT BIOL, V14, P190, DOI 10.1089/cmb.2006.0012; Walters RW, 2010, RNA, V16, P239, DOI 10.1261/rna.1795410; Wilbert ML, 2010, WILEY INTERDISCIP RE; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang JO, 2009, HUM MUTAT, V30, pE1010, DOI 10.1002/humu.21128; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zindy P, 2005, FEBS LETT, V579, P95, DOI 10.1016/j.febslet.2004.09.092	91	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36694	10.1371/journal.pone.0036694	http://dx.doi.org/10.1371/journal.pone.0036694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606281	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200038
J	Xiao, JF; Jiang, H; Zhang, R; Fan, GP; Zhang, Y; Jiang, DS; Li, HL				Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Fan, Guangpu; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang			Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; IN-VIVO; THERAPEUTIC TARGETS; SIGNALING PATHWAY; HEART; CARDIOMYOPATHY; FIBROSIS; GROWTH; RECEPTOR; STRESS	Background: Epidermal growth factor (EGF), latrophilin and seven transmembrane domain-containing protein 1 (ELTD1) is developmentally upregulated in the heart. Little is known about the relationship between ELTD1 and cardiac diseases. Therefore, we aimed to clarify the role of ELTD1 in pressure overload-induced cardiac hypertrophy. Methods and Results: C57BL/6J wild-type (WT) mice and ELTD1-knockout (KO) mice were subjected to left ventricular pressure overload by descending aortic banding (AB). KO mice exhibited more unfavorable cardiac remodeling than WT mice 28 days post AB; this remodeling was characterized by aggravated cardiomyocyte hypertrophy, thickening of the ventricular walls, dilated chambers, increased fibrosis, and blunted systolic and diastolic cardiac function. Analysis of signaling pathways revealed enhanced extracellular signal-regulated kinase (ERK) and the c-Jun amino-terminal kinase (JNK) phosphorylation in response to ELTD1 deletion. Conclusions: ELTD1 deficiency exacerbates cardiac hypertrophy and cardiac function induced by AB-induced pressure overload by promoting both cardiomyocyte hypertrophy and cardiac fibrosis. These effects are suggested to originate from the activation of the ERK and JNK pathways, suggesting that ELTD1 is a potential target for therapies that prevent the development of cardiac disease.	[Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China; [Xiao, Jinfeng; Jiang, Hong; Zhang, Rui; Zhang, Yan; Jiang, Dingsheng; Li, Hongliang] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430072, Peoples R China; [Fan, Guangpu] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Thorac & Cardiac Surg, Wuhan 430074, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Xiao, JF (corresponding author), Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430072, Peoples R China.	jianghong58@gmail.com; lihl@whu.edu.cn	Jiang, Ding-Sheng/GQZ-1348-2022		Fundamental Research Funds for the Central Universities of China [20103020101000198]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Fundamental Research Funds for the Central Universities of China. [20103020101000198]. (http://kfy.whu.edu.cn/kfy/inforead_2017_1.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmonte SL, 2011, CIRC RES, V109, P309, DOI 10.1161/CIRCRESAHA.110.231233; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Biagini E, 2005, J AM COLL CARDIOL, V46, P1543, DOI 10.1016/j.jacc.2005.04.062; BRAZ JC, 2003, J CLIN INVEST, V111, P1475, DOI DOI 10.1172/JCI200317295; Brooks WW, 2000, J MOL CELL CARDIOL, V32, P187, DOI 10.1006/jmcc.1999.1065; Choukroun G, 1999, J CLIN INVEST, V104, P391, DOI 10.1172/JCI6350; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Dingar D, 2010, CELL SIGNAL, V22, P1634, DOI 10.1016/j.cellsig.2010.06.002; Inesi G, 2008, BIOCHEM BIOPH RES CO, V369, P182, DOI 10.1016/j.bbrc.2007.11.161; Karin M, 1996, PHILOS T ROY SOC B, V351, P127, DOI 10.1098/rstb.1996.0008; Kim S, 1999, JPN J PHARMACOL, V80, P97, DOI 10.1254/jjp.80.97; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Liu W, 2009, CIRC RES, V104, P905, DOI 10.1161/CIRCRESAHA.108.188292; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Luttrell LM, 1997, ADV SEC MESS PHOSPH, V31, P263; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Nechiporuk T, 2001, J BIOL CHEM, V276, P4150, DOI 10.1074/jbc.M004814200; Pak Y, 1999, J BIOL CHEM, V274, P27610, DOI 10.1074/jbc.274.39.27610; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Proud CG, 2004, CARDIOVASC RES, V63, P403, DOI 10.1016/j.cardiores.2004.02.003; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; Xiao J, 2012, BASIC RES CARDIOL, V107, P1, DOI DOI 10.1007/S00395-011-0239-Z; Zhang LY, 2011, CARDIOVASC RES, V89, P148, DOI 10.1093/cvr/cvq266; Zhang P, 2011, CIRC RES, V109, P320, DOI 10.1161/CIRCRESAHA.110.231423; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	33	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35779	10.1371/journal.pone.0035779	http://dx.doi.org/10.1371/journal.pone.0035779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606234	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200012
J	Demetrovics, Z; Urban, R; Nagygyorgy, K; Farkas, J; Griffiths, MD; Papay, O; Kokonyei, G; Felvinczi, K; Olah, A				Demetrovics, Zsolt; Urban, Robert; Nagygyoergy, Katalin; Farkas, Judit; Griffiths, Mark D.; Papay, Orsolya; Koekoenyei, Gyoengyi; Felvinczi, Katalin; Olah, Attila			The Development of the Problematic Online Gaming Questionnaire (POGQ)	PLOS ONE			English	Article							GAME ADDICTION; ADOLESCENTS; SPECIFICITY; SENSITIVITY; VALIDATION; INTERNET; CONTEXT; MODEL	Background: Online gaming has become increasingly popular. However, this has led to concerns that these games might induce serious problems and/or lead to dependence for a minority of players. Aim: The aim of this study was to uncover and operationalize the components of problematic online gaming. Methods: A total of 3415 gamers (90% males; mean age 21 years), were recruited through online gaming websites. A combined method of exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) was applied. Latent profile analysis was applied to identify persons at-risk. Results: EFA revealed a six-factor structure in the background of problematic online gaming that was also confirmed by a CFA. For the assessment of the identified six dimensions - preoccupation, overuse, immersion, social isolation, interpersonal conflicts, and withdrawal - the 18-item Problematic Online Gaming Questionnaire (POGQ) proved to be exceedingly suitable. Based on the latent profile analysis, 3.4% of the gamer population was considered to be at high risk, while another 15.2% was moderately problematic. Conclusions: The POGQ seems to be an adequate measurement tool for the differentiated assessment of gaming related problems on six subscales.	[Demetrovics, Zsolt; Urban, Robert; Nagygyoergy, Katalin; Farkas, Judit; Papay, Orsolya; Koekoenyei, Gyoengyi; Felvinczi, Katalin; Olah, Attila] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Griffiths, Mark D.] Nottingham Trent Univ, Psychol Div, Nottingham, England; [Nagygyoergy, Katalin; Farkas, Judit; Papay, Orsolya] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary	Eotvos Lorand University; Nottingham Trent University; Eotvos Lorand University	Demetrovics, Z (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.	demetrovics@t-online.hu; mark.griffiths@ntu.ac.uk	Demetrovics, Zsolt/F-8613-2010; Griffiths, Mark D./AAY-3546-2021; Olah, Attila/I-7173-2017	Demetrovics, Zsolt/0000-0001-5604-7551; Griffiths, Mark D./0000-0001-8880-6524; Olah, Attila/0000-0001-9483-1347; Urban, Robert/0000-0002-2058-5937; Felvinczi, Katalin/0000-0003-1813-7227	Hungarian Scientific Research Fund [83884]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (grant number: 83884) (http://otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brockmyer JH, 2009, J EXP SOC PSYCHOL, V45, P624, DOI 10.1016/j.jesp.2009.02.016; Caplan S, 2009, COMPUT HUM BEHAV, V25, P1312, DOI 10.1016/j.chb.2009.06.006; Charlton JP, 2007, COMPUT HUM BEHAV, V23, P1531, DOI 10.1016/j.chb.2005.07.002; Chou TJ, 2003, CYBERPSYCHOL BEHAV, V6, P663, DOI 10.1089/109493103322725469; Cole H, 2007, CYBERPSYCHOL BEHAV, V10, P575, DOI 10.1089/cpb.2007.9988; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; Grant JE, 2010, AM J DRUG ALCOHOL AB, V36, P233, DOI 10.3109/00952990.2010.491884; Griffiths M., 1995, CLIN PSYCHOL FORUM, P14, DOI DOI 10.2307/40971629; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Griffiths M. D., 2008, NEW DIRECTIONS ADDIC, V12, P27; Griffiths MD, 2010, INT J MENT HEALTH AD, V8, P119, DOI 10.1007/s11469-009-9229-x; Kim MG, 2010, COMPUT HUM BEHAV, V26, P389, DOI 10.1016/j.chb.2009.11.010; King DL, 2011, INT J MENT HEALTH AD, V9, P72, DOI 10.1007/s11469-009-9254-9; Koronczai B, 2011, CYBERPSYCH BEH SOC N, V14, P657, DOI 10.1089/cyber.2010.0345; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; Muthen B., 2010, MPLUS USERS GUIDE; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Peters CS, 2008, CYBERPSYCHOL BEHAV, V11, P480, DOI 10.1089/cpb.2007.0140; Simon J., 2010, BORN DIGITAL GROWN D; Smahel D, 2008, CYBERPSYCHOL BEHAV, V11, P715, DOI 10.1089/cpb.2007.0210; Smyth JM, 2007, CYBERPSYCHOL BEHAV, V10, P717, DOI 10.1089/cpb.2007.9963; Vermunt J. K., 2002, ADV LATENT CLASS ANA; Wan CS, 2006, CYBERPSYCHOL BEHAV, V9, P762, DOI 10.1089/cpb.2006.9.762; Young K., 1998, CAUGHT NET RECOGNIZE; Young K, 2009, AM J FAM THER, V37, P355, DOI 10.1080/01926180902942191	29	116	117	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36417	10.1371/journal.pone.0036417	http://dx.doi.org/10.1371/journal.pone.0036417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TN	22590541	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400014
J	Murata, Y; Oda, S; Mitani, H				Murata, Yasuhiko; Oda, Shoji; Mitani, Hiroshi			Allelic Expression Changes in Medaka (Oryzias latipes) Hybrids between Inbred Strains Derived from Genetically Distant Populations	PLOS ONE			English	Article							GENE-EXPRESSION; DNMT3L; DIVERGENCE; EVOLUTION; FAMILY; SCALE; JAPAN; DNA	Variations in allele expressions between genetically distant populations are one of the most important factors which affects their morphological and physiological variations. These variations are caused by natural mutations accumulated in their habitats. It has been reported that allelic expression differences in the hybrids of genetically distant populations are different from parental strains. In that case, there is a possibility that allelic expression changes lead to novel phenotypes in hybrids. Based on genomic information of the genetically distant populations, quantification and comparison of allelic expression changes make importance of regulatory sequences (cis-acting factors) or upstream regulatory factors (transacting modulators) for these changes clearer. In this study, we focused on two Medaka inbred strains, Hd-rR and HNI, derived from genetically distant populations and their hybrids. They are highly polymorphic and we can utilize whole-genome information. To analyze allelic expression changes, we established a method to quantify and compare allele-specific expressions of 11 genes between the parental strains and their reciprocal hybrids. In intestines of reciprocal hybrids, allelic expression was either similar or different in comparison with the parental strains. Total expressions in Hd-rR and HNI were tissue-dependent in the case of HPRT1, with high up-regulation of Hd-rR allele expression in liver. The proportion of genes with differential allelic expression in Medaka hybrids seems to be the same as that in other animals, despite the high SNP rate in the genomes of the two inbred strains. It is suggested that each tissue of the strain difference in trans-acting modulators is more important than polymorphisms in cis-regulatory sequences in producing the allelic expression changes in reciprocal hybrids.	[Murata, Yasuhiko; Oda, Shoji; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Murata, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan.	mitani@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, and Technology of Japan [21221003]	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grand-in-Aid for Scientific Research (21221003) from the Ministry of Education, Culture, Sports, and Technology of Japan to H.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; EGAMI N., 1954, ANNOT ZOOL JAPONENSES, V27, P7; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Hata K, 2002, DEVELOPMENT, V129, P1983; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kimura T, 2004, MECH DEVELOP, V121, P915, DOI 10.1016/j.mod.2004.03.033; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; KWOK S, 1994, PCR METH APPL, V3, pS39; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Matsumoto Yoshifumi, 2009, BMC Res Notes, V2, P88, DOI 10.1186/1756-0500-2-88; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Oota H, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P339, DOI 10.1007/978-4-431-92691-7_22; SAKAIZUMI M, 1986, GENETICA, V69, P119, DOI 10.1007/BF00115131; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Setiamarga DHE, 2009, BIOL LETTERS, V5, P812, DOI 10.1098/rsbl.2009.0419; Shima A, 2004, MECH DEVELOP, V121, P599, DOI 10.1016/j.mod.2004.03.011; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; YAMAMOTO TO, 1968, J EXP ZOOL, V168, P215, DOI 10.1002/jez.1401680209; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36875	10.1371/journal.pone.0036875	http://dx.doi.org/10.1371/journal.pone.0036875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590630	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400042
J	Garcia, L; Ortiz, S; Osorio, G; Torrico, MC; Torrico, F; Solari, A				Garcia, Lineth; Ortiz, Sylvia; Osorio, Gonzalo; Cruz Torrico, Mary; Torrico, Faustino; Solari, Aldo			Phylogenetic Analysis of Bolivian Bat Trypanosomes of the Subgenus Schizotrypanum Based on Cytochrome b Sequence and Minicircle Analyses	PLOS ONE			English	Article							NEOTROPICAL BATS; TRIATOMINE BUGS; CRUZI; RANGELI; BRAZIL; MICROCHIROPTERA; BIOGEOGRAPHY; EVOLUTION; DIONISII; REGION	The aim of this study was to establish the phylogenetic relationships of trypanosomes present in blood samples of Bolivian Carollia bats. Eighteen cloned stocks were isolated from 115 bats belonging to Carollia perspicillata (Phyllostomidae) from three Amazonian areas of the Chapare Province of Bolivia and studied by xenodiagnosis using the vectors Rhodnius robustus and Triatoma infestans (Trypanosoma cruzi marenkellei) or haemoculture (Trypanosoma dionisii). The PCR DNA amplified was analyzed by nucleotide sequences of maxicircles encoding cytochrome b and by means of the molecular size of hyper variable regions of minicircles. Ten samples were classified as Trypanosoma cruzi marinkellei and 8 samples as Trypanosoma dionisii. The two species have a different molecular size profile with respect to the amplified regions of minicircles and also with respect to Trypanosoma cruzi and Trypanosoma rangeli used for comparative purpose. We conclude the presence of two species of bat trypanosomes in these samples, which can clearly be identified by the methods used in this study. The presence of these trypanosomes in Amazonian bats is discussed.	[Garcia, Lineth; Cruz Torrico, Mary; Torrico, Faustino] Univ Mayor de San Simon, Fac Med, Inst Invest Biomed IIBISMED, Cochabamba, Bolivia; [Ortiz, Sylvia; Solari, Aldo] Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile; [Osorio, Gonzalo] Univ Chile, Fac Med, ICBM, Programa Microbiol, Santiago 7, Chile	Universidad de Chile; Universidad de Chile	Garcia, L (corresponding author), Univ Mayor de San Simon, Fac Med, Inst Invest Biomed IIBISMED, Cochabamba, Bolivia.	asolari@med.uchile.cl	Solari, Aldo/ABB-8629-2021		European Community [223034]	European Community(European Commission)	This study was funded by the European Community's Seventh Framework Programme (FP7) under agreement 223034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vallejo GA, 2003, INFECT GENET EVOL, V3, P39, DOI 10.1016/S1567-1348(02)00150-8; BAKER JR, 1978, AM J TROP MED HYG, V27, P483, DOI 10.4269/ajtmh.1978.27.483; Barnabe C, 2003, INFECT GENET EVOL, V2, P201, DOI 10.1016/S1567-1348(02)00130-2; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; Botero A, 2010, DIAGN MICR INFEC DIS, V68, P265, DOI 10.1016/j.diagmicrobio.2010.06.020; Brisse S, 2003, INFECT GENET EVOL, V2, P173, DOI 10.1016/S1567-1348(02)00097-7; CAVAZZANA M, 2003, REV INST MED TROP SP, V45, P228; Cavazzana M, 2010, INT J PARASITOL, V40, P345, DOI 10.1016/j.ijpara.2009.08.015; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Da Silva FM, 2004, PARASITOLOGY, V129, P549, DOI 10.1017/S0031182004005931; Deane L., 1961, REV INST MED TROP SP, V3, P5; Dias E, 1942, REV BRAS BIOL, V2, P03; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; GARDNER RA, 1988, PARASITOLOGY, V97, P43, DOI 10.1017/S0031182000066725; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hoare C.A., 1972, P1; Hoffmann FG, 2003, MOL ECOL, V12, P3403, DOI 10.1046/j.1365-294X.2003.02009.x; Lisboa CV, 2008, VET PARASITOL, V156, P314, DOI 10.1016/j.vetpar.2008.06.004; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Maeda FY, 2012, ACTA TROP, V121, P141, DOI 10.1016/j.actatropica.2011.10.017; Marcili A, 2009, PARASITOLOGY, V136, P641, DOI 10.1017/S0031182009005861; Marinkelle C.J., 1976, P175; MARINKELLE CJ, 1982, ANN TROP MED PARASIT, V76, P125, DOI 10.1080/00034983.1982.11687517; MOLYNEUX DH, 1991, PARASITIC PROTOZOA, P95; PETRY K, 1986, ACTA TROP, V43, P5; Stevens JR, 2008, PARASITE, V15, P226, DOI 10.1051/parasite/2008153226; TAYLOR AER, 1982, SYST PARASITOL, V4, P155, DOI 10.1007/BF00018999; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; Westenberger SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-60; WINCKER P, 1994, AM J TROP MED HYG, V51, P771, DOI 10.4269/ajtmh.1994.51.771; Yeo M, 2007, INT J PARASITOL, V37, P111, DOI 10.1016/j.ijpara.2006.08.002; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	34	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36578	10.1371/journal.pone.0036578	http://dx.doi.org/10.1371/journal.pone.0036578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590570	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100041
J	Ormerod, KG; Rogasevskaia, TP; Coorssen, JR; Mercier, AJ				Ormerod, Kiel G.; Rogasevskaia, Tatiana P.; Coorssen, Jens R.; Mercier, A. Joffre			Cholesterol-Independent Effects of Methyl-beta-Cyclodextrin on Chemical Synapses	PLOS ONE			English	Article							CA2+-TRIGGERED MEMBRANE-FUSION; CRAYFISH NEUROMUSCULAR-JUNCTION; ACTION-POTENTIAL PROPAGATION; LIPID RAFTS; TRANSMITTER RELEASE; GLUTAMATE; MUSCLE; MICRODOMAINS; ASSOCIATION; EXTRACTION	The cholesterol chelating agent, methyl-beta-cyclodextrin (M beta CD), alters synaptic function in many systems. At crayfish neuromuscular junctions, M beta CD is reported to reduce excitatory junctional potentials (EJPs) by impairing impulse propagation to synaptic terminals, and to have no postsynaptic effects. We examined the degree to which physiological effects of M beta CD correlate with its ability to reduce cholesterol, and used thermal acclimatization as an alternative method to modify cholesterol levels. M beta CD impaired impulse propagation and decreased EJP amplitude by 40% (P < 0.05) in preparations from crayfish acclimatized to 14 degrees C but not from those acclimatized to 21 degrees C. The reduction in EJP amplitude in the cold-acclimatized group was associated with a 49% reduction in quantal content (P < 0.05). M beta CD had no effect on input resistance in muscle fibers but decreased sensitivity to the neurotransmitter L-glutamate in both warm- and cold-acclimatized groups. This effect was less pronounced and reversible in the warm-acclimatized group (90% reduction in cold, P < 0.05; 50% reduction in warm, P < 0.05). M beta CD reduced cholesterol in isolated nerve and muscle from cold- and warm-acclimatized groups by comparable amounts (nerve: 29% cold, 25% warm; muscle: 20% cold, 18% warm; P < 0.05). This effect was reversed by cholesterol loading, but only in the warm-acclimatized group. Thus, effects of M beta CD on glutamate-sensitivity correlated with its ability to reduce cholesterol, but effects on impulse propagation and resulting EJP amplitude did not. Our results indicate that M beta CD can affect both presynaptic and postsynaptic properties, and that some effects of M beta CD are unrelated to cholesterol chelation.	[Ormerod, Kiel G.; Mercier, A. Joffre] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Rogasevskaia, Tatiana P.] Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB, Canada; [Coorssen, Jens R.] Univ Western Sydney, Sch Med, Dept Mol Physiol, Penrith, NSW, Australia; [Coorssen, Jens R.] Univ Western Sydney, Mol Med Res Grp, Penrith, NSW, Australia	Brock University; University of Calgary; Western Sydney University; Western Sydney University	Ormerod, KG (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	j.coorssen@uws.edu.au; jmercier@brocku.ca		Ormerod, Kiel/0000-0002-9739-8777	Natural 509 Sciences and Engineering Research Council [46292, 261972]	Natural 509 Sciences and Engineering Research Council	This work was supported by Natural 509 Sciences and Engineering Research Council grants to AJM (46292) and JRC (261972). www.nserc-crsng.gc.ca. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2005, J NEUROCHEM, V92, P1477, DOI 10.1111/j.1471-4159.2005.03001.x; Atwood H.L., 1982, P105; Becher A, 2001, J NEUROCHEM, V79, P787, DOI 10.1046/j.1471-4159.2001.00614.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borisova T, 2010, NEUROCHEM INT, V56, P466, DOI 10.1016/j.neuint.2009.12.006; BRUNER J, 1970, J PHYSIOL-PARIS, V62, P137; Cheng HH, 2009, J NEUROSCI RES, V87, P460, DOI 10.1002/jnr.21852; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; Churchward Matthew A, 2008, J Chem Biol, V1, P79, DOI 10.1007/s12154-008-0007-1; Churchward MA, 2009, BIOCHEM J, V423, P1, DOI 10.1042/BJ20090969; Clark J, 2008, PEPTIDES, V29, P1140, DOI 10.1016/j.peptides.2008.02.013; Del Castillo, 1954, J PHYSL, V124, P560; Delint-Ramirez I, 2010, J NEUROSCI, V30, P8162, DOI 10.1523/JNEUROSCI.1792-10.2010; DUDEL J, 1981, PFLUG ARCH EUR J PHY, V391, P35, DOI 10.1007/BF00580691; DUDEL J, 1965, PFLUG ARCH GES PHYS, V282, P323, DOI 10.1007/BF00412507; EDWARDS FR, 1976, J PHYSIOL-LONDON, V259, P689, DOI 10.1113/jphysiol.1976.sp011489; Gasque G, 2005, FEBS LETT, V579, P5129, DOI 10.1016/j.febslet.2005.08.022; Gil C, 2006, BIOCHEM BIOPH RES CO, V348, P1334, DOI 10.1016/j.bbrc.2006.07.201; Giocondi MC, 2004, BIOPHYS J, V86, P861, DOI 10.1016/S0006-3495(04)74161-2; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; JOHNSON EW, 1971, J PHYSIOL-LONDON, V218, P757, DOI 10.1113/jphysiol.1971.sp009642; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; Lopez CA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002020; LUSCHER HR, 1990, BIOPHYS J, V58, P1377, DOI 10.1016/S0006-3495(90)82484-X; Ma MT, 2010, NEUROSCI LETT, V476, P36, DOI 10.1016/j.neulet.2010.03.078; Maccarrone M, 2009, J NEUROCHEM, V109, P371, DOI 10.1111/j.1471-4159.2009.05948.x; MATHERS DA, 1978, COMP BIOCHEM PHYS C, V59, P151, DOI 10.1016/0306-4492(78)90046-1; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MERCIER AJ, 1989, J EXP BIOL, V145, P9; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; PARNAS I, 1966, COMP BIOCHEM PHYSIOL, V18, P701, DOI 10.1016/0010-406X(66)90206-4; PEREZDELAMORA M, 1989, ANAL BIOCHEM, V180, P248, DOI 10.1016/0003-2697(89)90425-9; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; PRUITT NL, 1988, AM J PHYSIOL, V254, pR870, DOI 10.1152/ajpregu.1988.254.6.R870; ROCHE H, 1984, COMP BIOCHEM PHYS B, V78, P755, DOI 10.1016/0305-0491(84)90130-5; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Rogasevskaia Tatiana P, 2011, J Chem Biol, V4, P117, DOI 10.1007/s12154-011-0056-8; Rufini S, 2009, BRAIN RES, V1298, P178, DOI 10.1016/j.brainres.2009.08.037; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Smith AJ, 2010, J NEUROSCI, V30, P6116, DOI 10.1523/JNEUROSCI.0170-10.2010; SMITH DO, 1980, J PHYSIOL-LONDON, V301, P243, DOI 10.1113/jphysiol.1980.sp013202; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAKEUCHI A, 1964, J PHYSIOL-LONDON, V170, P296, DOI 10.1113/jphysiol.1964.sp007332; Tarasenko AS, 2010, J MOL NEUROSCI, V41, P358, DOI 10.1007/s12031-010-9351-z; Taverna E, 2004, J BIOL CHEM, V279, P5127, DOI 10.1074/jbc.M308798200; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Wang DS, 2010, NEUROSCI LETT, V479, P327, DOI 10.1016/j.neulet.2010.05.090; Wang N, 2010, J NEUROSCI, V30, P3904, DOI 10.1523/JNEUROSCI.4000-09.2010; Wasser CR, 2007, J PHYSIOL-LONDON, V579, P413, DOI 10.1113/jphysiol.2006.123133; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Zacco A, 2003, J NEUROSCI, V23, P11104; Zamir O, 2006, J PHYSIOL-LONDON, V571, P83, DOI 10.1113/jphysiol.2005.098319; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36395	10.1371/journal.pone.0036395	http://dx.doi.org/10.1371/journal.pone.0036395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590538	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500011
J	Gershon, AS; Guan, J; Wang, CN; Victor, JC; To, T				Gershon, Andrea S.; Guan, Jun; Wang, Chengning; Victor, J. Charles; To, Teresa			Describing and Quantifying Asthma Comorbidty: A Population Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH ADMINISTRATIVE DATABASES; DIAGNOSED COPD; PRIMARY-CARE; METAANALYSIS; INDIVIDUALS; PREVALENCE; WEIGHT; BURDEN; ADULTS	Background: Asthma comorbidity has been correlated with poor asthma control, increased health services use, and decreased quality of life. Managing it improves these outcomes. Little is known about the amount of different types of comorbidity associated with asthma and how they vary by age. Methodology/Principal Findings: The authors conducted a population study using health administrative data on all individuals living in Ontario, Canada (population 12 million). Types of asthma comorbidity were quantified by comparing physician health care claims between individuals with and without asthma in each of 14 major disease categories; results were adjusted for demographic factors and other comorbidity and stratified by age. Compared to those without asthma, individuals with asthma had higher rates of comorbidity in most major disease categories. Most notably, they had about fifty percent or more physician health care claims for respiratory disease (other than asthma) in all age groups; psychiatric disorders in individuals age four and under and age 18 to 44; perinatal disorders in individuals 17 years and under, and metabolic and immunity, and hematologic disorders in children four years and under. Conclusion/Significance: Asthma appears to be associated with significant rates of various types of comorbidity that vary according to age. These results can be used to develop strategies to recognize and address asthma comorbidity to improve the overall health of individuals with asthma.	[Gershon, Andrea S.; Guan, Jun; Victor, J. Charles; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gershon, Andrea S.; Wang, Chengning; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Gershon, Andrea S.; Victor, J. Charles; To, Teresa] Univ Toronto, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Gershon, AS (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	andrea.gershon@ices.on.ca	Victor, J Charles/F-8765-2011	Victor, J Charles/0000-0003-1720-9356	University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care	University of Toronto, Toronto, Ontario, Canada(University of Toronto); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Dr. Gershon was supported by an Ontario Ministry of Health Career Scientist Award when she worked on this study. Dr. To is supported by The Dales Award in Medical Research from the University of Toronto, Toronto, Ontario, Canada. Funding for this project was made available through the Government of Ontario who had no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the report for publication. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2008, CAN MED ASSOC J, V179, P1121, DOI 10.1503/cmaj.081332; Adams RJ, 2006, CHEST, V129, P285, DOI 10.1378/chest.129.2.285; [Anonymous], POPULATION SELECTED; Ben Noun L, 2001, PUBLIC HLTH REV, V29, P49; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Chida Y, 2008, PSYCHOSOM MED, V70, P102, DOI 10.1097/PSY.0b013e31815c1b71; Chun TH, 2008, CHEST, V134, P1176, DOI 10.1378/chest.08-1528; Deshmukh VM, 2008, RESPIROLOGY, V13, P695, DOI 10.1111/j.1440-1843.2008.01310.x; Eneli IU, 2008, THORAX, V63, P671, DOI 10.1136/thx.2007.086470; Ernst Pierre, 2008, Curr Infect Dis Rep, V10, P223, DOI 10.1007/s11908-008-0037-4; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Global Strategy for Asthma Management and Prevention, 2009, GLOB STRAT ASTHM MAN; Lehrer PM, 2008, J ANXIETY DISORD, V22, P671, DOI 10.1016/j.janxdis.2007.07.001; Onufrak SJ, 2008, AM J CARDIOL, V101, P1247, DOI 10.1016/j.amjcard.2007.12.024; Plessis V, 2002, DEFINITIONS RURAL; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Starfleld B, 2005, ANN FAM MED, V3, P215, DOI 10.1370/afm.307; Statistics Canada, 2004, PCCF VERS 4D US GUID; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; WATSON WTA, 1993, J ALLERGY CLIN IMMUN, V91, P97, DOI 10.1016/0091-6749(93)90301-U; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463; Yuksel H, 2008, J ASTHMA, V45, P545, DOI 10.1080/02770900801990016; Zhang TT, 2009, J ASTHMA, V46, P1021, DOI 10.3109/02770900903350473	31	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e34967	10.1371/journal.pone.0034967	http://dx.doi.org/10.1371/journal.pone.0034967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586445	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000007
J	Linsuwanon, P; Puenpa, J; Suwannakarn, K; Auksornkitti, V; Vichiwattana, P; Korkong, S; Theamboonlers, A; Poovorawan, Y				Linsuwanon, Piyada; Puenpa, Jiratchaya; Suwannakarn, Kamol; Auksornkitti, Vittawat; Vichiwattana, Preeyaporn; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong			Molecular Epidemiology and Evolution of Human Enterovirus Serotype 68 in Thailand, 2006-2011	PLOS ONE			English	Article							RESPIRATORY ILLNESS; SPECIES C; RECOMBINATION; INFECTIONS; CHILDREN; DYNAMICS; SEQUENCE; STRAINS; PCR; RHINOVIRUS	Background: Publications worldwide have reported on the re-occurrence of human enterovirus 68 (EV68), a rarely detected pathogen usually causing respiratory illness. However, epidemiological data regarding this virus in particular on the Asian continent has so far been limited. Methodology/Findings: We investigated the epidemiology and genetic variability of EV68 infection among Thai children with respiratory illnesses from 2006-2011 (n = 1810). Semi-nested PCR using primer sets for amplification of the 5'-untranslated region through VP2 was performed for rhino-enterovirus detection. Altogether, 25 cases were confirmed as EV68 infection indicating a prevalence of 1.4% in the entire study population. Interestingly, the majority of samples were children aged >5 years (64%). Also, co-infection with other viruses was found in 28%, while pandemic H1N1 influenza/2009 virus was the most common co-infection. Of EV68-positive patients, 36% required hospitalizations with the common clinical presentations of fever, cough, dyspnea, and wheezing. The present study has shown that EV68 was extremely rare until 2009 (0.9%). An increasing annual prevalence was found in 2010 (1.6%) with the highest detection frequency in 2011 (4.3%). Based on analysis of the VP1 gene, the evolutionary rate of EV68 was estimated at 4.93x10(-3) substitutions/site/year. Major bifurcation of the currently circulating EV68 strains occurred 66 years ago (1945.31 with (1925.95-1960.46)95% HPD). Among the current lineages, 3 clusters of EV68 were categorized based on the different molecular signatures in the BC and DE loops of VP1 combined with high posterior probability values. Each cluster has branched off from their common ancestor at least 36 years ago (1975.78 with (1946.13-1984.97) 95% HPD). Conclusion: Differences in epidemiological characteristic and seasonal profile of EV68 have been found in this study. Results from Bayesian phylogenetic investigations also revealed that EV68 should be recognized as a genetically diverse virus with a substitution rate identical to that of enterovirus 71 genotype B (4.2x10(-3) s/s/y).	[Linsuwanon, Piyada; Puenpa, Jiratchaya; Suwannakarn, Kamol; Auksornkitti, Vittawat; Vichiwattana, Preeyaporn; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Bangkok, Thailand	Chulalongkorn University	Linsuwanon, P (corresponding author), Chulalongkorn Univ, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Linsuwanon, Piyada/AAS-7642-2020	Poovorawan, Yong/0000-0002-2337-6807	Higher Commission of Education, Ministry of Education; Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program); Chulalongkorn University; King Chulalongkorn Memorial Hospital; Outstanding Professor Research Fund; Thailand Research Fund	Higher Commission of Education, Ministry of Education; Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program)(Thailand Research Fund (TRF)); Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Outstanding Professor Research Fund; Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by the Higher Commission of Education, Ministry of Education; The Center of Excellence Research Fund (Royal Golden Jubilee Ph. D. Program); CU Centenary Academic Development Project, Chulalongkorn University, King Chulalongkorn Memorial Hospital; CU Cluster Emerging HR1155A under National Research University Fund; and the Outstanding Professor Research Fund, Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2002, VIRUS RES, V85, P71, DOI 10.1016/S0168-1702(02)00019-9; [Anonymous], MMWR MORB MORTAL WKL, V60, P1301; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Calvert J, 2010, J GEN VIROL, V91, P1229, DOI 10.1099/vir.0.018747-0; Chevaliez S, 2004, VIROLOGY, V325, P56, DOI 10.1016/j.virol.2004.04.026; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Faria NR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-164; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; Hasegawa S, 2011, ALLERGY, V66, P1618, DOI 10.1111/j.1398-9995.2011.02725.x; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hicks AL, 2011, J VIROL, V85, P7942, DOI 10.1128/JVI.02535-10; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Imamura T, 2011, EMERG INFECT DIS, V17, P1430, DOI 10.3201/eid1708.101328; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Lewis-Rogers N, 2009, MOL BIOL EVOL, V26, P969, DOI 10.1093/molbev/msp009; Linsuwanon P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-5; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Moratorio G, 2007, J GEN VIROL, V88, P3039, DOI 10.1099/vir.0.83038-0; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Petitjean-Lecherbonnier J, 2011, PATHOL BIOL, V59, P113, DOI 10.1016/j.patbio.2010.07.010; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rahamat-Langendoen J, 2011, J CLIN VIROL, V52, P103, DOI 10.1016/j.jcv.2011.06.019; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	47	77	82	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35190	10.1371/journal.pone.0035190	http://dx.doi.org/10.1371/journal.pone.0035190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586446	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000008
J	Prideaux, M; Loveridge, N; Pitsillides, AA; Farquharson, C				Prideaux, Matthew; Loveridge, Nigel; Pitsillides, Andrew A.; Farquharson, Colin			Extracellular Matrix Mineralization Promotes E11/gp38 Glycoprotein Expression and Drives Osteocytic Differentiation	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BONE-FORMATION; OXYGEN-TENSION; OSTEOBLASTS; PODOPLANIN; SCLEROSTIN; CULTURE; CD44; MECHANOTRANSDUCTION; MATURATION	Osteocytes are terminally differentiated osteoblasts which reside in a mineralized extracellular matrix (ECM). The factors that regulate this differentiation process are unknown. We have investigated whether ECM mineralization could promote osteocyte formation. To do this we have utilised MLO-A5 pre-osteocyte-like cells and western blotting and comparative RTPCR to examine whether the expression of osteocyte-selective markers is elevated concurrently with the onset of ECM mineralization. Secondly, if mineralization of the ECM is indeed a driver of osteocyte formation, we reasoned that impairment of ECM mineralization would result in a reversible inhibition of osteocyte formation. Supplementation of MLO-A5 cell cultures with ascorbic acid and phosphate promoted progressive ECM mineralization as well as temporally associated increases in expression of the osteocyte-selective markers, E11/gp38 glycoprotein and sclerostin. Consistent with a primary role for ECM mineralization in osteocyte formation, we also found that inhibition of ECM mineralization, by omitting phosphate or adding sodium pyrophosphate, a recognized inhibitor of hydroxyapatite formation, resulted in a 15-fold decrease in mineral deposition that was closely accompanied by lower expression of E11 and other osteocyte markers such as Dmp1, Cd44 and Sost whilst expression of osteoblast markers Ocn and Col1a increased. To rule out the possibility that such restriction of ECM mineralization may produce an irreversible modification in osteoblast behaviour to limit E11 expression and osteocytogenesis, we also measured the capacity of MLO-A5 cells to re-enter the osteocyte differentiation programme. We found that the mineralisation process was re-initiated and closely allied to increased expression of E11 protein after re-administration of phosphate or omission of sodium pyrophosphate, indicating an ECM mineralization-induced restoration in osteocyte formation. These results emphasise the importance of cell-ECM interactions in regulating osteoblast behaviour and, more importantly, suggest that ECM mineralization exerts pivotal control during terminal osteoblast differentiation and acquisition of the osteocyte phenotype.	[Prideaux, Matthew; Farquharson, Colin] Univ Edinburgh, Roslin Inst, Div Dev Biol, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Prideaux, Matthew; Pitsillides, Andrew A.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Loveridge, Nigel] Univ Cambridge, Bone Res Grp, Cambridge, England; [Loveridge, Nigel] Univ Cambridge, Orthopaed Res Grp, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University of London Royal Veterinary College; University of Cambridge; University of Cambridge	Prideaux, M (corresponding author), Univ Missouri, Sch Dent, Kansas City, MO 64108 USA.	prideauxm@umkc.edu	farquharson, colin/C-2956-2011	farquharson, colin/0000-0002-4970-4039; Loveridge, Nigel/0000-0002-5550-7584	Biotechnology and Biological Sciences Research Council (BBSRC) UK; BBSRC; EU [Health-F2-2008-201099]; Arthritis Research UK; Versus Arthritis [18768] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK through a studentship award (MP) and Institute Strategic Programme Grant Funding from the BBSRC (CF). NL acknowledges the support of the EU FP7 (TALOS: Health-F2-2008-201099). AP acknowledges continued funding to his group from Arthritis Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Bonewald L. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P321; Boskey AL, 1998, J CELL BIOCHEM, P83, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<83::AID-JCB12>3.0.CO;2-F; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferretti A, 2002, ANAT EMBRYOL, V206, P21, DOI 10.1007/s00429-002-0265-6; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; HUGHES DE, 1994, J BONE MINER RES, V9, P39; Irie K, 2008, J HISTOCHEM CYTOCHEM, V56, P561, DOI 10.1369/jhc.2008.950527; Kato Y, 2001, J BONE MINER RES, V16, P1622, DOI 10.1359/jbmr.2001.16.9.1622; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Meury T, 2010, MOL CELL BIOL, V30, P43, DOI 10.1128/MCB.00378-09; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214; Nefussi J R, 1991, J Biol Buccale, V19, P75; Ohizumi I, 2000, BBA-MOL CELL RES, V1497, P197, DOI 10.1016/S0167-4889(00)00063-X; Palumbo C, 2004, ANAT REC PART A, V278A, P474, DOI 10.1002/ar.a.20032; PALUMBO C, 1986, CELL TISSUE RES, V246, P125; PALUMBO C, 1990, ACTA ANAT, V137, P350; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Tate MLK, 2004, INT J BIOCHEM CELL B, V36, P1, DOI 10.1016/S1357-2725(03)00241-3; Tate MLK, 2003, J BIOMECH, V36, P1409, DOI 10.1016/S0021-9290(03)00123-4; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Yang W., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P386; Zahm AM, 2008, BONE, V43, P25, DOI 10.1016/j.bone.2008.03.010; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhang R, 2011, J BONE MINER RES, V26, P1047, DOI 10.1002/jbmr.294; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	45	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36786	10.1371/journal.pone.0036786	http://dx.doi.org/10.1371/journal.pone.0036786			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586496	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335000058
J	Bandholtz, S; Wichard, J; Kuhne, R; Grotzinger, C				Bandholtz, Sebastian; Wichard, Joerg; Kuehne, Ronald; Groetzinger, Carsten			Molecular Evolution of a Peptide GPCR Ligand Driven by Artificial Neural Networks	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; CHEMERIN RECEPTOR; DESIGN; INFLAMMATION; RECOGNITION; GENERATION; ADIPOKINE; COMPLEX; OBESITY	Peptide ligands of G protein-coupled receptors constitute valuable natural lead structures for the development of highly selective drugs and high-affinity tools to probe ligand-receptor interaction. Currently, pharmacological and metabolic modification of natural peptides involves either an iterative trial-and-error process based on structure-activity relationships or screening of peptide libraries that contain many structural variants of the native molecule. Here, we present a novel neural network architecture for the improvement of metabolic stability without loss of bioactivity. In this approach the peptide sequence determines the topology of the neural network and each cell corresponds one-to-one to a single amino acid of the peptide chain. Using a training set, the learning algorithm calculated weights for each cell. The resulting network calculated the fitness function in a genetic algorithm to explore the virtual space of all possible peptides. The network training was based on gradient descent techniques which rely on the efficient calculation of the gradient by back-propagation. After three consecutive cycles of sequence design by the neural network, peptide synthesis and bioassay this new approach yielded a ligand with 70fold higher metabolic stability compared to the wild type peptide without loss of the subnanomolar activity in the biological assay. Combining specialized neural networks with an exploration of the combinatorial amino acid sequence space by genetic algorithms represents a novel rational strategy for peptide design and optimization.	[Bandholtz, Sebastian; Groetzinger, Carsten] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Bandholtz, Sebastian; Groetzinger, Carsten] Charite, Mol Canc Res Ctr MKFZ, Tumor Targeting Lab, D-13353 Berlin, Germany; [Wichard, Joerg; Kuehne, Ronald] Leibnitz Inst Mol Pharmakol Fmp, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bandholtz, S (corresponding author), Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany.	carsten.groetzinger@charite.de	Grötzinger, Carsten/B-6938-2008	Grötzinger, Carsten/0000-0001-9872-3087	InnoProfile program of the German Federal Ministry of Education and Research (BMBF) [03IP614]	InnoProfile program of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grant 03IP614 in the InnoProfile program of the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic-Kustrin S, 2000, J PHARMACEUT BIOMED, V22, P717, DOI 10.1016/S0731-7085(99)00272-1; Balakin KV, 2003, J CHEM INF COMP SCI, V43, P1553, DOI 10.1021/ci034114g; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Cash JL, 2010, J IMMUNOL, V184, P5315, DOI 10.4049/jimmunol.0903378; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Devillers J., 1996, NEURAL NETWORKS QSAR; Du QS, 2007, J COMPUT CHEM, V28, P2043, DOI 10.1002/jcc.20732; Du XY, 2009, ACTA BIOCH BIOPH SIN, V41, P973, DOI 10.1093/abbs/gmp091; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Goulon A, 2006, LECT NOTES COMPUT SC, V4135, P1; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hiss JA, 2007, PROTEIN ENG DES SEL, V20, P99, DOI 10.1093/protein/gzl054; Holland J, 1975, ADAPTATION NATURAL A; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jagla B, 2000, BIOINFORMATICS, V16, P245, DOI 10.1093/bioinformatics/16.3.245; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; John H, 2007, ANAL BIOCHEM, V362, P117, DOI 10.1016/j.ab.2006.12.001; Kaga C, 2008, BIOTECHNIQUES, V44, P393, DOI 10.2144/000112693; Kamphausen S, 2002, J COMPUT AID MOL DES, V16, P551, DOI 10.1023/A:1021928016359; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Krogh A, 2008, NAT BIOTECHNOL, V26, P195, DOI 10.1038/nbt1386; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lopez-Rodriguez ML, 2001, J MED CHEM, V44, P198, DOI 10.1021/jm000930t; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Martensson UEA, 2006, VIROLOGY, V355, P6, DOI 10.1016/j.virol.2006.07.010; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Melville JL, 2009, COMB CHEM HIGH T SCR, V12, P332, DOI 10.2174/138620709788167980; Merkwirth C, 2005, J CHEM INF MODEL, V45, P1159, DOI 10.1021/ci049613b; Milik M, 1998, NAT BIOTECHNOL, V16, P753, DOI 10.1038/nbt0898-753; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Perrone MP, 1993, NEURAL NETWORKS SPEE; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Riester D, 2005, P NATL ACAD SCI USA, V102, P8597, DOI 10.1073/pnas.0501983102; Scarselli F, 2009, IEEE T NEURAL NETWOR, V20, P61, DOI 10.1109/TNN.2008.2005605; Schneider G, 1998, P NATL ACAD SCI USA, V95, P12179, DOI 10.1073/pnas.95.21.12179; Schneider G, 1998, PROG BIOPHYS MOL BIO, V70, P175, DOI 10.1016/S0079-6107(98)00026-1; Shimamura K, 2009, PEPTIDES, V30, P1529, DOI 10.1016/j.peptides.2009.05.030; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Teixido M, 2005, J PEPT SCI, V11, P789, DOI 10.1002/psc.679; Terfloth L, 2001, DRUG DISCOV TODAY, V6, pS102; TETKO IV, 1994, J MED CHEM, V37, P2520, DOI 10.1021/jm00042a005; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wichard JD, 2010, LECT NOTES ARTIF INT, V6114, P132, DOI 10.1007/978-3-642-13232-2_16; Willett P, 1995, TRENDS BIOTECHNOL, V13, P516, DOI 10.1016/S0167-7799(00)89015-0; Wisniewska JM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/396847; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wrede P, 1998, BIOCHEMISTRY-US, V37, P3588, DOI 10.1021/bi9726032; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zupan J., 1993, NEURAL NETWORKS CHEM	62	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36948	10.1371/journal.pone.0036948	http://dx.doi.org/10.1371/journal.pone.0036948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606313	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400044
J	Brioschi, M; Polvani, G; Fratto, P; Parolari, A; Agostoni, P; Tremoli, E; Banfi, C				Brioschi, Maura; Polvani, Gianluca; Fratto, Pasquale; Parolari, Alessandro; Agostoni, Piergiuseppe; Tremoli, Elena; Banfi, Cristina			Redox Proteomics Identification of Oxidatively Modified Myocardial Proteins in Human Heart Failure: Implications for Protein Function	PLOS ONE			English	Article							MYOFIBRILLAR CREATINE-KINASE; LEFT-VENTRICULAR HYPERTROPHY; COVALENT MODIFICATION; OXIDIZED PROTEINS; OXIDASE ACTIVITY; S-NITROSYLATION; STRESS; ACTIN; INACTIVATION; DYSFUNCTION	Increased oxidative stress in a failing heart may contribute to the pathogenesis of heart failure (HF). The aim of this study was to identify the oxidised proteins in the myocardium of HF patients and analyse the consequences of oxidation on protein function. The carbonylated proteins in left ventricular tissue from failing (n = 14) and non-failing human hearts (n = 13) were measured by immunoassay and identified by proteomics. HL-1 cardiomyocytes were incubated in the presence of stimuli relevant for HF in order to assess the generation of reactive oxygen species (ROS), the induction of protein carbonylation, and its consequences on protein function. The levels of carbonylated proteins were significantly higher in the HF patients than in the controls (p<0.01). We identified two proteins that mainly underwent carbonylation: M-type creatine kinase (M-CK), whose activity is impaired, and, to a lesser extent, alpha-cardiac actin. Exposure of cardiomyocytes to angiotensin II and norepinephrine led to ROS generation and M-CK carbonylation with loss of its enzymatic activity. Our findings indicate that protein carbonylation is increased in the myocardium during HF and that these oxidative changes may help to explain the decreased CK activity and consequent defects in energy metabolism observed in HF.	[Brioschi, Maura; Polvani, Gianluca; Parolari, Alessandro; Agostoni, Piergiuseppe; Tremoli, Elena; Banfi, Cristina] Ctr Cardiol Monzino IRCCS, Milan, Italy; [Tremoli, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Polvani, Gianluca; Parolari, Alessandro; Agostoni, Piergiuseppe] Univ Milan, Dept Cardiovasc Sci, Milan, Italy; [Fratto, Pasquale] Osped Niguarda Ca Granda, Milan, Italy; [Agostoni, Piergiuseppe] Univ Washington, Dept Clin Care & Resp Med, Seattle, WA 98195 USA	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Washington; University of Washington Seattle	Brioschi, M (corresponding author), Ctr Cardiol Monzino IRCCS, Milan, Italy.	cristina.banfi@ccfm.it	Banfi, Cristina/G-6362-2018; PAROLARI, ALESSANDRO/AAB-1763-2021; POLVANI, GIANLUCA/I-4656-2018; Corrà, Ugo/AAF-8322-2020; Brioschi, Marcos/AAA-7034-2022; Brioschi, Maura/G-5687-2018; Agostoni, Piergiuseppe/ABG-9556-2020; Brioschi, Maura/AAB-4860-2019; TREMOLI, ELENA/I-8126-2018	Banfi, Cristina/0000-0003-3346-9879; PAROLARI, ALESSANDRO/0000-0002-6954-0422; POLVANI, GIANLUCA/0000-0003-1055-0965; Corrà, Ugo/0000-0002-9229-3298; Brioschi, Marcos/0000-0003-4822-8314; Brioschi, Maura/0000-0003-4706-4418; Agostoni, Piergiuseppe/0000-0002-8345-6382; Brioschi, Maura/0000-0003-4706-4418; TREMOLI, ELENA/0000-0002-0929-6106	European Commission, Sixth Framework Programme; LIFESCIHEALTH [LSHM-CT-2007-037273-PROCARDIS]; Italian Ministry of Health, Rome, Italy [2009 BIO 26]	European Commission, Sixth Framework Programme(European CommissionEuropean Commission Joint Research Centre); LIFESCIHEALTH; Italian Ministry of Health, Rome, Italy(Ministry of Health, Italy)	This study was conducted with the support of the European Commission, Sixth Framework Programme, LIFESCIHEALTH Contract No. LSHM-CT-2007-037273-PROCARDIS, and by a grant from Italian Ministry of Health, Rome, Italy (Ricerca Corrente 2009 BIO 26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2012, CURR HEART FAIL 0103; Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; Aldini G, 2005, J MASS SPECTROM, V40, P946, DOI 10.1002/jms.872; Banan A, 2000, GUT, V46, P830, DOI 10.1136/gut.46.6.830; Banfi C, 2005, PROTEOMICS, V5, P4443, DOI 10.1002/pmic.200402017; Banfi C, 2008, EUR J HEART FAIL, V10, P244, DOI 10.1016/j.ejheart.2008.01.016; Barreiro E, 2005, AM J RESP CELL MOL, V33, P636, DOI 10.1165/rcmb.2005-0114OC; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield DA, 1997, J NEUROCHEM, V68, P2451; Canton M, 2004, AM J PHYSIOL-HEART C, V286, pH870, DOI 10.1152/ajpheart.00714.2003; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Decking UKM, 2001, CARDIOVASC RES, V51, P313, DOI 10.1016/S0008-6363(01)00317-0; Dhalla AK, 1996, J AM COLL CARDIOL, V28, P506, DOI 10.1016/0735-1097(96)00140-4; Gayarre J, 2006, BIOCHEM BIOPH RES CO, V349, P1387, DOI 10.1016/j.bbrc.2006.09.005; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gonzalez DR, 2010, J BIOL CHEM, V285, P28938, DOI 10.1074/jbc.M110.154948; Griffiths HR, 2000, FREE RADICAL RES, V33, pS47; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; Koufen P, 2000, BBA-MOL BASIS DIS, V1501, P44, DOI 10.1016/S0925-4439(00)00005-3; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Linares M, 2011, J PROTEOME RES, V10, P1719, DOI 10.1021/pr101014e; Lokuta AJ, 2005, CIRCULATION, V111, P988, DOI 10.1161/01.CIR.0000156461.81529.D7; Lu Z, 2008, HYPERTENSION, V51, P19, DOI 10.1161/HYPERTENSIONAHA.107.098186; Mallat Z, 1998, CIRCULATION, V97, P1536, DOI 10.1161/01.CIR.97.16.1536; Mihm MJ, 2001, CARDIOVASC RES, V49, P798, DOI 10.1016/S0008-6363(00)00307-2; Missov E, 1997, CIRCULATION, V96, P2953, DOI 10.1161/01.CIR.96.9.2953; Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005; Nascimben L, 1996, CIRCULATION, V94, P1894, DOI 10.1161/01.CIR.94.8.1894; Nasr Gamela, 2010, J Cardiovasc Dis Res, V1, P191, DOI 10.4103/0975-3583.74262; Neubauer S, 1997, CIRCULATION, V96, P2190; O'Reilly PJ, 2003, AM J RESP CELL MOL, V28, P443, DOI 10.1165/rcmb.2002-0153OC; Oh-Ishi M, 2003, FREE RADICAL BIO MED, V34, P11, DOI 10.1016/S0891-5849(02)01239-X; Pantke U, 1999, FREE RADICAL BIO MED, V27, P1080, DOI 10.1016/S0891-5849(99)00144-6; Rabilloud T, 2005, EXPERT REV PROTEOMIC, V2, P949, DOI 10.1586/14789450.2.6.949; RAPPAPORT L, 1984, EUR HEART J, V5, P243, DOI 10.1093/eurheartj/5.suppl_F.243; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Sawyer DB, 2002, J MOL CELL CARDIOL, V34, P379, DOI 10.1006/jmcc.2002.1526; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Schulman IH, 2011, BIOCH BIOPHYS A 0416; Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605; SOBOTKA PA, 1993, FREE RADICAL BIO MED, V14, P643, DOI 10.1016/0891-5849(93)90145-K; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; THOMAS C, 1994, FREE RADICAL RES, V21, P387, DOI 10.3109/10715769409056591; VENTURACLAPIER R, 1994, MOL CELL BIOCHEM, V133, P125, DOI 10.1007/BF01267952; Wallimann T, 1985, Cell Muscle Motil, V6, P239; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wood TD, 1998, P NATL ACAD SCI USA, V95, P3362, DOI 10.1073/pnas.95.7.3362; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xu X, 2008, J CARD FAIL, V14, P746, DOI 10.1016/j.cardfail.2008.06.006; Zhang P, 2007, CIRC RES, V100, P1089, DOI 10.1161/01.RES.0000264081.78659.45	60	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35841	10.1371/journal.pone.0035841	http://dx.doi.org/10.1371/journal.pone.0035841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606238	gold, Green Published			2022-12-27	WOS:000305339400008
J	Chen, Q; Deng, HH; Brauth, SE; Ding, L; Tang, YZ				Chen, Qin; Deng, Huanhuan; Brauth, Steven E.; Ding, Li; Tang, Yezhong			Reduced Performance of Prey Targeting in Pit Vipers with Contralaterally Occluded Infrared and Visual Senses	PLOS ONE			English	Article							CROTALUS-VIRIDIS-OREGANUS; OPTIC TECTUM; STRIKE BEHAVIOR; RATTLESNAKE; DEPRIVATION; SNAKES; INTEGRATION	Both visual and infrared (IR) senses are utilized in prey targeting by pit vipers. Visual and IR inputs project to the contralateral optic tectum where they activate both multimodal and bimodal neurons. A series of ocular and pit organ occlusion experiments using the short-tailed pit viper (Gloydius brevicaudus) were conducted to investigate the role of visual and IR information during prey targeting. Compared with unoccluded controls, snakes with either both eyes or pit organs occluded performed more poorly in hunting prey although such subjects still captured prey on 75% of trials. Subjects with one eye and one pit occluded on the same side of the face performed as well as those with bilateral occlusion although these subjects showed a significant targeting angle bias toward the unoccluded side. Performance was significantly poorer when only a single eye or pit was available. Interestingly, when one eye and one pit organ were occluded on opposite sides of the face, performance was poorest, the snakes striking prey on no more than half the trials. These results indicate that, visual and infrared information are both effective in prey targeting in this species, although interference between the two modalities occurs if visual and IR information is restricted to opposite sides of the brain.	[Chen, Qin; Deng, Huanhuan; Ding, Li; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Chen, Qin] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Deng, Huanhuan] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University System of Maryland; University of Maryland College Park; Chongqing Normal University	Chen, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China.	tangyz@cib.ac.cn			Chinese Academy of Sciences Bairen Jihua [KSCX2-YW-R-077]; National Natural Science Foundation of China [NSFC 31071913, NSFC 30900141]; Chinese Academy of Sciences [KSCX2-EW-J-22]	Chinese Academy of Sciences Bairen Jihua(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the "Chinese Academy of Sciences Bairen Jihua'' (KSCX2-YW-R-077), the National Natural Science Foundation of China (NSFC 31071913), and the National Natural Science Foundation of China (NSFC 30900141) and Chinese Academy of Sciences (KSCX2-EW-J-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken GS, 2007, J EXP BIOL, V210, P2801, DOI 10.1242/jeb.006965; BLOCK MJ, 1950, NATURE, V165, P284, DOI 10.1038/165284b0; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Campbell AL, 2002, BIOL INFRARED IMAGIN, P211; de Cock Buning T, 1983, INTEGR COMP BIOL, V23, P363; EBBESSON SOE, 1981, SCIENCE, V214, P924, DOI 10.1126/science.6171033; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3; Grace MS, 2001, BRAIN RES, V919, P250, DOI 10.1016/S0169-328X(01)00248-0; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Haverly JE, 1996, COPEIA, P419; Herrero L, 1999, J COMP NEUROL, V411, P455, DOI 10.1002/(SICI)1096-9861(19990830)411:3<455::AID-CNE8>3.0.CO;2-7; Kardong K.V., 1992, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V122, P233; Kardong Kenneth V., 2002, P253; KARDONG KV, 1986, J COMP PSYCHOL, V100, P304; KARDONG KV, 1991, J HERPETOL, V25, P208, DOI 10.2307/1564650; Kardong KV, 1999, BRAIN BEHAV EVOLUT, V53, P20, DOI 10.1159/000006579; KASS L, 1978, J COMP NEUROL, V182, P811, DOI 10.1002/cne.901820505; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Maczko KA, 2006, J NEUROSCI, V26, P12799, DOI 10.1523/JNEUROSCI.3946-06.2006; NEWMAN EA, 1981, SCIENCE, V213, P789, DOI 10.1126/science.7256281; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; ROBERT F, 1969, EXP BRAIN RES, V9, P123; Robertson B, 2006, J COMP NEUROL, V499, P106, DOI 10.1002/cne.21078; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; Sichert AB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068105	26	14	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34989	10.1371/journal.pone.0034989	http://dx.doi.org/10.1371/journal.pone.0034989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606229	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400004
J	Jia, XM; Chang, TJ; Wilson, TW; Wu, LY				Jia, Xuming; Chang, Tuanjie; Wilson, Thomas W.; Wu, Lingyun			Methylglyoxal Mediates Adipocyte Proliferation by Increasing Phosphorylation of Akt1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; OXIDATIVE STRESS; ADIPOSE-TISSUE; DIABETES-MELLITUS; UP-REGULATION; INSULIN; ADIPOGENESIS; DIFFERENTIATION; PRODUCT	Methylglyoxal (MG) is a highly reactive metabolite physiologically presented in all biological systems. The effects of MG on diabetes and hypertension have been long recognized. In the present study, we investigated the potential role of MG in obesity, one of the most important factors to cause metabolic syndrome. An increased MG accumulation was observed in the adipose tissue of obese Zucker rats. Cell proliferation assay showed that 5-20 mu M of MG stimulated the proliferation of 3T3-L1 cells. Further study suggested that accumulated-MG stimulated the phosphorylation of Akt1 and its targets including p21 and p27. The activated Akt1 then increased the activity of CDK2 and accelerated the cell cycle progression of 3T3-L1 cells. The effects of MG were efficiently reversed by advanced glycation end product (AGE) breaker alagebrium and Akt inhibitor SH-6. In summary, our study revealed a previously unrecognized effect of MG in stimulating adipogenesis by up-regulation of Akt signaling pathway and this mechanism might offer a new approach to explain the development of obesity.	[Jia, Xuming; Chang, Tuanjie; Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Collage Med, Saskatoon, SK S7N 0W0, Canada; [Wilson, Thomas W.] Univ Saskatchewan, Dept Med, Collage Med, Saskatoon, SK S7N 0W0, Canada; [Wu, Lingyun] Lakehead Univ, Dept Hlth Sci, Thunder Bay, ON P7B 5E1, Canada; [Wu, Lingyun] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	University of Saskatchewan; University of Saskatchewan; Lakehead University; Northern Ontario School of Medicine	Jia, XM (corresponding author), Univ Saskatchewan, Dept Pharmacol, Collage Med, Saskatoon, SK S7N 0W0, Canada.	lwu@lakeheadu.ca			Canadian Institutes of Health Research [MOP-68938]; Heart Stroke foundation of Saskatchewan; Children's Hospital Foundation of Saskatchewan; Heart & Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart Stroke foundation of Saskatchewan; Children's Hospital Foundation of Saskatchewan; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work is supported by operating grants of Canadian Institutes of Health Research (MOP-68938) (http://www.cihr-irsc.gc.ca/); Heart Stroke foundation of Saskatchewan (http://www.heartandstroke.sk.ca/site/c.inKMILNlEmG/b.3657319/k.F889/Heart_Disease_Stroke_and_Healthy_Living.htm); and Children's Hospital Foundation of Saskatchewan to L. Wu (http://www.childrenshospitalsask.ca/); X. Jia received a doctoral award from Heart & Stroke Foundation of Canada (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger BGK, 2005, ANN NY ACAD SCI, V1043, P201, DOI 10.1196/annals.1333.025; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bhattacharya I, 2006, FEBS LETT, V580, P5765, DOI 10.1016/j.febslet.2006.09.032; Brady MJ, 1999, J BIOL CHEM, V274, P27497, DOI 10.1074/jbc.274.39.27497; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chang KC, 2002, MOL PHARMACOL, V61, P1184, DOI 10.1124/mol.61.5.1184; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Chang TJ, 2011, FASEB J, V25, P1746, DOI 10.1096/fj.10-178053; Chaplen FWR, 1996, ANAL BIOCHEM, V236, P262, DOI 10.1006/abio.1996.0165; Chuang CC, 2007, ENDOCRINOLOGY, V148, P4267, DOI 10.1210/en.2007-0179; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; HAGER A, 1977, METABOLISM, V26, P607, DOI 10.1016/0026-0495(77)90082-8; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Jia XM, 2007, MOL CELL BIOCHEM, V306, P133, DOI 10.1007/s11010-007-9563-x; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kani S, 2007, GENES CELLS, V12, P919, DOI 10.1111/j.1365-2443.2007.01100.x; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kim Jin-Bae, 2010, Korean Circ J, V40, P520, DOI 10.4070/kcj.2010.40.10.520; Liu JH, 2011, CARDIOVASC RES, V92, P494, DOI 10.1093/cvr/cvr239; Menghini R, 2005, CIRCULATION, V111, P1946, DOI 10.1161/01.CIR.0000161814.02942.B2; MONNIER VM, 1981, PROG FOOD NUTR SCI, V5, P315; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; Ota K, 2007, BIOCHEM BIOPH RES CO, V357, P270, DOI 10.1016/j.bbrc.2007.03.140; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pi J, 2007, DIABETES; REICHARD GA, 1986, DIABETES, V35, P668, DOI 10.2337/diabetes.35.6.668; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Rosen ED, 2000, GENE DEV, V14, P1293; Shamsi FA, 1998, J BIOL CHEM, V273, P6928, DOI 10.1074/jbc.273.12.6928; Thomas MC, 2005, CURR DRUG TARGETS, V6, P453, DOI 10.2174/1389450054021873; Vasdev Sudesh, 1998, Artery, V23, P10; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2007, AM J HYPERTENS, V20, P629, DOI 10.1016/j.amjhyper.2006.12.003; Wang XX, 2004, KIDNEY INT, V66, P2315, DOI 10.1111/j.1523-1755.2004.66034.x; Watson AMD, 2011, DIABETOLOGIA, V54, P681, DOI 10.1007/s00125-010-2000-9; Wu L, 2001, DIABETOLOGIA, V44, P2004, DOI 10.1007/s001250100004; Wu LY, 2009, LAB INVEST, V89, P59, DOI 10.1038/labinvest.2008.109; Wu LY, 2002, HYPERTENSION, V39, P809, DOI 10.1161/hy0302.105207; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	48	36	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36610	10.1371/journal.pone.0036610	http://dx.doi.org/10.1371/journal.pone.0036610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606274	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400025
J	Van der Velden, J; Barker, D; Barcham, G; Koumoundouros, E; Snibson, K				Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth			Increased Mast Cell Density and Airway Responses to Allergic and Non-Allergic Stimuli in a Sheep Model of Chronic Asthma	PLOS ONE			English	Article							SMOOTH-MUSCLE; LUNG-FUNCTION; INFLAMMATION; CHALLENGE	Background: Increased mast cell (MC) density and changes in their distribution in airway tissues is thought to contribute significantly to the pathophysiology of asthma. However, the time sequence for these changes and how they impact small airway function in asthma is not fully understood. The aim of the current study was to characterise temporal changes in airway MC density and correlate these changes with functional airway responses in sheep chronically challenged with house dust mite (HDM) allergen. Methodology/Principal Findings: MC density was examined on lung tissue from four spatially separate lung segments of allergic sheep which received weekly challenges with HDM allergen for 0, 8, 16 or 24 weeks. Lung tissue was collected from each segment 7 days following the final challenge. The density of tryptase-positive and chymase-positive MCs (MCT and MCTC respectively) was assessed by morphometric analysis of airway sections immunohistochemically stained with antibodies against MC tryptase and chymase. MCT and MCTC density was increased in small bronchi following 24 weeks of HDM challenges compared with controls (P<0.05). The MCTC/MCT ratio was significantly increased in HDM challenged sheep compared to controls (P<0.05). MCT and MCTC density was inversely correlated with allergen-induced increases in peripheral airway resistance after 24 weeks of allergen exposure (P<0.05). MCT density was also negatively correlated with airway responsiveness after 24 challenges (P<0.01). Conclusions: MCT and MCTC density in the small airways correlates with better lung function in this sheep model of chronic asthma. Whether this finding indicates that under some conditions mast cells have protective activities in asthma, or that other explanations are to be considered requires further investigation.	[Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth] Univ Melbourne, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia; [Van der Velden, Joanne] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Sch Engn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia.	ksnibson@unimelb.edu.au	; KOUMOUNDOUROS, EMMANUEL/H-5766-2016	Snibson, Kenneth/0000-0003-4772-9408; Barker, Donna/0000-0003-2005-5239; KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X	National Health and Medical Research Council (NHMRC) of Australia [454437]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (Grant no. 454437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WM, 2008, PULM PHARMACOL THER, V21, P743, DOI 10.1016/j.pupt.2008.01.010; Abraham WM, 2002, AM J PHYSIOL-LUNG C, V282, pL193, DOI 10.1152/ajplung.00429.2001; Andersson CK, 2010, AM J RESP CRIT CARE, V181, P206, DOI 10.1164/rccm.200906-0932OC; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Balzar S, 2005, AM J RESP CRIT CARE, V171, P431, DOI 10.1164/rccm.200407-949OC; Bradding P, 2009, THORAX, V64, P278, DOI 10.1136/thx.2008.106427; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Coffman RL, 2005, J EXP MED, V201, P1875, DOI 10.1084/jem.20050901; Collie DDS, 2003, CLIN EXP ALLERGY, V33, P282, DOI 10.1046/j.1365-2745.2003.01617.x; Collie DDS, 2001, CLIN EXP ALLERGY, V31, P1636, DOI 10.1046/j.1365-2222.2001.01225.x; CONNELL JT, 1971, J AMER MED ASSOC, V215, P769, DOI 10.1001/jama.215.5.769; Gosman MM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-64; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Hsieh FH, 2005, P NATL ACAD SCI USA, V102, P14380, DOI 10.1073/pnas.0503948102; IRANI AA, 1992, IMMUNOLOGY, V77, P136; Kariyawasam HH, 2005, CLIN EXP ALLERGY, V35, P117, DOI 10.1111/j.1365-2222.2005.02173.x; Lazaar AL, 2002, J IMMUNOL, V169, P1014, DOI 10.4049/jimmunol.169.2.1014; McParland BE, 2003, J APPL PHYSIOL, V95, P426, DOI 10.1152/japplphysiol.00159.2003; Miller HRP, 2002, IMMUNOLOGY, V105, P375, DOI 10.1046/j.1365-2567.2002.01375.x; Molinari JF, 1996, AM J RESP CRIT CARE, V154, P649, DOI 10.1164/ajrccm.154.3.8810600; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; Sommerhoff CP, 2001, AM J RESP CRIT CARE, V164, pS52, DOI 10.1164/ajrccm.164.supplement_2.2106058; Van der Velden J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028740; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Wong GW, 2002, J BIOL CHEM, V277, P41906, DOI 10.1074/jbc.M205868200; Zanini A, 2007, J ALLERGY CLIN IMMUN, V120, P329, DOI 10.1016/j.jaci.2007.04.021	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37161	10.1371/journal.pone.0037161	http://dx.doi.org/10.1371/journal.pone.0037161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606346	gold, Green Published			2022-12-27	WOS:000305339400072
J	Hen, G; Yosefi, S; Shinder, D; Or, A; Mygdal, S; Condiotti, R; Galun, E; Bor, A; Sela-Donenfeld, D; Friedman-Einat, M				Hen, Gideon; Yosefi, Sara; Shinder, Dmitry; Or, Adi; Mygdal, Sivan; Condiotti, Reba; Galun, Eithan; Bor, Amir; Sela-Donenfeld, Dalit; Friedman-Einat, Miriam			Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic Membrane	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; PRIMORDIAL GERM-CELLS; LONG-TERM EXPRESSION; TRANSFER IN-VIVO; ALPHA-MSH; TRANSGENIC CHICKENS; DEVELOPMENTAL BIOLOGY; NEUROPEPTIDE-Y; STEM-CELLS; TRANSDUCTION	The lack of affordable techniques for gene transfer in birds has inhibited the advancement of molecular studies in avian species. Here we demonstrate a new approach for introducing genes into chicken somatic tissues by administration of a lentiviral vector, derived from the feline immunodeficiency virus (FIV), into the chorioallantoic membrane (CAM) of chick embryos on embryonic day 11. The FIV-derived vectors carried yellow fluorescent protein (YFP) or recombinant alpha-melanocyte-stimulating hormone (alpha-MSH) genes, driven by the cytomegalovirus (CMV) promoter. Transgene expression, detected in chicks 2 days after hatch by quantitative real-time PCR, was mostly observed in the liver and spleen. Lower expression levels were also detected in the brain, kidney, heart and breast muscle. Immunofluorescence and flow cytometry analyses confirmed transgene expression in chick tissues at the protein level, demonstrating a transduction efficiency of similar to 0.46% of liver cells. Integration of the viral vector into the chicken genome was demonstrated using genomic repetitive (CR1)-PCR amplification. Viability and stability of the transduced cells was confirmed using terminal deoxynucleotidyl transferase (dUTP) nick end labeling (TUNEL) assay, immunostaining with anti-proliferating cell nuclear antigen (anti-PCNA), and detection of transgene expression 51 days post transduction. Our approach led to only 9% drop in hatching efficiency compared to non-injected embryos, and all of the hatched chicks expressed the transgenes. We suggest that the transduction efficiency of FIV vectors combined with the accessibility of the CAM vasculature as a delivery route comprise a new powerful and practical approach for gene delivery into somatic tissues of chickens. Most relevant is the efficient transduction of the liver, which specializes in the production and secretion of proteins, thereby providing an optimal target for prolonged study of secreted hormones and peptides.	[Hen, Gideon; Yosefi, Sara; Shinder, Dmitry; Or, Adi; Bor, Amir; Friedman-Einat, Miriam] Agr Res Org, Volcani Ctr, Minist Agr, IL-50250 Bet Dagan, Israel; [Hen, Gideon; Mygdal, Sivan; Sela-Donenfeld, Dalit] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Condiotti, Reba; Galun, Eithan] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Hen, G (corresponding author), Agr Res Org, Volcani Ctr, Minist Agr, IL-50250 Bet Dagan, Israel.	seladon@agri.huji.ac.il; einat@agri.huji.ac.il	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702; Sela-Donenfeld, Dalit/0000-0001-7498-061X; Friedman-Einat, Miriam/0000-0002-9451-1025	Chief Scientist Ministry of Agriculture, Israel; The Hebrew University Lohenshtein Fund for Medical Research; The Deutsche Forschungsgemeinschaft [SFB 841]	Chief Scientist Ministry of Agriculture, Israel; The Hebrew University Lohenshtein Fund for Medical Research; The Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by grants from the Chief Scientist Ministry of Agriculture, Israel, The Hebrew University Lohenshtein Fund for Medical Research and The Deutsche Forschungsgemeinschaft, grant number SFB 841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Andacht T, 2004, MOL REPROD DEV, V69, P31, DOI 10.1002/mrd.20155; Brzoska T, 2010, ADV EXP MED BIOL, V681, P107, DOI 10.1007/978-1-4419-6354-3_8; CAPUZZI DM, 1974, J BIOL CHEM, V249, P1286; Cline MA, 2007, PHYSIOL BEHAV, V91, P588, DOI 10.1016/j.physbeh.2007.03.021; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Condiotti R, 2004, BIOCHEM BIOPH RES CO, V320, P998, DOI 10.1016/j.bbrc.2004.06.044; Coullin P, 2005, CHROMOSOME RES, V13, P665, DOI 10.1007/s10577-005-1004-7; Di Domenico C, 2006, HUM GENE THER, V17, P1112; Grinshpun A, 2010, MOL THER, V18, P1592, DOI 10.1038/mt.2010.119; Hen G, 2006, DOMEST ANIM ENDOCRIN, V30, P135, DOI 10.1016/j.domaniend.2005.06.002; Hen G, 2006, J ENDOCRINOL, V190, P527, DOI 10.1677/joe.1.06783; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ivarie R, 2006, TRENDS BIOTECHNOL, V24, P99, DOI 10.1016/j.tibtech.2006.01.004; Kafri Tal, 2004, Methods Mol Biol, V246, P367; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kawakami S, 2000, EUR J PHARMACOL, V398, P361, DOI 10.1016/S0014-2999(00)00344-7; KUNZIRAPP K, 1992, IN VITRO CELL DEV-AN, V28A, P565; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee DJ, 2009, INT IMMUNOPHARMACOL, V9, P1079, DOI 10.1016/j.intimp.2009.05.001; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Motono M, 2010, J BIOSCI BIOENG, V109, P315, DOI 10.1016/j.jbiosc.2009.10.007; Mozdziak PE, 2004, DEV DYNAM, V229, P414, DOI 10.1002/dvdy.10461; Nakamura Y, 2010, BIOL REPROD, V83, P130, DOI 10.1095/biolreprod.110.083923; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Penno CA, 2010, TRANSGENIC RES, V19, P187, DOI 10.1007/s11248-009-9310-z; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Rapp JC, 2003, TRANSGENIC RES, V12, P569, DOI 10.1023/A:1025854217349; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; RUSSELL D, 1968, P NATL ACAD SCI USA, V60, P1420, DOI 10.1073/pnas.60.4.1420; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; Shai E, 2005, MOL THER, V12, P137, DOI 10.1016/j.ymthe.2005.02.022; SHEN RF, 1987, NUCLEIC ACIDS RES, V15, P8399, DOI 10.1093/nar/15.20.8399; Steiling W, 1999, TOXICOL IN VITRO, V13, P375, DOI 10.1016/S0887-2333(98)00091-5; Stern CD, 2004, MECH DEVELOP, V121, P1011, DOI 10.1016/j.mod.2004.06.009; Tachibana T, 2007, COMP BIOCHEM PHYS A, V148, P408, DOI 10.1016/j.cbpa.2007.05.023; Tachibana T, 2007, COMP BIOCHEM PHYS A, V147, P173, DOI 10.1016/j.cbpa.2006.12.044; Takeuchi S, 2003, ANN NY ACAD SCI, V994, P366, DOI 10.1111/j.1749-6632.2003.tb03201.x; Teshigawara K, 2001, J ENDOCRINOL, V168, P527, DOI 10.1677/joe.0.1680527; Thody AJ, 1999, ANN NY ACAD SCI, V885, P217, DOI 10.1111/j.1749-6632.1999.tb08679.x; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wang CH, 2006, GENE THER, V13, P1000, DOI 10.1038/sj.gt.3302744; Wei Q, 2001, POULTRY SCI, V80, P1671, DOI 10.1093/ps/80.12.1671; Wicker T, 2005, GENOME RES, V15, P126, DOI 10.1101/gr.2438005; Yin P, 2003, GENE THER, V10, P348, DOI 10.1038/sj.gt.3301902	54	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36531	10.1371/journal.pone.0036531	http://dx.doi.org/10.1371/journal.pone.0036531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606269	Green Published, gold			2022-12-27	WOS:000305338200032
J	Jeschke, MG; Williams, FN; Finnerty, CC; Rodriguez, NA; Kulp, GA; Ferrando, A; Norbury, WB; Suman, OE; Kraft, R; Branski, LK; Al-mousawi, AM; Herndon, DN				Jeschke, Marc G.; Williams, Felicia N.; Finnerty, Celeste C.; Rodriguez, Noe A.; Kulp, Gabriela A.; Ferrando, Arny; Norbury, William B.; Suman, Oscar E.; Kraft, Robert; Branski, Ludwik K.; Al-mousawi, Ahmed M.; Herndon, David N.			The Effect of Ketoconazole on Post-Burn Inflammation, Hypermetabolism and Clinical Outcomes	PLOS ONE			English	Article							SEVERELY BURNED CHILDREN; PITUITARY-ADRENAL AXIS; ENERGY-EXPENDITURE; SKELETAL-MUSCLE; CORTISOL; INJURY; SEPSIS; GLUCOCORTICOIDS; OXANDROLONE; INHIBITION	Background: Hypercortisolemia has been suggested as a primary hormonal mediator of whole-body catabolism following severe burn injury. Ketoconazole, an anti-fungal agent, inhibits cortisol synthesis. We, therefore, studied the effect of ketoconazole on post-burn cortisol levels and the hyper-catabolic response in a prospective randomized trial (block randomization 2:1). Methodology/Principal Findings: Fifty-five severely burned pediatric patients with >30% total body surface area (TBSA) burns were enrolled in this trial. Patients were randomized to receive standard care plus either placebo (controls, n = 38) or ketoconazole (n = 23). Demographics, clinical data, serum hormone levels, serum cytokine expression profiles, organ function, hypermetabolism measures, muscle protein synthesis, incidence of wound infection sepsis, and body composition were obtained throughout the acute hospital course. Statistical analysis was performed using Fisher's exact test, Student's t-test, and parametric and non-parametric two-way repeated measures analysis of variance where applicable. Patients were similar in demographics, age, and TBSA burned. Ketoconazole effectively blocked cortisol production, as indicated by normalization of the 8-fold elevation in urine cortisol levels [F(1, 376) = 85.34, p<.001] with the initiation of treatment. However, there were no significant differences in the inflammatory response, acute-phase proteins, body composition, muscle protein breakdown or synthesis, or organ function between groups. Conclusions: Both groups were markedly hypermetabolic and catabolic throughout the acute hospital stay. Normalization of hypercortisolemia with ketoconazole therapy had no effect on whole-body catabolism or the post-burn inflammatory or hypermetabolic response, suggesting that hypercortisolemia does not play a central role in the post-burn hypermetabolic catabolic response.	[Jeschke, Marc G.; Williams, Felicia N.; Finnerty, Celeste C.; Rodriguez, Noe A.; Kulp, Gabriela A.; Norbury, William B.; Suman, Oscar E.; Kraft, Robert; Branski, Ludwik K.; Al-mousawi, Ahmed M.; Herndon, David N.] Univ Texas Med Branch, Shriners Hosp Children, Galveston, TX 77555 USA; [Jeschke, Marc G.; Williams, Felicia N.; Finnerty, Celeste C.; Rodriguez, Noe A.; Kulp, Gabriela A.; Norbury, William B.; Suman, Oscar E.; Kraft, Robert; Branski, Ludwik K.; Al-mousawi, Ahmed M.; Herndon, David N.] Univ Texas Med Branch, Dept Surg, Galveston, TX USA; [Finnerty, Celeste C.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA; [Finnerty, Celeste C.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX USA; [Ferrando, Arny] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Jeschke, Marc G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Arkansas System; University of Arkansas Medical Sciences; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jeschke, MG (corresponding author), Univ Texas Med Branch, Shriners Hosp Children, Galveston, TX 77555 USA.	dherndon@utmb.edu	Herndon, David/AAC-3354-2020; Branski, Ludwik K./M-8775-2019; suman, oscar/GVS-8712-2022	Branski, Ludwik K./0000-0002-4736-7307; Rodriguez, Noe/0000-0002-3216-6545	Shriners Hospitals for Children [8660, 8490, 8640, 8760, 9145]; National Institutes of Health [2T32-GM008256-11, 1P50-GM060338-01, R01-GM56687, R01-HD049471, U54-GM062119, R01 GM087285-01]; National Institute on Disability and Rehabilitation Research [H133A020102, H133A70019]; American Surgical Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056687, P50GM060338, T32GM008256, U54GM062119, R01GM087285] Funding Source: NIH RePORTER	Shriners Hospitals for Children; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Disability and Rehabilitation Research; American Surgical Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from Shriners Hospitals for Children (8660, 8490, 8640, 8760, and 9145), National Institutes of Health (2T32-GM008256-11, 1P50-GM060338-01, R01-GM56687, R01-HD049471, U54-GM062119, R01 GM087285-01), National Institute on Disability and Rehabilitation Research (H133A020102, H133A70019), and the American Surgical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2006, AM J RESP CRIT CARE, V174, P1319, DOI 10.1164/rccm.200509-1369OC; Barrow RE, 2006, ANN SURG, V243, P115, DOI 10.1097/01.sla.0000193834.07413.91; Barrow RE, 2004, BURNS, V30, P565, DOI 10.1016/j.burns.2004.01.027; BOSCARO M, 1987, CLIN ENDOCRINOL, V27, P461, DOI 10.1111/j.1365-2265.1987.tb01174.x; BRILLON DJ, 1995, AM J PHYSIOL-ENDOC M, V268, pE501, DOI 10.1152/ajpendo.1995.268.3.E501; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cohen J, 2009, CRIT CARE RESUSC, V11, P287; DARMAUN D, 1988, AM J PHYSIOL, V255, pE366, DOI 10.1152/ajpendo.1988.255.3.E366; DeCoster R, 1996, J STEROID BIOCHEM, V56, P133, DOI 10.1016/0960-0760(95)00230-8; DEFELICE R, 1981, ANTIMICROB AGENTS CH, V19, P1073, DOI 10.1128/AAC.19.6.1073; Deuschle M, 2003, NEUROPSYCHOPHARMACOL, V28, P379, DOI 10.1038/sj.npp.1300044; ENGELHARDT D, 1985, KLIN WOCHENSCHR, V63, P607, DOI 10.1007/BF01733014; Ferrando AA, 1999, J CLIN ENDOCR METAB, V84, P3515, DOI 10.1210/jc.84.10.3515; Ferrando AA, 2007, CRIT CARE MED, V35, pS630, DOI 10.1097/01.CCM.0000278529.44899.57; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; Gauglitz GG, 2009, J CLIN ENDOCR METAB, V94, P1656, DOI 10.1210/jc.2008-1947; GORE DC, 1993, ANN SURG, V218, P679, DOI 10.1097/00000658-199321850-00015; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Hart DW, 2001, CRIT CARE MED, V29, P1318, DOI 10.1097/00003246-200107000-00004; Hart DW, 2000, ANN SURG, V232, P455, DOI 10.1097/00000658-200010000-00001; Hasselgren PO, 1995, BIOCHEM SOC T, V23, P1019, DOI 10.1042/bst0231019; Hasselgren PO, 1999, NUTR METAB, V2, P201, DOI DOI 10.1097/00075197-199905000-00002); Hazinski MF, 1992, NURSING CARE CRITICA, P117; Herndon DN, 2004, LANCET, V363, P1895, DOI 10.1016/S0140-6736(04)16360-5; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; Hobson KG, 2004, J BURN CARE REHABIL, V25, P491, DOI 10.1097/01.BCR.0000144532.02792.6E; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jeschke MG, 2007, CRIT CARE, V11, DOI 10.1186/cc6102; Jeschke MG, 2007, ANN SURG, V246, P351, DOI 10.1097/SLA.0b013e318146980e; Jeschke MG, 2007, SHOCK, V28, P172, DOI 10.1097/shk.0b013e318047b9e2; Jeschke MG, 2007, CRIT CARE MED, V35, P579, DOI 10.1097/01.CCM.0000253812.09236.98; Klein GL, 2004, OSTEOPOROSIS INT, V15, P468, DOI 10.1007/s00198-003-1572-3; LOOSE DS, 1983, J CLIN INVEST, V71, P1495, DOI 10.1172/JCI110903; MINIFEE PK, 1989, J PEDIATR SURG, V24, P806, DOI 10.1016/S0022-3468(89)80541-X; Mlcak RP, 2006, ANN SURG, V244, P121, DOI 10.1097/01.sla.0000217678.78472.d3; MOLTENI A, 1979, ANN CLIN LAB SCI, V9, P518; Norbury WB, 2008, J CLIN ENDOCR METAB, V93, P1270, DOI 10.1210/jc.2006-2158; OSULLIVAN ST, 1995, ANN SURG, V222, P482; Palmieri TL, 2006, J BURN CARE RES, V27, P742, DOI 10.1097/01.BCR.0000238098.43888.07; Pirlich M, 2002, J CLIN ENDOCR METAB, V87, P1078, DOI 10.1210/jc.87.3.1078; PONT A, 1982, ANN INTERN MED, V97, P370, DOI 10.7326/0003-4819-97-3-370; Przkora R, 2005, ANN SURG, V242, P384, DOI 10.1097/01.sla.0000180398.70103.24; Przkora R, 2006, J TRAUMA, V60, P968, DOI 10.1097/01.ta.0000214580.27501.19; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Tsigos C, 1996, ANNU REV MED, V47, P443; VANDENBOSSCHE H, 1980, ANTIMICROB AGENTS CH, V17, P922, DOI 10.1128/AAC.17.6.922; Wiedemann HP, 2000, JAMA-J AM MED ASSOC, V283, P1995; WILMORE DW, 1978, SURG CLIN N AM, V58, P1173; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; Wolfe R.R., 2005, PRINCIPLES PRACTICE	50	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35465	10.1371/journal.pone.0035465	http://dx.doi.org/10.1371/journal.pone.0035465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606232	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200010
J	Kayigamba, FR; Bakker, MI; Fikse, H; Mugisha, V; Asiimwe, A; van der Loeff, MFS				Kayigamba, Felix R.; Bakker, Mirjam I.; Fikse, Hadassa; Mugisha, Veronicah; Asiimwe, Anita; van der Loeff, Maarten F. Schim			Patient Enrolment into HIV Care and Treatment within 90 Days of HIV Diagnosis in Eight Rwandan Health Facilities: A Review of Facility-Based Registers	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; PROGRAM; MORTALITY; ADULTS; RETENTION; OUTCOMES; SERVICE; COHORT	Introduction: Access to antiretroviral therapy (ART) has increased greatly in sub-Saharan Africa. However many patients do not enrol timely into HIV care and treatment after HIV diagnosis. We studied enrolment into care and treatment and determinants of non-enrolment in Rwanda. Methods: Data were obtained from routine clinic registers from eight health facilities in Rwanda on patients who were diagnosed with HIV at the antenatal care, voluntary counselling-and-testing, outpatient or tuberculosis departments between March and May 2009. The proportion of patients enrolled into HIV care and treatment was calculated as the number of HIV infected patients registered in ART clinics for follow-up care and treatment within 90 days of HIV diagnosis divided by the total number of persons diagnosed with HIV in the study period. Results: Out of 482 patients diagnosed with HIV in the study period, 339 (70%) were females, and the median age was 29 years (interquartile range [IQR] 24-37). 201 (42%) enrolled into care and treatment within 90 days of HIV diagnosis. The median time between testing and enrolment was six days (IQR 2-14). Enrolment in care and treatment was not significantly associated with age, sex, or department of testing, but was associated with study site. None of those enrolled were in WHO stage 4. The median CD4 cell count among adult patients was 387 cells/mm(3) (IQR: 242-533 cells/mm(3)); 81 of 170 adult patients (48%) were eligible to start ART (CD4 count, 350 cells/mm 3 or WHO stage 4). Among those eligible, 45 (56%) started treatment within 90 days of HIV diagnosis. Conclusion: Less than 50% of diagnosed HIV patients from eight Rwandan health facilities had enrolled into care and treatment within 90 days of diagnosis. Improving linkage to care and treatment after HIV diagnosis is needed to harness the full potential of ART.	[Kayigamba, Felix R.] INTERACT, Kigali, Rwanda; [Bakker, Mirjam I.; Fikse, Hadassa] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands; [Mugisha, Veronicah] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Kigali, Rwanda; [Asiimwe, Anita] Minist Hlth, Inst HIV Dis Prevent & Control, RBC, Kigali, Rwanda; [van der Loeff, Maarten F. Schim] AIGHD, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] AMC, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), INTERACT, Kigali, Rwanda.	fkaigamba@gmail.com			Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research [W07.05.201.00]; European Union [SANTE/2006/105-316]	Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research; European Union(European Commission)	Both financial and technical support for this study were provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), an organization funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (NWO/WOTRO/Naccap: W07.05.201.00; URL: http://www.nwo.nl/nwohome.nsf/pages/NWOA_6MMGNF) and the European Union (SANTE/2006/105-316; URL: http://ec.europa.eu/europeaid/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lahuerta M, 2011, J ACQ IMMUN DEF SYND, V58, P75; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; McGrath N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-601; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; National Reference Laboratory Rwanda Ministry of Health, 2009, NAT STAND GUID TEST; National TB Control Program Rwanda Ministry of Health, 2005, TB TECHN MAN; Nsanzimana S, 2012, JAIDS-J ACQ IMM DEF, V59, pE17, DOI 10.1097/QAI.0b013e31823e2278; Nsigaye R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-31; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; TRAC Plus Rwanda Ministry of Health, 2009, GUID PROV COMPR CAR; Van Rompaey S, 2011, AIDS CARE, V23, P686, DOI 10.1080/09540121.2010.532538; World Health Organization, 2006, HIV AIDS PROGR UN AC; World Health Organization, 2011, GLOB AIDS RESP EP UP	26	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36792	10.1371/journal.pone.0036792	http://dx.doi.org/10.1371/journal.pone.0036792			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606289	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200044
J	Kratschmar, DV; Calabrese, D; Walsh, J; Lister, A; Birk, J; Appenzeller-Herzog, C; Moulin, P; Goldring, CE; Odermatt, A				Kratschmar, Denise V.; Calabrese, Diego; Walsh, Jo; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Moulin, Pierre; Goldring, Chris E.; Odermatt, Alex			Suppression of the Nrf2-Dependent Antioxidant Response by Glucocorticoids and 11 beta-HSD1-Mediated Glucocorticoid Activation in Hepatic Cells	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; TRANSCRIPTION FACTOR NRF2; TRANSFERASE A2 GENE; HEXOSE-6-PHOSPHATE DEHYDROGENASE; INDUCIBLE EXPRESSION; OXIDATIVE STRESS; BASAL LEVEL; INDUCTION; RECEPTOR; PATHWAY	Background: Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key transcription factor regulating a plethora of detoxifying enzymes and antioxidant genes involved in drug metabolism and defence against oxidative stress. The glucocorticoid receptor (GR) is a ligand-induced transcription factor involved in the regulation of energy supply for metabolic needs to cope with various stressors. GR activity is controlled by glucocorticoids, which are synthesized in the adrenal glands and regenerated mainly in the liver from inactive cortisone by 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-HSD1). Methods and Principal Findings: Using transfected HEK-293 cells and hepatic H4IIE cells we show that glucocorticoids, activated by 11 beta-HSD1 and acting through GR, suppress the Nrf2-dependent antioxidant response. The expression of the marker genes NQO1, HMOX1 and GST2A was suppressed upon treatment of 11 beta-HSD1 expressing cells with cortisone, an effect that was reversed by 11 beta-HSD1 inhibitors. Furthermore, our results demonstrate that elevated glucocorticoids lowered the ability of cells to detoxify H2O2. Moreover, a comparison of gene expression in male and female rats revealed an opposite sexual dimorphism with an inverse relationship between 11 beta-HSD1 and Nrf2 target gene expression. Conclusions: The results demonstrate a suppression of the cellular antioxidant defence capacity by glucocorticoids and suggest that elevated 11 beta-HSD1 activity may lead to impaired Nrf2-dependent antioxidant response. The gender-specific differences in hepatic expression levels of 11 beta-HSD1 and Nrf2 target genes and the impact of pharmacological inhibition of 11 beta-HSD1 on improving cellular capacity to cope with oxidative stress warrants further studies in vivo.	[Kratschmar, Denise V.; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Odermatt, Alex] Univ Basel, Swiss Ctr Appl Human Toxicol, Basel, Switzerland; [Kratschmar, Denise V.; Lister, Adam; Birk, Julia; Appenzeller-Herzog, Christian; Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, Basel, Switzerland; [Calabrese, Diego; Moulin, Pierre] Novartis Pharma AG, Novartis Inst Biomed Res PCS iTox Mol Pathol & Im, Basel, Switzerland; [Walsh, Jo; Goldring, Chris E.] Univ Liverpool, Inst Translat Med, Dept Clin & Mol Pharmacol, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England	University of Basel; University of Basel; Novartis; University of Liverpool	Kratschmar, DV (corresponding author), Univ Basel, Swiss Ctr Appl Human Toxicol, Basel, Switzerland.	alex.odermatt@unibas.ch	Appenzeller-Herzog, Christian/A-2894-2014	Appenzeller-Herzog, Christian/0000-0001-7430-294X; Odermatt, Alex/0000-0002-6820-2712; Walsh, Joanne/0000-0002-5109-2019; Winter, denise V./0000-0002-3764-1747; Calabrese, Diego/0000-0002-0259-8611	Swiss National Science Foundation [31003A-124912]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (No. 31003A-124912; http://www.snf.ch). A.O. has a Chair for Molecular and Systems Toxicology by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2008, CLIN ENDOCRINOL, V68, P898, DOI 10.1111/j.1365-2265.2007.03125.x; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; ALBISTON AL, 1995, MOL CELL ENDOCRINOL, V109, P183, DOI 10.1016/0303-7207(95)03501-W; Arampatzis S, 2005, J MOL ENDOCRINOL, V35, P89, DOI 10.1677/jme.1.01736; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; Atanasov AG, 2006, FEBS LETT, V580, P4081, DOI 10.1016/j.febslet.2006.06.046; Augustine LM, 2008, J BIOCHEM MOL TOXIC, V22, P93, DOI 10.1002/jbt.20224; BALISH E, 1977, JNCI-J NATL CANCER I, V58, P1103, DOI 10.1093/jnci/58.4.1103; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BLUMRICH M, 1994, EUR J CELL BIOL, V64, P339; Boes T, 2005, METHOD INFORM MED, V44, P414; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Dzyakanchuk AA, 2009, MOL CELL ENDOCRINOL, V301, P137, DOI 10.1016/j.mce.2008.08.009; Falkner KC, 2007, DRUG METAB REV, V39, P401, DOI 10.1080/03602530701511216; Falkner KC, 2001, MOL PHARMACOL, V60, P611; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Gomez-Sanchez EP, 2008, ENDOCRINOLOGY, V149, P525, DOI 10.1210/en.2007-0328; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; Kirsch-Volders M, 2010, MUTAGENESIS, V25, P213, DOI 10.1093/mutage/geq008; Kitamura Y, 2007, CANCER SCI, V98, P19, DOI 10.1111/j.1349-7006.2006.00352.x; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Lavery GG, 2007, ENDOCRINOLOGY, V148, P6100, DOI 10.1210/en.2007-0963; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Luo ZF, 2011, LIFE SCI, V88, P512, DOI 10.1016/j.lfs.2010.12.023; Maicas N, 2011, ANTIOXID REDOX SIGN, V15, P889, DOI 10.1089/ars.2010.3835; McMahon M, 2001, CANCER RES, V61, P3299; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Odermatt A, 2001, J BIOL CHEM, V276, P28484, DOI 10.1074/jbc.M100374200; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Platte HD, 1996, EUR J CELL BIOL, V70, P54; Rebuffat AG, 2004, MOL CELL ENDOCRINOL, V214, P27, DOI 10.1016/j.mce.2003.11.027; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; TELAKOWSKIHOPKINS CA, 1988, P NATL ACAD SCI USA, V85, P1000, DOI 10.1073/pnas.85.4.1000; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Zhu GZ, 2001, BIOCHEM BIOPH RES CO, V281, P951, DOI 10.1006/bbrc.2001.4439	51	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36774	10.1371/journal.pone.0036774	http://dx.doi.org/10.1371/journal.pone.0036774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606287	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200041
J	Nie, XJ; Lv, SZ; Zhang, YX; Du, XH; Wang, L; Biradar, SS; Tan, XF; Wan, FH; Song, WN				Nie, Xiaojun; Lv, Shuzuo; Zhang, Yingxin; Du, Xianghong; Wang, Le; Biradar, Siddanagouda S.; Tan, Xiufang; Wan, Fanghao; Song Weining			Complete Chloroplast Genome Sequence of a Major Invasive Species, Crofton Weed (Ageratina adenophora)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA; ASTERACEAE; IDENTIFICATION; ORGANIZATION; EVOLUTION; GENE; PHYLOGENIES; PROGRAM; MARKERS	Background: Crofton weed (Ageratina adenophora) is one of the most hazardous invasive plant species, which causes serious economic losses and environmental damages worldwide. However, the sequence resource and genome information of A. adenophora are rather limited, making phylogenetic identification and evolutionary studies very difficult. Here, we report the complete sequence of the A. adenophora chloroplast (cp) genome based on Illumina sequencing. Methodology/Principal Findings: The A. adenophora cp genome is 150, 689 bp in length including a small single-copy (SSC) region of 18, 358 bp and a large single-copy (LSC) region of 84, 815 bp separated by a pair of inverted repeats (IRs) of 23, 755 bp. The genome contains 130 unique genes and 18 duplicated in the IR regions, with the gene content and organization similar to other Asteraceae cp genomes. Comparative analysis identified five DNA regions (ndhD-ccsA, psbI-trnS, ndhF-ycf1, ndhI-ndhG and atpA-trnR) containing parsimony-informative characters higher than 2%, which may be potential informative markers for barcoding and phylogenetic analysis. Repeat structure, codon usage and contraction of the IR were also investigated to reveal the pattern of evolution. Phylogenetic analysis demonstrated a sister relationship between A. adenophora and Guizotia abyssinica and supported a monophyly of the Asterales. Conclusion: We have assembled and analyzed the chloroplast genome of A. adenophora in this study, which was the first sequenced plastome in the Eupatorieae tribe. The complete chloroplast genome information is useful for plant phylogenetic and evolutionary studies within this invasive species and also within the Asteraceae family.	[Nie, Xiaojun; Song Weining] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Nie, Xiaojun; Lv, Shuzuo; Zhang, Yingxin; Du, Xianghong; Wang, Le; Biradar, Siddanagouda S.; Tan, Xiufang; Song Weining] NW A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Du, Xianghong; Song Weining] NW A&F Univ, China Wheat Improvement Ctr, Yangling Branch, Yangling, Shaanxi, Peoples R China; [Wan, Fanghao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Nie, XJ (corresponding author), NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	wanfh@mail.caas.net.cn; sweining2002@yahoo.com	Nie, Xiaojun/ABE-2666-2021; Wang, Le/AAX-2622-2020	Nie, Xiaojun/0000-0002-4787-7550	Scientific Research Foundation of Northwest AF University; "973" project from the Ministry of Science and Technology, China [2009CB119201]	Scientific Research Foundation of Northwest AF University; "973" project from the Ministry of Science and Technology, China	This work was supported by the Scientific Research Foundation of Northwest A&F University and the "973" project from the Ministry of Science and Technology (2009CB119201), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock R, 2004, TRENDS BIOTECHNOL, V22, P311, DOI 10.1016/j.tibtech.2004.03.005; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bremer K., 1994, ASTERACEAE CLADISTIC; Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cui LY, 2006, NUCLEIC ACIDS RES, V34, pD692, DOI 10.1093/nar/gkj055; Daniell H, 2006, THEOR APPL GENET, V112, P1503, DOI 10.1007/s00122-006-0254-x; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Denda T, 1999, PLANT SYST EVOL, V217, P299, DOI 10.1007/BF00984372; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; GRAY MW, 1989, TRENDS GENET, V5, P294, DOI 10.1016/0168-9525(89)90111-X; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Howe CJ, 2003, PHILOS T ROY SOC B, V358, P99, DOI 10.1098/rstb.2002.1176; KLUGE RL, 1991, AGR ECOSYST ENVIRON, V37, P187, DOI 10.1016/0167-8809(91)90146-O; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Small RL, 1998, AM J BOT, V85, P1301, DOI 10.2307/2446640; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Sun Xiao-yu, 2004, Journal of Forestry Research (Harbin), V15, P319, DOI 10.1007/BF02844961; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triboush SO, 1998, PLANT MOL BIOL REP, V16, P183, DOI 10.1023/A:1007487806583; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; WEINING S, 1994, THEOR APPL GENET, V89, P509, DOI 10.1007/BF00225388; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yin P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-22; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]	54	162	173	5	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36869	10.1371/journal.pone.0036869	http://dx.doi.org/10.1371/journal.pone.0036869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606302	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200053
J	Benhamron, S; Reiner, I; Zcharia, E; Atallah, M; Grau, A; Vlodavsky, I; Mevorach, D				Benhamron, Sandrine; Reiner, Inna; Zcharia, Eyal; Atallah, Mizhir; Grau, Amir; Vlodavsky, Israel; Mevorach, Dror			Dissociation between Mature Phenotype and Impaired Transmigration in Dendritic Cells from Heparanase-Deficient Mice	PLOS ONE			English	Article							SUBENDOTHELIAL EXTRACELLULAR-MATRIX; 1-MATRIX METALLOPROTEINASE; REGULATES DEGRADATION; MAMMALIAN HEPARANASE; CHEMOKINE RECEPTOR; CANCER METASTASIS; LYMPH-NODES; MIGRATION; EXPRESSION; ANGIOGENESIS	To reach the lymphatics, migrating dendritic cells (DCs) need to interact with the extracellular matrix (ECM). Heparanase, a mammalian endo-beta-D-glucuronidase, specifically degrades heparan sulfate proteoglycans ubiquitously associated with the cell surface and ECM. The role of heparanase in the physiology of bone marrow-derived DCs was studied in mutant heparanase knock-out (Hpse-KO) mice. Immature DCs from Hpse-KO mice exhibited a more mature phenotype; however their transmigration was significantly delayed, but not completely abolished, most probably due to the observed upregulation of MMP-14 and CCR7. Despite their mature phenotype, uptake of beads was comparable and uptake of apoptotic cells was more efficient in DCs from Hpse-KO mice. Heparanase is an important enzyme for DC transmigration. Together with CCR7 and its ligands, and probably MMP-14, heparanase controls DC trafficking.	[Benhamron, Sandrine; Reiner, Inna; Atallah, Mizhir; Grau, Amir; Mevorach, Dror] Hadassah Hebrew Univ, Med Ctr, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel; [Zcharia, Eyal; Vlodavsky, Israel] Hadassah Hebrew Univ, Med Ctr, Sharett Inst Oncol, Jerusalem, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Benhamron, S (corresponding author), Hadassah Hebrew Univ, Med Ctr, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel.	mevorachd@hadassah.org.il			Hadassah Medical Organization	Hadassah Medical Organization	This study was supported by a grant from Hadassah Medical Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablin J, 2005, APOPTOSIS, V10, P1009, DOI 10.1007/s10495-005-1189-4; Baumjohann D, 2006, EUR J IMMUNOL, V36, P2544, DOI 10.1002/eji.200535742; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; D'Amico G, 1998, BLOOD, V92, P207, DOI 10.1182/blood.V92.1.207.413a02_207_214; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Duriancik DA, 2009, CYTOM PART A, V75A, P951, DOI 10.1002/cyto.a.20794; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matias-Roman S, 2005, BLOOD, V105, P3956, DOI 10.1182/blood-2004-06-2382; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Osman M, 2002, IMMUNOLOGY, V105, P73, DOI 10.1046/j.0019-2805.2001.01349.x; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Ratzinger G, 2002, J IMMUNOL, V168, P4361, DOI 10.4049/jimmunol.168.9.4361; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; Sasaki N, 2004, J IMMUNOL, V172, P3830, DOI 10.4049/jimmunol.172.6.3830; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Vaday GG, 2000, J LEUKOCYTE BIOL, V67, P149, DOI 10.1002/jlb.67.2.149; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1994, INVAS METAST, V14, P290; VLODAVSKY I, 1983, CANCER RES, V43, P2704; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 1999, CURR PROTOCOLS CE S1, P10; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yang MX, 2006, IMMUNOL CELL BIOL, V84, P557, DOI 10.1111/j.1440-1711.2006.01465.x; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	41	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35602	10.1371/journal.pone.0035602	http://dx.doi.org/10.1371/journal.pone.0035602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590508	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400004
J	Ring, H; Mendu, SK; Shirazi-Fard, S; Birnir, B; Hallbook, F				Ring, Henrik; Mendu, Suresh Kumar; Shirazi-Fard, Shahrzad; Birnir, Bryndis; Hallbook, Finn			GABA Maintains the Proliferation of Progenitors in the Developing Chick Ciliary Marginal Zone and Non-Pigmented Ciliary Epithelium	PLOS ONE			English	Article							RETINAL STEM-CELLS; GLUCAGON-EXPRESSING NEURONS; MULLER GLIA; TRANSCRIPTION FACTORS; INTERNATIONAL-UNION; NEURAL PROGENITORS; CALCIUM-CHANNELS; RECEPTORS; EYE; PHARMACOLOGY	GABA is more than the main inhibitory neurotransmitter found in the adult CNS. Several studies have shown that GABA regulates the proliferation of progenitor and stem cells. This work examined the effects of the GABA(A) receptor system on the proliferation of retinal progenitors and non-pigmented ciliary epithelial (NPE) cells. qRT-PCR and whole-cell patch-clamp electrophysiology were used to characterize the GABA(A) receptor system. To quantify the effects on proliferation by GABA(A) receptor agonists and antagonists, incorporation of thymidine analogues was used. The results showed that the NPE cells express functional extrasynaptic GABA(A) receptors with tonic properties and that low concentration of GABA is required for a baseline level of proliferation. Antagonists of the GABA(A) receptors decreased the proliferation of dissociated E12 NPE cells. Bicuculline also had effects on progenitor cell proliferation in intact E8 and E12 developing retina. The NPE cells had low levels of the Cl-transporter KCC2 compared to the mature retina, suggesting a depolarising role for the GABA(A) receptors. Treatment with KCl, which is known to depolarise membranes, prevented some of the decreased proliferation caused by inhibition of the GABA(A) receptors. This supported the depolarising role for the GABA(A) receptors. Inhibition of L-type voltage-gated Ca2+ channels (VGCCs) reduced the proliferation in the same way as inhibition of the GABA(A) receptors. Inhibition of the channels increased the expression of the cyclin-dependent kinase inhibitor p27(KIP1), along with the reduced proliferation. These results are consistent with that when the membrane potential indirectly regulates cell proliferation with hyperpolarisation of the membrane potential resulting in decreased cell division. The increased expression of p27(KIP1) after inhibition of either the GABA(A) receptors or the L-type VGCCs suggests a link between the GABA(A) receptors, membrane potential, and intracellular Ca2+ in regulating the cell cycle.	[Ring, Henrik; Mendu, Suresh Kumar; Shirazi-Fard, Shahrzad; Birnir, Bryndis; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University	Ring, H (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Finn.hallbook@neuro.uu.se		Mendu, Suresh Kumar/0000-0002-6785-0806; Birnir, Bryndis/0000-0002-1763-0266; Hallbook, Finn/0000-0001-7552-187X	Swedish Research Council [20859-01-3, 12187-15-3]; FORMAS, Barncancerfonden [PROJ09/038]; Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Swedish foundation for strategic research	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS, Barncancerfonden; Ogonfonden; Kronprinsessan Margaretas arbetsnamnd for synskadade; Swedish foundation for strategic research(Swedish Foundation for Strategic Research)	The work was supported by the Swedish Research Council (http://www.vr.se; 20859-01-3, 12187-15-3), FORMAS, Barncancerfonden (www.barncancerfonden.se; PROJ09/038), Ogonfonden (www.ogonfonden.se) and Kronprinsessan Margaretas arbetsnamnd for synskadade (www.stiftelsenkma.com), and a grant from the Swedish foundation for strategic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Amato MA, 2004, INT J DEV BIOL, V48, P993, DOI 10.1387/ijdb.041879ma; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bhatia B, 2011, EXP EYE RES, V93, P852, DOI 10.1016/j.exer.2011.09.015; Birnir B, 2007, CURR PHARM DESIGN, V13, P3169, DOI 10.2174/138161207782341330; Bjurstrom H, 2008, J NEUROIMMUNOL, V205, P44, DOI 10.1016/j.jneuroim.2008.08.017; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Catsicas M, 2001, J NEUROSCI, V21, P897, DOI 10.1523/JNEUROSCI.21-03-00897.2001; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Choi J, 2006, CELL CYCLE, V5, P2183, DOI 10.4161/cc.5.19.3265; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Diederen RMH, 2006, EXP EYE RES, V83, P45, DOI 10.1016/j.exer.2005.10.031; Donovan SL, 2005, SEMIN CELL DEV BIOL, V16, P407, DOI 10.1016/j.semcdb.2005.02.012; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Edqvist PHD, 2006, EUR J HISTOCHEM, V50, P147; EHRLICH D, 1987, J COMP NEUROL, V266, P220, DOI 10.1002/cne.902660208; Eilers J, 2001, J PHYSIOL-LONDON, V536, P429, DOI 10.1111/j.1469-7793.2001.0429c.xd; Fernando RN, 2011, P NATL ACAD SCI USA, V108, P5837, DOI 10.1073/pnas.1014993108; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fischer AJ, 2005, J NEUROSCI, V25, P10157, DOI 10.1523/JNEUROSCI.3247-05.2005; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 2003, DEV BIOL, V259, P225, DOI 10.1016/S0012-1606(03)00178-7; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fiszman ML, 1999, DEV BRAIN RES, V115, P1, DOI 10.1016/S0165-3806(99)00035-8; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Ghai K, 2008, BRAIN RES, V1192, P76, DOI 10.1016/j.brainres.2007.01.105; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARPER JW, 1993, CELL, V75, P805; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; HEAULME M, 1986, BRAIN RES, V384, P224, DOI 10.1016/0006-8993(86)91158-3; HEINAMAKI AA, 1986, NEUROCHEM RES, V11, P535, DOI 10.1007/BF00965323; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; HOKOC JN, 1990, BRAIN RES, V532, P197, DOI 10.1016/0006-8993(90)91760-E; Jackson JR, 2000, CANCER RES, V60, P566; JOHNSTON GA, 1968, BIOCHEM PHARMACOL, V17, P2488, DOI 10.1016/0006-2952(68)90141-X; Khattar E, 2010, J BIOL CHEM, V285, P4554, DOI 10.1074/jbc.M109.029280; Kokkinopoulos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018921; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Lindquist CEL, 2006, J NEUROCHEM, V97, P1349, DOI 10.1111/j.1471-4159.2006.03811.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; MARTIN DL, 1993, J NEUROCHEM, V60, P395, DOI 10.1111/j.1471-4159.1993.tb03165.x; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; Mendu SK, 2011, MOL IMMUNOL, V48, P399, DOI 10.1016/j.molimm.2010.08.005; Mitterdorfer J, 1998, J BIOENERG BIOMEMBR, V30, P319, DOI 10.1023/A:1021933504909; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; Morokuma J, 2008, P NATL ACAD SCI USA, V105, P16608, DOI 10.1073/pnas.0808328105; Moshiri A, 2005, DEV DYNAM, V233, P66, DOI 10.1002/dvdy.20299; Nguyen L, 2003, J NEUROSCI, V23, P3278; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Olsen RW, 2006, P NATL ACAD SCI USA, V103, P6081, DOI 10.1073/pnas.0601121103; OLSEN RW, 1976, BRAIN RES, V102, P283, DOI 10.1016/0006-8993(76)90883-0; Pai VP, 2012, DEVELOPMENT, V139, P313, DOI 10.1242/dev.073759; Purves D., 2012, NEUROSCIENCE; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; REH TA, 1987, NATURE, V330, P68, DOI 10.1038/330068a0; Reh TA, 2006, METHOD ENZYMOL, V419, P52, DOI 10.1016/S0076-6879(06)19003-5; Ring H, 2010, VISUAL NEUROSCI, V27, P149, DOI 10.1017/S0952523810000180; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; STONE LS, 1950, ANAT REC, V106, P89, DOI 10.1002/ar.1091060108; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; TAKUWA N, 1995, CELL SIGNAL, V7, P93, DOI 10.1016/0898-6568(94)00074-L; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Xue XY, 2011, DEV NEUROBIOL; YAMASHITA M, 1993, J NEUROBIOL, V24, P1600, DOI 10.1002/neu.480241205; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; Zhao YL, 2011, ANESTH ANALG, V113, P1152, DOI 10.1213/ANE.0b013e318230b3fd	75	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36874	10.1371/journal.pone.0036874	http://dx.doi.org/10.1371/journal.pone.0036874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590629	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100070
J	Vuistiner, P; Bochud, M; Rousson, V				Vuistiner, Philippe; Bochud, Murielle; Rousson, Valentin			A Comparison of Three Methods of Mendelian Randomization when the Genetic Instrument, the Risk Factor and the Outcome Are All Binary	PLOS ONE			English	Article							WEAK INSTRUMENTS; CAUSAL INFERENCE; GENOTYPES; IDENTIFICATION; VARIABLES; ALDH2	The method of instrumental variable (referred to as Mendelian randomization when the instrument is a genetic variant) has been initially developed to infer on a causal effect of a risk factor on some outcome of interest in a linear model. Adapting this method to nonlinear models, however, is known to be problematic. In this paper, we consider the simple case when the genetic instrument, the risk factor, and the outcome are all binary. We compare via simulations the usual two-stages estimate of a causal odds-ratio and its adjusted version with a recently proposed estimate in the context of a clinical trial with noncompliance. In contrast to the former two, we confirm that the latter is (under some conditions) a valid estimate of a causal odds-ratio defined in the subpopulation of compliers, and we propose its use in the context of Mendelian randomization. By analogy with a clinical trial with noncompliance, compliers are those individuals for whom the presence/absence of the risk factor X is determined by the presence/absence of the genetic variant Z (i.e., for whom we would observe X=Z whatever the alleles randomly received at conception). We also recall and illustrate the huge variability of instrumental variable estimates when the instrument is weak (i.e., with a low percentage of compliers, as is typically the case with genetic instruments for which this proportion is frequently smaller than 10%) where the inter-quartile range of our simulated estimates was up to 18 times higher compared to a conventional (e.g., intention-to-treat) approach. We thus conclude that the need to find stronger instruments is probably as important as the need to develop a methodology allowing to consistently estimate a causal odds-ratio.	[Vuistiner, Philippe] CHU Vaudois, Univ Inst Social & Prevent Med, Epalinges, Switzerland; Univ Lausanne, CH-1066 Epalinges, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Vuistiner, P (corresponding author), CHU Vaudois, Univ Inst Social & Prevent Med, Epalinges, Switzerland.	philippe.vuistiner@chuv.ch	Bochud, Murielle/A-3981-2010; Vuistiner, Philippe/AAD-5010-2020	Bochud, Murielle/0000-0002-5727-0218; Rousson, Valentin/0000-0001-8092-4446; Vuistiner, Philippe/0000-0002-2661-4970	Swiss School of Public Health Plus	Swiss School of Public Health Plus	MB is supported by the Swiss School of Public Health Plus (http://www.ssphplus.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amamoto K, 2002, HYPERTENS RES, V25, P857; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], 2010, R LANG ENV STAT COMP; Baker SG, 2011, BIOMETRICS, V67, P319, DOI 10.1111/j.1541-0420.2010.01451_1.x; Balke A, 1997, J AM STAT ASSOC, V92, P1171, DOI 10.2307/2965583; Bochud M, 2010, INT J ENV RES PUB HE, V7, P711, DOI 10.3390/ijerph7030711; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Didelez V, 2010, STAT SCI, V25, P22, DOI 10.1214/09-STS316; Greenland S, 1999, STAT SCI, V14, P29; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Lui KJ, 2010, J APPL STAT, V37, P2057, DOI 10.1080/02664760903214411; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Palmer TM, 2008, INT J EPIDEMIOL, V37, P2057; Palmer TM, 2011, AM J EPIDEMIOL, V173, P1392, DOI 10.1093/aje/kwr026; SOMMER A, 1991, STAT MED, V10, P45, DOI 10.1002/sim.4780100110; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Takeshita T, 1999, ALCOHOL CLIN EXP RES, V23, P1065, DOI 10.1111/j.1530-0277.1999.tb04226.x; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; Vansteelandt S, 2003, J ROY STAT SOC B, V65, P817, DOI 10.1046/j.1369-7412.2003.00417.x; Vansteelandt S, 2011, STAT SCI, V26, P403, DOI 10.1214/11-STS360; Yamada Y, 2006, J HUM GENET, V51, P104, DOI 10.1007/s10038-005-0330-0; [No title captured]	25	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35951	10.1371/journal.pone.0035951	http://dx.doi.org/10.1371/journal.pone.0035951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590516	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100014
J	Liu, YX; Sun, Y; Broaddus, R; Liu, JS; Sood, AK; Shmulevich, I; Zhang, W				Liu, Yuexin; Sun, Yan; Broaddus, Russell; Liu, Jinsong; Sood, Anil K.; Shmulevich, Ilya; Zhang, Wei			Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma	PLOS ONE			English	Article							CANCER; PREDICTION; CHEMORESISTANT; PATHWAY; DNA	Background: Small sample sizes used in previous studies result in a lack of overlap between the reported gene signatures for prediction of chemotherapy response. Although morphologic features, especially tumor nuclear morphology, are important for cancer grading, little research has been reported on quantitatively correlating cellular morphology with chemotherapy response, especially in a large data set. In this study, we have used a large population of patients to identify molecular and morphologic signatures associated with chemotherapy response in serous ovarian carcinoma. Methodology/Principal Findings: A gene expression model that predicts response to chemotherapy is developed and validated using a large-scale data set consisting of 493 samples from The Cancer Genome Atlas (TCGA) and 244 samples from an Australian report. An identified 227-gene signature achieves an overall predictive accuracy of greater than 85% with a sensitivity of approximately 95% and specificity of approximately 70%. The gene signature significantly distinguishes between patients with unfavorable versus favorable prognosis, when applied to either an independent data set (P = 0.04) or an external validation set (P < 0.0001). In parallel, we present the production of a tumor nuclear image profile generated from 253 sample slides by characterizing patients with nuclear features (such as size, elongation, and roundness) in incremental bins, and we identify a morphologic signature that demonstrates a strong association with chemotherapy response in serous ovarian carcinoma. Conclusions: A gene signature discovered on a large data set provides robustness in accurately predicting chemotherapy response in serous ovarian carcinoma. The combination of the molecular and morphologic signatures yields a new understanding of potential mechanisms involved in drug resistance.	[Liu, Yuexin; Sun, Yan; Broaddus, Russell; Liu, Jinsong; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Reprod Med & Canc Biol, Houston, TX 77030 USA; [Sun, Yan] Tianjin Med Univ, Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; Institute for Systems Biology (ISB)	Liu, YX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	wzhang@mdanderson.org			National Institutes of Health [U24 CA143835]; NATIONAL CANCER INSTITUTE [U24CA143835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding for the Genome Data Analysis Centers from the National Institutes of Health (U24 CA143835 to I.S. and W.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bachvarov D, 2006, INT J ONCOL, V29, P919; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardini M, 2005, NEOPLASIA, V7, P603, DOI 10.1593/neo.04760; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; Diest PJ, 1991, HUM PATHOL, V22, P326; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Fischer MJM, 2010, MICROVASC RES, V80, P258, DOI 10.1016/j.mvr.2010.04.004; Gandhi KS, 2010, PLOS ONE, V5; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Helleman J, 2010, GYNECOL ONCOL, V117, P170, DOI 10.1016/j.ygyno.2010.01.010; Hsu CY, 2005, HUM PATHOL, V36, P1049, DOI 10.1016/j.humpath.2005.07.014; Huang S, 1999, NAT CELL BIOL, V1, pE131, DOI 10.1038/13043; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jazaeri AA, 2005, CLIN CANCER RES, V11, P6300, DOI 10.1158/1078-0432.CCR-04-2682; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kashiwagi Y, 2010, MOL VIS, V16, P970; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Lysetska M, 2002, NUCLEIC ACIDS RES, V30, P2686, DOI 10.1093/nar/gkf378; Nafe R, 2005, CLIN CANCER RES, V11, P2141, DOI 10.1158/1078-0432.CCR-04-1198; National Cancer Institute, COMPR CANC INF; National Institutes of Health, IMAGEJ US GUID IJ 1; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ritter N, 2009, J MATH IMAGING VIS, V35, P117, DOI 10.1007/s10851-009-0158-x; Selvanayagam ZE, 2004, CANCER GENET CYTOGEN, V154, P63, DOI 10.1016/j.cancergencyto.2004.01.024; Spentzos D, 2004, J CLIN ONCOL, V22, P4700, DOI 10.1200/JCO.2004.04.070; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; WILS J, 1988, CANCER, V61, P1920, DOI 10.1002/1097-0142(19880501)61:9<1920::AID-CNCR2820610933>3.0.CO;2-2	41	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36383	10.1371/journal.pone.0036383	http://dx.doi.org/10.1371/journal.pone.0036383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590536	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335500010
J	Matta, H; Gopalakrishnan, R; Graham, C; Tolani, B; Khanna, A; Yi, H; Suo, YL; Chaudhary, PM				Matta, Hittu; Gopalakrishnan, Ramakrishnan; Graham, Ciaren; Tolani, Bhairavi; Khanna, Akshat; Yi, Han; Suo, Yulan; Chaudhary, Preet M.			Kaposi's Sarcoma Associated Herpesvirus Encoded Viral FLICE Inhibitory Protein K13 Activates NF-kappa B Pathway Independent of TRAF6, TAK1 and LUBAC	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CHAIN ASSEMBLY COMPLEX; TNF-R1 SIGNALING COMPLEX; KINASE COMPLEX; IKK-BETA; POLYUBIQUITIN CHAINS; INDUCED APOPTOSIS; UBIQUITIN CHAINS; GENE INDUCTION; KSHV VFLIP	Background: Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein (vFLIP) K13 activates the NF-kappa B pathway by binding to the NEMO/IKK gamma subunit of the I kappa B kinase (IKK) complex. However, it has remained enigmatic how K13-NEMO interaction results in the activation of the IKK complex. Recent studies have implicated TRAF6, TAK1 and linear ubiquitin chains assembled by a linear ubiquitin chain assembly complex (LUBAC) consisting of HOIL-1, HOIP and SHARPIN in IKK activation by proinflammatory cytokines. Methodology/Principal Findings: Here we demonstrate that K13-induced NF-kappa B DNA binding and transcriptional activities are not impaired in cells derived from mice with targeted disruption of TRAF6, TAK1 and HOIL-1 genes and in cells derived from mice with chronic proliferative dermatitis (cpdm), which have mutation in the Sharpin gene (Sharpin(cpdm/ cpdm)). Furthermore, reconstitution of NEMO-deficient murine embryonic fibroblast cells with NEMO mutants that are incapable of binding to linear ubiquitin chains supported K13-induced NF-kappa B activity. K13-induced NF-kappa B activity was not blocked by CYLD, a deubiquitylating enzyme that can cleave linear and Lys63-linked ubiquitin chains. On the other hand, NEMO was required for interaction of K13 with IKK1/IKK alpha and IKK2/IKK beta, which resulted in their activation by "T Loop'' phosphorylation. Conclusions/Significance: Our results demonstrate that K13 activates the NF-kappa B pathway by binding to NEMO which results in the recruitment of IKK1/IKK alpha and IKK2/IKK beta and their subsequent activation by phosphorylation. Thus, K13 activates NF-kappa B via a mechanism distinct from that utilized by inflammatory cytokines. These results have important implications for the development of therapeutic agents targeting K13-induced NF-kappa B for the treatment of KSHV-associated malignancies.	[Matta, Hittu] Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Ctr Study Blood Dis, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Matta, H (corresponding author), Univ So Calif, Keck Sch Med, Jane Anne Nohl Div Hematol, Los Angeles, CA 90033 USA.	preet.chaudhary@med.usc.edu	Chaudhary, Preet/E-1970-2018; Gopalakrishnan, Ramakrishnan/N-3454-2015; Khanna, Akshat/M-6621-2018	Gopalakrishnan, Ramakrishnan/0000-0002-5068-6886; Graham, Ciaren/0000-0003-1851-7369; Khanna, Akshat/0000-0001-7651-3265; Tolani, Bhairavi/0000-0001-9076-866X	National Institutes of Health [DE019811, CA139119]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA139119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (DE019811 and CA139119) and the Leukemia & Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Agou F, 2002, J BIOL CHEM, V277, P17464, DOI 10.1074/jbc.M201964200; Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bottero V, 2011, J VIROL, V85, P1980, DOI 10.1128/JVI.01911-10; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chaudhary PM, 1999, ONCOGENE, V18, P5738, DOI 10.1038/sj.onc.1202976; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Emmerich CH, 2011, ADV EXP MED BIOL, V691, P115, DOI 10.1007/978-1-4419-6612-4_12; Field N, 2003, J CELL SCI, V116, P3721, DOI 10.1242/jcs.00691; Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Matta H, 2008, ONCOGENE, V27, P5243, DOI 10.1038/onc.2008.150; Matta H, 2007, ONCOGENE, V26, P1656, DOI 10.1038/sj.onc.1209931; Matta H, 2004, P NATL ACAD SCI USA, V101, P9399, DOI 10.1073/pnas.0308016101; Matta H, 2003, J BIOL CHEM, V278, P52406, DOI 10.1074/jbc.M307308200; Matta H, 2007, J BIOL CHEM, V282, P24858, DOI 10.1074/jbc.M700118200; Matta H, 2011, J BIOL CHEM, V286, P21555, DOI 10.1074/jbc.M111.224048; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Moore PS, 2001, PHILOS T R SOC B, V356, P499, DOI 10.1098/rstb.2000.0777; Morris K, 2003, LANCET ONCOL, V4, P5, DOI 10.1016/S1470-2045(03)00969-0; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pasparakis M, 2002, J EXP MED, V196, P743, DOI 10.1084/jem.20020907; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ren H, 2002, J IMMUNOL, V168, P3721, DOI 10.4049/jimmunol.168.8.3721; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shimizu A, 2011, J VIROL, V85, P7444, DOI 10.1128/JVI.02337-10; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Sturzl M, 1999, J NATL CANCER I, V91, P1725, DOI 10.1093/jnci/91.20.1725; Sun Q, 2006, ONCOGENE, V25, P2717, DOI 10.1038/sj.onc.1209298; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Suzuki S, 2007, J BIOL CHEM, V282, P25177, DOI 10.1074/jbc.C700065200; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Zhao JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001067	71	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36601	10.1371/journal.pone.0036601	http://dx.doi.org/10.1371/journal.pone.0036601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590573	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500020
J	Strand, TA; Sharma, PR; Gjessing, HK; Ulak, M; Chandyo, RK; Adhikari, RK; Sommerfelt, H				Strand, Tor A.; Sharma, Pushpa R.; Gjessing, Hakon K.; Ulak, Manjeswori; Chandyo, Ram K.; Adhikari, Ramesh K.; Sommerfelt, Halvor			Risk Factors for Extended Duration of Acute Diarrhea in Young Children	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; ZINC SUPPLEMENTATION; PERSISTENT DIARRHEA; DEVELOPING-COUNTRIES; GUINEA-BISSAU; PLASMA ZINC; WEST-AFRICA; MORTALITY; DISEASE; INDIA	Objective and Background: We sought to identify predictors of extended duration of diarrhea in young children, which contributes substantially to the nearly 1 1/2 million annual diarrheal deaths globally. Methods: We followed 6-35 month old Nepalese children enrolled in the placebo-arm of a randomized controlled trial with 391 episodes of acute diarrhea from the day they were diagnosed until cessation of the episode. Using multiple logistic regression analysis, we identified independent risk factors for having diarrhea for more than 7 days after diagnosis. Results: Infants had a 17 (95% CI 3.5, 83)-fold and toddlers (12 to 23 month olds) a 9.9 (95% CI 2.1, 47)-fold higher odds of having such illness duration compared to the older children. Not being breastfed was associated with a 9.3 (95% CI 2.4, 35.7)-fold increase in the odds for this outcome. The odds also increased with increasing stool frequency. Furthermore, having diarrhea in the monsoon season also increased the risk of prolonged illness. Conclusion: We found that high stool frequency, not being breastfed, young age and acquiring diarrhea in the rainy season were risk factors for prolonged diarrhea. In populations such as ours, breastfeeding may be the most important modifiable risk factor for extended duration of diarrhea.	[Strand, Tor A.; Ulak, Manjeswori; Chandyo, Ram K.; Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Strand, Tor A.] Innlandet Hosp Trust, Lillehammer, Norway; [Strand, Tor A.; Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Sharma, Pushpa R.; Ulak, Manjeswori; Chandyo, Ram K.; Adhikari, Ramesh K.] Tribhuvan Univ, Dept Child Hlth, Kathmandu, Nepal; [Gjessing, Hakon K.] Norwegian Inst Publ Hlth, Dept Epidemiol, Oslo, Norway; [Gjessing, Hakon K.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway	University of Bergen; Innlandet Hospital Trust; Norwegian Institute of Public Health (NIPH); Tribhuvan University; Norwegian Institute of Public Health (NIPH); University of Bergen	Strand, TA (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	tors@me.com	Gjessing, Hakon K/A-5871-2012; Sommerfelt, Halvor/ABD-3552-2020; Strand, Tor/D-9836-2016	Sommerfelt, Halvor/0000-0002-5670-9786; Strand, Tor/0000-0002-4038-151X	EU-INCO-DC [IC18-CT96-0045]; NUFU [PRO 52-53/96]	EU-INCO-DC; NUFU	The study was funded by EU-INCO-DC (contract number IC18-CT96-0045: "Effect of zinc and vitamin A supplementation on diarrhea and physical growth in children''), NUFU (project number PRO 52-53/96: "Institutional capacity and competence building in research and education for promotion of child health and nutrition in South Asia''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl R, 1998, AM J CLIN NUTR, V68, p414S, DOI 10.1093/ajcn/68.2.414S; BAQUI AH, 1992, ACTA PAEDIATR, V81, P15, DOI 10.1111/j.1651-2227.1992.tb12366.x; BHANDARI N, 1992, ACTA PAEDIATR, V81, P3, DOI 10.1111/j.1651-2227.1992.tb12363.x; Bhutta ZA, 2008, J PEDIATR GASTR NUTR, V47, P260, DOI 10.1097/MPG.0b013e318181b334; Bhutta ZA, 2000, AM J CLIN NUTR, V72, P1516; BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193; BLACK RE, 1993, PEDIATR INFECT DIS J, V12, P751, DOI 10.1097/00006454-199309000-00010; BLACK RE, 1993, VACCINE, V11, P100, DOI 10.1016/0264-410X(93)90002-F; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brooks WA, 2005, LANCET, V366, P999, DOI 10.1016/S0140-6736(05)67109-7; Brown KH, 1998, AM J CLIN NUTR, V68, p425S, DOI 10.1093/ajcn/68.2.425S; Collett D, 1994, MODELLING SURVIVAL D; Cook Mills JM, 1990, ADV EXP MED BIOL, V262, P111; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; Lazzerini M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005436.pub2; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; MACDONALD TT, 1990, SPRINGER SEMIN IMMUN, V12, P129; MOLBAK K, 1994, BMJ-BRIT MED J, V308, P1403, DOI 10.1136/bmj.308.6941.1403; Molbak K, 1997, INT J EPIDEMIOL, V26, P458, DOI 10.1093/ije/26.2.458; MOLBAK K, 1993, BRIT MED J, V307, P417, DOI 10.1136/bmj.307.6901.417; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Perch M, 2001, ANN TROP PAEDIATR, V21, P313, DOI 10.1080/07430170120093490; ROWLAND HAK, 1978, T ROY SOC TROP MED H, V72, P289, DOI 10.1016/0035-9203(78)90210-9; SAZAWAL S, 1995, NEW ENGL J MED, V333, P839, DOI 10.1056/NEJM199509283331304; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Strand TA, 2004, AM J CLIN NUTR, V79, P451; Strand TA, 2002, PEDIATRICS, V109, P898, DOI 10.1542/peds.109.5.898; Tielsch JM, 2007, LANCET, V370, P1230, DOI 10.1016/S0140-6736(07)61539-6; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Walker CLF, 2006, J PEDIATR GASTR NUTR, V43, P357, DOI 10.1097/01.mpg.0000232018.40907.00; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO and UNICEF, 2004, JOINT STAT CLIN MAN; WHO UNICEF, 1997, INT MAN CHILDH ILLN; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	36	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36436	10.1371/journal.pone.0036436	http://dx.doi.org/10.1371/journal.pone.0036436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590543	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500012
J	Chatterjee, PK; Yeboah, MM; Dowling, O; Xue, XY; Powell, SR; Al-Abed, Y; Metz, CN				Chatterjee, Prodyot K.; Yeboah, Michael M.; Dowling, Oonagh; Xue, Xiangying; Powell, Saul R.; Al-Abed, Yousef; Metz, Christine N.			Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; TUMOR-NECROSIS-FACTOR; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL-CELL ACTIVATION; NITRIC-OXIDE SYNTHASE; KAPPA-B PATHWAY; PROTEIN-DEGRADATION; VAGUS NERVE; RAT-KIDNEY	Sepsis is one of the leading causes of acute kidney injury (AKI). Septic patients who develop acute kidney injury (AKI) are at increased risk of death. To date there is no effective treatment for AKI or septic AKI. Based on their anti-inflammatory properties, we examined the effects of nicotinic acetylcholine receptor agonists on renal damage using a mouse model of lipopolysaccharide (LPS)-induced AKI where localized LPS promotes inflammation-mediated kidney damage. Administration of nicotine (1 mg/kg) or GTS-21 (4 mg/kg) significantly abrogated renal leukocyte infiltration (by 40%) and attenuated kidney injury. These renoprotective effects were accompanied by reduced systemic and localized kidney inflammation during LPS-induced AKI. Consistent with these observations, nicotinic agonist treatment significantly decreased renal I kappa beta alpha degradation and NF kappa B activation during LPS-induced AKI. Treatment of human kidney cells with nicotinic agonists, an NF kappa beta inhibitor (Bay11), or a proteasome inhibitor (MG132) effectively inhibited their inflammatory responses following stimulation with LPS or TNF alpha. Renal proteasome activity, a major regulator of NF kappa beta-mediated inflammation, was enhanced by approximately 50% during LPS-induced AKI and elevated proteasome activity was significantly blunted by nicotinic agonist administration in vivo. Taken together, our results identify enhanced renal proteasome activity during LPS-induced AKI and the suppression of both proteasome activity and inflammation by nicotinic agonists to attenuate LPS-induced kidney injury.	[Chatterjee, Prodyot K.; Dowling, Oonagh; Xue, Xiangying; Metz, Christine N.] Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA; [Yeboah, Michael M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal, Boston, MA 02115 USA; [Powell, Saul R.] Feinstein Inst Med Res, Ctr Heart & Lung Res, Manhasset, NY USA; [Al-Abed, Yousef] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA	Northwell Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Northwell Health; Northwell Health	Chatterjee, PK (corresponding author), Feinstein Inst Med Res, Ctr Immunol & Inflammat, Manhasset, NY 11030 USA.	cmetz@nshs.edu		Christine, Metz/0000-0002-1013-1691	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) [R01 GM070727]; NIH/National Heart, Lung, and Blood Institute [HL68936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS)-R01 GM070727 (CNM) and NIH/National Heart, Lung, and Blood Institute-HL68936 (SRP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of this manuscript.	Ahmed AS, 2010, ARTHRITIS RHEUM-US, V62, P2160, DOI 10.1002/art.27492; Andersson U, 2011, ANN REV IMMUNOL 0324; BERTANI T, 1989, AM J PATHOL, V134, P419; Briggs CA, 1998, NEUROPHARMACOLOGY, V37, P1095, DOI 10.1016/S0028-3908(98)00110-5; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Chatterjee PK, 2009, AM J PHYSIOL-CELL PH, V297, pC1294, DOI 10.1152/ajpcell.00160.2009; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; D'hoedt D, 2009, EXPERT OPIN THER TAR, V13, P395, DOI [10.1517/14728220902841045 , 10.1517/14728220902841045]; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Vriese AS, 2003, J AM SOC NEPHROL, V14, P792, DOI 10.1097/01.ASN.0000055652.37763.F7; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; FOUQUERAY B, 1993, J AM SOC NEPHROL, V3, P1783; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, CELL, V84, P813, DOI 10.1016/S0092-8674(00)81058-2; Hoste EAJ, 2003, J AM SOC NEPHROL, V14, P1022, DOI 10.1097/01.ASN.0000059863.48590.E9; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; JEVNIKAR AM, 1991, KIDNEY INT, V40, P203, DOI 10.1038/ki.1991.201; Kamthong PJ, 2001, BIOCHEM J, V356, P525, DOI 10.1042/0264-6021:3560525; KANG YH, 1995, SHOCK, V4, P441; KITA T, 1993, INT J EXP PATHOL, V74, P471; Klaude M, 2007, CLIN SCI, V112, P499, DOI 10.1042/CS20060265; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Lecker SH, 2011, J AM SOC NEPHROL, V22, P821, DOI 10.1681/ASN.2010090958; Leelahavanichkul A, 2008, AM J PHYSIOL-RENAL, V295, pF1825, DOI 10.1152/ajprenal.90442.2008; Letoha T, 2007, WORLD J GASTROENTERO, V13, P4452; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Lutz J, 2008, J MOL MED, V86, P1329, DOI 10.1007/s00109-008-0405-4; Meyer-Schwesinger C, 2009, AM J PHYSIOL-RENAL, V296, pF1088, DOI 10.1152/ajprenal.90746.2008; Monteiro RMM, 2009, TRANSPL IMMUNOL, V21, P50, DOI 10.1016/j.trim.2009.02.003; Mustafa SB, 1998, J BIOL CHEM, V273, P5073, DOI 10.1074/jbc.273.9.5073; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pocock J, 2003, J IMMUNOL, V170, P6280, DOI 10.4049/jimmunol.170.12.6280; Powell SR, 2007, J MOL CELL CARDIOL, V42, P265, DOI 10.1016/j.yjmcc.2006.10.010; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Ricci Z, 2009, CURR DRUG TARGETS, V10, P1179, DOI 10.2174/138945009789753192; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sadis C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000469; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Schor N, 2002, KIDNEY INT, V61, P764, DOI 10.1046/j.1523-1755.2002.00178.x; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Szewczyk NJ, 2000, J CELL SCI, V113, P2003; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Viedt C, 2002, NEPHROL DIAL TRANSPL, V17, P2043, DOI 10.1093/ndt/17.12.2043; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94; Yeboah MM, 2008, AM J PHYSIOL-RENAL, V295, pF654, DOI 10.1152/ajprenal.90255.2008; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484; ZOLTEWICZ JA, 1993, HETEROCYCLES, V35, P171	66	65	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35361	10.1371/journal.pone.0035361	http://dx.doi.org/10.1371/journal.pone.0035361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586448	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000010
J	Han, X; Byrne, P; Kahana, MJ; Becker, S				Han, Xue; Byrne, Patrick; Kahana, Michael J.; Becker, Suzanna			When Do Objects Become Landmarks? A VR Study of the Effect of Task Relevance on Spatial Memory	PLOS ONE			English	Article							REAL-WORLD; MENTAL REPRESENTATIONS; NEURAL REPRESENTATION; INTRINSIC FRAMES; LAYOUT GEOMETRY; HIPPOCAMPUS; NAVIGATION; ROUTE; STRATEGIES; LOCATION	We investigated how objects come to serve as landmarks in spatial memory, and more specifically how they form part of an allocentric cognitive map. Participants performing a virtual driving task incidentally learned the layout of a virtual town and locations of objects in that town. They were subsequently tested on their spatial and recognition memory for the objects. To assess whether the objects were encoded allocentrically we examined pointing consistency across tested viewpoints. In three experiments, we found that spatial memory for objects at navigationally relevant locations was more consistent across tested viewpoints, particularly when participants had more limited experience of the environment. When participants' attention was focused on the appearance of objects, the navigational relevance effect was eliminated, whereas when their attention was focused on objects' locations, this effect was enhanced, supporting the hypothesis that when objects are processed in the service of navigation, rather than merely being viewed as objects, they engage qualitatively distinct attentional systems and are incorporated into an allocentric spatial representation. The results are consistent with evidence from the neuroimaging literature that when objects are relevant to navigation, they not only engage the ventral "object processing stream'', but also the dorsal stream and medial temporal lobe memory system classically associated with allocentric spatial memory.	[Han, Xue; Becker, Suzanna] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Byrne, Patrick] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Kahana, Michael J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	McMaster University; York University - Canada; University of Pennsylvania	Han, X (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	becker@mcmaster.ca	Becker, Suzanna/H-8197-2013	Byrne, Patrick/0000-0002-5276-5393; Becker, Suzanna/0000-0002-2645-070X	Natural Sciences and Engineering Council; National Institutes of Health [MH61975]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061975] Funding Source: NIH RePORTER	Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by a grant from the Natural Sciences and Engineering Council to Suzanna Becker, by scholarships CGS M and PGS D3 from the Natural Sciences and Engineering Council to XH, and by grant MH61975 from the National Institutes of Health to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; EVANS GW, 1980, J EXP PSYCHOL-HUM L, V6, P13, DOI 10.1037/0278-7393.6.1.13; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; Goodale MA, 1998, NEUROSCI BIOBEHAV R, V22, P161, DOI 10.1016/S0149-7634(97)00007-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gramann K, 2006, BRAIN RES, V1118, P116, DOI 10.1016/j.brainres.2006.08.005; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; HOLSCHER C, 1994, BEHAV BRAIN RES, V63, P187, DOI 10.1016/0166-4328(94)90090-6; Iaria G, 2003, J NEUROSCI, V23, P5945; Jacobs J, 2010, P NATL ACAD SCI USA, V107, P6487, DOI 10.1073/pnas.0911213107; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2007, BRAIN RES, V1165, P116, DOI 10.1016/j.brainres.2007.05.074; Jordan K, 2004, NEUROREPORT, V15, P135, DOI 10.1097/00001756-200401190-00026; Kelly JW, 2008, PSYCHON B REV, V15, P322, DOI 10.3758/PBR.15.2.322; King JA, 2004, NEUROPSYCHOLOGY, V18, P405, DOI 10.1037/0894-4105.18.3.405; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lavenex PB, 2010, BEHAV BRAIN RES, V207, P125, DOI 10.1016/j.bbr.2009.09.046; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Miller J, 2010, PSYCHONOMIC B R 1117; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; Mou WM, 2008, COGNITION, V108, P136, DOI 10.1016/j.cognition.2008.02.004; Mou WM, 2007, J EXP PSYCHOL LEARN, V33, P145, DOI 10.1037/0278-7393.33.1.145; Mou WM, 2006, J EXP PSYCHOL LEARN, V32, P1274, DOI 10.1037/0278-7393.32.6.1274; Mou WM, 2009, J EXP PSYCHOL HUMAN, V35, P83, DOI 10.1037/0096-1523.35.1.83; Mou WM, 2002, J EXP PSYCHOL LEARN, V28, P162, DOI 10.1037//0278-7393.28.1.162; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; MULLER RU, 1994, J NEUROSCI, V14, P7235; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Redish AD, 2000, NEUROCOMPUTING, V32, P235, DOI 10.1016/S0925-2312(00)00169-7; Roskos-Ewoldsen B, 1998, J EXP PSYCHOL LEARN, V24, P215, DOI 10.1037/0278-7393.24.1.215; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; Schinazi VR, 2010, NEUROIMAGE, V53, P725, DOI 10.1016/j.neuroimage.2010.06.065; Shelton AL, 2004, J EXP PSYCHOL LEARN, V30, P158, DOI 10.1037/0278-7393.30.1.158; Shelton AL, 1997, PSYCHON B REV, V4, P102, DOI 10.3758/BF03210780; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Valiquette C, 2007, PSYCHON B REV, V14, P676, DOI 10.3758/BF03196820; Valiquette CM, 2007, PSYCHOL RES-PSYCH FO, V71, P288, DOI 10.1007/s00426-006-0084-0; Valiquette CM, 2003, MEM COGNITION, V31, P479, DOI 10.3758/BF03194405; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Werner S., 1999, SPAT COGN COMPUT, V1, P447, DOI DOI 10.1023/A:1010095831166	54	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35940	10.1371/journal.pone.0035940	http://dx.doi.org/10.1371/journal.pone.0035940			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TC	22586455	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000017
J	Hartleben, B; Widmeier, E; Wanner, N; Schmidts, M; Kim, ST; Schneider, L; Mayer, B; Kerjaschki, D; Miner, JH; Walz, G; Huber, TB				Hartleben, Bjoern; Widmeier, Eugen; Wanner, Nicola; Schmidts, Miriam; Kim, Sung Tae; Schneider, Lisa; Mayer, Britta; Kerjaschki, Dontscho; Miner, Jeffrey H.; Walz, Gerd; Huber, Tobias B.			Role of the Polarity Protein Scribble for Podocyte Differentiation and Maintenance	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; TIGHT JUNCTION PROTEIN; LOOP-TAIL; CELL POLARITY; EPITHELIAL-CELLS; SLIT DIAPHRAGMS; E-CADHERIN; MOUSE; EXPRESSION; MUTANT	The kidney filter represents a unique assembly of podocyte epithelial cells that tightly enwrap the glomerular capillaries with their complex foot process network. While deficiency of the polarity proteins Crumbs and aPKC result in impaired podocyte foot process architecture, the function of basolateral polarity proteins for podocyte differentiation and maintenance remained unclear. Here we report, that Scribble is expressed in developing podocytes, where it translocates from the lateral aspects of immature podocytes to the basal cell membrane and foot processes of mature podocytes. Immunogold electron microscopy reveals membrane associated localisation of Scribble predominantly at the basolateral site of foot processes. To further study the role of Scribble for podocyte differentiation Scribble(flox/flox) mice were generated by introducing loxP-sites into the Scribble introns 1 and 8 and these mice were crossed to NPHS2.Cre mice and Cre deleter mice. Podocyte-specific Scribble knockout mice develop normally and display no histological, ultrastructural or clinical abnormalities up to 12 months of age. In addition, no increased susceptibility to glomerular stress could be detected in these mice. In contrast, constitutive Scribble knockout animals die during embryonic development indicating the fundamental importance of Scribble for embryogenesis. Like in podocyte-specific Scribble knockout mice, the development of podocyte foot processes and the slit diaphragm was unaffected in kidney cultures from constitutive Scribble knockout animals. In summary these results indicate that basolateral polarity signaling via Scribble is dispensable for podocyte function, highlighting the unique feature of podocyte development with its significant apical membrane expansions being dominated by apical polarity complexes rather than by basolateral polarity signaling.	[Hartleben, Bjoern; Widmeier, Eugen; Wanner, Nicola; Schmidts, Miriam; Schneider, Lisa; Mayer, Britta; Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Wanner, Nicola; Huber, Tobias B.] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79106 Freiburg, Germany; [Kim, Sung Tae] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA; [Kerjaschki, Dontscho] Med Univ, Clin Inst Pathol, Vienna, Austria; [Walz, Gerd; Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; Washington University (WUSTL); University of Freiburg	Hartleben, B (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Schmidts, Miriam/A-3777-2012; Widmeier, Eugen/AAQ-9854-2020	Schmidts, Miriam/0000-0002-1714-6749; Widmeier, Eugen/0000-0002-7773-5190; Huber, Tobias B./0000-0001-7175-5062	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft [SFB 592]; Excellence Initiative of the German Federal; State Governments [EXC 294]; Deutsche Nierenstiftung; Peter-Stiftung fur die Nierenwissenschaft; National Institutes of Health [R01DK081156, P30DK079333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333, R01DK081156] Funding Source: NIH RePORTER	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal; State Governments; Deutsche Nierenstiftung; Peter-Stiftung fur die Nierenwissenschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Else Kroner-Fresenius-Stiftung (T.B.H.), Deutsche Forschungsgemeinschaft SFB 592 (T.B.H.), the Excellence Initiative of the German Federal and State Governments EXC 294 (T.B.H.), Deutsche Nierenstiftung (B.H.), Peter-Stiftung fur die Nierenwissenschaft (M.S.), and National Institutes of Health R01DK081156 and P30DK079333 (J.H.M. and S.T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVNER ED, 1983, J UROLOGY, V129, P660, DOI 10.1016/S0022-5347(17)52273-9; Bilder D, 2000, NAT CELL BIOL, V2, pE114, DOI 10.1038/35017119; COPP AJ, 1994, DEV BIOL, V165, P20, DOI 10.1006/dbio.1994.1230; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Ebarasi L, 2009, DEV BIOL, V334, P1, DOI 10.1016/j.ydbio.2009.04.017; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; Hirose T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004194; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Nakagawa S, 2004, BRIT J CANCER, V90, P194, DOI 10.1038/sj.bjc.6601465; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Qin Y, 2005, J CELL BIOL, V171, P1061, DOI 10.1083/jcb.200506094; Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; WEENING JJ, 1987, AM J PATHOL, V129, P64; Zarbalis K, 2004, PLOS BIOL, V2, P1177, DOI 10.1371/journal.pbio.0020219; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	37	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36705	10.1371/journal.pone.0036705	http://dx.doi.org/10.1371/journal.pone.0036705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586490	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000051
J	Parrott, BB; Hudson, A; Brady, R; Schulz, C				Parrott, Benjamin B.; Hudson, Alicia; Brady, Regina; Schulz, Cordula			Control of Germline Stem Cell Division Frequency - A Novel, Developmentally Regulated Role for Epidermal Growth Factor Signaling	PLOS ONE			English	Article							SOMATIC SUPPORT CELLS; SELF-RENEWAL; DROSOPHILA SPERMATOGENESIS; GENE-EXPRESSION; TESTIS; PROLIFERATION; DIFFERENTIATION; MELANOGASTER; ACTIVATION; OOGENESIS	Exploring adult stem cell dynamics in normal and disease states is crucial to both better understanding their in vivo role and better realizing their therapeutic potential. Here we address the division frequency of Germline Stem Cells (GSCs) in testes of Drosophila melanogaster. We show that GSC division frequency is under genetic control of the highly conserved Epidermal Growth Factor (EGF) signaling pathway. When EGF signaling was attenuated, we detected a two-fold increase in the percentage of GSCs in mitotic division compared to GSCs in control animals. Ex vivo and in vivo experiments using a marker for cells in S-phase of the cell cycle showed that the GSCs in EGF mutant testes divide faster than GSCs in control testes. The increased mitotic activity of GSCs in EGF mutants was rescued by restoring EGF signaling in the GSCs, and reproduced in testes from animals with soma-depleted EGF-Receptor (EGFR). Interestingly, EGF attenuation specifically increased the GSC division frequency in adult testes, but not in larval testes. Furthermore, GSCs in testes with tumors resulting from the perturbation of other conserved signaling pathways divided at normal frequencies. We conclude that EGF signaling from the GSCs to the CySCs normally regulates GSC division frequency. The EGF signaling pathway is bifurcated and acts differently in adult compared to larval testes. In addition, regulation of GSC division frequency is a specific role for EGF signaling as it is not affected in all tumor models. These data advance our understanding concerning stem cell dynamics in normal tissues and in a tumor model.	[Parrott, Benjamin B.] Med Univ S Carolina, Hollings Marine Lab, Charleston, SC 29425 USA; [Hudson, Alicia; Schulz, Cordula] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Brady, Regina] Mercer Med Sch, Macon, GA USA	Medical University of South Carolina; University System of Georgia; University of Georgia	Parrott, BB (corresponding author), Med Univ S Carolina, Hollings Marine Lab, Charleston, SC 29425 USA.	cschulz@uga.edu			American Foundation for Aging; National Science Foundation (NSF) [0841419]; University of Georgia (UGA); Direct For Biological Sciences [0841419] Funding Source: National Science Foundation	American Foundation for Aging; National Science Foundation (NSF)(National Science Foundation (NSF)); University of Georgia (UGA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by an American Foundation for Aging Research fellowship to BBP, and a National Science Foundation (NSF) grant (#0841419) and University of Georgia (UGA) start-up funds awarded to CS. The funder had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	[Anonymous], NUCL ACIDS RES, V31, P172; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; Cheng T, 2006, ESSENTIALS STEM CELL, P63; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fuller Margaret T., 1993, P71; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Matunis E, 1997, DEVELOPMENT, V124, P4383; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Tsruya R, 2002, GENE DEV, V16, P222, DOI 10.1101/gad.214202; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Van Doren M, 1998, CURR BIOL, V8, P243; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2010, CURR OPIN CELL BIOL, V22, P605, DOI 10.1016/j.ceb.2010.07.009	38	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36460	10.1371/journal.pone.0036460	http://dx.doi.org/10.1371/journal.pone.0036460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586473	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000035
J	Willer, Y; Muller, B; Bumann, D				Willer, Yvonne; Mueller, Beatrice; Bumann, Dirk			Intestinal Inflammation Responds to Microbial Tissue Load Independent of Pathogen/Non-Pathogen Discrimination	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI NISSLE-1917; ORAL SALMONELLA INFECTION; INNATE IMMUNE-SYSTEM; DENDRITIC CELLS; ULCERATIVE-COLITIS; LYMPHOID-TISSUE; MUCOSAL DEFENSE; PEYERS-PATCHES; COMMENSAL	The intestinal immune system mounts inflammatory responses to pathogens but tolerates harmless commensal microbiota. Various mechanisms for pathogen/non-pathogen discrimination have been proposed but their general relevance for inflammation control is unclear. Here, we compared intestinal responses to pathogenic Salmonella and non-pathogenic E. coli. Both microbes entered intestinal Peyer's patches and, surprisingly, induced qualitatively and quantitatively similar initial inflammatory responses revealing a striking discrimination failure. Diverging inflammatory responses only occurred when Salmonella subsequently proliferated and induced escalating neutrophil infiltration, while harmless E. coli was rapidly cleared from the tissue and inflammation resolved. Transient intestinal inflammation induced by harmless E. coli tolerized against subsequent exposure thereby preventing chronic inflammation during repeated exposure. These data revealed a striking failure of the intestinal immune system to discriminate pathogens from harmless microbes based on distinct molecular signatures. Instead, appropriate intestinal responses to gut microbiota might be ensured by immediate inflammatory responses to any rise in microbial tissue loads, and desensitization after bacterial clearance.	[Willer, Yvonne; Bumann, Dirk] Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany; [Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Mueller, Beatrice; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland	Hannover Medical School; Max Planck Society; University of Basel	Willer, Y (corresponding author), Hannover Med Sch, Jr Grp Mucosal Infect, D-3000 Hannover, Germany.	Dirk.Bumann@unibas.ch			Deutsche Forschungsgemeinschaft [SFB 621 A9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was in part supported by Deutsche Forschungsgemeinschaft (SFB 621 A9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Broad A, 2006, CURR MED CHEM, V13, P2487, DOI 10.2174/092986706778201675; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fukushima K, 1999, J GASTROENTEROL, V34, P54, DOI 10.1007/s005350050216; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hopkins SA, 2000, CELL MICROBIOL, V2, P59; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Ogawa H, 2000, AM J PHYSIOL-GASTR L, V279, pG492, DOI 10.1152/ajpgi.2000.279.3.G492; Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Rydstrom A, 2009, EUR J IMMUNOL, V39, P3019, DOI 10.1002/eji.200939483; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Shreedhar VK, 2003, INFECT IMMUN, V71, P504, DOI 10.1128/IAI.71.1.504-509.2003; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vazquez-Torres A, 2004, J IMMUNOL, V172, P6202, DOI 10.4049/jimmunol.172.10.6202; Weiss DS, 2004, J IMMUNOL, V172, P4463, DOI 10.4049/jimmunol.172.7.4463	31	5	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35992	10.1371/journal.pone.0035992	http://dx.doi.org/10.1371/journal.pone.0035992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586458	Green Published, gold, Green Accepted			2022-12-27	WOS:000305335000020
J	Nygaard, TK; Pallister, KB; DuMont, AL; DeWald, M; Watkins, RL; Pallister, EQ; Malone, C; Griffith, S; Horswill, AR; Torres, VJ; Voyich, JM				Nygaard, Tyler K.; Pallister, Kyler B.; DuMont, Ashley L.; DeWald, Mark; Watkins, Robert L.; Pallister, Erik Q.; Malone, Cheryl; Griffith, Shannon; Horswill, Alexander R.; Torres, Victor J.; Voyich, Jovanka M.			Alpha-Toxin Induces Programmed Cell Death of Human T cells, B cells, and Monocytes during USA300 Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; VIRULENCE GENE-EXPRESSION; SHOCK SYNDROME; EMERGENCY-DEPARTMENT; SEPTICEMIA STRAINS; HEMOLYSIN; PNEUMONIA; SKIN; SAE	This investigation examines the influence of alpha-toxin (Hla) during USA300 infection of human leukocytes. Survival of an USA300 isogenic deletion mutant of hla (USA300 Delta hla) in human blood was comparable to the parental wild-type strain and polymorphonuclear leukocyte (PMN) plasma membrane permeability caused by USA300 did not require Hla. Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) following infection by USA300, USA300 Delta hla, and USA300 Delta hla transformed with a plasmid over-expressing Hla (USA300 Delta hla Comp) demonstrated this toxin plays a significant role inducing plasma membrane permeability of CD14(+), CD3(+), and CD19(+) PBMCs. Rapid plasma membrane permeability independent of Hla was observed for PMNs, CD14(+) and CD19(+) PBMCs following intoxication with USA300 supernatant while the majority of CD3(+) PBMC plasma membrane permeability induced by USA300 required Hla. Addition of recombinant Hla to USA300 Delta hla supernatant rescued CD3(+) and CD19(+) PBMC plasma membrane permeability generated by USA300 supernatant. An observed delay in plasma membrane permeability caused by Hla in conjunction with Annexin V binding and ApoBrdU Tunel assays examining PBMCs intoxicated with recombinant Hla or infected with USA300, USA300 Delta hla, USA300 Delta hla Comp, and USA300 Delta saeR/S suggest Hla induces programmed cell death of monocytes, B cells, and T cells that results in plasma membrane permeability. Together these findings underscore the importance of Hla during S. aureus infection of human tissue and specifically demonstrate Hla activity during USA300 infection triggers programmed cell death of human monocytes, T cells and B cells that leads to plasma membrane permeability.	[Nygaard, Tyler K.; Pallister, Kyler B.; DeWald, Mark; Watkins, Robert L.; Pallister, Erik Q.; Griffith, Shannon; Voyich, Jovanka M.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [DuMont, Ashley L.; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Malone, Cheryl; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	Montana State University System; Montana State University Bozeman; New York University; University of Iowa	Nygaard, TK (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	jovanka@montana.edu		Torres, Victor/0000-0002-7126-0489; Nygaard, Tyler/0000-0002-4736-0156	National Institute of Health (NIH) [NIH-PAR98-072, NIH-RR020185, NIH-R01, A1090046-01]; Molecular Biosciences Fellowship; Montana State University Agricultural Experiment Station; New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant [09SDG2060036]; NIH Training Grant [5T32 AI007180-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI090046, T32AI007180] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biosciences Fellowship; Montana State University Agricultural Experiment Station; New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant(American Heart Association); NIH Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (NIH) grants NIH-PAR98-072 and NIH-RR020185, and NIH-R01 award A1090046-01 and a Molecular Biosciences Fellowship (to RLW) as well as Montana State University Agricultural Experiment Station (TKN, KBP, RLW, EQP, SG, MD and JMV), and New York University School of Medicine Development Funds (VJT), American Heart Association Scientist Development Grant (09SDG2060036) (VJT), and NIH Training Grant 5T32 AI007180-27 (ALD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; CHRISTENSSON B, 1986, SCAND J INFECT DIS, V18, P297, DOI 10.3109/00365548609032340; CLYNE M, 1988, J CLIN MICROBIOL, V26, P535, DOI 10.1128/JCM.26.3.535-539.1988; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; Garcia-Lara J, 2009, CURR OPIN PHARMACOL, V9, P552, DOI 10.1016/j.coph.2009.07.008; Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kobayashi SD, 2010, J INNATE IMMUN, V2, P560, DOI 10.1159/000317134; Li DM, 2008, INFECT IMMUN, V76, P1068, DOI 10.1128/IAI.01069-07; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Menzies BE, 2000, FEMS IMMUNOL MED MIC, V29, P39, DOI 10.1016/S0928-8244(00)00185-1; Miller LS, 2011, NAT REV IMMUNOL; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nygaard TK, 2008, CURR OPIN INFECT DIS, V21, P147, DOI 10.1097/QCO.0b013e3282f64819; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; OREILLY M, 1990, MOL MICROBIOL, V4, P1947, DOI 10.1111/j.1365-2958.1990.tb02044.x; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2010, EXPERT OPIN BIOL TH, V10, P1049, DOI 10.1517/14712598.2010.495115; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; SCHLIEVERT PM, 1982, ANN INTERN MED, V96, P937, DOI 10.7326/0003-4819-96-6-937; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Valeva A, 1997, P NATL ACAD SCI USA, V94, P11607, DOI 10.1073/pnas.94.21.11607; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Xiong YQ, 2006, J INFECT DIS, V194, P1267, DOI 10.1086/508210	46	76	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36532	10.1371/journal.pone.0036532	http://dx.doi.org/10.1371/journal.pone.0036532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574180	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800077
J	Rogers, MS; Boyartchuk, V; Rohan, RM; Birsner, AE; Dietrich, WF; D'Amato, RJ				Rogers, Michael S.; Boyartchuk, Victor; Rohan, Richard M.; Birsner, Amy E.; Dietrich, William F.; D'Amato, Robert J.			The Classical Pink-Eyed Dilution Mutation Affects Angiogenic Responsiveness	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENETIC-LOCI; MICE; HETEROGENEITY; CHEMISTRY	Angiogenesis is the process by which new blood vessels are formed from existing vessels. Mammalian populations, including humans and mice, harbor genetic variations that alter angiogenesis. Angiogenesis-regulating gene variants can result in increased susceptibility to multiple angiogenesis-dependent diseases in humans. Our efforts to dissect the complexity of the genetic diversity that regulates angiogenesis have used laboratory animals due to the availability of genome sequence for many species and the ability to perform high volume controlled breeding. Using the murine corneal micropocket assay, we have observed more than ten-fold difference in angiogenic responsiveness among various mouse strains. This degree of difference is observed with either bFGF or VEGF induced corneal neovascularization. Ongoing mapping studies have identified multiple loci that affect angiogenic responsiveness in several mouse models. In this study, we used F2 intercrosses between C57BL/6J and the 129 substrains 129P1/ReJ and 129P3/J, as well as the SJL/J strain, where we have identified new QTLs that affect angiogenic responsiveness. In the case of AngFq5, on chromosome 7, congenic animals were used to confirm the existence of this locus and subcongenic animals, combined with a haplotype-based mapping approach that identified the pink-eyed dilution mutation as a candidate polymorphism to explain AngFq5. The ability of mutations in the pink-eyed dilution gene to affect angiogenic response was demonstrated using the p-J allele at the same locus. Using this allele, we demonstrate that pink-eyed dilution mutations in Oca2 can affect both bFGF and VEGF-induced corneal angiogenesis.	[Rogers, Michael S.; Rohan, Richard M.; Birsner, Amy E.; D'Amato, Robert J.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Rogers, Michael S.; Rohan, Richard M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [D'Amato, Robert J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Boyartchuk, Victor] UMass Med Sch, Program Gene Funct & Express, Worcester, MA USA; [Dietrich, William F.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; Novartis	Rogers, MS (corresponding author), Childrens Hosp, Vasc Biol Program, 300 Longwood Ave, Boston, MA 02115 USA.	michael.rogers@childrens.harvard.edu	Rogers, Michael S/A-9814-2009; Rogers, Michael/AAE-2217-2019	Rogers, Michael S/0000-0002-5250-8434; Rogers, Michael/0000-0002-5250-8434	National Institutes of Health [R01 EY12726]; NATIONAL EYE INSTITUTE [R01EY012726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; BRILLIANT MH, 1994, GENETICS, V138, P203; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chakroborty D, 2009, CANCER RES, V69, P3727, DOI 10.1158/0008-5472.CAN-08-4289; Chalothorn D, 2005, AM J PHYSIOL-HEART C, V289, pH947, DOI 10.1152/ajpheart.00952.2004; Chua CC, 1998, FREE RADICAL BIO MED, V25, P891, DOI 10.1016/S0891-5849(98)00115-4; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; Gospodarowicz D, 1976, Prog Clin Biol Res, V9, P1; Graff R J, 1966, Transplantation, V4, P425, DOI 10.1097/00007890-196607000-00007; Haldane JBS, 1915, J GENET, V5, P133, DOI 10.1007/BF02985370; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Kao CH, 1999, GENETICS, V152, P1203; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Land EJ, 2003, ACCOUNTS CHEM RES, V36, P300, DOI 10.1021/ar020062p; LANDER ES, 1989, GENETICS, V121, P185; Manga P, 2001, EXP EYE RES, V72, P695, DOI 10.1006/exer.2001.1006; Murakami M, 2008, CARDIOVASC RES, V78, P223, DOI 10.1093/cvr/cvm086; Nakai K, 2009, FASEB J, V23, P2235, DOI 10.1096/fj.08-124321; Rogers MS, 2007, NAT PROTOC, V2, P2545, DOI 10.1038/nprot.2007.368; Rogers MS, 2006, EXP CELL RES, V312, P561, DOI 10.1016/j.yexcr.2005.10.021; Rogers MS, 2004, FASEB J, V18, P1050, DOI 10.1096/fj.03-1241com; Rogers MS, 2003, FASEB J, V17, P2112, DOI 10.1096/fj.03-0246fje; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Sato H, 2005, CARDIOVASC RES, V67, P714, DOI 10.1016/j.cardiores.2005.04.017; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Wakamatsu K, 2007, PIGM CELL RES, V20, P222, DOI 10.1111/j.1600-0749.2007.00370.x; Wang S., 2007, WINDOWS QTL CARTOGRA; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35237	10.1371/journal.pone.0035237	http://dx.doi.org/10.1371/journal.pone.0035237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615734	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336300001
J	Deng, ZY; Sui, GC; Rosa, PM; Zhao, WL				Deng, Zhiyong; Sui, Guangchao; Rosa, Paulo Mottin; Zhao, Weiling			Radiation-Induced c-Jun Activation Depends on MEK1-ERK1/2 Signaling Pathway in Microglial Cells	PLOS ONE			English	Article							NF-KAPPA-B; IONIZING-RADIATION; INDUCED APOPTOSIS; MAP KINASES; TRANSCRIPTIONAL REGULATION; HIPPOCAMPAL NEUROGENESIS; OXIDATIVE STRESS; GENE-EXPRESSION; DNA-BINDING; TNF-ALPHA	Radiation-induced normal brain injury is associated with acute and/or chronic inflammatory responses, and has been a major concern in radiotherapy. Recent studies suggest that microglial activation is a potential contributor to chronic inflammatory responses following irradiation; however, the molecular mechanism underlying the response of microglia to radiation is poorly understood. c-Jun, a component of AP-1 transcription factors, potentially regulates neural cell death and neuroinflammation. We observed a rapid increase in phosphorylation of N-terminal c-Jun (on serine 63 and 73) and MAPK kinases ERK1/2, but not JNKs, in irradiated murine microglial BV2 cells. Radiation-induced c-Jun phosphorylation is dependent on the canonical MEK-ERK signaling pathway and required for both ERK1 and ERK2 function. ERK1/2 directly interact with c-Jun in vitro and in cells; meanwhile, the JNK binding domain on c-Jun is not required for its interaction with ERK kinases. Radiation-induced reactive oxygen species (ROS) potentially contribute to c-Jun phosphorylation through activating the ERK pathway. Radiation stimulates c-Jun transcriptional activity and upregulates c-Jun-regulated proinflammatory genes, such as tumor necrosis factor-alpha, interleukin-1 beta, and cyclooxygenase-2. Pharmacologic blockade of the ERK signaling pathway interferes with c-Jun activity and inhibits radiation-stimulated expression of c-Jun target genes. Overall, our study reveals that the MEK-ERK1/2 signaling pathway, but not the JNK pathway, contributes to the c-Jun-dependent microglial inflammatory response following irradiation.	[Deng, Zhiyong; Rosa, Paulo Mottin; Zhao, Weiling] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27106 USA; [Deng, Zhiyong; Rosa, Paulo Mottin; Zhao, Weiling] Wake Forest Univ, Bowman Gray Sch Med, Brain Tumor Ctr Excellence, Winston Salem, NC USA; [Sui, Guangchao] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Deng, ZY (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27106 USA.	wzhao@wakehealth.edu			Department of Radiation Oncology, Wake Forest University School of Medicine	Department of Radiation Oncology, Wake Forest University School of Medicine	The work was supported by the start-up funding from the Department of Radiation Oncology, Wake Forest University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; Barila D, 2000, EMBO J, V19, P273, DOI 10.1093/emboj/19.2.273; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Baumann B, 2000, P NATL ACAD SCI USA, V97, P4615, DOI 10.1073/pnas.080583397; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Cho YY, 2009, CANCER RES, V69, P272, DOI 10.1158/0008-5472.CAN-08-3125; Collins-Underwood JR, 2008, FREE RADICAL BIO MED, V45, P929, DOI 10.1016/j.freeradbiomed.2008.06.024; CROSSEN JR, 1994, J CLIN ONCOL, V12, P627, DOI 10.1200/JCO.1994.12.3.627; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Deng Z, 2009, ONCOGENE, V28, P3746, DOI 10.1038/onc.2009.231; Deng ZY, 2007, MOL CELL BIOL, V27, P3780, DOI 10.1128/MCB.01761-06; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Doi M, 2000, HYPERTENS RES, V23, P659, DOI 10.1291/hypres.23.659; ECONOMOU JS, 1989, J EXP MED, V170, P321, DOI 10.1084/jem.170.1.321; Ferrer I, 1995, NEUROSCI LETT, V202, P105, DOI 10.1016/0304-3940(95)12220-6; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Humar M, 2007, INT J BIOCHEM CELL B, V39, P2278, DOI 10.1016/j.biocel.2007.06.013; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kyrkanides S, 2002, MOL BRAIN RES, V104, P159, DOI 10.1016/S0169-328X(02)00353-4; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lallemand D, 1998, EMBO J, V17, P5615, DOI 10.1093/emboj/17.19.5615; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; PAPAVASSILIOU AG, 1995, EMBO J, V14, P2014, DOI 10.1002/j.1460-2075.1995.tb07193.x; Perez RL, 1999, AM J RESP CELL MOL, V20, P1059, DOI 10.1165/ajrcmb.20.5.3281; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Raivich G, 2008, J NEUROCHEM, V107, P898, DOI 10.1111/j.1471-4159.2008.05684.x; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reddy ST, 2000, J BIOL CHEM, V275, P3107, DOI 10.1074/jbc.275.5.3107; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; SAKLATVALA J, 1993, FEBS LETT, V334, P189, DOI 10.1016/0014-5793(93)81709-9; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Sui G, 2005, METH MOL B, V309, P205; Sweeney SE, 2005, J IMMUNOL, V174, P6424, DOI 10.4049/jimmunol.174.10.6424; Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162; TANABE O, 1988, J IMMUNOL, V141, P3875; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646; Zhao WL, 2007, RADIAT RES, V167, P581, DOI 10.1667/RR0814.1; Zhao WL, 2001, CANCER RES, V61, P5537	53	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36739	10.1371/journal.pone.0036739	http://dx.doi.org/10.1371/journal.pone.0036739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606284	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400031
J	Yi, DK; Kim, KJ				Yi, Dong-Keun; Kim, Ki-Joong			Complete Chloroplast Genome Sequences of Important Oilseed Crop Sesamum indicum L	PLOS ONE			English	Article							TRANSFER-RNA GENES; DNA-SEQUENCE; MOLECULAR EVOLUTION; SMALL INVERSIONS; DIVERSITY; RATES; DIVERGENCE; MULTIPLE; MARKERS; MAIZE	Sesamum indicum is an important crop plant species for yielding oil. The complete chloroplast (cp) genome of S. indicum (GenBank acc no. JN637766) is 153,324 bp in length, and has a pair of inverted repeat (IR) regions consisting of 25,141 bp each. The lengths of the large single copy (LSC) and the small single copy (SSC) regions are 85,170 bp and 17,872 bp, respectively. Comparative cp DNA sequence analyses of S. indicum with other cp genomes reveal that the genome structure, gene order, gene and intron contents, AT contents, codon usage, and transcription units are similar to the typical angiosperm cp genomes. Nucleotide diversity of the IR region between Sesamum and three other cp genomes is much lower than that of the LSC and SSC regions in both the coding region and noncoding region. As a summary, the regional constraints strongly affect the sequence evolution of the cp genomes, while the functional constraints weakly affect the sequence evolution of cp genomes. Five short inversions associated with short palindromic sequences that form step-loop structures were observed in the chloroplast genome of S. indicum. Twenty-eight different simple sequence repeat loci have been detected in the chloroplast genome of S. indicum. Almost all of the SSR loci were composed of A or T, so this may also contribute to the A-T richness of the cp genome of S. indicum. Seven large repeated loci in the chloroplast genome of S. indicum were also identified and these loci are useful to developing S. indicum-specific cp genome vectors. The complete cp DNA sequences of S. indicum reported in this paper are prerequisite to modifying this important oilseed crop by cp genetic engineering techniques.	[Yi, Dong-Keun; Kim, Ki-Joong] Korea Univ, Sch Life Sci, Seoul, South Korea	Korea University	Yi, DK (corresponding author), Korea Univ, Sch Life Sci, Seoul, South Korea.	kimkj@korea.ac.kr		Yi, Dong-Keun/0000-0002-3988-323X	Korea Research Foundation [KRF-2007-0053690, KRF-2010-0011796]; Korea Environmental Industry & Technology Institute [KEITI062-091-078]	Korea Research Foundation(National Research Foundation of Korea); Korea Environmental Industry & Technology Institute	KJK was funded by the Korea Research Foundation (KRF-2007-0053690 and KRF-2010-0011796) and by the Korea Environmental Industry & Technology Institute (KEITI062-091-078). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Adebowale A. A., 2011, World Journal of Agricultural Sciences, V7, P42; Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; BEDIGIAN D, 1985, BIOCHEM SYST ECOL, V13, P133, DOI 10.1016/0305-1978(85)90071-7; Bedigian D, 2003, GENET RESOUR CROP EV, V50, P779, DOI 10.1023/A:1025029903549; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Bryan GJ, 1999, THEOR APPL GENET, V99, P859, DOI 10.1007/s001220051306; Cato SA, 1996, THEOR APPL GENET, V93, P587, DOI 10.1007/BF00417952; Chen ECF, 1998, PLANT CELL PHYSIOL, V39, P935, DOI 10.1093/oxfordjournals.pcp.a029457; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; CURTIS SE, 1984, MOL BIOL EVOL, V1, P291; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Downie S, 1992, MOL SYSTEMATICS PLAN, P14, DOI DOI 10.1007/978-1-4615-3276-7_2; Echt CS, 1998, MOL ECOL, V7, P307, DOI 10.1046/j.1365-294X.1998.00350.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Grassi F, 2002, VITIS, V41, P157; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; JANSEN RK, 1987, P NATL ACAD SCI USA, V84, P5818, DOI 10.1073/pnas.84.16.5818; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Kim DH, 2002, PLANT BREEDING, V121, P259, DOI 10.1046/j.1439-0523.2002.00700.x; Kim KJ, 2005, MOL CELLS, V19, P104; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kumar Shashi, 2004, Methods Mol Biol, V267, P365; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Rivas JM, 2000, BIOCHEM SOC T, V28, P890, DOI 10.1042/BST0280890; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; MORTON BR, 1995, J MOL EVOL, V41, P597, DOI 10.1007/BF00175818; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Onginjo E O, 2009, AFRICAN CROP SCI J, V17, P101; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; Parsaeian M, 2011, RUSS J GENET+, V47, P314, DOI 10.1134/S1022795411030136; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Pham TD, 2010, AUST J CROP SCI, V4, P498; Pham TD, 2009, GENET RESOUR CROP EV, V56, P679, DOI 10.1007/s10722-008-9393-z; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POWELL W, 1995, CURR BIOL, V5, P1023, DOI 10.1016/S0960-9822(95)00206-5; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Provan J, 1996, P ROY SOC B-BIOL SCI, V263, P1275, DOI 10.1098/rspb.1996.0187; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Rousselin P, 2002, PLANT BREEDING, V121, P108, DOI 10.1046/j.1439-0523.2002.00682.x; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; SHINOZAKI K, 1988, PHOTOSYNTH RES, V18, P7, DOI 10.1007/BF00042978; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Weber S, 2003, PLANT CELL REP, V21, P475, DOI 10.1007/s00299-002-0548-7; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu DH, 2002, THEOR APPL GENET, V105, P645, DOI 10.1007/s00122-002-0972-7; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yue F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S15; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	82	110	114	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35872	10.1371/journal.pone.0035872	http://dx.doi.org/10.1371/journal.pone.0035872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606240	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400009
J	Hansen, S; Strom, M; Maslova, E; Mortensen, EL; Granstrom, C; Olsen, SF				Hansen, Susanne; Strom, Marin; Maslova, Ekaterina; Mortensen, Erik Lykke; Granstrom, Charlotta; Olsen, Sjurdur F.			A Comparison of Three Methods to Measure Asthma in Epidemiologic Studies: Results from the Danish National Birth Cohort	PLOS ONE			English	Article							CIVIL REGISTRATION SYSTEM; ALLERGIC DISEASES; 2 PARTS; CHILDREN; PRESCRIPTION; POPULATION; IMMUNOLOGY; PREVALENCE; MEDICATION; DIAGNOSIS	Asthma is a heterogeneous outcome and how the condition should be measured to best capture clinically relevant disease in epidemiologic studies remains unclear. We compared three methods of measuring asthma in the Danish National Birth Cohort (n>50.000). When the children were 7 years old, the prevalence of asthma was estimated from a self-administered questionnaire using parental report of doctor diagnoses, ICD-10 diagnoses from a population-based hospitalization registry, and data on anti-asthmatic medication from a population-based prescription registry. We assessed the agreement between the methods using kappa statistics. Highest prevalence of asthma was found using the prescription registry (32.2%) followed by the self-report (12.0%) and the hospitalization registry (6.6%). We found a substantial non-overlap between the methods (kappa = 0.21-0.38). When all three methods were combined the asthma prevalence was 3.6%. In conclusion, self-reported asthma, ICD-10 diagnoses from a hospitalization registry and data on anti-asthmatic medication use from a prescription registry lead to different prevalences of asthma in the same cohort of children. The non-overlap between the methods may be due to different abilities of the methods to identify cases with different phenotypes, in which case they should be treated as separate outcomes in future aetiological studies.	[Hansen, Susanne; Strom, Marin; Granstrom, Charlotta; Olsen, Sjurdur F.] Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark; [Maslova, Ekaterina] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Maslova, Ekaterina; Olsen, Sjurdur F.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Statens Serum Institut; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Copenhagen; University of Copenhagen	Hansen, S (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Ctr Fetal Programming, DK-2300 Copenhagen, Denmark.	suu@ssi.dk	Hansen, Susanne/AAE-7275-2021; Hansen, Susanne/F-1657-2017	Mortensen, Erik Lykke/0000-0002-6985-451X; Strom, Marin/0000-0003-1926-6610; Olsen, Sjurdur/0000-0003-3017-7096; Hansen, Susanne/0000-0002-9550-6703	Danish Council for Independent Research [09-068410]; Lundbeck Foundation [R13-A907]; Danish Lung Association [2-2010]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Danish Lung Association	The work was supported financially by the Danish Council for Independent Research (09-068410) (http://en.fi.dk/councils-commissions/the-danishcouncil-for-strategic-research), the Lundbeck Foundation (R13-A907) (Lundbeckfonden.dk) and the Danish Lung Association (2-2010) (www.lunge.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2011, SCAND J PUBLIC HEALT, V39, P115, DOI 10.1177/1403494811407674; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Furu K, 2007, EUR J CLIN PHARMACOL, V63, P693, DOI 10.1007/s00228-007-0301-9; Ingvardsen B K, 2000, Ugeskr Laeger, V162, P6062; Joesch Jutta M, 2006, J Pediatr Health Care, V20, P374, DOI 10.1016/j.pedhc.2006.02.003; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Kemp T, 1996, Respirology, V1, P183; Khaltaev N, 2007, GLOBAL SURVEILLANCE; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moth G, 2007, EUR J CLIN PHARMACOL, V63, P605, DOI 10.1007/s00228-007-0286-4; Nwaru BI, 2011, CLIN RESPIR J, V5, P211, DOI 10.1111/j.1752-699X.2010.00222.x; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Peat JK, 2001, THORAX, V56, P406, DOI 10.1136/thorax.56.5.406; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pekkanen J, 2005, EUR RESPIR J, V26, P28, DOI 10.1183/09031936.05.00120104; Roberts EM, 2003, ARCH PEDIAT ADOL MED, V157, P449, DOI 10.1001/archpedi.157.5.449; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; Yang CL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-52; Yuan W, 2002, INT J EPIDEMIOL, V31, P1240, DOI 10.1093/ije/31.6.1240; Zuidgeest MG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-16	24	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36328	10.1371/journal.pone.0036328	http://dx.doi.org/10.1371/journal.pone.0036328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606255	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200023
J	Sabehi, G; Lindell, D				Sabehi, Gazalah; Lindell, Debbie			The P-SSP7 Cyanophage Has a Linear Genome with Direct Terminal Repeats	PLOS ONE			English	Article							PHOTOSYNTHESIS GENES; MARINE; PROCHLOROCOCCUS; ORGANIZATION; PROTEINS	P-SSP7 is a T7-like phage that infects the cyanobacterium Prochlorococcus MED4. MED4 is a member of the high-light-adapted Prochlorococcus ecotypes that are abundant in the surface oceans and contribute significantly to primary production. P-SSP7 has become a model system for the investigation of T7-like phages that infect Prochlorococcus. It was classified as T7-like based on genome content and organization. However, because its genome assembled as a circular molecule, it was thought to be circularly permuted and to lack the direct terminal repeats found in other T7-like phages. Here we sequenced the ends of the P-SSP7 genome and found that the genome map is linear and contains a 206 bp repeat at both genome ends. Furthermore, we found that a 728 bp region of the genome originally placed downstream of the last ORF is actually located upstream of the first ORF on the genome map. These findings suggest that P-SSP7 is likely to use the direct terminal repeats for genome replication and packaging in a similar manner to other T7-like phages. Moreover, these results highlight the importance of experimentally verifying the ends of phage genomes, and will facilitate the use of P-SSP7 as a model for the correct assembly and end determination of the many T7-like phages isolated from the marine environment that are currently being sequenced.	[Sabehi, Gazalah; Lindell, Debbie] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	Technion Israel Institute of Technology	Sabehi, G (corresponding author), Technion Israel Inst Technol, Fac Biol, Haifa, Israel.	dlindell@tx.technion.ac.il		Lindell, Debbie/0000-0003-0612-4517	European Research Council [203406]	European Research Council(European Research Council (ERC)European Commission)	This research was funded by an European Research Council Starting Grant (#203406) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Molineux I.J., 2006, BACTERIOPHAGES, P227; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pope WH, 2007, J MOL BIOL, V368, P966, DOI 10.1016/j.jmb.2007.02.046; Sabehi G, 2012, P NATL ACAD SCI USA, V109, P2037, DOI 10.1073/pnas.1115467109; Sambrook J., 2001, MOL CLONING; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Zeidner G, 2003, ENVIRON MICROBIOL, V5, P212, DOI 10.1046/j.1462-2920.2003.00403.x	20	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36710	10.1371/journal.pone.0036710	http://dx.doi.org/10.1371/journal.pone.0036710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606283	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200039
J	Sutherland, ER; Goleva, E; King, TS; Lehman, E; Stevens, AD; Jackson, LP; Stream, AR; Fahy, JV; Leung, DYM				Sutherland, E. Rand; Goleva, Elena; King, Tonya S.; Lehman, Erik; Stevens, Allen D.; Jackson, Leisa P.; Stream, Amanda R.; Fahy, John V.; Leung, Donald Y. M.		Asthma Clin Res Network	Cluster Analysis of Obesity and Asthma Phenotypes	PLOS ONE			English	Article							BODY-MASS INDEX; VITAMIN-D LEVELS; ADIPOSE-TISSUE; RESISTANT ASTHMA; T-CELLS; SEVERITY; ACTIVATION; INFLAMMATION; OVERWEIGHT; INDUCTION	Background: Asthma is a heterogeneous disease with variability among patients in characteristics such as lung function, symptoms and control, body weight, markers of inflammation, and responsiveness to glucocorticoids (GC). Cluster analysis of well-characterized cohorts can advance understanding of disease subgroups in asthma and point to unsuspected disease mechanisms. We utilized an hypothesis-free cluster analytical approach to define the contribution of obesity and related variables to asthma phenotype. Methodology and Principal Findings: In a cohort of clinical trial participants (n = 250), minimum-variance hierarchical clustering was used to identify clinical and inflammatory biomarkers important in determining disease cluster membership in mild and moderate persistent asthmatics. In a subset of participants, GC sensitivity was assessed via expression of GC receptor alpha (GCR alpha) and induction of MAP kinase phosphatase-1 (MKP-1) expression by dexamethasone. Four asthma clusters were identified, with body mass index (BMI, kg/m(2)) and severity of asthma symptoms (AEQ score) the most significant determinants of cluster membership (F = 57.1, p, 0.0001 and F = 44.8, p, 0.0001, respectively). Two clusters were composed of predominantly obese individuals; these two obese asthma clusters differed from one another with regard to age of asthma onset, measures of asthma symptoms (AEQ) and control (ACQ), exhaled nitric oxide concentration (FENO) and airway hyperresponsiveness (methacholine PC20) but were similar with regard to measures of lung function (FEV1 (%) and FEV1/FVC), airway eosinophilia, IgE, leptin, adiponectin and C-reactive protein (hsCRP). Members of obese clusters demonstrated evidence of reduced expression of GCR alpha, a finding which was correlated with a reduced induction of MKP-1 expression by dexamethasone Conclusions and Significance: Obesity is an important determinant of asthma phenotype in adults. There is heterogeneity in expression of clinical and inflammatory biomarkers of asthma across obese individuals. Reduced expression of the dominant functional isoform of the GCR may mediate GC insensitivity in obese asthmatics.	[Sutherland, E. Rand; Stevens, Allen D.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Goleva, Elena; Jackson, Leisa P.; Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [King, Tonya S.; Lehman, Erik] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Sutherland, E. Rand; Stream, Amanda R.; Leung, Donald Y. M.] Univ Colorado, Dept Med, Denver, CO USA; [Fahy, John V.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	National Jewish Health; National Jewish Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California San Francisco	Sutherland, ER (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	sutherlande@njhealth.org			National Institutes of Health [HL090982, AI070140, RR025011, RR025780, HL074227, HL074231, HL074204, HL074212, HL074073, HL074206, HL074208, HL074225, HL074218]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL074227, U10HL074206, U10HL074218, U10HL074208, U10HL074204, U10HL074225, U10HL074073, U10HL074231, R01HL090982, U10HL074212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070140, R01AI070140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health (HL090982, AI070140, RR025011, RR025780, HL074227, HL074231, HL074204, HL074212, HL074073, HL074206, HL074208, HL074225, HL074218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Camargo CA, 2010, J ASTHMA, V47, P76, DOI 10.3109/02770900903338494; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; DeRijk RH, 2003, MOL BRAIN RES, V116, P17, DOI 10.1016/S0169-328X(03)00209-2; Dixon AE, 2006, J ASTHMA, V43, P553, DOI 10.1080/02770900600859123; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Farah CS, 2011, CHEST, V140, P659, DOI 10.1378/chest.11-0027; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Goleva E, 2006, AM J RESP CRIT CARE, V173, P607, DOI 10.1164/rccm.200507-1046OC; Goleva E, 2008, J ALLERGY CLIN IMMUN, V122, P550, DOI 10.1016/j.jaci.2008.07.007; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kattan M, 2010, J ALLERGY CLIN IMMUN, V125, P584, DOI 10.1016/j.jaci.2010.01.053; Li LB, 2004, J ALLERGY CLIN IMMUN, V114, P1059, DOI 10.1016/j.jaci.2004.08.005; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Michelson PH, 2009, ANN ALLERG ASTHMA IM, V103, P381, DOI 10.1016/S1081-1206(10)60356-0; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; National Institutes of Health, 2007, NIH PUBL, V02-3659; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759	40	139	145	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36631	10.1371/journal.pone.0036631	http://dx.doi.org/10.1371/journal.pone.0036631			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606276	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200035
J	Delaugerre, C; Gallien, S; Flandre, P; Mathez, D; Amarsy, R; Ferret, S; Timsit, J; Molina, JM; de Truchis, P				Delaugerre, Constance; Gallien, Sebastien; Flandre, Philippe; Mathez, Dominique; Amarsy, Rishma; Ferret, Samuel; Timsit, Julie; Molina, Jean-Michel; de Truchis, Pierre			Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients	PLOS ONE			English	Article							VIROLOGICAL FAILURE; INFECTED PATIENTS; THERAPY; LOPINAVIR/RITONAVIR; RALTEGRAVIR; NELFINAVIR; REGIMEN; TIME	Background: Drug-resistance mutations (DRAM) are frequently selected in patients with virological failure defined as viral load (pVL) above 500 copies/ml (c/mL), but few resistance data are available at low-level viremia (LLV). Our objective was to determine the emergence and evolution of DRAM during LLV in HIV-1-infected patients while receiving antiretroviral therapy (ART). Methods: Retrospective analysis of patients presenting a LLV episode defined as pVL between 40 and 500 c/mL on at least 3 occasions during a 6-month period or longer while on the same ART. Resistance genotypic testing was performed at the onset and at the end of LLV period. Emerging DRAM was defined during LLV if never detected on baseline genotype or before. Results: 48 patients including 4 naive and 44 pretreated (median 9 years) presented a LLV episode with a median duration of 11 months. Current ART included 2NRTI (94%), ritonavir-boosted PI (94%), NNRTI (23%), and/or raltegravir (19%). Median pVL during LLV was 134 c/mL. Successful resistance testing at both onset and end of the LLV episode were obtained for 37 patients (77%), among who 11 (30%) acquired at least 1 DRAM during the LLV period: for NRTI in 6, for NNRTI in 1, for PI in 4, and for raltegravir in 2. During the LLV period, number of drugs with genotypic resistance increased from a median of 4.5 to 6 drugs. Duration and pVL level of LLV episode, duration of previous ART, current and nadir CD4 count, number of baseline DRAM and GSS were not identified as predictive factors of resistance acquisition during LLV, probably due to limited number of patients. Conclusion: Persistent LLV episodes below 500 c/ml while receiving ART is associated with emerging DRAM for all drug classes and a decreasing in further therapeutic options, suggesting to earlier consider resistance monitoring and ART optimization in this setting.	[Delaugerre, Constance; Amarsy, Rishma] Hop St Louis, APHP, Virol Lab, Paris, France; [Delaugerre, Constance; Gallien, Sebastien; Molina, Jean-Michel] Univ Paris 07, Paris, France; [Delaugerre, Constance; Gallien, Sebastien; Molina, Jean-Michel] INSERM, U941, Paris, France; [Gallien, Sebastien; Ferret, Samuel; Molina, Jean-Michel] Hop St Louis, APHP, Serv Malad Infect & Trop, Paris, France; [Mathez, Dominique] Hop Raymond Poincare, APHP, Lab Hematol Immunol, Garches, France; [Flandre, Philippe] Univ Paris 06, Paris, France; [Flandre, Philippe] INSERM, U943, Paris, France; [Timsit, Julie] Hop St Louis, APHP, Unite MST, Paris, France; [de Truchis, Pierre] Hop Raymond Poincare, APHP, Serv Malad Infect & Trop, Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP	Delaugerre, C (corresponding author), Hop St Louis, APHP, Virol Lab, Paris, France.	constance.delaugerre@sls.aphp.fr	Flandre, Philippe/N-6314-2017; Gallien, Sébastien/F-9930-2015	Flandre, Philippe/0000-0002-2612-3522; Gallien, Sébastien/0000-0002-8033-0936	SIDACTION [AI20-2-01593]	SIDACTION	Funding was provided by SIDACTION AI20-2-01593. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, REC GROUP EXP DIR DE; [Anonymous], 2006, REC GROUP EXP DIR YE; [Anonymous], 2010, REC GROUP EXP DIR YE; Assoumou L, 2010, INT HIV DRUG RES WOR; Bansi L, 2010, HIV MED, V11, P432, DOI 10.1111/j.1468-1293.2009.00809.x; Caby F, 2010, SCAND J INFECT DIS, V42, P527, DOI 10.3109/00365541003621502; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Charpentier C, 2010, AIDS, V24, P2651, DOI 10.1097/QAD.0b013e32833ed2a7; Costagliola D, 2007, JAIDS-J ACQ IMM DEF, V46, P12; Cozzi-Lepri A, 2007, AIDS, V21, P721, DOI 10.1097/QAD.0b013e3280141fdf; Delaugerre C, 2011, 6 INT AIDS SOC C HIV; European Medicines Agency, 2011, GUIDELINE BIOANALYTI, P1, DOI DOI 10.2810/49457; Gallien S, 2011, AIDS, V25, P665, DOI 10.1097/QAD.0b013e3283445834; Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents, 2011, GUID US ANT AG HIV 1, P1; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Karlsson AC, 2004, AIDS, V18, P981, DOI 10.1097/00002030-200404300-00005; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Lambotte O, 2004, AIDS, V18, P1147, DOI 10.1097/00002030-200405210-00008; Lima V., 2010, PERSISTENT LOW LEVEL; Pilcher CD, 1999, AIDS, V13, P1337, DOI 10.1097/00002030-199907300-00010; Sax PE, 2011, J INFECT DIS, V204, P1191, DOI 10.1093/infdis/jir505; Sungkanuparph S, 2006, HIV MED, V7, P437, DOI 10.1111/j.1468-1293.2006.00403.x; Taiwo B, 2011, J INFECT DIS, V204, P515, DOI 10.1093/infdis/jir353; von Wyl V, 2011, CLIN INFECT DIS	25	65	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36673	10.1371/journal.pone.0036673	http://dx.doi.org/10.1371/journal.pone.0036673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590588	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400027
J	Elgbratt, K; Jansson, A; Hultgren-Hornquist, E				Elgbratt, Kristina; Jansson, Andreas; Hultgren-Hornquist, Elisabeth			A Quantitative Study of the Mechanisms behind Thymic Atrophy in G alpha i2-Deficient Mice during Colitis Development	PLOS ONE			English	Article							T-CELL HOMEOSTASIS; RHEUMATOID-ARTHRITIS; POPULATION-DYNAMICS; ULCERATIVE-COLITIS; OUTPUT; MOUSE; THYMOCYTES; EMIGRANTS; MIGRATION; POOL	Mice deficient for the G protein subunit G alpha i2 spontaneously develop colitis, a chronic inflammatory disease associated with dysregulated T cell responses. We and others have previously demonstrated a thymic involution in these mice and an aberrant thymocyte dynamics. The G alpha i2(-/-) mice have a dramatically reduced fraction of double positive thymocytes and an increased fraction of single positive (SP) thymocytes. In this study, we quantify a number of critical parameters in order to narrow down the underlying mechanisms that cause the dynamical changes of the thymocyte development in the G alpha i2(-/-) mice. Our data suggest that the increased fraction of SP thymocytes results only from a decreased number of DP thymocytes, since the number of SP thymocytes in the Gai2(-/-) mice is comparable to the control littermates. By measuring the frequency of T cell receptor excision circles (TRECs) in the thymocytes, we demonstrate that the number of cell divisions the G alpha i2(-/-) SP thymocytes undergo is comparable to SP thymocytes from control littermates. In addition, our data show that the mature SP CD4(+) and CD8(+) thymocytes divide to the same extent before they egress from the thymus. By estimating the number of peripheral TREC+ T lymphocytes and their death rate, we could calculate the daily egression of thymocytes. G alpha i2(-/-) mice with no/mild and moderate colitis were found to have a slower export rate in comparison to the control littermates. The quantitative measurements in this study suggest a number of dynamical changes in the thymocyte development during the progression of colitis.	[Elgbratt, Kristina; Hultgren-Hornquist, Elisabeth] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Jansson, Andreas] Univ Skovde, Syst Biol Res Ctr, Skovde, Sweden	Orebro University; University of Skovde	Elgbratt, K (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.	elisabeth.hultgren-hornquist@oru.se			Swedish Research Council [2008-4075]; Swedish Cancer Society [CAN 2008/591]; Foundation of Professor Nanna Svartz; Orebro University; Swedish Society of Medicine; Knowledge Foundation [2010/0171]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Foundation of Professor Nanna Svartz; Orebro University; Swedish Society of Medicine; Knowledge Foundation	The Swedish Research Council [Grant no. 2008-4075] to [EHH]; The Swedish Cancer Society [Grant no. CAN 2008/591] to [EHH]; The Foundation of Professor Nanna Svartz [KE]; Orebro University to [EHH] and The Swedish Society of Medicine to [EHH]: The Knowledge Foundation [2010/0171]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2001, INT IMMUNOPHARMACOL, V1, P1261, DOI 10.1016/S1567-5769(01)00057-1; Arron ST, 2005, EUR J IMMUNOL, V35, P46, DOI 10.1002/eji.200424996; Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Capparelli R, 1997, CYTOMETRY, V29, P261, DOI 10.1002/(SICI)1097-0320(19971101)29:3<261::AID-CYTO9>3.0.CO;2-E; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; CLARKE AG, 1994, IMMUNOL TODAY, V15, P545, DOI 10.1016/0167-5699(94)90212-7; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; Elgbratt K, 2010, CLIN EXP IMMUNOL, V162, P325, DOI 10.1111/j.1365-2249.2010.04230.x; Elgbratt K, 2007, IMMUNOLOGY, V122, P199, DOI 10.1111/j.1365-2567.2007.02629.x; Fredin MF, 2007, SCAND J IMMUNOL, V65, P421, DOI 10.1111/j.1365-3083.2007.01923.x; Graziano M, 1998, EXP CELL RES, V240, P75, DOI 10.1006/excr.1997.3900; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Hoff J, 2000, LAB ANIMAL, V29, P47; Hornquist CE, 1997, J IMMUNOL, V158, P1068; Hug A, 2003, J IMMUNOL, V171, P432, DOI 10.4049/jimmunol.171.1.432; Jin YZ, 2008, MOL IMMUNOL, V45, P3401, DOI 10.1016/j.molimm.2008.04.007; Koetz K, 2000, P NATL ACAD SCI USA, V97, P9203, DOI 10.1073/pnas.97.16.9203; Krenger W, 2004, J IMMUNOL, V172, P7359, DOI 10.4049/jimmunol.172.12.7359; Ludviksson BR, 1997, J IMMUNOL, V158, P104; Mitchell WA, 2006, BIOGERONTOLOGY, V7, P461, DOI 10.1007/s10522-006-9061-7; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Ponchel F, 2002, BLOOD, V100, P4550, DOI 10.1182/blood-2002-03-0671; Ribeiro RM, 2007, IMMUNOL REV, V216, P21; ROCHA B, 1983, J IMMUNOL, V131, P2158; RUDOLPH U, 1995, J CLIN IMMUNOL, V15, pS101, DOI 10.1007/BF01540899; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Shimizu T, 2000, SCAND J IMMUNOL, V51, P285; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; Thomas-Vaslin V, 2008, J IMMUNOL, V180, P2240, DOI 10.4049/jimmunol.180.4.2240; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; Zhang YJ, 2005, INT IMMUNOL, V17, P233, DOI 10.1093/intimm/dxh204	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36726	10.1371/journal.pone.0036726	http://dx.doi.org/10.1371/journal.pone.0036726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590596	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400031
J	Graham, RT; Witt, MJ; Castellanos, DW; Remolina, F; Maxwell, S; Godley, BJ; Hawkes, LA				Graham, Rachel T.; Witt, Matthew J.; Castellanos, Dan W.; Remolina, Francisco; Maxwell, Sara; Godley, Brendan J.; Hawkes, Lucy A.			Satellite Tracking of Manta Rays Highlights Challenges to Their Conservation	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; MARINE PROTECTED AREAS; LEATHERBACK TURTLES; DIVING BEHAVIOR; WHALE SHARKS; MOVEMENTS; ALFREDI	We describe the real-time movements of the last of the marine mega-vertebrate taxa to be satellite tracked - the giant manta ray (or devil fish, Manta birostris), the world's largest ray at over 6 m disc width. Almost nothing is known about manta ray movements and their environmental preferences, making them one of the least understood of the marine mega-vertebrates. Red listed by the International Union for the Conservation of Nature as 'Vulnerable' to extinction, manta rays are known to be subject to direct and incidental capture and some populations are declining. Satellite-tracked manta rays associated with seasonal upwelling events and thermal fronts off the Yucatan peninsula, Mexico, and made short-range shuttling movements, foraging along and between them. The majority of locations were received from waters shallower than 50 m deep, representing thermally dynamic and productive waters. Manta rays remained in the Mexican Exclusive Economic Zone for the duration of tracking but only 12% of tracking locations were received from within Marine Protected Areas (MPAs). Our results on the spatio-temporal distribution of these enigmatic rays highlight opportunities and challenges to management efforts.	[Graham, Rachel T.] Wildlife Conservat Soc, Gulf & Caribbean Sharks & Rays Program, Punta Gorda, Belize; [Graham, Rachel T.; Godley, Brendan J.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Witt, Matthew J.; Hawkes, Lucy A.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Remolina, Francisco] Natl Commiss Protected Areas, Domino Project, Cancun, Quintana Roo, Mexico; [Maxwell, Sara] Marine Conservat Inst, Glen Ellen, CA USA; [Maxwell, Sara] Univ Calif Santa Cruz, Long Marine Lab, Santa Cruz, CA 95064 USA; [Hawkes, Lucy A.] Bangor Univ, Brambell Labs, Bangor, Gwynedd, Wales	University of Exeter; University of Exeter; University of California System; University of California Santa Cruz; Bangor University	Graham, RT (corresponding author), Wildlife Conservat Soc, Gulf & Caribbean Sharks & Rays Program, Punta Gorda, Belize.	rgraham@wcs.org	godley, brendan/O-1959-2019; Witt, Matthew/V-3318-2018; godley, brendan j/A-6139-2009; Hawkes, Lucy/L-7407-2014	godley, brendan/0000-0003-3845-0034; Witt, Matthew/0000-0002-9498-5378; godley, brendan j/0000-0003-3845-0034; Hawkes, Lucy/0000-0002-6696-1862; Maxwell, Sara/0000-0002-4425-9378	Summit Foundation	Summit Foundation	This study was funded by the The Summit Foundation (http://www.summitfdn.org/ and by two other foundations who wish to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bograd Steven J., 2010, Endangered Species Research, V10, P1, DOI 10.3354/esr00269; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; Canadas A, 2005, AQUAT CONSERV, V15, P495, DOI 10.1002/aqc.689; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Gore MA, 2008, BIOL LETTERS, V4, P395, DOI 10.1098/rsbl.2008.0147; Graham Rachel T., 2007, Gulf and Caribbean Research, V19, P149; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hart KM, 2012, BIOL CONSERV, V145, P185, DOI 10.1016/j.biocon.2011.10.030; Hart Kristen M., 2010, Endangered Species Research, V10, P9, DOI 10.3354/esr00238; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kooyman G, 2007, MAR TECHNOL SOC J, V41, P6, DOI 10.4031/002533207787441935; Marshall A, 2011, IUCN 2011 IUCN RED L; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2009, ZOOTAXA, P1; Maxwell SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019905; Maxwell SM, 2012, MARINE MAMMAL SCI; OHMAN MD, 1983, SCIENCE, V220, P1404, DOI 10.1126/science.220.4604.1404; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Sims DW, 2010, CRC MAR BIOL SER, P351; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; White WT, 2006, FISH RES, V82, P65, DOI 10.1016/j.fishres.2006.08.008; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Witt MJ, 2011, P ROY SOC B-BIOL SCI, V278, P2338, DOI 10.1098/rspb.2010.2467; Witt MJ, 2010, AQUAT BIOL, V8, P169, DOI 10.3354/ab00221	46	83	86	2	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36834	10.1371/journal.pone.0036834	http://dx.doi.org/10.1371/journal.pone.0036834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590622	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400040
J	Honsa, P; Pivonkova, H; Dzamba, D; Filipova, M; Anderova, M				Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Filipova, Marcela; Anderova, Miroslava			Polydendrocytes Display Large Lineage Plasticity following Focal Cerebral Ischemia	PLOS ONE			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; SPINAL-CORD-INJURY; K+ CHANNEL EXPRESSION; NEURAL STEM-CELLS; GLIAL-CELLS; NG2 CELLS; PROGENITOR CELLS; NG2-EXPRESSING CELLS; SUBVENTRICULAR ZONE; RAT HIPPOCAMPUS	Polydendrocytes (also known as NG2 glial cells) constitute a fourth major glial cell type in the adult mammalian central nervous system (CNS) that is distinct from other cell types. Although much evidence suggests that these cells are multipotent in vitro, their differentiation potential in vivo under physiological or pathophysiological conditions is still controversial. To follow the fate of polydendrocytes after CNS pathology, permanent middle cerebral artery occlusion (MCAo), a commonly used model of focal cerebral ischemia, was carried out on adult NG2creBAC:ZEG double transgenic mice, in which enhanced green fluorescent protein (EGFP) is expressed in polydendrocytes and their progeny. The phenotype of the EGFP(+) cells was analyzed using immunohistochemistry and the patch-clamp technique 3, 7 and 14 days after MCAo. In sham-operated mice (control), EGFP(+) cells in the cortex expressed protein markers and displayed electrophysiological properties of polydendrocytes and oligodendrocytes. We did not detect any co-labeling of EGFP with neuronal, microglial or astroglial markers in this region, thus proving polydendrocyte unipotent differentiation potential under physiological conditions. Three days after MCAo the number of EGFP(+) cells in the gliotic tissue dramatically increased when compared to control animals, and these cells displayed properties of proliferating cells. However, in later phases after MCAo a large subpopulation of EGFP(+) cells expressed protein markers and electrophysiological properties of astrocytes that contribute to the formation of glial scar. Importantly, some EGFP(+) cells displayed membrane properties typical for neural precursor cells, and moreover these cells expressed doublecortin (DCX) - a marker of newly-derived neuronal cells. Taken together, our data indicate that polydendrocytes in the dorsal cortex display multipotent differentiation potential after focal ischemia.	[Honsa, Pavel; Pivonkova, Helena; Dzamba, David; Filipova, Marcela; Anderova, Miroslava] Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic; [Honsa, Pavel; Pivonkova, Helena; Dzamba, David] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague	Honsa, P (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Cellular Neurophysiol, Prague, Czech Republic.	anderova@biomed.cas.cz	Filipova, Marcela/P-2793-2016; Anderova, Miroslava/H-2249-2014; Pivonkova, Helena/ABE-4845-2021	Filipova, Marcela/0000-0003-3503-7973; Anderova, Miroslava/0000-0002-9030-4571; Pivonkova, Helena/0000-0003-2790-9778	Grant Agency of the Czech Republic [CZ: GA CR: GA309/09/0717, GA P303/12/0855, GA 309/08/H079]; Grant Agency of Charles University [CZ: GA UK:383711]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University	This work was supported by the Grant Agency of the Czech Republic - CZ: GA C.R: GA309/09/0717, GA P303/12/0855 and GA 309/08/H079, and by the Grant Agency of Charles University - CZ: GA UK:383711. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Anderova M, 2004, GLIA, V48, P311, DOI 10.1002/glia.20076; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chen PH, 2008, BRAIN RES, V1243, P27, DOI 10.1016/j.brainres.2008.09.029; Chvatal A, 2004, J NEUROSCI RES, V78, P668, DOI 10.1002/jnr.20284; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lacar, 2010, FRONT NEUROSCI; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Montiel-Eulefi E, 2012, CYTOM PART A, V81A, P65, DOI 10.1002/cyto.a.21152; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Nishiyama A, 1997, J NEUROSCI RES, V48, P299, DOI 10.1002/(SICI)1097-4547(19970515)48:4<299::AID-JNR2>3.0.CO;2-6; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schools GP, 2003, J NEUROSCI RES, V73, P765, DOI 10.1002/jnr.10680; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Tian DS, 2007, BRAIN RES, V1154, P206, DOI 10.1016/j.brainres.2007.04.005; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wohl SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022408; Xie M, 2007, NEUROSCIENCE, V150, P853, DOI 10.1016/j.neuroscience.2007.09.057; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yang Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-108; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhu L, 2010, NEUROSCIENCE, V166, P842, DOI 10.1016/j.neuroscience.2009.12.057; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	56	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36816	10.1371/journal.pone.0036816	http://dx.doi.org/10.1371/journal.pone.0036816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590616	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400038
J	Marballi, K; Cruz, D; Thompson, P; Walss-Bass, C				Marballi, Ketan; Cruz, Dianne; Thompson, Peter; Walss-Bass, Consuelo			Differential Neuregulin 1 Cleavage in the Prefrontal Cortex and Hippocampus in Schizophrenia and Bipolar Disorder: Preliminary Findings	PLOS ONE			English	Article							EXPRESSION; DEPRESSION; NRG1; REGIONS; PROTEIN; VOLUME; ERBB4; BRAIN	Background: Neuregulin 1 (NRG1) is a key candidate susceptibility gene for both schizophrenia (SCZ) and bipolar disorder (BPD). The function of the NRG1 transmembrane proteins is regulated by cleavage. Alteration of membrane bound-NRG1 cleavage has been previously shown to be associated with behavioral impairments in mouse models lacking expression of NRG1-cleavage enzymes such as BACE1 and gamma secretase. We sought to determine whether alterations in NRG1 cleavage and associated enzymes occur in patients with SCZ and BPD. Methodology/Principal Findings: Using human postmortem brain, we evaluated protein expression of NRG1 cleavage products and enzymes that cleave at the external (BACE1, ADAM17, ADAM19) and internal (PS1-gamma secretase) sides of the cell membrane. We used three different cohorts (Controls, SCZ and BPD) and two distinct brain regions: BA9-prefrontal cortex (Controls (n = 6), SCZ (n = 6) and BPD (n = 6)) and hippocampus (Controls (n = 5), SCZ (n = 6) and BPD (n = 6)). In BA9, the ratio of the NRG1 N-terminal fragment relative to full length was significantly upregulated in the SCZ cohort (Bonferroni test, p = 0.011). ADAM17 was negatively correlated with full length NRG1 levels in the SCZ cohort (r = -0.926, p = 0.008). In the hippocampus we found significantly lower levels of a soluble 50 kDa NRG1 fragment in the two affected groups compared the control cohort (Bonferroni test, p = 0.0018). We also examined the relationship of specific symptomatology criteria with measures of NRG1 cleavage using the Bipolar Inventory of Signs and Symptoms Scale (BISS) and the Montgomery Asberg Depression Rating Scale (MADRS). Our results showed a positive correlation between ADAM19 and psychosis (r = 0.595 p = 0.019); PS1 and mania (r = 0.535, p = 0.040); PS1 and depression ( r = 0.567, p = 0.027) in BA9, and BACE1 with anxiety (r = 0.608, p = 0.03) in the hippocampus. Conclusion/Significance: Our preliminary findings suggest region-specific alterations in NRG1 cleavage in SCZ and BPD patients. These changes may be associated with specific symptoms in these psychiatric disorders.	[Marballi, Ketan] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Cruz, Dianne; Thompson, Peter] Univ Texas Hlth Sci Ctr San Antonio, SW Brain Bank, Dept Psychiat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Marballi, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	walss@uthscsa.edu	Walss-Bass, Consuelo/K-5702-2015	Walss-Bass, Consuelo/0000-0003-2474-5448; Marballi, Ketan/0000-0002-6313-620X	National Institute of Mental Health [R24MH076039, K01MH077777]; NARSAD: Brain and Behavior Research Foundation; UT system; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH077777, R24MH076039] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD: Brain and Behavior Research Foundation; UT system; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding sources for this project included National Institute of Mental Health grant numbers R24MH076039 to PMT; K01MH077777 and NARSAD: Brain and Behavior Research Foundation to CW-B; and UT system grant to KM: translational science training across disciplines. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Barakat A, 2010, SCHIZOPHR RES, V124, P200, DOI 10.1016/j.schres.2010.09.001; Blackwood DHR, 2007, NEUROTOX RES, V11, P73, DOI 10.1007/BF03033484; Boer S, 2009, NEUROSCI LETT, V466, P27, DOI 10.1016/j.neulet.2009.09.019; Bowden CL, 2007, ACTA PSYCHIAT SCAND, V116, P189, DOI 10.1111/j.1600-0447.2006.00955.x; Chen Y, 2010, J NEUROSCI, V30, P9199, DOI 10.1523/JNEUROSCI.0605-10.2010; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Feng Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/859516; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hall J, 2010, PSYCHOL MED, V40, P761, DOI 10.1017/S0033291709991000; Hanlon FM, 2011, NEUROIMAGE; Hassel S, 2008, BIPOLAR DISORD, V10, P916, DOI 10.1111/j.1399-5618.2008.00641.x; Holmes AJ, 2005, SCHIZOPHR RES, V76, P199, DOI 10.1016/j.schres.2005.01.021; Kalinowski A, 2010, FASEB J, V24, P2567, DOI 10.1096/fj.08-129072; Koike S, 2011, CLIN NEUROPHYSIOL, V122, P1533, DOI 10.1016/j.clinph.2010.12.056; Kyosseva SV, 1999, BIOL PSYCHIAT, V46, P689, DOI 10.1016/S0006-3223(99)00104-3; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Muresan Z, 2006, MOL CELL BIOL, V26, P4982, DOI 10.1128/MCB.00371-06; Nason MW, 2011, NEUROPSYCHOPHARMACOL, V36, P488, DOI 10.1038/npp.2010.180; Parlapani E, 2010, WORLD J BIOL PSYCHIA, V11, P243, DOI 10.3109/15622970802022376; Radonic E, 2011, COLLEGIUM ANTROPOL, V35, P249; Rybnikova E, 2012, NEUROSCI RES, V72, P364, DOI 10.1016/j.neures.2011.12.010; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stefansson H, 2004, ANN MED, V36, P62, DOI 10.1080/07853890310017585; Thompson PM, 2010, PSYCHIAT RES, V175, P221, DOI 10.1016/j.psychres.2009.04.017; Townsend J, 2010, PSYCHIAT RES-NEUROIM, V182, P22, DOI 10.1016/j.pscychresns.2009.11.010; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; van Veelen NMJ, 2011, SCHIZOPHR RES, V129, P156, DOI 10.1016/j.schres.2011.03.026; Walker RM, 2010, NEUROSCI LETT, V478, P9, DOI 10.1016/j.neulet.2010.04.056; Walss-Bass C, 2006, BIOL PSYCHIAT, V60, P548, DOI 10.1016/j.biopsych.2006.03.017; Wang XD, 2008, INT J NEUROPSYCHOPH, V11, P553, DOI 10.1017/S1461145707008371; Yamamoto K, 2007, AM J PHYSIOL-HEART C, V293, pH1646, DOI 10.1152/ajpheart.01385.2006; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x	42	43	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36431	10.1371/journal.pone.0036431	http://dx.doi.org/10.1371/journal.pone.0036431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590542	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400015
J	Ecklund, EH; James, SA; Lincoln, AE				Ecklund, Elaine Howard; James, Sarah A.; Lincoln, Anne E.			How Academic Biologists and Physicists View Science Outreach	PLOS ONE			English	Article							SCIENTISTS	Scholars and pundits alike argue that U.S. scientists could do more to reach out to the general public. Yet, to date, there have been few systematic studies that examine how scientists understand the barriers that impede such outreach. Through analysis of 97 semi-structured interviews with academic biologists and physicists at top research universities in the United States, we classify the type and target audiences of scientists' outreach activities. Finally, we explore the narratives academic scientists have about outreach and its reception in the academy, in particular what they perceive as impediments to these activities. We find that scientists' outreach activities are stratified by gender and that university and disciplinary rewards as well as scientists' perceptions of their own skills have an impact on science outreach. Research contributions and recommendations for university policy follow.	[Ecklund, Elaine Howard; James, Sarah A.] Rice Univ, Dept Sociol, Houston, TX 77251 USA; [Lincoln, Anne E.] So Methodist Univ, Dept Sociol, Dallas, TX 75275 USA	Rice University; Southern Methodist University	Ecklund, EH (corresponding author), Rice Univ, Dept Sociol, Houston, TX 77251 USA.	ehe@rice.edu	Lincoln, Anne E./B-4281-2011		National Science Foundation [0920837]	National Science Foundation(National Science Foundation (NSF))	This study was conducted with funding from the National Science Foundation (award #0920837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews E, 2004, J GEOSCIENCE ED; Bauer M, 1993, PUBLIC UNDERST SCI, V2, P141, DOI DOI 10.1088/0963-6625/2/2/004; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; De Rond M, 2005, J MANAGE INQUIRY, V14, P321, DOI 10.1177/1056492605276850; Jensen P., 2008, SCI PUBL POLICY, V35, P527, DOI [10.3152/030234208x329130, DOI 10.3152/030234208X329130]; Kim C, 2008, J GREAT LAKES RES, V34, P98, DOI 10.3394/0380-1330(2008)34[98:GLSPOK]2.0.CO;2; Martin-Sempere MJ, 2008, PUBLIC UNDERST SCI, V17, P349, DOI 10.1177/0963662506067660; Mathews DJH, 2005, AM J MED GENET A, V137A, P161, DOI 10.1002/ajmg.a.30849; Miller JD, 2004, PUBLIC UNDERST SCI, V13, P273, DOI 10.1177/0963662504044908; Miller JD, 1998, PUBLIC UNDERST SCI, V7, P203, DOI 10.1088/0963-6625/7/3/001; *NAT SCI FDN, 2007, MER REV BROAD IMP CR; National Science Board, 2004, SCI ENG IND 2004; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x; Shermer MB, 2002, SOC STUD SCI, V32, P489, DOI 10.1177/030631202128967244	15	100	101	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36240	10.1371/journal.pone.0036240	http://dx.doi.org/10.1371/journal.pone.0036240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590526	Green Published, gold			2022-12-27	WOS:000305336100022
J	McCoy, D; Kinyua, K				McCoy, David; Kinyua, Kelvin			Allocating Scarce Resources Strategically - An Evaluation and Discussion of the Global Fund's Pattern of Disbursements	PLOS ONE			English	Article								Background: The Global Fund is under pressure to improve its rationing of financial support. This study describes the GF's pattern of disbursements in relation to total health expenditure (THE), government health expenditure (GHE), income status and the burden of HIV/AIDS, TB and malaria. It also examines the potential for recipient countries to increase domestic public financing for health. Methods: This is a cross-sectional study of 104 countries that received Global Fund disbursements in 2009. It analyses data on Global Fund disbursements; health financing indicators; government revenue and expenditure; and burden of disease. Findings: Global Fund disbursements made up 0.37% of THE across all 104 countries; but with considerable country variation ranging from 0.002% to 53.4%. Global Fund disbursements to government amounted to 0.47% of GHE across the 104 countries, but again with considerable variation (in three countries more than half of GHE was based on Global Fund support). Although the Global Fund provides progressively more funding for lower income countries on average, there is much variation at the country such that here was no correlation between per capita GF disbursements and per capita THE, nor between per capita GF disbursement to government and per capita GHE. There was only a slight positive correlation between per capita GF disbursement and burden of disease. Several countries with a high degree of 'financial dependency' upon the Fund have the potential to increase levels of domestic financing for health. Discussion: The Global Fund can improve its targeting of resources so that it better matches the pattern of global need. To do this it needs to: a) reduce the extent to which funds are allocated on a demand-driven basis; and b) align its funding model to broader health systems financing and patterns of health expenditure beyond the three diseases.	[McCoy, David; Kinyua, Kelvin] Aidspan, Nairobi, Kenya; [McCoy, David] UCL, Ctr Int Hlth & Dev, London, England	University of London; University College London	McCoy, D (corresponding author), Aidspan, Nairobi, Kenya.	d.mccoy@ucl.ac.uk			UK Department for International Development; NORAD	UK Department for International Development; NORAD(CGIAR)	Both Dr. McCoy and Mr. Kinyua are employed by Aidspan, a non-government organisation that is funded to act as a critical watchdog of the Global Fund. Aidspan is partly funded by the UK Department for International Development and NORAD, both of which are donors to the Global Fund. The funders of Aidspan had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FIN GLOB HLTH 2010 D; Bornemisza O, 2010, GLOB HLTH GOV, V4, P1; Glassman A., 2011, 270 CTR GLOB DEV; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Taskforce on Innovative International Financing for Health Systems, 2009, WORK GROUP 1 REP CON; The Global Fund, 2011, MAK DIFF GLOB FUNDS; The Global Fund, 2011, FIN REP HIGH LEV IND	7	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e34749	10.1371/journal.pone.0034749	http://dx.doi.org/10.1371/journal.pone.0034749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590496	Green Published, gold			2022-12-27	WOS:000305336100002
J	Bashar, MK; Komatsu, K; Fujimori, T; Kobayashi, TJ				Bashar, Md Khayrul; Komatsu, Koji; Fujimori, Toshihiko; Kobayashi, Tetsuya J.			Automatic Extraction of Nuclei Centroids of Mouse Embryonic Cells from Fluorescence Microscopy Images	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LINEAGE; SPECIFICATION	Accurate identification of cell nuclei and their tracking using three dimensional (3D) microscopic images is a demanding task in many biological studies. Manual identification of nuclei centroids from images is an error-prone task, sometimes impossible to accomplish due to low contrast and the presence of noise. Nonetheless, only a few methods are available for 3D bioimaging applications, which sharply contrast with 2D analysis, where many methods already exist. In addition, most methods essentially adopt segmentation for which a reliable solution is still unknown, especially for 3D bio-images having juxtaposed cells. In this work, we propose a new method that can directly extract nuclei centroids from fluorescence microscopy images. This method involves three steps: (i) Pre-processing, (ii) Local enhancement, and (iii) Centroid extraction. The first step includes two variations: first variation (Variant-1) uses the whole 3D pre-processed image, whereas the second one (Variant-2) modifies the preprocessed image to the candidate regions or the candidate hybrid image for further processing. At the second step, a multiscale cube filtering is employed in order to locally enhance the pre-processed image. Centroid extraction in the third step consists of three stages. In Stage-1, we compute a local characteristic ratio at every voxel and extract local maxima regions as candidate centroids using a ratio threshold. Stage-2 processing removes spurious centroids from Stage-1 results by analyzing shapes of intensity profiles from the enhanced image. An iterative procedure based on the nearest neighborhood principle is then proposed to combine if there are fragmented nuclei. Both qualitative and quantitative analyses on a set of 100 images of 3D mouse embryo are performed. Investigations reveal a promising achievement of the technique presented in terms of average sensitivity and precision (i. e., 88.04% and 91.30% for Variant-1; 86.19% and 95.00% for Variant-2), when compared with an existing method (86.06% and 90.11%), originally developed for analyzing C. elegans images.	[Bashar, Md Khayrul; Kobayashi, Tetsuya J.] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Komatsu, Koji; Fujimori, Toshihiko] Natl Inst Basic Biol, Div Embryol, Okazaki, Aichi 444, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Bashar, MK (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	kbashar@sat.t.u-tokyo.ac.jp	Bashar, Md Khayrul/AHB-9800-2022; Fujimori, Toshihiko/L-7711-2016	Bashar, Md Khayrul/0000-0002-5580-0422; Fujimori, Toshihiko/0000-0001-5200-4634	KAKENHI [2116006]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [21116005] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (KAKENHI), Grant No. 2116006; Japan Society for the Promotion of Science; and the Ministry of Education, Culture, Sports, Science and Technology. http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bukhari SS, 2009, J UNIVERS COMPUT SCI, V15, P3343; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Foucher S, 2001, IEEE T IMAGE PROCESS, V10, P49, DOI 10.1109/83.892442; Fujimori T, 2010, DEV GROWTH DIFFER, V52, P253, DOI 10.1111/j.1440-169X.2010.01172.x; Hamahashi S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-125; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Lakshmanan V, 2004, IEEE GEOSCI REMOTE S, V1, P192, DOI 10.1109/LGRS.2004.828178; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Makhoul John, 1999, P DARPA BROADCAST NE, P249; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Ostu Nobuyuki, 1979, IEEE T SYST MAN CYB, VSMC-9, P62, DOI DOI 10.1109/TSMC.1979.4310076; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; PLUTO, PLUTO COMP AID DIAGN; Russ JC, 2007, IMAGE PROCESSING HDB; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; Williams D. B, 1999, DETECTION DETERMININ	20	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35550	10.1371/journal.pone.0035550	http://dx.doi.org/10.1371/journal.pone.0035550			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590505	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500004
J	Eshoo, MW; Crowder, CC; Rebman, AW; Rounds, MA; Matthews, HE; Picuri, JM; Soloski, MJ; Ecker, DJ; Schutzer, SE; Aucott, JN				Eshoo, Mark W.; Crowder, Christopher C.; Rebman, Alison W.; Rounds, Megan A.; Matthews, Heather E.; Picuri, John M.; Soloski, Mark J.; Ecker, David J.; Schutzer, Steven E.; Aucott, John N.			Direct Molecular Detection and Genotyping of Borrelia burgdorferi from Whole Blood of Patients with Early Lyme Disease	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; ERYTHEMA-MIGRANS; RAPID IDENTIFICATION; SENSU-LATO; DIAGNOSIS; PCR; INFECTION; CULTURE; DNA	Direct molecular tests in blood for early Lyme disease can be insensitive due to low amount of circulating Borrelia burgdorferi DNA. To address this challenge, we have developed a sensitive strategy to both detect and genotype B. burgdorferi directly from whole blood collected during the initial patient visit. This strategy improved sensitivity by employing 1.25 mL of whole blood, a novel pre-enrichment of the entire specimen extract for Borrelia DNA prior to a multi-locus PCR and electrospray ionization mass spectrometry detection assay. We evaluated the assay on blood collected at the initial presentation from 21 endemic area patients who had both physician-diagnosed erythema migrans (EM) and positive two-tiered serology either at the initial visit or at a follow-up visit after three weeks of antibiotic therapy. Results of this DNA analysis showed detection of B. burgdorferi in 13 of 21 patients (62%). In most cases the new assay also provided the B. burgdorferi genotype. The combined results of our direct detection assay with initial physician visit serology resulted in the detection of early Lyme disease in 19 of 21 (90%) of patients at the initial visit. In 5 of 21 cases we demonstrate the ability to detect B. burgdorferi in early Lyme disease directly from whole blood specimens prior to seroconversion.	[Eshoo, Mark W.; Crowder, Christopher C.; Rounds, Megan A.; Matthews, Heather E.; Picuri, John M.; Ecker, David J.] Ibis Biosci Inc, Carlsbad, CA USA; [Soloski, Mark J.; Aucott, John N.] Johns Hopkins Sch Med, Dept Med, Div Rheumatol, Baltimore, MD USA; [Schutzer, Steven E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Rebman, Alison W.] Lyme Dis Res Fdn, Lutherville Timonium, MD USA; [Soloski, Mark J.; Aucott, John N.] Johns Hopkins Sch Med, Dept Med, Div Internal Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Medicine	Eshoo, MW (corresponding author), Ibis Biosci Inc, Carlsbad, CA USA.	mark.eshoo@abbott.com		Ecker, David/0000-0003-4350-9037	National Institutes of Health-National Institute of Allergy and Infectious Diseases [2R44A1077156-02]; Lyme Disease Research Foundation, Lutherville, Maryland; Ibis Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI077156] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lyme Disease Research Foundation, Lutherville, Maryland; Ibis Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge the National Institutes of Health-National Institute of Allergy and Infectious Diseases grant # 2R44A1077156-02, the Lyme Disease Research Foundation, Lutherville, Maryland, and Ibis Biosciences for financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero-Rosenfeld ME, 2005, CLIN MICROBIOL REV, V18, P484, DOI 10.1128/CMR.18.3.484-509.2005; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; CDC, 2011, REP CAS LYM DIS YEAR; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Coulter P, 2005, J CLIN MICROBIOL, V43, P5080, DOI 10.1128/JCM.43.10.5080-5084.2005; Crowder CD, 2012, AM J VET RE IN PRESS; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Crowder CD, 2010, J MED ENTOMOL, V47, P89, DOI 10.1603/033.047.0112; Ecker DJ, 2008, NAT REV MICROBIOL, V6, P553, DOI 10.1038/nrmicro1918; Eshoo MW, 2010, J CLIN MICROBIOL, V48, P472, DOI 10.1128/JCM.01669-09; Girard YA, 2011, J CLIN MICROBIOL, V49, P945, DOI 10.1128/JCM.01689-10; GOODMAN JL, 1995, AM J MED, V99, P6, DOI 10.1016/S0002-9343(99)80097-7; Grant-Klein RJ, 2010, MOL CELL PROBE, V24, P219, DOI 10.1016/j.mcp.2010.04.003; Jochimsen E, 1990, Wis Med J, V89, P677; Jones KL, 2006, J CLIN MICROBIOL, V44, P4407, DOI 10.1128/JCM.01077-06; Kondrusk M, 2007, ANN AGR ENV MED, V14, P209; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Liveris D, 2012, EUR J CLIN MICROBIOL, V31, P791, DOI 10.1007/s10096-011-1376-x; Liveris D, 2011, J CLIN MICROBIOL, V49, P2166, DOI 10.1128/JCM.00350-11; NADELMAN RB, 1994, J INFECT DIS, V169, P1410, DOI 10.1093/infdis/169.6.1410; Niscigorska-Olsen J, 2008, ANN AGR ENV MED, V15, P167; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Santino I, 2008, FEMS MICROBIOL LETT, V283, P30, DOI 10.1111/j.1574-6968.2008.01134.x; SAURO J, 2005, P HUM FACT ERG SOC 4, P2100; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; SMITH PF, 1988, ANN NY ACAD SCI, V539, P289, DOI 10.1111/j.1749-6632.1988.tb31863.x; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Tibbles CD, 2007, JAMA-J AM MED ASSOC, V297, P2617, DOI 10.1001/jama.297.23.2617; Wormser GP, 2008, CLIN VACCINE IMMUNOL, V15, P1519, DOI 10.1128/CVI.00109-08; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, NEW ENGL J MED, V354, P2794, DOI 10.1056/NEJMcp061181	32	60	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36825	10.1371/journal.pone.0036825	http://dx.doi.org/10.1371/journal.pone.0036825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590620	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500033
J	Kershenbaum, A; Stone, L; Ostfeld, RS; Blaustein, L				Kershenbaum, Arik; Stone, Lewi; Ostfeld, Richard S.; Blaustein, Leon			Modelling Transmission of Vector-Borne Pathogens Shows Complex Dynamics When Vector Feeding Sites Are Limited	PLOS ONE			English	Article							AEDES-TRISERIATUS DIPTERA; WEST-NILE-VIRUS; LYME-DISEASE; BIODIVERSITY; IMPACT; PERSISTENCE; COMPETITION; DIVERSITY; SCIURIDAE; COMMUNITY	The relationship between species richness and the prevalence of vector-borne disease has been widely studied with a range of outcomes. Increasing the number of host species for a pathogen may decrease infection prevalence (dilution effect), increase it (amplification), or have no effect. We derive a general model, and a specific implementation, which show that when the number of vector feeding sites on each host is limiting, the effects on pathogen dynamics of host population size are more complex than previously thought. The model examines vector-borne disease in the presence of different host species that are either competent or incompetent (i.e. that cannot transmit the pathogen to vectors) as reservoirs for the pathogen. With a single host species present, the basic reproduction ratio R-0 is a non-monotonic function of the population size of host individuals (H), i.e. a value (H) over cap exists that maximises R-0. Surprisingly, if H > (H) over cap, a reduction in host population size may actually increase R-0. Extending this model to a two-host species system, incompetent individuals from the second host species can alter the value of (H) over cap, which may reverse the effect on pathogen prevalence of host population reduction. We argue that when vector-feeding sites on hosts are limiting, the net effect of increasing host diversity might not be correctly predicted using simple frequency-dependent epidemiological models.	[Kershenbaum, Arik; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Kershenbaum, Arik; Blaustein, Leon] Univ Haifa, Fac Nat Sci, Inst Evolut, IL-31999 Haifa, Israel; [Stone, Lewi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA	University of Haifa; University of Haifa; Tel Aviv University; Cary Institute of Ecosystem Studies	Kershenbaum, A (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	arik.kershenbaum@gmail.com	Kershenbaum, Arik/C-3552-2012	Kershenbaum, Arik/0000-0003-0464-0243; Stone, Lewi/0000-0002-6465-579X; Ostfeld, Richard/0000-0002-3707-9301	University of Haifa	University of Haifa	The lead author (AK) received a personal PhD scholarship ($ 1000 pcm) from the University of Haifa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Brinkerhoff RJ, 2009, FRONTIERS ECOLOGY EN, V9, P103, DOI [DOI 10.1890/090062, DOI 10.1890/090062)]; BULL CM, 1993, OECOLOGIA, V96, P415, DOI 10.1007/BF00317513; Daley D. J., 2001, CAMBRIDGE STUDIES MA; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; GRIMM V, 1994, ECOL MODEL, V75, P641, DOI 10.1016/0304-3800(94)90056-6; Hart B, 1997, HOSTPARASITE EVOLUTI; Hawlena H, 2007, INT J PARASITOL, V37, P919, DOI 10.1016/j.ijpara.2007.01.015; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 1996, J ANIM ECOL, V65, P517, DOI 10.2307/5786; Levin ML, 1998, J PARASITOL, V84, P36, DOI 10.2307/3284526; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Ostfeld RS, 2010, INFECT DIS ECOLOGY E; Pacejka AJ, 1998, ECOLOGY, V79, P1797, DOI 10.1890/0012-9658(1998)079[1797:DPVMAH]2.0.CO;2; Peixoto ID, 2006, ECOLOGY, V87, P873, DOI 10.1890/0012-9658(2006)87[873:TEOBOT]2.0.CO;2; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Svobodova M, 2006, EMERG INFECT DIS, V12, P1860; Swei A, 2011, P ROY SOC B-BIOL SCI, V278, P2970, DOI 10.1098/rspb.2010.2402; TATCHELL RJ, 1987, INT J PARASITOL, V17, P597, DOI 10.1016/0020-7519(87)90136-6; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Tyre AJ, 2003, AUSTRAL ECOL, V28, P196, DOI 10.1046/j.1442-9993.2003.01270.x; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; WAAGE JK, 1986, J ANIM ECOL, V55, P171, DOI 10.2307/4700; WALKER ED, 1986, J MED ENTOMOL, V23, P1, DOI 10.1093/jmedent/23.1.1; WALKER ED, 1985, J MED ENTOMOL, V22, P287, DOI 10.1093/jmedent/22.3.287	40	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36730	10.1371/journal.pone.0036730	http://dx.doi.org/10.1371/journal.pone.0036730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590597	gold, Green Published			2022-12-27	WOS:000305335500025
J	Su, LF; Wang, LB; Chen, FL; Shen, H; Li, BJ; Hu, DW				Su, Longfei; Wang, Lubin; Chen, Fanglin; Shen, Hui; Li, Baojuan; Hu, Dewen			Sparse Representation of Brain Aging: Extracting Covariance Patterns from Structural MRI	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; AGE-RELATED-CHANGES; BASAL GANGLIA; GRAY-MATTER; CEREBRAL-CORTEX; INDIVIDUAL-DIFFERENCES; CONNECTIVITY PATTERNS; COGNITIVE DYSMETRIA; MOTOR; SCHIZOPHRENIA	An enhanced understanding of how normal aging alters brain structure is urgently needed for the early diagnosis and treatment of age-related mental diseases. Structural magnetic resonance imaging (MRI) is a reliable technique used to detect age-related changes in the human brain. Currently, multivariate pattern analysis (MVPA) enables the exploration of subtle and distributed changes of data obtained from structural MRI images. In this study, a new MVPA approach based on sparse representation has been employed to investigate the anatomical covariance patterns of normal aging. Two groups of participants (group 1:290 participants; group 2:56 participants) were evaluated in this study. These two groups were scanned with two 1.5 T MRI machines. In the first group, we obtained the discriminative patterns using a t-test filter and sparse representation step. We were able to distinguish the young from old cohort with a very high accuracy using only a few voxels of the discriminative patterns (group 1:98.4%; group 2:96.4%). The experimental results showed that the selected voxels may be categorized into two components according to the two steps in the proposed method. The first component focuses on the precentral and postcentral gyri, and the caudate nucleus, which play an important role in sensorimotor tasks. The strongest volume reduction with age was observed in these clusters. The second component is mainly distributed over the cerebellum, thalamus, and right inferior frontal gyrus. These regions are not only critical nodes of the sensorimotor circuitry but also the cognitive circuitry although their volume shows a relative resilience against aging. Considering the voxels selection procedure, we suggest that the aging of the sensorimotor and cognitive brain regions identified in this study has a covarying relationship with each other.	[Su, Longfei; Wang, Lubin; Chen, Fanglin; Shen, Hui; Li, Baojuan; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Su, LF (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Chen, Fanglin/I-1527-2013; Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Chen, Fanglin/0000-0002-9193-5412; Su, Longfei/0000-0003-0573-2756	National 973 program of China [2011CB707802]; National Natural Science Foundation of China [61003202, 61005084]	National 973 program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 program of China (2011CB707802) and the National Natural Science Foundation of China (61003202, 61005084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2008, NEUROBIOL AGING, V29, P102, DOI 10.1016/j.neurobiolaging.2006.09.003; Alexander GE, 2006, NEUROREPORT, V17, P951, DOI 10.1097/01.wnr.0000220135.16844.b6; Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Anstey KJ, 1997, PSYCHOL AGING, V12, P137, DOI 10.1037/0882-7974.12.1.137; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bergfield KL, 2010, NEUROIMAGE, V49, P1750, DOI 10.1016/j.neuroimage.2009.09.051; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Bray S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.032.2009; Brickman AM, 2007, NEUROBIOL AGING, V28, P284, DOI 10.1016/j.neurobiolaging.2005.12.016; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Butman JA, 2007, AM J NEURORADIOL, V28, P87; Carroll MK, 2009, NEUROIMAGE, V44, P112, DOI 10.1016/j.neuroimage.2008.08.020; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fogassi L, 2011, J ECON BEHAV ORGAN, V77, P66, DOI 10.1016/j.jebo.2010.04.009; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Galluzzi S, 2008, NEUROL SCI, V29, pS296, DOI 10.1007/s10072-008-1002-6; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Goble DJ, 2009, NEUROSCI BIOBEHAV R, V33, P271, DOI 10.1016/j.neubiorev.2008.08.012; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heemels MT, 2010, NATURE, V464, P503, DOI 10.1038/464503a; Hilgetag C. C., 2002, COMPUTATIONAL NEUROA; Huxhold O, 2009, Z GERONTOL GERIATR, V42, P93, DOI 10.1007/s00391-008-0566-3; Kennedy KM, 2005, CORTEX, V41, P560, DOI 10.1016/S0010-9452(08)70196-5; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Lee K, 2010, I S BIOMED IMAGING, P660, DOI 10.1109/ISBI.2010.5490090; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P729, DOI 10.1016/S0149-7634(02)00059-3; Li SY, 2011, NEUROIMAGE, V58, P381, DOI 10.1016/j.neuroimage.2011.06.041; Li YQ, 2004, NEURAL COMPUT, V16, P1193, DOI 10.1162/089976604773717586; Li YQ, 2009, IEEE T BIO-MED ENG, V56, P2439, DOI 10.1109/TBME.2009.2025866; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Luft AR, 1999, CEREB CORTEX, V9, P712, DOI 10.1093/cercor/9.7.712; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Meier TB, 2012, NEUROIMAGE, V60, P601, DOI 10.1016/j.neuroimage.2011.12.052; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; RAZ N, 1992, ARCH NEUROL-CHICAGO, V49, P412, DOI 10.1001/archneur.1992.00530280106030; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 1996, NEUROANATOMY AGING B; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Rosano C, 2008, J GERONTOL A-BIOL, V63, P1380, DOI 10.1093/gerona/63.12.1380; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; SCHAEFER GB, 1991, J CHILD NEUROL, V6, P15, DOI 10.1177/088307389100600103; Schaefer S, 2010, EUR J DEV PSYCHOL, V7, P371, DOI 10.1080/17405620802535666; Schafer S., 2006, EUR REV AGING PHYS A, V3, P45, DOI DOI 10.1007/S11556-006-0007-5; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; SHAH SA, 1991, NEUROBIOL AGING, V12, P371, DOI 10.1016/0197-4580(91)90025-F; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Sherwood CC, 2011, P NATL ACAD SCI USA, P1; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Takahashi R, 2011, HUM BRAIN MAPP, V32, P1050, DOI 10.1002/hbm.21088; Taki Y, 2004, NEUROBIOL AGING, V25, P455, DOI 10.1016/j.neurobiolaging.2003.09.002; Taki Y, 2011, NEUROBIOL AGING, V32, P907, DOI 10.1016/j.neurobiolaging.2009.05.003; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008; Tisserand DJ, 2004, CEREB CORTEX, V14, P966, DOI 10.1093/cercor/bhh057; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Utter AA, 2008, NEUROSCI BIOBEHAV R, V32, P333, DOI 10.1016/j.neubiorev.2006.11.003; Vapnik V., 2013, NATURE STAT LAERNING; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	84	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36147	10.1371/journal.pone.0036147	http://dx.doi.org/10.1371/journal.pone.0036147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TF	22590522	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500007
J	Lau, SKM; Shields, DJ; Murphy, EA; Desgrosellier, JS; Anand, S; Huang, M; Kato, S; Lim, ST; Weis, SM; Stupack, DG; Schlaepfer, DD; Cheresh, DA				Lau, Steven K. M.; Shields, David J.; Murphy, Eric A.; Desgrosellier, Jay S.; Anand, Sudarshan; Huang, Miller; Kato, Shumei; Lim, Ssang-Taek; Weis, Sara M.; Stupack, Dwayne G.; Schlaepfer, David D.; Cheresh, David A.			EGFR-Mediated Carcinoma Cell Metastasis Mediated by Integrin alpha v beta 5 Depends on Activation of c-Src and Cleavage of MUC1	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; BREAST-CANCER PATIENTS; CYTOPLASMIC TAIL; PROSTATE-CANCER; ONCOPROTEIN; PHOSPHORYLATION; TRANSCRIPTION; SURVIVAL; MOTILITY; INTRAVASATION	Receptor tyrosine kinases and integrins play an essential role in tumor cell invasion and metastasis. We previously showed that EGF and other growth factors induce human carcinoma cell invasion and metastasis mediated by integrin alpha v beta 5 that is prevented by Src blockade [1]. MUC1, a transmembrane glycoprotein, is expressed in most epithelial tumors as a heterodimer consisting of an extracellular and a transmembrane subunit. The MUC1 cytoplasmic domain of the transmembrane subunit (MUC1.CD) translocates to the nucleus where it promotes the transcription of a metastatic gene signature associated with epithelial to mesenchymal transition. Here, we demonstrate a requirement for MUC1 in carcinoma cell metastasis dependent on EGFR and Src without affecting primary tumor growth. EGF stimulates Src-dependent MUC1 cleavage and nuclear localization leading to the expression of genes linked to metastasis. Moreover, expression of MUC1.CD results in its nuclear localization and is sufficient for transcription of the metastatic gene signature and tumor cell metastasis. These results demonstrate that EGFR and Src activity contribute to carcinoma cell invasion and metastasis mediated by integrin alpha v beta 5 in part by promoting proteolytic cleavage of MUC1 and highlight the ability of MUC1.CD to promote metastasis in a context-dependent manner. Our findings may have implications for the use and future design of targeted therapies in cancers known to express EGFR, Src, or MUC1.	[Lau, Steven K. M.; Shields, David J.; Murphy, Eric A.; Desgrosellier, Jay S.; Anand, Sudarshan; Huang, Miller; Weis, Sara M.; Cheresh, David A.] Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA 92093 USA; [Kato, Shumei] Moores Univ Calif San Diego, Ctr Canc, Dept Med, La Jolla, CA USA; [Lim, Ssang-Taek; Stupack, Dwayne G.; Schlaepfer, David D.] Moores Univ Calif San Diego, Ctr Canc, Dept Reprod Med, La Jolla, CA USA		Lau, SKM (corresponding author), Moores Univ Calif San Diego, Ctr Canc, Dept Pathol, La Jolla, CA 92093 USA.	dcheresh@ucsd.edu	ANAND, SUDARSHAN/I-5316-2019; Desgrosellier, Jay S/A-8756-2008	ANAND, SUDARSHAN/0000-0002-4969-6884; Huang, Miller/0000-0002-3371-0100; Lim, Steve/0000-0003-0323-8607; Lau, Steven/0000-0002-6433-8735	National Institutes of Health [CA045726, CA102310]; UCSD [PHSGM07198]; NATIONAL CANCER INSTITUTE [R01CA045726, R01CA102310, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants CA045726 (D.A.C.), CA102310 (D.D.S.) (http://grants.nih.gov/grants/oer.htm) and PHSGM07198 (UCSD Medical Scientist Training Program) (http://mstp.ucsd.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Bitler BG, 2010, J CELL SCI, V123, P1716, DOI 10.1242/jcs.062661; Bitler BG, 2009, CLIN CANCER RES, V15, P100, DOI 10.1158/1078-0432.CCR-08-1745; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Brooks PC, 1997, J CLIN INVEST, V99, P1390, DOI 10.1172/JCI119298; Butts C, 2010, CLIN LUNG CANCER, V11, P391, DOI 10.3816/CLC.2010.n.101; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desgrosellier JS, 2009, NAT MED, V15, P1163, DOI 10.1038/nm.2009; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Golas JM, 2003, CANCER RES, V63, P375; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Joshi MD, 2009, MOL CANCER THER, V8, P3056, DOI 10.1158/1535-7163.MCT-09-0646; Kim J, 1998, CELL, V94, P353, DOI 10.1016/S0092-8674(00)81478-6; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KLEMKE RL, 1994, J CELL BIOL, V127, P859, DOI 10.1083/jcb.127.3.859; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kohlgraf KG, 2003, CANCER RES, V63, P5011; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li Y, 2003, CANCER BIOL THER, V2, P187, DOI 10.4161/cbt.2.2.282; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2003, MOL CANCER RES, V1, P765; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Oudard S, 2011, CANCER IMMUNOL IMMUN, V60, P261, DOI 10.1007/s00262-010-0935-9; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren J, 2006, ONCOGENE, V25, P20, DOI 10.1038/sj.onc.1209012; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Ricono JM, 2009, CANCER RES, V69, P1383, DOI 10.1158/0008-5472.CAN-08-3612; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shields DJ, 2011, ONCOGENE, V30, P2123, DOI 10.1038/onc.2010.589; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Thompson EJ, 2006, MOL CANCER RES, V4, P489, DOI 10.1158/1541-7786.MCR-06-0038; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou YC, 2011, MOL PHARMACOL, V79, P886, DOI 10.1124/mol.110.070797; Zijlstra A, 2002, CANCER RES, V62, P7083	60	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36753	10.1371/journal.pone.0036753	http://dx.doi.org/10.1371/journal.pone.0036753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586492	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000053
J	Krause, ET; Caspers, BA				Krause, E. Tobias; Caspers, Barbara A.			Are Olfactory Cues Involved in Nest Recognition in Two Social Species of Estrildid Finches?	PLOS ONE			English	Article							RECEPTOR GENE REPERTOIRES; ODOR RECOGNITION; INDIVIDUAL RECOGNITION; PARENTAL EFFORT; BEGGING CALLS; ZEBRA; SIZE; PROCELLARIIFORM; SITE; SONG	Reliably recognizing their own nest provides parents with a necessary skill to invest time and resources efficiently in raising their offspring and thereby maximising their own reproductive success. Studies investigating nest recognition in adult birds have focused mainly on visual cues of the nest or the nest site and acoustic cues of the nestlings. To determine whether adult songbirds also use olfaction for nest recognition, we investigated the use of olfactory nest cues for two estrildid finch species, zebra finches (Taeniopygia guttata) and Bengalese finches (Lonchura striata var. domestica) during the nestling and fledgling phase of their offspring. We found similar behavioural responses to nest odours in both songbird species. Females preferred the odour of their own nest over a control and avoided the foreign conspecific nest scent over a control during the nestling phase of their offspring, but when given the own odour and the foreign conspecific odour simultaneously we did not find a preference for the own nest odour. Males of both species did not show any preferences at all. The behavioural reaction to any nest odour decreased after fledging of the offspring. Our results show that only females show a behavioural response to olfactory nest cues, indicating that the use of olfactory cues for nest recognition seems to be sex-specific and dependent on the developmental stage of the offspring. Although estrildid finches are known to use visual and acoustic cues for nest recognition, the similar behavioural pattern of both species indicates that at least females gain additional information by olfactory nest cues during the nestling phase of their offspring. Thus olfactory cues might be important in general, even in situations in which visual and acoustic cues are known to be sufficient.	[Krause, E. Tobias; Caspers, Barbara A.] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany	University of Bielefeld	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany.	tobias.krause@uni-bielefeld.de	Caspers, Barbara/C-5573-2011; Krause, E. Tobias/A-9900-2009	Caspers, Barbara/0000-0002-4380-0476; Krause, E. Tobias/0000-0002-8327-3711				Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; Amo L, 2011, ARDEA, V99, P177, DOI 10.5253/078.099.0207; Arnaiz-Villena Antonio, 2009, Open Ornithology Journal, V2, P29; Aubin T, 1998, P ROY SOC B-BIOL SCI, V265, P1665, DOI 10.1098/rspb.1998.0486; BANG BG, 1968, AUK, V85, P55; BARG JJ, 1994, AUK, V111, P459, DOI 10.2307/4088610; BAUER JH, 1983, PHYSIOL BEHAV, V30, P229, DOI 10.1016/0031-9384(83)90010-0; BIRKE LIA, 1974, BEHAVIOUR, V48, P111, DOI 10.1163/156853974X00282; BOAG PT, 1987, AUK, V104, P155, DOI 10.1093/auk/104.2.155; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2003, BEHAV ECOL SOCIOBIOL, V54, P174, DOI 10.1007/s00265-003-0610-7; Bonadonna F, 2002, J EXP BIOL, V205, P2519; Bouwman KM, 2005, BEHAV ECOL, V16, P499, DOI 10.1093/beheco/ari021; Caspers BA, 2011, BIOL LETTERS, V7, P184, DOI 10.1098/rsbl.2010.0775; Celerier A, 2011, BIOL LETTERS, V7, P807, DOI 10.1098/rsbl.2011.0340; Coffin HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025002; Cunningham GB, 2011, J AVIAN BIOL, V42, P85, DOI 10.1111/j.1600-048X.2010.05184.x; DAVIES NB, 1992, ANIM BEHAV, V43, P729, DOI 10.1016/S0003-3472(05)80197-6; De Leon A, 2003, BEHAVIOUR, V140, P925, DOI 10.1163/156853903770238382; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Eisner E., 1961, Ardea, V49, P51; EISNER ERICA, 1960, AUK, V77, P271; FLEMING AS, 1989, PHYSIOL BEHAV, V46, P449, DOI 10.1016/0031-9384(89)90019-X; Goodwin, 1982, ESTRILDID FINCHES WO; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Holland RA, 2009, J EXP BIOL, V212, P4065, DOI 10.1242/jeb.034504; HUGHES BO, 1995, APPL ANIM BEHAV SCI, V42, P271, DOI 10.1016/0168-1591(94)00541-L; Immelmann K., 1965, AUSTR FINCHES BUSH A; Immelmann K., 1969, ZEBRAFINK TAENIOPYGI; Jacot A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1515, DOI 10.1007/s00265-010-0965-5; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krause ET, 2011, BEHAVIOUR, V148, P1239, DOI 10.1163/000579511X600619; Krause ET, 2011, ANIM BEHAV, V81, P1295, DOI 10.1016/j.anbehav.2011.03.021; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; LEMON WC, 1993, PHYSIOL ZOOL, V66, P946, DOI 10.1086/physzool.66.6.30163748; Leonard ML, 2012, BIOL LETTERS, V8, P530, DOI 10.1098/rsbl.2012.0032; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Mennerat A, 2008, BEHAV PROCESS, V79, P189, DOI 10.1016/j.beproc.2008.07.003; Mennerat A, 2005, BEHAV PROCESS, V70, P264, DOI 10.1016/j.beproc.2005.07.005; Nice MM, 1964, STUDIES LIVE HIST SO; O'Dwyer TW, 2008, J EXP BIOL, V211, P337, DOI 10.1242/jeb.010512; PEEK FW, 1972, WILSON BULL, V84, P243; Reers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018466; Rehling A, 2012, ANIM BEHAV, V83, P35, DOI 10.1016/j.anbehav.2011.10.003; Robiller F, 1978, PRACHTFINKEN VOGEL D; Soma M, 2006, ETHOLOGY, V112, P1071, DOI 10.1111/j.1439-0310.2006.01263.x; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; Steiger SS, 2008, P ROY SOC B-BIOL SCI, V275, P2309, DOI 10.1098/rspb.2008.0607; Steiger SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-446; Tinbergen JM, 2002, AVIAN INCUBATION BEH; TRILLMICH F, 1976, Z TIERPSYCHOL, V42, P1; Whittaker DJ, 2011, BEHAV ECOL, V22, P1256, DOI 10.1093/beheco/arr122; Whittaker DJ, 2010, BEHAV ECOL, V21, P608, DOI 10.1093/beheco/arq033; Whittaker DJ, 2009, J AVIAN BIOL, V40, P579, DOI 10.1111/j.1600-048X.2009.04813.x; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Zann RA., 1996, ZEBRA FINCH SYNTHESI	58	29	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36615	10.1371/journal.pone.0036615	http://dx.doi.org/10.1371/journal.pone.0036615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574196	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800093
J	Kumar, S; Chagne, D; Bink, MCAM; Volz, RK; Whitworth, C; Carlisle, C				Kumar, Satish; Chagne, David; Bink, Marco C. A. M.; Volz, Richard K.; Whitworth, Claire; Carlisle, Charmaine			Genomic Selection for Fruit Quality Traits in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; ESTIMATED BREEDING VALUE; MOLECULAR MARKERS; STATUS NUMBER; RED FLESH; ACCURACY; PREDICTION; VALUES; PROGRESS; MODELS	The genome sequence of apple (Malusxdomestica Borkh.) was published more than a year ago, which helped develop an 8K SNP chip to assist in implementing genomic selection (GS). In apple breeding programmes, GS can be used to obtain genomic breeding values (GEBV) for choosing next-generation parents or selections for further testing as potential commercial cultivars at a very early stage. Thus GS has the potential to accelerate breeding efficiency significantly because of decreased generation interval or increased selection intensity. We evaluated the accuracy of GS in a population of 1120 seedlings generated from a factorial mating design of four females and two male parents. All seedlings were genotyped using an Illumina Infinium chip comprising 8,000 single nucleotide polymorphisms (SNPs), and were phenotyped for various fruit quality traits. Random-regression best liner unbiased prediction (RR-BLUP) and the Bayesian LASSO method were used to obtain GEBV, and compared using a cross-validation approach for their accuracy to predict unobserved BLUP-BV. Accuracies were very similar for both methods, varying from 0.70 to 0.90 for various fruit quality traits. The selection response per unit time using GS compared with the traditional BLUP-based selection were very high (>100%) especially for low-heritability traits. Genome-wide average estimated linkage disequilibrium (LD) between adjacent SNPs was 0.32, with a relatively slow decay of LD in the long range (r(2) = 0.33 and 0.19 at 100 kb and 1,000 kb respectively), contributing to the higher accuracy of GS. Distribution of estimated SNP effects revealed involvement of large effect genes with likely pleiotropic effects. These results demonstrated that genomic selection is a credible alternative to conventional selection for fruit quality traits.	[Kumar, Satish; Volz, Richard K.; Whitworth, Claire] New Zealand Inst Plant & Food Res Ltd, Havelock North, New Zealand; [Chagne, David; Carlisle, Charmaine] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand; [Bink, Marco C. A. M.] Univ Wageningen & Res Ctr, Wageningen, Netherlands	New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; Wageningen University & Research	Kumar, S (corresponding author), New Zealand Inst Plant & Food Res Ltd, Havelock North, New Zealand.	Satish.Kumar@plantandfood.co.nz			PrevarTM [26015]; New Zealand Foundation for Research Science and Technology [C06X0812]; Commission of the European Communities [FP7-KBBE-2010-265582]; USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED [2009-51181-05808]; PrevarTM Limited	PrevarTM; New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Commission of the European Communities(European Commission); USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED; PrevarTM Limited	This research was partly funded by PrevarTM (Contract no. 26015) and the New Zealand Foundation for Research Science and Technology (Contract no. C06X0812). The contribution of M. Bink was carried out as part of the COST Action TD0801 "StatSeq" and the EU-FruitBreedomics project funded by the Commission of the European Communities (Contract FP7-KBBE-2010-265582) and supported by USDA's National Institute of Food and Agriculture - Speciality Crop Research Initiative RosBREED (2009-51181-05808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PrevarTM Limited (which is one of the funding sources of this study) is an incorporated joint venture between pipfruit industry organisations (Pipfruit New Zealand (PNZ); Apple & Pear Australia Limited (APAL)) and the New Zealand government-owned Crown Research Institute (The New Zealand Institute for Plant and Food Research Limited). All authors (except M. Bink - who is affiliated with Biometris department at the Wageningen University, The Netherlands) of this study are full-time employees of the New Zealand government-owned Crown Research Institute (The New Zealand Institute for Plant and Food Research Limited). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bus Vincent G. M., 2009, V6, P563, DOI 10.1007/978-0-387-77491-6_27; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Chagne D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-12; Chia JM, 2011, NAT BIOTECHNOL, V29, P138, DOI 10.1038/nbt.1756; Costa F, 2010, J EXP BOT, V61, P3029, DOI 10.1093/jxb/erq130; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Farnir F, 2000, GENOME RES, V10, P220, DOI 10.1101/gr.10.2.220; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Garrick DJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-55; GILMOUR AR, 2006, ASREML UPDATE WHATS; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Gredler B, 2010, P 9 WORLD C GEN APPL; Guo G, 2010, J ANIM BREED GENET, V127, P423, DOI 10.1111/j.1439-0388.2010.00878.x; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Kouassi AB, 2009, TREE GENET GENOMES, V5, P659, DOI 10.1007/s11295-009-0217-x; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Kumar S, 2010, EUPHYTICA, V173, P207, DOI 10.1007/s10681-009-0090-6; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Lindgren D, 1998, CAN J FOREST RES, V28, P276, DOI 10.1139/cjfr-28-2-276; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Moser G, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-56; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; Noiton DAM, 1996, J AM SOC HORTIC SCI, V121, P773, DOI 10.21273/JASHS.121.5.773; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2010, PLANT GENOME-US, V3, P106, DOI 10.3835/plantgenome2010.04.0005; R Core Team, 2020, R LANG ENV STAT COMP; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Volz RK, 2009, ACTA HORTIC, V814, P337, DOI 10.17660/ActaHortic.2009.814.54; Yao YX, 2007, PLANT PHYSIOL BIOCH, V45, P139, DOI 10.1016/j.plaphy.2007.01.010; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	47	147	151	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36674	10.1371/journal.pone.0036674	http://dx.doi.org/10.1371/journal.pone.0036674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574211	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800108
J	Valdivia, N; Gollety, C; Migne, A; Davoult, D; Molis, M				Valdivia, Nelson; Gollety, Claire; Migne, Aline; Davoult, Dominique; Molis, Markus			Stressed but Stable: Canopy Loss Decreased Species Synchrony and Metabolic Variability in an Intertidal Hard-Bottom Community	PLOS ONE			English	Article							COMPENSATORY DYNAMICS; BIODIVERSITY; DISTURBANCE; HABITAT; BIOMASS; COMPETITION; ALGAE; COEXISTENCE; STABILITY; KELP	The temporal stability of aggregate community properties depends on the dynamics of the component species. Since species growth can compensate for the decline of other species, synchronous species dynamics can maintain stability (i.e. invariability) in aggregate properties such as community abundance and metabolism. In field experiments we tested the separate and interactive effects of two stressors associated with storminess-loss of a canopy-forming species and mechanical disturbances-on species synchrony and community respiration of intertidal hard-bottom communities on Helgoland Island, NE Atlantic. Treatments consisted of regular removal of the canopy-forming seaweed Fucus serratus and a mechanical disturbance applied once at the onset of the experiment in March 2006. The level of synchrony in species abundances was assessed from estimates of species percentage cover every three months until September 2007. Experiments at two sites consistently showed that canopy loss significantly reduced species synchrony. Mechanical disturbance had neither separate nor interactive effects on species synchrony. Accordingly, in situ measurements of CO2-fluxes showed that canopy loss, but not mechanical disturbances, significantly reduced net primary productivity and temporal variation in community respiration during emersion periods. Our results support the idea that compensatory dynamics may stabilise aggregate properties. They further suggest that the ecological consequences of the loss of a single structurally important species may be stronger than those derived from smaller-scale mechanical disturbances in natural ecosystems.	[Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Valdivia, Nelson] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Gollety, Claire; Migne, Aline; Davoult, Dominique] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Gollety, Claire; Migne, Aline; Davoult, Dominique] CNRS, UMR 7144, Stn Biol Roscoff, Roscoff, France; [Gollety, Claire] Univ St Andrews, Scottish Oceans Inst, Sediment Ecol Res Grp, St Andrews, Fife, Scotland; [Molis, Markus] Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, Sect Funct Ecol, Helgoland, Germany	Universidad Austral de Chile; Universidad Catolica del Norte; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of St Andrews; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Gollety, Claire/D-6743-2011; Davoult, dominique/D-5932-2012; Valdivia, Nelson A/C-3613-2009	Davoult, dominique/0000-0001-8678-3998; Valdivia, Nelson A/0000-0002-5394-2072	European Community [GOCE-CT-2003-505446]; Alfred Wegener Institute for Polar and Marine Research; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [3100014]	European Community(European Commission); Alfred Wegener Institute for Polar and Marine Research; Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Research was supported by the Sustainable Development, Global Change and Ecosystems Programme of the European Community's Sixth Framework Programme (contract # GOCE-CT-2003-505446), and by funds from the Alfred Wegener Institute for Polar and Marine Research and the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT, grant # 3100014) to NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali A, 2007, CLIMATE CHANGE 2007; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bartsch I, 2004, HELGOLAND MAR RES, V58, P289, DOI 10.1007/s10152-004-0194-2; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Benedetti-Cecchi L, 2000, OECOLOGIA, V123, P265, DOI 10.1007/s004420051013; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V214, P137, DOI 10.3354/meps214137; Bertness MD, 1999, ECOLOGY, V80, P2711, DOI 10.1890/0012-9658(1999)080[2711:TTRCOP]2.0.CO;2; Bertocci I, 2010, MAR ECOL PROG SER, V414, P107, DOI 10.3354/meps08729; Box GE., 1978, STAT EXPT; Bulleri F, 2012, OIKOS, V121, P1801, DOI 10.1111/j.1600-0706.2011.19967.x; Burnaford JL, 2004, ECOLOGY, V85, P2837, DOI 10.1890/03-0113; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Connell J.H., 1985, P125; Connell SD, 2003, MAR BIOL, V142, P1065, DOI 10.1007/s00227-003-1021-z; Connell SD, 2003, OECOLOGIA, V137, P97, DOI 10.1007/s00442-003-1312-6; Connell Sean D., 2007, P556; Connolly SR, 2003, ECOLOGY, V84, P2979, DOI 10.1890/02-0347; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Downing AL, 2008, ECOLOGY, V89, P3204, DOI 10.1890/07-1652.1; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Dunstan PK, 2006, ECOLOGY, V87, P2842, DOI 10.1890/0012-9658(2006)87[2842:LRCVAI]2.0.CO;2; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Ernest SKM, 2009, ECOL LETT, V12, P507, DOI 10.1111/j.1461-0248.2009.01305.x; Ernest SKM, 2001, ECOLOGY, V82, P2118, DOI 10.2307/2680220; Eschweiler N, 2009, HELGOLAND MAR RES, V63, P119, DOI 10.1007/s10152-008-0131-x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Irving AD, 2006, OECOLOGIA, V148, P491, DOI 10.1007/s00442-006-0389-0; JANKE K, 1990, HELGOLANDER MEERESUN, V44, P219, DOI 10.1007/BF02365466; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Klug JL, 2000, ECOLOGY, V81, P387; Kohlmeier D, 2009, PHYSL REAKTIONEN UNT; Kornmann P, 1993, MEERESALGEN HELGOLAN; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; LITTLER MM, 1980, AM NAT, V116, P25, DOI 10.1086/283610; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Micheli F, 1999, OIKOS, V85, P161, DOI 10.2307/3546802; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Molis M, 2011, J ECOL, V99, P807, DOI 10.1111/j.1365-2745.2011.01800.x; Moore P, 2007, MAR ECOL PROG SER, V334, P11, DOI 10.3354/meps334011; Morrow K, 2008, MAR ECOL PROG SER, V361, P119, DOI 10.3354/meps07371; MUNDA IM, 1982, HELGOLANDER MEERESUN, V35, P131, DOI 10.1007/BF01997550; Nielsen KJ, 2007, ENCY TIDEPOOLS ROCKY, P10; Polley HW, 2007, OIKOS, V116, P2044, DOI 10.1111/j.2007.0030-1299.16080.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Rowe RJ, 2011, ECOLOGY, V92, P1366, DOI 10.1890/10-1634.1; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schiel DR, 2011, J EXP MAR BIOL ECOL, V407, P108, DOI 10.1016/j.jembe.2011.07.004; SCHLUTER D, 1984, ECOLOGY, V65, P998, DOI 10.2307/1938071; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Steiner CF, 2005, OIKOS, V110, P556, DOI 10.1111/j.0030-1299.2005.13665.x; Svensson JR, 2007, ECOLOGY, V88, P830, DOI 10.1890/06-0976; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Taper ML, 1996, AM NAT, V147, P1072, DOI 10.1086/285893; Thibaut L, 2011, ECOLOGY; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Underwood AJ, 2006, J EXP MAR BIOL ECOL, V330, P221, DOI 10.1016/j.jembe.2005.12.029; Valdivia N, 2009, AQUAT BIOL, V4, P263, DOI 10.3354/ab00114; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; White EP, 2004, AM NAT, V164, P670, DOI 10.1086/424766; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	82	19	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36541	10.1371/journal.pone.0036541	http://dx.doi.org/10.1371/journal.pone.0036541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574181	Green Published, gold			2022-12-27	WOS:000305349800078
J	Xu, J; Wang, SX; Viollet, B; Zou, MH				Xu, Jian; Wang, Shuangxi; Viollet, Benoit; Zou, Ming-Hui			Regulation of the Proteasome by AMPK in Endothelial Cells: The Role of O-GlcNAc Transferase (OGT)	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LINKED N-ACETYLGLUCOSAMINE; IN-VIVO; DEPENDENT DEGRADATION; UBIQUITIN SYSTEM; CYCLOHYDROLASE-I; CELLULAR-ENERGY; 26S PROTEASOME; DYSFUNCTION; PATHWAY	26S proteasome is a macromolecular multi-subunit complex responsible for recognizing, unfolding, and ultimately destroying proteins. It remains poorly understood how 26S proteasome activity is regulated. The present study was to investigate if AMP-activated protein kinase (AMPK) functions as a physiological suppressor of the 26S proteasome in endothelial cells. 26S proteasome assembly, activity, and O-GlcNAcylation of P700 were assayed in cultured human umbilical vein endothelial cells (HUVEC) and mouse aortas isolated from C57BL6 wild type and AMPK alpha 2 knockout mice with or without being exposed to selective AMPK activators or inhibitors. Pharmacological and genetic activation of AMPK effectively suppresses 26S proteasomes in endothelial cells. Conversely, inactivation of AMPK either pharmacologically or genetically increases 26S proteasome activity; furthermore, the inactivation decreases the O-GlcNAcylation of PA700/S10B (the regulatory complex in 26S proteasomes) and increases the assembly of 26S proteasomes. In contrast, AMPK activation increases levels of O-GlcNAcylated PA700/S10B, likely through enhanced association of PA700 with O-GlcNAc transferase (OGT), the enzyme that catalyzes protein O-GlcNAcylation. Finally, aortas from AMPK-KO vs wild type mice exhibit elevated 26S proteasome activity in parallel with decreased PA700/S10B O-GlcNAcylation and PA700/S10B-OGT association. Taken together, we conclude that AMPK functions as a physiological suppressor of 26S proteasomes.	[Xu, Jian] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol, Oklahoma City, OK USA; [Viollet, Benoit] Inst Cochin, INSERM, U1016, Paris, France; [Viollet, Benoit] CNRS, UMR 8104, Paris, France; [Viollet, Benoit] Univ Paris 05, Paris, France	University of Oklahoma System; University of Oklahoma Health Sciences Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Xu, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol, Oklahoma City, OK USA.	ming-hui-zou@ouhsc.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224	National Institutes of Health [HL079584, HL074399, HL080499, HL105157, HL110488]; American Diabetes Association (ADA); Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; National Established Investigator Award of American Heart Association; Scientist Development Grant (AHA) [10SDG2600164]; Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR) [5P20RR024215-5]; Junior Faculty Award (ADA) [1-12-JF-58]; Oklahoma Center for Advancement of Science and Technology [HR11-200]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL080499, R01HL110488, R01HL079584, R01HL105157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA)(American Diabetes Association); Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center; National Established Investigator Award of American Heart Association; Scientist Development Grant (AHA); Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR); Junior Faculty Award (ADA); Oklahoma Center for Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants (HL079584, HL074399, HL080499, HL105157, and HL110488), a research award from the American Diabetes Association (ADA), and funds from the Warren Chair in Diabetes Research of the University of Oklahoma Health Sciences Center (all to MHZ). MHZ is a recipient of the National Established Investigator Award of American Heart Association (AHA). JX is supported by a Scientist Development Grant (AHA, 10SDG2600164), a Center of Biomedical Research Excellence (COBRE) grant (NIH/NCRR: 5P20RR024215-5), a Junior Faculty Award (ADA, 1-12-JF-58), and a research award from the Oklahoma Center for Advancement of Science and Technology (HR11-200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Desterro JMP, 2000, CELL MOL LIFE SCI, V57, P1207, DOI 10.1007/PL00000760; Edwards CM, 2009, AM J HEMATOL, V84, P268, DOI 10.1002/ajh.21374; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2008, MOL CELL, V30, P263, DOI 10.1016/j.molcel.2008.04.012; Hardie DG, 2007, SCIENCE, V315, P1671, DOI 10.1126/science.1140737; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Li C, 2008, CURR OPIN LIPIDOL, V19, P541, DOI 10.1097/MOL.0b013e32830f4a44; Li Y, 2007, BIOCHEMISTRY-US, V46, P13163, DOI 10.1021/bi700694c; Luo B, 2007, J BIOL CHEM, V282, P7172, DOI 10.1074/jbc.M607362200; Madura K, 2009, NATURE, V459, P787, DOI 10.1038/459787a; Magill L, 2004, HAEMATOLOGICA, V89, P1428; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Marshall Stephen, 2006, Sci STKE, V2006, pre7; McCarty MF, 2005, MED HYPOTHESES, V64, P1211, DOI 10.1016/j.mehy.2004.01.042; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Orlowski RZ, 1999, CELL DEATH DIFFER, V6, P303, DOI 10.1038/sj.cdd.4400505; Poredos P, 2002, PATHOPHYSIOL HAEMO T, V32, P274, DOI 10.1159/000073580; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sherman D L, 1997, Cardiologia, V42, P177; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Sumegi M, 2003, BIOCHEM BIOPH RES CO, V312, P1284, DOI 10.1016/j.bbrc.2003.11.074; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whitsett J, 2007, ARTERIOSCL THROM VAS, V27, P2340, DOI 10.1161/ATVBAHA.107.153742; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029649; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	59	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36717	10.1371/journal.pone.0036717	http://dx.doi.org/10.1371/journal.pone.0036717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574218	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800115
J	Chu, C; Fan, SF; Li, CJ; Macken, C; Kim, JH; Hatta, M; Neumann, G; Kawaoka, Y				Chu, Caroline; Fan, Shufang; Li, Chengjun; Macken, Catherine; Kim, Jin Hyun; Hatta, Masato; Neumann, Gabriele; Kawaoka, Yoshihiro			Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein	PLOS ONE			English	Article							A VIRUSES; RNA-POLYMERASE; REPLICATION; TEMPLATE; POLYADENYLATION; TRANSCRIPTION	The influenza virus RNA polymerase complex is a heterotrimer composed of the PB1, PB2, and PA subunits. PB1, the catalytic core and structural backbone of the polymerase, possesses four highly conserved amino acid motifs that are present among all viral RNA-dependent RNA polymerases. A previous study demonstrated the importance of several of these conserved amino acids in PB1 for influenza polymerase activity through mutational analysis. However, a small number of viruses isolated in nature possesses non-consensus amino acids in one of the four motifs, most of which have not been tested for their replicative ability. Here, we assessed the transcription/ replication activities of 25 selected PB1 mutations found in natural isolates by using minireplicon assays in human and avian cells. Most of the mutations tested significantly reduced polymerase activity. One exception was mutation K480R, observed in several pandemic (H1N1) 2009 viruses, which slightly increased polymerase activity relative to wild-type. However, in the background of the pandemic A/California/04/2009 (H1N1) virus, this mutation did not affect virus titers in cell culture. Our results further demonstrate the functional importance of the four conserved PB1 motifs in influenza virus transcription/ replication. The finding of natural isolates with non-consensus PB1 motifs that are nonfunctional in minireplicon assays suggests compensatory mutations and/or mixed infections which may have 'rescued' the inactive PB1 protein.	[Chu, Caroline; Fan, Shufang; Li, Chengjun; Kim, Jin Hyun; Hatta, Masato; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA; [Macken, Catherine] Los Alamos Natl Lab, Los Alamos, NM USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Div Virol, Dept Microbiol & Immunol, Tokyo, Japan	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Tokyo	Chu, C (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Influenza Res Inst, Madison, WI 53706 USA.	neumanng@svm.vetmed.wisc.edu; kawaokay@svm.vetmed.wisc.edu	Li, Chengjun/GWM-7661-2022		Pfizer; Chugai Pharmaceuticals; Daiichi Sankyo Pharmaceutical; Toyama Chemical; Otsuka Pharmaceutical Co., Ltd.	Pfizer(Pfizer); Chugai Pharmaceuticals; Daiichi Sankyo Pharmaceutical(Daiichi Sankyo Company Limited); Toyama Chemical; Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical)	This work was supported by Pfizer Animal Health Veterinary Science Scholars Program (http://www.avmf.org/whatwedo/pfizerscholarship/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C.C. has received financial support from the Pfizer Animal Health Veterinary Science Scholars Program. G.N. was a consultant for Theraclone and is a Co-Founder of FluGen. Y.K. has received speaker's honoraria from Chugai Pharmaceuticals, Novartis, Daiichi-Sankyo, Toyama Chemical, Wyeth, and GlaxoSmithKline; grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Otsuka Pharmaceutical Co., Ltd.; is a consultant for Theraclone and Crucell, and is a Co-Founder of FluGen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; BISWAS SK, 1994, J VIROL, V68, P1819, DOI 10.1128/JVI.68.3.1819-1826.1994; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; CIANCI C, 1995, J VIROL, V69, P3995, DOI 10.1128/JVI.69.7.3995-3999.1995; Elton D, 2006, INFLUENZA VIROLOGY: CURRENT TOPICS, P1; HAY AJ, 1982, VIROLOGY, V116, P517, DOI 10.1016/0042-6822(82)90144-1; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KAMER G, 1984, NUCLEIC ACIDS RES, V12, P7269, DOI 10.1093/nar/12.18.7269; Kawakami E, 2011, J VIROL METHODS, V173, P1, DOI 10.1016/j.jviromet.2010.12.014; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, ADV VIRUS RES, V53, P265, DOI 10.1016/S0065-3527(08)60352-8; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Palese P., 2007, FIELDS VIROLOGY, P1647; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Poon LLM, 1999, J VIROL, V73, P3473, DOI 10.1128/JVI.73.4.3473-3476.1999; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zheng HY, 1999, J VIROL, V73, P5240, DOI 10.1128/JVI.73.6.5240-5243.1999	25	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36113	10.1371/journal.pone.0036113	http://dx.doi.org/10.1371/journal.pone.0036113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615752	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336300006
J	McKiernan, RC; Jimenez-Mateos, EM; Bray, I; Engel, T; Brennan, GP; Sano, T; Michalak, Z; Moran, C; Delanty, N; Farrell, M; O'Brien, D; Meller, R; Simon, RP; Stallings, RL; Henshall, DC				McKiernan, Ross C.; Jimenez-Mateos, Eva M.; Bray, Isabella; Engel, Tobias; Brennan, Gary P.; Sano, Takanori; Michalak, Zuzanna; Moran, Catherine; Delanty, Norman; Farrell, Michael; O'Brien, Donncha; Meller, Robert; Simon, Roger P.; Stallings, Raymond L.; Henshall, David C.			Reduced Mature MicroRNA Levels in Association with Dicer Loss in Human Temporal Lobe Epilepsy with Hippocampal Sclerosis	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; STATUS EPILEPTICUS; NEURONAL-ACTIVITY; MIRNA EXPRESSION; BRAIN MICRORNA; KAINIC ACID; BIOGENESIS; MICE; EPILEPTOGENESIS; DEATH	Hippocampal sclerosis (HS) is a common pathological finding in patients with temporal lobe epilepsy (TLE) and is associated with altered expression of genes controlling neuronal excitability, glial function, neuroinflammation and cell death. MicroRNAs (miRNAs), a class of small non-coding RNAs, function as post-transcriptional regulators of gene expression and are critical for normal brain development and function. Production of mature miRNAs requires Dicer, an RNAase III, loss of which has been shown to cause neuronal and glial dysfunction, seizures, and neurodegeneration. Here we investigated miRNA biogenesis in hippocampal and neocortical resection specimens from pharmacoresistant TLE patients and autopsy controls. Western blot analysis revealed protein levels of Dicer were significantly lower in certain TLE patients with HS. Dicer levels were also reduced in the hippocampus of mice subject to experimentally-induced epilepsy. To determine if Dicer loss was associated with altered miRNA processing, we profiled levels of 380 mature miRNAs in control and TLE-HS samples. Expression of nearly 200 miRNAs was detected in control human hippocampus. In TLE-HS samples there was a large-scale reduction of miRNA expression, with 51% expressed at lower levels and a further 24% not detectable. Primary transcript (pri-miRNAs) expression levels for several tested miRNAs were not different between control and TLE-HS samples. These findings suggest loss of Dicer and failure of mature miRNA expression may be a feature of the pathophysiology of HS in patients with TLE.	[McKiernan, Ross C.; Jimenez-Mateos, Eva M.; Engel, Tobias; Brennan, Gary P.; Sano, Takanori; Michalak, Zuzanna; Moran, Catherine; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Farrell, Michael] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland; [O'Brien, Donncha] Beaumont Hosp, Dept Neurol Surg, Dublin 9, Ireland; [Meller, Robert; Simon, Roger P.] Morehouse Sch Med, Inst Neurosci, Atlanta, GA 30310 USA; [Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Morehouse School of Medicine; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	McKiernan, RC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Brennan, Gary/K-4009-2019; Jimenez-Mateos, Eva/AAG-8072-2019; Stallings, Raymond/A-7213-2008	Brennan, Gary/0000-0002-4262-0481; Henshall, David/0000-0001-6237-9632; Delaney, Norman/0000-0002-3953-9842; Jimenez-Mateos, Eva/0000-0001-6417-6580; Engel, Tobias/0000-0001-9137-0637	Science Foundation Ireland [08/IN1/B1875]; Health Research Board [PHD/2007/11]; Irish Research Council for Science Engineering and Technology; National Biophotonics and Imaging Platform Ireland; Children's Medical and Research Foundation; Brainwave; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); National Biophotonics and Imaging Platform Ireland; Children's Medical and Research Foundation; Brainwave; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Science Foundation Ireland grant 08/IN1/B1875, Health Research Board PHD/2007/11, a postdoctoral fellowship from the Irish Research Council for Science Engineering and Technology (to EJ-M), the National Biophotonics and Imaging Platform Ireland, Brainwave, and Children's Medical and Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Baram TZ, 2011, EPILEPSY CURR, V11, P21, DOI 10.5698/1535-7511-11.1.21; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Bozzi Y, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00045; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dawodu S, 2005, EPILEPSIA, V46, P23, DOI 10.1111/j.0013-9580.2005.21804.x; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2004, ANN NEUROL, V55, P485, DOI 10.1002/ana.20001; Jimenez-Mateos EM, 2010, NEUROSCIENCE, V171, P556, DOI 10.1016/j.neuroscience.2010.09.003; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee ST, 2011, EXP NEUROL, V227, P172, DOI 10.1016/j.expneurol.2010.10.012; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shao NY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-409; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thom M, 2009, BRAIN PATHOL, V19, P565, DOI 10.1111/j.1750-3639.2008.00201.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a	56	93	100	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35921	10.1371/journal.pone.0035921	http://dx.doi.org/10.1371/journal.pone.0035921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615744	Green Published, gold			2022-12-27	WOS:000305336300004
J	Brandes, A; Lun, DS; Ip, K; Zucker, J; Colijn, C; Weiner, B; Galagan, JE				Brandes, Aaron; Lun, Desmond S.; Ip, Kuhn; Zucker, Jeremy; Colijn, Caroline; Weiner, Brian; Galagan, James E.			Inferring Carbon Sources from Gene Expression Profiles Using Metabolic Flux Models	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN EXPRESSION; GROWTH; OPTIMIZATION; TUBERCULOSIS; CONSTRAINTS; INFORMATION; NETWORKS; MG1655	Background: Bacteria have evolved the ability to efficiently and resourcefully adapt to changing environments. A key means by which they optimize their use of available nutrients is through adjustments in gene expression with consequent changes in enzyme activity. We report a new method for drawing environmental inferences from gene expression data. Our method prioritizes a list of candidate carbon sources for their compatibility with a gene expression profile using the framework of flux balance analysis to model the organism's metabolic network. Principal Findings: For each of six gene expression profiles for Escherichia coli grown under differing nutrient conditions, we applied our method to prioritize a set of eighteen different candidate carbon sources. Our method ranked the correct carbon source as one of the top three candidates for five of the six expression sets when used with a genome-scale model. The correct candidate ranked fifth in the remaining case. Additional analyses show that these rankings are robust with respect to biological and measurement variation, and depend on specific gene expression, rather than general expression level. The gene expression profiles are highly adaptive: simulated production of biomass averaged 94.84% of maximum when the in silico carbon source matched the in vitro source of the expression profile, and 65.97% when it did not. Conclusions: Inferences about a microorganism's nutrient environment can be made by integrating gene expression data into a metabolic framework. This work demonstrates that reaction flux limits for a model can be computed which are realistic in the sense that they affect in silico growth in a manner analogous to that in which a microorganism's alteration of gene expression is adaptive to its nutrient environment.	[Brandes, Aaron; Zucker, Jeremy; Weiner, Brian; Galagan, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Lun, Desmond S.; Ip, Kuhn] Rutgers State Univ, Dept Comp Sci, Camden, NJ 08102 USA; [Lun, Desmond S.; Ip, Kuhn] Rutgers State Univ, Ctr Computat & Integrat Biol, Camden, NJ 08102 USA; [Lun, Desmond S.; Ip, Kuhn] Univ S Australia, Sch Math & Stat, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia; [Lun, Desmond S.; Ip, Kuhn] Univ S Australia, Australian Ctr Plant Funct Genom, Mawson Lakes, SA, Australia; [Zucker, Jeremy] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Colijn, Caroline] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [Galagan, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James E.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; Rutgers State University New Brunswick; University of South Australia; University of South Australia; Harvard University; Harvard Medical School; University of Bristol; Boston University; Boston University	Brandes, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	jgalag@bu.edu	Zucker, Jeremy/M-3643-2016	Zucker, Jeremy/0000-0002-7276-9009; Weiner, Brian/0000-0002-7285-4385; Galagan, James/0000-0003-0542-3291	U.S. National Institute of Allergy and Infectious Diseases [HHSN 26620040000IC, HHSN 2722008000059C]; Bill and Melinda Gates Foundation [18651010-37352-A]	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	U.S. National Institute of Allergy and Infectious Diseases grants HHSN 26620040000IC and HHSN 2722008000059C, Bill and Melinda Gates Foundation grant 18651010-37352-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Lee JM, 2006, BRIEF BIOINFORM, V7, P140, DOI 10.1093/bib/bbl007; Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Palsson B, 2006, SYSTEMS BIOL PROPERT, Vxii, P322; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shimizu K, 2004, ADV BIOCHEM ENG BIOT, V91, P1; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Stralis-Pavese N, 2004, ENVIRON MICROBIOL, V6, P347, DOI 10.1111/j.1462-2920.2004.00582.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Kuile BH, 2001, FEBS LETT, V500, P169, DOI 10.1016/S0014-5793(01)02613-8; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100	33	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36947	10.1371/journal.pone.0036947	http://dx.doi.org/10.1371/journal.pone.0036947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606312	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305339400043
J	Lavoue, S; Miya, M; Arnegard, ME; Sullivan, JP; Hopkins, CD; Nishida, M				Lavoue, Sebastien; Miya, Masaki; Arnegard, Matthew E.; Sullivan, John P.; Hopkins, Carl D.; Nishida, Mutsumi			Comparable Ages for the Independent Origins of Electrogenesis in African and South American Weakly Electric Fishes	PLOS ONE			English	Article							JAMMING AVOIDANCE RESPONSES; FRESH-WATER FISHES; PHYLOGENETIC-RELATIONSHIPS; CONVERGENT EVOLUTION; MOLECULAR SYSTEMATICS; ELECTROSENSORY SYSTEM; MITOCHONDRIAL GENOME; OSTARIOPHYSAN FISHES; GENE DUPLICATION; EFFERENCE COPY	One of the most remarkable examples of convergent evolution among vertebrates is illustrated by the independent origins of an active electric sense in South American and African weakly electric fishes, the Gymnotiformes and Mormyroidea, respectively. These groups independently evolved similar complex systems for object localization and communication via the generation and reception of weak electric fields. While good estimates of divergence times are critical to understanding the temporal context for the evolution and diversification of these two groups, their respective ages have been difficult to estimate due to the absence of an informative fossil record, use of strict molecular clock models in previous studies, and/or incomplete taxonomic sampling. Here, we examine the timing of the origins of the Gymnotiformes and the Mormyroidea using complete mitogenome sequences and a parametric Bayesian method for divergence time reconstruction. Under two different fossil-based calibration methods, we estimated similar ages for the independent origins of the Mormyroidea and Gymnotiformes. Our absolute estimates for the origins of these groups either slightly postdate, or just predate, the final separation of Africa and South America by continental drift. The most recent common ancestor of the Mormyroidea and Gymnotiformes was found to be a non-electrogenic basal teleost living more than 85 millions years earlier. For both electric fish lineages, we also estimated similar intervals (16-19 or 22-26 million years, depending on calibration method) between the appearance of electroreception and the origin of myogenic electric organs, providing rough upper estimates for the time periods during which these complex electric organs evolved de novo from skeletal muscle precursors. The fact that the Gymnotiformes and Mormyroidea are of similar age enhances the comparative value of the weakly electric fish system for investigating pathways to evolutionary novelty, as well as the influences of key innovations in communication on the process of species radiation.	[Lavoue, Sebastien] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lavoue, Sebastien; Nishida, Mutsumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba, Japan; [Miya, Masaki] Nat Hist Museum & Inst, Dept Zool, Chiba, Japan; [Arnegard, Matthew E.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Sullivan, John P.] Cornell Univ, Museum Vertebrates, Ithaca, NY USA; [Hopkins, Carl D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	National Taiwan University; University of Tokyo; Fred Hutchinson Cancer Center; Cornell University; Cornell University	Lavoue, S (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	microceb@hotmail.com	Miya, Masaki/O-2664-2019; SULLIVAN, JOHN P./ABH-8966-2020; Lavoue, Sebastien/H-7118-2012	Lavoue, Sebastien/0000-0003-4798-6666; Miya, Masaki/0000-0002-9791-9886; Sullivan, John P./0000-0003-0585-5617	Japan Society for the Promotion of Science [16570082, 15380131, 17207007, 19207007, 22370035]; Research and Exploration Grant from the National Geographic Society [7879-05]; Taiwan's National Science Council [NSC100-2811-M-002-069]; Direct For Biological Sciences [0818305] Funding Source: National Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research and Exploration Grant from the National Geographic Society(National Geographic Society); Taiwan's National Science Council(Ministry of Science and Technology, Taiwan); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by Japan Society for the Promotion of Science Research Grants (Nos. 16570082, 15380131, 17207007, 19207007 and 22370035). Fieldwork in Odzala-Kokoua National Park (Republic of the Congo) in 2006 was funded by a Research and Exploration Grant from the National Geographic Society (award 7879-05 to MEA). SL completed this work while he was supported by a postdoctoral fellowship from Taiwan's National Science Council (NSC100-2811-M-002-069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert James S., 2006, P429; Alves-Gomes JA, 1999, J EXP BIOL, V202, P1167; Alves-Gomes JA, 2001, J FISH BIOL, V58, P1489, DOI 10.1006/jfbi.2001.1625; ALVESGOMES JA, 1995, MOL BIOL EVOL, V12, P298; ANDRES KH, 1988, ANAT EMBRYOL, V177, P523, DOI 10.1007/BF00305139; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; Arnegard ME, 2010, AM NAT, V176, P335, DOI 10.1086/655221; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Arnegard ME, 2005, EVOLUTION, V59, P324, DOI 10.1111/j.0014-3820.2005.tb00993.x; BARRON EJ, 1987, PALAEOGEOGR PALAEOCL, V59, P3, DOI 10.1016/0031-0182(87)90071-X; Bass A.H., 1986, P13; BASTIAN J, 1995, J COMP PHYSIOL A, V176, P63; Bastian J, 1996, J NEUROPHYSIOL, V76, P2483, DOI 10.1152/jn.1996.76.4.2483; Bastian J, 1996, J NEUROPHYSIOL, V76, P2497, DOI 10.1152/jn.1996.76.4.2497; BELL CC, 1982, J NEUROPHYSIOL, V47, P1043, DOI 10.1152/jn.1982.47.6.1043; Bell CC, 2002, BRAIN BEHAV EVOLUT, V59, P312, DOI 10.1159/000063567; Bell CC, 2001, CURR OPIN NEUROBIOL, V11, P481, DOI 10.1016/S0959-4388(00)00238-5; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Benton Michael J., 2009, P35; Brandley MC, 2011, SYST BIOL, V60, P3, DOI 10.1093/sysbio/syq045; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; BRIGGS JC, 1979, COPEIA, P111; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; BULLOCK TH, 1975, J COMP PHYSIOL, V103, P97, DOI 10.1007/BF01380047; BULLOCK TH, 1983, BRAIN RES REV, V6, P25, DOI 10.1016/0165-0173(83)90003-6; Bullock TH, 2005, ELECTRORECEPTION; Caputi AA, 2005, SPR HDB AUD, V21, P410; Carlson BA, 2002, J COMP NEUROL, V454, P440, DOI 10.1002/cne.10462; Carlson Bruce A., 2011, Communicative & Integrative Biology, V4, P720; Carlson BA, 2011, SCIENCE, V332, P583, DOI 10.1126/science.1201524; Carlson BA, 2009, J NEUROSCI, V29, P9417, DOI 10.1523/JNEUROSCI.1980-09.2009; Cavin L., 2008, GEOLOGICAL SOC SPECI; Crampton WGR, 2011, EVOLUTION, V65, P1650, DOI 10.1111/j.1558-5646.2011.01245.x; Czech-Damal NU, 2011, P R SOC LOND BIOL; DeVaney SC, 2008, INTERRELATIONSHIPS F, P1; Dimmick WW, 1996, MOL PHYLOGENET EVOL, V6, P120, DOI 10.1006/mpev.1996.0064; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Forey PL, 1997, S AFR J SCI, V93, P564; Fricke R, 2011, CATALOG FISHES ELECT; Gardiner BG, 2005, ZOOL J LINN SOC-LOND, V144, P511, DOI 10.1111/j.1096-3642.2005.00181.x; GAYET M, 1991, CR ACAD SCI II, V313, P471; Gayet M, 2000, CYBIUM, V24, P104; Gibbs MA, 2004, BRAIN BEHAV EVOLUT, V64, P163, DOI 10.1159/000079745; GOSLINE W A, 1975, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V88, P146; Greenwood P. H., 1959, Exploration du Parc National Albert Mission H de Braucourt (1950), VNo. 4, P1; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HEILIGENBERG W, 1974, J COMP PHYSIOL, V91, P223, DOI 10.1007/BF00698054; Heiligenberg W., 1977, PRINCIPLES ELECTROLO; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; Hopkins CD, 1999, J EXP BIOL, V202, P1217; Hopkins CD, 1995, CURR OPIN NEUROBIOL, V5, P769, DOI 10.1016/0959-4388(95)80105-7; Hopkins CD, 2010, ENCY PERCEPTION, P384; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Jacobs LL, 2009, B SOC GEOL FR, V180, P333, DOI 10.2113/gssgfbull.180.4.333; Kawaguchi M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-260; KAWASAKI M, 1993, J COMP PHYSIOL A, V173, P9; Kawasaki M, 2009, ZOOL SCI, V26, P587, DOI 10.2108/zsj.26.587; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; KIRSCHBAUM F, 1987, ENVIRON BIOL FISH, V20, P11, DOI 10.1007/BF00002023; Kirschbaum F, 2002, J PHYSIOLOGY-PARIS, V96, P557, DOI 10.1016/S0928-4257(03)00011-1; Kirschbaum F, 2008, J PHYSIOLOGY-PARIS, V102, P347, DOI 10.1016/j.jphysparis.2008.10.008; KIRSCHBAUM F, 1977, NATURWISSENSCHAFTEN, V64, P387, DOI 10.1007/BF00368748; Kirschbaum Frank, 1995, Fish and Fisheries Series, V17, P267; Krahe R, 2008, J NEUROPHYSIOL, V100, P852, DOI 10.1152/jn.90300.2008; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2004, MOL PHYLOGENET EVOL, V33, P171, DOI 10.1016/j.ympev.2004.04.021; Lavoue S, 2003, BIOL J LINN SOC, V78, P273, DOI 10.1046/j.1095-8312.2003.00170.x; Lavoue S, 2000, MOL PHYLOGENET EVOL, V14, P1, DOI 10.1006/mpev.1999.0687; Lavoue S, 2008, MOL PHYLOGENET EVOL, V47, P1111, DOI 10.1016/j.ympev.2007.12.002; Lavoue S, 2011, P ROY SOC B-BIOL SCI, V278, P1003, DOI 10.1098/rspb.2010.1639; Lavoue S, 2008, J PHYSIOL-PARIS, V102, P322, DOI 10.1016/j.jphysparis.2008.10.003; LAWVER L. A., 2007, PLATES 2006 ATLAS PL; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li Guo-Qing, 1996, P163; Li Guoqing, 1997, P54; Li J, 2010, MOL PHYLOGENET EVOL, V57, P932, DOI 10.1016/j.ympev.2010.07.016; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; Lovejoy NR, 2010, MOL PHYLOGENET EVOL, V54, P278, DOI 10.1016/j.ympev.2009.09.017; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Lukoschek V, 2012, SYST BIOL, V61, P22, DOI 10.1093/sysbio/syr075; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Maisey JG, 2000, CRETACEOUS RES, V21, P281, DOI 10.1006/cres.1999.0195; Markham MR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000203; MARRERO C, 1993, ENVIRON BIOL FISH, V38, P299, DOI 10.1007/BF00007523; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Modrell MS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1502; Modrell MS, 2011, GENESIS, V49, P278, DOI 10.1002/dvg.20707; Moller P., 1995, ELECT FISHES HIST BE; Monterio A, 2009, PLOS BIOL, V7, P209, DOI 10.1371/journal.pbio.1000037; Murray AM, 2010, J VERTEBR PALEONTOL, V30, P665, DOI 10.1080/02724631003758060; Nakatani M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-177; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nishikawa KC, 2002, BRAIN BEHAV EVOLUT, V59, P240, DOI 10.1159/000063561; Novak AE, 2006, J MOL EVOL, V63, P208, DOI 10.1007/s00239-005-0287-9; Ohno S., 1970, P1; Orti G, 1997, SYST BIOL, V46, P75, DOI 10.2307/2413637; Orti G, 1996, MOL BIOL EVOL, V13, P556, DOI 10.1093/oxfordjournals.molbev.a025616; Patterson C., 1993, P621; Patterson C., 1975, MEM MUS NATL HIST NA, V88, P155; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Peng ZG, 2006, GENE, V376, P290, DOI 10.1016/j.gene.2006.04.014; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Rose GJ, 2004, NAT REV NEUROSCI, V5, P943, DOI 10.1038/nrn1558; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Sato Y, 2010, ENVIRON BIOL FISH, V88, P169, DOI 10.1007/s10641-010-9628-7; SCOTESE CR, 1988, TECTONOPHYSICS, V155, P27, DOI 10.1016/0040-1951(88)90259-4; Shirgaonkar AA, 2008, J EXP BIOL, V211, P3490, DOI 10.1242/jeb.019224; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Smith A. G., 1994, ATLAS MESOZOIC CENOZ, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart KM, 2009, MONOGR BIOL, V89, P677; Stoddard PK, 1999, NATURE, V400, P254, DOI 10.1038/22301; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Sullivan JP, 2000, J EXP BIOL, V203, P665; Sullivan JP, 2004, EVOLUTION, V58, P825; SZABO T, 1960, NATURE, V188, P760, DOI 10.1038/188760b0; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taverne L., 1972, Annales Mus r Afr cent (Ser 8 Sci zool), VNo. 200, P1; Taverne Louis, 1998, Studi e Ricerche sui Giacimenti Terziari di Bolca, V7, P67; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; VANCOUVERING JAH, 1977, COPEIA, P163; Wagner GP, 2010, CURR BIOL, V20, pR48, DOI 10.1016/j.cub.2009.11.010; Wiley E.O., 2010, P123; Wilson MVH, 2008, GEOL SOC SPEC PUBL, V295, P185, DOI 10.1144/SP295.12; Winemiller KO, 1997, ENVIRON BIOL FISH, V49, P175, DOI 10.1023/A:1007376826609; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zakon H.H., 1988, P813; Zakon H.H., 1986, P103; Zakon HH, 2006, P NATL ACAD SCI USA, V103, P3675, DOI 10.1073/pnas.0600160103; Zakon HH, 2003, CURR OPIN NEUROBIOL, V13, P744, DOI 10.1016/j.conb.2003.07.001; Zakon HH, 1999, J EXP BIOL, V202, P1427; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	148	64	64	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36287	10.1371/journal.pone.0036287	http://dx.doi.org/10.1371/journal.pone.0036287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606250	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400015
J	Zhang, TY; Song, BW; Zhu, W; Xu, X; Gong, QQ; Morando, C; Dassopoulos, T; Newberry, RD; Hunt, SR; Li, E				Zhang, Tianyi; Song, Bowen; Zhu, Wei; Xu, Xiao; Gong, Qing Qing; Morando, Christopher; Dassopoulos, Themistocles; Newberry, Rodney D.; Hunt, Steven R.; Li, Ellen			An Ileal Crohn's Disease Gene Signature Based on Whole Human Genome Expression Profiles of Disease Unaffected Ileal Mucosal Biopsies	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MEMBRANE ANTIGEN-EXPRESSION; ULCERATIVE-COLITIS; CLOSTRIDIUM-DIFFICILE; PROSTATE; CLASSIFICATION; REGRESSION	Previous genome-wide expression studies have highlighted distinct gene expression patterns in inflammatory bowel disease (IBD) compared to control samples, but the interpretation of these studies has been limited by sample heterogeneity with respect to disease phenotype, disease activity, and anatomic sites. To further improve molecular classification of inflammatory bowel disease phenotypes we focused on a single anatomic site, the disease unaffected proximal ileal margin of resected ileum, and three phenotypes that were unlikely to overlap: ileal Crohn's disease (ileal CD), ulcerative colitis (UC), and control patients without IBD. Whole human genome (Agilent) expression profiling was conducted on two independent sets of disease-unaffected ileal samples collected from the proximal margin of resected ileum. Set 1 (47 ileal CD, 27 UC, and 25 Control non-IBD patients) was used as the training set and Set 2 was subsequently collected as an independent test set (10 ileal CD, 10 UC, and 10 control non-IBD patients). We compared the 17 gene signatures selected by four different feature-selection methods to distinguish ileal CD phenotype with non-CD phenotype. The four methods yielded different but overlapping solutions that were highly discriminating. All four of these methods selected FOLH1 as a common feature. This gene is an established biomarker for prostate cancer, but has not previously been associated with Crohn's disease. Immunohistochemical staining confirmed increased expression of FOLH1 in the ileal epithelium. These results provide evidence for convergent molecular abnormalities in the macroscopically disease unaffected proximal margin of resected ileum from ileal CD subjects.	[Zhang, Tianyi; Song, Bowen; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Xu, Xiao; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Gong, Qing Qing; Morando, Christopher; Dassopoulos, Themistocles; Newberry, Rodney D.; Li, Ellen] Washington Univ, Dept Med, St Louis Sch Med, St Louis, MO USA; [Hunt, Steven R.] Washington Univ, St Louis Sch Med, Dept Surg, St Louis, MO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Zhang, TY (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	Ellen.Li@stonybrook.edu		Newberry, Rodney/0000-0002-4152-5191	National Institutes of Health (NIH) [UH2DK083994]; Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574, UH2DK083994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Simons Foundation; Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported partially by National Institutes of Health (NIH) grant UH2DK083994, the Crohn's and Colitis Foundation of America, the Simons Foundation, and by the Leona M. and Harry B. Helmsley charitable trust through the Sinai-Helmsley Alliance for Research Excellence (SHARE) Network and NIH grant R21HG005964. We acknowledge use of the Washington University Digestive Diseases Research Core Center Tissue Procurement Facility (P30 DK52574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Arijs I, 2011, AM J GASTROENTEROL, V106, P748, DOI 10.1038/ajg.2011.27; Bousvaros A, 2007, J PEDIAT GASTROENTER, V44, P653, DOI DOI 10.1097/MPG.0B013E31805563F3]; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Buhlmann P, 2003, J AM STAT ASSOC, V98, P324, DOI 10.1198/016214503000125; Carpenter S, 2011, J BIOL CHEM, V286, P38795, DOI 10.1074/jbc.M111.255893; Carpenter S, 2009, J IMMUNOL, V183, P3989, DOI 10.4049/jimmunol.0901518; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Gong MC, 1999, CANCER METAST REV, V18, P483, DOI 10.1023/A:1006308826967; Gordon IO, 2008, MODERN PATHOL, V21, P1421, DOI 10.1038/modpathol.2008.143; Hamm CM, 2010, INFLAMM BOWEL DIS, V16, P1649, DOI 10.1002/ibd.21208; Hancock L, 2008, INFLAMM BOWEL DIS, V14, P1667, DOI 10.1002/ibd.20517; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; HARRELL JFE, 2001, REGRESSION MODELING; ISRAELI RS, 1994, CANCER RES, V54, P1807; Issa M, 2007, CLIN GASTROENTEROL H, V5, P345, DOI 10.1016/j.cgh.2006.12.028; Langley P, P 10 NAT C ART INT, P223; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Li E, 2012, PLOS ONE IN PRESS; Liu B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-136; Masson CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010380; McLachlan G. J., 1992, DISCRIMINANT ANAL ST, DOI DOI 10.1002/0471725293; Melton GB, 2008, ANN SURG, V248, P608, DOI [10.1097/SLA.0b013e318187ed64, 10.1097/SLA.0b013e3181883cd2]; Nelson RL, 2009, COCHRANE DB SYST REV, V1; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Noble CL, 2010, INFLAMM BOWEL DIS, V16, P1717, DOI 10.1002/ibd.21263; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Rodemann JF, 2007, CLIN GASTROENTEROL H, V5, P339, DOI 10.1016/j.cgh.2006.12.027; Saeys Y, 2008, LECT NOTES ARTIF INT, V5212, P313, DOI 10.1007/978-3-540-87481-2_21; Silver DA, 1997, CLIN CANCER RES, V3, P81; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uthoff SMS, 2001, INT J ONCOL, V19, P803; van Leuven SI, 2007, J LIPID RES, V48, P2640, DOI 10.1194/jlr.M700176-JLR200; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142; Zhang T, 2012, PLOS ONE IN PRESS	46	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37139	10.1371/journal.pone.0037139	http://dx.doi.org/10.1371/journal.pone.0037139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606341	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400067
J	Lavery, TJ; Roudnew, B; Seymour, J; Mitchell, JG; Jeffries, T				Lavery, Trish J.; Roudnew, Ben; Seymour, Justin; Mitchell, James G.; Jeffries, Thomas			High Nutrient Transport and Cycling Potential Revealed in the Microbial Metagenome of Australian Sea Lion (Neophoca cinerea) Faeces	PLOS ONE			English	Article							GUT MICROBIOME; GLYCINE REDUCTASE; HUMAN INTESTINE; ECOLOGY; OBESITY; BACTERIA; OCEAN	Metagenomic analysis was used to examine the taxonomic diversity and metabolic potential of an Australian sea lion (Neophoca cinerea) gut microbiome. Bacteria comprised 98% of classifiable sequences and of these matches to Firmicutes (80%) were dominant, with Proteobacteria and Actinobacteria representing 8% and 2% of matches respectively. The relative proportion of Firmicutes (80%) to Bacteriodetes (2%) is similar to that in previous studies of obese humans and obese mice, suggesting the gut microbiome may confer a predisposition towards the excess body fat that is needed for thermoregulation within the cold oceanic habitats foraged by Australian sea lions. Core metabolic functions, including carbohydrate utilisation (14%), protein metabolism (9%) and DNA metabolism (7%) dominated the metagenome, but in comparison to human and fish gut microbiomes there was a significantly higher proportion of genes involved in phosphorus metabolism (2.4%) and iron scavenging mechanisms (1%). When sea lions defecate at sea, the relatively high nutrient metabolism potential of bacteria in their faeces may accelerate the dissolution of nutrients from faecal particles, enhancing their persistence in the euphotic zone where they are available to stimulate marine production.	[Lavery, Trish J.; Roudnew, Ben; Seymour, Justin; Mitchell, James G.; Jeffries, Thomas] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seymour, Justin; Jeffries, Thomas] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Broadway, NSW, Australia	Flinders University South Australia; University of Technology Sydney	Lavery, TJ (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	trishlavery@hotmail.com	Jeffries, Thomas/D-4270-2018; Jeffries, Thomas/E-8679-2013	Mitchell, Jim/0000-0002-8445-0935; Seymour, Justin/0000-0002-3745-6541; Jeffries, Thomas/0000-0001-6479-0353	Australian Government	Australian Government(Australian GovernmentCGIAR)	TL was supported by an Australian Postgraduate Award scholarship from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Azam F, 2007, NAT REV MICROBIOL, V5, P966, DOI 10.1038/nrmicro1747; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; GALES NJ, 1992, WILDLIFE RES, V19, P447, DOI 10.1071/WR9920447; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldsworthy SD, 2007, ASSESSMENT IMPLICATI; Lavery TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3527, DOI 10.1098/rspb.2010.0863; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pabst DA, 1999, BIOL MARINE MAMMALS; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; TANAKA H, 1979, J BIOL CHEM, V254, P447; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; VENUGOPALAN V, 1980, J BACTERIOL, V141, P386, DOI 10.1128/JB.141.1.386-388.1980; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	24	31	31	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36478	10.1371/journal.pone.0036478	http://dx.doi.org/10.1371/journal.pone.0036478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606263	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200030
J	Li, R; Ren, MP; Chen, N; Luo, M; Zhang, Z; Wu, JB				Li, Rong; Ren, Meiping; Chen, Ni; Luo, Mao; Zhang, Zhuo; Wu, Jianbo			Vitronectin Increases Vascular Permeability by Promoting VE-Cadherin Internalization at Cell Junctions	PLOS ONE			English	Article							TISSUE-INJURY RESPONSES; ENDOTHELIAL-CELLS; IN-VIVO; MATRICRYPTIC SITES; ANGIOGENESIS; INTEGRIN; ACTIVATION; EXPRESSION; RECEPTOR; BINDING	Background: Cross-talk between integrins and cadherins regulates cell function. We tested the hypothesis that vitronectin (VN), a multi-functional adhesion molecule present in the extracellular matrix and plasma, regulates vascular permeability via effects on VE-cadherin, a critical regulator of endothelial cell (EC) adhesion. Methodology/Principal Findings: Addition of multimeric VN (mult VN) significantly increased VE-cadherin internalization in human umbilical vein EC (HUVEC) monolayers. This effect was blocked by the anti-alpha(V)beta(3) antibody, pharmacological inhibition and knockdown of Src kinase. In contrast to mult VN, monomeric VN did not trigger VE-cadherin internalization. In a modified Miles assay, VN deficiency impaired vascular endothelial growth factor-induced permeability. Furthermore, ischemia-induced enhancement of vascular permeability, expressed as the ratio of FITC-dextran leakage from the circulation into the ischemic and non-ischemic hindlimb muscle, was significantly greater in the WT mice than in the Vn(-/-) mice. Similarly, ischemia-mediated macrophage infiltration was significantly reduced in the Vn(-/-) mice vs. the WT controls. We evaluated changes in the multimerization of VN in ischemic tissue in a mouse hindlimb ischemia model. VN plays a previously unrecognized role in regulating endothelial permeability via conformational- and integrin-dependent effects on VE-cadherin trafficking. Conclusion/Significance: These results have important implications for the regulation of endothelial function and angiogenesis by VN under normal and pathological conditions.	[Li, Rong; Ren, Meiping; Chen, Ni; Luo, Mao; Zhang, Zhuo; Wu, Jianbo] Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Sichuan, Peoples R China; [Wu, Jianbo] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	Southwest Medical University; University of Missouri System; University of Missouri Columbia	Li, R (corresponding author), Luzhou Med Coll, Drug Discovery Res Ctr, Luzhou, Sichuan, Peoples R China.	wuji@missouri.edu			AHA National Scientist Development Grant [10SDG2570037]; Research Council Grant from the University of Missouri [URC-10-001-Wu]; National Natural Science Foundation of China [81172050]	AHA National Scientist Development Grant; Research Council Grant from the University of Missouri; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the AHA National Scientist Development Grant (10SDG2570037), a Research Council Grant from the University of Missouri (URC-10-001-Wu) (to JW) and the National Natural Science Foundation of China (81172050) (to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Brakenhielm E, 2007, CIRC RES, V101, P536, DOI 10.1161/CIRCRESAHA.107.160937; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Davis GE, 2010, J MOL CELL CARDIOL, V48, P454, DOI 10.1016/j.yjmcc.2009.09.002; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dufourcq P, 1998, ARTERIOSCL THROM VAS, V18, P168, DOI 10.1161/01.ATV.18.2.168; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gotsch U, 1997, J CELL SCI, V110, P583; Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858; Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kim HW, 2007, CIRC RES, V101, P409, DOI 10.1161/CIRCRESAHA.107.153791; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Liu YQ, 2004, FASEB J, V18, P457, DOI 10.1096/fj.03-0948com; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; QIAO RL, 1995, AM J PHYSIOL-CELL PH, V269, pC110, DOI 10.1152/ajpcell.1995.269.1.C110; Sano K, 2007, GLYCOBIOLOGY, V17, P784, DOI 10.1093/glycob/cwm031; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; Seiffert D, 1996, J BIOL CHEM, V271, P29644, DOI 10.1074/jbc.271.47.29644; Sen U, 2006, J CELL PHYSIOL, V209, P767, DOI 10.1002/jcp.20752; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; TOMASINI BR, 1988, BLOOD, V72, P903; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; vanAken BE, 1997, HISTOCHEM CELL BIOL, V107, P313, DOI 10.1007/s004180050116; Wang YX, 2006, P NATL ACAD SCI USA, V103, P1774, DOI 10.1073/pnas.0510774103; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wu MH, 2001, J PHYSIOL-LONDON, V532, P785, DOI 10.1111/j.1469-7793.2001.0785e.x; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; ZANETTI A, 1994, BLOOD, V84, P1116, DOI 10.1182/blood.V84.4.1116.bloodjournal8441116; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37195	10.1371/journal.pone.0037195	http://dx.doi.org/10.1371/journal.pone.0037195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606350	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200065
J	Migliore, M; Migliore, R				Migliore, Michele; Migliore, Rosanna			Know Your Current I-h: Interaction with a Shunting Current Explains the Puzzling Effects of Its Pharmacological or Pathological Modulations	PLOS ONE			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; K+ CHANNELS; INTRINSIC EXCITABILITY; SYNAPTIC INTEGRATION; RAT HIPPOCAMPUS; DENDRITIC I(H); CA1 NEURONS; CELLS; INTERNEURONS; EPILEPSY	The non-specific, hyperpolarization activated, I-h current is particularly involved in epilepsy and it exhibits an excitatory or inhibitory action on synaptic integration in an apparently inconsistent way. It has been suggested that most of the inconsistencies could be reconciled invoking an indirect interaction with the M-type K+ current, another current involved in epilepsy. However, here we show that the original experiments, and the simplified model used to explain and support them, cannot explain in a conclusive way the puzzling I-h actions observed in different experimental preparations. Using a realistic model, we show instead how and why a shunting current, such as that carried by TASK-like channels, and dependent on I-h channel is able to explain virtually all experimental findings on I-h up-or down-regulation by modulators or pathological conditions. The model results suggest several experimentally testable predictions to characterize in more details this elusive and peculiar interaction, which may be of fundamental importance in the development of new treatments for all those pathological and cognitive dysfunctions caused, mediated, or affected by I-h.	[Migliore, Michele; Migliore, Rosanna] CNR, Inst Biophys, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Migliore, M (corresponding author), CNR, Inst Biophys, Palermo, Italy.	michele.migliore@cnr.it	Migliore, Rosanna/N-6541-2013; Migliore, Michele/D-7448-2011	Migliore, Rosanna/0000-0001-9034-7849; Migliore, Michele/0000-0002-7584-6292	Italian National Research Council; National Insititutes of Health [AG25633, NS39600]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025633] Funding Source: NIH RePORTER	Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the Italian National Research Council and, in part, by National Insititutes of Health grants AG25633 and NS39600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2010, J NEUROSCI, V30, P6434, DOI 10.1523/JNEUROSCI.4066-09.2010; Barrow AJ, 2009, CHANNELS, V3, P301, DOI 10.4161/chan.3.5.9454; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Chen XX, 2004, J PHYSIOL-LONDON, V559, P187, DOI 10.1113/jphysiol.2004.068114; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI, V3, P1; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hu H, 2007, J NEUROSCI, V27, P1853, DOI 10.1523/JNEUROSCI.4463-06.2007; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kang YN, 2004, J NEUROSCI, V24, P3694, DOI 10.1523/JNEUROSCI.5641-03.2004; Khurana S, 2011, J NEUROSCI, V31, P8936, DOI 10.1523/JNEUROSCI.1079-11.2011; Lippert A, 2009, BIOL CYBERN, V101, P297, DOI 10.1007/s00422-009-0337-2; Lupica CR, 2001, J NEUROPHYSIOL, V86, P261, DOI 10.1152/jn.2001.86.1.261; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; Miceli F, 2009, NEUROBIOL DIS, V34, P501, DOI 10.1016/j.nbd.2009.03.009; Migliore M, 2003, J COMPUT NEUROSCI, V14, P185, DOI 10.1023/A:1021906818333; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Noam Y, 2011, CURR OPIN NEUROBIOL, V21, P873, DOI 10.1016/j.conb.2011.06.013; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Shah MM, 2011, J PHYSIOL-LONDON, V589, P6029, DOI 10.1113/jphysiol.2011.220913; Stuart G, 1998, J NEUROSCI, V18, P3501; Taverna S, 2005, J NEUROSCI, V25, P9162, DOI 10.1523/JNEUROSCI.2454-05.2005; Torborg CL, 2006, J NEUROSCI, V26, P7362, DOI 10.1523/JNEUROSCI.1257-06.2006; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005	32	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36867	10.1371/journal.pone.0036867	http://dx.doi.org/10.1371/journal.pone.0036867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606301	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200052
J	Orishchenko, KE; Pavlova, SV; Elisaphenko, EA; Sherstyuk, VV; Prinz, AV; Shevchenko, AI; Dementyeva, EV; Zakian, SM				Orishchenko, Konstantin E.; Pavlova, Sophia V.; Elisaphenko, Eugeny A.; Sherstyuk, Vladimir V.; Prinz, Alexander V.; Shevchenko, Alexander I.; Dementyeva, Elena V.; Zakian, Suren M.			A Regulatory Potential of the Xist Gene Promoter in Vole M. rossiaemeridionalis	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; INSULATOR PROTEIN CTCF; RNA-POLYMERASE-II; IN-VIVO; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; BINDING SITES; TRANSCRIPTION; EXPRESSION; REGION	X chromosome inactivation takes place in the early development of female mammals and depends on the Xist gene expression. The mechanisms of Xist expression regulation have not been well understood so far. In this work, we compared Xist promoter region of vole Microtus rossiaemeridionalis and other mammalian species. We observed three conserved regions which were characterized by computational analysis, DNaseI in vitro footprinting, and reporter construct assay. Regulatory factors potentially involved in Xist activation and repression in voles were determined. The role of CpG methylation in vole Xist expression regulation was established. A CTCF binding site was found in the 59 flanking region of the Xist promoter on the active X chromosome in both males and females. We suggest that CTCF acts as an insulator which defines an inactive Xist domain on the active X chromosome in voles.	[Orishchenko, Konstantin E.; Pavlova, Sophia V.; Elisaphenko, Eugeny A.; Sherstyuk, Vladimir V.; Prinz, Alexander V.; Shevchenko, Alexander I.; Dementyeva, Elena V.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Pavlova, Sophia V.; Elisaphenko, Eugeny A.; Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Dementyeva, Elena V.; Zakian, Suren M.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Pavlova, Sophia V.; Elisaphenko, Eugeny A.; Sherstyuk, Vladimir V.; Shevchenko, Alexander I.; Dementyeva, Elena V.; Zakian, Suren M.] State Res Inst Circulat Pathol, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Meshalkin National Medical Research Center	Orishchenko, KE (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Prinz, Alexander/O-2724-2013; Orishchenko, Konstantin/Q-6630-2016; Sherstyuk, Vladimir V/B-1939-2018; Elisaphenko, Eugeny/V-5115-2018; Orishchenko, Konstantin/AFR-5367-2022; Zakian, Suren/J-2196-2018; Shevchenko, Alexander I./T-3400-2018; Elisafenko, Eugeny/AAD-5901-2020; Pavlova, Sophia/I-5616-2017	Prinz, Alexander/0000-0002-4694-8695; Elisafenko, Eugeny/0000-0002-3204-8178; Pavlova, Sophia/0000-0003-1095-3692; Sherstyuk, Vladimir/0000-0001-8863-6545; Zakian, Suren/0000-0003-2448-6511	Russian Foundation for Basic Research [11-04-00799-a]; Integration Project of the Siberian Branch of the Russian Academy of Sciences [55]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Integration Project of the Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Foundation for Basic Research (grant no. 11-04-00799-a, http://www.rfbr.ru/rffi/eng/about), the Integration Project of the Siberian Branch of the Russian Academy of Sciences No. 55 (http://www.sbras.nsc.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chow JC, 2003, GENOMICS, V82, P309, DOI 10.1016/S0888-7543(03)00170-8; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Cleynen I, 2008, INT J ONCOL, V32, P289; Dementyeva EV, 2010, CHROMOSOMA, V119, P541, DOI 10.1007/s00412-010-0277-6; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Grunau C, 2000, NUCLEIC ACIDS RES, V28, P1053, DOI 10.1093/nar/28.5.1053; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hendrich BD, 1997, NUCLEIC ACIDS RES, V25, P2661, DOI 10.1093/nar/25.13.2661; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Kaczynski J, 2001, J BIOL CHEM, V276, P36749, DOI 10.1074/jbc.M105831200; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Komura J, 1997, J BIOL CHEM, V272, P10975; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Malin S, 2005, NUCLEIC ACIDS RES, V33, P4618, DOI 10.1093/nar/gki744; Mazurok N. A., 2003, Ontogenez, V34, P193; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; Migeon BR, 2001, AM J HUM GENET, V69, P951, DOI 10.1086/324022; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Nesterova TB, 2003, GENE DEV, V17, P2177, DOI 10.1101/gad.271203; NESTEROVA TB, 1994, CYTOGENET CELL GENET, V65, P250, DOI 10.1159/000133641; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Newall AET, 2001, HUM MOL GENET, V10, P581, DOI 10.1093/hmg/10.6.581; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Pillet N, 1995, P NATL ACAD SCI USA, V92, P12515, DOI 10.1073/pnas.92.26.12515; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; Quinlan KGR, 2006, MOL CELL BIOL, V26, P8159, DOI 10.1128/MCB.00680-06; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; RYAN WA, 1989, EMBO J, V8, P1785, DOI 10.1002/j.1460-2075.1989.tb03572.x; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Sheardown SA, 1997, GENE, V203, P159, DOI 10.1016/S0378-1119(97)00507-6; Shevchenko AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022771; Sierra F, 1993, GENE TRANSCRIPTION P, P127; Starmer J, 2009, DEVELOPMENT, V136, P1, DOI 10.1242/dev.025908; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Toth J, 2000, Nucleic Acids Res, V28, pe4, DOI 10.1093/nar/28.2.e4; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zakharova IS, 2009, CHROMOSOMA, V118, P279, DOI 10.1007/s00412-009-0206-8; ZAKIAN SM, 1987, GENET RES, V50, P23, DOI 10.1017/S0016672300023296; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou TY, 2002, NUCLEIC ACIDS RES, V30, P4145, DOI 10.1093/nar/gkf537	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33994	10.1371/journal.pone.0033994	http://dx.doi.org/10.1371/journal.pone.0033994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606223	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200005
J	Thomas, MG; Luchelli, L; Pascual, M; Gottifredi, V; Boccaccio, GL				Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela			A Monoclonal Antibody against p53 Cross-Reacts with Processing Bodies	PLOS ONE			English	Article							MESSENGER-RNA DECAY; STRESS GRANULES; CYTOPLASMIC SEQUESTRATION; DNA-DAMAGE; TUMOR-SUPPRESSOR; PROTEIN; ACTIVATION; PATHWAY; NEUROBLASTOMA; EXPRESSION	The p53 tumor suppressor protein is an important regulator of cell proliferation and apoptosis. p53 can be found in the nucleus and in the cytosol, and the subcellular location is key to control p53 function. In this work, we found that a widely used monoclonal antibody against p53, termed Pab 1801 (Pan antibody 1801) yields a remarkable punctate signal in the cytoplasm of several cell lines of human origin. Surprisingly, these puncta were also observed in two independent p53-null cell lines. Moreover, the foci stained with the Pab 1801 were present in rat cells, although Pab 1801 recognizes an epitope that is not conserved in rodent p53. In contrast, the Pab 1801 nuclear staining corresponded to genuine p53, as it was upregulated by p53-stimulating drugs and absent in p53-null cells. We identified the Pab 1801 cytoplasmic puncta as P Bodies (PBs), which are involved in mRNA regulation. We found that, in several cell lines, including U2OS, WI38, SK-N-SH and HCT116, the Pab 1801 puncta strictly colocalize with PBs identified with specific antibodies against the PB components Hedls, Dcp1a, Xrn1 or Rck/p54. PBs are highly dynamic and accordingly, the Pab 1801 puncta vanished when PBs dissolved upon treatment with cycloheximide, a drug that causes polysome stabilization and PB disruption. In addition, the knockdown of specific PB components that affect PB integrity simultaneously caused PB dissolution and the disappearance of the Pab 1801 puncta. Our results reveal a strong cross-reactivity of the Pab 1801 with unknown PB component(s). This was observed upon distinct immunostaining protocols, thus meaning a major limitation on the use of this antibody for p53 imaging in the cytoplasm of most cell types of human or rodent origin.	[Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] Inst Leloir, Buenos Aires, DF, Argentina; [Gabriela Thomas, Maria; Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] IIBBA CONICET, Buenos Aires, DF, Argentina; [Luchelli, Luciana; Pascual, Malena; Gottifredi, Vanesa; Lidia Boccaccio, Graciela] Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Thomas, MG (corresponding author), Inst Leloir, Av Patricias Argentinas, Buenos Aires, DF, Argentina.	mthomas@leloir.org.ar	Gottifredi, Vanesa/AAI-1788-2019	Gottifredi, Vanesa/0000-0001-9656-5951	University of Buenos Aires (UBA), Argentina [UBACyT X311]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) [PIP 205-2011-2013]; Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina [PICT 2010-2339, PICT 2008-0133, PICT 2011-1850]; Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnologicas	University of Buenos Aires (UBA), Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas	UBACyT X311 to GLB from University of Buenos Aires (UBA), Argentina; PIP 205-2011-2013 from the Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET) to MGT; PICT 2010-2339, PICT 2008-0133 and PICT 2011-1850 from the Agencia Nacional de Promocion Cientifica y Tecnologica, (ANPCyT), Argentina, to MGT, VG and GLB, respectively.Universidad de Buenos Aires http://www.uba.ar/homepage.php Agencia Nacional de Promocion Cientifica y Tecnologica: http://www.agencia.gov.ar/index.php Consejo Nacional de Investigaciones Cientificas y Tecnologicas: http://www.conicet.gov.ar/web/conicet/inicio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Baez MV, 2005, J BIOL CHEM, V280, P43131, DOI 10.1074/jbc.M508374200; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; Becker K, 2007, CELL DEATH DIFFER, V14, P1350, DOI 10.1038/sj.cdd.4402126; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cougot N, 2008, J NEUROSCI, V28, P13793, DOI 10.1523/JNEUROSCI.4155-08.2008; Dekanty A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000994; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Thomas MG, 2009, J CELL SCI, V122, P563, DOI 10.1242/jcs.038208; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; LEGROS Y, 1994, ONCOGENE, V9, P2071; Lin DL, 1996, J BIOL CHEM, V271, P14649, DOI 10.1074/jbc.271.25.14649; Loschi M, 2009, J CELL SCI, V122, P3973, DOI 10.1242/jcs.051383; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804; Rzeczkowski K, 2011, J CELL BIOL, V194, P581, DOI 10.1083/jcb.201006089; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; STEPHEN CW, 1992, J MOL BIOL, V225, P577, DOI 10.1016/0022-2836(92)90386-X; Takahashi S, 2011, NUCLEIC ACIDS RES, V39, P3446, DOI 10.1093/nar/gkq1302; Thomas MG, 2005, MOL BIOL CELL, V16, P405, DOI 10.1091/mbc.E04-06-0516; Baez MV, 2011, J CELL BIOL, V195, P1141, DOI 10.1083/jcb.201108159; VOJTESEK B, 1992, J IMMUNOL METHODS, V151, P237, DOI 10.1016/0022-1759(92)90122-A; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; Wang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013459; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36447	10.1371/journal.pone.0036447	http://dx.doi.org/10.1371/journal.pone.0036447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590546	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400016
J	van den Berg, G; van Eijsden, M; Vrijkotte, TGM; Gemke, RJBJ				van den Berg, Gerrit; van Eijsden, Manon; Vrijkotte, Tanja G. M.; Gemke, Reinoud J. B. J.			Educational Inequalities in Perinatal Outcomes: The Mediating Effect of Smoking and Environmental Tobacco Exposure	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; LOW-BIRTH-WEIGHT; MATERNAL CIGARETTE-SMOKING; SOCIOECONOMIC-STATUS; PRETERM BIRTH; SOCIAL-CLASS; PASSIVE SMOKING; RISK-FACTORS; PREGNANCY; HEALTH	Objective: Socioeconomic status (SES) is adversely associated with perinatal outcomes. This association is likely to be mediated by tobacco exposure. However, previous studies were limited to single perinatal outcomes and devoted no attention to environmental tobacco exposure. Therefore, this study aimed firstly to explain the role of maternal smoking in the association between maternal education and preterm birth (PTB), low birth weight (LBW) and small for gestational age (SGA), and secondly to explain whether environmental tobacco smoke mediates these associations further. Study Design: This study was nested in a population-based cohort study in the Netherlands, the Amsterdam Born Children and their Development (ABCD) study. Analyses were done in a sample of 3821 pregnant women of Dutch origin, using logistic regression analysis. Results: Least educated women, who were more often smoking and exposed to environmental tobacco smoke, had a significantly higher risk of PTB (OR 1.95 [95% CI: 1.19-3.20]), LBW (OR 2.41 [95% CI: 1.36-4.27]) and SGA (OR 1.90 [95% CI 1.32-2.74]) than highly educated women. The mediating effect of smoking in the least educated women was 43% for PTB, 55% for LBW and 66% for SGA. Environmental tobacco smoke did not explain these associations further. After adjustment for maternal smoking, the association between lower maternal education and pregnancy outcomes was no longer significant. Conclusions: Smoking explains to a considerable extent the association between lower maternal education and adverse perinatal outcomes. Therefore, tobacco-interventions in lower educated women should be primarily focussed on maternal smoking to reduce PTB, LBW, and SGA. Additional attention to environmental tobacco exposure does not seem to reduce educational inequalities in perinatal outcomes.	[van den Berg, Gerrit; Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands; [van den Berg, Gerrit; van Eijsden, Manon] Publ Hlth Serv, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [van Eijsden, Manon] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Public Health Service Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Berg, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands.	g.vandenberg@vumc.nl		Vrijkotte, Tanja/0000-0003-3641-4048				Auger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-237; Barker DJP, 1998, MOTHERS BABIES HLTH; Beard JR, 2009, ACTA OBSTET GYN SCAN, V88, P575, DOI 10.1080/00016340902818170; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Bolte G, 2009, EUR J PUBLIC HEALTH, V19, P52, DOI 10.1093/eurpub/ckn114; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; BURTON GJ, 1989, BRIT J OBSTET GYNAEC, V96, P907, DOI 10.1111/j.1471-0528.1989.tb03344.x; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; CNATTINGIUS S, 1992, J EPIDEMIOL COMMUN H, V46, P218, DOI 10.1136/jech.46.3.218; de la Chica RA, 2005, JAMA-J AM MED ASSOC, V293, P1212, DOI 10.1001/jama.293.10.1212; DESANJOSE S, 1991, J EPIDEMIOL COMMUN H, V45, P207, DOI 10.1136/jech.45.3.207; Fairley L, 2006, J EPIDEMIOL COMMUN H, V60, P31, DOI 10.1136/jech.2005.038380; Fantuzzi G, 2008, J MATERN-FETAL NEO M, V21, P643, DOI 10.1080/14767050802203744; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Gilman SE, 2008, INT J EPIDEMIOL, V37, P615, DOI 10.1093/ije/dym250; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Gissler M, 2009, J EPIDEMIOL COMMUN H, V63, P420, DOI 10.1136/jech.2008.079921; Hammoud AO, 2005, AM J OBSTET GYNECOL, V192, P1856, DOI 10.1016/j.ajog.2004.12.057; Jansen PW, 2009, ARCH DIS CHILD-FETAL, V94, pF28, DOI 10.1136/adc.2007.136945; Jansen PW, 2009, PAEDIATR PERINAT EP, V23, P216, DOI 10.1111/j.1365-3016.2009.01023.x; Joseph KS, 2007, CAN MED ASSOC J, V177, P583, DOI 10.1503/cmaj.061198; Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Lanting CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008363; LEHTOVIRTA P, 1978, BRIT J OBSTET GYNAEC, V85, P729, DOI 10.1111/j.1471-0528.1978.tb15592.x; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Meyer S, 2009, EUR J OBSTET GYN R B, V146, P37, DOI 10.1016/j.ejogrb.2009.05.031; Misra DP, 1999, ENVIRON HEALTH PERSP, V107, P897, DOI 10.2307/3434572; Morgen CS, 2008, INT J EPIDEMIOL, V37, P1109, DOI 10.1093/ije/dyn112; MORRISON JC, 1990, OBSTET GYNECOL, V76, pS5; Pattenden S, 1999, J EPIDEMIOL COMMUN H, V53, P355, DOI 10.1136/jech.53.6.355; Puga Beatriz, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P358; Schiaffino A, 2003, EUR J PUBLIC HEALTH, V13, P56, DOI 10.1093/eurpub/13.1.56; Secker-Walker RH, 2003, ADDICT BEHAV, V28, P55, DOI 10.1016/S0306-4603(01)00216-7; Spencer N, 1999, J EPIDEMIOL COMMUN H, V53, P495, DOI 10.1136/jech.53.8.495; Steyn K, 2006, PAEDIATR PERINAT EP, V20, P90, DOI 10.1111/j.1365-3016.2006.00707.x; Thompson JMD, 2001, J PAEDIATR CHILD H, V37, P369, DOI 10.1046/j.1440-1754.2001.00684.x; Tikkanen M, 2010, ACTA OBSTET GYN SCAN, V89, P1538, DOI 10.3109/00016349.2010.526187; Tromp M, 2009, PAEDIATR PERINAT EP, V23, P264, DOI 10.1111/j.1365-3016.2009.01030.x; van Eijsden M, 2010, INT J EPIDEMIOL; Villalbi JR, 2007, PAEDIATR PERINAT EP, V21, P441, DOI 10.1111/j.1365-3016.2007.00845.x; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195	45	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37002	10.1371/journal.pone.0037002	http://dx.doi.org/10.1371/journal.pone.0037002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TN	22590643	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400052
J	Chen, HC; Zhu, YT; Chen, SY; Tseng, SCG				Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.			Selective Activation of p120(ctn)-Kaiso Signaling to Unlock Contact Inhibition of ARPE-19 Cells without Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; BETA-CATENIN; P120 CATENIN; PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; NUCLEAR-LOCALIZATION; CADHERIN EXPRESSION; ENDOTHELIAL-CELLS; RISK-FACTORS; RHO-GTPASES	Contact-inhibition ubiquitously exists in non-transformed cells and explains the poor regenerative capacity of in vivo human retinal pigment epithelial cells (RPE) during aging, injury and diseases. RPE injury or degeneration may unlock mitotic block mediated by contact inhibition but may also promote epithelial-mesenchymal transition (EMT) contributing to retinal blindness. Herein, we confirmed that EMT ensued in post-confluent ARPE-19 cells when contact inhibition was disrupted with EGTA followed by addition of EGF and FGF-2 because of activation of canonical Wnt and Smad/ZEB signaling. In contrast, knockdown of p120-catenin (p120) unlocked such mitotic block by activating p120/Kaiso, but not activating canonical Wnt and Smad/ZEB signaling, thus avoiding EMT. Nuclear BrdU labeling was correlated with nuclear release of Kaiso through p120 nuclear translocation, which was associated with activation of RhoA-ROCK signaling, destabilization of microtubules. Prolonged p120 siRNA knockdown followed by withdrawal further expanded RPE into more compact monolayers with a normal phenotype and a higher density. This new strategy based on selective activation of p120/Kaiso but not Wnt/beta-catenin signaling obviates the need of using single cells and the risk of EMT, and may be deployed to engineer surgical grafts containing RPE and other tissues.	[Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.] Tissue Tech Inc, Ocular Surface Ctr, Miami, FL USA; [Chen, Hung-Chi; Zhu, Ying-Ting; Chen, Szu-Yu; Tseng, Scheffer C. G.] Ocular Surface Res & Educ Fdn, Miami, FL USA; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, HC (corresponding author), Tissue Tech Inc, Ocular Surface Ctr, Miami, FL USA.	stseng@ocularsurface.com		Zhu, Yingting/0000-0002-3332-9713	National Eye Institute, National Institutes of Health, Bethesda, MD, USA [R43 EY022502]; TissueTech, Inc., Miami, FL; Chang Gung Memorial Hospital [CMRPG-340191]; National Science Council in Taiwan [NSC100-2918-I-182A-001]; Tissue Tech Inc; NATIONAL EYE INSTITUTE [R01EY006819, R43EY022502] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); TissueTech, Inc., Miami, FL; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Tissue Tech Inc; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by R43 EY022502 from the National Eye Institute, National Institutes of Health, Bethesda, MD, USA (Zhu YT and Tseng SCG), a research grant from TissueTech, Inc., Miami, FL, and a grant from Chang Gung Memorial Hospital (CMRPG-340191) and National Science Council (NSC100-2918-I-182A-001) in Taiwan (Chen HC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: All authors are employed by Tissue Tech Inc, who provided a research grant for this study. Tseng SCG has filed a patent (12/446,740" and published as "2010-0003299'' on 1/7/10) on the method of isolation, preservation and expansion of human corneal endothelial cells and other cells by transient knockdown of cell junction proteins via p120 siRNA. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Ban Y, 1997, Mol Vis, V3, P18; Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002; Bovolenta P, 2009, NAT NEUROSCI, V12, P5, DOI 10.1038/nn0109-5; Daniel JM, 2007, BBA-MOL CELL RES, V1773, P59, DOI 10.1016/j.bbamcr.2006.08.052; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Ferreri DM, 2008, CELL COMMUN ADHES, V15, P333, DOI 10.1080/15419060802440377; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Hinterhuber G, 2004, J INVEST DERMATOL, V122, P406, DOI 10.1046/j.0022-202X.2004.22216.x; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7; Ichii T, 2007, GENES CELLS, V12, P827, DOI 10.1111/j.1365-2443.2007.01095.x; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Itoh Y, 2007, EXP EYE RES, V84, P464, DOI 10.1016/j.exer.2006.10.017; Iyer S, 2004, AM J PHYSIOL-LUNG C, V286, pL1143, DOI 10.1152/ajplung.00305.2003; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; Nagasaki H, 1998, PROG RETIN EYE RES, V17, P77, DOI 10.1016/S1350-9462(97)00007-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ogden SR, 2008, MOL BIOL CELL, V19, P4110, DOI 10.1091/mbc.E08-03-0283; OKAMI T, 1990, J HISTOCHEM CYTOCHEM, V38, P1267, DOI 10.1177/38.9.2167328; Parapuram SK, 2009, INVEST OPHTH VIS SCI, V50, P5965, DOI 10.1167/iovs.09-3621; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saika Shizuya, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P69, DOI 10.2174/187153008783928343; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang JH, 2010, MICROVASC RES, V80, P233, DOI 10.1016/j.mvr.2010.04.001; Zhu YT, 2012, J CELL SCI IN PRESS	62	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36864	10.1371/journal.pone.0036864	http://dx.doi.org/10.1371/journal.pone.0036864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590627	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100068
J	Maniaol, AH; Elsais, A; Lorentzen, AR; Owe, JF; Viken, MK; Saether, H; Flam, ST; Brathen, G; Kampman, MT; Midgard, R; Christensen, M; Rognerud, A; Kerty, E; Gilhus, NE; Tallaksen, CME; Lie, BA; Harbo, HF				Maniaol, Angelina H.; Elsais, Ahmed; Lorentzen, Aslaug R.; Owe, Jone F.; Viken, Marte K.; Saether, Hanne; Flam, Siri T.; Brathen, Geir; Kampman, Margitta T.; Midgard, Rune; Christensen, Marte; Rognerud, Anna; Kerty, Emilia; Gilhus, Nils Erik; Tallaksen, Chantal M. E.; Lie, Benedicte A.; Harbo, Hanne F.			Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population	PLOS ONE			English	Article							ANTI-TITIN ANTIBODIES; A ANTIGENS; ACETYLCHOLINE-RECEPTOR; THYMUS HYPERPLASIA; MULTIPLE-SCLEROSIS; HETEROGENEITY; SUSCEPTIBILITY; AUTOANTIBODIES; HAPLOTYPES; THYMOMA	Background: Acquired myasthenia gravis (MG) is a rare antibody-mediated autoimmune disease caused by impaired neuromuscular transmission, leading to abnormal muscle fatigability. The aetiology is complex, including genetic risk factors of the human leukocyte antigen (HLA) complex and unknown environmental factors. Although associations between the HLA complex and MG are well established, not all involved components of the HLA predisposition to this heterogeneous disease have been revealed. Well-powered and comprehensive HLA analyses of subgroups in MG are warranted, especially in late onset MG. Methodology/Principal Findings: This case-control association study is of a large population-based Norwegian cohort of 369 MG patients and 651 healthy controls. We performed comprehensive genotyping of four classical HLA loci (HLA-A, -B, -C and -DRB1) and showed that the DRB1*15:01 allele conferred the strongest risk in late onset MG (LOMG; onset >= 60years) (OR 2.38, p(c)7.4 x 10(-5)). DRB*13:01 was found to be a protective allele for both early onset MG (EOMG) and LOMG (OR 0.31, p(c) 4.71 x 10(-4)), a finding not previously described. No significant association was found to the DRB1*07:01 allele (p(nc) = 0.18) in a subset of nonthymomatous anti-titin antibody positive LOMG as reported by others. HLA-B*08 was mapped to give the strongest contribution to EOMG, supporting previous studies. Conclusion: The results from this study provide important new information concerning the susceptibility of HLA alleles in Caucasian MG, with highlights on DRB1*15:01 as being a major risk allele in LOMG.	[Maniaol, Angelina H.; Lorentzen, Aslaug R.; Saether, Hanne; Tallaksen, Chantal M. E.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Elsais, Ahmed; Kerty, Emilia] Oslo Univ Hosp, Dept Neurol, Rikshosp, Oslo, Norway; [Maniaol, Angelina H.; Lorentzen, Aslaug R.; Viken, Marte K.; Saether, Hanne; Flam, Siri T.; Lie, Benedicte A.] Oslo Univ Hosp, Dept Immunol, Rikshosp, Oslo, Norway; [Owe, Jone F.; Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Brathen, Geir] St Olavs Hosp, Dept Neurol, Trondheim, Norway; [Kampman, Margitta T.] Univ Hosp N Norway, Ctr Clin Res & Educ, Tromso, Norway; [Midgard, Rune] Molde Hosp, Dept Neurol, Molde, Norway; [Christensen, Marte] Stavanger Univ Hosp, Dept Neurol, Stavanger, Norway; [Rognerud, Anna] Lillehammer Hosp, Dept Neurol, Lillehammer, Norway; [Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Viken, Marte K.; Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Elsais, Ahmed; Kerty, Emilia; Tallaksen, Chantal M. E.; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Kampman, Margitta T.] Univ Tromso, Dept Clin Med, Tromo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; Stavanger University Hospital; University of Bergen; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Maniaol, AH (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	angman@ous-hf.no	Bråthen, Geir/H-9125-2016	Bråthen, Geir/0000-0003-3224-7983; Viken, Marte Kathrine/0000-0002-3917-9269; Midgard, Rune/0000-0002-6096-726X	South-Eastern Norway Regional Health Authority; Norwegian Association for Patients with Muscle Diseases (Foreningen for Muskelsyke); Odd Fellow Society, Norway	South-Eastern Norway Regional Health Authority; Norwegian Association for Patients with Muscle Diseases (Foreningen for Muskelsyke); Odd Fellow Society, Norway	The study was funded by the South-Eastern Norway Regional Health Authority and partly by grants from the Norwegian Association for Patients with Muscle Diseases (Foreningen for Muskelsyke) and Odd Fellow Society, Norway, all to AHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 2003, ANN NY ACAD SCI, V998, P424, DOI 10.1196/annals.1254.055; Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Aarli JA, 2008, ANN NY ACAD SCI, V1132, P238, DOI 10.1196/annals.1405.040; CARLSSON B, 1990, IMMUNOGENETICS, V31, P285, DOI 10.1007/BF02115001; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; COMPSTON DAS, 1980, BRAIN, V103, P579, DOI 10.1093/brain/103.3.579; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V35, P355; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Evoli A, 2002, NEUROLOGY, V59, P1844, DOI 10.1212/01.WNL.0000032502.89361.0C; Evoli A, 2000, J AM GERIATR SOC, V48, P1442, DOI 10.1111/j.1532-5415.2000.tb02635.x; FELTKAMP TE, 1974, BMJ-BRIT MED J, V1, P131, DOI 10.1136/bmj.1.5899.131; FRITZE D, 1974, LANCET, V1, P240; Gilhus NE, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/847393; Giraud M, 2001, NEUROLOGY, V57, P1555, DOI 10.1212/WNL.57.9.1555; Giraud M, 2008, ANN NY ACAD SCI, V1132, P180, DOI 10.1196/annals.1405.027; HAMMARSTROM L, 1975, CLIN EXP IMMUNOL, V21, P202; Hjelmstrom P, 1995, AUTOIMMUNITY, V22, P59, DOI 10.3109/08916939508995300; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Janer M, 1999, HUM IMMUNOL, V60, P909, DOI 10.1016/S0198-8859(99)00062-2; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Keesey JC, 2004, MUSCLE NERVE, V29, P484, DOI 10.1002/mus.20030; KIDA K, 1987, ANN NEUROL, V21, P274, DOI 10.1002/ana.410210309; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Lorentzen AR, 2009, ANN NEUROL, V65, P658, DOI 10.1002/ana.21695; Machens A, 1999, CLIN IMMUNOL, V91, P296, DOI 10.1006/clim.1999.4710; Machens A, 1998, J NEUROIMMUNOL, V88, P177, DOI 10.1016/S0165-5728(98)00120-9; Maverakis E, 2012, CLIN REV ALLERG IMMU, V42, P135, DOI 10.1007/s12016-010-8248-5; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; NEWSOMDAVIS J, 1987, ANN NY ACAD SCI, V505, P12; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; OOSTERHUIS HJGH, 1981, CLIN NEUROL NEUROSUR, V83, P105, DOI 10.1016/0303-8467(81)90014-7; OSSERMAN KE, 1971, MT SINAI J MED, V38, P497; PIRSKANEN R, 1976, J NEUROL NEUROSUR PS, V39, P23, DOI 10.1136/jnnp.39.1.23; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Romi F, 2000, J NEUROL, V247, P369, DOI 10.1007/s004150050604; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; SPURKLAND A, 1991, TISSUE ANTIGENS, V37, P90, DOI 10.1111/j.1399-0039.1991.tb01851.x; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Valdes AM, 1997, AM J HUM GENET, V60, P703; VANDENBERGLOONEN EM, 1977, J IMMUNOGENET, V4, P331; Vandiedonck C, 2004, P NATL ACAD SCI USA, V101, P15464, DOI 10.1073/pnas.0406756101; Vandiedonck C, 2009, J NEUROIMMUNOL, V210, P120, DOI 10.1016/j.jneuroim.2009.02.004; VIEIRA ML, 1993, J NEUROIMMUNOL, V47, P115, DOI 10.1016/0165-5728(93)90021-P; Vincent A, 2003, LANCET NEUROL, V2, P99, DOI 10.1016/S1474-4422(03)00306-5; VINCENT A, 1994, ADV NEUROIMMUNOL, V4, P355, DOI 10.1016/0960-5428(94)00041-L; Yamamoto AM, 2001, ARCH NEUROL-CHICAGO, V58, P885, DOI 10.1001/archneur.58.6.885	47	86	87	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36603	10.1371/journal.pone.0036603	http://dx.doi.org/10.1371/journal.pone.0036603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590574	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100045
J	Tiddi, B; Aureli, F; Schino, G				Tiddi, Barbara; Aureli, Filippo; Schino, Gabriele			Grooming Up the Hierarchy: The Exchange of Grooming and Rank-Related Benefits in a New World Primate	PLOS ONE			English	Article							FEMALE SOCIAL RELATIONSHIPS; BROWN CAPUCHIN MONKEYS; INDIVIDUAL SPATIAL CHOICE; WHITE-FACED CAPUCHINS; CEBUS-APELLA-NIGRITUS; AGONISTIC SUPPORT; RECIPROCAL ALTRUISM; COALITION-FORMATION; JAPANESE MACAQUES; RECEPTOR BLOCKADE	Seyfarth's model assumes that female primates derive rank-related benefits from higher-ranking females in exchange for grooming. As a consequence, the model predicts females prefer high-ranking females as grooming partners and compete for the opportunity to groom them. Therefore, allogrooming is expected to be directed up the dominance hierarchy and to occur more often between females with adjacent ranks. Although data from Old World primates generally support the model, studies on the relation between grooming and dominance rank in the New World genus Cebus have found conflicting results, showing considerable variability across groups and species. In this study, we investigated the pattern of grooming in wild tufted capuchin females (Cebus apella nigritus) in Iguazu National Park, Argentina by testing both the assumption (i.e., that females gain rank-related return benefits from grooming) and predictions (i.e., that females direct grooming up the dominance hierarchy and the majority of grooming occurs between females with adjacent ranks) of Seyfarth's model. Study subjects were 9 adult females belonging to a single group. Results showed that grooming was given in return for tolerance during naturally occurring feeding, a benefit that higher-ranking females can more easily grant. Female grooming was directed up the hierarchy and was given more often to partners with similar rank. These findings provide supporting evidence for both the assumption and predictions of Seyfarth's model and represent, more generally, the first evidence of reciprocal behavioural interchanges driven by rank-related benefits in New World female primates.	[Tiddi, Barbara] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Tiddi, Barbara] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Aureli, Filippo] Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico; [Schino, Gabriele] CNR, Ist Sci & Tecnol Cogniz, Rome, Italy	Deutsches Primatenzentrum (DPZ); Liverpool John Moores University; Universidad Veracruzana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Tiddi, B (corresponding author), German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany.	batiddi@gmail.com	Schino, Gabriele/B-7569-2015	Schino, Gabriele/0000-0002-5011-4896; Aureli, Filippo/0000-0002-0671-013X	University of Rome "La Sapienza.''	University of Rome "La Sapienza.''	Funding was provided by the University of Rome "La Sapienza.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2009, FIXED EFFECT REGRESS; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; BROWN AD, 1990, FOLIA PRIMATOL, V54, P187, DOI 10.1159/000156443; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEVRIES H, 1993, BEHAVIOUR, V125, P157, DOI 10.1163/156853993X00218; DEWAAL FBM, 1986, ANIM BEHAV, V34, P1033, DOI 10.1016/S0003-3472(86)80162-2; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Di Bitetti MS, 2001, INT J PRIMATOL, V22, P127, DOI 10.1023/A:1005611228927; DiBitetti MS, 1997, ANIM BEHAV, V54, P199, DOI 10.1006/anbe.1996.0416; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; FEDIGAN L, 1993, INT J PRIMATOL, V14, P853, DOI 10.1007/BF02220256; FRAGASZY D, 1994, INT J PRIMATOL, V15, P399, DOI 10.1007/BF02696101; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Henzi SP, 2007, ADV STUD BEHAV, V37, P43, DOI 10.1016/S0065-3454(07)37002-2; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Izar P, 2004, BEHAVIOUR, V141, P71, DOI 10.1163/156853904772746619; JANSON CH, 1986, NAT HIST, V95, P44; JANSON CH, 1990, ANIM BEHAV, V40, P910, DOI 10.1016/S0003-3472(05)80993-5; Janson CH, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P309; JANSON CH, 1990, ANIM BEHAV, V40, P922, DOI 10.1016/S0003-3472(05)80994-7; JANSON CH, 1984, Z TIERPSYCHOL, V65, P177; Janson Charles, 2012, P185; Kapsalis E, 1996, BEHAVIOUR, V133, P1235, DOI 10.1163/156853996X00387; KEVERNE EB, 1989, PSYCHONEUROENDOCRINO, V14, P155, DOI 10.1016/0306-4530(89)90065-6; MARTEL FL, 1995, DEV PSYCHOBIOL, V28, P71, DOI 10.1002/dev.420280202; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mitani JC, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P107, DOI 10.1007/3-540-28277-7_6; OBRIEN TG, 1993, ANIM BEHAV, V46, P499, DOI 10.1006/anbe.1993.1218; Parr LA, 1997, ANIM BEHAV, V54, P361, DOI 10.1006/anbe.1996.0419; Perez A, 2000, INT J PRIMATOL, V21, P255, DOI 10.1023/A:1005425520658; Perry S, 1996, AM J PRIMATOL, V40, P167, DOI 10.1002/(SICI)1098-2345(1996)40:2<167::AID-AJP4>3.0.CO;2-W; Perry S, 2008, ANIM BEHAV, V76, P187, DOI 10.1016/j.anbehav.2008.01.020; Schino G, 2001, ANIM BEHAV, V62, P265, DOI 10.1006/anbe.2001.1750; SCHINO G, 1992, BRAIN RES, V576, P125, DOI 10.1016/0006-8993(92)90617-I; Schino G, 2008, BIOL J LINN SOC, V95, P439, DOI 10.1111/j.1095-8312.2008.01067.x; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schino G, 2009, AM J PRIMATOL, V71, P101, DOI 10.1002/ajp.20627; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; SEYFARTH RM, 1980, ANIM BEHAV, V28, P798, DOI 10.1016/S0003-3472(80)80140-0; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Silk JB, 2004, ANIM BEHAV, V67, P573, DOI 10.1016/j.anbehav.2003.07.001; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Tiddi B, 2011, AM J PRIMATOL, V73, P812, DOI 10.1002/ajp.20939; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314	53	43	45	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36641	10.1371/journal.pone.0036641	http://dx.doi.org/10.1371/journal.pone.0036641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590582	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305335500023
J	Samocha-Bonet, D; Campbell, LV; Mori, TA; Croft, KD; Greenfield, JR; Turner, N; Heilbronn, LK				Samocha-Bonet, Dorit; Campbell, Lesley V.; Mori, Trevor A.; Croft, Kevin D.; Greenfield, Jerry R.; Turner, Nigel; Heilbronn, Leonie K.			Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans	PLOS ONE			English	Article							HIGH-FAT DIET; SKELETAL-MUSCLE; RESISTANCE; CAPACITY; ASSOCIATION; METABOLISM; EXPRESSION; PROTEIN; GENES; RATS	Background: Mitochondrial dysfunction and increased oxidative stress are associated with obesity and type 2 diabetes. High fat feeding induces insulin resistance and increases skeletal muscle oxidative stress in rodents, but there is controversy as to whether skeletal muscle mitochondrial biogenesis and function is altered. Methodology and Principal Findings: Forty (37 +/- 2 y) non-obese (25.6 +/- 0.6 kg/m(2)) sedentary men (n = 20) and women (n = 20) were overfed (+1040 +/- 100 kcal/day, 46 +/- 1% of energy from fat) for 28 days. Hyperinsulinemic-euglycemic clamps were performed at baseline and day 28 of overfeeding and skeletal muscle biopsies taken at baseline, day 3 and day 28 of overfeeding in a sub cohort of 26 individuals (13 men and 13 women) that consented to having all 3 biopsies performed. Weight increased on average in the whole cohort by 0.6 +/- 0.1 and 2.7 +/- 0.3 kg at days 3 and 28, respectively (P<0.0001, without a significant difference in the response between men and women (P=0.4). Glucose infusion rate during the hyperinsulinemic-euglycemic clamp decreased from 54.8 +/- 2.8 at baseline to 50.3 +/- 2.5 mu mol/min/kg FFM at day 28 of overfeeding (P=0.03) without a significant difference between men and women (P=0.4). Skeletal muscle protein carbonyls and urinary F2-isoprostanes increased with overfeeding (P<0.05). Protein levels of muscle peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC1 alpha) and subunits from complex I, II and V of the electron transport chain were increased at day 3 (all P<0.05) and returned to basal levels at day 28. No changes were detected in muscle citrate synthase activity or ex vivo CO2 production at either time point. Conclusions: Peripheral insulin resistance was induced by overfeeding, without reducing any of the markers of mitochondrial content that were examined. Oxidative stress was however increased, and may have contributed to the reduction in insulin sensitivity observed.	[Samocha-Bonet, Dorit; Campbell, Lesley V.; Greenfield, Jerry R.; Turner, Nigel; Heilbronn, Leonie K.] St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia; [Samocha-Bonet, Dorit; Campbell, Lesley V.; Greenfield, Jerry R.; Turner, Nigel] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Mori, Trevor A.; Croft, Kevin D.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Heilbronn, Leonie K.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Western Australia; University of Adelaide	Samocha-Bonet, D (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Diabet & Obes Program, Darlinghurst, NSW 2010, Australia.	leonie.heilbronn@adelaide.edu.au	Turner, Nigel/H-7176-2013; Croft, Kevin D/C-4675-2013; Heilbronn, Leonie K/H-1874-2013; Mori, Trevor/H-5485-2014	Turner, Nigel/0000-0002-0119-9328; Heilbronn, Leonie K/0000-0003-2106-7303; Mori, Trevor/0000-0002-5264-9229; Croft, Kevin/0000-0003-1596-4913; Samocha-Bonet, Dorit/0000-0001-9422-7852	National Health and Medical Research Council Australia (NHMRC); Australian Diabetes Society (ADS)	National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Diabetes Society (ADS)	The study was funded by the National Health and Medical Research Council Australia (NHMRC), LKH and NT were supported by NHMRC Career Development Award, JRG by NHMRC Neil Hamilton Fairley Fellowship and DS-B by the Australian Diabetes Society (ADS) Skip Martin Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bachmann OP, 2001, DIABETES, V50, P2579, DOI 10.2337/diabetes.50.11.2579; Boyle KE, 2011, J CLIN ENDOCR METAB, V96, P775, DOI 10.1210/jc.2010-2253; Brehm A, 2010, AM J PHYSIOL-ENDOC M, V299, pE33, DOI 10.1152/ajpendo.00756.2009; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; Gregersen S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/238056; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Heilbronn LK, 2007, J CLIN ENDOCR METAB, V92, P1467, DOI 10.1210/jc.2006-2210; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iossa S, 2002, PFLUG ARCH EUR J PHY, V445, P431, DOI 10.1007/s00424-002-0964-0; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Meigs JB, 2007, DIABETES CARE, V30, P2529, DOI 10.2337/dc07-0817; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Mori TA, 1999, ANAL BIOCHEM, V268, P117, DOI 10.1006/abio.1998.3037; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Samocha-Bonet D, 2010, DIABETOLOGIA, V53, P1700, DOI 10.1007/s00125-010-1768-y; Samocha-Bonet D, 2010, TRENDS ENDOCRIN MET, V21, P83, DOI 10.1016/j.tem.2009.09.008; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tam CS, 2010, DIABETES, V59, P2164, DOI 10.2337/db10-0162; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wijers SLJ, 2010, J PROTEOME RES, V9, P2226, DOI 10.1021/pr9010074	34	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36320	10.1371/journal.pone.0036320	http://dx.doi.org/10.1371/journal.pone.0036320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586466	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000028
J	Sander, G; Borner, T; Kriegeskorte, A; von Eiff, C; Becker, K; Mahabir, E				Sander, Gunnar; Boerner, Tina; Kriegeskorte, Andre; von Eiff, Christof; Becker, Karsten; Mahabir, Esther			Catheter Colonization and Abscess Formation Due to Staphylococcus epidermidis with Normal and Small-Colony-Variant Phenotype Is Mouse Strain Dependent	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INFECTION MODEL; HEMB MUTANT; BIOFILM FORMATION; SLIME PRODUCTION; MEDICAL DEVICES; IN-VIVO; AUREUS; MICE; VIRULENCE	Coagulase-negative staphylococci (CoNS) form a thick, multilayered biofilm on foreign bodies and are a major cause of nosocomial implant-associated infections. Although foreign body infection models are well-established, limited in vivo data are available for CoNS with small-colony-variant (SCV) phenotype described as causative agents in implant-associated infections. Therefore, we investigated the impact of the Staphylococcus epidermidis phenotype on colonization of implanted PVC catheters and abscess formation in three different mouse strains. Following introduction of a catheter subcutaneously in each flank of 8- to 12-week-old inbred C57BL/6JCrl (B6J), outbred Crl:CD1(ICR) (CD-1), and inbred BALB/cAnNCrl (BALB/c) male mice, doses of S. epidermidis O-47 wild type, its hemB mutant with stable SCV phenotype, or its complemented mutant at concentrations of 10(6) to 10(9) colony forming units (CFUs) were gently spread onto each catheter. On day 7, mice were sacrificed and the size of the abscesses as well as bacterial colonization was determined. A total of 11,500 CFUs of the complemented mutant adhered to the catheter in BALB/c followed by 9,960 CFUs and 9,900 CFUs from S. epidermidis wild type in BALB/c and CD-1, respectively. SCV colonization was highest in CD-1 with 9,500 CFUs, whereas SCVs were not detected in B6J. The minimum dose that led to colonization or abscess formation in all mouse strains was 10(7) or 10(8) CFUs of the normal phenotype, respectively. A minimum dose of 10(8) or 10(9) CFU of the hemB mutant with stable SCV phenotype led to colonization only or abscess formation, respectively. The largest abscesses were detected in BALB/c inoculated with wild type bacteria or SCV (64 mm(2) vs. 28 mm(2)). Our results indicate that colonization and abscess formation by different phenotypes of S. epidermidis in a foreign body infection model is most effective in inbred BALB/c followed by outbred CD-1 and inbred B6J mice.	[Sander, Gunnar; Boerner, Tina; Mahabir, Esther] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Kriegeskorte, Andre; von Eiff, Christof; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany	University of Cologne; University of Munster	Sander, G (corresponding author), Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany.	gunnar.sander@uk-koeln.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341	Center for Molecular Medicine, University of Cologne (CMMC); Bundesministerium fur Bildung und Forschung (BMBF), Germany [01KI1009A]	Center for Molecular Medicine, University of Cologne (CMMC); Bundesministerium fur Bildung und Forschung (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This study was supported by intramural funding from the Center for Molecular Medicine, University of Cologne (CMMC) to EM and GS and in part by a grant to KB from the Bundesministerium fur Bildung und Forschung (BMBF), Germany (01KI1009A "Skin Staph" [Susceptibility and Resistance towards Infections]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07; BADDOUR LM, 1987, REV INFECT DIS, V9, P1168; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870, DOI 10.1128/IAI.55.12.2870-2877.1987; Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448; Hart E, 2010, J ANTIMICROB CHEMOTH, V65, P974, DOI 10.1093/jac/dkq057; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028366; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Otto M, 2011, SEMIN IMMUNOPATHOL; PATRICK CC, 1992, INFECT IMMUN, V60, P1363, DOI 10.1128/IAI.60.4.1363-1367.1992; PFALLER M, 1988, EUR J CLIN MICROBIOL, V7, P30, DOI 10.1007/BF01962167; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Rupp ME, 1999, INFECT IMMUN, V67, P2627, DOI 10.1128/IAI.67.5.2627-2632.1999; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; von Eiff C, 1999, CLIN INFECT DIS, V29, P932, DOI 10.1086/520462; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487; Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239; Vuong C, 2008, J INFECT DIS, V198, P258, DOI 10.1086/589307; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	31	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36602	10.1371/journal.pone.0036602	http://dx.doi.org/10.1371/journal.pone.0036602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586482	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000043
J	Saunders, MI; Thompson, PA; Jeffs, AG; Sawstrom, C; Sachlikidis, N; Beckley, LE; Waite, AM				Saunders, Megan I.; Thompson, Peter A.; Jeffs, Andrew G.; Saewstroem, Christin; Sachlikidis, Nikolas; Beckley, Lynnath E.; Waite, Anya M.			Fussy Feeders: Phyllosoma Larvae of the Western Rocklobster (Panulirus cygnus) Demonstrate Prey Preference	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; SOUTHERN ROCK LOBSTER; EARLY-STAGE PHYLLOSOMA; FATTY-ACID-COMPOSITION; SPINY LOBSTER; BIOCHEMICAL-COMPOSITION; CONTINENTAL-SHELF; LIPID-COMPOSITION; FOOD-WEB; GROWTH	The Western Rocklobster (Panulirus cygnus) is the most valuable single species fishery in Australia and the largest single country spiny lobster fishery in the world. In recent years a well-known relationship between oceanographic conditions and lobster recruitment has become uncoupled, with significantly lower recruitment than expected, generating interest in the factors influencing survival and development of the planktonic larval stages. The nutritional requirements and wild prey of the planktotrophic larval stage (phyllosoma) of P. cygnus were previously unknown, hampering both management and aquaculture efforts for this species. Ship-board feeding trials of wild-caught mid-late stage P. cygnus phyllosoma in the eastern Indian Ocean, off the coast of Western Australia, were conducted in July 2010 and August-September 2011. In a series of experiments, phyllosoma were fed single and mixed species diets of relatively abundant potential prey items (chaetognaths, salps, and krill). Chaetognaths were consumed in 2-8 times higher numbers than the other prey, and the rate of consumption of chaetognaths increased with increasing concentration of prey. The highly variable lipid content of the phyllosoma, and the fatty acid profiles of the phyllosoma and chaetognaths, indicated they were from an oligotrophic oceanic food chain where food resources for macrozooplankton were likely to be constrained. Phyllosoma fed chaetognaths over 6 days showed significant changes in some fatty acids and tended to accumulate lipid, indicating an improvement in overall nutritional condition. The discovery of a preferred prey for P. cygnus will provide a basis for future oceanographic, management and aquaculture research for this economically and ecologically valuable species.	[Saunders, Megan I.; Saewstroem, Christin; Waite, Anya M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Saunders, Megan I.; Saewstroem, Christin; Waite, Anya M.] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia; [Saunders, Megan I.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Thompson, Peter A.] Australian Commonwealth Sci Ind & Res Org, Hobart, Tas, Australia; [Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, Northland, New Zealand; [Sachlikidis, Nikolas] Queensland Govt, Dept Primary Ind & Fisheries, Cairns, Qld, Australia; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia	University of Western Australia; University of Western Australia; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Auckland; Murdoch University	Saunders, MI (corresponding author), Univ Western Australia, Oceans Inst, Crawley, WA, Australia.	anya.waite@uwa.edu.au	Saunders, Megan/I-7731-2012; Thompson, Peter A/A-2361-2012; Jeffs, Andrew G/D-9474-2012; Säwström, Christin/F-5462-2018; Waite, Anya M/A-5492-2015	Saunders, Megan/0000-0002-8549-5609; Thompson, Peter A/0000-0002-9504-5433; Säwström, Christin/0000-0001-9297-3093; Waite, Anya M/0000-0003-2965-0296; Jeffs, Andrew/0000-0002-8504-1949	Fisheries Research Development Corporation, (FRDC) [2010/047]; CSIRO Australian National Marine Facility; Australian National Government; Australian Research Council (Super Science scheme); Glenn Family Foundation	Fisheries Research Development Corporation, (FRDC)(Fisheries R&D Corp); CSIRO Australian National Marine Facility; Australian National Government; Australian Research Council (Super Science scheme)(Australian Research Council); Glenn Family Foundation	This research was funded by a grant from the Fisheries Research Development Corporation, (FRDC) project number: 2010/047 "The Biological Oceanography of Western Rock Lobster Larvae" awarded to AMW et al. Ship time on the R.V. Southern Surveyor was funded by the CSIRO Australian National Marine Facility. MIS was supported in part by Postdoctoral Research Fellowships from the Australian National Government (Endeavour Awards), and Australian Research Council (Super Science scheme). AJ was supported by the Glenn Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudes M, 2008, COMP BIOCHEM PHYS A, V150, P40, DOI 10.1016/j.cbpa.2008.02.023; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braine S, 1979, CSIRO AUSTR DIVISION, V13; Brown R, 2011, GOVERNANCE W ROCK LO; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caputi N, 2008, FISH OCEANOGR, V17, P147, DOI 10.1111/j.1365-2419.2008.00471.x; Caputi Nicolavito, 1993, Fisheries Oceanography, V2, P1, DOI 10.1111/j.1365-2419.1993.tb00007.x; Chittleborough RG, 1969, MARINE FRESHWATER RE, V20, P199, DOI DOI 10.1071/MF9690199; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; COBB JS, 1980, BIOL MANAGEMENT LOBS; Cox SL, 2003, REV FISH SCI, V11, P89, DOI 10.1080/713610924; de Lestang S., 2006, STATE FISHERIES REPO; de Lestang S, 2009, STATE FISHERIES REPO; DEXTER DM, 1972, CALIF FISH GAME, V58, P107; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Gaughan D, 1997, ESTUARINE COASTAL SH, V45, P88; Gaughan DJ, 2009, ESTUAR COAST SHELF S, V83, P443, DOI 10.1016/j.ecss.2009.04.015; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jeffs AG, 2004, COMP BIOCHEM PHYS B, V137, P487, DOI 10.1016/j.cbpc.2004.02.003; Jeffs AG, 2002, COMP BIOCHEM PHYS A, V131, P305, DOI 10.1016/S1095-6433(01)00455-X; Jeffs AG, 1999, COMP BIOCHEM PHYS A, V123, P351, DOI 10.1016/S1095-6433(99)00073-2; Jeffs Andrew, 2007, Bulletin of Fisheries Research Agency, P9; Johnston DJ, 2001, MAR FRESHWATER RES, V52, P1375, DOI 10.1071/MF01105; KITTAKA J, 1994, CRUSTACEANA, V66, P258, DOI 10.1163/156854094X00026; Kittaka J, 2001, MAR FRESHWATER RES, V52, P1439, DOI 10.1071/MF01188; Kruse S, 2010, MAR ECOL PROG SER, V416, P105, DOI 10.3354/meps08773; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; LEMMENS JWTJ, 1994, J MORPHOL, V220, P271, DOI 10.1002/jmor.1052200306; Liddy GC, 2004, AQUACULTURE, V242, P207, DOI 10.1016/j.aquaculture.2004.05.034; Liddy GC, 2004, J SHELLFISH RES, V23, P265; Liddy GC, 2003, AQUACULT INT, V11, P53, DOI 10.1023/A:1024100110378; Limbourn AJ, 2009, COMP BIOCHEM PHYS B, V152, P292, DOI 10.1016/j.cbpb.2008.12.009; Macmillan DL, 1997, MAR FRESHWATER RES, V48, P19, DOI 10.1071/MF96040; MAYZAUD P, 1989, MAR ECOL PROG SER, V56, P189, DOI 10.3354/meps056189; Mitchell JR, 1971, FOOD PREFERENCES FEE; Najdek M, 1996, MAR ECOL PROG SER, V139, P219, DOI 10.3354/meps139219; Nelson MM, 2004, AQUACULT NUTR, V10, P237, DOI 10.1111/j.1365-2095.2004.00295.x; Nelson MM, 2003, J SHELLFISH RES, V22, P225; Nelson MM, 2002, J WORLD AQUACULT SOC, V33, P146, DOI 10.1111/j.1749-7345.2002.tb00489.x; NICHOLS PD, 1991, PHYTOCHEMISTRY, V30, P3209, DOI 10.1016/0031-9422(91)83177-M; OLSON RR, 1989, ANNU REV ECOL SYST, V20, P225; PEARCE AF, 1994, BIOPHYSICS MARINE LA, P279; Phillips BF, 2006, COMP BIOCHEM PHYS B, V143, P219, DOI 10.1016/j.cbpb.2005.11.009; PHILLIPS BF, 1979, AUST J MAR FRESH RES, V30, P773; PHILLIPS BF, 1986, CAN J FISH AQUAT SCI, V43, P2126, DOI 10.1139/f86-261; Phleger CF, 2001, MAR FRESHWATER RES, V52, P1475, DOI 10.1071/MF01071; Reuss N, 2002, MAR BIOL, V141, P423, DOI 10.1007/s00227-002-0841-6; RIMMER DW, 1979, MAR BIOL, V54, P109, DOI 10.1007/BF00386590; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; Saisho T, 1966, INFORMATION B PLANKT, V13, P67; SKERRATT JH, 1995, MAR CHEM, V51, P93, DOI 10.1016/0304-4203(95)00047-U; Suzuki N, 2008, MAR BIOTECHNOL, V10, P49, DOI 10.1007/s10126-007-9038-9; Suzuki N, 2006, FISHERIES SCI, V72, P342, DOI 10.1111/j.1444-2906.2006.01155.x; THOMAS LR, 1963, NATURE, V198, P208, DOI 10.1038/198208a0; Thompson PA, 2009, MAR ECOL PROG SER, V394, P1, DOI 10.3354/meps08297; Tong LJ, 1997, MAR FRESHWATER RES, V48, P935, DOI 10.1071/MF97073; Waite AM, 2007, DEEP-SEA RES PT II, V54, P1055, DOI 10.1016/j.dsr2.2006.12.010; Wilkin JL., 2011, LIMNOLOGY OCEANOGRAP, V1, P163, DOI [10.1215/21573698-1504363, DOI 10.1215/21573698-1504363]	58	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36580	10.1371/journal.pone.0036580	http://dx.doi.org/10.1371/journal.pone.0036580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586479	gold, Green Published			2022-12-27	WOS:000305335000040
J	Shah, M; DiPietro, D; Greenbaum, A; Ketemepi, S; Martins-Evora, M; Marsiglia, V; Dorman, SE				Shah, Maunank; DiPietro, Danielle; Greenbaum, Adena; Ketemepi, Sherry; Martins-Evora, Maria; Marsiglia, Vincent; Dorman, Susan E.			Programmatic Impact of QuantiFERON-TB Gold In-Tube Implementation on Latent Tuberculosis Diagnosis and Treatment in a Public Health Clinic	PLOS ONE			English	Article							INFECTION; ASSAYS	Background: QuantiFERON-TB Gold In-Tube (QFT-GIT) is considered an alternative to the tuberculin skin test (TST) for the diagnosis of tuberculosis (TB) infection, but the programmatic impact of QFT-GIT implementation is largely unknown. In March, 2010, the Baltimore City Health Department (BCHD) introduced routine QFT-GIT testing for individuals referred to the TB program for suspected latent TB infection (LTBI). Design: Retrospective study comparing LTBI diagnosis and treatment during the 13 months before and after QFT-GIT implementation at the BCHD TB clinic. Results: 607 and 750 individuals were referred by community-providers for suspected LTBI in the pre- and post-QFT-GIT periods, respectively. Most individuals in the pre- and post-QFT-GIT periods were referred on the basis of a positive TST (597/607 [98%] vs. 690/750 [92%], respectively) and were foreign-born (363/607[59%] vs. 507/750[68%], respectively). BCHD performed QFT-GIT testing for 375/543 (69%) eligible individuals in the post-QFT-GIT period, of which 185 (49%) were positive, 178 (47%) were negative, 1 (0.25%) was indeterminate, and 11 (3%) did not yield results. Concordance of QFT-GIT with TST was low (183/352[52%]). Foreign-born individuals had higher proportions of QFT-GIT positivity (57%) than US-born individuals (36%; AOR 3.3 [95% CI 1.7-6.2]). Significantly fewer individuals received a final diagnosis of LTBI in the post-QFT-GIT period (397/567 [70%]) compared to the pre- QFT-GIT period (445/452 [98%], p, 0.001). In the post-QFT-GIT period, only 230/399 (58%) of those receiving QFT-GIT testing had a final diagnosis of LTBI, while 167/168 (99%) of those without QFT-GIT testing were diagnosed with LTBI (p, 0.001). There was no difference in treatment initiation between those with and without QFT-GIT testing (175/230 [76%]) vs. 133/167 [80%], respectively) in the post-QFT-GIT period. Conclusion: QFT-GIT implementation for LTBI evaluation in a public health clinic significantly reduced the proportion of referred individuals in whom LTBI was diagnosed. QFT-GIT testing had no impact on treatment initiation or completion among those diagnosed with LTBI.	[Shah, Maunank; Greenbaum, Adena; Dorman, Susan E.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Ketemepi, Sherry; Martins-Evora, Maria; Marsiglia, Vincent] Baltimore City Dept Hlth, Baltimore, MD USA; [DiPietro, Danielle] Tulane Univ, New Orleans, LA 70118 USA	Johns Hopkins University; Tulane University	Shah, M (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mshah28@jhmi.edu			National Institutes Health [AI089259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089259] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MS is supported through a National Institutes Health K23 grant(AI089259) to study novel TB diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Cellestis, 2006, QUANT TB GOLD IN TUB; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Dewan PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-47; DHMH-Maryland, 2011, MAR TB STAT; Grinsdale JA, 2011, INT J TUBERC LUNG D, V15, P1614, DOI 10.5588/ijtld.11.0102; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Horsburgh CR, 2011, NEW ENGL J MED, V364, P1441, DOI 10.1056/NEJMcp1005750; Kunimoto D, 2009, INT J TUBERC LUNG D, V13, P726; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Ozuah PO, 1999, CHEST, V116, P104, DOI 10.1378/chest.116.1.104; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413	14	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36551	10.1371/journal.pone.0036551	http://dx.doi.org/10.1371/journal.pone.0036551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586476	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000037
J	Ogmundsdottir, MH; Heublein, S; Kazi, S; Reynolds, B; Visvalingam, SM; Shaw, MK; Goberdhan, DCI				Oegmundsdottir, Margret H.; Heublein, Sabine; Kazi, Shubana; Reynolds, Bruno; Visvalingam, Shivanthy M.; Shaw, Michael K.; Goberdhan, Deborah C. I.			Proton-Assisted Amino Acid Transporter PAT1 Complexes with Rag GTPases and Activates TORC1 on Late Endosomal and Lysosomal Membranes	PLOS ONE			English	Article							PROMOTES CELL-GROWTH; TUMOR-SUPPRESSOR; SLC36 FAMILY; MTOR; DROSOPHILA; CANCER; IDENTIFICATION; METABOLISM; INHIBITORS; AUTOPHAGY	Mammalian Target of Rapamycin Complex 1 (mTORC1) is activated by growth factor-regulated phosphoinositide 3-kinase (PI3K)/Akt/Rheb signalling and extracellular amino acids (AAs) to promote growth and proliferation. These AAs induce translocation of mTOR to late endosomes and lysosomes (LELs), subsequent activation via mechanisms involving the presence of intralumenal AAs, and interaction between mTORC1 and a multiprotein assembly containing Rag GTPases and the heterotrimeric Ragulator complex. However, the mechanisms by which AAs control these different aspects of mTORC1 activation are not well understood. We have recently shown that intracellular Proton-assisted Amino acid Transporter 1 (PAT1)/SLC36A1 is an essential mediator of AA-dependent mTORC1 activation. Here we demonstrate in Human Embryonic Kidney (HEK-293) cells that PAT1 is primarily located on LELs, physically interacts with the Rag GTPases and is required for normal AA-dependent mTOR relocalisation. We also use the powerful in vivo genetic methodologies available in Drosophila to investigate the regulation of the PAT1/Rag/Ragulator complex. We show that GFP-tagged PATs reside at both the cell surface and LELs in vivo, mirroring PAT1 distribution in several normal mammalian cell types. Elevated PI3K/Akt/Rheb signalling increases intracellular levels of PATs and synergistically enhances PAT-induced growth via a mechanism requiring endocytosis. In light of the recent identification of the vacuolar H+-ATPase as another Rag-interacting component, we propose a model in which PATs function as part of an AA-sensing engine that drives mTORC1 activation from LEL compartments.	[Oegmundsdottir, Margret H.; Heublein, Sabine; Kazi, Shubana; Reynolds, Bruno; Visvalingam, Shivanthy M.; Goberdhan, Deborah C. I.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Shaw, Michael K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Ogmundsdottir, MH (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford, England.	deborah.goberdhan@dpag.ox.ac.uk			Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund [C19591/A6181, C19591/A9093, C7713/A6174, C38302/A12278]; Newton Abraham Studentship (Oxford); Overseas Research Student Award (Oxford); Studiensiftung des deutschen Volkes; Max Weber Programm Bayern (Germany); Biotechnology and Biological Sciences Research Council (BBSRC)	Cancer Research UK (CR-UK) through the Oxford Cancer Research Centre Development Fund; Newton Abraham Studentship (Oxford); Overseas Research Student Award (Oxford); Studiensiftung des deutschen Volkes; Max Weber Programm Bayern (Germany); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding to DCIG from Cancer Research UK (CR-UK) grant numbers C19591/A6181, C19591/A9093, C7713/A6174 and also C38302/A12278, through the Oxford Cancer Research Centre Development Fund. In addition, these studies were supported by a Newton Abraham Studentship (Oxford) and an Overseas Research Student Award (Oxford) to MHO, funding from the Studiensiftung des deutschen Volkes and the Max Weber Programm Bayern (Germany) to SH, and a Biotechnology and Biological Sciences Research Council (BBSRC) Studentship to SMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Azim H, 2010, TARGET ONCOL, V5, P269, DOI 10.1007/s11523-010-0141-x; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Boll M, 2002, J BIOL CHEM, V277, P22966, DOI 10.1074/jbc.M200374200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broer S, 2008, PHYSIOLOGY, V23, P95, DOI 10.1152/physiol.00045.2007; Bryk B, 2010, DEV BIOL, V344, P150, DOI 10.1016/j.ydbio.2010.04.027; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Chen Z, 2003, J PHYSIOL-LONDON, V546, P349, DOI 10.1113/jphysiol.2002.026500; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cohen A, 2009, CELL, V136, P399, DOI 10.1016/j.cell.2009.01.021; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Garcia-Echeverria C, 2010, BIOORG MED CHEM LETT, V20, P4308, DOI 10.1016/j.bmcl.2010.05.099; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Goberdhan DCI, 2005, DEVELOPMENT, V132, P2365, DOI 10.1242/dev.01821; Goberdhan DCI, 2003, HUM MOL GENET, V12, pR239, DOI 10.1093/hmg/ddg288; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Goberdhan DCI, 2002, DEV GENES EVOL, V212, P196, DOI 10.1007/s00427-002-0226-3; Goberdhan DCI, 2010, CURR OPIN INVEST DR, V11, P1360; Goberdhan DCI, 2009, BIOCHEM SOC T, V37, P248, DOI 10.1042/BST0370248; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hafen E, 2004, SWISS MED WKLY, V134, P711; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hennig KM, 2006, J CELL BIOL, V173, P963, DOI 10.1083/jcb.200511140; Heublein S, 2010, ONCOGENE, V29, P4068, DOI 10.1038/onc.2010.177; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Moline MM, 1999, DEVELOPMENT, V126, P4375; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Radimerski T, 2002, NAT CELL BIOL, V4, P251, DOI 10.1038/ncb763; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Resnik-Docampo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014528; Reynolds B, 2007, BIOCHEM SOC T, V35, P1215, DOI 10.1042/BST0351215; Rubio-Aliaga I, 2004, J BIOL CHEM, V279, P2754, DOI 10.1074/jbc.M305556200; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sparks CA, 2010, ONCOGENE, V29, P3733, DOI 10.1038/onc.2010.139; Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; Toba G, 1999, GENETICS, V151, P725; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Wreden CC, 2003, J NEUROSCI, V23, P1265, DOI 10.1523/JNEUROSCI.23-04-01265.2003; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	73	91	94	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36616	10.1371/journal.pone.0036616	http://dx.doi.org/10.1371/journal.pone.0036616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574197	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800094
J	Shao, M; Lin, YS; Liu, ZZ; Zhang, Y; Wang, LF; Liu, CB; Zhang, HW				Shao, Ming; Lin, Yushuang; Liu, Zhongzhen; Zhang, Ying; Wang, Lifeng; Liu, Changbin; Zhang, Hongwei			GSK-3 Activity Is Critical for the Orientation of the Cortical Microtubules and the Dorsoventral Axis Determination in Zebrafish Embryos	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; XENOPUS-LAEVIS EMBRYOS; DORSAL DETERMINATION; ORGANIZER FORMATION; SPEMANNS ORGANIZER; YOLK CELL; LITHIUM; MECHANISM; MESODERM; NEUROECTODERM	The formation of dorsal-ventral (D-V) axis is the earliest event that breaks the radial symmetry and determines the bilateral body plan of a vertebrate embryo, however, the maternal control of this process is not fully understood. Here, we discovered a new dorsalizing window of acute lithium treatment, which covers only less than 10 minutes after fertilization. Lithium treatment in this window was not able to reverse the ventralized phenotype in tokkeabi (tkk) mutant embryos, and its dorsalizing activity on wild-type embryos was inhibited by nocodazole co-treatment. These evidences indicate that the underlying mechanism is independent of a direct activation of Wnt/beta-catenin signaling, but depends on the upstream level of the microtubule mediated dorsal determinant transport. In order to identify the target of lithium in this newly discovered sensitive window, GSK-3 inhibitor IX as well as the IMPase inhibitor L690, 330 treatments were performed. We found that only GSK-3 inhibitor IX treatment mimicked the lithium treatment in the dorsalizing activity. Further study showed that the parallel pattern of cortical microtubules in the vegetal pole region and the directed migration of the Wnt8a mRNA were randomized by either lithium or GSK-3 inhibitor IX treatment. These results thus revealed an early and critical role of GSK-3 activity that regulates the orientation of the cortical microtubules and the directed transport of the dorsal determinants in zebrafish embryos.	[Shao, Ming; Lin, Yushuang; Liu, Zhongzhen; Zhang, Ying; Wang, Lifeng; Liu, Changbin; Zhang, Hongwei] Shandong Univ, Life Sci Coll, Key Lab Anim Cells & Dev Biol Shandong Prov, Key Lab Expt Teratol,Minist Educ, Jinan 250100, Peoples R China	Shandong University	Shao, M (corresponding author), Shandong Univ, Life Sci Coll, Key Lab Anim Cells & Dev Biol Shandong Prov, Key Lab Expt Teratol,Minist Educ, Jinan 250100, Peoples R China.	zhw@sdu.edu.cn	Shao, Ming/AAZ-8099-2021		Independent Innovation Foundation of Shandong University, IIFSDU [11200070614069]; China Postdoctoral Science Foundation [10000070311136]; National Natural Science Foundation of China [30570967, 30671072]; 973 Major Science Programs from the Ministry of Science and Technology of China [2007CB947100, 2007CB815800]	Independent Innovation Foundation of Shandong University, IIFSDU; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Major Science Programs from the Ministry of Science and Technology of China	This work was supported by the Independent Innovation Foundation of Shandong University, IIFSDU (11200070614069) and China Postdoctoral Science Foundation (10000070311136), the National Natural Science Foundation of China (30570967, 30671072), and the 973 Major Science Programs (2007CB947100, 2007CB815800) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstad P, 1999, MECH DEVELOP, V88, P33, DOI 10.1016/S0925-4773(99)00171-9; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; DRIEVER W, 1995, CURR OPIN GENET DEV, V5, P610, DOI 10.1016/0959-437X(95)80030-1; Fekany K, 1999, DEVELOPMENT, V126, P1427; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gurvich N, 2002, PHARMACOL THERAPEUT, V96, P45, DOI 10.1016/S0163-7258(02)00299-1; HAINSKI AM, 1992, DEVELOPMENT, V116, P347; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hibi M, 2002, RES PRO CEL, V40, P48; Inoue D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019713; Jesuthasan S, 1997, CURR BIOL, V7, P31, DOI 10.1016/S0960-9822(06)00025-X; Johnson G V, 1999, J Alzheimers Dis, V1, P329; Joore J, 1996, MECH DEVELOP, V55, P3, DOI 10.1016/0925-4773(95)00481-5; KAO KR, 1989, DEV BIOL, V132, P81, DOI 10.1016/0012-1606(89)90207-8; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kelly C, 2000, DEVELOPMENT, V127, P3899; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Langdon YG, 2010, MATERNAL ZYGOTIC CON; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Mizuno T, 1999, MECH DEVELOP, V81, P51, DOI 10.1016/S0925-4773(98)00202-0; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Ober EA, 1999, DEV BIOL, V215, P167, DOI 10.1006/dbio.1999.9455; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; SCHARF SR, 1989, DEV BIOL, V134, P175, DOI 10.1016/0012-1606(89)90087-0; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Sconzo G, 1998, CELL BIOL INT, V22, P91, DOI 10.1006/cbir.1998.0229; Shaldubina A, 2001, PROG NEURO-PSYCHOPH, V25, P855, DOI 10.1016/S0278-5846(01)00154-3; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; STRAHLE U, 1993, DEVELOPMENT, V119, P909; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Weaver C, 2003, DEVELOPMENT, V130, P5425, DOI 10.1242/dev.00737; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Westfall TA, 2003, DEV BIOL, V259, P380, DOI 10.1016/S0012-1606(03)00209-4; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012	48	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36655	10.1371/journal.pone.0036655	http://dx.doi.org/10.1371/journal.pone.0036655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574208	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800105
J	Neuhoff, N; Bruder, J; Bartling, J; Warnke, A; Remschmidt, H; Muller-Myhsok, B; Schulte-Korne, G				Neuhoff, Nina; Bruder, Jennifer; Bartling, Juergen; Warnke, Andreas; Remschmidt, Helmut; Mueller-Myhsok, Bertram; Schulte-Koerne, Gerd			Evidence for the Late MMN as a Neurophysiological Endophenotype for Dyslexia	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY MMN; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; AUDITORY-DISCRIMINATION; PROCESSING DEFICITS; SUSCEPTIBILITY GENE; SPEECH-PERCEPTION; NOVELTY DETECTION; CHILDREN	Dyslexia affects 5-10% of school-aged children and is therefore one of the most common learning disorders. Research on auditory event related potentials (AERP), particularly the mismatch negativity (MMN) component, has revealed anomalies in individuals with dyslexia to speech stimuli. Furthermore, candidate genes for this disorder were found through molecular genetic studies. A current challenge for dyslexia research is to understand the interaction between molecular genetics and brain function, and to promote the identification of relevant endophenotypes for dyslexia. The present study examines MMN, a neurophysiological correlate of speech perception, and its potential as an endophenotype for dyslexia in three groups of children. The first group of children was clinically diagnosed with dyslexia, whereas the second group of children was comprised of their siblings who had average reading and spelling skills and were therefore "unaffected'' despite having a genetic risk for dyslexia. The third group consisted of control children who were not related to the other groups and were also unaffected. In total, 225 children were included in the study. All children showed clear MMN activity to/da/-/ba/ contrasts that could be separated into three distinct MMN components. Whilst the first two MMN components did not differentiate the groups, the late MMN component (300-700 ms) revealed significant group differences. The mean area of the late MMN was attenuated in both the dyslexic children and their unaffected siblings in comparison to the control children. This finding is indicative of analogous alterations of neurophysiological processes in children with dyslexia and those with a genetic risk for dyslexia, without a manifestation of the disorder. The present results therefore further suggest that the late MMN might be a potential endophenotype for dyslexia.	[Neuhoff, Nina; Bruder, Jennifer; Bartling, Juergen; Schulte-Koerne, Gerd] Univ Munich, Dept Child & Adolescent Psychiat, Munich, Germany; [Warnke, Andreas] Univ Wurzburg, Dept Child & Adolescent Psychiat & Psychotherapy, Wurzburg, Germany; [Remschmidt, Helmut] Univ Hosp Giessen & Marburg, Dept Child & Adolescent Psychiat & Psychotherapy, Marburg, Germany; [Mueller-Myhsok, Bertram] Stat Genet Max Planck Inst Psychiat, Munich, Germany	University of Munich; University of Wurzburg; University Hospital of Giessen & Marburg; Max Planck Society	Neuhoff, N (corresponding author), Univ Munich, Dept Child & Adolescent Psychiat, Munich, Germany.	Gerd.Schulte-Koerne@med.uni-muenchen.de	Müller-Myhsok, Bertram/A-3289-2013; Schulte-Körne, Gerd/AAI-4828-2021; Bruder, Jennifer/GLN-6445-2022	Schulte-Körne, Gerd/0000-0002-9960-1572; Bruder, Jennifer/0000-0002-3815-6313	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was suppoorted by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Bua B, 2006, INT J PSYCHOPHYSIOL, V59, P159, DOI 10.1016/j.ijpsycho.2005.03.020; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Brahler, 2002, BRICKENKAMP HDB PSYC; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Ceponiene R, 1998, EVOKED POTENTIAL, V108, P345, DOI 10.1016/S0168-5597(97)00081-6; Ceponiene R, 2004, PSYCHOPHYSIOLOGY, V41, P130, DOI 10.1111/j.1469-8986.2003.00138.x; Ceponiene R, 2002, INT J PSYCHOPHYSIOL, V43, P199, DOI 10.1016/S0167-8760(01)00172-6; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; Dalebout S D, 2001, J Am Acad Audiol, V12, P245; Dilling H., 1994, INT KLASSIFIKATION P; Froyen DJW, 2009, J COGNITIVE NEUROSCI, V21, P567, DOI 10.1162/jocn.2009.21061; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Hannula-Jouppi K, 2005, PLOS GENET, V1, P467, DOI 10.1371/journal.pgen.0010050; Heim S, 2000, NEUROPSYCHOLOGIA, V38, P1749, DOI 10.1016/S0028-3932(00)00075-0; Hommet C, 2009, NEUROPSYCHOLOGIA, V47, P761, DOI 10.1016/j.neuropsychologia.2008.12.010; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; KORPILAHTI P, 1994, ELECTROEN CLIN NEURO, V91, P256, DOI 10.1016/0013-4694(94)90189-9; Lachmann T, 2005, INT J PSYCHOPHYSIOL, V56, P105, DOI 10.1016/j.ijpsycho.2004.11.005; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Ludwig KU, 2008, J NEURAL TRANSM, V115, P1587, DOI 10.1007/s00702-008-0124-6; Maurer U, 2003, NEUROREPORT, V14, P2245, DOI 10.1097/00001756-200312020-00022; Maurer U, 2009, BIOL PSYCHIAT; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McCrory EJ, 2005, BRAIN, V128, P261, DOI 10.1093/brain/awh340; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Meng XZ, 2005, DYSLEXIA, V11, P292, DOI 10.1002/dys.309; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Paavilainen P., 2007, CLIN NEUROPHYSIOLOGY; Paracchini S, 2007, ANN REV GENOMICS HUM; Paul I, 2006, EUR J NEUROSCI, V24, P2945, DOI 10.1111/j.1460-9568.2006.05153.x; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pugh KR, 2000, MENT RETARD DEV D R, V6, P207, DOI 10.1002/1098-2779(2000)6:3<207::AID-MRDD8>3.0.CO;2-P; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Roeske D, 2011, MOL PSYCHIAT; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Schulte-Korne G, 2007, ANN HUM GENET, V71, P160, DOI 10.1111/j.1469-1809.2006.00312.x; Schulte-Korne G, 2010, CLIN NEUROPHYSIOL, V121, P1794, DOI 10.1016/j.clinph.2010.04.028; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Schulte-Korne G, 1998, PERCEPT MOTOR SKILL, V86, P1043, DOI 10.2466/pms.1998.86.3.1043; Schulte-Korne G, 1999, EUR CHILD ADOLES PSY, V8, P28; Schulte-Korne G, 2001, Z KINDER JUG-PSYCH, V29, P113, DOI 10.1024//1422-4917.29.2.113; Schulte-Korne G, 2001, INT J PSYCHOPHYSIOL, V40, P77, DOI 10.1016/S0167-8760(00)00152-5; Schulte-Korne G, 1999, NEUROSCI LETT, V276, P41, DOI 10.1016/S0304-3940(99)00785-5; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Sebastian C, 2008, INT J PSYCHOPHYSIOL, V70, P115, DOI 10.1016/j.ijpsycho.2008.08.004; Shafer VL, 2005, J COGNITIVE NEUROSCI, V17, P1168, DOI 10.1162/0898929054475217; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz SE, 2008, DEV PSYCHOPATHOL, V20, P1329, DOI 10.1017/S0954579408000631; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Shestakova A, 2003, CLIN NEUROPHYSIOL, V114, P1507, DOI 10.1016/S1388-2457(03)00134-2; Simmons FR, 2008, DYSLEXIA, V14, P77, DOI 10.1002/dys.341; Stoodley CJ, 2006, BRAIN RES, V1121, P190, DOI 10.1016/j.brainres.2006.08.095; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Unnewehr S., 1998, KINDER DIPS DIAGNOST; Wei RH, 1997, GRUNDINTELLIGENZTEST; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; Wimmer H, 1996, READ WRIT, V8, P171, DOI 10.1007/BF00555368; Wolf M, 2000, J LEARN DISABIL-US, V33, P322, DOI 10.1177/002221940003300404; Zachau S, 2005, NEUROREPORT, V16, P2015, DOI 10.1097/00001756-200512190-00009; Ziegler JC, 2006, DEVELOPMENTAL SCI, V9, P429, DOI 10.1111/j.1467-7687.2006.00509.x	70	41	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e34909	10.1371/journal.pone.0034909	http://dx.doi.org/10.1371/journal.pone.0034909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606227	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400002
J	Schmukler, E; Shai, B; Ehrlich, M; Pinkas-Kramarski, R				Schmukler, Eran; Shai, Ben; Ehrlich, Marcelo; Pinkas-Kramarski, Ronit			Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HYDROGEN-PEROXIDE; PROTEIN; BECLIN-1; CARCINOMA; COMPLEX; DEATH; PHOSPHORYLATION; EXPRESSION; C-ERBB-2	Background: Growth factors activating the ErbB receptors have been described in prostate tumors. The androgen dependent prostate cancer cell line, LNCaP, expresses the ErbB-1, ErbB-2 and ErbB-3 receptor tyrosine kinases. Previously, it was demonstrated that NRG activates ErbB-2/ErbB-3 heterodimers to induce LNCaP cell death, whereas, EGF activates ErbB1/ErbB-1 or ErbB-1/ErbB-2 dimers to induce cell growth and survival. It was also demonstrated that PI3K inhibitors repressed this cell death suggesting that in androgen deprived LNCaP cells, NRG activates a PI3K-dependent pathway associated with cell death. Methodology/Principal Findings: In the present study we demonstrate that NRG induces autophagy in LNCaP cells, using LC3 as a marker. However, the autophagy induced by NRG may be incomplete since p62 levels elevate. We also demonstrated that NRG- induced autophagy is independent of mammalian target of rapamycin (mTOR) inhibition since NRG induces Akt and S6K activation. Interestingly, inhibition of reactive oxygen species (ROS) by N-acetylcysteine (NAC), inhibited NRG-induced autophagy and cell death. Our study also identified JNK and Beclin 1 as important components in NRG-induced autophagy and cell death. NRG induced elevation in JNK phosphorylation that was inhibited by NAC. Moreover, inhibitor of JNK inhibited NRG-induced autophagy and cell death. Also, in cells overexpressing Bcl-2 or cells expressing sh-RNA against Beclin 1, the effects of NRG, namely induction of autophagy and cell death, were inhibited. Conclusions/Significance: Thus, in LNCaP cells, NRG-induces incomplete autophagy and cell death that depend on ROS levels. These effects of NRG are mediated by signaling pathway that activates JNK and Beclin 1, but is independent of mTOR inhibition.	[Schmukler, Eran; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel; [Shai, Ben; Ehrlich, Marcelo] Tel Aviv Univ, Dept Cell Res & Immunol, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Schmukler, E (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X; Migliaccio, Antimo/0000-0002-4197-2055; Ehrlich, Marcelo/0000-0002-2352-1808	Israel Science Foundation [732/08]; Israel Ministry of Health [3942]; Israel Cancer Association [4914422]; Kauffman Prostate Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Health; Israel Cancer Association; Kauffman Prostate Cancer Research Fund	This work was supported by the Israel Science Foundation (grant No. 732/08), by the Israel Ministry of Health (grant No. 3942), by the Israel Cancer Association (grant No. 4914422) and by the Kauffman Prostate Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Byun YJ, 2009, NEUROSCI LETT, V461, P131, DOI 10.1016/j.neulet.2009.06.011; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; FONG CJ, 1992, CANCER RES, V52, P5887; FOX SB, 1994, BRIT J UROL, V74, P214, DOI 10.1111/j.1464-410X.1994.tb16589.x; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grasso AW, 1997, ONCOGENE, V15, P2705, DOI 10.1038/sj.onc.1201447; Harris A L, 1992, J Natl Cancer Inst Monogr, P181; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KUHN EJ, 1993, J UROLOGY, V150, P1427, DOI 10.1016/S0022-5347(17)35799-3; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 2001, CANCER RES, V61, P3443; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Notte A, 2011, BIOCH PHARM; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; Pinkas-Kramarski RY, 1995, STRUCTURE FUNCTION N; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schwartz S, 1999, INT J ONCOL, V14, P367; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Tal-Or P, 2003, PROSTATE, V55, P147, DOI 10.1002/pros.10200; WARE JL, 1991, HUM PATHOL, V22, P254, DOI 10.1016/0046-8177(91)90159-M; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791	50	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36828	10.1371/journal.pone.0036828	http://dx.doi.org/10.1371/journal.pone.0036828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606295	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400036
J	Aida, T; Ito, Y; Takahashi, YK; Tanaka, K				Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi			Overstimulation of NMDA Receptors Impairs Early Brain Development in vivo	PLOS ONE			English	Article							GENE-EXPRESSION; GLUTAMATE; SCHIZOPHRENIA; INJURY; GLAST; MICE; NEUROPATHOLOGY; EXACERBATION; SYMPTOMS; KETAMINE	Background: Brains of patients with schizophrenia show both neurodevelopmental and functional deficits that suggest aberrant glutamate neurotransmission. Evidence from both genetic and pharmacological studies suggests that glutamatergic dysfunction, particularly with involvement of NMDARs, plays a critical role in the pathophysiology of schizophrenia. However, how prenatal disturbance of NMDARs leads to schizophrenia-associated developmental defects is largely unknown. Methodology/Principal Findings: Glutamate transporter GLAST/GLT1 double-knockout (DKO) mice carrying the NMDA receptor 1 subunit (NR1)-null mutation were generated. Bouin-fixed and paraffin-embedded embryonic day 16.5 coronal brain sections were stained with hematoxylin, anti-microtubule-associated protein 2 (MAP2), and anti-L1 antibodies to visualize cortical, hippocampal, and olfactory bulb laminar structure, subplate neurons, and axonal projections. NR1 deletion in DKO mice almost completely rescued multiple brain defects including cortical, hippocampal, and olfactory bulb disorganization and defective corticothalamic and thalamocortical axonal projections. Conclusions/Significance: Excess glutamatergic signaling in the prenatal stage compromises early brain development via overstimulation of NMDARs.	[Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi] Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Mol Neurosci, Tokyo, Japan; [Aida, Tomomi; Ito, Yoshimasa; Takahashi, Yuko K.; Tanaka, Kohichi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo, Japan; [Tanaka, Kohichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Aida, T (corresponding author), Tokyo Med & Dent Univ, Sch Biomed Sci, Lab Mol Neurosci, Tokyo, Japan.	tanaka.aud@mri.tmd.ac.jp						Aamodt SM, 2000, J NEUROPHYSIOL, V83, P1580, DOI 10.1152/jn.2000.83.3.1580; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Arnold SE, 2000, ANN NY ACAD SCI, V911, P275; BAHN S, 1994, J NEUROSCI, V14, P5525; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kargieman L, 2007, P NATL ACAD SCI USA, V104, P14843, DOI 10.1073/pnas.0704848104; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kolevzon A, 2007, ARCH PEDIAT ADOL MED, V161, P326, DOI 10.1001/archpedi.161.4.326; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malhotra AK, 1997, NEUROPSYCHOPHARMACOL, V17, P141; Matsugami TR, 2006, P NATL ACAD SCI USA, V103, P12161, DOI 10.1073/pnas.0509144103; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; SHIGEMOTO R, 1992, J COMP NEUROL, V322, P121, DOI 10.1002/cne.903220110; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36853	10.1371/journal.pone.0036853	http://dx.doi.org/10.1371/journal.pone.0036853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606296	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200049
J	Cota, I; Blanc-Potard, AB; Casadesus, J				Cota, Ignacio; Blanc-Potard, Anne Beatrice; Casadesus, Josep			STM2209-STM2208 (opvAB): A Phase Variation Locus of Salmonella enterica Involved in Control of O-Antigen Chain Length	PLOS ONE			English	Article							DNA ADENINE METHYLATION; MGTC VIRULENCE FACTOR; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; MEMBRANE-PROTEINS; SERUM RESISTANCE; OUTER-MEMBRANE; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL GENES; TYPE-1 FIMBRIAE	STM2209 and STM2208 are contiguous loci annotated as putative protein-coding genes in the chromosome of Salmonella enterica. Lack of homologs in related Enterobacteria and low G+C content suggest that S. enterica may have acquired STM2209-STM2208 by horizontal transfer. STM2209 and STM2208 are co-transcribed from a promoter upstream STM2209, and their products are inner (cytoplasmic) membrane proteins. Analysis with the bacterial adenylate cyclase two-hybrid system suggests that STM2209 and STM2208 may interact. Expression of STM2209-STM2208 is subjected to phase variation in wild type Salmonella enterica serovar Typhimurium. Switching frequencies in LB medium are 6.1x10x(-5) (OFF -> ON) and 3.7x10(-2) (ON -> OFF) per cell and generation. Lack of DNA adenine methylation locks STM2209-STM2208 in the ON state, and lack of the LysR-type factor OxyR locks STM2209-STM2208 in the OFF state. OxyR-dependent activation of STM2209-STM2208 expression is independent of the oxidation state of OxyR. Salmonella cultures locked in the ON state show alteration of O-antigen length in the lipopolysaccharide, reduced absorption of bacteriophage P22, impaired resistance to serum, and reduced proliferation in macrophages. Phenotypic heterogeneity generated by STM2209-STM2208 phase variation may thus provide defense against phages. In turn, formation of a subpopulation unable to proliferate in macrophages may restrain Salmonella spread in animal organs, potentially contributing to successful infection.	[Cota, Ignacio; Casadesus, Josep] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Blanc-Potard, Anne Beatrice] CNRS, UMR 5235, Montpellier, France; [Blanc-Potard, Anne Beatrice] Univ Montpellier 2, Montpellier, France	University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Cota, I (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.	casadesus@us.es	Blanc-Potard, Anne/AAI-9542-2021; Casadesús, Josep/C-6222-2016; Cota, Ignacio/R-9217-2018	Casadesús, Josep/0000-0002-2308-293X; Cota, Ignacio/0000-0003-3367-7037; Blanc-Potard, Anne/0000-0001-9963-6786	Spanish Ministry of Science and Innovation (MICINN) [BIO2007-67457-CO2-02, CSD2008-00013]; European Regional Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [CVI-5879]; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Fund; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This study was supported by grants BIO2007-67457-CO2-02 and CSD2008-00013 from the Spanish Ministry of Science and Innovation (MICINN) and the European Regional Fund, and grant CVI-5879 from the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (to J.C.). I.C. holds a FPU (Formacion de Profesorado Universitario) fellowship from the MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Alix E, 2008, EMBO J, V27, P546, DOI 10.1038/sj.emboj.7601983; Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAGA M, 1985, EMBO J, V4, P3887, DOI 10.1002/j.1460-2075.1985.tb04162.x; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Casjens SR, 2008, RES MICROBIOL, V159, P340, DOI 10.1016/j.resmic.2008.04.005; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; Crost C, 2003, J BACTERIOL, V185, P1886, DOI 10.1128/JB.185.6.1886-1894.2003; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daubin V, 2004, CURR OPIN GENET DEV, V14, P616, DOI 10.1016/j.gde.2004.09.004; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Pescaretti MD, 2011, MICROBIOL-SGM, V157, P2515, DOI 10.1099/mic.0.050088-0; EISENSTEIN BI, 1981, SCIENCE, V214, P337, DOI 10.1126/science.6116279; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gabig M, 2002, MICROBIOL-SGM, V148, P1533, DOI 10.1099/00221287-148-5-1533; GARZON A, 1995, GENETICS, V140, P427; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Hasset DJ, 2000, J BACTERIOL, V182, P4557, DOI 10.1128/JB.182.16.4557-4563.2000; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; Holden NJ, 2001, MOL MICROBIOL, V42, P319, DOI 10.1046/j.1365-2958.2001.02656.x; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Liu JY, 1999, J BIOL CHEM, V274, P22977, DOI 10.1074/jbc.274.33.22977; Lopez-Garrido J, 2010, GENETICS, V184, P637, DOI 10.1534/genetics.109.108985; Low DA, 2008, CURR OPIN MICROBIOL, V11, P106, DOI 10.1016/j.mib.2008.02.012; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; MARQUES S, 1993, BIOCHIM BIOPHYS ACTA, V1216, P227, DOI 10.1016/0167-4781(93)90149-8; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MEDIGUE C, 1991, J MOL BIOL, V222, P851, DOI 10.1016/0022-2836(91)90575-Q; Miller J.H., 1972, EXPT MOL GENETICS; MORONA R, 1995, J BACTERIOL, V177, P1059, DOI 10.1128/jb.177.4.1059-1068.1995; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; NOU XW, 1995, EMBO J, V14, P5785, DOI 10.1002/j.1460-2075.1995.tb00267.x; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Piao HH, 2010, J MICROBIOL, V48, P486, DOI 10.1007/s12275-010-0023-z; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rang C, 2007, MOL MICROBIOL, V63, P605, DOI 10.1111/j.1365-2958.2006.05542.x; Rappleye CA, 1997, J BACTERIOL, V179, P5827, DOI 10.1128/jb.179.18.5827-5834.1997; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Stewart MK, 2011, P NATL ACAD SCI USA, V108, P20742, DOI 10.1073/pnas.1108963108; STORZ G, 1990, ANTON LEEUW INT J G, V58, P157, DOI 10.1007/BF00548927; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; TOMAS JM, 1988, J GEN MICROBIOL, V134, P1009; Torreblanca J, 1999, GENETICS, V152, P31; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van der Woude MW, 2011, CURR OPIN MICROBIOL, V14, P205, DOI 10.1016/j.mib.2011.01.002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; White-Ziegler CA, 1998, MOL MICROBIOL, V28, P1121, DOI 10.1046/j.1365-2958.1998.00872.x; WRIGHT A, 1971, PHYSIOL REV, V51, P748, DOI 10.1152/physrev.1971.51.4.748; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yoon H, 2011, INFECT IMMUN, V79, P2182, DOI 10.1128/IAI.01277-10	84	33	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36863	10.1371/journal.pone.0036863	http://dx.doi.org/10.1371/journal.pone.0036863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606300	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200051
J	Cuttler, C; McLaughlin, RJ; Graf, P				Cuttler, Carrie; McLaughlin, Ryan J.; Graf, Peter			Mechanisms Underlying the Link between Cannabis Use and Prospective Memory	PLOS ONE			English	Article							EVERYDAY PROSPECTIVE MEMORY; USE DISORDERS; RETROSPECTIVE MEMORY; SELF-REPORTS; DEFICITS; DEPRESSION; QUESTIONNAIRE; INVENTORY; ECSTASY; SCHIZOPHRENIA	While the effects of cannabis use on retrospective memory have been extensively examined, only a limited number of studies have focused on the links between cannabis use and prospective memory. We conducted two studies to examine the links between cannabis use and both time-based and event-based prospective memory as well as potential mechanisms underlying these links. For the first study, 805 students completed an online survey designed to assess cannabis consumption, problems with cannabis use indicative of a disorder, and frequency of experiencing prospective memory failures. The results showed small to moderate sized correlations between cannabis consumption, problems with cannabis use, and prospective memory. However, a series of mediation analyses revealed that correlations between problems with cannabis use and prospective memory were driven by self-reported problems with retrospective memory. For the second study, 48 non-users (who had never used cannabis), 48 experimenters (who had used cannabis five or fewer times in their lives), and 48 chronic users (who had used cannabis at least three times a week for one year) were administered three objective prospective memory tests and three self-report measures of prospective memory. The results revealed no objective deficits in prospective memory associated with chronic cannabis use. In contrast, chronic cannabis users reported experiencing more internally-cued prospective memory failures. Subsequent analyses revealed that this effect was driven by self-reported problems with retrospective memory as well as by use of alcohol and other drugs. Although our samples were not fully characterized with respect to variables such as neurological disorders and family history of substance use disorders, leaving open the possibility that these variables may play a role in the detected relationships, the present findings indicate that cannabis use has a modest effect on self-reported problems with prospective memory, with a primary problem with retrospective memory appearing to underlie this relationship.	[Cuttler, Carrie] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [McLaughlin, Ryan J.; Graf, Peter] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Cuttler, C (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	cuttler@mail.ubc.ca	McLaughlin, Ryan/M-9547-2016; Cuttler, Carrie/J-4316-2019	McLaughlin, Ryan/0000-0002-2875-0685; Cuttler, Carrie/0000-0002-5890-2985	Michael Smith Foundation for Health Research [ST-PDF-01284-(07-1]; Canadian Institutes of Health [194972]; Natural Sciences and Engineering Research Council of Canada [RGPIN 38733-06]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a postdoctoral fellowship to CC from the Michael Smith Foundation for Health Research [Application Number: ST-PDF-01284-(07-1; URL: http://www.msfhr.org/], a doctoral research award to RJM from the Canadian Institutes of Health [Application Number: 194972; URL: http://www.cihr-irsc.gc.ca/e/193.html] and a discovery grant to PG from the Natural Sciences and Engineering Research Council of Canada (RGPIN 38733-06; URL: http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti V, 2002, AM J DRUG ALCOHOL AB, V28, P645, DOI 10.1081/ADA-120015873; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Alexander DE, 2004, AM J DRUG ALCOHOL AB, V30, P321, DOI 10.1081/ADA-120037381; [Anonymous], UN NAT OFF DRUGS CRI; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartholomew J, 2010, J PSYCHOPHARMACOL, V24, P241, DOI 10.1177/0269881109106909; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Bovasso GB, 2001, AM J PSYCHIAT, V158, P2033, DOI 10.1176/appi.ajp.158.12.2033; Casey P, 1999, J PSYCHOSOM OBST GYN, V20, P158, DOI 10.3109/01674829909075590; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Cuttler C, 2008, J ANXIETY DISORD, V22, P642, DOI 10.1016/j.janxdis.2007.06.003; Cuttler C, 2011, CAN J EXP PSYCHOL, V65, P27, DOI 10.1037/a0022844; Cuttler C, 2009, CLIN PSYCHOL REV, V29, P393, DOI 10.1016/j.cpr.2009.04.003; Cuttler C, 2009, J ANXIETY DISORD, V23, P813, DOI 10.1016/j.janxdis.2009.03.006; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fish J, 2010, NEUROPSYCHOL REHABIL, V20, P161, DOI 10.1080/09602010903126029; Fisk JE, 2008, J PSYCHOPHARMACOL, V22, P727, DOI 10.1177/0269881107084000; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Graf P, 2001, CONSCIOUS COGN, V10, P437, DOI 10.1006/ccog.2001.0504; Hadjiefthyvoulou F, 2011, J PSYCHOPHARMACOL, V25, P453, DOI 10.1177/0269881109359101; Hadjiefthyvoulou F, 2011, PSYCHOPHARMACOLOGY, V215, P761, DOI 10.1007/s00213-011-2174-y; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris LM, 1999, MEMORY, V7, P117, DOI 10.1080/741943717; Harris LM, 2010, BEHAV CHANGE, V27, P84, DOI 10.1375/bech.27.2.84; Heffernan T, 2010, DRUG ALCOHOL DEPEN, V109, P73, DOI 10.1016/j.drugalcdep.2009.12.013; Heffernan T, 2010, DRUG ALCOHOL DEPEN, V112, P234, DOI 10.1016/j.drugalcdep.2010.06.012; Heffernan Thomas M, 2008, Curr Drug Abuse Rev, V1, P36; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; McGee R, 2000, ADDICTION, V95, P491, DOI 10.1046/j.1360-0443.2000.9544912.x; McHale S, 2008, HUM PSYCHOPHARM CLIN, V23, P409, DOI 10.1002/hup.941; Merikangas KR, 1998, ARCH GEN PSYCHIAT, V55, P973, DOI 10.1001/archpsyc.55.11.973; Messinis L, 2006, NEUROLOGY, V66, P737, DOI 10.1212/01.wnl.0000201279.83203.c6; Montgomery C, 2007, J PSYCHOPHARMACOL, V21, P709, DOI 10.1177/0269881107077220; Riedel G, 2005, HANDB EXP PHARMACOL, V168, P445; Rodgers J, 2003, J PSYCHOPHARMACOL, V17, P389, DOI 10.1177/0269881103174016; Rodgers J, 2001, HUM PSYCHOPHARM CLIN, V16, P619, DOI 10.1002/hup.345; Rude SS, 1999, COGNITION EMOTION, V13, P267, DOI 10.1080/026999399379276; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Sellen AJ, 1997, MEMORY, V5, P483, DOI 10.1080/741941433; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Shum D, 2004, SCHIZOPHRENIA BULL, V30, P693, DOI 10.1093/oxfordjournals.schbul.a007123; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; SOBELL LC, 1995, ADDICT BEHAV, V20, P233, DOI 10.1016/0306-4603(94)00071-9; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spreen O., 1991, PROFILE TEST RESULTS; Stinson FS, 2006, PSYCHOL MED, V36, P1447, DOI 10.1017/S0033291706008361; Tapert SF, 2000, ADDICTION, V95, P1043, DOI 10.1046/j.1360-0443.2000.95710436.x; Titov N, 2001, APPL COGNITIVE PSYCH, V15, P61, DOI 10.1002/1099-0720(200101/02)15:1<61::AID-ACP689>3.0.CO;2-Y; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013	59	17	17	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36820	10.1371/journal.pone.0036820	http://dx.doi.org/10.1371/journal.pone.0036820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606293	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200047
J	Abdelkrim, J; Hunt, GR; Gray, RD; Gemmell, NJ				Abdelkrim, Jawad; Hunt, Gavin R.; Gray, Russell D.; Gemmell, Neil J.			Population Genetic Structure and Colonisation History of the Tool-Using New Caledonian Crow	PLOS ONE			English	Article							MANUFACTURE; WILD; INFERENCE; NUMBER; G(ST); LOCI	New Caledonian crows exhibit considerable variation in tool making between populations. Here, we present the first study of the species' genetic structure over its geographical distribution. We collected feathers from crows on mainland Grande Terre, the inshore island of Toupeti, and the nearby island of Mare where it is believed birds were introduced after European colonisation. We used nine microsatellite markers to establish the genotypes of 136 crows from these islands and classical population genetic tools as well as Approximate Bayesian Computations to explore the distribution of genetic diversity. We found that New Caledonian crows most likely separate into three main distinct clusters: Grande Terre, Toupeti and Mare. Furthermore, Toupeti and Mare crows represent a subset of the genetic diversity observed on Grande Terre, confirming their mainland origin. The genetic data are compatible with a colonisation of Mare taking place after European colonisation around 1900. Importantly, we observed (1) moderate, but significant, genetic differentiation across Grande Terre, and (2) that the degree of differentiation between populations on the mainland increases with geographic distance. These data indicate that despite individual crows' potential ability to disperse over large distances, most gene flow occurs over short distances. The temporal and spatial patterns described provide a basis for further hypothesis testing and investigation of the geographical variation observed in the tool skills of these crows.	[Abdelkrim, Jawad; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand; [Abdelkrim, Jawad; Gemmell, Neil J.] Univ Otago, Dept Anat, Ctr Reprod & Genom, Dunedin, New Zealand; [Abdelkrim, Jawad] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, F-75231 Paris, France; [Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Canterbury; University of Otago; Museum National d'Histoire Naturelle (MNHN); University of Auckland	Abdelkrim, J (corresponding author), Univ Canterbury, Sch Biol Sci, Mol Ecol Lab, Christchurch 1, New Zealand.	jawad@mnhn.fr; g.hunt@auckland.ac.nz	Gemmell, Neil J/C-6774-2009; Gray, Russell/H-2078-2015	Gemmell, Neil J/0000-0003-0671-3637; Gray, Russell/0000-0002-9858-0191	New Zealand Marsden Fund; University of Auckland; University of Canterbury; University of Otago	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); University of Auckland; University of Canterbury; University of Otago	This research was funded by grants from the New Zealand Marsden Fund (RDG and GRH), the University of Auckland (RDG and GRH), the University of Canterbury and the University of Otago (JA and NJG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Delacourt J, 1966, GUIDE OISEAUX NOUVEL; Earl DA, 2011, CONSERVATION GENETIC; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fidler AE, 2007, P ROY SOC B-BIOL SCI, V274, P1685, DOI 10.1098/rspb.2007.0337; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., FSTAT PROGRAM ESTIMA; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holzhaider JC, 2011, ANIM BEHAV, V81, P83, DOI 10.1016/j.anbehav.2010.09.015; Holzhaider JC, 2010, BEHAVIOUR, V147, P553, DOI 10.1163/000579510X12629536366284; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunt GR, 2007, NEW ZEAL J ZOOL, V34, P1; Hunt GR, 2007, AUST J ZOOL, V55, P291, DOI 10.1071/ZO07048; Hunt GR, 2012, ETHOLOGY, V118, P423, DOI 10.1111/j.1439-0310.2012.02027.x; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Hunt GR, 2002, EMU, V102, P349, DOI 10.1071/MU01056; Hunt GR, 2003, P ROY SOC B-BIOL SCI, V270, P867, DOI 10.1098/rspb.2002.2302; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P2094, DOI 10.1098/rspb.2011.0391; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Lycett SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2091, DOI 10.1098/rspb.2010.2599; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rutz C, 2012, NATURWISSENSCHAFTEN, V99, P313, DOI 10.1007/s00114-012-0904-6; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Schoenle LA, 2007, MOL ECOL NOTES, V7, P46, DOI 10.1111/j.1471-8286.2006.01520.x; Tarr CL, 1998, MOL ECOL, V7, P253; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Weir JT, 2009, P NATL ACAD SCI USA, V106, P21737, DOI 10.1073/pnas.0903811106	36	11	11	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36608	10.1371/journal.pone.0036608	http://dx.doi.org/10.1371/journal.pone.0036608			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590576	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100047
J	Noell, S; Ritz, R; Wolburg-Buchholz, K; Wolburg, H; Fallier-Becker, P				Noell, Susan; Ritz, Rainer; Wolburg-Buchholz, Karen; Wolburg, Hartwig; Fallier-Becker, Petra			An Allograft Glioma Model Reveals the Dependence of Aquaporin-4 Expression on the Brain Microenvironment	PLOS ONE			English	Article							CHANNEL PROTEIN AQUAPORIN-4; ORTHOGONAL ARRAYS; GLIOBLASTOMA-MULTIFORME; CULTURED ASTROCYTES; WATER CHANNELS; CELL-ADHESION; M23 ISOFORMS; AGRIN; TUMORS; EDEMA	Aquaporin-4 (AQP4), the main water channel of the brain, is highly expressed in animal glioma and human glioblastoma in situ. In contrast, most cultivated glioma cell lines don't express AQP4, and primary cell cultures of human glioblastoma lose it during the first passages. Accordingly, in C6 cells and RG2 cells, two glioma cell lines of the rat, and in SMA mouse glioma cell lines, we found no AQP4 expression. We confirmed an AQP4 loss in primary human glioblastoma cell cultures after a few passages. RG-2 glioma cells if grafted into the brain developed AQP4 expression. This led us consider the possibility of AQP4 expression depends on brain microenvironment. In previous studies, we observed that the typical morphological conformation of AQP4 as orthogonal arrays of particles (OAP) depended on the extracellular matrix component agrin. In this study, we showed for the first time implanted AQP4 negative glioma cells in animal brain or flank to express AQP4 specifically in the intracerebral gliomas but neither in the extracranial nor in the flank gliomas. AQP4 expression in intracerebral gliomas went along with an OAP loss, compared to normal brain tissue. AQP4 staining in vivo normally is polarized in the astrocytic endfoot membranes at the glia limitans superficialis and perivascularis, but in C6 and RG2 tumors the AQP4 staining is redistributed over the whole glioma cell as in human glioblastoma. In contrast, primary rat or mouse astrocytes in culture did not lose their ability to express AQP4, and they were able to form few OAPs.	[Noell, Susan; Ritz, Rainer] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Wolburg-Buchholz, Karen; Wolburg, Hartwig; Fallier-Becker, Petra] Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Noell, S (corresponding author), Univ Tubingen, Dept Neurosurg, Tubingen, Germany.	petra.fallier-becker@med.uni-tuebingen.de			Deutsche Krebshilfe (Mildred Scheel Foundation) [107686, 109219]	Deutsche Krebshilfe (Mildred Scheel Foundation)(Deutsche Krebshilfe)	This work was supported by grants of the Deutsche Krebshilfe (Mildred Scheel Foundation; grant numbers 107686 and 109219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAS AT, 1995, J NEURO-ONCOL, V23, P175, DOI 10.1007/BF01059948; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DERMIETZEL R, 1973, NATURWISSENSCHAFTEN, V60, P208, DOI 10.1007/BF00599446; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Engelhorn T, 2009, CANCER SCI, V100, P1856, DOI 10.1111/j.1349-7006.2009.01259.x; Fallier-Becker P, 2011, BRAIN RES, V1367, P2, DOI 10.1016/j.brainres.2010.09.092; Frericks M, 2008, BBA-GENE REGUL MECH, V1779, P830, DOI 10.1016/j.bbagrm.2008.08.007; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ivanova T, 2002, J NEUROENDOCRINOL, V14, P73, DOI 10.1046/j.0007-1331.2001.00742.x; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Lee J, 2009, BRAIN RES, V1288, P125, DOI 10.1016/j.brainres.2009.06.095; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mccoy ES, 2010, NEUROSCIENCE, V168, P971, DOI 10.1016/j.neuroscience.2009.09.020; Mccoy E, 2007, GLIA, V55, P1034, DOI 10.1002/glia.20524; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Noell S, 2007, EUR J NEUROSCI, V26, P2109, DOI 10.1111/j.1460-9568.2007.05850.x; Noell S, 2009, CELL TISSUE RES, V337, P185, DOI 10.1007/s00441-009-0812-z; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; ROHLMANN A, 1992, GLIA, V5, P259, DOI 10.1002/glia.440050404; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; SERANO RD, 1980, ACTA NEUROPATHOL, V51, P53, DOI 10.1007/BF00688850; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sontheimer H, 2004, MOL NEUROBIOL, V29, P61, DOI 10.1385/MN:29:1:61; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Verkman AS, 2000, CURR OPIN NEPHROL HY, V9, P517, DOI 10.1097/00041552-200009000-00010; Warth A, 2005, ACTA NEUROPATHOL, V109, P418, DOI 10.1007/s00401-005-0984-x; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Wolburg H, 2012, MOL ASPECTS IN PRESS; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; ZELENINA M N, 1985, Biokhimiya, V50, P439; ZELENINA M N, 1986, Biokhimiya, V51, P77; Zhang H, 2008, J MOL BIOL, V382, P1136, DOI 10.1016/j.jmb.2008.07.089	43	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36555	10.1371/journal.pone.0036555	http://dx.doi.org/10.1371/journal.pone.0036555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590566	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100039
J	Wilson, C; Maxwell, PJ; Longley, DB; Wilson, RH; Johnston, PG; Waugh, DJJ				Wilson, Catherine; Maxwell, Pamela J.; Longley, Daniel B.; Wilson, Richard H.; Johnston, Patrick G.; Waugh, David J. J.			Constitutive and Treatment-Induced CXCL8-Signalling Selectively Modulates the Efficacy of Anti-Metabolite Therapeutics in Metastatic Prostate Cancer	PLOS ONE			English	Article							THYMIDYLATE SYNTHASE; PHASE-II; INTERLEUKIN-8; EXPRESSION; 5-FLUOROURACIL; PROLIFERATION; CHEMOTHERAPY; CELLS; GENE; OXALIPLATIN	Background: The current study was undertaken to characterize the effect of anti-metabolites on inducing CXCL8 signaling and determining whether the constitutive and/or drug-induced CXCL8 signaling in metastatic prostate cancer (CaP) cells modulates their sensitivity to this class of agent. Methods: The response of metastatic CaP cells to 5-Fluorouracil (5-FU), Pemetrexed or Tomudex was determined using cell count assays, flow cytometry and PARP cleavage analysis. Quantitative-PCR, ELISA and immunoblots were employed to determine effects of drugs or CXCL8 administration on target gene/protein expression. Results: Administration of 5-FU but not pemetrexed potentiated CXCL8 secretion and increased CXCR1 and CXCR2 gene expression in metastatic PC3 cells. Consistent with this, the inhibition of CXCL8 signaling using a CXCR2 antagonist, AZ10397767, increased the cytotoxicity of 5-FU by 4-fold ( P<0.001), and increased 5-FU-induced apoptosis in PC3 cells (P<0.01). In contrast, while administration of AZ10397767 had no effect on the sensitivity of pemetrexed, the CXCR2 antagonist exerted the greatest effect in increasing the sensitivity of PC3 cells to Tomudex, a directed thymidylate synthase (TS) inhibitor. Subsequent experiments confirmed that administration of recombinant human CXCL8 increased TS expression, a response mediated in part by the CXCR2 receptor. Moreover, siRNA-mediated knockdown of the CXCL8-target gene Bcl-2 increased the sensitivity of PC3 cells to 5-FU. Conclusions: CXCL8 signaling provides a selective resistance of metastatic prostate cancer cells to specific anti-metabolites by promoting a target-associated resistance, in addition to underpinning an evasion of treatment-induced apoptosis.	[Wilson, Catherine; Maxwell, Pamela J.; Longley, Daniel B.; Wilson, Richard H.; Johnston, Patrick G.; Waugh, David J. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Wilson, C (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	d.waugh@qub.ac.uk		WAUGH, DAVID/0000-0002-4022-3765	Ulster Cancer Foundation; Department of Employment and Learning, Northern Ireland	Ulster Cancer Foundation; Department of Employment and Learning, Northern Ireland	Research was supported by an unrestricted research grant from the Ulster Cancer Foundation (DJJW and PGJ) and a PhD Stipend award ( CW) from the Department of Employment and Learning, Northern Ireland. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei AA, 2004, CLIN CANCER RES, V10, p4276S, DOI 10.1158/1078-0432.CCR-040010; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Attard G, 2010, J CLIN ONCOL, V28, pE560, DOI 10.1200/JCO.2010.29.5170; Bendre MS, 2002, CANCER RES, V62, P5571; Caffo O, 2011, UROL ONCOL; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Droz JP, 2003, ANN ONCOL, V14, P1291, DOI 10.1093/annonc/mdg342; Blesa JMG, 2011, AM J CLIN ONCOL-CANC, V34, P155, DOI 10.1097/COC.0b013e3181d6b453; Hahn NM, 2009, ANN ONCOL, V20, P1971, DOI 10.1093/annonc/mdp244; JOHNSTON PG, 1995, CANCER RES, V55, P1407; KAIGHN ME, 1979, INVEST UROL, V17, P16; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Seaton A, 2009, BRIT J CANCER, V101, P1620, DOI 10.1038/sj.bjc.6605356; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Uehara H, 2005, PROSTATE, V64, P40, DOI 10.1002/pros.20223; Vaishampayan UN, 2009, J UROLOGY, V182, P317, DOI 10.1016/j.juro.2009.02.105; Veltri RW, 2001, CANCER-AM CANCER SOC, V91, P2322, DOI 10.1002/1097-0142(20010615)91:12<2322::AID-CNCR1264>3.0.CO;2-H; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148	25	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36545	10.1371/journal.pone.0036545	http://dx.doi.org/10.1371/journal.pone.0036545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590561	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100036
J	Yoder, AR; Robinson, JW; Dickey, DM; Andersland, J; Rose, BA; Stone, MD; Griffin, TJ; Potter, LR				Yoder, Andrea R.; Robinson, Jerid W.; Dickey, Deborah M.; Andersland, Joshua; Rose, Beth A.; Stone, Matthew D.; Griffin, Timothy J.; Potter, Lincoln R.			A Functional Screen Provides Evidence for a Conserved, Regulatory, Juxtamembrane Phosphorylation Site in Guanylyl Cyclase A and B	PLOS ONE			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; PROTEIN-KINASE-C; DEPENDENT DESENSITIZATION; DEPHOSPHORYLATION; ACTIVATION; IDENTIFICATION; MECHANISM; INHIBITION	Kinase homology domain (KHD) phosphorylation is required for activation of guanylyl cyclase (GC)-A and -B. Phosphopeptide mapping identified multiple phosphorylation sites in GC-A and GC-B, but these approaches have difficulty identifying sites in poorly detected peptides. Here, a functional screen was conducted to identify novel sites. Conserved serines or threonines in the KHDs of phosphorylated receptor GCs were mutated to alanine and tested for reduced hormone to detergent activity ratios. Mutation of Ser-489 in GC-B to alanine but not glutamate reduced the activity ratio to 60% of wild type (WT) levels. Similar results were observed with Ser-473, the homologous site in GC-A. Receptors containing glutamates for previously identified phosphorylation sites (GC-A-6E and GC-B-6E) were activated to similar to 20% of WT levels but the additional glutamate substitution for S473 or S489 increased activity to near WT levels. Substrate-velocity assays indicated that GC-B-WT-S489E and GC-B-6E-S489E had lower Km values and that WT-GC-B-S489A, GC-B-6E and GC-B-6E-S489A had higher Km values than WT-GC-B. Homologous desensitization was enhanced when GC-A contained the S473E substitution, and GC-B-6E-S489E was resistant to inhibition by a calcium elevating treatment or protein kinase C activation - processes that dephosphorylate GC-B. Mass spectrometric detection of a synthetic phospho-Ser-473 containing peptide was 200-1300-fold less sensitive than other phosphorylated peptides and neither mass spectrometric nor (PO4)-P-32 co-migration studies detected phospho-Ser-473 or phospho-Ser-489 in cells. We conclude that Ser-473 and Ser-489 are Km-regulating phosphorylation sites that are difficult to detect using current methods.	[Yoder, Andrea R.; Robinson, Jerid W.; Potter, Lincoln R.] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Dickey, Deborah M.; Andersland, Joshua; Rose, Beth A.; Stone, Matthew D.; Griffin, Timothy J.; Potter, Lincoln R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Potter, LR (corresponding author), Univ Minnesota, Dept Pharmacol, Sch Med, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	potter@umn.edu		Griffin, Timothy/0000-0001-6801-2559	NHLBI NIH HHS [R21 HL093402] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093402] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbey-Hosch SE, 2005, BIOCHEM PHARMACOL, V70, P686, DOI 10.1016/j.bcp.2005.04.034; Antos LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1756, DOI 10.1152/ajpendo.00321.2007; Antos LK, 2005, J BIOL CHEM, V280, P26928, DOI 10.1074/jbc.M505648200; BENTLEY JK, 1986, J BIOL CHEM, V261, P4859; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Joubert S, 2001, BIOCHEMISTRY-US, V40, P11096, DOI 10.1021/bi010580s; KOLLER KJ, 1993, J BIOL CHEM, V268, P5997; Misono KS, 2011, FEBS J, V278, P1818, DOI 10.1111/j.1742-4658.2011.08083.x; Muller D, 2006, ENDOCRINOLOGY, V147, P2974, DOI 10.1210/en.2006-0092; Potter LR, 2011, CELL SIGNAL, V23, P1921, DOI 10.1016/j.cellsig.2011.09.001; Potter LR, 2011, PHARMACOL THERAPEUT, V130, P71, DOI 10.1016/j.pharmthera.2010.12.005; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Potter LR, 2000, J BIOL CHEM, V275, P31099, DOI 10.1074/jbc.M005506200; Potter LR, 1998, J BIOL CHEM, V273, P15533, DOI 10.1074/jbc.273.25.15533; POTTER LR, 1992, J BIOL CHEM, V267, P14531; Potter LR, 1998, BIOCHEMISTRY-US, V37, P2422, DOI 10.1021/bi972303k; POTTER LR, 1994, J BIOL CHEM, V269, P14636; Potter LR, 1999, MOL BIOL CELL, V10, P1811, DOI 10.1091/mbc.10.6.1811; Potter LR, 1999, METHODS, V19, P506, DOI 10.1006/meth.1999.0893; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potter LR, 1998, MOL CELL BIOL, V18, P2164, DOI 10.1128/MCB.18.4.2164; Potthast R, 2004, J BIOL CHEM, V279, P48513, DOI 10.1074/jbc.M408247200; RAMARAO CS, 1988, J BIOL CHEM, V263, P1524; Robinson JW, 2011, J BIOL CHEM, V286, P33841, DOI 10.1074/jbc.M111.273565; Schroter J, 2010, FEBS J, V277, P2440, DOI 10.1111/j.1742-4658.2010.07658.x; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VACQUIER VD, 1986, BIOCHEM BIOPH RES CO, V137, P1148, DOI 10.1016/0006-291X(86)90345-1; Yoder AR, 2010, BIOCHEMISTRY-US, V49, P10137, DOI 10.1021/bi101700e	29	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36747	10.1371/journal.pone.0036747	http://dx.doi.org/10.1371/journal.pone.0036747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590601	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100058
J	Chatonnet, F; Guyot, R; Picou, F; Bondesson, M; Flamant, F				Chatonnet, Fabrice; Guyot, Romain; Picou, Frederic; Bondesson, Maria; Flamant, Frederic			Genome-Wide Search Reveals the Existence of a Limited Number of Thyroid Hormone Receptor Alpha Target Genes in Cerebellar Neurons	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CELL; IDENTIFICATION; EXPRESSION; MUTATION; ABSENCE; MICE; THYROID-HORMONE-RECEPTOR-ALPHA-1; DISRUPTION; IMPAIRMENT	Thyroid hormone (T3) has a major influence on cerebellum post-natal development. The major phenotypic landmark of exposure to low levels of T3 during development (hypothyroidism) in the cerebellum is the retarded inward migration of the most numerous cell type, granular neurons. In order to identify the direct genetic regulation exerted by T3 on cerebellar neurons and their precursors, we used microarray RNA hybridization to perform a time course analysis of T3 induced gene expression in primary cultures of cerebellar neuronal cell. These experiments suggest that we identified a small set of genes which are directly regulated, both in vivo and in vitro, during cerebellum post-natal development. These modest changes suggest that T3 does not acts directly on granular neurons and mainly indirectly influences the cellular interactions taking place during development.	[Chatonnet, Fabrice; Guyot, Romain; Picou, Frederic; Flamant, Frederic] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France; [Bondesson, Maria] Karolinska Inst, Novum, Stockholm, Sweden	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Karolinska Institutet	Chatonnet, F (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, INRA,Ecole Normale Super Lyon, F-69365 Lyon, France.	Frederic.Flamant@ens-lyon.fr	Bondesson, Maria/H-3027-2012; Chatonnet, Fabrice/AHI-8250-2022; PICOU, FREDERIC/AAC-4695-2022	Bondesson, Maria/0000-0001-6358-5788; Chatonnet, Fabrice/0000-0003-3639-6775; PICOU, FREDERIC/0000-0002-2066-2146	CRESCENDO [LSHM-CT-2005-018652]; CASCADE network of excellence [FOOD-CT-2004-506319]; Agence Nationale pour la Recherche	CRESCENDO(European Commission); CASCADE network of excellence; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the CRESCENDO European integrated project (LSHM-CT-2005-018652), CASCADE network of excellence (FOOD-CT-2004-506319), and Agence Nationale pour la Recherche (Switch program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CDC, 2005, PROG EXP TUMOR RES, V38, P139; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Chatonnet F, 2011, J THROID RES, V2011, DOI 10.4061/2011/145762; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chesney J, 2005, BIOCHEM BIOPH RES CO, V331, P139, DOI 10.1016/j.bbrc.2005.02.193; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Diez D, 2008, ENDOCRINOLOGY; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Dong HY, 2005, BIOCHEM BIOPH RES CO, V330, P1182, DOI 10.1016/j.bbrc.2005.03.099; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Durand B, 2000, BIOESSAYS, V22, P64; Fauquier T, 2011, DEV BIOL, V356, P350, DOI 10.1016/j.ydbio.2011.05.657; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; Hashimoto K, 2001, P NATL ACAD SCI USA, V98, P3998, DOI 10.1073/pnas.051454698; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Heuer H, 2003, J NEUROSCI, V23, P10604; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P9913, DOI 10.1073/pnas.171319498; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Kobayashi K, 2009, BRAIN RES, V1264, P24, DOI 10.1016/j.brainres.2008.12.029; Koibuchi N, 2009, CEREBELLUM, V8, P89, DOI 10.1007/s12311-008-0089-x; Komuro H, 2003, CELL MOL LIFE SCI, V60, P1084, DOI 10.1007/s00018-003-2248-z; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Manzano J, 2007, ENDOCRINOLOGY, V148, P5746, DOI 10.1210/en.2007-0567; Manzano J, 2007, INT J DEV NEUROSCI, V25, P171, DOI 10.1016/j.ijdevneu.2007.01.003; Martel J, 2002, NEUROREPORT, V13, P1849, DOI 10.1097/00001756-200210280-00003; Mi RF, 2005, EXP NEUROL, V194, P301, DOI 10.1016/j.expneurol.2004.07.011; Michalski JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019772; Molnar ZN, 2002, J NEUROSCI, V22, P10313; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; Morte B, 2010, ENDOCRINOLOGY, V151, P810, DOI 10.1210/en.2009-0958; NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9; Nielsen JV, 2010, CEREB CORTEX, V20, P1904, DOI 10.1093/cercor/bhp261; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pitari G, 2000, FEBS LETT, V483, P149, DOI 10.1016/S0014-5793(00)02110-4; Poguet AL, 2003, DEV BIOL, V254, P188, DOI 10.1016/S0012-1606(02)00039-8; Potter GB, 2001, J NEUROSCI, V21, P4373, DOI 10.1523/JNEUROSCI.21-12-04373.2001; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sutherland APR, 2009, MOL CELL BIOL, V29, P2804, DOI 10.1128/MCB.01667-08; Takahashi M, 2008, J NEUROCHEM, V104, P640, DOI 10.1111/j.1471-4159.2007.05049.x; Thompson CC, 2000, CEREB CORTEX, V10, P939, DOI 10.1093/cercor/10.10.939; Trentin AG, 1998, IN VITRO CELL DEV-AN, V34, P280; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wallis K, 2010, MOL ENDOCRINOL, V24, P1904, DOI 10.1210/me.2010-0175; Xie ZF, 2010, P NATL ACAD SCI USA, V107, P6510, DOI 10.1073/pnas.0912315107; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhang HM, 2008, MOL CELL BIOCHEM, V307, P169, DOI 10.1007/s11010-007-9596-1	65	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e30703	10.1371/journal.pone.0030703	http://dx.doi.org/10.1371/journal.pone.0030703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586439	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335000001
J	Lee, S; Rocha, LEC; Liljeros, F; Holme, P				Lee, Sungmin; Rocha, Luis E. C.; Liljeros, Fredrik; Holme, Petter			Exploiting Temporal Network Structures of Human Interaction to Effectively Immunize Populations	PLOS ONE			English	Article							TRANSMISSION; VACCINATION; SPREAD	Decreasing the number of people who must be vaccinated to immunize a community against an infectious disease could both save resources and decrease outbreak sizes. A key to reaching such a lower threshold of immunization is to find and vaccinate people who, through their behavior, are more likely than average to become infected and to spread the disease further. Fortunately, the very behavior that makes these people important to vaccinate can help us to localize them. Earlier studies have shown that one can use previous contacts to find people that are central in static contact networks. However, real contact patterns are not static. In this paper, we investigate if there is additional information in the temporal contact structure for vaccination protocols to exploit. We answer this affirmative by proposing two immunization methods that exploit temporal correlations and showing that these methods outperform a benchmark static-network protocol in four empirical contact datasets under various epidemic scenarios. Both methods rely only on obtainable, local information, and can be implemented in practice. For the datasets directly related to contact patterns of potential disease spreading ( of sexually-transmitted and nosocomial infections respectively), the most efficient protocol is to sample people at random and vaccinate their latest contacts. The network datasets are temporal, which enables us to make more realistic evaluations than earlier studies-we use only information about the past for the purpose of vaccination, and about the future to simulate disease outbreaks. Using analytically tractable models, we identify two temporal structures that explain how the protocols earn their efficiency in the empirical data. This paper is a first step towards real vaccination protocols that exploit temporal-network structure-future work is needed both to characterize the structure of real contact sequences and to devise immunization methods that exploit these.	[Lee, Sungmin; Rocha, Luis E. C.; Holme, Petter] Umea Univ, Dept Phys, IceLab, Umea, Sweden; [Liljeros, Fredrik; Holme, Petter] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Holme, Petter] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	Umea University; Stockholm University; Sungkyunkwan University (SKKU)	Lee, S (corresponding author), Umea Univ, Dept Phys, IceLab, Umea, Sweden.	petter.holme@physics.umu.se	Rocha, Luis/D-5333-2011; Rocha, Luis/AAB-4049-2019; Liljeros, Fredrik G I/I-2667-2018; Lee, Sungmin/F-2317-2010; Holme, Petter/A-7646-2008	Rocha, Luis/0000-0001-9046-8739; Liljeros, Fredrik G I/0000-0001-8642-6624; Lee, Sungmin/0000-0001-7902-3229; Holme, Petter/0000-0003-2156-1096	Wenner-Gren Foundations; Swedish Research Council; National Research Foundation Korea; Ministry of Education, Science and Technology [R31-2008-000-10029-0]; Riksbankens Jubileumsfond	Wenner-Gren Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); National Research Foundation Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Riksbankens Jubileumsfond	This research was supported by the Wenner-Gren Foundations (SL), the Swedish Research Council (PH) and the World Class University program through National Research Foundation Korea funded by Ministry of Education, Science and Technology R31-2008-000-10029-0 (PH) and Riksbankens Jubileumsfond (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2004, INFECT DIS HUMANS; Balthrop J, 2004, SCIENCE, V304, P527, DOI 10.1126/science.1095845; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Holme P, 2004, EUROPHYS LETT, V68, P908, DOI 10.1209/epl/i2004-10286-2; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; KATZ BP, 1992, STAT MED, V11, P565, DOI 10.1002/sim.4780110502; Khan A, 2005, SEX TRANSM DIS, V32, P260, DOI 10.1097/01.olq.0000161089.53411.cb; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Liljeros F, 2007, MATH POPUL STUD, V14, P269, DOI 10.1080/08898480701612899; Litvak-Hinenzon A, 2009, J R SOC INTERFACE, V6, P749, DOI 10.1098/rsif.2008.0343; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Moore C, 2000, PHYS REV E, V61, P5678, DOI 10.1103/PhysRevE.61.5678; Nordvik MK, 2006, SEX TRANSM DIS, V33, P342, DOI 10.1097/01.olq.0000194601.25488.b8; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Riolo CS, 2001, J URBAN HEALTH, V78, P446, DOI 10.1093/jurban/78.3.446; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Shaw LB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046120; Thomas HC, 1998, ENCY IMMUNOLOGY, P1075; Wang B, 2009, PHYS LETT A, V373, P3877, DOI 10.1016/j.physleta.2009.08.023; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201	30	66	71	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36439	10.1371/journal.pone.0036439	http://dx.doi.org/10.1371/journal.pone.0036439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586472	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305335000034
J	Nonaka, D; Jimba, M; Mizoue, T; Kobayashi, J; Yasuoka, J; Ayi, I; Jayatilleke, AC; Shrestha, S; Kikuchi, K; Haque, SE; Yi, SY				Nonaka, Daisuke; Jimba, Masamine; Mizoue, Tetsuya; Kobayashi, Jun; Yasuoka, Junko; Ayi, Irene; Jayatilleke, Achini C.; Shrestha, Sabina; Kikuchi, Kimiyo; Haque, Syed E.; Yi, Siyan			Content Analysis of Primary and Secondary School Textbooks Regarding Malaria Control: A Multi-Country Study	PLOS ONE			English	Article							HEALTH-EDUCATION; NET USE; COMMUNITY; KNOWLEDGE; SCHOOLCHILDREN; CONSEQUENCES; CHILDREN	Background: In tropical settings, malaria education at school is potentially useful, but textbook content related to malaria education has so far received little attention. This study aimed to examine whether school textbooks contain sufficient knowledge and skills to help children in primary and lower secondary schools and their family members to cope with malaria. Methodology/Principal Findings: This was a descriptive, cross-country study. We collected textbooks that were used by children in grades one to nine from nine countries endemic for malaria: Laos, Cambodia, Nepal, Bangladesh, Sri Lanka, Zambia, Niger, Benin, and Ghana. Two reviewers per country identified descriptions about malaria by seeking the term "malaria" or a local word that corresponds to malaria in languages other than English. The authors categorized the identified descriptions according to the content of the descriptions. Additionally, the authors examined whether the identified contents addressed life skill messages. Of a total of 474 textbooks collected, 35 contained descriptions about malaria. The most commonly included content was transmission mode/vector (77.1%), followed by preventive measures (60.0%), epidemiology (57.1%), cause/agent (54.3%), signs/symptoms (37.1%) and treatment (22.9%). Treatment-related content was not included in any textbooks from four countries and textbooks failed to recommend the use of insecticide-treated bed nets in five countries. Very few textbooks included content that facilitated prompt treatment, protection of risk groups, and use of recommended therapy. Conclusion/Significance: Textbooks rarely included knowledge and skills that are crucial to protect schoolchildren and their families from malaria. This study identified the need for improvement to textbook contents regarding malaria.	[Nonaka, Daisuke] Univ Ryukyus, Grad Sch Med, Dept Parasitol & Int Hlth, Okinawa, Japan; [Jimba, Masamine; Yasuoka, Junko; Jayatilleke, Achini C.; Shrestha, Sabina; Kikuchi, Kimiyo; Haque, Syed E.] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Int Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Kobayashi, Jun] Nagasaki Univ, Grad Sch Int Hlth Dev, Nagasaki 852, Japan; [Kobayashi, Jun] Natl Ctr Global Hlth & Med, Dept Int Med Cooperat, Tokyo, Japan; [Ayi, Irene] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Yi, Siyan] Stanford Univ, Walter H Shorenstein Asia Pacific Res Ctr, Freeman Spogli Inst Int Studies, Palo Alto, CA 94304 USA	University of the Ryukyus; University of Tokyo; National Center for Global Health & Medicine - Japan; Nagasaki University; National Center for Global Health & Medicine - Japan; University of Ghana; Stanford University	Nonaka, D (corresponding author), Univ Ryukyus, Grad Sch Med, Dept Parasitol & Int Hlth, Okinawa, Japan.	laodaisuke@hotmail.co.jp	Nonaka, Daisuke/AAP-7918-2021; Yasuoka, Junko/GVT-8950-2022; Ayi, Irene/AAD-3588-2020; Ayi, Irene/AFR-9042-2022; Daisuke, Nonaka/AAB-8509-2020; Jimba, Masamine/AAF-5630-2020	Ayi, Irene/0000-0003-3054-9494; Daisuke, Nonaka/0000-0001-6793-2062; Emdadul Haque, Syed/0000-0002-9739-1225	Ministry of Health, Labour, and Welfare of Japan [H21-chikyukibo-wakate-011]	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded by the Ministry of Health, Labour, and Welfare of Japan (research grant number: H21-chikyukibo-wakate-011; http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo16/02-01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Akello Grace, 2007, Afr Health Sci, V7, P73; Alper Z, 2005, EDUC HEALTH, V18, P209, DOI 10.1080/13576280500148163; [Anonymous], ROLL BACK MAL STRAT; [Anonymous], 2004, COCHRANE DB SYST REV; Arogundade ED, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-170; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; Biswas AK, 2010, T ROY SOC TROP MED H, V104, P423, DOI 10.1016/j.trstmh.2010.01.001; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; CNN, 2012, IPAD SOL ED TOOL STU; d'Almeida TCDA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-108; de Irala J, 2008, PUBLIC HEALTH, V122, P1093, DOI 10.1016/j.puhe.2008.01.005; Edson F, 2007, Tanzan Health Res Bull, V9, P207; FRESH tool kit, 2001, LEARN MAL PRIM SCH; Garcia-Basteiro AL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-179; Geissler PW, 2001, HEALTH POLICY PLANN, V16, P362, DOI 10.1093/heapol/16.4.362; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Ibidapo Comfort A, 2005, Aust J Rural Health, V13, P214, DOI 10.1111/j.1440-1584.2005.00704.x; Imbahale SS, 2010, ACTA TROP, V115, P248, DOI 10.1016/j.actatropica.2010.04.005; Khun S, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000143; Kinung'hi SM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-395; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Matranga A, 2007, THE J, V34, P40; Midzi N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-169; Ministry of Education Youth Sport, 2006, SCH HLTH POL; Nomoto M, 2011, BIOSCI TRENDS, V5, P61, DOI 10.5582/bst.2011.v5.2.61; Nonaka D, 2008, PARASITOL INT, V57, P76, DOI 10.1016/j.parint.2007.09.005; Paulander Johan, 2009, Glob Health Action, V2, DOI 10.3402/gha.v2i0.1839; Phinney R, 1993, Dev Commun Rep, P7; Pleasant A, 2008, HEALTH PROMOT INT, V23, P152, DOI 10.1093/heapro/dan001; UNESCO, 2011, OV IN WHY GOV MATT; United Nations Children's Fund (UNICEF), 2010, FACTS LIF, VFourth; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organisation, 2008, WORLD MAL REP 2008; World Health Organization, 2007, WHO INF SER SCH HLTH; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	41	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36629	10.1371/journal.pone.0036629	http://dx.doi.org/10.1371/journal.pone.0036629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574203	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800100
J	Yaffe, J; Montgomery, P; Hopewell, S; Shepard, LD				Yaffe, Joanne; Montgomery, Paul; Hopewell, Sally; Shepard, Lindsay Dianne			Empty Reviews: A Description and Consideration of Cochrane Systematic Reviews with No Included Studies	PLOS ONE			English	Review								Background: There is no specific guidance for the reporting of Cochrane systematic reviews that do not have studies eligible for inclusion. As a result, the reporting of these so-called "empty reviews" may vary across reviews. This research explores the incidence of empty systematic reviews in The Cochrane Database of Systematic Reviews (The CDSR) and describes their current characteristics. Methodology/Principal Findings: Empty reviews within The CDSR as of 15 August 2010 were identified, extracted, and coded for analysis. Review group, original publication year, and time since last update, as well as number of studies listed as excluded, awaiting assessment, or on-going within empty reviews were examined. 376 (8.7%) active reviews in The CDSR reported no included studies. At the time of data collection, 45 (84.9%) of the Cochrane Collaboration's 53 Review Groups sustained at least one empty review, with the number of empty reviews for each of these 45 groups ranging from 1 to 35 (2.2-26.9%). Time since original publication of empty reviews ranged from 0 to 15 years with a mean of 4.2 years (SD = 3.4). Time since last assessed as up-to-date ranged from 0 to 12 years with a mean of 2.8 years (SD = 2.2). The number of excluded studies reported in these reviews ranged from 0 to 124, with an average of 9.6 per review (SD = 14.5). Eighty-eight (23.4%) empty reviews reported no excluded studies, studies awaiting assessment, or on-going studies. Conclusions: There is a substantial number of empty reviews in The CDSR, and there is some variation in the reporting and updating of empty reviews across Cochrane Review Groups. This variation warrants further analysis, and may indicate a need to develop guidance for the reporting of empty systematic reviews in The CDSR.	[Yaffe, Joanne; Shepard, Lindsay Dianne] Univ Utah, Coll Social Work, Salt Lake City, UT 84112 USA; [Montgomery, Paul] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Hopewell, Sally] Univ Oxford, Ctr Stat Med, Oxford, England	Utah System of Higher Education; University of Utah; University of Oxford; University of Oxford	Yaffe, J (corresponding author), Univ Utah, Coll Social Work, Salt Lake City, UT 84112 USA.	joanne.yaffe@utah.edu	Yaffe, Joanne/W-1101-2019	Yaffe, Joanne/0000-0003-4874-6787; Hopewell, Sally/0000-0002-6881-6984	Cochrane Opportunities Fund	Cochrane Opportunities Fund	The Cochrane Empty Reviews Project is funded by the Cochrane Opportunities Fund (http://www.cochrane.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clarke M, 2008, LANCET, V371, P384, DOI 10.1016/S0140-6736(08)60196-8; Cooper H, 2010, RES SYNTHESIS META A, V4; Green S, 2007, J CLIN EPIDEMIOL, V60, P598, DOI 10.1016/j.jclinepi.2007.02.001; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Kristiansen IS, 2008, LANCET, V371, P384, DOI 10.1016/S0140-6736(08)60195-6; Lang A, 2007, J CLIN EPIDEMIOL, V60, P595, DOI 10.1016/j.jclinepi.2007.01.005; Pagliaro L, 2010, DIGEST LIVER DIS, V42, P1, DOI 10.1016/j.dld.2009.07.003; Schlosser R, 2009, EVID BASED COMMUN AS, V3, P1, DOI DOI 10.1080/17489530902801067	9	89	91	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36626	10.1371/journal.pone.0036626	http://dx.doi.org/10.1371/journal.pone.0036626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574201	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800098
J	Stanton-Geddes, J; Shaw, RG; Tiffin, P				Stanton-Geddes, John; Shaw, Ruth G.; Tiffin, Peter			Interactions between Soil Habitat and Geographic Range Location Affect Plant Fitness	PLOS ONE			English	Article							COAST DUNE PLANT; LOCAL ADAPTATION; CLARKIA-XANTIANA; CLINAL PATTERNS; TRADE-OFFS; SELECTION; EVOLUTION; FASCICULATA; PERFORMANCE; GROWTH	Populations are often found on different habitats at different geographic locations. This habitat shift may be due to biased dispersal, physiological tolerances or biotic interactions. To explore how fitness of the native plant Chamaecrista fasciculata depends on habitat within, at and beyond its range edge, we planted seeds from five populations in two soil substrates at these geographic locations. We found that with reduced competition, lifetime fitness was always greater or equivalent in one habitat type, loam soils, though early-season survival was greater on sand soils. At the range edge, natural populations are typically found on sand soil habitats, which are also less competitive environments. Early-season survival and fitness differed among source populations, and when transplanted beyond the range edge, range edge populations had greater fitness than interior populations. Our results indicate that even when the optimal soil substrate for a species does not change with geographic range location, the realized niche of a species may be restricted to sub-optimal habitats at the range edge because of the combined effects of differences in abiotic and biotic effects (e.g. competitors) between substrates.	[Stanton-Geddes, John; Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tiffin, Peter] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stanton-Geddes, J (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	stant067@umn.edu		Stanton-Geddes, John/0000-0003-4667-2542; Tiffin, Peter/0000-0003-1975-610X	Rothman Fellowship from the Univ. of Minnesota; Dayton Fellowship from the Univ. of Minnesota; Carolyn Crosby Fellowship from the Univ. of Minnesota; Ray C. Anderson and John Hall Memorial Research Fellowship from the Univ. of Minnesota; Minnesota Center for Community Genetics; National Science Foundation [DEB-0544970, DEB-0515466, DBI-0701911]; Direct For Biological Sciences [1051791] Funding Source: National Science Foundation	Rothman Fellowship from the Univ. of Minnesota; Dayton Fellowship from the Univ. of Minnesota; Carolyn Crosby Fellowship from the Univ. of Minnesota; Ray C. Anderson and John Hall Memorial Research Fellowship from the Univ. of Minnesota; Minnesota Center for Community Genetics; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Rothman, Dayton, Carolyn Crosby, Ray C. Anderson and John Hall Memorial Research Fellowships from the Univ. of Minnesota, the Minnesota Center for Community Genetics, and National Science Foundation (http://www.nsf.gov, http://www.nsf.gov/) grants DEB-0544970, DEB-0515466 and DBI-0701911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; BAZZAZ FA, 1991, AM NAT, V137, pS116, DOI 10.1086/285142; Bischoff A, 2006, J ECOL, V94, P1130, DOI 10.1111/j.1365-2745.2006.01174.x; Bissett A, 2010, MOL ECOL, V19, P4315, DOI 10.1111/j.1365-294X.2010.04804.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Clausen J., 1940, CARNEGIE I WASH PUBL, V520; Cremieux L, 2008, NEW PHYTOL, V180, P524, DOI 10.1111/j.1469-8137.2008.02545.x; Darling E, 2008, NEW PHYTOL, V178, P424, DOI 10.1111/j.1469-8137.2007.02349.x; Eckhart VM, 2010, INT J PLANT SCI, V171, P749, DOI 10.1086/654845; Ehlers BK, 2004, OECOLOGIA, V141, P511, DOI 10.1007/s00442-004-1663-7; Etterson JR, 2004, EVOLUTION, V58, P1446, DOI 10.1111/j.0014-3820.2004.tb01726.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; FOOTE LE, 1966, ECOLOGY, V47, P968, DOI 10.2307/1935644; Galloway LF, 2000, EVOLUTION, V54, P1173, DOI 10.1111/j.0014-3820.2000.tb00552.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Geber MA, 2005, EVOLUTION, V59, P521; Geyer CJ, 2007, BIOMETRIKA, V94, P415, DOI 10.1093/biomet/asm030; Griffith TM, 2006, AM NAT, V167, P153, DOI 10.1086/498945; Griggs R. F., 1914, B TORREY BOT CLUB, V41, P25, DOI [10.2307/2479433, DOI 10.2307/2479433]; Henne PD, 2007, J ECOL, V95, P517, DOI 10.1111/j.1365-2745.2007.01220.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Irwin HS, 1982, AM CASSIINAE SYNOPTI, P802; KAVANAGH K, 1986, J BIOGEOGR, V13, P145, DOI 10.2307/2844989; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lopez S, 2009, CONSERV BIOL, V23, P1618, DOI 10.1111/j.1523-1739.2009.01326.x; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; MACNAIR MR, 1987, TRENDS ECOL EVOL, V2, P354, DOI 10.1016/0169-5347(87)90135-2; Marsico TD, 2009, OIKOS, V118, P1783, DOI 10.1111/j.1600-0706.2009.17698.x; Ownbey GB, 1993, VASCULAR PLANTS MINN; PRINCE SD, 1985, J ECOL, V73, P49, DOI 10.2307/2259767; R Core Team, 2020, R LANG ENV STAT COMP; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Sagarin RD, 2002, ECOL LETT, V5, P137, DOI 10.1046/j.1461-0248.2002.00297.x; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Samis KE, 2009, ECOLOGY, V90, P3051, DOI 10.1890/08-1914.1; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SCHOENER TW, 1975, ECOL MONOGR, V45, P233, DOI 10.2307/1942423; Shaw R. G., 2007, 658 U MINN SCH STAT; Shaw RG, 2008, AM NAT, V172, pE35, DOI 10.1086/588063; Stanton-Geddes J, ECOLOGY IN PRESS; Turreson G, 1922, HEREDITAS, V3; Venables WN., 2002, MODERN APPL STAT S 4; Warren RJ, 2010, NEW PHYTOL, V185, P1038, DOI 10.1111/j.1469-8137.2009.03147.x; WERNER EE, 1977, ECOLOGY, V58, P869, DOI 10.2307/1936222; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	48	24	24	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36015	10.1371/journal.pone.0036015	http://dx.doi.org/10.1371/journal.pone.0036015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615745	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200004
J	Schadelin, FC; Fischer, S; Wagner, RH				Schaedelin, Franziska C.; Fischer, Stefan; Wagner, Richard H.			Reduction in Predator Defense in the Presence of Neighbors in a Colonial Fish	PLOS ONE			English	Article							BY-PRODUCT MUTUALISM; RECIPROCAL ALTRUISM; PARENTAL DEFENSE; NEST DEFENSE; PARUS-MAJOR; GROUP-SIZE; BEHAVIOR; MITOCHONDRIAL; INFORMATION; COOPERATION	Predation pressure has long been considered a leading explanation of colonies, where close neighbors may reduce predation via dilution, alarming or group predator attacks. Attacking predators may be costly in terms of energy and survival, leading to the question of how neighbors contribute to predator deterrence in relationship to each other. Two hypotheses explaining the relative efforts made by neighbors are byproduct-mutualism, which occurs when breeders inadvertently attack predators by defending their nests, and reciprocity, which occurs when breeders deliberately exchange predator defense efforts with neighbors. Most studies investigating group nest defense have been performed with birds. However, colonial fish may constitute a more practical model system for an experimental approach because of the greater ability of researchers to manipulate their environment. We investigated in the colonial fish, Neolamprologus caudopunctatus, whether prospecting pairs preferred to breed near conspecifics or solitarily, and how breeders invested in anti-predator defense in relation to neighbors. In a simple choice test, prospecting pairs selected breeding sites close to neighbors versus a solitary site. Predators were then sequentially presented to the newly established test pairs, the previously established stimulus pairs or in between the two pairs. Test pairs attacked the predator eight times more frequently when they were presented on their non-neighbor side compared to between the two breeding sites, where stimulus pairs maintained high attack rates. Thus, by joining an established pair, test pairs were able to reduce their anti-predator efforts near neighbors, at no apparent cost to the stimulus pairs. These findings are unlikely to be explained by reciprocity or byproduct-mutualism. Our results instead suggest a commensal relationship in which new pairs exploit the high anti-predator efforts of established pairs, which invest similarly with or without neighbors. Further studies are needed to determine the scope of commensalism as an anti-predator strategy in colonial animals.	[Schaedelin, Franziska C.; Wagner, Richard H.] Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria; [Fischer, Stefan] Univ Bern, Inst Ecol & Evolut, Hinterkappelen, Switzerland	University of Veterinary Medicine Vienna; University of Bern	Schadelin, FC (corresponding author), Univ Vet Med, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Savoyenstr, Vienna, Austria.	franziska.schaedelin@vetmeduni.ac.at	Fischer, Stefan/J-1846-2019	Fischer, Stefan/0000-0001-8811-7518	Austrian Science Fund [FWF: P20401, P17468]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 20401] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF: P20401, P17468) and the Austrian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marlene Mann and Martina Krakhofer for support and assistance in daily housekeeping of fishes, Roland Sasse for constructing the experimental setup and the KLIVV research group for discussions. We acknowledge support from the Austrian Academy of Science in conducting this research.	Ackerman JT, 2003, BEHAV ECOL SOCIOBIOL, V54, P264, DOI 10.1007/s00265-003-0628-x; ANDERSSON M, 1980, ANIM BEHAV, V28, P536, DOI 10.1016/S0003-3472(80)80062-5; Arroyo B, 2001, BEHAV ECOL SOCIOBIOL, V50, P109, DOI 10.1007/s002650100342; Brown CR, 2001, PROGRESS 5 PROBLEMS; BROWN JL, 1983, ADV STUD BEHAV, V13, P1, DOI 10.1016/S0065-3454(08)60284-3; BRUNTON DH, 1986, WILSON BULL, V98, P605; Caro T., 2005, ANTIPREDATOR DEFENCE; CURIO E, 1985, BEHAV ECOL SOCIOBIOL, V16, P273, DOI 10.1007/BF00310991; CURIO E, 1985, Z TIERPSYCHOL, V69, P3; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Demus P, 2010, THESIS U VIENNA VIEN; FELS D, 1995, BEHAVIOUR, V132, P49, DOI 10.1163/156853995X00270; GAGLIARDO A, 1993, P ROY SOC B-BIOL SCI, V251, P69, DOI 10.1098/rspb.1993.0010; Gravel MA, 2009, ETHOLOGY, V115, P608, DOI 10.1111/j.1439-0310.2009.01641.x; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Koblmuller S, 2007, GENETICA, V130, P121, DOI 10.1007/s10709-006-0027-0; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Krams I, 2010, P ROY SOC B-BIOL SCI, V277, P513, DOI 10.1098/rspb.2009.1614; Krause J, 2002, LIVING GROUPS; Neff BD, 2001, P ROY SOC B-BIOL SCI, V268, P1559, DOI 10.1098/rspb.2001.1678; Ochi H, 1999, ICHTHYOL RES, V46, P419, DOI 10.1007/BF02673984; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Ros AFH, 2009, ANIM BEHAV, V78, P25, DOI 10.1016/j.anbehav.2009.03.006; RUBENSTEIN DI, 1989, OIKOS, V55, P312, DOI 10.2307/3565589; Russell AF, 2009, TRENDS ECOL EVOL, V24, P3, DOI 10.1016/j.tree.2008.09.003; SARGENT RC, 1985, BEHAV ECOL SOCIOBIOL, V17, P43, DOI 10.1007/BF00299427; Schelly R, 2006, MOL PHYLOGENET EVOL, V38, P426, DOI 10.1016/j.ympev.2005.04.023; Stiassny MLJ, 1997, S AFR J SCI, V93, P513; STURMBAUER C, 1994, MOL BIOL EVOL, V11, P691; Swaisgood RR, 2003, BEHAV ECOL SOCIOBIOL, V55, P22, DOI 10.1007/s00265-003-0684-2; SWEENEY BW, 1982, EVOLUTION, V36, P810, DOI 10.1111/j.1558-5646.1982.tb05447.x; TREHERNE JE, 1980, ANIM BEHAV, V28, P1119, DOI 10.1016/S0003-3472(80)80100-X; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Varela SAM, 2007, J EVOLUTION BIOL, V20, P1490, DOI 10.1111/j.1420-9101.2007.01334.x; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; Wagner Richard H., 1998, Ornithological Monographs, V49, P123; Wagner RH, 2010, OIKOS, V119, P203, DOI 10.1111/j.1600-0706.2009.17315.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wheatcroft DJ, 2008, TRENDS ECOL EVOL, V23, P416, DOI 10.1016/j.tree.2008.04.011; Wheatcroft DJ, 2009, TRENDS ECOL EVOL, V24, P5, DOI 10.1016/j.tree.2008.09.002; WINKLER DW, 1994, ANIM BEHAV, V47, P595, DOI 10.1006/anbe.1994.1083; WRONA FJ, 1991, AM NAT, V137, P186, DOI 10.1086/285153	44	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35833	10.1371/journal.pone.0035833	http://dx.doi.org/10.1371/journal.pone.0035833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615741	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300008
J	Vinod, KY; Xie, S; Psychoyos, D; Hungund, BL; Cooper, TB; Tejani-Butt, SM				Vinod, K. Yaragudri; Xie, Shan; Psychoyos, Delphine; Hungund, Basalingappa L.; Cooper, Thomas B.; Tejani-Butt, Shanaz M.			Dysfunction in Fatty Acid Amide Hydrolase Is Associated with Depressive-Like Behavior in Wistar Kyoto Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; ANTIDEPRESSANT-LIKE ACTIVITY; ENDOCANNABINOID SYSTEM; PREFRONTAL CORTEX; ELECTROCONVULSIVE-THERAPY; ANXIOLYTIC-LIKE; CHRONIC STRESS; CB1 RECEPTORS; ANIMAL-MODELS; HIPPOCAMPUS	Background: While the etiology of depression is not clearly understood at the present time, this mental disorder is thought be a complex and multifactorial trait with important genetic and environmental contributing factors. Methodology/Principal Findings: The role of the endocannabinoid (eCB) system in depressive behavior was examined in Wistar Kyoto (WKY) rat strain, a genetic model of depression. Our findings revealed selective abnormalities in the eCB system in the brains of WKY rats compared to Wistar (WIS) rats. Immunoblot analysis indicated significantly higher levels of fatty acid amide hydrolase (FAAH) in frontal cortex and hippocampus of WKY rats with no alteration in the level of N-arachidonyl phosphatidyl ethanolamine specific phospholipase-D (NAPE-PLD). Significantly higher levels of CB1 receptor-mediated G-protein coupling and lower levels of anandamide (AEA) were found in frontal cortex and hippocampus of WKY rats. While the levels of brain derived neurotropic factor (BDNF) were significantly lower in frontal cortex and hippocampus of WKY rats compared to WIS rats, pharmacological inhibition of FAAH elevated BDNF levels in WKY rats. Inhibition of FAAH enzyme also significantly increased sucrose consumption and decreased immobility in the forced swim test in WKY rats. Conclusions/Significance: These findings suggest a critical role for the eCB system and BDNF in the genetic predisposition to depressive-like behavior in WKY rats and point to the potential therapeutic utility of eCB enhancing agents in depressive disorder.	[Vinod, K. Yaragudri; Xie, Shan; Hungund, Basalingappa L.; Cooper, Thomas B.] Nathan S Kline Inst Psychiat Res, Div Analyt Psychopharmacol, Orangeburg, NY 10962 USA; [Vinod, K. Yaragudri] NYU, Sch Med, Dept Child & Adolescent Psychiat, New York, NY USA; [Psychoyos, Delphine] Texas A&M Hlth Sci Ctr, Ctr Environm & Genet Med, Houston, TX USA; [Hungund, Basalingappa L.; Cooper, Thomas B.] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA; [Hungund, Basalingappa L.; Cooper, Thomas B.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Tejani-Butt, Shanaz M.] Univ Sci Philadelphia, Dept Pharmaceut Sci, Philadelphia, PA USA	Nathan Kline Institute for Psychiatric Research; New York University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York State Psychiatry Institute; Columbia University	Vinod, KY (corresponding author), Nathan S Kline Inst Psychiat Res, Div Analyt Psychopharmacol, Orangeburg, NY 10962 USA.	vyaragudri@nki.rfmh.org			National Institutes of Health (NIH) [MH085079, DA021977]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) grants MH085079 (KYV) and DA021977 (DP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Bambico FR, 2007, J NEUROSCI, V27, P11700, DOI 10.1523/JNEUROSCI.1636-07.2007; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Carrier EJ, 2005, CNS NEUROL DISORD-DR, V4, P657, DOI 10.2174/156800705774933023; De La Garza R, 2004, BRAIN RES, V1021, P209, DOI 10.1016/j.brainres.2004.06.052; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Domschke K, 2008, EUR NEUROPSYCHOPHARM, V18, P751, DOI 10.1016/j.euroneuro.2008.05.003; Domschke K, 2010, INT J NEUROPSYCHOPH, V13, P93, DOI 10.1017/S1461145709000030; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Haenisch B, 2009, J NEUROCHEM, V111, P403, DOI 10.1111/j.1471-4159.2009.06345.x; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hill MN, 2008, J NEUROCHEM, V106, P2322, DOI 10.1111/j.1471-4159.2008.05567.x; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hill MN, 2005, BEHAV PHARMACOL, V16, P333, DOI 10.1097/00008877-200509000-00006; Hungund BL, 2004, MOL PSYCHIATR, V9, P184, DOI 10.1038/sj.mp.4001376; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kinsey SG, 2011, PHARMACOL BIOCHEM BE, V98, P21, DOI 10.1016/j.pbb.2010.12.002; Krystal AD, 1999, J ECT, V15, P27; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malkesman O, 2006, BIOL PSYCHIAT, V59, P17, DOI 10.1016/j.biopsych.2005.05.039; Mangleri RA, 2007, PHARMACOL RES, V56, P360, DOI 10.1016/j.phrs.2007.09.003; Mann JJ, 2006, INT REV NEUROBIOL, V73, P153, DOI 10.1016/S0074-7742(06)73005-7; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McLaughlin RJ, 2007, BEHAV PHARMACOL, V18, P431, DOI 10.1097/FBP.0b013e3282ee7b44; Monteleone P, 2010, PHARMACOL RES, V61, P400, DOI 10.1016/j.phrs.2010.01.002; Neumeister A, 2005, AM J PSYCHIAT, V162, P1057, DOI 10.1176/appi.ajp.162.6.1057; Okamoto T, 2008, PROG NEURO-PSYCHOPH, V32, P1185, DOI 10.1016/j.pnpbp.2008.02.009; Owens MJ, 2004, J CLIN PSYCHIAT, V65, P5; Pare W, 2003, DEPRESSION BEHAV BRA; Pearson KA, 2006, NEUROPSYCHOPHARMACOL, V31, P2449, DOI 10.1038/sj.npp.1301100; Reierson GW, 2009, NEUROREPORT, V20, P307, DOI 10.1097/WNR.0b013e328321b5a0; Ren XG, 2011, PSYCHIAT RES, V185, P108, DOI 10.1016/j.psychres.2010.04.013; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Rittenhouse PA, 2002, PSYCHONEUROENDOCRINO, V27, P303, DOI 10.1016/S0306-4530(01)00052-X; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Samuels BA, 2011, NEUROPHARMACOLOGY, V61, P408, DOI 10.1016/j.neuropharm.2011.02.017; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Shearman LP, 2003, BEHAV PHARMACOL, V14, P573, DOI 10.1097/00008877-200312000-00001; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Taylor SM, 2008, J ECT, V24, P160, DOI 10.1097/YCT.0b013e3181571ad0; TEJANIBUTT SM, 1994, BRAIN RES, V649, P27, DOI 10.1016/0006-8993(94)91045-6; Tzavara ET, 2003, BRIT J PHARMACOL, V138, P544, DOI 10.1038/sj.bjp.0705100; Umathe SN, 2011, BEHAV BRAIN RES, V223, P125, DOI 10.1016/j.bbr.2011.04.031; Vinod KY, 2006, TRENDS PHARMACOL SCI, V27, P539, DOI 10.1016/j.tips.2006.08.006; Vinod KY, 2010, J PSYCHIATR RES, V44, P591, DOI 10.1016/j.jpsychires.2009.11.013; Vinod KY, 2005, BIOL PSYCHIAT, V57, P480, DOI 10.1016/j.biopsych.2004.11.033; Will CC, 2003, MOL PSYCHIATR, V8, P925, DOI 10.1038/sj.mp.4001345; Witkin JM, 2005, TRENDS PHARMACOL SCI, V26, P609, DOI 10.1016/j.tips.2005.10.006	57	63	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36743	10.1371/journal.pone.0036743	http://dx.doi.org/10.1371/journal.pone.0036743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606285	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400032
J	van Doesburg, MHM; Henderson, J; van der Molen, ABM; An, KN; Amadio, PC				van Doesburg, Margriet H. M.; Henderson, Jacqueline; van der Molen, Aebele B. Mink; An, Kai-Nan; Amadio, Peter C.			Transverse Plane Tendon and Median Nerve Motion in the Carpal Tunnel: Ultrasound Comparison of Carpal Tunnel Syndrome Patients and Healthy Volunteers	PLOS ONE			English	Article							SUBSYNOVIAL CONNECTIVE-TISSUE; FLEXOR TENDON; DISPLACEMENT; FINGER; WRIST; TENOSYNOVIUM; DEFORMATION; EXCURSION; FLEXION	Background: The median nerve and flexor tendons are known to translate transversely in the carpal tunnel. The purpose of this study was to investigate these motions in differential finger motion using ultrasound, and to compare them in healthy people and carpal tunnel syndrome patients. Methods: Transverse ultrasounds clips were taken during fist, index finger, middle finger and thumb flexion in 29 healthy normal subjects and 29 CTS patients. Displacement in palmar-dorsal and radial-ulnar direction was calculated using Analyze software. Additionally, the distance between the median nerve and the tendons was calculated. Results: We found a changed motion pattern of the median nerve in middle finger, index finger and thumb motion between normal subjects and CTS patients (p < 0.05). Also, we found a changed motion direction in CTS patients of the FDS III tendon in fist and middle finger motion, and of the FDS II and flexor pollicis longus tendon in index finger and thumb motion, respectively (p < 0.05). The distance between the median nerve and the FDS II or FPL tendon is significantly greater in patients than in healthy volunteers for index finger and thumb motion, respectively (p < 0.05). Conclusion: Our results suggest a changed motion pattern of the median nerve and several tendons in carpal tunnel syndrome patients compared to normal subjects. Such motion patterns may be useful in distinguishing affected from unaffected individuals, and in studies of the pathomechanics of carpal tunnel syndrome.	[van Doesburg, Margriet H. M.; Henderson, Jacqueline; An, Kai-Nan; Amadio, Peter C.] Mayo Clin, Div Orthoped Res, Orthoped Biomech Lab, Rochester, MN USA; [van Doesburg, Margriet H. M.; van der Molen, Aebele B. Mink] Univ Med Ctr, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands	Mayo Clinic; Utrecht University; Utrecht University Medical Center	van Doesburg, MHM (corresponding author), Mayo Clin, Div Orthoped Res, Orthoped Biomech Lab, Rochester, MN USA.	pamadio@mayo.edu			United States National Institutes of Health (NIH) [RO1 AR49823]; NIH/National Center for Research Resources; Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA) [UL1 RR024150]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049823] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding was provided by United States National Institutes of Health (NIH) RO1 AR49823 and NIH/National Center for Research Resources and Mayo Clinic's Center for Translational Science Activities (NIH/NCRR CTSA) Grant Number UL1 RR024150. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cigali BS, 1996, EUR J RADIOL, V23, P217, DOI 10.1016/S0720-048X(96)00767-X; Donato G, 2009, CLIN NEUROPATHOL, V28, P129; Erel E, 2003, J HAND SURG-BRIT EUR, V28B, P439, DOI 10.1016/S0266-7681(03)00107-4; Ettema AM, 2008, J BIOMECH, V41, P292, DOI 10.1016/j.jbiomech.2007.09.017; Ettema AM, 2007, CLIN ANAT, V20, P292, DOI 10.1002/ca.20379; Ettema AM, 2006, PLAST RECONSTR SURG, V118, P1413, DOI 10.1097/01.prs.0000239593.55293.c7; Hough AD, 2007, ARCH PHYS MED REHAB, V88, P569, DOI 10.1016/j.apmr.2007.02.015; LLUCH AL, 1992, J HAND SURG-BRIT EUR, V17B, P209, DOI 10.1016/0266-7681(92)90091-F; NAKAMICHI K, 1992, J HAND SURG-BRIT EUR, V17B, P213, DOI 10.1016/0266-7681(92)90092-G; NAKAMICHI K, 1995, J HAND SURG-BRIT EUR, V20B, P460, DOI 10.1016/S0266-7681(05)80153-6; Osamura N, 2007, CLIN BIOMECH, V22, P999, DOI 10.1016/j.clinbiomech.2007.07.009; SKIE M, 1990, J HAND SURG-AM, V15A, P934, DOI 10.1016/0363-5023(90)90019-N; Ugbolue UC, 2005, CLIN BIOMECH, V20, P50, DOI 10.1016/j.clinbiomech.2004.08.006; van Doesburg MHM, 2010, J ORTHOP RES, V28, P1387, DOI 10.1002/jor.21131; Yoshii YC, 2008, J ORTHOP RES, V26, P1153, DOI 10.1002/jor.20640; Yoshii Y, 2009, J BONE JOINT SURG AM, V91A, P2922, DOI 10.2106/JBJS.H.01653	16	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37081	10.1371/journal.pone.0037081	http://dx.doi.org/10.1371/journal.pone.0037081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606333	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200063
J	Wegner, F; Kraft, R; Busse, K; Hartig, W; Ahrens, J; Leffler, A; Dengler, R; Schwarz, J				Wegner, Florian; Kraft, Robert; Busse, Kathy; Haertig, Wolfgang; Ahrens, Joerg; Leffler, Andreas; Dengler, Reinhard; Schwarz, Johannes			Differentiated Human Midbrain-Derived Neural Progenitor Cells Express Excitatory Strychnine-Sensitive Glycine Receptors Containing alpha 2 beta Subunits	PLOS ONE			English	Article							BETA-SUBUNIT; DOPAMINERGIC DIFFERENTIATION; HYPEREKPLEXIA; MUTATIONS; GABA(A); BINDING; PROLIFERATION; PICROTOXININ; POTENTIATION; MODULATION	Background: Human fetal midbrain-derived neural progenitor cells (NPCs) may deliver a tissue source for drug screening and regenerative cell therapy to treat Parkinson's disease. While glutamate and GABA(A) receptors play an important role in neurogenesis, the involvement of glycine receptors during human neurogenesis and dopaminergic differentiation as well as their molecular and functional characteristics in NPCs are largely unknown. Methodology/Principal Findings: Here we investigated NPCs in respect to their glycine receptor function and subunit expression using electrophysiology, calcium imaging, immunocytochemistry, and quantitative real-time PCR. Whole-cell recordings demonstrate the ability of NPCs to express functional strychnine-sensitive glycine receptors after differentiation for 3 weeks in vitro. Pharmacological and molecular analyses indicate a predominance of glycine receptor heteromers containing alpha 2 beta subunits. Intracellular calcium measurements of differentiated NPCs suggest that glycine evokes depolarisations mediated by strychnine-sensitive glycine receptors and not by D-serine-sensitive excitatory glycine receptors. Culturing NPCs with additional glycine, the glycine-receptor antagonist strychnine, or the Na+-K+-Cl- co-transporter 1 (NKCC1)-inhibitor bumetanide did not significantly influence cell proliferation and differentiation in vitro. Conclusions/Significance: These data indicate that NPCs derived from human fetal midbrain tissue acquire essential glycine receptor properties during neuronal maturation. However, glycine receptors seem to have a limited functional impact on neurogenesis and dopaminergic differentiation of NPCs in vitro.	[Wegner, Florian; Dengler, Reinhard] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Kraft, Robert] Univ Leipzig, Carl Ludwig Inst Physiol, Leipzig, Germany; [Busse, Kathy; Schwarz, Johannes] Univ Leipzig, Dept Neurol, Leipzig, Germany; [Haertig, Wolfgang] Univ Leipzig, Paul Flechsig Inst Brain Res, Dept Neurophysiol, Leipzig, Germany; [Ahrens, Joerg; Leffler, Andreas] Hannover Med Sch, Dept Anaesthesiol & Intens Care, D-3000 Hannover, Germany	Hannover Medical School; Leipzig University; Leipzig University; Leipzig University; Hannover Medical School	Wegner, F (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	wegner.florian@mh-hannover.de	Leffler, Andreas/K-1191-2012; Kraft, Robert/E-9199-2011	Leffler, Andreas/0000-0003-1121-6387; Kraft, Robert/0000-0002-5774-6001	Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication"; grant from the DFG [KR 3408/2-1]	Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication"(German Research Foundation (DFG)); grant from the DFG(German Research Foundation (DFG))	This publication is funded from the Deutsche Forschungsgemeinschaft (DFG)-sponsorship "Open Access Publication". RK is supported by a grant from the DFG (KR 3408/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; Alvarez FJ, 1997, J COMP NEUROL, V379, P150; Andrew M, 1997, BRIT J PSYCHIAT, V170, P106, DOI 10.1192/bjp.170.2.106; Baer K, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.025.2009; Bakker MJ, 2006, LANCET NEUROL, V5, P513, DOI 10.1016/S1474-4422(06)70470-7; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Dieterlen MT, 2009, J NEUROSCI METH, V178, P15, DOI 10.1016/j.jneumeth.2008.11.007; Engemaier E, 2006, GENOMICS, V87, P254, DOI 10.1016/j.ygeno.2005.10.001; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; Li P, 2007, VISUAL NEUROSCI, V24, P513, DOI 10.1017/S0952523807070368; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maksay G, 1999, J NEUROCHEM, V73, P802, DOI 10.1046/j.1471-4159.1999.0730802.x; Maksay G, 2001, NEUROPHARMACOLOGY, V41, P369, DOI 10.1016/S0028-3908(01)00071-5; Meyer AK, 2010, J NEUROL SCI, V289, P93, DOI 10.1016/j.jns.2009.08.024; Miller PS, 2005, J PHYSIOL-LONDON, V566, P657, DOI 10.1113/jphysiol.2005.088575; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Milosevic J, 2005, J NEUROCHEM, V92, P718, DOI 10.1111/j.1471-4159.2004.02893.x; Milosevic J, 2007, STEM CELLS DEV, V16, P625, DOI 10.1089/scd.2006.0113; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Milosevic J, 2006, J NEUROCHEM, V99, P913, DOI 10.1111/j.1471-4159.2006.04132.x; Piechotta K, 2001, J COMP NEUROL, V438, P336; Piper DR, 2000, J NEUROPHYSIOL, V84, P534, DOI 10.1152/jn.2000.84.1.534; Piper DR, 2001, J NEUROSCI RES, V66, P356, DOI 10.1002/jnr.1228; Pistis M, 1997, BRIT J PHARMACOL, V122, P1707, DOI 10.1038/sj.bjp.0701563; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Rees MI, 2001, HUM GENET, V109, P267, DOI 10.1007/s004390100569; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rohrbough J, 1996, J NEUROSCI, V16, P82; Schaarschmidt G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006168; Schaarschmidt G, 2009, J NEUROCHEM, V109, P238, DOI 10.1111/j.1471-4159.2009.05954.x; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Seigel GM, 2003, MOL VIS, V9, P159; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Sun W, 2005, STEM CELLS, V23, P931, DOI 10.1634/stemcells.2004-0316; Supplisson S, 2000, MOL PHARMACOL, V58, P763, DOI 10.1124/mol.58.4.763; Wegner F, 2008, J NEUROCHEM, V111, P204; Wegner F, 2009, J NEUROCHEM, V107, P1056; Wegner F, 2007, NEUROPHARMACOLOGY, V52, P672, DOI 10.1016/j.neuropharm.2006.09.009; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Young-Pearse TL, 2006, MOL CELL BIOL, V26, P5728, DOI 10.1128/MCB.00237-06	53	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36946	10.1371/journal.pone.0036946	http://dx.doi.org/10.1371/journal.pone.0036946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606311	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200058
J	Leida, C; Conejero, A; Arbona, V; Gomez-Cadenas, A; Llacer, G; Badenes, ML; Rios, G				Leida, Carmen; Conejero, Ana; Arbona, Vicent; Gomez-Cadenas, Aurelio; Llacer, Gerardo; Luisa Badenes, Maria; Rios, Gabino			Chilling-Dependent Release of Seed and Bud Dormancy in Peach Associates to Common Changes in Gene Expression	PLOS ONE			English	Article							PRUNUS-PERSICA L.; MADS-BOX GENES; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; SPURGE EUPHORBIA-ESULA; FLOWERING-LOCUS-T; ARABIDOPSIS-THALIANA; LEAFY SPURGE; JAPANESE APRICOT; GROWTH CESSATION; VEGETATIVE BUDS	Reproductive meristems and embryos display dormancy mechanisms in specialized structures named respectively buds and seeds that arrest the growth of perennial plants until environmental conditions are optimal for survival. Dormancy shows common physiological features in buds and seeds. A genotype-specific period of chilling is usually required to release dormancy by molecular mechanisms that are still poorly understood. In order to find common transcriptional pathways associated to dormancy release, we analyzed the chilling-dependent expression in embryos of certain genes that were previously found related to dormancy in flower buds of peach. We propose the presence of short and long-term dormancy events affecting respectively the germination rate and seedling development by independent mechanisms. Short periods of chilling seem to improve germination in an abscisic acid-dependent manner, whereas the positive effect of longer cold treatments on physiological dwarfing coincides with the accumulation of phenylpropanoids in the seed.	[Leida, Carmen; Conejero, Ana; Arbona, Vicent; Llacer, Gerardo; Luisa Badenes, Maria; Rios, Gabino] IVIA, Valencia, Spain; [Gomez-Cadenas, Aurelio] Univ Jaume 1, Dept Ciencias Agr & Medio Nat, Castellon De La Plana, Spain	Universitat Jaume I	Leida, C (corresponding author), IVIA, Valencia, Spain.	rios_gab@gva.es	Gomez-Cadenas, Aurelio/K-6084-2012; Rios, Gabino/F-4046-2011; Arbona, Vicent/K-1748-2015; Badenes, Maria Luisa/C-6606-2014	Gomez-Cadenas, Aurelio/0000-0002-4598-2664; Rios, Gabino/0000-0002-1398-282X; Arbona, Vicent/0000-0003-2232-106X; Badenes, Maria Luisa/0000-0001-9722-6783; Leida, Carmen Alice/0000-0001-9513-8448	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER [RTA2007-00060]; Ministry of Science and Innovation of Spain [AGL2010-20595]; IVIA (Instituto Valenciano de Investigaciones Agrarias)	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER(Instituto de Investigacion Agropecuaria (INIA)European Commission); Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IVIA (Instituto Valenciano de Investigaciones Agrarias)	This work was supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)-FEDER (grant no. RTA2007-00060), and the Ministry of Science and Innovation of Spain (grant no. AGL2010-20595). CL was funded by a fellowship from IVIA (Instituto Valenciano de Investigaciones Agrarias). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JV, 2001, WEED SCI, V49, P581, DOI 10.1614/0043-1745(2001)049[0581:RCROTR]2.0.CO;2; Arend M, 2009, PLANT PHYSIOL, V151, P2110, DOI 10.1104/pp.109.144956; Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; Bentsink L., 2007, Seed development, dormancy and germination, P113; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Carles C, 2002, PLANT J, V30, P373, DOI 10.1046/j.1365-313X.2002.01295.x; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DAVIES FT, 1983, HORTSCIENCE, V18, P959; Debeaujon I, 2000, PLANT PHYSIOL, V122, P403, DOI 10.1104/pp.122.2.403; DHARMAWARDHANA DP, 1992, CAN J BOT, V70, P2238, DOI 10.1139/b92-277; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FRISBY JW, 1993, J AM SOC HORTIC SCI, V118, P248, DOI 10.21273/JASHS.118.2.248; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Horvath DP, 2010, PLANT MOL BIOL, V73, P169, DOI 10.1007/s11103-009-9596-5; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Jia Y, 2006, PLANT MOL BIOL, V61, P329, DOI 10.1007/s11103-006-0015-x; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; KESTER D.E., 2011, HARTMANN KESTERS PLA, V8th; KESTER DE, 1969, J AM SOC HORTIC SCI, V94, P318; KESTER DE, 1977, J AM SOC HORTIC SCI, V102, P145; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; LANG GA, 1987, HORTSCIENCE, V22, P817; Leida C, 2012, NEW PHYTOL, V193, P67, DOI 10.1111/j.1469-8137.2011.03863.x; Leida C, 2010, TREE PHYSIOL, V30, P655, DOI 10.1093/treephys/tpq008; Liu YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022241; Lloyd GB, 1980, COMB P INT PLANT PRO, V30, P421; Martinez-Gomez P, 2001, SCI HORTIC-AMSTERDAM, V91, P51, DOI 10.1016/S0304-4238(01)00235-7; Mathiason K, 2009, FUNCT INTEGR GENOMIC, V9, P81, DOI 10.1007/s10142-008-0090-y; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MEHLENBACHER SA, 1991, J AM SOC HORTIC SCI, V116, P565, DOI 10.21273/JASHS.116.3.565; Nakamura S, 2001, PLANT J, V26, P627, DOI 10.1046/j.1365-313x.2001.01069.x; North H, 2010, PLANT J, V61, P971, DOI 10.1111/j.1365-313X.2009.04095.x; PASTERNAK G, 1980, HORTSCIENCE, V15, P408; PerezGonzalez S, 1997, HORTSCIENCE, V32, P1064, DOI 10.21273/HORTSCI.32.6.1064; POLLOCK BM, 1962, PLANT PHYSIOL, V37, P190, DOI 10.1104/pp.37.2.190; POWELL LE, 1987, HORTSCIENCE, V22, P845; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Ren J, 2010, J PLANT PHYSIOL, V167, P1486, DOI 10.1016/j.jplph.2010.05.027; Rinne PLH, 2011, PLANT CELL, V23, P130, DOI 10.1105/tpc.110.081307; Rohde A, 2002, PLANT CELL, V14, P1885, DOI 10.1105/tpc.003186; Rohde A, 2007, J EXP BOT, V58, P4047, DOI 10.1093/jxb/erm261; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sasaki R, 2011, PLANT PHYSIOL, V157, P485, DOI 10.1104/pp.111.181982; Thevenin J, 2011, MOL PLANT, V4, P70, DOI 10.1093/mp/ssq045; VEGIS A, 1964, ANN REV PLANT PHYSIO, V15, P185, DOI 10.1146/annurev.pp.15.060164.001153; Xue GP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf076; Yamane H, 2008, J AM SOC HORTIC SCI, V133, P708, DOI 10.21273/JASHS.133.5.708; Yamane H, 2011, J JPN SOC HORTIC SCI, V80, P276, DOI 10.2503/jjshs1.80.276; Yamane H, 2011, J EXP BOT, V62, P3481, DOI 10.1093/jxb/err028	65	52	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35777	10.1371/journal.pone.0035777	http://dx.doi.org/10.1371/journal.pone.0035777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590512	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400007
J	Bayer, M; Sommer, W; Schacht, A				Bayer, Mareike; Sommer, Werner; Schacht, Annekathrin			Font Size Matters-Emotion and Attention in Cortical Responses to Written Words	PLOS ONE			English	Article							BRAIN POTENTIALS; AROUSAL; MODULATION; TASK; FEAR	For emotional pictures with fear-, disgust-, or sex-related contents, stimulus size has been shown to increase emotion effects in attention-related event-related potentials (ERPs), presumably reflecting the enhanced biological impact of larger emotion-inducing pictures. If this is true, size should not enhance emotion effects for written words with symbolic and acquired meaning. Here, we investigated ERP effects of font size for emotional and neutral words. While P1 and N1 amplitudes were not affected by emotion, the early posterior negativity started earlier and lasted longer for large relative to small words. These results suggest that emotion-driven facilitation of attention is not necessarily based on biological relevance, but might generalize to stimuli with arbitrary perceptual features. This finding points to the high relevance of written language in today's society as an important source of emotional meaning.	[Bayer, Mareike; Sommer, Werner] Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany; [Schacht, Annekathrin] Univ Gottingen, Courant Res Ctr Text Struct, Gottingen, Germany	Humboldt University of Berlin; University of Gottingen	Bayer, M (corresponding author), Humboldt Univ, Dept Psychol, D-10099 Berlin, Germany.	mareike.bayer@hu-berlin.de	Bayer, Mareike/AAV-5768-2021; Sommer, Werner/H-4672-2011; Sommer, Werner/N-1945-2019; Schacht, Annekathrin/B-2521-2014	Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; 	Berlin School of Mind and Brain; Geman Initiative of Excellence	Berlin School of Mind and Brain; Geman Initiative of Excellence	This research was supported by the Berlin School of Mind and Brain and by the Geman Initiative of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen R. H, 1995, CELEX LEXICAL DATABA; Bayer M, 2012, PSYCHOPHYSI IN PRESS; Codispoti M, 2007, PSYCHOPHYSIOLOGY, V44, P680, DOI 10.1111/j.1469-8986.2007.00545.x; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Johnson Jr. R., 1988, ADV PSYCHOPHYSIOLOGY, V3, P69; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Lang PJ, 1997, ATTENTION ORIENTING; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Moratti S, 2004, NEUROIMAGE, V21, P954, DOI 10.1016/j.neuroimage.2003.10.030; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palazova M, 2011, NEUROPSYCHOLOGIA, V49, P2766, DOI 10.1016/j.neuropsychologia.2011.06.005; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Schupp HT, 2007, J NEUROSCI, V27, P1082, DOI 10.1523/JNEUROSCI.3223-06.2007; TEGHTSOONIAN R, 1982, J BEHAV THER EXP PSY, V13, P181, DOI 10.1016/0005-7916(82)90002-7; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341	26	45	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36042	10.1371/journal.pone.0036042	http://dx.doi.org/10.1371/journal.pone.0036042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590518	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100016
J	Huang, GJ; Huang, SS; Deng, JS				Huang, Guan-Jhong; Huang, Shyh-Shyun; Deng, Jeng-Shyan			Anti-Inflammatory Activities of Inotilone from Phellinus linteus through the Inhibition of MMP-9, NF-kappa B, and MAPK Activation In Vitro and In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SIGNAL-REGULATED KINASE; RAW264.7 CELLS; ANTI-INFLAMMATION; PROTEIN-KINASES; LIPOPOLYSACCHARIDE; EXPRESSION; PATHWAYS; P38; CYCLOOXYGENASE-2	Inotilone was isolated from Phellinus linteus. The anti-inflammatory effects of inotilone were studied by using lipopolysaccharide (LPS)-stimulated mouse macrophage RAW264.7 cells and lambda-carrageenan (Carr)-induced hind mouse paw edema model. Inotilone was tested for its ability to reduce nitric oxide (NO) production, and the inducible nitric oxide synthase (iNOS) expression. Inotilone was tested in the inhibitor of mitogen-activated protein kinase (MAPK) [extracellular signal-regulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), p38], and nuclear factor-kappa B (NF-kappa B), matrix-metalloproteinase (MMP)-9 protein expressions in LPS-stimulated RAW264.7 cells. When RAW264.7 macrophages were treated with inotilone together with LPS, a significant concentration-dependent inhibition of NO production was detected. Western blotting revealed that inotilone blocked the protein expression of iNOS, NF-kappa B, and MMP-9 in LPS-stimulated RAW264.7 macrophages, significantly. Inotilone also inhibited LPS-induced ERK, JNK, and p38 phosphorylation. In in vivo tests, inotilone decreased the paw edema at the 4th and the 5th h after Carr administration, and it increased the activities of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx). We also demonstrated that inotilone significantly attenuated the malondialdehyde (MDA) level in the edema paw at the 5th h after Carr injection. Inotilone decreased the NO and tumor necrosis factor (TNF-alpha) levels on serum at the 5th h after Carr injection. Western blotting revealed that inotilone decreased Carr-induced iNOS, cyclooxygenase-2 (COX-2), NF-kappa B, and MMP-9 expressions at the 5th h in the edema paw. An intraperitoneal (i.p.) injection treatment with inotilone diminished neutrophil infiltration into sites of inflammation, as did indomethacin (Indo). The anti-inflammatory activities of inotilone might be related to decrease the levels of MDA, iNOS, COX-2, NF-kappa B, and MMP-9 and increase the activities of CAT, SOD, and GPx in the paw edema through the suppression of TNF-alpha and NO. This study presents the potential utilization of inotilone, as a lead for the development of anti-inflammatory drugs.	[Huang, Guan-Jhong] China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan; [Huang, Shyh-Shyun] China Med Univ, Coll Pharm, Dept Pharm, Taichung, Taiwan; [Deng, Jeng-Shyan] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Huang, GJ (corresponding author), China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan.	gjhuang@mail.cmu.edu.tw; dengjs@asia.edu.tw			National Science Council [NSC100-2313-B-039-004-, NSC 100-2320-B-039-033-]; China Medical University (CMU) [CMU99-S-29, CCM-P99-RD-042, CMU99-COL-10]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University (CMU)(China Medical University); Taiwan Department of Health Clinical Trial and Research Center of Excellence	The authors want to thank for financial support the National Science Council (NSC100-2313-B-039-004- and NSC 100-2320-B-039-033-), China Medical University (CMU) (CMU99-S-29, CCM-P99-RD-042, and CMU99-COL-10), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105; Aebi H, 1984, Methods Enzymol, V105, P121; Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bhat NR, 1998, J NEUROSCI, V18, P1633; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Chang CT, 2011, FOOD CHEM, V127, P1131, DOI 10.1016/j.foodchem.2011.01.114; Chang Heng-Yuan, 2011, Evid Based Complement Alternat Med, V2011, P478246, DOI 10.1093/ecam/nep027; Chang TN, 2011, J AGR FOOD CHEM, V59, P9112, DOI 10.1021/jf201375u; Chapelsky S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001421; Chaturvedi P, 2008, EVID-BASED COMPL ALT, V5, P55, DOI 10.1093/ecam/nel077; Committee for Research and Ethical Issues of the IASP, 1983, PAIN, V16, P161; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Haddad JJ, 2002, BRIT J PHARMACOL, V135, P520, DOI 10.1038/sj.bjp.0704467; Handy RLC, 1998, BRIT J PHARMACOL, V123, P1119, DOI 10.1038/sj.bjp.0701735; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Huang GJ, 2011, J AGR FOOD CHEM, V59, P11211, DOI 10.1021/jf200576f; Huang GJ, 2011, J AGR FOOD CHEM, V59, P7104, DOI 10.1021/jf201289e; Huang GJ, 2011, J AGR FOOD CHEM, V59, P5702, DOI 10.1021/jf2003943; Huang GJ, 2010, J AGR FOOD CHEM, V58, P9468, DOI 10.1021/jf101508r; Huang GJ, 2010, J AGR FOOD CHEM, V58, P7445, DOI 10.1021/jf1013764; Huang MH, 2011, J ETHNOPHARMACOL, V135, P545, DOI 10.1016/j.jep.2011.03.057; Huang MH, 2011, J ETHNOPHARMACOL, V133, P743, DOI 10.1016/j.jep.2010.11.005; Huang SS, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/895857; Jeong JB, 2010, FOOD CHEM TOXICOL, V48, P2148, DOI 10.1016/j.fct.2010.05.020; Jung JY, 2008, J APPL MICROBIOL, V104, P1824, DOI 10.1111/j.1365-2672.2008.03737.x; Ku KT, 2008, J AGR FOOD CHEM, V56, P8911, DOI 10.1021/jf8019369; Kuo YC, 2009, MOL NUTR FOOD RES, V53, P1386, DOI 10.1002/mnfr.200800583; Lai CS, 2009, J AGR FOOD CHEM, V57, P10990, DOI 10.1021/jf9025713; Lee IK, 2011, J ANTIBIOT, V64, P349, DOI 10.1038/ja.2011.2; Liao YC, 2009, J AGR FOOD CHEM, V57, P8933, DOI 10.1021/jf902630w; Lu Y, 2010, BIOL PHARM BULL, V33, P1944, DOI 10.1248/bpb.33.1944; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027739; Rajapakse N, 2008, IMMUNOLOGY, V123, P348, DOI 10.1111/j.1365-2567.2007.02683.x; Wen CL, 2011, J ETHNOPHARMACOL, V137, P575, DOI 10.1016/j.jep.2011.06.009; Woo CH, 2004, J IMMUNOL, V173, P6973, DOI 10.4049/jimmunol.173.11.6973; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948	39	75	80	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35922	10.1371/journal.pone.0035922	http://dx.doi.org/10.1371/journal.pone.0035922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590514	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500005
J	Shen, GP; Xu, FH; He, F; Ruan, HL; Cui, C; Chen, LZ; Zeng, YX; Jia, WH				Shen, Guo-Ping; Xu, Feng-Hua; He, Fen; Ruan, Hong-Lian; Cui, Cui; Chen, Li-Zhen; Zeng, Yi-Xin; Jia, Wei-Hua			Pretreatment Lifestyle Behaviors as Survival Predictors for Patients with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; RISK-FACTORS; PROGNOSTIC-FACTORS; CANCER PREVENTION; CIGARETTE-SMOKING; ALCOHOL-USE; IMPACT; HEAD; POPULATION	Background: Lifestyle behaviors have been widely reported to influence the survival of patients with head and neck cancer. However, the relationship between pretreatment lifestyle behaviors and survival among patients with nasopharyngeal carcinoma (NPC) is unclear. Methods: A prospective cohort study was designed to determine the relationship between lifestyle behaviors and survival in 1,533 NPC patients recruited from October 2005 to October 2007. Pretreatment lifestyle behaviors (such as body-mass index [BMI], smoking, alcohol, diet) of the patients were investigated. Univariate and multivariate proportional-hazards models were used to assess the impact of lifestyle behaviors on patient survival. Results: Smoking was a predictor of survival; both current smokers (hazard ratio [HR] = 1.88; 95% CI, 1.33 to 2.65) and heavy smokers (>= 25 Pack-years; HR = 1.84; 95% CI, 1.30 to 2.60) showed associations with poor survival. Higher BMI was significantly associated with a lower risk of death (P-trend = 0.002). Compared with under/normal-weight patients (BMI less than 22.99 kg/m(2)), the multivariate HR for survival was 0.66 (95% CI, 0.48 to 0.90) and 0.47 (95% CI, 0.23 to 0.97) for overweight and obese patients, respectively. No alcohol intake and high fruit intake were associated with favorable survival in the univariate analysis but lost significance in the multivariate model. Conclusion: Our findings indicate that pretreatment lifestyle behaviors, especially smoking status and BMI, as easily available data, provide prognostic value for survival in NPC patients.	[Shen, Guo-Ping; Xu, Feng-Hua; He, Fen; Ruan, Hong-Lian; Cui, Cui; Chen, Li-Zhen; Zeng, Yi-Xin; Jia, Wei-Hua] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Shen, Guo-Ping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [He, Fen] Guangzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University	Shen, GP (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China.	jiaweih@mail.sysu.edu.cn	cui, cui/HHM-4146-2022		National Natural Science Foundation of China [30671798, 30471487, 81000925]; National Science and Technology Support Program of China [2006BAI02A11]; National Major Basic Research Program of China [863:2006AA02A404, 973:2006CB910104]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0663]; Science and Technology Planning Project of Guangdong Province [2008A060201009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; National Major Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Science and Technology Planning Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (30671798, 30471487, 81000925), National Science and Technology Support Program of China (2006BAI02A11), National Major Basic Research Program of China (863:2006AA02A404, 973:2006CB910104), Program for Changjiang Scholars and Innovative Research Team in University (IRT0663), and Science and Technology Planning Project of Guangdong Province (2008A060201009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LIF DRINK HIST; [Anonymous], QUEST; Asghari-Jafarabadi M, 2009, ASIAN PAC J CANCER P, V10, P815; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Belsley D, 1991, CONDITIONAL DIAGNOST; Boffetta P, 1997, AM J EPIDEMIOL, V145, P1100; BROWMAN GP, 1993, NEW ENGL J MED, V328, P159, DOI 10.1056/NEJM199301213280302; Burke MV, 2008, MAYO CLIN PROC, V83, P479, DOI 10.4065/83.4.479; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Centers for Disease Control and Prevention Alcohol, ALC; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; CHEN AM, 2010, INT J RAD ONCOL BIOL; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Cook RT, 1998, ALCOHOL CLIN EXP RES, V22, P1927, DOI 10.1097/00000374-199812000-00007; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Crosignani P, 1996, INT J CANCER, V65, P308, DOI 10.1002/(SICI)1097-0215(19960126)65:3&lt;308::AID-IJC5&gt;3.0.CO;2-3; Dal Maso L, 2008, INT J CANCER, V123, P2188, DOI 10.1002/ijc.23747; Dikshit RP, 2005, INT J CANCER, V117, P992, DOI 10.1002/ijc.21244; Dolecek TA, 2010, J AM DIET ASSOC, V110, P369, DOI 10.1016/j.jada.2009.11.014; Duffy SA, 2009, J CLIN ONCOL, V27, P1969, DOI 10.1200/JCO.2008.18.2188; Fang FM, 2010, J CLIN ONCOL, V28, P4384, DOI 10.1200/JCO.2010.28.8324; Farshadpour F, 2010, HEAD NECK; Fortin A, 2009, INT J RADIAT ONCOL, V74, P1062, DOI 10.1016/j.ijrobp.2008.09.021; Friborg JT, 2007, CANCER-AM CANCER SOC, V109, P1183, DOI 10.1002/cncr.22501; Greene FL, 2002, AJCC CANC STAGING HD; Gritz ER, 2009, J CLIN ONCOL, V27, P1930, DOI 10.1200/JCO.2008.21.3769; Gritz ER, 2006, CANCER-AM CANCER SOC, V106, P17, DOI 10.1002/cncr.21598; Guo XC, 2009, INT J CANCER, V124, P2942, DOI 10.1002/ijc.24293; Hayashi Y, 2010, CANCER-AM CANCER SOC, V116, P5619, DOI 10.1002/cncr.25745; Ji X, INT J CANC; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kwong DLW, 1997, INT J RADIAT ONCOL, V39, P703, DOI 10.1016/S0360-3016(97)00339-8; Lai SZ, 2011, INT J RAD ONCOL BIOL; Lee SW, 2006, INT J RADIAT ONCOL, V65, P152, DOI 10.1016/j.ijrobp.2005.10.040; Lieber CS, 2003, ALCOHOL RES HEALTH, V27, P220; Liu H, 2006, MED ONCOL, V23, P341, DOI 10.1385/MO:23:3:341; Mandrekar SJ, 2006, CANCER-AM CANCER SOC, V107, P781, DOI 10.1002/cncr.22049; Marret H, 2001, BREAST CANCER RES TR, V66, P17, DOI 10.1023/A:1010699912768; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Meyer F, 2009, J CLIN ONCOL, V27, P2970, DOI 10.1200/JCO.2008.20.0295; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Pierce JP, 2007, J CLIN ONCOL, V25, P2345, DOI 10.1200/JCO.2006.08.6819; Ramakrishnan Y, 2007, CLIN OTOLARYNGOL, V32, P484, DOI 10.1111/j.1749-4486.2007.01543.x; Ren ZF, 2010, CANCER EPIDEMIOL, V34, P419, DOI 10.1016/j.canep.2010.04.011; Sandoval M, 2009, INT J ORAL MAX SURG, V38, P31, DOI 10.1016/j.ijom.2008.09.004; Silvera SAN, 2006, CANCER EPIDEM BIOMAR, V15, P395, DOI 10.1158/1055-9965.EPI-05-0835; SRIAMPORN S, 1992, CANCER EPIDEM BIOMAR, V1, P345; Stanczyk Malgorzata, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P15; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; STEVENS MH, 1983, ARCH OTOLARYNGOL, V109, P746; Su SF, 2012, INT J RAD ONCOL BIOL; Tsai S, 2010, J GASTROINTEST SURG, V14, P1143, DOI 10.1007/s11605-010-1201-3; Van Steen K, 2002, STAT MED, V21, P3865, DOI 10.1002/sim.1358; Wu WJ, 1996, J PHARMACOL EXP THER, V278, P1325; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E	59	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36515	10.1371/journal.pone.0036515	http://dx.doi.org/10.1371/journal.pone.0036515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590554	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335500014
J	Tveteras, S; Asche, F; Bellemare, MF; Smith, MD; Guttormsen, AG; Lem, A; Lien, K; Vannuccini, S				Tveteras, Sigbjorn; Asche, Frank; Bellemare, Marc F.; Smith, Martin D.; Guttormsen, Atle G.; Lem, Audun; Lien, Kristin; Vannuccini, Stefania			Fish Is Food - The FAO's Fish Price Index	PLOS ONE			English	Article							EXCHANGE-RATES; SALMON	World food prices hit an all-time high in February 2011 and are still almost two and a half times those of 2000. Although three billion people worldwide use seafood as a key source of animal protein, the Food and Agriculture Organization (FAO) of the United Nations-which compiles prices for other major food categories-has not tracked seafood prices. We fill this gap by developing an index of global seafood prices that can help to understand food crises and may assist in averting them. The fish price index (FPI) relies on trade statistics because seafood is heavily traded internationally, exposing non-traded seafood to price competition from imports and exports. Easily updated trade data can thus proxy for domestic seafood prices that are difficult to observe in many regions and costly to update with global coverage. Calculations of the extent of price competition in different countries support the plausibility of reliance on trade data. Overall, the FPI shows less volatility and fewer price spikes than other food price indices including oils, cereals, and dairy. The FPI generally reflects seafood scarcity, but it can also be separated into indices by production technology, fish species, or region. Splitting FPI into capture fisheries and aquaculture suggests increased scarcity of capture fishery resources in recent years, but also growth in aquaculture that is keeping pace with demand. Regionally, seafood price volatility varies, and some prices are negatively correlated. These patterns hint that regional supply shocks are consequential for seafood prices in spite of the high degree of seafood tradability.	[Tveteras, Sigbjorn] Pontificia Univ Catolica Peru, CTR Catolica Grad Sch Business, Lima, Peru; [Asche, Frank] Univ Stavanger, Dept Ind Econ, Stavanger, Norway; [Bellemare, Marc F.] Duke Univ, Sanford Sch Publ Policy, Durham, NC USA; [Bellemare, Marc F.; Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Smith, Martin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, As, Norway; [Lem, Audun; Vannuccini, Stefania] Food & Agr Org United Nations, Fisheries & Aquaculture Policy & Econ Div, Rome, Italy; [Lien, Kristin] Norwegian Seafood Council, Tromso, Norway	Pontificia Universidad Catolica del Peru; Universitetet i Stavanger; Duke University; Duke University; Duke University; Norwegian University of Life Sciences; Food & Agriculture Organization of the United Nations (FAO)	Tveteras, S (corresponding author), Pontificia Univ Catolica Peru, CTR Catolica Grad Sch Business, Lima, Peru.	stveteras@pucp.pe	Smith, Martin D/D-9168-2016; Bellemare, Marc F./HCH-3192-2022; Tveteraas, SIgbjorn/Y-2283-2019; Asche, Frank/AAG-9920-2020; Guttormsen, Atle/GZG-2356-2022	Smith, Martin D/0000-0002-4714-463X; Asche, Frank/0000-0002-1540-9728; 	Food and Agricultural Organization of the United Nations; CENTRUM Catolica; Department of Industrial Economics; Sanford School of Public Policy; Nicholas School of the Environment, Duke University, Durham; Department of Economics; Department of Economics and Resource Management; Norwegian Seafood Export Council; Pontificia Universidad Catolica del Peru; University of Stavanger; Duke University, Durham; Norwegian University of Life Sciences	Food and Agricultural Organization of the United Nations; CENTRUM Catolica; Department of Industrial Economics; Sanford School of Public Policy; Nicholas School of the Environment, Duke University, Durham; Department of Economics; Department of Economics and Resource Management; Norwegian Seafood Export Council; Pontificia Universidad Catolica del Peru; University of Stavanger; Duke University, Durham; Norwegian University of Life Sciences	The funder of this study is the Food and Agricultural Organization of the United Nations, and the respective institutions of the coauthors (CENTRUM Catolica, Pontificia Universidad Catolica del Peru; Department of Industrial Economics, University of Stavanger; Sanford School of Public Policy, Duke University; Nicholas School of the Environment, Duke University, Durham; Department of Economics, Duke University, Durham; Department of Economics and Resource Management, Norwegian University of Life Sciences; Norwegian Seafood Export Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.L., 2003, INT SEAFOOD TRADE; Anderson J.L., 2010, HDB MARINE FISHERIES; [Anonymous], 2011, LET THEM EAT BREAD F; Asche F, 2007, APPL ECON, V39, P2535, DOI 10.1080/00036840500486524; Asche Frank, 2009, Aquaculture Economics and Management, V13, P76, DOI 10.1080/13657300902881641; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; Barrett CB, 1996, AM J AGR ECON, V78, P656, DOI 10.2307/1243283; Barrett CB, 1996, J DEV ECON, V51, P193, DOI 10.1016/S0304-3878(96)00412-9; Bellemare MF, 2012, YOU SOW SO SHALL YOU; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Deaton A, 2010, AM ECON REV, V100, P5, DOI 10.1257/aer.100.1.5; Diewert W.E., 2008, NEW PALGRAVE DICT EC, P1, DOI [10.1057/978-1-349-95121-5_940-2, DOI 10.1057/978-1-349-95121-5_940-2]; Diewert WE, 1998, J ECON PERSPECT, V12, P47, DOI 10.1257/jep.12.1.47; Duarte CM, 2009, BIOSCIENCE, V59, P967, DOI 10.1525/bio.2009.59.11.8; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ 2; Food and Agricultural Organization of the United Nations, 2011, FAO FOOD OUTL GLOB M; Food and Agricultural Organization of the United Nations, 2011, FISHST J; Food and Agriculture Organization of the United Nations, 2012, FAO FOOD PRIC IND; Funke H., 1978, THEORY APPL EC INDIC; Goldberg PK, 1997, J ECON LIT, V35, P1243; Hu YW, 2009, P NATL ACAD SCI USA, V106, P10971, DOI 10.1073/pnas.0904826106; McMichael P, 2009, AGR HUM VALUES, V26, P281, DOI 10.1007/s10460-009-9218-5; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; OECD, 2008, OECD BENCHM DEF FOR, V4th; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Smith MD, 2010, SCIENCE, V330, P1052, DOI 10.1126/science.1197769; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Timmer CP, 2010, J NUTR, V140, p224S, DOI 10.3945/jn.109.110379; Tveteras S, 2008, APPL ECON, V40, P1745, DOI 10.1080/00036840600905134; Valderrama D, 2010, J ENVIRON ECON MANAG, V59, P115, DOI 10.1016/j.jeem.2009.12.001; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	33	182	185	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36731	10.1371/journal.pone.0036731	http://dx.doi.org/10.1371/journal.pone.0036731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TF	22590598	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500026
J	Sun, QQ; Jiang, S; Li, X; Huang, XH; Xie, KN; Cheng, DR; Chen, JS; Ji, SM; Wen, JQ; Zhang, MC; Zeng, CH; Liu, ZH				Sun, Qiquan; Jiang, Song; Li, Xue; Huang, Xianghua; Xie, Kenan; Cheng, Dongrui; Chen, Jinsong; Ji, Shuming; Wen, Jiqiu; Zhang, Mingchao; Zeng, Caihong; Liu, Zhihong			The Prevalence of Immunologic Injury in Renal Allograft Recipients with De Novo Proteinuria	PLOS ONE			English	Article							ANTIBODY-MEDIATED REJECTION; RECURRENT IGA NEPHROPATHY; BETA-D-GLUCOSAMINIDASE; KIDNEY-TRANSPLANTATION; GRAFT; SURVIVAL; BIOPSIES; CLASSIFICATION; GLOMERULOPATHY; MANAGEMENT	Post-transplant proteinuria is a common complication after renal transplantation; it is associated with reduced graft and recipient survival. However, the prevalence of histological causes has been reported with considerable variation. A clinicopathological re-evaluation of post-transplant proteinuria is necessary, especially after dismissal of the term "chronic allograft nephropathy," which had been considered to be an important cause of proteinuria. Moreover, urinary protein can promote interstitial inflammation in native kidney, whether this occurs in renal allograft remains unknown. Factors that affect the graft outcome in patients with proteinuria also remain unclear. Here we collected 98 cases of renal allograft recipients who developed proteinuria after transplant, histological features were characterized using Banff scoring system. Cox proportional hazard regression models were used for graft survival predictors. We found that transplant glomerulopathy was the leading (40.8%) cause of post-transplant proteinuria. Immunological causes, including transplant glomerulopathy, acute rejection, and chronic rejection accounted for the majority of all pathological causes of proteinuria. Nevertheless, almost all patients that developed proteinuria had immunological lesions in the graft, especially for interstitial inflammation. Intraglomerular C3 deposition was unexpectedly correlated with the severity of proteinuria. Moreover, the severity of interstitial inflammation was an independent risk factor for graft loss, while high level of hemoglobin was a protective factor for graft survival. This study revealed a predominance of immunological parameters in renal allografts with post-transplant proteinuria. These parameters not only correlate with the severity of proteinuria, but also with the outcome of the graft.	[Sun, Qiquan; Jiang, Song; Li, Xue; Huang, Xianghua; Xie, Kenan; Cheng, Dongrui; Chen, Jinsong; Ji, Shuming; Wen, Jiqiu; Zhang, Mingchao; Zeng, Caihong; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Sun, QQ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing 210008, Jiangsu, Peoples R China.	sunqiquan@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726; Li, Xue/0000-0001-7073-7532; Sun, Qiquan/0000-0002-7296-316X	National Natural Science Foundation of China [81070593, 30600572]; 333 Talent Training Program of Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 333 Talent Training Program of Jiangsu Province, China	This study was supported by a grant from the General Program of National Natural Science Foundation of China (No. 81070593, No. 30600572), and a grant from 333 Talent Training Program of Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer H, 2007, AM J TRANSPLANT, V7, P2748, DOI 10.1111/j.1600-6143.2007.02006.x; Amer H, 2009, J AM SOC NEPHROL, V20, P2490, DOI 10.1681/ASN.2008091005; BERNARD AM, 1987, CLIN CHEM, V33, P775; Borchhardt K, 1997, KIDNEY INT, V52, P1622, DOI 10.1038/ki.1997.494; Chandrakantan A, 2005, NEPHROL DIAL TRANSPL, V20, P1214, DOI 10.1093/ndt/gfh773; Cherukuri A, 2010, TRANSPLANTATION, V89, P200, DOI 10.1097/TP.0b013e3181c352c5; Choukroun G, 2012, J AM SOC NEPHROL, V23, P360, DOI 10.1681/ASN.2011060546; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Fernandez-Fresnedo G, 2004, NEPHROL DIAL TRANSPL, V19, P47, DOI 10.1093/ndt/gfh1015; FIRST MR, 1984, TRANSPLANTATION, V38, P607, DOI 10.1097/00007890-198412000-00012; GREKAS D, 1995, CLIN NEPHROL, V44, P299; Halimi JM, 2005, AM J TRANSPLANT, V5, P2281, DOI 10.1111/j.1600-6143.2005.01020.x; Hohage H, 1997, NEPHRON, V75, P160, DOI 10.1159/000189525; ISONIEMI HM, 1992, KIDNEY INT, V41, P155, DOI 10.1038/ki.1992.21; Issa N, 2008, TRANSPLANTATION, V86, P681, DOI 10.1097/TP.0b013e3181837626; Kotanko P, 2000, NEPHRON, V84, P228, DOI 10.1159/000045582; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Morath C, 2007, NAT CLIN PRACT NEPHR, V3, P18, DOI 10.1038/ncpneph0376; Myslak M, 2006, AM J TRANSPLANT, V6, P1660, DOI 10.1111/j.1600-6143.2006.01361.x; Navarro JF, 1998, AM J NEPHROL, V18, P261, DOI 10.1159/000013332; Pei R, 1998, HUM IMMUNOL, V59, P313, DOI 10.1016/S0198-8859(98)00020-2; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Reichel H, 2004, NEPHROL DIAL TRANSPL, V19, P301, DOI 10.1093/ndt/gfh002; RELL K, 1993, TRANSPLANT INT, V6, P213, DOI 10.1007/BF00337102; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Roodnat JL, 2001, TRANSPLANTATION, V72, P438, DOI 10.1097/00007890-200108150-00014; SETHI K, 1977, NEPHRON, V18, P49, DOI 10.1159/000180766; Sis B, 2007, AM J TRANSPLANT, V7, P1743, DOI 10.1111/j.1600-6143.2007.01836.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Sund S, 2003, TRANSPLANTATION, V75, P1204, DOI 10.1097/01.TP.0000062835.30165.2C; Sund S, 1998, APMIS, V106, P1017, DOI 10.1111/j.1699-0463.1998.tb00254.x; Wang AYM, 2001, AM J KIDNEY DIS, V38, P588, DOI 10.1053/ajkd.2001.26885; Wiland P, 1997, BRIT J RHEUMATOL, V36, P59; Yakupoglu U, 2004, KIDNEY INT, V65, P2360, DOI 10.1111/j.1523-1755.2004.00655.x	37	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36654	10.1371/journal.pone.0036654	http://dx.doi.org/10.1371/journal.pone.0036654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586485	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000046
J	Li, SG; Wang, JY; Luo, F				Li, Sheng-Guang; Wang, Jin-Yan; Luo, Fei			Adult-Age Inflammatory Pain Experience Enhances Long-Term Pain Vigilance in Rats	PLOS ONE			English	Article							REPETITIVE NOCICEPTIVE STIMULATION; CHRONIC BACK-PAIN; PSYCHOLOGICAL VARIABLES; SUBJECTIVE EXPERIENCE; PREEMPTIVE ANALGESIA; LASTING HYPERALGESIA; NEURONAL RESPONSES; CINGULUM BUNDLE; ANIMAL-MODELS; FORMALIN TEST	Background: Previous animal studies have illustrated a modulatory effect of neonatal pain experience on subsequent pain-related behaviors. However, the relationship between chronic pain status in adulthood and future pain perception remains unclear. Methodology/Principal Findings: In the current study, we investigated the effects of inflammatory pain experience on subsequent formalin-evoked pain behaviors and fear conditioning induced by noxious stimulation in adult rats. Our results demonstrated an increase of the second but not the first phase of formalin-induced pain behaviors in animals with a history of inflammatory pain that have recovered. Similarly, rats with persistent pain experience displayed facilitated acquisition and prolonged retention of pain-related conditioning. These effects of prior pain experience on subsequent behavior were prevented by repeated morphine administration at an early stage of inflammatory pain. Conclusions/Significance: These results suggest that chronic pain diseases, if not properly and promptly treated, may have a long-lasting impact on processing and perception of environmental threats. This may increase the susceptibility of patients to subsequent pain-related disorders, even when chronic pain develops in adulthood. These data highlight the importance of treatment of chronic pain at an early stage.	[Li, Sheng-Guang; Wang, Jin-Yan; Luo, Fei] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Li, Sheng-Guang] Chinese Acad Sci, Grad Univ, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, SG (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangjy@psych.ac.cn; luof@psych.ac.cn			NNSF [30700223, 30770688, 30970959, 61033011, 31171067]; Knowledge Innovation Project from the Chinese Academy of Sciences [KSCX2-EW-Q-18]; Knowledge Innovation Project of the Chinese Academy of Sciences [YZ200944, KSCX2-YW-R-254, KSCX2-EW-J-8]; National Institutes of Health Fogarty International Center [R03 TW008038]; FOGARTY INTERNATIONAL CENTER [R03TW008038] Funding Source: NIH RePORTER	NNSF(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project from the Chinese Academy of Sciences; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was funded by an NNSF grant (30700223) and the Knowledge Innovation Project (KSCX2-EW-Q-18) from the Chinese Academy of Sciences to JYW; NNSF grants (30770688, 30970959, 61033011, and 31171067), the Knowledge Innovation Project (YZ200944, KSCX2-YW-R-254, and KSCX2-EW-J-8) of the Chinese Academy of Sciences, and a grant from National Institutes of Health Fogarty International Center (R03 TW008038) to FL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi AM, 2003, ANN NY ACAD SCI, V1007, P232, DOI 10.1196/annals.1286.022; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; BACHIOCCO V, 1993, CLIN J PAIN, V9, P266, DOI 10.1097/00002508-199312000-00008; Bayer TL, 1998, PAIN, V74, P327, DOI 10.1016/S0304-3959(97)00196-6; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Boersma K, 2005, BEHAV RES THER, V43, P1495, DOI 10.1016/j.brat.2004.11.006; Boersma K, 2006, CLIN J PAIN, V22, P160, DOI 10.1097/01.ajp.0000159582.37750.39; BORSZCZ GS, 1995, BEHAV NEUROSCI, V109, P648, DOI 10.1037/0735-7044.109.4.648; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Ceccarelli I, 2003, PAIN, V104, P35, DOI 10.1016/S0304-3959(02)00460-8; Ceccarelli I, 2006, BRAIN RES, V1106, P142, DOI 10.1016/j.brainres.2006.05.089; Celerier E, 2000, ANESTHESIOLOGY, V92, P465, DOI 10.1097/00000542-200002000-00029; Cipher DJ, 1997, BEHAV RES THER, V35, P437, DOI 10.1016/S0005-7967(96)00121-0; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; FAN RJ, 1995, PHYSIOL BEHAV, V57, P1131, DOI 10.1016/0031-9384(94)00372-C; Fan RJ, 2009, PHYSIOL BEHAV, V98, P108, DOI 10.1016/j.physbeh.2009.04.022; Flor H, 2007, Handb Exp Pharmacol, P415; Flor H, 2003, J REHABIL MED, V35, P66, DOI 10.1080/16501960310010179; GAMSA A, 1991, PAIN, V44, P271, DOI 10.1016/0304-3959(91)90096-G; Gatchel RJ, 2003, J OCCUP REHABIL, V13, P1, DOI 10.1023/A:1021823505774; GRAF P, 1987, J EXP PSYCHOL LEARN, V13, P45, DOI 10.1037/0278-7393.13.1.45; Hasenbring M, 2001, SCHMERZ, V15, P442, DOI 10.1007/s004820100030; Hermann C, 2006, PAIN, V125, P278, DOI 10.1016/j.pain.2006.08.026; Holzl R, 2005, PAIN, V115, P12, DOI 10.1016/j.pain.2005.01.026; Huang J, 2006, EXP NEUROL, V200, P124, DOI 10.1016/j.expneurol.2006.01.036; Hummel M, 2008, PAIN, V140, P436, DOI 10.1016/j.pain.2008.09.020; JACOBY LL, 1983, J EXP PSYCHOL LEARN, V9, P21, DOI 10.1037/0278-7393.9.1.21; KATZ J, 1992, ANESTHESIOLOGY, V77, P439, DOI 10.1097/00000542-199209000-00006; Kissin I, 2000, ANESTHESIOLOGY, V93, P1138, DOI 10.1097/00000542-200010000-00040; Ko S, 2004, DRUG DISCOV TODAY, V1, P101; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; Lehner M, 2010, ACTA NEUROBIOL EXP, V70, P56; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Lidow MS, 2002, PAIN, V99, P377, DOI 10.1016/S0304-3959(02)00258-0; Loyd DR, 2008, EUR J NEUROSCI, V27, P1517, DOI 10.1111/j.1460-9568.2008.06100.x; MELZACK R, 1957, J COMP PHYSIOL PSYCH, V50, P155, DOI 10.1037/h0047770; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Pedersen LH, 2007, PAIN, V127, P17, DOI 10.1016/j.pain.2006.06.036; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Rivat C, 2002, ANESTHESIOLOGY, V96, P381, DOI 10.1097/00000542-200202000-00025; Robinson ME, 2004, J PAIN, V5, P264, DOI 10.1016/j.jpain.2004.04.003; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCHINDLER CW, 1983, J PHARMACOL EXP THER, V227, P639; SCHINDLER CW, 1984, PSYCHOPHARMACOLOGY, V83, P114, DOI 10.1007/BF00427434; Schmelzle-Lublecki BM, 2007, EUR J PAIN, V11, P799, DOI 10.1016/j.ejpain.2006.12.009; Schmulson M, 1999, AM J GASTROENTEROL, V94, P2929, DOI 10.1111/j.1572-0241.1999.01440.x; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHIBATA M, 1989, PAIN, V38, P347, DOI 10.1016/0304-3959(89)90222-4; Shyu BC, 2003, BRAIN RES PROTOC, V12, P1, DOI 10.1016/S1385-299X(03)00041-2; Slipp S, 2000, J Am Acad Psychoanal, V28, P191; SLOMAN SA, 1988, J EXP PSYCHOL LEARN, V14, P223, DOI 10.1037/0278-7393.14.2.223; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sternberg WF, 2005, PAIN, V113, P347, DOI 10.1016/j.pain.2004.11.013; TASKER RAR, 1987, PAIN, V31, P237, DOI 10.1016/0304-3959(87)90039-X; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Vaccarino AL, 1997, NEUROSCI LETT, V236, P117, DOI 10.1016/S0304-3940(97)00770-2; VACCARINO AL, 1989, PAIN, V39, P213, DOI 10.1016/0304-3959(89)90008-0; VACCARINO AL, 1992, PAIN, V49, P257, DOI 10.1016/0304-3959(92)90150-A; Wang N, 2009, PAIN, V142, P108, DOI 10.1016/j.pain.2008.12.016; Whitehead WE, 1998, GASTROENTEROLOGY, V115, P1263, DOI 10.1016/S0016-5085(98)70099-X; Yu YC, 2002, J NEUROSCI METH, V115, P107, DOI 10.1016/S0165-0270(02)00011-0; Zhuo M, 2008, TRENDS NEUROSCI, V31, P199, DOI 10.1016/j.tins.2008.01.003; Zhuo M, 2006, J NEUROSCI RES, V84, P927, DOI 10.1002/jnr.21003	71	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36767	10.1371/journal.pone.0036767	http://dx.doi.org/10.1371/journal.pone.0036767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574223	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800120
J	Sztal, T; Chung, H; Berger, S; Currie, PD; Batterham, P; Daborn, PJ				Sztal, Tamar; Chung, Henry; Berger, Silke; Currie, Peter D.; Batterham, Philip; Daborn, Phillip J.			A Cytochrome P450 Conserved in Insects Is Involved in Cuticle Formation	PLOS ONE			English	Article							HUMAN-BODY LOUSE; DROSOPHILA-MELANOGASTER; HALLOWEEN GENES; MOLTING HORMONE; P450 ENZYMES; DEVELOPMENTAL EXPRESSION; DETOXIFICATION GENES; ECDYSONE; BIOSYNTHESIS; MORPHOGENESIS	The sequencing of numerous insect genomes has revealed dynamic changes in the number and identity of cytochrome P450 genes in different insects. In the evolutionary sense, the rapid birth and death of many P450 genes is observed, with only a small number of P450 genes showing orthology between insects with sequenced genomes. It is likely that these conserved P450s function in conserved pathways. In this study, we demonstrate the P450 gene, Cyp301a1, present in all insect genomes sequenced to date, affects the formation of the adult cuticle in Drosophila melanogaster. A Cyp301a1 piggyBac insertion mutant and RNAi of Cyp301a1 both show a similar cuticle malformation phenotype, which can be reduced by 20-hydroxyecdysone, suggesting that Cyp301a1 is an important gene involved in the formation of the adult cuticle and may be involved in ecdysone regulation in this tissue.	[Sztal, Tamar; Chung, Henry; Batterham, Philip; Daborn, Phillip J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Genet, Melbourne, Vic, Australia; [Sztal, Tamar] Monash Univ, Dept Biol Sci, Melbourne, Vic 3004, Australia; [Sztal, Tamar; Berger, Silke; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University; Australian Regenerative Medicine Institute; Monash University	Sztal, T (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Genet, Melbourne, Vic, Australia.	tamar.sztal@monash.edu	Chung, Henry/C-9374-2014; Batterham, Philip/G-5914-2012	Chung, Henry/0000-0001-5056-2755; Batterham, Philip/0000-0001-9840-9119; Sztal, Tamar/0000-0001-9745-3580; Currie, Peter/0000-0001-8874-8862	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council through an Australian Research Fellowship to PJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff M, 2009, DEVELOPMENT, V136, P2403, DOI 10.1242/dev.035410; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Horn C, 2003, GENETICS, V163, P647; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lafont R., 2005, P125; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li LO, 2008, P NATL ACAD SCI USA, V105, P13883, DOI 10.1073/pnas.0804099105; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; MADHAVAN MM, 1980, J EMBRYOL EXP MORPH, V60, P1; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; MILNER MJ, 1977, J EMBRYOL EXP MORPH, V37, P105; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Rewitz KF, 2006, BIOCHEM SOC T, V34, P1256, DOI 10.1042/BST0341256; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Rewitz KF, 2006, INSECT BIOCHEM MOLEC, V36, P188, DOI 10.1016/j.ibmb.2005.12.002; Rewitz KF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-60; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Riddiford L. M., 1994, ADV INSECT PHYSL; ROSELAND CR, 1979, ROUX ARCH DEV BIOL, V186, P235, DOI 10.1007/BF00848591; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sekyrova P, 2010, DEVELOPMENT, V137, P141, DOI 10.1242/dev.037861; Stoilov I, 2001, TRENDS GENET, V17, P629, DOI 10.1016/S0168-9525(01)02444-1; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Sztal T, 2007, INSECT BIOCHEM MOLEC, V37, P1044, DOI 10.1016/j.ibmb.2007.05.017; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	51	44	46	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36544	10.1371/journal.pone.0036544	http://dx.doi.org/10.1371/journal.pone.0036544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574182	Green Published, gold			2022-12-27	WOS:000305349800079
J	Spector, JM; Agrawal, P; Kodkany, B; Lipsitz, S; Lashoher, A; Dziekan, G; Bahl, R; Merialdi, M; Mathai, M; Lemer, C; Gawande, A				Spector, Jonathan M.; Agrawal, Priya; Kodkany, Bhala; Lipsitz, Stuart; Lashoher, Angela; Dziekan, Gerald; Bahl, Rajiv; Merialdi, Mario; Mathai, Matthews; Lemer, Claire; Gawande, Atul			Improving Quality of Care for Maternal and Newborn Health: Prospective Pilot Study of the WHO Safe Childbirth Checklist Program	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; BLOOD-STREAM INFECTIONS; SYSTEMATIC ANALYSIS; NEONATAL DEATHS; SURVIVAL 1; MORTALITY; IMPLEMENTATION; INTERVENTION; STILLBIRTHS; OUTCOMES	Background: Most maternal deaths, intrapartum-related stillbirths, and newborn deaths in low income countries are preventable but simple, effective methods for improving safety in institutional births have not been devised. Checklist-based interventions aid management of complex or neglected tasks and have been shown to reduce harm in healthcare. We hypothesized that implementation of the WHO Safe Childbirth Checklist program, a novel childbirth safety program for institutional births incorporating a 29-item checklist, would increase delivery of essential childbirth practices linked with improved maternal and perinatal health outcomes. Methods and Findings: A pilot, pre-post-intervention study was conducted in a sub-district level birth center in Karnataka, India between July and December 2010. We prospectively observed health workers that attended to women and newborns during 499 consecutively enrolled birth events and compared these with observed practices during 795 consecutively enrolled birth events after the introduction of the WHO Safe Childbirth Checklist program. Twenty-nine essential practices that target the major causes of childbirth-related mortality, such as hand hygiene and uterotonic administration, were evaluated. The primary end point was the average rate of successful delivery of essential childbirth practices by health workers. Delivery of essential childbirth-related care practices at each birth event increased from an average of 10 of 29 practices at baseline (95% CI 9.4, 10.1) to an average of 25 of 29 practices afterwards (95% CI 24.6, 25.3; p < 0.001). There was significant improvement in the delivery of 28 out of 29 individual practices. No adverse outcomes relating to the intervention occurred. Study limitations are the pre-post design, potential Hawthorne effect, and focus on processes of care versus health outcomes. Conclusions: Introduction of the WHO Safe Childbirth Checklist program markedly improved delivery of essential safety practices by health workers. Future study will determine if this program can be implemented at scale and improve health outcomes.	[Spector, Jonathan M.; Gawande, Atul] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Agrawal, Priya] London Sch Hyg & Trop Med, Infect Dis Epidemiol Dept, Fac Epidemiol & Populat Hlth, London WC1, England; [Kodkany, Bhala] Jawaharlal Nehru Med Coll, Womens & Childrens Hlth Res Unit, Belgaum, Karnataka, India; [Lipsitz, Stuart] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Lashoher, Angela; Dziekan, Gerald] World Hlth Org, Dept Patient Safety, Geneva, Switzerland; [Bahl, Rajiv; Mathai, Matthews] World Hlth Org, Dept Maternal Newborn Child & Adolescent Hlth, Geneva, Switzerland; [Merialdi, Mario] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Lemer, Claire] London Deanery Barnet & Chase Farm Hosp NHS Trust, Enfield, Middx, England	Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; K.L.E. Academy of Higher Education & Research; Jawaharlal Nehru Medical College, Belgaum; Harvard University; Brigham & Women's Hospital; World Health Organization; World Health Organization; World Health Organization	Spector, JM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	jmspector@partners.org	Spector, Jonathan M/B-1780-2014	Spector, Jonathan M/0000-0002-6270-3073; Gawande, Atul/0000-0002-1824-9176	World Health Organization (WHO); Children's Investment Fund Foundation (CIFF)	World Health Organization (WHO)(World Health Organization); Children's Investment Fund Foundation (CIFF)	This work was supported by grants from World Health Organization (WHO) and the Children's Investment Fund Foundation (CIFF). WHO provided input on study design, data analyses, decision to publish, and preparation of the manuscript. WHO had no role in data collection. CIFF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althabe F, 2008, NEW ENGL J MED, V358, P1929, DOI 10.1056/NEJMsa071456; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Ekirapa-Kiracho E, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S11; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; King H, 2008, PERFORMANCE TOOLS, V3; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lipsitz SR, 2000, BIOMETRICS, V56, P528, DOI 10.1111/j.0006-341X.2000.00528.x; Mayo, 1933, HUMAN PROBLEMS IND C; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Nilsson L, 2010, ACTA ANAESTH SCAND, V54, P176, DOI 10.1111/j.1399-6576.2009.02109.x; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Powell-Jackson T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-97; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; PRONOVOST PJ, 2005, J PATIENT SAF, V1, P33; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rana TG, 2007, INT J GYNECOL OBSTET, V98, P271, DOI 10.1016/j.ijgo.2007.05.017; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Weiser TG, 2010, INT J QUAL HEALTH C, V22, P365, DOI 10.1093/intqhc/mzq039; WHO, 2010, TRENDS MAT MORT 1990; Yinong YX, 2011, ARCH SURG-CHICAGO, V146, P1368, DOI 10.1001/archsurg.2011.762; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	38	126	131	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35151	10.1371/journal.pone.0035151	http://dx.doi.org/10.1371/journal.pone.0035151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615733	Green Published, gold			2022-12-27	WOS:000305341300004
J	Berga, M; Szekely, AJ; Langenheder, S				Berga, Merce; Szekely, Anna J.; Langenheder, Silke			Effects of Disturbance Intensity and Frequency on Bacterial Community Composition and Function	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; INTERMEDIATE DISTURBANCE; ECOSYSTEM FUNCTION; SPECIES-DIVERSITY; PATTERNS; SOIL; BIODIVERSITY; RESISTANCE; SALINITY; RESILIENCE	Disturbances influence community structure and ecosystem functioning. Bacteria are key players in ecosystems and it is therefore crucial to understand the effect of disturbances on bacterial communities and how they respond to them, both compositionally and functionally. The main aim of this study was to test the effect of differences in disturbance strength on bacterial communities. For this, we implemented two independent short-term experiments with dialysis bags containing natural bacterial communities, which were transplanted between ambient and 'disturbed' incubation tanks, manipulating either the intensity or the frequency of a salinity disturbance. We followed changes in community composition by terminal restriction fragment analysis (T-RFLP) and measured various community functions (bacterial production, carbon substrate utilization profiles and rates) directly after and after a short period of recovery under ambient conditions. Increases in disturbance strength resulted in gradually stronger changes in bacterial community composition and functions. In the disturbance intensity experiment, the sensitivity to the disturbance and the ability of recovery differed between different functions. In the disturbance frequency experiment, effects on the different functions were more consistent and recovery was not observed. Moreover, in case of the intensity experiment, there was also a time lag in the responses of community composition and functions, with functional responses being faster than compositional ones. To summarize, our study shows that disturbance strength has the potential to change the functional performance and composition of bacterial communities. It further highlights that the overall effects, rates of recovery and the degree of congruence in the response patterns of community composition and functioning along disturbance gradients depend on the type of function and the character of the disturbance.	[Berga, Merce; Szekely, Anna J.; Langenheder, Silke] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden	Uppsala University	Berga, M (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	merce.berga@ebc.uu.se	Berga Quintana, Mercè/E-3305-2018; Székely, Anna/J-5876-2018; Langenheder, Silke/C-9614-2017	Berga Quintana, Mercè/0000-0002-9518-8776; Langenheder, Silke/0000-0002-5245-9935	Swedish Research Council Formas; Marie Curie Reintegration Grant; Carl Tryggers Foundation	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Marie Curie Reintegration Grant(European Commission); Carl Tryggers Foundation	This work was funded by grants from the Swedish Research Council Formas, a Marie Curie Reintegration Grant, and the Carl Tryggers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Banning NC, 2008, APPL SOIL ECOL, V40, P109, DOI 10.1016/j.apsoil.2008.03.011; Barberan A, 2011, MOL ECOLOGY; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Bowen JL, 2011, ISME J, V5, P1540, DOI 10.1038/ismej.2011.22; Bressan M, 2008, ENVIRON MICROBIOL, V10, P2184, DOI 10.1111/j.1462-2920.2008.01641.x; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Chaer G, 2009, MICROB ECOL, V58, P414, DOI 10.1007/s00248-009-9508-x; Christian BW, 2007, HYDROBIOLOGIA, V586, P43, DOI 10.1007/s10750-006-0476-6; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; COLLINS SL, 1995, ECOLOGY, V76, P486, DOI 10.2307/1941207; Comte J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025266; Comte J, 2010, ECOLOGY, V91, P1466, DOI 10.1890/09-0848.1; Comte J, 2009, ENVIRON MICROBIOL, V11, P1704, DOI 10.1111/j.1462-2920.2009.01897.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; delGiorgio P, 1996, LIMNOL OCEANOGR, V41, P783, DOI 10.4319/lo.1996.41.4.0783; Fayolle S, 1998, ARCH HYDROBIOL, V143, P57; Floder S, 2010, J EXP MAR BIOL ECOL, V395, P223, DOI 10.1016/j.jembe.2010.09.006; Fried Guillaume, 2010, BMC Ecology, V10, P20, DOI 10.1186/1472-6785-10-20; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; Gasol JM, 2004, AQUAT MICROB ECOL, V34, P193, DOI 10.3354/ame034193; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Hammer O, 2001, PALEONTOLOGI ELECT, V25, P1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Inagaki F, 2002, GEOMICROBIOL J, V19, P535, DOI 10.1080/01490450290098577; Jocque M, 2010, FRESHWATER BIOL, V55, P1587, DOI 10.1111/j.1365-2427.2010.02402.x; Langenheder S, 2005, LIMNOL OCEANOGR, V50, P957, DOI 10.4319/lo.2005.50.3.0957; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Langenheder S, 2003, FEMS MICROBIOL ECOL, V45, P189, DOI 10.1016/S0168-6496(03)00149-1; Langenheder S, 2007, ECOLOGY, V88, P2154, DOI 10.1890/06-2098.1; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mackey RL, 2001, ECOLOGY, V82, P3479, DOI 10.1890/0012-9658(2001)082[3479:TDDRII]2.0.CO;2; Marxsen J, 2010, FEMS MICROBIOL ECOL, V71, P374, DOI 10.1111/j.1574-6941.2009.00819.x; McCabe DJ, 2000, OECOLOGIA, V124, P270, DOI 10.1007/s004420000369; Molinos JG, 2011, OECOLOGIA, V166, P795, DOI 10.1007/s00442-011-1923-2; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Muller AK, 2002, MICROB ECOL, V44, P49, DOI 10.1007/s00248-001-0042-8; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Nielsen DL, 2003, AUST J BOT, V51, P655, DOI 10.1071/BT02115; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; REICE SR, 1985, OECOLOGIA, V67, P90, DOI 10.1007/BF00378456; REICE SR, 1984, VEHR INT VEREIN LIMN, V22, P1906; Saikaly PE, 2011, MICROB ECOL, V61, P557, DOI 10.1007/s00248-010-9783-6; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Svensson JR, 2009, ECOLOGY, V90, P496, DOI 10.1890/07-1628.1; Townsend CR, 1997, LIMNOL OCEANOGR, V42, P938, DOI 10.4319/lo.1997.42.5.0938; Waterkeyn A, 2011, LIMNOL OCEANOGR, V56, P1008, DOI 10.4319/lo.2011.56.3.1008; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Widenfalk A, 2008, ENVIRON POLLUT, V152, P576, DOI 10.1016/j.envpol.2007.07.003; Wikner J, 1999, AQUAT MICROB ECOL, V17, P289, DOI 10.3354/ame017289; Wohl DL, 2004, ECOLOGY, V85, P1534, DOI 10.1890/03-3050; ZAK JC, 1994, SOIL BIOL BIOCHEM, V26, P1101, DOI 10.1016/0038-0717(94)90131-7	66	89	96	1	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36959	10.1371/journal.pone.0036959	http://dx.doi.org/10.1371/journal.pone.0036959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606316	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400046
J	Camp, JV; Svensson, TL; McBrayer, A; Jonsson, CB; Liljestrom, P; Bruder, CE				Camp, Jeremy V.; Svensson, Thomas L.; McBrayer, Alexis; Jonsson, Colleen B.; Liljestrom, Peter; Bruder, Carl E.			De-Novo Transcriptome Sequencing of a Normalized cDNA Pool from Influenza Infected Ferrets	PLOS ONE			English	Article							GENE DISCOVERY; ANIMAL-MODEL; VIRUS; DNA; TRANSMISSION; ANNOTATION; MICROARRAY; EXPRESSION; PLATFORM; GENOME	The ferret is commonly used as a model for studies of infectious diseases. The genomic sequence of this animal model is not yet characterized, and only a limited number of fully annotated cDNAs are currently available in GenBank. The majority of genes involved in innate or adaptive immune response are still lacking, restricting molecular genetic analysis of host response in the ferret model. To enable de novo identification of transcriptionally active ferret genes in response to infection, we performed de-novo transcriptome sequencing of animals infected with H1N1 A/California/07/2009. We also included splenocytes induced with bacterial lipopolysaccharide to allow for identification of transcripts specifically induced by Gram-negative bacteria. We pooled and normalized the cDNA library in order to delimit the risk of sequencing only highly expressed genes. While normalization of the cDNA library removes the possibility of assessing expression changes between individual animals, it has been shown to increase identification of low abundant transcripts. In this study, we identified more than 19000 partial ferret transcripts, including more than 1000 gene orthologs known to be involved in the innate and the adaptive immune response.	[Camp, Jeremy V.; Jonsson, Colleen B.; Bruder, Carl E.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Svensson, Thomas L.] Sci Life Lab, Solna, Sweden; [McBrayer, Alexis] So Res Inst, Birmingham, AL 35255 USA; [Liljestrom, Peter; Bruder, Carl E.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Louisville; Karolinska Institutet	Camp, JV (corresponding author), Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA.	carl.bruder@ki.se	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; Liljestrom, Peter/0000-0002-2132-0981; Svensson, Thomas/0000-0002-9190-2979	NIAID [N01-AI-30063]; Marie Curie IIF grant from the European Research Council (FP-PEOPLE-IIF) [251456]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Marie Curie IIF grant from the European Research Council (FP-PEOPLE-IIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the contract N01-AI-30063 from the NIAID. CEB is a recipient of a Marie Curie IIF grant from the European Research Council (FP-PEOPLE-2009-IIF, contract 251456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borrell V, 2002, J NEUROSCI, V22, P6682; Borrell V, 2010, J NEUROSCI METH, V186, P186, DOI 10.1016/j.jneumeth.2009.11.016; Bruder CE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-251; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Chu YK, 2008, VIROLOGY, V374, P151, DOI 10.1016/j.virol.2007.12.032; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hoffman JI, 2011, MOL ECOL RESOUR, V11, P703, DOI 10.1111/j.1755-0998.2011.02999.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Kaplan D, 2001, P NATL ACAD SCI USA, V98, P13850, DOI 10.1073/pnas.241509398; Kirkeby S, 2009, VIRUS RES; LARIN N M, 1955, J Comp Pathol, V65, P325, DOI 10.1016/S0368-1742(55)80033-1; Lipatov AS, 2009, J INFECT DIS, V199, P717, DOI 10.1086/596740; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; McBrayer A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-149; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Polato NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028634; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Torabinejad M, 2011, J ENDODONT, V37, P197, DOI 10.1016/j.joen.2010.10.011; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vogel H, 2011, METHODS MOL BIOL, V772, P105, DOI 10.1007/978-1-61779-228-1_6; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37104	10.1371/journal.pone.0037104	http://dx.doi.org/10.1371/journal.pone.0037104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606336	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200064
J	Yassouridis, A; Ludwig, T; Steiger, A; Leisch, F				Yassouridis, Alexander; Ludwig, Tonia; Steiger, Axel; Leisch, Friedrich			A New Way of Identifying Biomarkers in Biomedical Basic-Research Studies	PLOS ONE			English	Article								A simple, nonparametric and distribution free method was developed for quick identification of the most meaningful biomarkers among a number of candidates in complex biological phenomena, especially in relatively small samples. This method is independent of rigid model forms or other link functions. It may be applied both to metric and non-metric data as well as to independent or matched parallel samples. With this method identification of the most relevant biomarkers is not based on inferential methods; therefore, its application does not require corrections of the level of significance, even in cases of thousands of variables. Hence, the introduced method is appropriate to analyze and evaluate data of complex investigations in clinical and pre-clinical basic research, such as gene or protein expressions, phenotype-genotype associations in case-control studies on the basis of thousands of genes and SNPs (single nucleotide polymorphism), search of prevalence in sleep EEG-Data, functional magnetic resonance imaging (fMRI) or others.	[Yassouridis, Alexander] Max Planck Inst Psychiat, Munich, Germany; [Ludwig, Tonia] Max Planck Inst Psychiat, RG Stat Genet, D-80804 Munich, Germany; [Steiger, Axel] Max Planck Inst Psychiat, RG Endocrinol Sleep, D-80804 Munich, Germany; [Leisch, Friedrich] Univ Nat Resources & Life Sci, Inst Appl Stat & Comp, Vienna, Austria	Max Planck Society; Max Planck Society; Max Planck Society; University of Natural Resources & Life Sciences, Vienna	Yassouridis, A (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	yassou@mpipsykl.mpg.de	Leisch, Friedrich/A-6977-2013	Leisch, Friedrich/0000-0001-7278-1983; Steiger, Axel/0000-0001-5977-5896				[Anonymous], 2002, ANGEW STAT ANWENDUNG; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czibere L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023604; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; EINOT I, 1975, J AM STAT ASSOC, V70, P574, DOI 10.2307/2285935; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Hand DJ, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1435; Hartung J., 1986, MULTIVARIATE STAT LE; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000; Hedges L. V., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Kam-Thong Tony, 2011, Eur J Hum Genet, V19, P465, DOI 10.1038/ejhg.2010.196; Kirk R., 1994, EXPT DESIGN PROCEDUR; Kneib T, 2011, J R STAT SOC C-APPL, V60, P51, DOI 10.1111/j.1467-9876.2010.00723.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rosenthal R, 1991, METAANALYTIC PROCEDU; Schussler P, 2010, NEUROPSYCHOBIOLOGY, V61, P113, DOI 10.1159/000279301; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tibshirani R, 2006, CORRELATION SHARING; Zuber V, 2009, BIOINFORMATICS, V25, P2700, DOI 10.1093/bioinformatics/btp460	21	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35741	10.1371/journal.pone.0035741	http://dx.doi.org/10.1371/journal.pone.0035741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606233	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200011
J	Mo, JS; Yoon, JH; Hong, JA; Kim, MY; Ann, EJ; Ahn, JS; Kim, SM; Baek, HJ; Lang, F; Choi, EJ; Park, HS				Mo, Jung-Soon; Yoon, Ji-Hye; Hong, Ji-Ae; Kim, Mi-Yeon; Ann, Eun-Jung; Ahn, Ji-Seon; Kim, Su-Man; Baek, Hyeong-Jin; Lang, Florian; Choi, Eui-Ju; Park, Hee-Sae			Phosphorylation of Nicastrin by SGK1 Leads to Its Degradation through Lysosomal and Proteasomal Pathways	PLOS ONE			English	Article							GAMMA-SECRETASE ACTIVITY; AMYLOID PRECURSOR PROTEIN; GLUCOCORTICOID-INDUCED KINASE-1; MEMBRANE-PROTEIN; BETA-APP; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; PRESENILIN	The gamma-secretase complex is involved in the intramembranous proteolysis of a variety of substrates, including the amyloid precursor protein and the Notch receptor. Nicastrin (NCT) is an essential component of the gamma-secretase complex and functions as a receptor for gamma-secretase substrates. In this study, we determined that serum- and glucocorticoid-induced protein kinase 1 (SGK1) markedly reduced the protein stability of NCT. The SGK1 kinase activity was decisive for NCT degradation and endogenous SGK1 inhibited gamma-secretase activity. SGK1 downregulates NCT protein levels via proteasomal and lysosomal pathways. Furthermore, SGK1 directly bound to and phosphorylated NCT on Ser437, thereby promoting protein degradation. Collectively, our findings indicate that SGK1 is a gamma-secretase regulator presumably effective through phosphorylation and degradation of NCT.	[Mo, Jung-Soon; Yoon, Ji-Hye; Hong, Ji-Ae; Kim, Mi-Yeon; Ann, Eun-Jung; Ahn, Ji-Seon; Kim, Su-Man; Baek, Hyeong-Jin; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Choi, Eui-Ju] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea	Chonnam National University; Eberhard Karls University of Tubingen; Korea University	Mo, JS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea.	proteome@jnu.ac.kr	Ahn, Ji-Seon/GRO-6218-2022	Kim, Su-Man/0000-0002-0588-8294; Ahn, Ji-Seon/0000-0001-9465-2517	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology (MEST)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work (2010-0014122) was supported by Mid-career Research Program through the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (MEST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Bagshaw RD, 2003, BIOCHEM BIOPH RES CO, V300, P615, DOI 10.1016/S0006-291X(02)02865-6; Berezovska O, 2003, J NEUROSCI, V23, P4560; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; De Strooper B, 2005, CELL, V122, P318, DOI 10.1016/j.cell.2005.07.021; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gianni D, 2003, J BIOL CHEM, V278, P9290, DOI 10.1074/jbc.M211899200; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; He GQ, 2007, J NEUROCHEM, V101, P982, DOI 10.1111/j.1471-4159.2007.04449.x; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kamynina E, 2002, AM J PHYSIOL-RENAL, V283, pF377, DOI 10.1152/ajprenal.00143.2002; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kopan R, 2002, NEURON, V33, P321, DOI 10.1016/S0896-6273(02)00585-8; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Lai EC, 2002, CURR BIOL, V12, pR200, DOI 10.1016/S0960-9822(02)00749-2; Lang F, 2001, SCI STKE, V2001; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Maeda T, 2009, FEBS J, V276, P5832, DOI 10.1111/j.1742-4658.2009.07264.x; Mo JS, 2011, J CELL SCI, V124, P100, DOI 10.1242/jcs.073924; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pearce D, 2003, CELL PHYSIOL BIOCHEM, V13, P13, DOI 10.1159/000070245; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shaw RW, 2006, FASEB J, V20, pA898, DOI 10.1096/fj.05-4055fje; Shelly C, 2002, J CELL SCI, V115, P1985; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tang K, 2003, EUR J NEUROSCI, V18, P102, DOI 10.1046/j.1460-9568.2003.02731.x; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang DS, 2002, J BIOL CHEM, V277, P28135, DOI 10.1074/jbc.M110871200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	63	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37111	10.1371/journal.pone.0037111	http://dx.doi.org/10.1371/journal.pone.0037111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590650	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400059
J	Toepel, U; Knebel, JF; Hudry, J; le Coutre, J; Murray, MM				Toepel, Ulrike; Knebel, Jean-Francois; Hudry, Julie; le Coutre, Johannes; Murray, Micah M.			Gender and Weight Shape Brain Dynamics during Food Viewing	PLOS ONE			English	Article							SEX-DIFFERENCES; HIGH-CALORIE; ORBITOFRONTAL CORTEX; HUMAN AMYGDALA; REWARD; OBESE; PREVALENCE; POTENTIALS; ACTIVATION; DIFFERENCE	Hemodynamic imaging results have associated both gender and body weight to variation in brain responses to food-related information. However, the spatio-temporal brain dynamics of gender-related and weight-wise modulations in food discrimination still remain to be elucidated. We analyzed visual evoked potentials (VEPs) while normal-weighted men (n = 12) and women (n = 12) categorized photographs of energy-dense foods and non-food kitchen utensils. VEP analyses showed that food categorization is influenced by gender as early as 170 ms after image onset. Moreover, the female VEP pattern to food categorization co-varied with participants' body weight. Estimations of the neural generator activity over the time interval of VEP modulations (i.e. by means of a distributed linear inverse solution [LAURA]) revealed alterations in prefrontal and temporo-parietal source activity as a function of image category and participants' gender. However, only neural source activity for female responses during food viewing was negatively correlated with body-mass index (BMI) over the respective time interval. Women showed decreased neural source activity particularly in ventral prefrontal brain regions when viewing food, but not non-food objects, while no such associations were apparent in male responses to food and non-food viewing. Our study thus indicates that gender influences are already apparent during initial stages of food-related object categorization, with small variations in body weight modulating electrophysiological responses especially in women and in brain areas implicated in food reward valuation and intake control. These findings extend recent reports on prefrontal reward and control circuit responsiveness to food cues and the potential role of this reactivity pattern in the susceptibility to weight gain.	[Toepel, Ulrike; Knebel, Jean-Francois; Murray, Micah M.] Vaudois Univ Hosp Ctr, Dept Clin Neurosci, Funct Elect Neuroimaging Lab, Lausanne, Switzerland; [Toepel, Ulrike; Knebel, Jean-Francois; Murray, Micah M.] Univ Lausanne, Lausanne, Switzerland; [Toepel, Ulrike; Murray, Micah M.] Vaudois Univ Hosp Ctr, Funct Elect Neuroimaging Lab, Dept Radiol, Lausanne, Switzerland; [Hudry, Julie; le Coutre, Johannes] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [le Coutre, Johannes] Univ Tokyo, Org Interdisciplinary Res Projects, Tokyo, Japan; [Murray, Micah M.] Ctr Biomed Imaging CIBM, EEG Brain Mapping Core, Lausanne, Switzerland; [Murray, Micah M.] Ctr Biomed Imaging CIBM, EEG Brain Mapping Core, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Nestle SA; University of Tokyo	Toepel, U (corresponding author), Vaudois Univ Hosp Ctr, Dept Clin Neurosci, Funct Elect Neuroimaging Lab, Lausanne, Switzerland.	Ulrike.Toepel@chuv.ch	Murray, Micah/A-8851-2008	Murray, Micah/0000-0002-7821-117X; Knebel, Jean-Francois/0000-0003-1665-1724; Hudry, Julie/0000-0001-6566-4594; Toepel, Ulrike/0000-0003-4816-6491	Swiss National Science Foundation [310030B-133136]; National Center of Competence in Research [51AU40_125759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research(Swiss National Science Foundation (SNSF))	MMM is supported by the Swiss National Science Foundation (grant 310030B-133136). JFK is supported through the National Center of Competence in Research project "SYNAPSY - The Synaptic Bases of Mental Disease'' (project no. 51AU40_125759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alonso M, 2007, JAMA-J AM MED ASSOC, V297, P1819, DOI 10.1001/jama.297.16.1819; Andino SLG, 2005, EXP BRAIN RES, V166, P298, DOI 10.1007/s00221-005-2371-1; Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P1441, DOI 10.1016/j.clinph.2009.06.012; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Cornier MA, 2010, PHYSIOL BEHAV, V99, P538, DOI 10.1016/j.physbeh.2010.01.008; Costain L, 2005, P NUTR SOC, V64, P89, DOI 10.1079/PNS2004413; Davy SR, 2006, J AM DIET ASSOC, V106, P1673, DOI 10.1016/j.jada.2006.07.017; De Lucia M, 2010, BRAIN TOPOGR, V23, P119, DOI 10.1007/s10548-010-0145-y; Del Parigi A, 2002, AM J CLIN NUTR, V75, P1017, DOI 10.1093/ajcn/75.6.1017; Dolan RJ, 2007, PHILOS T R SOC B, V362, P787, DOI 10.1098/rstb.2007.2088; Fabricatore AN, 2007, J AM DIET ASSOC, V107, P92, DOI 10.1016/j.jada.2006.10.005; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Guillem F, 2005, BRAIN COGNITION, V57, P84, DOI 10.1016/j.bandc.2004.08.026; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Karhunen LJ, 1997, BRAIN, V120, P1675, DOI 10.1093/brain/120.9.1675; Killgore WDS, 2005, NEUROREPORT, V16, P859, DOI 10.1097/00001756-200505310-00016; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Killgore WDS, 2010, NEUROREPORT, V21, P354, DOI 10.1097/WNR.0b013e32833774f7; Knebel JF, 2008, BRAIN TOPOGR, V20, P284, DOI 10.1007/s10548-008-0046-5; Knebel JF, 2012, NEUROIMAGE, V59, P2808, DOI 10.1016/j.neuroimage.2011.09.031; Koenig T, 2010, BRAIN TOPOGR, V23, P233, DOI 10.1007/s10548-010-0142-1; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Michel CM, 2012, NEUROIMAGE, V61, P371, DOI 10.1016/j.neuroimage.2011.12.039; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nijs IMT, 2010, EAT BEHAV, V11, P258, DOI 10.1016/j.eatbeh.2010.07.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliver-Rodriguez JC, 1999, PSYCHOPHYSIOLOGY, V36, P176; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Proverbio AM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-44; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Simmons WK, 2005, CEREB CORTEX, V15, P1602, DOI 10.1093/cercor/bhi038; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Stockburger J, 2008, BEHAV NEUROSCI, V122, P936, DOI 10.1037/a0012517; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Striegel-Moore RH, 2009, INT J EAT DISORDER, V42, P471, DOI 10.1002/eat.20625; Talairach J., 1988, COPLANAR STEREOTAXIC; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Uher R, 2006, BEHAV BRAIN RES, V169, P111, DOI 10.1016/j.bbr.2005.12.008; Woods SC, 2003, EXP BIOL MED, V228, P1175	56	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36778	10.1371/journal.pone.0036778	http://dx.doi.org/10.1371/journal.pone.0036778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590605	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400034
J	Nagasawa, K; Giannetto, A; Fernandes, JMO				Nagasawa, Kazue; Giannetto, Alessia; Fernandes, Jorge M. O.			Photoperiod Influences Growth and mll (Mixed-Lineage Leukaemia) Expression in Atlantic Cod	PLOS ONE			English	Article							GADUS-MORHUA; GENE-EXPRESSION; H3K4 METHYLATION; METHYLTRANSFERASE COMPLEX; HISTONE MODIFICATIONS; DROSOPHILA-TRITHORAX; MYELOID-LEUKEMIA; MUTANT MICE; IDENTIFICATION; HOMOLOG	Photoperiod is associated to phenotypic plasticity of somatic growth in several teleost species. However, the molecular mechanisms underlying this phenomenon are currently unknown but it is likely that epigenetic regulation by methyltransferases is involved. The MLL (mixed-lineage leukaemia) family comprises histone methyltransferases that play a critical role in regulating gene expression during early development in mammals. So far, these genes have received scant attention in teleost fish. In the present study, the mean weight of Atlantic cod juveniles reared under continuous illumination was found to be 13% greater than those kept under natural photoperiod conditions for 120 days. We newly determined cDNA sequences of five mll (mll1, mll2, mll3a, mll4b and mll5) and two setd1 (setd1a and setd1ba) paralogues from Atlantic cod. Phylogenetic analysis revealed that the cod genes clustered within the appropriate mll clade and comparative mapping of mll paralogues showed that these genes lie within a region of conserved synteny among teleosts. All mll and setd1 genes were highly expressed in gonads and fast muscle of adult cod, albeit at different levels, and they were differentially regulated with photoperiod in muscle of juvenile fish. Following only one day of exposure to constant light, mll1, mll4b and setd1a were up to 57% lower in these fish compared to the natural photoperiod group. In addition, mRNA expression of myogenic regulatory factors (myog and myf-5) and pax7 in fast muscle was also affected by different photoperiod conditions. Notably, myog was significantly elevated in the continuous illumination group throughout the time course of the experiment. The absence of a day/night cycle is associated with a generalised decrease in mll expression concomitant with an increase in myog transcript levels in fast muscle of Atlantic cod, which may be involved in the observed epigenetic regulation of growth by photoperiod in this species.	[Nagasawa, Kazue; Giannetto, Alessia; Fernandes, Jorge M. O.] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway	Nord University	Nagasawa, K (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	Jorge.fernandes@uin.no	Nagasawa, Kazue/ABH-6117-2020; Fernandes, Jorge/AAC-4632-2022; Giannetto, Alessia/AAA-6735-2019; Fernandes, Jorge MO/A-3526-2013	Nagasawa, Kazue/0000-0003-2819-3302; Fernandes, Jorge/0000-0002-2550-1640; Giannetto, Alessia/0000-0002-5853-2881; Fernandes, Jorge MO/0000-0002-2550-1640	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This work was supported by a grant to Jorge Fernandes from the Research Council of Norway (ref. 190350/S40, http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amali AA, 2004, DEV DYNAM, V229, P847, DOI 10.1002/dvdy.10454; Ansari KI, 2008, BBA-GENE REGUL MECH, V1779, P66, DOI 10.1016/j.bbagrm.2007.11.006; Ansari KI, 2010, FEBS J, V277, P1790, DOI 10.1111/j.1742-4658.2010.07606.x; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Caldas C, 1998, ONCOGENE, V16, P3233, DOI 10.1038/sj.onc.1201873; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Davie A, 2007, CAN J FISH AQUAT SCI, V64, P98, DOI 10.1139/F06-170; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Endal HP, 2000, AQUACULTURE, V191, P337, DOI 10.1016/S0044-8486(00)00444-0; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; FitzGerald KT, 1999, GENOMICS, V59, P187, DOI 10.1006/geno.1999.5860; Fulberth M, 2009, AQUACULTURE, V292, P225, DOI 10.1016/j.aquaculture.2009.04.028; Glaser S, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-5; Grant SM, 1998, CAN J FISH AQUAT SCI, V55, P1307, DOI 10.1139/cjfas-55-6-1307; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hansen T, 2001, AQUACULTURE, V203, P51, DOI 10.1016/S0044-8486(01)00610-X; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Imsland AK, 2007, J FISH BIOL, V71, P1371, DOI 10.1111/j.1095-8649.2007.01600.x; Imsland AK, 2005, AQUACULTURE, V250, P525, DOI 10.1016/j.aquaculture.2005.03.001; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lappin Terence R J, 2006, Ulster Med J, V75, P23; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Nagasawa K, 2011, AQUACULTURE, P1; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	43	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36908	10.1371/journal.pone.0036908	http://dx.doi.org/10.1371/journal.pone.0036908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590633	gold, Green Published			2022-12-27	WOS:000305336100072
J	Gulyas-Kovacs, A				Gulyas-Kovacs, Attila			Integrated Analysis of Residue Coevolution and Protein Structure in ABC Transporters	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING CASSETTE TRANSPORTERS; MULTIPLE SEQUENCE ALIGNMENTS; CYSTIC-FIBROSIS; MUTUAL INFORMATION; ATP-BINDING; COEVOLVING POSITIONS; CORRELATED MUTATIONS; PHYLOGENETIC TREES; CONTACT PREDICTION	Intraprotein side chain contacts can couple the evolutionary process of amino acid substitution at one position to that at another. This coupling, known as residue coevolution, may vary in strength. Conserved contacts thus not only define 3-dimensional protein structure, but also indicate which residue-residue interactions are crucial to a protein's function. Therefore, prediction of strongly coevolving residue-pairs helps clarify molecular mechanisms underlying function. Previously, various coevolution detectors have been employed separately to predict these pairs purely from multiple sequence alignments, while disregarding available structural information. This study introduces an integrative framework that improves the accuracy of such predictions, relative to previous approaches, by combining multiple coevolution detectors and incorporating structural contact information. This framework is applied to the ABC-B and ABC-C transporter families, which include the drug exporter P-glycoprotein involved in multidrug resistance of cancer cells, as well as the CFTR chloride channel linked to cystic fibrosis disease. The predicted coevolving pairs are further analyzed based on conformational changes inferred from outward- and inward-facing transporter structures. The analysis suggests that some pairs coevolved to directly regulate conformational changes of the alternating-access transport mechanism, while others to stabilize rigid-body-like components of the protein structure. Moreover, some identified pairs correspond to residues previously implicated in cystic fibrosis.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA	Rockefeller University	Gulyas-Kovacs, A (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	agulyaskov@rockefeller.edu	Jones, Attila/AAP-9804-2021	Jones, Attila/0000-0003-0257-8781	National Institutes of Health (NIH) [NIH DK51767]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported from National Institutes of Health (NIH) research grant NIH DK51767 (to D. C. Gadsby). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fawcett T, 2004, MACHINE LEARNING, V31; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galtier N., 2007, V3, P1, DOI 10.1159/000107599; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Haq O, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S10; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Jeon J, 2011, MOL BIOL EVOL, V28, P2675, DOI 10.1093/molbev/msr094; Jeon J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000522; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kosiol C, 2011, J MOL BIOL, V411, P910, DOI 10.1016/j.jmb.2011.06.005; Lee BC, 2009, BIOINFORMATICS, V25, P2506, DOI 10.1093/bioinformatics/btp455; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Pagant S, 2010, J BIOL CHEM, V285, P36304, DOI 10.1074/jbc.M110.142760; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Poon AFY, 2010, MOL BIOL EVOL, V27, P819, DOI 10.1093/molbev/msp289; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000008; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Szollosi A, 2011, J GEN PHYSIOL, V137, P549, DOI 10.1085/jgp.201110608; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	74	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36546	10.1371/journal.pone.0036546	http://dx.doi.org/10.1371/journal.pone.0036546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590562	Green Published, gold			2022-12-27	WOS:000305335500016
J	Patschull, AOM; Gooptu, B; Ashford, P; Daviter, T; Nobeli, I				Patschull, Anathe O. M.; Gooptu, Bibek; Ashford, Paul; Daviter, Tina; Nobeli, Irene			In Silico Assessment of Potential Druggable Pockets on the Surface of alpha(1)-Antitrypsin Conformers	PLOS ONE			English	Article							PROTEIN SURFACES; HIGH-THROUGHPUT; NATIVE STRAIN; BINDING; MECHANISM; SERPINS; IDENTIFICATION; VISUALIZATION; INHIBITION; LIGANDS	The search for druggable pockets on the surface of a protein is often performed on a single conformer, treated as a rigid body. Transient druggable pockets may be missed in this approach. Here, we describe a methodology for systematic in silico analysis of surface clefts across multiple conformers of the metastable protein alpha 1-antitrypsin (A1AT). Pathological mutations disturb the conformational landscape of A1AT, triggering polymerisation that leads to emphysema and hepatic cirrhosis. Computational screens for small molecule inhibitors of polymerisation have generally focused on one major druggable site visible in all crystal structures of native A1AT. In an alternative approach, we scan all surface clefts observed in crystal structures of A1AT and in 100 computationally produced conformers, mimicking the native solution ensemble. We assess the persistence, variability and druggability of these pockets. Finally, we employ molecular docking using publicly available libraries of small molecules to explore scaffold preferences for each site. Our approach identifies a number of novel target sites for drug design. In particular one transient site shows favourable characteristics for druggability due to high enclosure and hydrophobicity. Hits against this and other druggable sites achieve docking scores corresponding to a K-d in the mu M-nM range, comparing favourably with a recently identified promising lead. Preliminary ThermoFluor studies support the docking predictions. In conclusion, our strategy shows considerable promise compared with the conventional single pocket/single conformer approach to in silico screening. Our best-scoring ligands warrant further experimental investigation.	[Patschull, Anathe O. M.; Gooptu, Bibek; Ashford, Paul; Daviter, Tina; Nobeli, Irene] Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England; [Daviter, Tina] Univ London, Sch Sci, ISMB Biophys Ctr, London, England	University of London; Birkbeck University London; University of London	Patschull, AOM (corresponding author), Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England.	i.nobeli@mail.cryst.bbk.ac.uk		Ashford, Paul/0000-0003-4079-0257; Gooptu, Bibek/0000-0002-5223-1121; Nobeli, Irene/0000-0001-8616-170X	Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer; University of Cambridge	Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); University of Cambridge(University of Cambridge)	AOMP was supported by a Wellcome Trust PhD studentship. PA was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Collaborative Awards in Science and Engineering (CASE) studentship, which was part-funded by Pfizer. BG was supported by a Wellcome Trust Intermediate Clinical Fellowship and a Clinical Lectureship from the University of Cambridge. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Ashford P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-39; Berjanskii M, 2010, NUCLEIC ACIDS RES, V38, pW633, DOI 10.1093/nar/gkq375; Bottegoni G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018845; Chang YP, 2011, METHOD ENZYMOL, V501, P139, DOI 10.1016/B978-0-12-385950-1.00008-0; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; Gooptu B, 2008, J EXP MED, V205, P1529, DOI 10.1084/jem.20072080; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gooptu B, 2009, J MOL BIOL, V387, P857, DOI 10.1016/j.jmb.2009.01.069; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Im H, 1999, J BIOL CHEM, V274, P11072, DOI 10.1074/jbc.274.16.11072; Im H, 2002, J BIOL CHEM, V277, P46347, DOI 10.1074/jbc.M207682200; Ivetac A, 2012, METHODS MOL BIOL, V819, P3, DOI 10.1007/978-1-61779-465-0_1; Kim SJ, 2001, J MOL BIOL, V306, P109, DOI 10.1006/jmbi.2000.4357; Kumar S, 2000, PROTEIN SCI, V9, P10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Nichols SE, 2012, METHODS MOL BIOL, V819, P93, DOI 10.1007/978-1-61779-465-0_7; Parfrey H, 2003, J BIOL CHEM, V278, P33060, DOI 10.1074/jbc.M302646200; Pearce MC, 2008, PROTEIN SCI, V17, P2127, DOI 10.1110/ps.037234.108; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ryu SE, 1996, STRUCTURE, V4, P1181, DOI 10.1016/S0969-2126(96)00126-8; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Seo EJ, 2000, J BIOL CHEM, V275, P16904, DOI 10.1074/jbc.M001006200; Seo EJ, 2002, J BIOL CHEM, V277, P14216, DOI 10.1074/jbc.M110272200; Sheridan RP, 2010, J CHEM INF MODEL, V50, P2029, DOI 10.1021/ci100312t; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Singh P, 2012, J MOL MODEL, V18, P1143, DOI 10.1007/s00894-011-1110-8; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; WEBER AE, 1991, J MED CHEM, V34, P2692, DOI 10.1021/jm00113a005; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	51	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36612	10.1371/journal.pone.0036612	http://dx.doi.org/10.1371/journal.pone.0036612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590577	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305335500021
J	Huang, AJ; Yu, KD; Li, J; Fan, L; Shao, ZM				Huang, A-Ji; Yu, Ke-Da; Li, Jing; Fan, Lei; Shao, Zhi-Ming			Polymorphism rs4919510:C > G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes	PLOS ONE			English	Article							GENETIC-VARIATION; SUSCEPTIBILITY; ASSOCIATION	Background: A few polymorphisms are located in the mature microRNA sequences. Such polymorphisms could directly affect the binding of microRNA to hundreds of target mRNAs. It remains unknown whether rs4919510:C>G located in the mature miR-608 alters breast cancer susceptibility. Methods: The association of rs4919510:C>G with risk and pathologic features of breast cancer were investigated in two independent case-control studies, the first set including 1,138 sporadic breast cancer patients (including 927 invasive ductal carcinoma patients, 777 of them with known subtypes: 496 luminal-like, 133 HER2-positive, and 148 triple-negative) and 1,434 community-based controls, and the second set including 294 familial/early-onset breast cancer patients and 500 hospital-based cancer-free controls. Odds ratios (ORs) were estimated by logistic regression. Predicted targets of miR-608 and complementary sequences containing rs4919510:C>G were surveyed to reveal potential pathological mechanism. Results: In the first set, although rs4919510:C>G was unrelated to breast cancer in general patients, variant genotypes (CG/GG) were specifically associated with increased risk of HER2-positive subtype (Adjusted OR = 1.97, 95% CI, 1.34-2.90 in the recessive model). Variant G-allele was the risk allele with OR of 1.62 (95% CI, 1.23-2.15). Patients carrying GG-genotype also had larger HER2-positive tumors (P for Kruskal-Wallis test = 0.006). The relationship between rs4919510:C>G and risk of HER2-positive subgroup was validated in the second set (Bonferroni corrected P = 0.06). The adjusted combined OR (total 164 HER2-positive cases) in the recessive model was 1.97 (95% CI, 1.43-2.72) for GG genotype (corrected P = 1.1x10(-4)). Bioinformatic analysis indicated that, HSF1, which is required for HER2-induced tumorigenesis, might be a target of miR-608. The minimum free-energy of ancestral-miR-608 (C-allele) binding to HSF1 is -35.9 kcal/mol, while that of variant-form (G-allele) is -31.5 kcal/mol, indicating a lower affinity of variant-miR-608 to HSF1 mRNA. Conclusion: rs4919510:C>G in mature miR-608 may influence HER2-positive breast cancer risk and tumor proliferation.	[Huang, A-Ji] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Huang, AJ (corresponding author), Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			National Natural Science Foundation of China [30971143, 30972936, 81001169]; Municipal Hospitals [SHDC12010116]; Ministry of Health; Fudan University; Shanghai Public Health Bureau; Shanghai Committee of Science and Technology [11QA1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Municipal Hospitals; Ministry of Health; Fudan University; Shanghai Public Health Bureau; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This research is supported by grants from the National Natural Science Foundation of China (30971143, 30972936, 81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012), the Zhuo-Xue Project of Fudan University, the 2009 Youth Fund of Shanghai Public Health Bureau, and the Shanghai Committee of Science and Technology Fund for 2011 Qimingxing Project (11QA1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broeks A, 2011, HUM MOL GENET, V20, P3289, DOI 10.1093/hmg/ddr228; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hu Z, 2010, BREAST CANCER RES TR, V120, P705, DOI 10.1007/s10549-009-0488-9; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Knowlden JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3018; Landi D, 2008, DNA CELL BIOL, V27, P35, DOI 10.1089/dna.2007.0650; Latif A, 2010, J MED GENET, V47, P126, DOI 10.1136/jmg.2009.067256; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Peterlongo P, 2011, J MED GENET, V48, P703, DOI 10.1136/jmedgenet-2011-100103; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yu KD, 2009, HUM MOL GENET, V18, P2502, DOI 10.1093/hmg/ddp171; Zhao YH, 2009, ONCOGENE, V28, P3689, DOI 10.1038/onc.2009.229	18	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35252	10.1371/journal.pone.0035252	http://dx.doi.org/10.1371/journal.pone.0035252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586447	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335000009
J	Link, J; Kockum, I; Lorentzen, AR; Lie, BA; Celius, EG; Westerlind, H; Schaffer, M; Alfredsson, L; Olsson, T; Brynedal, B; Harbo, HF; Hillert, J				Link, Jenny; Kockum, Ingrid; Lorentzen, Aslaug R.; Lie, Benedicte A.; Celius, Elisabeth G.; Westerlind, Helga; Schaffer, Marie; Alfredsson, Lars; Olsson, Tomas; Brynedal, Boel; Harbo, Hanne F.; Hillert, Jan			Importance of Human Leukocyte Antigen (HLA) Class I and II Alleles on the Risk of Multiple Sclerosis	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; CLINICAL-COURSE; MHC HAPLOTYPES; SUSCEPTIBILITY; GENES; COMPLEX; REGION; ASSOCIATION; HLA-DRB1; HETEROGENEITY	Multiple sclerosis (MS) is a complex disease of the central nervous system of unknown etiology. The human leukocyte antigen (HLA) locus on chromosome 6 confers a considerable part of the susceptibility to MS, and the most important factor is the class II allele HLA-DRB1*15:01. In addition, we and others have previously established a protective effect of HLA-A*02. Here, we genotyped 1,784 patients and 1,660 healthy controls from Scandinavia for the HLA-A, HLA-B, HLA-C and HLA-DRB1 genes and investigated their effects on MS risk by logistic regression. Several allele groups were found to exert effects independently of DRB1*15 and A*02, in particular DRB1*01 (OR = 0.82, p = 0.034) and B*12 (including B*44/45, OR = 0.76, p = 0.0028), confirming previous reports. Furthermore, we observed interaction between allele groups: DRB1*15 and DRB1*01 (multiplicative: OR = 0.54, p = 0.0041; additive: AP = 0.47, p = 4x10(-06)), DRB1*15 and C*12 (multiplicative: OR = 0.37, p = 0.00035; additive: AP = 0.58, p = 2.6x10(-05)), indicating that the effect size of these allele groups varies when taking DRB1*15 into account. Analysis of inferred haplotypes showed that almost all DRB1*15 bearing haplotypes were risk haplotypes, and that all A*02 bearing haplotypes were protective as long as they did not carry DRB1*15. In contrast, we found one class I haplotype, carrying A*02-C*05-B*12, which abolished the risk of DRB1*15. In conclusion, these results confirms a complex role of HLA class I and II genes that goes beyond DRB1*15 and A*02, in particular by including all three classical HLA class I genes as well as functional interactions between DRB1*15 and several alleles of DRB1 and class I genes.	[Link, Jenny; Kockum, Ingrid; Westerlind, Helga; Olsson, Tomas; Brynedal, Boel; Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lorentzen, Aslaug R.; Lie, Benedicte A.] Oslo Univ Hosp, Inst Immunol, Rikshosp, Oslo, Norway; [Lorentzen, Aslaug R.; Celius, Elisabeth G.; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, Oslo, Norway; [Schaffer, Marie] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway	Karolinska Institutet; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Karolinska Institutet; Karolinska Institutet; University of Oslo	Link, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	jenny.link@ki.se	Kockum, Ingrid/O-8781-2018; Celius, Elisabeth Gulowsen/S-1387-2019; Link, Jenny/J-1629-2012; Alfredsson, Lars/AAC-9007-2019; Westerlind, Helga/T-6191-2018	Kockum, Ingrid/0000-0002-0867-4726; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Alfredsson, Lars/0000-0003-1688-6697; Westerlind, Helga/0000-0003-3380-5342; Olsson, Tomas/0000-0002-2938-1877; Link, Jenny/0000-0002-6134-9404; Brynedal, Boel/0000-0002-7872-2981	Bibbi & Nils Jensen Foundation; Swedish Research Council; Swedish Council for Working Life and Social Research; Karolinska Institutet; European Union, NeuroproMiSe [LSHM-CT-2005-018637]; University of Oslo; Research Council of Norway [166005/V5]; South and Eastern Regional Health Authority; Ulleval University Hospital Scientific Advisory Council (UUHSAC); Odd Fellow MS Society	Bibbi & Nils Jensen Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Karolinska Institutet(Karolinska Institutet); European Union, NeuroproMiSe(European Commission); University of Oslo; Research Council of Norway(Research Council of Norway); South and Eastern Regional Health Authority; Ulleval University Hospital Scientific Advisory Council (UUHSAC); Odd Fellow MS Society	This study was funded by the Bibbi & Nils Jensen Foundation, the Swedish Research Council, the Swedish Council for Working Life and Social Research, Karolinska Institutet, and the 6th Framework Program of the European Union, NeuroproMiSe (LSHM-CT-2005-018637). The Norwegian work was supported by the University of Oslo, the Research Council of Norway (166005/V5), South and Eastern Regional Health Authority, Ulleval University Hospital Scientific Advisory Council (UUHSAC) and Odd Fellow MS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi L, 2010, GENES IMMUN, V11, P173, DOI 10.1038/gene.2009.101; Bergamaschi L, 2011, J MED GENET; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; D'Alfonso S, 2008, GENES IMMUN, V9, P7, DOI 10.1038/sj.gene.6364437; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Friese MA, 2006, CURR OPIN IMMUNOL, V18, P704, DOI 10.1016/j.coi.2006.09.003; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Healy BC, 2010, NEUROLOGY, V75, P634, DOI 10.1212/WNL.0b013e3181ed9c9c; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; HILLERT J, 1992, J NEUROL NEUROSUR PS, V55, P887, DOI 10.1136/jnnp.55.10.887; Hoppenbrouwers IA, 2011, BBA-MOL BASIS DIS, V1812, P194, DOI 10.1016/j.bbadis.2010.09.017; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; JERSILD C, 1973, LANCET, V2, P1221; JERSILD C, 1972, ACTA NEUROL SCAND, V48, P377; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Link J, 2010, J NEUROIMMUNOL, V226, P172, DOI 10.1016/j.jneuroim.2010.07.006; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McMahon RM, 2011, ACTA CRYSTALLOGR D, V67, P447, DOI 10.1107/S0907444911007888; MUSTAFA M, 1994, J IMMUNOL, V153, P3337; NAITO S, 1972, TISSUE ANTIGENS, V2, P1; NEPOM BS, 1987, DIABETES, V36, P114, DOI 10.2337/diabetes.36.1.114; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; R Core Team, 2018, R LANG ENV STAT COMP; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Wu JS, 2010, MULT SCLER J, V16, P526, DOI 10.1177/1352458510362997; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	37	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36779	10.1371/journal.pone.0036779	http://dx.doi.org/10.1371/journal.pone.0036779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586495	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000056
J	Judah, D; Rudkouskaya, A; Wilson, R; Carter, DE; Dagnino, L				Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Carter, David E.; Dagnino, Lina			Multiple Roles of Integrin-Linked Kinase in Epidermal Development, Maturation and Pigmentation Revealed by Molecular Profiling	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; HAIR FOLLICLE; SKIN; GROWTH; EXPRESSION; BETA; MORPHOGENESIS; PROLIFERATION; KERATINOCYTES; ADHESION	Integrin-linked kinase (ILK) is an important scaffold protein that mediates a variety of cellular responses to integrin stimulation by extracellular matrix proteins. Mice with epidermis-restricted inactivation of the Ilk gene exhibit pleiotropic phenotypic defects, including impaired hair follicle morphogenesis, reduced epidermal adhesion to the basement membrane, compromised epidermal integrity, as well as wasting and failure to thrive leading to perinatal death. To better understand the underlying molecular mechanisms that cause such a broad range of alterations, we investigated the impact of Ilk gene inactivation on the epidermis transcriptome. Microarray analysis showed over 700 differentially regulated mRNAs encoding proteins involved in multiple aspects of epidermal function, including keratinocyte differentiation and barrier formation, inflammation, regeneration after injury, and fundamental epidermal developmental pathways. These studies also revealed potential effects on genes not previously implicated in ILK functions, including those important for melanocyte and melanoblast development and function, regulation of cytoskeletal dynamics, and homeobox genes. This study shows that ILK is a critical regulator of multiple aspects of epidermal function and homeostasis, and reveals the previously unreported involvement of ILK not only in epidermal differentiation and barrier formation, but also in melanocyte genesis and function.	[Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Childrens Hlth Res Inst, London, ON, Canada; [Judah, David; Rudkouskaya, Alena; Wilson, Ryan; Dagnino, Lina] Lawson Hlth Res Inst, London, ON, Canada; [Carter, David E.] Univ Western Ontario, London Reg Genom Ctr, London, ON, Canada; [Dagnino, Lina] Univ Western Ontario, Dept Paediat, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Judah, D (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159; Rudkouskaya, Alena/0000-0002-3632-9743	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from an operating grant of the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) to Lina Dagnino. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; BEERMANN F, 1992, P NATL ACAD SCI USA, V89, P2809, DOI 10.1073/pnas.89.7.2809; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botchkarev VA, 2003, J EXP ZOOL PART B, V298B, P164, DOI 10.1002/jez.b.00033; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; Dassule HR, 2000, DEVELOPMENT, V127, P4775; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harris PJ, 2010, CANCER PREV RES, V3, P1217, DOI 10.1158/1940-6207.CAPR-10-0210; Hirobe T, 2011, PIGM CELL MELANOMA R, V24, P462, DOI 10.1111/j.1755-148X.2011.00845.x; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Ho E, 2009, MOL BIOL CELL, V20, P3033, DOI 10.1091/mbc.E09-01-0050; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Inoue S, 2004, J INVEST DERMATOL, V122, P565, DOI 10.1046/j.0022-202X.2004.12628.x; Ivanova IA, 2007, ONCOGENE, V26, P1147, DOI 10.1038/sj.onc.1209894; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kizawa K, 2011, BIOCHIMIE; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lewis DA, 2008, MOL BIOL CELL, V19, P1346, DOI 10.1091/mbc.E07-10-1041; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Nakrieko KA, 2008, MOL BIOL CELL, V19, P1462, DOI 10.1091/mbc.E07-06-0526; Nakrieko KA, 2008, CELL CYCLE, V7, P2157, DOI 10.4161/cc.7.14.6241; Nakrieko KA, 2011, MOL BIOL CELL, V22, P2532, DOI 10.1091/mbc.E11-01-0035; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Novak A, 1998, P NATL ACAD SCI USA, V95, P4374, DOI 10.1073/pnas.95.8.4374; Oklu R, 2000, BIOCHEM J, V352, P601, DOI 10.1042/0264-6021:3520601; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rallis C, 2010, DEVELOPMENT, V137, P3591, DOI 10.1242/dev.050070; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Wang X, 2011, STEM CELLS DEV; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Yang JX, 2010, J CELL BIOL, V188, P935, DOI 10.1083/jcb.200910126	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36704	10.1371/journal.pone.0036704	http://dx.doi.org/10.1371/journal.pone.0036704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574216	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800113
J	Patel, DA; Patel, AC; Nolan, WC; Zhang, Y; Holtzman, MJ				Patel, Dhara A.; Patel, Anand C.; Nolan, William C.; Zhang, Yong; Holtzman, Michael J.			High Throughput Screening for Small Molecule Enhancers of the Interferon Signaling Pathway to Drive Next-Generation Antiviral Drug Discovery	PLOS ONE			English	Article							RESPIRATORY VIRAL-INFECTION; VASCULAR DISRUPTING AGENT; INNATE IMMUNE-RESPONSE; HOUSEKEEPING GENES; STAT1 DEFICIENCY; TOPOISOMERASE-II; DOUBLE-BLIND; PCR DATA; VIRUS; VALIDATION	Most of current strategies for antiviral therapeutics target the virus specifically and directly, but an alternative approach to drug discovery might be to enhance the immune response to a broad range of viruses. Based on clinical observation in humans and successful genetic strategies in experimental models, we reasoned that an improved interferon (IFN) signaling system might better protect against viral infection. Here we aimed to identify small molecular weight compounds that might mimic this beneficial effect and improve antiviral defense. Accordingly, we developed a cell-based high-throughput screening (HTS) assay to identify small molecules that enhance the IFN signaling pathway components. The assay is based on a phenotypic screen for increased IFN-stimulated response element (ISRE) activity in a fully automated and robust format (Z'>0.7). Application of this assay system to a library of 2240 compounds (including 2160 already approved or approvable drugs) led to the identification of 64 compounds with significant ISRE activity. From these, we chose the anthracycline antibiotic, idarubicin, for further validation and mechanism based on activity in the sub-mu M range. We found that idarubicin action to increase ISRE activity was manifest by other members of this drug class and was independent of cytotoxic or topoisomerase inhibitory effects as well as endogenous IFN signaling or production. We also observed that this compound conferred a consequent increase in IFN-stimulated gene (ISG) expression and a significant antiviral effect using a similar dose-range in a cell-culture system inoculated with encephalomyocarditis virus (EMCV). The antiviral effect was also found at compound concentrations below the ones observed for cytotoxicity. Taken together, our results provide proof of concept for using activators of components of the IFN signaling pathway to improve IFN efficacy and antiviral immune defense as well as a validated HTS approach to identify small molecules that might achieve this therapeutic benefit.	[Patel, Dhara A.; Patel, Anand C.; Nolan, William C.; Zhang, Yong; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, Drug Discovery Program, St Louis, MO 63110 USA; [Patel, Anand C.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Holtzman, Michael J.] Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Patel, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Drug Discovery Program, St Louis, MO 63110 USA.	holtzmanm@wustl.edu	; Patel, Anand/B-1441-2009	Patel, Dhara/0000-0002-2736-124X; Patel, Anand/0000-0002-6570-8582	National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases); Martin Schaeffer Fund; Roche Postdoctoral Fellowship; Hoffmann-La Roche; Forest Labs	National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Heart Lung & Blood Institute (NHLBI)); Martin Schaeffer Fund; Roche Postdoctoral Fellowship; Hoffmann-La Roche(Hoffmann-La Roche); Forest Labs	This work was supported by grants from the National Institutes of Health (National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases) and the Martin Schaeffer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DAP is the recipient of a Roche Postdoctoral Fellowship, and MJH is the principal investigator for research grants to Washington University from Hoffmann-La Roche and Forest Labs. These awards do not alter the authors' adherence to all of the PLoS ONE policies on sharing data and materials.	Adams O, 2010, CLIN INFECT DIS, V51, P185, DOI 10.1086/653534; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ASHESHOV IN, 1961, BIOCHEM J, V81, P101, DOI 10.1042/bj0810101; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvaruso V, 2011, EXPERT OPIN DRUG SAF, V10, P429, DOI 10.1517/14740338.2011.559161; Cencic R, 2011, J VIROL, V85, P6381, DOI 10.1128/JVI.00078-11; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen B, 2008, MOL MED, V14, P374, DOI 10.2119/2008-00028.Chen; Cheng GJ, 2011, AM J RESP CELL MOL, V45, P480, DOI 10.1165/rcmb.2010-0288OC; Cheng GJ, 2010, J BIOL CHEM, V285, P10553, DOI 10.1074/jbc.M109.065631; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; COHEN A, 1969, NATURE, V222, P36, DOI 10.1038/222036a0; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Eastwood B, 2011, NATL CTR TRANSLATION; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groothuis JR, 2011, ADV THER, V28, P91, DOI 10.1007/s12325-010-0100-z; Gu BH, 2006, ANTIVIR RES, V70, P39, DOI 10.1016/j.antiviral.2006.01.005; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Holtzman MJ, 2011, CURR OPIN IMMUNOL, V23, P487, DOI 10.1016/j.coi.2011.05.010; HUME V, 1965, J GEN MICROBIOL, V38, P143, DOI 10.1099/00221287-38-1-143; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ketley NJ, 1997, BLOOD, V90, P4578, DOI 10.1182/blood.V90.11.4578.4578_4578_4587; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kogan NM, 2007, MOL CANCER THER, V6, P173, DOI 10.1158/1535-7163.MCT-06-0039; Kumar B, 2011, SEX TRANSM INFECT, V87, P432, DOI 10.1136/sextrans-2011-050025; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lee YK, 2009, ARCH PHARM RES, V32, P1409, DOI 10.1007/s12272-009-2010-7; Leonov H, 2011, J AM CHEM SOC, V133, P9903, DOI 10.1021/ja202288m; Lynch RA, 2007, CANCER RES, V67, P1254, DOI 10.1158/0008-5472.CAN-06-2439; Mata MA, 2011, NAT CHEM BIOL, V7, P712, DOI [10.1038/NCHEMBIO.645, 10.1038/nchembio.645]; McHutchison JG, 2007, HEPATOLOGY, V46, P1341, DOI 10.1002/hep.21773; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Monto AS, 2008, PEDIATR INFECT DIS J, V27, pS110, DOI 10.1097/INF.0b013e318168b739; Nguyen DN, 2009, BIOTECHNOL BIOENG, V103, P664, DOI 10.1002/bit.22312; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Patel U, 2011, BRIT J DERMATOL, V164, P670, DOI 10.1111/j.1365-2133.2010.10124.x; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Pelz O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-185; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Phillips T, 2011, J VIROL METHODS, V173, P182, DOI 10.1016/j.jviromet.2011.02.002; Pizzorno A, 2011, SEMIN RESP CRIT CARE, V32, P409, DOI 10.1055/s-0031-1283281; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TANABE K, 1991, CANCER RES, V51, P4903; Tang JW, 2010, INFECT DIS CLIN N AM, V24, P603, DOI 10.1016/j.idc.2010.04.001; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; Webster D, 2011, CAN MED ASSOC J, V183, pE420, DOI 10.1503/cmaj.100313; Wiles AM, 2008, J BIOMOL SCREEN, V13, P777, DOI 10.1177/1087057108323125; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P7227, DOI 10.1073/pnas.94.14.7227; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200; Zhang Y, 2010, AM J RESP CELL MOL, V43, P507, DOI 10.1165/rcmb.2009-0213ED; Zhao LL, 2007, INVEST NEW DRUG, V25, P271, DOI 10.1007/s10637-006-9029-0; Zhu Q, 2011, J INFECT DIS, V203, P674, DOI 10.1093/infdis/jiq100	68	34	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36594	10.1371/journal.pone.0036594	http://dx.doi.org/10.1371/journal.pone.0036594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574190	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800087
J	Zhang, CY; de Silva, S; Wang, JH; Wu, L				Zhang, Chiyu; de Silva, Suresh; Wang, Jian-Hua; Wu, Li			Co-Evolution of Primate SAMHD1 and Lentivirus Vpx Leads to the Loss of the vpx Gene in HIV-1 Ancestor	PLOS ONE			English	Article							RESTRICTION FACTOR SAMHD1; POSITIVE SELECTION; ORIGIN; EVOLUTIONARY; ADAPTATION; LIKELIHOOD; DIVERSITY; PARSIMONY; INFECTION; INFERENCE	Cross-species transmission and adaptation of simian immunodeficiency viruses (SIVs) to humans have given rise to human immunodeficiency viruses (HIVs). HIV type 1 (HIV-1) and type 2 (HIV-2) were derived from SIVs that infected chimpanzee (SIVcpz) and sooty mangabey (SIVsm), respectively. The HIV-1 restriction factor SAMHD1 inhibits HIV-1 infection in human myeloid cells and can be counteracted by the Vpx protein of HIV-2 and the SIVsm lineage. However, HIV-1 and its ancestor SIVcpz do not encode a Vpx protein and HIV-1 has not evolved a mechanism to overcome SAMHD1-mediated restriction. Here we show that the co-evolution of primate SAMHD1 and lentivirus Vpx leads to the loss of the vpx gene in SIVcpz and HIV-1. We found evidence for positive selection of SAMHD1 in orangutan, gibbon, rhesus macaque, and marmoset, but not in human, chimpanzee and gorilla that are natural hosts of Vpx-negative HIV-1, SIVcpz and SIVgor, respectively, indicating that vpx drives the evolution of primate SAMHD1. Ancestral host state reconstruction and temporal dynamic analyses suggest that the most recent common ancestor of SIVrcm, SIVmnd, SIVcpz, SIVgor and HIV-1 was a SIV that had a vpx gene; however, the vpx gene of SIVcpz was lost approximately 3643 to 2969 years ago during the infection of chimpanzees. Thus, HIV-1 could not inherit the lost vpx gene from its ancestor SIVcpz. The lack of Vpx in HIV-1 results in restricted infection in myeloid cells that are important for antiviral immunity, which could contribute to the AIDS pandemic by escaping the immune responses.	[Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [de Silva, Suresh; Wu, Li] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Zhang, Chiyu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Pathogen Diagnost Ctr, Shanghai, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Jiangsu University; University System of Ohio; Ohio State University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); University System of Ohio; Ohio State University	Zhang, CY (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	zhangcy1999@ips.ac.cn; wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Zhang, Chiyu/0000-0001-8735-9857	"Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China from the National Institutes of Health (NIH) [81071391, AI078762, AI098524]; Public Health Preparedness for Infectious Diseases Program of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078762, R21AI098524, R21AI102822] Funding Source: NIH RePORTER	"Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases Program of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the "Top-notch personnel" Project of Jiangsu University and the National Natural Science Foundation of China (No. 81071391) to Dr. Zhang, by grants (AI078762 and AI098524) to Dr. Wu from the National Institutes of Health (NIH), and by the Public Health Preparedness for Infectious Diseases Program of The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bashirova AA, 2003, J VIROL, V77, P217, DOI 10.1128/JVI.77.1.217-227.2003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Freed EO, 2007, FIELDS VIROLOGY; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; HUGHES AL, 1990, MOL BIOL EVOL, V7, P515; Kanthaswamy S, 2009, J MED PRIMATOL, V38, P17, DOI 10.1111/j.1600-0684.2009.00371.x; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2012, TRENDS IMMUNOL, V33, P26, DOI 10.1016/j.it.2011.11.002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Nelson MI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002077; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Shin EC, 2008, J VIROL, V82, P9782, DOI 10.1128/JVI.00475-08; Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87; Soares AER, 2008, J MOL EVOL, V66, P598, DOI 10.1007/s00239-008-9112-6; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2000, J MOL EVOL, V50, P56, DOI 10.1007/s002399910007	44	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e37477	10.1371/journal.pone.0037477	http://dx.doi.org/10.1371/journal.pone.0037477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574228	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800125
J	Burklew, CE; Ashlock, J; Winfrey, WB; Zhang, BH				Burklew, Caitlin E.; Ashlock, Jordan; Winfrey, William B.; Zhang, Baohong			Effects of Aluminum Oxide Nanoparticles on the Growth, Development, and microRNA Expression of Tobacco (Nicotiana tabacum)	PLOS ONE			English	Article							PLANT MICRORNA; ARABIDOPSIS; TOLERANCE; PHYTOTOXICITY; INDUCTION; GENES; TOXICITY; MIR398; RICE	Nanoparticles are a class of newly emerging environmental pollutions. To date, few experiments have been conducted to investigate the effect nanoparticles may have on plant growth and development. It is important to study the effects nanoparticles have on plants because they are stationary organisms that cannot move away from environmental stresses like animals can, therefore they must overcome these stresses by molecular routes such as altering gene expression. microRNAs (miRNA) are a newly discovered, endogenous class of post-transcriptional gene regulators that function to alter gene expression by either targeting mRNAs for degradation or inhibiting mRNAs translating into proteins. miRNAs have been shown to mediate abiotic stress responses such as drought and salinity in plants by altering gene expression, however no study has been performed on the effect of nanoparticles on the miRNA expression profile; therefore our aim in this study was to classify if certain miRNAs play a role in plant response to Al2O3 nanoparticle stress. In this study, we exposed tobacco (Nicotiana tabacum) plants (an important cash crop as well as a model organism) to 0%, 0.1%, 0.5%, and 1% Al2O3 nanoparticles and found that as exposure to the nanoparticles increased, the average root length, the average biomass, and the leaf count of the seedlings significantly decreased. We also found that miR395, miR397, miR398, and miR399 showed an extreme increase in expression during exposure to 1% Al2O3 nanoparticles as compared to the other treatments and the control, therefore these miRNAs may play a key role in mediating plant stress responses to nanoparticle stress in the environment. The results of this study show that Al2O3 nanoparticles have a negative effect on the growth and development of tobacco seedlings and that miRNAs may play a role in the ability of plants to withstand stress to Al2O3 nanoparticles in the environment.	[Burklew, Caitlin E.; Ashlock, Jordan; Winfrey, William B.; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Burklew, CE (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	zhangb@ecu.edu	Zhang, Baohong/O-4948-2016					Asli S, 2009, PLANT CELL ENVIRON, V32, P577, DOI 10.1111/j.1365-3040.2009.01952.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Doerner P, 2008, CURR OPIN PLANT BIOL, V11, P536, DOI 10.1016/j.pbi.2008.05.006; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Frazier TP, 2011, MOL BIOTECHNOL; Gao P, 2010, PLANTA, V231, P991, DOI 10.1007/s00425-010-1104-2; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kikui S, 2005, J INORG BIOCHEM, V99, P1837, DOI 10.1016/j.jinorgbio.2005.06.031; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima JC, 2011, GENET MOL RES, V10, P2817, DOI 10.4238/2011.November.10.4; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P5580, DOI 10.1021/es800422x; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rittner MN, 1998, JOM-J MIN MET MAT S, V50, P36, DOI 10.1007/s11837-998-0065-4; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Saito K, 2004, PLANT PHYSIOL, V136, P2443, DOI 10.1104/pp.104.046755; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang Feng-Xi, 2009, Acta Botanica Yunnanica, V31, P421, DOI 10.3724/SP.J.1143.2009.09044; Yang L, 2005, TOXICOL LETT, V158, P122, DOI 10.1016/j.toxlet.2005.03.003; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083	35	127	132	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34783	10.1371/journal.pone.0034783	http://dx.doi.org/10.1371/journal.pone.0034783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606225	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200007
J	Chandna, R; Augustine, R; Bisht, NC				Chandna, Ruby; Augustine, Rehna; Bisht, Naveen C.			Evaluation of Candidate Reference Genes for Gene Expression Normalization in Brassica juncea Using Real Time Quantitative RT-PCR	PLOS ONE			English	Article							INTERNAL CONTROL; VALIDATION; SELECTION; REVEALS	The real time quantitative reverse transcription PCR (qRT-PCR) is becoming increasingly important to gain insight into function of genes. Given the increased sensitivity, ease and reproducibility of qRT-PCR, the requirement of suitable reference genes for normalization has become important and stringent. It is now known that the expression of internal control genes in living organism vary considerably during developmental stages and under different experimental conditions. For economically important Brassica crops, only a couple of reference genes are reported till date. In this study, expression stability of 12 candidate reference genes including ACT2, ELFA, GAPDH, TUA, UBQ9 (traditional housekeeping genes), ACP, CAC, SNF, TIPS-41, TMD, TSB and ZNF (new candidate reference genes), in a diverse set of 49 tissue samples representing different developmental stages, stress and hormone treated conditions and cultivars of Brassica juncea has been validated. For the normalization of vegetative stages the ELFA, ACT2, CAC and TIPS-41 combination would be appropriate whereas TIPS-41 along with CAC would be suitable for normalization of reproductive stages. A combination of GAPDH, TUA, TIPS-41 and CAC were identified as the most suitable reference genes for total developmental stages. In various stress and hormone treated samples, UBQ9 and TIPS-41 had the most stable expression. Across five cultivars of B. juncea, the expression of CAC and TIPS-41 did not vary significantly and were identified as the most stably expressed reference genes. This study provides comprehensive information that the new reference genes selected herein performed better than the traditional housekeeping genes. The selection of most suitable reference genes depends on the experimental conditions, and is tissue and cultivar-specific. Further, to attain accuracy in the results more than one reference genes are necessary for normalization.	[Chandna, Ruby; Augustine, Rehna; Bisht, Naveen C.] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chandna, R (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	ncbisht@nipgr.res.in			core grant from National Institute of Plant Genome Research (NIPGR), New Delhi, India; Research Associate fellowship from NIPGR; fellowship from Council of Scientific and Industrial Research (CSIR), India	core grant from National Institute of Plant Genome Research (NIPGR), New Delhi, India; Research Associate fellowship from NIPGR; fellowship from Council of Scientific and Industrial Research (CSIR), India	The study was financially supported by the core grant from National Institute of Plant Genome Research (NIPGR), New Delhi, India. RC was supported by the Research Associate fellowship from NIPGR. RA was funded by a fellowship from Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner AM, 2004, BMC PLANT BIOL, V13, P4; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jami SK, 2008, PLANT PHYSIOL BIOCH, V46, P1019, DOI 10.1016/j.plaphy.2008.07.006; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kaur P, 2011, J EXP BOT, V62, P1285, DOI 10.1093/jxb/erq365; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; MCNULTY SE, 1995, BIOCHEM BIOPH RES CO, V212, P165, DOI 10.1006/bbrc.1995.1951; Muthukumar B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-32; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu Y, 2009, MOL PLANT, V2, P1107, DOI 10.1093/mp/ssp042; Obrero A, 2011, J AGR FOOD CHEM, V59, P5402, DOI 10.1021/jf200689r; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Srivastava S, 2009, J EXP BOT, V60, P3419, DOI 10.1093/jxb/erp181; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu J, 2009, PLANT CELL REP, V28, P1235, DOI 10.1007/s00299-009-0723-1; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3	42	145	155	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36918	10.1371/journal.pone.0036918	http://dx.doi.org/10.1371/journal.pone.0036918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606308	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200056
J	Mavandadi, S; Dimitrov, S; Feng, S; Yu, F; Sikora, U; Yaglidere, O; Padmanabhan, S; Nielsen, K; Ozcan, A				Mavandadi, Sam; Dimitrov, Stoyan; Feng, Steve; Yu, Frank; Sikora, Uzair; Yaglidere, Oguzhan; Padmanabhan, Swati; Nielsen, Karin; Ozcan, Aydogan			Distributed Medical Image Analysis and Diagnosis through Crowd-Sourced Games: A Malaria Case Study	PLOS ONE			English	Article								In this work we investigate whether the innate visual recognition and learning capabilities of untrained humans can be used in conducting reliable microscopic analysis of biomedical samples toward diagnosis. For this purpose, we designed entertaining digital games that are interfaced with artificial learning and processing back-ends to demonstrate that in the case of binary medical diagnostics decisions (e. g., infected vs. uninfected), with the use of crowd-sourced games it is possible to approach the accuracy of medical experts in making such diagnoses. Specifically, using non-expert gamers we report diagnosis of malaria infected red blood cells with an accuracy that is within 1.25% of the diagnostics decisions made by a trained medical professional.	[Mavandadi, Sam; Dimitrov, Stoyan; Feng, Steve; Yu, Frank; Sikora, Uzair; Yaglidere, Oguzhan; Padmanabhan, Swati; Ozcan, Aydogan] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Nielsen, Karin] Univ Calif Los Angeles, Sch Med, Dept Pediat, Div Infect Dis, Los Angeles, CA 90024 USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Ozcan, Aydogan] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mavandadi, S (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA.	ozcan@ucla.edu	Ozcan, Aydogan/I-2608-2013	Ozcan, Aydogan/0000-0002-0717-683X				Amory A, 1999, BRIT J EDUC TECHNOL, V30, P311, DOI 10.1111/1467-8535.00121; Anderson E, 2010, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON INFORMATION WARFARE AND SECURITY, P1, DOI 10.1145/1822348.1822349; Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cooper S., 2010, P 5 INT C FDN DIG GA, P40, DOI DOI 10.1145/1822348.1822354; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Diaz G, 2009, J BIOMED INFORM, V42, P296, DOI 10.1016/j.jbi.2008.11.005; Huberman BA, 2008, COMPUTER, V41, P103, DOI 10.1109/MC.2008.450; Kafai YB., 2006, GAMES CULT, V1, P36, DOI [10.1177/1555412005281767, DOI 10.1177/1555412005281767]; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Mudanyali O, 2010, LAB CHIP, V10, P1417, DOI 10.1039/c000453g; Roman D, 2009, COMMUN ACM, V52, P12; Sio SWS, 2007, MALARIACOUNT IMAGE A; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Tek F.B., 2006, BRIT MACHINE VISION; Tek FB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-153; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Tuite K., 2010, P 5 INT C FDN DIG GA, P232; Tuite K, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1383; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; von Ahn L, 2008, COMMUN ACM, V51, P58, DOI 10.1145/1378704.1378719; Von Ahn Luis, 2004, P SIGCHI C HUM FACT, P319, DOI DOI 10.1145/985692.985733; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zhu HY, 2011, ANAL CHEM, V83, P6641, DOI 10.1021/ac201587a; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	28	77	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37245	10.1371/journal.pone.0037245	http://dx.doi.org/10.1371/journal.pone.0037245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606353	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200067
J	Yang, MY; Lin, PM; Liu, YC; Hsiao, HH; Yang, WC; Hsu, JF; Hsu, CM; Lin, SF				Yang, Ming-Yu; Lin, Pai-Mei; Liu, Yi-Chang; Hsiao, Hui-Hua; Yang, Wen-Chi; Hsu, Jui-Feng; Hsu, Cheng-Ming; Lin, Sheng-Fung			Induction of Cellular Senescence by Doxorubicin Is Associated with Upregulated miR-375 and Induction of Autophagy in K562 Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; MICRORNA; CANCER; ACCUMULATION; P53; DIFFERENTIATION; PATHOGENESIS; CARCINOMAS; BIOMARKER	Background: Cellular senescence is a specialized form of growth arrest that is generally irreversible. Upregulated p16, p53, and p21 expression and silencing of E2F target genes have been characterized to promote the establishment of senescence. It can be further aided by the transcriptional repression of proliferation-associated genes by the action of HP1 gamma, HMGA, and DNMT proteins to produce a repressive chromatin environment. Therefore, senescence has been suggested to functions as a natural brake for tumor development and plays a critical role in tumor suppression and aging. Methodology/Principal Findings: An in vitro senescence model has been established by using K562 cells treated with 50 nM doxorubicin (DOX). Since p53 and p16 are homozygously deleted in the K562 cells, the DOX-induced senescence in K562 cells ought to be independent of p53 and p16-pRb pathways. Indeed, no change in the expression of the typical senescence-associated premalignant cell markers in the DOX-induced senescent K562 cells was found. MicroRNA profiling revealed upregulated miR-375 in DOX-induced senescent K562 cells. Treatment with miR-375 inhibitor was able to reverse the proliferation ability suppressed by DOX (p<0.05) and overexpression of miR-375 suppressed the normal proliferation of K562 cells. Upregulated miR-375 expression was associated with downregulated expression of 14-3-3zeta and SP1 genes. Autophagy was also investigated since DOX treatment was able to induce cells entering senescence and eventually lead to cell death. Among the 24 human autophagy-related genes examined, a 12-fold increase of ATG9B at day 4 and a 20-fold increase of ATG18 at day 2 after DOX treatment were noted. Conclusions/Significance: This study has demonstrated that in the absence of p53 and p16, the induction of senescence by DOX was associated with upregulation of miR-375 and autophagy initiation. The anti-proliferative function of miR-375 is possibly exerted, at least in part, by targeting 14-3-3zeta and SP1 genes.	[Yang, Ming-Yu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Yang, Ming-Yu; Liu, Yi-Chang; Hsiao, Hui-Hua; Yang, Wen-Chi; Hsu, Jui-Feng; Lin, Sheng-Fung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Lin, Pai-Mei] I Shou Univ, Dept Nursing, Kaohsiung, Taiwan; [Liu, Yi-Chang; Hsiao, Hui-Hua; Lin, Sheng-Fung] Kaohsiung Med Univ, Fac Med, Kaohsiung, Taiwan; [Hsu, Cheng-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Hsu, Cheng-Ming] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; I Shou University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University	Yang, MY (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan.	yangmy@mail.cgu.edu.tw; shlin@cc.kmu.edu.tw		Hsu, Cheng-Ming/0000-0003-3792-3784; Yang, Ming-Yu/0000-0002-6841-5478	National Science Council [NSC96- 2314- B -037-019 - MY3, NSC96-2320- B -242-002 - MY3]; Kaohsiung Medical University [96-25, 97-39]; Chang Gung University [CMRPD880021, CMRPD880022]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; Chang Gung University	This work was supported by National Science Council grants NSC96- 2314- B -037-019 - MY3 (SFL) and NSC96-2320- B -242-002 - MY3 (MYY), Kaohsiung Medical University Hospital internal grants 96-25 and 97-39 (SFL) and Chang Gung University internal grants CMRPD880021 and CMRPD880022 (MYY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Czyz M, 2008, BIOCHEM PHARMACOL, V75, P1761, DOI 10.1016/j.bcp.2008.02.004; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faderl S, 1999, ONCOLOGY-NY, V13, P169; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Grillari J, 2010, EXP GERONTOL, V45, P302, DOI 10.1016/j.exger.2010.01.007; Gruber HE, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-5; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Khoshnaw SM, 2009, J CLIN PATHOL, V62, P422, DOI 10.1136/jcp.2008.060681; Kinoshita T, 2012, INT J ONCOL, V40, P185, DOI 10.3892/ijo.2011.1196; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nair U, 2010, J BIOL CHEM, V285, P11476, DOI 10.1074/jbc.M109.080374; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Nielsen GP, 1999, LAB INVEST, V79, P1137; Nohata N, 2011, J HUM GENET, V56, P595, DOI 10.1038/jhg.2011.66; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OGAWA S, 1994, BLOOD, V84, P2431, DOI 10.1182/blood.V84.8.2431.bloodjournal8482431; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; SUGIMOTO K, 1992, BLOOD, V79, P2378, DOI 10.1182/blood.V79.9.2378.2378; Szulawska A, 2007, BIOCHEM PHARMACOL, V73, P175, DOI 10.1016/j.bcp.2006.09.028; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vaz C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-288; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Wang FF, 2011, AM J PATHOL, V179, P2580, DOI 10.1016/j.ajpath.2011.07.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	56	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37205	10.1371/journal.pone.0037205	http://dx.doi.org/10.1371/journal.pone.0037205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606351	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200066
J	Pinton, G; Manente, AG; Angeli, G; Mutti, L; Moro, L				Pinton, Giulia; Manente, Arcangela Gabriella; Angeli, Giovanni; Mutti, Luciano; Moro, Laura			Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							CANCER CELLS; PHASE-II; KINASE-B; RECEPTOR; GROWTH; ACTIVATION; MET; ASBESTOS; CARCINOGENESIS; PATHWAY	Background: PI3K/AKT signalling pathway is aberrantly active and plays a critical role for cell cycle progression of human malignant pleural mesothelioma (MMe) cells. AKT is one of the important cellular targets of perifosine, a novel bio-available alkylphospholipid that has displayed significant anti-proliferative activity in vitro and in vivo in several human tumour model systems and is currently being tested in clinical trials. Methods: We tested Perifosine activity on human mesothelial cells and different mesothelioma cell lines, in order to provide evidence of its efficacy as single agent and combined therapy. Results: We demonstrate here that perifosine, currently being evaluated as an anti-cancer agent in phase 1 and 2 clinical trials, caused a dose-dependent reduction of AKT activation, at concentrations causing MMe cell growth arrest. In this study we firstly describe that MMe cells express aside from AKT1 also AKT3 and that either the myristoylated, constitutively active, forms of the two proteins, abrogated perifosine-mediated cell growth inhibition. Moreover, we describe here a novel mechanism of perifosine that interferes, upstream of AKT, affecting EGFR and MET phosphorylation. Finally, we demonstrate a significant increase in cell toxicity when MMe cells were treated with perifosine in combination with cisplatin. Conclusions: This study provides a novel mechanism of action of perifosine, directly inhibiting EGFR/MET-AKT1/3 axis, providing a rationale for a novel translational approach to the treatment of MMe.	[Pinton, Giulia; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy; [Pinton, Giulia; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Novara, Italy; [Angeli, Giovanni] Vercelli Hosp, Serv Pathol, Vercelli, Italy; [Mutti, Luciano] Vercelli Hosp, Dept Med, Vercelli, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Pinton, G (corresponding author), Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy.	moro@pharm.unipmn.it	Moro, Laura/ABF-2175-2020; Mutti, Luciano/A-3545-2011; Pinton, Giulia/ABF-2199-2020	Pinton, Giulia/0000-0003-0496-0378; Moro, Laura/0000-0003-3421-2522; Mutti, Luciano/0000-0002-1578-2637	Mesothelioma Applied Research Foundation (MARF); Fondazione Buzzi Unicem; GIMe (Italian Mesothelioma interest Group)	Mesothelioma Applied Research Foundation (MARF); Fondazione Buzzi Unicem; GIMe (Italian Mesothelioma interest Group)	Work was supported by Mesothelioma Applied Research Foundation (MARF grant 2009), Fondazione Buzzi Unicem and GIMe (Italian Mesothelioma interest Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bendell JC, 2011, J CLIN ONCOL, V29, P4394, DOI 10.1200/JCO.2011.36.1980; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brognard J, 2001, CANCER RES, V61, P3986; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Campbell NP, 2011, SEMIN RESP CRIT CARE, V32, P102, DOI 10.1055/s-0031-1272874; Carbone M, 2012, CLIN CANCER RES, V18, P598, DOI 10.1158/1078-0432.CCR-11-2259; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Festuccia C, 2008, PROSTATE, V68, P965, DOI 10.1002/pros.20757; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hideshima T, 2006, BLOOD, V107, P4053, DOI 10.1182/blood-2005-08-3434; Jagadeeswaran R, 2006, CANCER RES, V66, P352, DOI 10.1158/0008-5472.CAN-04-4567; Kawaguchi K, 2009, CARCINOGENESIS, V30, P1097, DOI 10.1093/carcin/bgp097; Kazan-Allen L, 2005, LUNG CANCER, V49, pS3, DOI 10.1016/j.lungcan.2005.03.002; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Li X, 2006, ONCOGENE, V25, P525, DOI 10.1038/sj.onc.1209075; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; Pinton G, 2009, CANCER RES, V69, P4598, DOI 10.1158/0008-5472.CAN-08-4523; Ray M, 2009, CHEST, V136, P888, DOI 10.1378/chest.08-2665; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tolnay E, 1998, J CANCER RES CLIN, V124, P291, DOI 10.1007/s004320050171; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241	34	33	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36856	10.1371/journal.pone.0036856	http://dx.doi.org/10.1371/journal.pone.0036856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590625	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400041
J	Pare, A; Kim, M; Juarez, MT; Brody, S; McGinnis, W				Pare, Adam; Kim, Myungjin; Juarez, Michelle T.; Brody, Stuart; McGinnis, William			The Functions of Grainy Head-Like Proteins in Animals and Fungi and the Evolution of Apical Extracellular Barriers	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR FAMILY; DROSOPHILA-MELANOGASTER; NEUROSPORA-CRASSA; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-FUMIGATUS; SIGNALING PATHWAYS; EPIDERMAL BARRIER; IMMUNE-RESPONSES; STRESS-RESPONSE	The Grainy head (GRH) family of transcription factors are crucial for the development and repair of epidermal barriers in all animals in which they have been studied. This is a high-level functional conservation, as the known structural and enzymatic genes regulated by GRH proteins differ between species depending on the type of epidermal barrier being formed. Interestingly, members of the CP2 superfamily of transcription factors, which encompasses the GRH and LSF families in animals, are also found in fungi - organisms that lack epidermal tissues. To shed light on CP2 protein function in fungi, we characterized a Neurospora crassa mutant lacking the CP2 member we refer to as grainy head-like (grhl). We show that Neurospora GRHL has a DNA-binding specificity similar to that of animal GRH proteins and dissimilar to that of animal LSF proteins. Neurospora grhl mutants are defective in conidial-spore dispersal due to an inability to remodel the cell wall, and we show that grhl mutants and the long-known conidial separation-2 (csp-2) mutants are allelic. We then characterized the transcriptomes of both Neurospora grhl mutants and Drosophila grh mutant embryos to look for similarities in the affected genes. Neurospora grhl appears to play a role in the development and remodeling of the cell wall, as well as in the activation of genes involved in defense and virulence. Drosophila GRH is required to activate the expression of many genes involved in cuticular/epidermal-barrier formation. We also present evidence that GRH plays a role in adult antimicrobial defense. These results, along with previous studies of animal GRH proteins, suggest the fascinating possibility that the apical extracellular barriers of some animals and fungi might share an evolutionary connection, and that the formation of physical barriers in the last common ancestor was under the control of a transcriptional code that included GRH-like proteins.	[Pare, Adam; Kim, Myungjin; Juarez, Michelle T.; McGinnis, William] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Brody, Stuart] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Pare, A (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	adamcpare@gmail.com; wmcginnis@ucsd.edu		Juarez, Michelle/0000-0002-6910-0881	National Institutes of Health [GM077197, HD28315, T32GM007240]; family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028315] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM077197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); family of Herbert Stern; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health Grants (http://grants.nih.gov/) GM077197 and HD28315 (to WM), NIH Training Grant T32GM007240 (to AP) and also received support from the family of Herbert Stern. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Auden A, 2006, GENE EXPR PATTERNS, V6, P964, DOI 10.1016/j.modgep.2006.03.011; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Brody S, 2010, FUNGAL GENET BIOL, V47, P159, DOI 10.1016/j.fgb.2009.09.006; Bruneau JM, 2001, ELECTROPHORESIS, V22, P2812, DOI 10.1002/1522-2683(200108)22:13&lt;2812::AID-ELPS2812&gt;3.0.CO;2-Q; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carroll SB., 2005, DNA DIVERSITY; Casso David, 2000, Mechanisms of Development, V91, P451, DOI 10.1016/S0925-4773(00)00248-3; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Chalmers AD, 2006, MECH DEVELOP, V123, P702, DOI 10.1016/j.mod.2006.04.006; Chung H, 2009, P NATL ACAD SCI USA, V106, P5731, DOI 10.1073/pnas.0812141106; Davis R.H., 2000, NEUROSPORA CONTRIBUT; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Delserone LM, 1999, PHYSIOL MOL PLANT P, V55, P317, DOI 10.1006/pmpp.1999.0237; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; Guo JR, 2005, BIOTECHNOL LETT, V27, P3, DOI 10.1007/s10529-004-6294-x; Gustavsson P, 2008, BIRTH DEFECTS RES A, V82, P728, DOI 10.1002/bdra.20494; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Kasuga T, 2008, EUKARYOT CELL, V7, P1549, DOI 10.1128/EC.00195-08; Kim M, 2011, P NATL ACAD SCI USA, V108, P650, DOI 10.1073/pnas.1016386108; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Kokoszynska K, 2008, CELL CYCLE, V7, P2907, DOI 10.4161/cc.7.18.6680; Kraaijeveld Alex R., 2009, P187; Kudryavtseva EI, 2003, DEV DYNAM, V226, P604, DOI 10.1002/dvdy.10255; Lambreghts R, 2009, GENETICS, V181, P767, DOI 10.1534/genetics.108.089292; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; Liaw GJ, 1995, GENE DEV, V9, P3163, DOI 10.1101/gad.9.24.3163; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Matova N, 2010, J CELL SCI, V123, P627, DOI 10.1242/jcs.060731; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Meek IB, 2003, APPL ENVIRON MICROB, V69, P1607, DOI 10.1128/AEM.69.3.1607-1613.2003; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Ostrowski S, 2002, GENETICS, V161, P171; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Percudani R, 2005, PROTEINS, V60, P670, DOI 10.1002/prot.20543; PERKINS DD, 2000, FUNGAL GENET NEWSL, V47, P40; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Sebe-Pedros A, 2011, MOL BIOL EVOL, V28, P1241, DOI 10.1093/molbev/msq309; SELITRENNIKOFF CP, 1974, GENETICS, V78, P679; Shirra MK, 1998, J BIOL CHEM, V273, P19260, DOI 10.1074/jbc.273.30.19260; SPRINGER ML, 1989, GENE DEV, V3, P559, DOI 10.1101/gad.3.4.559; Sun W, 2006, INSECT MOL BIOL, V15, P455, DOI 10.1111/j.1365-2583.2006.00662.x; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Ting Stephen B, 2005, Organogenesis, V2, P33; Traylor-Knowles N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-101; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Veljkovic J, 2004, GENE, V343, P23, DOI 10.1016/j.gene.2004.08.010; Venkatesan K, 2003, NUCLEIC ACIDS RES, V31, P4304, DOI 10.1093/nar/gkg644; Wang SQ, 2009, NAT CELL BIOL, V11, P890, DOI 10.1038/ncb1898; Werth M, 2010, DEVELOPMENT, V137, P3835, DOI 10.1242/dev.055483; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1; Yin QY, 2008, TRENDS MICROBIOL, V16, P20, DOI 10.1016/j.tim.2007.10.011; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200; Yu ZQ, 2008, DEV BIOL, V319, P56, DOI 10.1016/j.ydbio.2008.04.001; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015; Yu ZQ, 2009, EMBO J, V28, P1890, DOI 10.1038/emboj.2009.142; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131	94	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36254	10.1371/journal.pone.0036254	http://dx.doi.org/10.1371/journal.pone.0036254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590528	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100024
J	Ahmed, SE; Ewers, RM				Ahmed, Sadia E.; Ewers, Robert M.			Spatial Pattern of Standing Timber Value across the Brazilian Amazon	PLOS ONE			English	Article							ABOVEGROUND LIVE BIOMASS; NATURAL-RESOURCE; CLIMATE-CHANGE; WOOD DENSITY; LAND-USE; DEFORESTATION; FORESTS; FRAGMENTATION; ECOSYSTEM; TURNOVER	The Amazon is a globally important system, providing a host of ecosystem services from climate regulation to food sources. It is also home to a quarter of all global diversity. Large swathes of forest are removed each year, and many models have attempted to predict the spatial patterns of this forest loss. The spatial patterns of deforestation are determined largely by the patterns of roads that open access to frontier areas and expansion of the road network in the Amazon is largely determined by profit seeking logging activities. Here we present predictions for the spatial distribution of standing value of timber across the Amazon. We show that the patterns of timber value reflect large-scale ecological gradients, determining the spatial distribution of functional traits of trees which are, in turn, correlated with timber values. We expect that understanding the spatial patterns of timber value across the Amazon will aid predictions of logging movements and thus predictions of potential future road developments. These predictions in turn will be of great use in estimating the spatial patterns of deforestation in this globally important biome.	[Ahmed, Sadia E.; Ewers, Robert M.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England	Imperial College London	Ahmed, SE (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England.	sadia.ahmed05@imperial.ac.uk			Grantham Institute for Climate Change and Microsoft Research	Grantham Institute for Climate Change and Microsoft Research(Microsoft)	The work was funded by The Grantham Institute for Climate Change (http://www3.imperial.ac.uk/climatechange) and Microsoft Research (http://research.microsoft.com/en-us/labs/cambridge/) through Ph.D. funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima EY, 2008, PHOTOGRAMM ENG REM S, V74, P699, DOI 10.14358/PERS.74.6.699; Arima EY, 2005, ANN ASSOC AM GEOGR, V95, P525, DOI 10.1111/j.1467-8306.2005.00473.x; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2004, P NATL ACAD SCI USA, V101, P6039, DOI 10.1073/pnas.0400168101; Baker TR, 2009, BIOGEOSCIENCES, V6, P297, DOI 10.5194/bg-6-297-2009; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; Betts RA, 2008, PHILOS T R SOC B, V363, P1729, DOI 10.1098/rstb.2008.0011; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Caldas MM, 2010, J LAT AM GEOGR, V9, P125, DOI 10.1353/lag.0.0066; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Evans TP, 2001, ECOL MODEL, V143, P95, DOI 10.1016/S0304-3800(01)00357-X; FEARNSIDE P M, 1987, Conservation Biology, V1, P214, DOI 10.1111/j.1523-1739.1987.tb00035.x; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GENTRY AH, 1992, ANN MO BOT GARD, V79, P53, DOI 10.2307/2399809; Gerwing JJ, 1996, REDUCING WASTE LOGGI, V187; Giraudoux P., 2011, PGIRMESS DATA ANAL E; Kirby KR, 2006, FUTURES, V38, P432, DOI 10.1016/j.futures.2005.07.011; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2004, GLOBAL CHANGE BIOL, V10, P563, DOI 10.1111/j.1529-8817.2003.00778.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Melillo JM, 1996, ANNU REV ENERG ENV, V21, P293, DOI 10.1146/annurev.energy.21.1.293; Merry F, 2009, ENVIRON MANAGE, V44, P395, DOI 10.1007/s00267-009-9337-1; Mertens B, 2002, AGR ECON, V27, P269, DOI 10.1016/S0169-5150(02)00076-2; MONTAGNINI F, 2005, TROP FOR, P1; MORAN EF, 1993, HUM ECOL, V21, P1, DOI 10.1007/BF00890069; Nepstad D, 2007, REDD UN FRAM CONV CL; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Perz SG, 2007, DEV CHANGE, V38, P529, DOI 10.1111/j.1467-7660.2007.00422.x; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Prates-Clark CD, 2008, ECOL MODEL, V211, P309, DOI 10.1016/j.ecolmodel.2007.09.024; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; R Core Team, 2020, R LANG ENV STAT COMP; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Southworth J, 2011, REMOTE SENS-BASEL, V3, P1047, DOI 10.3390/rs3051047; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Stone SW, 1998, ECOL ECON, V27, P43, DOI 10.1016/S0921-8009(97)00130-4; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Uhl C, 1997, BIOSCIENCE, V47, P160, DOI 10.2307/1313035; VERISSIMO A, 1995, FOREST ECOL MANAG, V72, P39, DOI 10.1016/0378-1127(94)03432-V; Verissimo A, 2002, CONSERV ECOL, V6	50	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36099	10.1371/journal.pone.0036099	http://dx.doi.org/10.1371/journal.pone.0036099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590520	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500006
J	Lee, JW; Yeo, SG; Kang, BH; Lee, HK; Kim, JW; Lee, SH; Kim, KS; Cheon, DS				Lee, June-Woo; Yeo, Sang-Gu; Kang, Byung-Hak; Lee, Hoe-Kyu; Kim, Jin-Won; Lee, Sun-Hwa; Kim, Ki-Sang; Cheon, Doo-Sung			Echovirus 30 Induced Neuronal Cell Death through TRIO-RhoA Signaling Activation	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; STRESS FIBER FORMATION; ASEPTIC-MENINGITIS; CYTOSKELETON REORGANIZATION; GEF INHIBITOR; IDENTIFICATION; EXPRESSION; FAMILY; KOREA; ENTEROVIRUS-71	Background: Echovirus 30 (Echo30) is one of the most frequently identified human enteroviruses (EVs) causing aseptic meningitis and encephalitis. However the mechanism underlying the pathogenesis of Echo30 infection with significant clinical outcomes is not completely understood. The aim of this investigation is to illustrate molecular pathologic alteration in neuronal cells induced by Echo30 infection using clinical isolate from young patient with neurologic involvement. Methodology/Principal Findings: To characterize the neuronal cellular response to Echo30 infection, we performed a proteomic analysis based on two-dimensional gel electrophoresis (2-DE) and MALDI-TOF/TOF Mass Spectrophotometric (MS) analysis. We identified significant alteration of several protein expression levels in Echo30-infected SK-N-SH cells. Among these proteins, we focused on an outstanding up-regulation of Triple functional domain (TRIO) in Echo30-infected SK-N-SH cells. Generally, TRIO acts as a key component in the regulation of axon guidance and cell migration. In this study, we determined that TRIO plays a role in the novel pathways in Echo30 induced neuronal cell death. Conclusions/Significance: Our finding shows that TRIO plays a critical role in neuronal cell death by Echo30 infection. Echo30 infection activates TRIO-guanine nucleotide exchange factor (GEF) domains (GEFD2) and RhoA signaling in turn. These results suggest that Echo30 infection induced neuronal cell death by activation of the TRIO-RhoA signaling. We expect the regulation of TRIO-RhoA signaling may represent a new therapeutic approach in treating aseptic meningitis and encephalitis induced by Echo30.	[Lee, June-Woo; Yeo, Sang-Gu; Kang, Byung-Hak; Lee, Hoe-Kyu; Kim, Jin-Won; Lee, Sun-Hwa; Kim, Ki-Sang; Cheon, Doo-Sung] Natl Inst Hlth, Ctr Infect Dis, Div Enter & Hepatitis Viruses, Osong, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Lee, JW (corresponding author), Natl Inst Hlth, Ctr Infect Dis, Div Enter & Hepatitis Viruses, Osong, South Korea.	cheonds@hanmail.net			Korean National Institutes of Health [2011-N42002-00]	Korean National Institutes of Health	This work was supported by research grants from the Korean National Institutes of Health (2011-N42002-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Allen C, 2010, STROKE, V41, P2056, DOI 10.1161/STROKEAHA.109.574939; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Bateman J, 2001, J CELL SCI, V114, P1973; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Brunel D, 2008, J CLIN VIROL, V42, P225, DOI 10.1016/j.jcv.2008.02.008; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Choi YJ, 2010, J MICROBIOL BIOTECHN, V20, P643, DOI 10.4014/jmb.0909.09002; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dalwai A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-236; Dyer Jamie O, 2010, Small GTPases, V1, P44; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Frantzidou F, 2008, EUR J NEUROL, V15, P995, DOI 10.1111/j.1468-1331.2008.02233.x; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; Kadi A, 2007, CLIN HEMORHEOL MICRO, V37, P131; Kim HJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-38; Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639; Lee JS, 2005, AM J PATHOL, V166, P1861, DOI 10.1016/S0002-9440(10)62495-9; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Leong SK, 2002, ANN NY ACAD SCI, V962, P161, DOI 10.1111/j.1749-6632.2002.tb04066.x; Leong WF, 2006, CELL MICROBIOL, V8, P565, DOI 10.1111/j.1462-5822.2005.00644.x; Ma XM, 2005, J COMP NEUROL, V482, P333, DOI 10.1002/cne.20404; Medley QG, 2000, J BIOL CHEM, V275, P36116, DOI 10.1074/jbc.M003775200; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Palacios G, 2002, J VIROL, V76, P4940, DOI 10.1128/JVI.76.10.4940-4949.2002; Peng YJ, 2010, J BIOL CHEM, V285, P24834, DOI 10.1074/jbc.M109.096537; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; Seipel K, 1999, J CELL SCI, V112, P1825; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Xu D, 2012, CELL SIGNAL, V24, P282, DOI 10.1016/j.cellsig.2011.09.013; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347	40	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36656	10.1371/journal.pone.0036656	http://dx.doi.org/10.1371/journal.pone.0036656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586486	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335000047
J	Luo, C; Guo, ZW; Lai, YX; Liao, W; Liu, Q; Kendrick, KM; Yao, DZ; Li, H				Luo, Cheng; Guo, Zhi-wei; Lai, Yong-xiu; Liao, Wei; Liu, Qiang; Kendrick, Keith M.; Yao, De-zhong; Li, Hong			Musical Training Induces Functional Plasticity in Perceptual and Motor Networks: Insights from Resting-State fMRI	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN BRAIN; CAUSAL CONNECTIVITY; GRANGER CAUSALITY; SMALL-WORLD; AUDITORY-CORTEX; MUSICIANS BRAIN; NEURAL-NETWORKS; GLOBAL SIGNAL; LOW-FREQUENCY	A number of previous studies have examined music-related plasticity in terms of multi-sensory and motor integration but little is known about the functional and effective connectivity patterns of spontaneous intrinsic activity in these systems during the resting state in musicians. Using functional connectivity and Granger causal analysis, functional and effective connectivity among the motor and multi-sensory (visual, auditory and somatosensory) cortices were evaluated using resting-state functional magnetic resonance imaging (fMRI) in musicians and non-musicians. The results revealed that functional connectivity was significantly increased in the motor and multi-sensory cortices of musicians. Moreover, the Granger causality results demonstrated a significant increase outflow-inflow degree in the auditory cortex with the strongest causal outflow pattern of effective connectivity being found in musicians. These resting state fMRI findings indicate enhanced functional integration among the lower-level perceptual and motor networks in musicians, and may reflect functional consolidation (plasticity) resulting from long-term musical training, involving both multi-sensory and motor functional integration.	[Luo, Cheng; Guo, Zhi-wei; Lai, Yong-xiu; Liao, Wei; Kendrick, Keith M.; Yao, De-zhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Liu, Qiang; Li, Hong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	University of Electronic Science & Technology of China; Southwest University - China	Luo, C (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn; lihong1@swnu.edu.cn	Liu, Qiang/AAA-2260-2020; Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Kendrick, Keith/0000-0002-0371-5904; Yao, Dezhong/0000-0002-8042-879X	National Nature Science Foundation of China [60736029, 2011CB707803]; PCSIRT	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This project was funded by grants from the National Nature Science Foundation of China (60736029), the 973 project 2011CB707803 and the PCSIRT project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Altenmuller EO, 2001, ANN NY ACAD SCI, V930, P273, DOI 10.1111/j.1749-6632.2001.tb05738.x; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEVER TG, 1974, SCIENCE, V185, P537, DOI 10.1126/science.185.4150.537; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gaser C, 2003, J NEUROSCI, V23, P9240; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Habib M, 2009, MUSIC PERCEPT, V26, P279, DOI 10.1525/MP.2009.26.3.279; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Krause V, 2010, NEUROIMAGE, V52, P245, DOI 10.1016/j.neuroimage.2010.03.081; Lee DJ, 2003, NEUROREPORT, V14, P205, DOI 10.1097/00001756-200302100-00009; Levitin DJ, 2009, ANN NY ACAD SCI, V1156, P211, DOI 10.1111/j.1749-6632.2009.04417.x; Li R, 2011, NEUROIMAGE, V56, P1035, DOI 10.1016/j.neuroimage.2011.03.010; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Liao W, 2009, IEEE T MED IMAGING, V28, P1825, DOI 10.1109/TMI.2009.2025126; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Luo C, 2012, HUM BRAIN MAPP, V33, P1279, DOI 10.1002/hbm.21286; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Pantev C, 2009, ANN NY ACAD SCI, V1169, P143, DOI 10.1111/j.1749-6632.2009.04588.x; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tian L, 2007, HUM BRAIN MAPP, V28, P681, DOI 10.1002/hbm.20300; Tramo MJ, 2001, SCIENCE, V291, P54, DOI 10.1126/SCIENCE.1056899; Upadhyay J, 2008, J NEUROSCI, V28, P3341, DOI 10.1523/JNEUROSCI.4434-07.2008; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Yasui T, 2009, HUM BRAIN MAPP, V30, P588, DOI 10.1002/hbm.20529; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	66	64	66	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36568	10.1371/journal.pone.0036568	http://dx.doi.org/10.1371/journal.pone.0036568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586478	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335000039
J	Zhang, X; Cheng, W; Listgarten, J; Kadie, C; Huang, SP; Wang, W; Heckerman, D				Zhang, Xiang; Cheng, Wei; Listgarten, Jennifer; Kadie, Carl; Huang, Shunping; Wang, Wei; Heckerman, David			Learning Transcriptional Regulatory Relationships Using Sparse Graphical Models	PLOS ONE			English	Article							NETWORK COMPONENT ANALYSIS; GENE; RECONSTRUCTION; MICROARRAY	Understanding the organization and function of transcriptional regulatory networks by analyzing high-throughput gene expression profiles is a key problem in computational biology. The challenges in this work are 1) the lack of complete knowledge of the regulatory relationship between the regulators and the associated genes, 2) the potential for spurious associations due to confounding factors, and 3) the number of parameters to learn is usually larger than the number of available microarray experiments. We present a sparse (L1 regularized) graphical model to address these challenges. Our model incorporates known transcription factors and introduces hidden variables to represent possible unknown transcription and confounding factors. The expression level of a gene is modeled as a linear combination of the expression levels of known transcription factors and hidden factors. Using gene expression data covering 39,296 oligonucleotide probes from 1109 human liver samples, we demonstrate that our model better predicts out-of-sample data than a model with no hidden variables. We also show that some of the gene sets associated with hidden variables are strongly correlated with Gene Ontology categories. The software including source code is available at http://grnl1.codeplex.com.	[Zhang, Xiang; Listgarten, Jennifer; Kadie, Carl; Heckerman, David] Microsoft Res, Los Angeles, CA 90024 USA; [Zhang, Xiang] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Zhang, Xiang; Cheng, Wei; Huang, Shunping; Wang, Wei] Univ N Carolina, Chapel Hill, NC USA	Microsoft; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill	Zhang, X (corresponding author), Microsoft Res, Los Angeles, CA 90024 USA.	heckerma@microsoft.com		Wang, Wei/0000-0002-8180-2886				Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Andrew G., 2007, INT C MACH LEARN; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop C. M, 2006, PATTERN RECOGNITION; Boorsma A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003112; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; Edgar R., 2002, NUCLEIC ACIDS RES, V30; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guan Y, 2009, INT C AR INT STAT; Hache H, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/617281; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Ng A., 2004, INT C MACH LEARN; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Sabatti C, 2006, BIOINFORMATICS, V22, P739, DOI 10.1093/bioinformatics/btk017; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Stegle O, 2008, LECT N BIOINFORMAT, V4955, P411; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zou H, 2006, J COMPUTATIONAL GRAP, V15	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35762	10.1371/journal.pone.0035762	http://dx.doi.org/10.1371/journal.pone.0035762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586449	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000011
J	Ali, SS; Hsiao, M; Zhao, HWW; Dugan, LL; Haddad, GG; Zhou, D				Ali, Sameh S.; Hsiao, Mary; Zhao, Huiwen W.; Dugan, Laura L.; Haddad, Gabriel G.; Zhou, Dan			Hypoxia-Adaptation Involves Mitochondrial Metabolic Depression and Decreased ROS Leakage	PLOS ONE			English	Article							REACTIVE OXYGEN; COMPLEX-III; DROSOPHILA-MELANOGASTER; EXPERIMENTAL SELECTION; ELECTRON-TRANSPORT; RESPIRATORY-CHAIN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NEURONAL DEATH; FREE-RADICALS	Through long-term laboratory selection, we have generated a Drosophila melanogaster population that tolerates severe, normally lethal, level of hypoxia. This strain lives perpetually under severe hypoxic conditions (4% O-2). In order to shed light on the mechanisms involved in this adaptation, we studied the respiratory function of isolated mitochondria from the thorax of hypoxia-adapted flies (AF) using polarographic oxygen consumption while monitoring superoxide generation by electron paramagnetic resonance (EPR) techniques. AF mitochondria exhibited a significant 30% decrease in respiratory rate during state 3, while enhancing the resting respiratory rate during State 4-oligo by 220%. The activity of individual electron transport complexes I, II and III were 107%, 65%, and 120% in AF mitochondria as compared to those isolated from control flies. The sharp decrease in complex II activity and modest increase in complexes I and III resulted in >60% reduction in superoxide leakage from AF mitochondria during both NAD(+)-linked state 3 and State 4-oligo respirations. These results provide evidence that flies with mitochondria exhibiting decreased succinate dehydrogenase activity and reduced superoxide leakage give flies an advantage for survival in long-term hypoxia.	[Ali, Sameh S.; Dugan, Laura L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Ali, Sameh S.] Zewail City Sci & Technol, Ctr Aging & Associated Dis, Helmy Inst Med Sci, Giza, Egypt; [Hsiao, Mary; Zhao, Huiwen W.; Haddad, Gabriel G.; Zhou, Dan] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Dugan, Laura L.; Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Haddad, Gabriel G.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Ali, SS (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.	ssali@ucsd.edu; d2zhou@ucsd.edu	Zhou, Dan/T-7203-2017	Ali, Sameh Saad/0000-0002-0339-6106; Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [PO1HD32573, O1NS037756]; American Heart Association [0835188N]; National Institute on Aging [1K25AG026379]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG026379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants PO1HD32573 and O1NS037756 to GGH, American Heart Association grant 0835188N to DZ, and by the National Institute on Aging grant 1K25AG026379 to SSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biniecka M, 2011, ARTHRITIS RHEUM-US, V63, P2172, DOI 10.1002/art.30395; Bosc LVG, 2010, J CELL MOL MED, V14, P3, DOI 10.1111/j.1582-4934.2009.00929.x; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; Chalier F, 2002, J CHEM SOC P2, V12, P2110; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Douglas RM, 2010, AM J PHYSIOL-CELL PH, V298, pC1594, DOI 10.1152/ajpcell.00298.2009; Esteva S, 2010, WILD ENVIRON MED, V21, P325, DOI 10.1016/j.wem.2010.09.004; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Grishko V, 2001, FASEB J, V15, P1267, DOI 10.1096/fj.00-0755fje; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kovacic P, 2005, CURR MED CHEM, V12, P2601, DOI 10.2174/092986705774370646; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Stolze K, 2000, FREE RADICAL BIO MED, V29, P1005, DOI 10.1016/S0891-5849(00)00401-9; SUGIOKA K, 1988, BIOCHIM BIOPHYS ACTA, V936, P377, DOI 10.1016/0005-2728(88)90014-X; Tormos KV, 2010, J CELL MOL MED; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wigfield SM, 2008, BRIT J CANCER, V98, P1975, DOI 10.1038/sj.bjc.6604356; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	43	59	61	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36801	10.1371/journal.pone.0036801	http://dx.doi.org/10.1371/journal.pone.0036801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574227	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800124
J	Ge, E; Haining, R; Li, CP; Yu, ZG; Waye, MY; Chu, KH; Leung, Y				Ge, Erjia; Haining, Robert; Li, Chi Pang; Yu, Zuguo; Waye, Miu Yee; Chu, Ka Hou; Leung, Yee			Using Knowledge Fusion to Analyze Avian Influenza H5N1 in East and Southeast Asia	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; VIRUS; SPREAD; PHYLOGEOGRAPHY; EVOLUTION; OUTBREAKS; GENETICS	Highly pathogenic avian influenza (HPAI) H5N1, a disease associated with high rates of mortality in infected human populations, poses a serious threat to public health in many parts of the world. This article reports findings from a study aimed at improving our understanding of the spatial pattern of the highly pathogenic avian influenza, H5N1, risk in East-Southeast Asia where the disease is both persistent and devastating. Though many disciplines have made important contributions to our understanding of H5N1, it remains a challenge to integrate knowledge from different disciplines. This study applies genetic analysis that identifies the evolution of the H5N1 virus in space and time, epidemiological analysis that determines socio-ecological factors associated with H5N1 occurrence, and statistical analysis that identifies outbreak clusters, and then applies a methodology to formally integrate the findings of the three sets of methodologies. The present study is novel in two respects. First it makes the initiative attempt to use genetic sequences and space-time data to create a space-time phylogenetic tree to estimate and map the virus' ability to spread. Second, by integrating the results we are able to generate insights into the space-time occurrence and spread of H5N1 that we believe have a higher level of corroboration than is possible when analysis is based on only one methodology. Our research identifies links between the occurrence of H5N1 by area and a set of socio-ecological factors including altitude, population density, poultry density, and the shortest path distances to inland water, coastlines, migrating routes, railways, and roads. This study seeks to lay a solid foundation for the interdisciplinary study of this and other influenza outbreaks. It will provide substantive information for containing H5N1 outbreaks.	[Ge, Erjia; Leung, Yee] Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China; [Ge, Erjia] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Haining, Robert] Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; [Li, Chi Pang; Chu, Ka Hou] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Zuguo] Xiangtan Univ, Sch Math & Computat Sci, Xiangtan, Hunan, Peoples R China; [Waye, Miu Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Yee] Chinese Univ Hong Kong, Inst Environm Energy & Sustainabil, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; University of Cambridge; Chinese University of Hong Kong; Xiangtan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, E (corresponding author), Chinese Univ Hong Kong, Dept Geog & Resource Management, Hong Kong, Hong Kong, Peoples R China.	yeeleung@cuhk.edu.hk	Chu, Ka Hou/B-8010-2011; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008	Chu, Ka Hou/0000-0001-8107-5415; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917	Hong Kong Research Grants Council [CUHK447109]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by an earmarked grant (CUHK447109) of the Hong Kong Research Grants Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamek T, 2007, 2007 IEEE INT C IM P, V2, pII, DOI [10.1109/ICIP.2007.4379144, DOI 10.1109/ICIP.2007.4379144]; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Botts BN, 1988, SCI GEOGRAPHY SERIES, V8, P1; Carrel MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008631; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Clements Archie C A, 2006, Int J Health Geogr, V5, P57, DOI 10.1186/1476-072X-5-57; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enserink M, 2006, SCIENCE, V311, P932; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; FAO, 2010, TECHN TASK FORC AV I; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GETIS A, 1987, ECOLOGY, V68, P473, DOI 10.2307/1938452; GETIS A, 1984, ENVIRON PLANN A, V16, P173, DOI 10.1068/a160173; Getis A., 1996, SPATIAL ANAL MODELLI, P261; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; HAINING R, 1991, GEOGR ANAL, V23, P210, DOI 10.1111/j.1538-4632.1991.tb00235.x; Haining R., 2003, SPATIAL DATA ANAL TH; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jones L, 2006, J BIOMECH, V39, P2512, DOI 10.1016/j.jbiomech.2005.07.024; Kaftandjian V, 2003, PATTERN RECOGN LETT, V24, P547, DOI 10.1016/S0167-8655(02)00276-3; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Luo WB, 1997, J ENVIRON MANAGE, V49, P73, DOI 10.1006/jema.1996.0117; Malpica JA, 2007, EXPERT SYST APPL, V32, P47, DOI 10.1016/j.eswa.2005.11.011; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Openshaw S., 1984, MODIFIABLE AREAL UNI; PENNY D, 1992, TRENDS ECOL EVOL, V7, P73, DOI 10.1016/0169-5347(92)90244-6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Preiser KH, 2006, INFLUENZA REPORT 200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shafer G., 1976, MATH THEORY EVIDENCE; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Smallman-Raynor M, 2008, ANN ASSOC AM GEOGR, V98, P553, DOI 10.1080/00045600802098958; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; WHO, 2010, CUM NUMB CONF HUM CA; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	52	8	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e29617	10.1371/journal.pone.0029617	http://dx.doi.org/10.1371/journal.pone.0029617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615729	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200001
J	Qiu, LJ; Swaab, TY; Chen, HC; Wang, SP				Qiu, Lijing; Swaab, Tamara Y.; Chen, Hsuan-Chih; Wang, Suiping			The Role of Gender Information in Pronoun Resolution: Evidence from Chinese	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; THEMATIC RELATIONSHIPS; ANAPHORIC REFERENCE; NEURAL MECHANISMS; SENTENCES; REPRESENTATIONS; EXPRESSIONS; MEMORY; ERP	Although previous studies have consistently demonstrated that gender information is used to resolve pronouns, the mechanisms underlying the use of gender information continue to be controversial. The present study used event-related potentials (ERPs) to investigate whether working memory modulates the effect of gender information on pronoun resolution. The critical pronoun agreed or disagreed with its antecedent in gender. Moreover, the distance between a pronoun and its antecedent was varied to assess the influence of working memory. Compared with the congruent pronouns, the incongruent pronouns elicited an N400 effect in the short distance condition and a P600 effect in the long distance condition. The results suggest that the effect of gender information on pronoun comprehension is modulated by working memory.	[Qiu, Lijing; Wang, Suiping] S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China; [Swaab, Tamara Y.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Swaab, Tamara Y.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Chen, Hsuan-Chih] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China	South China Normal University; University of California System; University of California Davis; University of California System; University of California Davis; Chinese University of Hong Kong	Qiu, LJ (corresponding author), S China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.	suipingscnu@gmail.com		Swaab, Tamara/0000-0001-6551-0229; Wang, Suiping/0000-0001-8726-169X	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Chinese Ministry of Education of Key Research Institute of Humanities and Social Sciences in Universities [10JJDXLX005]; Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University	Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS); Chinese Ministry of Education of Key Research Institute of Humanities and Social Sciences in Universities; Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University	This study was supported by "Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS 2011)," grants from the Chinese Ministry of Education Project of Key Research Institute of Humanities and Social Sciences in Universities (10JJDXLX005), as well as a grant from the Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARREIRAS M, 1993, EUR J COGN PSYCHOL, V5, P93, DOI 10.1080/09541449308406516; Chen HC, 2000, MEM COGNITION, V28, P427, DOI 10.3758/BF03198558; Chomsky Noam, 1981, LECT GOVT BINDING; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; CLARK HH, 1979, MEM COGNITION, V7, P35, DOI 10.3758/BF03196932; Duffy SA, 2004, MEM COGNITION, V32, P551, DOI 10.3758/BF03195846; GARNHAM A, 1995, J MEM LANG, V34, P41, DOI 10.1006/jmla.1995.1003; Gordon PC, 1998, COGNITIVE SCI, V22, P389, DOI 10.1207/s15516709cog2204_1; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hammer A, 2005, J COGNITIVE NEUROSCI, V17, P227, DOI 10.1162/0898929053124947; Hammer A, 2008, BRAIN RES, V1230, P177, DOI 10.1016/j.brainres.2008.07.004; Hammer A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00032; Heine A, 2006, NEUROSCI LETT, V400, P7, DOI 10.1016/j.neulet.2006.02.006; Kaan E, 2003, COGNITIVE BRAIN RES, V17, P621, DOI 10.1016/S0926-6410(03)00175-7; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2007, BRAIN LANG, V100, P223, DOI 10.1016/j.bandl.2005.12.006; Kuperberg GR, 2006, LANG COGNITIVE PROC, V21, P489, DOI 10.1080/01690960500094279; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lamers MJ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-23; Lamers MJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-55; Li XQ, 2010, BRAIN RES, V1331, P96, DOI 10.1016/j.brainres.2010.03.050; Osterhout L, 1997, MEM COGNITION, V25, P273, DOI 10.3758/BF03211283; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Osterhout L, 1995, J MEM LANG, V34, P739, DOI 10.1006/jmla.1995.1033; Reynolds DJ, 2006, Q J EXP PSYCHOL, V59, P886, DOI 10.1080/02724980543000088; Schmitt BM, 2002, COGNITIVE BRAIN RES, V14, P333, DOI 10.1016/S0926-6410(02)00136-2; Streb J, 2004, J PSYCHOLINGUIST RES, V33, P175, DOI 10.1023/B:JOPR.0000027961.12577.d8; Sturt P, 2003, J MEM LANG, V48, P542, DOI 10.1016/S0749-596X(02)00536-3; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Van Berkum JJA, 2007, BRAIN RES, V1146, P158, DOI 10.1016/j.brainres.2006.06.091; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; Yang CL, 2003, COGNITION, V86, P283, DOI 10.1016/S0010-0277(02)00182-8; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Zhou AB, 2010, NEUROSCI LETT, V480, P162, DOI 10.1016/j.neulet.2010.06.033	39	16	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36156	10.1371/journal.pone.0036156	http://dx.doi.org/10.1371/journal.pone.0036156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UR	22615754	Green Published, gold			2022-12-27	WOS:000305341300012
J	Llufriu, S; Blanco, Y; Martinez-Heras, E; Casanova-Molla, J; Gabilondo, I; Sepulveda, M; Falcon, C; Berenguer, J; Bargallo, N; Villoslada, P; Graus, F; Valls-Sole, J; Saiz, A				Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Casanova-Molla, Jordi; Gabilondo, Inigo; Sepulveda, Maria; Falcon, Carles; Berenguer, Joan; Bargallo, Nuria; Villoslada, Pablo; Graus, Francesc; Valls-Sole, Josep; Saiz, Albert			Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study	PLOS ONE			English	Article							TRANSCALLOSALLY MEDIATED INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; IPSILATERAL SILENT PERIOD; HUMAN MOTOR CORTEX; INTERHEMISPHERIC INHIBITION; WHITE-MATTER; AXONAL LOSS; IMPAIRMENT; MRI; DYSFUNCTION	Background: Corpus callosum (CC) is a common target for multiple sclerosis (MS) pathology. We investigated the influence of CC damage on physical disability and cognitive dysfunction using a multimodal approach. Methods: Twenty-one relapsing-remitting MS patients and 13 healthy controls underwent structural MRI and diffusion tensor of the CC (fractional anisotropy; mean diffusivity, MD; radial diffusivity, RD; axial diffusivity). Interhemisferic transfer of motor inhibition was assessed by recording the ipsilateral silent period (iSP) to transcranial magnetic stimulation. We evaluated cognitive function using the Brief Repeatable Battery and physical disability using the Expanded Disability Status Scale (EDSS) and the MS Functional Composite (MSFC) z-score. Results: The iSP latency correlated with physical disability scores (r ranged from 0.596 to 0.657, P values from 0.004 to 0.001), and with results of visual memory (r = -0.645, P = 0.002), processing speed (r = -0.51, P = 0.018) and executive cognitive domain tests (r = -0.452, P = 0.039). The area of the rostrum correlated with the EDSS (r = -0.442, P = 0.045). MD and RD correlated with cognitive performance, mainly with results of visual and verbal memory tests (r ranged from -0.446 to -0.546, P values from 0.048 to 0.011). The iSP latency correlated with CC area (r = -0.345, P = 0.049), volume (r = -0.401, P = 0.002), MD (r = 0.404, P = 0.002) and RD (r = 0.415, P = 0.016). Conclusions: We found evidence for structural and microstructural CC abnormalities associated with impairment of motor callosal inhibitory conduction in MS. CC damage may contribute to cognitive dysfunction and in less extent to physical disability likely through a disconnection mechanism.	[Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Gabilondo, Inigo; Sepulveda, Maria; Villoslada, Pablo; Graus, Francesc; Saiz, Albert] Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain; [Llufriu, Sara; Blanco, Yolanda; Martinez-Heras, Eloy; Gabilondo, Inigo; Sepulveda, Maria; Falcon, Carles; Berenguer, Joan; Bargallo, Nuria; Villoslada, Pablo; Graus, Francesc; Saiz, Albert] IDIBAPS, Barcelona, Spain; [Falcon, Carles] Ctr Invest Biomed Red CIBER BBN, Barcelona, Spain; [Berenguer, Joan; Bargallo, Nuria] Hosp Clin Barcelona, Serv Radiol, Barcelona, Spain; [Berenguer, Joan; Bargallo, Nuria] Hosp Clin Barcelona, Imaging Diagnost Ctr, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Llufriu, S (corresponding author), Hosp Clin Barcelona, Serv Neurol, Ctr Neuroimmunol, Barcelona, Spain.	asaiz@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Graus, Francesc/K-9904-2018; Sepulveda, Maria/K-9451-2014; Saiz, Albert/K-8236-2014; Llufriu, Sara/K-2987-2014; Llufriu, Sara/T-6761-2019; Martinez-Heras, Eloy/AAN-1849-2020; Bargallo, Nuria/G-6854-2016; Gabilondo, Iñigo/I-8274-2012	Sepulveda, Maria/0000-0002-3078-645X; Saiz, Albert/0000-0002-5793-8791; Llufriu, Sara/0000-0003-4273-9121; Martinez-Heras, Eloy/0000-0001-9937-3162; Bargallo, Nuria/0000-0001-6284-5402; Gabilondo, Iñigo/0000-0001-6045-2840; Graus, Francesc/0000-0002-8924-8322; falcon, carles/0000-0001-5564-2025; Villoslada, Pablo/0000-0002-8735-6119	Red Espanola de Esclerosis Multiple (REEM) [RD07/0060/0001, RD07/0060/0012]; Spanish Ministry of Health	Red Espanola de Esclerosis Multiple (REEM)(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	The work was supported in part by a grant from the Red Espanola de Esclerosis Multiple (REEM) RD07/0060/0001, RD07/0060/0012. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sara Llufriu is a multiple sclerosis fellow granted by the Spanish Ministry of Health. The authors would like to thank all the subjects for their participation in the study.	Audoin B, 2007, MULT SCLER, V13, P41, DOI 10.1177/1352458506071215; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Boretius S, 2011, NEUROIMAGE; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Compta Y, 2006, CLIN NEUROPHYSIOL, V117, P2512, DOI 10.1016/j.clinph.2006.08.005; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Glanz BI, 2011, J NEUROL NEUROSURG P; Hoppner J, 1999, CLIN NEUROPHYSIOL, V110, P748, DOI 10.1016/S1388-2457(98)00075-3; Jung P, 2006, J NEUROL SCI, V250, P133, DOI 10.1016/j.jns.2006.08.008; Kale N, 2009, NEUROL RES; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lenzi D, 2007, HUM BRAIN MAPP, V28, P636, DOI 10.1002/hbm.20305; Lin X, 2008, J NEUROL NEUROSUR PS, V79, P437, DOI 10.1136/jnnp.2006.112177; Mesaros S, 2009, HUM BRAIN MAPP, V30, P2656, DOI 10.1002/hbm.20692; Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649; Pelletier J, 2001, ARCH NEUROL-CHICAGO, V58, P105, DOI 10.1001/archneur.58.1.105; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Rossini PM, 1999, EEG CL N SU, P199; Rovaris M, 2007, J NEUROIMAGING, V17, p27S, DOI 10.1111/j.1552-6569.2007.00133.x; Rovaris M, 2011, MULT SCLER J, V17, P319, DOI 10.1177/1352458510388824; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Schmierer K, 2000, J NEUROL NEUROSUR PS, V68, P633, DOI 10.1136/jnnp.68.5.633; Schmierer K, 2002, NEUROLOGY, V59, P1218, DOI 10.1212/WNL.59.8.1218; Schnitzler A, 1996, EXP BRAIN RES, V112, P381; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Sigal T, 2010, J NEUROIMAGING; Trompetto C, 2003, CLIN NEUROPHYSIOL, V114, P2181, DOI 10.1016/S1388-2457(03)00213-X; Van Hecke W, 2010, J MAGN RESON IMAGING, V31, P1492, DOI 10.1002/jmri.22198; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wahl M, 2011, HUM BRAIN MAPP, V32, P846, DOI 10.1002/hbm.21071; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yaldizli O, 2010, J NEUROL, V257, P1256, DOI 10.1007/s00415-010-5503-x	40	60	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37167	10.1371/journal.pone.0037167	http://dx.doi.org/10.1371/journal.pone.0037167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606347	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400073
J	Meliopoulos, VA; Andersen, LE; Brooks, P; Yan, XZ; Bakre, A; Coleman, JK; Tompkins, SM; Tripp, RA				Meliopoulos, Victoria A.; Andersen, Lauren E.; Brooks, Paula; Yan, Xiuzhen; Bakre, Abhijeet; Coleman, J. Keegan; Tompkins, S. Mark; Tripp, Ralph A.			MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; WEST-NILE-VIRUS; A H1N1 VIRUS; RNA INTERFERENCE; CARBOXYPEPTIDASE-E; IMMUNOHISTOCHEMICAL LOCALIZATION; EXPRESSION PROFILES; CELL-PROLIFERATION; INHIBITION; IDENTIFICATION	Influenza A virus causes seasonal epidemics and periodic pandemics threatening the health of millions of people each year. Vaccination is an effective strategy for reducing morbidity and mortality, and in the absence of drug resistance, the efficacy of chemoprophylaxis is comparable to that of vaccines. However, the rapid emergence of drug resistance has emphasized the need for new drug targets. Knowledge of the host cell components required for influenza replication has been an area targeted for disease intervention. In this study, the human protease genes required for influenza virus replication were determined and validated using RNA interference approaches. The genes validated as critical for influenza virus replication were ADAMTS7, CPE, DPP3, MST1, and PRSS12, and pathway analysis showed these genes were in global host cell pathways governing inflammation (NF-kappa B), cAMP/calcium signaling (CRE/CREB), and apoptosis. Analyses of host microRNAs predicted to govern expression of these genes showed that eight miRNAs regulated gene expression during virus replication. These findings identify unique host genes and microRNAs important for influenza replication providing potential new targets for disease intervention strategies.	[Meliopoulos, Victoria A.; Andersen, Lauren E.; Brooks, Paula; Yan, Xiuzhen; Bakre, Abhijeet; Coleman, J. Keegan; Tompkins, S. Mark; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Meliopoulos, VA (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	ratripp@uga.edu	Tompkins, Stephen/A-3317-2008; Bakre, Abhijeet A./A-4632-2013	Tompkins, Stephen/0000-0002-1523-5588; Bakre, Abhijeet A./0000-0002-6755-5233; Tripp, Ralph/0000-0002-2924-9956	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN266200700006C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (HHSN266200700006C) (www.niaid.nih.gov). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2009, ANTIMICROB AGENTS CH, V53, P3952, DOI 10.1128/AAC.00014-09; Barakat MR, 2009, EXPERT OPIN INV DRUG, V18, P637, DOI [10.1517/13543780902855316, 10.1517/13543780902855316 ]; Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012; Basler Christopher F., 2007, Infectious Disorders - Drug Targets, V7, P282, DOI 10.2174/187152607783018745; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Betakova T, 2007, CURR PHARM DESIGN, V13, P3231, DOI 10.2174/138161207782341295; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bovee ML, 1998, VIROLOGY, V245, P229, DOI 10.1006/viro.1998.9171; Bradel-Tretheway BG, 2011, J VIROL, V85, P8569, DOI 10.1128/JVI.00496-11; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P11; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Ekchariyawat P, 2011, INNATE IMMUNITY; Fan XM, 2002, J HISTOCHEM CYTOCHEM, V50, P1509, DOI 10.1177/002215540205001111; Fan XM, 2001, J HISTOCHEM CYTOCHEM, V49, P783, DOI 10.1177/002215540104900612; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; He P, 2004, HUM PATHOL, V35, P1196, DOI 10.1016/j.humpath.2004.06.014; He T, 2009, BIOINFORMATION, V4, P112, DOI 10.6026/97320630004112; Hirsch AJ, 2010, FUTURE MICROBIOL, V5, P303, DOI 10.2217/FMB.09.121; Hsieh HP, 2007, CURR PHARM DESIGN, V13, P3531, DOI 10.2174/138161207782794248; Jefferson T, 2006, Cochrane Database Syst Rev, pCD001169, DOI 10.1002/14651858.CD001265.pub2; Johnston RA, 2006, AM J PHYSIOL-REG I, V290, pR126, DOI 10.1152/ajpregu.00306.2005; Kandel R, 2001, BIODRUGS, V15, P303, DOI 10.2165/00063030-200115050-00003; Karlas A, 2010, NATURE; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim JH, 2009, CELL PHYSIOL BIOCHEM, V23, P43, DOI 10.1159/000204088; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lackenby A, 2008, CURR OPIN INFECT DIS, V21, P626, DOI 10.1097/QCO.0b013e3283199797; Latronico MV, 2011, THERAPEUTIC USE MICR; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liu CJ, 2006, FASEB J, V20, P988, DOI 10.1096/fj.05-3877fje; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Lowen Anice C., 2007, Infectious Disorders - Drug Targets, V7, P318; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Mallakin A, 2006, AM J RESP CELL MOL, V34, P15, DOI 10.1165/rcmb.2005-0093OC; Matheson NJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002744.pub2; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Meliopoulos VA, 2012, FASEB J OFFICIAL PUB; Navarathna DHMLP, 2007, INFECT IMMUN, V75, P1609, DOI 10.1128/IAI.01182-06; Olsson T, 1983, J Appl Biochem, V5, P437; Ostano P, 2012, OMICS, V16, P24, DOI 10.1089/omi.2011.0049; Pan HY, 2011, CARDIOVASC RES, V89, P595, DOI 10.1093/cvr/cvq358; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schonrock N, 2011, J MOL NEUROSCIENCE M; Schultz-Cherry S, 2003, AVIAN DIS, V47, P968, DOI 10.1637/0005-2086-47.s3.968; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shin MR, 2005, MOL REPROD DEV, V70, P390, DOI 10.1002/mrd.20219; Shukla AA, 2010, FEBS J, V277, P1861, DOI 10.1111/j.1742-4658.2010.07603.x; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; SOMEYA A, 1990, BIOCHEM BIOPH RES CO, V169, P148, DOI 10.1016/0006-291X(90)91446-Y; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stakkestad O, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-7; SUBBARAO EK, 1992, J CLIN MICROBIOL, V30, P996, DOI 10.1128/JCM.30.4.996-999.1992; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tripp RA, 2009, METHODS MOL BIOL, V555, P43, DOI 10.1007/978-1-60327-295-7_4; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Woolcock Peter R., 2008, V436, P35, DOI 10.1007/978-1-59745-279-3_6; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174; Zhang WL, 2008, J VIROL, V82, P12221, DOI 10.1128/JVI.01557-08; Zheng ZM, 2011, BIOCH BIOPHYSICA ACT	85	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37169	10.1371/journal.pone.0037169	http://dx.doi.org/10.1371/journal.pone.0037169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606348	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400074
J	Batista, FAH; Trivella, DBB; Bernardes, A; Gratieri, J; Oliveira, PSL; Figueira, ACM; Webb, P; Polikarpov, I				Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Oliveira, Paulo S. L.; Figueira, Ana Carolina M.; Webb, Paul; Polikarpov, Igor			Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding	PLOS ONE			English	Article							CRYSTALLOGRAPHY BEAMLINE; BETA/DELTA; AGONISTS; ANGIOGENESIS; DISCOVERY; ACID	Peroxisome proliferator activated receptors (PPARs delta, alpha and gamma) are closely related transcription factors that exert distinct effects on fatty acid and glucose metabolism, cardiac disease, inflammatory response and other processes. Several groups developed PPAR subtype specific modulators to trigger desirable effects of particular PPARs without harmful side effects associated with activation of other subtypes. Presently, however, many compounds that bind to one of the PPARs cross-react with others and rational strategies to obtain highly selective PPAR modulators are far from clear. GW0742 is a synthetic ligand that binds PPAR delta more than 300-fold more tightly than PPAR alpha or PPAR gamma but the structural basis of PPAR delta: GW0742 interactions and reasons for strong selectivity are not clear. Here we report the crystal structure of the PPAR delta:GW0742 complex. Comparisons of the PPAR delta:GW0742 complex with published structures of PPARs in complex with alpha and gamma selective agonists and pan agonists suggests that two residues (Val312 and Ile328) in the buried hormone binding pocket play special roles in PPAR delta selective binding and experimental and computational analysis of effects of mutations in these residues confirms this and suggests that bulky substituents that line the PPAR alpha and gamma ligand binding pockets as structural barriers for GW0742 binding. This analysis suggests general strategies for selective PPAR delta ligand design.	[Batista, Fernanda A. H.; Trivella, Daniela B. B.; Bernardes, Amanda; Gratieri, Joyce; Polikarpov, Igor] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Oliveira, Paulo S. L.; Figueira, Ana Carolina M.] Ctr Nacl Pesquisas Energia & Mat CNPEM ABTLUS Lab, Lab Nacl Biociencias, Sao Paulo, Brazil; [Webb, Paul] Methodist Hosp Res Inst, Ctr Diabet, Houston, TX USA; [Webb, Paul] Methodist Hosp Res Inst, Canc Res Unit, Houston, TX USA	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Batista, FAH (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil.	ipolikarpov@ifsc.usp.br	Oliveira, Paulo S/K-5588-2013; Polikarpov, Igor/D-2575-2012; Oliveira, Paulo/D-5463-2011; trivella, daniela b b/K-2328-2012; Figueira, Ana Carolina/X-1649-2019; Trivella, Daniela B B/L-5685-2013; Bernardes, Amanda/H-8910-2012; Batista, Fernanda A.H./E-1633-2013	Oliveira, Paulo/0000-0002-1287-8019; Figueira, Ana Carolina/0000-0002-7023-8490; Trivella, Daniela B B/0000-0002-7505-2345; Polikarpov, Igor/0000-0001-9496-4174	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2009/53853-5]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP [2006/00182-8, 2010/17048-8]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors are grateful for the utilization of the high-performance computing multi-user facility supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) grant 2009/53853-5, hosted by Ludwig Institute for Cancer Research (Sao Paulo, Brazil). This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and FAPESP (2006/00182-8, 2010/17048-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bility MT, 2010, TOXICOL SCI, V113, P27, DOI 10.1093/toxsci/kfp212; Bility MT, 2008, CARCINOGENESIS, V29, P2406, DOI 10.1093/carcin/bgn219; Delano SW, 2002, PYMOL MOL GRAPHICS S; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Guimaraes BG, 2009, J SYNCHROTRON RADIAT, V16, P69, DOI 10.1107/S0909049508034870; Heikkinen S, 2007, BBA-MOL CELL BIOL L, V1771, P999, DOI 10.1016/j.bbalip.2007.03.006; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polikarpov I, 1998, J SYNCHROTRON RADIAT, V5, P72, DOI 10.1107/S0909049597014684; Sierra ML, 2007, J MED CHEM, V50, P685, DOI 10.1021/jm058056x; Sundriyal S, 2009, EUR J MED CHEM, V44, P3488, DOI 10.1016/j.ejmech.2009.01.024; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Takada I, 2000, MOL ENDOCRINOL, V14, P733, DOI 10.1210/me.14.5.733; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	33	32	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33643	10.1371/journal.pone.0033643	http://dx.doi.org/10.1371/journal.pone.0033643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606221	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200003
J	Bidan, CM; Kommareddy, KP; Rumpler, M; Kollmannsberger, P; Brechet, YJM; Fratzl, P; Dunlop, JWC				Bidan, Cecile M.; Kommareddy, Krishna P.; Rumpler, Monika; Kollmannsberger, Philip; Brechet, Yves J. M.; Fratzl, Peter; Dunlop, John W. C.			How Linear Tension Converts to Curvature: Geometric Control of Bone Tissue Growth	PLOS ONE			English	Article							SCAFFOLD DESIGN; FOCAL ADHESIONS; STRESS FIBERS; CELL; OSTEOBLASTS; MORPHOGENESIS; MECHANICS; FORCES; MODEL; PROLIFERATION	This study investigated how substrate geometry influences in-vitro tissue formation at length scales much larger than a single cell. Two-millimetre thick hydroxyapatite plates containing circular pores and semi-circular channels of 0.5 mm radius, mimicking osteons and hemi-osteons respectively, were incubated with MC3T3-E1 cells for 4 weeks. The amount and shape of the tissue formed in the pores, as measured using phase contrast microscopy, depended on the substrate geometry. It was further demonstrated, using a simple geometric model, that the observed curvature-controlled growth can be derived from the assembly of tensile elements on a curved substrate. These tensile elements are cells anchored on distant points of the curved surface, thus creating an actin "chord" by generating tension between the adhesion sites. Such a chord model was used to link the shape of the substrate to cell organisation and tissue patterning. In a pore with a circular cross-section, tissue growth increases the average curvature of the surface, whereas a semi-circular channel tends to be flattened out. Thereby, a single mechanism could describe new tissue growth in both cortical and trabecular bone after resorption due to remodelling. These similarities between in-vitro and in-vivo patterns suggest geometry as an important signal for bone remodelling.	[Bidan, Cecile M.; Kommareddy, Krishna P.; Kollmannsberger, Philip; Fratzl, Peter; Dunlop, John W. C.] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Rumpler, Monika] Hanusch Hosp, Dept Med 1, WGKK & AUVA Trauma Ctr Meidling, Ludwig Boltzmann Inst Osteol, Vienna, Austria; [Brechet, Yves J. M.] Mat & Proc Sci & Engn Lab SIMaP, Grenoble, France	Max Planck Society; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Bidan, CM (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	Cecile.Bidan@mpikg.mpg.de; John.Dunlop@mpikg.mpg.de	Kollmannsberger, Philip/D-7925-2011; Fratzl, Peter/H-9095-2012; Dunlop, John W C/A-1997-2012	Kollmannsberger, Philip/0000-0002-8049-6186; Fratzl, Peter/0000-0003-4437-7830; Dunlop, John W C/0000-0003-2741-6383; Bidan, Cecile/0000-0002-6243-562X	Deutsche Forschungs Gemeinschaft [FR2190/4-1]	Deutsche Forschungs Gemeinschaft(German Research Foundation (DFG))	Financial support was provided by the Leibniz Prize of PF running under Deutsche Forschungs Gemeinschaft contract number FR2190/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBAEK MO, 1991, BONE MINER, V12, P101, DOI 10.1016/0169-6009(91)90039-3; Bement WM, 2002, CURR BIOL, V12, pR12, DOI 10.1016/S0960-9822(01)00639-X; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bischofs IB, 2008, BIOPHYS J, V95, P3488, DOI 10.1529/biophysj.108.134296; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k; BULLARD JW, 1995, COMP MATER SCI, V4, P103, DOI 10.1016/0927-0256(95)00014-H; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303; Frette OI, 2009, COMP MATER SCI, V44, P867, DOI 10.1016/j.commatsci.2008.06.006; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496; Harland B, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015011; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489; Jinnai H, 2002, BONE, V30, P191, DOI 10.1016/S8756-3282(01)00672-X; Kerschnitzki M, 2011, J STRUCT BIOL, V173, P303, DOI 10.1016/j.jsb.2010.11.014; Kollmannsberger P, 2011, SOFT MATTER, V7, P9549, DOI 10.1039/c1sm05588g; Kommareddy KP, 2010, BIOINTERPHASES, V5, P45, DOI 10.1116/1.3431524; Latimer A, 2010, MATRIX BIOL, V29, P89, DOI 10.1016/j.matbio.2009.10.002; Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Nicolella DP, 2006, J BIOMECH, V39, P1735, DOI 10.1016/j.jbiomech.2005.04.032; Owan I, 1997, AM J PHYSIOL-CELL PH, V273, pC810, DOI 10.1152/ajpcell.1997.273.3.C810; Parfitt A., 1984, CALCIF TISSUE INT S, V36, P37; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; RADHAKRISHNAN B, 1995, METALL MATER TRANS A, V26, P167, DOI 10.1007/BF02669802; Rasband W.S., 1997, IMAGEJ; Ripamonti U, 2009, J CELL MOL MED, V13, P2953, DOI 10.1111/j.1582-4934.2008.00562.x; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064; Saito M, 2004, CALCIFIED TISSUE INT, V75, P384, DOI 10.1007/s00223-004-0292-9; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817; Schulte FA, 2011, BONE; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Sethian JA, 2008, J COMPUTATIONAL PHYS; Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6; St-Pierre JP, 2005, BIOMATERIALS, V26, P7319, DOI 10.1016/j.biomaterials.2005.05.046; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Travasso RDM, 2011, PHILOS MAG, V91, P183, DOI 10.1080/14786435.2010.501771; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2005, BIOCHEM BIOPH RES CO, V328, P1133, DOI 10.1016/j.bbrc.2005.01.070; Wheeler D, 2003, J ELECTROCHEM SOC, V150, pC302, DOI 10.1149/1.1562598; Woesz A, 2005, MAT SCI ENG C-BIO S, V25, P181, DOI 10.1016/j.msec.2005.01.014; WORRING M, 1993, CVGIP-IMAG UNDERSTAN, V58, P366, DOI 10.1006/ciun.1993.1048; Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183; Zhu MF, 2001, ISIJ INT, V41, P992, DOI 10.2355/isijinternational.41.992	67	127	128	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36336	10.1371/journal.pone.0036336	http://dx.doi.org/10.1371/journal.pone.0036336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606256	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200024
J	Huo, R; Tang, KF; Wei, ZY; Shen, L; Xiong, YY; Wu, X; Niu, JM; Han, X; Tian, ZA; Yang, L; Feng, GY; He, L; Qin, SY				Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Niu, Jiamin; Han, Xia; Tian, Zhengan; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying			Genetic Polymorphisms in CYP2E1: Association with Schizophrenia Susceptibility and Risperidone Response in the Chinese Han Population	PLOS ONE			English	Article							CYTOCHROME-P450 2E1; CLINICAL-RESPONSE; OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; 1ST-EPISODE SCHIZOPHRENIA; PLASMA RISPERIDONE; PROLACTIN RESPONSE; 9-HYDROXYRISPERIDONE; IDENTIFICATION; ETHANOL	Background: CYP2E1 is a member of the cytochrome P450 superfamily, which is involved in the metabolism and activation of both endobiotics and xenobiotics. The genetic polymorphisms of CYP2E1 gene (Chromosome 10q26.3, Accession Number NC_000010.10) are reported to be related to the development of several mental diseases and to be involved in the clinical efficacy of some psychiatric medications. We investigated the possible association of CYP2E1 polymorphisms with susceptibility to schizophrenia in the Chinese Han Population as well as the relationship with response to risperidone in schizophrenia patients. Methods: In a case-control study, we identified 11 polymorphisms in the 5' flanking region of CYP2E1 in 228 schizophrenia patients and 384 healthy controls of Chinese Han origin. From among the cases, we chose 130 patients who had undergone 8 weeks of risperidone monotherapy to examine the relationship between their response to risperidone and CYP2E1 polymorphisms. Clinical efficacy was assessed using the Brief Psychiatric Rating Scale (BPRS). Results: Statistically significant differences in allele or genotype frequencies were found between cases and controls at rs8192766 (genotype p = 0.0048, permutation p = 0.0483) and rs2070673 (allele: p = 0.0018, permutation p = 0.0199, OR = 1.4528 95%CI = 1.1487-1.8374; genotype: p = 0.0020, permutation p = 0.0225). In addition, a GTCAC haplotype containing 5 SNPs (rs3813867, rs2031920, rs2031921, rs3813870 and rs2031922) was observed to be significantly associated with schizophrenia (p = 7.47E-12, permutation p<0.0001). However, no association was found between CYP2E1 polymorphisms/haplotypes and risperidone response. Conclusions: Our results suggest that CYP2E1 may be a potential risk gene for schizophrenia in the Chinese Han population. However, polymorphisms of the CYP2E1 gene may not contribute significantly to individual differences in the therapeutic efficacy of risperidone. Further studies in larger groups are warranted to confirm our results.	[Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Huo, Ran; Tang, Kefu; Wei, Zhiyun; Shen, Lu; Xiong, Yuyu; Wu, Xi; Yang, Lun; Feng, Guoyin; He, Lin; Qin, Shengying] Shanghai Genomepilot Inst, Shanghai, Peoples R China; [Tian, Zhengan] Shanghai Int Travel Healthcare Ctr, Shanghai, Peoples R China; [Feng, Guoyin] Shanghai Inst Mental Hlth, Shanghai, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Huo, R (corresponding author), Shanghai Jiao Tong Univ, Bio X Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helin@bio-x.cn; chinsir@sjtu.edu.cn	Yang, Lun/B-4859-2012; Wei, Zhiyun/E-2008-2016; Lu, Shen/B-2644-2008	Wei, Zhiyun/0000-0002-3554-4142; Lu, Shen/0000-0002-0659-2399; Tang, Kefu/0000-0002-0058-1509	973 Program [2010CB529600]; National Key Technology Research & Development Program [2006BAI05A09, 2012BAI01B09]; National Nature Science Foundation of China [30900799, 30972823, 81121001]; Shanghai Jiaotong University Med-X Fund [YG2010MS61]; Public Science and Technology Research Funds [201210056]; Shanghai Jiaotong University Interdisciplinary Research fund; 863 Program [2012AA02A515, 2009AA022701]; Major Program of Shanghai Committee of Science and Technology [11dz1950300]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); National Key Technology Research & Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University Med-X Fund; Public Science and Technology Research Funds; Shanghai Jiaotong University Interdisciplinary Research fund; 863 Program(National High Technology Research and Development Program of China); Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by the 973 Program (2010CB529600), the National Key Technology Research & Development Program (2006BAI05A09, 2012BAI01B09), the National Nature Science Foundation of China (30900799, 30972823, 81121001), the Shanghai Jiaotong University Med-X Fund (YG2010MS61), Public Science and Technology Research Funds(201210056), the Shanghai Jiaotong University Interdisciplinary Research fund, the 863 Program (2012AA02A515, 2009AA022701), the Major Program of Shanghai Committee of Science and Technology (11dz1950300), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; CADET JL, 1987, INTEGRATIVE PSYCHIAT, V5, P40; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Csernansky JG, 2002, CNS DRUGS, V16, P473, DOI 10.2165/00023210-200216070-00004; Dey A, 2011, CELL BIOL TOXICOL, V27, P285, DOI 10.1007/s10565-011-9188-4; Du J, 2010, J PSYCHOPHARMACOL, V24, P1115, DOI 10.1177/0269881109104932; Fang J, 1999, N-S ARCH PHARMACOL, V359, P147, DOI 10.1007/PL00005334; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gregg C, 2007, J NEUROSCI, V27, P1812, DOI 10.1523/JNEUROSCI.4441-06.2007; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hanioka N, 2003, XENOBIOTICA, V33, P575, DOI 10.1080/0049825031000086400; HANSSON T, 1990, NEUROSCIENCE, V34, P451, DOI 10.1016/0306-4522(90)90154-V; Heck AH, 2000, SCHIZOPHR RES, V46, P97, DOI 10.1016/S0920-9964(00)00009-8; Hu Y, 1999, BIOCHEM BIOPH RES CO, V263, P286, DOI 10.1006/bbrc.1999.1362; HUANG ML, 1993, CLIN PHARMACOL THER, V54, P257, DOI 10.1038/clpt.1993.146; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Iwahashi K, 1997, HUM EXP TOXICOL, V16, P208, DOI 10.1177/096032719701600409; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; KHARASCH ED, 1993, ANESTHESIOLOGY, V79, P795, DOI 10.1097/00000542-199310000-00023; Lane HY, 2002, AM J PSYCHIAT, V159, P1593, DOI 10.1176/appi.ajp.159.9.1593; Lee BH, 2006, PROG NEURO-PSYCHOPH, V30, P658, DOI 10.1016/j.pnpbp.2005.11.037; Lee SA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-72; Lencz T, 2006, AM J PSYCHIAT, V163, P529, DOI 10.1176/appi.ajp.163.3.529; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Mauri MC, 2001, EUR PSYCHIAT, V16, P57, DOI 10.1016/S0924-9338(00)00536-8; MONTOLIU C, 1995, J NEUROCHEM, V65, P2561; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Ogony J, 2008, J APPL TOXICOL, V28, P345, DOI 10.1002/jat.1285; Olesen OV, 1997, J CHROMATOGR B, V698, P209, DOI 10.1016/S0378-4347(97)00302-2; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU, Vxx; OVERALL JE, 1962, PSYCHOL REP, V10, P799; PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Reynolds GP, 2005, EUR NEUROPSYCHOPHARM, V15, P143, DOI 10.1016/j.euroneuro.2004.07.001; Riedel M, 2005, EUR ARCH PSY CLIN N, V255, P261, DOI 10.1007/s00406-004-0556-4; Schultz SK, 1999, LANCET, V353, P1425, DOI 10.1016/S0140-6736(98)07549-7; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Spina E, 2001, PSYCHOPHARMACOLOGY, V153, P238, DOI 10.1007/s002130000576; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Tang KF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-575; Tang KF, 2010, GENOMICS, V95, P224, DOI 10.1016/j.ygeno.2010.01.005; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; VANBEIJSTERVELDT LEC, 1994, PSYCHOPHARMACOLOGY, V114, P53, DOI 10.1007/BF02245444; Wang L, 2007, J PSYCHOPHARMACOL, V21, P837, DOI 10.1177/0269881107077357; Wang L, 2007, NEUROSCI LETT, V414, P1, DOI 10.1016/j.neulet.2006.09.014; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Xing QH, 2003, SCHIZOPHR RES, V65, P9, DOI 10.1016/S0920-9964(03)00064-1; Xing QH, 2006, PHARMACOGENOMICS, V7, P987, DOI 10.2217/14622416.7.7.987	56	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34809	10.1371/journal.pone.0034809	http://dx.doi.org/10.1371/journal.pone.0034809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606226	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200008
J	Hayes, S; Horbay, MA; Hayes, C				Hayes, Sidney; Horbay, Monique A.; Hayes, Connie			A CI-Independent Form of Replicative Inhibition: Turn Off of Early Replication of Bacteriophage Lambda	PLOS ONE			English	Article							SPECIALIZED NUCLEOPROTEIN STRUCTURES; ESCHERICHIA-COLI O157-H7; PHAGE-LAMBDA; NUCLEOTIDE-SEQUENCE; DNA-REPLICATION; GENETIC-STRUCTURE; COLIPHAGE-LAMBDA; OOP-RNA; ESTABLISHMENT TRANSCRIPTION; DELETION ANALYSIS	Several earlier studies have described an unusual exclusion phenotype exhibited by cells with plasmids carrying a portion of the replication region of phage lambda. Cells exhibiting this inhibition phenotype (IP) prevent the plating of homo-immune and hybrid hetero-immune lambdoid phages. We have attempted to define aspects of IP, and show that it is directed to rep lambda phages. IP was observed in cells with plasmids containing a l DNA fragment including oop, encoding a short OOP micro RNA, and part of the lambda origin of replication, ori lambda, defined by iteron sequences ITN1-4 and an adjacent high AT-rich sequence. Transcription of the intact oop sequence from its promoter, p(O) is required for IP, as are iterons ITN3-4, but not the high AT-rich portion of oril. The results suggest that IP silencing is directed to theta mode replication initiation from an infecting repl genome, or an induced repl prophage. Phage mutations suppressing IP, i.e., Sip, map within, or adjacent to cro or in O, or both. Our results for plasmid based IP suggest the hypothesis that there is a natural mechanism for silencing early theta-mode replication initiation, i.e. the buildup of l genomes with oop(+) ori lambda(+) sequence.	[Hayes, Sidney; Horbay, Monique A.; Hayes, Connie] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Hayes, S (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada.	sjh092@mail.usask.ca		Hayes, Sidney/0000-0002-4218-3939	NSERC Canada [138296]	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC Canada Discovery grant 138296 to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1968, P NATL ACAD SCI USA, V61, P956, DOI 10.1073/pnas.61.3.956; ANDERL A, 1982, NUCLEIC ACIDS RES, V10, P1733, DOI 10.1093/nar/10.5.1733; Bachmann B.J., 1987, E COLI S TYPHIMURIUM, V2, P1192; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; Bull H. J, 1995, BACTERIOPHAGE LAMBDA; Bull HJ, 1996, MOL GEN GENET, V252, P755, DOI 10.1007/BF02173984; Casjens S, 2004, J MOL BIOL, V339, P379, DOI 10.1016/j.jmb.2004.03.068; Clark AJ, 2001, J MOL BIOL, V311, P657, DOI 10.1006/jmbi.2001.4868; COHEN A, 1986, J BACTERIOL, V167, P327, DOI 10.1128/jb.167.1.327-335.1986; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; DANIELS DL, 1983, LAMBDA, V2, P519; DENNISTONTHOMPSON K, 1977, SCIENCE, V198, P1051, DOI 10.1126/science.929187; DODSON M, 1985, P NATL ACAD SCI USA, V82, P4678, DOI 10.1073/pnas.82.14.4678; DODSON M, 1986, P NATL ACAD SCI USA, V83, P7638, DOI 10.1073/pnas.83.20.7638; DODSON M, 1989, J BIOL CHEM, V264, P10719; DOVE WF, 1971, BACTERIOPHAGE LAMBDA, P747; EISEN H, 1975, VIROLOGY, V68, P266, DOI 10.1016/0042-6822(75)90168-3; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; ENQUIST LW, 1973, J MOL BIOL, V75, P185, DOI 10.1016/0022-2836(73)90016-8; FEISS M, 1983, LAMBDA 2, P305; FOLKMANIS A, 1977, VIROLOGY, V81, P352, DOI 10.1016/0042-6822(77)90151-9; FREIFELDER D, 1974, J MOL BIOL, V83, P503, DOI 10.1016/0022-2836(74)90510-5; FURTH ME, 1977, SCIENCE, V198, P1046, DOI 10.1126/science.929186; Gamage LNA, 2009, VACCINE, V27, P6595, DOI 10.1016/j.vaccine.2009.08.019; GROSSCHEDL R, 1979, NUCLEIC ACIDS RES, V6, P867, DOI 10.1093/nar/6.3.867; GROSSCHEDL R, 1979, NATURE, V277, P621, DOI 10.1038/277621a0; Gussin G.N., 1983, LAMBDA 2, P93; HAYES S, 1990, MOL GEN GENET, V222, P17, DOI 10.1007/BF00283017; HAYES S, 1991, MOL GEN GENET, V231, P139, DOI 10.1007/BF00293831; Hayes S, 2005, GENETICS, V170, P1485, DOI 10.1534/genetics.105.042341; HAYES S, 1979, VIROLOGY, V97, P415, DOI 10.1016/0042-6822(79)90352-0; Hayes S, 2005, CAN J MICROBIOL, V51, P37, DOI 10.1139/W04-115; Hayes S, 1998, GENE, V223, P115, DOI 10.1016/S0378-1119(98)00363-1; HAYES S, 1978, MOL GEN GENET, V164, P63, DOI 10.1007/BF00267600; Hayes S, 1997, GENE, V189, P35, DOI 10.1016/S0378-1119(96)00824-4; HAYES S, 1973, MOL GEN GENET, V126, P275, DOI 10.1007/BF00269438; HAYES S, 1979, MOL GEN GENET, V170, P75, DOI 10.1007/BF00268582; HAYES S, 1986, J VIROL, V58, P835, DOI 10.1128/JVI.58.3.835-842.1986; Hayes S, 1999, ACTA BIOCHIM POL, V46, P879, DOI 10.18388/abp.1999_4109; Hayes S., 1988, DNA REPLICATION MUTA, P367; Hayes S, 2010, VACCINE, V28, P6789, DOI 10.1016/j.vaccine.2010.07.047; Horbay M. A., 2006, MODERN BACTERIOPHAGE, P37; Horbay M.A., 2005, INHIBITION PHENOTYPE; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Juhala RJ, 2000, J MOL BIOL, V299, P27, DOI 10.1006/jmbi.2000.3729; Kobiler O, 2002, P NATL ACAD SCI USA, V99, P14964, DOI 10.1073/pnas.222172499; KRINKE L, 1990, GENE DEV, V4, P2223, DOI 10.1101/gad.4.12a.2223; KUMAR S, 1970, VIROLOGY, V41, P665, DOI 10.1016/0042-6822(70)90431-9; KUSANO K, 1989, J MOL BIOL, V209, P623, DOI 10.1016/0022-2836(89)90000-4; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LUSKY M, 1979, GENE, V6, P137, DOI 10.1016/0378-1119(79)90068-4; MATSUBARA K, 1976, J MOL BIOL, V102, P427, DOI 10.1016/0022-2836(76)90325-9; Matsubara K, 1968, LAMBDADV AUTONOMOUSL, P769; MCMILIN KD, 1972, J MOL BIOL, V68, P49, DOI 10.1016/0022-2836(72)90261-6; Miyamoto H, 1999, DNA Res, V6, P235, DOI 10.1093/dnares/6.4.235; Mmolawa PT, 2003, J BACTERIOL, V185, P3473, DOI 10.1128/JB.185.11.3473-3475.2003; MOORE DD, 1979, COLD SPRING HARB SYM, V43, P155, DOI 10.1101/SQB.1979.043.01.022; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; OBERTO J, 1994, NUCLEIC ACIDS RES, V22, P354, DOI 10.1093/nar/22.3.354; OGAWA T, 1988, J MOL BIOL, V202, P537, DOI 10.1016/0022-2836(88)90284-7; Oppenheim AB, 2004, VIROLOGY, V319, P185, DOI 10.1016/j.virol.2003.11.007; PACKMAN S, 1968, VIROLOGY, V34, P778, DOI 10.1016/0042-6822(68)90099-8; PARKINSO.JS, 1968, GENETICS, V59, P311; Pedulla ML, 2003, J BACTERIOL, V185, P1475, DOI 10.1128/JB.185.4.1475-1477.2003; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; Poteete AR, 2008, MOL MICROBIOL, V68, P66, DOI 10.1111/j.1365-2958.2008.06133.x; RAO RN, 1978, GENE, V3, P247; ROSENBERG M, 1978, NATURE, V272, P414, DOI 10.1038/272414a0; SALZMAN LA, 1967, J MOL BIOL, V28, P53, DOI 10.1016/S0022-2836(67)80077-9; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; Sato T, 2003, GENE, V309, P35, DOI 10.1016/S0378-1119(03)00487-6; Sato T, 2003, J BACTERIOL, V185, P3966, DOI 10.1128/JB.185.13.3966-3971.2003; SCHERER G, 1977, NATURE, V265, P117, DOI 10.1038/265117a0; SCHERER G, 1978, NUCLEIC ACIDS RES, V5, P3141, DOI 10.1093/nar/5.9.3141; Schicklmaier P, 1997, GENE, V195, P93, DOI 10.1016/S0378-1119(97)00182-0; SCHWARZ E, 1978, NATURE, V272, P410, DOI 10.1038/272410a0; SCLAFANI RA, 1981, VIROLOGY, V113, P314, DOI 10.1016/0042-6822(81)90158-6; SILBERSTEIN Z, 1987, J BACTERIOL, V169, P3131, DOI 10.1128/jb.169.7.3131-3137.1987; Skalka A, 1975, DNA SYNTHESIS ITS RE, P460; SKALKA AM, 1977, CURR TOP MICROBIOL, P201; SMITH GR, 1975, VIROLOGY, V64, P544, DOI 10.1016/0042-6822(75)90131-2; STAHL FW, 1972, J MOL BIOL, V68, P57, DOI 10.1016/0022-2836(72)90262-8; Stephens KM, 1997, J BIOL CHEM, V272, P28800, DOI 10.1074/jbc.272.45.28800; Struble EB, 2007, ACTA CRYSTALLOGR F, V63, P542, DOI 10.1107/S1744309107022762; TAKAYAMA KM, 1987, MOL GEN GENET, V210, P184, DOI 10.1007/BF00337778; Tanaka K, 2004, J CLIN MICROBIOL, V42, P1807, DOI 10.1128/JCM.42.4.1807-1812.2004; TAYLOR KD, 1981, J BACTERIOL, V145, P1113, DOI 10.1128/JB.145.2.1113-1115.1981; THOMAS R, 1964, VIROLOGY, V24, P241, DOI 10.1016/0042-6822(64)90163-1; TSURIMOTO T, 1981, NUCLEIC ACIDS RES, V9, P1789, DOI 10.1093/nar/9.8.1789; TSURIMOTO T, 1982, P NATL ACAD SCI-BIOL, V79, P7639, DOI 10.1073/pnas.79.24.7639; Vander Byl C, 2000, J BACTERIOL, V182, P6472, DOI 10.1128/JB.182.22.6472-6481.2000; WEIGLE J, 1966, P NATL ACAD SCI USA, V55, P1462, DOI 10.1073/pnas.55.6.1462; WICKNER S, 1987, J BIOL CHEM, V262, P13163; Wulff D.L., 1983, LAMBDA 2, P519	95	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36498	10.1371/journal.pone.0036498	http://dx.doi.org/10.1371/journal.pone.0036498			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590552	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400019
J	Kawashima, J; Alquier, T; Tsuji, Y; Peroni, OD; Kahn, BB				Kawashima, Junji; Alquier, Thierry; Tsuji, Youki; Peroni, Odile D.; Kahn, Barbara B.			Ca2+/Calmodulin-Dependent Protein Kinase Kinase Is Not Involved in Hypothalamic AMP-Activated Protein Kinase Activation by Neuroglucopenia	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; UPSTREAM KINASE; GLUCOSE-UPTAKE; CELLS; BETA; HYPOGLYCEMIA; RESPONSES	Hypoglycemia and neuroglucopenia stimulate AMP-activated protein kinase (AMPK) activity in the hypothalamus and this plays an important role in the counterregulatory responses, i.e. increased food intake and secretion of glucagon, corticosterone and catecholamines. Several upstream kinases that activate AMPK have been identified including Ca2+/Calmodulin-dependent protein kinase kinase (CaMKK), which is highly expressed in neurons. However, the involvement of CaMKK in neuroglucopenia-induced activation of AMPK in the hypothalamus has not been tested. To determine whether neuroglucopenia-induced AMPK activation is mediated by CaMKK, we tested whether STO-609 (STO), a CaMKK inhibitor, would block the effects of 2-deoxy-D-glucose (2DG)-induced neuroglucopenia both ex vivo on brain sections and in vivo. Preincubation of rat brain sections with STO blocked KCl-induced alpha 1 and alpha 2-AMPK activation but did not affect AMPK activation by 2DG in the medio-basal hypothalamus. To confirm these findings in vivo, STO was pre-administrated intracerebroventricularly (ICV) in rats 30 min before 2DG ICV injection (40 mu mol) to induce neuroglucopenia. 2DG-induced neuroglucopenia lead to a significant increase in glycemia and food intake compared to saline-injected control rats. ICV pre-administration of STO (5, 20 or 50 nmol) did not affect 2DG-induced hyperglycemia and food intake. Importantly, activation of hypothalamic alpha 1 and alpha 2-AMPK by 2DG was not affected by ICV pre-administration of STO. In conclusion, activation of hypothalamic AMPK by 2DG-induced neuroglucopenia is not mediated by CaMKK.	Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kawashima, J (corresponding author), Kumamoto Univ, Dept Metab Med, Fac Life Sci, Kumamoto, Japan.	bkahn@bidmc.harvard.edu	Alquier, Thierry/Z-1917-2019	Alquier, Thierry/0000-0001-8171-802X	National Institutes of Health [P01 DK56116, P30 DK57521]; ADA; Picower Foundation; ADA-EASD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, P30DK057521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Picower Foundation; ADA-EASD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 DK56116 and P30 DK57521, an ADA Mentor-Based Fellowship, a grant from the Picower Foundation (BBK), and an ADA-EASD fellowship grant (TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alquier T, 2007, ENDOCRINOLOGY, V148, P1367, DOI 10.1210/en.2006-1039; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Claret M, 2011, DIABETES, V60, P735, DOI 10.2337/db10-1055; Han SM, 2005, DIABETOLOGIA, V48, P2170, DOI 10.1007/s00125-005-1913-1; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; Lee K, 2005, ENDOCRINOLOGY, V146, P3, DOI 10.1210/en.2004-0968; McCrimmon RJ, 2008, DIABETES, V57, P444, DOI 10.2337/db07-0837; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Sakagami H, 2000, EUR J NEUROSCI, V12, P89, DOI 10.1046/j.1460-9568.2000.00883.x; Shen QWW, 2007, AM J PHYSIOL-CELL PH, V293, pC1395, DOI 10.1152/ajpcell.00115.2007; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Tekkok S, 1999, J NEUROPHYSIOL, V81, P174, DOI 10.1152/jn.1999.81.1.174; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	23	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36335	10.1371/journal.pone.0036335	http://dx.doi.org/10.1371/journal.pone.0036335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590531	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400010
J	Lee, JP; Yang, SH; Lee, HY; Kim, B; Cho, JY; Paik, JH; Oh, YJ; Kim, DK; Lim, CS; Kim, YS				Lee, Jung Pyo; Yang, Seung Hee; Lee, Hee-Yoon; Kim, Bora; Cho, Joo-Youn; Paik, Jin Ho; Oh, Yun Jung; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su			Soluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in Kidney	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; 12-(3-ADAMANTAN-1-YL-UREIDO)DODECANOIC ACID; THERAPEUTIC TARGET; VEGF EXPRESSION; BLOOD-PRESSURE; GENE DELETION; RENAL INJURY; IN-VIVO; HYPERTENSION	Soluble epoxide hydrolase (sEH) in endothelial cells determines the plasma concentrations of epoxyeicosatrienoic acids (EETs), which may act as vasoactive agents to control vascular tone. We hypothesized that the regulation of sEH activity may have a therapeutic value in preventing acute kidney injury by controlling the concentration of EETs. In this study, we therefore induced ischemia-reperfusion injury (IRI) in C57BL/6 mice and controlled sEH activity by intraperitoneal administration of the sEH inhibitor 12-(3-adamantan-1-ylureido)-dodecanoic acid (AUDA). The deterioration of kidney function induced by IRI was partially moderated and prevented by AUDA treatment. In addition, AUDA treatment significantly attenuated tubular necrosis induced by IRI. Ischemic injury induced the down-regulation of sEH, and AUDA administration had no effect on the expression pattern of sEH induced by IRI. In vivo sEH activity was assessed by measuring the substrate epoxyoctadecenoic acid (EpOME) and its metabolite dihydroxyoctadec-12-enoic acid (DHOME). Ischemic injury had no effects on the plasma concentrations of EpOME and DHOME, but inhibition of sEH by AUDA significantly increased plasma EpOME and the EpOME/DHOME ratio. The protective effect of the sEH inhibitor was achieved by suppression of proinflammatory cytokines and up-regulation of regulatory cytokines. AUDA treatment prevented the intrarenal infiltration of inflammatory cells, but promoted endothelial cell migration and neovascularization. The results of this study suggest that treatment with sEH inhibitors can reduce acute kidney injury.	[Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Jung Pyo; Yang, Seung Hee; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Lee, Jung Pyo; Yang, Seung Hee; Oh, Yun Jung; Kim, Dong Ki; Lim, Chun Soo; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Hee-Yoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon, South Korea; [Kim, Bora; Cho, Joo-Youn] Seoul Natl Univ, Coll Med, Dept Pharmacol & Clin Pharmacol, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Lee, JP (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	yonsukim@snu.ac.kr	Kim, Dong Ki/J-5389-2012; Cho, Joo-Youn/J-5672-2012; Lim, Chun Soo/J-5624-2012; Cho, Joo-Youn/ABC-2044-2021; lee, hee yoon/B-8354-2011	Kim, Dong Ki/0000-0002-5195-7852; Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; 	Korea Healthcare technology RD Project; Ministry for Health and Welfare, Republic of Korea [A080656]	Korea Healthcare technology RD Project; Ministry for Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A080656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2008, AM J PHYSIOL-RENAL, V294, pF928, DOI 10.1152/ajprenal.00596.2007; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Daemen MARC, 2001, TRANSPLANTATION, V71, P1007; Deng JP, 2001, KIDNEY INT, V60, P2118, DOI 10.1046/j.1523-1755.2001.00043.x; Donnahoo KK, 1999, AM J PHYSIOL-REG I, V277, pR922, DOI 10.1152/ajpregu.1999.277.3.R922; Dorrance AM, 2005, J CARDIOVASC PHARM, V46, P842, DOI 10.1097/01.fjc.0000189600.74157.6d; Fang X, 2004, AM J PHYSIOL-HEART C, V287, pH2412, DOI 10.1152/ajpheart.00527.2004; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fornage M, 2005, HUM MOL GENET, V14, P2829, DOI 10.1093/hmg/ddi315; Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Haq M, 1998, J AM SOC NEPHROL, V9, P614; HEIZER ML, 1991, STROKE, V22, P1389, DOI 10.1161/01.STR.22.11.1389; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Kim IH, 2007, BIOORGAN MED CHEM, V15, P312, DOI 10.1016/j.bmc.2006.09.057; Koerner IP, 2007, J NEUROSCI, V27, P4642, DOI 10.1523/JNEUROSCI.0056-07.2007; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee JP, 2011, AM J PHYSIOL-RENAL, V300, pF1283, DOI 10.1152/ajprenal.00733.2010; Lee SH, 2008, TRANSPL P, V40, P1353, DOI 10.1016/j.transproceed.2008.03.137; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Liu M, 2005, J CEREBR BLOOD F MET, V25, P939, DOI 10.1038/sj.jcbfm.9600085; Manhiani M, 2009, AM J PHYSIOL-RENAL, V297, pF740, DOI 10.1152/ajprenal.00098.2009; MCPHERSON C, 1980, J ANIM SCI, V51, P492, DOI 10.2527/jas1980.512492x; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nangaku M, 2007, J MOL MED, V85, P1325, DOI 10.1007/s00109-007-0278-y; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Santos WJQ, 2006, CRIT CARE, V10, DOI 10.1186/cc4904; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103; Yang SH, 2011, J AM SOC NEPHROL, V22, P1305, DOI 10.1681/ASN.2010080815; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhang WR, 2007, J CEREBR BLOOD F MET, V27, P1931, DOI 10.1038/sj.jcbfm.9600494; Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244	47	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37075	10.1371/journal.pone.0037075	http://dx.doi.org/10.1371/journal.pone.0037075			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590647	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400056
J	Lupold, SE; Johnson, T; Chowdhury, WH; Rodriguez, R				Lupold, Shawn E.; Johnson, Tamara; Chowdhury, Wasim H.; Rodriguez, Ronald			A Real Time Metridia Luciferase Based Non-Invasive Reporter Assay of Mammalian Cell Viability and Cytotoxicity via the beta-actin Promoter and Enhancer	PLOS ONE			English	Article							IN-VIVO; SECRETED LUCIFERASE; GENE; EXPRESSION; ENZYME; CDNA; UPSTREAM; CULTURE; CLONING; GROWTH	Secreted reporter molecules offer a means to evaluate biological processes in real time without the need to sacrifice samples at pre-determined endpoints. Here we have adapted the secreted bioluminescent reporter gene, Metridia luciferase, for use in a real-time viability assay for mammalian cells. The coding region of the marine copepod gene has been codon optimized for expression in human cells (hMLuc) and placed under the control of the human beta-actin promoter and enhancer. Metridia luciferase activity of stably transfected cell models corresponded linearly with cell number over a 4-log dynamic range, detecting as few as 40 cells. When compared to standard endpoint viability assays, which measure the mitochondrial dehydrogenase reduction of tetrazolium salts, the hMLuc viability assay had a broader linear range of detection, was applicable to large tissue culture vessels, and allowed the same sample to be repeatedly measured over several days. Additional studies confirmed that MLuc activity was inhibited by serum, but demonstrated that assay activity remained linear and was measurable in the serum of mice bearing subcutaneous hMLuc-expressing tumors. In summary, these comparative studies demonstrate the value of humanized Metridia luciferase as an inexpensive and non-invasive method for analyzing viable cell number, growth, tumor volume, and therapeutic response in real time.	[Lupold, Shawn E.; Johnson, Tamara; Chowdhury, Wasim H.; Rodriguez, Ronald] Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Lupold, SE (corresponding author), Johns Hopkins Univ, James Buchanan Brady Urol Inst, Sch Med, Baltimore, MD 21218 USA.	slupold@jhmi.edu; rrodrig@jhmi.edu	Chowdhury, Wasim/ABD-5379-2020	Chowdhury, Wasim/0000-0002-6731-646X	National Institutes of Health, National Cancer Institute [5R01CA121153-05]; Department of Defense Prostate Cancer [W81XWH-11-1-0475]; NATIONAL CANCER INSTITUTE [R01CA121153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from the National Institutes of Health, National Cancer Institute: 5R01CA121153-05 and The Department of Defense Prostate Cancer Research Program: W81XWH-11-1-0475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr CE, 2011, ASSAY DRUG DEV TECHN, V9, P281, DOI 10.1089/adt.2010.0324; Berger F, 2008, EUR J NUCL MED MOL I, V35, P2275, DOI 10.1007/s00259-008-0870-6; Coombe DR, 1998, J IMMUNOL METHODS, V215, P145, DOI 10.1016/S0022-1759(98)00081-7; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Hiramatsu N, 2005, ANAL BIOCHEM, V339, P249, DOI 10.1016/j.ab.2005.01.023; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421; Lupold SE, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm914; Markova SV, 2004, J BIOL CHEM, V279, P3212, DOI 10.1074/jbc.M309639200; Markova SV, 2012, BIOCHEM BIOPH RES CO, V417, P98, DOI 10.1016/j.bbrc.2011.11.063; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SHRIVASTAVA R, 1992, CELL BIOL TOXICOL, V8, P157; SUGIYAMA H, 1988, GENE, V65, P135; Takenaka Y, 2008, GENE, V425, P28, DOI 10.1016/j.gene.2008.07.041; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944	23	22	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36535	10.1371/journal.pone.0036535	http://dx.doi.org/10.1371/journal.pone.0036535			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590558	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100034
J	Purushotham, P; Arun, PVPS; Prakash, JSS; Podile, AR				Purushotham, Pallinti; Arun, P. V. Parvati Sai; Prakash, Jogadhenu S. S.; Podile, Appa Rao			Chitin Binding Proteins Act Synergistically with Chitinases in Serratia proteamaculans 568	PLOS ONE			English	Article							ALPHA-CHITIN; BETA-CHITIN; MARCESCENS; DEGRADATION; CBP21; RESOLUTION; RESIDUES; CHITOSAN; SYSTEM; ENZYME	Genome sequence of Serratia proteamaculans 568 revealed the presence of three family 33 chitin binding proteins (CBPs). The three Sp CBPs (Sp CBP21, Sp CBP28 and Sp CBP50) were heterologously expressed and purified. Sp CBP21 and Sp CBP50 showed binding preference to beta-chitin, while Sp CBP28 did not bind to chitin and cellulose substrates. Both Sp CBP21 and Sp CBP50 were synergistic with four chitinases from S. proteamaculans 568 (Sp ChiA, Sp ChiB, Sp ChiC and Sp ChiD) in degradation of alpha- and beta-chitin, especially in the presence of external electron donor (reduced glutathione). Sp ChiD benefited most from Sp CBP21 or Sp CBP50 on alpha-chitin, while Sp ChiB and Sp ChiD had major advantage with these Sp CBPs on beta-chitin. Dose responsive studies indicated that both the Sp CBPs exhibit synergism >= 0.2 mu M. The addition of both Sp CBP21 and Sp CBP50 in different ratios to a synergistic mixture did not significantly increase the activity. Highly conserved polar residues, important in binding and activity of CBP21 from S. marcescens (Sm CBP21), were present in Sp CBP21 and Sp CBP50, while Sp CBP28 had only one such polar residue. The inability of Sp CBP28 to bind to the test substrates could be attributed to the absence of important polar residues.	[Purushotham, Pallinti; Arun, P. V. Parvati Sai; Prakash, Jogadhenu S. S.; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Purushotham, P (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India.	arpsl@uohyd.ernet.in	Arun, PV Parvati Sai/ABI-6028-2020; Podile, Appa Rao/W-5077-2018	Arun, PV Parvati Sai/0000-0002-9175-7900; Pallinti, Purushotham Naidu/0000-0002-5565-1762; Podile, Appa Rao/0000-0003-3208-765X	Department of Biotechnology, Government of India; DST-FIST; UGC-SAP; DBT-CREBB; University of Hyderabad	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST-FIST(Department of Science & Technology (India)); UGC-SAP(University Grants Commission, India); DBT-CREBB(Department of Biotechnology (DBT) India); University of Hyderabad(University of Hyderabad)	The work was supported by Department of Biotechnology, Government of India in the form of a research project to ARP; http://dbtindia.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank DST-FIST, UGC-SAP and DBT-CREBB for the support to the Department of Plant Sciences, University of Hyderabad. PP thanks the University of Hyderabad for research fellowship, Dr. Daniel van der Lelie, Brookhaven National Laboratory, USA for providing the S. proteamaculans 568, and Dr. Dominique Gillete, Mahatani Chitosan, Veraval, Gujarat, for chitinous substrates.	Berger LR, 1988, METHODS ENZYMOLOGY, V161, P140; Chu HH, 2001, MICROBIOL-SGM, V147, P1793, DOI 10.1099/00221287-147-7-1793; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Folders J, 2000, J BACTERIOL, V182, P1257, DOI 10.1128/JB.182.5.1257-1263.2000; Hardt M, 2004, ARCH BIOCHEM BIOPHYS, V426, P286, DOI 10.1016/j.abb.2004.03.017; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Kolbe S, 1998, MICROBIOL-SGM, V144, P1291, DOI 10.1099/00221287-144-5-1291; Mehmood MA, 2011, ANTON LEEUW INT J G, V53, P125; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; Neeraja C, 2010, CRIT REV BIOTECHNOL, V30, P231, DOI 10.3109/07388551.2010.487258; Neeraja C, 2010, MOL BIOSYST, V6, P1492, DOI 10.1039/b923048c; Neeraja C, 2010, BIORESOURCE TECHNOL, V101, P3635, DOI 10.1016/j.biortech.2009.12.118; Orikoshi H, 2005, APPL ENVIRON MICROB, V71, P1811, DOI 10.1128/AEM.71.4.1811-1815.2005; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Purushotham P, 2012, BIORESOURCE TECHNOL, V112, P261, DOI 10.1016/j.biortech.2012.02.062; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Saito A, 2001, APPL ENVIRON MICROB, V67, P1268, DOI 10.1128/AEM.67.3.1268-1273.2001; SCHNELLMANN J, 1994, MOL MICROBIOL, V13, P807, DOI 10.1111/j.1365-2958.1994.tb00473.x; Suetake T, 2000, J BIOL CHEM, V275, P17929, DOI 10.1074/jbc.C000184200; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2012, J MOL BIOL, V416, P239, DOI 10.1016/j.jmb.2011.12.033; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Zamil SS, 2010, BIORESOURCE TECHNOL, V101, P7177, DOI 10.1016/j.biortech.2010.03.141; Zeltins A, 1997, EUR J BIOCHEM, V246, P557, DOI 10.1111/j.1432-1033.1997.t01-1-00557.x	29	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36714	10.1371/journal.pone.0036714	http://dx.doi.org/10.1371/journal.pone.0036714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590591	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100054
J	Heine, M; Freund, B; Nielsen, P; Jung, C; Reimer, R; Hohenberg, H; Zangemeister-Wittke, U; Wester, HJ; Luers, GH; Schumacher, U				Heine, Markus; Freund, Barbara; Nielsen, Peter; Jung, Caroline; Reimer, Rudolph; Hohenberg, Heinrich; Zangemeister-Wittke, Uwe; Wester, Hans-Juergen; Lueers, Georg H.; Schumacher, Udo			High Interstitial Fluid Pressure Is Associated with Low Tumour Penetration of Diagnostic Monoclonal Antibodies Applied for Molecular Imaging Purposes	PLOS ONE			English	Article							EP-CAM EXPRESSION; BREAST-CANCER; MELANOMA CELLS; CARCINOMA; THERAPY; SURVIVAL; TARGET; EPCAM; BIODISTRIBUTION; OVEREXPRESSION	The human epithelial cell adhesion molecule (EpCAM) is highly expressed in a variety of clinical tumour entities. Although an antibody against EpCAM has successfully been used as an adjuvant therapy in colon cancer, this therapy has never gained wide-spread use. We have therefore investigated the possibilities and limitations for EpCAM as possible molecular imaging target using a panel of preclinical cancer models. Twelve human cancer cell lines representing six tumour entities were tested for their EpCAM expression by qPCR, flow cytometry analysis and immunocytochemistry. In addition, EpCAM expression was analyzed in vivo in xenograft models for tumours derived from these cells. Except for melanoma, all cell lines expressed EpCAM mRNA and protein when grown in vitro. Although they exhibited different mRNA levels, all cell lines showed similar EpCAM protein levels upon detection with monoclonal antibodies. When grown in vivo, the EpCAM expression was unaffected compared to in vitro except for the pancreatic carcinoma cell line 5072 which lost its EpCAM expression in vivo. Intravenously applied radio-labelled anti EpCAM MOC31 antibody was enriched in HT29 primary tumour xenografts indicating that EpCAM binding sites are accessible in vivo. However, bound antibody could only be immunohistochemically detected in the vicinity of perfused blood vessels. Investigation of the fine structure of the HT29 tumour blood vessels showed that they were immature and prone for higher fluid flux into the interstitial space. Consistent with this hypothesis, a higher interstitial fluid pressure of about 12 mbar was measured in the HT29 primary tumour via "wick-in-needle'' technique which could explain the limited diffusion of the antibody into the tumour observed by immunohistochemistry.	[Heine, Markus; Lueers, Georg H.; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany; [Freund, Barbara; Nielsen, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Jung, Caroline] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Reimer, Rudolph; Hohenberg, Heinrich] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany; [Zangemeister-Wittke, Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Wester, Hans-Juergen] Tech Univ Munich, D-8046 Garching, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg; University of Bern; Technical University of Munich	Heine, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Anat & Expt Morphol, Hamburg, Germany.	ma.heine@uke.uni-hamburg.de			Bundesministerium fur Bildung und Forschung (TOMCAT) [01EZ0824]; Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME)	Bundesministerium fur Bildung und Forschung (TOMCAT); Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME)	This work was supported by the Bundesministerium fur Bildung und Forschung (TOMCAT, grant number 01EZ0824; http://www.bmbf.de/) and Landesexzellenzinitiative Hamburg (State Excellence Initiative, Nanotechnology in Medicine - NAME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2011, ONCOGENE, V30, P3468, DOI 10.1038/onc.2011.59; Andratschke M, 2007, ANTICANCER RES, V27, P431; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; BOUCHER Y, 1991, CANCER RES, V51, P6691; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; DEJONGE MWA, 1993, EUR J CANCER, V29A, P1885, DOI 10.1016/0959-8049(93)90543-O; FADNES HO, 1977, MICROVASC RES, V14, P27, DOI 10.1016/0026-2862(77)90138-8; FERNSTEN PD, 1990, CANCER RES, V50, P4656; FODSTAD O, 1988, CANCER RES, V48, P4382; Fong D, 2008, J CLIN PATHOL, V61, P31, DOI 10.1136/jcp.2006.037333; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Hall MA, 2011, PROSTATE; Heine M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028030; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Klosowska-Wardega A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008149; Kosterink JGW, 2007, J IMMUNOL, V179, P1362, DOI 10.4049/jimmunol.179.2.1362; Lange A, 2011, LUNG CANCER, V74, P178, DOI 10.1016/j.lungcan.2011.03.017; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; MOMBURG F, 1987, CANCER RES, V47, P2883; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; SEARS HF, 1982, LANCET, V1, P762; Seligson DB, 2004, CLIN CANCER RES, V10, P2659, DOI 10.1158/1078-0432.CCR-1132-03; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; Stoecklein NH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-165; Thurber GM, 2010, J SURG ONCOL, V102, P758, DOI 10.1002/jso.21735; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Varga M, 2004, CLIN CANCER RES, V10, P3131, DOI 10.1158/1078-0432.CCR-03-0528; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5	34	42	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36258	10.1371/journal.pone.0036258	http://dx.doi.org/10.1371/journal.pone.0036258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590529	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500009
J	Furukawa, H; Oka, S; Shimada, K; Sugii, S; Ohashi, J; Matsui, T; Ikenaka, T; Nakayama, H; Hashimoto, A; Takaoka, H; Arinuma, Y; Okazaki, Y; Futami, H; Komiya, A; Fukui, N; Nakamura, T; Migita, K; Suda, A; Nagaoka, S; Tsuchiya, N; Tohma, S				Furukawa, Hiroshi; Oka, Shomi; Shimada, Kota; Sugii, Shoji; Ohashi, Jun; Matsui, Toshihiro; Ikenaka, Tatsuoh; Nakayama, Hisanori; Hashimoto, Atsushi; Takaoka, Hirokazu; Arinuma, Yoshiyuki; Okazaki, Yuko; Futami, Hidekazu; Komiya, Akiko; Fukui, Naoshi; Nakamura, Tadashi; Migita, Kiyoshi; Suda, Akiko; Nagaoka, Shouhei; Tsuchiya, Naoyuki; Tohma, Shigeto			Association of Human Leukocyte Antigen with Interstitial Lung Disease in Rheumatoid Arthritis: A Protective Role for Shared Epitope	PLOS ONE			English	Article							EXTRAARTICULAR MANIFESTATIONS; HAPLOTYPE RECONSTRUCTION; PULMONARY-FIBROSIS; JAPANESE PATIENTS; HLA-DRB1-ASTERISK-15; COMPLEX; IMPACT; GENES	Introduction: Interstitial Lung Disease (ILD) is frequently associated with Rheumatoid Arthritis (RA) as one of extra-articularmanifestations. Many studies for Human Leukocyte Antigen (HLA) allelic association with RA have been reported, but few have been validated in an RA subpopulation with ILD. In this study, we investigated the association of HLA class II alleles with ILD in RA. Methods: An association study was conducted on HLA-DRB1, DQB1, and DPB1 in 450 Japanese RA patients that were or were not diagnosed with ILD, based on the findings of computed tomography images of the chest. Results: Unexpectedly, HLA-DRB1*04 (corrected P [Pc] = 0.0054, odds ratio [OR] 0.57), shared epitope (SE) (P = 0.0055, OR 0.66) and DQB1*04 (Pc = 0.0036, OR 0.57) were associated with significantly decreased risk of ILD. In contrast, DRB1*16 (Pc = 0.0372, OR 15.21), DR2 serological group (DRB1*15 and *16 alleles) (P = 0.0020, OR 1.75) and DQB1*06 (Pc = 0.0333, OR 1.57, respectively) were significantly associated with risk of ILD. Conclusion: HLA-DRB1 SE was associated with reduced, while DR2 serological group (DRB1*15 and *16) with increased, risk for ILD in Japanese patients with RA.	[Furukawa, Hiroshi; Oka, Shomi; Komiya, Akiko; Fukui, Naoshi; Tohma, Shigeto] Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji; Matsui, Toshihiro; Ikenaka, Tatsuoh; Nakayama, Hisanori; Hashimoto, Atsushi; Takaoka, Hirokazu; Arinuma, Yoshiyuki; Okazaki, Yuko; Futami, Hidekazu] Natl Hosp Org, Sagamihara Hosp, Dept Rheumatol, Sagamihara, Kanagawa, Japan; [Shimada, Kota; Sugii, Shoji] Tokyo Metropolitan Tama Med Ctr, Fuchu, Tokyo, Japan; [Ohashi, Jun; Tsuchiya, Naoyuki] Univ Tsukuba, Fac Med, Mol & Genet Epidemiol Lab, Tsukuba, Ibaraki, Japan; [Nakamura, Tadashi] Kumamoto Ctr Arthrit & Rheumatol, Kumamoto, Japan; [Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Omura, Japan; [Suda, Akiko; Nagaoka, Shouhei] Yokohama Minami Kyosai Hosp, Dept Rheumatol, Kanazawa Ku, Yokohama, Kanagawa, Japan	University of Tsukuba	Furukawa, H (corresponding author), Natl Hosp Org, Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan.	h-furukawa@sagamihara-hosp.gr.jp	Tsuchiya, Naoyuki/CAA-4545-2022; OHASHI, JUN/G-5907-2015; Arinuma, Yoshiyuki/CAH-4707-2022; Matsui, Toshihiro/AFU-8893-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580; Matsui, Toshihiro/0000-0002-7686-3211	Japan Society for the Promotion of Science, Health and Labour Science Research; Clinical Research from National Hospital Organization; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation; Daiwa Securities Health Foundation,; Nakatomi Foundation; Manabe Foundation; Takeda Pharmaceutical Company; Hisamitsu Pharmaceutical Co., Inc.; Daiwa Securities Health Foundation	Japan Society for the Promotion of Science, Health and Labour Science Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Clinical Research from National Hospital Organization; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Daiwa Securities Health Foundation,; Nakatomi Foundation; Manabe Foundation; Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Hisamitsu Pharmaceutical Co., Inc.; Daiwa Securities Health Foundation	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Health and Labour Science Research Grants from the Ministry of Health, Labour, and Welfare of Japan, Grants-in-Aid for Clinical Research from National Hospital Organization, Research Grants from Japan Research Foundation for Clinical Pharmacology, Research Grants from Takeda Science Foundation, Research Grants from Daiwa Securities Health Foundation, Research Grants from The Nakatomi Foundation, and Research Grants from The Manabe Foundation. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The following funders are supported in whole or in part by the subsequent pharmaceutical companies. The Japan Research Foundation for Clinical Pharmacology is run by Daiichi Sankyo, the Takeda Science Foundation is supported by an endowment from Takeda Pharmaceutical Company and the Nakatomi Foundation was established by Hisamitsu Pharmaceutical Co., Inc. The Daiwa Securities Health Foundation was established by Daiwa Securities Group Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Falfan-Valencia R, 2005, HUM GENET, V118, P235, DOI 10.1007/s00439-005-0035-7; Kim HY, 1997, BRIT J RHEUMATOL, V36, P440; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; LANCHBURY JSS, 1991, HUM IMMUNOL, V32, P56, DOI 10.1016/0198-8859(91)90117-R; Lewis SN, 2011, PLOS ONE, V6; Mattey DL, 2000, J RHEUMATOL, V27, P2611; Migita K, 2010, J RHEUMATOL, V37, P205, DOI 10.3899/jrheum.090303; Ohashi J, 2001, ANN HUM GENET, V65, P197, DOI 10.1017/S000348000100851X; Perricone C, 2011, AUTOIMMUN REV, V10, P599, DOI 10.1016/j.autrev.2011.04.021; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Scott IC, 2011, BEST PRACT RES CL RH, V25, P447, DOI 10.1016/j.berh.2011.10.010; Shibue T, 2000, ARTHRITIS RHEUM, V43, P753, DOI 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O; Simeon CP, 2009, J RHEUMATOL, V36, P2733, DOI 10.3899/jrheum.090377; Sirikong M, 2002, TISSUE ANTIGENS, V59, P113, DOI 10.1034/j.1399-0039.2002.590206.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tokunaga NK, 1999, NEPHRON, V81, P165, DOI 10.1159/000045273; Turesson C, 2005, ARTHRITIS RES THER, V7, pR1386, DOI 10.1186/ar1837; Turesson C, 2004, ARTHRIT RHEUM-ARTHR, V51, P853, DOI 10.1002/art.20693; Turesson C, 2004, SCAND J RHEUMATOL, V33, P65, DOI 10.1080/03009740310004621; Webb WR, 2006, RADIOLOGY, V239, P322, DOI 10.1148/radiol.2392041968; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814; WUCHERPFENNIG KW, 1994, J EXP MED, V179, P279, DOI 10.1084/jem.179.1.279; Xue JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014715	26	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e33133	10.1371/journal.pone.0033133	http://dx.doi.org/10.1371/journal.pone.0033133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586441	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000003
J	Franca-Costa, J; Wanderley, JLM; Deolindo, P; Zarattini, JB; Costa, J; Soong, L; Barcinski, MA; Barral, A; Borges, VM				Franca-Costa, Jaqueline; Mendes Wanderley, Joao Luiz; Deolindo, Poliana; Zarattini, Jessica B.; Costa, Jackson; Soong, Lynn; Barcinski, Marcello Andre; Barral, Aldina; Borges, Valeria M.			Exposure of Phosphatidylserine on Leishmania amazonensis Isolates Is Associated with Diffuse Cutaneous Leishmaniasis and Parasite Infectivity	PLOS ONE			English	Article							CELLS IN-VITRO; APOPTOTIC CELLS; MEXICANA-AMAZONENSIS; HOST-CELLS; AMASTIGOTES; DISEASE; MACROPHAGES; MIMICRY; EVASION; MICE	Diffuse cutaneous leishmaniasis (DCL) is a rare clinical manifestation of leishmaniasis, characterized by an inefficient parasite-specific cellular response and heavily parasitized macrophages. In Brazil, Leishmania (Leishmania) amazonensis is the main species involved in DCL cases. In the experimental model, recognition of phosphatidylserine (PS) molecules exposed on the surface of amastigotes forms of L. amazonensis inhibits the inflammatory response of infected macrophages as a strategy to evade the host immune surveillance. In this study, we examined whether PS exposure on L. amazonensis isolates from DCL patients operated as a parasite pathogenic factor and as a putative suppression mechanism of immune response during the infection. Peritoneal macrophages from F1 mice (BALB/cxC57BL/6) were infected with different L. amazonensis isolates from patients with localized cutaneous leishmaniasis (LCL) or DCL. DCL isolates showed higher PS exposure than their counterparts from LCL patients. In addition, PS exposure was positively correlated with clinical parameters of the human infection (number of lesions and time of disease) and with characteristics of the experimental infection (macrophage infection and anti-inflammatory cytokine induction). Furthermore, parasites isolated from DCL patients displayed an increased area in parasitophorous vacuoles (PV) when compared to those isolated from LCL patients. Thus, this study shows for the first time that a parasite factor (exposed PS) might be associated with parasite survival/persistence in macrophages and lesion exacerbation during the course of DCL, providing new insights regarding pathogenic mechanism in this rare chronic disease.	[Franca-Costa, Jaqueline; Costa, Jackson; Barral, Aldina; Borges, Valeria M.] Ctr Pesquisas Goncalo Moniz FIOCRUZ BA, Salvador, BA, Brazil; [Franca-Costa, Jaqueline; Barral, Aldina; Borges, Valeria M.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Mendes Wanderley, Joao Luiz] Univ Fed Rio de Janeiro, Polo Univ Macae, Rio de Janeiro, Brazil; [Mendes Wanderley, Joao Luiz; Deolindo, Poliana; Zarattini, Jessica B.; Barcinski, Marcello Andre] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil; [Deolindo, Poliana; Barcinski, Marcello Andre] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil; [Zarattini, Jessica B.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Franca-Costa, J (corresponding author), Ctr Pesquisas Goncalo Moniz FIOCRUZ BA, Salvador, BA, Brazil.	vborges@bahia.fiocruz.br	Barral, Aldina/B-4191-2009; Borges, Valeria/G-2009-2014; Wanderley, Joao Luiz/J-6711-2014; Borges, Val/N-6647-2019	Barral, Aldina/0000-0002-7177-464X; Borges, Val/0000-0002-2775-5409	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ; National Institutes of Health [AI043003]; CAPES; CNPq; Programa de Cooperacao INCA/FIOCRUZ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043003, R56AI043003] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Cooperacao INCA/FIOCRUZ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) e PAPES V-FIOCRUZ (V. Borges), Programa de Cooperacao INCA/FIOCRUZ (M. Barcinski and A. Barral) and by National Institutes of Health grant AI043003 (L. Soong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Manoel Barral-Netto, Dr. Ana Cristina Rodrigues Saldanha, Dr. Roque Almeida and Dr. Camila Indiani de Oliveira for helpful discussions. We thank Fernanda Lourenco for helpful technical assistance, Mr. Theo Araujo dos Santos for assistance with the image processing, and Ms. Mardelle Susman for proofreading. JFC is recipient of a CAPES fellowship and JLMW is recipient of a CNPq fellowship. VMB, AB, JC and MAB are senior investigators from CNPq.	AKUFFO JH, 1987, SCAND J IMMUNOL, V26, P717, DOI 10.1111/j.1365-3083.1987.tb02308.x; Almeida RP, 1996, AM J TROP MED HYG, V54, P178, DOI 10.4269/ajtmh.1996.54.178; Balanco JMD, 2001, CURR BIOL, V11, P1870, DOI 10.1016/S0960-9822(01)00563-2; Balestieri FMP, 2002, MICROBES INFECT, V4, P23, DOI 10.1016/S1286-4579(01)01505-2; BARCINSKI MA, 1992, INFECT IMMUN, V60, P3523, DOI 10.1128/IAI.60.9.3523-3527.1992; BENCHIMOL M, 1981, Z PARASITENKD, V66, P25, DOI 10.1007/BF00941942; Bomfim G, 1996, EXP PARASITOL, V84, P188, DOI 10.1006/expr.1996.0104; CARVALHO EM, 1994, ACTA TROP, V56, P315, DOI 10.1016/0001-706X(94)90103-1; CONVIT J, 1972, T ROY SOC TROP MED H, V66, P603, DOI 10.1016/0035-9203(72)90306-9; CONVIT J, 1993, T ROY SOC TROP MED H, V87, P444, DOI 10.1016/0035-9203(93)90030-T; Courret N, 2002, J CELL SCI, V115, P2303; CUPOLILLO E, 1994, AM J TROP MED HYG, V50, P296, DOI 10.4269/ajtmh.1994.50.296; DaMatta RA, 2007, FEMS MICROBIOL LETT, V266, P29, DOI 10.1111/j.1574-6968.2006.00495.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Giudice A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-7; Kawakami K, 1997, INFECT IMMUN, V65, P1307, DOI 10.1128/IAI.65.4.1307-1312.1997; LEAO SD, 1995, J CELL SCI, V108, P3219; McMahon-Pratt D, 2004, IMMUNOL REV, V201, P206, DOI 10.1111/j.0105-2896.2004.00190.x; Wanderley JLM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005733; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; Sanabria MXH, 2008, INFECT IMMUN, V76, P5100, DOI 10.1128/IAI.00438-08; Saraiva EM, 2005, EXP PARASITOL, V110, P39, DOI 10.1016/j.exppara.2005.01.004; SARAIVA EMB, 1983, J PARASITOL, V69, P627, DOI 10.2307/3281388; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Wanderley JLM, 2006, J IMMUNOL, V176, P1834, DOI 10.4049/jimmunol.176.3.1834; Wilson J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000179; Xin LJ, 2008, MOL IMMUNOL, V45, P3371, DOI 10.1016/j.molimm.2008.04.018; Xin LJ, 2007, INFECT IMMUN, V75, P5018, DOI 10.1128/IAI.00499-07	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36595	10.1371/journal.pone.0036595	http://dx.doi.org/10.1371/journal.pone.0036595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574191	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800088
J	Koch, E; Thorp, J; Bravo, M; Gatica, S; Romero, CX; Aguilera, H; Ahlers, I				Koch, Elard; Thorp, John; Bravo, Miguel; Gatica, Sebastian; Romero, Camila X.; Aguilera, Hernan; Ahlers, Ivonne			Women's Education Level, Maternal Health Facilities, Abortion Legislation and Maternal Deaths: A Natural Experiment in Chile from 1957 to 2007	PLOS ONE			English	Article							PAUPER-RICH PARADOX; FERTILITY DECLINE; MORTALITY; BIRTH; TIME; CARE; CONCEPTION; PREGNANCY; SURVIVAL; TRENDS	Background: The aim of this study was to assess the main factors related to maternal mortality reduction in large time series available in Chile in context of the United Nations' Millennium Development Goals (MDGs). Methods: Time series of maternal mortality ratio (MMR) from official data (National Institute of Statistics, 1957-2007) along with parallel time series of education years, income per capita, fertility rate (TFR), birth order, clean water, sanitary sewer, and delivery by skilled attendants were analysed using autoregressive models (ARIMA). Historical changes on the mortality trend including the effect of different educational and maternal health policies implemented in 1965, and legislation that prohibited abortion in 1989 were assessed utilizing segmented regression techniques. Results: During the 50-year study period, the MMR decreased from 293.7 to 18.2/100,000 live births, a decrease of 93.8%. Women's education level modulated the effects of TFR, birth order, delivery by skilled attendants, clean water, and sanitary sewer access. In the fully adjusted model, for every additional year of maternal education there was a corresponding decrease in the MMR of 29.3/100,000 live births. A rapid phase of decline between 1965 and 1981 (-13.29/100,000 live births each year) and a slow phase between 1981 and 2007 (-1.59/100,000 live births each year) were identified. After abortion was prohibited, the MMR decreased from 41.3 to 12.7 per 100,000 live births (-69.2%). The slope of the MMR did not appear to be altered by the change in abortion law. Conclusion: Increasing education level appears to favourably impact the downward trend in the MMR, modulating other key factors such as access and utilization of maternal health facilities, changes in women's reproductive behaviour and improvements of the sanitary system. Consequently, different MDGs can act synergistically to improve maternal health. The reduction in the MMR is not related to the legal status of abortion.	[Koch, Elard; Bravo, Miguel; Gatica, Sebastian] Univ Catolica Santisima Concepcion, Fac Med, Ctr Embryon Med & Maternal Hlth, Inst Mol Epidemiol MELISA, Concepcion, Chile; [Koch, Elard; Romero, Camila X.; Aguilera, Hernan; Ahlers, Ivonne] Univ Chile, Fac Med, Dept Primary Care & Family Med, Santiago 7, Chile; [Koch, Elard] Univ Chile, Fac Med, Sch Publ Hlth, Div Epidemiol,Doctoral Program, Santiago 7, Chile; [Thorp, John] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA	Universidad Catolica de la Santisima Concepcion; Universidad de Chile; Universidad de Chile; University of North Carolina; University of North Carolina Chapel Hill	Koch, E (corresponding author), Univ Catolica Santisima Concepcion, Fac Med, Ctr Embryon Med & Maternal Hlth, Inst Mol Epidemiol MELISA, Concepcion, Chile.	elardkoch@gmail.com	Gatica, Sebastián/F-5669-2012	Gatica, Sebastián/0000-0003-1652-5314; Bravo, Miguel/0000-0002-5244-1751	University of North Carolina Center for Women's Health Research [UNC102010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	University of North Carolina Center for Women's Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a research grant UNC102010 by the University of North Carolina Center for Women's Health Research (http://cwhr.unc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2001, B WORLD HEALTH ORGAN, V79, P561; Abraha Mulu W, 2009, Health Res Policy Syst, V7, P29, DOI 10.1186/1478-4505-7-29; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; [Anonymous], 2008, CUADR; [Anonymous], 2012, RAZ MORTAL MAT DEF; [Anonymous], 2010, MAT MORT RAT ITS CAU; [Anonymous], 2008, INF BAS 2008; [Anonymous], CONS INT DAT EST NAT; [Anonymous], 2008, CUADR; [Anonymous], TABL 102 0535 DEATHS; ARMIJO R, 1965, MILBANK FUND Q, V43, P263, DOI 10.2307/3348925; Backlund E, 1999, SOC SCI MED, V49, P1373, DOI 10.1016/S0277-9536(99)00209-9; Banco Central de Chile, 2001, IND EC SOC CHIL 1960; Berer M, 2000, B WORLD HEALTH ORGAN, V78, P580; Bewley S, 2012, LANCET, V379, P1198, DOI 10.1016/S0140-6736(12)60511-X; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Braun-Llona J, 1998, 187 PUC EC I; Castaneda T, 1985, Cuad Econ, V22, P195; Chamy P Verónica, 2009, Rev. chil. obstet. ginecol., V74, P331; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Cook RJ, 2000, ANN NY ACAD SCI, V913, P74; Culwell KR, 2010, INT J GYNECOL OBSTET, V110, pS13, DOI 10.1016/j.ijgo.2010.04.003; Donoso S. Enrique, 2002, Rev. chil. obstet. ginecol., V67, P139; Donoso S Enrique, 2008, Rev. chil. obstet. ginecol., V73, P359, DOI 10.4067/S0717-75262008000600001; Donoso S. Enrique, 2005, Rev. chil. obstet. ginecol., V70, P79; Donoso S Enrique, 2006, Rev. chil. obstet. ginecol., V71, P246; Donoso SE, 2003, REV MED CHILE, V131, P55; Donoso Sina Enrique, 2004, Rev Panam Salud Publica, V15, P326, DOI 10.1590/S1020-49892004000500007; Feldstein AC, 2006, ARCH INTERN MED, V166, P1009, DOI 10.1001/archinte.166.9.1009; Fredrick B, 2007, LANCET, V370, P1295, DOI 10.1016/S0140-6736(07)61556-6; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; GILLINGS D, 1981, AM J PUBLIC HEALTH, V71, P38, DOI 10.2105/AJPH.71.1.38; Gonzalez R, 2009, AM J PUBLIC HEALTH, V99, P1220, DOI 10.2105/AJPH.2008.143578; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Huneeus Carlos, 2002, Historia (Santiago), V35, P151; INE, 2011, EST VIT INF AN 2009; Instituto Nacional de Estadistica (INE), 2009, EST VIT INF AN 2007; Instituto Nacional de Estadistica (INE), 2010, EST VIT INF AN 2008; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Jain AK, 2011, STUD FAMILY PLANN, V42, P247, DOI 10.1111/j.1728-4465.2011.00288.x; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Karlsen S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-606; Koch E, 2005, J EPIDEMIOL COMMUN H, V59, P1000, DOI 10.1136/jech.2004.031633; Koch E, 2010, PUBLIC HEALTH, V124, P39, DOI 10.1016/j.puhe.2009.11.008; Koch E, 2012, GINECOL OBS IN PRESS; Koch E, 2010, ANN EPIDEMIOL, V20, P487, DOI 10.1016/j.annepidem.2010.03.009; Kulczycki A, 2011, STUD FAMILY PLANN, V42, P199, DOI 10.1111/j.1728-4465.2011.00282.x; Leridon H, 2006, HUM REPROD UPDATE, V12, P603, DOI 10.1093/humupd/dml025; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Fernandez MAL, 2009, J EPIDEMIOL COMMUN H, V63, P433, DOI 10.1136/jech.2008.082735; Lynch CD, 2006, PAEDIATR PERINAT EP, V20, P3, DOI 10.1111/j.1365-3016.2006.00765.x; Martin JA, 2010, NATL VITAL STAT REPO; Mbonye Anthony K, 2010, Int J Adolesc Med Health, V22, P249, DOI 10.1515/IJAMH.2010.22.2.249; McAlister C, 2006, J OBSTET GYNAECOL CA, V28, P983, DOI 10.1016/S1701-2163(16)32294-0; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; Mhyre JM, 2012, CURR OPIN ANAESTHESI; Minino A. M., 2011, NATL VITAL STAT REPO; Ministerio de SaludGobiernodeChile, 2007, SEG ENC NAC CAL VID; MONCKEBERG F, 1987, NUTR RES, V7, P327, DOI 10.1016/S0271-5317(87)80022-2; Monckeberg F, 1978, Adv Exp Med Biol, V105, P11; Nabukera S, 2006, J REPROD MED, V51, P676; Nunez ML, 2006, REV MED CHILE, V134, P1191; Pan American Health Organization, 2009, HLTH INF AN PROJ; Robinson JJA, 2001, J ADV NURS, V34, P445, DOI 10.1046/j.1365-2648.2001.01773.x; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosenfield A, 2008, NEW ENGL J MED, V359, P1869, DOI 10.1056/NEJMp0806807; Rosenfield A, 2007, NEW ENGL J MED, V356, P1395, DOI 10.1056/NEJMp078026; Ross L, 2005, J PUBLIC HEALTH, V27, P331, DOI 10.1093/pubmed/fdi058; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Seoud MAF, 2002, AM J PERINAT, V19, P1, DOI 10.1055/s-2002-20175; Shah I, 2009, J OBSTET GYNAECOL CA, V31, P1149, DOI 10.1016/S1701-2163(16)34376-6; Shah QH, 2007, REPROD HEALTH MATTER, V15, P17, DOI 10.1016/S0968-8080(07)30339-X; Shen C, 1999, SOC SCI MED, V49, P197, DOI 10.1016/S0277-9536(99)00112-4; Shepard BL, 2007, REPROD HEALTH MATTER, V15, P202, DOI 10.1016/S0968-8080(07)30328-5; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh K, 1998, INT J GYNECOL OBSTET, V63, pS123, DOI 10.1016/S0020-7292(98)00194-5; Singh-Manoux A, 2005, INT J EPIDEMIOL, V34, P638, DOI 10.1093/ije/dyi074; Smith DH, 2006, ARCH INTERN MED, V166, P1098, DOI 10.1001/archinte.166.10.1098; Stanton C, 2007, J BIOSOC SCI, V39, P109, DOI 10.1017/S0021932006001271; Szot M Jorge, 2003, Rev. chil. obstet. ginecol., V68, P309; Vahidnia F, 2007, POPUL ENVIRON, V28, P259, DOI 10.1007/s11111-007-0050-9; VIEL B, 1969, AM J PUBLIC HEALTH N, V59, P1898, DOI 10.2105/AJPH.59.10.1898; Viel B, 1987, Perspect Int Planif Fam, P24; Wang XB, 2003, FERTIL STERIL, V79, P577, DOI 10.1016/S0015-0282(02)04694-0; West SG, 2010, PSYCHOL METHODS, V15, P18, DOI 10.1037/a0015917; WHO, 2010, TRENDS MAT MORT 1990; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; World Health Organization, 2003, SAF AB TECHN POL GUI; World Health Organization Department of Reproductive Health and Research, 2007, UNS AB GLOB REG EST; Yazbeck AS, 2007, LANCET, V370, P1291, DOI 10.1016/S0140-6736(07)61553-0; Ziadeh SM, 2002, GYNECOL OBSTET INVES, V54, P6, DOI 10.1159/000064689	96	44	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36613	10.1371/journal.pone.0036613	http://dx.doi.org/10.1371/journal.pone.0036613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574194	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800091
J	Li, L; Lu, JR; Tao, Z; Huang, Q; Chai, YC; Li, XH; Huang, ZW; Li, Y; Xiang, ML; Yang, J; Yao, GY; Wang, Y; Yang, T; Wu, H				Li, Lei; Lu, Jingrong; Tao, Zheng; Huang, Qi; Chai, Yongchuan; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yao, Guoyin; Wang, Yu; Yang, Tao; Wu, Hao			The p.V37I Exclusive Genotype Of GJB2: A Genetic Risk-Indicator of Postnatal Permanent Childhood Hearing Impairment	PLOS ONE			English	Article							CONNEXIN-26 MUTATIONS; HIGH PREVALENCE; CHILDREN; DEAFNESS; INTERVENTION; IDENTIFY; LANGUAGE	Postnatal permanent childhood hearing impairment (PCHI) is frequent (0.25%-0.99%) and difficult to detect in the early stage, which may impede the speech, language and cognitive development of affected children. Genetic tests of common variants associated with postnatal PCHI in newborns may provide an efficient way to identify those at risk. In this study, we detected a strong association of the p.V37I exclusive genotype of GJB2 with postnatal PCHI in Chinese Hans (P = 1.4x10(-10); OR 62.92, 95% CI 21.27-186.12). This common genotype in Eastern Asians was present in a substantial percentage (20%) of postnatal PCHI subjects, and its prevalence was significantly increased in normal-hearing newborns who failed at least one newborn hearing screen. Our results indicated that the p.V37I exclusive genotype of GJB2 may cause subclinical hearing impairment at birth and increases risk for postnatal PCHI. Genetic testing of GJB2 in East Asian newborns will facilitate prompt detection and intervention of postnatal PCHI.	[Li, Lei; Lu, Jingrong; Huang, Qi; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Li, Lei; Lu, Jingrong; Tao, Zheng; Huang, Qi; Chai, Yongchuan; Li, Xiaohua; Huang, Zhiwu; Li, Yun; Xiang, Mingliang; Yang, Jun; Yang, Tao; Wu, Hao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China; [Tao, Zheng] Shanghai Childrens Med Ctr, Shanghai, Peoples R China; [Yao, Guoyin; Wang, Yu] Shanghai Child Hlth Care Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	yangtfxl@sina.com; wuhao@shsmu.edu.cn		Yang, Tao/0000-0001-6011-987X	National Basic Research Program of China [2011CB504501]; Shanghai Municipal Science and Technology Commission [08DZ1980100, 09DJ1400604, 11PJ1407000]; National Science Foundation of China [30971596]; "Shu Guang" project [09SG19]; Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation; Shanghai Jiaotong University School of Medicine [BXJ201121]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Shu Guang" project(Chinese Academy of Sciences); Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation; Shanghai Jiaotong University School of Medicine	This research was supported by a grant from National Basic Research Program of China 2011CB504501 (HW); grants from Shanghai Municipal Science and Technology Commission 08DZ1980100 (HW), 09DJ1400604 and 11PJ1407000 (TY); a grant from National Science Foundation of China 30971596 (TY); "Shu Guang" project 09SG19 and Oriental Scholar project from Shanghai Municipal Education Commission and Shanghai Education Development Foundation (TY); and a grant from Shanghai Jiaotong University School of Medicine BXJ201121 (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Chan DK, 2010, GENET MED, V12, P174, DOI 10.1097/GIM.0b013e3181d0d42b; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Downs MP, 1999, PEDIATR CLIN N AM, V46, P79, DOI 10.1016/S0031-3955(05)70082-1; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Fortnum HM, 2001, BRIT MED J, V323, P536, DOI 10.1136/bmj.323.7312.536; Green GE, 2000, JAMA-J AM MED ASSOC, V284, P1245, DOI 10.1001/jama.284.10.1245; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Han SH, 2008, J HUM GENET, V53, P1022, DOI 10.1007/s10038-008-0342-7; Lu JR, 2011, INT J PEDIATR OTORHI, V75, P1045, DOI 10.1016/j.ijporl.2011.05.022; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Norris VW, 2006, EAR HEARING, V27, P732, DOI 10.1097/01.aud.0000240492.78561.d3; Oguchi T, 2005, J HUM GENET, V50, P76, DOI 10.1007/s10038-004-0223-7; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Sun Xiaoming, 2009, World Health Popul, V11, P14; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Weichbold V, 2006, PEDIATRICS, V117, pE631, DOI 10.1542/peds.2005-1455; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	21	29	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36621	10.1371/journal.pone.0036621	http://dx.doi.org/10.1371/journal.pone.0036621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574200	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800097
J	Chakraborty, K; Zhou, ZH; Wakamatsu, N; Guerrero-Plata, A				Chakraborty, Krishnendu; Zhou, Zehua; Wakamatsu, Nobuko; Guerrero-Plata, Antonieta			Interleukin-12p40 Modulates Human Metapneumovirus-Induced Pulmonary Disease in an Acute Mouse Model of Infection	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IL-12 P40 HOMODIMER; IN-VITRO; GENE-EXPRESSION; IFN-GAMMA; AIRWAY HYPERRESPONSIVENESS; MYCOBACTERIUM-TUBERCULOSIS; MONOCYTIC CELLS; INTERFERON; CHILDREN	The mechanisms that regulate the host immune response induced by human metapneumovirus (hMPV), a newly-recognized member of the Paramyxoviridae family, are largely unknown. Cytokines play an important role in modulating inflammatory responses during viral infections. IL-12p40, a known important mediator in limiting lung inflammation, is induced by hMPV and its production is sustained after the resolution phase of infection suggesting that this cytokine plays a role in the immune response against hMPV. In this work, we demonstrated that in mice deficient in IL-12p40, hMPV infection induced an exacerbated pulmonary inflammatory response and mucus production, altered cytokine response, and decreased lung function. However, hMPV infection in these mice does not have an effect on viral replication. These results identify an important regulatory role of IL-12p40 in hMPV infection.	[Chakraborty, Krishnendu; Zhou, Zehua; Wakamatsu, Nobuko; Guerrero-Plata, Antonieta] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Guerrero-Plata, Antonieta] Louisiana State Univ, Ctr Expt Infect Dis Res, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Chakraborty, K (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	aguerrp@lsu.edu			National Institute of Allergy and Infectious Diseases [1R03AI08117]; National Center for Research Resources [5P20RR020159-09]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103458-09]; Louisiana State University-Competitive Research Program [LAV-3016]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI081171, F32AI008117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103458] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Louisiana State University-Competitive Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work was supported by Grants from the National Institute of Allergy and Infectious Diseases 1R03AI08117, the National Center for Research Resources 5P20RR020159-09, and the National Institute of General Medical Sciences 8 P20 GM103458-09 from the National Institutes of Health and the Louisiana State University-Competitive Research Program Award LAV-3016 (AG-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi K, 2002, SCAND J IMMUNOL, V56, P1, DOI 10.1046/j.1365-3083.2002.01101.x; AFFORD SC, 1992, J BIOL CHEM, V267, P21612; Alimam MZ, 2000, AM J RESP CELL MOL, V22, P253, DOI 10.1165/ajrcmb.22.3.3768; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; BIONDILLO DE, 1994, AM J PHYSIOL-LUNG C, V267, pL564, DOI 10.1152/ajplung.1994.267.5.L564; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; BOSCO MC, 1994, BLOOD, V83, P537; CASSATELLA MA, 1993, IMMUNOLOGY, V78, P177; Ehl S, 2004, EUR J IMMUNOL, V34, P1146, DOI 10.1002/eji.200324449; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Falsey AR, 2008, PEDIATR INFECT DIS J, V27, pS80, DOI 10.1097/INF.0b013e3181684dac; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Gately MK, 1996, ANN NY ACAD SCI, V795, P1, DOI 10.1111/j.1749-6632.1996.tb52650.x; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Guerrero-Plata A, 2005, J VIROL, V79, P10190, DOI 10.1128/JVI.79.16.10190-10199.2005; Guerrero-Plata A, 2005, J VIROL, V79, P14992, DOI 10.1128/JVI.79.23.14992-14997.2005; Guerrero-Plata A, 2009, J IMMUNOL, V182, P3072, DOI 10.4049/jimmunol.0802262; GUSELLA GL, 1993, J IMMUNOL, V151, P2725; Gutierrez JG, 2008, INFLAMM RES, V57, P504, DOI 10.1007/s00011-008-7162-2; Ha SJ, 1999, J IMMUNOL, V163, P2902; Haeberle HA, 2001, J VIROL, V75, P878, DOI 10.1128/JVI.75.2.878-890.2001; Hamelin ME, 2006, J INFECT DIS, V193, P1634, DOI 10.1086/504262; Honda H, 2006, J AM GERIATR SOC, V54, P177, DOI 10.1111/j.1532-5415.2005.00575_10.x; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kahn JS, 2003, PEDIATR INFECT DIS J, V22, P923, DOI 10.1097/01.inf.0000091347.27554.ff; Kalinski P, 2001, BLOOD, V97, P3466, DOI 10.1182/blood.V97.11.3466; Khader SA, 2006, J EXP MED, V203, P1805, DOI 10.1084/jem.20052545; Kinjo Y, 2002, J IMMUNOL, V169, P323, DOI 10.4049/jimmunol.169.1.323; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kolli D, 2008, J VIROL, V82, P8560, DOI 10.1128/JVI.00699-08; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Leung J, 2005, J CLIN MICROBIOL, V43, P1213, DOI 10.1128/JCM.43.3.1213-1219.2005; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Mikols CL, 2006, AM J RESP CRIT CARE, V174, P461, DOI 10.1164/rccm.200512-1886OC; Miyamasu M, 1999, INT IMMUNOL, V11, P1001, DOI 10.1093/intimm/11.6.1001; MULLER G, 1994, J CLIN INVEST, V94, P1799, DOI 10.1172/JCI117528; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Onari Y, 2009, CLIN EXP ALLERGY, V39, P290, DOI 10.1111/j.1365-2222.2008.03131.x; Reid CJ, 1997, AM J RESP CELL MOL, V17, P592, DOI 10.1165/ajrcmb.17.5.2798; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; SANCEAU J, 1992, J IMMUNOL, V149, P1671; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shtrichman R, 2001, CURR OPIN MICROBIOL, V4, P251, DOI 10.1016/S1369-5274(00)00199-5; Stack AM, 2000, VACCINE, V18, P1412, DOI 10.1016/S0264-410X(99)00399-0; Tekkanat KK, 2001, AM J PATHOL, V159, P631, DOI 10.1016/S0002-9440(10)61734-8; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Walter MJ, 2001, J EXP MED, V193, P339, DOI 10.1084/jem.193.3.339; Wang SZ, 2004, J IMMUNOL, V173, P4040, DOI 10.4049/jimmunol.173.6.4040; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Young HWJ, 2007, AM J RESP CELL MOL, V37, P273, DOI 10.1165/rcmb.2005-0460OC; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	60	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37173	10.1371/journal.pone.0037173	http://dx.doi.org/10.1371/journal.pone.0037173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606349	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400075
J	Illoldi-Rangel, P; Ciarleglio, M; Sheinvar, L; Linaje, M; Sanchez-Cordero, V; Sarkar, S				Illoldi-Rangel, Patricia; Ciarleglio, Michael; Sheinvar, Leia; Linaje, Miguel; Sanchez-Cordero, Victor; Sarkar, Sahotra			Opuntia in Mexico: Identifying Priority Areas for Conserving Biodiversity in a Multi-Use Landscape	PLOS ONE			English	Article							INCORPORATING MULTIPLE CRITERIA; RESERVE SITE SELECTION; PLACE PRIORITIZATION; SPECIES DISTRIBUTIONS; CONSERVATION; CACTACEAE; NETWORKS; SOFTWARE; REPRESENTATION; CONNECTIVITY	Background: Mexico is one of the world's centers of species diversity (richness) for Opuntia cacti. Yet, in spite of their economic and ecological importance, Opuntia species remain poorly studied and protected in Mexico. Many of the species are sparsely but widely distributed across the landscape and are subject to a variety of human uses, so devising implementable conservation plans for them presents formidable difficulties. Multi-criteria analysis can be used to design a spatially coherent conservation area network while permitting sustainable human usage. Methods and Findings: Species distribution models were created for 60 Opuntia species using MaxEnt. Targets of representation within conservation area networks were assigned at 100% for the geographically rarest species and 10% for the most common ones. Three different conservation plans were developed to represent the species within these networks using total area, shape, and connectivity as relevant criteria. Multi-criteria analysis and a metaheuristic adaptive tabu search algorithm were used to search for optimal solutions. The plans were built on the existing protected areas of Mexico and prioritized additional areas for management for the persistence of Opuntia species. All plans required around one-third of Mexico's total area to be prioritized for attention for Opuntia conservation, underscoring the implausibility of Opuntia conservation through traditional land reservation. Tabu search turned out to be both computationally tractable and easily implementable for search problems of this kind. Conclusions: Opuntia conservation in Mexico require the management of large areas of land for multiple uses. The multi-criteria analyses identified priority areas and organized them in large contiguous blocks that can be effectively managed. A high level of connectivity was established among the prioritized areas resulting in the enhancement of possible modes of plant dispersal as well as only a small number of blocks that would be recommended for conservation management.	[Illoldi-Rangel, Patricia; Ciarleglio, Michael; Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Biodivers & Biocultural Conservat Lab, Austin, TX 78712 USA; [Sheinvar, Leia] Univ Nacl Autonoma Mexico, Inst Biol, Jardin Bot Exterior, Mexico City 04510, DF, Mexico; [Linaje, Miguel; Sanchez-Cordero, Victor] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Sistemas Informac Geog, Mexico City 04510, DF, Mexico; [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Texas System; University of Texas Austin	Illoldi-Rangel, P (corresponding author), Univ Texas Austin, Sect Integrat Biol, Biodivers & Biocultural Conservat Lab, Austin, TX 78712 USA.	patz30@gmail.com			(Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO) [GE005]; CONACyT [51562/25048]	(Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Database development was supported by a project of the (Mexican) Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO, Project No.GE005). PIR was supported by a post-doctoral grant from CONACyT (Project No. 51562/25048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P449, DOI 10.1016/B978-0-12-373631-4.00017-4; Al E., 2009, CAPITAL NATURAL MEXI, VII, P651; Arrow KJ, 1986, SOCIAL CHOICE MULTIC; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ball IR, 1996, THESIS U ADELAIDE; Battiti R., 1994, ORSA Journal on Computing, V6, P126, DOI 10.1287/ijoc.6.2.126; Belton V, 1986, EUR J OPER RES, V26, P721; Bravo HH, 1995, INTERESANTE MUNDO CA; Camm JD, 2002, OPER RES, V50, P946, DOI 10.1287/opre.50.6.946.351; Camm JD, 2002, BIOL CONSERV, V78; Cerdeira JO, 2005, J COMB OPTIM, V9, P35, DOI 10.1007/s10878-005-5482-5; Chavez-Moreno CK, 2009, BIODIVERS CONSERV, V18, P3337, DOI 10.1007/s10531-009-9647-x; Ciarleglio M, 2008, THESIS U TEXAS AUSTI; Ciarleglio M, 2010, J HEURISTICS, V16, P537, DOI 10.1007/s10732-008-9098-7; Ciarleglio M, 2009, ECOGRAPHY, V32, P205, DOI 10.1111/j.1600-0587.2008.05721.x; Conservation International, 2010, OPT CONS PROD COLL C; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; DASKIN MS, 1983, TRANSPORT SCI, V17, P48, DOI 10.1287/trsc.17.1.48; Dell'Amico M., 1993, Annals of Operations Research, V41, P231, DOI 10.1007/BF02023076; Dowie M., 2009, CONSERVATION REFUGEE, DOI [DOI 10.1080/09614520903564298, DOI 10.7551/MITPRESS/7532.001.0001]; Dyer J, 1990, MANAGE SCI, V36; DYER JS, 1979, OPER RES, V27, P810, DOI 10.1287/opre.27.4.810; Edwards W, 2007, ADV DECISION THEORY; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Faith D. P, 1995, BIODIVERSITY REGIONA; Figuera J., 2005, MULTIPLE CRITERIA DE; Figueroa F., 2010, ENVIRON CONSERV, V36, P180; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; Glover F, 1997, SEARCH; Gomez-Hinostrosa C, 2000, BIODIVERS CONSERV, V9, P403, DOI 10.1023/A:1008935710910; Griffith MP, 2004, AM J BOT, V91, P1915, DOI 10.3732/ajb.91.11.1915; Hernandez H, 1994, ACTA BOTANICA MEXICA, V26, P33, DOI DOI 10.21829/abm26.1994.690; Hernandez HM, 2001, BIODIVERS CONSERV, V10, P1097, DOI 10.1023/A:1016606216041; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffman K, 2001, ENCY OPTIMIZATION; Justus J, 2008, CONSERV BIOL, V22, P673, DOI 10.1111/j.1523-1739.2008.00928.x; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Kelley C, 2002, DIVERS DISTRIB, V8, P297, DOI 10.1046/j.1472-4642.2002.00155.x; Kincaid RK, 2008, COMPUT OPER RES, V35, P499, DOI 10.1016/j.cor.2006.03.013; Mandujano MD, 1997, J ARID ENVIRON, V36, P259, DOI 10.1006/jare.1996.0210; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moffett A, 2006, DIVERS DISTRIB, V12, P125, DOI 10.1111/j.1366-9516.2005.00202.x; Moffett A, 2006, BIOL CONSERV, V129, P181, DOI 10.1016/j.biocon.2005.10.033; Moffett A, 2005, ENVIRON MODELL SOFTW, V20, P1315, DOI 10.1016/j.envsoft.2004.10.001; Moilanen A., 2009, SPATIAL CONSERVATION; Montiel S, 2000, PLANT ECOL, V146, P221; Norton Bryan G., 1987, WHY PRESERVE NATURAL; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pressey RL, 1996, BIOL CONSERV, V76, P259, DOI 10.1016/0006-3207(95)00120-4; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; Rebman JP, 2001, FLA ENTOMOL, V84, P474, DOI 10.2307/3496374; Resnik MD., 1987, CHOICES INTRO DECISI; Rodrigues ASL, 2002, BIOL CONSERV, V107, P123, DOI 10.1016/S0006-3207(02)00042-3; Rothley KD, 1999, ECOL APPL, V9, P741, DOI 10.1890/1051-0761(1999)009[0741:DBNTSM]2.0.CO;2; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; Saaty TL., 1980, ANAL HIERARCHY PROCE; Sarkar S, 2004, DIVERS DISTRIB, V10, P125, DOI 10.1111/j.1366-9516.2004.00060.x; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Sarkar S, 2002, J BIOSCIENCES, V27, P339, DOI 10.1007/BF02704964; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sarkar S, 2003, CONSERV SOC, V1, pv; Sarkar S, 2004, CONSERV SOC, V2, P433; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Sarkar S, 2009, BIODIVERS CONSERV, V18, P1793, DOI 10.1007/s10531-008-9559-1; Scheinvar L., 1995, FAO Plant Production and Protection Paper, P20; Sober E., 1986, P173; Soberon J, 2001, FLA ENTOMOL, V84, P486, DOI 10.2307/3496376; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Szekely Alberto, 2005, P87; Valdez CAF, 1997, J PROF ASSOC CACTUS, V2, P3; Vermuganti RR, 1998, HDB COMBINATORIAL OP, V1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	79	12	16	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36650	10.1371/journal.pone.0036650	http://dx.doi.org/10.1371/journal.pone.0036650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606279	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339400028
J	Kiefer, C; Koch, MA				Kiefer, Christiane; Koch, Marcus A.			A Continental-Wide Perspective: The Genepool of Nuclear Encoded Ribosomal DNA and Single-Copy Gene Sequences in North American Boechera (Brassicaceae)	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MOLECULAR SYSTEMATICS; PHYLOGENETIC UTILITY; ARABIS-DRUMMONDII; PHYLOGEOGRAPHY; EVOLUTION; CONSEQUENCES; REPRODUCTION; ARABIDOPSIS; HYBRIDIZATION	74 of the currently accepted 111 taxa of the North American genus Boechera (Brassicaceae) were subject to pyhlogenetic reconstruction and network analysis. The dataset comprised 911 accessions for which ITS sequences were analyzed. Phylogenetic analyses yielded largely unresolved trees. Together with the network analysis confirming this result this can be interpreted as an indication for multiple, independent, and rapid diversification events. Network analyses were superimposed with datasets describing i) geographical distribution, ii) taxonomy, iii) reproductive mode, and iv) distribution history based on phylogeographic evidence. Our results provide first direct evidence for enormous reticulate evolution in the entire genus and give further insights into the evolutionary history of this complex genus on a continental scale. In addition two novel single-copy gene markers, orthologues of the Arabidopsis thaliana genes At2g25920 and At3g18900, were analyzed for subsets of taxa and confirmed the findings obtained through the ITS data.	[Kiefer, Christiane] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Koch, Marcus A.] Heidelberg Univ, Dept Biodivers & Plant Systemat, Ctr Organismal Studies Heidelberg, Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Kiefer, C (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany.	marcus.koch@cos.uni-heidelberg.de	Koch, Marcus A/A-4924-2011	Koch, Marcus A/0000-0002-1693-6829	German Research Foundation (DFG) [KO2302/4.1, KO2302/4.2]	German Research Foundation (DFG)(German Research Foundation (DFG))	The project was funded by the German Research Foundation (DFG KO2302/4.1 and KO2302/4.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Al-Shehbaz IA, 2003, NOVON, V13, P381, DOI 10.2307/3393366; Al-Shehbaz Ihsan A., 2007, Harvard Papers in Botany, V12, P425, DOI 10.3100/1043-4534(2007)12[425:TNAGSB]2.0.CO;2; Aliyu OM, 2010, AM J BOT, V97, P1719, DOI 10.3732/ajb.1000188; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Anderson JT, 2011, EVOLUTION, V65, P771, DOI 10.1111/j.1558-5646.2010.01175.x; Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Bailey CD, 2002, SYST BOT, V27, P318; Beilstein MA, 2008, AM J BOT, V95, P1307, DOI 10.3732/ajb.0800065; Buckler ES, 1997, GENETICS, V145, P821; Calonje M, 2009, PLANT SYST EVOL, V282, P257, DOI 10.1007/s00606-008-0031-1; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dobes C, 2004, AM J BOT, V91, P2087, DOI 10.3732/ajb.91.12.2087; Dobes CH, 2004, MOL ECOL, V13, P349, DOI 10.1046/j.1365-294X.2003.02064.x; Dobes C, 2006, ANN MO BOT GARD, V93, P517, DOI 10.3417/0026-6493(2007)93[517:EKAMOR]2.0.CO;2; Doyle J. J., 1987, PHYTOCHEM B, P11; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Horandl E, 2009, ANN BOT-LONDON, V104, P81, DOI 10.1093/aob/mcp093; Hornemann JW, 1827, FLORA DANICA, V11, P1879; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Janssens S, 2007, MOL PHYLOGENET EVOL, V43, P225, DOI 10.1016/j.ympev.2006.11.016; Jordon-Thaden I, 2008, PLANT ECOL DIVERS, V1, P255, DOI 10.1080/17550870802349112; Jordon-Thaden I, 2010, MOL PHYLOGENET EVOL, V55, P524, DOI 10.1016/j.ympev.2010.02.012; Kantama L, 2007, P NATL ACAD SCI USA, V104, P14026, DOI 10.1073/pnas.0706647104; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kiefer C, 2009, TAXON, V58, P1109, DOI 10.1002/tax.584005; Kiefer C, 2009, MOL PHYLOGENET EVOL, V52, P303, DOI 10.1016/j.ympev.2009.03.016; Koch M, 1999, PLANT BIOLOGY, V1, P529, DOI 10.1055/s-2007-978548; Koch M, 2002, ANN MO BOT GARD, V89, P88, DOI 10.2307/3298659; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2006, MOL ECOL, V15, P825, DOI 10.1111/j.1365-294X.2005.02848.x; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Koch MA, 2009, BIOL BREEDING CRUCIF; Koch MA, 2010, AM J BOT, V97, P1040, DOI 10.3732/ajb.0900366; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Love A, 1976, BOT NOTISER, V128, P513; Lovell JT, 2011, MOL ECOL, V20, P4840, DOI 10.1111/j.1365-294X.2011.05346.x; Ludena B, 2011, ANN BOT-LONDON, V108, P1433, DOI 10.1093/aob/mcr191; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Muir G, 2001, MOL BIOL EVOL, V18, P112, DOI 10.1093/oxfordjournals.molbev.a003785; Mummenhoff K, 1997, CAN J BOT, V75, P469, DOI 10.1139/b97-051; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oh SH, 2005, AM J BOT, V92, P179, DOI 10.3732/ajb.92.1.179; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pleines T, 2009, PLANT SYST EVOL, V282, P281, DOI 10.1007/s00606-008-0036-9; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Randall LS, 2004, AUSTR SYSTEMATIC BOT, V17, P145; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Rollins R.C., 1993, CRUCIFERAE CONTINENT; Rollins RC, 1941, RHODORA, V43, P425; Rollins RC, 1941, RHODORA, V43, P348; Rollins Reed C., 1941, RHODORA, V43, P289; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Schluter PM, 2007, TAXON, V56, P493, DOI 10.1002/tax.562019; Schranz ME, 2005, AM J BOT, V92, P1797, DOI 10.3732/ajb.92.11.1797; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Sharbel TF, 2001, HEREDITY, V87, P59, DOI 10.1046/j.1365-2540.2001.00908.x; Sharbel TF, 2010, PLANT CELL, V22, P655, DOI 10.1105/tpc.109.072223; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Volkov RA, 1999, MOL BIOL EVOL, V16, P311, DOI 10.1093/oxfordjournals.molbev.a026112; Warwick SI, 2006, PLANT SYST EVOL, V259, P237, DOI 10.1007/s00606-006-0421-1; Warwick SI, 2010, PLANT SYST EVOL, V285, P209, DOI 10.1007/s00606-010-0271-8; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Windham MD, 1993, FLORA N AM N MEXICO, V7, P348; Windham Michael D., 2006, Harvard Papers in Botany, V11, P61, DOI 10.3100/1043-4534(2006)11[61:NANSOB]2.0.CO;2; Windham Michael D., 2007, Harvard Papers in Botany, V11, P257, DOI 10.3100/1043-4534(2007)11[257:NANSOB]2.0.CO;2; Wissemann V, 1999, J APPL BOT-ANGEW BOT, V73, P191; Won H, 2006, SYST BIOL, V55, P610, DOI 10.1080/10635150600812619	76	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36491	10.1371/journal.pone.0036491	http://dx.doi.org/10.1371/journal.pone.0036491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606266	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400020
J	Yoo, YE; Ko, CP				Yoo, Young-Eun; Ko, Chien-Ping			Dihydrotestosterone Ameliorates Degeneration in Muscle, Axons and Motoneurons and Improves Motor Function in Amyotrophic Lateral Sclerosis Model Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; ANDROGEN RECEPTOR MODULATORS; TRANSGENIC MOUSE MODEL; SKELETAL-MUSCLE; NEURON DEGENERATION; DISEASE ONSET; ELDERLY-MEN; RAT MODEL; TESTOSTERONE; STRENGTH	Amyotrophic lateral sclerosis (ALS) is a lethal disease characterized by a progressive loss of motoneurons. The clinical symptoms include skeletal muscle weakness and atrophy, which impairs motor performance and eventually leads to respiratory failure. We tested whether dihydrotestosterone (DHT), which has both anabolic effects on muscle and neuroprotective effects on axons and motoneurons, can ameliorate clinical symptoms in ALS. A silastic tube containing DHT crystals was implanted subcutaneously in SOD1-G93A mice at early symptomatic age when decreases in body weight and grip-strength were observed as compared to wild-type mice. DHT-treated SOD1-G93A mice demonstrated ameliorated muscle atrophy and increased body weight, which was associated with stronger grip-strength. DHT treatment increased the expression of insulin-like growth factor-1 in muscle, which can exert myotrophic as well as neurotrophic effects through retrograde transport. DHT treatment attenuated neuromuscular junction denervation, and axonal and motoneuron loss. DHT-treated SOD1-G93A mice demonstrated improvement in motor behavior as assessed by rota-rod and gait analyses, and an increased lifespan. Application of DHT is a relatively simple and non-invasive procedure, which may be translated into therapy to improve the quality of life for ALS patients.	[Yoo, Young-Eun; Ko, Chien-Ping] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Yoo, YE (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@dornsife.usc.edu	Ko, Chien-Ping/AAN-2314-2020		ALS Association; Muscular Dystrophy Association	ALS Association; Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported by ALS Association, http://www.alsa.org/ and Muscular Dystrophy Association, http://www.mdausa.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Brooks BP, 1998, J NEUROCHEM, V70, P1054; CARY GA, 2008, PHYS MED REH CLIN N, V19, pR8; Cary GA, 2008, PHYS MED REH CLIN N, V19, P479, DOI 10.1016/j.pmr.2008.03.002; Chambon C, 2010, P NATL ACAD SCI USA, V107, P14327, DOI 10.1073/pnas.1009536107; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Comley LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017639; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fargo KN, 2008, HORM BEHAV, V53, P716, DOI 10.1016/j.yhbeh.2008.01.014; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Frey D, 2000, J NEUROSCI, V20, P2534; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Gould TW, 1999, J NEUROBIOL, V41, P585, DOI 10.1002/(SICI)1097-4695(199912)41:4<585::AID-NEU13>3.0.CO;2-#; Grounds MD, 2002, BIOGERONTOLOGY, V3, P19, DOI 10.1023/A:1015234709314; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAUSER KF, 1989, BRAIN RES, V485, P157, DOI 10.1016/0006-8993(89)90677-X; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; HOBBS CJ, 1993, J CLIN ENDOCR METAB, V77, P776, DOI 10.1210/jc.77.3.776; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Katsuno M, 2004, J MOL MED, V82, P298, DOI 10.1007/s00109-004-0530-7; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; KNOL BW, 1991, VET QUART, V13, P104, DOI 10.1080/01652176.1991.9694292; KUJAWA KA, 1993, J NEUROSCI RES, V35, P268, DOI 10.1002/jnr.490350306; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; Militello A, 2002, J NEUROL SCI, V195, P67, DOI 10.1016/S0022-510X(01)00688-8; Mitchell JD, 2002, COCHRANE DATABASE SY; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagano I, 2005, NEUROL RES, V27, P768, DOI 10.1179/016164105X39860; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ottenbacher KJ, 2006, J AM GERIATR SOC, V54, P1666, DOI 10.1111/j.1532-5415.2006.00938.x; OYAMA T, 1977, BRIT J ANAESTH, V49, P983, DOI 10.1093/bja/49.10.983; Pike CJ, 2008, HORM BEHAV, V53, P693, DOI 10.1016/j.yhbeh.2007.11.006; Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Smith ER, 1977, HORMONE ADM PERIPHER, P259; Smith J, 2000, CELL DEATH DIFFER, V7, P1109, DOI 10.1038/sj.cdd.4400738; SOBUE G, 1981, J NEUROL SCI, V50, P413, DOI 10.1016/0022-510X(81)90153-2; Stewart CEH, 1996, J BIOL CHEM, V271, P11330, DOI 10.1074/jbc.271.19.11330; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; TENOVER JS, 1991, ENDOCRIN METAB CLIN, V20, P893, DOI 10.1016/S0889-8529(18)30249-4; URBAN RJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE820, DOI 10.1152/ajpendo.1995.269.5.E820; VITA G, 1983, EXP NEUROL, V80, P279, DOI 10.1016/0014-4886(83)90282-0; Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Yoo YE, 2011, EXP NEUROL, V231, P147, DOI 10.1016/j.expneurol.2011.06.003	75	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37258	10.1371/journal.pone.0037258	http://dx.doi.org/10.1371/journal.pone.0037258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606355	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400078
J	Louzao, M; Delord, K; Garcia, D; Boue, A; Weimerskirch, H				Louzao, Maite; Delord, Karine; Garcia, David; Boue, Amelie; Weimerskirch, Henri			Protecting Persistent Dynamic Oceanographic Features: Transboundary Conservation Efforts Are Needed for the Critically Endangered Balearic Shearwater	PLOS ONE			English	Article							ANCHOVY ENGRAULIS-ENCRASICOLUS; SPECIES DISTRIBUTION; MEDITERRANEAN-SEA; DISTRIBUTION MODELS; SEABIRD; FISHERIES; HABITAT; PHYTOPLANKTON; POPULATIONS; PERFORMANCE	The protection of key areas for biodiversity at sea is not as widespread as on land and research investment is necessary to identify biodiversity hotspots in the open ocean. Spatially explicit conservation measures such as the creation of representative networks of marine protected areas (MPAs) is a critical step towards the conservation and management of marine ecosystems, as well as to improve public awareness. Conservation efforts in ecologically rich and threatened ecosystems are specially needed. This is particularly urgent for the Mediterranean marine biodiversity, which includes highly mobile marine vertebrates. Here, we studied the at sea distribution of one of the most endangered Mediterranean seabird, the critically endangered Balearic shearwater Puffinus mauretanicus. Present knowledge, from vessel-based surveys, suggests that this species has a coastal distribution over the productive Iberian shelf in relation to the distribution of their main prey, small pelagic fish. We used miniaturised satellite transmitters to determine the key marine areas of the southern population of Balearic shearwaters breeding on Eivissa and spot the spatial connections between breeding and key marine areas. Our tracking study indicates that Balearic shearwaters do not only forage along the Iberian continental shelf but also in more distant marine areas along the North African coast, in particular W of Algeria, but also NE coast of Morocco. Birds recurrently visit these shelf areas at the end of the breeding season. Species distribution modelling identified chlorophyll a as the most important environmental variable in defining those oceanographic features characterizing their key habitats in the western Mediterranean. We identified persistent oceanographic features across time series available in the study area and discuss our results within the current conservation scenario in relation to the ecology of the species.	[Louzao, Maite; Delord, Karine; Weimerskirch, Henri] Ctr Natl Rech Sci UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Louzao, Maite] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Louzao, Maite] Inst Espanol Oceanog, Ctr Oceanog Xixon, Xixon, Spain; [Garcia, David] SEO BirdLife, Barcelona, Spain; [Boue, Amelie] LPO Birdlife France Serv Etud Patrimoine Nat, Rochefort, France	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Spanish Institute of Oceanography	Louzao, M (corresponding author), Ctr Natl Rech Sci UPR 1934, Ctr Etud Biol Chize, Villiers En Bois, France.	maite.louzao@gmail.com	Weimerskirch, Henri/F-5562-2013; Louzao, Maite/N-5379-2014; Weimerskirch, Henri/K-7306-2019	Weimerskirch, Henri/0000-0002-0457-586X; Louzao, Maite/0000-0002-9997-5144	LPO; SEO/BirdLife; Marie Curie Individual Fellowship [PIEF-GA-2008-220063]; Juan de la Cierva postdoctoral programme [JCI-2010-07639]	LPO; SEO/BirdLife; Marie Curie Individual Fellowship(European Commission); Juan de la Cierva postdoctoral programme	Funding support was provided by LPO and SEO/BirdLife through the Future Atlantic Marine Environment Interreg FAME project. ML was supported by the Marie Curie Individual Fellowship (PIEF-GA-2008-220063) and Juan de la Cierva postdoctoral programme (JCI-2010-07639, Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Abello P, 2003, SCI MAR, V67, P69, DOI 10.3989/scimar.2003.67s269; Agreement on the Conservation of Albatrosses and Petrels, 2010, SPEC ASS BAL SHEARW; Arcos J.M., 2009, AREAS IMPORTANTES CO; Arcos J. M, 2011, INT SPECIES ACTION P; Arcos JM, 2002, MAR ECOL PROG SER, V239, P209, DOI 10.3354/meps239209; Arcos JM, 2008, AM FISH S S, V49, P1471; Bacha M, 2010, CYBIUM, V34, P47; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Boyd IL, 2006, CONSERV BIOL SER, P1, DOI 10.2277/ 052161256X; BROOKE M, 1990, MANX SHEARWATER; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; FAO, 2011, FISHSTATJ UN SOFTW F; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Genovart M, 2003, WATERBIRDS, V26, P72, DOI 10.1675/1524-4695(2003)026[0072:ADFFPS]2.0.CO;2; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guilford TC, 2008, IBIS, V150, P462, DOI 10.1111/j.1474-919X.2008.00805.x; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hafferssas A, 2010, ZOOL STUD, V49, P353; Hunt G.L. Jr, 1987, P7; ICES, 2008, REP WORK GROUP SEAB; IUCN and UNEP-WCMC, 2010, WORLD DAT PROT AR WD; Kahru M, 1999, INT J REMOTE SENS, V20, P3423, DOI 10.1080/014311699211453; Laneri K, 2010, MAR ECOL PROG SER, V420, P241, DOI 10.3354/meps08847; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Louzao M, 2011, MAR ECOL PROG SER, V429, P291, DOI 10.3354/meps09126; Louzao M, 2009, MAR ECOL PROG SER, V391, P183, DOI 10.3354/meps08124; Louzao M, 2012, ACT 6 C GIAM TALL IN; Louzao M, 2006, ECOL APPL, V16, P1683, DOI 10.1890/1051-0761(2006)016[1683:OHOAEM]2.0.CO;2; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McAlpine CA, 2008, J APPL ECOL, V45, P558, DOI 10.1111/j.1365-2664.2007.01431.x; Moran XAG, 2001, DEEP-SEA RES PT I, V48, P405, DOI 10.1016/S0967-0637(00)00042-X; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; Orians G.H., 1979, P155; Oro D, 2004, BIOL CONSERV, V116, P93, DOI 10.1016/S0006-3207(03)00180-0; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; RAIMBAULT P, 1993, DEEP-SEA RES PT I, V40, P791, DOI 10.1016/0967-0637(93)90072-B; Riandey V, 2005, DEEP-SEA RES PT I, V52, P2029, DOI 10.1016/j.dsr.2005.06.004; Ruiz A, 2004, PARDELA BALEAR; Seridji R, 2000, CRUSTACEANA, V73, P1, DOI 10.1163/156854000504084; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Trathan PN, 2007, PHILOS T R SOC B, V362, P2351, DOI 10.1098/rstb.2006.1953; VLIZ, 2011, MAR BOUND GEOD VERS; Weimerskirch H, 2003, ANTARCT SCI, V15, P249, DOI 10.1017/S0954102003001202; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wurtz M., 2010, MEDITERRANEAN PELAGI	57	43	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35728	10.1371/journal.pone.0035728	http://dx.doi.org/10.1371/journal.pone.0035728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590510	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400006
J	Mackintosh, KA; Fairclough, SJ; Stratton, G; Ridgers, ND				Mackintosh, Kelly A.; Fairclough, Stuart J.; Stratton, Gareth; Ridgers, Nicola D.			A Calibration Protocol for Population-Specific Accelerometer Cut-Points in Children	PLOS ONE			English	Article							FITNESS INSTRUCTION TIME; PHYSICAL-ACTIVITY; SOFIT; THRESHOLDS; PRINCIPLES; VALIDATION; SEDENTARY; AGREEMENT; SYSTEM	Purpose: To test a field-based protocol using intermittent activities representative of children's physical activity behaviours, to generate behaviourally valid, population-specific accelerometer cut-points for sedentary behaviour, moderate, and vigorous physical activity. Methods: Twenty-eight children (46% boys) aged 10-11 years wore a hip-mounted uniaxial GT1M ActiGraph and engaged in 6 activities representative of children's play. A validated direct observation protocol was used as the criterion measure of physical activity. Receiver Operating Characteristics (ROC) curve analyses were conducted with four semi-structured activities to determine the accelerometer cut-points. To examine classification differences, cut-points were cross-validated with free-play and DVD viewing activities. Results: Cut-points of <= 372, >2160 and >4806 counts.min(-1) representing sedentary, moderate and vigorous intensity thresholds, respectively, provided the optimal balance between the related needs for sensitivity (accurately detecting activity) and specificity (limiting misclassification of the activity). Cross-validation data demonstrated that these values yielded the best overall kappa scores (0.97; 0.71; 0.62), and a high classification agreement (98.6%; 89.0%; 87.2%), respectively. Specificity values of 96-97% showed that the developed cut-points accurately detected physical activity, and sensitivity values (89-99%) indicated that minutes of activity were seldom incorrectly classified as inactivity. Conclusion: The development of an inexpensive and replicable field-based protocol to generate behaviourally valid and population-specific accelerometer cut-points may improve the classification of physical activity levels in children, which could enhance subsequent intervention and observational studies.	[Mackintosh, Kelly A.] Liverpool John Moores Univ, Fac Educ Community & Leisure, Liverpool L3 5UX, Merseyside, England; [Fairclough, Stuart J.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Stratton, Gareth] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Stratton, Gareth] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA 6009, Australia; [Ridgers, Nicola D.] Deakin Univ, Ctr Phys Act & Nutr Res, Geelong, Vic 3217, Australia	Liverpool John Moores University; Liverpool John Moores University; Swansea University; University of Western Australia; Deakin University	Mackintosh, KA (corresponding author), Liverpool John Moores Univ, Fac Educ Community & Leisure, Liverpool L3 5UX, Merseyside, England.	k.a.mackintosh@2009.ljmu.ac.uk	Fairclough, Stuart/F-8900-2015; Ridgers, Nicola/B-2092-2013; Fairclough, Stuart/AAE-8512-2020; stratton, Gareth/Z-5471-2019; Ridgers, Nicola/AGN-1339-2022	Fairclough, Stuart/0000-0001-8358-1979; Ridgers, Nicola/0000-0001-5713-3515; Fairclough, Stuart/0000-0001-8358-1979; stratton, Gareth/0000-0001-5618-0803; Mackintosh, Kelly/0000-0003-0355-6357	Liverpool John Moores University Institute for Health Research; Alfred Deakin Postdoctoral Research Fellowship	Liverpool John Moores University Institute for Health Research; Alfred Deakin Postdoctoral Research Fellowship	This project was partially funded by the Liverpool John Moores University Institute for Health Research, and was carried out by the Liverpool John Moores University Research Institute for Sport and Exercise Sciences. Professor Stratton is now based at the University of Swansea and Dr Ridgers is now based at Deakin University, and is supported by an Alfred Deakin Postdoctoral Research Fellowship. The results of the present study do not constitute endorsement by ACSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan S, 2010, J PHYS ACT HEALTH, V7, P45, DOI 10.1123/jpah.7.1.45; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Edwardson CL, 2010, MED SCI SPORT EXER, V42, P928, DOI 10.1249/MSS.0b013e3181c301f5; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Elder JP, 1998, J DEV BEHAV PEDIATR, V19, P26, DOI 10.1097/00004703-199802000-00004; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 2000, RES Q EXERCISE SPORT, V71, pS21, DOI 10.1080/02701367.2000.11082782; Guinhouya CB, 2009, ACTA PAEDIATR, V98, P708, DOI 10.1111/j.1651-2227.2008.01187.x; Honas JJ, 2008, PEDIATR EXERC SCI, V20, P439, DOI 10.1123/pes.20.4.439; Jago R, 2007, J SPORT SCI, V25, P937, DOI 10.1080/02640410600908027; Mackintosh KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-831; Martinez-Gomez D, 2011, AM J PREV MED, V41, pe1; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; McKenzie TL, 2010, RES Q EXERCISE SPORT, V81, P113; McKenzie TL, 2000, PREV MED, V30, P70, DOI 10.1006/pmed.1999.0591; MCKENZIE TL, 1992, J TEACH PHYS EDUC, V11, P195, DOI 10.1123/jtpe.11.2.195; McKenzie TL, 2002, PHYS ACTIVITY ASSESS, P179; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2006, ARCH PEDIAT ADOL MED, V160, P1262, DOI 10.1001/archpedi.160.12.1262; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Rowe P, 2004, J TEACH PHYS EDUC, V23, P235, DOI 10.1123/jtpe.23.3.235; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Scruggs PW, 2005, MEAS PHYS EDUC EXERC, V9, P203, DOI 10.1207/s15327841mpee0904_1; Sharma SV, 2011, MEAS PHYS EDUC EXERC, V15, P257, DOI 10.1080/1091367X.2011.594361; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Sirard JR, 2005, J PHYS ACT HEALTH, V2, P345, DOI DOI 10.1123/JPAH.2.3.345; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Van Cauwenberghe E, 2011, INT J PEDIATR OBES, V6, pE582, DOI 10.3109/17477166.2010.526223; Welk G., 2002, PHYS ACTIVITY ASSESS; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; Welk GJ, 2007, PEDIAT EX SCI, V19, P33; ZWEIG MH, 1993, CLIN CHEM, V39, P561	37	22	23	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36919	10.1371/journal.pone.0036919	http://dx.doi.org/10.1371/journal.pone.0036919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TN	22590635	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400045
J	Fonseca, MM; Rocha, S; Posada, D				Fonseca, Miguel M.; Rocha, Sara; Posada, David			Base-Pairing Versatility Determines Wobble Sites in tRNA Anticodons of Vertebrate Mitogenomes	PLOS ONE			English	Article							FUNGAL MITOCHONDRIAL GENOMES; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; NUCLEOTIDE COMPOSITION; CODON USAGE; SELECTION; MUTATION; GENES	Background: Vertebrate mitochondrial genomes typically have one transfer RNA (tRNA) for each synonymous codon family. This limited anticodon repertoire implies that each tRNA anticodon needs to wobble (establish a non-Watson-Crick base pairing between two nucleotides in RNA molecules) to recognize one or more synonymous codons. Different hypotheses have been proposed to explain the factors that determine the nucleotide composition of wobble sites in vertebrate mitochondrial tRNA anticodons. Until now, the two major postulates - the "codon-anticodon adaptation hypothesis'' and the "wobble versatility hypothesis'' - have not been formally tested in vertebrate mitochondria because both make the same predictions regarding the composition of anticodon wobble sites. The same is true for the more recent "wobble cost hypothesis''. Principal Findings: In this study we have analyzed the occurrence of synonymous codons and tRNA anticodon wobble sites in 1553 complete vertebrate mitochondrial genomes, focusing on three fish species with mtDNA codon usage bias reversal (L-strand is GT-rich). These mitogenomes constitute an excellent opportunity to study the evolution of the wobble nucleotide composition of tRNA anticodons because due to the reversal the predictions for the anticodon wobble sites differ between the existing hypotheses. We observed that none of the wobble sites of tRNA anticodons in these unusual mitochondrial genomes coevolved to match the new overall codon usage bias, suggesting that nucleotides at the wobble sites of tRNA anticodons in vertebrate mitochondrial genomes are determined by wobble versatility. Conclusions/Significance: Our results suggest that, at wobble sites of tRNA anticodons in vertebrate mitogenomes, selection favors the most versatile nucleotide in terms of wobble base-pairing stability and that wobble site composition is not influenced by codon usage. These results are in agreement with the "wobble versatility hypothesis''.	[Fonseca, Miguel M.; Rocha, Sara; Posada, David] Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO, P-4100 Oporto, Portugal; [Fonseca, Miguel M.; Rocha, Sara; Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain	Universidade do Porto; Universidade de Vigo	Fonseca, MM (corresponding author), Univ Porto, Res Ctr Biodivers & Genet Resources, CIBIO, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mig.m.fonseca@gmail.com	Posada, David/C-4502-2008; Rocha, Sara/L-9557-2013; Fonseca, Miguel M/L-7944-2013	Posada, David/0000-0003-1407-3406; Rocha, Sara/0000-0002-9705-1511; Fonseca, Miguel M/0000-0003-4598-670X	European Social Fund; Operational Human of Potential Program - POPH; FCT (Portuguese Foundation for Science and Technology) [SFRH/BPD/73115/2010, SFRH/BD/31158/2006, SFRH/BPD/70654/2010]	European Social Fund(European Social Fund (ESF)); Operational Human of Potential Program - POPH; FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology)	The European Social Fund and the Operational Human of Potential Program - POPH, supported this study. FCT (Portuguese Foundation for Science and Technology) research grants SFRH/BPD/73115/2010 (SR), SFRH/BD/31158/2006 (MMF) and SFRH/BPD/70654/2010 ( MMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ASAKAWA S, 1991, J MOL EVOL, V32, P511, DOI 10.1007/BF02102653; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; FOLLEY LS, 1991, GENETICS, V129, P659; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; MULERO JJ, 1994, MOL GEN GENET, V242, P383, DOI 10.1007/BF00281787; Nett JH, 2001, EUR J BIOCHEM, V268, P5209, DOI 10.1046/j.0014-2956.2001.02454.x; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-134; ROMERO A, 1991, FEMS MICROBIOL LETT, V84, P325, DOI 10.1016/0378-1097(91)90377-M; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Tong KL, 2004, GENE, V333, P169, DOI 10.1016/j.gene.2004.02.028; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 1998, GENETICS, V149, P37; Xia XH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-211; Xia XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000227; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	22	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36605	10.1371/journal.pone.0036605	http://dx.doi.org/10.1371/journal.pone.0036605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590575	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100046
J	Shanahan, M; Wildie, M				Shanahan, Murray; Wildie, Mark			Knotty-Centrality: Finding the Connective Core of a Complex Network	PLOS ONE			English	Article							ORGANIZATION	A network measure called knotty-centrality is defined that quantifies the extent to which a given subset of a graph's nodes constitutes a densely intra-connected topologically central connective core. Using this measure, the knotty centre of a network is defined as a sub-graph with maximal knotty-centrality. A heuristic algorithm for finding subsets of a network with high knotty-centrality is presented, and this is applied to previously published brain structural connectivity data for the cat and the human, as well as to a number of other networks. The cognitive implications of possessing a connective core with high knotty-centrality are briefly discussed.	[Shanahan, Murray; Wildie, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London	Shanahan, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England.	m.shanahan@imperial.ac.uk			EPSRC [EP/F033516/1]; Engineering and Physical Sciences Research Council [EP/F033516/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by grant no. EP/F033516/1 from EPSRC (www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Kintali S., 2008, 08091906 ARXIV; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sackur J, 2009, COGNITION, V111, P187, DOI 10.1016/j.cognition.2009.01.010; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Shanahan MP, 2010, EMBODIMENT INER LIFE; Shanahan M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041924; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zamora-Lopez G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00083; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zhang HQ, 2009, LECT NOTES COMPUT SC, V5652, P131, DOI 10.1007/978-3-642-02924-0_11; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426; Zylberberg A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000765	24	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36579	10.1371/journal.pone.0036579	http://dx.doi.org/10.1371/journal.pone.0036579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590571	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100042
J	Braun, TE; Poole, E; Sinclair, J				Braun, Tamara Evans; Poole, Emma; Sinclair, John			Depletion of Cellular Pre-Replication Complex Factors Results in Increased Human Cytomegalovirus DNA Replication	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; IE86 PROTEIN; S-PHASE; FUNCTIONAL INTERACTION; CYCLE PROGRESSION; TERMINAL REPEATS; MCM PROTEINS; ORC; EXPRESSION; INHIBITION	Although HCMV encodes many genes required for the replication of its DNA genome, no HCMV-encoded orthologue of the origin binding protein, which has been identified in other herpesviruses, has been identified. This has led to speculation that HCMV may use other viral proteins or possibly cellular factors for the initiation of DNA synthesis. It is also unclear whether cellular replication factors are required for efficient replication of viral DNA during or after viral replication origin recognition. Consequently, we have asked whether cellular pre-replication (pre-RC) factors that are either initially associated with cellular origin of replication (e. g. ORC2), those which recruit other replication factors (e. g. Cdt1 or Cdc6) or those which are subsequently recruited (e. g. MCMs) play any role in the HCMV DNA replication. We show that whilst RNAi-mediated knock-down of these factors in the cell affects cellular DNA replication, as predicted, it results in concomitant increases in viral DNA replication. These data show that cellular factors which initiate cellular DNA synthesis are not required for the initiation of replication of viral DNA and suggest that inhibition of cellular DNA synthesis, in itself, fosters conditions which are conducive to viral DNA replication.	[Braun, Tamara Evans; Poole, Emma; Sinclair, John] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Braun, TE (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk		Poole, Emma/0000-0003-3904-6121	British Medical Research Council; MRC [G9202171, G0701279] Funding Source: UKRI; Medical Research Council [G9202171, G0701279] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; BELL SP, 1993, SCIENCE, V262, P1844, DOI 10.1126/science.8266072; Bennett NJ, 2010, J IMMUNOL, V185, P1093, DOI 10.4049/jimmunol.1000789; Biswas N, 2003, J VIROL, V77, P2369, DOI 10.1128/JVI.77.4.2369-2376.2003; Bresnahan WA, 1998, J BIOL CHEM, V273, P22075, DOI 10.1074/jbc.273.34.22075; Castillo JP, 2000, J VIROL, V74, P8028, DOI 10.1128/JVI.74.17.8028-8037.2000; Chaudhuri B, 2001, P NATL ACAD SCI USA, V98, P10085, DOI 10.1073/pnas.181347998; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Colletti KS, 2007, J VIROL, V81, P7077, DOI 10.1128/JVI.00058-07; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Da-Silva LF, 2007, CELL CYCLE, V6, P128, DOI 10.4161/cc.6.2.3743; DePamphilis ML, 2003, GENE, V310, P1, DOI 10.1016/S0378-1119(03)00546-8; DEPTO AS, 1992, J VIROL, V66, P3241, DOI 10.1128/JVI.66.5.3241-3246.1992; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; ERTL PF, 1991, J GEN VIROL, V72, P1729, DOI 10.1099/0022-1317-72-7-1729; ERTL PF, 1992, J VIROL, V66, P4126, DOI 10.1128/JVI.66.7.4126-4133.1992; Fortunato EA, 2002, J VIROL, V76, P5369, DOI 10.1128/JVI.76.11.5369-5379.2002; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gao Y, 2008, J VIROL, V82, P96, DOI 10.1128/JVI.01559-07; Gao Y, 2009, J VIROL, V83, P2393, DOI 10.1128/JVI.02339-08; Griffin C, 2005, J GEN VIROL, V86, P2999, DOI 10.1099/vir.0.81126-0; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Ishimi Y, 2003, EUR J BIOCHEM, V270, P1089, DOI 10.1046/j.1432-1033.2003.03440.x; Iskenderian AC, 1996, J VIROL, V70, P383, DOI 10.1128/JVI.70.1.383-392.1996; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; Kagele D, 2009, VIROLOGY, V392, P16, DOI 10.1016/j.virol.2009.06.035; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Machida YJ, 2005, J BIOL CHEM, V280, P27624, DOI 10.1074/jbc.M502615200; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Nevis KR, 2009, CELL CYCLE, V8, P1952, DOI 10.4161/cc.8.12.8811; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pari GS, 2008, CURR TOP MICROBIOL, V325, P153; Park MY, 2006, J VIROL, V80, P2718, DOI 10.1128/JVI.80.6.2718-2727.2006; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Qian Z, 2008, PLOS PATHOG, V6; Radichev I, 2006, J BIOL CHEM, V281, P23264, DOI 10.1074/jbc.M603873200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Rialland M, 2002, J CELL SCI, V115, P1435; RIPALTI A, 1995, J VIROL, V69, P2047, DOI 10.1128/JVI.69.4.2047-2057.1995; Salvant BS, 1998, J VIROL, V72, P3729, DOI 10.1128/JVI.72.5.3729-3741.1998; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Sinclair J, 2000, J GEN VIROL, V81, P1553, DOI 10.1099/0022-1317-81-6-1553; Song YJ, 2002, P NATL ACAD SCI USA, V99, P2836, DOI 10.1073/pnas.052010099; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Spector DJ, 2010, VIROLOGY, V407, P171, DOI 10.1016/j.virol.2010.08.029; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Sun JY, 2010, ACTA BIOCH BIOPH SIN, V42, P433, DOI 10.1093/abbs/gmq048; Verma SC, 2006, J VIROL, V80, P11178, DOI 10.1128/JVI.01334-06; White EA, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P264; Wiebusch L, 2003, EMBO REP, V4, P42, DOI 10.1038/sj.embor.embor707; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Woon HG, 2008, VIRUS GENES, V37, P193, DOI 10.1007/s11262-008-0255-8; Ying CY, 2005, EMBO J, V24, P4334, DOI 10.1038/sj.emboj.7600892; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200	62	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36057	10.1371/journal.pone.0036057	http://dx.doi.org/10.1371/journal.pone.0036057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586460	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000022
J	Powell, AA; Talasaz, AH; Zhang, HY; Coram, MA; Reddy, A; Deng, G; Telli, ML; Advani, RH; Carlson, RW; Mollick, JA; Sheth, S; Kurian, AW; Ford, JM; Stockdale, FE; Quake, SR; Pease, RF; Mindrinos, MN; Bhanot, G; Dairkee, SH; Davis, RW; Jeffrey, SS				Powell, Ashley A.; Talasaz, AmirAli H.; Zhang, Haiyu; Coram, Marc A.; Reddy, Anupama; Deng, Glenn; Telli, Melinda L.; Advani, Ranjana H.; Carlson, Robert W.; Mollick, Joseph A.; Sheth, Shruti; Kurian, Allison W.; Ford, James M.; Stockdale, Frank E.; Quake, Stephen R.; Pease, R. Fabian; Mindrinos, Michael N.; Bhanot, Gyan; Dairkee, Shanaz H.; Davis, Ronald W.; Jeffrey, Stefanie S.			Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; NF-KAPPA-B; TGF-BETA; PROGNOSTIC-SIGNIFICANCE; CLINICAL-IMPLICATIONS; PROSTATE-CANCER; HER2 STATUS; STEM-CELL; RT-QPCR	Background: To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may play a key role in cancer dissemination. Uncovering CTC phenotypes offers a potential avenue to inform treatment. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. Here we demonstrate feasibility of performing high dimensional single CTC profiling, providing early insight into CTC heterogeneity and allowing comparisons to breast cancer cell lines widely used for drug discovery. Methodology/Principal Findings: We purified CTCs using the MagSweeper, an immunomagnetic enrichment device that isolates live tumor cells from unfractionated blood. CTCs that met stringent criteria for further analysis were obtained from 70% (14/20) of primary and 70% (21/30) of metastatic breast cancer patients; none were captured from patients with non-epithelial cancer (n = 20) or healthy subjects (n = 25). Microfluidic-based single cell transcriptional profiling of 87 cancer-associated and reference genes showed heterogeneity among individual CTCs, separating them into two major subgroups, based on 31 highly expressed genes. In contrast, single cells from seven breast cancer cell lines were tightly clustered together by sample ID and ER status. CTC profiles were distinct from those of cancer cell lines, questioning the suitability of such lines for drug discovery efforts for late stage cancer therapy. Conclusions/Significance: For the first time, we directly measured high dimensional gene expression in individual CTCs without the common practice of pooling such cells. Elevated transcript levels of genes associated with metastasis NPTN, S100A4, S100A9, and with epithelial mesenchymal transition: VIM, TGF beta 1, ZEB2, FOXC1, CXCR4, were striking compared to cell lines. Our findings demonstrate that profiling CTCs on a cell-by-cell basis is possible and may facilitate the application of 'liquid biopsies' to better model drug discovery.	[Powell, Ashley A.; Zhang, Haiyu; Deng, Glenn; Dairkee, Shanaz H.; Jeffrey, Stefanie S.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Talasaz, AmirAli H.; Mindrinos, Michael N.; Davis, Ronald W.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Talasaz, AmirAli H.; Pease, R. Fabian] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Coram, Marc A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Biostat, Stanford, CA 94305 USA; [Reddy, Anupama; Bhanot, Gyan] Rutgers State Univ, Dept Phys, BioMaPS Inst Quantitat Biol, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Telli, Melinda L.; Advani, Ranjana H.; Carlson, Robert W.; Mollick, Joseph A.; Sheth, Shruti; Kurian, Allison W.; Ford, James M.; Stockdale, Frank E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Bhanot, Gyan] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Dairkee, Shanaz H.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; Rutgers State University New Brunswick; Stanford University; Howard Hughes Medical Institute; Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Institute for Advanced Study - USA; California Pacific Medical Center; California Pacific Medical Center Research Institute	Powell, AA (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	dairkes@cpmcri.org; dbowe@stanford.edu; ssj@stanford.edu	Carlson, Robert/AAQ-8098-2020; Kurian, Allison/A-4560-2019	Jeffrey, Stefanie/0000-0003-4478-2764; Coram, Marc/0000-0002-8877-2501; Kurian, Allison/0000-0002-6175-9470; Dairkee, Shanaz/0000-0002-2073-9684; Ford, James/0000-0002-2513-7025; Advani, Ranjana/0000-0002-3219-2292	National Institutes of Health [R01GM085601, P01HG00020, U54GM621195, DP1OD000251, R01CA109325]; California Breast Cancer Research; Office of the University of California [11IB-0175]; Marva Warnock Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA109325] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085601, U54GM062119] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Breast Cancer Research; Office of the University of California; Marva Warnock Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by National Institutes of Health grants R01GM085601 (SSJ), P01HG000205 (RWD), U54GM62119 (RWD), DP1OD000251 (SRQ), R01CA109325 (SHD); the California Breast Cancer Research Grants Program Office of the University of California, Grant Number 11IB-0175 (SSJ); the John and Marva Warnock Cancer Research Fund; and generous contributions from Andrew and Debra Rachleff and Vladimir and Natalie Ermakoff. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas B, 2011, GYNECOL ONCOL, V122, P356, DOI 10.1016/j.ygyno.2011.04.039; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Ameri K, 2010, BRIT J CANCER, V102, P561, DOI 10.1038/sj.bjc.6605491; Arai K, 2008, CURR CANCER DRUG TAR, V8, P243, DOI 10.2174/156800908784533445; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Bertran E, 2009, CELL SIGNAL, V21, P1595, DOI 10.1016/j.cellsig.2009.06.006; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Chow JYC, 2008, AM J PHYSIOL-GASTR L, V294, pG899, DOI 10.1152/ajpgi.00411.2007; Chow JYC, 2007, CARCINOGENESIS, V28, P2321, DOI 10.1093/carcin/bgm159; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Cohen SJ, 2009, ANN ONCOL, V20, P1223, DOI 10.1093/annonc/mdn786; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dairkee SH, 2007, ONCOGENE, V26, P6269, DOI 10.1038/sj.onc.1210452; Dairkee SH, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-47; DAIRKEE SH, 1987, LANCET, V1, P514; Dairkee SH, 2009, CANCER RES, V69, P7826, DOI 10.1158/0008-5472.CAN-09-1564; Fehm T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1783; Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Jeffrey Stefanie S, 2005, J Natl Compr Canc Netw, V3, P291; Jensen JD, 2011, CLIN CANCER RES, V17, P667, DOI 10.1158/1078-0432.CCR-10-1133; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Luciani MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020016; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Niikura N, 2012, J CLIN ONCOL, V30, P593, DOI 10.1200/JCO.2010.33.8889; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Patel AS, 2011, ONCOTARGET, V2, P752, DOI 10.18632/oncotarget.336; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Rodriguez-Pinto D, 2009, CANCER IMMUNOL IMMUN, V58, P221, DOI 10.1007/s00262-008-0543-0; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van de Stolpe A, 2011, CANCER RES, V71, P5955, DOI 10.1158/0008-5472.CAN-11-1254; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087	62	415	437	6	231	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e33788	10.1371/journal.pone.0033788	http://dx.doi.org/10.1371/journal.pone.0033788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586443	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000005
J	Cherutich, P; Kaiser, R; Galbraith, J; Williamson, J; Shiraishi, RW; Ngare, C; Mermin, J; Marum, E; Bunnell, R				Cherutich, Peter; Kaiser, Reinhard; Galbraith, Jennifer; Williamson, John; Shiraishi, Ray W.; Ngare, Carol; Mermin, Jonathan; Marum, Elizabeth; Bunnell, Rebecca		KAIS Study Grp	Lack of Knowledge of HIV Status a Major Barrier to HIV Prevention, Care and Treatment Efforts in Kenya: Results from a Nationally Representative Study	PLOS ONE			English	Article							RISK-REDUCTION; TRANSMISSION; AFRICA	Background: We analyzed HIV testing rates, prevalence of undiagnosed HIV, and predictors of testing in the Kenya AIDS Indicator Survey (KAIS) 2007. Methods: KAIS was a nationally representative sero-survey that included demographic and behavioral indicators and testing for HIV, HSV-2, syphilis, and CD4 cell counts in the population aged 15-64 years. We used gender-specific multivariable regression models to identify factors independently associated with HIV testing in sexually active persons. Results: Of 19,840 eligible persons, 80% consented to interviews and blood specimen collection. National HIV prevalence was 7.1% (95% CI 6.5-7.7). Among ever sexually active persons, 27.4% (95% CI 25.6-29.2) of men and 44.2% (95% CI 42.5-46.0) of women reported previous HIV testing. Among HIV-infected persons, 83.6% (95% CI 76.2-91.0) were unaware of their HIV infection. Among sexually active women aged 15-49 years, 48.7% (95% CI 46.8-50.6) had their last HIV test during antenatal care (ANC). In multivariable analyses, the adjusted odds ratio (AOR) for ever HIV testing in women >= 35 versus 15-19 years was 0.2 (95% CI: 0.1-0.3; p<0.0001). Other independent associations with ever HIV testing included urban residence (AOR 1.6, 95% CI: 1.2-2.0; p = 0.0005, women only), highest wealth index versus the four lower quintiles combined (AOR 1.8, 95% CI: 1.3-2.5; p = 0.0006, men only), and an increasing testing trend with higher levels of education. Missed opportunities for testing were identified during general or pregnancy-specific contacts with health facilities; 89% of adults said they would participate in home-based HIV testing. Conclusions: The vast majority of HIV-infected persons in Kenya are unaware of their HIV status, posing a major barrier to HIV prevention, care and treatment efforts. New approaches to HIV testing provision and education, including home-based testing, may increase coverage. Targeted interventions should involve sexually active men, sexually active women without access to ANC, and rural and disadvantaged populations.	[Cherutich, Peter; Ngare, Carol] Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya; [Kaiser, Reinhard; Galbraith, Jennifer; Williamson, John; Mermin, Jonathan; Bunnell, Rebecca] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Nairobi, Kenya; [Shiraishi, Ray W.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Mermin, Jonathan] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Marum, Elizabeth] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Lusaka, Zambia; [Bunnell, Rebecca] Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cherutich, P (corresponding author), Natl AIDS STI Control Programme NASCOP, Nairobi, Kenya.	r_kaiser@gmx.de	Mermin, Jonathan/J-9847-2012	Kim, Evelyn/0000-0002-9650-2093; Shiraishi, Ray/0000-0001-7640-0666	United States President's Emergency Plan for AIDS Relief; Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)	United States President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of Health and Human Services; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded through the United States President's Emergency Plan for AIDS Relief and the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded through the Centers for Disease Control and Prevention (CDC). Several authors are employees of CDC and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ALLEN S, 1992, JAMA-J AM MED ASSOC, V268, P3338, DOI 10.1001/jama.268.23.3338; Bunnell R, 2008, AIDS, V22, P617, DOI 10.1097/QAD.0b013e3282f56b53; CBS Kenya ORC Macro, 2004, KEN DEM HLTH SURV 20; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; [Joint United Nations Program on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2007, AIDS EP UPD 2007; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kellerman S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000285; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2010, KEN DEM HLTH SURV 20; Kim AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017535; KNBS, 2006, REV POP PROJ KEN 200; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; NASCOP, 2001, NAT GUID HIV TEST CO; National AIDS and STI Control Programme (NASCOP) Ministry of Health Kenya, 2008, NAT GUID HIV TEST CO; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Rutstein SO, 2004, DHS COMP REPORTS, V6; Wanyenze R, 2006, AIDS BEHAV, V10, P361, DOI 10.1007/s10461-005-9035-9; Were W, 2003, LANCET, V361, P1569, DOI 10.1016/S0140-6736(03)13212-6; WHO, 2009, UN ACC SCAL PRIOR HI; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI	30	61	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36797	10.1371/journal.pone.0036797	http://dx.doi.org/10.1371/journal.pone.0036797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574226	Green Published, gold			2022-12-27	WOS:000305349800123
J	van de Sande, MGH; de Hair, MJH; Schuller, Y; van de Sande, GPM; Wijbrandts, CA; Dinant, HJ; Gerlag, DM; Tak, PP				van de Sande, Marleen G. H.; de Hair, Maria J. H.; Schuller, Yvonne; van de Sande, Gijs P. M.; Wijbrandts, Carla A.; Dinant, Huib J.; Gerlag, Danielle M.; Tak, Paul P.			The Features of the Synovium in Early Rheumatoid Arthritis According to the 2010 ACR/EULAR Classification Criteria	PLOS ONE			English	Article							RHEUMATOLOGY/EUROPEAN LEAGUE; AMERICAN-COLLEGE; PREDICTION RULE; CELL INFILTRATE; TISSUE; DIAGNOSIS; BIOPSIES	Objective: It has been shown in early arthritis cohorts that the 2010 ACR/EULAR criteria for rheumatoid arthritis (RA) enable an earlier diagnosis, perhaps at the cost of a somewhat more heterogeneous patient population. We describe the features of synovial inflammation in RA patients classified according to these new criteria. Methods: At baseline, synovial tissue biopsy samples were obtained from disease-modifying antirheumatic drug (DMARD)-naive early RA patients (clinical signs and symptoms <1 year). Synovial tissue was analyzed for cell infiltration, vascularity, and expression of adhesion molecules. Stained sections were evaluated by digital image analysis. Patients were classified according to the two different sets of classification criteria, autoantibody status, and outcome. Findings: Synovial tissue of 69 RA patients according to 2010 ACR/EULAR criteria was analyzed: 56 patients who fulfilled the criteria for RA at baseline and 13 who were initially diagnosed as undifferentiated arthritis but fulfilled criteria for RA upon follow up. The synovium at baseline was infiltrated by plasma cells, macrophages, and T cells as well as other cells, and findings were comparable to those when patients were selected based on the 1987 ACR criteria for RA. There was no clear cut difference in the characteristics of the synovium between RA patients initially diagnosed as undifferentiated arthritis and those who already fulfilled classification criteria at baseline. Conclusion: The features of synovial inflammation are similar when the 2010 ACR/EULAR classification criteria are used compared to the 1987 ACR criteria.	[van de Sande, Marleen G. H.; de Hair, Maria J. H.; Schuller, Yvonne; van de Sande, Gijs P. M.; Wijbrandts, Carla A.; Dinant, Huib J.; Gerlag, Danielle M.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van de Sande, MGH (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.p.tak@amc.uva.nl			Dutch Arthritis Association [06-1-303]; European Community's FP6 funding (Autocure)	Dutch Arthritis Association; European Community's FP6 funding (Autocure)	This research project was funded by the Dutch Arthritis Association (nr 06-1-303) and the European Community's FP6 funding (Autocure). This publication reflects only the authors' views; the European Community is not liable for any use that may be made of the information herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cader MZ, 2011, ANN RHEUM DIS; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; de Hair MJH, 2012, ARTHRITIS RHEUM-US, V64, P389, DOI 10.1002/art.33348; de Hair MJH, 2011, J RHEUMATOL, V38, P2068, DOI 10.3899/jrheum.110426; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Gerlag D, 2005, BEST PRACT RES CL RH, V19, P387, DOI 10.1016/j.berh.2005.01.005; Gerlag DM, 2007, NAT CLIN PRACT RHEUM, V3, P248, DOI 10.1038/ncprheum0485; Goekoop-Ruiterman YPM, 2005, ARTHRITIS RHEUM-US, V52, P3381, DOI [10.1002/art.21405, 10.1002/art.23364]; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Kraan MC, 1999, RHEUMATOLOGY, V38, P1074, DOI 10.1093/rheumatology/38.11.1074; Kraan MC, 2000, RHEUMATOLOGY, V39, P43, DOI 10.1093/rheumatology/39.1.43; Nell VPK, 2004, RHEUMATOLOGY, V43, P906, DOI 10.1093/rheumatology/keh199; Smeets TJM, 2003, ANN RHEUM DIS, V62, P635, DOI 10.1136/ard.62.7.635; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; Thurlings RM, 2008, ARTHRITIS RHEUM, V58, P1582, DOI 10.1002/art.23505; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; van der Hall Pascal O., 2007, V135, P121; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van der Helm-van Mil AH, 2008, ARTHRITIS RHEUM-US, V58, P2241, DOI 10.1002/art.23681; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P433, DOI 10.1002/art.22380; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; van Oosterhout M, 2008, ARTHRITIS RHEUM, V58, P53, DOI 10.1002/art.23148; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117	26	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36668	10.1371/journal.pone.0036668	http://dx.doi.org/10.1371/journal.pone.0036668			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574210	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800107
J	Shi, GQ; Huang, WL; Zhang, J; Zhao, H; Shen, T; Fontaine, RE; Yang, L; Zhao, S; Lu, BL; Wang, YB; Ma, L; Li, ZX; Gao, Y; Yang, ZL; Zeng, G				Shi, Guo-Qing; Huang, Wen-Li; Zhang, Jian; Zhao, Hong; Shen, Tao; Fontaine, Robert E.; Yang, Lin; Zhao, Su; Lu, Bu-Lai; Wang, Yue-Bing; Ma, Lin; Li, Zhao-Xiang; Gao, Yang; Yang, Zhu-Liang; Zeng, Guang			Clusters of Sudden Unexplained Death Associated with the Mushroom, Trogia venenata, in Rural Yunnan Province, China	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC LEADS; SYNDROME SURVIVORS; BRUGADA-SYNDROME; MANAGEMENT; POISONINGS; SLEEP	Introduction: Since the late 1970's, time-space clusters of sudden unexplained death (SUD) in northwest Yunnan, China have alarmed the public and health authorities. From 2006-2009, we initiated enhanced surveillance for SUD to identify a cause, and we warned villagers to avoid eating unfamiliar mushrooms. Methods: We established surveillance for SUD, defined as follows: sudden onset of serious, unexplained physical impairment followed by death in,24 hours. A mild case was onset of any illness in a member of the family or close socially related group of a SUD victim within 1 week of a SUD. We interviewed witnesses of SUD and mild case-persons to identify exposures to potentially toxic substances. We tested blood from mild cases, villagers, and for standard biochemical, enzyme, and electrolyte markers of disease. Results: We identified 33 SUD, a 73% decline from 2002-2005, distributed among 21 villages of 11 counties. We found a previously undescribed mushroom, Trogia venenata, was eaten by 5 of 7 families with SUD clusters compared to 0 of 31 other control-families from the same villages. In T. venenata-exposed persons SUD was characterized by sudden loss of consciousness during normal activities. This mushroom grew nearby 75% of 61 villages that had time-space SUD clusters from 1975 to 2009 compared to 17% of 18 villages with only single SUD (p < 0.001, Fisher's exact test). Discussion: Epidemiologic data has implicated T. venenata as a probable cause of clusters of SUD in northwestern Yunnan Province. Warnings to villagers about eating this mushroom should continue.	[Shi, Guo-Qing; Shen, Tao; Fontaine, Robert E.; Lu, Bu-Lai; Gao, Yang; Zeng, Guang] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Huang, Wen-Li; Yang, Lin; Zhao, Su; Wang, Yue-Bing; Ma, Lin; Li, Zhao-Xiang] Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan Province, Peoples R China; [Zhang, Jian; Zhao, Hong] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China; [Zhang, Jian; Zhao, Hong] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China; [Zhang, Jian; Zhao, Hong] Peking Union Med Coll, Beijing, Peoples R China; [Fontaine, Robert E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Yang, Zhu-Liang] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan Province, Peoples R China	Chinese Center for Disease Control & Prevention; Yunnan Institute for Endemic Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Centers for Disease Control & Prevention - USA; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Shi, GQ (corresponding author), Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China.	zeng4605@vip.sina.com			Ministry of Health, China [200802002]	Ministry of Health, China	Funding was from Scientific Research Special Funds (200802002) of Ministry of Health, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaenen R, 2011, HEART, V97, P1365, DOI 10.1136/hrt.2011.223883; Bedry R, 2001, NEW ENGL J MED, V345, P798, DOI 10.1056/NEJMoa010581; Berger KJ, 2005, J EMERG MED, V28, P53, DOI 10.1016/j.jemermed.2004.08.013; Berger KJ, 2005, J EMERG MED, V28, P175, DOI 10.1016/j.jemermed.2004.08.019; Corrado D, 2011, HEART, V97, P530, DOI 10.1136/hrt.2010.193276; Diaz JH, 2005, CRIT CARE MED, V33, P427, DOI 10.1097/01.CCM.0000153531.69448.49; Diaz JH, 2005, CRIT CARE MED, V33, P419, DOI 10.1097/01.CCM.0000153530.32162.B7; Gervacio-Domingo G, 2007, J CLIN EPIDEMIOL, V60, P567, DOI 10.1016/j.jclinepi.2006.10.003; Himmunngan Pensiri, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P357; Karlson-Stiber C, 2003, TOXICON, V42, P339, DOI 10.1016/S0041-0101(03)00238-1; Lee PT, 2001, AM J KIDNEY DIS, V38, DOI 10.1053/ajkd.2001.27725; Lu BL, 2010, CHIN J DIS CONTROL P, V14, P305; Matsuura M, 2009, NAT CHEM BIOL, V5, P465, DOI 10.1038/nchembio.179; Munger RG, 1998, INT J EPIDEMIOL, V27, P677, DOI 10.1093/ije/27.4.677; Nademanee K, 1997, CIRCULATION, V96, P2595, DOI 10.1161/01.CIR.96.8.2595; PARRISH G, 1986, JAMA-J AM MED ASSOC, V255, P2893; Ren Jin-ma, 2007, Zhonghua Yufang Yixue Zazhi, V41, P143; Sangwatanaroj S, 2001, CLIN CARDIOL, V24, P776, DOI 10.1002/clc.4960241205; Sangwatanaroj S, 2001, EUR HEART J, V22, P2290, DOI 10.1053/euhj.2001.2691; Sangwatanaroj Somkiat, 2001, Journal of the Medical Association of Thailand, V84, pS443; Sangwatanaroj Somkiat, 2002, Journal of the Medical Association of Thailand, V85, pS54; Saviuc Philippe, 2006, Toxicol Rev, V25, P199, DOI 10.2165/00139709-200625030-00004; Shi GQ, 2006, CHIN J EPIDEMIOL, V272, P96; TATSANAVIVAT P, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P195; TUNGSANGA K, 1993, INT J EPIDEMIOL, V22, P81, DOI 10.1093/ije/22.1.81; Vatta M, 2002, HUM MOL GENET, V11, P337, DOI 10.1093/hmg/11.3.337; Wang Hong-yue, 2007, Zhonghua Yi Xue Za Zhi, V87, P2209; Woods AE, 1994, HAEMATOXYLIN COUNTER; Yang L, 2008, J PREVENTIVE MED INF, V21, P110; Yang ZL, 2012, MYCOL PROG, V11, P937, DOI 10.1007/s11557-012-0809-y; Zhou ZY, 2012, ANGEW CHEM INT EDIT, V51, P2368, DOI 10.1002/anie.201106502	31	19	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e35894	10.1371/journal.pone.0035894	http://dx.doi.org/10.1371/journal.pone.0035894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615743	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341200003
J	Yu, M; Bell, RH; Ho, MM; Leung, G; Haegert, A; Carr, N; Shapiro, J; McElwee, KJ				Yu, Mei; Bell, Robert H.; Ho, Maggie M.; Leung, Gigi; Haegert, Anne; Carr, Nicholas; Shapiro, Jerry; McElwee, Kevin J.			Deficiency in Nucleotide Excision Repair Family Gene Activity, Especially ERCC3, Is Associated with Non-Pigmented Hair Fiber Growth	PLOS ONE			English	Article							MELANOCYTE STEM-CELLS; DNA-REPAIR; MONOCLONAL-ANTIBODIES; RT-PCR; TRANSCRIPTION; FOLLICLE; PIGMENTATION; EXPRESSION; DAMAGE; NICHE	We conducted a microarray study to discover gene expression patterns associated with a lack of melanogenesis in nonpigmented hair follicles (HF) by microarray. Pigmented and non-pigmented HFs were collected and micro-dissected into the hair bulb (HB) and the upper hair sheaths (HS) including the bulge region. In comparison to pigmented HS and HBs, nucleotide excision repair (NER) family genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, ERCC6, XPA, NTPBP, HCNP, DDB2 and POLH exhibited statistically significantly lower expression in non- pigmented HS and HBs. Quantitative PCR verified microarray data and identified ERCC3 as highly differentially expressed. Immunohistochemistry confirmed ERCC3 expression in HF melanocytes. A reduction in ERCC3 by siRNA interference in human melanocytes in vitro reduced their tyrosinase production ability. Our results suggest that loss of NER gene function is associated with a loss of melanin production capacity. This may be due to reduced gene transcription and/or reduced DNA repair in melanocytes which may eventually lead to cell death. These results provide novel information with regard to melanogenesis and its regulation.	[Yu, Mei; Ho, Maggie M.; Leung, Gigi; Shapiro, Jerry; McElwee, Kevin J.] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Yu, Mei; Ho, Maggie M.; Leung, Gigi; McElwee, Kevin J.] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Bell, Robert H.; Haegert, Anne] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada; [Bell, Robert H.; Haegert, Anne; Carr, Nicholas] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Yu, M (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	kmcelwee@interchange.ubc.ca	Carr, Nicholas/ABD-2360-2021	McElwee, Kevin/0000-0003-1020-3832	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR) [MSH-95328]; Michael Smith Foundation for Health Research (MSFHR) [CI-SCH-00480(06-1)]	Canadian Dermatology Foundation (CDF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Dermatology Foundation (CDF). KJM is a recipient of Canadian Institutes of Health Research (CIHR) (MSH-95328) and Michael Smith Foundation for Health Research (MSFHR - CI-SCH-00480(06-1)) investigator awards. CDF founding wesite is following: http://www.cdf.ca/cdf-grant.php. CIHR founding website is following: http://www.cihr-irsc.gc.ca/e/805.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 1999, J LIPID RES, V40, P1312; Andressoo JO, 2009, MOL CELL BIOL, V29, P1276, DOI 10.1128/MCB.01229-08; Arck PC, 2006, FASEB J, V20, P1567, DOI 10.1096/fj.05-4039fje; Beck BD, 2008, ADV EXP MED BIOL, V637, P39; Commo S, 2000, PIGM CELL RES, V13, P253, DOI 10.1034/j.1600-0749.2000.130407.x; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; CUI J, 1991, J INVEST DERMATOL, V97, P410, DOI 10.1111/1523-1747.ep12480997; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; ESCLAMADO RM, 1986, AM J SURG, V152, P376, DOI 10.1016/0002-9610(86)90308-9; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Gilchrest BA, 1997, FASEB J, V11, P322, DOI 10.1096/fasebj.11.5.9141498; GOWN AM, 1982, J CELL BIOL, V95, P414, DOI 10.1083/jcb.95.2.414; Green ML, 2006, NUCLEIC ACIDS RES, V34, P3687, DOI 10.1093/nar/gkl438; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; KAPUR RP, 1992, J HISTOCHEM CYTOCHEM, V40, P207, DOI 10.1177/40.2.1552165; Kim D, 2002, J KOREAN MED SCI, V17, P648, DOI 10.3346/jkms.2002.17.5.648; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim NS, 2000, ARCH DERMATOL RES, V292, P233, DOI 10.1007/s004030050480; Le Page F, 2005, CELL, V123, P711, DOI 10.1016/j.cell.2005.11.005; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Nelson Colleen C, 2003, Methods Mol Med, V81, P299; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Passeron T, 2007, EXP DERMATOL, V16, P162, DOI 10.1111/j.1600-0625.2006.00538.x; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Sarin KY, 2007, STEM CELL REV, V3, P212, DOI 10.1007/s12015-007-0028-0; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Steingrimsson E, 2005, CELL, V121, P9, DOI 10.1016/j.cell.2005.03.021; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Tobin DJ, 2005, J INVEST DERM SYMP P, V10, P275, DOI 10.1111/j.1087-0024.2005.10117.x; Tobin DJ, 2001, EXP GERONTOL, V36, P29, DOI 10.1016/S0531-5565(00)00210-2; Tobin DJ, 1998, J INVEST DERMATOL, V111, P941, DOI 10.1046/j.1523-1747.1998.00417.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006; Weeda G, 1997, AM J HUM GENET, V60, P320; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243	47	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e34185	10.1371/journal.pone.0034185	http://dx.doi.org/10.1371/journal.pone.0034185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615732	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300003
J	Herbert, BM; Muth, ER; Pollatos, O; Herbert, C				Herbert, Beate M.; Muth, Eric R.; Pollatos, Olga; Herbert, Cornelia			Interoception across Modalities: On the Relationship between Cardiac Awareness and the Sensitivity for Gastric Functions	PLOS ONE			English	Article							WATER LOAD TEST; CEPHALIC-VAGAL INFLUENCES; EMOTIONAL EXPERIENCE; HEARTBEAT PERCEPTION; MYOELECTRIC ACTIVITY; CARDIOVASCULAR AROUSAL; DYSPEPTIC SYMPTOMS; BALLOON-DISTENSION; EATING-DISORDERS; ANTERIOR INSULA	The individual sensitivity for ones internal bodily signals ("interoceptive awareness'') has been shown to be of relevance for a broad range of cognitive and affective functions. Interoceptive awareness has been primarily assessed via measuring the sensitivity for ones cardiac signals ("cardiac awareness'') which can be non-invasively measured by heartbeat perception tasks. It is an open question whether cardiac awareness is related to the sensitivity for other bodily, visceral functions. This study investigated the relationship between cardiac awareness and the sensitivity for gastric functions in healthy female persons by using non-invasive methods. Heartbeat perception as a measure for cardiac awareness was assessed by a heartbeat tracking task and gastric sensitivity was assessed by a water load test. Gastric myoelectrical activity was measured by electrogastrography (EGG) and subjective feelings of fullness, valence, arousal and nausea were assessed. The results show that cardiac awareness was inversely correlated with ingested water volume and with normogastric activity after water load. However, persons with good and poor cardiac awareness did not differ in their subjective ratings of fullness, nausea and affective feelings after drinking. This suggests that good heartbeat perceivers ingested less water because they subjectively felt more intense signals of fullness during this lower amount of water intake compared to poor heartbeat perceivers who ingested more water until feeling the same signs of fullness. These findings demonstrate that cardiac awareness is related to greater sensitivity for gastric functions, suggesting that there is a general sensitivity for interoceptive processes across the gastric and cardiac modality.	[Herbert, Beate M.] Univ Tubingen, Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Muth, Eric R.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA; [Pollatos, Olga] Univ Potsdam, Dept Psychol Psychol Motivat & Emot, Potsdam, Germany; [Herbert, Cornelia] Univ Wurzburg, Dept Psychol Biol Psychol Clin Psychol & Psychoth, Wurzburg, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Clemson University; University of Potsdam; University of Wurzburg	Herbert, BM (corresponding author), Univ Tubingen, Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	beate.herbert@gmx.de	Herbert, Beate/L-5036-2015	Herbert, Beate/0000-0002-3284-4529				Abid S, 2009, SCAND J GASTROENTERO, V44, P551, DOI 10.1080/00365520902767546; Andresen V, 2009, BEST PRACT RES CL GA, V23, P313, DOI 10.1016/j.bpg.2009.04.007; Andrew D, 2001, J PHYSIOL-LONDON, V537, P489, DOI 10.1111/j.1469-7793.2001.00489.x; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; BESTLER M, 1990, Z EXP ANGEW PSYCHOL, V37, P361; Boeckxstaens GE, 1999, GASTROENTEROLOGY, V116, pA960; BRENER J, 1988, PSYCHOPHYSIOLOGY, V25, P554, DOI 10.1111/j.1469-8986.1988.tb01891.x; BRENER J, 1993, PSYCHOPHYSIOLOGY, V30, P657, DOI 10.1111/j.1469-8986.1993.tb02091.x; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Chen CL, 2005, SCAND J GASTROENTERO, V40, P28, DOI 10.1080/00365520410009483; Chen CL, 2004, DIGEST DIS SCI, V49, P715, DOI 10.1023/B:DDAS.0000030079.20501.62; CHEN JDZ, 1995, DIGEST DIS, V13, P275, DOI 10.1159/000171508; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2004, TRENDS COGN SCI, V8, P239, DOI 10.1016/j.tics.2004.04.004; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DEGEUS EJC, 1990, PSYCHOPHYSIOLOGY, V27, P457; Delgado-Aros S, 2004, GASTROENTEROLOGY, V126, P432, DOI 10.1053/j.gastro.2003.11.007; Diamanti A, 2003, J PEDIATR GASTR NUTR, V37, P35, DOI 10.1097/00005176-200307000-00006; Dunn BD, 2007, BEHAV RES THER, V45, P1921, DOI 10.1016/j.brat.2006.09.008; Fruehauf H, 2009, NEUROGASTROENT MOTIL, V21, P697, DOI 10.1111/j.1365-2982.2009.01267.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Herbert BM, 2007, INT J PSYCHOPHYSIOL, V65, P214, DOI 10.1016/j.ijpsycho.2007.04.007; Herbert BM, 2007, PSYCHOPHYSIOLOGY, V44, P194, DOI 10.1111/j.1469-8986.2007.00493.x; Herbert BM, 2010, PSYCHOPHYSIOLOGY, V47, P342, DOI 10.1111/j.1469-8986.2009.00931.x; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jokerst MD, 1997, GASTROENTEROLOGY, V112, pA755; Jones G.E., 1994, PERCEPTION VISCERAL; Jones MP, 2003, AM J PHYSIOL-GASTR L, V284, pG896, DOI 10.1152/ajpgi.00361.2002; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; Kern MK, 2001, AM J PHYSIOL-GASTR L, V281, pG1512, DOI 10.1152/ajpgi.2001.281.6.G1512; Kim DY, 2001, OBES RES, V9, P655, DOI 10.1038/oby.2001.89; Koch KL, 2000, J CLIN GASTROENTEROL, V31, P125, DOI 10.1097/00004836-200009000-00007; KOCH KL, 1989, AM J GASTROENTEROL, V84, P1069; Koch KL, 1993, ILLUSTRATED GUIDE GA, P290; Kollenbaum VE, 1996, BIOL PSYCHOL, V42, P183, DOI 10.1016/0301-0511(95)05154-6; Laux L., 1981, STATE TRAIT ANGSTINV; Li QX, 2004, ZHONGHUA NEI KE ZA Z, V43, P436; Matthias E, 2009, INT J PSYCHOPHYSIOL, V72, P154, DOI 10.1016/j.ijpsycho.2008.12.001; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Mertz H, 1998, GUT, V42, P814, DOI 10.1136/gut.42.6.814; Moisset X, 2010, EUR J PAIN, V14, P142, DOI 10.1016/j.ejpain.2009.04.011; MONTGOMERY WA, 1984, PSYCHOPHYSIOLOGY, V21, P459, DOI 10.1111/j.1469-8986.1984.tb00227.x; MONTOYA P, 1993, ELECTROEN CLIN NEURO, V88, P163, DOI 10.1016/0168-5597(93)90001-6; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ogawa A, 2004, PSYCHIAT CLIN NEUROS, V58, P300, DOI 10.1111/j.1440-1819.2004.01236.x; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Pollatos O, 2005, COGNITIVE BRAIN RES, V25, P948, DOI 10.1016/j.cogbrainres.2005.09.019; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V65, P167, DOI 10.1016/j.ijpsycho.2007.03.005; Pollatos O, 2007, BRAIN RES, V1141, P178, DOI 10.1016/j.brainres.2007.01.026; Pollatos O, 2007, INT J PSYCHOPHYSIOL, V63, P117, DOI 10.1016/j.ijpsycho.2006.09.003; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; SCHANDRY R, 1981, PSYCHOPHYSIOLOGY, V18, P483, DOI 10.1111/j.1469-8986.1981.tb02486.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steptoe A, 1997, BEHAV RES THER, V35, P901, DOI 10.1016/S0005-7967(97)00055-7; STERN RM, 1989, DIGEST DIS SCI, V34, P521, DOI 10.1007/BF01536327; Stern RM, 2001, NEUROGASTROENT MOTIL, V13, P151, DOI 10.1046/j.1365-2982.2001.00250.x; Stern RM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P211, DOI 10.1017/CBO9780511546396.009; Tack J, 2003, GUT, V52, P1271, DOI 10.1136/gut.52.9.1271; Tosetti C, 1999, GASTROENTEROLOGY, V116, pA336; Vaitl D, 1996, BIOL PSYCHOL, V42, P1, DOI 10.1016/0301-0511(95)05144-9; Van der Does AJW, 2000, BEHAV RES THER, V38, P47, DOI 10.1016/S0005-7967(98)00184-3; Vandenberghe J, 2005, GUT, V54, P914, DOI 10.1136/gut.2004.052605; Vandenberghe J, 2007, GASTROENTEROLOGY, V132, P1684, DOI 10.1053/j.gastro.2007.03.037; Werner NS, 2009, PSYCHOPHYSIOLOGY, V46, P1123, DOI 10.1111/j.1469-8986.2009.00855.x; WHITEHEAD WE, 1980, PSYCHOPHYSIOLOGY, V17, P552, DOI 10.1111/j.1469-8986.1980.tb02296.x; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99; XU LH, 1993, AM J PHYSIOL, V265, pE578, DOI 10.1152/ajpendo.1993.265.4.E578; Yuan YZ, 2003, WORLD J GASTROENTERO, V9, P1356, DOI 10.3748/wjg.v9.i6.1356; Zhou RL, 2006, PERCEPT MOTOR SKILL, V103, P829, DOI 10.2466/PMS.103.3.829-833	77	177	180	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36646	10.1371/journal.pone.0036646	http://dx.doi.org/10.1371/journal.pone.0036646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TW	22606278	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200036
J	Liu, Z; Zhao, J; Li, YH; Zhang, WW; Jian, GL; Peng, YF; Qi, FJ				Liu, Zhi; Zhao, Jie; Li, Yunhe; Zhang, Wenwei; Jian, Guiliang; Peng, Yufa; Qi, Fangjun			Non-Uniform Distribution Pattern for Differentially Expressed Genes of Transgenic Rice Huahui 1 at Different Developmental Stages and Environments	PLOS ONE			English	Article							TRANSCRIPTOME; PROTEOMICS; VARIETIES; PLANTS; GRAIN	DNA microarray analysis is an effective method to detect unintended effects by detecting differentially expressed genes (DEG) in safety assessment of genetically modified (GM) crops. With the aim to reveal the distribution of DEG of GM crops under different conditions, we performed DNA microarray analysis using transgenic rice Huahui 1 (HH1) and its non-transgenic parent Minghui 63 (MH63) at different developmental stages and environmental conditions. Considerable DEG were selected in each group of HH1 under different conditions. For each group of HH1, the number of DEG was different; however, considerable common DEG were shared between different groups of HH1. These findings suggested that both DEG and common DEG were adequate for investigation of unintended effects. Furthermore, a number of significantly changed pathways were found in all groups of HH1, indicating genetic modification caused everlasting changes to plants. To our knowledge, our study for the first time provided the non-uniformly distributed pattern for DEG of GM crops at different developmental stages and environments. Our result also suggested that DEG selected in GM plants at specific developmental stage and environment could act as useful clues for further evaluation of unintended effects of GM plants.	[Liu, Zhi; Zhao, Jie; Li, Yunhe; Zhang, Wenwei; Jian, Guiliang; Peng, Yufa; Qi, Fangjun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Liu, Z (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yfpeng@ippcaas.cn; fjqi@ippcaas.cn	peng, yu/GXW-2071-2022		National Genetically Modified Organisms Breeding Major Project [2008ZX08011-001]; Special Funding of State Key Laboratory of BPDIP, China [SKL2010SR01]	National Genetically Modified Organisms Breeding Major Project; Special Funding of State Key Laboratory of BPDIP, China	This work was supported by the National Genetically Modified Organisms Breeding Major Project (2008ZX08011-001) and Special Funding of State Key Laboratory of BPDIP, China (SKL2010SR01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-69; Abdeen A, 2009, PLANT BIOTECHNOL J, V7, P266, DOI [10.1111/j.1467-7652.2008.00398.x, 10.1111/j.1467-7652.2009.00398.x]; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Baudo MM, 2006, PLANT BIOTECHNOL J, V4, P369, DOI 10.1111/j.1467-7652.2006.00193.x; Baudo Maria Marcela, 2009, V478, P247, DOI 10.1007/978-1-59745-379-0_15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks G, 2011, GM CROPS GLOBAL SOCI; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; CRUZ CMV, 1984, J GEN MICROBIOL, V130, P2983; Deng PJ, 2008, J SCI FOOD AGR, V88, P2401, DOI 10.1002/jsfa.3371; Dubouzet JG, 2007, J EXP BOT, V58, P3309, DOI 10.1093/jxb/erm179; FAO/WHO, 2009, FOOD DER MOD BIOT, VSecond; Gregersen PL, 2005, TRANSGENIC RES, V14, P887, DOI 10.1007/s11248-005-1526-y; James C., 2010, GLOBAL STATUS COMMER; Joung JG, 2009, PLANT PHYSIOL, V151, P1758, DOI 10.1104/pp.109.145169; Kogel KH, 2010, P NATL ACAD SCI USA, V107, P6198, DOI 10.1073/pnas.1001945107; Kuiper HA, 2003, CURR OPIN BIOTECH, V14, P238, DOI 10.1016/S0958-1669(03)00021-1; Montero M, 2011, PLANT BIOTECHNOL J, V9, P693, DOI 10.1111/j.1467-7652.2010.00572.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ouakfaoui SE, 2004, PLANT J, V41, P791; Ren YF, 2009, J GENET GENOMICS, V36, P629, DOI 10.1016/S1673-8527(08)60155-1; Tu GM, 2006, CN, Patent No. [1840655A, 1840655]; Tu JM, 2003, PLANT BIOTECHNOL J, V1, P155, DOI 10.1046/j.1467-7652.2003.00012.x; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; VANETTEN HD, 1983, PHYTOCHEMISTRY, V22, P2291, DOI 10.1016/S0031-9422(00)80164-8	28	9	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37078	10.1371/journal.pone.0037078	http://dx.doi.org/10.1371/journal.pone.0037078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606331	Green Published, gold			2022-12-27	WOS:000305338200062
J	Polizzotti, BD; Arab, S; Kuhn, B				Polizzotti, Brian D.; Arab, Shima; Kuehn, Bernhard			Intrapericardial Delivery of Gelfoam Enables the Targeted Delivery of Periostin Peptide after Myocardial Infarction by Inducing Fibrin Clot Formation	PLOS ONE			English	Article							CONTROLLED-RELEASE POLYMER; SYSTEMIC DELIVERY; OCULAR DEVICE; CARDIAC-HYPERTROPHY; TGF-BETA; PROLIFERATION; EXPRESSION; INSULIN; REPAIR; HEART	Background: Administration of a recombinant peptide of Periostin (rPN) has recently been shown to stimulate cardiomyocyte proliferation and angiogensis after myocardial infarction (MI) [1]. However, strategies for targeting the delivery of rPN to the heart are lacking. Intrapericardial administration of drug-eluting hydrogels may provide a clinically viable strategy for increasing myocardial retention, therapeutic efficacy, and bioactivity of rPN and to decrease systemic re-circulation. Methods and Results: We investigated the ability of intrapericardial injections of drug-eluting hydrogels to deliver and prolong the release of rPN to the myocardium in a large animal model of myocardial infarction. Gelfoam is an FDA-approved hemostatic material commonly used in surgery, and is known to stimulate fibrin clot formation. We show that Gelfoam disks loaded with rPN, when implanted within the pericardium or peritoneum of mammals becomes encapsulated within a non-fibrotic fibrin-rich hydrogel, prolonging the in vitro and in vivo release of rPN. Administration into the pericardial cavity of pigs, following a complete occlusion of the left anterior descending artery, leads to greater induction of cardiomyocyte mitosis, increased cardiomyocyte cell cycle activity, and enhanced angiogenesis compared to direct injection of rPN alone. Conclusions: The results of this study suggest that intrapericardial drug delivery of Gelfoam, enhanced by triggered clot formation, can be used to effectively deliver rPN to the myocardium in a clinically relevant model of myocardial infarction. The work presented here should enhance the translational potential of pharmaceutical-based strategies that must be targeted to the myocardium.	[Polizzotti, Brian D.; Arab, Shima; Kuehn, Bernhard] Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA; [Polizzotti, Brian D.; Kuehn, Bernhard] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Polizzotti, BD (corresponding author), Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA.	brian.polizzotti@childrens.harvard.edu; bkuhn@enders.tch.harvard.edu	Polizzotti, Brian/K-1617-2019		NIH [K08HL085143, R01HL106302-01]; Department of Cardiology; Translational Investigator Service at Children's Hospital Boston;  [NIH T32HL007572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106302, K08HL085143, T32HL007572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Cardiology; Translational Investigator Service at Children's Hospital Boston; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BDP was supported with an institutional training grant (NIH T32HL007572). This work was supported by the NIH (K08HL085143, R01HL106302-01), the Department of Cardiology, and the Translational Investigator Service at Children's Hospital Boston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2008, HURSTS HEART, P724; ARNAD AG, 1986, NEUROSURGERY, V18, P223, DOI 10.1227/00006123-198602000-00022; Barbolt TA, 2001, NEUROL RES, V23, P537, DOI 10.1179/016164101101198794; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55; Chan JM, 2010, P NATL ACAD SCI USA, V107, P2213, DOI 10.1073/pnas.0914585107; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Hamalainen KM, 1998, J CONTROL RELEASE, V56, P273, DOI 10.1016/S0168-3659(98)00094-7; Hirsh J, 2001, CHEST, V119, p64S, DOI 10.1378/chest.119.1_suppl.64S; Howard MA, 2003, BRAIN RES PROTOC, V10, P125, DOI 10.1016/S1385-299X(02)00202-7; Johnatty SE, 2000, J MOL CELL CARDIOL, V32, P805, DOI 10.1006/jmcc.2000.1122; Kobayashi H, 2008, CARDIOVASC RES, V79, P611, DOI 10.1093/cvr/cvn154; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Ladage D, 2011, GENE THER; Laham RJ, 2003, CATHETER CARDIO INTE, V58, P375, DOI 10.1002/ccd.10378; Lee YC, 1997, J PHARM SCI, V86, P430, DOI 10.1021/js960423s; Lee YC, 1997, J PHARM SCI, V86, P1361, DOI 10.1021/js970191c; Lin CC, 2009, PHARM RES-DORDR, V26, P631, DOI 10.1007/s11095-008-9801-2; Maurer FW, 1940, AM J PHYSIOL, V129, P0635, DOI 10.1152/ajplegacy.1940.129.3.635; Morawiecki A, 1995, COLLAGEN CONTAINING; NADKARNI SR, 1993, PHARMACEUT RES, V10, P109, DOI 10.1023/A:1018985332376; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Scott RC, 2007, BIOTECHNOL BIOENG, V96, P795, DOI 10.1002/bit.21233; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Simamora P, 1996, J PHARM SCI, V85, P1128, DOI 10.1021/js960176s; Simamora P, 1998, INT J PHARM, V170, P209, DOI 10.1016/S0378-5173(98)00141-0; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stanton LW, 2000, CIRC RES, V86, P939, DOI 10.1161/01.RES.86.9.939; TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Wang DJ, 2003, HYPERTENSION, V42, P88, DOI 10.1161/01.HYP.0000074905.22908.A6; Woo YJ, 2007, J THORAC CARDIOV SUR, V133, P927, DOI 10.1016/j.jtcvs.2006.07.057; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104	38	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36788	10.1371/journal.pone.0036788	http://dx.doi.org/10.1371/journal.pone.0036788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590609	Green Published, gold			2022-12-27	WOS:000305336400036
J	Yang, MJ; Lv, YZ; Xiao, JF; Wu, HZ; Zheng, HJ; Liu, Q; Zhang, YX; Wang, QY				Yang, Minjun; Lv, Yuanzhi; Xiao, Jingfan; Wu, Haizhen; Zheng, Huajun; Liu, Qin; Zhang, Yuanxing; Wang, Qiyao			Edwardsiella Comparative Phylogenomics Reveal the New Intra/Inter-Species Taxonomic Relationships, Virulence Evolution and Niche Adaptation Mechanisms	PLOS ONE			English	Article							SECRETION SYSTEM; TARDA STRAINS; III SECRETION; ICTALURI; MEMBRANE; IDENTIFICATION; SEQUENCE; TURBOT; GENES; PCR	Edwardsiella bacteria are leading fish pathogens causing huge losses to aquaculture industries worldwide. E. tarda is a broad-host range pathogen that infects more than 20 species of fish and other animals including humans while E. ictaluri is host-adapted to channel catfish causing enteric septicemia of catfish (ESC). Thus, these two species consist of a useful comparative system for studying the intricacies of pathogen evolution. Here we present for the first time the phylogenomic comparisons of 8 genomes of E. tarda and E. ictaluri isolates. Genome-based phylogenetic analysis revealed that E. tarda could be separate into two kinds of genotypes (genotype I, EdwGI and genotype II, EdwGII) based on the sequence similarity. E. tarda strains of EdwGI were clustered together with the E. ictaluri lineage and showed low sequence conservation to E. tarda strains of EdwGII. Multilocus sequence analysis (MLSA) of 48 distinct Edwardsiella strains also supports the new taxonomic relationship of the lineages. We identified the type III and VI secretion systems (T3SS and T6SS) as well as iron scavenging related genes that fulfilled the criteria of a key evolutionary factor likely facilitating the virulence evolution and adaptation to a broad range of hosts in EdwGI E. tarda. The surface structure-related genes may underlie the adaptive evolution of E. ictaluri in the host specification processes. Virulence and competition assays of the null mutants of the representative genes experimentally confirmed their contributive roles in the evolution/niche adaptive processes. We also reconstructed the hypothetical evolutionary pathway to highlight the virulence evolution and niche adaptation mechanisms of Edwardsiella. This study may facilitate the development of diagnostics, vaccines, and therapeutics for this under-studied pathogen.	[Yang, Minjun; Lv, Yuanzhi; Xiao, Jingfan; Wu, Haizhen; Liu, Qin; Zhang, Yuanxing; Wang, Qiyao] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China; [Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China	East China University of Science & Technology	Yang, MJ (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	oaiwqiyao@ecust.edu.cn	Yang, Minjun/AGJ-3201-2022	Yang, Minjun/0000-0002-3324-1498	National High Technology Research and Development Program of China [2008AA092501]; Ministry of Agriculture of China [CARS-50]; Shanghai Leading Academic Discipline Project [B505]; National Special Fund for State Key Laboratory of Bioreactor Engineering [2060204]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Special Fund for State Key Laboratory of Bioreactor Engineering	This work was supported by grants from the National High Technology Research and Development Program of China (2008AA092501), Ministry of Agriculture of China (No. CARS-50), Shanghai Leading Academic Discipline Project (No. B505) as well as the National Special Fund for State Key Laboratory of Bioreactor Engineering (No. 2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P72, DOI 10.1007/0-387-30746-x_4; Acharya M, 2007, COMP IMMUNOL MICROB, V30, P33, DOI 10.1016/j.cimid.2006.10.003; AMANDI A, 1982, APPL ENVIRON MICROB, V43, P1380, DOI 10.1128/AEM.43.6.1380-1384.1982; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baek JH, 2007, FEMS MICROBIOL LETT, V277, P254, DOI 10.1111/j.1574-6968.2007.00965.x; Baya AM, 1997, J WILDLIFE DIS, V33, P517, DOI 10.7589/0090-3558-33.3.517; Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998; BOCKEMUHL J, 1971, PATHOL MICROBIOL, V37, P393, DOI 10.1159/000162341; Castro N, 2006, J FISH DIS, V29, P541, DOI 10.1111/j.1365-2761.2006.00750.x; Castro N, 2011, DIS AQUAT ORGAN, V95, P253, DOI 10.3354/dao02363; Chamnongpol S, 2002, MOL MICROBIOL, V45, P711, DOI 10.1046/j.1365-2958.2002.03041.x; Chappey C, 2007, COMPUTATIONAL GENOMI, P109; Cheng S, 2010, VACCINE, V28, P2716, DOI 10.1016/j.vaccine.2010.01.023; Dumpala PR, 2009, PROTEOMICS, V9, P1353, DOI 10.1002/pmic.200800652; EWING W. H., 1965, INT BULL BACTERIOL NOMENCL TAXONOM, V15, P33; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Golub V, 2010, INFECTION, V38, P487, DOI 10.1007/s15010-010-0057-5; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; HAWKE JP, 1981, INT J SYST BACTERIOL, V31, P396, DOI 10.1099/00207713-31-4-396; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; Jovanovic G, 1996, J BACTERIOL, V178, P1936, DOI 10.1128/jb.178.7.1936-1945.1996; Kawai T, 2011, INFECTION, V39, P171, DOI 10.1007/s15010-011-0080-1; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kumar G, 2007, AQUACULTURE, V272, P98, DOI 10.1016/j.aquaculture.2007.08.054; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lai TH, 2009, J BACTERIOL, V191, P693, DOI 10.1128/JB.01218-08; Lan J, 2008, J APPL MICROBIOL, V105, P644, DOI 10.1111/j.1365-2672.2008.03779.x; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; LOBB CJ, 1993, APPL ENVIRON MICROB, V59, P2830, DOI 10.1128/AEM.59.9.2830-2836.1993; Loprasert S, 2005, BIOCHEM BIOPH RES CO, V331, P1324, DOI 10.1016/j.bbrc.2005.04.050; Maiti NK, 2008, AQUACULTURE, V280, P60, DOI 10.1016/j.aquaculture.2008.04.025; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; Morrison Edward E., 1994, Journal of Aquatic Animal Health, V6, P101, DOI 10.1577/1548-8667(1994)006&lt;0101:OOOCCA&gt;2.3.CO;2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEI M, 1986, MOL BIOL EVOL, V3, P418; Panangala VS, 2006, AQUAC RES, V37, P49, DOI 10.1111/j.1365-2109.2005.01394.x; Panangala VS, 2005, J APPL MICROBIOL, V99, P657, DOI 10.1111/j.1365-2672.2005.02626.x; Partridge SR, 2003, J BACTERIOL, V185, P6371, DOI 10.1128/JB.185.21.6371-6384.2003; Rogge ML, 2011, APPL ENVIRON MICROB, V77, P4293, DOI 10.1128/AEM.00195-11; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Soest JJ, 2011, INFECT DIS STUDIES Z; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; TAMURA K, 1988, J CLIN MICROBIOL, V26, P2343, DOI 10.1128/JCM.26.11.2343-2346.1988; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Thune RL, 1999, J AQUAT ANIM HEALTH, V11, P358, DOI 10.1577/1548-8667(1999)011&lt;0358:AAMOEI&gt;2.0.CO;2; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; Wang QY, 2007, ARCH MICROBIOL, V188, P433, DOI 10.1007/s00203-007-0261-6; Wang QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007646; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wang X, 2010, FISH SHELLFISH IMMUN, V29, P1082, DOI 10.1016/j.fsi.2010.08.025; Wang X, 2009, FISH SHELLFISH IMMUN, V27, P469, DOI 10.1016/j.fsi.2009.06.013; Wang YM, 2011, J APPL MICROBIOL, V111, P1337, DOI 10.1111/j.1365-2672.2011.05166.x; Wipat A, 1996, MICROBIOL-UK, V142, P3067, DOI 10.1099/13500872-142-11-3067; Xiao JF, 2008, AQUAC RES, V40, P13, DOI 10.1111/j.1365-2109.2008.02101.x; Xu CX, 2006, PROTEOMICS, V6, P462, DOI 10.1002/pmic.200500219; Xu LL, 2010, ARCH MICROBIOL, V192, P1039, DOI 10.1007/s00203-010-0635-z; YAMAMOTO S, 1994, J BIOCHEM-TOKYO, V115, P868, DOI 10.1093/oxfordjournals.jbchem.a124432; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	66	76	79	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36987	10.1371/journal.pone.0036987	http://dx.doi.org/10.1371/journal.pone.0036987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590641	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400050
J	Yang, TT; Puckerin, A; Colecraft, HM				Yang, Tingting; Puckerin, Akil; Colecraft, Henry M.			Distinct RGK GTPases Differentially Use alpha 1-and Auxiliary beta-Binding-Dependent Mechanisms to Inhibit Ca(V)1.2/Ca(V)2.2 Channels	PLOS ONE			English	Article							GATED CA2+ CHANNELS; PROTEIN-KINASE-C; CA(V)1.2 CHANNELS; CALCIUM-CHANNELS; REM; SUBUNIT; RAD; TRAFFICKING; CALMODULIN; EXPRESSION	Ca(V)1/Ca(V)2 channels, comprised of pore-forming alpha(1) and auxiliary (beta,alpha(2)delta) subunits, control diverse biological responses in excitable cells. Molecules blocking Ca(V)1/Ca(V)2 channel currents (I-Ca) profoundly regulate physiology and have many therapeutic applications. Rad/Rem/Rem2/Gem GTPases (RGKs) strongly inhibit Ca(V)1/Ca(V)2 channels. Understanding how RGKs block I-Ca is critical for insights into their physiological function, and may provide design principles for developing novel Ca(V)1/Ca(V)2 channel inhibitors. The RGK binding sites within Ca(V)1/Ca(V)2 channel complexes responsible for I-Ca inhibition are ambiguous, and it is unclear whether there are mechanistic differences among distinct RGKs. All RGKs bind beta subunits, but it is unknown if and how this interaction contributes to I-Ca inhibition. We investigated the role of RGK/beta interaction in Rem inhibition of recombinant Ca(V)1.2 channels, using a mutated beta (beta(2aTM)) selectively lacking RGK binding. Rem blocked beta(2aTM)-reconstituted channels (74% inhibition) less potently than channels containing wild-type beta(2a) (96% inhibition), suggesting the prevalence of both beta-binding-dependent and independent modes of inhibition. Two mechanistic signatures of Rem inhibition of Ca(V)1.2 channels (decreased channel surface density and open probability), but not a third (reduced maximal gating charge), depended on Rem binding to beta. We identified a novel Rem binding site in Ca(V)1.2 alpha(1C) N-terminus that mediated beta-binding-independent inhibition. The Ca(V)2.2 alpha(1B) subunit lacks the Rem binding site in the N-terminus and displays a solely beta-binding-dependent form of channel inhibition. Finally, we discovered an unexpected functional dichotomy amongst distinct RGKs- while Rem and Rad use both beta-binding-dependent and independent mechanisms, Gem and Rem2 use only a beta-binding-dependent method to inhibit Ca(V)1.2 channels. The results provide new mechanistic perspectives, and reveal unexpected variations in determinants, underlying inhibition of Ca(V)1.2/Ca(V)2.2 channels by distinct RGK GTPases.	[Yang, Tingting; Puckerin, Akil; Colecraft, Henry M.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA	Columbia University	Yang, TT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10027 USA.	ty2190@columbia.edu; hc2405@columbia.edu			National Institutes of Health [RO1 HL069911, RO1 HL084332]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069911, R01HL084332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to HMC from the National Institutes of Health (RO1 HL069911 and RO1 HL084332). HMC is an Established Investigator of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekonda TS, 2011, NEUROBIOL DIS, V41, P62, DOI 10.1016/j.nbd.2010.08.020; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Beguin P, 2007, J BIOL CHEM, V282, P11509, DOI 10.1074/jbc.M606423200; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Correll RN, 2007, J BIOL CHEM, V282, P28431, DOI 10.1074/jbc.M706176200; Crump SM, 2006, AM J PHYSIOL-HEART C, V291, pH1959, DOI 10.1152/ajpheart.00956.2005; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Fang K, 2011, J PHYSIOL-LONDON, V589, P4437, DOI 10.1113/jphysiol.2011.214247; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Kochegarov AA, 2003, CELL CALCIUM, V33, P145, DOI 10.1016/S0143-4160(02)00239-7; Kolosov A, 2010, PAIN MED, V11, P262, DOI 10.1111/j.1526-4637.2009.00741.x; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; PANG C, 2010, CHANNELS AUSTIN, V4; Sasaki T, 2005, J BIOL CHEM, V280, P9308, DOI 10.1074/jbc.M413773200; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Seu L, 2006, J GEN PHYSIOL, V128, P605, DOI 10.1085/jgp.200609631; Tateyama M, 2003, CIRCULATION, V107, P3216, DOI 10.1161/01.CIR.0000070936.65183.97; Triggle DJ, 2007, BIOCHEM PHARMACOL, V74, P1, DOI 10.1016/j.bcp.2007.01.016; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Wang G, 2010, CIRC RES, V106, P317, DOI 10.1161/CIRCRESAHA.109.208272; Xu XH, 2010, CIRC RES, V107, P620, DOI 10.1161/CIRCRESAHA.110.224717; Xu XH, 2009, PHYSIOLOGY, V24, P210, DOI 10.1152/physiol.00010.2009; Yang T, 2007, NAT CHEM BIOL, V3, P795, DOI 10.1038/nchembio.2007.42; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203	40	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37079	10.1371/journal.pone.0037079	http://dx.doi.org/10.1371/journal.pone.0037079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590648	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400057
J	Huang, CY; Chen, JY; Wu, SC; Tan, CH; Tzeng, RY; Lu, PJ; Wu, YF; Chen, RH; Wu, YC				Huang, Chun-Yi; Chen, Jia-Yun; Wu, Shu-Chun; Tan, Chieh-Hsiang; Tzeng, Ruei-Ying; Lu, Pei-Ju; Wu, Yu-Feng; Chen, Ruey-Hwa; Wu, Yi-Chun			C. elegans EIF-3.K Promotes Programmed Cell Death through CED-3 Caspase	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; INTERMEDIATE-FILAMENTS; INDUCED APOPTOSIS; CRYSTAL-STRUCTURE; DNA-DEGRADATION; GENETIC-CONTROL; PROTEIN; NEMATODE; HOMOLOG; SUBUNIT	Programmed cell death (apoptosis) is essential for the development and homeostasis of metazoans. The central step in the execution of programmed cell death is the activation of caspases. In C. elegans, the core cell death regulators EGL-1(a BH3 domain-containing protein), CED-9 (Bcl-2), and CED-4 (Apaf-1) act in an inhibitory cascade to activate the CED-3 caspase. Here we have identified an additional component eif-3.K (eukaryotic translation initiation factor 3 subunit k) that acts upstream of ced-3 to promote programmed cell death. The loss of eif-3. K reduced cell deaths in both somatic and germ cells, whereas the overexpression of eif-3.K resulted in a slight but significant increase in cell death. Using a cell-specific promoter, we show that eif-3.K promotes cell death in a cell-autonomous manner. In addition, the loss of eif-3.K significantly suppressed cell death-induced through the overexpression of ced-4, but not ced-3, indicating a distinct requirement for eif-3.K in apoptosis. Reciprocally, a loss of ced-3 suppressed cell death induced by the overexpression of eif-3.K. These results indicate that eif-3.K requires ced-3 to promote programmed cell death and that eif-3. K acts upstream of ced-3 to promote this process. The EIF-3. K protein is ubiquitously expressed in embryos and larvae and localizes to the cytoplasm. A structure-function analysis revealed that the 61 amino acid long WH domain of EIF-3.K, potentially involved in protein-DNA/RNA interactions, is both necessary and sufficient for the cell death-promoting activity of EIF-3. K. Because human eIF3k was able to partially substitute for C. elegans eif-3. K in the promotion of cell death, this WH domain-dependent EIF-3.K-mediated cell death process has potentially been conserved throughout evolution.	[Huang, Chun-Yi; Chen, Jia-Yun; Wu, Shu-Chun; Tan, Chieh-Hsiang; Tzeng, Ruei-Ying; Wu, Yu-Feng; Wu, Yi-Chun] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chen, Jia-Yun; Lu, Pei-Ju; Chen, Ruey-Hwa] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan; [Chen, Ruey-Hwa] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10764, Taiwan; [Wu, Yi-Chun] Natl Taiwan Univ, Ctr Syst Biol, Taipei 10764, Taiwan; [Wu, Yi-Chun] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Ruey-Hwa] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Wu, Yi-Chun] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, CY (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	rhchen@gate.sinica.edu.tw; yichun@ntu.edu.tw	Wu, Yi-Chun/F-7934-2012; Chen, Ruey-Hwa/G-6121-2019	Wu, Yi-Chun/0000-0002-8621-4098; Chen, Ruey-Hwa/0000-0001-8124-5832; Tzeng, Ruei-Ying/0000-0002-9009-9483; Tan, Chieh-Hsiang/0000-0002-5432-0160	National Taiwan University [10R70602A3]; National Science Council (Taiwan)	National Taiwan University(National Taiwan University); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by a National Taiwan University grant (10R70602A3) and the National Science Council (Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; BRENNER S, 1974, GENETICS, V77, P71; Browning KS, 2001, TRENDS BIOCHEM SCI, V26, P284, DOI 10.1016/S0968-0004(01)01825-4; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Chen L, 2008, CURR BIOL, V18, P1025, DOI 10.1016/j.cub.2008.06.065; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; De Martelaere K, 2007, CELL SIGNAL, V19, P278, DOI 10.1016/j.cellsig.2006.06.012; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Geng X, 2009, CELL DEATH DIFFER, V16, P1385, DOI 10.1038/cdd.2009.88; Geng X, 2008, NAT STRUCT MOL BIOL, V15, P1094, DOI 10.1038/nsmb.1488; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Guenther C, 1996, DEVELOPMENT, V122, P3509; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; Kelly WG, 1997, GENETICS, V146, P227; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; Ledwich D, 2000, METHOD ENZYMOL, V322, P76; Lin YM, 2008, J CELL SCI, V121, P2382, DOI 10.1242/jcs.021394; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Oshima RG, 2002, CELL DEATH DIFFER, V9, P486, DOI 10.1038/sj.cdd.4400988; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pourkarimi E, 2012, CELL DEATH DIFFER, V19, P406, DOI 10.1038/cdd.2011.104; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shaham S, 1999, GENETICS, V153, P1655; Shaham S, 1996, GENE DEV, V10, P578, DOI 10.1101/gad.10.5.578; Shen QF, 2009, MOL CELL BIOL, V29, P3881, DOI 10.1128/MCB.01509-08; Shen XY, 2004, FEBS LETT, V573, P139, DOI 10.1016/j.febslet.2004.07.071; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Wu DY, 1999, DEVELOPMENT, V126, P2021; Wu DY, 1997, J BIOL CHEM, V272, P21449, DOI 10.1074/jbc.272.34.21449; Wu YC, 2000, GENE DEV, V14, P536; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; YUAN JY, 1992, DEVELOPMENT, V116, P309; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	70	7	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36584	10.1371/journal.pone.0036584	http://dx.doi.org/10.1371/journal.pone.0036584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590572	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100043
J	Van Hout, AJM; Pinxten, R; Geens, A; Eens, M				Van Hout, Alain J. -M.; Pinxten, Rianne; Geens, Ann; Eens, Marcel			Non-Breeding Song Rate Reflects Nutritional Condition Rather than Body Condition	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SINGING BEHAVIOR; SEASONAL-CHANGES; BIRD SONG; TESTOSTERONE; MASS; EVOLUTION; TRAITS; TITS	Numerous studies have focused on song in songbirds as a signal involved in mate choice and intrasexual competition. It is expected that song traits such as song rate reflect individual quality by being dependent on energetic state or condition. While seasonal variation in bird song (i.e., breeding versus non-breeding song) and its neural substrate have received a fair amount of attention, the function and information content of song outside the breeding season is generally much less understood. Furthermore, typically only measures of condition involving body mass are examined with respect to song rate. Studies investigating a potential relationship between song rate and other indicators of condition, such as physiological measures of nutritional condition, are scant. In this study, we examined whether non-breeding song rate in male European starlings (Sturnus vulgaris) reflects plasma metabolite levels (high-density lipoproteins (HDL), albumin, triglycerides and cholesterol) and/or body mass. Song rate was significantly positively related to a principal component representing primarily HDL, albumin and cholesterol (and to a lesser degree plasma triglyceride levels). There was only a trend toward a significant positive correlation between song rate and body mass, and no significant correlation between body mass and the abovementioned principal component. Therefore, our results indicate that nutritional condition and body mass represent different aspects of condition, and that song rate reflects nutritional rather than body condition. Additionally, we also found that intra-individual song rate consistency (though not song rate itself) was significantly positively related to lutein levels, but not to body mass or nutritional condition. Together our results suggest that the relation between physiological measures of nutritional condition and song rate, as well as other signals, may present an interesting line of future research, both inside and outside the breeding season.	[Van Hout, Alain J. -M.; Pinxten, Rianne; Geens, Ann; Eens, Marcel] Univ Antwerp, Res Grp Ethol, Antwerp, Belgium	University of Antwerp	Van Hout, AJM (corresponding author), Univ Antwerp, Res Grp Ethol, Antwerp, Belgium.	alain.vanhout@ua.ac.be	Eens, Marcel/AAC-8466-2020		FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen) [G.0130.07]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen); University of Antwerp	FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen)(FWO); University of Antwerp	This study was supported by a research project (G.0130.07) to ME from FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). AVH was funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). AG was funded by FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). ME and RP were funded by the University of Antwerp and supported by FWO-Flanders (Fonds Wetenschappelijk Onderzoek - Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN PC, 1987, COMP BIOCHEM PHYS B, V87, P313, DOI 10.1016/0305-0491(87)90145-3; Alonso-Alvarez C, 2002, WATERBIRDS, V25, P253, DOI 10.1675/1524-4695(2002)025[0253:CIPBAB]2.0.CO;2; Andersson Malte, 1994; Ardia DR, 2006, COMP BIOCHEM PHYS A, V143, P62, DOI 10.1016/j.cbpa.2005.10.024; Atagan Y, 2012, ANIM BEHAV, V83, P69, DOI 10.1016/j.anbehav.2011.10.006; BALL GF, 1987, PHYSIOL ZOOL, V60, P191, DOI 10.1086/physzool.60.2.30158643; Ball GF, 2004, ANN NY ACAD SCI, V1016, P586, DOI 10.1196/annals.1298.043; Barnett CA, 2011, ETHOLOGY, V117, P28, DOI 10.1111/j.1439-0310.2010.01844.x; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Foerster K, 2002, J AVIAN BIOL, V33, P269, DOI 10.1034/j.1600-048X.2002.330309.x; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Goode EL, 2007, TWIN RES HUM GENET, V10, P703, DOI 10.1375/twin.10.5.703; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Hegyi G, 2010, NATURWISSENSCHAFTEN, V97, P567, DOI 10.1007/s00114-010-0672-0; Heimovics SA, 2011, NEUROSCIENCE, V182, P133, DOI 10.1016/j.neuroscience.2011.03.012; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; Kwiterovich PO, 2000, AM J CARDIOL, V86, p5L; Lailvaux SP, 2011, P ROY SOC B-BIOL SCI, V278, P321, DOI 10.1098/rspb.2010.1591; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; Pascalon-Pekelniczky A, 1998, VET RES, V29, P197; Pavlova DZ, 2007, BEHAVIOUR, V144, P663, DOI 10.1163/156853907781347835; Pinxten R, 2002, HORM BEHAV, V42, P307, DOI 10.1006/hbeh.2002.1824; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 2001, J NEUROENDOCRINOL, V13, P985, DOI 10.1046/j.1365-2826.2001.00723.x; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Van Hout AJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016326; Van Hout AJM, 2009, HORM BEHAV, V56, P564, DOI 10.1016/j.yhbeh.2009.09.010; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P11, DOI 10.1093/icb/42.1.11	36	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36547	10.1371/journal.pone.0036547	http://dx.doi.org/10.1371/journal.pone.0036547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590563	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100037
J	Leke, R; de Oliveira, DL; Mussulini, BHM; Pereira, MS; Kazlauckas, V; Mazzini, G; Hartmann, CR; Silveira, TR; Simonsen, M; Bak, LK; Waagepetersen, HS; Keiding, S; Schousboe, A; Portela, LV				Leke, Renata; de Oliveira, Diogo L.; Mussulini, Ben Hur M.; Pereira, Mery S.; Kazlauckas, Vanessa; Mazzini, Guilherme; Hartmann, Carolina R.; Silveira, Themis R.; Simonsen, Mette; Bak, Lasse K.; Waagepetersen, Helle S.; Keiding, Susanne; Schousboe, Arne; Portela, Luis V.			Impairment of the Organization of Locomotor and Exploratory Behaviors in Bile Duct-Ligated Rats	PLOS ONE			English	Article							MINIMAL HEPATIC-ENCEPHALOPATHY; CHRONIC LIVER-FAILURE; PORTACAVAL ANASTOMOSIS; MOVEMENT INITIATION; EXPERIMENTAL-MODELS; CIRRHOTIC-PATIENTS; MOTOR-ACTIVITY; HYPERAMMONEMIA; BRADYKINESIA; OBSTRUCTION	Hepatic encephalopathy (HE) arises from acute or chronic liver diseases and leads to several problems, including motor impairment. Animal models of chronic liver disease have extensively investigated the mechanisms of this disease. Impairment of locomotor activity has been described in different rat models. However, these studies are controversial and the majority has primarily analyzed activity parameters. Therefore, the aim of the present study was to evaluate locomotor and exploratory behavior in bile duct-ligated (BDL) rats to explore the spatial and temporal structure of behavior. Adult female Wistar rats underwent common bile duct ligation (BDL rats) or the manipulation of common bile duct without ligation (control rats). Six weeks after surgery, control and BDL rats underwent open-field, plus-maze and foot-fault behavioral tasks. The BDL rats developed chronic liver failure and exhibited a decrease in total distance traveled, increased total immobility time, smaller number of rearings, longer periods in the home base area and decreased percentage of time in the center zone of the arena, when compared to the control rats. Moreover, the performance of the BDL rats was not different from the control rats for the elevated plus-maze and foot-fault tasks. Therefore, the BDL rats demonstrated disturbed spontaneous locomotor and exploratory activities as a consequence of altered spatio-temporal organization of behavior.	[Leke, Renata; de Oliveira, Diogo L.; Mussulini, Ben Hur M.; Pereira, Mery S.; Kazlauckas, Vanessa; Mazzini, Guilherme; Portela, Luis V.] Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Porto Alegre, RS, Brazil; [Hartmann, Carolina R.] Hosp Clin Porto Alegre, Dept Pathol, Porto Alegre, RS, Brazil; [Silveira, Themis R.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Res Ctr, Expt Hepatol & Gastroenterol Lab, Porto Alegre, RS, Brazil; [Simonsen, Mette; Keiding, Susanne] Aarhus Univ Hosp, Positron Emiss Tomog Ctr, DK-8000 Aarhus, Denmark; [Keiding, Susanne] Aarhus Univ Hosp, Dept Med Hepatol & Gastroenterol 5, DK-8000 Aarhus, Denmark; [Bak, Lasse K.; Waagepetersen, Helle S.; Schousboe, Arne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Aarhus University; Aarhus University; University of Copenhagen	Leke, R (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Biochem, Porto Alegre, RS, Brazil.	renataleke@hotmail.com	Silveira, Themis/H-4286-2016; Portela, Luis V/I-3410-2014	Portela, Luis Valmor/0000-0001-6113-8466; Bak, Lasse K./0000-0003-0784-7864; Marins Mussulini, Ben Hur/0000-0003-4321-5709; Waagepetersen, Helle/0000-0003-4583-8379; Losch de Oliveira, Diogo/0000-0002-9028-6959; Schousboe, Arne/0000-0001-9600-402X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN)	This work has been supported by Brazilian funding agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Instituto Nacional de Ciencia e Tecnologia em Excitotoxicidade e Neuroprotecao (INCT-EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahboucha S, 2008, NEUROGASTROENT MOTIL, V20, P949, DOI 10.1111/j.1365-2982.2008.01132.x; Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Amodio P, 2005, METAB BRAIN DIS, V20, P115, DOI 10.1007/s11011-005-4149-3; Amodio P, 2004, METAB BRAIN DIS, V19, P253, DOI 10.1023/B:MEBR.0000043975.01841.de; Apelqvist C, 1999, BEHAV BRAIN RES, V106, P165, DOI 10.1016/S0166-4328(99)00104-7; Bruck J, 2011, J HEPATOL, V54, P251, DOI 10.1016/j.jhep.2010.06.035; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; CAMPBELL A, 1984, PHARMACOL BIOCHEM BE, V20, P875, DOI 10.1016/0091-3057(84)90010-8; Cauli O, 2007, EUR J NEUROSCI, V25, P2112, DOI 10.1111/j.1460-9568.2007.05435.x; Cauli O, 2006, J HEPATOL, V45, P654, DOI 10.1016/j.jhep.2006.06.019; Chan CY, 2004, EUR J CLIN INVEST, V34, P122, DOI 10.1111/j.1365-2362.2004.01295.x; Eilam D, 2003, BEHAV BRAIN RES, V142, P53, DOI 10.1016/S0166-4328(02)00382-0; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Giewekemeyer K, 2007, J HEPATOL, V46, P1034, DOI 10.1016/j.jhep.2007.01.038; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Hazell AS, 1999, P SOC EXP BIOL MED, V222, P99, DOI 10.1046/j.1525-1373.1999.d01-120.x; Joebges EM, 2003, J HEPATOL, V38, P273, DOI 10.1016/S0168-8278(02)00423-3; Jover R, 2005, J HEPATOL, V42, P659, DOI 10.1016/j.jhep.2004.12.030; Jover R, 2006, HEPATOLOGY, V43, P1257, DOI 10.1002/hep.21180; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Leke R, 2011, J NEUROCHEM, V117, P824, DOI 10.1111/j.1471-4159.2011.07244.x; MARTIN JR, 1983, PHARMACOL BIOCHEM BE, V18, P269, DOI 10.1016/0091-3057(83)90374-X; Mendez M, 2008, BEHAV BRAIN RES, V188, P32, DOI 10.1016/j.bbr.2007.10.019; Mendez M, 2009, BEHAV BRAIN RES, V198, P346, DOI 10.1016/j.bbr.2008.11.015; Oria M, 2010, HEPATOLOGY, V52, P2077, DOI 10.1002/hep.23938; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; SCOTTCONNER CEH, 1994, J SURG RES, V57, P316, DOI 10.1006/jsre.1994.1151; Sergeeva OA, 2005, NEUROSCIENCE, V134, P1091, DOI 10.1016/j.neuroscience.2005.05.031; TARTER RE, 1984, GASTROENTEROLOGY, V86, P1421; Violle N, 2009, BEHAV BRAIN RES, V203, P35, DOI 10.1016/j.bbr.2009.04.015; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; Weissenborn K, 2003, J HEPATOL, V39, P320, DOI 10.1016/S0168-8278(03)00295-2	34	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36322	10.1371/journal.pone.0036322	http://dx.doi.org/10.1371/journal.pone.0036322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586467	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000029
J	Luo, JX; Turner, MS				Luo, Jamie X.; Turner, Matthew S.			Evolving Sensitivity Balances Boolean Networks	PLOS ONE			English	Article							GENETIC NETWORKS; CELL; MODEL; ROBUSTNESS; FIBROBLASTS; EVOLUTION; PREDICTS; CLOCK; NOISY	We investigate the sensitivity of Boolean Networks (BNs) to mutations. We are interested in Boolean Networks as a model of Gene Regulatory Networks (GRNs). We adopt Ribeiro and Kauffman's Ergodic Set and use it to study the long term dynamics of a BN. We define the sensitivity of a BN to be the mean change in its Ergodic Set structure under all possible loss of interaction mutations. Insilico experiments were used to selectively evolve BNs for sensitivity to losing interactions. We find that maximum sensitivity was often achievable and resulted in the BNs becoming topologically balanced, i.e. they evolve towards network structures in which they have a similar number of inhibitory and excitatory interactions. In terms of the dynamics, the dominant sensitivity strategy that evolved was to build BNs with Ergodic Sets dominated by a single long limit cycle which is easily destabilised by mutations. We discuss the relevance of our findings in the context of Stem Cell Differentiation and propose a relationship between pluripotent stem cells and our evolved sensitive networks.	[Luo, Jamie X.; Turner, Matthew S.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Luo, Jamie X.; Turner, Matthew S.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Luo, JX (corresponding author), Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England.	m.s.turner@warwick.ac.uk	Turner, Matthew/D-1121-2011	Turner, Matthew/0000-0002-3441-678X	UK EPSRC (Engineering and Physical Sciences Research Council) [EP/E501311/1, EP/I005439/1]; Engineering and Physical Sciences Research Council [EP/I005439/1] Funding Source: researchfish; EPSRC [EP/I005439/1] Funding Source: UKRI	UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the UK EPSRC (Engineering and Physical Sciences Research Council) under grant numbers EP/E501311/1 and EP/I005439/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Ayed A, 2011, MOL BIOL INTELLIGENC, V1, p[65, 53], DOI DOI 10.1007/978-1-4419-8231-5-5; Azpeitia E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-134; Baron MH, 1993, CURR OPIN CELL BIOL, V5, P1050, DOI 10.1016/0955-0674(93)90091-4; Benitez M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-98; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Bornholdt S, 1998, PHYS REV LETT, V81, P236, DOI 10.1103/PhysRevLett.81.236; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Braunewell S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.060902; Burda Z, 2011, P NATL ACAD SCI USA, V108, P17263, DOI 10.1073/pnas.1109435108; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DERRIDA B, 1986, EUROPHYS LETT, V1, P45, DOI 10.1209/0295-5075/1/2/001; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Ge H, 2009, J COMPUT BIOL, V16, P119, DOI 10.1089/cmb.2007.0181; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; KNABE JF, 2006, ARTIF LIFE, V10, P15; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Qian XN, 2009, J THEOR BIOL, V257, P560, DOI 10.1016/j.jtbi.2008.12.023; Ribeiro AS, 2007, J THEOR BIOL, V247, P743, DOI 10.1016/j.jtbi.2007.04.020; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shmulevich I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.048701; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szejka A, 2007, EUR PHYS J B, V56, P373, DOI 10.1140/epjb/e2007-00135-2; Szejka A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021908; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707	44	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36010	10.1371/journal.pone.0036010	http://dx.doi.org/10.1371/journal.pone.0036010			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586459	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000021
J	Ravasi, G; Pelucchi, S; Trombini, P; Mariani, R; Tomosugi, N; Modignani, GL; Pozzi, M; Nemeth, E; Ganz, T; Hayashi, H; Barisani, D; Piperno, A				Ravasi, Giulia; Pelucchi, Sara; Trombini, Paola; Mariani, Raffaella; Tomosugi, Naohisa; Modignani, Giulia Litta; Pozzi, Matteo; Nemeth, Elizabeth; Ganz, Tomas; Hayashi, Hisao; Barisani, Donatella; Piperno, Alberto			Hepcidin Expression in Iron Overload Diseases Is Variably Modulated by Circulating Factors	PLOS ONE			English	Article							HEMOCHROMATOSIS; THALASSEMIA; DIAGNOSIS; SYSTEM; HFE	Hepcidin is a regulatory hormone that plays a major role in controlling body iron homeostasis. Circulating factors (holotransferrin, cytokines, erythroid regulators) might variably contribute to hepcidin modulation in different pathological conditions. There are few studies analysing the relationship between hepcidin transcript and related protein expression profiles in humans. Our aims were: a. to measure hepcidin expression at either hepatic, serum and urinary level in three paradigmatic iron overload conditions (hemochromatosis, thalassemia and dysmetabolic iron overload syndrome) and in controls; b. to measure mRNA hepcidin expression in two different hepatic cell lines (HepG2 and Huh-7) exposed to patients and controls sera to assess whether circulating factors could influence hepcidin transcription in different pathological conditions. Our findings suggest that hepcidin assays reflect hepatic hepcidin production, but also indicate that correlation is not ideal, likely due to methodological limits and to several post trascriptional events. In vitro study showed that THAL sera down-regulated, HFE-HH and C-NAFLD sera up-regulated hepcidin synthesis. HAMP mRNA expression in Huh-7 cells exposed to sera form C-Donors, HFE-HH and THAL reproduced, at lower level, the results observed in HepG2, suggesting the important but not critical role of HFE in hepcidin regulation.	[Ravasi, Giulia; Pelucchi, Sara; Modignani, Giulia Litta; Pozzi, Matteo; Piperno, Alberto] Univ Milano Bicocca, Dept Clin Med & Prevent, Monza, Italy; [Trombini, Paola; Mariani, Raffaella; Piperno, Alberto] S Gerardo Hosp, Ctr Diag & Treatment Hemochromatosis, Monza, Italy; [Tomosugi, Naohisa; Hayashi, Hisao] Kanazawa Med Univ, Dept Internal Med, Div Nephrol, Uchinada, Ishikawa, Japan; [Nemeth, Elizabeth; Ganz, Tomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Med, Los Angeles, CA 90095 USA; [Barisani, Donatella] Univ Milano Bicocca, Dept Expt Med, Monza, Italy; [Piperno, Alberto] Consortium Human Mol Genet, Monza, Italy	University of Milano-Bicocca; Kanazawa Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Milano-Bicocca	Ravasi, G (corresponding author), Univ Milano Bicocca, Dept Clin Med & Prevent, Monza, Italy.	alberto.piperno@unimib.it	Ganz, Tomas/AAN-3308-2020; Ganz, Tomas/D-4567-2009	Nemeth, Elizabeta/0000-0002-3477-2397; Pozzi, Matteo/0000-0001-8235-9313; Ganz, Tomas/0000-0002-2830-5469; Piperno, Alberto/0000-0002-0343-0204	PRIN [CUP H41J10000000001]; CARIPLO [CUP H51J09000950003]; Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082717] Funding Source: NIH RePORTER	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO(Fondazione Cariplo); Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by PRIN 2008 (CUP H41J10000000001) and CARIPLO 2009 (CUP H51J09000950003) to AP. SP was partially supported by Associazione per lo Studio dell'Emocromatosi +Fe - ONLUS, Monza, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barisani D, 2008, J HEPATOL, V49, P123, DOI 10.1016/j.jhep.2008.03.011; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Camaschella C, 2011, THESCIENTIFICWORLDJO, V11, P1357, DOI 10.1100/tsw.2011.130; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kaneko Y, 2010, J GASTROENTEROL, V45, P1163, DOI 10.1007/s00535-010-0259-8; Kattamis A, 2006, HAEMATOLOGICA, V91, P809; Kemna EHJM, 2008, BLOOD CELL MOL DIS, V40, P339, DOI 10.1016/j.bcmd.2007.10.002; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendler MH, 2005, LIVER INT, V25, P294, DOI 10.1111/j.1478-3231.2005.01052.x; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Murphy AT, 2007, BLOOD, V110, P1048, DOI 10.1182/blood-2006-11-057471; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Pantopoulos K, 2008, WORLD J GASTROENTERO, V14, P6893, DOI 10.3748/wjg.14.6893; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Piperno A, 2004, LIVER INT, V24, P471, DOI 10.1111/j.1478-3231.2004.0988.x; Piperno A, 2011, BLOOD, V117, P2953, DOI 10.1182/blood-2010-08-299859; Piperno A, 2009, WORLD J GASTROENTERO, V15, P538, DOI 10.3748/wjg.15.538; Riva A, 2008, WORLD J GASTROENTERO, V14, P4745, DOI 10.3748/wjg.14.4745; Ruivard M, 2009, J HEPATOL, V50, P1219, DOI 10.1016/j.jhep.2009.01.029; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Theurl I, 2010, BRIT J HAEMATOL, V148, P449, DOI 10.1111/j.1365-2141.2009.07961.x; Traglia M, 2011, J MED GENET, V48, P629, DOI 10.1136/jmedgenet-2011-100061; Trombini P, 2007, J HEPATOL, V46, P549, DOI 10.1016/j.jhep.2007.01.004; Trombini P, 2011, LIVER INT, V31, P994, DOI 10.1111/j.1478-3231.2011.02520.x; Tsochatzis E, 2010, J VIRAL HEPATITIS, V17, P800, DOI 10.1111/j.1365-2893.2009.01244.x; Vecchi C, 2010, HEPATOLOGY, V51, P654, DOI 10.1002/hep.23410; Weizer-Stern O, 2006, BRIT J HAEMATOL, V135, P129, DOI 10.1111/j.1365-2141.2006.06258.x	37	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36425	10.1371/journal.pone.0036425	http://dx.doi.org/10.1371/journal.pone.0036425			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586470	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000032
J	Vergnes, JN; Kaminski, M; Lelong, N; Musset, AM; Sixou, M; Nabet, C				Vergnes, Jean-Noel; Kaminski, Monique; Lelong, Nathalie; Musset, Anne-Marie; Sixou, Michel; Nabet, Cathy		EPIPAP Grp	Frequency and Risk Indicators of Tooth Decay among Pregnant Women in France: A Cross-Sectional Analysis	PLOS ONE			English	Article							ORAL-HEALTH STATUS; PRETERM BIRTH; DENTAL-CARIES; COUNT DATA; LIFE; PROGRESSION	Introduction: Little is known on the prevalence of tooth decay among pregnant women. Better knowledge of tooth decayrisk indicators during pregnancy could help to develop follow-up protocols for women at risk, along with better prevention strategies. The aim of this study was to assess the frequency of tooth decay and the number of decayed teeth per woman in a large sample of pregnant women in France, and to study associated risk indicators. Methods: A secondary cross-sectional analysis of data from a French multicentre case-control study was performed. The sample was composed of 1094 at-term women of six maternity units. A dental examination was carried out within 2 to 4 days post-partum. Socio-demographic and behavioural characteristics were obtained through a standardised interview with the women. Medical characteristics were obtained from the women's medical records. Risk indicators associated with tooth decay were identified using a negative binomial hurdle model. Results: 51.6% of the women had tooth decay. The mean number of decayed teeth among women having at least one was 3.1 (s.d. = 2.8). Having tooth decay was statistically associated with lower age (aOR = 1.58, 95% CI [1.03,2.45]), lower educational level (aOR = 1.53, 95% CI [1.06,2.23]) and dental plaque (aOR = 1.75, 95% CI [1.27,2.41]). The number of decayed teeth was associated with the same risk indicators and with non-French nationality and inadequate prenatal care. Discussion: The frequency of tooth decay and the number of decayed teeth among pregnant women were high. Oral health promotion programmes must continue to inform women and care providers about the importance of dental care before, during and after pregnancy. Future research should also assess the effectiveness of public policies related to oral health in target populations of pregnant women facing challenging social or economic situations.	[Vergnes, Jean-Noel; Kaminski, Monique; Lelong, Nathalie; Nabet, Cathy] INSERM, UMRS 953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Villejuif, France; [Vergnes, Jean-Noel; Sixou, Michel; Nabet, Cathy] Univ Toulouse 3, Dept Epidemiol, Fac Dent, F-31062 Toulouse, France; [Kaminski, Monique; Lelong, Nathalie] UMPC UnivP06, UMRS 953, Paris, France; [Musset, Anne-Marie] Univ Strasbourg, Fac Dent, Strasbourg, France; [Nabet, Cathy] Paris Descartes Univ, Fac Dent, Paris, France; [Nabet, Cathy] Charles Foix Hosp, Ivry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite	Vergnes, JN (corresponding author), INSERM, UMRS 953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Villejuif, France.	jn.vergnes@gmail.com	Nabet, Cathy/AAC-4008-2019; Vergnes, Jean-Noel/I-7688-2019; kayem, gilles/I-1776-2017	Vergnes, Jean-Noel/0000-0001-7322-6551; kayem, gilles/0000-0002-8218-8814; GOFFINET, Francois/0000-0001-9643-0299	National Programme for Hospital Clinical Research [PHRC2004, AOM04047]; National Institute of Health and Medical Research (INSERM)	National Programme for Hospital Clinical Research; National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This study was supported by the National Programme for Hospital Clinical Research (national PHRC2004, AOM04047) and National Institute of Health and Medical Research (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarslan ZZ, 2008, MED ORAL PATOL ORAL, V13, pE800; BERKEY CS, 1988, COMMUNITY DENT ORAL, V16, P83, DOI 10.1111/j.1600-0528.1988.tb01849.x; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Blondel B., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P729; Blondel B, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P552; Bonet M, 2010, PUBLIC HEALTH NUTR, V13, P1946, DOI 10.1017/S136898001000159X; Broadbent JM, 2006, CARIES RES, V40, P459, DOI 10.1159/000095643; Brown LJ, 2002, J AM DENT ASSOC, V133, P827, DOI 10.14219/jada.archive.2002.0296; Burt B A, 2001, J Dent Educ, V65, P1007; Dauphinot V, 2006, CETAF, V2006, P1; de Oliveira BH, 2006, J OROFAC PAIN, V20, P297; Greene JC., 1960, J AM DENT ASSOC, V61, P172, DOI 10.14219/jada.archive.1960.0177; Hescot P, 1997, Int Dent J, V47, P94; Khan A, 2011, INJURY PREV, V17, P266, DOI 10.1136/ip.2011.031740; Kumar Jayanth, 2009, N Y State Dent J, V75, P29; Laine MA, 2002, ACTA ODONTOL SCAND, V60, P257, DOI 10.1080/00016350260248210; Le Vu S, 2010, LANCET INFECT DIS, V10, P682, DOI 10.1016/S1473-3099(10)70167-5; McKenna L, 2006, J ADV NURS, V56, P636, DOI 10.1111/j.1365-2648.2006.04037.x; Mobeen N, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.010; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Nabet C, 2010, J CLIN PERIODONTOL, V37, P37, DOI 10.1111/j.1600-051X.2009.01503.x; National Institute for Clinical Excellence (NICE), DENT REC REC INT ROU; Paulander J, 2003, J CLIN PERIODONTOL, V30, P697, DOI 10.1034/j.1600-051X.2003.00357.x; Philibert M, 2008, BJOG-INT J OBSTET GY, V115, P1411, DOI 10.1111/j.1471-0528.2008.01860.x; Radnai M, 2007, COMMUNITY DENT HLTH, V24, P111; Raynaud D, 2005, DREES, V2005, P1; Reilly M, 2005, STAT MED, V24, P4009, DOI 10.1002/sim.2398; SHWARTZ M, 1984, ARCH ORAL BIOL, V29, P529, DOI 10.1016/0003-9969(84)90074-8; Silk H, 2008, AM FAM PHYSICIAN, V77, P1139; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Slack-Smith LM, 2007, AUST DENT J, V52, P205, DOI 10.1111/j.1834-7819.2007.tb00490.x; Tubert-Jeannin S, 2009, COMMUNITY DENT HLTH, V26, P23, DOI 10.1922/CDH_2226Jeannin06; Vergnes JN, 2011, ACTA ODONTOL SCAND, V69, P248, DOI 10.3109/00016357.2011.563242; World Health Organization, 1997, WHO OR HLTH SURV BAS, V4th	34	32	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e33296	10.1371/journal.pone.0033296	http://dx.doi.org/10.1371/journal.pone.0033296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586442	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000004
J	Kim, SU; Lee, JH; Kim, DY; Ahn, SH; Jung, KS; Choi, EH; Park, YN; Han, KH; Chon, CY; Park, JY				Kim, Seung Up; Lee, Ji Hoon; Kim, Do Young; Ahn, Sang Hoon; Jung, Kyu Sik; Choi, Eun Hee; Park, Young Nyun; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong			Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; STIFFNESS MEASUREMENT; TRANSIENT ELASTOGRAPHY; NONINVASIVE ASSESSMENT; ESOPHAGEAL-VARICES; CIRRHOSIS; RISK; MANAGEMENT; LAMIVUDINE; INFECTION	Background: Liver stiffness measurement (LSM) using transient elastography (FibroScan (R)) can assess liver fibrosis noninvasively. This study investigated whether LSM can predict the development of liver-related events (LREs) in chronic hepatitis B (CHB) patients showing histologically advanced liver fibrosis. Methods: Between March 2006 and April 2010, 128 CHB patients with who underwent LSM and liver biopsy (LB) before starting nucleot(s)ide analogues and showed histologically advanced fibrosis (>= F3) with a high viral loads [HBV DNA >= 2,000 IU/mL] were enrolled. All patients were followed regularly to detect LRE development, including hepatic decompensation (variceal bleeding, ascites, hepatic encephalopathy, spontaneous bacterial peritonitis, hepatorenal syndrome) and hepatocellular carcinoma (HCC). Results: The mean age of the patient (72 men, 56 women) was 52.2 years. During the median follow-up period [median 27.8 (12.6-61.6) months], LREs developed in 19 (14.8%) patients (five with hepatic decompensation, 13 with HCC, one with both). Together with age, multivariate analysis identified LSM as an independent predictor of LRE development [P<0.044; hazard ratio (HR), 1.038; 95% confidence interval (CI), 1.002-1.081]. When the study population was stratified into two groups using the optimal cutoff value (19 kPa), which maximized the sum of sensitivity (61.1%) and specificity (86.2%) from a time-dependent receiver operating characteristic curve, patients with LSM>19 kPa were at significantly greater risk than those with LSM <= 19 kPa for LRE development (HR, 7.176; 95% CI, 2.257-22.812; P = 0.001). Conclusion: LSM can be a useful predictor of LRE development in CHB patients showing histologically advanced liver fibrosis.	[Kim, Seung Up; Lee, Ji Hoon; Kim, Do Young; Ahn, Sang Hoon; Jung, Kyu Sik; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Choi, Eun Hee] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Seung Up; Kim, Do Young; Ahn, Sang Hoon; Han, Kwang-Hyub; Chon, Chae Yoon; Park, Jun Yong] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Park, Young Nyun; Han, Kwang-Hyub] Brain Korea 21 Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	DRPJY@yuhs.ac	Park, Jun Yong/H-7127-2019	Kim, Seung Up/0000-0002-9658-8050; Choi, Eunhee/0000-0002-3449-0672; Han, Kwang-Hyub/0000-0003-3960-6539; Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Young Nyun/0000-0003-0357-7967	grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]	grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R & D project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Fattovich G, 2002, AM J GASTROENTEROL, V97, P2886, DOI 10.1111/j.1572-0241.2002.07057.x; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Fung SK, 2005, J HEPATOL, V42, pS54, DOI 10.1016/j.jhep.2004.11.014; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Gines P, 1999, J AM SOC NEPHROL, V10, P1833; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; KATO Y, 1994, CANCER, V74, P2234, DOI 10.1002/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Kim BK, 2010, AM J GASTROENTEROL, V105, P1382, DOI 10.1038/ajg.2009.750; Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2; Kim SU, 2010, HEPATOL INT, V4, P673, DOI 10.1007/s12072-010-9201-7; Kim SU, 2012, PLOS ONE, V7; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; LIAW YF, 1989, LIVER, V9, P235; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin SM, 1999, HEPATOLOGY, V29, P971, DOI 10.1002/hep.510290312; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; Masuzaki R, 2008, J CLIN GASTROENTEROL, V42, P839, DOI 10.1097/MCG.0b013e318050074f; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; Min Albert D, 2007, Clin Liver Dis, V11, P851, DOI 10.1016/j.cld.2007.08.003; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; OON CJ, 1992, CANCER CHEMOTH PHARM, V31, pS137, DOI 10.1007/BF00687123; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; 김화숙, 2007, [The Korean Journal of Medicine, 대한내과학회지], V72, P459; Patch D, 2001, WORLD J GASTROENTERO, V7, P466; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sobesky R, 1999, GASTROENTEROLOGY, V116, P378, DOI 10.1016/S0016-5085(99)70135-6; Such J, 1998, CLIN INFECT DIS, V27, P669, DOI 10.1086/514940; Suzuki Y, 1999, J HEPATOL, V30, P743, DOI 10.1016/S0168-8278(99)80123-8; Talaat Zakareya, 2010, NILE LIVER J, V1, P49; TANAKA R, 1987, LIVER, V7, P316; Wong GLH, 2011, ANTIVIR THER, V16, P165, DOI 10.3851/IMP1726	46	76	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36676	10.1371/journal.pone.0036676	http://dx.doi.org/10.1371/journal.pone.0036676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574212	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800109
J	Urbaniak, MD; Guther, MLS; Ferguson, MAJ				Urbaniak, Michael D.; Guther, M. Lucia S.; Ferguson, Michael A. J.			Comparative SILAC Proteomic Analysis of Trypanosoma brucei Bloodstream and Procyclic Lifecycle Stages	PLOS ONE			English	Article							TRANSCRIPTIONAL CONTROL; GENE-EXPRESSION; AMINO-ACIDS; METABOLISM	The protozoan parasite Trypanosoma brucei has a complex digenetic lifecycle between a mammalian host and an insect vector, and adaption of its proteome between lifecycle stages is essential to its survival and virulence. We have optimized a procedure for growing Trypanosoma brucei procyclic form cells in conditions suitable for stable isotope labeling by amino acids in culture (SILAC) and report a comparative proteomic analysis of cultured procyclic form and bloodstream form T. brucei cells. In total we were able to identify 3959 proteins and quantify SILAC ratios for 3553 proteins with a false discovery rate of 0.01. A large number of proteins (10.6%) are differentially regulated by more the 5-fold between lifecycle stages, including those involved in the parasite surface coat, and in mitochondrial and glycosomal energy metabolism. Our proteomic data is broadly in agreement with transcriptomic studies, but with significantly larger fold changes observed at the protein level than at the mRNA level.	[Urbaniak, Michael D.; Guther, M. Lucia S.; Ferguson, Michael A. J.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee	Urbaniak, MD (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	m.j.ferguson@dundee.ac.uk		Ferguson, Michael/0000-0003-1321-8714; Urbaniak, Michael/0000-0003-2745-9420	Wellcome Trust [085622, 083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust (www.wellcome.ac.uk) Programme Grant (085622) and Strategic Award (083481). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; BRUN R, 1979, ACTA TROP, V36, P289; Carrington M, 1998, MOL BIOCHEM PARASIT, V91, P153, DOI 10.1016/S0166-6851(97)00190-4; Carrington M, 2009, PARASITES, P8; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; GIBSON WC, 1988, J MOL BIOL, V201, P315, DOI 10.1016/0022-2836(88)90140-4; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; Harsha HC, 2008, NAT PROTOC, V3, P505, DOI 10.1038/nprot.2008.2; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	30	115	116	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36619	10.1371/journal.pone.0036619	http://dx.doi.org/10.1371/journal.pone.0036619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574199	gold, Green Published, Green Accepted			2022-12-27	WOS:000305349800096
J	Clavijo-Baquet, S; Bozinovic, F				Clavijo-Baquet, Sabrina; Bozinovic, Francisco			Testing the Fitness Consequences of the Thermoregulatory and Parental Care Models for the Origin of Endothermy	PLOS ONE			English	Article							MAXIMUM METABOLIC-RATE; AEROBIC CAPACITY MODEL; BODY-MASS; UNDERSTANDING ENDOTHERMY; GENETIC CORRELATIONS; WILD RODENT; EVOLUTION; BASAL; BIRDS; RATES	The origin of endothermy is a puzzling phenomenon in the evolution of vertebrates. To address this issue several explicative models have been proposed. The main models proposed for the origin of endothermy are the aerobic capacity, the thermoregulatory and the parental care models. Our main proposal is that to compare the alternative models, a critical aspect is to determine how strongly natural selection was influenced by body temperature, and basal and maximum metabolic rates during the evolution of endothermy. We evaluate these relationships in the context of three main hypotheses aimed at explaining the evolution of endothermy, namely the parental care hypothesis and two hypotheses related to the thermoregulatory model (thermogenic capacity and higher body temperature models). We used data on basal and maximum metabolic rates and body temperature from 17 rodent populations, and used intrinsic population growth rate (R-max) as a global proxy of fitness. We found greater support for the thermogenic capacity model of the thermoregulatory model. In other words, greater thermogenic capacity is associated with increased fitness in rodent populations. To our knowledge, this is the first test of the fitness consequences of the thermoregulatory and parental care models for the origin of endothermy.	[Clavijo-Baquet, Sabrina; Bozinovic, Francisco] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Clavijo-Baquet, S (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Alameda 340, Santiago, Chile.	sclavijo@bio.puc.cl		Clavijo-Baquet, Sabrina/0000-0002-9784-9144	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [AT- 24100180]; Fondo de Areas Prioritarias (FONDAP) [1501-0001]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo de Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	Funded by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) AT- 24100180 PhD thesis fellowship to SC and Fondo de Areas Prioritarias (FONDAP) 1501-0001 (Program 1) to FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2003, AM NAT, V162, P821; [Anonymous], 2002, CAUSE CORRELATION BI; Bennett AF, 2000, EVOLUTION, V54, P1768; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Berryman A., 1999, PRINCIPLES POPULATIO; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boratynski Z, 2010, FUNCT ECOL, V24, P1252, DOI 10.1111/j.1365-2435.2010.01764.x; Boratynski Z, 2009, FUNCT ECOL, V23, P330, DOI 10.1111/j.1365-2435.2008.01505.x; BOZINOVIC F, 1989, FUNCT ECOL, V3, P173, DOI 10.2307/2389298; BOZINOVIC F, 1992, PHYSIOL ZOOL, V65, P921, DOI 10.1086/physzool.65.5.30158550; Bozinovic F, 2007, EVOL ECOL RES, V9, P547; Caswell, 2000, MATRIX POPULATION MO; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; CROMPTON AW, 1978, NATURE, V272, P333, DOI 10.1038/272333a0; DAVISON AC, 1986, BIOMETRIKA, V73, P555, DOI 10.2307/2336519; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dutenhoffer MS, 1996, PHYSIOL ZOOL, V69, P1232, DOI 10.1086/physzool.69.5.30164255; Else PL, 2004, PHYSIOL BIOCHEM ZOOL, V77, P950, DOI 10.1086/422767; Estay SA, 2011, POPUL ECOL, V53, P53, DOI 10.1007/s10144-010-0216-7; Farmer CG, 2000, AM NAT, V155, P326, DOI 10.1086/303323; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Grigg GC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P982, DOI 10.1086/425188; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hayes JP, 2010, J EVOLUTION BIOL, V23, P1868, DOI 10.1111/j.1420-9101.2010.02053.x; HAYES JP, 1995, EVOLUTION, V49, P836, DOI 10.1111/j.1558-5646.1995.tb02320.x; HEINRICH B, 1977, AM NAT, V111, P623, DOI 10.1086/283196; HENNEMANN WW, 1983, OECOLOGIA, V56, P104, DOI 10.1007/BF00378224; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; Hulbert AJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P869, DOI 10.1086/422768; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Jansa SA, 2009, J MAMMAL, V90, P1083, DOI 10.1644/08-MAMM-A-318.1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kemp TS, 2006, ZOOL J LINN SOC-LOND, V147, P473, DOI 10.1111/j.1096-3642.2006.00226.x; Koteja P, 2000, P ROY SOC B-BIOL SCI, V267, P479, DOI 10.1098/rspb.2000.1025; Koteja P, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1043, DOI 10.1086/423741; KOTEJA P, 1987, COMP BIOCHEM PHYS A, V87, P205, DOI 10.1016/0300-9629(87)90447-6; KOTEJA P, 1991, FUNCT ECOL, V5, P56, DOI 10.2307/2389555; Lomolino M. V., 2005, BIOGEOGRAPHY; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1978, AM NAT, V112, P1, DOI 10.1086/283249; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nespolo RF, 2005, EVOLUTION, V59, P1829, DOI 10.1111/j.0014-3820.2005.tb01829.x; Nespolo RF, 2003, EVOLUTION, V57, P1679; Nespolo RF, 2011, TRENDS ECOL EVOL, V26, P414, DOI 10.1016/j.tree.2011.04.004; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2006, ANAL PHYLOGENETICS E; Pugesek BH, 2003, STRUCTURAL EQUATION; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; RUBEN J, 1995, ANNU REV PHYSIOL, V57, P69, DOI 10.1146/annurev.ph.57.030195.000441; Sadowska ET, 2009, EVOLUTION, V63, P1530, DOI 10.1111/j.1558-5646.2009.00641.x; Sadowska ET, 2005, EVOLUTION, V59, P672; Shipley B, 1997, AM NAT, V149, P1113, DOI 10.1086/286041; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Stearns S.C., 1992, pi; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338	62	14	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37069	10.1371/journal.pone.0037069	http://dx.doi.org/10.1371/journal.pone.0037069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606328	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400056
J	Ni, H; Li, L; Liu, G; Hu, SQ				Ni, He; Li, Lin; Liu, Guang; Hu, Song-Qing			Inhibition Mechanism and Model of an Angiotensin I-Converting Enzyme (ACE)-Inhibitory Hexapeptide from Yeast (Saccharomyces cerevisiae)	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PEPTIDES; BINDING; DOMAIN; ACID; BIOAVAILABILITY; IDENTIFICATION; PURIFICATION; HYDROLYSATE; CAPTOPRIL	Angiotensin I-converting enzyme (ACE) has an important function in blood pressure regulation. ACE-inhibitory peptides can lower blood pressure by inhibiting ACE activity. Based on the sequence of an ACE-inhibitory hexapeptide (TPTQQS) purified from yeast, enzyme kinetics experiments, isothermal titration calorimetry (ITC), and a docking simulation were performed. The hexapeptide was found to inhibit ACE in a non-competitive manner, as supported by the structural model. The hexapeptide bound to ACE via interactions of the N-terminal Thr1, Thr3, and Gln4 residues with the residues on the lid structure of ACE, and the C-terminal Ser6 attracted the zinc ion, which is vital for ACE catalysis. The displacement of the zinc ion from the active site resulted in the inhibition of ACE activity. The structural model based on the docking simulation was supported by experiments in which the peptide was modified. This study provides a new inhibitory mechanism of ACE by a peptide which broads our knowledge for drug designing against enzyme targets.	[Ni, He; Li, Lin; Liu, Guang; Hu, Song-Qing] S China Univ Technol, Coll Light Ind & Food Sci, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou, Guangdong, Peoples R China	South China University of Technology	Ni, H (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Guangdong Prov Key Lab Green Proc Nat Prod & Prod, Guangzhou, Guangdong, Peoples R China.	fesqhu@scut.edu.cn	Liu, Guang/AAB-9356-2022	Hu, Song-Qing/0000-0003-3262-8911	National Natural Science Fund of China [31171630]; Fundamental Research Funds for the Central Universities, SCUT [2012ZG0007]; Program for New Century Excellent Talents in University [NCET-10-0362]; Major State Basic Research Development Program of China (973 Program) [2012CB720801]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	The authors are grateful for the financial support from the National Natural Science Fund of China (Grant No. 31171630), the Fundamental Research Funds for the Central Universities, SCUT (Grant No. 2012ZG0007), the Program for New Century Excellent Talents in University (Grant No. NCET-10-0362) and the Major State Basic Research Development Program of China (973 Program) (Grant No. 2012CB720801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akif M, 2010, J MOL BIOL, V400, P502, DOI 10.1016/j.jmb.2010.05.024; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Cai LF, 2001, ANAL BIOCHEM, V299, P19, DOI 10.1006/abio.2001.5397; Ciulli A, 2005, BIOCHEM SOC T, V33, P767, DOI 10.1042/BST0330767; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Gowthaman U, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S14; Hariprasad G, 2010, INT J BIOL MACROMOLE; Jang JH, 2011, FOOD CHEM; KOIKE H, 1980, HYPERTENSION, V2, P299, DOI 10.1161/01.HYP.2.3.299; Li GH, 2004, NUTR RES, V24, P469, DOI [10.1016/S0271-5317(04)00058-2, 10.1016/j.nutres.2003.10.014]; Li GH, 2007, ASIA PAC J CLIN NUTR, V16, P275; Liu YQ, 2011, PESTIC BIOCHEM PHYS, V99, P39, DOI 10.1016/j.pestbp.2010.10.002; MATSUFUJI H, 1994, BIOSCI BIOTECH BIOCH, V58, P2244, DOI 10.1271/bbb.58.2244; NAKAMURA Y, 1995, J DAIRY SCI, V78, P777, DOI 10.3168/jds.S0022-0302(95)76689-9; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Ni H, 2012, CURR ANAL CHEM, V8, P180, DOI 10.2174/157341112798472224; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Pedroche J, 2002, J SCI FOOD AGR, V82, P960, DOI 10.1002/jsfa.1126; Pina AS, 2009, J MOL RECOGNIT, V22, P162, DOI 10.1002/jmr.905; Qian ZJ, 2007, J AGR FOOD CHEM, V55, P8398, DOI 10.1021/jf0710635; Quiros A, 2008, INT DAIRY J, V18, P279, DOI 10.1016/j.idairyj.2007.09.006; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Si DY, 2009, DRUG METAB DISPOS, V37, P629, DOI 10.1124/dmd.108.023416; Sturrock E.D., 2004, CELL MOL LIFE SCI, V61, P2677, DOI [10.1007/s00018-004-4239-0, DOI 10.1007/S00018-004-4239-0]; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Tsai JS, 2006, PROCESS BIOCHEM, V41, P1282, DOI 10.1016/j.procbio.2005.12.026; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; Wang JP, 2008, FOOD CHEM, V111, P302, DOI 10.1016/j.foodchem.2008.03.059; Watermeyer JM, 2008, BIOCHEMISTRY-US, V47, P5942, DOI 10.1021/bi8002605; Watermeyer JM, 2006, BIOCHEMISTRY-US, V45, P12654, DOI 10.1021/bi061146z; WEI L, 1992, J BIOL CHEM, V267, P13398; Yu Y, 2006, PEPTIDES, V27, P2950, DOI 10.1016/j.peptides.2006.05.025	38	72	73	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37077	10.1371/journal.pone.0037077	http://dx.doi.org/10.1371/journal.pone.0037077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606330	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400058
J	Rogers, ED; Ramalie, JR; McMurray, EN; Schmidt, JV				Rogers, Eric D.; Ramalie, Jenniffer R.; McMurray, Erin N.; Schmidt, Jennifer V.			Localizing Transcriptional Regulatory Elements at the Mouse Dlk1 Locus	PLOS ONE			English	Article							FETAL ANTIGEN 1; INHIBITS ADIPOCYTE DIFFERENTIATION; IMPRINTED NONCODING RNA; EGF-LIKE REPEATS; FACTOR-I PREF-1; DELTA-LIKE; GTL2 GENE; EMBRYONIC-DEVELOPMENT; POLAR OVERDOMINANCE; STEM-CELLS	Much effort has focused recently on determining the mechanisms that control the allele-specific expression of genes subject to genomic imprinting, yet imprinting regulation is only one aspect of configuring appropriate expression of these genes. Imprinting control mechanisms must interact with those regulating the tissue-specific expression pattern of each imprinted gene in a cluster. Proper expression of the imprinted Delta-like 1 (Dlk1) - Maternally expressed gene 3 (Meg3) gene pair is required for normal fetal development in mammals, yet the mechanisms that control tissue-specific expression of these genes are unknown. We have used a combination of in vivo and in vitro expression assays to localize cis-regulatory elements that may regulate Dlk1 expression in the mouse embryo. A bacterial artificial chromosome transgene encompassing the Dlk1 gene and 77 kb of flanking sequence conferred expression in most endogenous Dlk1-expressing tissues. In combination with previous transgenic data, these experiments localize the majority of Dlk1 cis-regulatory elements to a 41 kb region upstream of the gene. Cross-species sequence conservation was used to further define potential regulatory elements, several of which functioned as enhancers in a luciferase expression assay. Two of these elements were able to drive expression of a lacZ reporter transgene in Dlk1-expressing tissues in the mouse embryo. The sequence proximal to Dlk1 therefore contains at least two discrete regions that may regulate tissue-specificity of Dlk1 expression.	[Rogers, Eric D.; Ramalie, Jenniffer R.; McMurray, Erin N.; Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rogers, ED (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jvs@uic.edu			National Institutes of Health [HD042013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grant HD042013 from the National Institutes of Health awarded to JVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Bachmann E, 1996, J REPROD FERTIL, V107, P279; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Costaglioli P, 2001, FEBS LETT, V509, P413, DOI 10.1016/S0014-5793(01)03205-7; Couture JP, 2011, BIOCHEM J, V438, P93, DOI 10.1042/BJ20101840; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Fowden AL, 2011, PROG BIOPHYS MOL BIO, V106, P281, DOI 10.1016/j.pbiomolbio.2010.11.005; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kaufman M.H, 1999, ATLAS MOUSE DEV; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Larsen JB, 1996, LANCET, V347, P191, DOI 10.1016/S0140-6736(96)90374-8; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; McLaughlin D, 2006, GENE EXPR PATTERNS, V6, P394, DOI 10.1016/j.modgep.2005.09.007; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Moore KA, 1997, P NATL ACAD SCI USA, V94, P4011, DOI 10.1073/pnas.94.8.4011; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Okamoto M, 1998, ENDOCR RES, V24, P515, DOI 10.3109/07435809809032640; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Ruiz-Hidalgo MJ, 2002, EXP CELL RES, V274, P178, DOI 10.1006/excr.2001.5464; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Shen YN, 2009, BMB REP, V42, P691, DOI 10.5483/BMBRep.2009.42.10.691; Smas CM, 1998, J BIOL CHEM, V273, P31751, DOI 10.1074/jbc.273.48.31751; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Steshina EY, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-44; Takada S, 2000, CURR BIOL, V10, P1135, DOI 10.1016/S0960-9822(00)00704-1; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Takemori H, 2001, EUR J BIOCHEM, V268, P205, DOI 10.1046/j.1432-1327.2001.01847.x; Tornehave D, 1996, HISTOCHEM CELL BIOL, V106, P535; Tunster SJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/283013; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Yevtodiyenko A, 2002, MAMM GENOME, V13, P633, DOI 10.1007/s00335-002-2208-1; Yevtodiyenko A, 2004, GENOMICS, V84, P277, DOI 10.1016/j.ygeno.2004.04.005; Zhou Y, 2012, J MOL ENDOCRINOL ONL; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	64	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36483	10.1371/journal.pone.0036483	http://dx.doi.org/10.1371/journal.pone.0036483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606264	Green Published, gold			2022-12-27	WOS:000305338200031
J	Hammouda, A; Selmi, S; Pearce-Duvet, J; Chokri, MA; Arnal, A; Gauthier-Clerc, M; Boulinier, T				Hammouda, Abdessalem; Selmi, Slaheddine; Pearce-Duvet, Jessica; Chokri, Mohamed Ali; Arnal, Audrey; Gauthier-Clerc, Michel; Boulinier, Thierry			Maternal Antibody Transmission in Relation to Mother Fluctuating Asymmetry in a Long-Lived Colonial Seabird: The Yellow-Legged Gull Larus michahellis	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; IMMUNE-RESPONSE; TESTOSTERONE; YOLK; QUALITY; GROWTH; COSTS; BIRD; MECHANISM; ECOLOGY	Female birds transfer antibodies to their offspring via the egg yolk, thus possibly providing passive immunity against infectious diseases to which hatchlings may be exposed, thereby affecting their fitness. It is nonetheless unclear whether the amount of maternal antibodies transmitted into egg yolks varies with female quality and egg laying order. In this paper, we investigated the transfer of maternal antibodies against type A influenza viruses (anti-AIV antibodies) by a long-lived colonial seabird, the yellow-legged gull (Larus michahellis), in relation to fluctuating asymmetry in females, i.e. the random deviation from perfect symmetry in bilaterally symmetric morphological and anatomical traits. In particular, we tested whether females with greater asymmetry transmitted fewer antibodies to their eggs, and whether within-clutch variation in yolk antibodies varied according to the maternal level of fluctuating asymmetry. We found that asymmetric females were in worse physical condition, produced fewer antibodies, and transmitted lower amounts of antibodies to their eggs. We also found that, within a given clutch, yolk antibody level decreased with egg laying order, but this laying order effect was more pronounced in clutches laid by the more asymmetric females. Overall, our results support the hypothesis that maternal quality interacts with egg laying order in determining the amount of maternal antibodies transmitted to the yolks. They also highlight the usefulness of fluctuating asymmetry as a sensitive indicator of female quality and immunocompetence in birds.	[Hammouda, Abdessalem; Selmi, Slaheddine; Chokri, Mohamed Ali] UR, Fac Sci Gabes, Dept Sci Vie, UR11ES86, Gabes, Tunisia; [Pearce-Duvet, Jessica; Arnal, Audrey; Boulinier, Thierry] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34033 Montpellier, France; [Gauthier-Clerc, Michel] Ctr Rech Tour Valat, Arles, France	Universite de Gabes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Hammouda, A (corresponding author), UR, Fac Sci Gabes, Dept Sci Vie, UR11ES86, Gabes, Tunisia.	h_abdesslem@yahoo.fr	arnal, audrey/ABR-6358-2022; Slaheddine, Selmi/AAD-1495-2021	Slaheddine, Selmi/0000-0002-7204-9159; HAMMOUDA, Abdessalem/0000-0003-4078-7592; BOULINIER, Thierry/0000-0002-5898-7667	Agence Inter-etablissements de Recherche pour le Developpement, France; Chateaubriand Postdoctoral Fellowship (France); National Science Foundation; CNRS (French National Centre for Scientific Research); ANR (French National Research Agency)	Agence Inter-etablissements de Recherche pour le Developpement, France; Chateaubriand Postdoctoral Fellowship (France); National Science Foundation(National Science Foundation (NSF)); CNRS (French National Centre for Scientific Research)(Centre National de la Recherche Scientifique (CNRS)); ANR (French National Research Agency)(French National Research Agency (ANR))	This work was supported by ARDIGRIP project (Agence Inter-etablissements de Recherche pour le Developpement, France), Chateaubriand Postdoctoral Fellowship (France), National Science Foundation (International Research Fellowship Program), CNRS (French National Centre for Scientific Research), and ANR (French National Research Agency; Evolutionary Ecology of the Maternal Transfer Antibodies grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2007, ECOL RES, V22, P282, DOI 10.1007/s11284-006-0022-z; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Blount JD, 2002, P ROY SOC B-BIOL SCI, V269, P29, DOI 10.1098/rspb.2001.1840; BOLTON M, 1993, CAN J ZOOL, V71, P273, DOI 10.1139/z93-039; Bosch M, 2000, J APPL ECOL, V37, P369, DOI 10.1046/j.1365-2664.2000.00501.x; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Brown CR, 2002, J EVOLUTION BIOL, V15, P1067, DOI 10.1046/j.1420-9101.2002.00474.x; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; CRAMP S, 1998, BIRDS W PALEARCTIC C; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Fair JM, 1999, P ROY SOC B-BIOL SCI, V266, P1735, DOI 10.1098/rspb.1999.0840; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; HARRIS M. P., 1964, IBIS, V106, P432, DOI 10.1111/j.1474-919X.1964.tb03725.x; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Heeb P, 1998, P ROY SOC B-BIOL SCI, V265, P51, DOI 10.1098/rspb.1998.0263; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Isenmann P, 2005, OISEAUX TUNISIE; Klasing K.C., 1999, OSTRICH, V69, P32; Klasing KC, 1998, POULTRY SCI, V77, P1119, DOI 10.1093/ps/77.8.1119; Lipar JL, 1999, AUK, V116, P231, DOI 10.2307/4089471; Mateos C, 2008, ANIM BEHAV, V75, P1629, DOI 10.1016/j.anbehav.2007.10.016; MOHAMMED HO, 1986, AVIAN DIS, V30, P398, DOI 10.2307/1590547; Moller A.P., 1997, DEV STABILITY EVOLUT; Moller AP, 2006, INFECT GENET EVOL, V6, P133, DOI 10.1016/j.meegid.2005.03.005; Moller AP, 1999, J EVOLUTION BIOL, V12, P450; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Oro D, 2007, ANIM CONSERV, V10, P117, DOI 10.1111/j.1469-1795.2006.00082.x; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Polak M., 2003, CAUSES CONSEQUENCES; Potti J, 1999, OECOLOGIA, V120, P1, DOI 10.1007/s004420050826; Read AF, 2000, SCIENCE, V290, P1104, DOI 10.1126/science.290.5494.1104; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Saino N, 2001, J EVOLUTION BIOL, V14, P95, DOI 10.1046/j.1420-9101.2001.00252.x; Saino N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P211, DOI 10.1086/527454; SAS Statistical Institute, 1998, SAS STAT US GUID VER; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; SLAGSVOLD T, 1984, AUK, V101, P685, DOI 10.2307/4086895; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Vidal E, 1998, BIODIVERS CONSERV, V7, P1013, DOI 10.1023/A:1008805030578; WATSON PJ, 1994, TRENDS ECOL EVOL, V9, P21, DOI 10.1016/0169-5347(94)90227-5	54	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e34966	10.1371/journal.pone.0034966	http://dx.doi.org/10.1371/journal.pone.0034966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590497	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100003
J	Heyndrickx, L; Heath, A; Sheik-Khalil, E; Alcami, J; Bongertz, V; Jansson, M; Malnati, M; Montefiori, D; Moog, C; Morris, L; Osmanov, S; Polonis, V; Ramaswamy, M; Sattentau, Q; Tolazzi, M; Schuitemaker, H; Willems, B; Wrin, T; Fenyo, EM; Scarlatti, G				Heyndrickx, Leo; Heath, Alan; Sheik-Khalil, Enas; Alcami, Jose; Bongertz, Vera; Jansson, Marianne; Malnati, Mauro; Montefiori, David; Moog, Christiane; Morris, Lynn; Osmanov, Saladin; Polonis, Victoria; Ramaswamy, Meghna; Sattentau, Quentin; Tolazzi, Monica; Schuitemaker, Hanneke; Willems, Betty; Wrin, Terri; Fenyo, Eva Maria; Scarlatti, Gabriella			International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCLONAL-ANTIBODIES; TYPE-2 HIV-2; SUBTYPE; TRANSMISSION; REPLICATION; SEROTYPES; EVOLUTION; VACCINES; RECEPTOR	Background: Neutralizing antibodies provide markers for vaccine-induced protective immunity in many viral infections. By analogy, HIV-1 neutralizing antibodies induced by immunization may well predict vaccine effectiveness. Assessment of neutralizing antibodies is therefore of primary importance, but is hampered by the fact that we do not know which assay(s) can provide measures of protective immunity. An international collaboration (NeutNet) involving 18 different laboratories previously compared different assays using monoclonal antibodies (mAbs) and soluble CD4 (Phase I study). Methods: In the present study (Phase II), polyclonal reagents were evaluated by 13 laboratories. Each laboratory evaluated nine plasmas against an 8 virus panel representing different genetic subtypes and phenotypes. TriMab, a mixture of three mAbs, was used as a positive control allowing comparison of the results with Phase I in a total of nine different assays. The assays used either uncloned virus produced in peripheral blood mononuclear cells (PBMCs) (Virus Infectivity Assays, VIA), or Env (gp160)-pseudotyped viruses (pseudoviruses, PSV) produced in HEK293T cells from molecular clones or from uncloned virus. Target cells included PBMC and genetically engineered cell lines in either single- or multiple-cycle infection format. Infection was quantified by using a range of assay read-outs including extra- or intra-cellular p24 antigen detection, luciferase, beta-galactosidase or green fluorescent protein (GFP) reporter gene expression. Findings: Using TriMab, results of Phase I and Phase II were generally in agreement for six of the eight viruses tested and confirmed that the PSV assay is more sensitive than PBMC (p = 0.014). Comparisons with the polyclonal reagents showed that sensitivities were dependent on both virus and plasma. Conclusions: Here we further demonstrate clear differences in assay sensitivities that were dependent on both the neutralizing reagent and the virus. Consistent with the Phase I study, we recommend parallel use of PSV and VIA for vaccine evaluation.	[Heyndrickx, Leo; Willems, Betty] Inst Trop Med, Biomed Dept, Virol Unit, B-2000 Antwerp, Belgium; [Alcami, Jose] Inst Salud Carlos III, Unidad Immunopatol SIDA, Madrid, Spain; [Bongertz, Vera] Fundacao Oswaldo Cruz, Lab AIDS & Mol Immunol, Rio De Janeiro, Brazil; [Sheik-Khalil, Enas; Fenyo, Eva Maria] Lund Univ, Dept Lab Med, Lund, Sweden; [Heath, Alan; Ramaswamy, Meghna; Scarlatti, Gabriella] Natl Inst Biol Stand & Controls, Potters Bar, Herts, England; [Jansson, Marianne] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Malnati, Mauro] Ist Sci San Raffaele, Unit Human Virol, I-20132 Milan, Italy; [Montefiori, David] Duke Univ, Med Ctr, Durham, NC USA; [Moog, Christiane] Univ Strasbourg, Strasbourg, France; [Morris, Lynn] Natl Inst Communicable Dis, Johannesburg, South Africa; [Osmanov, Saladin] WHO, UNAIDS HIV Vaccine Initiat, CH-1211 Geneva, Switzerland; [Polonis, Victoria] Henry Jackson Fdn Adv Mil Med, Dept Vaccine Res, Rockville, MD USA; [Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Tolazzi, Monica] Ist Sci San Raffaele, Viral Evolut & Transmiss Unit, I-20132 Milan, Italy; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Wrin, Terri] Monogram Biosci, San Francisco, CA USA	Institute of Tropical Medicine (ITM); Instituto de Salud Carlos III; Fundacao Oswaldo Cruz; Lund University; National Institute for Biological Standards & Control; Karolinska Institutet; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Duke University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National Institute for Communicable Diseases (NICD); UNAIDS; World Health Organization; University of Oxford; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Amsterdam; Academic Medical Center Amsterdam	Heyndrickx, L (corresponding author), Inst Trop Med, Biomed Dept, Virol Unit, B-2000 Antwerp, Belgium.	lheyndrickx@itg.be	C, Moog/E-3962-2016; Tolazzi, Monica/ABH-5652-2020; scarlatti, gabriella/H-1482-2018; Malnati, Mauro/AAN-4207-2020; Alcami, Pepe/T-2242-2018; Morris, Lynn/V-3941-2018	C, Moog/0000-0002-0916-156X; scarlatti, gabriella/0000-0003-2316-2689; Alcami, Pepe/0000-0003-0023-7377; Morris, Lynn/0000-0003-3961-7828; Jansson, Marianne/0000-0001-6536-8146; Malnati, mauro/0000-0001-5355-1680; Ramaswamy, Meghna/0000-0003-0333-8544	European Community [LSSP-CT-2004-012190]; EUROPRISE-Network of Excellence [LSHP CT-2006-037611]; NGIN [201433]; WHO/UNAIDS HIV Vaccine Initiative; Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Departamento de DST, Aids e Hepatites Virais, MS-Brasil [147/08]; Medical Research Council [G0000635] Funding Source: researchfish; MRC [G0000635] Funding Source: UKRI	European Community(European Commission); EUROPRISE-Network of Excellence; NGIN; WHO/UNAIDS HIV Vaccine Initiative(World Health Organization); Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Departamento de DST, Aids e Hepatites Virais, MS-Brasil; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The project "NeutNet: Standardisation of HIV neutralization assays to be used in vaccine research and clinical trials'' was sponsored by the European Community under grant numbers LSSP-CT-2004-012190, EUROPRISE-Network of Excellence grant number LSHP CT-2006-037611 and NGIN grant number 201433. The WHO/UNAIDS HIV Vaccine Initiative provided partial support for the conduct of the project, including the activities of the Repository, such as preparation and shipment of reagents. Additional support was received from The Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD), and Departamento de DST, Aids e Hepatites Virais, MS-Brasil 147/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, Nature, V449, P390; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Davis D, 2003, J MED VIROL, V71, P332, DOI 10.1002/jmv.10490; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; DSOUZA MP, 1991, AIDS, V5, P1061, DOI 10.1097/00002030-199109000-00001; Esparza J, 2003, CURR MOL MED, V3, P183, DOI 10.2174/1566524033479825; Fenyo E M, 1996, AIDS, V10 Suppl A, pS97, DOI 10.1097/00002030-199601001-00014; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Garcia-Perez J, 2008, HIV MED, V9, P160, DOI 10.1111/j.1468-1293.2007.00540.x; Gonzalez N, 2010, J ANTIMICROB CHEMOTH, V65, P2493, DOI 10.1093/jac/dkq379; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Heyndrickx L, 2008, J VIROL METHODS, V148, P166, DOI 10.1016/j.jviromet.2007.11.009; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Lauren A, 2006, J GEN VIROL, V87, P595, DOI 10.1099/vir.0.81409-0; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; LJUNGGREN K, 1987, J IMMUNOL, V139, P2263; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; McCarthy M, 2003, LANCET, V361, P755, DOI 10.1016/S0140-6736(03)12669-4; McElrath MJ, 2000, AIDS RES HUM RETROV, V16, P907, DOI 10.1089/08892220050042846; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; Morner A, 1999, J VIROL, V73, P2343; Nordqvist Anna, 2005, Methods Mol Biol, V304, P273; Nyambi PN, 1996, J VIROL, V70, P6235, DOI 10.1128/JVI.70.9.6235-6243.1996; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1325, DOI 10.1089/aid.1994.10.1325; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Polonis VR, 2001, AIDS RES HUM RETROV, V17, P69, DOI 10.1089/088922201750056807; Quakkelaar ED, 2007, J VIROL, V81, P8533, DOI 10.1128/JVI.02816-06; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sahin GO, 2012, J VIROL, V86, P961, DOI 10.1128/JVI.06315-11; Sahin GO, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001084; SCARLATTI G, 1993, J INFECT DIS, V168, P207, DOI 10.1093/infdis/168.1.207; Shi Y, 2002, AIDS RES HUM RETROV, V18, P957, DOI 10.1089/088922202760265623; Todd CA, 2011, J IMMUNOLOGICAL METH; von Bubnoff Andreas, 2010, IAVI Rep, V14, P8; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996	43	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36438	10.1371/journal.pone.0036438	http://dx.doi.org/10.1371/journal.pone.0036438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590544	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100029
J	Lin, C; Zhao, XY; Li, L; Liu, HY; Cao, K; Wan, Y; Liu, XY; Nie, CL; Liu, L; Tong, AP; Deng, HX; Li, J; Yuan, Z; Wei, YQ				Lin, Chao; Zhao, Xin-Yu; Li, Lei; Liu, Huan-Yi; Cao, Kang; Wan, Yang; Liu, Xin-Yu; Nie, Chun-Lai; Liu, Lei; Tong, Ai-Ping; Deng, Hong-Xin; Li, Jiong; Yuan, Zhu; Wei, Yu-Quan			NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin	PLOS ONE			English	Article							BCL-X-L; INDUCED APOPTOSIS; CARCINOMA CELLS; DOWN-REGULATION; BH3-ONLY MEMBER; TUMOR-GROWTH; P53 STATUS; IN-VIVO; DEATH; GENE	Ovarian cancer is the most common cause of death from gynecologic malignancy. Deregulation of p53 and/or p73-associated apoptotic pathways contribute to the platinum-based resistance in ovarian cancer. NOXA, a pro-apoptotic BH3-only protein, is identified as a transcription target of p53 and/or p73. In this study, we found that genetic variants of Bcl-2 proteins exist among cisplatin-sensitive and -resistant ovarian cancer cells, and the responses of NOXA and Bax to cisplatin are regulated mainly by p53. We further evaluated the effect of NOXA on cisplatin. NOXA induced apoptosis and sensitized A2780s and SKOV3 cells to cisplatin in vitro and in vivo. The effects were mediated by elevated Bax expression, enhanced caspase activation, release of Cyt C and Smac into the cytosol. Furthermore, gene silencing of Bax or Smac significantly attenuated NOXA and/or cisplatin-induced apoptosis in chemosensitive A2780s cells, whereas overexpression of Bax or addition of Smac-N7 peptide significantly increased NOXA and/or cisplatin-induced apoptosis in chemoresistant SKOV3 cells. To our knowledge, these data suggest a new mechanism by which NOXA chemosensitized ovarian cancer cells to cisplatin by inducing alterations in the Bax/Smac axis. Taken together, our findings show that NOXA is potentially useful as a chemosensitizer in ovarian cancer therapy.	[Lin, Chao; Zhao, Xin-Yu; Li, Lei; Wan, Yang; Liu, Xin-Yu; Nie, Chun-Lai; Liu, Lei; Tong, Ai-Ping; Deng, Hong-Xin; Li, Jiong; Yuan, Zhu; Wei, Yu-Quan] Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China; [Liu, Huan-Yi] Chengdu Mil Gen Hosp, Ctr Canc, Chengdu, Peoples R China; [Cao, Kang] Chengdu Med Coll, Dept Pathogen Biol, Chengdu, Peoples R China	Sichuan University; Chengdu Medical College	Lin, C (corresponding author), Sichuan Univ, W China Med Sch, W China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu 610064, Peoples R China.	niecl1022@scu.edu.cn; yuanzhujyx@gmail.com; niecl1022@scu.edu.cn	Li, Li/AEM-3636-2022; li, li/HII-4157-2022; Cao, Kang/AAV-1997-2020; LI, LI/GVS-5344-2022		National Key Basic Research Program of China [2010CB529900]; Natural Science Foundation of China [30900744, 81071817/H1609, 81001010]	National Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China (2010CB529900) and Natural Science Foundation of China (30900744; 81071817/H1609; 81001010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Asselin E, 2001, CANCER RES, V61, P1862; Blezinger P, 1999, NAT BIOTECHNOL, V17, P343, DOI 10.1038/7895; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Debernardis D, 1997, CANCER RES, V57, P870; DeFeudis P, 1997, BRIT J CANCER, V76, P474, DOI 10.1038/bjc.1997.412; Deng YB, 2002, GENE DEV, V16, P33, DOI 10.1101/gad.949602; Dodier P, 2006, GYNECOL ONCOL, V100, P254, DOI 10.1016/j.ygyno.2005.08.028; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gallardo D, 1996, CANCER RES, V56, P4891; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Henkels KM, 1999, CANCER RES, V59, P3077; Hu WB, 2012, J BIOL CHEM, V287, P68, DOI 10.1074/jbc.M111.271205; Ibrahim N, 2010, CANCER RES, V70, P7155, DOI 10.1158/0008-5472.CAN-10-0668; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kassim SK, 1999, CLIN BIOCHEM, V32, P333, DOI 10.1016/S0009-9120(99)00026-0; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Perego P, 1996, CANCER RES, V56, P556; Reles A, 2001, CLIN CANCER RES, V7, P2984; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Salzberg M, 2005, ONCOLOGY-BASEL, V68, P293, DOI 10.1159/000086967; Sasaki H, 2000, CANCER RES, V60, P5659; Sauter BV, 2000, P NATL ACAD SCI USA, V97, P4802, DOI 10.1073/pnas.090065597; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Suzuki S, 2009, CANCER SCI, V100, P759, DOI 10.1111/j.1349-7006.2009.01096.x; Villedieu M, 2007, GYNECOL ONCOL, V105, P31, DOI 10.1016/j.ygyno.2006.12.011; WEI YQ, 1994, CANCER RES, V54, P4952; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196; Yu J, 2004, CURR OPIN ONCOL, V16, P19, DOI 10.1097/00001622-200401000-00005; Yuan Z, 2009, CANCER SCI, V100, P1757, DOI 10.1111/j.1349-7006.2009.01242.x; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	44	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36722	10.1371/journal.pone.0036722	http://dx.doi.org/10.1371/journal.pone.0036722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590594	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100055
J	Fontela, PS; Quach, C; Buckeridge, D; Pai, M; Platt, RW				Fontela, Patricia S.; Quach, Caroline; Buckeridge, David; Pai, Madukhar; Platt, Robert W.			Surveillance Length and Validity of Benchmarks for Central Line-Associated Bloodstream Infection Incidence Rates in Intensive Care Units	PLOS ONE			English	Article							NETWORK NHSN REPORT; SYSTEM; NETHERLANDS; HOSPITALS	Introduction: Several national and regional central line-associated bloodstream infections (CLABSI) surveillance programs do not require continuous hospital participation. We evaluated the effect of different hospital participation requirements on the validity of annual CLABSI incidence rate benchmarks for intensive care units (ICUs). Methods: We estimated the annual pooled CLABSI incidence rates for both a real regional (< 100 ICUs) and a simulated national (600 ICUs) surveillance program, which were used as a reference for the simulations. We simulated scenarios where the annual surveillance participation was randomly or non-randomly reduced. Each scenario's annual pooled CLABSI incidence rate was estimated and compared to the reference rates in terms of validity, bias, and proportion of simulation iterations that presented valid estimates (ideal if >= 90%). Results: All random scenarios generated valid CLABSI incidence rates estimates (bias -0.37 to 0.07 CLABSI/1000 CVC-days), while non-random scenarios presented a wide range of valid estimates (0 to 100%) and higher bias (-22.18 to 1.27 CLABSI/1000 CVC-days). In random scenarios, the higher the number of participating ICUs, the shorter the participation required to generate >= 90% valid replicates. While participation requirements in a countrywide program ranged from 3 to 13 surveillance blocks (1 block = 28 days), requirements for a regional program ranged from 9 to 13 blocks. Conclusions: Based on the results of our model of national CLABSI reporting, the shortening of participation requirements may be suitable for nationwide ICU CLABSI surveillance programs if participation months are randomly chosen. However, our regional models showed that regional programs should opt for continuous participation to avoid biased benchmarks.	[Fontela, Patricia S.; Quach, Caroline; Buckeridge, David; Pai, Madukhar; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Fontela, Patricia S.; Quach, Caroline; Platt, Robert W.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University	Fontela, PS (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	robert.platt@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; Fontela, Patricia/S-6455-2019; Quach, Caroline/AAT-6987-2021	PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Quach, Caroline/0000-0002-1170-9475; Platt, Robert/0000-0002-5981-8443				Burton A, 2006, STAT MED, V25, P4279, DOI 10.1002/sim.2673; Coello R, 2001, INFECT CONT HOSP EP, V22, P393, DOI 10.1086/501923; Cooke EM, 2000, J HOSP INFECT, V46, P1, DOI 10.1053/jhin.2000.0801; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; EMORI TG, 1991, AM J INFECT CONTROL, V19, P19, DOI 10.1016/0196-6553(91)90157-8; Fontela PS, 2011, AM J INFECT CONTROL, V39, P329, DOI 10.1016/j.ajic.2010.07.007; Geubbels ELPE, 2000, INFECT CONT HOSP EP, V21, P311, DOI 10.1086/501762; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McKibben L, 2005, INFECT CONT HOSP EP, V26, P580, DOI 10.1086/502585; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Perla RJ, 2009, AM J INFECT CONTROL, V37, P615, DOI 10.1016/j.ajic.2009.03.003; Quach C, 2006, RAPPORT SURVEILLANCE; Quach C, 2005, RAPPORT SURVEILLANCE; Quach C, 2007, RAPPORT SURVEILLANCE; Richards C, 2001, AM J INFECT CONTROL, V29, P400, DOI 10.1067/mic.2001.118408; Robert J, 2000, INFECT CONT HOSP EP, V21, P12, DOI 10.1086/501690; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; WENZEL RP, 1983, INFECT CONT HOSP EP, V4, P371, DOI 10.1017/S0195941700059774	22	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36582	10.1371/journal.pone.0036582	http://dx.doi.org/10.1371/journal.pone.0036582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586480	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000041
J	Ferguson, BW; Gao, XS; Kil, H; Lee, JH; Benavides, F; Abba, MC; Aldaz, CM				Ferguson, Brent W.; Gao, Xinsheng; Kil, Hyunsuk; Lee, Jaeho; Benavides, Fernando; Abba, Martin C.; Aldaz, C. Marcelo			Conditional Wwox Deletion in Mouse Mammary Gland by Means of Two Cre Recombinase Approaches	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITE; TUMOR-SUPPRESSOR PROTEIN; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; WNT5A; FRA16D; TUMORIGENICITY; BIOINFORMATICS; IDENTIFICATION	Loss of WWOX expression has been reported in many different cancers including breast cancer. Elucidating the function of this gene in adult tissues has not been possible with full Wwox knockout models. Here we characterize the first conditional models of Wwox ablation in mouse mammary epithelium utilizing two transgenic lines expressing Cre recombinase, keratin 5-Cre (BK5-Cre) and MMTV-Cre. In the BK5-Cre model we observed very efficient Wwox ablation in KO mammary glands. However, BK5-Cre Wwox KO animals die prematurely for unknown reasons. In the MMTV-Cre model we observed significant ablation of Wwox in mammary epithelium with no effect on survival. In both of these models we found that Wwox deletion resulted in impaired mammary branching morphogenesis. We demonstrate that loss of Wwox is not carcinogenic in our KO models. Furthermore, no evidence of increase proliferation or development of premalignant lesions was observed. In none of the models did loss of a single Wwox allele (i.e. haploinsufficiency) have any observable phenotypic effect in mammary gland. To better understand the function of Wwox in the mammary gland, transcriptome profiling was performed. We observed that Wwox ablation results in the deregulation of genes involved in various cellular processes. We found that expression of the non-canonical Wnt ligand, Wnt5a, was significantly upregulated in Wwox KO mammary epithelium. Interestingly, we also determined that components of the Jak/Stat3 signaling pathway were upregulated in KO mice and this correlated with a very robust increase in phospho-Stat3 signaling, which warrants further testing. Even though the loss of Wwox expression in breast and other cancers is very well documented, our findings suggest that Wwox does not act as a classical tumor suppressor as previously thought.	[Ferguson, Brent W.; Gao, Xinsheng; Kil, Hyunsuk; Lee, Jaeho; Benavides, Fernando; Aldaz, C. Marcelo] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Abba, Martin C.] Univ Nacl La Plata, Fac Med, CINIBA, La Plata, Buenos Aires, Argentina	University of Texas System; UTMD Anderson Cancer Center; National University of La Plata	Ferguson, BW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	maaldaz@mdanderson.org	Aldaz, C. Marcelo/E-7868-2011	Aldaz, C. Marcelo/0000-0002-2453-2939; Abba, Martin/0000-0002-9206-2369; Benavides, Fernando/0000-0003-1275-4320	National Institutes of Health/National Cancer Institute [R01 CA102444-6]; National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease [ES007784]; Cancer Center Support Grant [CA016672]; Research Training in Carcinogenesis and Mutagenesis [T32CA009480]; NATIONAL CANCER INSTITUTE [T32CA009480, R01CA102444, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease; Cancer Center Support Grant; Research Training in Carcinogenesis and Mutagenesis; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Health/National Cancer Institute (grant number R01 CA102444-6; http://cancer.gov/) to CMA; the National Institute of Environmental Health Sciences (NIEHS) Center for Research on Environmental Disease (grant number ES007784; http://cred.mdanderson.org/); a Cancer Center Support Grant (grant number CA016672; http://cancer.gov/); and Research Training in Carcinogenesis and Mutagenesis (grant number T32CA009480; http://cancer.gov/) to BWF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen SK, 2011, ONCOGENE, V30, P3900, DOI 10.1038/onc.2011.115; Aldaz CM, 2002, ONCOGENE, V21, P6366, DOI 10.1038/sj.onc.1205816; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; DEOME KB, 1959, CANCER RES, V19, P515; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gourley C, 2009, CANCER RES, V69, P4835, DOI 10.1158/0008-5472.CAN-08-2974; Guler G, 2005, PATHOL INT, V55, P471, DOI 10.1111/j.1440-1827.2005.01855.x; Guler G, 2009, CANCER-AM CANCER SOC, V115, P899, DOI 10.1002/cncr.24103; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Katoh M, 2007, INT J MOL MED, V19, P273; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Krummel KA, 2000, GENOMICS, V69, P37, DOI 10.1006/geno.2000.6321; Krummel KA, 2002, GENE CHROMOSOME CANC, V34, P154, DOI 10.1002/gcc.10047; Kurek KC, 2010, CANCER RES, V70, P5577, DOI 10.1158/0008-5472.CAN-09-4602; Lewandowska U, 2009, J PHYSIOL PHARMACOL, V60, P47; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2003, CYTOGENET GENOME RES, V100, P101, DOI 10.1159/000072844; Ludes-Meyers JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007775; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; McCall KD, 2007, ENDOCRINOLOGY, V148, P4226, DOI 10.1210/en.2007-0459; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nunez M, 2005, BREAST CANCER RES TR, V89, P99, DOI 10.1007/s10549-004-1474-x; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Ramos D, 2006, ADV EXP MED BIOL, V587, P149; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496	48	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36618	10.1371/journal.pone.0036618	http://dx.doi.org/10.1371/journal.pone.0036618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574198	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800095
J	Pau, E; Cheung, YH; Loh, C; Lajoie, G; Wither, JE				Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Lajoie, Ginette; Wither, Joan E.			TLR Tolerance Reduces IFN-Alpha Production Despite Plasmacytoid Dendritic Cell Expansion and Anti-Nuclear Antibodies in NZB Bicongenic Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; I INTERFERON; B-CELL; IMMUNE-COMPLEXES; AUTOANTIBODY PRODUCTION; T-CELL; DISEASE; ACTIVATION; RESPONSES; STIMULATION	Genetic loci on New Zealand Black (NZB) chromosomes 1 and 13 play a significant role in the development of lupus-like autoimmune disease. We have previously shown that C57BL/6 (B6) congenic mice with homozygous NZB chromosome 1 (B6.NZBc1) or 13 (B6.NZBc13) intervals develop anti-nuclear antibodies and mild glomerulonephritis (GN), together with increased T and B cell activation. Here, we produced B6. NZBc1c13 bicongenic mice with both intervals, and demonstrate several novel phenotypes including: marked plasmacytoid and myeloid dendritic cell expansion, and elevated IgA production. Despite these changes, only minor increases in anti-nuclear antibody production were seen, and the severity of GN was reduced as compared to B6.NZBc1 mice. Although bicongenic mice had increased levels of baff and tnf-alpha mRNA in their spleens, the levels of IFN-alpha-induced gene expression were reduced. Splenocytes from bicongenic mice also demonstrated reduced secretion of IFN-alpha following TLR stimulation in vitro. This reduction was not due to inhibition by TNF-alpha and IL-10, or regulation by other cellular populations. Because pDC in bicongenic mice are chronically exposed to nuclear antigen-containing immune complexes in vivo, we examined whether repeated stimulation of mouse pDC with TLR ligands leads to impaired IFN-alpha production, a phenomenon termed TLR tolerance. Bone marrow pDC from both B6 and bicongenic mice demonstrated markedly inhibited secretion of IFN-alpha following repeated stimulation with a TLR9 ligand. Our findings suggest that the expansion of pDC and production of anti-nuclear antibodies need not be associated with increased IFN-alpha production and severe kidney disease, revealing additional complexity in the regulation of autoimmunity in systemic lupus erythematosus.	[Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Wither, Joan E.] Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada; [Pau, Evelyn; Cheung, Yui-Ho; Loh, Christina; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Lajoie, Ginette] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Lajoie, Ginette] William Osler Hlth Ctr, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Pau, E (corresponding author), Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Arthritis Society of Canada; Canadian Institutes of Health Research (CIHR); Arthritis Centre of Excellence; CIHR studentship; Edward Dunlop award	Arthritis Society of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence; CIHR studentship(Canadian Institutes of Health Research (CIHR)); Edward Dunlop award	This work was supported by grants from The Arthritis Society of Canada and Canadian Institutes of Health Research (CIHR). JW and YHC are supported by the Arthritis Centre of Excellence. CL is the recipient of a CIHR studentship and EP is the recipient of an Edward Dunlop award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bjoerck P, 2011, J IMMUNOL, V186, P1477, DOI 10.4049/jimmunol.1000454; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; BURLINGAME RW, 1994, J CLIN INVEST, V94, P184, DOI 10.1172/JCI117305; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Cheung YH, 2009, SEMIN IMMUNOL, V21, P372, DOI 10.1016/j.smim.2009.10.005; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Eloranta ML, 2009, ARTHRITIS RHEUM-US, V60, P2418, DOI 10.1002/art.24686; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gohlke PR, 2009, AUTOIMMUNITY, V42, P183, DOI 10.1080/08916930802668586; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jorgensen TN, 2010, J IMMUNOL, V184, P775, DOI 10.4049/jimmunol.0901322; Kikuchi S, 2005, BLOOD, V106, P1323, DOI 10.1182/blood-2005-02-0558; Kwok SK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2382; Lech M, 2008, J EXP MED, V205, P1879, DOI 10.1084/jem.20072646; Lian ZX, 2004, J IMMUNOL, V173, P5283, DOI 10.4049/jimmunol.173.8.5283; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lovgren T, 2006, ARTHRITIS RHEUM-US, V54, P1917, DOI 10.1002/art.21893; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Palucka AK, 2005, P NATL ACAD SCI USA, V102, P3372, DOI 10.1073/pnas.0408506102; Pau E, 2011, CLIN IMMUNOL, V139, P215, DOI 10.1016/j.clim.2011.02.005; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Savarese E, 2006, BLOOD, V107, P3229, DOI 10.1182/blood-2005-07-2650; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; Waibler Z, 2008, EUR J IMMUNOL, V38, P3127, DOI 10.1002/eji.200838184; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wither JE, 2005, J IMMUNOL, V175, P4309, DOI 10.4049/jimmunol.175.7.4309; Wither JE, 2003, J IMMUNOL, V171, P1697, DOI 10.4049/jimmunol.171.4.1697; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045	40	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36761	10.1371/journal.pone.0036761	http://dx.doi.org/10.1371/journal.pone.0036761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574220	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800117
J	Li, C; Meng, QL; Yu, XF; Jing, X; Xu, PX; Luo, DL				Li, Chen; Meng, Qingli; Yu, Xinfeng; Jing, Xian; Xu, Pingxiang; Luo, Dali			Regulatory Effect of Connexin 43 on Basal Ca2+ Signaling in Rat Ventricular Myocytes	PLOS ONE			English	Article							C6 GLIOMA-CELLS; GAP JUNCTIONAL COMMUNICATION; ATP RELEASE; HEMICHANNELS; EXPRESSION; HYPERCONTRACTURE; PROPAGATION; CONTRIBUTE; MECHANISM; SPARKS	Background: It has been found that gap junction-associated intracellular Ca2+ [Ca2+](i) disturbance contributes to the arrhythmogenesis and hyperconstriction in diseased heart. However, whether functional gaps are also involved in the regulation of normal Ca2+ signaling, in particular the basal [Ca2+](i) activities, is unclear. Methods and Results: Global and local Ca2+ signaling and gap permeability were monitored in cultured neonatal rat ventricular myocytes (NRVMs) and freshly isolated mouse ventricular myocytes by Fluo4/AM and Lucifer yellow (LY), respectively. The results showed that inhibition of gap communication by heptanol, Gap 27 and flufenamic acid or interference of connexin 43 (Cx43) with siRNA led to a significant suppression of LY uptake and, importantly, attenuations of global Ca2+ transients and local Ca2+ sparks in monolayer NRVMs and Ca2+ sparks in adult ventricular myocytes. In contrast, overexpression of rat-Cx43 in NRVMs induced enhancements in the above measurements, and so did in HEK293 cells expressing rat Cx43. Additionally, membrane-permeable inositol 1,4,5-trisphosphate (IP3 butyryloxymethyl ester) and phenylephrine, an agonist of adrenergic receptor, could relieve the inhibited Ca2+ signal and LY uptake by gap uncouplers, whereas blockade of IP3 receptor with xestospongin C or 2-aminoethoxydiphenylborate mimicked the effects of gap inhibitors. More importantly, all these gap-associated effects on Ca2+ signaling were also found in single NRVMs that only have hemichannels instead of gap junctions. Further immunostaining/immunoblotting single myocytes with antibody against Cx43 demonstrated apparent increases in membrane labeling of Cx43 and non-junctional Cx43 in overexpressed cells, suggesting functional hemichannels exist and also contribute to the Ca2+ signaling regulation in cardiomyocytes. Conclusions: These data demonstrate that Cx43-associated gap coupling plays a role in the regulation of resting Ca2+ signaling in normal ventricular myocytes, in which IP3/IP3 receptor coupling is involved. This finding may provide a novel regulatory pathway for mediation of spontaneous global and local Ca2+ activities in cardiomyocytes.	[Li, Chen; Meng, Qingli; Yu, Xinfeng; Jing, Xian; Xu, Pingxiang; Luo, Dali] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing, Peoples R China	Capital Medical University	Li, C (corresponding author), Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing, Peoples R China.	luodl@ccmu.edu.cn			National Natural Science Foundation [30973537]; Beijing Natural Science Foundation [7082018, 5122006]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation (30973537), and the Beijing Natural Science Foundation (7082018 and 5122006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2010, CARDIOVASC RES, V85, P751, DOI 10.1093/cvr/cvp353; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Bruzzone S, 2001, FASEB J, V15, P10; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fry T, 2001, MICROSC RES TECHNIQ, V52, P289, DOI 10.1002/1097-0029(20010201)52:3<289::AID-JEMT1014>3.0.CO;2-0; GarciaDorado D, 1997, CIRCULATION, V96, P3579; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Gossman DG, 2008, CELL COMMUN ADHES, V15, P305, DOI 10.1080/15419060802357217; Hayashi H, 2010, CIRC J, V74, P2558, DOI 10.1253/circj.CJ-10-0983; Hoeker GS, 2009, AM J PHYSIOL-HEART C, V297, pH1235, DOI 10.1152/ajpheart.01320.2008; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Kostin S, 2003, MOL CELL BIOCHEM, V242, P135, DOI 10.1023/A:1021154115673; Leite MF, 2002, J BIOL CHEM, V277, P16313, DOI 10.1074/jbc.M109207200; Li FG, 2001, J MOL CELL CARDIOL, V33, P2145, DOI 10.1006/jmcc.2001.1477; Li WH, 1997, TETRAHEDRON, V53, P12017, DOI 10.1016/S0040-4020(97)00714-X; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; NAUS CCG, 1992, CELL MOL NEUROBIOL, V12, P163, DOI 10.1007/BF00713370; Opsahl H, 2000, CELL ADHES COMMUN, V7, P367, DOI 10.3109/15419060009109019; Oyamada Y, 2002, EXP CELL RES, V273, P85, DOI 10.1006/excr.2001.5411; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Ruiz-Meana M, 1999, CIRC RES, V85, P280, DOI 10.1161/01.RES.85.3.280; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Tong D, 2006, AM J PHYSIOL-CELL PH, V290, pC290, DOI 10.1152/ajpcell.00297.2005; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; WATTS SW, 1994, J VASC RES, V31, P307, DOI 10.1159/000159057; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	40	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36165	10.1371/journal.pone.0036165	http://dx.doi.org/10.1371/journal.pone.0036165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22577485	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000144
J	Chadwick, W; Martin, B; Chapter, MC; Park, SS; Wang, LY; Daimon, CM; Brenneman, R; Maudsley, S				Chadwick, Wayne; Martin, Bronwen; Chapter, Megan C.; Park, Sung-Soo; Wang, Liyun; Daimon, Caitlin M.; Brenneman, Randall; Maudsley, Stuart			GIT2 Acts as a Potential Keystone Protein in Functional Hypothalamic Networks Associated with Age-Related Phenotypic Changes in Rats	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; LIFE-SPAN; ALZHEIMERS-DISEASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION; GENE-EXPRESSION; NERVOUS-SYSTEM; MICE; BRAIN	The aging process affects every tissue in the body and represents one of the most complicated and highly integrated inevitable physiological entities. The maintenance of good health during the aging process likely relies upon the coherent regulation of hormonal and neuronal communication between the central nervous system and the periphery. Evidence has demonstrated that the optimal regulation of energy usage in both these systems facilitates healthy aging. However, the proteomic effects of aging in regions of the brain vital for integrating energy balance and neuronal activity are not well understood. The hypothalamus is one of the main structures in the body responsible for sustaining an efficient interaction between energy balance and neurological activity. Therefore, a greater understanding of the effects of aging in the hypothalamus may reveal important aspects of overall organismal aging and may potentially reveal the most crucial protein factors supporting this vital signaling integration. In this study, we examined alterations in protein expression in the hypothalami of young, middle-aged, and old rats. Using novel combinatorial bioinformatics analyses, we were able to gain a better understanding of the proteomic and phenotypic changes that occur during the aging process and have potentially identified the G protein-coupled receptor/cytoskeletal-associated protein GIT2 as a vital integrator and modulator of the normal aging process.	[Chadwick, Wayne; Chapter, Megan C.; Park, Sung-Soo; Wang, Liyun; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, Neurosci Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA; [Martin, Bronwen; Daimon, Caitlin M.] NIA, Metab Unit, Clin Invest Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA; [Brenneman, Randall] Univ Miami, Miller Sch Med, Dodson Interdisciplinary Immunotherapy Inst, Miami, FL 33136 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Miami	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, Neurosci Lab, NIH,Biomed Res Ctr, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; Maudsley, Stuart/AAV-9929-2021	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925	National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZIAAG000325, ZIAAG000916, ZIAAG000318, ZIAAG000917] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported entirely by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Alexia C, 2006, ANN NY ACAD SCI, V1090, P1, DOI 10.1196/annals.1378.001; Ashford JW, 1998, J NEUROPATH EXP NEUR, V57, P972, DOI 10.1097/00005072-199810000-00009; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Chadwick W., 2010, INT J ALZHEIMERS DIS; CHADWICK W, 2011, J SIGNAL TRANSUCT; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chen R, 2011, EXPERT SYST APPL, V38, P9958, DOI 10.1016/j.eswa.2011.02.034; Conrad CD, 2010, PROG BRAIN RES, V182, P31, DOI 10.1016/S0079-6123(10)82002-3; COTZIAS GC, 1974, P NATL ACAD SCI USA, V71, P2466, DOI 10.1073/pnas.71.6.2466; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DORMAN JB, 1995, GENETICS, V141, P1399; ELAHI D, 1993, EXP GERONTOL, V28, P393, DOI 10.1016/0531-5565(93)90066-M; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; FRIEDMAN DB, 1988, GENETICS, V118, P75; FROLKIS VV, 1972, EXP GERONTOL, V7, P169, DOI 10.1016/0531-5565(72)90024-1; Galea LAM, 2008, CAN J EXP PSYCHOL, V62, P247, DOI 10.1037/a0014501; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Himeda T, 2005, MECH AGEING DEV, V126, P673, DOI 10.1016/j.mad.2004.12.004; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hwang IK, 2011, RES VET SCI; Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kushner EJ, 2011, J VASC RES, V48, P408, DOI 10.1159/000324837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Li Q, 2008, REJUV RES, V11, P725, DOI 10.1089/rej.2008.0717; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2006, AGEING RES REV, V5, P332, DOI 10.1016/j.arr.2006.04.002; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Maudsley S, 2011, METHODS MOL BIOL, V756, P99, DOI 10.1007/978-1-61779-160-4_5; Mielke JG, 2011, PROG MOL BIOL TRANSL, V98, P133, DOI 10.1016/B978-0-12-385506-0.00004-1; Nakagami Y, 2004, DRUG NEWS PERSPECT, V17, P655, DOI 10.1358/dnp.2004.17.10.873917; Nyberg F, 2009, INT REV NEUROBIOL, V88, P399, DOI 10.1016/S0074-7742(09)88014-8; Park SS, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-63; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Sastry PS, 2000, J NEUROCHEM, V74, P1, DOI 10.1046/j.1471-4159.2000.0740001.x; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, GENETICA, V136, P259, DOI 10.1007/s10709-009-9359-x; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Simon D, 2011, CNS NEUROL DISORD-DR, V10, P208, DOI 10.2174/187152711794480401; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Troy CM, 2011, PROG MOL BIOL TRANSL, V99, P265, DOI 10.1016/S1877-1173(11)99007-3; Wang XK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-360; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Zalewska T, 2005, INT J DEV NEUROSCI, V23, P657, DOI 10.1016/j.ijdevneu.2005.05.010; Zheng WH, 2000, ADV RES NEURODEGENER, V8, P261; Zhou Y, 2011, J PROTEOMICS, V74, P1030, DOI 10.1016/j.jprot.2011.02.007; Zschauer TC, 2011, ARTERIOSCL THROM VAS, V31, P650, DOI 10.1161/ATVBAHA.110.218982	74	31	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36975	10.1371/journal.pone.0036975	http://dx.doi.org/10.1371/journal.pone.0036975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606319	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400048
J	Gunawardena, J				Gunawardena, Jeremy			A Linear Framework for Time-Scale Separation in Nonlinear Biochemical Systems	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; MULTISITE PHOSPHORYLATION; QUANTITATIVE MODEL; MECHANISM; RECEPTOR; NUMBERS; STATE; EXPRESSION; ROLES	Cellular physiology is implemented by formidably complex biochemical systems with highly nonlinear dynamics, presenting a challenge for both experiment and theory. Time-scale separation has been one of the few theoretical methods for distilling general principles from such complexity. It has provided essential insights in areas such as enzyme kinetics, allosteric enzymes, G-protein coupled receptors, ion channels, gene regulation and post-translational modification. In each case, internal molecular complexity has been eliminated, leading to rational algebraic expressions among the remaining components. This has yielded familiar formulas such as those of Michaelis-Menten in enzyme kinetics, Monod-Wyman-Changeux in allostery and Ackers-Johnson-Shea in gene regulation. Here we show that these calculations are all instances of a single graph-theoretic framework. Despite the biochemical nonlinearity to which it is applied, this framework is entirely linear, yet requires no approximation. We show that elimination of internal complexity is feasible when the relevant graph is strongly connected. The framework provides a new methodology with the potential to subdue combinatorial explosion at the molecular level.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu			National Science Foundation [0856285]	National Science Foundation(National Science Foundation (NSF))	The work described here was supported by the National Science Foundation under grant number 0856285. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Anderson KS, 2003, KINETIC ANAL MACROMO, P19; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chung F., 1997, REGIONAL C SERIES MA, V92; Colquhoun D, 2006, BRIT J PHARMACOL, V147, pS17, DOI 10.1038/sj.bjp.0706502; Colquhoun D, 2006, TRENDS PHARMACOL SCI, V27, P149, DOI 10.1016/j.tips.2006.01.008; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; Craciun G, 2009, J SYMB COMPUT, V44, P1551, DOI 10.1016/j.jsc.2008.08.006; Davidson EH, 2006, REG GEN GEN REG; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dill K. A., 2003, MOL DRIVING FORCES S; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; FEINBERG M, 1977, ARCH RATION MECH AN, V66, P83, DOI 10.1007/BF00250853; FEINBERG M, 1979, LECT NOTES U WISCONS; Feliu E, 2012, B MATH BIOL, V74, P45, DOI 10.1007/s11538-011-9658-0; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gunawardena J, 2012, COMPREHENSIVE BIOPHY, V9; Gunawardena J, 2012, MOL BIOL CELL, V23, P517, DOI 10.1091/mbc.E11-07-0643; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; HERZFELD J, 1974, J MOL BIOL, V82, P231, DOI 10.1016/0022-2836(74)90343-X; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; HILL TL, 1966, J THEOR BIOL, V10, P442, DOI 10.1016/0022-5193(66)90137-8; Hill TL, 1985, SPRINGER SERIES MOL; HORN F, 1972, ARCH RATION MECH AN, V47, P81; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Kirchhoff G., 1847, ANN PHYS CHEM, V72, P497, DOI [DOI 10.1002/ANDP.18471481202, 10.1002/andp.18471481202]; KLONOWSKI W, 1983, BIOPHYS CHEM, V18, P73, DOI 10.1016/0301-4622(83)85001-7; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee CH, 2010, J MATH BIOL, V60, P387, DOI 10.1007/s00285-009-0269-4; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lewis GN, 1925, P NATL ACAD SCI USA, V11, P179, DOI 10.1073/pnas.11.3.179; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MAHAN BH, 1975, J CHEM EDUC, V52, P299, DOI 10.1021/ed052p299; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mescam M, 2011, J BIOL CHEM, V286, P21100, DOI 10.1074/jbc.M110.214452; Michaelis L, 1913, BIOCHEM Z, V49, P333; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOON JW, 1970, CANADIAN MATH MONOGR, V1; Najdi Tarek S., 2006, Journal of Bioinformatics and Computational Biology, V4, P335, DOI 10.1142/S0219720006001862; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Parker DS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002077; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabakaran S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.15; Prabhakaran S, 2012, POSTTRANSLATIO UNPUB; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Schnell S, 2003, COMMENTS THEOR BIOL, V8, P169, DOI DOI 10.1080/08948550390206768; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Segel IH., 1993, ENZYME KINETICS BEHA; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson M, 2009, J THEOR BIOL, V261, P626, DOI 10.1016/j.jtbi.2009.09.003; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Tolman RC, 1938, PRINCIPLES STAT MECH; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; TUTTE WT, 1948, P CAMB PHILOS SOC, V44, P463, DOI 10.1017/S030500410002449X; Weiss JM, 1996, J THEOR BIOL, V178, P151, DOI 10.1006/jtbi.1996.0014; Wyman J, 1990, BINDING LINKAGE FUNC; Xu Y, REALISTIC ENZY UNPUB; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044	77	79	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36321	10.1371/journal.pone.0036321	http://dx.doi.org/10.1371/journal.pone.0036321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606254	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400017
J	Kelley, RY; Williams, WP; Mylroie, JE; Boykin, DL; Harper, JW; Windham, GL; Ankala, A; Shan, XY				Kelley, Rowena Y.; Williams, W. Paul; Mylroie, J. Erik; Boykin, Deborah L.; Harper, Jonathan W.; Windham, Gary L.; Ankala, Arunkanth; Shan, Xueyan			Identification of Maize Genes Associated with Host Plant Resistance or Susceptibility to Aspergillus flavus Infection and Aflatoxin Accumulation	PLOS ONE			English	Article							REGISTRATION; LINE; CONTAMINATION; ARABIDOPSIS; REGULATORS; PATHOGENS; MP313E; FIELD; CORN	Background: Aspergillus flavus infection and aflatoxin contamination of maize pose negative impacts in agriculture and health. Commercial maize hybrids are generally susceptible to this fungus. Significant levels of host plant resistance have been observed in certain maize inbred lines. This study was conducted to identify maize genes associated with host plant resistance or susceptibility to A. flavus infection and aflatoxin accumulation. Results: Genome wide gene expression levels with or without A. flavus inoculation were compared in two resistant maize inbred lines (Mp313E and Mp04: 86) in contrast to two susceptible maize inbred lines (Va35 and B73) by microarray analysis. Principal component analysis (PCA) was used to find genes contributing to the larger variances associated with the resistant or susceptible maize inbred lines. The significance levels of gene expression were determined by using SAS and LIMMA programs. Fifty candidate genes were selected and further investigated by quantitative RT-PCR (qRT-PCR) in a time-course study on Mp313E and Va35. Sixteen of the candidate genes were found to be highly expressed in Mp313E and fifteen in Va35. Out of the 31 highly expressed genes, eight were mapped to seven previously identified quantitative trait locus (QTL) regions. A gene encoding glycine-rich RNA binding protein 2 was found to be associated with the host hypersensitivity and susceptibility in Va35. A nuclear pore complex protein YUP85-like gene was found to be involved in the host resistance in Mp313E. Conclusion: Maize genes associated with host plant resistance or susceptibility were identified by a combination of microarray analysis, qRT-PCR analysis, and QTL mapping methods. Our findings suggest that multiple mechanisms are involved in maize host plant defense systems in response to Aspergillus flavus infection and aflatoxin accumulation. These findings will be important in identification of DNA markers for breeding maize lines resistant to aflatoxin accumulation.	[Kelley, Rowena Y.; Mylroie, J. Erik; Ankala, Arunkanth; Shan, Xueyan] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Williams, W. Paul; Windham, Gary L.] ARS, Corn Host Plant Resistance Res Unit, USDA, Mississippi State, MS USA; [Boykin, Deborah L.] ARS, Stat Off, USDA, Stoneville, MS USA; [Harper, Jonathan W.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Mississippi State University	Kelley, RY (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	xshan@bch.msstate.edu	Ankala, Arunkanth/G-6330-2011	Ankala, Arunkanth/0000-0002-6373-9916; Harper, Jeffrey/0000-0002-6944-7236	USDA Agricultural Research Service (ARS) [58-6406-6-0039]	USDA Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported through the USDA Agricultural Research Service (ARS) funded Specific Cooperative Agreement (No. 58-6406-6-0039) between USDA-ARS and Mississippi Agri & Forestry Exp Station (MAFES) at Mississippi State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, STAT AN SOFTW; [Anonymous], GENEX SOFTW 5 0 1; Basha E, 2010, J BIOL CHEM, V285, P11489, DOI 10.1074/jbc.M109.074088; Bhatnagar D, 2006, MYCOPATHOLOGIA, V162, P155, DOI 10.1007/s11046-006-0050-9; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brooks TD, 2005, CROP SCI, V45, P171; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cleveland TE, 2004, J TOXICOL-TOXIN REV, V23, P345, DOI 10.1081/TXR-200027892; Davis G.L., 2000, MAIZE GENET C, V41, P22; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Freire MA, 1995, PLANT MOL BIOL, V29, P797, DOI 10.1007/BF00041169; Garcia AV, 2009, TRENDS PLANT SCI, V14, P479, DOI 10.1016/j.tplants.2009.07.004; GARDINER JM, 1993, GENETICS, V134, P917; Gourama H, 1995, J FOOD PROTECT, V58, P1395, DOI 10.4315/0362-028X-58.12.1395; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Kelley RY, 2009, TOXIN REV, V28, P129, DOI 10.1080/15569540903089239; LILLEHOJ EB, 1974, APPL MICROBIOL, V28, P763, DOI 10.1128/AEM.28.5.763-767.1974; Lorang JM, 2007, P NATL ACAD SCI USA, V104, P14861, DOI 10.1073/pnas.0702572104; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Oliver RP, 2004, MOL PLANT PATHOL, V5, P347, DOI 10.1111/j.1364-3703.2004.00228.x; Pechanova O, 2011, PROTEOMICS, V11, P114, DOI 10.1002/pmic.201000368; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piffanelli P, 1999, CURR OPIN PLANT BIOL, V2, P295, DOI 10.1016/S1369-5266(99)80052-1; Pontius J., 2003, NCBI HDB, P1; R Core Team, 2018, R LANG ENV STAT COMP; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SCOTT GE, 1990, CROP SCI, V30, P1378, DOI 10.2135/cropsci1990.0011183X003000060080x; Singh Upasana, 2011, BMC Res Notes, V4, P18, DOI 10.1186/1756-0500-4-18; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Warburton ML, 2009, CROP SCI, V49, P1403, DOI 10.2135/cropsci2008.12.0696; Wild CP, 2000, MUTAT RES-REV MUTAT, V462, P381, DOI 10.1016/S1383-5742(00)00027-2; Williams W P, 2006, Mycotoxin Res, V22, P27, DOI 10.1007/BF02954554; Williams WP, 2006, CROP SCI, V46, P1407, DOI 10.2135/cropsci2005.09-0330; Williams WP, 2001, CROP SCI, V41, P1374, DOI 10.2135/cropsci2001.4141374x; Windham GL, 2002, PLANT DIS, V86, P232, DOI 10.1094/PDIS.2002.86.3.232; Windham GL, 1998, PLANT DIS, V82, P281, DOI 10.1094/PDIS.1998.82.3.281; ZUMMO N, 1989, PLANT DIS, V73, P313, DOI 10.1094/PD-73-0313	40	50	51	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36892	10.1371/journal.pone.0036892	http://dx.doi.org/10.1371/journal.pone.0036892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606305	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400040
J	Preuss, C; Riemenschneider, M; Wiedmann, D; Stoll, M				Preuss, Christoph; Riemenschneider, Mona; Wiedmann, David; Stoll, Monika			Evolutionary Dynamics of Co-Segregating Gene Clusters Associated with Complex Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; RECOMBINATION RATE; SUSCEPTIBILITY; LOCI; POPULATIONS; DIVERGENCE	Background: The distribution of human disease-associated mutations is not random across the human genome. Despite the fact that natural selection continually removes disease-associated mutations, an enrichment of these variants can be observed in regions of low recombination. There are a number of mechanisms by which such a clustering could occur, including genetic perturbations or demographic effects within different populations. Recent genome-wide association studies (GWAS) suggest that single nucleotide polymorphisms (SNPs) associated with complex disease traits are not randomly distributed throughout the genome, but tend to cluster in regions of low recombination. Principal Findings: Here we investigated whether deleterious mutations have accumulated in regions of low recombination due to the impact of recent positive selection and genetic hitchhiking. Using publicly available data on common complex diseases and population demography, we observed an enrichment of hitchhiked disease associations in conserved gene clusters subject to selection pressure. Evolutionary analysis revealed that these conserved gene clusters arose by multiple concerted rearrangements events across the vertebrate lineage. We observed distinct clustering of disease-associated SNPs in evolutionary rearranged regions of low recombination and high gene density, which harbor genes involved in immunity, that is, the interleukin cluster on 5q31 or RhoA on 3p21. Conclusions: Our results suggest that multiple lineage specific rearrangements led to a physical clustering of functionally related and linked genes exhibiting an enrichment of susceptibility loci for complex traits. This implies that besides recent evolutionary adaptations other evolutionary dynamics have played a role in the formation of linked gene clusters associated with complex disease traits.	[Preuss, Christoph; Riemenschneider, Mona; Wiedmann, David; Stoll, Monika] Univ Munster, Leibniz Inst Arteriosclerosis Res LIFA, Munster, Germany	University of Munster	Preuss, C (corresponding author), Univ Munster, Leibniz Inst Arteriosclerosis Res LIFA, Munster, Germany.	christoph.preuss@lifa-muenster.de			Joint Initative for Research and Innovation from the Leibniz science association [2008/V2]	Joint Initative for Research and Innovation from the Leibniz science association	The work has been funded by the Joint Initative for Research and Innovation from the Leibniz science association (2008/V2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Cheng F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-221; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; Cutter AD, 2010, GENOME RES, V20, P1103, DOI 10.1101/gr.104331.109; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Foster CB, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-56; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Friedrichs F, 2009, GENOME RES, V19, P395, DOI 10.1101/gr.076653.108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Huff CD, 2012, MOL BIOL EVOL, V29, P101, DOI 10.1093/molbev/msr151; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Keinan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000886; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P1467, DOI 10.1002/ibd.21234; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; O'Reilly PF, 2008, GENOME RES, V18, P1304, DOI 10.1101/gr.067181.107; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Reed FA, 2006, GENETICS, V172, P2011, DOI 10.1534/genetics.105.052183; Reed FA, 2005, GENOME RES, V15, P1211, DOI 10.1101/gr.3413205; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Santiago E, 2005, GENETICS, V169, P475, DOI 10.1534/genetics.104.032813; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Shiina T, 2006, GENETICS, V173, P1555, DOI 10.1534/genetics.106.057034; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Tang MX, 1998, JAMA-J AM MED ASSOC, V279, P751, DOI 10.1001/jama.279.10.751; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wegner KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002835; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36205	10.1371/journal.pone.0036205	http://dx.doi.org/10.1371/journal.pone.0036205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606245	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400013
J	Berns, GS; Brooks, AM; Spivak, M				Berns, Gregory S.; Brooks, Andrew M.; Spivak, Mark			Functional MRI in Awake Unrestrained Dogs	PLOS ONE			English	Article							DECISION-MAKING; DORSAL STRIATUM; REWARD; FMRI; DOMESTICATION; ANTICIPATION; PREDICTION; RESPONSES; MONKEYS	Because of dogs' prolonged evolution with humans, many of the canine cognitive skills are thought to represent a selection of traits that make dogs particularly sensitive to human cues. But how does the dog mind actually work? To develop a methodology to answer this question, we trained two dogs to remain motionless for the duration required to collect quality fMRI images by using positive reinforcement without sedation or physical restraints. The task was designed to determine which brain circuits differentially respond to human hand signals denoting the presence or absence of a food reward. Head motion within trials was less than 1 mm. Consistent with prior reinforcement learning literature, we observed caudate activation in both dogs in response to the hand signal denoting reward versus no-reward.	[Berns, Gregory S.; Brooks, Andrew M.] Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA; [Spivak, Mark] Comprehens Pet Therapy, Atlanta, GA USA	Emory University	Berns, GS (corresponding author), Emory Univ, Ctr Neuropolicy, Atlanta, GA 30322 USA.	gberns@emory.edu			funds from Emory College of Arts and Sciences	funds from Emory College of Arts and Sciences	No external funds were used for this study. The project was supported by funds from the Emory College of Arts and Sciences, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Assheuer J, 1997, MRI CT ATLAS DOG; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bekoff M., 2007, EMOTIONAL LIVES ANIM; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bradshaw John, 2011, DOG SENSE NEW SCI DO; Chen G, 2012, MAGN RESON IMAGING, V30, P36, DOI 10.1016/j.mri.2011.09.010; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Keliris GA, 2007, NEUROIMAGE, V36, P550, DOI 10.1016/j.neuroimage.2007.02.057; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kulkarni P, 2012, BEHAV BRAIN RES, V230, P201, DOI 10.1016/j.bbr.2012.02.002; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Palazzi X., 2011, BEAGLE BRAIN STEREOT; Saveraid TC, 2009, CANINE HEAD MRI ATLA; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Shipman P., 2011, ANIMAL CONNECTION NE; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Stoewer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029697; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x	32	98	99	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e38027	10.1371/journal.pone.0038027	http://dx.doi.org/10.1371/journal.pone.0038027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606363	gold, Green Published			2022-12-27	WOS:000305338200072
J	Ryan, BM; McClary, AC; Valeri, N; Robinson, D; Paone, A; Bowman, ED; Robles, AI; Croce, C; Harris, CC				Ryan, Brid M.; McClary, Andrew C.; Valeri, Nicola; Robinson, Dillon; Paone, Alessio; Bowman, Elise D.; Robles, Ana I.; Croce, Carlo; Harris, Curtis C.			rs4919510 in hsa-mir-608 Is Associated with Outcome but Not Risk of Colorectal Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; EXPRESSION; TARGETS; POLYMORPHISMS; DISPARITIES; PROGNOSIS; SITES	Background: Colorectal cancer is the third most incident cancer and cause of cancer-related death in the United States. MicroRNAs, a class of small non-coding RNAs, have been implicated in the pathogenesis and prognosis of colorectal cancer, although few studies have examined the relationship between germline mutation in the microRNAs with risk and prognosis. We therefore investigated the association between a SNP in hsa-mir-608, which lies within the 10q24 locus, and colorectal cancer. Methods and Results: A cohort consisting of 245 cases and 446 controls was genotyped for rs4919510. The frequency of the GG genotype was significantly higher in African Americans (15%) compared to Caucasians (3%) controls. There was no significant association between rs4919510 and colorectal cancer risk (African American: ORGG (vs.) (CC) 0.89 [95% CI, 0.41-1.80]) (Caucasian: ORGG vs. CC 1.76, ([95% CI, 0.48-6.39]). However, we did observe an association with survival. The GG genotype was associated with an increased risk of death in Caucasians (HRGG vs. CC 3.54 ([95% CI, 1.38-9.12]) and with a reduced risk of death in African Americans (HRGG vs. CC 0.36 ([95% CI 0.12-1.07). Conclusions: These results suggest that rs4910510 may be associated with colorectal cancer survival in a manner that is dependent on race.	[Ryan, Brid M.; McClary, Andrew C.; Robinson, Dillon; Bowman, Elise D.; Robles, Ana I.; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [McClary, Andrew C.] NCI, Howard Hughes Med Inst, Bethesda, MD 20892 USA; [Valeri, Nicola; Paone, Alessio; Croce, Carlo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ryan, BM (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov	Young, Richard A/F-6495-2012; Paone, Alessio/AAB-4957-2019; Ryan, Brid/AAS-4854-2020	Young, Richard A/0000-0001-8855-8647; Paone, Alessio/0000-0001-9406-3982; Ryan, Brid/0000-0003-0038-131X; valeri, nicola/0000-0002-5426-5683; Robles, Ana/0000-0001-5019-4374	National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics; NATIONAL CANCER INSTITUTE [ZIABC011495, ZIABC011492, ZIABC010878] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research and in part by the National Cancer Institute Center of Excellence for the Integration of Chromosome Biology and Genetics. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Dominik D., 2007, Cancer Biomarkers, V3, P301; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Boni V, 2010, PHARMACOGENOMICS J; Daido S, 2004, ONCOL REP, V12, P789; Goodman JE, 2004, CARCINOGENESIS, V25, P2467, DOI 10.1093/carcin/bgh260; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ji D, 2007, ONCOL REP, V18, P1499; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim JM, 2011, MOL CELL BIOCHEM, V346, P125, DOI 10.1007/s11010-010-0599-y; Kim JH, 2007, CANCER RES, V67, P8229, DOI 10.1158/0008-5472.CAN-07-1297; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Mafra L, 2012, J AM CHEM SOC, V134, P71, DOI 10.1021/ja208647n; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sanoff HK, 2009, J CLIN ONCOL, V27, P4109, DOI 10.1200/JCO.2009.21.9527; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thai TH, 2010, DISCOV MED, V10, P184; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XL, 2008, HEPATO-GASTROENTEROL, V55, P2039; Xing JL, 2011, CANC EPIDEMIOL BIOMA; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zanetti KA, 2012, CANCER RES, V72, P1467, DOI 10.1158/0008-5472.CAN-11-3073; Zheng Hai-tao, 2005, Zhonghua Yi Xue Za Zhi, V85, P2124	31	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36306	10.1371/journal.pone.0036306	http://dx.doi.org/10.1371/journal.pone.0036306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606253	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200022
J	Yang, YZ; Wang, F; Shi, CZ; Zou, Y; Qin, HL; Ma, YL				Yang, Yongzhi; Wang, Feng; Shi, Chenzhang; Zou, Yang; Qin, Huanlong; Ma, Yanlei			Cyclin D1 G870A Polymorphism Contributes to Colorectal Cancer Susceptibility: Evidence from a Systematic Review of 22 Case-Control Studies	PLOS ONE			English	Article							AGE-OF-ONSET; E-CADHERIN CDH1; A870G POLYMORPHISM; SPLICE VARIANTS; INCREASED RISK; ASSOCIATION; CCND1; METAANALYSIS; HETEROGENEITY; EXPRESSION	Background: Cyclin D1 (CCND1) plays a vital role in cancer cell cycle progression. Numerous epidemiological studies have evaluated the association between the CCND1 G870A polymorphism and the risk of colorectal cancer. However, these studies have yielded conflicting results. To derive a more precise estimation of this association, we conducted a meta-analysis and systematic review. Methodology/Principal Findings: A comprehensive search was conducted to identify eligible studies of the CCND1 G870A polymorphism and colorectal cancer risk. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were derived from a fixed effect or random effect model. We applied a grading system (Venice criteria) that assessed the epidemiological strength of the association. A total of 22 publications that included 6157 cases and 8198 controls were identified. We found that the CCND1 G870A polymorphism was significantly associated with overall colorectal cancer risk (homozygote genetic model: OR = 1.130, 95% CI = 1.023-1.248, P = 0.016; heterozygote genetic model: OR = 1.124, 95% CI = 1.030-1.226, P = 0.009; dominant genetic model: OR = 1.127, 95% CI = 1.037-1.224, P = 0.005). After further stratified analyses, the increased risk was observed only in the subgroups of hospital-based studies, PCR-RFLP genotyping methods, sporadic colorectal cancer, and Caucasian ethnicity. Conclusions: The available evidence demonstrates that the CCND1 870A allele might be a low-penetrant risk factor for colorectal cancer.	[Yang, Yongzhi; Wang, Feng; Qin, Huanlong; Ma, Yanlei] Tongji Univ, Dept Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Yang, Yongzhi; Shi, Chenzhang; Zou, Yang] Shanghai Jiao Tong Univ, Dept Surg, Peoples Hosp 6, Shanghai 200030, Peoples R China	Tongji University; Shanghai Jiao Tong University	Yang, YZ (corresponding author), Tongji Univ, Dept Surg, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	hl-qin@hotmail.com; yanleima@live.cn	huanlong, Qin/B-3844-2015		Shanghai Rising-Star Program [11QA1404800]; National Natural Science Foundation of China [81001069]; National 863 High Technology Foundation [2009AA02Z118]	Shanghai Rising-Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technology Foundation(National High Technology Research and Development Program of China)	This work was financially sponsored by Shanghai Rising-Star Program (No. 11QA1404800), grants from the National Natural Science Foundation of China (No. 81001069) and the National 863 High Technology Foundation (No. 2009AA02Z118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2001, CANCER RES, V61, P6042; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Chen B, 2011, CANC EPIDEMIOL; Comstock CES, 2009, CLIN CANCER RES, V15, P5338, DOI 10.1158/1078-0432.CCR-08-2865; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forones Nora Manoukian, 2008, J Gastrointest Cancer, V39, P118, DOI 10.1007/s12029-009-9057-z; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Grieu F, 2003, ANTICANCER RES, V23, P4257; Grunhage F, 2008, INT J COLORECTAL DIS, V23, P147, DOI 10.1007/s00384-007-0388-6; HABER M, 1981, HUM HERED, V31, P161, DOI 10.1159/000153199; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; Hong Y, 2005, EUR J CANCER, V41, P1037, DOI 10.1016/j.ejca.2005.01.009; Huang WS, 2006, DIS COLON RECTUM, V49, P602, DOI 10.1007/s10350-005-0311-6; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang J, 2006, J CANCER RES CLIN, V132, P193, DOI 10.1007/s00432-005-0039-7; Kanaan Z, 2010, INT J BIOL MARKER, V25, P27, DOI 10.1177/172460081002500104; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kong SM, 2001, JNCI-J NATL CANCER I, V93, P1106, DOI 10.1093/jnci/93.14.1106; Kong SM, 2000, CANCER RES, V60, P249; Kruger S, 2006, CANCER LETT, V236, P191, DOI 10.1016/j.canlet.2005.05.013; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Le Marchand L, 2003, JAMA-J AM MED ASSOC, V290, P2843, DOI 10.1001/jama.290.21.2843; Lewis RC, 2003, CANCER RES, V63, P8549; Liu B, 2010, MOL CARCINOGEN, V49, P75, DOI 10.1002/mc.20579; Lu FM, 2003, CANCER RES, V63, P7056; MANTEL N, 1959, J NATL CANCER I, V22, P719; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McKay JA, 2000, INT J CANCER, V88, P77, DOI 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O; Pabalan N, 2008, CANCER EPIDEM BIOMAR, V17, P2773, DOI 10.1158/1055-9965.EPI-08-0169; Porter TR, 2002, ONCOGENE, V21, P1928, DOI 10.1038/sj.onc.1205245; Probst-Hensch NM, 2006, CARCINOGENESIS, V27, P2475, DOI 10.1093/carcin/bgl116; Schernhammer ES, 2006, BRIT J CANCER, V94, P928, DOI 10.1038/sj.bjc.6603007; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Song FJ, 1999, J CLIN EPIDEMIOL, V52, P725, DOI 10.1016/S0895-4356(99)00066-9; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Talseth BA, 2008, INT J CANCER, V122, P1273, DOI 10.1002/ijc.23177; Tan XL, 2008, INT J CANCER, V122, P2573, DOI 10.1002/ijc.23363; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yaylim-Eraltan I, 2010, ANTICANCER RES, V30, P2875	53	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36813	10.1371/journal.pone.0036813	http://dx.doi.org/10.1371/journal.pone.0036813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606291	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200045
J	Arrowsmith, S; Quenby, S; Weeks, A; Burdyga, T; Wray, S				Arrowsmith, Sarah; Quenby, Siobhan; Weeks, Andrew; Burdyga, Theodor; Wray, Susan			Poor Spontaneous and Oxytocin-Stimulated Contractility in Human Myometrium from Postdates Pregnancies	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; PROLONGED PREGNANCY; POSTTERM DELIVERY; MATERNAL OBESITY; UTERINE ACTIVITY; LIGHT-CHAIN; LABOR; DECREASES; INDUCTION; GESTATION	Prolongation of pregnancy i.e. going more than 10 days over the estimated due date, complicates up to 10% of all pregnancies and is associated with increased risk to both mother and fetus. Despite the obvious need for contractions of the uterus to end pregnancy, there have been no studies directly examining the role of uterine smooth muscle, myometrium, in the aetiology of prolonged pregnancy. This study tested the hypothesis that the intrinsic contractile characteristics of myometrium taken from women with prolonged pregnancy (>41 weeks and 3 days) was reduced compared to those delivering at term (39-41 weeks). We recruited women undergoing Caesarean Section (CS) delivery either pre-labour (n = 27) or in labour (n = 66) at term or postdates. The contractile ability of the postdates myometrium, whether spontaneous or elicited by oxytocin or high-K solution, was significantly reduced compared to term myometrium. These differences remained when adjusted for parity and other maternal characteristics. The findings remained significant when expressed per cross sectional area. Histological examination revealed no differences between the two groups. The contractile differences were however related to intracellular Ca transients suggesting an effect of [Ca] on reduced force production in the postdates group. In summary, myometrium from prolonged pregnancies contracts poorly in vitro even when stimulated with oxytocin and in active labour. Responses to high K+ and measurements of Ca suggest that alterations in excitation contraction coupling, rather than any histological changes of the myometrium, may underlie the differences between term and postdates myometrium. We show that postdates pregnancy is associated with poor myometrial activity and suggest that this may contribute to increased myometrial quiescence and hence, prolonged gestation.	[Arrowsmith, Sarah; Burdyga, Theodor; Wray, Susan] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Quenby, Siobhan] Univ Warwick, Clin Sci Res Inst, Warwick, England; [Weeks, Andrew] Univ Liverpool, Dept Women & Childrens Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Warwick; University of Liverpool	Arrowsmith, S (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	s.arrowsmith@liv.ac.uk	wray, susan/B-1197-2009	Burdyga, Theodor/0000-0002-6312-1550; Wray, Susan/0000-0002-0086-1359; Quenby, Siobhan/0000-0003-3221-5471; Arrowsmith, Sarah/0000-0003-1102-1934; Weeks, Andrew/0000-0002-1909-337X	Wellcome Trust Prize Studentship [WT080913MA]	Wellcome Trust Prize Studentship(Wellcome Trust)	S.A. was the recipient of a Wellcome Trust Prize Studentship (Ref. WT080913MA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani S, 2011, DIABETOLOGIA; Alexander JM, 2000, OBSTET GYNECOL, V96, P291, DOI 10.1016/S0029-7844(00)00862-0; Arrowsmith S, 2011, BJOG-INT J OBSTET GY, V118, P578, DOI 10.1111/j.1471-0528.2010.02889.x; Bennett KA, 2004, AM J OBSTET GYNECOL, V190, P1077, DOI 10.1016/j.ajog.2003.09.065; Burdyga T, 2009, EUR J OBSTET GYN R B, V144, pS25, DOI 10.1016/j.ejogrb.2009.02.017; Burdyga TV, 1998, PFLUG ARCH EUR J PHY, V436, P801, DOI 10.1007/s004240050705; Caughey AB, 2006, AM J OBSTET GYNECOL, V195, P700, DOI 10.1016/j.ajog.2006.07.003; Caughey AB, 2007, AM J OBSTET GYNECOL, V196, pe151; Challis John R. G., 1994, P985; Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x; Divon MY, 2002, AM J OBSTET GYNECOL, V187, P1081, DOI 10.1067/mob.2002.126645; FUCHS AR, 1984, AM J OBSTET GYNECOL, V150, P734, DOI 10.1016/0002-9378(84)90677-X; HENDRICKS CH, 1964, AM J OBSTET GYNECOL, V90, P485, DOI 10.1016/0002-9378(64)90807-5; Hovi M, 2006, ACTA OBSTET GYN SCAN, V85, P805, DOI 10.1080/00016340500442472; Jones K, 2004, PFLUG ARCH EUR J PHY, V448, P36, DOI 10.1007/s00424-003-1224-7; Kiran TSU, 2005, BJOG-INT J OBSTET GY, V112, P768, DOI 10.1111/j.1471-0528.2004.00546.x; KUC A, 1975, Zentralblatt fuer Gynaekologie, V97, P1647; Kupittayanant S, 2002, BJOG-INT J OBSTET GY, V109, P289, DOI 10.1016/S1470-0328(02)01110-2; LAMMERS WJEP, 1994, AM J PHYSIOL-CELL PH, V267, pC1210, DOI 10.1152/ajpcell.1994.267.5.C1210; Laursen M, 2004, AM J OBSTET GYNECOL, V190, P489, DOI 10.1016/j.ajog.2003.08.036; Luckas M, 1998, J PERINAT MED, V26, P475, DOI 10.1515/jpme.1998.26.6.475; Luckas MJM, 1999, AM J OBSTET GYNECOL, V181, P468, DOI 10.1016/S0002-9378(99)70580-6; LYE SJ, 1993, ENDOCRINOLOGY, V132, P2380, DOI 10.1210/en.132.6.2380; Norwitz ER, 2007, CLIN OBSTET GYNECOL, V50, P547, DOI 10.1097/GRF.0b013e31804c9b11; Olesen AW, 2006, ACTA OBSTET GYN SCAN, V85, P1338, DOI 10.1080/00016340600935508; Olesen AW, 1999, EPIDEMIOLOGY, V10, P468, DOI 10.1097/00001648-199907000-00026; Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446; PARRATT J, 1994, LANCET, V344, P717, DOI 10.1016/S0140-6736(94)92209-8; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Reynolds S, 1954, CLIN MEASUREMENT UTE; Robinson C, 2003, AM J OBSTET GYNECOL, V188, P497, DOI 10.1067/mob.2003.22; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Shmigol A, 1998, PFLUG ARCH EUR J PHY, V437, P158, DOI 10.1007/s004240050761; Shmigol AV, 1999, J PHYSIOL-LONDON, V520, P153, DOI 10.1111/j.1469-7793.1999.00153.x; Shmygol A, 2007, J PHYSIOL-LONDON, V581, P445, DOI 10.1113/jphysiol.2007.129452; Shmygol A, 2005, CELL CALCIUM, V37, P215, DOI 10.1016/j.ceca.2004.10.002; Smith RD, 2005, AM J PHYSIOL-CELL PH, V288, pC982, DOI 10.1152/ajpcell.00120.2004; Stotland NE, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.05.048; Taggart MJ, 1997, J PHYSIOL-LONDON, V499, P485, DOI 10.1113/jphysiol.1997.sp021943; Tribe RM, 2000, BIOL REPROD, V63, P748, DOI 10.1095/biolreprod63.3.748; Turnbull A C, 1968, J Obstet Gynaecol Br Commonw, V75, P278; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Zhang J, 2007, REPROD SCI, V14, P456, DOI 10.1177/1933719107306229	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36787	10.1371/journal.pone.0036787	http://dx.doi.org/10.1371/journal.pone.0036787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590608	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400035
J	Chen, W; DelProposto, Z; Wu, DM; Wang, J; Jiang, Q; Xuan, S; Ye, YQ; Zhang, ZS; Hu, JN				Chen, Wei; DelProposto, Zachary; Wu, Dongmei; Wang, Jian; Jiang, Quan; Xuan, Stephanie; Ye, YongQuan; Zhang, Zishu; Hu, Jiani			Improved Siderotic Nodule Detection in Cirrhosis with Susceptibility-Weighted Magnetic Resonance Imaging: A Prospective Study	PLOS ONE			English	Article							HEPATIC IRON CONCENTRATION; HEPATOCELLULAR-CARCINOMA; MACROREGENERATIVE NODULES; REGENERATING NODULES; DYSPLASTIC NODULES; LIVER; DEPOSITION; VARIABILITY; METABOLISM; LESIONS	Background: Hepatic cirrhosis is a common pathway of progressive liver destruction from multiple causes. Iron uptake can occur within the hepatic parenchyma or within the various nodules that form in a cirrhotic liver, termed siderotic nodules. Siderotic nodule formation has been shown to correlate with inflammatory activity, and while the relationship between siderotic nodule formation and malignancy remains unclear, iron distribution within hepatic nodules has known implications for the detection of hepatocellular carcinoma. We aimed to evaluate the role of abdominal susceptibility-weighted imaging in the detection of siderotic nodules in cirrhotic patients. Methodology/Principal Findings: Forty-six (46) cirrhotic patients with at least one siderotic nodule detected on previous imaging underwent both computed tomography and magnetic resonance imaging (T1-, T2-, T2*-, and susceptibility-weighted imaging) at 3.0 Tesla. Imaging data was independently analyzed by two radiologists. Siderotic nodule count was determined for each modality and imaging sequence. For each magnetic resonance imaging technique, siderotic nodule conspicuity was assessed on a 3 point scale (1 = weak, 2 = moderate, 3 = strong). More nodules were detected by susceptibility weighted imaging (n = 2935) than any other technique, and significantly more than by T2* weighted imaging (n = 1696, p<0.0001). Lesion conspicuity was also highest with susceptibility- weighted imaging, with all nodules found to be moderate (n = 6) or strong (n = 40); a statistically significant difference (p<0.001). Conclusions: Susceptibility-weighted imaging had the greatest lesion conspicuity and detected the highest number of siderotic nodules suggesting it is the most sensitive imaging technique to detect siderotic nodules in cirrhotic patients.	[Chen, Wei; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Wu, Dongmei] E China Normal Univ, Dept Phys, Shanghai Key Lab MR, Shanghai 200062, Peoples R China; [Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Xuan, Stephanie] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Ye, YongQuan; Zhang, Zishu; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Army Medical University; Henry Ford Health System; Henry Ford Hospital; East China Normal University; Henry Ford Health System; Henry Ford Hospital; University of Toronto; Wayne State University	Chen, W (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	jianwng842@yahoo.com; jhu@med.wayne.edu		Ye, Yongquan/0000-0002-6673-6753	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064134] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS064134] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503; Breitkopf K, 2009, ALCOHOL CLIN EXP RES, V33, P1647, DOI 10.1111/j.1530-0277.2009.01015.x; Cheng YCN, 2001, NMR BIOMED, V14, P468, DOI 10.1002/nbm.727; Dai Y, 2010, ISMRM 18 SCI M EXH P; DEUGNIER Y, 1991, J HEPATOL, V13, P286, DOI 10.1016/0168-8278(91)90070-R; Emond MJ, 1999, CLIN CHEM, V45, P340; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; ITAI Y, 1987, RADIOLOGY, V165, P419, DOI 10.1148/radiology.165.2.2821574; Ito K, 1999, RADIOLOGY, V212, P235, DOI 10.1148/radiology.212.1.r99jl41235; KADOYA M, 1994, RADIOLOGY, V193, P671, DOI 10.1148/radiology.193.3.7972806; Kim MJ, 2002, J COMPUT ASSIST TOMO, V26, P988, DOI 10.1097/00004728-200211000-00023; Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5; Krinsky GA, 2002, ACAD RADIOL, V9, P336, DOI 10.1016/S1076-6332(03)80375-6; Krinsky GA, 2001, RADIOLOGY, V218, P47, DOI 10.1148/radiology.218.1.r01ja4047; Krinsky GA, 2000, J COMPUT ASSIST TOMO, V24, P773, DOI 10.1097/00004728-200009000-00019; Kudo M, 2009, J GASTROENTEROL, V44, P112, DOI 10.1007/s00535-008-2274-6; Kushner J P, 2001, Hematology Am Soc Hematol Educ Program, P47; MITCHELL DG, 1991, RADIOLOGY, V178, P101, DOI 10.1148/radiology.178.1.1845784; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; MURAKAMI T, 1992, J COMPUT ASSIST TOMO, V16, P578, DOI 10.1097/00004728-199207000-00015; Paley MR, 1998, RADIOL CLIN N AM, V36, P391, DOI 10.1016/S0033-8389(05)70030-0; Park YN, 2011, ABDOM IMAGING, V36, P232, DOI 10.1007/s00261-011-9688-y; Pomerantz S, 2002, MAGN RESON IMAGING C, V10, pvi; Pomerantz Stuart, 2002, Magn Reson Imaging Clin N Am, V10, P105, DOI 10.1016/S1064-9689(03)00052-7; SADEK AG, 1995, RADIOLOGY, V195, P753, DOI 10.1148/radiology.195.3.7754006; Siegelman ES, 1996, RADIOLOGY, V199, P13, DOI 10.1148/radiology.199.1.8633135; TERADA T, 1990, CANCER, V65, P1994, DOI 10.1002/1097-0142(19900501)65:9<1994::AID-CNCR2820650919>3.0.CO;2-B; TERADA T, 1989, HEPATOLOGY, V10, P851, DOI 10.1002/hep.1840100517; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Villeneuve JP, 1996, J HEPATOL, V25, P172, DOI 10.1016/S0168-8278(96)80070-5; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Wood JC, 2011, HEMATOLOGY AM SOC HE, V443- 450, P443, DOI [10.1182/asheducation-2011.1.443, DOI 10.1182/ASHEDUCA-TION-2011.1.443]; Zhang JB, 2004, NMR BIOMED, V17, P459, DOI 10.1002/nbm.926; ZHOU XD, 1987, CANCER, V59, P1430, DOI 10.1002/1097-0142(19870415)59:8<1430::AID-CNCR2820590808>3.0.CO;2-A	35	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36454	10.1371/journal.pone.0036454	http://dx.doi.org/10.1371/journal.pone.0036454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590548	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400017
J	Wang, CJ; Tang, SM; Wilkes, A; Jiang, YY; Han, GD; Huang, D				Wang, Cheng-Jie; Tang, Shi-Ming; Wilkes, Andreas; Jiang, Yuan-Yuan; Han, Guo-Dong; Huang, Ding			Effect of Stocking Rate on Soil-Atmosphere CH4 Flux during Spring Freeze-Thaw Cycles in a Northern Desert Steppe, China	PLOS ONE			English	Article							CARBON-DIOXIDE; METHANE UPTAKE; INNER; GRASSLANDS; CATTLE; IMPACT; SHEEP	Background: Methane (CH4) uptake by steppe soils is affected by a range of specific factors and is a complex process. Increased stocking rate promotes steppe degradation, with unclear consequences for gas exchanges. To assess the effects of grazing management on CH4 uptake in desert steppes, we investigated soil-atmosphere CH4 exchange during the winter-spring transition period. Methodology/Main Finding: The experiment was conducted at twelve grazing plots denoting four treatments defined along a grazing gradient with three replications: non-grazing (0 sheep/ha, NG), light grazing (0.75 sheep/ha, LG), moderate grazing (1.50 sheep/ha, MG) and heavy grazing (2.25 sheep/ha, HG). Using an automatic cavity ring-down spectrophotometer, we measured CH4 fluxes from March 1 to April 29 in 2010 and March 2 to April 27 in 2011. According to the status of soil freeze-thaw cycles (positive and negative soil temperatures occurred in alternation), the experiment was divided into periods I and II. Results indicate that mean CH4 uptake in period I (7.51 mu g CH4-C m(-2) h(-1)) was significantly lower than uptake in period II (83.07 mu g CH4-C m(-2) h(-1)). Averaged over 2 years, CH4 fluxes during the freeze-thaw period were -84.76 mu g CH4-C m(-2) h(-1) (NG), -88.76 mu g CH4-C m(-2) h(-1) (LG), -64.77 mu g CH4-C m(-2) h(-1) (MG) and -28.80 mu g CH4-C m(-2) h(-1) (HG). Conclusions/Significance: CH4 uptake activity is affected by freeze-thaw cycles and stocking rates. CH4 uptake is correlated with the moisture content and temperature of soil. MG and HG decreases CH4 uptake while LG exerts a considerable positive impact on CH4 uptake during spring freeze-thaw cycles in the northern desert steppe in China.	[Wang, Cheng-Jie; Tang, Shi-Ming; Jiang, Yuan-Yuan; Han, Guo-Dong] Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China; [Wilkes, Andreas] World Agroforestry Ctr, Beijing, Peoples R China; [Huang, Ding] China Agr Univ, Inst Grassland Sci, Beijing 100094, Peoples R China	Inner Mongolia Agricultural University; China Agricultural University	Wang, CJ (corresponding author), Inner Mongolia Agr Univ, Coll Ecol & Environm Sci, Hohhot, Peoples R China.	cjwang3@sohu.com	Wang, Chengjie/A-3984-2013; jiang, anyi/GPT-0379-2022; han, guodong/A-2303-2013		Chinese National Natural Science Foundation [31160109, 30960072, 31070413]; Inner Mongolia Palmary Youth Project [2010JQ04]; National Commonweal Project [200903060, 201003019]; Inner Mongolia Agricultural University Innovation Group [NDTD2010-5]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Inner Mongolia Palmary Youth Project; National Commonweal Project; Inner Mongolia Agricultural University Innovation Group	This research was funded by the Chinese National Natural Science Foundation (31160109, 30960072, 31070413), Inner Mongolia Palmary Youth Project (2010JQ04), and National Commonweal Project (200903060, 201003019), Inner Mongolia Agricultural University Innovation Group (NDTD2010-5) and Management and Policy Support to Combat Land Degradation Project: PRC-GEF Partnership on Land Degradation in Dryland Ecosystems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SPSS STAT PACK SOC S; Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Chen WW, 2011, GLOBAL CHANGE BIOL, V17, P2803, DOI 10.1111/j.1365-2486.2011.02444.x; Clegg CD, 2006, APPL SOIL ECOL, V31, P73, DOI 10.1016/j.apsoil.2005.04.003; Dorsch P, 2004, NUTR CYCL AGROECOSYS, V70, P117, DOI 10.1023/B:FRES.0000048473.11362.63; Holst J, 2008, PLANT SOIL, V308, P105, DOI 10.1007/s11104-008-9610-8; IPCC [Intergovernmental Panel on Climate Change], 2007, CONTR WORK GROUP 3 4; Jiang YY, 2012, ASIAN AUSTRAL J ANIM, V25, P207, DOI 10.5713/ajas.2011.11261; Kotelnikova S, 2002, EARTH-SCI REV, V58, P367, DOI 10.1016/S0012-8252(01)00082-4; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Li CL, 2008, AGR ECOSYST ENVIRON, V128, P109, DOI 10.1016/j.agee.2008.05.008; LIAO G, 1996, GRASSLAND RESOURCE C; Liu CY, 2007, ATMOS ENVIRON, V41, P5948, DOI 10.1016/j.atmosenv.2007.03.017; Mosier AR, 1996, GLOBAL BIOGEOCHEM CY, V10, P387, DOI 10.1029/96GB01454; NSBC (National Statistics Bureau of China), 2002, CHIN STAT YB 2002; Pietola L, 2005, SOIL TILL RES, V82, P99, DOI 10.1016/j.still.2004.08.004; [齐玉春 Qi Yuchun], 2005, [资源科学, Resources science], V27, P103; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Sharma S, 2006, APPL ENVIRON MICROB, V72, P2148, DOI 10.1128/AEM.72.3.2148-2154.2006; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Soussana JF, 2004, SOIL USE MANAGE, V20, P219, DOI 10.1079/SUM2003234; van den Pol-van Dasselaar A, 1998, PLANT SOIL, V204, P213, DOI 10.1023/A:1004371309361; Wager C, 1996, APPL ENVIRON MICROB, V62, P494; Wang YS, 2005, CHEMOSPHERE, V58, P205, DOI 10.1016/j.chemosphere.2004.04.043; Wolf B, 2010, NATURE, V464, P881, DOI 10.1038/nature08931; Zhou XQ, 2008, NUTR CYCL AGROECOSYS, V80, P145, DOI 10.1007/s10705-007-9127-1	26	15	17	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36794	10.1371/journal.pone.0036794	http://dx.doi.org/10.1371/journal.pone.0036794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590610	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335500029
J	Guo, Y; Wang, YX; Xu, L; Jonas, JB				Guo, Yin; Wang, Ya Xing; Xu, Liang; Jonas, Jost B.			Five-Year Follow-Up of Parapapillary Atrophy: The Beijing Eye Study	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPTIC-NERVE DAMAGE; VISUAL-FIELD DAMAGE; OPEN-ANGLE GLAUCOMA; PERIPAPILLARY ATROPHY; CHORIORETINAL ATROPHY; OCULAR HYPERTENSION; DISC MORPHOLOGY; PROGRESSION; POPULATION	Purpose: To assess longitudinal changes in parapapillary atrophy in the adult population of Greater Beijing. Methods: The population-based Beijing Eye Study 2006 included 3251 subjects who had participated in the Beijing Eye Study 2001 and returned for re-examination. The mean age was 60.4 +/- 10.1 years. Using optic disc photographs, we measured parapapillary atrophy which was divided into alpha zone and beta zone. Results: Overall progression rate of alpha zone was seen in 0.6 +/- 0.1% (95% confidence interval (CI): 0.3,0.9) of the subjects and of beta zone in 8.2 +/- 0.5% (95% CI: 7.2,9.1) of the subjects. In binary regression analysis, rate of progression of alpha zone was significantly associated higher age (P = 0.04) and the co-progression of zone Beta (P<0.001). Rate of progression of beta zone was significantly associated with higher age (P< 0.001; odds ratio (OR): 1.11; 95% CI: 1.10,1.14), higher intraocular pressure (P<0.001; OR: 1.10; 95% CI: 1.05,1.14), higher myopic refractive error (P<0.001; OR: 0.71; 95% CI: 0.67,0.75), rural region of habitation (P = 0.002; OR: 0.58; 95% CI: 0.41,0.82), presence of glaucomatous optic nerve damage (P<0.001; OR: 2.89; 95% CI: 1.62,5.14), co-progression of alpha zone (P<0.001; OR: 7.13; 95% CI: 2.43,20.9), absence of arterial hypertension (P = 0.03; OR: 0.70; 95% CI: 0.51,0.96), and thicker central corneal thickness (P = 0.02; OR: 1.01; 95% CI: 1.00,1.01). Subjects with a non-glaucomatous optic nerve damage (n = 22) as compared to the remaining subjects did not vary in the progression rate of alpha zone (0.0% versus 0.6 +/- 0.1%; P = 1.0) and beta zone (8.2 +/- 0.5% versus 6.3 +/- 0.6%; P = 1.0). Conclusions: In adult Chinese in Greater Beijing, the 5-year progression rate of beta zone of parapapillary atrophy (seen in 8.2 +/- 0.5% of subjects) was significantly correlated with higher age, rural region of habitation, absence of arterial hypertension, higher intraocular pressure, higher myopic refractive error, thicker central corneal thickness, and presence of glaucoma. It was not associated with non-glaucomatous optic nerve damage.	[Guo, Yin; Wang, Ya Xing; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Guo, Y (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@gmail.com	wang, YA XING/K-9671-2016; Guo, Yin/ABC-2134-2020	wang, YA XING/0000-0003-2749-7793; Guo, Yin/0000-0003-3806-3771	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China	National Key Laboratory Fund, Beijing, China; Beijing Natural Science Foundation, Beijing, China(Beijing Natural Science Foundation)	This work is supported by the National Key Laboratory Fund, Beijing, China, and the Beijing Natural Science Foundation, Beijing, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440; Bucklers M., 1929, ARCH OPHTHALMOL-CHIC, V121, P243; De Moraes CGV, 2011, ARCH OPHTHALMOL-CHIC, V129, P562, DOI 10.1001/archophthalmol.2011.72; Elschnig A., 1901, DENKSCHR AKAD WISS, V70, P219; Emdadi A, 1999, AM J OPHTHALMOL, V128, P595, DOI 10.1016/S0002-9394(99)00189-0; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hayreh SS, 2001, OPHTHALMOLOGY, V108, P1586, DOI 10.1016/S0161-6420(01)00649-2; Jonas JB, 1999, AM J OPHTHALMOL, V127, P523, DOI 10.1016/S0002-9394(99)00030-6; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P2942; Jonas JB, 1997, GRAEF ARCH CLIN EXP, V235, P627, DOI 10.1007/BF00946938; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Kawano J, 2006, AM J OPHTHALMOL, V142, P40, DOI 10.1016/j.ajo.2006.01.087; Kono Y, 1999, AM J OPHTHALMOL, V127, P674, DOI 10.1016/S0002-9394(99)00045-8; Lee EJ, 2011, INVEST OPHTH VIS SCI, V52, P4422, DOI 10.1167/iovs.10-6818; PANDAJONAS S, 1994, OPHTHALMOLOGY, V101, P519; Park KH, 1996, OPHTHALMOLOGY, V103, P1899, DOI 10.1016/S0161-6420(96)30409-0; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Primrose J, 1971, T OPHTHAL SOC UK, V89, P585; Radcliffe NM, 2008, AM J OPHTHALMOL, V146, P735, DOI 10.1016/j.ajo.2008.06.018; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 1997, ARCH OPHTHALMOL-CHIC, V115, P1503, DOI 10.1001/archopht.1997.01100160673001; Tezel G, 1997, ARCH OPHTHALMOL-CHIC, V115, P1509, DOI 10.1001/archopht.1997.01100160679003; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813; Uchida H, 1998, OPHTHALMOLOGY, V105, P1541, DOI 10.1016/S0161-6420(98)98044-7; Wang Y, 2008, EYE, V22, P261, DOI 10.1038/sj.eye.6702601; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; WILENSKY JT, 1976, AM J OPHTHALMOL, V81, P341, DOI 10.1016/0002-9394(76)90251-8; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; You QS, 2011, OPHTHALMOLOGY, V118, P1069, DOI 10.1016/j.ophtha.2010.09.032	34	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e32005	10.1371/journal.pone.0032005	http://dx.doi.org/10.1371/journal.pone.0032005			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586440	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000002
J	Mao, C; Zhou, JH; Yang, ZY; Huang, YF; Wu, XY; Shen, H; Tang, JL; Chen, Q				Mao, Chen; Zhou, Junhua; Yang, Zuyao; Huang, Yafang; Wu, Xinyin; Shen, Hong; Tang, Jinling; Chen, Qing			KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer	PLOS ONE			English	Article							TARGETED MONOCLONAL-ANTIBODIES; CETUXIMAB PLUS IRINOTECAN; K-RAS; EGFR; CHEMOTHERAPY; BENEFIT; DETERMINANTS; ASSOCIATION; PANITUMUMAB; RESISTANCE	Background: To investigate the frequency and relationship of the KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer (CRC). Methodology/Principal Findings: Genomic DNA was extracted from the formalin-fixed paraffin-embedded (FFPE) tissues of 69 patients with histologically confirmed CRC. Automated sequencing analysis was conducted to detect mutations in the KRAS (codons 12, 13, and 14), BRAF (codon 600) and PIK3CA (codons 542, 545 and 1047). PTEN protein expression was evaluated by immunohistochemistry on 3 mm FFPE tissue sections. Statistical analysis was carried out using SPSS 16.0 software. The frequency of KRAS, BRAF and PIK3CA mutations and loss of PTEN expression was 43.9% (25/57), 25.4% (15/59), 8.2% (5/61) and 47.8% (33/69), respectively. The most frequent mutation in KRAS, BRAF and PIK3CA was V14G (26.7% of all mutations), V600E (40.0% of all mutations) and V600L (40.0% of all mutations), and H1047L (80.0% of all mutations), respectivly. Six KRAS mutatant patients (24.0%) harbored BRAF mutations. BRAF and PIK3CA mutations were mutually exclusive. No significant correlation was observed between the four biomarkers and patients' characteristics. Conclusions/Significance: BRAF mutation rate is much higher in this study than in other studies, and overlap a lot with KRAS mutations. Besides, the specific types of KRAS and PIK3CA mutations in Chinese patients could be quite different from that of patients in other countries. Further studies are warranted to examine their impact on prognosis and response to targeted treatment.	[Mao, Chen; Zhou, Junhua; Chen, Qing] So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Mao, Chen; Yang, Zuyao; Huang, Yafang; Wu, Xinyin; Tang, Jinling] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Shen, Hong] So Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Chinese University of Hong Kong; Southern Medical University - China	Mao, C (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China.	jltang@cuhk.edu.hk; qingchen@fimmu.com	Mao, Chen/AAW-2742-2020; Tang, JL/G-1759-2013; Mao, Chen/G-9805-2013	Mao, Chen/0000-0002-6537-6215; Mao, Chen/0000-0001-7471-1516				Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Fiore F, 2010, BRIT J CANCER, V103, P1765, DOI 10.1038/sj.bjc.6606008; Food and Drug Administration, 2011, CLASS LAB CHANG ANT; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Freeman DJ, 2008, CLIN COLORECTAL CANC, V7, P184, DOI 10.3816/CCC.2008.n.024; He X, 2009, MODERN PRACTICAL MED, V21, P698; Huang WF, 2010, MED J CHIN PAPF, V21, P925; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li HT, 2011, ONCOL REP, V25, P1691, DOI 10.3892/or.2011.1217; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; Liou JM, 2011, INT J COLORECTAL DIS, V26, P1387, DOI 10.1007/s00384-011-1229-1; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Lu X, 2009, CANC RES CLIN, V21, P596; Lu X, 2009, CANC RES CLIN, V21, P588; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Negri FV, 2010, BRIT J CANCER, V102, P162, DOI 10.1038/sj.bjc.6605471; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sartore-Bianchi A, 2010, TARGET ONCOL, V5, P19, DOI 10.1007/s11523-010-0138-5; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; Shen H, 2011, WORLD J GASTROENTERO, V17, P809, DOI 10.3748/wjg.v17.i6.809; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tol J, 2010, CLIN THER, V32, P437, DOI 10.1016/j.clinthera.2010.03.012; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854	38	54	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36653	10.1371/journal.pone.0036653	http://dx.doi.org/10.1371/journal.pone.0036653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586484	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000045
J	Zhang, ZL; Wu, XM; Duan, J; Hinrichs, D; Wegmann, K; Zhang, GL; Hall, M; Rosenbaum, JT				Zhang, Zili; Wu, Xiumei; Duan, Jie; Hinrichs, David; Wegmann, Keith; Zhang, Gary L.; Hall, Mark; Rosenbaum, James T.			Low Dose Rapamycin Exacerbates Autoimmune Experimental Uveitis	PLOS ONE			English	Article							INDUCED CELL-DEATH; MAMMALIAN TARGET; METABOLIC-REGULATION; T-CELLS; MTOR; SIROLIMUS; ACTIVATION; AUTOPHAGY; EXPRESSION; RESPONSES	Background: Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that low dose rapamycin enhances the memory T cell population and function. However, it is unclear how low dose rapamycin influences the immune response in the setting of uveitis. Design and Methods: B10.RIII mice were immunized to induce experimental autoimmune uveitis (EAU). Ocular inflammation of control and rapamycin-treated mice was compared based on histological change. ELISPOT and T cell proliferation assays were performed to assess splenocyte response to ocular antigen. In addition, we examined the effect of rapamycin on activation-induced cell death (AICD) using the MitoCapture assay and Annexin V staining. Results: Administration of low dose rapamycin exacerbated EAU, whereas treating mice with high dose rapamycin attenuated ocular inflammation. The progression of EAU by low dose rapamycin coincided with the increased frequency of antigen-reactive lymphocytes. Lastly, fewer rapamycin-treated T cells underwent AICD, which might contribute to exaggerated ocular inflammation and the uveitogenic immune response. Conclusion: These data reveal a paradoxical role for rapamycin in uveitis in a dose-dependent manner. This study has a potentially important clinical implication as rapamycin might cause unwanted consequences dependent on dosing and pharmacokinetics. Thus, more research is needed to further define the mechanism by which low dose rapamycin augments the immune response.	[Zhang, Zili; Wu, Xiumei; Duan, Jie; Zhang, Gary L.; Hall, Mark] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Hinrichs, David; Wegmann, Keith] Portland VA Med Ctr, Portland, OR USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University	Zhang, ZL (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	zhangzi@ohsu.edu; rosenbaj@ohsu.edu			National Institutes of Health [EY016788, EY013093, EY006484]; Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Research to Prevent Blindness; William C. Kuzell Foundation; NATIONAL EYE INSTITUTE [R01EY006484, F32EY006484, R01EY013093, K08EY016788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stan and Madelle Rosenfeld Family Trust; William and Mary Bauman Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); William C. Kuzell Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY016788 (ZZ), EY013093 (JTR), and EY006484 (JTR). Funds from the Stan and Madelle Rosenfeld Family Trust, the William and Mary Bauman Foundation, Research to Prevent Blindness and William C. Kuzell Foundation also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Anglicheau D, 2007, TRANSPL P, V39, P2142, DOI 10.1016/j.transproceed.2007.06.018; Anglicheau D, 2007, PHARMACOGENOMICS, V8, P835, DOI 10.2217/14622416.8.7.835; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; Cao JT, 2010, INVEST OPHTH VIS SCI, V51, P6009, DOI 10.1167/iovs.09-4956; CASPI RR, 1988, J IMMUNOL, V140, P1490; Cortes LM, 2008, INVEST OPHTH VIS SCI, V49, P1946, DOI 10.1167/iovs.07-0868; Delgoffe GM, 2009, IMMUNOLOGY, V127, P459, DOI 10.1111/j.1365-2567.2009.03125.x; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Ferrer IR, 2010, J IMMUNOL, V185, P2004, DOI 10.4049/jimmunol.1001176; FEUERSTEIN N, 1995, J BIOL CHEM, V270, P9454, DOI 10.1074/jbc.270.16.9454; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haydar AA, 2004, AM J TRANSPLANT, V4, P137, DOI 10.1046/j.1600-6135.2003.00292.x; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jham BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019103; Land SC, 2007, J BIOL CHEM, V282, P20534, DOI 10.1074/jbc.M611782200; Luger D, 2008, SEMIN IMMUNOPATHOL, V30, P135, DOI 10.1007/s00281-008-0108-5; Mayer DF, 2003, CURR OPIN RHEUMATOL, V15, P219, DOI 10.1097/00002281-200305000-00008; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Nussenblatt RB, 1996, J AUTOIMMUN, V9, P575, DOI 10.1006/jaut.1996.0077; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peter C, 2010, CURR OPIN IMMUNOL, V22, P655, DOI 10.1016/j.coi.2010.08.010; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6; Pierdominici M, 2011, CURR PHARM DESIGN, V17, P3888, DOI 10.2174/138161211798357809; Powell JD, 2010, IMMUNITY, V33, P301, DOI 10.1016/j.immuni.2010.09.002; Prlic M, 2009, NATURE, V460, P41, DOI 10.1038/460041a; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Strasser A, 1996, Behring Inst Mitt, P101; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Thaunat O, 2005, TRANSPLANTATION, V80, P1212, DOI 10.1097/01.tp.0000179106.07382.6a; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turner AP, 2011, AM J TRANSPLANT, V11, P613, DOI 10.1111/j.1600-6143.2010.03407.x; Uthaisangsook S, 2003, EXP BIOL MED, V228, P1023, DOI 10.1177/153537020322800906; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Walmsley SR, 2005, TRENDS IMMUNOL, V26, P434, DOI 10.1016/j.it.2005.06.007; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Wang Y, 2011, J IMMUNOL, V186, P2809, DOI 10.4049/jimmunol.0903805; Weiner SM, 2007, NEPHROL DIAL TRANSPL, V22, P3631, DOI 10.1093/ndt/gfm420; Wu XM, 2011, INVEST OPHTH VIS SCI, V52, P8520, DOI 10.1167/iovs.11-7664; Wulff BC, 2008, J INVEST DERMATOL, V128, P2467, DOI 10.1038/jid.2008.121; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Young DA, 2005, CURR OPIN PHARMACOL, V5, P418, DOI 10.1016/j.coph.2005.03.004; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36589	10.1371/journal.pone.0036589	http://dx.doi.org/10.1371/journal.pone.0036589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574188	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800085
J	Pence, BW; Shirey, K; Whetten, K; Agala, B; Itemba, D; Adams, J; Whetten, R; Yao, J; Shao, J				Pence, Brian W.; Shirey, Kristen; Whetten, Kathryn; Agala, Bernard; Itemba, Dafrosa; Adams, Julie; Whetten, Rachel; Yao, Jia; Shao, John			Prevalence of Psychological Trauma and Association with Current Health and Functioning in a Sample of HIV-infected and HIV-uninfected Tanzanian Adults	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; US DEEP SOUTH; RISK BEHAVIORS; PHYSICAL ABUSE; HOUSEHOLD DYSFUNCTION; EXPERIENCES SURVEY; POSITIVE PERSONS	Background: In high income nations, traumatic life experiences such as childhood sexual abuse are much more common in people living with HIV/AIDS (PLWHA) than the general population, and trauma is associated with worse current health and functioning. Virtually no data exist on the prevalence or consequences of trauma for PLWHA in low income nations. Methodology/Principal Findings: We recruited four cohorts of Tanzanian patients in established medical care for HIV infection (n = 228), individuals newly testing positive for HIV (n = 267), individuals testing negative for HIV at the same sites (n = 182), and a random sample of community-dwelling adults (n = 249). We assessed lifetime prevalence of traumatic experiences, recent stressful life events, and current mental health and health-related physical functioning. Those with established HIV infection reported a greater number of childhood and lifetime traumatic experiences (2.1 and 3.0 respectively) than the community cohort (1.8 and 2.3). Those with established HIV infection reported greater post-traumatic stress disorder (PTSD) symptomatology and worse current health-related physical functioning. Each additional lifetime traumatic experience was associated with increased PTSD symptomatology and worse functioning. Conclusions/Significance: This study is the first to our knowledge in an HIV population from a low income nation to report the prevalence of a range of potentially traumatic life experiences compared to a matched community sample and to show that trauma history is associated with poorer health-related physical functioning. Our findings underscore the importance of considering psychosocial characteristics when planning to meet the health needs of PLWHA in low income countries.	[Pence, Brian W.; Whetten, Kathryn; Agala, Bernard; Whetten, Rachel; Yao, Jia] Duke Univ, Dept Community & Family Med, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27710 USA; [Shirey, Kristen; Adams, Julie] Duke Univ, Dept Psychiat, Duke Global Hlth Inst, Durham, NC 27706 USA; [Shirey, Kristen; Adams, Julie] Duke Univ, Dept Med, Duke Global Hlth Inst, Durham, NC 27706 USA; [Itemba, Dafrosa; Shao, John] Tanzania Women Res Fdn, Moshi, Tanzania	Duke University; Duke University; Duke University	Pence, BW (corresponding author), Duke Univ, Dept Community & Family Med, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC 27710 USA.	brian.pence@duke.edu	Whetten, Kathryn/C-8572-2009	Whetten, Kathryn/0000-0002-4841-7695; Agala, Chris B/0000-0001-7157-814X	National Institute of Mental Health [5R01MH078756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078756, R25MH080916] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant 5R01MH078756 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; ALLERS CT, 1991, J COUNS DEV, V70, P309, DOI 10.1002/j.1556-6676.1991.tb01602.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Basile Kathleen C, 2007, Violence Vict, V22, P437, DOI 10.1891/088667007781553955; Bensley LS, 2000, AM J PREV MED, V18, P151, DOI 10.1016/S0749-3797(99)00084-7; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boarts JM, 2006, AIDS BEHAV, V10, P253, DOI 10.1007/s10461-006-9069-7; Campsmith Michael L, 2003, Health Qual Life Outcomes, V1, P12, DOI 10.1186/1477-7525-1-12; Cohen MA, 2001, GEN HOSP PSYCHIAT, V23, P294, DOI 10.1016/S0163-8343(01)00152-9; de Paul J, 2000, CHILD ABUSE NEGLECT, V24, P701, DOI 10.1016/S0145-2134(00)00124-1; Delahanty DL, 2004, AIDS CARE, V16, P247, DOI 10.1080/09540120410001641084; Dobalian A, 2004, MED CARE, V42, P129, DOI 10.1097/01.mlr.0000108744.45327.d4; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Epstein JN, 1997, J TRAUMA STRESS, V10, P573, DOI 10.1023/A:1024841718677; Epstein JN, 1998, CHILD ABUSE NEGLECT, V22, P223, DOI 10.1016/S0145-2134(97)00133-6; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fleming J, 1999, CHILD ABUSE NEGLECT, V23, P145, DOI 10.1016/S0145-2134(98)00118-5; Gill CJ, 2002, J ACQ IMMUN DEF SYND, V30, P485, DOI 10.1097/00126334-200208150-00004; Hamburger ME, 2004, AIDS BEHAV, V8, P333, DOI 10.1023/B:AIBE.0000044080.04397.97; Hutton HE, 2001, PSYCHIATR SERV, V52, P508, DOI 10.1176/appi.ps.52.4.508; Israelski DM, 2007, AIDS CARE, V19, P220, DOI 10.1080/09540120600774230; Jacobson DL, 2003, J CLIN EPIDEMIOL, V56, P874, DOI 10.1016/S0895-4356(03)00062-3; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Kalichman SC, 2002, J TRAUMA STRESS, V15, P289, DOI 10.1023/A:1016247727498; KELLY JA, 1993, HEALTH PSYCHOL, V12, P215, DOI 10.1037/0278-6133.12.3.215; KILPATRICK DG, 1993, POSTTRAUMATIC STRESS; KOSS MP, 1985, J CONSULT CLIN PSYCH, V53, P422, DOI 10.1037/0022-006X.53.3.422; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kunitz SJ, 1998, CHILD ABUSE NEGLECT, V22, P1079, DOI 10.1016/S0145-2134(98)00089-1; Leserman J, 2005, PSYCHOSOM MED, V67, P500, DOI 10.1097/01.psy.0000160459.78182.d9; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Leserman J, 1997, PSYCHOSOM MED, V59, P152, DOI 10.1097/00006842-199703000-00007; Leserman J, 2008, AIDS PATIENT CARE ST, V22, P403, DOI 10.1089/apc.2007.0175; Leserman J, 2007, AM J PSYCHIAT, V164, P1707, DOI 10.1176/appi.ajp.2007.06111775; Liebschutz JM, 2000, ARCH INTERN MED, V160, P1659, DOI 10.1001/archinte.160.11.1659; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Martin L, 2009, AFR J PSYCHIATRY, V12, P270; Martin L, 2011, AIDS BEHAV, V15, P125, DOI 10.1007/s10461-008-9498-6; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Merrill LL, 1999, J TRAUMA STRESS, V12, P211, DOI 10.1023/A:1024789723779; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Mugavero MJ, 2007, AIDS PATIENT CARE ST, V21, P681, DOI 10.1089/apc.2006.0167; Mugavero MJ, 2009, PSYCHOSOM MED, V71, P920, DOI 10.1097/PSY.0b013e3181bfe8d2; Myer L, 2008, AIDS PATIENT CARE ST, V22, P147, DOI 10.1089/apc.2007.0102; Olley BO, 2006, J PSYCHOSOM RES, V61, P479, DOI 10.1016/j.jpsychores.2006.03.010; Paolucci EO, 2001, J PSYCHOL, V135, P17, DOI 10.1080/00223980109603677; Parillo KM, 2001, CHILD ABUSE NEGLECT, V25, P335, DOI 10.1016/S0145-2134(00)00253-2; Pence BW, 2007, SOUTH MED J, V100, P1114, DOI 10.1097/01.smj.0000286756.54607.9f; Rodriguez N, 1997, J CONSULT CLIN PSYCH, V65, P53, DOI 10.1037/0022-006X.65.1.53; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Saunders B.E., 2000, PREVALENCE CONSEQUEN; Schonnesson LN, 2007, AIDS BEHAV, V11, P175, DOI 10.1007/s10461-006-9160-0; SPRINGS FE, 1992, MAYO CLIN PROC, V67, P527, DOI 10.1016/S0025-6196(12)60458-3; Styron T, 1997, CHILD ABUSE NEGLECT, V21, P1015, DOI 10.1016/S0145-2134(97)00062-8; Tjaden P, 2000, EXTENT NATURE CONSEQ; UNAIDS and WHO, 2009, AIDS EP REP; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Weathers FW, 1996, MEASUREMENT STRESS T; Wenninger K, 1998, J TRAUMA STRESS, V11, P281, DOI 10.1023/A:1024451103931; Whetten K, 2008, AIDS CARE, V20, P1233, DOI 10.1080/09540120801918636; Whetten K, 2006, AM J PUBLIC HEALTH, V96, P1028, DOI 10.2105/AJPH.2005.063263; Whetten K, 2008, PSYCHOSOM MED, V70, P531, DOI 10.1097/PSY.0b013e31817749dc; Widom CS, 1999, AM J PSYCHIAT, V156, P1223; Wyatt GE, 2004, AIDS BEHAV, V8, P401, DOI 10.1007/s10461-004-7324-3; Zlotnick C, 1997, J NERV MENT DIS, V185, P761, DOI 10.1097/00005053-199712000-00007	70	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36304	10.1371/journal.pone.0036304	http://dx.doi.org/10.1371/journal.pone.0036304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UF	22606252	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400016
J	Scialo, F; Hansson, BS; Giordano, E; Polito, CL; Digilio, FA				Scialo, Filippo; Hansson, Bill S.; Giordano, Ennio; Polito, Catello L.; Digilio, F. Anna			Molecular and Functional Characterization of the Odorant Receptor2 (OR2) in the Tiger Mosquito Aedes albopictus	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; OLFACTORY RECEPTORS; CELLULAR BASIS; DROSOPHILA; BEHAVIOR; VECTOR; EXPRESSION; CULICIDAE; CHANNELS; ANTENNAE	In mosquitoes, the olfactory system plays a crucial role in many types of behavior, including nectar feeding, host preference selection and oviposition. Aedes albopictus, known also as the tiger mosquito, is an anthropophilic species, which in the last few years, due to its strong ecological plasticity, has spread throughout the world. Although long considered only a secondary vector of viruses, the potential of its vector capacity may constitute a threat to public health. Based on the idea that an improved understanding of the olfactory system of mosquitoes may assist in the development of control methods that interfere with their behavior, we have undertaken a study aimed at characterizing the A. albopictus Odorant Receptors. Here we report the identification, cloning and functional characterization of the AalOR2 ortholog, that represents the first candidate member of the odorant receptor (OR) family of proteins from A. albopictus. AalOR2 is expressed in the larval heads and antennae of adults. Our data indicate that A. albopictus OR2 (AalOR2) shares a high degree of identity with other mosquito OR2 orthologs characterized to date, confirming that OR2 is one of the most conserved mosquito ORs. Our data indicate that AalOR2 is narrowly tuned to indole, and inhibited by (-)-menthone. In agreement with this results, these two compounds elicit two opposite effects on the olfactory-based behavior of A. albopictus larvae, as determined through a larval behavioral assay. In summary, this work has led to the cloning and de-orphaning of the first Odorant Receptor in the tiger mosquito A. albopictus. In future control strategies this receptor may be used as a potential molecular target.	[Scialo, Filippo; Polito, Catello L.; Digilio, F. Anna] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Hansson, Bill S.] Max Planck Inst Chem Ecol Jena, Jena, Germany; [Giordano, Ennio; Polito, Catello L.] Univ Naples Federico II, Dept Biol Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Max Planck Society; University of Naples Federico II	Scialo, F (corresponding author), CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy.	digilio@igb.cnr.it	Scialò, Filippo/GQQ-0164-2022; Hansson, Bill S/G-2774-2013; Digilio, Filomena A/C-1548-2015	Hansson, Bill S/0000-0002-4811-1223; Digilio, Filomena A/0000-0002-9342-3760; Scialo', Filippo/0000-0001-6648-1503	MIUR, program MIUR-CNR; Insect Science and Biotechnology Doctorate; EMBO Short-Term Fellowship	MIUR, program MIUR-CNR(Ministry of Education, Universities and Research (MIUR)); Insect Science and Biotechnology Doctorate; EMBO Short-Term Fellowship(European Molecular Biology Organization (EMBO))	CNR Department Molecular Design project: 'Sviluppo delle esportazioni di prodotti agroalimentari del Mezzogiorno' was supported by MIUR, program MIUR-CNR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our gratitude to Drs Gabriella Colucci, Fabio Apone and Annalisa Tito for their help on the cloning studies as well as to Drs Marcus Carl Stensmyr and Merid Negash Getahun for their help on Drosophila electrophysiology. We would like to thank Dr. John Carlson for sending us the Delta-halo strain and the Bloomington Stock Center for the fly stocks. We gratefully acknowledge the expert technical assistance of Daniela Cavaliere, Sara Salvia and Aurora Quattromani. Filippo Scialo's work experience in Germany was sponsored by the Insect Science and Biotechnology Doctorate and an EMBO Short-Term Fellowship.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; BOWEN MF, 1991, ANNU REV ENTOMOL, V36, P139, DOI 10.1146/annurev.en.36.010191.001035; BRAND AH, 1993, DEVELOPMENT, V118, P401; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dutto M, 2010, Bull Soc Pathol Exot, V103, P309, DOI 10.1007/s13149-010-0094-4; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Meijerink J, 2001, J INSECT PHYSIOL, V47, P455, DOI 10.1016/S0022-1910(00)00136-0; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Sambrook J., 2002, MOL CLONING LAB MANU; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Siju KP, 2010, J INSECT PHYSIOL, V56, P659, DOI 10.1016/j.jinsphys.2010.02.002; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	34	11	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36538	10.1371/journal.pone.0036538	http://dx.doi.org/10.1371/journal.pone.0036538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606270	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339400023
J	Yadav, PS; Prashar, P; Bandyopadhyay, A				Yadav, Prem Swaroop; Prashar, Paritosh; Bandyopadhyay, Amitabha			BRITER: A BMP Responsive Osteoblast Reporter Cell Line	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; NAPHTHOL AS-PHOSPHATES; OPEN TIBIAL FRACTURES; GROWTH-FACTOR BETA-1; SENSITIVE BIOASSAY; DISTINCT ROLES; DIFFERENTIATION; IDENTIFICATION; PROMOTER; SMADS	Background: BMP signaling pathway is critical for vertebrate development and tissue homeostasis. High-throughput molecular genetic screening may reveal novel players regulating BMP signaling response while chemical genetic screening of BMP signaling modifiers may have clinical significance. It is therefore important to generate a cell-based tool to execute such screens. Methodology/Principal Findings: We have established a BMP responsive reporter cell line by stably integrating a BMP responsive dual luciferase reporter construct in the immortalized calvarial osteoblast cells isolated from tamoxifen inducible Bmp2; Bmp4 double conditional knockout mouse strain. This cell line, named BRITER (BMP Responsive Immortalized Reporter cell line), responds robustly, promptly and specifically to exogenously added BMP2 protein. The sensitivity to added BMP may be further increased by depleting the endogenous BMP2 and BMP4 proteins. Conclusion: As the dynamic range of the assay (for BMP responsiveness) is very high for BRITER and as it responds specifically and promptly to exogenously added BMP2 protein, BRITER may be used effectively for chemical or molecular genetic screening for BMP signaling modifiers. Identification of novel molecular players capable of influencing BMP signaling pathway may have clinical significance.	[Yadav, Prem Swaroop; Prashar, Paritosh; Bandyopadhyay, Amitabha] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Yadav, PS (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	abandopa@iitk.ac.in	Yadav, Prem Swaroop/AAO-2848-2020; Bandyopadhyay, Amitabha/B-9735-2008; Yadav, Prem Swaroop/F-8691-2010	Yadav, Prem Swaroop/0000-0003-2213-5320; Prashar, Paritosh/0000-0003-1005-6756; Bandyopadhyay, Amitabha/0000-0002-0429-438X	Council of Scientific and Industrial Research, India [37(1286)/07/EMR-II]; Indo-UK Science Bridge; Research Councils UK; Department of Science and Technology, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indo-UK Science Bridge; Research Councils UK(UK Research & Innovation (UKRI)); Department of Science and Technology, India(Department of Science & Technology (India))	This work was carried out with funding from Council of Scientific and Industrial Research, India, (http://csirhrdg.res.in/) grant No. 37(1286)/07/EMR-II and Indo-UK Science Bridge (co-sponsored by Research Councils UK and Department of Science and Technology, India) (http://www.serc-dst.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bialkowska AB, 2009, MOL CANCER THER, V8, P563, DOI 10.1158/1535-7163.MCT-08-0767; BILLS CE, 1971, J HOPKINS MED J, V128, P194; Bonatus T, 1997, CLIN ORTHOP RELAT R, P58; BURSTONE MS, 1958, J NATL CANCER I, V20, P601; BURSTONE MS, 1958, J NATL CANCER I, V21, P523; CAUDLE RJ, 1987, J BONE JOINT SURG AM, V69A, P801, DOI 10.2106/00004623-198769060-00002; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; ECAROTCHARRIER B, 1983, J CELL BIOL, V96, P639, DOI 10.1083/jcb.96.3.639; EDWARDS CC, 1988, CLIN ORTHOP RELAT R, P98; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; Kang MI, 2009, MOL CANCER THER, V8, P571, DOI 10.1158/1535-7163.MCT-08-0811; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Mushinski JF, 2009, J BIOL CHEM, V284, P15206, DOI 10.1074/jbc.M806324200; Pardali E, 2000, J BIOL CHEM, V275, P3552, DOI 10.1074/jbc.275.5.3552; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Rickard DJ, 1998, J CLIN INVEST, V101, P413, DOI 10.1172/JCI119880; RIEMER BL, 1995, J ORTHOP TRAUMA, V9, P66, DOI 10.1097/00005131-199502000-00011; Saito N, 2005, ADV DRUG DELIVER REV, V57, P1037, DOI 10.1016/j.addr.2004.12.016; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; SANDERS R, 1994, J ORTHOP TRAUMA, V8, P504, DOI 10.1097/00005131-199408060-00008; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wendler F, EMBO J, V29, P304; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Zhang YW, 2000, P NATL ACAD SCI USA, V97, P10549, DOI 10.1073/pnas.180309597; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	50	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37134	10.1371/journal.pone.0037134	http://dx.doi.org/10.1371/journal.pone.0037134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22611465	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400066
J	Kwok, H; Tong, AHY; Lin, CH; Lok, S; Farrell, PJ; Kwong, DLW; Chiang, AKS				Kwok, Hin; Tong, Amy H. Y.; Lin, Chi Ho; Lok, Si; Farrell, Paul J.; Kwong, Dora L. W.; Chiang, Alan K. S.			Genomic Sequencing and Comparative Analysis of Epstein-Barr Virus Genome Isolated from Primary Nasopharyngeal Carcinoma Biopsy	PLOS ONE			English	Article							30-BP DELETION; STRAIN; GENE; SELECTION; VARIANTS; PROTEIN; PREVALENCE; ALIGNMENT	Whether certain Epstein-Barr virus (EBV) strains are associated with pathogenesis of nasopharyngeal carcinoma (NPC) is still an unresolved question. In the present study, EBV genome contained in a primary NPC tumor biopsy was amplified by Polymerase Chain Reaction (PCR), and sequenced using next-generation (Illumina) and conventional dideoxy-DNA sequencing. The EBV genome, designated HKNPC1 (Genbank accession number JQ009376) is a type 1 EBV of approximately 171.5 kb. The virus appears to be a uniform strain in line with accepted monoclonal nature of EBV in NPC but is heterogeneous at 172 nucleotide positions. Phylogenetic analysis with the four published EBV strains, B95-8, AG876, GD1, and GD2, indicated HKNPC1 was more closely related to the Chinese NPC patient-derived strains, GD1 and GD2. HKNPC1 contains 1,589 single nucleotide variations (SNVs) and 132 insertions or deletions (indels) in comparison to the reference EBV sequence (accession number NC007605). When compared to AG876, a strain derived from Ghanaian Burkitt's lymphoma, we found 322 SNVs, of which 76 were non-synonymous SNVs and were shared amongst the Chinese GD1, GD2 and HKNPC1 isolates. We observed 88 non-synonymous SNVs shared only by HKNPC1 and GD2, the only other NPC tumor-derived strain reported thus far. Non-synonymous SNVs were mainly found in the latent, tegument and glycoprotein genes. The same point mutations were found in glycoprotein (BLLF1 and BALF4) genes of GD1, GD2 and HKNPC1 strains and might affect cell type specific binding. Variations in LMP1 and EBNA3B epitopes and mutations in Cp (11404 C>T) and Qp (50134 G>C) found in GD1, GD2 and HKNPC1 could potentially affect CD8(+) T cell recognition and latent gene expression pattern in NPC, respectively. In conclusion, we showed that whole genome sequencing of EBV in NPC may facilitate discovery of previously unknown variations of pathogenic significance.	[Kwok, Hin; Chiang, Alan K. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Tong, Amy H. Y.; Lin, Chi Ho; Lok, Si] Univ Hong Kong, Li Ka Shing Fac Med, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Farrell, Paul J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; Imperial College London	Kwok, H (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	chiangak@hku.hk	Chiang, Alan/L-8849-2018	Chiang, Alan/0000-0002-1089-5325; Farrell, Paul/0000-0002-6754-9351	Research Grant Council GRF [HKU763208M]; EBV Research of AKSC [20004525]; University of Hong Kong to the Genome Research Centre; University of Hong Kong; HoTung Paediatrics Education and Research Fund	Research Grant Council GRF; EBV Research of AKSC; University of Hong Kong to the Genome Research Centre; University of Hong Kong(University of Hong Kong); HoTung Paediatrics Education and Research Fund	This study was funded by Research Grant Council GRF grant HKU763208M and EBV Research grant 20004525 of AKSC and a grant from the University Development Fund of the University of Hong Kong to the Genome Research Centre. HK was supported by The University of Hong Kong's postgraduate studentship and HoTung Paediatrics Education and Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chang CM, 2009, VIRUS RES, V143, P209, DOI 10.1016/j.virusres.2009.07.005; Chang KP, 2006, LARYNGOSCOPE, V116, P541, DOI 10.1097/01.mlg.0000201993.53410.40; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Cheung ST, 1998, INT J CANCER, V76, P399, DOI 10.1002/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6; Chiang AKS, 1999, INT J CANCER, V80, P356, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;356::AID-IJC4&gt;3.0.CO;2-D; Dardari R, 2006, INT J CANCER, V118, P1977, DOI 10.1002/ijc.21595; Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805; Dolan A, 2006, VIROLOGY, V350, P164, DOI 10.1016/j.virol.2006.01.015; Edwards RH, 2004, J VIROL, V78, P868, DOI 10.1128/JVI.78.2.868-881.2004; Grunewald V, 1998, INT J CANCER, V75, P497, DOI 10.1002/(SICI)1097-0215(19980209)75:4<497::AID-IJC2>3.0.CO;2-O; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KNECHT H, 1995, ONCOGENE, V10, P523; Knipe DM, 2007, FIELDS VIROLOGY; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin JC, 2004, J GEN VIROL, V85, P2023, DOI 10.1099/vir.0.19696-0; Liu P, 2011, J VIROL; Mainou BA, 2006, J VIROL, V80, P6458, DOI 10.1128/JVI.00135-06; Midgley RS, 2003, J VIROL, V77, P11517, DOI 10.1128/JVI.77.21.11517-11530.2003; Midgley RS, 2003, J VIROL, V77, P11507, DOI 10.1128/JVI.77.21.11507-11516.2003; Nguyen-Van D, 2008, VIRUS GENES, V37, P273, DOI 10.1007/s11262-008-0262-9; PARKER BD, 1990, VIROLOGY, V179, P339, DOI 10.1016/0042-6822(90)90302-8; PIZZO PA, 1978, NATURE, V272, P629, DOI 10.1038/272629a0; Sacaze C, 2001, VIRUS RES, V81, P133, DOI 10.1016/S0168-1702(01)00376-8; See HS, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-18; Swaminathan S, 2008, J CELL PHYSIOL, V216, P321, DOI 10.1002/jcp.21480; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarbouriech N, 2006, ACTA CRYSTALLOGR D, V62, P1276, DOI 10.1107/S0907444906030034; Wang FW, 2011, EUR ARCH OTORHINOLAR; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; Zhang XS, 2004, CANCER LETT, V211, P11, DOI 10.1016/j.canlet.2004.01.035; ZIMBER U, 1986, VIROLOGY, V154, P56, DOI 10.1016/0042-6822(86)90429-0	36	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36939	10.1371/journal.pone.0036939	http://dx.doi.org/10.1371/journal.pone.0036939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590638	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400048
J	Staunstrup, NH; Madsen, J; Primo, MN; Li, J; Liu, Y; Kragh, PM; Li, R; Schmidt, M; Purup, S; Dagnaes-Hansen, F; Svensson, L; Petersen, TK; Callesen, H; Bolund, L; Mikkelsen, JG				Staunstrup, Nicklas Heine; Madsen, Johannes; Primo, Maria Nascimento; Li, Juan; Liu, Ying; Kragh, Peter M.; Li, Rong; Schmidt, Mette; Purup, Stig; Dagnaes-Hansen, Frederik; Svensson, Lars; Petersen, Thomas K.; Callesen, Henrik; Bolund, Lars; Mikkelsen, Jacob Giehm			Development of Transgenic Cloned Pig Models of Skin Inflammation by DNA Transposon-Directed Ectopic Expression of Human beta 1 and alpha 2 Integrin	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; SLEEPING-BEAUTY; NUCLEAR TRANSFER; GENE-EXPRESSION; MOUSE MODEL; KERATINOCYTE ADHESION; PROTEIN PSORIASIN; HANDMADE CLONING; EGF RECEPTOR	Integrins constitute a superfamily of transmembrane signaling receptors that play pivotal roles in cutaneous homeostasis by modulating cell growth and differentiation as well as inflammatory responses in the skin. Subrabasal expression of integrins alpha 2 and/or beta 1 entails hyperproliferation and aberrant differentiation of keratinocytes and leads to dermal and epidermal influx of activated T-cells. The anatomical and physiological similarities between porcine and human skin make the pig a suitable model for human skin diseases. In efforts to generate a porcine model of cutaneous inflammation, we employed the Sleeping Beauty DNA transposon system for production of transgenic cloned Gottingen minipigs expressing human beta 1 or alpha 2 integrin under the control of a promoter specific for subrabasal keratinocytes. Using pools of transgenic donor fibroblasts, cloning by somatic cell nuclear transfer was utilized to produce reconstructed embryos that were subsequently transferred to surrogate sows. The resulting pigs were all transgenic and harbored from one to six transgene integrants. Molecular analyses on skin biopsies and cultured keratinocytes showed ectopic expression of the human integrins and localization within the keratinocyte plasma membrane. Markers of perturbed skin homeostasis, including activation of the MAPK pathway, increased expression of the pro-inflammatory cytokine IL-1 alpha, and enhanced expression of the transcription factor c-Fos, were identified in keratinocytes from beta 1 and alpha 2 integrin-transgenic minipigs, suggesting the induction of a chronic inflammatory phenotype in the skin. Notably, cellular dysregulation obtained by overexpression of either beta 1 or alpha 2 integrin occurred through different cellular signaling pathways. Our findings mark the creation of the first cloned pig models with molecular markers of skin inflammation. Despite the absence of an overt psoriatic phenotype, these animals may possess increased susceptibility to severe skin damage-induced inflammation and should be of great potential in studies aiming at the development and refinement of topical therapies for cutaneous inflammation including psoriasis.	[Staunstrup, Nicklas Heine; Primo, Maria Nascimento; Dagnaes-Hansen, Frederik; Bolund, Lars; Mikkelsen, Jacob Giehm] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Madsen, Johannes; Svensson, Lars; Petersen, Thomas K.] LEO Pharma, Dept Dis Pharmacol, Ballerup, Denmark; [Li, Juan; Liu, Ying; Kragh, Peter M.; Li, Rong; Purup, Stig; Callesen, Henrik] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Liu, Ying] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Schmidt, Mette] Univ Copenhagen, Dept Vet Reprod & Obstet, Frederiksberg, Denmark; [Svensson, Lars] HuaDa JiYin BGI, Shenzhen, Peoples R China	Aarhus University; LEO Pharma; Aarhus University; Nanjing Agricultural University; University of Copenhagen	Staunstrup, NH (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	giehm@hum-gen.au.dk	Liu, Ying/T-5064-2019; Primo, Maria/P-1780-2017; Staunstrup, Nicklas Heine/D-4870-2017	Primo, Maria/0000-0003-2808-0607; Staunstrup, Nicklas Heine/0000-0002-5989-9298; Callesen, Henrik/0000-0002-0185-7300; Dagnaes-Hansen, Frederik/0000-0002-6622-0853; Mikkelsen, Jacob Giehm/0000-0002-1322-3209	Danish National Advanced Technology Foundation; Lundbeck Foundation; Novo Nordisk Foundation; Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation	Danish National Advanced Technology Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Kgl. Hofbuntmager Aage Bangs Foundation; Helga and Peter Kornings Foundation	This work was made possible by support from the Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk/en/),the Lundbeck Foundation (http://www.lundbeckfoundation.com/Frontpage.20.aspx), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/), Kgl. Hofbuntmager Aage Bangs Foundation (http://www.danderm-pdv.is.kkh.dk/h11u-5.htm), and Helga and Peter Kornings Foundation (http://www.korningfonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; BARTEK MJ, 1972, J INVEST DERMATOL, V58, P114, DOI 10.1111/1523-1747.ep12538909; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; CARROLL JM, 1992, J CELL SCI, V103, P925; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; DeMali KA, 1999, J BIOL CHEM, V274, P19551, DOI 10.1074/jbc.274.28.19551; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Eckert RL, 1996, MOL BIOL REP, V23, P59, DOI 10.1007/BF00357073; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; GROVES RW, 1995, P NATL ACAD SCI USA, V92, P11874, DOI 10.1073/pnas.92.25.11874; GROVES RW, 1992, J INVEST DERMATOL, V98, P384, DOI 10.1111/1523-1747.ep12499816; Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153; HERTLE MD, 1995, J INVEST DERMATOL, V104, P260, DOI 10.1111/1523-1747.ep12612801; Hobbs RM, 2003, J BIOL CHEM, V278, P19798, DOI 10.1074/jbc.M300513200; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; HOTCHIN NA, 1993, J CELL SCI, V106, P1131; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Ivaska J, 2003, NAT CELL BIOL, V5, P363, DOI 10.1038/ncb957; Ivaska J, 1999, J CELL BIOL, V147, P401, DOI 10.1083/jcb.147.2.401; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Jakobsen JE, 2010, TRANSGENIC RES; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Klekotka PA, 2001, J BIOL CHEM, V276, P9503, DOI 10.1074/jbc.M006286200; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; Lee RT, 1997, J IMMUNOL, V159, P5084; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Li SP, 2003, CANCER RES, V63, P3473; Liu L, 2006, MOL THER, V13, P1006, DOI 10.1016/j.ymthe.2005.11.021; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Mee JB, 2005, J INVEST DERMATOL, V124, P1267, DOI 10.1111/j.0022-202X.2005.23684.x; Meyer W, 1978, Curr Probl Dermatol, V7, P39; Mikkelsen JG, 2003, MOL THER, V8, P654, DOI 10.1016/S1525-0016(03)00216-8; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Ottaviani C, 2006, EUR J IMMUNOL, V36, P118, DOI 10.1002/eji.200535243; Owens DM, 2001, CANCER RES, V61, P5248; Park KW, 2001, ANIM BIOTECHNOL, V12, P173, DOI 10.1081/ABIO-100108344; Park KW, 2002, BIOL REPROD, V66, P1001, DOI 10.1095/biolreprod66.4.1001; Petersson S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-205; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Ramirez-Amador V, 1996, Oral Dis, V2, P188; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Schiller M, 2006, ONCOGENE, V25, P4449, DOI 10.1038/sj.onc.1209479; SCHLAAK JF, 1994, J INVEST DERMATOL, V102, P145, DOI 10.1111/1523-1747.ep12371752; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sinzelle L, 2006, TRANSGENIC RES, V15, P751, DOI 10.1007/s11248-006-9014-6; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Teige I, 2010, INT IMMUNOPHARMACOL, V10, P107, DOI 10.1016/j.intimp.2009.10.004; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Watanabe S, 2005, BIOL REPROD, V72, P309, DOI 10.1095/biolreprod.104.031591; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Xue W, 1997, CANCER RES, V57, P1682; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yu X, 2000, J CELL SCI, V113, P2139	84	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36658	10.1371/journal.pone.0036658	http://dx.doi.org/10.1371/journal.pone.0036658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590584	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400025
J	Xie, GQ; Ye, JH				Xie, Guiqin; Ye, Jiang-Hong			Salsolinol Facilitates Glutamatergic Transmission to Dopamine Neurons in the Posterior Ventral Tegmental Area of Rats	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; NUCLEUS-ACCUMBENS; IN-VITRO; CENTRAL AMYGDALA; MESSENGER-RNA; BRAIN-SLICES; ETHANOL; ALCOHOL; INVOLVEMENT; BEHAVIOR	Although in vivo evidence indicates that salsolinol, the condensation product of acetaldehyde and dopamine, has properties that may contribute to alcohol abuse, the underlying mechanisms have not been fully elucidated. We have reported previously that salsolinol stimulates dopamine neurons in the posterior ventral tegmental area (p-VTA) partly by reducing inhibitory GABAergic transmission, and that ethanol increases glutamatergic transmission to VTA-dopamine neurons via the activation of dopamine D-1 receptors (D(1)Rs). In this study, we tested the hypothesis that salsolinol stimulates dopamine neurons involving activation of D(1)Rs. By using whole-cell recordings on p-VTA-dopamine neurons in acute brain slices of rats, we found that salsolinol-induced increase in spike frequency of dopamine neurons was substantially attenuated by DL-2-amino-5phosphono-valeric acid and 6, 7-dinitroquinoxaline-2, 3-dione, the antagonists of glutamatergic N-Methyl-D-aspartic acid and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Moreover, salsolinol increased the amplitude of evoked excitatory postsynaptic currents (EPSCs) and the frequency but not the amplitude of spontaneous EPSCs. Additionally, SKF83566, a D1R antagonist attenuated the salsolinol-induced facilitation of EPSCs and of spontaneous firing of dopamine neurons. Our data reveal that salsolinol enhances glutamatergic transmission onto dopamine neurons via activation of D(1)Rs at the glutamatergic afferents in dopamine neurons, which contributes to salsolinol's stimulating effect on p-VTA dopamine neurons. This appears to be a novel mechanism which contributes toward rewarding properties of salsolinol.	[Xie, Guiqin; Ye, Jiang-Hong] Univ Med & Dent New Jersey, Dept Anesthesiol Pharmacol & Physiol, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Xie, GQ (corresponding author), Univ Med & Dent New Jersey, Dept Anesthesiol Pharmacol & Physiol, New Jersey Med Sch, Newark, NJ 07103 USA.	ye@umdnj.edu			National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [AA016964, AA016618]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016618, R01AA016964] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is made possible by the support from National Institutes of Health - National Institute on Alcohol Abuse and Alcoholism [grants AA016964 and AA016618] to JHY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Bonci A, 1997, J NEUROSCI, V17, P796; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; Dahchour A, 2000, ALCOHOL ALCOHOLISM, V35, P548, DOI 10.1093/alcalc/35.6.548; DAVIS VE, 1970, SCIENCE, V167, P1005; Deng CY, 2009, NEUROPSYCHOPHARMACOL, V34, P1233, DOI 10.1038/npp.2008.143; Deng Xin-sheng, 2008, Curr Drug Abuse Rev, V1, P3; Dobi A, 2010, J NEUROSCI, V30, P218, DOI 10.1523/JNEUROSCI.3884-09.2010; DUNCAN C, 1980, PHARMACOL BIOCHEM BE, V13, P265, DOI 10.1016/0091-3057(80)90083-0; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Guan YZ, 2010, NEUROPSYCHOPHARMACOL, V35, P1841, DOI 10.1038/npp.2010.51; Haber H, 1996, ALCOHOL CLIN EXP RES, V20, P87, DOI 10.1111/j.1530-0277.1996.tb01049.x; Hernandez A, 2007, NEUROSCI LETT, V425, P188, DOI 10.1016/j.neulet.2007.08.026; Hipolito L, 2011, NEUROCHEM INT, V59, P559, DOI 10.1016/j.neuint.2011.04.014; Johnson SW, 2004, BRAIN RES, V1019, P293, DOI 10.1016/j.brainres.2004.06.022; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; Liu X, 2002, J NEUROSCI, V22, P7856; Lu XY, 1997, SYNAPSE, V25, P205, DOI 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X; MANSOUR A, 1992, NEUROSCIENCE, V46, P959, DOI 10.1016/0306-4522(92)90197-A; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Mereu G, 1997, NEUROSCIENCE, V77, P1029, DOI 10.1016/S0306-4522(96)00474-5; Morikawa H, 2010, INT REV NEUROBIOL, V91, P235, DOI 10.1016/S0074-7742(10)91008-8; MYERS RD, 1982, PHARMACOL BIOCHEM BE, V16, P995, DOI 10.1016/0091-3057(82)90059-4; Omelchenko N, 2007, NEUROSCIENCE, V146, P1259, DOI 10.1016/j.neuroscience.2007.02.016; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paladini CA, 1999, BRAIN RES, V832, P145, DOI 10.1016/S0006-8993(99)01484-5; Roberto M, 2004, J NEUROSCI, V24, P1594, DOI 10.1523/JNEUROSCI.5077-03.2004; Rodd ZA, 2003, ALCOHOL CLIN EXP RES, V27, P440, DOI 10.1097/01.ALC.0000056612.89957.B4; Rodd ZA, 2008, ALCOHOL CLIN EXP RES, V32, P230, DOI 10.1111/j.1530-0277.2007.00572.x; ROMMELSPACHER H, 1995, ALCOHOL, V12, P309, DOI 10.1016/0741-8329(95)00004-B; Selim M, 1996, BRAIN RES, V716, P157, DOI 10.1016/0006-8993(95)01385-7; Siggins GR, 2005, PHARMACOL THERAPEUT, V107, P80, DOI 10.1016/j.pharmthera.2005.01.006; SUAUDCHAGNY MF, 1992, NEUROSCIENCE, V49, P63, DOI 10.1016/0306-4522(92)90076-E; Threlfell S., 2007, USING FAST SCAN CYCL; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Xiao C, 2009, NEUROPSYCHOPHARMACOL, V34, P307, DOI 10.1038/npp.2008.99; Xie G, 2011, J PHARM EXP THER; Ye JH, 2004, J NEUROSCI, V24, P8961, DOI 10.1523/JNEUROSCI.2016-04.2004; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; Zhu W, 2007, J NEUROSCI, V27, P289, DOI 10.1523/JNEUROSCI.3912-06.2007	47	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36716	10.1371/journal.pone.0036716	http://dx.doi.org/10.1371/journal.pone.0036716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590592	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400028
J	Das, M; Quint, DA; Schwarz, JM				Das, Moumita; Quint, D. A.; Schwarz, J. M.			Redundancy and Cooperativity in the Mechanics of Compositely Crosslinked Filamentous Networks	PLOS ONE			English	Article							BOND-BENDING FORCES; F-ACTIN NETWORKS; ELASTIC NETWORKS; ALPHA-ACTININ; ARP2/3 COMPLEX; PERCOLATION; PROTEINS; DYNAMICS; LAMELLIPODIA; FILAMINS	The cytoskeleton of living cells contains many types of crosslinkers. Some crosslinkers allow energy-free rotations between filaments and others do not. The mechanical interplay between these different crosslinkers is an open issue in cytoskeletal mechanics. Therefore, we develop a theoretical framework based on rigidity percolation to study a generic filamentous system containing both stretching and bond-bending forces to address this issue. The framework involves both analytical calculations via effective medium theory and numerical simulations on a percolating triangular lattice with very good agreement between both. We find that the introduction of angle-constraining crosslinkers to a semiflexible filamentous network with freely rotating crosslinks can cooperatively lower the onset of rigidity to the connectivity percolation threshold-a result argued for years but never before obtained via effective medium theory. This allows the system to ultimately attain rigidity at the lowest concentration of material possible. We further demonstrate that introducing angle-constraining crosslinks results in mechanical behaviour similar to just freely rotating crosslinked semflexible filaments, indicating redundancy and universality. Our results also impact upon collagen and fibrin networks in biological and bio-engineered tissues.	[Das, Moumita] Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands; [Quint, D. A.; Schwarz, J. M.] Syracuse Univ, Dept Phys, Syracuse, NY USA	Vrije Universiteit Amsterdam; Syracuse University	Das, M (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Amsterdam, Netherlands.	jschwarz@physics.syr.edu		Quint, David/0000-0003-0323-0402	NWO, The Netherlands;  [NSF-DMR-0645373]	NWO, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); 	JMS is supported by NSF-DMR-0645373. MD is supported by a VENI fellowship from NWO, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander S, 1998, PHYS REP, V296, P65, DOI 10.1016/S0370-1573(97)00069-0; Bai M, 2011, ACTA BIOMATER, V7, P2109, DOI 10.1016/j.actbio.2010.12.025; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Broedersz CP, 2011, NAT PHYS, V7, P983, DOI [10.1038/nphys2127, 10.1038/NPHYS2127]; Carlisle CR, 2010, J THROMB HAEMOST, V8, P1135, DOI 10.1111/j.1538-7836.2010.03824.x; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Das M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038101; Das M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.138102; DEGENNES PG, 1976, J PHYS LETT-PARIS, V37, pL1, DOI 10.1051/jphyslet:019760037010100; DiDonna BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068104; Esue O, 2010, PHYS REV LETT, V105; FENG S, 1984, PHYS REV LETT, V52, P216, DOI 10.1103/PhysRevLett.52.216; FENG S, 1985, PHYS REV B, V31, P276, DOI 10.1103/PhysRevB.31.276; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Head DA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108102; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Heussinger C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017802; Heussinger C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105501; HUGHES GD, 1990, J PHYS-CONDENS MAT, V2, P3399, DOI 10.1088/0953-8984/2/14/024; Huisman EM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.118101; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; KANTOR Y, 1984, PHYS REV LETT, V52, P1891, DOI 10.1103/PhysRevLett.52.1891; Kreis T., 1999, GUIDEBOOK CYTOSKELET, V2nd; Lammers G, 2009, BIOMATERIALS, V30, P6213, DOI 10.1016/j.biomaterials.2009.07.050; Maxwell JC., 1864, LOND EDINBURGH DUBLI, V27, P294, DOI [10.1080/14786446408643668, DOI 10.1080/14786446408643668]; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Press W. H., 1992, ART SCI COMPUTING; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Rivero F, 1999, J CELL SCI, V112, P2737; SAHIMI M, 1993, PHYS REV B, V47, P703, DOI 10.1103/PhysRevB.47.703; Schmoller KM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.118102; Schmoller KM, 2009, BIOPHYS J, V97, P83, DOI 10.1016/j.bpj.2009.04.040; SCHWARTZ LM, 1985, PHYS REV B, V32, P4607, DOI 10.1103/PhysRevB.32.4607; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; THORPE MF, 1989, J NON-CRYST SOLIDS, V114, P19, DOI 10.1016/0022-3093(89)90056-2; Tseng Y, 2005, BIOCHEM BIOPH RES CO, V334, P183, DOI 10.1016/j.bbrc.2005.05.205; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Wagner B, 2006, P NATL ACAD SCI USA, V103, P13974, DOI 10.1073/pnas.0510190103; Wilhelm J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.108103; Wyart M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.215501; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	49	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35939	10.1371/journal.pone.0035939	http://dx.doi.org/10.1371/journal.pone.0035939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590515	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100013
J	Sugimura, S; Akai, T; Hashiyada, Y; Somfai, T; Inaba, Y; Hirayama, M; Yamanouchi, T; Matsuda, H; Kobayashi, S; Aikawa, Y; Ohtake, M; Kobayashi, E; Konishi, K; Imai, K				Sugimura, Satoshi; Akai, Tomonori; Hashiyada, Yutaka; Somfai, Tamas; Inaba, Yasushi; Hirayama, Muneyuki; Yamanouchi, Tadayuki; Matsuda, Hideo; Kobayashi, Shuji; Aikawa, Yoshio; Ohtake, Masaki; Kobayashi, Eiji; Konishi, Kazuyuki; Imai, Kei			Promising System for Selecting Healthy In Vitro-Fertilized Embryos in Cattle	PLOS ONE			English	Article							INDIVIDUAL BOVINE EMBRYOS; NUCLEAR TRANSFER EMBRYOS; DEVELOPMENTAL COMPETENCE; INTERFERON-TAU; OXYGEN-CONSUMPTION; PREGNANCY RATE; 1ST CLEAVAGE; VIVO; CULTURE; TIME	Conventionally, in vitro-fertilized (IVF) bovine embryos are morphologically evaluated at the time of embryo transfer to select those that are likely to establish a pregnancy. This method is, however, subjective and results in unreliable selection. Here we describe a novel selection system for IVF bovine blastocysts for transfer that traces the development of individual embryos with time-lapse cinematography in our developed microwell culture dish and analyzes embryonic metabolism. The system can noninvasively identify prognostic factors that reflect not only blastocyst qualities detected with histological, cytogenetic, and molecular analysis but also viability after transfer. By assessing a combination of identified prognostic factors-(i) timing of the first cleavage; (ii) number of blastomeres at the end of the first cleavage; (iii) presence or absence of multiple fragments at the end of the first cleavage; (iv) number of blastomeres at the onset of lag-phase, which results in temporary developmental arrest during the fourth or fifth cell cycle; and (v) oxygen consumption at the blastocyst stage-pregnancy success could be accurately predicted (78.9%). The conventional method or individual prognostic factors could not accurately predict pregnancy. No newborn calves showed neonatal overgrowth or death. Our results demonstrate that these five predictors and our system could provide objective and reliable selection of healthy IVF bovine embryos.	[Sugimura, Satoshi; Hashiyada, Yutaka; Somfai, Tamas; Inaba, Yasushi; Hirayama, Muneyuki; Yamanouchi, Tadayuki; Matsuda, Hideo; Kobayashi, Shuji; Aikawa, Yoshio; Ohtake, Masaki; Kobayashi, Eiji; Konishi, Kazuyuki; Imai, Kei] Natl Livestock Breeding Ctr, Fukushima, Japan; [Akai, Tomonori] Dai Nippon Printing Co Ltd, Kashiwa, Chiba, Japan; [Somfai, Tamas; Inaba, Yasushi] Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan	Dai Nippon Printing Co. Ltd.; National Agriculture & Food Research Organization - Japan	Sugimura, S (corresponding author), Natl Livestock Breeding Ctr, Fukushima, Japan.	k0imai@nlbc.go.jp	Sugimura, Satoshi/B-9877-2015	Sugimura, Satoshi/0000-0002-6473-5941	Research and Development Program for New Bio-Industry Initiatives	Research and Development Program for New Bio-Industry Initiatives	This work was supported by the Research and Development Program for New Bio-Industry Initiatives. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; De Sousa PA, 2001, BIOL REPROD, V65, P23, DOI 10.1095/biolreprod65.1.23; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Ezashi T, 1998, P NATL ACAD SCI USA, V95, P7882, DOI 10.1073/pnas.95.14.7882; FARIN PW, 1995, THERIOGENOLOGY, V44, P339, DOI 10.1016/0093-691X(95)00189-F; Farin PW, 1999, THERIOGENOLOGY, V52, P659, DOI 10.1016/S0093-691X(99)00160-0; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Gjorret JO, 2003, BIOL REPROD, V69, P1193, DOI 10.1095/biolreprod.102.013243; HARE WCD, 1980, CAN J GENET CYTOL, V22, P615, DOI 10.1139/g80-067; Hashiyada Y, 2005, J REPROD DEVELOP, V51, P749, DOI 10.1262/jrd.17032; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Holm P, 2002, REPRODUCTION, V123, P553, DOI 10.1530/rep.0.1230553; Imai K., 2006, J REPROD DEVELOP, V52, pS19; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Keltz MD, 2006, FERTIL STERIL, V86, P321, DOI 10.1016/j.fertnstert.2006.01.048; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; KOYAMA H, 1994, BIOL REPROD, V50, P163, DOI 10.1095/biolreprod50.1.163; Lequarre AS, 2003, BIOL REPROD, V69, P1707, DOI 10.1095/biolreprod.103.017178; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Lopes AS, 2007, HUM REPROD, V22, P558, DOI 10.1093/humrep/del404; Magli MC, 2007, FERTIL STERIL, V87, P534, DOI 10.1016/j.fertnstert.2006.07.1512; MASSIP A, 1982, J ANAT, V134, P399; Matoba S, 2010, REPROD FERT DEVELOP, V22, P839, DOI 10.1071/RD09277; Menard S., 2000, APPL LOGISTIC REGRES; Roberts RM, 1996, J INTERF CYTOK RES, V16, P271, DOI 10.1089/jir.1996.16.271; Robertson I., 1998, MANUAL INT EMBRYO TR, P103; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Sakurai T, 2009, BIOL REPROD, V80, P1223, DOI 10.1095/biolreprod.108.073916; Schroder B., 2004, ROC PLOTTING AUC CAL; Shiku H, 2001, ANAL CHEM, V73, P3751, DOI 10.1021/ac010339j; Shoukir Y, 1997, HUM REPROD, V12, P1531, DOI 10.1093/humrep/12.7.1531; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Sugimura S, 2012, CELL REPROGRAM, V14, P29, DOI 10.1089/cell.2011.0060; Sugimura S, 2010, BIOL REPROD, V83, P970, DOI 10.1095/biolreprod.110.085522; Sugimura S, 2010, CELL REPROGRAM, V12, P463, DOI 10.1089/cell.2009.0111; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Thrasher AJ, 2004, REPROD BIOMED ONLINE, V8, P99, DOI 10.1016/S1472-6483(10)60503-2; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Viuff D, 1999, BIOL REPROD, V60, P1273, DOI 10.1095/biolreprod60.6.1273; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yabe-Nishimura C, 2003, CHEM-BIOL INTERACT, V143, P317, DOI 10.1016/S0009-2797(02)00189-8; Yamanaka K, 2009, J REPROD DEVELOP, V55, P299, DOI 10.1262/jrd.20174; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769; Ziebe S, 1997, HUM REPROD, V12, P1545, DOI 10.1093/humrep/12.7.1545	46	74	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36627	10.1371/journal.pone.0036627	http://dx.doi.org/10.1371/journal.pone.0036627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590579	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100049
J	Meynard, CN; Mouillot, D; Mouquet, N; Douzery, EJP				Meynard, Christine N.; Mouillot, David; Mouquet, Nicolas; Douzery, Emmanuel J. P.			A Phylogenetic Perspective on the Evolution of Mediterranean Teleost Fishes	PLOS ONE			English	Article							MITOCHONDRIAL CYTOCHROME-B; MOLECULAR PHYLOGENY; TETRAODONTIFORM FISHES; DIVERGENCE TIME; NUCLEAR; PERCIFORMES; SEQUENCES; PISCES; GENOME; MODEL	The Mediterranean Sea is a highly diverse, highly studied, and highly impacted biogeographic region, yet no phylogenetic reconstruction of fish diversity in this area has been published to date. Here, we infer the timing and geographic origins of Mediterranean teleost species diversity using nucleotide sequences collected from GenBank. We assembled a DNA supermatrix composed of four mitochondrial genes (12S ribosomal DNA, 16S ribosomal DNA, cytochrome c oxidase subunit I and cytochrome b) and two nuclear genes (rhodopsin and recombination activating gene I), including 62% of Mediterranean teleost species plus 9 outgroups. Maximum likelihood and Bayesian phylogenetic and dating analyses were calibrated using 20 fossil constraints. An additional 124 species were grafted onto the chronogram according to their taxonomic affinity, checking for the effects of taxonomic coverage in subsequent diversification analyses. We then interpreted the time-line of teleost diversification in light of Mediterranean historical biogeography, distinguishing non-endemic natives, endemics and exotic species. Results show that the major Mediterranean orders are of Cretaceous origin, specifically similar to 100-80 Mya, and most Perciformes families originated 80-50 Mya. Two important clade origin events were detected. The first at 100-80 Mya, affected native and exotic species, and reflects a global diversification period at a time when the Mediterranean Sea did not yet exist. The second occurred during the last 50 Mya, and is noticeable among endemic and native species, but not among exotic species. This period corresponds to isolation of the Mediterranean from Indo-Pacific waters before the Messinian salinity crisis. The Mediterranean fish fauna illustrates well the assembly of regional faunas through origination and immigration, where dispersal and isolation have shaped the emergence of a biodiversity hotspot.	[Meynard, Christine N.] INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Montferrier Sur Lez, France; [Meynard, Christine N.; Mouquet, Nicolas; Douzery, Emmanuel J. P.] Univ Montpellier 2, CNRS IRD, UMR 5554, Inst Sci Evolut, Montpellier, France; [Mouillot, David] UMR 5119 CNRS UM2 IFREMER IRD, Montpellier, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS)	Meynard, CN (corresponding author), INRA, UMR CBGP INRA IRD Cirad Montpellier SupAgro, Campus Int Baillarguet,CS 30016, Montferrier Sur Lez, France.	Christine.Meynard@supagro.inra.fr	DOUZERY, Emmanuel J. P./ABC-4050-2020; MOUQUET, Nicolas/AAL-1440-2021; Meynard, Christine N/B-2082-2010	DOUZERY, Emmanuel J. P./0000-0001-5286-647X; Meynard, Christine N/0000-0002-5983-6289; Mouquet, Nicolas/0000-0003-1840-6984	bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M); computer grid of University Montpellier 2; Agence Nationale de la Recherche [ANR-08-EMER-011, BIOSYS06_136906, ANR-09-PEXT-01102]; Fondation pour la Recherche sur la Biodiversite; Fondation TOTAL; Institut Universitaire de France; FABIO; BIODIVMED	bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M); computer grid of University Montpellier 2; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur la Biodiversite; Fondation TOTAL; Institut Universitaire de France; FABIO; BIODIVMED	This work has been supported by the bioinformatics cluster of the Institut des Sciences de l'Evolution de Montpellier (ISE-M), the computer grid of University Montpellier 2, by the Agence Nationale de la Recherche "Domaines Emergents'' (ANR-08-EMER-011 "PhylAriane''), "Biologie Systemique'' (BIOSYS06_136906 "MITOSYS''), and "6eme extinction'' (ANR-09-PEXT-01102 "EVORANGE''), by two projects from the "Fondation pour la Recherche sur la Biodiversite" (FABIO and BIODIVMED), and by the "Fondation TOTAL.'' DM received funding from the "Institut Universitaire de France.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arratia Gloria, 2000, Estudios Oceanologicos, V19, P19; Azevedo MFC, 2008, GENET MOL BIOL, V31, P284, DOI 10.1590/S1415-47572008000200023; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Benton Michael J., 2009, P35; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Carnevale G, 2006, J GEOL SOC LONDON, V163, P75, DOI 10.1144/0016-764904-158; Carnevale G, 2008, PALAEOGEOGR PALAEOCL, V257, P81, DOI 10.1016/j.palaeo.2007.09.005; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavin L, 2007, PALAEOGEOGR PALAEOCL, V245, P353, DOI 10.1016/j.palaeo.2006.08.010; Cavin L, 2007, BIOL LETTERS, V3, P201, DOI 10.1098/rsbl.2006.0602; Cavin L, 2008, GEOL SOC SPEC PUBL, V295, P165, DOI 10.1144/SP295.11; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Chiba SN, 2009, GENES GENET SYST, V84, P153, DOI 10.1266/ggs.84.153; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Criscuolo A, 2006, SYST BIOL, V55, P740, DOI 10.1080/10635150600969872; De la Herran R, 2001, HEREDITY, V87, P691, DOI 10.1046/j.1365-2540.2001.00967.x; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Felsenstein J., 2004, INFERRING PHYLOGENIE; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Giovannotti M, 2007, J EXP ZOOL PART B, V308B, P722, DOI 10.1002/jez.b.21192; Girone A, 2010, FACIES, V56, P399, DOI 10.1007/s10347-010-0212-6; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Inoue JG, 2009, MOL PHYLOGENET EVOL, V51, P486, DOI 10.1016/j.ympev.2009.01.020; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Landini W, 2005, QUATERN INT, V131, P101, DOI 10.1016/j.quaint.2004.07.006; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lasram FB, 2009, BIOL INVASIONS, V11, P697, DOI 10.1007/s10530-008-9284-4; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Li B, 2009, MOL PHYLOGENET EVOL, V50, P345, DOI 10.1016/j.ympev.2008.11.013; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Li JT, 2009, MOL PHYLOGENET EVOL, V53, P509, DOI 10.1016/j.ympev.2009.06.023; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Orrell TM, 2004, MOL PHYLOGENET EVOL, V32, P425, DOI 10.1016/j.ympev.2004.01.012; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson C., 1993, P621; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Pinardi N, 2000, PALAEOGEOGR PALAEOCL, V158, P153, DOI 10.1016/S0031-0182(00)00048-1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2016, R FDN STAT COMP; Reed DL, 2002, MOL PHYLOGENET EVOL, V23, P513, DOI 10.1016/S1055-7903(02)00036-2; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stiassny MLJ, 2004, ASSEMBLING THE TREE OF LIFE, P410; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Westneat MW, 2005, MOL PHYLOGENET EVOL, V36, P370, DOI 10.1016/j.ympev.2005.02.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Yamanoue Y, 2007, MOL PHYLOGENET EVOL, V45, P89, DOI 10.1016/j.ympev.2007.03.008; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yamanoue Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-212; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Zheng LP, 2010, ZOOL SCR, V39, P559, DOI 10.1111/j.1463-6409.2010.00441.x	70	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36443	10.1371/journal.pone.0036443	http://dx.doi.org/10.1371/journal.pone.0036443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590545	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500013
J	Zhu, JL; Wang, JF; Sheng, Y; Zou, Y; Bo, LL; Wang, F; Lou, JS; Fan, XH; Bao, R; Wu, YP; Chen, F; Deng, XM; Li, JB				Zhu, Jiali; Wang, Jiafeng; Sheng, Ying; Zou, Yun; Bo, Lulong; Wang, Fei; Lou, Jingsheng; Fan, Xiaohua; Bao, Rui; Wu, Youping; Chen, Feng; Deng, Xiaoming; Li, Jinbao			Baicalin Improves Survival in a Murine Model of Polymicrobial Sepsis via Suppressing Inflammatory Response and Lymphocyte Apoptosis	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; SEPTIC SHOCK; RATS; EPIDEMIOLOGY; SCUTELLARIA; MULTICENTER; ACTIVATION; ENDOTOXIN; MICE	Background: An imbalance between overwhelming inflammation and lymphocyte apoptosis is the main cause of high mortality in patients with sepsis. Baicalin, the main active ingredient of the Scutellaria root, exerts anti-inflammatory, anti-apoptotic, and even antibacterial properties in inflammatory and infectious diseases. However, the therapeutic effect of baicalin on polymicrobial sepsis remains unknown. Methodology/Principal Findings: Polymicrobial sepsis was induced by cecal ligation and puncture (CLP) in C57BL/6 mice. Mice were infused with baicalin intraperitoneally at 1 h, 6 h and 12 h after CLP. Survival rates were assessed over the subsequent 8 days. Bacterial burdens in blood and peritoneal cavity were calculated to assess the bacterial clearance. Neutrophil count in peritoneal lavage fluid was also calculated. Injuries to the lung and liver were detected by hematoxylin and eosin staining. Levels of cytokines, including tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-10 and IL-17, in blood and peritoneum were measured by enzyme-linked immunosorbent assay. Adaptive immune function was assessed by apoptosis of lymphocytes in the thymus and counts of different cell types in the spleen. Baicalin significantly enhanced bacterial clearance and improved survival of septic mice. The number of neutrophils in peritoneal lavage fluid was reduced by baicalin. Less neutrophil infiltration of the lung and liver in baicalin-treated mice was associated with attenuated injuries to these organs. Baicalin significantly reduced the levels of proinflammatory cytokines but increased the level of anti-inflammatory cytokine in blood and peritoneum. Apoptosis of CD3(+) T cell was inhibited in the thymus. The numbers of CD4(+), CD8(+) T lymphocytes and dendritic cells (DCs) were higher, while the number of CD4(+)CD25(+) regulatory T cells was lower in the baicalin group compared with the CLP group. Conclusions/Significance: Baicalin improves survival of mice with polymicrobial sepsis, and this may be attributed to its antibacterial property as well as its anti-inflammatory and anti-apoptotic effects.	[Zhu, Jiali; Wang, Jiafeng; Sheng, Ying; Zou, Yun; Bo, Lulong; Wang, Fei; Lou, Jingsheng; Fan, Xiaohua; Bao, Rui; Wu, Youping; Chen, Feng; Deng, Xiaoming; Li, Jinbao] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Crit Care, Shanghai, Peoples R China	Naval Medical University	Zhu, JL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Crit Care, Shanghai, Peoples R China.	deng_x@yahoo.com; lijinbaoshanghai@163.com	Deng, Xiaoming/E-2876-2010; Lou, Jingsheng/ABF-7902-2021	Lou, Jingsheng/0000-0002-0295-5105; Wang, Jia-feng/0000-0002-1753-6499; Chen, Feng/0000-0003-0013-479X	National Natural Science Foundation of China [81171788]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81171788 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2006, LANCET, DOI DOI 10.1016/S0140-6736(06)69005-3; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Cheng BL, 2007, CRIT CARE MED, V35, P2538, DOI 10.1097/01.CCM.0000284492.30800.00; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cushnie TPT, 2003, MICROBIOL RES, V158, P281, DOI 10.1078/0944-5013-00206; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Ji Y, 2011, PLOS ONE, V6; Joshi VD, 2003, FEBS LETT, V555, P180, DOI 10.1016/S0014-5793(03)01271-7; KIBE S, 2011, J ANTIMICROB CHEMOTH, V2, P33; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lee YM, 2011, J ETHNOPHARMACOL, V135, P179, DOI 10.1016/j.jep.2011.03.009; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Liu LL, 2008, BIOCHEM PHARMACOL, V75, P914, DOI 10.1016/j.bcp.2007.10.009; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Novy P, 2011, J ANTIMICROB CHEMOTH, V66, P1298, DOI 10.1093/jac/dkr108; Peck-Palmer OM, 2009, SHOCK, V31, P359, DOI 10.1097/SHK.0b013e31818ba2a2; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Shi C., 2011, J IMMUNOL; Tang YJ, 2010, INFLAMMATION, V33, P180, DOI 10.1007/s10753-009-9172-9; Tanino Y, 2002, AM J PHYSIOL-LUNG C, V283, pL156, DOI 10.1152/ajplung.00155.2001; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang XP, 2009, HEPATOB PANCREAT DIS, V8, P85; Zhang XP, 2009, PANCREAS, V38, P732, DOI 10.1097/MPA.0b013e3181ad9735; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354; Zhao ZQ, 2002, CARDIOVASC RES, V55, P438, DOI 10.1016/S0008-6363(02)00442-X	38	73	81	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e35523	10.1371/journal.pone.0035523	http://dx.doi.org/10.1371/journal.pone.0035523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590504	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335500003
J	Leenders, JJ; Wijnen, WJ; van der Made, I; Hiller, M; Swinnen, M; Vandendriessche, T; Chuah, M; Pinto, YM; Creemers, EE				Leenders, Joost J.; Wijnen, Wino J.; van der Made, Ingeborg; Hiller, Monika; Swinnen, Melissa; Vandendriessche, Thierry; Chuah, Marinee; Pinto, Yigal M.; Creemers, Esther E.			Repression of Cardiac Hypertrophy by KLF15: Underlying Mechanisms and Therapeutic Implications	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; KRUPPEL-LIKE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIOMYOCYTE HYPERTROPHY; BINDING-PROTEIN; MUSCLE-CELLS; IN-VIVO; MYOCARDIN; ACTIVATION	The Kruppel-like factor (KLF) family of transcription factors regulates diverse cell biological processes including proliferation, differentiation, survival and growth. Previous studies have shown that KLF15 inhibits cardiac hypertrophy by repressing the activity of pivotal cardiac transcription factors such as GATA4, MEF2 and myocardin. We set out this study to characterize the interaction of KLF15 with putative other transcription factors. We first show that KLF15 interacts with myocardin-related transcription factors (MRTFs) and strongly represses the transcriptional activity of MRTF-A and MRTF-B. Second, we identified a region within the C-terminal zinc fingers of KLF15 that contains the nuclear localization signal. Third, we investigated whether overexpression of KLF15 in the heart would have therapeutic potential. Using recombinant adeno-associated viruses (rAAV) we have overexpressed KLF15 specifically in the mouse heart and provide the first evidence that elevation of cardiac KLF15 levels prevents the development of cardiac hypertrophy in a model of Angiotensin II induced hypertrophy.	[Leenders, Joost J.; Wijnen, Wino J.; van der Made, Ingeborg; Hiller, Monika; Pinto, Yigal M.; Creemers, Esther E.] Univ Amsterdam, AMC, Heart Failure Res Ctr, Amsterdam, Netherlands; [Swinnen, Melissa; Vandendriessche, Thierry; Chuah, Marinee] Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Vandendriessche, Thierry; Chuah, Marinee] Free Univ Brussels, Dept Gene Therapy & Regenerat Med, Brussels, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Leenders, JJ (corresponding author), Univ Amsterdam, AMC, Heart Failure Res Ctr, Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	Wijnen, Wino/P-4774-2015	Wijnen, Wino/0000-0002-3513-3618; Vandendriessche, Thierry/0000-0003-4230-745X; Chuah, Marinee/0000-0001-8569-0175; Creemers, Esther/0000-0002-9001-3854	Dutch Heart Foundation [NHS2007-B077]; Research Foundation Flanders (FWO); Association Francaise contre les Myopathies (AFM)	Dutch Heart Foundation(Netherlands Heart Foundation); Research Foundation Flanders (FWO)(FWO); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Dutch Heart Foundation (NHS2007-B077), Research Foundation Flanders (FWO), and Association Francaise contre les Myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Creemers EE, 2011, NAT REV GENET, V12, P357, DOI 10.1038/nrg2983; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013; Kuwahara K, 2010, MOL CELL BIOL, V30, P4134, DOI 10.1128/MCB.00154-10; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Leenders JJ, 2011, J MOL CELL CARDIOL, V51, P156, DOI 10.1016/j.yjmcc.2011.04.017; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Ma HL, 2004, AM J PHYSIOL-CELL PH, V286, pC556, DOI 10.1152/ajpcell.00328.2003; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Otteson DC, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-15; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Swinnen M, 2009, CIRCULATION, V120, P1585, DOI 10.1161/CIRCULATIONAHA.109.863266; Uchida S, 2000, MOL CELL BIOL, V20, P7319, DOI 10.1128/MCB.20.19.7319-7331.2000; van Vliet J, 2006, GENOMICS, V87, P474, DOI 10.1016/j.ygeno.2005.12.011; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Vandendriessche T, 2007, J THROMB HAEMOST, V5, P16, DOI 10.1111/j.1538-7836.2006.02220.x; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e	44	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36754	10.1371/journal.pone.0036754	http://dx.doi.org/10.1371/journal.pone.0036754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586493	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000054
J	Gaiffe, E; Pretet, JL; Launay, S; Jacquin, E; Saunier, M; Hetzel, G; Oudet, P; Mougin, C				Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Hetzel, Genevieve; Oudet, Pierre; Mougin, Christiane			Apoptotic HPV Positive Cancer Cells Exhibit Transforming Properties	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; STAUROSPORINE-INDUCED APOPTOSIS; HUMAN-PAPILLOMAVIRUS; CERVICAL-CARCINOMA; ENDOTHELIAL-CELLS; TRANSFERRED DNA; UTERINE CERVIX; BODIES; TUMOR; P53	Previous studies have shown that DNA can be transferred from dying engineered cells to neighboring cells through the phagocytosis of apoptotic bodies, which leads to cellular transformation. Here, we provide evidence of an uptake of apoptotic-derived cervical cancer cells by human mesenchymal cells. Interestingly, HeLa (HPV 18+) or Ca Ski (HPV16+) cells, harboring integrated high-risk HPV DNA but not C-33 A cells (HPV-), were able to transform the recipient cells. Human primary fibroblasts engulfed the apoptotic bodies effectively within 30 minutes after co-cultivation. This mechanism is active and involves the actin cytoskeleton. In situ hybridization of transformed fibroblasts revealed the presence of HPV DNA in the nucleus of a subset of phagocytosing cells. These cells expressed the HPV16/18 E6 gene, which contributes to the disruption of the p53/p21 pathway, and the cells exhibited a tumorigenic phenotype, including an increased proliferation rate, polyploidy and anchorage independence growth. Such horizontal transfer of viral oncogenes to surrounding cells that lack receptors for HPV could facilitate the persistence of the virus, the main risk factor for cervical cancer development. This process might contribute to HPV-associated disease progression in vivo.	[Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Mougin, Christiane] Univ Franche Comte, Equipe Accueil 3181, F-25030 Besancon, France; [Gaiffe, Emilie; Pretet, Jean-Luc; Launay, Sophie; Jacquin, Elise; Saunier, Maelle; Mougin, Christiane] Univ Franche Comte, Inst Federatif Rech 133, F-25030 Besancon, France; [Pretet, Jean-Luc; Mougin, Christiane] Ctr Hosp Univ Besancon, Lab Biol Cellulaire & Mol, F-25030 Besancon, France; [Hetzel, Genevieve; Oudet, Pierre] Univ Strasbourg, Hop Univ Strasbourg, Strasbourg, France	Universite de Franche-Comte; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gaiffe, E (corresponding author), Univ Franche Comte, Equipe Accueil 3181, F-25030 Besancon, France.	christiane.mougin@univ-fcomte.fr	Jacquin, Elise/J-5293-2015; Prétet, Jean-Luc/B-2911-2012; Jacquin, Elise/GPX-1868-2022	Jacquin, Elise/0000-0003-0368-4113; Prétet, Jean-Luc/0000-0002-8430-214X; MOUGIN, CHRISTIANE/0000-0002-1573-8695	Region de Franche-Comte; Institut National du Cancer; Ligue Contre le Cancer, Comite du Doubs	Region de Franche-Comte(Region Bourgogne-Franche-Comte); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Contre le Cancer, Comite du Doubs	Fellowships and works were supported by public funds from the "Region de Franche-Comte," "Institut National du Cancer" and "Ligue Contre le Cancer, Comite du Doubs." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergsmedh A, 2006, MOL CANCER RES, V4, P187, DOI 10.1158/1541-7786.MCR-05-0262; Bergsmedh A, 2002, CANCER RES, V62, P575; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Bernard B, 2001, CELL DEATH DIFFER, V8, P234, DOI 10.1038/sj.cdd.4400796; Charlot JF, 2006, APOPTOSIS, V11, P813, DOI 10.1007/s10495-006-5876-6; COLBURN NH, 1978, CANCER RES, V38, P624; de la Taille A, 1999, CANCER RES, V59, P5461; DINI L, 1995, J CELL SCI, V108, P967; DIPAOLO JA, 1989, ONCOGENE, V4, P395; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ehnfors J, 2009, CELL DEATH DIFFER, V16, P749, DOI 10.1038/cdd.2009.7; Elit L, 2009, GYNECOL ONCOL, V114, P528, DOI 10.1016/j.ygyno.2009.06.001; Grayson W, 1997, INT J GYNECOL PATHOL, V16, P307, DOI 10.1097/00004347-199710000-00003; HALL SE, 1994, J IMMUNOL, V153, P3218; Hampson L, 2001, FASEB J, V15, P1445, DOI 10.1096/fj.00-0728fje; HAUSEN HZ, 1986, LANCET, V2, P489; HAYFLICK L, 1964, NATURE, V204, P146, DOI 10.1038/204146a0; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Isacson C, 1996, CANCER RES, V56, P669; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Laurendeau I, 1999, CLIN CHEM, V45, P982; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; LEVINE EL, 1995, RADIOTHER ONCOL, V37, P1, DOI 10.1016/0167-8140(95)01622-N; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; LOWY DR, 1994, P NATL ACAD SCI USA, V91, P2436, DOI 10.1073/pnas.91.7.2436; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Plumb JA, 2004, METH MOLEC MED, V88, P159; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saunier M, 2008, J CLIN MICROBIOL, V46, P3678, DOI 10.1128/JCM.01212-08; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Simbulan-Rosenthal CM, 2002, J BIOL CHEM, V277, P24709, DOI 10.1074/jbc.M200281200; Slagle BL, 1998, CANCER-AM CANCER SOC, V83, P1401, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1401::AID-CNCR18>3.0.CO;2-8; SOMMERS GM, 1989, GYNECOL ONCOL, V35, P150, DOI 10.1016/0090-8258(89)90033-4; Spetz AL, 1999, J IMMUNOL, V163, P736; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsang RW, 1999, RADIOTHER ONCOL, V50, P85, DOI 10.1016/S0167-8140(98)00120-0; Unger ER, 1999, HUM PATHOL, V30, P483, DOI 10.1016/S0046-8177(99)90127-2; van Elsas JD, 2002, FEMS MICROBIOL ECOL, V42, P187, DOI 10.1111/j.1574-6941.2002.tb01008.x; Weber JC, 2007, INT J CANCER, V120, P524, DOI 10.1002/ijc.22343; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; WINKLER B, 1984, CANCER, V53, P1081, DOI 10.1002/1097-0142(19840301)53:5<1081::AID-CNCR2820530511>3.0.CO;2-L; Yan B, 2006, BRIT J CANCER, V95, P1696, DOI 10.1038/sj.bjc.6603484; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36766	10.1371/journal.pone.0036766	http://dx.doi.org/10.1371/journal.pone.0036766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574222	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800119
J	Iqbal, MA; Bamezai, RNK				Iqbal, Mohd Askandar; Bamezai, Rameshwar N. K.			Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin	PLOS ONE			English	Article							GLUCOSE-METABOLISM; COLORECTAL-CANCER; SCREENING TOOL; TUMOR-GROWTH; EXPRESSION; APOPTOSIS; ARREST; PTEN; AKT	Metabolism of cancer cells with pyruvate kinase M2 (PKM2) at its centre stage has assumed a prime significance in cancer research in recent times. Cancer cell metabolism, characterized by enhanced glucose uptake, production of lactate and anabolism is considered an ideal target for therapeutic interventions. Expression of PKM2 switches metabolism in favor of cancer cells, therefore, the present study was designed to investigate the hitherto unknown effect of resveratrol, a phytoalexin, on PKM2 expression and resultant implications on cancer metabolism. We observed that resveratrol down-regulated PKM2 expression by inhibiting mTOR signaling and suppressed cancer metabolism, adjudged by decreased glucose uptake, lactate production (aerobic glycolysis) and reduced anabolism (macromolecule synthesis) in various cancer cell lines. A contingent decrease in intracellular levels of ribose-5-phosphate (R5P), a critical intermediate of pentose phosphate pathway, accounted for a reduced anabolism. Consequently, the state of suppressed cancer metabolism resulted in decreased cellular proliferation. Interestingly, shRNA-mediated silencing of PKM2 inhibited glucose uptake and lactate production, providing evidence for the critical role of PKM2 and its mediation in the observed effects of resveratrol on cancer metabolism. Further, an over-expression of PKM2 abolished the observed effects of resveratrol, signifying the role of PKM2 downregulation as a critical function of resveratrol. The study reports a novel PKM2-mediated effect of resveratrol on cancer metabolism and provides a new dimension to its therapeutic potential.	[Iqbal, Mohd Askandar; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Iqbal, MA (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com		Iqbal, Mohammad Askandar/0000-0003-3485-3530; Bamezai, R.N.K/0000-0002-5128-2859	University Grants Commission, Government of India; University Grants Commission (UGC); UGC, Government of India	University Grants Commission, Government of India(University Grants Commission, India); University Grants Commission (UGC)(University Grants Commission, India); UGC, Government of India(University Grants Commission, India)	Research was funded by University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RNKB acknowledges the support provided by the University Grants Commission (UGC) to the Centre (NCAHG) and MA Iqbal acknowledges the support of UGC, Government of India, for research fellowship.	Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Ewald N, 2005, Z GASTROENTEROL, V43, P1313, DOI 10.1055/s-2005-858657; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Fustier P, 2003, BRIT J CANCER, V89, P168, DOI 10.1038/sj.bjc.6600983; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2008, EXPERT REV MOL DIAGN, V8, P579, DOI 10.1586/14737159.8.5.579; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill R, CANC RES, V70, P7114; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; Kim YA, 2003, INT J ONCOL, V23, P1143; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; Lin JN, 2010, J AGR FOOD CHEM, V58, P1584, DOI 10.1021/jf9035782; Liu M., J BIOL CHEM, V285, P36387; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; NETZKER R, 1992, J BIOL CHEM, V267, P6421; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samuels Y, CURR TOP MICROBIOL I, V347, P21; Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7; Sun Q, P NATL ACAD SCI US, V108, P4129; TENNANT DA, NAT REV CANC, V10, P267; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yamada K, 1999, BIOCHEM J, V337, P1, DOI 10.1042/0264-6021:3370001	36	72	77	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36764	10.1371/journal.pone.0036764	http://dx.doi.org/10.1371/journal.pone.0036764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574221	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800118
J	Cao, H; Dai, PH; Wang, WY; Li, H; Yuan, JD; Wang, FJ; Fang, CM; Pitha, PM; Liu, J; Condit, RC; McFadden, G; Merghoub, T; Houghton, AN; Young, JW; Shuman, S; Deng, L				Cao, Hua; Dai, Peihong; Wang, Weiyi; Li, Hao; Yuan, Jianda; Wang, Fangjin; Fang, Chee-Mun; Pitha, Paula M.; Liu, Jia; Condit, Richard C.; McFadden, Grant; Merghoub, Taha; Houghton, Alan N.; Young, James W.; Shuman, Stewart; Deng, Liang			Innate Immune Response of Human Plasmacytoid Dendritic Cells to Poxvirus Infection Is Subverted by Vaccinia E3 via Its Z-DNA/RNA Binding Domain	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INTERFERON-PRODUCING CELLS; EDITING ENZYME ADAR1; KAPPA-B KINASE; Z-ALPHA DOMAIN; Z-DNA-BINDING; HANDED Z-DNA; MYXOMA VIRUS; I INTERFERON; VIRULENCE FACTOR	Plasmacytoid dendritic cells (pDCs) play important roles in antiviral innate immunity by producing type I interferon (IFN). In this study, we assess the immune responses of primary human pDCs to two poxviruses, vaccinia and myxoma virus. Vaccinia, an orthopoxvirus, was used for immunization against smallpox, a contagious human disease with high mortality. Myxoma virus, a Leporipoxvirus, causes lethal disease in rabbits, but is non-pathogenic in humans. We report that myxoma virus infection of human pDCs induces IFN-alpha and TNF production, whereas vaccinia infection does not. Co-infection of pDCs with myxoma virus plus vaccinia blocks myxoma induction effects. We find that heat-inactivated vaccinia (Heat-VAC; by incubating the virus at 55 degrees C for 1 h) gains the ability to induce IFN-alpha and TNF in primary human pDCs. Induction of IFN-alpha in pDCs by myxoma virus or Heat-VAC is blocked by chloroquine, which inhibits endosomal acidification required for TLR7/9 signaling, and by inhibitors of cellular kinases PI3K and Akt. Using purified pDCs from genetic knockout mice, we demonstrate that Heat-VAC-induced type I IFN production in pDCs requires the endosomal RNA sensor TLR7 and its adaptor MyD88, transcription factor IRF7 and the type I IFN feedback loop mediated by IFNAR1. These results indicate that (i) vaccinia virus, but not myxoma virus, expresses inhibitor(s) of the poxvirus sensing pathway(s) in pDCs; and (ii) Heat-VAC infection fails to produce inhibitor(s) but rather produces novel activator(s), likely viral RNA transcripts that are sensed by the TLR7/MyD88 pathway. Using vaccinia gene deletion mutants, we show that the Z-DNA/RNA binding domain at the N-terminus of the vaccinia immunomodulatory E3 protein is an antagonist of the innate immune response of human pDCs to poxvirus infection and TLR agonists. The myxoma virus ortholog of vaccinia E3 (M029) lacks the N-terminal Z-DNA/RNA binding domain, which might contribute to the immunostimulating properties of myxoma virus.	[Cao, Hua; Wang, Weiyi; Wang, Fangjin; Deng, Liang] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA; [Cao, Hua; Dai, Peihong; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Li, Hao; Yuan, Jianda] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Immune Monitoring Core Facil, New York, NY 10021 USA; [Young, James W.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Hematol Oncol, Lab Cellular Immunobiol,Adult Allogen Bone Marrow, New York, NY 10021 USA; [Merghoub, Taha; Houghton, Alan N.] Mem Sloan Kettering Canc Ctr, Program Immunol, Sloan Kettering Inst, New York, NY 10021 USA; [Shuman, Stewart; Deng, Liang] Mem Sloan Kettering Canc Ctr, Lucille Castori Ctr Microbes Inflammat & Canc, New York, NY 10021 USA; [Fang, Chee-Mun; Pitha, Paula M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Liu, Jia; Condit, Richard C.; McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; State University System of Florida; University of Florida	Cao, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA.	dengl@mskcc.org	Merghoub, Taha/ABD-8362-2021; Wang, Weiyi/GZN-0408-2022; Fang, Chee-Mun/F-4106-2014; Deng, Liang/GXH-6710-2022; wang, fang/GYD-4295-2022	Fang, Chee-Mun/0000-0002-4934-5697; Young, James/0000-0002-0032-6559; McFadden, Grant/0000-0002-2556-3526; Liu, Jia/0000-0001-8424-7972	NIH [K-08 AI073736, R56AI095692, AI080607, CA13854]; Northeast Biodefense Center via NIH [U54-AI057158]; National Cancer Institute, National Institutes of Health [R01-CA018920]; University of Florida, College of Medicine; Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095692, R01AI080607, K08AI073736, U54AI057158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center via NIH; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Florida, College of Medicine(University of Florida); Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant K-08 AI073736 (L. D.) and R56AI095692 (L. D.) and a Targeted Project Award (S. S., L. D.) from the Northeast Biodefense Center via NIH grant U54-AI057158. J.W.Y. is supported by R01-CA018920 from the National Cancer Institute, National Institutes of Health. G. M. is supported by NIH R01 grants AI080607 and CA13854, and by start-up funds from the University of Florida, College of Medicine. L. D. is the recipient of a Dermatologist Investigator Research Fellowship and a Physician Scientist Career Development Award from the Dermatology Foundation. S. S. is an American Cancer Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Barrett JW, 2001, SEMIN IMMUNOL, V13, P73, DOI 10.1006/smim.2000.0298; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Cao WP, 2008, NAT IMMUNOL, V9, P1157, DOI 10.1038/ni.1645; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chen RAJ, 2006, J GEN VIROL, V87, P1451, DOI 10.1099/vir.0.81736-0; Chen RAJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040022; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Dai PH, 2011, J VIROL, V85, P10814, DOI 10.1128/JVI.00104-11; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Deng L, 2008, J VIROL, V82, P10735, DOI 10.1128/JVI.01305-08; Deng L, 2006, J VIROL, V80, P9977, DOI 10.1128/JVI.00354-06; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Drillien R, 2004, J GEN VIROL, V85, P2167, DOI 10.1099/vir.0.79998-0; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000128; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Ha SC, 2004, P NATL ACAD SCI USA, V101, P14367, DOI 10.1073/pnas.0405586101; HARPER JMM, 1978, J VIROL, V26, P646, DOI 10.1128/JVI.26.3.646-659.1978; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; KOTWAL GJ, 1989, VIROLOGY, V171, P579, DOI 10.1016/0042-6822(89)90627-2; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Motes C.M., 2011, PLOS PATHOG, V7; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Oda S, 2009, STRUCTURE, V17, P1528, DOI 10.1016/j.str.2009.09.005; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Turner PC, 2007, VIROLOGY, V366, P62, DOI 10.1016/j.virol.2007.03.060; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	68	23	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36823	10.1371/journal.pone.0036823	http://dx.doi.org/10.1371/journal.pone.0036823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606294	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339400035
J	Lakis, G; Navascues, M; Rekima, S; Simon, M; Remigereau, MS; Leveugle, M; Takvorian, N; Lamy, F; Depaulis, F; Robert, T				Lakis, Ghayas; Navascues, Miguel; Rekima, Samah; Simon, Mathieu; Remigereau, Marie-Stanislas; Leveugle, Magalie; Takvorian, Najat; Lamy, Francoise; Depaulis, Frantz; Robert, Thierry			Evolution of Neutral and Flowering Genes along Pearl Millet (Pennisetum glaucum) Domestication	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CONSTANS-LIKE GENE; HAPLOTYPE RECONSTRUCTION; NUCLEOTIDE DIVERSITY; ARTIFICIAL SELECTION; POPULATION-STRUCTURE; STATISTICAL-METHOD; NATURAL VARIATION; DNA POLYMORPHISM; ENZYME DIVERSITY	Background: Pearl millet landraces display an important variation in their cycle duration. This diversity contributes to the stability of crop production in the Sahel despite inter-annual rainfall fluctuation. Conservation of phenological diversity is important for the future of pearl millet improvement and sustainable use. Identification of genes contributing to flowering time variation is therefore relevant. In this study we focused on three flowering candidate genes, PgHd3a, PgDwarf8 and PgPHYC. We tested for signatures of past selective events within polymorphism patterns of these three genes that could have been associated with pearl millet domestication and/or landraces differentiation. In order to implement ad hoc neutrality tests, a plausible demographic history of pearl millet domestication was inferred through Approximate Bayesian Computation by using eight neutral STS loci. Results: Domesticated pearl millet exhibited 84% of the nucleotide diversity level found in the wild population. No specific polymorphisms were found either in the wild or in the domestic populations. The Bayesian approach and previous studies suggest that gene flow between wild relatives and domesticated pearl millets is a main factor explaining these results. Early and late landraces did not show significant genetic differentiation at both the neutral and the candidate loci. A positive selection was evidenced in PgHd3a and PgDwarf8 genes of domestic forms but not in the wild population. Conclusion: Our results strongly suggest that PgHd3a and PgDwarf8 were likely targeted by selection during domestication. However, a potential role of any of the three candidate genes in the phenological differentiation between early and late landraces was not supported by our data. Reasons why these results contrast with previous results that have shown a slight but significant association between PgPHYC polymorphisms and variation in flowering time in pearl millet are discussed.	[Lakis, Ghayas; Rekima, Samah; Leveugle, Magalie; Takvorian, Najat; Lamy, Francoise; Robert, Thierry] Univ Paris 11, UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France; [Navascues, Miguel] INRA Campus Int Baillarguet, Ctr Biol Gest Populat, Montferrier Sur Lez, France; [Simon, Mathieu] INRA Versailles, Genet & Ameliorat Plantes Stn, Versailles, France; [Remigereau, Marie-Stanislas] Univ So Calif, Los Angeles, CA USA; [Depaulis, Frantz] Univ Paris 06, CNRS, UMR7625, Lab Ecol & Evolut,ENS, Paris, France; [Lamy, Francoise] UVSQ, Versailles, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; University of Southern California; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Lakis, G (corresponding author), Univ Paris 11, UMR 8079, Lab Ecol Systemat & Evolut, Orsay, France.	ghayas.lakis@u-psud.fr	de Navascués Melero, Miguel/C-8705-2009	de Navascués Melero, Miguel/0000-0001-8342-6047; Depaulis, Frantz/0000-0001-5761-2751	Agence Nationale pour la Recherche Scientifique [ANR-07Biodiv-005-04, ANR-06-BDIV-003-01]	Agence Nationale pour la Recherche Scientifique(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche Scientifique (ANR-07Biodiv-005-04) - project PLANTADIV, and (ANR-06-BDIV-003-01) project Transbiodiv. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; [Anonymous], 1989, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01116840; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Balter M, 2007, SCIENCE, V316, P1830, DOI 10.1126/science.316.5833.1830; Beaumont MA, 2008, SIMULATIONS GENETICS, P135; Belanger AE, 2002, ANTIMICROB AGENTS CH, V46, P2507, DOI 10.1128/AAC.46.8.2507-2512.2002; Belliard J, 1985, CRC HDB FLOWERING, V4, P22; BERTHAUD J, 2001, BROADENING GENETIC B; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; Bonnin I, 2008, THEOR APPL GENET, V116, P383, DOI 10.1007/s00122-007-0676-0; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Clark RM, 2005, MOL BIOL EVOL, V22, P2304, DOI 10.1093/molbev/msi228; Clerget B, 2007, J SAT AGR RES, V5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Colasanti J, 2009, PLANT PHYSIOL, V149, P56, DOI 10.1104/pp.108.130500; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FU YX, 1993, GENETICS, V133, P693; GAUT BS, 1993, GENETICS, V135, P1091; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HALL TA, 1999, BIOEDIT USER FRIENDL, V41, P95; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Hammer K., 1984, KULTURPFLANZE, V32, P11, DOI [DOI 10.1007/BF02098682, 10.1007/BF02098682]; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; HARPENDING HC, 1994, HUM BIOL, V66, P591; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; HAUSSMANN BIG, 2007, J SAT AGR RES, V3; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; HILLMAN GC, 1990, BIOL J LINN SOC, V39, P39, DOI 10.1111/j.1095-8312.1990.tb01611.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lakis G, 2012, GENETICA; Lazakis CM, 2011, J EXPT BOT; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Manning K, 2011, J ARCHAEOL SCI, V38, P312, DOI 10.1016/j.jas.2010.09.007; Mariac C, 2006, THEOR APPL GENET, V113, P1003, DOI 10.1007/s00122-006-0360-9; Mariac C, 2011, MOL ECOL, V20, P80, DOI 10.1111/j.1365-294X.2010.04893.x; Miller TA, 2008, PLANTA, V227, P1377, DOI 10.1007/s00425-008-0709-1; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Nei M., 2000, MOL EVOLUTION PHYLOG; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Niangado O., 2000, Broadening the genetic base of crop production, P147, DOI 10.1079/9780851994116.0147; Oumar I, 2008, THEOR APPL GENET, V117, P489, DOI 10.1007/s00122-008-0793-4; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pernes J, 1986, ACTUALITES BOT, V133, P27; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Ramirez-Soriano A, 2008, BIOINFORMATICS, V24, P2790, DOI 10.1093/bioinformatics/btn531; Remigereau MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022404; Robert T, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P217, DOI 10.1007/978-3-642-14255-0_13; Ross-Ibarra J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002411; Roussel B., 1997, CHANGEMENTS ECOLOGIQ; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Schepens I, 2004, CURR OPIN PLANT BIOL, V7, P564, DOI 10.1016/j.pbi.2004.07.004; SIVAKUMAR MVK, 1992, CLIMATIC CHANGE, V20, P297, DOI 10.1007/BF00142424; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TOSTAIN S, 1987, THEOR APPL GENET, V74, P188, DOI 10.1007/BF00289967; TOSTAIN S, 1989, THEOR APPL GENET, V77, P634, DOI 10.1007/BF00261235; TOSTAIN S, 1990, RAPPORT MISSION ICRI; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Wakeley J, 1997, GENETICS, V145, P847; WENDORF F, 1992, NATURE, V359, P721, DOI 10.1038/359721a0; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoo SY, 2004, MOL CELLS, V17, P95	96	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36642	10.1371/journal.pone.0036642	http://dx.doi.org/10.1371/journal.pone.0036642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606277	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339400027
J	Vimmerstedt, LJ; Bush, B; Peterson, S				Vimmerstedt, Laura J.; Bush, Brian; Peterson, Steve			Ethanol Distribution, Dispensing, and Use: Analysis of a Portion of the Biomass-to-Biofuels Supply Chain Using System Dynamics	PLOS ONE			English	Article							ENERGY	The Energy Independence and Security Act of 2007 targets use of 36 billion gallons of biofuels per year by 2022. Achieving this may require substantial changes to current transportation fuel systems for distribution, dispensing, and use in vehicles. The U.S. Department of Energy and the National Renewable Energy Laboratory designed a system dynamics approach to help focus government action by determining what supply chain changes would have the greatest potential to accelerate biofuels deployment. The National Renewable Energy Laboratory developed the Biomass Scenario Model, a system dynamics model which represents the primary system effects and dependencies in the biomass-to-biofuels supply chain. The model provides a framework for developing scenarios and conducting biofuels policy analysis. This paper focuses on the downstream portion of the supply chain-represented in the distribution logistics, dispensing station, and fuel utilization, and vehicle modules of the Biomass Scenario Model. This model initially focused on ethanol, but has since been expanded to include other biofuels. Some portions of this system are represented dynamically with major interactions and feedbacks, especially those related to a dispensing station owner's decision whether to offer ethanol fuel and a consumer's choice whether to purchase that fuel. Other portions of the system are modeled with little or no dynamics; the vehicle choices of consumers are represented as discrete scenarios. This paper explores conditions needed to sustain an ethanol fuel market and identifies implications of these findings for program and policy goals. A large, economically sustainable ethanol fuel market (or other biofuel market) requires low end-user fuel price relative to gasoline and sufficient producer payment, which are difficult to achieve simultaneously. Other requirements (different for ethanol vs. other biofuel markets) include the need for infrastructure for distribution and dispensing and widespread use of high ethanol blends in flexible-fuel vehicles.	[Vimmerstedt, Laura J.; Bush, Brian] Natl Renewable Energy Lab, Strateg Energy Anal Ctr, Golden, CO 80401 USA; [Peterson, Steve] Peterson Grp, W Lebanon, NH USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Vimmerstedt, LJ (corresponding author), Natl Renewable Energy Lab, Strateg Energy Anal Ctr, Golden, CO 80401 USA.	laura.vimmerstedt@nrel.gov		Bush, Brian/0000-0003-2864-7028	United States Department of Energy; Model development and analysis is sponsored by the DOE	United States Department of Energy(United States Department of Energy (DOE)); Model development and analysis is sponsored by the DOE	All the funding was from United States Department of Energy, who had a role in the study design, data collection and analysis.; The Biomass Scenario Model development and analysis is sponsored by the DOE Biomass Program. We thank Zia Haq and Sheila Moynihan of DOE for supporting this effort and reviewing this paper. We appreciate the laboratory program management support from Debbie Sandor and Mark Ruth at the National Renewable Energy Laboratory. We thank Dana Stright, consultant, for assistance with database management and figure development. We greatly appreciate assistance from other National Renewable Energy Laboratory staff: Mike Meshek and Mary Lukkonen, for assistance in editing the manuscript; the Biomass Scenario Model team (Jesse Geiger, David Hsu, Daniel Inman, and Emily Newes) for contributions to the development of the model; and Walter Short, Andy Aden, Chris Kinchin, and Helena Chum for reviewing a draft version of this paper. We thank external reviewers John Sheehan, University of Minnesota; Bob Wallace, Booz Allen Hamilton (at Pennsylvania State University at the time of the review); and Mark Paich and Corey Peck of Lexidyne, LLC. We greatly appreciate the review and editing from PLoS ONE.	[Anonymous], 2009, ETHANOL PRODUCER MAG; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bromiley P., 2008, NRELSR54042984; Bush B, 2008, NRELCP15043153; Energy Information Administration, 2008, ANN EN OUTL; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; isee systems, 2014, STELLA SYST THINK ED; Johnson C, 2007, NRELTP54041590; Newes E, 2011, ECONOMIC EFFECTS OF BIOFUEL PRODUCTION, P373; Parker L, 2009, R40809 C RES SERV; Riley C, 2008, NRELCP15042990; Russell DM, 2009, TRANSPORT J, V48, P5; Sandor D, 2008, NRELTP1504210; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; U.S. Census Bureau American Fact Finder, 2007, 2007 EC CENS; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy, 2021, ENH GEOTH SYST DEM P; U.S. Environmental Protection Agency, 2009, FED REG, V75, P14669; U.S. Environmental Protection Agency, 2011, INV US GREENH GAS EM; U.S. EPA, E15 BLEND GAS ETH; US Environmental Protection Agency, 2009, FED REG, V74, P49454	20	29	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35082	10.1371/journal.pone.0035082	http://dx.doi.org/10.1371/journal.pone.0035082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606230	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400005
J	Bajpai, AK; Davuluri, S; Chandrashekar, DS; Ilakya, S; Dinakaran, M; Acharya, KK				Bajpai, Akhilesh K.; Davuluri, Sravanthi; Chandrashekar, Darshan S.; Ilakya, Selvarajan; Dinakaran, Mahalakshmi; Acharya, Kshitish K.			MGEx-Udb: A Mammalian Uterus Database for Expression-Based Cataloguing of Genes across Conditions, Including Endometriosis and Cervical Cancer	PLOS ONE			English	Article							METAANALYSIS APPROACH; MICROARRAY; IMPLEMENTATION; INFORMATION; P16(INK4A); MIAME; TOOL	Background: Gene expression profiling of uterus tissue has been performed in various contexts, but a significant amount of the data remains underutilized as it is not covered by the existing general resources. Methodology/Principal Findings: We curated 2254 datasets from 325 uterus related mass scale gene expression studies on human, mouse, rat, cow and pig species. We then computationally derived a 'reliability score' for each gene's expression status (transcribed/dormant), for each possible combination of conditions and locations, based on the extent of agreement or disagreement across datasets. The data and derived information has been compiled into the Mammalian Gene Expression Uterus database (MGEx-Udb, http://resource.ibab.ac.in/MGEx-Udb/). The database can be queried with gene names/IDs, sub-tissue locations, as well as various conditions such as the cervical cancer, endometrial cycles and disorders, and experimental treatments. Accordingly, the output would be a) transcribed and dormant genes listed for the queried condition/location, or b) expression profile of the gene of interest in various uterine conditions. The results also include the reliability score for the expression status of each gene. MGEx-Udb also provides information related to Gene Ontology annotations, protein-protein interactions, transcripts, promoters, and expression status by other sequencing techniques, and facilitates various other types of analysis of the individual genes or co-expressed gene clusters. Conclusions/Significance: In brief, MGEx-Udb enables easy cataloguing of co-expressed genes and also facilitates biomarker discovery for various uterine conditions.	[Bajpai, Akhilesh K.; Davuluri, Sravanthi; Chandrashekar, Darshan S.; Ilakya, Selvarajan; Dinakaran, Mahalakshmi; Acharya, Kshitish K.] IBAB, Bengaluru Bangalore, Karnataka, India; [Acharya, Kshitish K.] Shodhaka Life Sci Pvt Ltd, Bengaluru Bangalore, Karnataka, India		Bajpai, AK (corresponding author), IBAB, Bengaluru Bangalore, Karnataka, India.	kshitish@ibab.ac.in		Selvarajan, Ilakya/0000-0003-3357-9576	Department of Information Technology, Government of India [DIT/R&D/BIO/15(5)/2008]	Department of Information Technology, Government of India(Ministry of Electronics and Information Technology (MEITY), Government of India)	This work was supported by Department of Information Technology [Grant number DIT/R&D/BIO/15(5)/2008 to KKA & an institutional grant under the center of excellence scheme] Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-467; Agarwal SM, 2011, NUCLEIC ACIDS RES, V39, pD975, DOI 10.1093/nar/gkq1024; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian A, 2009, CANCER EPIDEM BIOMAR, V18, P3008, DOI 10.1158/1055-9965.EPI-09-0328; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen Huei-Wen, 2006, Chang Gung Med J, V29, P15; Chen J, 2004, NUCLEIC ACIDS RES, V32, pD578, DOI 10.1093/nar/gkh003; Choi H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-364; Hubble J, 2009, NUCLEIC ACIDS RES, V37, pD898, DOI 10.1093/nar/gkn786; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Kong XR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-98; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Ochsner SA, 2008, NAT METHODS, V5, P991, DOI 10.1038/nmeth1208-991; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Rayner TF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-489; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Spellman PT, 2002, GENOME BIOL, V3; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor E, 2008, FERTIL STERIL, V89, P1, DOI 10.1016/j.fertnstert.2007.09.069; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Werner T, 2011, REPROD FERT DEVELOP, V23, P75, DOI 10.1071/RD10247; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36776	10.1371/journal.pone.0036776	http://dx.doi.org/10.1371/journal.pone.0036776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606288	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200042
J	Hereu, B; Linares, C; Sala, E; Garrabou, J; Garcia-Rubies, A; Diaz, D; Zabala, M				Hereu, Bernat; Linares, Cristina; Sala, Enric; Garrabou, Joaquim; Garcia-Rubies, Antoni; Diaz, David; Zabala, Mikel			Multiple Processes Regulate Long-Term Population Dynamics of Sea Urchins on Mediterranean Rocky Reefs	PLOS ONE			English	Article							PARACENTROTUS-LIVIDUS ECHINODERMATA; KELP FOREST ECOSYSTEMS; MARINE PROTECTED AREAS; ARBACIA-LIXULA; EVECHINUS-CHLOROTICUS; MASS MORTALITY; STRONGYLOCENTROTUS-DROEBACHIENSIS; DISTRIBUTION PATTERNS; TROPHIC CASCADES; NOVA-SCOTIA	We annually monitored the abundance and size structure of herbivorous sea urchin populations (Paracentrotus lividus and Arbacia lixula) inside and outside a marine reserve in the Northwestern Mediterranean on two distinct habitats (boulders and vertical walls) over a period of 20 years, with the aim of analyzing changes at different temporal scales in relation to biotic and abiotic drivers. P. lividus exhibited significant variability in density over time on boulder bottoms but not on vertical walls, and temporal trends were not significantly different between the protection levels. Differences in densities were caused primarily by variance in recruitment, which was less pronounced inside the MPA and was correlated with adult density, indicating density-dependent recruitment under high predation pressure, as well as some positive feedback mechanisms that may facilitate higher urchin abundances despite higher predator abundance. Populations within the reserve were less variable in abundance and did not exhibit the hyper-abundances observed outside the reserve, suggesting that predation effects maybe more subtle than simply lowering the numbers of urchins in reserves. A. lixula densities were an order of magnitude lower than P. lividus densities and varied within sites and over time on boulder bottoms but did not differ between protection levels. In December 2008, an exceptionally violent storm reduced sea urchin densities drastically (by 50% to 80%) on boulder substrates, resulting in the lowest values observed over the entire study period, which remained at that level for at least two years (up to the present). Our results also showed great variability in the biological and physical processes acting at different temporal scales. This study highlights the need for appropriate temporal scales for studies to fully understand ecosystem functioning, the concepts of which are fundamental to successful conservation and management.	[Hereu, Bernat; Linares, Cristina; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Sala, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Garrabou, Joaquim; Garcia-Rubies, Antoni] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Diaz, David] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma de Mallorca, Spain	University of Barcelona; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Spanish Institute of Oceanography	Hereu, B (corresponding author), Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain.	hereu@ub.edu	DIAZ, DAVID/AAS-8722-2021; Linares, Cristina/A-5244-2018; Hereu, Bernat/K-9150-2015	DIAZ, DAVID/0000-0003-0611-2516; Linares, Cristina/0000-0003-3855-2743; Hereu, Bernat/0000-0001-6247-7638; Garcia-Rubies, Antoni/0000-0002-4824-9337	Direccio General de Pesca Maritima; "Departament de Medi Natural" of the "Generalitat de Catalunya'; CSIC project [PIEC 200430E599]	Direccio General de Pesca Maritima; "Departament de Medi Natural" of the "Generalitat de Catalunya'; CSIC project	This study was partially funded by the "Direccio General de Pesca Maritima", the "Departament de Medi Natural" of the "Generalitat de Catalunya' and the CSIC project (PIEC 200430E599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; ANDREW NL, 1991, AUST J ECOL, V16, P353, DOI 10.1111/j.1442-9993.1991.tb01063.x; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Ballesteros E, 2008, MONITORING MARINE PR; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; Behrens MD, 2004, MAR ECOL PROG SER, V279, P129, DOI 10.3354/meps279129; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bonaviri C, 2009, MAR ECOL PROG SER, V382, P129, DOI 10.3354/meps07976; Boudouresque CF, 1980, SCI REP PORT CROS NA; Boudouresque Charles F., 2001, Developments in Aquaculture and Fisheries Science, V32, P177; Brady SM, 2005, J MAR BIOL ASSOC UK, V85, P1511, DOI 10.1017/S0025315405012713; BREEN PA, 1985, J EXP MAR BIOL ECOL, V92, P45, DOI 10.1016/0022-0981(85)90021-8; Bulleri F, 1999, J EXP MAR BIOL ECOL, V241, P81, DOI 10.1016/S0022-0981(99)00073-8; Cole RG, 1998, MAR ECOL PROG SER, V173, P215, DOI 10.3354/meps173215; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; DUGGINS DO, 1981, OECOLOGIA, V48, P157, DOI 10.1007/BF00347958; Duran S, 2004, MOL ECOL, V13, P3317, DOI 10.1111/j.1365-294X.2004.02338.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Fernandez C, 2006, ESTUAR COAST SHELF S, V68, P259, DOI 10.1016/j.ecss.2006.02.020; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Frantzis A., 1989, Travaux Scientifiques du Parc National de Port-Cros, V14, P81; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; Garcia-Rubies A, 2009, 11 PLIN C MED STORMS; GARCIARUBIES A, 1999, NATURALISTA SICILIAN, V23, P59; Gianguzza P, 2006, FISH RES, V81, P37, DOI 10.1016/j.fishres.2006.06.002; Gianguzza P, 2011, CHEM ECOL, V27, P129, DOI 10.1080/02757540.2010.547484; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; GRANELI E, 2002, 10 INT C HARMF ALG F; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2003, MAR BIOL, V143, P1135, DOI 10.1007/s00227-003-1163-z; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hereu B, 2004, MAR BIOL, V144, P1011, DOI 10.1007/s00227-003-1266-6; Hereu B, THESIS U BARCELONA; Hereu B., 2004, MAR BIOL, V146, P243; Hereu B, 2006, MAR ECOL PROG SER, V313, P95, DOI 10.3354/meps313095; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kempf M., 1962, REC TRAV STA MAR END, V25, P47; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lessios HA, 2005, CORAL REEFS, V24, P125, DOI 10.1007/s00338-004-0443-5; LOZANO J, 1995, MAR ECOL PROG SER, V122, P179, DOI 10.3354/meps122179; Macpherson E, 2002, ESTUAR COAST SHELF S, V55, P777, DOI 10.1006/ecss.2001.0939; McNaught DC, 1999, INDIRECT EFFECTS MAC; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Miller RJ, 2007, J EXP MAR BIOL ECOL, V349, P215, DOI 10.1016/j.jembe.2007.05.014; Pais A, 2007, ESTUAR COAST SHELF S, V73, P589, DOI 10.1016/j.ecss.2007.02.011; PEARSE JS, 1987, MAR ECOL PROG SER, V39, P275, DOI 10.3354/meps039275; PEDROTTI ML, 1992, MAR ECOL PROG SER, V86, P217, DOI 10.3354/meps086217; Phillips NE, 2006, MAR ECOL PROG SER, V314, P149, DOI 10.3354/meps314149; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Privitera D, 2008, J SEA RES, V60, P184, DOI 10.1016/j.seares.2008.07.001; Privitera D, 2011, J EXP MAR BIOL ECOL, V407, P6, DOI 10.1016/j.jembe.2011.06.030; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramsey F., 2001, STAT SLEUTH COURSE M; ROS J, 1984, ELS SISTEMES NATURAL; Sala E, 1998, MAR ECOL PROG SER, V168, P135, DOI 10.3354/meps168135; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1996, MAR ECOL PROG SER, V140, P71, DOI 10.3354/meps140071; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sala E., 1996, THESIS U AIX MARSEIL; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sansoni G., 2003, BIOL AMBIENT, V17, P17, DOI DOI 10.1021/AC060250J; Scheibling RE, 1997, MAR ECOL PROG SER, V152, P155, DOI 10.3354/meps152155; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V365, P59, DOI 10.1016/j.jembe.2008.07.041; Shears NT, 2010, ECOL LETT, V13, P1149, DOI 10.1111/j.1461-0248.2010.01512.x; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; TEGNER MJ, 1981, MAR ECOL PROG SER, V5, P255, DOI 10.3354/meps005255; TEGNER MJ, 1983, J EXP MAR BIOL ECOL, V73, P125, DOI 10.1016/0022-0981(83)90079-5; TEGNER MJ, 1977, SCIENCE, V196, P324, DOI 10.1126/science.847476; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Tomas F, 2004, MAR ECOL PROG SER, V282, P173, DOI 10.3354/meps282173; TURON X, 1995, MAR ECOL PROG SER, V122, P193, DOI 10.3354/meps122193; VERLAQUE M, 1983, Vie et Milieu, V33, P191; Verlaque MV, 1987, C INT PAR LIV OURS C, P5; Walker JW, 2007, MAR ECOL PROG SER, V331, P109, DOI 10.3354/meps331109; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125; Wing SR, 2003, ESTUAR COAST SHELF S, V57, P859, DOI 10.1016/S0272-7714(02)00416-X; Witman JD, 1998, ECOLOGY, V79, P2429, DOI 10.1890/0012-9658(1998)079[2429:LBRSAP]2.0.CO;2	95	49	51	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36901	10.1371/journal.pone.0036901	http://dx.doi.org/10.1371/journal.pone.0036901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606306	Green Published, gold			2022-12-27	WOS:000305338200055
J	van Elk, M; Bousardt, R; Bekkering, H; van Schie, HT				van Elk, Michiel; Bousardt, Roel; Bekkering, Harold; van Schie, Hein T.			Using Goal- and Grip-Related Information for Understanding the Correctness of Other's Actions: An ERP Study	PLOS ONE			English	Article							CORTICAL BETA OSCILLATIONS; REAL-WORLD EVENTS; SEMANTIC INTEGRATION; VISUAL-ATTENTION; OBJECT USE; BRAIN; MECHANISMS; KNOWLEDGE; ERROR; COMPREHENSION	Detecting errors in other's actions is of pivotal importance for joint action, competitive behavior and observational learning. Although many studies have focused on the neural mechanisms involved in detecting low-level errors, relatively little is known about error-detection in everyday situations. The present study aimed to identify the functional and neural mechanisms whereby we understand the correctness of other's actions involving well-known objects (e. g. pouring coffee in a cup). Participants observed action sequences in which the correctness of the object grasped and the grip applied to a pair of objects were independently manipulated. Observation of object violations (e.g. grasping the empty cup instead of the coffee pot) resulted in a stronger P3-effect than observation of grip errors (e.g. grasping the coffee pot at the upper part instead of the handle), likely reflecting a reorienting response, directing attention to the relevant location. Following the P3-effect, a parietal slow wave positivity was observed that persisted for grip-errors, likely reflecting the detection of an incorrect hand-object interaction. These findings provide new insight in the functional significance of the neurophysiological markers associated with the observation of incorrect actions and suggest that the P3-effect and the subsequent parietal slow wave positivity may reflect the detection of errors at different levels in the action hierarchy. Thereby this study elucidates the cognitive processes that support the detection of action violations in the selection of objects and grips.	[van Elk, Michiel; Bousardt, Roel; Bekkering, Harold] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Elk, Michiel] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, Lausanne, Switzerland; [van Schie, Hein T.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Radboud University Nijmegen	van Elk, M (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	michiel.vanelk@epfl.ch	van Schie, Hein T/D-2281-2010; Bekkering, Harold/A-6357-2009		Netherlands Organization for Scientific Research [453-05-001]; Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF) [252713]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF)	This work was supported by the Netherlands Organization for Scientific Research (grant 453-05-001 awarded to HB) and by the Marie Curie Intra European Fellowship within the Seventh European Community Framework Program (IEF grant 252713 to MVE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach P, 2005, J EXP PSYCHOL HUMAN, V31, P465, DOI 10.1037/0096-1523.31.3.465; Cooper R, 2002, NEUROCASE, V8, P61, DOI 10.1093/neucas/8.1.61; Costello A.M., 2005, PRACT ASSESS RES EVA, V10, P7, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868]; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; de Bruijn ERA, 2007, COGN AFFECT BEHAV NE, V7, P278, DOI 10.3758/CABN.7.4.278; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; Majdandzic J, 2007, NEUROIMAGE, V37, P589, DOI 10.1016/j.neuroimage.2007.04.071; Manthey S, 2003, COGNITIVE BRAIN RES, V15, P296, DOI 10.1016/S0926-6410(02)00201-X; Newman-Norlund R, 2010, BRAIN RES, V1315, P63, DOI 10.1016/j.brainres.2009.11.065; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; SCHNEIDER WX, 1993, PSYCHOL RES-PSYCH FO, V56, P35, DOI 10.1007/BF00572131; Sitnikova T, 2003, PSYCHOPHYSIOLOGY, V40, P160, DOI 10.1111/1469-8986.00016; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; Soto D, 2004, VISION RES, V44, P69, DOI 10.1016/j.visres.2003.08.013; Stapel J.C., 2010, SOC NEUROSCI, P1; van Elk M, 2008, EXP BRAIN RES, V189, P99, DOI 10.1007/s00221-008-1408-7; van Elk M, 2010, J NEUROPHYSIOL, V104, P972, DOI 10.1152/jn.01079.2009; van Elk M, 2012, EXP BRAIN RES; van Elk M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.008.2010; van Elk M, 2009, J EXP PSYCHOL HUMAN, V35, P1118, DOI 10.1037/a0015024; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; van Veen V, 2006, CLIN EEG NEUROSCI, V37, P330, DOI 10.1177/155005940603700411	28	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36450	10.1371/journal.pone.0036450	http://dx.doi.org/10.1371/journal.pone.0036450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TW	22606261	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200029
J	Albuquerque, AS; Marques, JG; Silva, SL; Ligeiro, D; Devlin, BH; Dutrieux, J; Cheynier, R; Pignata, C; Victorino, RMM; Markert, ML; Sousa, AE				Albuquerque, Adriana S.; Marques, Jose G.; Silva, Susana L.; Ligeiro, Dario; Devlin, Blythe H.; Dutrieux, Jacques; Cheynier, Remi; Pignata, Claudio; Victorino, Rui M. M.; Markert, M. Louise; Sousa, Ana E.			Human FOXN1-Deficiency Is Associated with alpha beta Double-Negative and FoxP3+T-Cell Expansions That Are Distinctly Modulated upon Thymic Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; 22Q11.2 DELETION SYNDROME; GENE-EXPRESSION; OMENN SYNDROME; NUDE-MICE; FOXP3; FOXN1; MOUSE; DIFFERENTIATION; PHENOTYPE	Forkhead box N1 (FOXN1) is a transcription factor crucial for thymic epithelium development and prevention of its involution. Investigation of a patient with a rare homozygous FOXN1 mutation (R255X), leading to alopecia universalis and thymus aplasia, unexpectedly revealed non-maternal circulating T-cells, and, strikingly, large numbers of aberrant double-negative alpha beta T-cells (CD4negCD8neg, DN) and regulatory-like T-cells. These data raise the possibility that a thymic rudiment persisted, allowing T-cell development, albeit with disturbances in positive/negative selection, as suggested by DN and FoxP3+ cell expansions. Although regulatory-like T-cell numbers normalized following HLA-mismatched thymic transplantation, the alpha beta DN subset persisted 5 years post-transplantation. Involution of thymus allograft likely occurred 3 years post-transplantation based on sj/beta TREC ratio, which estimates intrathymic precursor T-cell divisions and, consequently, thymic explant output. Nevertheless, functional immune-competence was sustained, providing new insights for the design of immunological reconstitution strategies based on thymic transplantation, with potential applications in other clinical settings.	[Albuquerque, Adriana S.; Marques, Jose G.; Silva, Susana L.; Victorino, Rui M. M.; Sousa, Ana E.] Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal; [Marques, Jose G.; Silva, Susana L.; Victorino, Rui M. M.] Ctr Hosp Lisboa Norte, Hosp Santa Maria, Lisbon, Portugal; [Ligeiro, Dario] CHSul, Immunogenet Lab, Lisbon, Portugal; [Devlin, Blythe H.; Markert, M. Louise] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Dutrieux, Jacques; Cheynier, Remi] Dept Immunol Hematol, Inst Cochin, Paris, France; [Dutrieux, Jacques; Cheynier, Remi] INSERM, U567, Paris, France; [Cheynier, Remi] Univ Paris 05, Fac Med Rene Descartes, UMR S 8104, Paris, France; [Pignata, Claudio] Univ Naples Federico II, Dept Pediat, Pediat Immunol Unit, Naples, Italy; [Markert, M. Louise] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Dutrieux, Jacques; Cheynier, Remi] CNRS, UMR 8104, Paris, France	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; Duke University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Naples Federico II; Duke University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Albuquerque, AS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal.	asousa@fm.ul.pt	Sousa, Ana E./L-2642-2014; Silva, Susana/L-1833-2014; Cheynier, Remi/E-9921-2010; Pignata, Claudio/O-2466-2013; Victorino, Rui/N-7948-2013	Sousa, Ana E./0000-0002-4618-9799; Cheynier, Remi/0000-0003-1146-660X; Pignata, Claudio/0000-0003-1568-9843; Ligeiro, Dario/0000-0001-5306-3679; Albuquerque, Adriana/0000-0002-4455-4916; Victorino, Rui/0000-0001-7567-1704; Albuquerque, Adriana/0000-0003-3391-0396; Dutrieux, Jacques/0000-0003-4416-6136	"Fundacao para a Ciencia e a Tecnologia'' (FCT); "Programa Operacional Ciencia e Inovacao'' (POCI); Portuguese National Health Services	"Fundacao para a Ciencia e a Tecnologia'' (FCT)(Portuguese Foundation for Science and Technology); "Programa Operacional Ciencia e Inovacao'' (POCI)(Portuguese Foundation for Science and Technology); Portuguese National Health Services	This work was supported by grants from "Fundacao para a Ciencia e a Tecnologia'' (FCT) and by "Programa Operacional Ciencia e Inovacao 2010'' (POCI2010) to RMMV and AES. ASA received a scholarship from FCT. Thymus transplantation performed at the Duke University Medical Center, Durham, USA was financially supported by the Portuguese National Health Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Azevedo RI, 2009, BLOOD, V113, P2999, DOI 10.1182/blood-2008-07-166223; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blais ME, 2008, J IMMUNOL, V180, P2299, DOI 10.4049/jimmunol.180.4.2299; Bristeau-Leprince A, 2008, J IMMUNOL, V181, P440, DOI 10.4049/jimmunol.181.1.440; Cassani B, 2010, J ALLERGY CLIN IMMUN, V125, P209, DOI 10.1016/j.jaci.2009.10.023; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Dulude G, 2008, J IMMUNOL, V181, P7818, DOI 10.4049/jimmunol.181.11.7818; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Foxall RB, 2008, CLIN IMMUNOL, V127, P158, DOI 10.1016/j.clim.2008.01.008; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Garderet L, 1998, BLOOD, V91, P340, DOI 10.1182/blood.V91.1.340.340_340_346; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; IKEHARA S, 1984, P NATL ACAD SCI-BIOL, V81, P886, DOI 10.1073/pnas.81.3.886; Kanaya Y, 2006, CLIN EXP IMMUNOL, V144, P85, DOI 10.1111/j.1365-2249.2006.03038.x; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Lambolez F, 2006, NAT IMMUNOL, V7, P76, DOI 10.1038/ni1293; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Markert ML, 2008, AM J TRANSPLANT, V8, P1729, DOI 10.1111/j.1600-6143.2008.02301.x; Markert ML, 2007, BLOOD, V109, P4539, DOI 10.1182/blood-2006-10-048652; Markert ML, 2011, BLOOD, V117, P688, DOI 10.1182/blood-2010-06-292490; Markert ML, 2004, BLOOD, V104, P2574, DOI 10.1182/blood-2003-08-2984; McLean-Tooke A, 2008, J ALLERGY CLIN IMMUN, V122, P362, DOI 10.1016/j.jaci.2008.03.033; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morrhaye G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005668; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Nunes-Cabaco H, 2011, EUR J IMMUNOL, V41, P3604, DOI 10.1002/eji.201141614; Nunes-Cabaco H, 2010, IMMUNOL CELL BIOL, V88, P523, DOI 10.1038/icb.2010.4; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; Poliani PL, 2009, BLOOD, V114, P105, DOI 10.1182/blood-2009-03-211029; PUISIEUX I, 1994, J IMMUNOL, V153, P2807; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Schlake T, 2001, EXP DERMATOL, V10, P293, DOI 10.1034/j.1600-0625.2001.100501.x; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Somech R, 2009, J ALLERGY CLIN IMMUN, V124, P793, DOI 10.1016/j.jaci.2009.06.048; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zook EC, 2011, BLOOD, V118, P5723, DOI 10.1182/blood-2011-03-342097	45	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37042	10.1371/journal.pone.0037042	http://dx.doi.org/10.1371/journal.pone.0037042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590644	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400053
J	Chatterjee, C; Sparks, DL				Chatterjee, Cynthia; Sparks, Daniel L.			Extracellular Nucleotides Inhibit Insulin Receptor Signaling, Stimulate Autophagy and Control Lipoprotein Secretion	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HDL ENDOCYTOSIS; ATP SYNTHASE; HEPG2 CELLS; BETA-CHAIN; P2Y(13); ADP; BINDING; DYSLIPIDEMIA; DEGRADATION	Hyperglycemia is associated with abnormal plasma lipoprotein metabolism and with an elevation in circulating nucleotide levels. We evaluated how extracellular nucleotides may act to perturb hepatic lipoprotein secretion. Adenosine diphosphate (ADP) (>10 mu M) acts like a proteasomal inhibitor to stimulate apoB100 secretion and inhibit apoA-I secretion from human liver cells at 4 h and 24 h. ADP blocks apoA-I secretion by stimulating autophagy. The nucleotide increases cellular levels of the autophagosome marker, LC3-II, and increases co-localization of LC3 with apoA-I in punctate autophagosomes. ADP affects autophagy and apoA-I secretion through P2Y(13). Overexpression of P2Y(13) increases cellular LC3-II levels by -50% and blocks induction of apoA-I secretion. Conversely, a siRNA-induced reduction in P2Y(13) protein expression of 50% causes a similar reduction in cellular LC3-II levels and a 3-fold stimulation in apoA-I secretion. P2Y(13) gene silencing blocks the effects of ADP on autophagy and apoA-I secretion. A reduction in P2Y(13) expression suppresses ERK1/2 phosphorylation, increases the phosphorylation of IR-beta and protein kinase B (Akt) >3-fold, and blocks the inhibition of Akt phosphorylation by TNF alpha and ADP. Conversely, increasing P2Y(13) expression significantly inhibits insulin-induced phosphorylation of insulin receptor (IR-beta) and Akt, similar to that observed after treatment with ADP. Nucleotides therefore act through P2Y(13), ERK1/2 and insulin receptor signaling to stimulate autophagy and affect hepatic lipoprotein secretion.	[Chatterjee, Cynthia; Sparks, Daniel L.] Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	Chatterjee, C (corresponding author), Univ Ottawa, Inst Heart, Atherosclerosis Genet & Cell Biol Grp, Ottawa, ON, Canada.	dsparks@ottawaheart.ca			Heart and Stroke Foundation of Ontario; Government of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Government of Ontario	This work was supported by a grant from the Heart and Stroke Foundation of Ontario (DLS). CC is the recipient of a Government of Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeli K, 1997, J BIOL CHEM, V272, P22489, DOI 10.1074/jbc.272.36.22489; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Amisten S, 2010, DIABETOLOGIA, V53, P1927, DOI 10.1007/s00125-010-1807-8; Behan MW, 2010, CURR OPIN CARDIOL, V25, P321, DOI 10.1097/HCO.0b013e328338f7b5; Berthou L, 1996, J CLIN INVEST, V97, P2408, DOI 10.1172/JCI118687; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; BROWN PR, 1973, CLIN CHEM, V19, P919; Cattaneo M, 2010, CIRCULATION, V121, P171, DOI 10.1161/CIRCULATIONAHA.109.853069; Chatterjee C, 2009, BIOCHEMISTRY-US, V48, P5994, DOI 10.1021/bi802009e; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Denis M, 2008, J BIOL CHEM, V283, P16178, DOI 10.1074/jbc.M709597200; Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524; Di Virgilio F, 2009, CURR OPIN PHARMACOL, V9, P507, DOI 10.1016/j.coph.2009.06.021; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Dixon CJ, 2003, BRIT J PHARMACOL, V138, P272, DOI 10.1038/sj.bjp.0705016; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Fabre ACS, 2006, CELL MOL LIFE SCI, V63, P2829, DOI 10.1007/s00018-006-6325-y; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HARKNESS RA, 1984, CLIN CHIM ACTA, V143, P91, DOI 10.1016/0009-8981(84)90216-X; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Hopewell S, 2008, METABOLISM, V57, P1677, DOI 10.1016/j.metabol.2008.07.023; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Li XY, 2010, BIOCHEM PHARMACOL, V80, P1450, DOI 10.1016/j.bcp.2010.07.023; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; Malaval C, 2009, CELL SIGNAL, V21, P120, DOI 10.1016/j.cellsig.2008.09.016; Marteau F, 2003, MOL PHARMACOL, V64, P104, DOI 10.1124/mol.64.1.104; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nemchenko A, 2011, J MOL CELL CARDIOL, V51, P584, DOI 10.1016/j.yjmcc.2011.06.010; Nilsson J, 2006, ARTERIOSCL THROM VAS, V26, P794, DOI 10.1161/01.ATV.0000209513.00765.13; Pandey NR, 2009, NEUROSCIENCE, V164, P1744, DOI 10.1016/j.neuroscience.2009.09.062; Pandey NR, 2008, BIOCHEMISTRY-US, V47, P1579, DOI 10.1021/bi702148f; Pandey NR, 2009, AM J PATHOL, V175, P1777, DOI 10.2353/ajpath.2009.090082; RANGANATHAN S, 1990, BIOCHIM BIOPHYS ACTA, V1046, P223, DOI 10.1016/0005-2760(90)90193-2; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rutledge AC, 2009, ARTERIOSCL THROM VAS, V29, P579, DOI 10.1161/ATVBAHA.108.181859; Schofl C, 1999, AM J PHYSIOL-GASTR L, V276, pG164, DOI 10.1152/ajpgi.1999.276.1.G164; Sellers MB, 2009, CURR OPIN CARDIOL, V24, P307, DOI 10.1097/HCO.0b013e32832e2b44; Solini A, 2005, KIDNEY INT, V67, P875, DOI 10.1111/j.1523-1755.2005.00152.x; Tan CY, 2010, CELL MOL LIFE SCI, V67, P445, DOI 10.1007/s00018-009-0191-3; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang LH, 2008, J LIPID RES, V49, P1195, DOI 10.1194/jlr.M700426-JLR200; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	53	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36916	10.1371/journal.pone.0036916	http://dx.doi.org/10.1371/journal.pone.0036916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590634	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400044
J	DeGraff, DJ; Clark, PE; Cates, JM; Yamashita, H; Robinson, VL; Yu, XP; Smolkin, ME; Chang, SS; Cookson, MS; Herrick, MK; Shariat, SF; Steinberg, GD; Frierson, HF; Wu, XR; Theodorescu, D; Matusik, RJ				DeGraff, David J.; Clark, Peter E.; Cates, Justin M.; Yamashita, Hironobu; Robinson, Victoria L.; Yu, Xiuping; Smolkin, Mark E.; Chang, Sam S.; Cookson, Michael S.; Herrick, Mary K.; Shariat, Shahrokh F.; Steinberg, Gary D.; Frierson, Henry F.; Wu, Xue-Ru; Theodorescu, Dan; Matusik, Robert J.			Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; TO-MESENCHYMAL TRANSITION; EMBRYONIC STEM-CELLS; FORKHEAD BOX A1; URINARY-BLADDER; SQUAMOUS METAPLASIA; RECEPTOR FUNCTION; PPAR-GAMMA; VITAMIN-A; EXPRESSION	Approximately 50% of patients with muscle-invasive bladder cancer (MIBC) develop metastatic disease, which is almost invariably lethal. However, our understanding of pathways that drive aggressive behavior of MIBC is incomplete. Members of the FOXA subfamily of transcription factors are implicated in normal urogenital development and urologic malignancies. FOXA proteins are implicated in normal urothelial differentiation, but their role in bladder cancer is unknown. We examined FOXA expression in commonly used in vitro models of bladder cancer and in human bladder cancer specimens, and used a novel in vivo tissue recombination system to determine the functional significance of FOXA1 expression in bladder cancer. Logistic regression analysis showed decreased FOXA1 expression is associated with increasing tumor stage (p<0.001), and loss of FOXA1 is associated with high histologic grade (p<0.001). Also, we found that bladder urothelium that has undergone keratinizing squamous metaplasia, a precursor to the development of squamous cell carcinoma (SCC) exhibited loss of FOXA1 expression. Furthermore, 81% of cases of SCC of the bladder were negative for FOXA1 staining compared to only 40% of urothelial cell carcinomas. In addition, we showed that a subpopulation of FOXA1 negative urothelial tumor cells are highly proliferative. Knockdown of FOXA1 in RT4 bladder cancer cells resulted in increased expression of UPK1B, UPK2, UPK3A, and UPK3B, decreased E-cadherin expression and significantly increased cell proliferation, while overexpression of FOXA1 in T24 cells increased E-cadherin expression and significantly decreased cell growth and invasion. In vivo recombination of bladder cancer cells engineered to exhibit reduced FOXA1 expression with embryonic rat bladder mesenchyme and subsequent renal capsule engraftment resulted in enhanced tumor proliferation. These findings provide the first evidence linking loss of FOXA1 expression with histological subtypes of MIBC and urothelial cell proliferation, and suggest an important role for FOXA1 in the malignant phenotype of MIBC.	[DeGraff, David J.; Clark, Peter E.; Yamashita, Hironobu; Yu, Xiuping; Chang, Sam S.; Cookson, Michael S.; Herrick, Mary K.; Matusik, Robert J.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN 37203 USA; [Cates, Justin M.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Robinson, Victoria L.; Steinberg, Gary D.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Smolkin, Mark E.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Shariat, Shahrokh F.] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [Frierson, Henry F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Wu, Xue-Ru] NYU, Deparment Urol, New York, NY USA; [Wu, Xue-Ru] NYU, Deparment Pathol, New York, NY USA; [Theodorescu, Dan] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA; [Matusik, Robert J.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Matusik, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of Chicago; University of Virginia; Cornell University; University of Virginia; New York University; New York University; University of Colorado System; University of Colorado Anschutz Medical Campus; Vanderbilt University; Vanderbilt University	DeGraff, DJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN 37203 USA.	david.degraff@vanderbilt.edu	Clark, Peter/E-1423-2011; Cates, Justin M/D-5927-2014	Clark, Peter/0000-0002-8006-7015; Cates, Justin M/0000-0002-7336-5196; Yu, Xiuping/0000-0003-2844-7026; Matusik, Robert/0000-0003-2057-9892; Yamashita, Hironobu/0000-0003-2587-7100; Herrick, Mary/0000-0002-7284-9762; Steinberg, Gary/0000-0003-4469-0624; Wu, Xue-Ru/0000-0001-6058-6291	American Cancer Society; United States National Institutes of Health (NIH) [K08-CA113452]; NIH [CA143971, R01-DK55748]; Vanderbilt CTSA from NCRR/NIH [UL1RR024975-01]; Bladder Cancer Research Network (BCRN); Bladder Cancer Advocacy Network (BCAN); Diane Zipursky Quale; Veterans Administration; NATIONAL CANCER INSTITUTE [U54CA163072, K08CA113452, T32CA119925, R01CA143971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055748, T32DK007563] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt CTSA from NCRR/NIH; Bladder Cancer Research Network (BCRN); Bladder Cancer Advocacy Network (BCAN); Diane Zipursky Quale; Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DJD was supported by the American Cancer Society Great Lakes Division-Michigan Cancer Research Fund Postdoctoral Fellowship. PEC was supported by United States National Institutes of Health (NIH) grant K08-CA113452. This study was also supported in part by NIH grant CA143971 to DT, a Merit Review Award from the Veterans Administration to XW, and NIH grant R01-DK55748 to RJM. This research was also supported in part by Vanderbilt CTSA grant UL1RR024975-01 from NCRR/NIH. The authors wish to acknowledge the technical expertise and advice of Doug Strand and Simon Hayward during the design of tissue recombination experiments, and the support of Michael Kidd, Tom Case and Manik Paul, as well as the Bladder Cancer Research Network (BCRN), the Bladder Cancer Advocacy Network (BCAN), and Diane Zipursky Quale for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ahmad I, 2008, UROL INT, V81, P247, DOI 10.1159/000151398; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Besnard V, 2004, GENE EXPR PATTERNS, V5, P193, DOI 10.1016/j.modgep.2004.08.006; Black PC, 2008, CLIN CANCER RES, V14, P1478, DOI 10.1158/1078-0432.CCR-07-1593; Bryan RT, 2008, J PATHOL, V215, P184, DOI 10.1002/path.2346; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; CHYTIL F, 1992, AM J PHYSIOL, V262, pL517, DOI 10.1152/ajplung.1992.262.5.L517; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; CUNHA GR, 1979, IN VITRO CELL DEV B, V15, P50; Degraff DJ, 2007, J CELL PHYSIOL, V213, P261, DOI 10.1002/jcp.21123; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Fajkovic H, 2011, WORLD J UROL, V29, P457, DOI 10.1007/s00345-011-0709-9; Fogh J, 1978, Natl Cancer Inst Monogr, P5; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Gao N, 2005, DEVELOPMENT, V132, P3431, DOI 10.1242/dev.01917; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Georgopoulos NT, 2011, EUR UROL, V60, P141, DOI 10.1016/j.eururo.2011.02.022; GIERER A, 1973, COLD SPRING HARB SYM, V38, P951, DOI 10.1101/SQB.1974.038.01.097; HICKS RM, 1977, CANCER RES, V37, P2822; HODGES GM, 1977, CANCER RES, V37, P3720; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Ishii K, 2005, LAB INVEST, V85, P1086, DOI 10.1038/labinvest.3700310; Jacob A, 1999, EXP CELL RES, V250, P1, DOI 10.1006/excr.1999.4512; KAIGHN ME, 1979, INVEST UROL, V17, P16; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kwon DN, 2006, J CELL BIOCHEM, V99, P462, DOI 10.1002/jcb.20931; Li XH, 2009, DIFFERENTIATION, V77, P95, DOI 10.1016/j.diff.2008.09.012; Liang FX, 2005, J CELL BIOL, V171, P835, DOI 10.1083/jcb.200505035; Lochter A, 1997, J BIOL CHEM, V272, P5007, DOI 10.1074/jbc.272.8.5007; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; MOLLOY CJ, 1988, EXP MOL PATHOL, V49, P128, DOI 10.1016/0014-4800(88)90027-5; Munday JS, 2009, J AM ASSOC LAB ANIM, V48, P790; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; OTOOLE C, 1978, BRIT J CANCER, V38, P64, DOI 10.1038/bjc.1978.164; OTOOLE C, 1976, INT J CANCER, V17, P707, DOI 10.1002/ijc.2910170604; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Puzio-Kuter AM, 2009, GENE DEV, V23, P675, DOI 10.1101/gad.1772909; Retz M, 2011, EUR UROL, V60, P231, DOI 10.1016/j.eururo.2010.12.014; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Shokeir AA, 2004, BJU INT, V93, P216, DOI 10.1111/j.1464-410X.2004.04588.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Tanaka ST, 2010, J UROLOGY, V183, P386, DOI 10.1016/j.juro.2009.08.107; Thomas JC, 2008, J UROLOGY, V180, P1784, DOI 10.1016/j.juro.2008.03.098; UCHIDA K, 1990, J UROLOGY, V143, P618, DOI 10.1016/S0022-5347(17)40041-3; Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; WILSON GN, 1987, J UROLOGY, V137, P324, DOI 10.1016/S0022-5347(17)44014-6; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; WU XR, 1994, J BIOL CHEM, V269, P13716; Wu XR, 2009, CANCER METAST REV, V28, P281, DOI 10.1007/s10555-009-9189-4; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560	63	65	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36669	10.1371/journal.pone.0036669	http://dx.doi.org/10.1371/journal.pone.0036669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590586	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400026
J	Ferrara, S; Brugnoli, M; De Bonis, A; Righetti, F; Delvillani, F; Deho, G; Horner, D; Briani, F; Bertoni, G				Ferrara, Silvia; Brugnoli, Margherita; De Bonis, Angela; Righetti, Francesco; Delvillani, Francesco; Deho, Gianni; Horner, David; Briani, Federica; Bertoni, Giovanni			Comparative Profiling of Pseudomonas aeruginosa Strains Reveals Differential Expression of Novel Unique and Conserved Small RNAs	PLOS ONE			English	Article							VIRULENCE FACTORS; REGULATORY RNA; ANTISENSE RNA; DUAL-FUNCTION; SOLUBLE-RNAS; GENOME; PATHOGENICITY; CRISPR; IDENTIFICATION; BACTERIA	Pseudomonas aeruginosa is a highly adaptable bacterium that thrives in a broad range of ecological niches and can infect multiple hosts as diverse as plants, nematodes and mammals. In humans, it is an important opportunistic pathogen. This wide adaptability correlates with its broad genetic diversity. In this study, we used a deep-sequencing approach to explore the complement of small RNAs (sRNAs) in P. aeruginosa as the number of such regulatory molecules previously identified in this organism is relatively low, considering its genome size, phenotypic diversity and adaptability. We have performed a comparative analysis of PAO1 and PA14 strains which share the same host range but differ in virulence, PA14 being considerably more virulent in several model organisms. Altogether, we have identified more than 150 novel candidate sRNAs and validated a third of them by Northern blotting. Interestingly, a number of these novel sRNAs are strain-specific or showed strain-specific expression, strongly suggesting that they could be involved in determining specific phenotypic traits.	[Ferrara, Silvia; Brugnoli, Margherita; De Bonis, Angela; Righetti, Francesco; Delvillani, Francesco; Deho, Gianni; Horner, David; Briani, Federica; Bertoni, Giovanni] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy	University of Milan	Ferrara, S (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	federica.briani@unimi.it; giovanni.bertoni@unimi.it	Ferrara, Silvia/AAR-4497-2020; BERTONI, GIOVANNI/J-3437-2012; BRIANI, FEDERICA/B-4596-2017; FERRARA, SILVIA/ABB-8803-2020; Horner, David/AAC-2274-2022; Briani, Federica/AAM-5213-2020	BERTONI, GIOVANNI/0000-0001-5761-9494; BRIANI, FEDERICA/0000-0002-5876-4463; FERRARA, SILVIA/0000-0002-8024-7147; Briani, Federica/0000-0002-5876-4463; Righetti, Francesco/0000-0003-4903-2321; DEHO', GIOVANNI/0000-0001-5492-7766	European Commission [223670]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by European Commission (grant NABATIVI, EU-FP7-HEALTH-2007-B contract number 223670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Briani F, 1996, VIROLOGY, V223, P57, DOI 10.1006/viro.1996.0455; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Carter MQ, 2010, J BACTERIOL, V192, P3249, DOI 10.1128/JB.00041-10; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Dotsch A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031092; Georg J, 2011, MICROBIOL MOL BIOL R, V75, P286, DOI 10.1128/MMBR.00032-10; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; GOTTESMAN S, 2010, COLD SPRING HARB PER; Gourbeyre E, 2010, RES MICROBIOL, V161, P136, DOI 10.1016/j.resmic.2009.11.005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; MA C, 1990, EMBO J, V9, P1267, DOI 10.1002/j.1460-2075.1990.tb08235.x; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SIMONS RW, 1983, CELL, V34, P683, DOI 10.1016/0092-8674(83)90401-4; Sonnleitner E, 2008, MICROBIOL-SGM, V154, P3175, DOI 10.1099/mic.0.2008/019703-0; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Vanderpool CK, 2011, BIOCHIMIE, V93, P1943, DOI 10.1016/j.biochi.2011.07.016; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Wagner Victoria E., 2008, P129; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	49	41	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36553	10.1371/journal.pone.0036553	http://dx.doi.org/10.1371/journal.pone.0036553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590564	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400023
J	Ishisaka, M; Kakefuda, K; Oyagi, A; Ono, Y; Tsuruma, K; Shimazawa, M; Kitaichi, K; Hara, H				Ishisaka, Mitsue; Kakefuda, Kenichi; Oyagi, Atsushi; Ono, Yoko; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Kitaichi, Kiyoyuki; Hara, Hideaki			Diacylglycerol Kinase beta Knockout Mice Exhibit Attention-Deficit Behavior and an Abnormal Response on Methylphenidate-Induced Hyperactivity	PLOS ONE			English	Article							DOPAMINE-RECEPTORS; MOLECULAR-CLONING; BIPOLAR DISORDER; GENE-EXPRESSION; PROTEIN-KINASE; IN-VIVO; BINDING; AMPHETAMINE; COMORBIDITY; ACTIVATION	Background: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol to produce phosphatidic acid. DGK beta is one of the subtypes of the DGK family and regulates many intracellular signaling pathways in the central nervous system. Previously, we demonstrated that DGK beta knockout (KO) mice showed various dysfunctions of higher brain function, such as cognitive impairment (with lower spine density), hyperactivity, reduced anxiety, and careless behavior. In the present study, we conducted further tests on DGK beta KO mice in order to investigate the function of DGK beta in the central nervous system, especially in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Methodology/Principal Findings: DGK beta KO mice showed attention-deficit behavior in the object-based attention test and it was ameliorated by methylphenidate (MPH, 30 mg/kg, i.p.). In the open field test, DGK beta KO mice displayed a decreased response to the locomotor stimulating effects of MPH (30 mg/kg, i.p.), but showed a similar response to an N-methyl-D-aspartate (NMDA) receptor antagonist, MK-801 (0.3 mg/kg, i.p.), when compared to WT mice. Examination of the phosphorylation of extracellular signal-regulated kinase (ERK), which is involved in regulation of locomotor activity, indicated that ERK1/2 activation induced by MPH treatment was defective in the striatum of DGK beta KO mice. Conclusions/Significance: These findings suggest that DGK beta KO mice showed attention-deficit and hyperactive phenotype, similar to ADHD. Furthermore, the hyporesponsiveness of DGK beta KO mice to MPH was due to dysregulation of ERK phosphorylation, and that DGK beta has a pivotal involvement in ERK regulation in the striatum.	[Ishisaka, Mitsue; Kakefuda, Kenichi; Oyagi, Atsushi; Ono, Yoko; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Kitaichi, Kiyoyuki] Gifu Univ Hosp, Dept Pharm, Gifu, Japan	Gifu Pharmaceutical University; Gifu University	Ishisaka, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp			Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding of this work was provided only by the Gifu Pharmaceutical University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkam T, 2011, BEHAV BRAIN RES, V220, P185, DOI 10.1016/j.bbr.2011.01.039; Krapacher FA, 2010, J NEUROCHEM, V114, P203, DOI 10.1111/j.1471-4159.2010.06748.x; Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; CARLSSON M, 1989, J NEURAL TRANSM, V75, P221, DOI 10.1007/BF01258633; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Fukui R, 2003, J NEUROCHEM, V87, P1391, DOI 10.1046/j.1471-4159.2003.02101.x; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; Goto K, 2007, INT REV CYTOL, V264, P25, DOI 10.1016/S0074-7696(07)64002-9; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Hozumi Y, 2008, EUR J NEUROSCI, V28, P2409, DOI 10.1111/j.1460-9568.2008.06547.x; Kakefuda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013447; KANOH H, 1990, TRENDS BIOCHEM SCI, V15, P47, DOI 10.1016/0968-0004(90)90172-8; Kiguchi M, 2008, J NEURAL TRANSM, V115, P1079, DOI 10.1007/s00702-008-0044-5; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nierenberg AA, 2005, BIOL PSYCHIAT, V57, P1467, DOI 10.1016/j.biopsych.2005.01.036; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; PAN DF, 1994, EUR J PHARMACOL, V264, P177, DOI 10.1016/0014-2999(94)00460-9; Park SW, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-83; Pascoli V, 2005, MOL PHARMACOL, V68, P421, DOI 10.1124/mol.105.011809; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Reich W, 2005, TWIN RES HUM GENET, V8, P459, DOI 10.1375/183242705774310105; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; Shioda N, 2010, J NEUROSCI, V30, P3146, DOI 10.1523/JNEUROSCI.4140-09.2010; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Valjent E, 2000, J NEUROSCI, V20, P8701; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; VEREBEY K, 1981, PSYCHOPHARMACOLOGY, V75, P44, DOI 10.1007/BF00433500; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Yan Z, 1999, P NATL ACAD SCI USA, V96, P11607, DOI 10.1073/pnas.96.20.11607; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zhou MM, 2010, P NATL ACAD SCI USA, V107, P4401, DOI 10.1073/pnas.0915173107	46	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37058	10.1371/journal.pone.0037058	http://dx.doi.org/10.1371/journal.pone.0037058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590645	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400054
J	Sertel, S; Tome, M; Briehl, MM; Bauer, J; Hock, K; Plinkert, PK; Efferth, T				Sertel, Serkan; Tome, Margaret; Briehl, Margaret M.; Bauer, Judith; Hock, Kai; Plinkert, Peter K.; Efferth, Thomas			Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MYELOID-LEUKEMIA CELLS; MULTIDRUG-RESISTANCE; OXIDATIVE STRESS; INDUCED APOPTOSIS; P-GLYCOPROTEIN; MULTIPLE-MYELOMA; MELANOMA-CELLS; IN-VITRO; CANCER	Previously, arsenic trioxide showed impressive regression rates of acute promyelocytic leukemia. Here, we investigated molecular determinants of sensitivity and resistance of cell lines of different tumor types towards arsenic trioxide. Arsenic trioxide was the most cytotoxic compound among 8 arsenicals investigated in the NCI cell line panel. We correlated transcriptome-wide microarray-based mRNA expression to the IC50 values for arsenic trioxide by bioinformatic approaches (COMPARE and hierarchical cluster analyses, Ingenuity signaling pathway analysis). Among the identified pathways were signaling routes for p53, integrin-linked kinase, and actin cytoskeleton. Genes from these pathways significantly predicted cellular response to arsenic trioxide. Then, we analyzed whether classical drug resistance factors may also play a role for arsenic trioxide. Cell lines transfected with cDNAs for catalase, thioredoxin, or the anti-apoptotic bcl-2 gene were more resistant to arsenic trioxide than mock vector transfected cells. Multidrug-resistant cells overexpressing the MDR1, MRP1 or BCRP genes were not cross-resistant to arsenic trioxide. Our approach revealed that response of tumor cells towards arsenic trioxide is multi-factorial.	[Sertel, Serkan; Plinkert, Peter K.] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Tome, Margaret; Briehl, Margaret M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Sertel, Serkan; Bauer, Judith; Hock, Kai; Efferth, Thomas] German Canc Res Ctr, D-6900 Heidelberg, Germany; [Sertel, Serkan; Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharmaceut Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; University of Arizona; Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz	Sertel, S (corresponding author), Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany.	efferth@uni-mainz.de		Efferth, Thomas/0000-0002-3096-3292				Ahn WS, 2004, ONCOL REP, V12, P573; Allen T, 2004, BIOL TRACE ELEM RES, V100, P39, DOI 10.1385/BTER:100:1:039; ALLEY MC, 1988, CANCER RES, V48, P589; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Anderson KC, 2002, CANCER J, V8, P12, DOI 10.1097/00130404-200201000-00003; Au WY, 2002, HAEMATOLOGICA, V87, P1109; Baker A, 1997, CANCER RES, V57, P5162; Biswas S, 2010, LEUKEMIA RES, V34, P925, DOI 10.1016/j.leukres.2010.01.020; Bourdonnay E, 2009, MOL IMMUNOL, V46, P649, DOI 10.1016/j.molimm.2008.08.268; Bowling BD, 2008, CANCER CHEMOTH PHARM, V63, P37, DOI 10.1007/s00280-008-0705-y; Brown E, 2008, METAL IONS BIOL MED, V10, P583; Brugger D, 1999, LEUKEMIA RES, V23, P467, DOI 10.1016/S0145-2126(98)00192-1; Burnichon V, 2003, TOXICOL LETT, V143, P155, DOI 10.1016/S0378-4274(03)00171-1; Chan JYW, 2006, CANCER LETT, V236, P250, DOI 10.1016/j.canlet.2005.05.017; Chan PC, 1997, J ENVIRON SCI HEAL C, V15, P83; Chen GQ, 1996, BLOOD, V88, P1052; Chen X, 2009, ONCOL REP, V22, P73, DOI 10.3892/or_00000408; Coe E, 2008, LEUKEMIA LYMPHOMA, V49, P1976, DOI 10.1080/10428190802353617; Diaz Z, 2008, LEUKEMIA, V22, P1853, DOI 10.1038/leu.2008.194; Diaz Z, 2009, LEUKEMIA, V23, P431, DOI 10.1038/leu.2008.328; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Efferth T, 1997, LEUKEMIA, V11, P1180, DOI 10.1038/sj.leu.2400669; Efferth T, 2003, INT J ONCOL, V23, P1231; Efferth T, 2003, BIOCHEM PHARMACOL, V66, P613, DOI 10.1016/S0006-2952(03)00341-1; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2002, BIOCHEM PHARMACOL, V64, P617, DOI 10.1016/S0006-2952(02)01221-2; Efferth T, 2002, BLOOD CELL MOL DIS, V28, P160, DOI 10.1006/bcmd.2002.0492; Efferth Thomas, 2004, Cancer Genomics & Proteomics, V1, P363; Efferth Thomas, 2001, Current Molecular Medicine (Hilversum), V1, P45, DOI 10.2174/1566524013364194; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Gillet JP, 2004, CANCER RES, V64, P8987, DOI 10.1158/0008-5472.CAN-04-1978; Giommarelli C, 2009, FREE RADICAL BIO MED, V46, P1516, DOI 10.1016/j.freeradbiomed.2009.03.006; Haller J S, 1975, Pharm Hist, V17, P87; Han Bo, 2004, J Exp Ther Oncol, V4, P335; Han YH, 2008, MOL CELLS, V26, P18; Han YH, 2008, J CELL BIOCHEM, V104, P862, DOI 10.1002/jcb.21673; Hayashi T, 2002, MOL CANCER THER, V1, P851; Huang XJ, 1999, MED ONCOL, V16, P58, DOI 10.1007/BF02787360; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; KIMMIG A, 1990, CANCER RES, V50, P6793; Klassen CD, 1996, GOODMAN GILMANS PHAR, P1649; KNOWLES FC, 1983, TRENDS BIOCHEM SCI, V8, P178, DOI 10.1016/0968-0004(83)90168-8; LAM M, 1994, P NATL ACAD SCI USA, V91, P6569, DOI 10.1073/pnas.91.14.6569; Laparra JM, 2008, TOXICOL IN VITRO, V22, P444, DOI 10.1016/j.tiv.2007.11.004; Lee CC, 2006, LEUKEMIA LYMPHOMA, V47, P521, DOI 10.1080/10428190500305851; Lehmann S, 2001, EUR J HAEMATOL, V66, P357, DOI 10.1034/j.1600-0609.2001.066006357.x; LETEURTRE F, 1994, J NATL CANCER I, V86, P1239, DOI 10.1093/jnci/86.16.1239; Li JJ, 2006, ACTA PHARMACOL SIN, V27, P1078, DOI 10.1111/j.1745-7254.2006.00345.x; Liang Hong, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P647; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu QA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-37; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Miller WH, 2002, CANCER RES, V62, P3893; Nakagawa Y, 2002, LIFE SCI, V70, P2253, DOI 10.1016/S0024-3205(01)01545-4; Perkins C, 2000, BLOOD, V95, P1014, DOI 10.1182/blood.V95.3.1014.003k04_1014_1022; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Salerno M, 2002, J BIOENERG BIOMEMBR, V34, P135, DOI 10.1023/A:1015180026665; Sawyers CL, 2001, SCIENCE, V294, P1834; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Seo T, 2005, ANTICANCER RES, V25, P991; Seo T, 2007, INT J HEMATOL, V85, P26, DOI 10.1532/IJH97.05142; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Takeshita A, 2003, LEUKEMIA, V17, P648, DOI 10.1038/sj.leu.2402851; Tome ME, 2001, CELL DEATH DIFFER, V8, P953, DOI 10.1038/sj.cdd.4400904; Tome ME, 2001, CANCER RES, V61, P2766; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Vernhet L, 2001, BIOCHEM PHARMACOL, V61, P1387, DOI 10.1016/S0006-2952(01)00606-2; Wang DH, 2005, PHARMACOL RES, V52, P376, DOI 10.1016/j.phrs.2005.05.010; Wang HY, 2003, ACTA PHARMACOL SIN, V24, P646; Wang Tao, 2007, Zhonghua Xue Ye Xue Za Zhi, V28, P438; Wang Xiuli, 2002, Zhonghua Zhongliu Zazhi, V24, P339; Wei HL, 2003, CHINESE MED J-PEKING, V116, P1644; Woo SH, 2002, INT J ONCOL, V21, P57; Wosikowski K, 1997, JNCI-J NATL CANCER I, V89, P1505, DOI 10.1093/jnci/89.20.1505; Xue DB, 2007, CHINESE MED J-PEKING, V120, P690, DOI 10.1097/00029330-200704020-00015; Xue Ying-wei, 2007, Yaoxue Xuebao, V42, P949; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; Yeh JY, 2002, CELL MOL LIFE SCI, V59, P1972, DOI 10.1007/PL00012519; Zhao SG, 2008, MOL BIOL REP, V35, P421, DOI 10.1007/s11033-007-9102-6; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	83	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35584	10.1371/journal.pone.0035584	http://dx.doi.org/10.1371/journal.pone.0035584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590507	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400003
J	Briney, BS; Willis, JR; Crowe, JE				Briney, Bryan S.; Willis, Jordan R.; Crowe, James E., Jr.			Human Peripheral Blood Antibodies with Long HCDR3s Are Established Primarily at Original Recombination Using a Limited Subset of Germline Genes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODY; B-CELL DEVELOPMENT; H READING FRAME; NEUTRALIZING ANTIBODIES; HEAVY-CHAIN; COMBINATORIAL LIBRARIES; BROAD NEUTRALIZATION; CRYSTAL-STRUCTURE; VACCINE DESIGN	A number of antibodies that efficiently neutralize microbial targets contain long heavy chain complementarity determining region 3 (HCDR3) loops. For HIV, several of the most broad and potently neutralizing antibodies have exceptionally long HCDR3s. Two broad potently neutralizing HIV-specific antibodies, PG9 and PG16, exhibit secondary structure. Two other long HCDR3 antibodies, 2F5 and 4E10, protect against mucosal challenge with SHIV. Induction of such long HCDR3 antibodies may be critical to the design of an effective vaccine strategy for HIV and other pathogens, however it is unclear at present how to induce such antibodies. Here, we present genetic evidence that human peripheral blood antibodies containing long HCDR3s are not primarily generated by insertions introduced during the somatic hypermutation process. Instead, they are typically formed by processes occurring as part of the original recombination event. Thus, the response of B cells encoding antibodies with long HCDR3s results from selection of unusual clones from the naive repertoire rather than through accumulation of insertions. These antibodies typically use a small subset of D and J gene segments that are particularly suited to encoding long HCDR3s, resulting in the incorporation of highly conserved genetic elements in the majority of antibody sequences encoding long HCDR3s.	[Briney, Bryan S.; Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37203 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Willis, Jordan R.] Vanderbilt Univ, Chem & Phys Biol Program, Med Ctr, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Briney, BS (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37203 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	National Institutes of Health [U01 AI 78407]; NIAID [HHSN272200900047C]; Vanderbilt CTSA from NCRR/NIH [UL1 RR024975-01]; NIH [T32 HL069765, T32 AI060571]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024975, KL2RR024977] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060571, U01AI078407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vanderbilt CTSA from NCRR/NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health U01 AI 78407 and NIAID Contract HHSN272200900047C, and supported in part by the Vanderbilt CTSA grant UL1 RR024975-01 from NCRR/NIH. BSB was supported by NIH T32 HL069765, and JRW by NIH T32 AI060571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Burton DR, 2010, P NATL ACAD SCI USA, V107, P17859, DOI 10.1073/pnas.1012923107; Burton DR, 2005, P NATL ACAD SCI USA, V102, P14943, DOI 10.1073/pnas.0505126102; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; CROUZIER R, 1995, J IMMUNOL, V154, P4526; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; Ivanov I, 2002, ANTIBODIES; Ivanov II, 2005, J IMMUNOL, V174, P7773, DOI 10.4049/jimmunol.174.12.7773; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Reason DC, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-24; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schelonka RL, 2007, EUR J IMMUNOL, V37, P1010, DOI 10.1002/eji.200636569; Schelonka RL, 2008, J IMMUNOL, V181, P8409, DOI 10.4049/jimmunol.181.12.8409; Schroeder HW, 2010, CRIT REV IMMUNOL, V30, P327; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; Spurrier B, 2011, STRUCTURE, V19, P691, DOI 10.1016/j.str.2011.02.012; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Vale AM, 2010, J IMMUNOL, V185, P6085, DOI 10.4049/jimmunol.1001423; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zemlin M, 2008, J IMMUNOL, V181, P8416, DOI 10.4049/jimmunol.181.12.8416; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004	52	92	105	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36750	10.1371/journal.pone.0036750	http://dx.doi.org/10.1371/journal.pone.0036750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590602	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336100059
J	Jacobelli, S; Sanaa, F; Moyal-Barracco, M; Pelisse, M; Berville, S; Villefroy, P; North, MO; Figueiredo, S; Charmeteau, B; Clerici, T; Plantier, F; Arnold, F; Touze, A; Dupin, N; Avril, MF; Guillet, JG; Cheynier, R; Bourgault-Villada, I				Jacobelli, Simon; Sanaa, Fedoua; Moyal-Barracco, Micheline; Pelisse, Monique; Berville, Sophie; Villefroy, Pascale; North, Marie Odile; Figueiredo, Suzanne; Charmeteau, Benedicte; Clerici, Thierry; Plantier, Francoise; Arnold, Francoise; Touze, Antoine; Dupin, Nicolas; Avril, Marie-Francoise; Guillet, Jean-Gerard; Cheynier, Remi; Bourgault-Villada, Isabelle			Anti-HPV16 E2 Protein T-Cell Responses and Viral Control in Women with Usual Vulvar Intraepithelial Neoplasia and Their Healthy Partners	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MALE SEXUAL PARTNERS; CERVICAL-CANCER; FUNCTIONAL SIGNATURES; CD4+T-CELL IMMUNITY; HPV16 E2; LESIONS; INFECTION; E7; E6	T-cell responses ( proliferation, intracellular cytokine synthesis and IFN gamma ELISPOT) against human papillomavirus 16 (HPV16) E2 peptides were tested during 18 months in a longitudinal study in eight women presenting with HPV16-related usual vulvar intraepithelial neoplasia (VIN) and their healthy male partners. In six women, anti-E2 proliferative responses and cytokine production ( single IFN gamma and/or dual IFN gamma/IL2 and/or single IL2) by CD4+ T lymphocytes became detectable after treating and healing of the usual VIN. In the women presenting with persistent lesions despite therapy, no proliferation was observed. Anti-E2 proliferative responses were also observed with dual IFN gamma/IL2 production by CD4+ T-cells in six male partners who did not exhibit any genital HPV-related diseases. Ex vivo IFN gamma ELISPOT showed numerous effector T-cells producing IFN gamma after stimulation by a dominant E2 peptide in all men and women. Since the E2 protein is absent from the viral particles but is required for viral DNA replication, these results suggest a recent infection with replicative HPV16 in male partners. The presence of polyfunctional anti-E2 T-cell responses in the blood of asymptomatic men unambiguously establishes HPV infection even without detectable lesions. These results, despite the small size of the studied group, provide an argument in favor of prophylactic HPV vaccination of young men in order to prevent HPV16 infection and viral transmission from men to women.	[Jacobelli, Simon; Sanaa, Fedoua; Villefroy, Pascale; North, Marie Odile; Figueiredo, Suzanne; Charmeteau, Benedicte; Avril, Marie-Francoise; Guillet, Jean-Gerard; Cheynier, Remi; Bourgault-Villada, Isabelle] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Jacobelli, Simon; Sanaa, Fedoua; Villefroy, Pascale; North, Marie Odile; Figueiredo, Suzanne; Charmeteau, Benedicte; Avril, Marie-Francoise; Guillet, Jean-Gerard; Cheynier, Remi; Bourgault-Villada, Isabelle] INSERM, U1016, Paris, France; [Jacobelli, Simon; Moyal-Barracco, Micheline; Pelisse, Monique; Berville, Sophie; North, Marie Odile; Plantier, Francoise; Dupin, Nicolas; Avril, Marie-Francoise] Hop Cochin, AP HP, F-75674 Paris, France; [Arnold, Francoise; Touze, Antoine] INSERM, U618, Tours, France; [Moyal-Barracco, Micheline; Berville, Sophie; Clerici, Thierry; Bourgault-Villada, Isabelle] Hop Ambroise Pare, AP HP, Boulogne Billancourt, France; [Clerici, Thierry; Bourgault-Villada, Isabelle] UVSQ, Versailles, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay	Jacobelli, S (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	simonjacobelli@gmail.com	Cheynier, Remi/E-9921-2010	Cheynier, Remi/0000-0003-1146-660X; Dupin, Nicolas/0000-0002-6237-4951; Touze, antoine/0000-0002-9856-9945	UVSQ (Bonus Quality Research); Academie Nationale de Medecine; French Society for Dermatology	UVSQ (Bonus Quality Research); Academie Nationale de Medecine; French Society for Dermatology	This work was supported by UVSQ (Bonus Quality Research) and by the Academie Nationale de Medecine. The French Society for Dermatology offered some valuable help in the form of grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERUMEN J, 1994, INT J CANCER, V56, P640, DOI 10.1002/ijc.2910560506; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BUCKLEY JD, 1981, LANCET, V2, P1010; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; Davidson EJ, 2003, CANCER RES, V63, P6032; Davidson EJ, 2003, J GEN VIROL, V84, P2089, DOI 10.1099/vir.0.19095-0; de Jong A, 2004, CANCER RES, V64, P5449, DOI 10.1158/0008-5472.CAN-04-0831; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; Dillon S, 2007, J GEN VIROL, V88, P803, DOI 10.1099/vir.0.82678-0; Evans C, 1996, CANCER IMMUNOL IMMUN, V42, P151, DOI 10.1007/s002620050265; Giraldo PC, 2008, EUR J OBSTET GYN R B, V137, P88, DOI 10.1016/j.ejogrb.2006.12.026; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; HIPPELAINEN MI, 1994, SEX TRANSM DIS, V21, P76, DOI 10.1097/00007435-199403000-00004; JULLIAN EH, 1993, LAB INVEST, V68, P242; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; LECANN P, 1994, FEMS MICROBIOL LETT, V117, P269; McCluggage WG, 2009, HISTOPATHOLOGY, V54, P156, DOI 10.1111/j.1365-2559.2008.03098.x; Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Reiter PL, 2010, CANCER EPIDEM BIOMAR, V19, P2916, DOI 10.1158/1055-9965.EPI-10-0576; Ressing ME, 1996, CANCER RES, V56, P582; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; Tsukui T, 1996, CANCER RES, V56, P3967; van Poelgeest MIE, 2005, CLIN CANCER RES, V11, P5273, DOI 10.1158/1078-0432.CCR-05-0616; Villada IB, 2010, CLIN EXP IMMUNOL, V159, P45, DOI 10.1111/j.1365-2249.2009.04006.x; Villada IB, 2004, CANCER RES, V64, P8761, DOI 10.1158/0008-5472.CAN-04-2455; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; Woo YL, 2010, INT J CANCER, V126, P133, DOI 10.1002/ijc.24804; Xue YZ, 2010, CANCER RES, V70, P5316, DOI 10.1158/0008-5472.CAN-09-3789	33	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36651	10.1371/journal.pone.0036651	http://dx.doi.org/10.1371/journal.pone.0036651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590583	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100050
J	Mendoza, R; Silverman, RH; Klein, EA; Miller, AD				Mendoza, Ramon; Silverman, Robert H.; Klein, Eric A.; Miller, A. Dusty			No Biological Evidence of XMRV in Blood or Prostatic Fluid from Prostate Cancer Patients	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; HUMAN RETROVIRUS XMRV; CELL-LINE; ENDOGENOUS RETROVIRUS; INFECTIOUS RETROVIRUS; HELPER VIRUS; HUMAN SERUM; SEQUENCES; DONORS	Background: XMRV (xenotropic murine leukemia virus-related virus) was initially discovered in association with prostate cancer and later with chronic fatigue syndrome (CFS). Its association with CFS is now largely discredited, and current results support a laboratory origin for XMRV with no reproducible evidence for infection of humans. However, some results indicating the presence of XMRV in prostate cancer are difficult to attribute to sample contamination. Here we have sought biological evidence that might confirm the presence of XMRV in prostate cancer samples previously having tested positive. Methods and Results: We have tested for infectious XMRV and neutralizing antibodies against XMRV in blood plasma from 29 subjects with prostate cancer, and for infectious XMRV in prostate secretions from another five prostate cancer subjects. Nine of these subjects had previously tested positive for XMRV by PCR or by virus assay. We did not detect XMRV or related retroviruses in any sample, and the neutralizing activities of the plasma samples were all very low, a result inconsistent with XMRV infection of the plasma donors. Conclusions: We find no evidence for XMRV infection of any human subject tested, either by assay for infectious virus or for neutralizing antibodies. Our results are consistent with the majority of published studies on XMRV, which find that XMRV is not present in humans. The observed low to undetectable XMRV neutralization by human plasma indicates a lack of innate restriction of XMRV replication by soluble factors in human blood.	[Mendoza, Ramon; Miller, A. Dusty] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Silverman, Robert H.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Klein, Eric A.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Miller, A. Dusty] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle	Mendoza, R (corresponding author), Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.	dmiller@fhcrc.org		Miller, Dusty/0000-0002-3736-3660	National Cancer Institute [T32 CA080416]; Core Center of Excellence in Hematology [DK56465]; Fred Hutchinson Cancer Research Center; Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Core Center of Excellence in Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fred Hutchinson Cancer Research Center; Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories(Abbott Laboratories); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by training grant T32 CA080416 from the National Cancer Institute (RM); by pilot project funding from the Core Center of Excellence in Hematology grant DK56465 and by funding from the Fred Hutchinson Cancer Research Center (ADM); and by the Charlotte Geyer Foundation, the Maltz Family Foundation and Abbott Laboratories (RHS and EAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Barton M, THESIS KENT STATE U; Bonham L, 1997, J VIROL, V71, P4663, DOI 10.1128/JVI.71.6.4663-4670.1997; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; HAAPALA DK, 1985, J VIROL, V53, P827, DOI 10.1128/JVI.53.3.827-833.1985; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; MICKEY DD, 1977, CANCER RES, V37, P4049; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Miller AD, 1997, J VIROL, V71, P4531, DOI 10.1128/JVI.71.6.4531-4535.1997; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Miller AD, 1996, J VIROL, V70, P1804, DOI 10.1128/JVI.70.3.1804-1809.1996; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; ROTHER RP, 1995, J EXP MED, V182, P1345, DOI 10.1084/jem.182.5.1345; Ruscetti F, 2010, 12 INT C MAL AIDS OT; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-70; Takefman DM, 2002, J VIROL, V76, P1999, DOI 10.1128/JVI.76.4.1999-2002.2002; Takeuchi Y, 1996, NATURE, V379, P85, DOI 10.1038/379085a0; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Zhou YC, 2012, TRANSFUSION, V52, P332, DOI 10.1111/j.1537-2995.2011.03519.x	31	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e36073	10.1371/journal.pone.0036073	http://dx.doi.org/10.1371/journal.pone.0036073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615749	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341300011
J	Vitovski, S; Chantry, AD; Lawson, MA; Croucher, PI				Vitovski, Srdjan; Chantry, Andrew D.; Lawson, Michelle A.; Croucher, Peter I.			Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; CANCER STEM-CELLS; CHEMOTHERAPEUTIC DRUGS; DECOY RECEPTORS; PLASMA-CELL; DEATH; LEUKEMIA; EXPRESSION; MELPHALAN; VITRO	Multiple myeloma (MM) remains an incurable disease despite improvements to available treatments and efforts to identify new drug targets. Consequently new approaches are urgently required. We have investigated the potential of native tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), in combination with doxorubicin, to induce apoptotic cell death in phenotypically distinct populations of myeloma cells in vitro and in vivo. The cytotoxic potential of TRAIL alone, and in combination with DOX, was assessed in vitro in purified CD138(+) and CD138(-) cells from the MM cell lines and samples from patients with MM. Mouse xenografts obtained by implanting CD138(-) MM cells were used to assess the efficacy of TRAIL, alone and in combination with DOX, in vivo. CD138(-) cells were shown to be more resistant to the cytotoxic activity of TRAIL than CD138(+) cells and have reduced expression of TRAIL death receptors. This resistance results in preferential killing of CD 138(+) cells during exposure of MM culture to TRAIL. Furthermore, prolonged exposure results in the appearance of TRAIL-resistant CD138(-) cells. However, when TRAIL is combined with doxorubicin, this results in complete eradication of MM cells in vivo. Most importantly, this treatment successfully eliminates CD138(-) cells implicated in tumour initiation and growth maintenance. These findings may explain the failure of current therapies and offer a promising new approach in the quest to cure MM and disseminated cancers.	[Vitovski, Srdjan; Chantry, Andrew D.; Lawson, Michelle A.; Croucher, Peter I.] Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Vitovski, Srdjan] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Sheffield; University of Sheffield; Garvan Institute of Medical Research	Vitovski, S (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	P.Croucher@garvan.org.au	Lawson, Michelle/M-6095-2019	Lawson, Michelle/0000-0002-5446-923X; Croucher, Peter/0000-0002-7102-2413; Chantry, Andrew/0000-0002-2797-7626	Leukemia Research Foundation [LRF08008]; Yorkshire Cancer Research grant [YCR121464]; Mrs Janice Gibson and Ernest Heine Family Foundation	Leukemia Research Foundation; Yorkshire Cancer Research grant; Mrs Janice Gibson and Ernest Heine Family Foundation	This work is supported by Leukemia Research Foundation grant LRF08008 (PIC, SV) and Yorkshire Cancer Research grant YCR121464 (SV, PIC). PIC is supported by the Mrs Janice Gibson and Ernest Heine Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2007, EXP MOL PATHOL, V83, P405, DOI 10.1016/j.yexmp.2007.04.001; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bai JR, 2005, CANCER RES, V65, P2344, DOI 10.1158/0008-5472.CAN-04-3502; BERGSAGEL DE, 1979, NEW ENGL J MED, V301, P743, DOI 10.1056/NEJM197910043011402; BILLADEAU D, 1993, J EXP MED, V178, P1023, DOI 10.1084/jem.178.3.1023; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Fulda S, 2010, INT J BIOCHEM CELL B, V42, P31, DOI 10.1016/j.biocel.2009.06.010; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gazitt Y, 1999, LEUKEMIA, V13, P1817, DOI 10.1038/sj.leu.2401501; Govindarajan R, 1996, BRIT J HAEMATOL, V95, P349, DOI 10.1046/j.1365-2141.1996.d01-1891.x; GREGORY WM, 1992, J CLIN ONCOL, V10, P334, DOI 10.1200/JCO.1992.10.2.334; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hjorth M, 1999, EUR J HAEMATOL, V62, P271; Jagani Z, 2008, ADV EXP MED BIOL, V615, P331, DOI 10.1007/978-1-4020-6554-5_15; Jazirehi AR, 2001, CLIN CANCER RES, V7, P3874; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim KH, 2000, CLIN CANCER RES, V6, P335; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2000, ANN ONCOL, V11, P55, DOI 10.1023/A:1008357107496; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lincz LF, 2001, LEUKEMIA, V15, P1650, DOI 10.1038/sj.leu.2402251; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades N, 2001, EXPERT OPIN INV DRUG, V10, P1521, DOI 10.1517/13543784.10.8.1521; Morisot S, 2010, LEUKEMIA, V24, P1859, DOI 10.1038/leu.2010.184; Nagane M, 2000, CANCER RES, V60, P847; Pasquali S, 1998, J CLIN ONCOL, V16, P3832; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shipman CM, 2003, CANCER RES, V63, P912; Singh TR, 2003, CANCER RES, V63, P5390; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Thai L, 2006, CANCER RES, V66, P5363, DOI 10.1158/0008-5472.CAN-05-4386; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Yones RJ, 2008, BIOL BLOOD MARROW TR, V14, P12, DOI 10.1016/j.bbmt.2007.10.012; Zerafa N, 2005, J IMMUNOL, V175, P5586, DOI 10.4049/jimmunol.175.9.5586	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35830	10.1371/journal.pone.0035830	http://dx.doi.org/10.1371/journal.pone.0035830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615740	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305341300007
J	Davoodi-Semiromi, A; Wasserfall, CH; Xia, CQ; Cooper-DeHoff, RM; Wabitsch, M; Clare-Salzler, M; Atkinson, M				Davoodi-Semiromi, Abdoreza; Wasserfall, Clive H.; Xia, Chang Qing; Cooper-DeHoff, Rhonda M.; Wabitsch, Martin; Clare-Salzler, Michael; Atkinson, Mark			The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; JAK2 INHIBITOR; JANUS KINASE-3; ACTIVATION; BETA; PATHWAYS; THERAPY; STAT; IMMUNOSUPPRESSION	Background: Recent studies in the NOD (non-obese diabetic) mouse model of type 1 diabetes (T1D) support the notion that tyrosine kinase inhibitors have the potential for modulating disease development. However, the therapeutic effects of AG490 on the development of T1D are unknown. Materials and Methods: Female NOD mice were treated with AG490 (i.p, 1 mg/mouse) or DMSO starting at either 4 or 8 week of age, for five consecutive week, then once per week for 5 additional week. Analyses for the development and/or reversal of diabetes, insulitis, adoptive transfer, and other mechanistic studies were performed. Results: AG490 significantly inhibited the development of T1D (p = 0.02, p = 0.005; at two different time points). Monotherapy of newly diagnosed diabetic NOD mice with AG490 markedly resulted in disease remission in treated animals (n = 23) in comparision to the absolute inability (0%; 0/10, p = 0.003, Log-rank test) of DMSO and sustained eugluycemia was maintained for several months following drug withdrawal. Interestingly, adoptive transfer of splenocytes from AG490 treated NOD mice failed to transfer diabetes to recipient NOD. Scid mice. CD4 T-cells as well as bone marrow derived dendritic cells (BMDCs) from AG490 treated mice, showed higher expression of Foxp3 (p<0.004) and lower expression of costimulatory molecules, respectively. Screening of the mouse immune response gene arrary indicates that expression of costimulaotry molecule Ctla4 was upregulated in CD4+ T-cell in NOD mice treated with AG490, suggesting that AG490 is not a negative regulator of the immune system. Conclusion: The use of such agents, given their extensive safety profiles, provides a strong foundation for their translation to humans with or at increased risk for the disease.	[Davoodi-Semiromi, Abdoreza; Cooper-DeHoff, Rhonda M.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA; [Wasserfall, Clive H.; Xia, Chang Qing; Clare-Salzler, Michael; Atkinson, Mark] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol, Diabet & Obes Unit, Dept Pediat & Adolescent Med, Ulm, Germany	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Ulm University	Davoodi-Semiromi, A (corresponding author), Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA.	dsemiromi@cop.ufl.edu; atkinson@ufl.edu	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932	Juvenile Diabetes Research Foundation International (Innovative grant) [5-2006-937]; National Institutes of Health [R21A176394-01]; University of Florida Open-Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International (Innovative grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Open-Access Publishing Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by grants from the Juvenile Diabetes Research Foundation International (Innovative grant # 5-2006-937), and National Institutes of Health R21A176394-01 (The American Recovery And Reinvestment Act) awarded to ADS. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bates SH, 2002, HORM METAB RES, V34, P111, DOI 10.1055/s-2002-23192; Behbod F, 2001, J IMMUNOL, V166, P3724, DOI 10.4049/jimmunol.166.6.3724; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bright JJ, 1999, J IMMUNOL, V162, P6255; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Constantin G, 1998, EUR J IMMUNOL, V28, P3523, DOI 10.1002/(SICI)1521-4141(199811)28:11<3523::AID-IMMU3523>3.0.CO;2-X; Constantin G, 1999, J IMMUNOL, V162, P1144; Couzin-Frankel J, 2011, SCIENCE, V333, P819, DOI 10.1126/science.333.6044.819; Crespo O, 2011, J CLIN IMMUNOL, V31, P1010, DOI 10.1007/s10875-011-9579-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Davoodi-Semiromi A, 2004, J BIOL CHEM, V279, P11553, DOI 10.1074/jbc.M312110200; Davoodi-Semiromi A, 2007, BIOCH BIOPHYS RES CO; Davoodi-Semiromi A, 2007, J IMMUNOL, V178; Davoodi-Semiromi A, 2012, BIOCHEM PHARMACOL, V83, P821, DOI 10.1016/j.bcp.2011.12.033; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; GILMOUR KC, 1995, P NATL ACAD SCI USA, V92, P10772, DOI 10.1073/pnas.92.23.10772; Goncalves S, 2010, CURR MED CHEM, V17, P974, DOI 10.2174/092986710790820642; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Howson JMM, 2011, DIABETES, V60, P2645, DOI 10.2337/db11-0364; Ihle JN, 1996, PHILOS T R SOC B, V351, P159, DOI 10.1098/rstb.1996.0012; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; MAKI T, 1992, P NATL ACAD SCI USA, V89, P3434, DOI 10.1073/pnas.89.8.3434; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Mokhtari D, 2010, CLIN SCI, V118, P241, DOI 10.1042/CS20090348; O'Shea JJ, 2004, ANN RHEUM DIS, V63, P67, DOI 10.1136/ard.2004.028290; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; O'Shea JJ, 2005, CURR OPIN RHEUMATOL, V17, P305, DOI 10.1097/01.bor.0000160781.07174.db; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; Parker MJ, 2009, DIABETES, V58, P2277, DOI 10.2337/db09-0557; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Rumore-Maton B, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/769795; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Sherry NA, 2007, ENDOCRINOLOGY, V148, P5136, DOI 10.1210/en.2007-0358; Sidhu M, 2011, INFLAMM BOWEL DIS, V17, P2416, DOI 10.1002/ibd.21646; Simon G, 2008, DIABETES, V57, P405, DOI 10.2337/db06-1384; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Thirone ACP, 2006, DIABETES, V55, P942, DOI 10.2337/diabetes.55.04.06.db05-1265; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; van Gurp E, 2008, AM J TRANSPLANT, V8, P1711, DOI 10.1111/j.1600-6143.2008.02307.x; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Wang LH, 1999, J IMMUNOL, V162, P3897; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Zhang F, 2006, AM J PHYSIOL-CELL PH, V291, pC466, DOI 10.1152/ajpcell.00418.2005	62	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36079	10.1371/journal.pone.0036079	http://dx.doi.org/10.1371/journal.pone.0036079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22615750	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339400012
J	Somers, EC; Zhao, WP; Lewis, EE; Wang, L; Wing, JJ; Sundaram, B; Kazerooni, EA; McCune, WJ; Kaplan, MJ				Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; Wang, Lu; Wing, Jeffrey J.; Sundaram, Baskaran; Kazerooni, Ella A.; McCune, W. Joseph; Kaplan, Mariana J.			Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; RISK-FACTORS; ACCELERATED ATHEROSCLEROSIS; COMPUTED-TOMOGRAPHY; VASCULAR-DISEASE; GENE-EXPRESSION; IFN-ALPHA; WOMEN; PREVALENCE; PLAQUE	Background: Systemic lupus erythematosus (SLE) patients have a striking increase in cardiovascular (CV) comorbidity not fully explained by the Framingham risk score. Recent evidence from in vitro studies suggests that type I interferons (IFN) could promote premature CV disease (CVD) in SLE. We assessed the association of type I IFN signatures with functional and anatomical evidence of vascular damage, and with biomarkers of CV risk in a cohort of lupus patients without overt CVD. Methodology/Principal Findings: Serum type I IFN activity (induction of five IFN-inducible genes; IFIGs) from 95 SLE patient and 38 controls was quantified by real-time PCR. Flow mediated dilatation (FMD) of the brachial artery and carotid intima media thickness (CIMT) were quantified by ultrasound, and coronary calcification by computed tomography. Serum vascular biomarkers were measured by ELISA. We evaluated the effect of type I IFNs on FMD, CIMT and coronary calcification by first applying principal components analysis to combine data from five IFIGs into summary components that could be simultaneously modeled. Three components were derived explaining 97.1% of the total IFIG variation. Multivariable linear regression was utilized to investigate the association between the three components and other covariates, with the outcomes of FMD and CIMT; zero-inflated Poisson regression was used for modeling of coronary calcification. After controlling for traditional CV risk factors, enhanced serum IFN activity was significantly associated with decreased endothelial function in SLE patients and controls (p < 0.05 for component 3), increased CIMT among SLE patients (p < 0.01 for components 1 and 2), and severity of coronary calcification among SLE patients (p < 0.001 for component 3). Conclusions: Type I IFNs are independently associated with atherosclerosis development in lupus patients without history of overt CVD and after controlling for Framingham risk factors. This study further supports the hypothesis that type I IFNs promote premature vascular damage in SLE.	[Somers, Emily C.; Zhao, Wenpu; Lewis, Emily E.; McCune, W. Joseph; Kaplan, Mariana J.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Somers, Emily C.] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Wang, Lu; Wing, Jeffrey J.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Sundaram, Baskaran; Kazerooni, Ella A.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Somers, EC (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.	jmccune@umich.edu; makaplan@umich.edu	Wing, Jeffrey/AAN-7814-2020	Somers, Emily/0000-0001-5234-3978; Wing, Jeffrey/0000-0001-6999-6019	National Institutes of Health through PHS [HL088419]; University of Michigan CTSA [UL1RR024986]; Arthritis Foundation; Herbert and Carol Amster Lupus Research Fund; Michael and Marcia Klein Lupus Research Fund; Postdoctoral Translational Scholars Program; Arthritis Foundation New Investigator Award; National Institutes of Health through the Rheumatic Disease Core Center [P30 AR48310]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER	National Institutes of Health through PHS; University of Michigan CTSA; Arthritis Foundation; Herbert and Carol Amster Lupus Research Fund; Michael and Marcia Klein Lupus Research Fund; Postdoctoral Translational Scholars Program; Arthritis Foundation New Investigator Award; National Institutes of Health through the Rheumatic Disease Core Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by the National Institutes of Health through PHS grant HL088419 and the University of Michigan CTSA grant UL1RR024986 (both to MJK) and the Arthritis Foundation, the Herbert and Carol Amster Lupus Research Fund, and the Michael and Marcia Klein Lupus Research Fund (to WJM). ECS was supported by the Postdoctoral Translational Scholars Program and also through University of Michigan CTSA grant UL1RR024986, and an Arthritis Foundation New Investigator Award. The study was funded in part by the National Institutes of Health through the Rheumatic Disease Core Center Grant (P30 AR48310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bruce IN, 2000, J RHEUMATOL, V27, P2372; Crow MK, 2004, CURR OPIN RHEUMATOL, V16, P541, DOI 10.1097/01.bor.0000135453.70424.1b; Crow MK, 2003, ARTHRITIS RES THER, V5, P279, DOI 10.1186/ar1015; Denny MF, 2007, BLOOD, V110, P2907, DOI 10.1182/blood-2007-05-089086; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008; Grisar J, 2005, CIRCULATION, V111, P204, DOI 10.1161/01.CIR.0000151875.21836.AE; Gustafsson J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2878; HAIDER YS, 1981, AM J MED, V70, P775, DOI 10.1016/0002-9343(81)90532-5; Higashiyama M, 2010, CLIN EXP IMMUNOL; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOLM S, 1979, SCAND J STAT, V6, P65; HOSENPUD JD, 1984, AM J MED, V77, P286, DOI 10.1016/0002-9343(84)90704-6; Hua J, 2006, ARTHRITIS RHEUM-US, V54, P1906, DOI 10.1002/art.21890; Kao AH, 2003, CURR OPIN RHEUMATOL, V15, P519, DOI 10.1097/00002281-200309000-00001; Lee PY, 2007, ARTHRITIS RHEUM-US, V56, P3759, DOI 10.1002/art.23035; Levy Zohar, 2003, Eur J Intern Med, V14, P479, DOI 10.1016/j.ejim.2003.08.010; Li J, 2011, ARTHRITIS RHEUM-US, V63, P492, DOI 10.1002/art.30165; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Niessner A, 2007, CIRCULATION, V116, P2043, DOI 10.1161/CIRCULATIONAHA.107.697789; Niessner A, 2006, CIRCULATION, V114, P2482, DOI 10.1161/CIRCULATIONAHA.106.642801; Pieretti J, 2007, CIRCULATION, V116, P419, DOI 10.1161/CIRCULATIONAHA.106.673319; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Reynier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024828; Rho YH, 2008, J RHEUMATOL, V35, P1789; Rogers JL, 2007, J WOMENS HEALTH, V16, P721, DOI 10.1089/jwh.2006.0242; Roman MJ, 2007, ARTHRITIS RHEUM, V56, P3412, DOI 10.1002/art.22924; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Santer DM, 2010, J IMMUNOL, V185, P4738, DOI 10.4049/jimmunol.1001731; Somers EC, 2005, ANN NY ACAD SCI, V1051, P271, DOI 10.1196/annals.1361.068; Thacker SG, 2010, LUPUS, V19, P288, DOI 10.1177/0961203309353773; Thacker SG, 2010, J IMMUNOL, V185, P4457, DOI 10.4049/jimmunol.1001782; Vita JA, 2004, CIRCULATION, V110, P3604, DOI 10.1161/01.CIR.0000148821.97162.5E; von Marschall Z, 2003, J NATL CANCER I, V95, P437, DOI 10.1093/jnci/95.6.437; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	46	102	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37000	10.1371/journal.pone.0037000	http://dx.doi.org/10.1371/journal.pone.0037000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606325	Green Published, gold			2022-12-27	WOS:000305339400053
J	Vyleta, ML; Wong, J; Magun, BE				Vyleta, Meghan L.; Wong, John; Magun, Bruce E.			Suppression of Ribosomal Function Triggers Innate Immune Signaling through Activation of the NLRP3 Inflammasome	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NALP3 INFLAMMASOME; INTRACELLULAR POTASSIUM; STRESS-RESPONSE; PULMONARY INFLAMMATION; HEART-MITOCHONDRIA; RIBOTOXIC STRESS; CELL-SURVIVAL; KINASE PKR; KAPPA-B	Some inflammatory stimuli trigger activation of the NLRP3 inflammasome by inducing efflux of cellular potassium. Loss of cellular potassium is known to potently suppress protein synthesis, leading us to test whether the inhibition of protein synthesis itself serves as an activating signal for the NLRP3 inflammasome. Murine bone marrow-derived macrophages, either primed by LPS or unprimed, were exposed to a panel of inhibitors of ribosomal function: ricin, cycloheximide, puromycin, pactamycin, and anisomycin. Macrophages were also exposed to nigericin, ATP, monosodium urate (MSU), and poly I: C. Synthesis of pro-IL-beta and release of IL-1 beta from cells in response to these agents was detected by immunoblotting and ELISA. Release of intracellular potassium was measured by mass spectrometry. Inhibition of translation by each of the tested translation inhibitors led to processing of IL-1 beta, which was released from cells. Processing and release of IL-1 beta was reduced or absent from cells deficient in NLRP3, ASC, or caspase-1, demonstrating the role of the NLRP3 inflammasome. Despite the inability of these inhibitors to trigger efflux of intracellular potassium, the addition of high extracellular potassium suppressed activation of the NLRP3 inflammasome. MSU and double-stranded RNA, which are known to activate the NLRP3 inflammasome, also substantially inhibited protein translation, supporting a close association between inhibition of translation and inflammasome activation. These data demonstrate that translational inhibition itself constitutes a heretofore-unrecognized mechanism underlying IL-1 beta dependent inflammatory signaling and that other physical, chemical, or pathogen-associated agents that impair translation may lead to IL-1 beta-dependent inflammation through activation of the NLRP3 inflammasome. For agents that inhibit translation through decreased cellular potassium, the application of high extracellular potassium restores protein translation and suppresses activation of the NLRP inflammasome. For agents that inhibit translation through mechanisms that do not involve loss of potassium, high extracellular potassium suppresses IL-1 beta processing through a mechanism that remains undefined.	[Vyleta, Meghan L.; Wong, John; Magun, Bruce E.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Vyleta, ML (corresponding author), IST Austria, Klosterneuburg, Austria.	magunb@ohsu.edu		Wong, John/0000-0002-6317-2067	National Institutes of Health [GM071338, AI059355]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM071338 (ML) and AI059355 (BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2011, J IMMUNOL, V186, P2714, DOI 10.4049/jimmunol.1002657; ALONSO MA, 1979, ANTIMICROB AGENTS CH, V16, P750, DOI 10.1128/AAC.16.6.750; ALONSO MA, 1981, J VIROL, V37, P535, DOI 10.1128/JVI.37.2.535-540.1981; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; BREITBART H, 1981, BIOCHIM BIOPHYS ACTA, V656, P160, DOI 10.1016/0005-2787(81)90082-4; BURROW GN, 1969, ENDOCRINOLOGY, V84, P979, DOI 10.1210/endo-84-4-979; CAHN F, 1978, J BIOL CHEM, V253, P7798; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Darisipudi MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019588; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; FRANZ DR, 1997, TXB MILITARY MED, P631; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Griffiths GD, 1994, 742 MIN DEF; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Iordanov MS, 1998, J BIOL CHEM, V273, P3528, DOI 10.1074/jbc.273.6.3528; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; LEDBETTER MLS, 1977, EXP CELL RES, V105, P223, DOI 10.1016/0014-4827(77)90120-3; Lee HM, 2011, IMMUNOL CELL BIOL; Li J, 2011, J NAT PROD, V74, P1894, DOI 10.1021/np200370z; Lindauer M, 2010, TOXINS, V2, P1500, DOI 10.3390/toxins2061500; Lindauer ML, 2009, J IMMUNOL, V183, P1419, DOI 10.4049/jimmunol.0901119; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; LUBIN M, 1967, NATURE, V213, P451, DOI 10.1038/213451a0; Magnani M., 2000, Current Drug Targets, V1, P387, DOI 10.2174/1389450003349056; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Menu P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.132; Meunier E, 2011, NANOMEDICINE; Muaddi H, 2010, MOL BIOL CELL, V21, P3220, DOI 10.1091/mbc.E10-01-0023; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; NASLUND PH, 1971, BIOCHIM BIOPHYS ACTA, V254, P104, DOI 10.1016/0005-2787(71)90117-1; PANET R, 1979, BIOCHEM BIOPH RES CO, V88, P619, DOI 10.1016/0006-291X(79)92093-X; Papadakis AI, 2010, CANCER RES, V70, P7820, DOI 10.1158/0008-5472.CAN-10-0215; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; POOLE DT, 1972, BIOCHIM BIOPHYS ACTA, V266, P463, DOI 10.1016/0005-2736(72)90102-2; PREEDY VR, 1985, BIOCHEM J, V225, P487, DOI 10.1042/bj2250487; Rajan JV, 2010, FEBS LETT, V584, P4627, DOI 10.1016/j.febslet.2010.10.036; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Schorn C, 2009, AUTOIMMUNITY, V42, P314, DOI 10.1080/08916930902832058; SHARP TV, 1993, EUR J BIOCHEM, V214, P945, DOI 10.1111/j.1432-1033.1993.tb17998.x; Shmueli A, 2004, MOL CELL, V13, P4, DOI 10.1016/S1097-2765(03)00529-X; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Vazquez D, 1974, Hamatol Bluttransfus, V14, P327; Wilhelmsen CL, 1996, VET PATHOL, V33, P296, DOI 10.1177/030098589603300306; Wong J, 2007, AM J PATHOL, V170, P1497, DOI 10.2353/ajpath.2007.060703; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; YANG PC, 1968, ARCH BIOCHEM BIOPHYS, V125, P506, DOI 10.1016/0003-9861(68)90608-5	74	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36044	10.1371/journal.pone.0036044	http://dx.doi.org/10.1371/journal.pone.0036044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606244	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400011
J	Wachtler, B; Citiulo, F; Jablonowski, N; Forster, S; Dalle, F; Schaller, M; Wilson, D; Hube, B				Waechtler, Betty; Citiulo, Francesco; Jablonowski, Nadja; Foerster, Stephanie; Dalle, Frederic; Schaller, Martin; Wilson, Duncan; Hube, Bernhard			Candida albicans-Epithelial Interactions: Dissecting the Roles of Active Penetration, Induced Endocytosis and Host Factors on the Infection Process	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; BACTERIAL ENTRY; E-CADHERIN; FIBRONECTIN; ADHESION; PROTEIN; GENE; INTERNALIZATION; VITRONECTIN; MECHANISMS	Candida albicans frequently causes superficial infections by invading and damaging epithelial cells, but may also cause systemic infections by penetrating through epithelial barriers. C. albicans is a remarkable pathogen because it can invade epithelial cells via two distinct mechanisms: induced endocytosis, analogous to facultative intracellular enteropathogenic bacteria, and active penetration, similar to plant pathogenic fungi. Here we investigated the contributions of the two invasion routes of C. albicans to epithelial invasion. Using selective cellular inhibition approaches and differential fluorescence microscopy, we demonstrate that induced endocytosis contributes considerably to the early time points of invasion, while active penetration represents the dominant epithelial invasion route. Although induced endocytosis depends mainly on Als3-E-cadherin interactions, we observed E-cadherin independent induced endocytosis. Finally, we provide evidence of a protective role for serum factors in oral infection: human serum strongly inhibited C. albicans adhesion to, invasion and damage of oral epithelial cells.	[Waechtler, Betty; Citiulo, Francesco; Jablonowski, Nadja; Foerster, Stephanie; Wilson, Duncan; Hube, Bernhard] Hans Knoell Inst Jena HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Dalle, Frederic] Univ Bourgogne, Fac Med, Lab Interact Muqueuses Agents Transmissibles, IFR Sante STIC,EA 562, Dijon, France; [Dalle, Frederic] Univ Hosp, Dijon, France; [Schaller, Martin] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany; [Hube, Bernhard] Ctr Sepsis Control & Care, Jena, Germany	Hans Knoll Institute (HKI); Universite de Bourgogne; CHU Dijon Bourgogne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena	Wachtler, B (corresponding author), Hans Knoell Inst Jena HKI, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	bernhard.hube@hki-jena.de		Wilson, Duncan/0000-0001-6617-0123; Citiulo, Francesco/0000-0003-2322-6742; Hube, Bernhard/0000-0002-6028-0425	Deutsche Forschungsgemeinschaft [Hu528/10, Sch 897/3, SPP1160]; EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination; Bundesministerium fur Bildung und Forschung [BMBF 0315901B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was partially supported by the Deutsche Forschungsgemeinschaft Hu528/10 and Sch 897/3 within the priority program SPP1160 "Colonisation and infection by human-pathogenic fungi" and the EU ERA-NET PathoGenoMics Program: Colonisation and the transition to pathogenic dissemination by Candida species: towards early diagnostic and therapeutic approaches - CandiCol. Bundesministerium fur Bildung und Forschung (BMBF 0315901B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Dalle F, 2009, CELL MICROBIOL; Denk C, 1997, CANCER LETT, V120, P185, DOI 10.1016/S0304-3835(97)00308-X; Dersch Petra, 2003, Contrib Microbiol, V10, P183; Drago L, 2000, INT J ANTIMICROB AG, V16, P545, DOI 10.1016/S0924-8579(00)00296-X; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; FONZI WA, 1993, GENETICS, V134, P717; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Moreno-Ruiz E, 2009, CELL MICROBIOL, V11, P1179, DOI 10.1111/j.1462-5822.2009.01319.x; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; NAIDU AS, 1988, J CLIN MICROBIOL, V26, P1549, DOI 10.1128/JCM.26.8.1549-1554.1988; Odds F, 1988, ECOLOGY EPIDEMIOLOGY; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Phan QT, 2005, J BIOL CHEM, V280, P10455, DOI 10.1074/jbc.M412592200; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RUHNKE M, 2002, SKIN MUCOUS MEMBRANE, P307; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Santoni G, 2001, MICROB PATHOGENESIS, V31, P159, DOI 10.1006/mpat.2001.0459; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Spreghini E, 1999, J INFECT DIS, V180, P156, DOI 10.1086/314822; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Stocks SZ, 1999, AUST NZ J OPHTHALMOL, V27, P247, DOI 10.1046/j.1440-1606.1999.00199.x; Sun JN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001181; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tatley FD, 2003, INFECT IMMUN, V71, P1580, DOI 10.1128/IAI.71.3.1580-1583.2003; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Tsujihata M, 2006, INT J UROL, V13, P743, DOI 10.1111/j.1442-2042.2006.01396.x; Vanier G, 2007, CAN J VET RES, V71, P81; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Wilson D, 2010, EUKARYOT CELL, V9, P278, DOI 10.1128/EC.00307-09; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zipfel PF, 2011, INT J MED MICROBIOL, V301, P423, DOI 10.1016/j.ijmm.2011.04.010	45	127	137	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36952	10.1371/journal.pone.0036952	http://dx.doi.org/10.1371/journal.pone.0036952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606314	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400045
J	Ho, YS; Yang, XF; Yeung, SC; Chiu, K; Lau, CF; Tsang, AWT; Mak, JCW; Chang, RCC				Ho, Yuen-Shan; Yang, Xifei; Yeung, Sze-Chun; Chiu, Kin; Lau, Chi-Fai; Tsang, Andrea Wing-Ting; Mak, Judith Choi-Wo; Chang, Raymond Chuen-Chung			Cigarette Smoking Accelerated Brain Aging and Induced Pre-Alzheimer-Like Neuropathology in Rats	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OXIDATIVE DNA-DAMAGE; RISK-FACTOR; SYNAPTIC PATHOLOGY; DENDRITIC SPINES; SECONDHAND SMOKE; CEREBRAL-CORTEX; GAMMA-SECRETASE; DISEASE; DEMENTIA	Cigarette smoking has been proposed as a major risk factor for aging-related pathological changes and Alzheimer's disease (AD). To date, little is known for how smoking can predispose our brains to dementia or cognitive impairment. This study aimed to investigate the cigarette smoke-induced pathological changes in brains. Male Sprague-Dawley (SD) rats were exposed to either sham air or 4% cigarette smoke 1 hour per day for 8 weeks in a ventilated smoking chamber to mimic the situation of chronic passive smoking. We found that the levels of oxidative stress were significantly increased in the hippocampus of the smoking group. Smoking also affected the synapse through reducing the expression of pre-synaptic proteins including synaptophysin and synapsin-1, while there were no changes in the expression of postsynaptic protein PSD95. Decreased levels of acetylated-tubulin and increased levels of phosphorylated-tau at 231, 205 and 404 epitopes were also observed in the hippocampus of the smoking rats. These results suggested that axonal transport machinery might be impaired, and the stability of cytoskeleton might be affected by smoking. Moreover, smoking affected amyloid precursor protein (APP) processing by increasing the production of sAPP beta and accumulation of beta-amyloid peptide in the CA3 and dentate gyrus region. In summary, our data suggested that chronic cigarette smoking could induce synaptic changes and other neuropathological alterations. These changes might serve as evidence of early phases of neurodegeneration and may explain why smoking can predispose brains to AD and dementia.	[Ho, Yuen-Shan; Chiu, Kin; Lau, Chi-Fai; Tsang, Andrea Wing-Ting; Chang, Raymond Chuen-Chung] Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-Wo; Chang, Raymond Chuen-Chung] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Yeung, Sze-Chun; Mak, Judith Choi-Wo] Univ Hong Kong, LKS Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-Wo] Univ Hong Kong, LKS Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Yang, Xifei] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC)	Ho, YS (corresponding author), Univ Hong Kong, Dept Anat, Lab Neurodegenerat Dis, Hong Kong, Hong Kong, Peoples R China.	judithmak@hku.hk; rccchang@hku.hk	Chiu, Kin/ABI-7938-2020; Chang, Raymond Chuen-Chung/C-1107-2009	Chiu, Kin/0000-0001-6581-9007; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; HO, Yuen-Shan/0000-0002-2557-6554; Mak, Judith/0000-0002-8234-1313	HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging [GRF 761609M, NSFC/RGC70707M]; Seed Funding for Basic Science Research [201011159058]; Small Grant Research [201007176112]	HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Seed Funding for Basic Science Research; Small Grant Research	Sources of funding support include: HKU (University of Hong Kong) Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging, GRF 761609M & NSFC/RGC70707M, Seed Funding for Basic Science Research (201011159058) to RCCC, Small Grant Research (201007176112) to YSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberg AJ, 2002, TOXICOLOGY, V180, P121, DOI 10.1016/S0300-483X(02)00386-4; Anbarasi K, 2006, LIFE SCI, V78, P1378, DOI 10.1016/j.lfs.2005.07.030; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Asami S, 1996, CANCER RES, V56, P2546; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barnes DE, 2010, AM J EPIDEMIOL, V171, P292, DOI 10.1093/aje/kwp376; Barr J, 2007, MOL CELL BIOCHEM, V297, P93, DOI 10.1007/s11010-006-9333-1; Berg L, 1998, ARCH NEUROL-CHICAGO, V55, P326, DOI 10.1001/archneur.55.3.326; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Blennow K, 1996, J NEURAL TRANSM, V103, P603, DOI 10.1007/BF01273157; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chan KH, 2009, RESP MED, V103, P1746, DOI 10.1016/j.rmed.2009.04.027; CHENG KC, 1992, J BIOL CHEM, V267, P166; Chow JYC, 1996, LIFE SCI, V58, P2415, DOI 10.1016/0024-3205(96)00245-7; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Fuller BF, 2010, J MOL NEUROSCI, V41, P165, DOI 10.1007/s12031-009-9316-2; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Hayashi K, 1999, J NEUROSCI, V19, P3918; Hayashi K, 1996, J NEUROSCI, V16, P7161; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Hempen B, 1996, J NEUROPATH EXP NEUR, V55, P964, DOI 10.1097/00005072-199609000-00003; Henriques AG, 2010, J NEUROCHEM, V113, P761, DOI 10.1111/j.1471-4159.2010.06643.x; Isobe C, 2010, J NEUROL, V257, P399, DOI 10.1007/s00415-009-5333-x; Kim SH, 2003, NUTRITION, V19, P240, DOI 10.1016/S0899-9007(02)01002-X; Lai CSW, 2009, MOL CELL NEUROSCI, V41, P32, DOI 10.1016/j.mcn.2009.01.006; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; Llewellyn DJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b462; Nicita-Mauro V, 2008, EXP GERONTOL, V43, P95, DOI 10.1016/j.exger.2007.06.011; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Ott A, 2004, NEUROLOGY, V62, P920, DOI 10.1212/01.WNL.0000115110.35610.80; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Ozguner F, 2005, TOXICOL IND HEALTH, V21, P21, DOI 10.1191/0748233705th211oa; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quiroz-Baez R, 2009, NEUROCHEM INT, V55, P662, DOI 10.1016/j.neuint.2009.06.012; Rueff-Barroso CR, 2010, MED SCI MONITOR, V16, pBR218; Sabbagh MN, 2005, NEUROLOGY, V64, P1301, DOI 10.1212/01.WNL.0000156912.54593.65; Saporito MS, 2000, J NEUROCHEM, V75, P1200, DOI 10.1046/j.1471-4159.2000.0751200.x; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Sigala R, 2007, CURR BIOL, V17, pR18, DOI 10.1016/j.cub.2006.11.036; Sonnen JA, 2009, ANN NEUROL, V65, P226, DOI 10.1002/ana.21508; Su B, 2010, NEUROSCI LETT, V468, P267, DOI 10.1016/j.neulet.2009.11.010; Thome GR, 2011, NICOTINE TOB RES, V13, P1210, DOI 10.1093/ntr/ntr154; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; Tuon T, 2010, NEUROSCI LETT, V475, P16, DOI 10.1016/j.neulet.2010.03.030; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Ulrich J, 1997, ACTA NEUROPATHOL, V94, P450, DOI 10.1007/s004010050732; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VanGuilder HD, 2011, NEUROBIOL DIS, V43, P201, DOI 10.1016/j.nbd.2011.03.012; Wang JZ, 2008, PROG NEUROBIOL, V85, P148, DOI 10.1016/j.pneurobio.2008.03.002	59	78	79	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36752	10.1371/journal.pone.0036752	http://dx.doi.org/10.1371/journal.pone.0036752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606286	Green Published, gold			2022-12-27	WOS:000305338200040
J	Cancela, AL; Santos, RD; Titan, SM; Goldenstein, PT; Rochitte, CE; Lemos, PA; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moyses, RM				Cancela, Ana Ludimila; Santos, Raul Dias; Titan, Silvia Maria; Goldenstein, Patricia Taschner; Rochitte, Carlos Eduardo; Lemos, Pedro Alves; dos Reis, Luciene Machado; Graciolli, Fabiana Giorgetti; Jorgetti, Vanda; Moyses, Rosa Maria			Phosphorus Is Associated with Coronary Artery Disease in Patients with Preserved Renal Function	PLOS ONE			English	Article							GROWTH-FACTOR 23; CHRONIC KIDNEY-DISEASE; SERUM-CALCIUM; CARDIOVASCULAR MORTALITY; HEMODIALYSIS-PATIENTS; COMPUTED-TOMOGRAPHY; PARATHYROID-HORMONE; MINERAL METABOLISM; YOUNG-ADULTS; CALCIFICATION	High serum phosphorus levels have been associated with mortality and cardiovascular events in patients with chronic kidney disease and in the general population. In addition, high phosphorus levels have been shown to induce vascular calcification and endothelial dysfunction in vitro. The aim of this study was to evaluate the relation of phosphorus and coronary calcification and atherosclerosis in the setting of normal renal function. This was a cross-sectional study involving 290 patients with suspected coronary artery disease and undergoing elective coronary angiography, with a creatinine clearance >60 ml/min/1.73 m(2). Coronary artery obstruction was assessed by the Friesinger score and coronary artery calcification by multislice computed tomography. Serum phosphorus was higher in patients with an Agatston score >10 than in those with an Agatston score <= 10 (3.63 +/- 0.55 versus 3.49 +/- 0.52 mg/dl; p = 0.02). In the patients with Friesinger scores >4, serum phosphorus was higher (3.6 +/- 0.5 versus 3.5 +/- 0.6 mg/dl, p = 0.04) and median intact fibroblast growth factor 23 was lower (40.3 pg/ml versus 45.7 pg/ml, p = 0.01). Each 0.1-mg/dl higher serum phosphate was associated with a 7.4% higher odds of having a Friesinger score >4 (p = 0.03) and a 6.1% greater risk of having an Agatston score >10 (p = 0.01). Fibroblast growth factor 23 was a negative predictor of Friesinger score ( p = 0.002). In conclusion, phosphorus is positively associated with coronary artery calcification and obstruction in patients with suspected coronary artery disease and preserved renal function.	[Cancela, Ana Ludimila; Titan, Silvia Maria; Goldenstein, Patricia Taschner; dos Reis, Luciene Machado; Graciolli, Fabiana Giorgetti; Jorgetti, Vanda; Moyses, Rosa Maria] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil; [Santos, Raul Dias; Rochitte, Carlos Eduardo; Lemos, Pedro Alves] Univ Sao Paulo, Inst Heart, Sch Med, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Cancela, AL (corresponding author), Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.	analudicancela@yahoo.com.br	Santos, Raul/A-1170-2010; Moyses, Rosa M A/F-8268-2012; Lemos, Pedro A./G-5758-2013; dos Reis, Luciene M/C-7143-2013; JORGETTI, VANDA/C-9470-2012	Santos, Raul/0000-0002-9860-6582; Moyses, Rosa M A/0000-0002-7902-2127; Lemos, Pedro A./0000-0002-6782-750X; dos Reis, Luciene M/0000-0001-8476-6780; JORGETTI, VANDA/0000-0002-4824-8879	FAPESP, Fundacoa de Amparo a Pesquisa do Estado de Sao Paulo [2007/56238-4]; FAPESP; CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303325/2010-0]	FAPESP, Fundacoa de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by FAPESP, Fundacoa de Amparo a Pesquisa do Estado de Sao Paulo (grant 2007/56238-4). FGG is supported by FAPESP. RMM is supported by CNPQ, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (grant 303325/2010-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Calvo MS, 1996, J NUTR, V126, pS1168, DOI 10.1093/jn/126.suppl_4.1168S; Cancela ALE, 2011, NEPHRON CLIN PRACT, V117, pC74, DOI 10.1159/000319650; Canziani MEF, 2011, BLOOD PURIFICAT, V31, P26, DOI 10.1159/000321368; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Friesinger G C, 1970, Trans Assoc Am Physicians, V83, P78; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kanbay M, 2010, CLIN J AM SOC NEPHRO, V5, P1780, DOI 10.2215/CJN.02560310; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lundgren E, 2001, SURGERY, V130, P978, DOI 10.1067/msy.2001.118377; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Narang R, 1997, INT J CARDIOL, V60, P73, DOI 10.1016/S0167-5273(97)02971-9; Onufrak SJ, 2008, ATHEROSCLEROSIS, V199, P424, DOI 10.1016/j.atherosclerosis.2007.11.004; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Rasouli M, 2006, CLIN CHEM LAB MED, V44, P43, DOI 10.1515/CCLM.2006.009; Roos M, 2008, CLIN ENDOCRINOL, V68, P660, DOI 10.1111/j.1365-2265.2007.03074.x; Saab G, 2010, AM J KIDNEY DIS, V56, P496, DOI 10.1053/j.ajkd.2010.03.030; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tuttle KR, 2009, CLIN J AM SOC NEPHRO, V4, P1968, DOI 10.2215/CJN.01250209; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	37	57	60	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36883	10.1371/journal.pone.0036883	http://dx.doi.org/10.1371/journal.pone.0036883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590632	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400043
J	Lhachimi, SK; Nusselder, WJ; Smit, HA; van Baal, P; Baili, P; Bennett, K; Fernandez, E; Kulik, MC; Lobstein, T; Pomerleau, J; Mackenbach, JP; Boshuizen, HC				Lhachimi, Stefan K.; Nusselder, Wilma J.; Smit, Henriette A.; van Baal, Pieter; Baili, Paolo; Bennett, Kathleen; Fernandez, Esteve; Kulik, Margarete C.; Lobstein, Tim; Pomerleau, Joceline; Mackenbach, Johan P.; Boshuizen, Hendriek C.			DYNAMO-HIA-A Dynamic Modeling Tool for Generic Health Impact Assessments	PLOS ONE			English	Article							STANDARD TOOL; CARE; PROJECTION; COSTS	Background: Currently, no standard tool is publicly available that allows researchers or policy-makers to quantify the impact of policies using epidemiological evidence within the causal framework of Health Impact Assessment (HIA). A standard tool should comply with three technical criteria (real-life population, dynamic projection, explicit risk-factor states) and three usability criteria (modest data requirements, rich model output, generally accessible) to be useful in the applied setting of HIA. With DYNAMO-HIA (Dynamic Modeling for Health Impact Assessment), we introduce such a generic software tool specifically designed to facilitate quantification in the assessment of the health impacts of policies. Methods and Results: DYNAMO-HIA quantifies the impact of user-specified risk-factor changes on multiple diseases and in turn on overall population health, comparing one reference scenario with one or more intervention scenarios. The Markov-based modeling approach allows for explicit risk-factor states and simulation of a real-life population. A built-in parameter estimation module ensures that only standard population-level epidemiological evidence is required, i.e. data on incidence, prevalence, relative risks, and mortality. DYNAMO-HIA provides a rich output of summary measures - e.g. life expectancy and disease-free life expectancy - and detailed data - e.g. prevalences and mortality/survival rates - by age, sex, and risk-factor status over time. DYNAMO-HIA is controlled via a graphical user interface and is publicly available from the internet, ensuring general accessibility. We illustrate the use of DYNAMO-HIA with two example applications: a policy causing an overall increase in alcohol consumption and quantifying the disease-burden of smoking. Conclusion: By combining modest data needs with general accessibility and user friendliness within the causal framework of HIA, DYNAMO-HIA is a potential standard tool for health impact assessment based on epidemiologic evidence.	[Lhachimi, Stefan K.; Nusselder, Wilma J.; Kulik, Margarete C.; Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lhachimi, Stefan K.; Boshuizen, Hendriek C.] Natl Inst Publ Hlth & Environm RIVM, Dept Stat & Math Modeling, Bilthoven, Netherlands; [Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van Baal, Pieter] Erasmus Univ, iBMG iMTA, Rotterdam, Netherlands; [van Baal, Pieter] Natl Inst Publ Hlth & Environm RIVM, Expertise Ctr Methodol & Informat Serv, Bilthoven, Netherlands; [Baili, Paolo] Fdn IRCCS Ist Nazl Tumori, Descript Studies & Hlth Planning Unit, Milan, Italy; [Bennett, Kathleen] St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin 8, Ireland; [Fernandez, Esteve] Inst Catala Oncol ICO, Tobacco Control Unit, Canc Control & Prevent Programme, Barcelona, Spain; [Fernandez, Esteve] Inst Invest Biomed Bellvitge IDIBELL, Canc Control & Prevent Grp, Barcelona, Spain; [Fernandez, Esteve] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Kulik, Margarete C.] Natl Inst Publ Hlth & Environm RIVM, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Lobstein, Tim] IASO Int Assoc Study Obes, IOTF Int Obes TaskForce, London, England; [Pomerleau, Joceline; Boshuizen, Hendriek C.] Wageningen Univ, Dept Biometr, Wageningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; Fondazione IRCCS Istituto Nazionale Tumori Milan; Trinity College Dublin; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Netherlands National Institute for Public Health & the Environment; Wageningen University & Research	Lhachimi, SK (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	S.Lhachimi@erasmusmc.nl	Boshuizen, Hendriek/M-3415-2014; Baili, Paolo/J-7422-2016; Boshuizen, Hendriek C/B-3718-2014; Fernandez, Esteve/A-9750-2008; Lhachimi, Stefan K/D-9227-2014	Boshuizen, Hendriek/0000-0002-3916-9095; Baili, Paolo/0000-0003-0335-2418; Fernandez, Esteve/0000-0003-4239-723X; Lhachimi, Stefan K/0000-0001-8597-0935; Lobstein, Tim/0000-0003-4102-0545; Bennett, Kathleen/0000-0002-2861-7665; van Baal, Pieter/0000-0001-9913-2393	EU of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO); Erasmus Medical Center Rotterdam; Institute of Public Health and the Environment in the Netherlands; Catalan Institute of Oncology; International Obesity task force; London School for Hygiene and Tropical Medicine; Haughton Institute in Dublin; Instituto Tumori in Milan; Thematic Network of Cooperative Research on Cancer from the Instituto de Salud Carlos III, Government of Spain [RD06/0020/0089]; Ministry of Universities and Research, Government of Catalonia [2009SGR192]	EU of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO); Erasmus Medical Center Rotterdam; Institute of Public Health and the Environment in the Netherlands; Catalan Institute of Oncology; International Obesity task force; London School for Hygiene and Tropical Medicine; Haughton Institute in Dublin; Instituto Tumori in Milan; Thematic Network of Cooperative Research on Cancer from the Instituto de Salud Carlos III, Government of Spain; Ministry of Universities and Research, Government of Catalonia	The DYNAMO-HIA project was funded by the EU Public Health Programme 2003-2008 of the European Commission's Directorate General for Health and Consumer Affairs (DG SANCO), with co-financing from the Erasmus Medical Center Rotterdam, the Institute of Public Health and the Environment in the Netherlands, the Catalan Institute of Oncology, the International Obesity task force, the London School for Hygiene and Tropical Medicine, the Haughton Institute in Dublin and the Instituto Tumori in Milan. E. Fernandez was also partly supported by the Thematic Network of Cooperative Research on Cancer (RD06/0020/0089) from the Instituto de Salud Carlos III, Government of Spain; and by the Ministry of Universities and Research (2009SGR192), Government of Catalonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams D, 2004, HLTH IMPACT ASSESSME; Barendregt J J, 1998, Math Popul Stud, V7, P29; Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Boshuizen HC, 2012, DEMOGRAPHY, V49, P1259, DOI 10.1007/s13524-012-0122-z; Bray D, 2009, SCI COMMUN, V30, P534, DOI 10.1177/1075547009333698; Bronnum-Hansen H, 2009, SCAND J PUBLIC HEALT, V37, P447, DOI 10.1177/1403494809340387; Cobiac LJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000110; Cole BL, 2005, J EPIDEMIOL COMMUN H, V59, P645, DOI 10.1136/jech.2004.028142; Cole BL, 2007, ANNU REV PUBL HEALTH, V28, P393, DOI 10.1146/annurev.publhealth.28.083006.131942; European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO; Fehr R, 2003, B WORLD HEALTH ORGAN, V81, P408; Holder H., 2005, ESTIMATES HARM ASS C; HOOGENVEEN RT, 2009, MATH MED BIOL; Karnon J, 2003, HEALTH ECON, V12, P837, DOI 10.1002/hec.770; Kemm J., 2007, The effectiveness of health impact assessment: scope and limitations of supporting decision-making in Europe, P3; Kulik MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032363; Lhachimi SK, 2010, EUR J PUBLIC HEALTH, V20, P211; Lhachimi SK, 2011, HLTH IMPACTS INCREAS; Lhachimi SK, 2010, AM J PREV MED, V38, P78, DOI 10.1016/j.amepre.2009.08.030; Massad E, 2005, MED HYPOTHESES, V65, P17, DOI 10.1016/j.mehy.2004.09.029; McPherson K, 2007, TACKELING OBESITIES; Mindell JS, 2008, PUBLIC HEALTH, V122, P1177, DOI 10.1016/j.puhe.2008.03.014; Salay R, 2008, LANCET, V372, P860, DOI 10.1016/S0140-6736(08)61337-9; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van de Kassteele J, 2012, STAT MED, V31, P533, DOI 10.1002/sim.4423; Van Imhoff E, 1998, Popul, V10, P97; Veerman J.L., 2007, QUANTITATIVE HLTH IM; Veerman JL, 2007, J EPIDEMIOL COMMUN H, V61, P362, DOI 10.1136/jech.2006.047480; Wismar M., 2007, The effectiveness of health impact assessment: scope and limitations of supporting decision-making in Europe, P57	29	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e33317	10.1371/journal.pone.0033317	http://dx.doi.org/10.1371/journal.pone.0033317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TN	22590491	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400001
J	Pinto, AR; Paolicelli, R; Salimova, E; Gospocic, J; Slonimsky, E; Bilbao-Cortes, D; Godwin, JW; Rosenthal, NA				Pinto, Alexander R.; Paolicelli, Rosa; Salimova, Ekaterina; Gospocic, Janko; Slonimsky, Esfir; Bilbao-Cortes, Daniel; Godwin, James W.; Rosenthal, Nadia A.			An Abundant Tissue Macrophage Population in the Adult Murine Heart with a Distinct Alternatively-Activated Macrophage Profile	PLOS ONE			English	Article							DIET-INDUCED OBESITY; GROWTH FACTOR-I; ADIPOSE-TISSUE; DENDRITIC CELLS; STEM-CELLS; FRACTALKINE RECEPTOR; MUSCLE REGENERATION; GENE SIGNATURE; MONOCYTE; VIVO	Cardiac tissue macrophages (cTMs) are a previously uncharacterised cell type that we have identified and characterise here as an abundant GFP(+) population within the adult Cx(3)cr1(GFP/+) knock-in mouse heart. They comprise the predominant myeloid cell population in the myocardium, and are found throughout myocardial interstitial spaces interacting directly with capillary endothelial cells and cardiomyocytes. Flow cytometry-based immunophenotyping shows that cTMs exhibit canonical macrophage markers. Gene expression analysis shows that cTMs (CD45(+)CD11b(+)GFP(+)) are distinct from mononuclear CD45(+)CD11b(+)GFP(+) cells sorted from the spleen and brain of adult Cx(3)cr1(GFP/+) mice. Gene expression profiling reveals that cTMs closely resemble alternatively-activated anti-inflammatory M2 macrophages, expressing a number of M2 markers, including Mrc1, CD163, and Lyve-1. While cTMs perform normal tissue macrophage homeostatic functions, they also exhibit a distinct phenotype, involving secretion of salutary factors (including IGF-1) and immune modulation. In summary, the characterisation of cTMs at the cellular and molecular level defines a potentially important role for these cells in cardiac homeostasis.	[Pinto, Alexander R.; Paolicelli, Rosa; Salimova, Ekaterina; Gospocic, Janko; Slonimsky, Esfir; Bilbao-Cortes, Daniel; Rosenthal, Nadia A.] European Mol Biol Lab, Mouse Biol Unit, Rome, Italy; [Pinto, Alexander R.; Godwin, James W.; Rosenthal, Nadia A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Rosenthal, Nadia A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, London, England	European Molecular Biology Laboratory (EMBL); Australian Regenerative Medicine Institute; Monash University; Imperial College London	Pinto, AR (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Rome, Italy.	alex.pinto@monash.edu; nadia.rosenthal@monash.edu	Pinto, Alexander/AAF-5556-2021	Pinto, Alexander/0000-0001-6421-4970; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Godwin, James/0000-0002-9234-7807; Rosenthal, Nadia/0000-0002-7599-7365; Bilbao Cortes, Daniel/0000-0003-1630-8811; , Ekaterina/0000-0002-4362-7108	European Union [EUCOMM:LSHM-CT-2005-018931, EUMODIC:LSHG-CT-2006-037188, EUCOMMTOOLS:HEALTH-F4-2010-261492]; HeartRepair: Heart Failure and Repair [LSHM-CT-2005-018630]; Australian Government; State Government of Victoria	European Union(European Commission); HeartRepair: Heart Failure and Repair; Australian Government(Australian GovernmentCGIAR); State Government of Victoria	This work was funded by grants to NR from the European Union (EUCOMM:LSHM-CT-2005-018931; EUMODIC:LSHG-CT-2006-037188; EUCOMMTOOLS:HEALTH-F4-2010-261492; and HeartRepair: Heart Failure and Repair LSHM-CT-2005-018630). The Australian Regenerative Medicine Institute is supported by grants from the Australian Government and State Government of Victoria. NR is an NHMRC Australia Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cihakova D, 2008, AM J PATHOL, V172, P1195, DOI 10.2353/ajpath.2008.070207; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fairweather D, 2006, J IMMUNOL, V176, P3516, DOI 10.4049/jimmunol.176.6.3516; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GRANT MB, 1993, DIABETOLOGIA, V36, P282, DOI 10.1007/BF00400229; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lim JP, IMMUNOL CELL BIOL; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002; Musaro A, 2007, EUR J HISTOCHEM, V51, P35; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	57	143	150	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36814	10.1371/journal.pone.0036814	http://dx.doi.org/10.1371/journal.pone.0036814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590615	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336400037
J	Plano, SA; Agostino, PV; de la Iglesia, HO; Golombek, DA				Plano, Santiago A.; Agostino, Patricia V.; de la Iglesia, Horacio O.; Golombek, Diego A.			cGMP-Phosphodiesterase Inhibition Enhances Photic Responses and Synchronization of the Biological Circadian Clock in Rodents	PLOS ONE			English	Article							INDUCED PHASE ADVANCES; NITRIC-OXIDE SYNTHASE; CHRONIC JET-LAG; SUPRACHIASMATIC NUCLEUS; BODY-TEMPERATURE; ACCELERATES REENTRAINMENT; TYPE-5 INHIBITORS; FOS EXPRESSION; DOUBLE-BLIND; KINASE-II	The master circadian clock in mammals is located in the hypothalamic suprachiasmatic nuclei (SCN) and is synchronized by several environmental stimuli, mainly the light-dark (LD) cycle. Light pulses in the late subjective night induce phase advances in locomotor circadian rhythms and the expression of clock genes (such as Per1-2). The mechanism responsible for light-induced phase advances involves the activation of guanylyl cyclase (GC), cGMP and its related protein kinase (PKG). Pharmacological manipulation of cGMP by phosphodiesterase (PDE) inhibition (e.g., sildenafil) increases low-intensity light-induced circadian responses, which could reflect the ability of the cGMP-dependent pathway to directly affect the photic sensitivity of the master circadian clock within the SCN. Indeed, sildenafil is also able to increase the phase-shifting effect of saturating (1200 lux) light pulses leading to phase advances of about 9 hours, as well as in C57 a mouse strain that shows reduced phase advances. In addition, sildenafil was effective in both male and female hamsters, as well as after oral administration. Other PDE inhibitors (such as vardenafil and tadalafil) also increased light-induced phase advances of locomotor activity rhythms and accelerated reentrainment after a phase advance in the LD cycle. Pharmacological inhibition of the main downstream target of cGMP, PKG, blocked light-induced expression of Per1. Our results indicate that the cGMP-dependent pathway can directly modulate the light-induced expression of clock-genes within the SCN and the magnitude of light-induced phase advances of overt rhythms, and provide promising tools to design treatments for human circadian disruptions.	[Plano, Santiago A.; Agostino, Patricia V.; Golombek, Diego A.] Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina; [de la Iglesia, Horacio O.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Washington; University of Washington Seattle	Plano, SA (corresponding author), Univ Nacl Quilmes, CONICET, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina.	dgolombek@unq.edu.ar		Golombek, Diego/0000-0002-6291-5586	US National Institutes of Health Research [R01 MH075016]; National University of Quilmes; National Science Agency [R03TW008037]; FOGARTY INTERNATIONAL CENTER [R03TW008037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075016] Funding Source: NIH RePORTER	US National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National University of Quilmes; National Science Agency; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health Research Grants R01 MH075016 (to HdlI), grants from the National University of Quilmes and the National Science Agency (to DAG) and R03TW008037 (to HdlI and DAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino PV, 2007, P NATL ACAD SCI USA, V104, P9834, DOI 10.1073/pnas.0703388104; Agostino PV, 2004, NEUROCHEM INT, V44, P617, DOI 10.1016/j.neuint.2003.09.005; ARENDT J, 1982, BRIT MED J, V284, P144, DOI 10.1136/bmj.284.6310.144; Atkinson G, 2007, EUR J APPL PHYSIOL, V99, P331, DOI 10.1007/s00421-006-0361-z; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Briganti A, 2005, NAT CLIN PRACT UROL, V2, P239, DOI 10.1038/ncpuro0186; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cambras T, 2007, P NATL ACAD SCI USA, V104, P7634, DOI 10.1073/pnas.0702424104; Colwell CS, 2001, EUR J NEUROSCI, V13, P1420, DOI 10.1046/j.0953-816x.2001.01517.x; COMPERATORE CA, 1990, OCCUP MED, V5, P323; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; Dallmann R, 2006, PHYSIOL BEHAV, V88, P459, DOI 10.1016/j.physbeh.2006.04.022; Dauvilliers Y, 2008, CURR PHARM DESIGN, V14, P3386, DOI 10.2174/138161208786549308; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; de la Iglesia Horacio O, 2007, Methods Mol Biol, V362, P513; Ding JM, 1998, NATURE, V394, P381, DOI 10.1038/28639; Ebling FJP, 1996, PROG NEUROBIOL, V50, P109, DOI 10.1016/S0301-0082(96)00032-9; Edelstein K, 2003, NEUROSCIENCE, V118, P253, DOI 10.1016/S0306-4522(02)00908-9; Ferreyra GA, 2001, AM J PHYSIOL-REG I, V280, pR1348, DOI 10.1152/ajpregu.2001.280.5.R1348; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Francis SH, 2003, INT J IMPOT RES, V15, P369, DOI 10.1038/sj.ijir.3901040; Gabrieli CB, 2003, DOC OPHTHALMOL, V107, P111, DOI 10.1023/A:1026271404384; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Golombek DA, 2003, FRONT BIOSCI-LANDMRK, V8, pS285, DOI 10.2741/1038; Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023; GOLOMBEK DA, 1993, PHYSIOL BEHAV, V53, P1049, DOI 10.1016/0031-9384(93)90358-M; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hirai K, 2005, J BIOL RHYTHM, V20, P27, DOI 10.1177/0748730404269890; Sande PH, 2008, AM J PATHOL, V173, P1702, DOI 10.2353/ajpath.2008.080518; Jagle H, 2004, AM J OPHTHALMOL, V137, P842, DOI 10.1016/j.ajo.2003.11.081; Johnson CH, 2003, CHRONOBIOL INT, V20, P741, DOI 10.1081/CBI-120024211; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; Laties AM, 2002, PROG RETIN EYE RES, V21, P485, DOI 10.1016/S1350-9462(02)00013-7; Lee ML, 2009, CURR BIOL, V19, P848, DOI 10.1016/j.cub.2009.03.051; Luke M, 2005, J OCUL PHARMACOL TH, V21, P305, DOI 10.1089/jop.2005.21.305; Mahoney MM, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/813764; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Montoliu C, 2010, METAB BRAIN DIS, V25, P39, DOI 10.1007/s11011-010-9184-z; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; Neves C, 2010, SLEEP MED, V11, P545, DOI 10.1016/j.sleep.2010.02.010; Oster H, 2003, CURR BIOL, V13, P725, DOI 10.1016/S0960-9822(03)00252-5; Pfeffer M, 2009, J NEUROSCI, V29, P6114, DOI 10.1523/JNEUROSCI.0275-09.2009; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Plano SA, 2007, FEBS LETT, V581, P5500, DOI 10.1016/j.febslet.2007.10.058; Plano SA, 2010, EUR J NEUROSCI, V31, P876, DOI 10.1111/j.1460-9568.2010.07120.x; Prickaerts J, 2002, NEUROSCIENCE, V113, P351, DOI 10.1016/S0306-4522(02)00199-9; REFINETTI R, 1992, J EXP ZOOL, V263, P453, DOI 10.1002/jez.1402630413; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roizenblatt S, 2006, ARCH INTERN MED, V166, P1763, DOI 10.1001/archinte.166.16.1763; Sabayan B, 2010, INT J NEUROSCI, V120, P746, DOI 10.3109/00207454.2010.520381; Sack RL, 2009, TRAVEL MED INFECT DI, V7, P102, DOI 10.1016/j.tmaid.2009.01.006; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stockman Andrew, 2007, J Vis, V7, P4; Tischkau SA, 2003, J NEUROSCI, V23, P7543; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Van Someren EJW, 2000, CHRONOBIOL INT, V17, P313, DOI 10.1081/CBI-100101050; Waterhouse J, 2005, CHRONOBIOL INT, V22, P207, DOI 10.1081/CBI-200053477; WEBER ET, 1995, BRAIN RES, V692, P137; WEBER ET, 1995, NEUROSCI LETT, V197, P227, DOI 10.1016/0304-3940(95)11961-U; Weeks JL, 2005, INT J IMPOT RES, V17, P5, DOI 10.1038/sj.ijir.3901283; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Williams G, 1996, CLIN PHYSIOL, V16, P327, DOI 10.1111/j.1475-097X.1996.tb00722.x; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan L, 2002, EUR J NEUROSCI, V16, P1531, DOI 10.1046/j.1460-9568.2002.02224.x; Yan L, 2006, J NEUROSCI, V26, P9434, DOI 10.1523/JNEUROSCI.2538-06.2006; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Zisapel N, 2001, CELL MOL NEUROBIOL, V21, P605, DOI 10.1023/A:1015187601628; Zoumalan CI, 2009, DOC OPHTHALMOL, V118, P225, DOI 10.1007/s10633-008-9148-3	79	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37121	10.1371/journal.pone.0037121	http://dx.doi.org/10.1371/journal.pone.0037121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590651	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400060
J	Alter, SE; Newsome, SD; Palumbi, SR				Alter, S. Elizabeth; Newsome, Seth D.; Palumbi, Stephen R.			Pre-Whaling Genetic Diversity and Population Ecology in Eastern Pacific Gray Whales: Insights from Ancient DNA and Stable Isotopes	PLOS ONE			English	Article							TIME DEPENDENCY; CYTOCHROME-B; SIZE; COALESCENT; PATTERNS; BIOGEOCHEMISTRY; RADIOCARBON; MANAGEMENT; MIGRATION; WILDLIFE	Commercial whaling decimated many whale populations, including the eastern Pacific gray whale, but little is known about how population dynamics or ecology differed prior to these removals. Of particular interest is the possibility of a large population decline prior to whaling, as such a decline could explain the similar to 5-fold difference between genetic estimates of prior abundance and estimates based on historical records. We analyzed genetic (mitochondrial control region) and isotopic information from modern and prehistoric gray whales using serial coalescent simulations and Bayesian skyline analyses to test for a pre-whaling decline and to examine prehistoric genetic diversity, population dynamics and ecology. Simulations demonstrate that significant genetic differences observed between ancient and modern samples could be caused by a large, recent population bottleneck, roughly concurrent with commercial whaling. Stable isotopes show minimal differences between modern and ancient gray whale foraging ecology. Using rejection-based Approximate Bayesian Computation, we estimate the size of the population bottleneck at its minimum abundance and the pre-bottleneck abundance. Our results agree with previous genetic studies suggesting the historical size of the eastern gray whale population was roughly three to five times its current size.	[Alter, S. Elizabeth; Palumbi, Stephen R.] Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Newsome, Seth D.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Stanford University; University of Wyoming	Alter, SE (corresponding author), CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA.	ealter@york.cuny.edu			Teresa Heinz Scholars for Environmental Research award	Teresa Heinz Scholars for Environmental Research award	Funding was provided by a Teresa Heinz Scholars for Environmental Research award to SEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Alter SE, 2009, J MOL EVOL, V68, P97, DOI 10.1007/s00239-008-9193-2; Alter SE, 2009, J HERED, V100, P34, DOI 10.1093/jhered/esn090; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Aurioles D, 2006, MAR MAMMAL SCI, V22, P326, DOI 10.1111/j.1748-7692.2006.00023.x; Axelsson E, 2008, MOL BIOL EVOL, V25, P2181, DOI 10.1093/molbev/msn163; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Barnes I, 2007, CURR BIOL, V17, P1072, DOI 10.1016/j.cub.2007.05.035; Beaumont MA, 2002, GENETICS, V162, P2025; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Chan YL, 2006, PLOS GENET, V2, P451, DOI 10.1371/journal.pgen.0020059; CLAPHAM P, 2005, J CETACEAN RES MAN S, V7, P386; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Darling JD, 1998, MAR MAMMAL SCI, V14, P692, DOI 10.1111/j.1748-7692.1998.tb00757.x; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Druffel ERM, 2001, RADIOCARBON, V43, P15; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frasier Timothy R., 2011, Endangered Species Research, V14, P39, DOI 10.3354/esr00340; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hedrick P, 2005, EVOLUTION, V59, P1596; HENDERSON DA, 1972, MEN WHALES SCAMMONS; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Hideshima S, 2001, RADIOCARBON, V43, P473; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, MOL BIOL EVOL, V24, P1416, DOI 10.1093/molbev/msm062; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HUDSON RR, 1992, GENETICS, V132, P583; Huelsbeck D. R., 1994, OZETTE ARCHAEOLOGICA, VII, P265; Jackson JA, 2009, MOL BIOL EVOL, V26, P2427, DOI 10.1093/molbev/msp169; Kalinowski ST, 2002, CONSERV BIOL, V16, P129, DOI 10.1046/j.1523-1739.2002.00134.x; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Krupnik II, 1984, GRAY WHALE; LeDuc R. G., 2002, Journal of Cetacean Research and Management, V4, P1; Moore SE, 2003, CAN J ZOOL, V81, P734, DOI 10.1139/Z03-043; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Perryman WL, 2002, MAR MAMMAL SCI, V18, P121, DOI 10.1111/j.1748-7692.2002.tb01023.x; Phillips CD, 2009, MOL ECOL, V18, P3379, DOI 10.1111/j.1365-294X.2009.04283.x; Pinksky ML, 2010, MOL ECOL, V19, P2418; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyenson ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021295; Ramakrishnan U, 2005, MOL ECOL, V14, P2915, DOI 10.1111/j.1365-294X.2005.02586.x; Rambaut A, 2009, MOL BIOL EVOL, V26, P245, DOI 10.1093/molbev/msn256; Reeves RR, 2002, MAMMAL REV, V32, P71, DOI 10.1046/j.1365-2907.2002.00100.x; Rice DW., 1971, LIFE HIST ECOLOGY GR, DOI DOI 10.5962/BHL.TITLE.39537; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rooney AP, 2001, EVOLUTION, V55, P1678; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Steeves TE, 2001, CONSERV GENET, V2, P379, DOI 10.1023/A:1012590315579; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Townsend CH, 1885, B US FISHERIES COMMI, V6, P340; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Wade PR, 2002, IWC SCI COMM S UNPUB; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang DY, 2006, MOL ECOL NOTES, V6, P605, DOI 10.1111/j.1471-8286.2006.01370.x; Yoneda M, 2007, NUCL INSTRUM METH B, V259, P432, DOI 10.1016/j.nimb.2007.01.184	77	50	53	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35039	10.1371/journal.pone.0035039	http://dx.doi.org/10.1371/journal.pone.0035039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590499	Green Published, gold			2022-12-27	WOS:000305336100005
J	Hartwig, T; Corvalan, C; Best, NB; Budka, JS; Zhu, JY; Choe, S; Schulz, B				Hartwig, Thomas; Corvalan, Claudia; Best, Norman B.; Budka, Joshua S.; Zhu, Jia-Ying; Choe, Sunghwa; Schulz, Burkhard			Propiconazole Is a Specific and Accessible Brassinosteroid (BR) Biosynthesis Inhibitor for Arabidopsis and Maize	PLOS ONE			English	Article							TRACHEARY-ELEMENT DIFFERENTIATION; GIBBERELLIN BIOSYNTHESIS; SIGNAL-TRANSDUCTION; LAMINA INCLINATION; DWARF4 EXPRESSION; GENE-EXPRESSION; MUTANT; GROWTH; CYTOCHROME-P450; DEGRADATION	Brassinosteroids (BRs) are steroidal hormones that play pivotal roles during plant development. In addition to the characterization of BR deficient mutants, specific BR biosynthesis inhibitors played an essential role in the elucidation of BR function in plants. However, high costs and limited availability of common BR biosynthetic inhibitors constrain their key advantage as a species-independent tool to investigate BR function. We studied propiconazole (Pcz) as an alternative to the BR inhibitor brassinazole (Brz). Arabidopsis seedlings treated with Pcz phenocopied BR biosynthetic mutants. The steady state mRNA levels of BR, but not gibberellic acid (GA), regulated genes increased proportional to the concentrations of Pcz. Moreover, root inhibition and Pcz-induced expression of BR biosynthetic genes were rescued by 24epi-brassinolide, but not by GA3 co-applications. Maize seedlings treated with Pcz showed impaired mesocotyl, coleoptile, and true leaf elongation. Interestingly, the genetic background strongly impacted the tissue specific sensitivity towards Pcz. Based on these findings we conclude that Pcz is a potent and specific inhibitor of BR biosynthesis and an alternative to Brz. The reduced cost and increased availability of Pcz, compared to Brz, opens new possibilities to study BR function in larger crop species.	[Hartwig, Thomas; Best, Norman B.; Budka, Joshua S.; Schulz, Burkhard] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Corvalan, Claudia; Choe, Sunghwa] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Zhu, Jia-Ying] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Seoul National University (SNU); Carnegie Institution for Science; Seoul National University (SNU)	Hartwig, T (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	shchoe@snu.ac.kr; bschulz@purdue.edu	Best, Norman B/G-1969-2015; Choe, Sunghwa/K-5650-2013	Best, Norman B/0000-0002-6572-5999; Choe, Sunghwa/0000-0001-5541-484X	Plant Molecular Breeding Center [PJ008051]; Cooperative Research Program for Agriculture Science & Technology Development [PJ906910]; Rural Development Administration, Republic of Korea; Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [110033-5]; Ministry of Education, Science, and Technology of the Korean Government; Department of Horticulture and Landscape Architecture, Purdue University; Direct For Biological Sciences [1054918] Funding Source: National Science Foundation	Plant Molecular Breeding Center; Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; Ministry of Education, Science, and Technology of the Korean Government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Department of Horticulture and Landscape Architecture, Purdue University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008051) and the Cooperative Research Program for Agriculture Science & Technology Development (project no. PJ906910), Rural Development Administration, Republic of Korea, by Technology Development Program (110033-5) for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (to SC), and the BK21 Research Fellowships funded by the Ministry of Education, Science, and Technology of the Korean Government (to CC). This work was also supported by startup funds from the Department of Horticulture and Landscape Architecture, Purdue University (to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Asami T, 2001, J BIOL CHEM, V276, P25687, DOI 10.1074/jbc.M103524200; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bai MY, 2007, P NATL ACAD SCI USA, V104, P13839, DOI 10.1073/pnas.0706386104; Belkhadir Y, 2010, GENETICS, V185, P1283, DOI 10.1534/genetics.109.111898; Blackwell HE, 2003, PLANT PHYSIOL, V133, P448, DOI 10.1104/pp.103.031138; Cheon J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-270; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Chung Y, 2011, PLANT J, V66, P564, DOI 10.1111/j.1365-313X.2011.04513.x; Clouse SD, 1999, BRASSINOSTEROIDS, P163; Clouse Steven D, 2011, Arabidopsis Book, V9, pe0151, DOI 10.1199/tab.0151; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; DELEENS E, 1984, PLANT SCI LETT, V37, P35, DOI 10.1016/0304-4211(84)90199-8; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; Fernandez MGS, 2009, TRENDS PLANT SCI, V14, P454, DOI 10.1016/j.tplants.2009.06.005; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Fukuda H, 2004, NAT REV MOL CELL BIO, V5, P379, DOI 10.1038/nrm1364; GACHOTTE D, 1995, PLANT J, V8, P407, DOI 10.1046/j.1365-313X.1995.08030407.x; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gomes MMA, 2011, BRASSINOSTEROIDS: A CLASS OF PLANT HORMONE, P193, DOI 10.1007/978-94-007-0189-2_7; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; IWAHORI S, 1990, PLANT GROWTH REGUL, V9, P119, DOI 10.1007/BF00027439; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007, DOI 10.1093/oxfordjournals.pcp.a078163; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kim HB, 2006, PLANT PHYSIOL, V140, P548, DOI 10.1104/pp.105.067918; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2012, NATURE; Kim YS, 2005, PHYTOCHEMISTRY, V66, P1000, DOI 10.1016/j.phytochem.2005.03.007; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Li L, 2009, PLANT J, V58, P275, DOI 10.1111/j.1365-313X.2008.03778.x; Li ZH, 2013, ENVIRON TOXICOL, V28, P119, DOI 10.1002/tox.20701; Liu KJ, 2003, GENETICS, V165, P2117; Maharjan PM, 2011, J PLANT BIOL, V54, P425, DOI 10.1007/s12374-011-9183-6; Maharjan PM, 2011, J PLANT BIOL, V54, P126, DOI 10.1007/s12374-010-9138-3; Makarevitch I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030798; Min YK, 1999, BIOORG MED CHEM LETT, V9, P425, DOI 10.1016/S0960-894X(99)00008-6; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Noguchi T, 1999, PLANT PHYSIOL, V120, P833, DOI 10.1104/pp.120.3.833; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; OWEN WJ, 1986, PESTIC BIOCHEM PHYS, V26, P75, DOI 10.1016/0048-3575(86)90064-7; Rademacher W, 2000, ANNU REV PLANT PHYS, V51, P501, DOI 10.1146/annurev.arplant.51.1.501; Rademacher W., 2020, PLANT BIOCH REGULATO, P169; Raikhel N, 2005, PLANT PHYSIOL, V138, P563, DOI 10.1104/pp.104.900155; SASSE JM, 1995, P PLANT GROWTH REGUL, V22, P136; Schnabel G, 2003, PEST MANAG SCI, V59, P1143, DOI 10.1002/ps.744; Schulz B, 2006, FEBS LETT, V580, P1010, DOI 10.1016/j.febslet.2006.01.002; Sekimata K, 2002, J AGR FOOD CHEM, V50, P3486, DOI 10.1021/jf011716w; Sekimata K, 2001, PLANTA, V213, P716, DOI 10.1007/s004250100546; Song L, 2009, MOL PLANT, V2, P755, DOI 10.1093/mp/ssp039; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Thorstensen CW, 2001, J ENVIRON QUAL, V30, P947, DOI 10.2134/jeq2001.303947x; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; WADA K, 1981, PLANT CELL PHYSIOL, V22, P323; WADA K, 1984, AGR BIOL CHEM TOKYO, V48, P719, DOI 10.1080/00021369.1984.10866208; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; WIGGINS TE, 1984, PESTIC SCI, V15, P206, DOI 10.1002/ps.2780150212; Xu YL, 1997, PLANT PHYSIOL, V114, P1471, DOI 10.1104/pp.114.4.1471; Xu YL, 1999, PLANT CELL, V11, P927, DOI 10.1105/tpc.11.5.927; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980, DOI 10.1093/oxfordjournals.pcp.a029262; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; YOKOTA T, 1991, GIBBERELLINS, P339; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zar JH., 2010, BIOSTAT ANAL, V5th; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	74	91	95	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36625	10.1371/journal.pone.0036625	http://dx.doi.org/10.1371/journal.pone.0036625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590578	gold, Green Published			2022-12-27	WOS:000305336100048
J	Liu, WZ; Wu, JB; Xiao, L; Bai, YJ; Qu, AQ; Zheng, Z; Yuan, ZQ				Liu, Weizhe; Wu, Junbing; Xiao, Lei; Bai, Yujie; Qu, Aiqin; Zheng, Zheng; Yuan, Zengqiang			Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway	PLOS ONE			English	Article							KINASE MST2; TYROSINE KINASE; C-ABL; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; CASPASE	Background: Mammalian Ste20-like kinases (MSTs) are the mammalian homologue of Drosophila hippo and play critical roles in regulation of cell death, organ size control, proliferation and tumorigenesis. MSTs exert pro-apoptotic function through cleavage, autophosphorylation and in turn phosphorylation of downstream targets, such as Histone H2B and FOXO ( Forkhead box O). Previously we reported that protein kinase c-Abl mediates oxidative stress-induced neuronal cell death through phosphorylating MST1 at Y433, which is not conserved among mammalian MST2, Drosophila Hippo and C. elegans cst-1/2. Methodology/Principal Findings: Using immunoblotting, in vitro kinase and cell death assay, we demonstrate that c-Abl kinase phosphorylates MST2 at an evolutionarily conserved site, Y81, within the kinase domain. We further show that the phosphorylation of MST2 by c-Abl leads to the disruption of the interaction with Raf-1 proteins and the enhancement of homodimerization of MST2 proteins. It thereby enhances the MST2 activation and induces neuronal cell death. Conclusions/Significance: The identification of the c-Abl tyrosine kinase as a novel upstream activator of MST2 suggests that the conserved c-Abl-MST signaling cascade plays an important role in oxidative stress-induced neuronal cell death.	[Wu, Junbing; Xiao, Lei; Bai, Yujie; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Liu, Weizhe] Dalian Med Univ, Ctr Canc, Inst Canc Stem Cell, Liaoning, Peoples R China; [Liu, Weizhe; Qu, Aiqin] Shandong Univ, Coll Life Sci, Jinan, Shandong, Peoples R China; [Zheng, Zheng] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Beijing, Peoples R China; [Wu, Junbing; Xiao, Lei; Bai, Yujie] Chinese Acad Sci, Grad Univ, Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Dalian Medical University; Shandong University; Capital Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, WZ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zqyuan@ibp.ac.cn	Xiao, Lei/I-3655-2017; xiao, Lei/J-4217-2017	Yuan, Zengqiang/0000-0001-5739-2867	National Science Foundation of China [30870792, 81030025]; National Basic Research Program of China (973 Program) [2009CB918704, 2012CB910701]; CAS	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); CAS(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (Grant No. 30870792 and 81030025), the National Basic Research Program of China (973 Program, Grant No. 2009CB918704 and 2012CB910701) and CAS Knowledge Innovation Program to Z.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT RL, 1992, DEVELOPMENT, V116, P953; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; Cancino GI, 2011, NEUROBIOL AGING, V32, P1249, DOI 10.1016/j.neurobiolaging.2009.07.007; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Kharbanda S, 1998, ONCOGENE, V17, P3309, DOI 10.1038/sj.onc.1202571; Kim D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009616; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Pan D, DEV CELL, V19, P491; Romano D, 2010, CANCER RES, V70, P1195, DOI 10.1158/0008-5472.CAN-09-3147; Xiao L, 2011, J NEUROSCI, V31, P9611, DOI 10.1523/JNEUROSCI.0035-11.2011; Xiao L, 2010, PROTEIN CELL, V1, P706, DOI 10.1007/s13238-010-0097-8; Yoshida K, 2007, ADV EXP MED BIOL, V604, P155, DOI 10.1007/978-0-387-69116-9_15; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	18	43	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36562	10.1371/journal.pone.0036562	http://dx.doi.org/10.1371/journal.pone.0036562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590567	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100040
J	Miyata, H; Minagawa-Kawai, Y; Watanabe, S; Sasaki, T; Ueda, K				Miyata, Hiromitsu; Minagawa-Kawai, Yasuyo; Watanabe, Shigeru; Sasaki, Toyofumi; Ueda, Kazuhiro			Reading Speed, Comprehension and Eye Movements While Reading Japanese Novels: Evidence from Untrained Readers and Cases of Speed-Reading Trainees	PLOS ONE			English	Article							TIME; TEXT	Background: A growing body of evidence suggests that meditative training enhances perception and cognition. In Japan, the Park-Sasaki method of speed-reading involves organized visual training while forming both a relaxed and concentrated state of mind, as in meditation. The present study examined relationships between reading speed, sentence comprehension, and eye movements while reading short Japanese novels. In addition to normal untrained readers, three middle-level trainees and one high-level expert on this method were included for the two case studies. Methodology/Principal Findings: In Study 1, three of 17 participants were middle-level trainees on the speed-reading method. Immediately after reading each story once on a computer monitor, participants answered true or false questions regarding the content of the novel. Eye movements while reading were recorded using an eye-tracking system. Results revealed higher reading speed and lower comprehension scores in the trainees than in the untrained participants. Furthermore, eye-tracking data by untrained participants revealed multiple correlations between reading speed, accuracy and eye-movement measures, with faster readers showing shorter fixation durations and larger saccades in X than slower readers. In Study 2, participants included a high-level expert and 14 untrained students. The expert showed higher reading speed and statistically comparable, although numerically lower, comprehension scores compared with the untrained participants. During test sessions this expert moved her eyes along a nearly straight horizontal line as a first pass, without moving her eyes over the whole sentence display as did the untrained students. Conclusions/Significance: In addition to revealing correlations between speed, comprehension and eye movements in reading Japanese contemporary novels by untrained readers, we describe cases of speed-reading trainees regarding relationships between these variables. The trainees overall tended to show poor performance influenced by the speed-accuracy trade-off, although this trade-off may be reduced in the case of at least one high-level expert.	[Miyata, Hiromitsu] Japan Soc Promot Sci, Tokyo, Japan; [Miyata, Hiromitsu; Minagawa-Kawai, Yasuyo] Keio Univ, Grad Sch Human Relat, Tokyo, Japan; [Watanabe, Shigeru] Keio Univ, Dept Psychol, Tokyo, Japan; [Sasaki, Toyofumi] NBS Japan Soc Speed Reading Educ, Tokyo, Japan; [Ueda, Kazuhiro] Univ Tokyo, CREST, Japan Sci & Technol Agcy, Interfac Initiat Informat Studies, Tokyo, Japan	Japan Society for the Promotion of Science; Keio University; Keio University; Japan Science & Technology Agency (JST); University of Tokyo	Miyata, H (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	miyata@cog.human.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) for Young Scientists; JSPS [21118005]; Japan Ministry of Education, Culture, Sports, Science and Technology [D-09]	Japan Society for the Promotion of Science (JSPS) for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata, the Grants-in-Aid for Scientific Research No. 21118005 from JSPS to Kazuhiro Ueda, and by the Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program, D-09, to Keio University, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 2011, J GEN PSYCHOL, V138, P127, DOI 10.1080/00221309.2010.542510; Baker T, 2009, J VIS, V9, p835a; Bell T, 2001, EXTENSIVE READING SP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berkoff N. A., 1979, J RES READ, V2, P95, DOI [10.1111/jrir.1979.2.issue-2, DOI 10.1111/J.1467-9817.1979.TB00197.X]; Bernhardt E. B., 1993, READING DEV 2 LANGUA; Carver R. P., 1990, READING RATE REV RES; CRANNEY AG, 1982, J READING, V25, P526; Duggan GB, 2009, J EXP PSYCHOL-APPL, V15, P228, DOI 10.1037/a0016995; Dyson MC, 2001, INT J HUM-COMPUT ST, V54, P585, DOI 10.1006/ijhc.2001.0458; Ferreira P., 2011, J EYE TRACKING VISUA, V1, P64; Fujimaki N, 2004, NEUROREPORT, V15, P239, DOI 10.1097/00001756-200402090-00005; Fujimaki N, 2009, NEUROSCI RES, V65, P335, DOI 10.1016/j.neures.2009.08.009; Haselgrove, 2000, J RES READ, V23, P210, DOI [DOI 10.1111/1467-9817.00115, 10.1111/1467-9817.00115]; IWATA M, 1984, TRENDS NEUROSCI, V7, P290, DOI 10.1016/S0166-2236(84)80198-8; Just M.A., 1987, PSYCHOL READING LANG, P425; Kallmark F, 2010, ACTA OPHTHALMOL, P88, DOI [10.1111/j.1755-3768.2010.289.x, DOI 10.1111/J.1755-3768.2010.289.X]; Kato M., 2005, P 27 ANN C COGN SCI, P1102; Kato N, 2008, P 6 INT C COGN SCI, P639; Kawano K, 2005, J INT SOC LIFE INF S, V23, P174; Kinnunen R, 2010, TRENDS AND PROSPECTS IN METACOGNITION RESEARCH, P209, DOI 10.1007/978-1-4419-6546-2_10; Komatsu C, 2010, 99 NO NAMIDA TSUKI, P136; Lai F. -K, 1993, SYSTEM, V21, P87, DOI [10.1016/0346-251X(93)90009-6, DOI 10.1016/0346-251X(93)90009-6]; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Martin C, 2011, LECT NOTES ARTIF INT, V6781, P592, DOI 10.1007/978-3-642-21741-8_63; MASSON MEJ, 1982, J EXP PSYCHOL LEARN, V8, P400, DOI 10.1037/0278-7393.8.5.400; McNamara DS, 2000, NAG21319; Minagawa-Kawai Y., 2009, NEW APPROACH FUNCTIO; Miyata H, 2010, STUDIES SOCIOLOGY PS, V70, P125; Miyata H, 2011, BRAIN RES, V1374, P90, DOI 10.1016/j.brainres.2010.12.047; Murakami M, 2009, 99 NO NAMIDA AME, P180; Natori S, 2010, 99 NO NAMIDA TSUKI, P7; NELL V, 1988, READ RES QUART, V23, P6, DOI 10.2307/747903; Oakhill J. V., 2005, READ WRIT, V18, P657, DOI [10.1007/s11145-005-3355-z, DOI 10.1007/S11145-005-3355-Z, 10.1007/S11145-005-3355-Z]; PERFETTI CA, 1976, J VERB LEARN VERB BE, V15, P33, DOI 10.1016/S0022-5371(76)90004-9; Philip HKS, 1990, COGNITIVE PSYCHOL IN, P135; POULTON EC, 1958, BRIT J PSYCHOL, V49, P230, DOI 10.1111/j.2044-8295.1958.tb00661.x; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; Sandra BK, 2011, EMOTION, V11, P299, DOI 10.1037/a0022764; Sasaki T, 1986, KAGAKU TEKI SOKUDOKU; Sasaki T, 1995, SOKUDOKU NO KAGAKU; Tanaka T, 2010, 99 NO NAMIDA HOSHI, P122; Taniguchi M, 2010, 99 NO NAMIDA HIKARI, P7; Tinker M.A., 1963, LEGIBILITY PRINT; Uchida-Ota M, 2008, NEUROIMAGE, V42, P357, DOI 10.1016/j.neuroimage.2008.03.055; Usui K, 2005, COGNITIVE BRAIN RES, V24, P274, DOI 10.1016/j.cogbrainres.2005.02.001; Walczyk JJ, 1999, CONTEMP EDUC PSYCHOL, V24, P156, DOI 10.1006/ceps.1998.0992; Wu R, 2010, J EXP CHILD PSYCHOL, V107, P118, DOI 10.1016/j.jecp.2010.04.014; Yokoyama S, 1992, NICHIDAI IGAKU ZASSH, V59, P234	51	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36091	10.1371/journal.pone.0036091	http://dx.doi.org/10.1371/journal.pone.0036091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590519	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100017
J	Rossenkhan, R; Novitsky, V; Sebunya, TK; Musonda, R; Gashe, BA; Essex, M				Rossenkhan, Raabya; Novitsky, Vladimir; Sebunya, Theresa K.; Musonda, Rosemary; Gashe, Berhanu A.; Essex, M.			Viral Diversity and Diversification of Major Non-Structural Genes vif, vpr, vpu, tat exon 1 and rev exon 1 during Primary HIV-1 Subtype C Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACCESSORY GENES; PHYLOGENETIC ANALYSIS; EVOLUTION; SEQUENCE; REPLICATION; DYNAMICS; LOAD; CTL; SEROCONVERSION	To assess the level of intra-patient diversity and evolution of HIV-1C non-structural genes in primary infection, viral quasispecies obtained by single genome amplification (SGA) at multiple sampling timepoints up to 500 days post-seroconversion (p/s) were analyzed. The mean intra-patient diversity was 0.11% (95% CI; 0.02 to 0.20) for vif, 0.23% (95% CI; 0.08 to 0.38) for vpr, 0.35% (95% CI; -0.05 to 0.75) for vpu, 0.18% (95% CI; 0.01 to 0.35) for tat exon 1 and 0.30% (95% CI; 0.02 to 0.58) for rev exon 1 during the time period 0 to 90 days p/s. The intra-patient diversity increased gradually in all non-structural genes over the first year of HIV-1 infection, which was evident from the vif mean intra-patient diversity of 0.46% (95% CI; 0.28 to 0.64), vpr 0.44% (95% CI; 0.24 to 0.64), vpu 0.84% (95% CI; 0.55 to 1.13), tat exon 1 0.35% (95% CI; 0.14 to 0.56) and rev exon 1 0.42% (95% CI; 0.18 to 0.66) during the time period of 181 to 500 days p/s. There was a statistically significant increase in viral diversity for vif (p = 0.013) and vpu (p = 0.002). No associations between levels of viral diversity within the non-structural genes and HIV-1 RNA load during primary infection were found. The study details the dynamics of the non-structural viral genes during the early stages of HIV-1C infection.	[Rossenkhan, Raabya; Sebunya, Theresa K.; Gashe, Berhanu A.] Univ Botswana, Dept Biol Sci, Gaborone, Botswana; [Rossenkhan, Raabya; Novitsky, Vladimir; Musonda, Rosemary; Essex, M.] Botswana Harvard AIDS Inst, Gaborone, Botswana; [Rossenkhan, Raabya; Novitsky, Vladimir; Musonda, Rosemary; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	University of Botswana; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health	Rossenkhan, R (corresponding author), Univ Botswana, Dept Biol Sci, Gaborone, Botswana.	messex@hsph.harvard.edu			NIH [R01 AI057027, D43 TW000004]; Office of Research and Development (ORD), University of Botswana; AAMC FIC (Association of American Medical Colleges Fogarty International Centre); FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development (ORD), University of Botswana; AAMC FIC (Association of American Medical Colleges Fogarty International Centre); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary HIV-1 subtype C infection study in Botswana, the Tshedimoso study, was supported by NIH grant R01 AI057027. This work was supported in part by a Research Grant from the Office of Research and Development (ORD), University of Botswana (TKS). This work was also supported in part by the AAMC FIC (Association of American Medical Colleges Fogarty International Centre)/Ellison Overseas Fellowships in Global Health and Clinical Research (RR) and by the NIH grant D43 TW000004 (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2001, J IMMUNOL, V167, P2743, DOI 10.4049/jimmunol.167.5.2743; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], FIGTREE V1 1 2; Barroso Helena, 2005, Infection Genetics and Evolution, V5, P239, DOI 10.1016/j.meegid.2004.07.008; Bell CM, 2007, AIDS RES HUM RETROV, V23, P322, DOI 10.1089/aid.2006.0181; Bello G, 2004, ARCH VIROL, V149, P1761, DOI 10.1007/s00705-004-0322-y; Bibollet-Ruche F, 1998, AIDS RES HUM RETROV, V14, P951, DOI 10.1089/aid.1998.14.951; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; Chamberland A, 2011, INT J STD AIDS, V22, P146, DOI 10.1258/ijsa.2010.010292; CHANG LJ, 1995, VIROLOGY, V211, P157, DOI 10.1006/viro.1995.1388; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Guillon C, 2006, AIDS RES HUM RETROV, V22, P1283, DOI 10.1089/aid.2006.22.1283; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Hutto C, 1996, J VIROL, V70, P3589, DOI 10.1128/JVI.70.6.3589-3598.1996; IVERSEN AKN, 1995, J VIROL, V69, P5743, DOI 10.1128/JVI.69.9.5743-5753.1995; Iwami S, 2008, THEOR POPUL BIOL, V73, P332, DOI 10.1016/j.tpb.2008.01.003; Jacobs GB, 2008, AIDS RES HUM RETROV, V24, P991, DOI 10.1089/aid.2008.0077; Kim GJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-239; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mani I, 2002, J VIROL, V76, P10745, DOI 10.1128/JVI.76.21.10745-10755.2002; MICHAEL NL, 1995, J VIROL, V69, P4228, DOI 10.1128/JVI.69.7.4228-4236.1995; Miller V, 2005, INT J EPIDEMIOL, V34, P584, DOI 10.1093/ije/dyi090; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Novitsky V, 2001, J VIROL, V75, P9210, DOI 10.1128/JVI.75.19.9210-9228.2001; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2011, AIDS, V25, P1515, DOI 10.1097/QAD.0b013e3283471eb2; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; NOWAK MA, 1991, MATH BIOSCI, V106, P1, DOI 10.1016/0025-5564(91)90037-J; Papathanasopoulos MA, 2003, AIDS RES HUM RETROV, V19, P1033, DOI 10.1089/088922203322588396; Romani B, 2009, AIDS RES HUM RETROV, V25, P357, DOI 10.1089/aid.2008.0251; Rong LB, 2007, J THEOR BIOL, V247, P804, DOI 10.1016/j.jtbi.2007.04.014; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Rousseau CM, 2008, J VIROL, V82, P6434, DOI 10.1128/JVI.02455-07; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Scriba TJ, 2001, AIDS RES HUM RETROV, V17, P775, DOI 10.1089/088922201750237059; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; Wang B, 2003, VIROLOGY, V312, P135, DOI 10.1016/S0042-6822(03)00159-4; Wieland U, 1997, J GEN VIROL, V78, P393, DOI 10.1099/0022-1317-78-2-393; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yedavalli VRK, 2001, AIDS RES HUM RETROV, V17, P911, DOI 10.1089/088922201750290032; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	55	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35491	10.1371/journal.pone.0035491	http://dx.doi.org/10.1371/journal.pone.0035491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590503	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100009
J	Smal, C; Alonso, LG; Wetzler, DE; Heer, A; Gay, GD				Smal, Clara; Alonso, Leonardo G.; Wetzler, Diana E.; Heer, Angeles; de Prat Gay, Gonzalo			Ordered Self-Assembly Mechanism of a Spherical Oncoprotein Oligomer Triggered by Zinc Removal and Stabilized by an Intrinsically Disordered Domain	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; E7 ONCOPROTEIN; VIRAL ONCOPROTEIN; IN-VITRO; PROTEIN; DEGRADATION; AGGREGATION; PEPTIDE; MODEL; PHOSPHORYLATION	Background: Self-assembly is a common theme in proteins of unrelated sequences or functions. The human papillomavirus E7 oncoprotein is an extended dimer with an intrinsically disordered domain, that can form large spherical oligomers. These are the major species in the cytosol of HPV transformed and cancerous cells. E7 binds to a large number of targets, some of which lead to cell transformation. Thus, the assembly process not only is of biological relevance, but represents a model system to investigate a widely distributed mechanism. Methodology/Principal Findings: Using various techniques, we monitored changes in secondary, tertiary and quaternary structure in a time course manner. By applying a robust kinetic model developed by Zlotnik, we determined the slow formation of a monomeric "Z-nucleus'' after zinc removal, followed by an elongation phase consisting of sequential second-order events whereby one monomer is added at a time. This elongation process takes place at a strikingly slow overall average rate of one monomer added every 28 seconds at 20 mu M protein concentration, strongly suggesting either a rearrangement of the growing complex after binding of each monomer or the existence of a "conformation editing'' mechanism through which the monomer binds and releases until the appropriate conformation is adopted. The oligomerization determinant lies within its small 5 kDa C-terminal globular domain and, remarkably, the E7 N-terminal intrinsically disordered domain stabilizes the oligomer, preventing an insoluble amyloid route. Conclusion: We described a controlled ordered mechanism with features in common with soluble amyloid precursors, chaperones, and other spherical oligomers, thus sharing determining factors for symmetry, size and shape. In addition, such a controlled and discrete polymerization reaction provides a valuable tool for nanotechnological applications. Finally, its increased immunogenicity related to its supramolecular structure is the basis for the development of a promising therapeutic vaccine candidate for treating HPV cancerous lesions.	[Smal, Clara; Heer, Angeles; de Prat Gay, Gonzalo] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Smal, Clara; Heer, Angeles; de Prat Gay, Gonzalo] Inst Invest Bioquim Conicet, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] XBio Inc, Buenos Aires, DF, Argentina; [Wetzler, Diana E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Leloir Institute; University of Buenos Aires	Smal, C (corresponding author), Fdn Inst Leloir, Buenos Aires, DF, Argentina.	gpg@leloir.org.ar		Alonso, Leonardo Gabriel/0000-0002-0596-703X; Wetzler, Diana Elena/0000-0003-2231-6690; Prat Gay, Gonzalo/0000-0001-5748-6863	Universidad de Buenos Aires (UBA)	Universidad de Buenos Aires (UBA)(University of Buenos Aires)	LGA, DEW and GdPG are Career Investigator from Concejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). CS held a doctoral fellowship from Universidad de Buenos Aires (UBA). AH holds a doctoral fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LG, 2006, BIOCHEMISTRY-US, V45, P657, DOI 10.1021/bi0522549; Alonso LG, 2004, BIOCHEMISTRY-US, V43, P3310, DOI 10.1021/bi036037o; Alonso LG, 2002, BIOCHEMISTRY-US, V41, P10510, DOI 10.1021/bi025579n; Angeline M, 2003, VIROLOGY, V317, P13, DOI 10.1016/j.virol.2003.08.024; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; Bartolini M, 2007, CHEMBIOCHEM, V8, P2152, DOI 10.1002/cbic.200700427; Boyer SN, 1996, CANCER RES, V56, P4620; Cerutti ML, 2011, INT J CANC; Chemes LB, 2012, WILEY SER PROTEIN P, P313; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Clements A, 2000, BIOCHEMISTRY-US, V39, P16033, DOI 10.1021/bi002111g; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; CSERMELY P, 1988, BIOCHEM BIOPH RES CO, V154, P578, DOI 10.1016/0006-291X(88)90179-9; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; DOBSON CM, 2005, PROTEIN FOLDING HDB, P1093; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Endres D, 2002, BIOPHYS J, V83, P1217, DOI 10.1016/S0006-3495(02)75245-4; Freire E, 2008, PROTEINS, V70, P450, DOI 10.1002/prot.21580; Gammoh N, 2006, J VIROL, V80, P1787, DOI 10.1128/JVI.80.4.1787-1797.2006; Garcia-Alai MM, 2007, BIOCHEMISTRY-US, V46, P10405, DOI 10.1021/bi7007917; Gelain F, 2011, ACS NANO, V5, P1845, DOI 10.1021/nn102663a; Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026; Grana-Montes R, 2012, ANTIOXID REDOX SIGN, V16, P1, DOI 10.1089/ars.2011.3936; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Hou SY, 2002, J BIOL CHEM, V277, P45619, DOI 10.1074/jbc.M206829200; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Liu DX, 2006, BIOCHEMISTRY-US, V45, P10963, DOI 10.1021/bi060955f; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Mishra PP, 2008, LANGMUIR, V24, P9308, DOI 10.1021/la801366r; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Pigga JM, 2010, LANGMUIR, V26, P9449, DOI 10.1021/la100467p; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Rey O, 2000, VIROLOGY, V268, P372, DOI 10.1006/viro.1999.0175; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smal C, 2009, BIOCHEMISTRY-US, V48, P11939, DOI 10.1021/bi901415k; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; Uversky VN, 2006, J PROTEOME RES, V5, P1829, DOI 10.1021/pr0602388; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Wetzler DE, 2007, PROTEIN SCI, V16, P744, DOI 10.1110/ps.062594007; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang J, 2009, J AM CHEM SOC, V131, P15152, DOI 10.1021/ja903548m; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 2003, TRENDS BIOTECHNOL, V21, P536, DOI 10.1016/j.tibtech.2003.09.012; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473; Zlotnick A, 2011, TRENDS MICROBIOL, V19, P14, DOI 10.1016/j.tim.2010.11.003	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36457	10.1371/journal.pone.0036457	http://dx.doi.org/10.1371/journal.pone.0036457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590549	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100031
J	Haynes, GD; Latch, EK				Haynes, Gwilym D.; Latch, Emily K.			Identification of Novel Single Nucleotide Polymorphisms (SNPs) in Deer (Odocoileus spp.) Using the BovineSNP50 BeadChip	PLOS ONE			English	Article							WHITE-TAILED DEER; MULE DEER; POPULATION-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; GENETIC-RELATIONSHIPS; MITOCHONDRIAL; LOCI; CONSERVATION; VIRGINIANUS; SELECTION	Single nucleotide polymorphisms (SNPs) are growing in popularity as a genetic marker for investigating evolutionary processes. A panel of SNPs is often developed by comparing large quantities of DNA sequence data across multiple individuals to identify polymorphic sites. For non-model species, this is particularly difficult, as performing the necessary large-scale genomic sequencing often exceeds the resources available for the project. In this study, we trial the Bovine SNP50 BeadChip developed in cattle (Bos taurus) for identifying polymorphic SNPs in cervids Odocoileus hemionus (mule deer and black-tailed deer) and O. virginianus (white-tailed deer) in the Pacific Northwest. We found that 38.7% of loci could be genotyped, of which 5% (n = 1068) were polymorphic. Of these 1068 polymorphic SNPs, a mixture of putatively neutral loci (n = 878) and loci under selection (n = 190) were identified with the F-ST-outlier method. A range of population genetic analyses were implemented using these SNPs and a panel of 10 microsatellite loci. The three types of deer could readily be distinguished with both the SNP and microsatellite datasets. This study demonstrates that commercially developed SNP chips are a viable means of SNP discovery for non-model organisms, even when used between very distantly related species (the Bovidae and Cervidae families diverged some 25.1-30.1 million years before present).	[Haynes, Gwilym D.; Latch, Emily K.] Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Haynes, GD (corresponding author), Univ Wisconsin, Dept Biol Sci, Behav & Mol Ecol Res Grp, POB 413, Milwaukee, WI 53201 USA.	latch@uwm.edu			University of Wisconsin - Milwaukee Research Growth Initiative	University of Wisconsin - Milwaukee Research Growth Initiative	This research was funded by the University of Wisconsin - Milwaukee Research Growth Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Anderson EC, 2006, GENETICS, V172, P2567, DOI 10.1534/genetics.105.048074; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Baker RH, 1984, WHITE TAILED DEER EC; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Belkhir K., 2004, GENETIX LOGICIEL SOU; Benjamini Y, 2001, ANN STAT, V29, P1165; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bradley RD, 2003, SOUTHWEST NAT, V48, P654, DOI 10.1894/0038-4909(2003)048&lt;0654:IOHBWD&gt;2.0.CO;2; Brooks SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000909; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bunch TD, 2006, J HERED, V97, P21, DOI 10.1093/jhered/esi127; CARR SM, 1993, J MAMMAL, V74, P331, DOI 10.2307/1382388; CARR SM, 1986, P NATL ACAD SCI USA, V83, P9576, DOI 10.1073/pnas.83.24.9576; Cathey JC, 1998, EVOLUTION, V52, P1224, DOI [10.1111/j.1558-5646.1998.tb01850.x, 10.2307/2411253]; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; CRONIN MA, 1991, CAN J ZOOL, V69, P1270, DOI 10.1139/z91-179; CRONIN MA, 1991, J MAMMAL, V72, P553, DOI 10.2307/1382139; CRONIN MA, 1988, J WILDLIFE MANAGE, V52, P320, DOI 10.2307/3801243; Davoli R, 2003, ANIM GENET, V34, P221, DOI 10.1046/j.1365-2052.2003.00992.x; DERR JN, 1991, J WILDLIFE MANAGE, V55, P228, DOI 10.2307/3809144; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; DeYoung RW, 2003, WILDLIFE SOC B, V31, P220; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; GALLAGHER DS, 1994, J HERED, V85, P204, DOI 10.1093/oxfordjournals.jhered.a111436; Garvin MR, 2010, MOL ECOL RESOUR, V10, P915, DOI 10.1111/j.1755-0998.2010.02891.x; GAVIN TA, 1988, J WILDLIFE MANAGE, V52, P1, DOI 10.2307/3801048; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Groves C, 2006, EUR J WILDLIFE RES, V52, P14, DOI 10.1007/s10344-005-0011-5; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hornbeck GE, 2000, WILDLIFE SOC B, V28, P1012; Hubisz MJ, 2009, MOL ECOLOGY RESOURCE, P9; HUGHES GA, 1993, CAN J ZOOL, V71, P524, DOI 10.1139/z93-073; Jackson H. H. T., 1921, Journal of Mammalogy, V2, P140, DOI 10.2307/1373602; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; KAY CE, 1992, GREAT BASIN NAT, V52, P290; Kolbehdari D, 2008, J DAIRY SCI, V91, P2844, DOI 10.3168/jds.2007-0585; Krawczak M, 1999, ELECTROPHORESIS, V20, P1676, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1676::AID-ELPS1676>3.3.CO;2-4; Langella O., 1999, POPULATIONS 1 2 30 P; Latch EK, 2008, ANIM CONSERV, V11, P234, DOI 10.1111/j.1469-1795.2008.00174.x; Latch EK, 2011, MOL ECOL, V20, P5265, DOI 10.1111/j.1365-294X.2011.05349.x; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-177; Mackie R.J., 1981, MULE BLACK TAILED DE, P487; MCCLYMONT RA, 1982, J WILDLIFE MANAGE, V46, P540, DOI 10.2307/3808677; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Miller JM, 2011, MOL ECOL RESOUR, V11, P314, DOI 10.1111/j.1755-0998.2010.02918.x; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Moscarella RA, 2003, J MAMMAL, V84, P1300, DOI 10.1644/BRB-028; Nagylaki T, 1998, GENETICS, V148, P1325; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nosil P, 2011, TRENDS ECOL EVOL, V26, P160, DOI 10.1016/j.tree.2011.01.001; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Pertoldi C, 2010, CONSERV GENET, V11, P627, DOI 10.1007/s10592-009-9977-y; Pollard KS, 2008, DIVISION BIOSTATISTI; Polziehn RO, 1998, MOL PHYLOGENET EVOL, V10, P249, DOI 10.1006/mpev.1998.0527; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Slate J, 2010, TRENDS GENET, V26, P275, DOI 10.1016/j.tig.2010.03.005; Smith CT, 2007, T AM FISH SOC, V136, P1674, DOI 10.1577/T06-227.1; TAYLOR WP, 1956, DEER N AM; U.S. Fish and Wildlife Service, 2011, END SPEC DAT; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WALLMO OC, 1981, MULE BLACK TAILED DE; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wright S, 1931, GENETICS, V16, P0097; Wright S., 1978, EVOLUTION GENETIC PO; Xu TJ, 2011, GENET MOL RES, V10, P53, DOI 10.4238/vol10-1gmr960	86	45	51	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36536	10.1371/journal.pone.0036536	http://dx.doi.org/10.1371/journal.pone.0036536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590559	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500015
J	Chung, RH; Chen, YE				Chung, Ren-Hua; Chen, Ying-Erh			A Two-Stage Random Forest-Based Pathway Analysis Method	PLOS ONE			English	Article							GENE-GENE; ASSOCIATION; SUSCEPTIBILITY; POLYMORPHISMS; GENOTYPES; RISK; MDM2; SNPS	Pathway analysis provides a powerful approach for identifying the joint effect of genes grouped into biologically-based pathways on disease. Pathway analysis is also an attractive approach for a secondary analysis of genome-wide association study (GWAS) data that may still yield new results from these valuable datasets. Most of the current pathway analysis methods focused on testing the cumulative main effects of genes in a pathway. However, for complex diseases, gene-gene interactions are expected to play a critical role in disease etiology. We extended a random forest-based method for pathway analysis by incorporating a two-stage design. We used simulations to verify that the proposed method has the correct type I error rates. We also used simulations to show that the method is more powerful than the original random forest-based pathway approach and the set-based test implemented in PLINK in the presence of gene-gene interactions. Finally, we applied the method to a breast cancer GWAS dataset and a lung cancer GWAS dataset and interesting pathways were identified that have implications for breast and lung cancers.	[Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli, Taiwan; [Chung, Ren-Hua] Univ Miami, Miller Sch Med, John P Hussman Inst Human Gen, Ctr Genet Epidemiol & Stat Genet, Miami, FL 33136 USA; [Chen, Ying-Erh] N Carolina State Univ, Dept Econ, Raleigh, NC 27695 USA	National Health Research Institutes - Taiwan; University of Miami; University of North Carolina; North Carolina State University	Chung, RH (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Zhunan, Miaoli, Taiwan.	rchung@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019; Chung, Ren-Hua/A-8833-2012		National Health Research Institutes [PH-101-PP-47]	National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by a grant from the National Health Research Institutes (PH-101-PP-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Chatterjee N, 2006, AM J HUM GENET, V79, P1002, DOI 10.1086/509704; Chen LS, 2010, AM J HUM GENET, V86, P860, DOI 10.1016/j.ajhg.2010.04.014; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; De Lobel L, 2010, EUR J HUM GENET, V18, P1127, DOI 10.1038/ejhg.2010.48; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meng YA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-78; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pang H, 2006, BIOINFORMATICS, V22, P2028, DOI 10.1093/bioinformatics/btl344; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schwarz DF, 2010, BIOINFORMATICS, V26, P1752, DOI 10.1093/bioinformatics/btq257; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277	27	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36662	10.1371/journal.pone.0036662	http://dx.doi.org/10.1371/journal.pone.0036662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586488	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000049
J	Castro, DP; Moraes, CS; Gonzalez, MS; Ratcliffe, NA; Azambuja, P; Garcia, ES				Castro, Daniele P.; Moraes, Caroline S.; Gonzalez, Marcelo S.; Ratcliffe, Norman A.; Azambuja, Patricia; Garcia, Eloi S.			Trypanosoma cruzi Immune Response Modulation Decreases Microbiota in Rhodnius prolixus Gut and Is Crucial for Parasite Survival and Development	PLOS ONE			English	Article							NITRIC-OXIDE; SERRATIA-MARCESCENS; RANGELI; VECTOR; TRANSMISSION; AZADIRACHTIN; TRIATOMINAE; DYNAMICS; INSECTS; MIDGUT	Trypanosoma cruzi in order to complete its development in the digestive tract of Rhodnius prolixus needs to overcome the immune reactions and microbiota trypanolytic activity of the gut. We demonstrate that in R. prolixus following infection with epimastigotes of Trypanosoma cruzi clone Dm28c and, in comparison with uninfected control insects, the midgut contained (i) fewer bacteria, (ii) higher parasite numbers, and (iii) reduced nitrite and nitrate production and increased phenoloxidase and antibacterial activities. In addition, in insects pre-treated with antibiotic and then infected with Dm28c, there were also reduced bacteria numbers and a higher parasite load compared with insects solely infected with parasites. Furthermore, and in contrast to insects infected with Dm28c, infection with T. cruzi Y strain resulted in a slight decreased numbers of gut bacteria but not sufficient to mediate a successful parasite infection. We conclude that infection of R. prolixus with the T. cruzi Dm28c clone modifies the host gut immune responses to decrease the microbiota population and these changes are crucial for the parasite development in the insect gut.	[Castro, Daniele P.; Moraes, Caroline S.; Ratcliffe, Norman A.; Azambuja, Patricia; Garcia, Eloi S.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil; [Gonzalez, Marcelo S.] UFF Niteroi, Inst Biol, Dept Biol Geral, Lab Biol Insetos, Rio De Janeiro, Brazil; [Azambuja, Patricia; Garcia, Eloi S.] Inst Nacl Entomol Mol INCT EM, Dept Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Castro, DP (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Rio De Janeiro, Brazil.	danicastro@ioc.fiocruz.br	de Castro, Daniele Pereira/R-4194-2019; de Azambuja Penna, Patricia/AAA-3763-2019; Castro, Daniele/A-9337-2013; Gonzalez, Marcelo/G-6128-2012	de Castro, Daniele Pereira/0000-0002-2827-6258; , Caroline/0000-0003-2197-6937; Azambuja, Patricia/0000-0002-1405-8743	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fiocruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fiocruz	The work is supported by funds by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fiocruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; Araujo CAC, 2006, INSECT BIOCHEM MOLEC, V36, P547, DOI 10.1016/j.ibmb.2006.04.003; Ascenzi P, 2002, IUBMB LIFE, V53, P121, DOI [10.1080/10399710290039016, 10.1080/15216540211472]; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Azambuja P, 1983, J INSECT PHYSL, V29, P833; Azambuja P. de, 1997, The molecular biology of insect disease vectors: a methods manual., P56; Bexfield A, 2004, MICROBES INFECT, V6, P1297, DOI 10.1016/j.micinf.2004.08.011; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Carton Y, 2009, J PARASITOL, V95, P1134, DOI 10.1645/GE-2091.1; Castro DP, 2007, EXP PARASITOL, V117, P201, DOI 10.1016/j.exppara.2007.04.014; Castro DP, 2007, EXP PARASITOL, V115, P200, DOI 10.1016/j.exppara.2006.08.001; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092; Dias João Carlos Pinto, 2002, Rev. Soc. Bras. Med. Trop., V35, P669, DOI 10.1590/S0037-86822002000600021; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; Garcia E. de S., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P43; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Garcia ES, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-33; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Garcia ES, 2004, TOXICON, V44, P431, DOI 10.1016/j.toxicon.2004.05.007; Genta FA, 2010, J INSECT PHYSIOL, V56, P1253, DOI 10.1016/j.jinsphys.2010.03.027; Gomes SAO, 2003, J INSECT PHYSIOL, V49, P829, DOI 10.1016/S0022-1910(03)00133-1; Gonzalez MS, 1999, EXP PARASITOL, V92, P100, DOI 10.1006/expr.1998.4387; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; Mello CB, 1996, EXP PARASITOL, V82, P112, DOI 10.1006/expr.1996.0015; MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x; Nogueira NFS, 1997, J INVERTEBR PATHOL, V69, P58, DOI 10.1006/jipa.1996.4635; POMERANTZ SH, 1963, J BIOL CHEM, V238, P2351; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rivero A, 2006, TRENDS PARASITOL, V22, P219, DOI 10.1016/j.pt.2006.02.014; Thomas S, 1999, J Tissue Viability, V9, P127; Ursic-Bedoya R, 2011, INSECT MOL BIOL, V20, P775, DOI 10.1111/j.1365-2583.2011.01107.x; Ursic-Bedoya RJ, 2007, DEV COMP IMMUNOL, V31, P109, DOI 10.1016/j.dci.2006.05.008; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Vijay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018400; Waniek PJ, 2011, VECTOR-BORNE ZOONOT, V11, P845, DOI 10.1089/vbz.2010.0020; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Whitten MMA, 2007, INSECT BIOCHEM MOLEC, V37, P440, DOI 10.1016/j.ibmb.2007.02.001; Whitten MMA, 2001, EXP PARASITOL, V98, P44, DOI 10.1006/expr.2001.4615	45	86	88	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36591	10.1371/journal.pone.0036591	http://dx.doi.org/10.1371/journal.pone.0036591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574189	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800086
J	Liu, SH; Lin, JL; Weng, CH; Yang, HY; Hsu, CW; Chen, KH; Huang, WH; Yen, TH				Liu, Shou-Hsuan; Lin, Ja-Liang; Weng, Cheng-Hao; Yang, Huang-Yu; Hsu, Ching-Wei; Chen, Kuan-Hsing; Huang, Wen-Hung; Yen, Tzung-Hai			Heart Rate-Corrected QT Interval Helps Predict Mortality after Intentional Organophosphate Poisoning	PLOS ONE			English	Article							RESPIRATORY-FAILURE; PROLONGED QTC; DISEASE; POINTES; ARRHYTHMIAS; DISPERSION; TRAUMA; AGE	Introduction: In this study, we investigated the outcomes for patients with intentional organophosphate poisoning. Previous reports indicate that in contrast to normal heart rate-corrected QT intervals (QTc), QTc prolongation might be indicative of a poor prognosis for patients exposed to organophosphates. . Methods: We analyzed the records of 118 patients who were referred to Chang Gung Memorial Hospital for management of organophosphate poisoning between 2000 and 2011. Patients were grouped according to their initial QTc interval, i.e., normal (<0.44 s) or prolonged (<0.44 s). Demographic, clinical, laboratory, and mortality data were obtained for analysis. Results: The incidence of hypotension in patients with prolonged QTc intervals was higher than that in the patients with normal QTc intervals (P = 0.019). By the end of the study, 18 of 118 (15.2%) patients had died, including 3 of 75 (4.0%) patients with normal QTc intervals and 15 of 43 (34.9%) patients with prolonged QTc intervals. Using multivariate-Cox-regression analysis, we found that hypotension (OR = 10.930, 95% CI = 2.961-40.345, P = 0.000), respiratory failure (OR = 4.867, 95% CI = 1.062-22.301, P = 0.042), coma (OR = 3.482, 95% CI = 1.184-10.238, P = 0.023), and QTc prolongation (OR = 7.459, 95% CI = 2.053-27.099, P = 0.002) were significant risk factors for mortality. Furthermore, it was revealed that non-survivors not only had longer QTc interval (503.00 +/- 41.56 versus 432.71 +/- 51.21 ms, P = 0.002), but also suffered higher incidences of hypotension (83.3 versus 12.0%, P = 0.000), shortness of breath (64 versus 94.4%, P = 0.010), bronchorrhea (55 versus 94.4%, P = 0.002), bronchospasm (50.0 versus 94.4%, P = 0.000), respiratory failure (94.4 versus 43.0%, P = 0.000) and coma (66.7 versus 11.0%, P = 0.000) than survivors. Finally, Kaplan-Meier analysis demonstrated that cumulative mortality was higher among patients with prolonged QTc intervals than among those with normal QTc intervals (Log-rank test, Chi-square test = 20.36, P<0.001). Conclusions: QTc interval helps predict mortality after intentional organophosphate poisoning.	[Liu, Shou-Hsuan] Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Taipei, Taiwan; Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, SH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Nephrol, Div Clin Toxicol, Taipei, Taiwan.	m19570@adm.cgmh.org.tw	huang, wen/GXW-0661-2022; Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505; YANG, HUANG-YU/0000-0001-6826-9717				Akdur O, 2010, HUM EXP TOXICOL, V29, P419, DOI 10.1177/0960327110364640; Anand S, 2009, CLIN TOXICOL, V47, P230, DOI 10.1080/15563650902724813; Antonijevic B, 2007, CLIN MED RES, V5, P71, DOI 10.3121/cmr.2007.701; Bar-Meir E, 2007, CRIT REV TOXICOL, V37, P279, DOI 10.1080/10408440601177855; Baydin A, 2007, INT J CLIN PRACT, V61, P927, DOI 10.1111/j.1742-1241.2006.00931.x; BURNS TR, 1990, MODERN PATHOL, V3, P336; CAPASSO JM, 1983, AM J PHYSIOL, V245, pH72, DOI 10.1152/ajpheart.1983.245.1.H72; Chuang FR, 1996, AM J EMERG MED, V14, P451, DOI 10.1016/S0735-6757(96)90148-5; Foroughi Mahnoosh, 2009, Asian Cardiovasc Thorac Ann, V17, P604, DOI 10.1177/0218492309349068; Gaspari RJ, 2009, NEUROTOXICOLOGY, V30, P298, DOI 10.1016/j.neuro.2009.01.006; Hage FG, 2010, CLIN CARDIOL, V33, P361, DOI 10.1002/clc.20768; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Kamanyire R, 2004, OCCUP MED-OXFORD, V54, P69, DOI 10.1093/occmed/kqh018; Kosar F, 2007, ANGIOLOGY, V58, P218, DOI 10.1177/0003319707300368; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin TJ, 2008, CLIN TOXICOL, V46, P794, DOI 10.1080/15563650801986695; LUDOMIRSKY A, 1982, AM J CARDIOL, V49, P1654, DOI 10.1016/0002-9149(82)90242-9; Luhr OR, 1999, AM J RESP CRIT CARE, V159, P1849, DOI 10.1164/ajrccm.159.6.9808136; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; PFEIFER MA, 1983, AM J MED, V75, P249, DOI 10.1016/0002-9343(83)91201-9; Rossing P, 2001, DIABETIC MED, V18, P199, DOI 10.1046/j.1464-5491.2001.00446.x; Shadnia S, 2009, J MED TOXICOL, V5, P196, DOI 10.1007/BF03178266; Shantsila E, 2007, EUROPACE, V9, P37, DOI 10.1093/europace/eum169; Sicouri S, 2008, EXPERT OPIN DRUG SAF, V7, P181, DOI [10.1517/14740338.7.2.181, 10.1517/14740338.7.2.181 ]; Stead LG, 2009, J STROKE CEREBROVASC, V18, P469, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.006; Steinberg DH, 2010, EUR HEART J SUPPL, V12, pE2, DOI 10.1093/eurheartj/suq012; Su HM, 2006, AGE AGEING, V35, P636, DOI 10.1093/ageing/afl114; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; Vijayakumar S, 2011, CARDIOVASC TOXICOL, V11, P113, DOI 10.1007/s12012-011-9104-4; WHO, 2009, WHO REC CLASS PEST H; Yurumez Y, 2009, J EMERG MED, V36, P39, DOI 10.1016/j.jemermed.2007.08.063; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433; Zulli R, 2006, INTERN EMERG MED, V1, P279, DOI 10.1007/BF02934761	33	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36576	10.1371/journal.pone.0036576	http://dx.doi.org/10.1371/journal.pone.0036576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574184	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800081
J	Sabbagh, SC; Lepage, C; McClelland, M; Daigle, F				Sabbagh, Sebastien C.; Lepage, Christine; McClelland, Michael; Daigle, France			Selection of Salmonella enterica Serovar Typhi Genes Involved during Interaction with Human Macrophages by Screening of a Transposon Mutant Library	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; HELICOBACTER-PYLORI UREASE; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; INTRACELLULAR SURVIVAL; ANTIBIOTIC-RESISTANCE; BACTERIAL VIRULENCE; PROTEIN ANTIGENS; CANNOT SURVIVE	The human-adapted Salmonella enterica serovar Typhi (S. Typhi) causes a systemic infection known as typhoid fever. This disease relies on the ability of the bacterium to survive within macrophages. In order to identify genes involved during interaction with macrophages, a pool of approximately 10(5) transposon mutants of S. Typhi was subjected to three serial passages of 24 hours through human macrophages. Mutants recovered from infected macrophages ( output) were compared to the initial pool (input) and those significantly underrepresented resulted in the identification of 130 genes encoding for cell membrane components, fimbriae, flagella, regulatory processes, pathogenesis, and many genes of unknown function. Defined deletions in 28 genes or gene clusters were created and mutants were evaluated in competitive and individual infection assays for uptake and intracellular survival during interaction with human macrophages. Overall, 26 mutants had defects in the competitive assay and 14 mutants had defects in the individual assay. Twelve mutants had defects in both assays, including acrA, exbDB, flhCD, fliC, gppA, mlc, pgtE, typA, waaQGP, SPI-4, STY1867-68, and STY2346. The complementation of several mutants by expression of plasmid-borne wild-type genes or gene clusters reversed defects, confirming that the phenotypic impairments within macrophages were gene-specific. In this study, 35 novel phenotypes of either uptake or intracellular survival in macrophages were associated with Salmonella genes. Moreover, these results reveal several genes encoding molecular mechanisms not previously known to be involved in systemic infection by human-adapted typhoidal Salmonella that will need to be elucidated.	[Sabbagh, Sebastien C.; Lepage, Christine; Daigle, France] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [McClelland, Michael] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	Universite de Montreal; University of California System; University of California Irvine	Sabbagh, SC (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada.	france.daigle@umontreal.ca		McClelland, Michael/0000-0003-1788-9347; Daigle, France/0000-0001-6847-4729	Canadian Natural Sciences and Engineering Research Council (NSERC) [251114-06]; NSERC; Fonds de la Recherche en Sante du Quebec (FRSQ); Centre de Recherche en Infectiologie Porcine(CRIP)	Canadian Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Centre de Recherche en Infectiologie Porcine(CRIP)	The work described in this manuscript was supported by the Canadian Natural Sciences and Engineering Research Council (NSERC) grant number 251114-06. SCS was supported by scholarships from NSERC and the Fonds de la Recherche en Sante du Quebec (FRSQ). CL was supported by a scholarship from the Centre de Recherche en Infectiologie Porcine(CRIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2005, FEMS MICROBIOL LETT, V242, P305, DOI 10.1016/j.femsle.2004.11.024; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Basso H, 2002, INFECT IMMUN, V70, P5404, DOI 10.1128/IAI.70.10.5404-5411.2002; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; BEAMAN L, 1984, ANNU REV MICROBIOL, V38, P27; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; Blair JMA, 2009, J ANTIMICROB CHEMOTH, V64, P965, DOI 10.1093/jac/dkp311; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Charles RC, 2010, CLIN VACCINE IMMUNOL, V17, P1188, DOI 10.1128/CVI.00104-10; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; CREEGER ES, 1979, J BIOL CHEM, V254, P804; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; DRAGUNSKY EM, 1990, VACCINE, V8, P263, DOI 10.1016/0264-410X(90)90056-R; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P1145, DOI 10.1128/AAC.48.4.1145-1150.2004; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; Faucher SP, 2009, MICROBIOL-SGM, V155, P477, DOI 10.1099/mic.0.022988-0; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Forest CG, 2010, MICROBIOL-SGM, V156, P3689, DOI 10.1099/mic.0.041624-0; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Garvis SG, 2001, CELL MICROBIOL, V3, P731, DOI 10.1046/j.1462-5822.2001.00153.x; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; Grant AJ, 2001, GENE, V280, P145, DOI 10.1016/S0378-1119(01)00769-7; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111; Haneda T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-324; HARA A, 1983, J BIOL CHEM, V258, P1678; Harris JB, 2006, INFECT IMMUN, V74, P5161, DOI 10.1128/IAI.00488-06; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; HONE DM, 1988, INFECT IMMUN, V56, P1326, DOI 10.1128/IAI.56.5.1326-1333.1988; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; Hu Y, 2009, SCI CHINA SER C, V52, P942, DOI 10.1007/s11427-009-0127-z; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; KEASLING JD, 1993, P NATL ACAD SCI USA, V90, P7029, DOI 10.1073/pnas.90.15.7029; Kim JS, 2011, INFECT IMMUN, V79, P1440, DOI 10.1128/IAI.01231-10; Kimata K, 1998, MOL MICROBIOL, V29, P1509, DOI 10.1046/j.1365-2958.1998.01035.x; Kitagawa R, 2010, J BACTERIOL, V192, P5645, DOI 10.1128/JB.00590-10; Kong QK, 2011, INFECT IMMUN, V79, P4227, DOI 10.1128/IAI.05398-11; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Libby SJ, 2010, P NATL ACAD SCI USA, V107, P15589, DOI 10.1073/pnas.1005566107; LIU SL, 1988, INFECT IMMUN, V56, P1967, DOI 10.1128/IAI.56.8.1967-1973.1988; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Merighi M, 2006, J BACTERIOL, V188, P141, DOI 10.1128/JB.188.1.141-149.2006; Merighi M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-42; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Morgan E, 2007, INFECT IMMUN, V75, P1524, DOI 10.1128/IAI.01438-06; Nagy G, 2006, INFECT IMMUN, V74, P5914, DOI 10.1128/IAI.00619-06; OCALLAGHAN D, 1990, MOL GEN GENET, V223, P156, DOI 10.1007/BF00315809; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Parker CT, 2001, FEMS MICROBIOL LETT, V204, P287, DOI 10.1111/j.1574-6968.2001.tb10899.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2008, CURR OPIN INFECT DIS, V21, P531, DOI 10.1097/QCO.0b013e32830f453a; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Reva ON, 2006, J BACTERIOL, V188, P4079, DOI 10.1128/JB.00101-06; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; SAMBROOK J, 1989, MOLE CLONING LAB MAN; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; Stepanova H, 2011, FEMS MICROBIOL LETT, V321, P37, DOI 10.1111/j.1574-6968.2011.02305.x; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; TACKET CO, 1992, VACCINE, V10, P443, DOI 10.1016/0264-410X(92)90392-W; Tamayo R, 2005, FEMS IMMUNOL MED MIC, V43, P249, DOI 10.1016/j.femsim.2004.08.007; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Webber MA, 2009, J BACTERIOL, V191, P4276, DOI 10.1128/JB.00363-09; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Yu EW, 2003, J BACTERIOL, V185, P5657, DOI 10.1128/JB.185.19.5657-5664.2003; Zenk SF, 2009, J IMMUNOL, V183, P2697, DOI 10.4049/jimmunol.0900937; Zhao YX, 2002, INFECT IMMUN, V70, P5319, DOI 10.1128/IAI.70.9.5319-5321.2002	99	22	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36643	10.1371/journal.pone.0036643	http://dx.doi.org/10.1371/journal.pone.0036643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574205	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800102
J	Cheung, HY; Wong, MMK; Cheung, SH; Liang, LY; Lam, YW; Chiu, SK				Cheung, Hon-Yeung; Wong, Matthew Man-Kin; Cheung, Sau-Ha; Liang, Longman Yimin; Lam, Yun-Wah; Chiu, Sung-Kay			Differential Actions of Chlorhexidine on the Cell Wall of Bacillus subtilis and Escherichia coli	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; TEICHOIC-ACID; GLUCONATE; DOMAINS	Chlorhexidine is a chlorinated phenolic disinfectant used commonly in mouthwash for its action against bacteria. However, a comparative study of the action of chlorhexidine on the cell morphology of Gram-positive and Gram-negative bacteria is lacking. In this study, the actions of chlorhexidine on the cell morphology were identified with the aids of electron microscopy. After exposure to chlorhexidine, numerous spots of indentation on the cell wall were found in both Bacillus subtilis and Escherichia coli. The number of indentation spots increased with time of incubation and increasing chlorhexidine concentration. Interestingly, the dented spots found in B. subtilis appeared mainly at the hemispherical caps of the cells, while in E. coli the dented spots were found all over the cells. After being exposed to chlorhexidine for a prolonged period, leakage of cellular contents and subsequent ghost cells were observed, especially from B subtilis. By using 2-D gel/MS-MS analysis, five proteins related to purine nucleoside interconversion and metabolism were preferentially induced in the cell wall of E. coli, while three proteins related to stress response and four others in amino acid biosynthesis were up-regulated in the cell wall materials of B. subtilis. The localized morphological damages together with the biochemical and protein analysis of the chlorhexidine-treated cells suggest that chlorhexidine may act on the differentially distributed lipids in the cell membranes/wall of B. subtilis and E. coli.	[Cheung, Hon-Yeung; Wong, Matthew Man-Kin; Cheung, Sau-Ha; Liang, Longman Yimin; Lam, Yun-Wah; Chiu, Sung-Kay] City Univ Hong Kong, Dept Biol & Chem, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China	City University of Hong Kong	Cheung, HY (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Res Grp Bioact Prod, Hong Kong, Hong Kong, Peoples R China.	kaychiu@cityu.edu.hk	Cheung, H.Y./K-3191-2014	Wong, Matthew Man-Kin/0000-0003-3296-3277; Lam, Yun Wah/0000-0001-8929-5965; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	City University of Hong Kong [7002714]	City University of Hong Kong(City University of Hong Kong)	The work described in this paper was partially supported by a grant from City University of Hong Kong (Project No. 7002714). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al-Tannir M A, 1994, Spec Care Dentist, V14, P116, DOI 10.1111/j.1754-4505.1994.tb01116.x; Andre G, 2011, ACS CHEM BIOL, V6, P366, DOI 10.1021/cb1003509; AUDUS KL, 1992, J DENT RES, V71, P1298, DOI 10.1177/00220345920710060601; BARRETTBEE K, 1994, FEMS MICROBIOL LETT, V119, P249; Bloomfield SF, 1996, HDB DISINFECTANTS AN, P133; CHEUNG HY, 1988, CAN J MICROBIOL, V34, P583, DOI 10.1139/m88-097; DOYLE RJ, 1975, J BACTERIOL, V122, P152, DOI 10.1128/JB.122.1.152-158.1975; ELDER M, 1977, PROC R SOC LON SER-A, V354, P157, DOI 10.1098/rspa.1977.0062; Ellepola ANB, 2001, ORAL DIS, V7, P11, DOI 10.1034/j.1601-0825.2001.0070103.x; Glassman Paul, 2003, Spec Care Dentist, V23, P157, DOI 10.1111/j.1754-4505.2003.tb00303.x; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; HIOM SJ, 1995, LETT APPL MICROBIOL, V20, P353, DOI 10.1111/j.1472-765X.1995.tb01319.x; IWAMI Y, 1995, ORAL MICROBIOL IMMUN, V10, P360, DOI 10.1111/j.1399-302X.1995.tb00167.x; Kanisavaran ZM, 2008, INT DENT J, V58, P247, DOI 10.1922/IDJ_1910Mohamadi11; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Khunkitti W, 1998, J APPL MICROBIOL, V84, P53; Kuyyakanond T, 1992, FEMS MICROBIOL LETT, V79, P211; Longworth AR, 1971, INHIBITION DESTRUCTI, P95; MAILLARD JY, 1995, LETT APPL MICROBIOL, V20, P357, DOI 10.1111/j.1472-765X.1995.tb01320.x; MARIS P, 1995, REV SCI TECH OIE, V14, P47, DOI 10.20506/rst.14.1.829; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003; MERAD T, 1989, J GEN MICROBIOL, V135, P645; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; PAULSON DS, 1993, AM J INFECT CONTROL, V21, P205, DOI 10.1016/0196-6553(93)90033-Z; Shalamanov DS., 2005, BIOTECHNOL BIOTEC EQ, V19, P121, DOI [10.1080/13102818.2005.10817165, DOI 10.1080/13102818.2005.10817165]; SONNENFELD EM, 1985, CAN J MICROBIOL, V31, P875, DOI 10.1139/m85-163; Sreenivasan P, 2004, MICROBIOL RES, V159, P365, DOI 10.1016/j.micres.2004.08.002; Steinberg D, 1999, J ORAL REHABIL, V26, P151, DOI 10.1046/j.1365-2842.1999.00343.x; STICKLER DJ, 1983, BRIT J CLIN PRACT, V25, P23; Tattawasart U, 2000, J ANTIMICROB CHEMOTH, V45, P145, DOI 10.1093/jac/45.2.145; TEUBER M, 1973, Z NATURFORSCH C, VC 28, P476; VANDENBRINKVAND.E, 2003, J BACTERIOL, V185, P3773, DOI DOI 10.1128/JB.185.13.3773-3779.2003; WADE HE, 1965, BIOCHEM J, V96, P753, DOI 10.1042/bj0960753	34	74	75	8	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36659	10.1371/journal.pone.0036659	http://dx.doi.org/10.1371/journal.pone.0036659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606280	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200037
J	Fu, C; Whitfield, CW				Fu, Chen; Whitfield, Charles W.			Genes Associated with Honey Bee Behavioral Maturation Affect Clock-Dependent and -Independent Aspects of Daily Rhythmic Activity in Fruit Flies	PLOS ONE			English	Article							DIVISION-OF-LABOR; DROSOPHILA-MELANOGASTER; LOCOMOTOR-ACTIVITY; APIS-MELLIFERA; CIRCADIAN-RHYTHMS; EXPRESSION; EVOLUTION; COLONIES; BRAIN; COMPONENTS	Background: In the honey bee, the age-related and socially regulated transition of workers from in-hive task performance (e.g., caring for young) to foraging (provisioning the hive) is associated with changes in many behaviors including the 24-hour pattern of rhythmic activity. We have previously shown that the hive-bee to forager transition is associated with extensive changes in brain gene expression. In this study, we test the possible function of a subset of these genes in daily rhythmic activity pattern using neural-targeted RNA interference (RNAi) of an orthologous gene set in Drosophila melanogaster. Principal Findings: Of 10 genes tested, knockdown of six affected some aspect of locomotor activity under a 12 h: 12 h light: dark regime (LD). Inos affected anticipatory activity preceding lights-off, suggesting a possible clock-dependent function. BM-40-SPARC, U2af50 and fax affected peak activity at dawn without affecting anticipation or overall inactivity (proportion of 15-min intervals without activity), suggesting that these effects may depend on the day-night light cycle. CAH1 affected overall inactivity. The remaining gene, abl, affected peak activity levels but was not clearly time-of-day-specific. No gene tested affected length of period or strength of rhythmicity in constant dark (DD), suggesting that these genes do not act in the core clock. Significance: Taking advantage of Drosophila molecular genetic tools, our study provides an important step in understanding the large set of gene expression changes that occur in the honey bee transition from hive bee to forager. We show that orthologs of many of these genes influence locomotor activity in Drosophila, possibly through both clock-dependent and -independent pathways. Our results support the importance of both circadian clock and direct environmental stimuli (apart from entrainment) in shaping the bee's 24-hour pattern of activity. Our study also outlines a new approach to dissecting complex behavior in a social animal.	[Fu, Chen; Whitfield, Charles W.] Univ Illinois, Neurosci Program, Urbana, IL USA; [Fu, Chen; Whitfield, Charles W.] Univ Illinois, Neurosci Program, Champaign, IL USA; [Whitfield, Charles W.] Univ Illinois, Dept Entomol, Champaign, IL USA; [Whitfield, Charles W.] Univ Illinois, Dept Entomol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Fu, C (corresponding author), Univ Illinois, Neurosci Program, Urbana, IL USA.	cww@illinois.edu			School of Integrative Biology, University of Illinois	School of Integrative Biology, University of Illinois	This work was funded by startup funds from the School of Integrative Biology, University of Illinois. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Ben-Shahar Y, 2004, J EXP BIOL, V207, P3281, DOI 10.1242/jeb.01151; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bloch G, 2001, NATURE, V410, P1048, DOI 10.1038/35074183; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch G, 2007, J COMP PHYSIOL A, V193, P181, DOI 10.1007/s00359-006-0179-5; Bloch G, 2010, J BIOL RHYTHM, V25, P307, DOI 10.1177/0748730410380149; Chang DC, 2006, BEHAV PROCESS, V71, P211, DOI 10.1016/j.beproc.2005.12.008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; McNabb SL, 2008, J EXP BIOL, V211, P2263, DOI 10.1242/jeb.015818; Meshi A, 2007, J BIOL RHYTHM, V22, P343, DOI 10.1177/0748730407301989; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Robinson GE, 2002, AM NAT, V160, pS160, DOI 10.1086/342901; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sheeba V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011628; Shemesh Y, 2010, J NEUROSCI, V30, P12517, DOI 10.1523/JNEUROSCI.1490-10.2010; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729	33	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e29157	10.1371/journal.pone.0029157	http://dx.doi.org/10.1371/journal.pone.0029157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606218	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200001
J	Johnson, RE; Hamill, M; Harvey, R; Nicolson, C; Robertson, JS; Engelhardt, OG				Johnson, Rachel E.; Hamill, Michelle; Harvey, Ruth; Nicolson, Carolyn; Robertson, James S.; Engelhardt, Othmar G.			Permissible Variation in the 3 ' Non-Coding Region of the Haemagglutinin Genome Segment of the H5N1 Candidate Influenza Vaccine Cirus NIBRG-14	PLOS ONE			English	Article							VIRUS RNA-POLYMERASE; 5 ENDS; SEQUENCES	The candidate H5N1 vaccine virus NIBRG-14 was created in response to a call from the World Health Organisation in 2004 to prepare candidate vaccine viruses (CVVs) to combat the threat of an H5N1 pandemic. NIBRG-14 was created by reverse genetics and is composed of the neuraminidase (NA) and modified haemagglutinin (HA) genes from A/Vietnam/1194/2004 and the internal genes of PR8, a high growing laboratory adapted influenza A(H1N1) strain. Due to time constraints, the non-coding regions (NCRs) of A/Vietnam/1194/2004 HA were not determined prior to creating NIBRG-14. Consequently, the sequence of the primers used to clone the modified A/Vietnam/1194/2004 HA was based upon previous experience of cloning H5N1 viruses. We report here that the HA 3' NCR sequence of NIBRG-14 is different to that of the parental wild type virus A/Vietnam/1194/2004; however this does not appear to impact on its growth or antigen yield. We introduced additional small changes into the 3'NCR of NIBRG-14; these had only minor effects on viral growth and antigen content. These findings may serve to assure the influenza vaccine community that generation of CVVs using best-guess NCR sequences, based on sequence alignments, are likely to produce robust viruses.	[Johnson, Rachel E.; Harvey, Ruth; Nicolson, Carolyn; Robertson, James S.; Engelhardt, Othmar G.] Hlth Protect Agcy, Div Virol, Natl Inst Biol Stand & Control, Potters Bar, Herts, England	Health Protection Agency; National Institute for Biological Standards & Control	Johnson, RE (corresponding author), Hlth Protect Agcy, Div Virol, Natl Inst Biol Stand & Control, Blanche Lane, Potters Bar, Herts, England.	othmar.engelhardt@nibsc.hpa.org.uk			Medical Research Council [G0600509]; MRC [G0600509] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded in part by a grant from the Medical Research Council; (http://www.mrc.ac.uk/index.htm) to JSR (number G0600509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	de Wit E, 2007, J VIROL METHODS, V139, P85, DOI 10.1016/j.jviromet.2006.09.015; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; Harvey R, 2011, J VIROL, V85, P6086, DOI 10.1128/JVI.00096-11; Harvey R, 2010, VACCINE, V28, P8008, DOI 10.1016/j.vaccine.2010.09.006; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Hsu J., 1996, MULTIPLE COMP THEORY; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Szymkowiak C, 2003, J VIROL METHODS, V107, P15, DOI 10.1016/S0166-0934(02)00184-2; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Zheng HY, 1996, VIROLOGY, V217, P242, DOI 10.1006/viro.1996.0111	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36241	10.1371/journal.pone.0036241	http://dx.doi.org/10.1371/journal.pone.0036241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606247	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200019
J	Dudaniec, RY; Spear, SF; Richardson, JS; Storfer, A				Dudaniec, Rachael Y.; Spear, Stephen F.; Richardson, John S.; Storfer, Andrew			Current and Historical Drivers of Landscape Genetic Structure Differ in Core and Peripheral Salamander Populations	PLOS ONE			English	Article							DICAMPTODON-TENEBROSUS; AMPHIBIAN DECLINES; DIVERSITY; RANGE; EXPANSION; REFUGIA; FROG; SOFTWARE; TESTS; FLOW	With predicted decreases in genetic diversity and greater genetic differentiation at range peripheries relative to their cores, it can be difficult to distinguish between the roles of current disturbance versus historic processes in shaping contemporary genetic patterns. To address this problem, we test for differences in historic demography and landscape genetic structure of coastal giant salamanders (Dicamptodon tenebrosus) in two core regions (Washington State, United States) versus the species' northern peripheral region (British Columbia, Canada) where the species is listed as threatened. Coalescent-based demographic simulations were consistent with a pattern of post-glacial range expansion, with both ancestral and current estimates of effective population size being much larger within the core region relative to the periphery. However, contrary to predictions of recent human-induced population decline in the less genetically diverse peripheral region, there was no genetic signature of population size change. Effects of current demographic processes on genetic structure were evident using a resistance-based landscape genetics approach. Among core populations, genetic structure was best explained by length of the growing season and isolation by resistance (i.e. a 'flat' landscape), but at the periphery, topography (slope and elevation) had the greatest influence on genetic structure. Although reduced genetic variation at the range periphery of D. tenebrosus appears to be largely the result of biogeographical history rather than recent impacts, our analyses suggest that inherent landscape features act to alter dispersal pathways uniquely in different parts of the species' geographic range, with implications for habitat management.	[Dudaniec, Rachael Y.; Richardson, John S.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Spear, Stephen F.; Storfer, Andrew] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of British Columbia; Washington State University	Dudaniec, RY (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	rachael.dudaniec@gmail.com	Dudaniec, Rachael Y/F-4001-2011; Richardson, John S/G-1513-2012; Dudaniec, Rachael/AAR-7034-2020	Richardson, John S/0000-0001-8135-7447; Dudaniec, Rachael/0000-0002-1854-6808	Forest Investment Account/Forest Science Program, British Columbia [Y102082]; Canadian Wildlife Federation; Cooperative Monitoring, Evaluation and Research Committee [IAA-06-047]	Forest Investment Account/Forest Science Program, British Columbia; Canadian Wildlife Federation; Cooperative Monitoring, Evaluation and Research Committee	This work was supported by the Forest Investment Account/Forest Science Program, British Columbia (grant number Y102082), the Canadian Wildlife Federation (www.cwf-fcf.org), and the Cooperative Monitoring, Evaluation and Research Committee under the Washington Department of Natural Resources Forest Practices Management Program (grant number IAA-06-047 to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Bahn V, 2006, OIKOS, V115, P89, DOI 10.1111/j.2006.0030-1299.14825.x; Beaumont MA, 1999, GENETICS, V153, P2013; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Chiucci JE, 2010, MOL ECOL, V19, P5435; Cornuet JM, 1996, GENETICS, V144, P2001; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dudaniec RY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014333; Dudaniec Rachael Y., 2008, BMC Ecology, V8, P13, DOI 10.1186/1472-6785-8-13; Dudaniec RY, HERPETOLOGI IN PRESS; Duellman W. E., 1986, BIOL AMPHIBIANS; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Faurby S, 2010, MOL ECOL, V19, P3088, DOI 10.1111/j.1365-294X.2010.04732.x; Ferguson H, 1998, THESIS U BRIT COLUMB; Ferguson HM, 2000, CAN J ZOOL, V78, P1238, DOI 10.1139/cjz-78-7-1238; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gapare WJ, 2008, CONSERV GENET, V9, P411, DOI 10.1007/s10592-007-9353-8; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hoban SM, 2010, MOL ECOL, V19, P4876, DOI 10.1111/j.1365-294X.2010.04834.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Johansson M, 2006, MOL ECOL, V15, P975, DOI 10.1111/j.1365-294X.2006.02866.x; Johnston B, 2002, CAN J ZOOL, V80, P2170, DOI 10.1139/Z02-213; Jordan MA, 2009, CONSERV GENET, V10, P1647, DOI 10.1007/s10592-008-9741-8; Kark S, 2004, BIOL J LINN SOC, V81, P313, DOI 10.1111/j.1095-8312.2004.00296.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Kroll AJ, 2008, FOREST ECOL MANAG, V255, P3726, DOI 10.1016/j.foreco.2008.03.005; Lee-Yaw JA, 2008, MOL ECOL, V17, P867, DOI 10.1111/j.1365-294X.2007.03611.x; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lowe WH, 2008, MOL ECOL, V17, P4459, DOI 10.1111/j.1365-294X.2008.03928.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Munwes I, 2010, MOL ECOL, V19, P2675, DOI 10.1111/j.1365-294X.2010.04712.x; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; Nussbaum RA, 1976, GEOGRAPIC VARIATION; Okello JBA, 2008, MOL ECOLOGY, P17; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rehfeldt G.E, 2006, SPLINE MODEL CLIMATE; Sambrook J., 2001, MOL CLONING LAB MANU; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; SMITH BJ, 2005, BOA BAYESIAN OUTPUT; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Steele CA, 2009, MOL ECOL, V18, P1629, DOI 10.1111/j.1365-294X.2009.04135.x; Steele CA, 2008, MOL ECOLOGY RESOURCE; Steele CA, 2006, MOL ECOL, V15, P2477, DOI 10.1111/j.1365-294X.2006.02950.x; Storfer A, 2003, DIVERS DISTRIB, V9, P151, DOI 10.1046/j.1472-4642.2003.00014.x; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Storz JF, 2002, EVOLUTION, V56, P154; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Zellmer AJ, 2009, MOL ECOL, V18, P3593, DOI 10.1111/j.1365-294X.2009.04305.x	79	34	34	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36769	10.1371/journal.pone.0036769	http://dx.doi.org/10.1371/journal.pone.0036769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590604	Green Published, gold			2022-12-27	WOS:000305336400033
J	Montoya, JL; Landi, N; Kober, H; Worhunsky, PD; Rutherford, HJV; Mencl, WE; Mayes, LC; Potenza, MN				Montoya, Jessica L.; Landi, Nicole; Kober, Hedy; Worhunsky, Patrick D.; Rutherford, Helena J. V.; Mencl, W. Einar; Mayes, Linda C.; Potenza, Marc N.			Regional Brain Responses in Nulliparous Women to Emotional Infant Stimuli	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; BEHAVIORAL-INHIBITION; SOCIAL COGNITION; CINGULATE CORTEX; NEURAL SYSTEMS; REWARD; FMRI; AMYGDALA; REPRESENTATIONS; PERCEPTION	Infant cries and facial expressions influence social interactions and elicit caretaking behaviors from adults. Recent neuroimaging studies suggest that neural responses to infant stimuli involve brain regions that process rewards. However, these studies have yet to investigate individual differences in tendencies to engage or withdraw from motivationally relevant stimuli. To investigate this, we used event-related fMRI to scan 17 nulliparous women. Participants were presented with novel infant cries of two distress levels (low and high) and unknown infant faces of varying affect (happy, sad, and neutral) in a randomized, counter-balanced order. Brain activation was subsequently correlated with scores on the Behavioral Inhibition System/Behavioral Activation System scale. Infant cries activated bilateral superior and middle temporal gyri (STG and MTG) and precentral and postcentral gyri. Activation was greater in bilateral temporal cortices for low-relative to high-distress cries. Happy relative to neutral faces activated the ventral striatum, caudate, ventromedial prefrontal, and orbitofrontal cortices. Sad versus neutral faces activated the precuneus, cuneus, and posterior cingulate cortex, and behavioral activation drive correlated with occipital cortical activations in this contrast. Behavioral inhibition correlated with activation in the right STG for high- and low-distress cries relative to pink noise. Behavioral drive correlated inversely with putamen, caudate, and thalamic activations for the comparison of high-distress cries to pink noise. Reward-responsiveness correlated with activation in the left precentral gyrus during the perception of low-distress cries relative to pink noise. Our findings indicate that infant cry stimuli elicit activations in areas implicated in auditory processing and social cognition. Happy infant faces may be encoded as rewarding, whereas sad faces activate regions associated with empathic processing. Differences in motivational tendencies may modulate neural responses to infant cues.	[Montoya, Jessica L.; Kober, Hedy; Worhunsky, Patrick D.; Mayes, Linda C.; Potenza, Marc N.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Landi, Nicole; Rutherford, Helena J. V.; Mayes, Linda C.; Potenza, Marc N.] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Landi, Nicole; Mencl, W. Einar] Haskins Labs Inc, New Haven, CT 06511 USA; [Potenza, Marc N.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Haskins Laboratories; Yale University	Montoya, JL (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	marc.potenza@yale.edu	kober, hedy/GPK-6402-2022; landi, nicole/ABG-5374-2020; Landi, Nicole/P-2954-2014	kober, hedy/0000-0001-9893-1046; Worhunsky, Patrick/0000-0001-9629-1428; Landi, Nicole/0000-0003-2890-2519	National Institutes of Health (National Institute on Drug Abuse) [P01 DA022446, R01 DA026437, K12 DA00167]; CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research [UL1 RR024139]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA022446, K12DA000167, R01DA026437] Funding Source: NIH RePORTER	National Institutes of Health (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CTSA from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (National Institute on Drug Abuse) grants P01 DA022446, R01 DA026437 and K12 DA00167. This publication was also made possible by CTSA Grant Number UL1 RR024139 from the National Center for Research Resources, a component of the National Institutes of Health (NIH), and NIH roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bohon C, 2010, INT J EAT DISORD; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Cherbuin N, 2008, SOC COGN AFFECT NEUR, V3, P262, DOI 10.1093/scan/nsn018; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; GREEN JA, 1983, DEV PSYCHOBIOL, V16, P485, DOI 10.1002/dev.420160604; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Ishai A, 2005, BRAIN RES BULL, V67, P87, DOI 10.1016/j.brainresbull.2005.05.027; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Landi Nicole, 2011, Front Psychiatry, V2, P32, DOI 10.3389/fpsyt.2011.00032; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; McClure S, 2002, ANN SCI M SOC NEUR; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Petrovic P, 2008, SOC COGN AFFECT NEUR, V3, P109, DOI 10.1093/scan/nsn002; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Ranote S, 2004, NEUROREPORT, V15, P1825, DOI 10.1097/01.wnr.0000137078.64128.6a; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schulze L, 2011, BIOL PSYCHIAT, V69, P564, DOI 10.1016/j.biopsych.2010.10.025; Seiferth NY, 2009, NEUROPSYCHOPHARMACOL, V34, P477, DOI 10.1038/npp.2008.93; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Stingl JC, 2012, NEUROIMAGE, V59, P2818, DOI 10.1016/j.neuroimage.2011.07.052; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Swain JE, 2008, NEUROBIOLOGY OF THE PARENTAL BRAIN, P83, DOI 10.1016/B978-0-12-374285-8.00006-8; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; Swain JE, 2004, BEHAV BRAIN SCI, V27, P472, DOI 10.1017/S0140525X0437010X; Swain JE, 2004, BIOL PSYCHIAT, V55, p153S; Swain JE, 2003, P AM COLL NEUR 42 AN, V114, P192; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 2011, J PSYCHIATR RES, V45, P526, DOI 10.1016/j.jpsychires.2010.08.004; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wittmann M, 2007, EXP BRAIN RES, V179, P643, DOI 10.1007/s00221-006-0822-y	69	47	49	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36270	10.1371/journal.pone.0036270	http://dx.doi.org/10.1371/journal.pone.0036270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TN	22590530	gold, Green Published			2022-12-27	WOS:000305336400009
J	Pasche, M; Matti, U; Hof, D; Rettig, J; Becherer, U				Pasche, Mathias; Matti, Ulf; Hof, Detlef; Rettig, Jens; Becherer, Ute			Docking of LDCVs Is Modulated by Lower Intracellular [Ca2+] than Priming	PLOS ONE			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; SECRETORY GRANULE MOTION; CHROMAFFIN CELLS; VESICLE DOCKING; PLASMA-MEMBRANE; EXOCYTOSIS; RELEASE; PROTEIN; ACTS; TRANSPORT	Many regulatory steps precede final membrane fusion in neuroendocrine cells. Some parts of this preparatory cascade, including fusion and priming, are dependent on the intracellular Ca2+ concentration ([Ca2+](i)). However, the functional implications of [Ca2+](i) in the regulation of docking remain elusive and controversial due to an inability to determine the modulatory effect of [Ca2+](i). Using a combination of TIRF-microscopy and electrophysiology we followed the movement of large dense core vesicles (LDCVs) close to the plasma membrane, simultaneously measuring membrane capacitance and [Ca2+](i). We found that a free [Ca2+](i) of 700 nM maximized the immediately releasable pool and minimized the lateral mobility of vesicles, which is consistent with a maximal increase of the pool size of primed LDCVs. The parameters that reflect docking, i.e. axial mobility and the fraction of LDCVs residing at the plasma membrane for less than 5 seconds, were strongly decreased at a free [Ca2+](i) of 500 nM. These results provide the first evidence that docking and priming occur at different free intracellular Ca2+ concentrations, with docking efficiency being the most robust at 500 nM.	[Pasche, Mathias; Matti, Ulf; Hof, Detlef; Rettig, Jens; Becherer, Ute] Univ Saarland, Inst Physiol, Homburg, Germany	Saarland University	Pasche, M (corresponding author), MRC Lab Mol Biol, Cambridge, England.	Ute.Becherer@uks.eu	Becherer, Ute/AGW-2576-2022; Rettig, Jens/K-5103-2013; Becherer, Ute/F-6711-2010	Rettig, Jens/0000-0001-6160-3954; Becherer, Ute/0000-0001-6005-7517; Matti, Ulf/0000-0001-5548-1081	HOMFOR, Universitat des Saarlandes; Deutsche Forschungsgemeinschaft Sonderforschungsbereich [530]	HOMFOR, Universitat des Saarlandes; Deutsche Forschungsgemeinschaft Sonderforschungsbereich(German Research Foundation (DFG))	This work was supported by local funding (HOMFOR, Universitat des Saarlandes; http://www.uniklinikum-saarland.de/de/forschung/HOMFOR) and by grants from the Deutsche Forschungsgemeinschaft Sonderforschungsbereich 530 (to J.R. and U.B.; http://www. dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 2006, MOL BIOL CELL, V17, P2424, DOI 10.1091/mbc.E05-10-0938; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; DELCASTILLO AR, 1990, EMBO J, V9, P43, DOI 10.1002/j.1460-2075.1990.tb08078.x; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; Fish KN, 2009, CURR PROTOCOL CYTOM, V50; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Karatekin E, 2008, BIOPHYS J, V94, P2891, DOI 10.1529/biophysj.107.116756; Keyel PA, 2004, J BIOL CHEM, V279, P13190, DOI 10.1074/jbc.M312717200; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sorensen JB, 2002, P NATL ACAD SCI USA, V99, P1627, DOI 10.1073/pnas.251673298; Stevens D, 2009, MOL NEUROBIOL, V39, P62, DOI 10.1007/s12035-009-8052-5; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Yizhar O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002694; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36416	10.1371/journal.pone.0036416	http://dx.doi.org/10.1371/journal.pone.0036416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590540	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336400013
J	Yu, HL; Wang, NN; Ju, XD; Yang, Y; Sun, D; Lai, MM; Cui, L; Sheikh, MA; Zhang, JH; Wang, XZ; Zhu, XJ				Yu, Huali; Wang, Nannan; Ju, Xingda; Yang, Yan; Sun, Dong; Lai, Mingming; Cui, Lei; Sheikh, Muhammad Abid; Zhang, Jianhua; Wang, Xingzhi; Zhu, Xiaojuan			PtdIns (3,4,5) P3 Recruitment of Myo10 Is Essential for Axon Development	PLOS ONE			English	Article							MYOSIN-X; NEURONAL POLARITY; HIPPOCAMPAL-NEURONS; FILOPODIA FORMATION; MOLECULAR MOTOR; ESTABLISHMENT; EXTENSION; POLARIZATION; DYNAMICS; NEURITOGENESIS	Myosin X (Myo10) with pleckstrin homology (PH) domains is a motor protein acting in filopodium initiation and extension. However, its potential role has not been fully understood, especially in neuronal development. In the present study the preferential accumulation of Myo10 in axon tips has been revealed in primary culture of hippocampal neurons with the aid of immunofluorescence from anti-Myo10 antibody in combination with anti-Tuj1 antibody as specific marker. Knocking down Myo10 gene transcription impaired outgrowth of axon with loss of Tau-1-positive phenotype. Interestingly, inhibition of actin polymerization by cytochalasin D rescued the defect of axon outgrowth. Furthermore, ectopic expression of Myo10 with enhanced green fluorescence protein (EGFP) labeled Myo10 mutants induced multiple axon-like neurites in a motor-independent way. Mechanism studies demonstrated that the recruitment of Myo10 through its PH domain to phosphatidylinositol (3,4,5)-trisphosphate (PtdIns (3,4,5) P3) was essential for axon formation. In addition, in vivo studies confirmed that Myo10 was required for neuronal morphological transition during radial neuronal migration in the developmental neocortex.	[Yu, Huali; Wang, Nannan; Ju, Xingda; Yang, Yan; Sun, Dong; Lai, Mingming; Cui, Lei; Sheikh, Muhammad Abid; Zhang, Jianhua; Wang, Xingzhi; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China	Northeast Normal University - China	Yu, HL (corresponding author), NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China.	mailwxz@yahoo.com.cn; zhuxj720@nenu.edu.cn	Sun, Dong/AAN-3325-2021	Zhu, Xiao-Juan/0000-0001-8386-8064	National Natural Science Foundation of China [30871302, 301170142]; Program of Introducing Talents of Discipline to Universities Project [B07017]; Program for New Century Excellent Talents in University [NCET-07-0173]; Doctoral Program of High Education [20060200008]; Northeast Normal University [09ZDQD04, 10JCXK002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities Project; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctoral Program of High Education; Northeast Normal University	This work is supported by the National Natural Science Foundation of China (30871302, 301170142), the Program of Introducing Talents of Discipline to Universities Project (B07017), the Program for New Century Excellent Talents in University (NCET-07-0173), Specialized Research Fund for the Doctoral Program of High Education (20060200008) and the Scientific Research Foundation from Northeast Normal University (09ZDQD04, 10JCXK002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro S, 2010, MOL CELL BIOL, V30, P1703, DOI 10.1128/MCB.01226-09; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bennett RD, 2008, FEBS LETT, V582, P2377, DOI 10.1016/j.febslet.2008.05.051; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Flynn KC, 2009, DEV NEUROBIOL, V69, P761, DOI 10.1002/dneu.20734; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kollins KM, 2009, DEV NEUROBIOL, V69, P279, DOI 10.1002/dneu.20704; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Plantard L, 2010, J CELL SCI, V123, P3525, DOI 10.1242/jcs.069609; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	36	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36988	10.1371/journal.pone.0036988	http://dx.doi.org/10.1371/journal.pone.0036988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590642	Green Published, gold			2022-12-27	WOS:000305336400051
J	Zhang, RY; Sun, Y; Tsai, HJ; Tang, CS; Jin, HF; Du, JB				Zhang, Rongyuan; Sun, Yan; Tsai, Haojan; Tang, Chaoshu; Jin, Hongfang; Du, Junbao			Hydrogen Sulfide Inhibits L-Type Calcium Currents Depending upon the Protein Sulfhydryl State in Rat Cardiomyocytes	PLOS ONE			English	Article							SUBUNIT; CHANNEL; HEART; CA2+; MECHANISM; RESIDUES; SYSTEM; PORE	Hydrogen sulfide (H2S) is a novel gasotransmitter that inhibits L-type calcium currents (I (Ca, L)). However, the underlying molecular mechanisms are unclear. In particular, the targeting site in the L-type calcium channel where H2S functions remains unknown. The study was designed to investigate if the sulfhydryl group could be the possible targeting site in the L-type calcium channel in rat cardiomyocytes. Cardiac function was measured in isolated perfused rat hearts. The L-type calcium currents were recorded by using a whole cell voltage clamp technique on the isolated cardiomyocytes. The L-type calcium channel containing free sulfhydryl groups in H9C2 cells were measured by using Western blot. The results showed that sodium hydrosulfide (NaHS, an H2S donor) produced a negative inotropic effect on cardiac function, which could be partly inhibited by the oxidant sulfhydryl modifier diamide (DM). H2S donor inhibited the peak amplitude of I (Ca, L) in a concentration-dependent manner. However, dithiothreitol (DTT), a reducing sulfhydryl modifier markedly reversed the H2S donor-induced inhibition of I (Ca, L) in cardiomyocytes. In contrast, in the presence of DM, H2S donor could not alter cardiac function and L-type calcium currents. After the isolated rat heart or the cardiomyocytes were treated with DTT, NaHS could markedly alter cardiac function and L-type calcium currents in cardiomyocytes. Furthermore, NaHS could decrease the functional free sulfhydryl group in the L-type Ca2+ channel, which could be reversed by thiol reductant, either DTT or reduced glutathione. Therefore, our results suggest that H2S might inhibit L-type calcium currents depending on the sulfhydryl group in rat cardiomyocytes.	[Zhang, Rongyuan; Sun, Yan; Jin, Hongfang; Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Tsai, Haojan] Peking Univ, Hosp 1, Dept Cent Lab, Beijing 100871, Peoples R China; [Tang, Chaoshu] Peking Univ, Hosp 1, Inst Cardiovasc Res, Beijing 100871, Peoples R China; [Tang, Chaoshu; Du, Junbao] Minist Educ, Key Lab Mol Cardiovasc Dis, Beijing, Peoples R China	Peking University; Peking University; Peking University	Zhang, RY (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	jinhongfang51@126.com; junbaodu1@126.com		Jin, Hongfang/0000-0002-1606-8988	Major Basic Research Development Program of People's Republic of China [2011CB503904, 2012CB517806]; National Natural Science Foundation of China [30821001, 30801251]; Beijing Natural Science Foundation [7112130]	Major Basic Research Development Program of People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Major Basic Research Development Program of People's Republic of China (2011CB503904, 2012CB517806, http://www.973.gov.cn), the National Natural Science Foundation of China (30821001 and 30801251, http://isis.nsfc.gov.cn), and Beijing Natural Science Foundation (7112130,http://www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHIAMVIMONVAT N, 1995, CIRC RES, V76, P325, DOI 10.1161/01.RES.76.3.325; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Du JB, 2006, CURR HYPERTENS REV, V2, P123, DOI 10.2174/157340206776877307; Eghbal MA, 2004, TOXICOLOGY, V203, P69, DOI 10.1016/j.tox.2004.05.020; Gao TY, 2000, J BIOL CHEM, V275, P25436, DOI 10.1074/jbc.M003465200; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; Hullin R, 1999, CIRCULATION, V100, P155, DOI 10.1161/01.CIR.100.2.155; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; KOBAYASHI O, 1985, J BIOCHEM-TOKYO, V97, P37, DOI 10.1093/oxfordjournals.jbchem.a135063; Liang HX, 2008, J MOL CELL CARDIOL, V44, P1062, DOI 10.1016/j.yjmcc.2008.03.011; Pearson RJ, 2006, CLIN INVEST MED, V29, P146; Perret P, 2002, J RECEPT SIGNAL TR R, V22, P345, DOI 10.1081/RRS-120014606; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; SMITH RP, 1966, TOXICOL APPL PHARM, V9, P209, DOI 10.1016/0041-008X(66)90115-3; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; Szentesi P, 2004, CIRC RES, V95, P807, DOI 10.1161/01.RES.0000146029.80463.7d; Tanaka Y, 1998, CIRCULATION, V98, P805; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; Thompson RW, 2003, TOXICOLOGY, V188, P149, DOI 10.1016/S0300-483X(03)00079-9; Wiser O, 1996, FEBS LETT, V379, P15, DOI 10.1016/0014-5793(95)01475-6; Xu M, 2011, CHINESE MED J-PEKING, V124, P3455, DOI 10.3760/cma.j.issn.0366-6999.2011.21.004; Yamaoka K, 2000, PFLUG ARCH EUR J PHY, V440, P207, DOI 10.1007/s004249900242; ZHANG ZH, 1994, CIRC RES, V75, P711, DOI 10.1161/01.RES.75.4.711; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002	24	48	54	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37073	10.1371/journal.pone.0037073	http://dx.doi.org/10.1371/journal.pone.0037073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590646	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400055
J	Colombo, C; Mosconi, P; Villani, W; Garattini, S				Colombo, Cinzia; Mosconi, Paola; Villani, Walter; Garattini, Silvio			Patient Organizations' Funding from Pharmaceutical Companies: Is Disclosure Clear, Complete and Accessible to the Public? An Italian Survey	PLOS ONE			English	Article							HEALTH ADVOCACY ORGANIZATIONS; INDUSTRY	Background: Many patients' and consumers' organizations accept drug industry funding to support their activities. As drug companies and patient groups move closer, disclosure become essential for transparency, and the internet could be a useful means of making sponsorship information accessible to the public. This survey aims to assess the transparency of a large group of Italian patient and consumer groups and a group of pharmaceutical companies, focusing on their websites. Methodology/Principal Findings: Patient and consumer groups were selected from those stated to be sponsored by a group of pharmaceutical companies on their websites. The websites were examined using two forms with principal (name of drug companies providing funds, amount of funding) and secondary indicators of transparency (section where sponsors are disclosed, update of sponsorship). Principal indicators were applied independently by two reviewers to the patient and consumer groups' websites. Discordances were solved by discussion. One hundred fifty-seven Italian patient and consumer groups and 17 drug companies were considered. Thirteen drug companies (76%) named at least one group funded, on their Italian websites. Of these, four (31%) indicated the activities sponsored and two (15%) the amount of funding. Of the 157 patient and consumer groups, 46 (29%) named at least one pharmaceutical company as providing funds. Three (6%) reported the amount of funding, 25 (54%) the activities funded, none the proportion of income derived from drug companies. Among the groups naming pharmaceutical company sponsors, 15 (33%) declared them in a dedicated section, five (11%) on the home page, the others in the financial report or other sections. Conclusions/Significance: Disclosure of funds is scarce on Italian patient and consumer groups' websites. The levels of transparency need to be improved. Disclosure of patient and consumer groups provided with funds is frequent on Italian pharmaceutical companies' websites, but information are often not complete.	[Colombo, Cinzia; Mosconi, Paola; Villani, Walter] Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Med Res Consumer Involvement, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Colombo, C (corresponding author), Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Med Res Consumer Involvement, Milan, Italy.	cinzia.colombo@marionegri.it	COLOMBO, CINZIA/ABG-6433-2020; Colombo, Cinzia/K-8981-2016; Garattini, Silvio/AAA-6390-2020; Paola, Mosconi/K-5596-2016; Villani, Walter/K-1801-2014	COLOMBO, CINZIA/0000-0001-6639-694X; Colombo, Cinzia/0000-0001-6639-694X; Garattini, Silvio/0000-0003-0647-9297; Paola, Mosconi/0000-0003-0415-3744; Villani, Walter/0000-0003-0681-2598	Mario Negri Institute; Pfizer	Mario Negri Institute; Pfizer(Pfizer)	The study was supported by internal institutional funds from the Mario Negri Institute. In December 2011, the Mario Negri Institute, on behalf of the Laboratory of Medical Research on Consumer Involvement, received a 6000 euro grant from Pfizer to participate in discussions on a project supported by this drug company. This activity was not related in any way in content or timing to the work submitted here. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], CONS PERSP CORP SOC; Ball DE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-201; Chalmers I, 2007, BRIT MED J, V335, P400, DOI 10.1136/bmj.39309.704016.BD; Hemminki E, 2010, SOC SCI MED, V70, P1171, DOI 10.1016/j.socscimed.2010.01.005; Herxheimer A, 2003, BRIT MED J, V326, P1208, DOI 10.1136/bmj.326.7400.1208; IMS Health Midas, 2009, TOP 15 GLOB CORP 200; Jones K, 2008, SOCIOL HEALTH ILL, V30, P929, DOI 10.1111/j.1467-9566.2008.01109.x; Kent A, 2007, BRIT MED J, V334, P934, DOI 10.1136/bmj.39185.461968.AD; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Mosconi P, 2003, BRIT MED J, V327, P344, DOI 10.1136/bmj.327.7410.344; Mosconi P, 2010, J AMBUL CARE MANAG, V33, P223, DOI 10.1097/JAC.0b013e3181e5eb4e; O'Donovan O, 2007, INT J HEALTH SERV, V37, P711, DOI 10.2190/HS.37.4.h; Rothman SM, 2011, AM J PUBLIC HEALTH, V101, P602, DOI 10.2105/AJPH.2010.300027; Siliquini R, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-21; Yamey G, 2000, BRIT MED J, V320, P207, DOI 10.1136/bmj.320.7229.207	16	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e34974	10.1371/journal.pone.0034974	http://dx.doi.org/10.1371/journal.pone.0034974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590498	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100004
J	Yang, MZ; Chen, YY; Zhou, Y; Wang, LW; Zhang, HT; Bi, LJ; Zhang, XE				Yang, Mingzhang; Chen, Yuanyuan; Zhou, Ying; Wang, Liwei; Zhang, Hongtai; Bi, Li-Jun; Zhang, Xian-En			MSMEG_2731, an Uncharacterized Nucleic Acid Binding Protein from Mycobacterium smegmatis, Physically Interacts with RPS1	PLOS ONE			English	Article							RIBOSOMAL PROTEIN-S1; ESCHERICHIA-COLI; TUBERCULOSIS H37RV; GENOME SEQUENCE; RNA-POLYMERASE; S1; TRANSLATION; DOMAINS	While the M. smegmatis genome has been sequenced, only a small portion of the genes have been characterized experimentally. Here, we purify and characterize MSMEG_2731, a conserved hypothetical alanine and arginine rich M. smegmatis protein. Using ultracentrifugation, we show that MSMEG_2731 is a monomer in vitro. MSMEG_2731 exists at a steady level throughout the M. smegmatis life-cycle. Combining results from pull-down techniques and LS-MS/MS, we show that MSMEG_2731 interacts with ribosomal protein S1. The existence of this interaction was confirmed by co-immunoprecipitation. We also show that MSMEG_2731 can bind ssDNA, dsDNA and RNA in vitro. Based on the interactions of MSMEG_2731 with RPS1 and RNA, we propose that MSMEG_2731 is involved in the transcription-translation process in vivo.	[Yang, Mingzhang; Chen, Yuanyuan; Zhou, Ying; Wang, Liwei; Zhang, Hongtai; Bi, Li-Jun] Chinese Acad Sci, Inst Biophys, Key Lab Noncoding RNA, Beijing 100080, Peoples R China; [Zhang, Xian-En] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Yang, Mingzhang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, MZ (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Noncoding RNA, Beijing 100080, Peoples R China.	blj@sun5.ibp.ac.cn; x.zhang@wh.iov.cn	Yang, Mingzhang/AAF-3510-2020; Chen, Yuanyuan/GXG-2130-2022; ZHANG, Xian-En/AAJ-5579-2021; Yang, Mingzhang/AAN-1046-2021	Yang, Mingzhang/0000-0002-7038-5677; 	Chinese Academy of Sciences [KSCX2-YW-R-164]; National Natural Science Foundation of China [30970590]; National Protein Research Fund [2009CB825402, 2011CB910302]; Chinese Ministry of Health [2008ZX10003-005]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Protein Research Fund; Chinese Ministry of Health	The support of the Chinese Academy of Sciences (Grant No. KSCX2-YW-R-164) and the National Natural Science Foundation of China (Grant No. 30970590) is acknowledged. Li-Jun Bi was supported by the National Protein Research Fund (Grant Nos. 2009CB825402 and 2011CB910302), and the Chinese Ministry of Health's Key Projects for Infectious Diseases (2008ZX10003-005) are also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprandi P, 2008, J BIOL CHEM, V283, P13289, DOI 10.1074/jbc.M707111200; Auerbach D, 2002, PROTEOMICS, V2, P611, DOI 10.1002/1615-9861(200206)2:6<611::AID-PROT611>3.0.CO;2-Y; Biswas T, 2009, BIOCHEMISTRY-US, V48, P2839, DOI 10.1021/bi8022416; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dick T, 1998, FEMS MICROBIOL LETT, V163, P159, DOI 10.1111/j.1574-6968.1998.tb13040.x; Domenech P, 2001, CURR OPIN MICROBIOL, V4, P28, DOI 10.1016/S1369-5274(00)00160-0; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARWELL MA, 1992, MOL MICROBIOL, V6, P3375, DOI 10.1111/j.1365-2958.1992.tb02205.x; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Mukherjee A, 2009, FEMS MICROBIOL LETT, V291, P232, DOI 10.1111/j.1574-6968.2008.01458.x; POTAPOV AP, 1992, BIOCHEM INT, V27, P745; Rosenkrands I, 2000, ELECTROPHORESIS, V21, P3740, DOI 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.3.CO;2-V; Salah P, 2009, NUCLEIC ACIDS RES, V37, P5578, DOI 10.1093/nar/gkp547; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; SUBRAMANIAN AR, 1977, MOL GEN GENET, V158, P1, DOI 10.1007/BF00455113; SUBRAMANIAN AR, 1983, PROG NUCLEIC ACID RE, V28, P101, DOI 10.1016/S0079-6603(08)60085-9; Sukhodolets MV, 2006, RNA, V12, P1505, DOI 10.1261/rna.2321606; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; Tyagi JS, 2002, TRENDS MICROBIOL, V10, P68, DOI 10.1016/S0966-842X(01)02296-X; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Wang Z, 1994, TRANSCRIPTION FACTOR; YAMADA T, 1982, FEBS LETT, V142, P267, DOI 10.1016/0014-5793(82)80149-X; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	28	2	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36666	10.1371/journal.pone.0036666	http://dx.doi.org/10.1371/journal.pone.0036666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590585	Green Published, gold			2022-12-27	WOS:000305336100051
J	Burns, ALJ; Herbert-Read, JE; Morrell, LJ; Ward, AJW				Burns, Alicia L. J.; Herbert-Read, James E.; Morrell, Lesley J.; Ward, Ashley J. W.			Consistency of Leadership in Shoals of Mosquitofish (Gambusia holbrooki) in Novel and in Familiar Environments	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; ROACH RUTILUS-RUTILUS; 3-SPINED STICKLEBACKS; ANIMAL GROUPS; NOTEMIGONUS-CRYSOLEUCAS; NUTRITIONAL STATE; INDIVIDUALS LEAD; SCHOOLING FISH; GOLDEN SHINERS; GPS TRACKING	In social animal groups, an individual's spatial position is a major determinant of both predation risk and foraging rewards. Additionally, the occupation of positions in the front of moving groups is generally assumed to correlate with the initiation of group movements. However, whether some individuals are predisposed to consistently occupy certain positions and, in some instances, to consistently lead groups over time is as yet unresolved in many species. Using the mosquitofish (Gambusia holbrooki), we examined the consistency of individuals' spatial positions within a moving group over successive trials. We found that certain individuals consistently occupied front positions in moving groups and also that it was typically these individuals that initiated group decisions. The number of individuals involved in leading the group varied according to the amount of information held by group members, with a greater number of changes in leadership in a novel compared to a relatively familiar environment. Finally, our results show that the occupation of lead positions in moving groups was not explained by characteristics such as dominance, size or sex, suggesting that certain individuals are predisposed to leadership roles. This suggests that being a leader or a follower may to some extent be an intrinsic property of the individual.	[Burns, Alicia L. J.; Herbert-Read, James E.; Ward, Ashley J. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Morrell, Lesley J.] Univ Hull, Dept Biol Sci, Kingston Upon Hull, East Yorkshire, England	University of Sydney; University of Hull	Burns, ALJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ashleyjwward@gmail.com	Ward, Ashley/B-6227-2011; Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871; Ward, Ashley/0000-0003-0842-533X; Herbert-Read, James/0000-0003-0243-4518	University of Sydney	University of Sydney(University of Sydney)	This work was funded by a Vice Chancellor's Grant provided by the University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Biro D, 2002, J EXP BIOL, V205, P3833; Bouissou MF, 2001, FARM ANIMALS, P113; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; BREDER CM, 1951, COPEIA, P162; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; BUMANN D, 1993, BEHAVIOUR, V125, P189, DOI 10.1163/156853993X00236; CALDWELL MELBA C., 1962, BULL SOUTHERN CALIFORNIA ACAD SCI, V61, P37; Chen T, 2011, BIOL LETTERS, V7, P343, DOI 10.1098/rsbl.2010.1020; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Dell'Ariccia G, 2009, J EXP BIOL, V212, P178, DOI 10.1242/jeb.024554; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Ihl C, 2011, J MAMMAL, V92, P819, DOI 10.1644/10-MAMM-A-109.1; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1994, BIOL REV, V69, P187, DOI 10.1111/j.1469-185X.1994.tb01505.x; Krause J, 1998, BEHAVIOUR, V135, P1031, DOI 10.1163/156853998792913519; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; LAMPRECHT J, 1992, BEHAVIOUR, V122, P105, DOI 10.1163/156853992X00336; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Levin LE, 1996, BEHAV PROCESS, V37, P1, DOI 10.1016/0376-6357(95)00067-4; Leyhausen P, 1975, APPL ANIM ETHOL, V1, P206; Lusseau D, 2009, BEHAV ECOL SOCIOBIOL, V63, P1067, DOI 10.1007/s00265-009-0740-7; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Morrell LJ, 2008, BEHAV ECOL, V19, P909, DOI 10.1093/beheco/arn050; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pavlov D.S., 2000, J ICHTHYOL+, V40, pS163; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; PITCHER TJ, 1982, ANIM BEHAV, V30, P932, DOI 10.1016/S0003-3472(82)80170-X; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; RHINE RJ, 1981, FOLIA PRIMATOL, V35, P77, DOI 10.1159/000155968; ROWELL TE, 1969, ANIM BEHAV, V17, P159, DOI 10.1016/0003-3472(69)90125-0; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; SHAW E, 1962, SCI AM, V206, P128, DOI 10.1038/scientificamerican0662-128; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Squires V. R., 1975, Applied Animal Ethology, V1, P263, DOI 10.1016/0304-3762(75)90019-X; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013059; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Utne-Palm AC, 2000, OIKOS, V91, P225, DOI 10.1034/j.1600-0706.2000.910203.x; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2003, FISH FISH, V4, P348, DOI 10.1046/j.1467-2979.2003.00135.x; Ward AJW, 2002, J ANIM ECOL, V71, P10, DOI 10.1046/j.0021-8790.2001.00571.x; Ward AJW, 2012, BEHAV ECOL SOCIOBIOL, V66, P223, DOI 10.1007/s00265-011-1270-7; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Webster MM, 2007, ANIM BEHAV, V74, P253, DOI 10.1016/j.anbehav.2006.07.021; Wilson ADM, 2010, BEHAV ECOL, V21, P57, DOI 10.1093/beheco/arp157	59	38	39	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36567	10.1371/journal.pone.0036567	http://dx.doi.org/10.1371/journal.pone.0036567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590568	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500017
J	Avitabile, C; Moggio, L; Malgieri, G; Capasso, D; Di Gaetano, S; Saviano, M; Pedone, C; Romanelli, A				Avitabile, Concetta; Moggio, Loredana; Malgieri, Gaetano; Capasso, Domenica; Di Gaetano, Sonia; Saviano, Michele; Pedone, Carlo; Romanelli, Alessandra			gamma sulphate PNA (PNA S): Highly Selective DNA Binding Molecule Showing Promising Antigene Activity	PLOS ONE			English	Article							PEPTIDE NUCLEIC-ACID; SEQUENCE B-DNA; STRAND INVASION; MIXED-SEQUENCE; CELLULAR DELIVERY; GENE-EXPRESSION; DUPLEX DNA; RECOGNITION; INHIBITION; CLEAVAGE	Peptide Nucleic Acids (PNAs), nucleic acid analogues showing high stability to enzyme degradation and strong affinity and specificity of binding toward DNA and RNA are widely investigated as tools to interfere in gene expression. Several studies have been focused on PNA analogues with modifications on the backbone and bases in the attempt to overcome solubility, uptake and aggregation issues. gamma PNAs, PNA derivatives having a substituent in the gamma position of the backbone show interesting properties in terms of secondary structure and affinity of binding toward complementary nucleic acids. In this paper we illustrate our results obtained on new analogues, bearing a sulphate in the gamma position of the backbone, developed to be more DNA-like in terms of polarity and charge. The synthesis of monomers and oligomers is described. NMR studies on the conformational properties of monomers and studies on the secondary structure of single strands and triplexes are reported. Furthermore the hybrid stability and the effect of mismatches on the stability have also been investigated. Finally, the ability of the new analogue to work as antigene, interfering with the transcription of the ErbB2 gene on a human cell line overexpressing ErbB2 (SKBR3), assessed by FACS and qPCR, is described.	[Avitabile, Concetta; Moggio, Loredana; Capasso, Domenica; Pedone, Carlo; Romanelli, Alessandra] Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Sci Biol, Naples, Italy; [Malgieri, Gaetano] Seconda Univ Napoli, Dipartimento Sci Ambientali, Caserta, Italy; [Di Gaetano, Sonia; Pedone, Carlo; Romanelli, Alessandra] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Saviano, Michele] CNR, Ist Cristallog, I-70126 Bari, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Avitabile, C (corresponding author), Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Sci Biol, Naples, Italy.	alessandra.romanelli@unina.it	Saviano, Michele/R-1693-2016; Malgieri, Gaetano/N-1678-2016	Saviano, Michele/0000-0001-5086-2459; Capasso, Domenica/0000-0001-7201-3431; Di Gaetano, Sonia/0000-0001-5523-3619; MALGIERI, Gaetano/0000-0002-4070-9458; Avitabile, Concetta/0000-0001-5542-6920; ROMANELLI, Alessandra/0000-0002-7609-4061	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale [MIUR PRIN2009, 20093N774P]	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale	Ministero dell'Universita, dell'lstruzione e della Ricerca- Progetti di ricerca di Rilevante Interesse Nazionale (MIUR PRIN2009, Prot 20093N774P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian-Herrada G, 1998, J PEPT SCI, V4, P266, DOI 10.1002/(SICI)1099-1387(199806)4:4<266::AID-PSC143>3.0.CO;2-C; Armitage B, 1997, NUCLEIC ACIDS RES, V25, P4674, DOI 10.1093/nar/25.22.4674; Avitabile C, 2010, TETRAHEDRON LETT, V51, P3716, DOI 10.1016/j.tetlet.2010.05.026; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bentin T, 2003, J AM CHEM SOC, V125, P6378, DOI 10.1021/ja029936t; BETTS L, 1995, SCIENCE, V270, P1838, DOI 10.1126/science.270.5243.1838; Bigey P, 1997, BIOCONJUGATE CHEM, V8, P267, DOI 10.1021/bc9700190; Borgatti M, 2002, BIOCHEM PHARMACOL, V64, P609, DOI 10.1016/S0006-2952(02)01188-7; Campos SV, 2002, J CHEM SOC PERK T 1, P682, DOI 10.1039/b107320f; Chen J, 2010, P NATL ACAD SCI USA, V107, P16846, DOI 10.1073/pnas.0912896107; Cortesi R, 2004, AAPS PHARMSCI, V6; de Koning MC, 2006, TETRAHEDRON, V62, P3248, DOI 10.1016/j.tet.2006.01.065; DEMIDOV V, 1993, NUCLEIC ACIDS RES, V21, P2103, DOI 10.1093/nar/21.9.2103; Doyle DF, 2001, BIOCHEMISTRY-US, V40, P53, DOI 10.1021/bi0020630; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P16104, DOI 10.1021/ja063383v; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P10258, DOI 10.1021/ja0625576; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Englund EA, 2007, ANGEW CHEM INT EDIT, V46, P1414, DOI 10.1002/anie.200603483; Finn PJ, 1996, NUCLEIC ACIDS RES, V24, P3357, DOI 10.1093/nar/24.17.3357; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Hamilton SE, 1999, CHEM BIOL, V6, P343, DOI 10.1016/S1074-5521(99)80046-5; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; He GF, 2009, J AM CHEM SOC, V131, P12088, DOI 10.1021/ja900228j; Herbert BS, 1999, P NATL ACAD SCI USA, V96, P14276, DOI 10.1073/pnas.96.25.14276; Ishizuka T, 2008, NUCLEIC ACIDS RES, V36, P1464, DOI 10.1093/nar/gkm1154; Jensen KK, 1997, BIOCHEMISTRY-US, V36, P5072, DOI 10.1021/bi9627525; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Koppelhus U, 2003, ADV DRUG DELIVER REV, V55, P267, DOI 10.1016/S0169-409X(02)00182-5; KOSYNKINA L, 1994, TETRAHEDRON LETT, V35, P5173, DOI 10.1016/S0040-4039(00)77056-0; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kumar VA, 2005, ACCOUNTS CHEM RES, V38, P404, DOI 10.1021/ar030277e; Mitra R, 2011, CHEM COMMUN, V47, P1198, DOI 10.1039/c0cc03988h; Mokhir AA, 2003, BIOCONJUGATE CHEM, V14, P877, DOI 10.1021/bc0256345; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Okamoto A, 2001, ORG LETT, V3, P925, DOI 10.1021/ol015549x; Pensato S, 2007, EXPERT OPIN BIOL TH, V7, P1219, DOI 10.1517/14712598.7.8.1219; Pensato S, 2010, BIOORG CHEM, V38, P196, DOI 10.1016/j.bioorg.2010.06.002; Petraccone L, 2005, J AM CHEM SOC, V127, P16215, DOI 10.1021/ja0545923; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Rapireddy S, 2011, BIOCHEMISTRY-US, V50, P3913, DOI 10.1021/bi2002554; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f; Roviello GN, 2010, MOL BIOSYST, V6, P199, DOI 10.1039/b910278g; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sahu B, 2009, J ORG CHEM, V74, P1509, DOI 10.1021/jo802211n; Seo YJ, 2011, NUCLEIC ACIDS RES, V39, P7329, DOI 10.1093/nar/gkr360; Sforza S, 2007, EUR J ORG CHEM, V2007, P5879, DOI 10.1002/ejoc.200700644; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; Tedeschi T, 2005, TETRAHEDRON LETT, V46, P8395, DOI 10.1016/j.tetlet.2005.09.157; Timar Z, 2000, J CHEM SOC PERK T 1, P19, DOI 10.1039/a907832k; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Wu Y, 2001, TETRAHEDRON, V57, P8107, DOI 10.1016/S0040-4020(01)00789-X; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yeh JI, 2010, J AM CHEM SOC, V132, P10717, DOI 10.1021/ja907225d; Zhilina ZV, 2006, BIOCONJUGATE CHEM, V17, P214, DOI 10.1021/bc0502964	57	37	41	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35774	10.1371/journal.pone.0035774	http://dx.doi.org/10.1371/journal.pone.0035774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586450	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000012
J	Gepner, AD; Ramamurthy, R; Krueger, DC; Korcarz, CE; Binkley, N; Stein, JH				Gepner, Adam D.; Ramamurthy, Rekha; Krueger, Diane C.; Korcarz, Claudia E.; Binkley, Neil; Stein, James H.			A Prospective Randomized Controlled Trial of the Effects of Vitamin D Supplementation on Cardiovascular Disease Risk	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ENDOTHELIAL FUNCTION; 25-HYDROXYVITAMIN D; ARTERIAL STIFFNESS; D DEFICIENCY; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; BLOOD-PRESSURE; HEART-FAILURE; ADULTS	Vitamin D (VitD) supplementation has been advocated for cardiovascular risk reduction; however, supporting data are sparse. The objective of this study was to determine whether VitD supplementation reduces cardiovascular risk. Subjects in this prospective, randomized, double-blind, placebo-controlled trial of post-menopausal women with serum 25-hydroxyvitamin D concentrations > 10 and <60 ng/mL were randomized to Vitamin D3 2500 IU or placebo, daily for 4 months. Primary endpoints were changes in brachial artery flow-mediated vasodilation (FMD), carotid-femoral pulse wave velocity (PWV), and aortic augmentation index (AIx). The 114 subjects were mean (standard deviation) 63.9 (3.0) years old with a 25-hydroxyvitamin D level of 31.3 (10.6) ng/mL. Low VitD (<30 ng/mL) was present in 47% and was associated with higher body-mass index, systolic blood pressure, glucose, CRP, and lower FMD (all p<0.05). After 4 months, 25-hydroxyvitamin D levels increased by 15.7 (9.3) ng/mL on vitamin D3 vs. -0.2 (6.1) ng/mL on placebo (p<0.001). There were no significant differences between groups in changes in FMD (0.3 [3.4] vs. 0.3 [2.6] %, p = 0.77), PWV (0.00 [1.06] vs. 0.05 [0.92] m/s, p = 0.65), AIx (2.7 [6.3] vs. 0.9 [5.6] %, p = 0.10), or CRP (0.3 [1.9] vs. 0.3 [4.2] mg/L, p = 0.97). Multivariable models showed no significant interactions between treatment group and low VitD status (, 30 ng/mL) for changes in FMD (p = 0.65), PWV (p = 0.93), AIx (p = 0.97), or CRP (p = 0.26). In conclusion, VitD supplementation did not improve endothelial function, arterial stiffness, or inflammation. These observations do not support use of VitD supplementation to reduce cardiovascular disease risk.	[Gepner, Adam D.; Ramamurthy, Rekha; Krueger, Diane C.; Korcarz, Claudia E.; Binkley, Neil; Stein, James H.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Gepner, AD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jhs@medicine.wisc.edu	Ramamurthy, Rekha/HGE-6904-2022; Korcarz, Claudia/A-5728-2018	Stein, James/0000-0002-2770-8223; Korcarz, Claudia/0000-0001-9691-9027	University of Wisconsin School of Medicine and Public Health Institute of Clinical and Translational Research; University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL094760] Funding Source: NIH RePORTER	University of Wisconsin School of Medicine and Public Health Institute of Clinical and Translational Research; University of Wisconsin; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work has no commercial sponsor but was supported by the University of Wisconsin School of Medicine and Public Health Institute of Clinical and Translational Research and the University of Wisconsin Osteoporosis Clinical Center and Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Amer M, 2012, AM J CARDIOL, V109, P226, DOI 10.1016/j.amjcard.2011.08.032; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P1800, DOI 10.2215/CJN.00900208; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Binkley N, 2006, CLIN CHEM, V52, P2124, DOI 10.1373/clinchem.2006.074922; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cannell J, 2008, EXPERT OPIN PHARMACO, V9, P107, DOI 10.1517/14656566.9.1.107; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Geleijnse JM, 2011, AM J HYPERTENS, V24, P253, DOI 10.1038/ajh.2010.199; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; INOUE M, 1992, LIFE SCI, V51, P1105, DOI 10.1016/0024-3205(92)90511-M; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; Korcarz CE, 2010, SLEEP, V33, P1081, DOI 10.1093/sleep/33.8.1081; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; LIND L, 1995, AM J HYPERTENS, V8, P894, DOI 10.1016/0895-7061(95)00154-H; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; O'Keefe JH, 2011, JAMA-J AM MED ASSOC, V306, P1546, DOI 10.1001/jama.2011.1465; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6; Poole KES, 2006, STROKE, V37, P243, DOI 10.1161/01.STR.0000195184.24297.c1; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCRAGG R, 1990, INT J EPIDEMIOL, V19, P559, DOI 10.1093/ije/19.3.559; Sepulveda JL, 2005, CURR OPIN CARDIOL, V20, P407; Shapses SA, 2011, JAMA-J AM MED ASSOC, V305, P2565, DOI 10.1001/jama.2011.881; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Vanga SR, 2010, AM J CARDIOL, V106, P798, DOI 10.1016/j.amjcard.2010.04.042; Vieth R, 2006, J NUTR, V136, P1117, DOI 10.1093/jn/136.4.1117; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Witham MD, 2010, DIABETOLOGIA, V53, P2112, DOI 10.1007/s00125-010-1838-1; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899	46	132	133	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36617	10.1371/journal.pone.0036617	http://dx.doi.org/10.1371/journal.pone.0036617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586483	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335000044
J	He, JD; Peng, MS; Quang, HH; Dang, KP; Trieu, AV; Wu, SF; Jin, JQ; Murphy, RW; Yao, YG; Zhang, YP				He, Jun-Dong; Peng, Min-Sheng; Huy Ho Quang; Khoa Pham Dang; An Vu Trieu; Wu, Shi-Fang; Jin, Jie-Qiong; Murphy, Robert W.; Yao, Yong-Gang; Zhang, Ya-Ping			Patrilineal Perspective on the Austronesian Diffusion in Mainland Southeast Asia	PLOS ONE			English	Article							INFERRING ADMIXTURE PROPORTIONS; Y-CHROMOSOME; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; MOLECULAR-DATA; POPULATIONS; DIVERSITY; POLYMORPHISMS; RESOLUTION; INDIA	The Cham people are the major Austronesian speakers of Mainland Southeast Asia (MSEA) and the reconstruction of the Cham population history can provide insights into their diffusion. In this study, we analyzed non-recombining region of the Y chromosome markers of 177 unrelated males from four populations in MSEA, including 59 Cham, 76 Kinh, 25 Lao, and 17 Thai individuals. Incorporating published data from mitochondrial DNA (mtDNA), our results indicated that, in general, the Chams are an indigenous Southeast Asian population. The origin of the Cham people involves the genetic admixture of the Austronesian immigrants from Island Southeast Asia (ISEA) with the local populations in MSEA. Discordance between the overall patterns of Y chromosome and mtDNA in the Chams is evidenced by the presence of some Y chromosome lineages that prevail in South Asians. Our results suggest that male-mediated dispersals via the spread of religions and business trade might play an important role in shaping the patrilineal gene pool of the Cham people.	[He, Jun-Dong; Peng, Min-Sheng; Wu, Shi-Fang; Jin, Jie-Qiong; Murphy, Robert W.; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [He, Jun-Dong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [He, Jun-Dong; Peng, Min-Sheng; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming, Peoples R China; [Huy Ho Quang; Khoa Pham Dang; An Vu Trieu] Hanoi Med Univ, Dept Immunol, Hanoi, Vietnam; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers & Conservat Biol, Toronto, ON M5S 2C6, Canada; [Peng, Min-Sheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Yunnan University; Hanoi Medical University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, JD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Yao, Yong-Gang/AAH-2303-2021	Yao, Yong-Gang/0000-0002-2955-0693; Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China; Bureau of Science and Technology of Yunnan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This research was supported by grants from National Natural Science Foundation of China, and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P, 2006, AUSTRONESIANS: HISTORICAL AND COMPARATIVE PERSPECTIVES, P103; Bellwood P, 2006, AUSTRONESIANS: HISTORICAL AND COMPARATIVE PERSPECTIVES, P1; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Cruciani F, 2011, AM J HUM GENET, V88, P814, DOI 10.1016/j.ajhg.2011.05.002; Debnath M, 2011, J HUM GENET, V56, P765, DOI 10.1038/jhg.2011.98; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; HE P, 2006, ORIGIN EVOLUTION NAT; Higham C., 2002, EARLY CULTURES MAINL; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Kim Soon-Hee, 2011, Investig Genet, V2, P10, DOI 10.1186/2041-2223-2-10; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kutanan W, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-56; Lewis M. P., ETHNOLOGUE LANGUAGES; Mohammad T, 2009, HEREDITY, V103, P425, DOI 10.1038/hdy.2009.72; Nakamura R, 2009, CHAMPA ARCHAEOLOGY M, P78; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Prinz M, 1997, FORENSIC SCI INT, V85, P209, DOI 10.1016/S0379-0738(96)02096-8; Reid, 1988, SE ASIA AGE COMMERCE, V2; REID ANTHONY, 1988, SE ASIA AGE COMMERCE, VI; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; SOLHEIM WG, 2006, ARCHAEOLOGY CULTURE; Southworth W. A., 2004, SE ASIA PREHISTORY H, P209; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thurgood G, 2005, AUSTRONESIAN LANGUAG, P489; Thurgood G, 1999, ANCIENT CHAM MODERN, Vxvii, P407; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Yao YG, 2002, AM J PHYS ANTHROPOL, V118, P63, DOI 10.1002/ajpa.10052	40	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36437	10.1371/journal.pone.0036437	http://dx.doi.org/10.1371/journal.pone.0036437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586471	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000033
J	Rubach, MP; Mukemba, J; Florence, S; John, B; Crookston, B; Lopansri, BK; Yeo, TW; Piera, KA; Alder, SC; Weinberg, JB; Anstey, NM; Granger, DL; Mwaikambo, ED				Rubach, Matthew P.; Mukemba, Jackson; Florence, Salvatore; John, Bernard; Crookston, Benjamin; Lopansri, Bert K.; Yeo, Tsin W.; Piera, Kim A.; Alder, Stephen C.; Weinberg, J. Brice; Anstey, Nicholas M.; Granger, Donald L.; Mwaikambo, Esther D.			Plasma Plasmodium falciparum Histidine-Rich Protein-2 Concentrations Are Associated with Malaria Severity and Mortality in Tanzanian Children	PLOS ONE			English	Article								Plasma Plasmodium falciparum histidine-rich protein-2 (PfHRP-2) concentrations, a measure of parasite biomass, have been correlated with malaria severity in adults, but not yet in children. We measured plasma PfHRP-2 in Tanzanian children with uncomplicated (n = 61) and cerebral malaria (n = 45; 7 deaths). Median plasma PfHRP-2 concentrations were higher in cerebral malaria (1008 [IQR 342-2572] ng/mL) than in uncomplicated malaria (465 [IQR 36-1426] ng/mL; p = 0.017). In cerebral malaria, natural log plasma PfHRP-2 was associated with coma depth (r = -0.42; p = 0.006) and mortality (OR: 3.0 [95% CI 1.03-8.76]; p = 0.04). In this relatively small cohort study in a mesoendemic transmission area of Africa, plasma PfHRP-2 was associated with pediatric malaria severity and mortality. Further studies among children in areas of Africa with higher malaria transmission and among children with different clinical manifestations of severe malaria will help determine the wider utility of quantitative PfHRP-2 as a measure of parasite biomass and prognosis in sub-Saharan Africa.	[Rubach, Matthew P.; Crookston, Benjamin; Alder, Stephen C.; Granger, Donald L.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Rubach, Matthew P.; Crookston, Benjamin; Alder, Stephen C.; Granger, Donald L.] Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Mukemba, Jackson; Florence, Salvatore; John, Bernard; Mwaikambo, Esther D.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Lopansri, Bert K.] Loyola Univ, Med Ctr, Maywood, IL 60153 USA; [Yeo, Tsin W.; Piera, Kim A.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Yeo, Tsin W.; Piera, Kim A.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Darwin, NT, Australia; [Weinberg, J. Brice] VA Med Ctr, Durham, NC USA; [Rubach, Matthew P.] Duke Univ, Div Infect Dis, Durham, NC 27705 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Loyola University Chicago; Charles Darwin University; Charles Darwin University; Menzies School of Health Research; Duke University	Rubach, MP (corresponding author), Duke Univ, Div Infect Dis, Durham, NC 27705 USA.	Donald.Granger@va.gov	Yeo, Tsin Wen/F-9505-2015	Rubach, Matthew/0000-0001-5262-1421	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [U01 AI0575655, 2R01AI041764-11]; VA Research Service; American Academy of Pediatrics; National Health and Medical Research Council; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI041764, R01AI041764] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); VA Research Service(US Department of Veterans Affairs); American Academy of Pediatrics; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (U01 AI0575655 to DLG and 2R01AI041764-11 to JBW), by the VA Research Service (DLG and JBW), and by the American Academy of Pediatrics (Residency Research Grant to MPR). TWY and NMA are supported by National Health and Medical Research Council Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Manning L, 2011, CLIN INFECT DIS, V52, P440, DOI 10.1093/cid/ciq105; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Tjitra E, 2001, J CLIN MICROBIOL, V39, P1025, DOI 10.1128/JCM.39.3.1025-1031.2001; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	14	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35985	10.1371/journal.pone.0035985	http://dx.doi.org/10.1371/journal.pone.0035985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586457	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000019
J	Pagano, K; Torella, R; Foglieni, C; Bugatti, A; Tomaselli, S; Zetta, L; Presta, M; Rusnati, M; Taraboletti, G; Colombo, G; Ragona, L				Pagano, Katiuscia; Torella, Rubben; Foglieni, Chiara; Bugatti, Antonella; Tomaselli, Simona; Zetta, Lucia; Presta, Marco; Rusnati, Marco; Taraboletti, Giulia; Colombo, Giorgio; Ragona, Laura			Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; HEPARIN-BINDING; FGF BINDING; PROTEIN; ANGIOGENESIS; MUTATIONS; DERIVATIVES	Fibroblast growth factors (FGFs) are recognized targets for the development of therapies against angiogenesis-driven diseases, including cancer. The formation of a ternary complex with the transmembrane tyrosine kinase receptors (FGFRs), and heparan sulphate proteoglycans (HSPGs) is required for FGF2 pro-angiogenic activity. Here by using a combination of techniques including Nuclear Magnetic Resonance, Molecular Dynamics, Surface Plasmon Resonance and cell-based binding assays we clarify the molecular mechanism of inhibition of an angiostatic small molecule, sm27, mimicking the endogenous inhibitor of angiogenesis, thrombospondin-1. NMR and MD data demonstrate that sm27 engages the heparin-binding site of FGF2 and induces long-range dynamics perturbations along FGF2/FGFR1 interface regions. The functional consequence of the inhibitor binding is an impaired FGF2 interaction with both its receptors, as demonstrated by SPR and cell-based binding assays. We propose that sm27 antiangiogenic activity is based on a twofold-direct and allosteric-mechanism, inhibiting FGF2 binding to both its receptors.	[Pagano, Katiuscia; Tomaselli, Simona; Zetta, Lucia; Ragona, Laura] CNR, Ist Studio Macromol, Lab NMR, Milan, Italy; [Torella, Rubben; Colombo, Giorgio] CNR, Ist Chim Riconoscimento Mol, Milan, Italy; [Foglieni, Chiara; Taraboletti, Giulia] Mario Negri Inst Pharmacol Res, Dept Oncol, I-24100 Bergamo, Italy; [Bugatti, Antonella; Presta, Marco; Rusnati, Marco] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, Brescia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia	Pagano, K (corresponding author), CNR, Ist Studio Macromol, Lab NMR, Milan, Italy.	g.colombo@icrm.cnr.it; laura.ragona@ismac.cnr.it	Pagano, Katiuscia/AAB-9495-2020; tomaselli, simona/A-6075-2012; Colombo, Giorgio/A-2730-2012; Ragona, Laura/AAB-9691-2020; Taraboletti, Giulia/J-4089-2018; Rusnati, Marco/F-1168-2010	tomaselli, simona/0000-0002-8627-6838; Colombo, Giorgio/0000-0002-1318-668X; Ragona, Laura/0000-0003-3893-7117; Taraboletti, Giulia/0000-0001-8780-5001; Rusnati, Marco/0000-0001-9968-5908; pagano, katiuscia/0000-0002-0462-2056; PRESTA, Marco/0000-0002-4398-8376	Fondazione Cariplo [2008.2198]; Ministero della Salute [GR2007]; Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR); Associazione Italiana per la Ricerca sul Cancro (AIRC); Fondazione De Marco	Fondazione Cariplo(Fondazione Cariplo); Ministero della Salute(Ministry of Health, Italy); Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione De Marco	This work was supported by Fondazione Cariplo (project: 2008.2198), Ministero della Salute (GR2007), Ministero dell'Istruzione dell'Universita e della Ricerca (MIUR) and Associazione Italiana per la Ricerca sul Cancro (AIRC). LR acknowledges Fondazione De Marco for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Canales-Mayordomo A, 2006, J BIOMOL NMR, V35, P225, DOI 10.1007/s10858-006-9024-y; Case D, 2006, AMBER 9; Colombo G, 2010, J BIOL CHEM, V285, P8733, DOI 10.1074/jbc.M109.085605; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; Fernandez IS, 2010, J BIOL CHEM, V285, P11714, DOI 10.1074/jbc.M109.064618; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; HEATH WF, 1991, BIOCHEMISTRY-US, V30, P5608, DOI 10.1021/bi00236a039; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Krishnamoorthy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008943; Leali D, 2001, J BIOL CHEM, V276, P37900; Leali D, 2010, J CELL MOL MED, V14, P2109, DOI 10.1111/j.1582-4934.2009.00855.x; LI LY, 1994, BIOCHEMISTRY-US, V33, P10999, DOI 10.1021/bi00202a020; Liekens S, 1999, MOL PHARMACOL, V56, P204, DOI 10.1124/mol.56.1.204; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Margosio B, 2003, BLOOD, V102, P4399, DOI 10.1182/blood-2003-03-0893; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mauldin RV, 2009, STRUCTURE, V17, P386, DOI 10.1016/j.str.2009.01.005; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Niccolai N, 2001, PROTEIN SCI, V10, P1498, DOI 10.1110/ps.30101; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Otting G, 1997, PROG NUCL MAG RES SP, V31, P259, DOI 10.1016/S0079-6565(97)00012-5; Peng JW, 2009, STRUCTURE, V17, P319, DOI 10.1016/j.str.2009.02.004; Pontiggia F, 2008, BIOPHYS J, V95, P5901, DOI 10.1529/biophysj.108.135467; Presta M, 2005, ARTERIOSCL THROM VAS, V25, P71, DOI 10.1161/01.ATV.0000148863.24445.b4; Ravindranathan S, 2010, J MOL BIOL, V396, P732, DOI 10.1016/j.jmb.2009.12.004; Rusnati M, 2001, J BIOL CHEM, V276, P22420, DOI 10.1074/jbc.M010779200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SENO M, 1990, EUR J BIOCHEM, V188, P239, DOI 10.1111/j.1432-1033.1990.tb15395.x; Taraboletti G, 1997, CELL GROWTH DIFFER, V8, P471; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; TARABOLETTI G, 1993, CANCER RES, V53, P3812; Taraboletti G, 2010, ONCOTARGET, V1, P662; Torella R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-42; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603	53	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36990	10.1371/journal.pone.0036990	http://dx.doi.org/10.1371/journal.pone.0036990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606323	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339400052
J	Isanaka, S; Aboud, S; Mugusi, F; Bosch, RJ; Willett, WC; Spiegelman, D; Duggan, C; Fawzi, WW				Isanaka, Sheila; Aboud, Said; Mugusi, Ferdinand; Bosch, Ronald J.; Willett, Walter C.; Spiegelman, Donna; Duggan, Christopher; Fawzi, Wafaie W.			Iron Status Predicts Treatment Failure and Mortality in Tuberculosis Patients: A Prospective Cohort Study from Dar es Salaam, Tanzania	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; DEFICIENCY ANEMIA; URBAN TANZANIA; DIETARY IRON; MACROPHAGE; SUPPLEMENTATION; PREVALENCE; MICE; OVERLOAD	Background: Experimental data suggest a role for iron in the course of tuberculosis (TB) infection, but there is limited evidence on the potential effects of iron deficiency or iron overload on the progression of TB disease in humans. The aim of the present analysis was to examine the association of iron status with the risk of TB progression and death. Methodology/Principal Findings: We analyzed plasma samples and data collected as part a randomized micronutrient supplementation trial (not including iron) among HIV-infected and HIV-uninfected TB patients in Dar es Salaam, Tanzania. We prospectively related baseline plasma ferritin concentrations from 705 subjects (362 HIV-infected and 343 HIV-uninfected) to the risk of treatment failure at one month after initiation, TB recurrence and death using binomial and Cox regression analyses. Overall, low (plasma ferritin<30 mu g/L) and high (plasma ferritin>150 mu g/L for women and>200 mu g/L for men) iron status were seen in 9% and 48% of patients, respectively. Compared with normal levels, low plasma ferritin predicted an independent increased risk of treatment failure overall (adjusted RR = 1.95, 95% CI: 1.07 to 3.52) and of TB recurrence among HIV-infected patients (adjusted RR = 4.21, 95% CI: 1.22 to 14.55). High plasma ferritin, independent of C-reactive protein concentrations, was associated with an increased risk of overall mortality (adjusted RR = 3.02, 95% CI: 1.95 to 4.67). Conclusions/Significance: Both iron deficiency and overload exist in TB patients and may contribute to disease progression and poor clinical outcomes. Strategies to maintain normal iron status in TB patients could be helpful to reduce TB morbidity and mortality.	[Isanaka, Sheila; Willett, Walter C.; Duggan, Christopher; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Spiegelman, Donna; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Bosch, Ronald J.; Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Populat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Willett, Walter C.] Harvard Univ, Sch Med, Dept Med, Channing Lab, Boston, MA USA; [Duggan, Christopher] Childrens Hosp Boston, Div Gastroenterol & Nutr, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Isanaka, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	sisanaka@hsph.harvard.edu	Isanaka, Sheila/AAQ-9056-2020		National Institutes of Health [U01AI045441, 1K24HD058795]; Harvard University Committee on African Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD058795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI045441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Committee on African Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [grant numbers U01AI045441, 1K24HD058795 to CD] and the Harvard University Committee on African Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boom J, 2007, HIV MED, V8, P388, DOI 10.1111/j.1468-1293.2007.00481.x; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; DALLMAN PR, 1987, AM J CLIN NUTR, V46, P329, DOI 10.1093/ajcn/46.2.329; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Devi U, 2003, BRIT J NUTR, V90, P541, DOI 10.1079/BJN2003936; DOUVAS GS, 1993, J INFECT DIS, V167, P857, DOI 10.1093/infdis/167.4.857; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Ekiz C, 2005, HEMATOL J, V5, P579, DOI 10.1038/sj.thj.6200574; Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Gordeuk VR, 2009, INT J TUBERC LUNG D, V13, P1267; Gordeuk VR, 1996, BLOOD, V87, P3470, DOI 10.1182/blood.V87.8.3470.bloodjournal8783470; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; HALLQUIST NA, 1992, AM J CLIN NUTR, V55, P741, DOI 10.1093/ajcn/55.3.741; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Kochan I, 1973, Curr Top Microbiol Immunol, V60, P1; Kotru M, 2004, ANN HEMATOL, V83, P95, DOI 10.1007/s00277-003-0788-9; Kuvibidila S, 2004, CYTOKINE, V26, P73, DOI 10.1016/j.cyto.2003.12.010; LEPPER AWD, 1988, VET MICROBIOL, V16, P369, DOI 10.1016/0378-1135(88)90017-X; Lounis N, 2001, J CLIN VIROL, V20, P123, DOI 10.1016/S1386-6532(00)00136-0; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; MORRIS CDW, 1989, Q J MED, V73, P1151; Njelekela MA, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-30; Olsen A, 2004, JAIDS-J ACQ IMM DEF, V36, P637, DOI 10.1097/00126334-200405010-00013; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Sahiratmadja E, 2007, BRIT J NUTR, V98, P684, DOI 10.1017/S0007114507742691; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Sipahi T, 1998, PEDIATR HEMAT ONCOL, V15, P69, DOI 10.3109/08880019809009510; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Trousseau A, 1872, LECT CLIN MED; United Nations Children's Fund United Nations University and World Health Organization, 2001, IR DEF AN ASS PREV C; van Lettow M, 2005, EUR J CLIN NUTR, V59, P526, DOI 10.1038/sj.ejcn.1602116; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; WHO, 2004, ASS IR STAT POP; World Health Organization, 2010, GLOB TUB CONTR WHO R	38	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37350	10.1371/journal.pone.0037350	http://dx.doi.org/10.1371/journal.pone.0037350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606361	Green Published, gold			2022-12-27	WOS:000305338200071
J	Mou, XZ; Chen, L; Liu, FL; Lin, J; Diao, PP; Wang, HH; Li, YF; Lin, JJ; Teng, LS; Xiang, C				Mou, Xiaozhou; Chen, Ling; Liu, Fanlong; Lin, Jian; Diao, Pingping; Wang, Haohao; Li, Yifei; Lin, Jianjiang; Teng, Lisong; Xiang, Charlie			Prevalence of JC Virus in Chinese Patients with Colorectal Cancer	PLOS ONE			English	Article							T-ANTIGEN EXPRESSION; HUMAN POLYOMAVIRUS; COLON-CANCER; DNA-SEQUENCES; ASSOCIATION; ANTIBODIES; REPAIR; RISK	Background: JCV is a DNA polyomavirus very well adapted to humans. Although JCV DNA has been detected in colorectal cancers (CRC), the association between JCV and CRC remains controversial. In China, the presence of JCV infection in CRC patients has not been reported. Here, we investigated JCV infection and viral DNA load in Chinese CRC patients and to determine whether the JCV DNA in peripheral blood (PB) can be used as a diagnostic marker for JCV-related CRC. Methodology/Principal Findings: Tumor tissues, non-cancerous tumor-adjacent tissues and PB samples were collected from 137 CRC patients. In addition, 80 normal colorectal tissue samples from patients without CRC and PB samples from 100 healthy volunteers were also harvested as controls. JCV DNA was detected by nested PCR and glass slide-based dot blotting. Viral DNA load of positive samples were determined by quantitative real-time PCR. JCV DNA was detected in 40.9% (56/137) of CRC tissues at a viral load of 49.1 to 10.3x10(4) copies/mu g DNA. Thirty-four (24.5%) non-cancerous colorectal tissues (192.9 to 4.4x10(3) copies/mu g DNA) and 25 (18.2%) PB samples (81.3 to 4.9x10(3) copies/mu g DNA) from CRC patients were positive for JCV. Tumor tissues had higher levels of JCV than non-cancerous tissues (P = 0.003) or PB samples (P<0.001). No correlation between the presence of JCV and demographic or medical characteristics was observed. The JCV prevalence in PB samples was significantly associated with the JCV status in tissue samples (P<0.001). Eleven (13.8%) normal colorectal tissues and seven (7.0%) PB samples from healthy donors were positive for JCV. Conclusions/Significance: JCV infection is frequently present in colorectal tumor tissues of CRC patients. Although the association between JCV presence in PB samples and JCV status in tissue samples was identified in this study, whether PB JCV detection can serve as a marker for JCV status of CRC requires further study.	[Mou, Xiaozhou; Chen, Ling; Liu, Fanlong; Lin, Jian; Diao, Pingping; Li, Yifei; Xiang, Charlie] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Liu, Fanlong; Wang, Haohao; Lin, Jianjiang; Teng, Lisong] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou] Zhejiang Univ, Sch Med, Inst Mol Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Mou, Xiaozhou; Xiang, Charlie] Zhejiang California Int Nanosyst Inst ZCNI, Mol Diag Div, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Mou, XZ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	lsteng@zju.edu.cn; cxiang@zju.edu.cn			China's National Science and Technology Major Project [2012ZX10002006-003]; National Basic Research Program of China (973 program) [2007CB513001]; Zhejiang University	China's National Science and Technology Major Project; National Basic Research Program of China (973 program)(National Basic Research Program of China); Zhejiang University	This study was funded by grants from China's National Science and Technology Major Project No. 2012ZX10002006-003, the National Basic Research Program of China (973 program) No. 2007CB513001, and a Qiu Shi Professorship from Zhejiang University to CX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz HO, 2007, APPL IMMUNOHISTO M M, V15, P394, DOI 10.1097/01.pai.0000213126.96590.64; Berger JR, 2011, CURR OPIN NEUROL, V24, P262, DOI 10.1097/WCO.0b013e328346d2a3; Bodaghi S, 2005, J CLIN MICROBIOL, V43, P5428, DOI 10.1128/JCM.43.11.5428-5434.2005; Caldarelli-Stefano R, 2000, HUM PATHOL, V31, P394, DOI 10.1016/S0046-8177(00)80256-7; Campello C, 2010, J MED VIROL, V82, P1197, DOI 10.1002/jmv.21798; Casini B, 2005, ANTICANCER RES, V25, P1079; Chapagain ML, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-3; Enam S, 2002, CANCER RES, V62, P7093; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Hori R, 2005, VIRCHOWS ARCH, V447, P723, DOI 10.1007/s00428-005-0014-3; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Ksiaa F, 2010, MODERN PATHOL, V23, P522, DOI 10.1038/modpathol.2009.184; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Lin PY, 2008, J MED VIROL, V80, P1828, DOI 10.1002/jmv.21296; Liu F, 2011, COLORECTAL DIS, V13, P865, DOI 10.1111/j.1463-1318.2010.02335.x; Losa JH, 2003, GASTROENTEROLOGY, V124, P268, DOI 10.1053/gast.2003.50033; Lundstig A, 2007, INT J CANCER, V121, P1098, DOI 10.1002/ijc.22770; Newcomb PA, 2004, CANCER EPIDEM BIOMAR, V13, P662; Niv Y, 2005, CURR OPIN GASTROEN, V21, P85; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Reiss K, 2006, J CELL PHYSIOL, V206, P295, DOI 10.1002/jcp.20455; Reiss K, 2003, ONCOGENE, V22, P6517, DOI 10.1038/sj.onc.1206959; Rollison DE, 2009, CANCER EPIDEM BIOMAR, V18, P1515, DOI 10.1158/1055-9965.EPI-08-1119; Rollison DEM, 2003, CANCER EPIDEM BIOMAR, V12, P460; Selgrad M, 2008, CLIN CANCER RES, V14, P6717, DOI 10.1158/1078-0432.CCR-08-0961; Theodoropoulos G, 2005, DIS COLON RECTUM, V48, P86, DOI 10.1007/s10350-004-0737-2; Trojanek J, 2006, J CELL PHYSIOL, V206, P35, DOI 10.1002/jcp.20425; Vilkin A, 2012, DIGEST DIS SCI, V57, P79, DOI 10.1007/s10620-011-1855-z	29	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35900	10.1371/journal.pone.0035900	http://dx.doi.org/10.1371/journal.pone.0035900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606241	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200015
J	Zhu, JX; Zheng, HJ; Ai, GM; Zhang, GS; Liu, D; Liu, XL; Dong, XZ				Zhu, Jinxing; Zheng, Huajun; Ai, Guomin; Zhang, Guishan; Liu, Di; Liu, Xiaoli; Dong, Xiuzhu			The Genome Characteristics and Predicted Function of Methyl-Group Oxidation Pathway in the Obligate Aceticlastic Methanogens, Methanosaeta spp.	PLOS ONE			English	Article							ENERGY-CONSERVATION; ELECTRON-TRANSPORT; ISOTOPE RATIO; ACETIVORANS; REVEALS; THERMOPHILA; DATABASE; GENES; MAZEI	In this work, we report the complete genome sequence of an obligate aceticlastic methanogen, Methanosaeta harundinacea 6Ac. Genome comparison indicated that the three cultured Methanosaeta spp., M. thermophila, M. concilii and M. harundinacea 6Ac, each carry an entire suite of genes encoding the proteins involved in the methyl-group oxidation pathway, a pathway whose function is not well documented in the obligately aceticlastic methanogens. Phylogenetic analysis showed that the methyl-group oxidation-involving proteins, Fwd, Mtd, Mch, and Mer from Methanosaeta strains cluster with the methylotrophic methanogens, and were not closely related to those from the hydrogenotrophic methanogens. Quantitative PCR detected the expression of all genes for this pathway, albeit ten times lower than the genes for aceticlastic methanogenesis in strain 6Ac. Western blots also revealed the expression of fwd and mch, genes involved in methyl-group oxidation. Moreover, C-13-labeling experiments suggested that the Methanosaeta strains might use the pathway as a methyl oxidation shunt during the aceticlastic metabolism. Because the mch mutants of Methanosarcina barkeri or M. acetivorans failed to grow on acetate, we suggest that Methanosaeta may use methyl-group oxidation pathway to generate reducing equivalents, possibly for biomass synthesis. An fpo operon, which encodes an electron transport complex for the reduction of CoM-CoB heterodisulfide, was found in the three genomes of the Methanosaeta strains. However, an incomplete protein complex lacking the FpoF subunit was predicted, as the gene for this protein was absent. Thus, F420H2 was predicted not to serve as the electron donor. In addition, two gene clusters encoding the two types of heterodisulfide reductase (Hdr), hdrABC, and hdrED, respectively, were found in the three Methanosaeta genomes. Quantitative PCR determined that the expression of hdrED was about ten times higher than hdrABC, suggesting that hdrED plays a major role in aceticlastic methanogenesis.	[Zhu, Jinxing; Ai, Guomin; Zhang, Guishan; Liu, Xiaoli; Dong, Xiuzhu] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Zhu, Jinxing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Liu, Di] Chinese Acad Sci, Inst Microbiol, Informat Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Zhu, JX (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.	dongxz@im.ac.cn	Liu, Di/ABD-2729-2021; Dong, Xiuzhu/EBF-2196-2022; Liu, Xiaoli/HGE-7614-2022; Liu, Di/G-6135-2014	Liu, Di/0000-0003-3693-2726; Dong, Xiuzhu/0000-0002-6926-5459; Liu, Di/0000-0003-3693-2726	National Natural Science Foundation of China [30621005, 30830007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China under grant no. 30621005 and 30830007 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Buan NR, 2010, MOL MICROBIOL, V75, P843, DOI 10.1111/j.1365-2958.2009.06990.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Deppenmeier U, 1996, ARCH MICROBIOL, V165, P149, DOI 10.1007/BF01692856; Deppenmeier U, 1999, FEBS LETT, V457, P291, DOI 10.1016/S0014-5793(99)01026-1; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Egwuagu CE, 1997, J IMMUNOL, V159, P3109; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Guss AM, 2005, MOL MICROBIOL, V55, P1671, DOI 10.1111/j.1365-2958.2005.04514.x; HAROLD FM, 1972, BACTERIOL REV, V36, P172, DOI 10.1128/MMBR.36.2.172-230.1972; Hattori R, 2010, J AGR FOOD CHEM, V58, P7115, DOI 10.1021/jf100406y; Hochheimer A, 1998, ARCH MICROBIOL, V170, P389, DOI 10.1007/s002030050658; HUSER BA, 1982, ARCH MICROBIOL, V132, P1, DOI 10.1007/BF00690808; Li JB, 2011, APPL ENVIRON MICROB, V77, P6141, DOI 10.1128/AEM.00657-11; Li QB, 2006, J BACTERIOL, V188, P702, DOI 10.1128/JB.188.2.702-710.2006; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Ma K, 2006, INT J SYST EVOL MICR, V56, P127, DOI 10.1099/ijs.0.63887-0; Maeder DL, 2006, J BACTERIOL, V188, P7922, DOI 10.1128/JB.00810-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Paiva S, 2004, YEAST, V21, P201, DOI 10.1002/yea.1056; Serra F, 2007, J MASS SPECTROM, V42, P361, DOI 10.1002/jms.1168; Spring S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/690737; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TERLESKY KC, 1987, J BIOL CHEM, V262, P15392; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Welander PV, 2005, P NATL ACAD SCI USA, V102, P10664, DOI 10.1073/pnas.0502623102; Welte C, 2011, J BACTERIOL IN PRESS; Welte C, 2010, J BACTERIOL, V192, P674, DOI 10.1128/JB.01307-09; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Zhu J, 2011, INT J SYST IN PRESS	45	24	28	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36756	10.1371/journal.pone.0036756	http://dx.doi.org/10.1371/journal.pone.0036756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590603	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400032
J	Guryanov, SG; Selivanova, OM; Nikulin, AD; Enin, GA; Melnik, BS; Kretov, DA; Serdyuk, IN; Ovchinnikov, LP				Guryanov, Sergey G.; Selivanova, Olga M.; Nikulin, Alexey D.; Enin, Gennady A.; Melnik, Bogdan S.; Kretov, Dmitry A.; Serdyuk, Igor N.; Ovchinnikov, Lev P.			Formation of Amyloid-Like Fibrils by Y-Box Binding Protein 1 (YB-1) Is Mediated by Its Cold Shock Domain and Modulated by Disordered Terminal Domains	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; MIGRATION INHIBITORY FACTOR; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VITRO; NONCLASSICAL PATHWAY; GENE-EXPRESSION; BREAST-CANCER; RNA; PROMOTES	YB-1, a multifunctional DNA- and RNA-binding nucleocytoplasmic protein, is involved in the majority of DNA- and mRNA-dependent events in the cell. It consists of three structurally different domains: its central cold shock domain has the structure of a beta-barrel, while the flanking domains are predicted to be intrinsically disordered. Recently, we showed that YB1 is capable of forming elongated fibrils under high ionic strength conditions. Here we report that it is the cold shock domain that is responsible for formation of YB-1 fibrils, while the terminal domains differentially modulate this process depending on salt conditions. We demonstrate that YB-1 fibrils have amyloid-like features, including affinity for specific dyes and a typical X-ray diffraction pattern, and that in contrast to most of amyloids, they disassemble under nearly physiological conditions.	[Guryanov, Sergey G.; Kretov, Dmitry A.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Grp Prot Biosynth Regulat, Pushchino 142292, Russia; [Selivanova, Olga M.; Enin, Gennady A.; Serdyuk, Igor N.] Russian Acad Sci, Inst Prot Res, Grp Nucleoprot Phys, Pushchino 142292, Russia; [Nikulin, Alexey D.] Russian Acad Sci, Inst Prot Res, Grp Struct Studies Ribosomal Prot, Pushchino 142292, Russia; [Melnik, Bogdan S.] Russian Acad Sci, Inst Prot Res, Lab Prot Phys, Pushchino 142292, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences	Guryanov, SG (corresponding author), Russian Acad Sci, Inst Prot Res, Grp Prot Biosynth Regulat, Pushchino 142292, Russia.	ovchinn@vega.protres.ru	Melnik, Bogdan/U-1988-2017; Nikulin, Alexey/B-8226-2011; Selivanova, Olga/HDL-9515-2022; Selivanova, Olga/M-3184-2015; Kretov, Dmitry/AAU-6058-2020; Ovchinnikov, Lev/L-2397-2015	Melnik, Bogdan/0000-0002-9176-6452; Nikulin, Alexey/0000-0001-5391-6184; Gurianov, Sergei/0000-0003-3058-5460; Kretov, Dmitry/0000-0003-1829-8610	Russian Foundation for Basic Research [11-04-00267]; Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This work has been performed with financial support of the Russian Foundation for Basic Research grant 11-04-00267 and grants of the "Molecular and Cellular Biology'' and "Fundamental Sciences to Medicine'' Programs, Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu AT, 1999, J MOL BIOL, V291, P1191, DOI 10.1006/jmbi.1999.3039; Bader AG, 2003, P NATL ACAD SCI USA, V100, P12384, DOI 10.1073/pnas.2135336100; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Chansky HA, 2001, CANCER RES, V61, P3586; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Davies AH, 2011, ONCOGENE, V30, P3649, DOI 10.1038/onc.2011.82; Dutertre M, 2010, NAT STRUCT MOL BIOL, V17, P1358, DOI 10.1038/nsmb.1912; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; Evdokimova VM, 1999, INT J BIOCHEM CELL B, V31, P139, DOI 10.1016/S1357-2725(98)00137-X; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Holm PS, 2002, J BIOL CHEM, V277, P10427, DOI 10.1074/jbc.M106955200; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; JANZ M, 2000, GENE FUNCT DIS, V1, P57; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Lashuel HA, 2005, BIOCHEM BIOPH RES CO, V338, P973, DOI 10.1016/j.bbrc.2005.10.040; Lobanov MY, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035004; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; McGlinchey RP, 2011, BIOCHEMISTRY-US, V50, P10567, DOI 10.1021/bi201578h; Mertens PR, 1998, J BIOL CHEM, V273, P32957, DOI 10.1074/jbc.273.49.32957; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Norman JT, 2001, J BIOL CHEM, V276, P29880, DOI 10.1074/jbc.M103145200; OZER J, 1990, J BIOL CHEM, V265, P22143; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Ruzanov PV, 1999, J CELL SCI, V112, P3487; Selivanova OM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P115, DOI 10.1134/S0006297910010153; Serpell LC, 1999, METHOD ENZYMOL, V309, P526; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Tacke F, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-185; TAFURI SR, 1992, NEW BIOL, V4, P349; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907	56	22	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36969	10.1371/journal.pone.0036969	http://dx.doi.org/10.1371/journal.pone.0036969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590640	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500034
J	Pedeboscq, S; Rey, C; Petit, M; Harpey, C; De Giorgi, F; Ichas, F; Lartigue, L				Pedeboscq, Stephane; Rey, Christophe; Petit, Muriel; Harpey, Catherine; De Giorgi, Francesca; Ichas, Francois; Lartigue, Lydia			Non-Antioxidant Properties of alpha-Tocopherol Reduce the Anticancer Activity of Several Protein Kinase Inhibitors In Vitro	PLOS ONE			English	Article							MUSCLE-CELL-PROLIFERATION; VITAMIN-E; LUNG-CANCER; HUMAN MONOCYTES; BCR-ABL; PHASE-I; APOPTOSIS; STAUROSPORINE; MUTATIONS; GEFITINIB	The antioxidant properties of alpha-tocopherol have been proposed to play a beneficial chemopreventive role against cancer. However, emerging data also indicate that it may exert contrasting effects on the efficacy of chemotherapeutic treatments when given as dietary supplement, being in that case harmful for patients. This dual role of alpha-tocopherol and, in particular, its effects on the efficacy of anticancer drugs remains poorly documented. For this purpose, we studied here, using high throughput flow cytometry, the direct impact of alpha-tocopherol on apoptosis and cell cycle arrest induced by different cytotoxic agents on various models of cancer cell lines in vitro. Our results indicate that physiologically relevant concentrations of alpha-tocopherol strongly compromise the cytotoxic and cytostatic action of various protein kinase inhibitors (KI), while other classes of chemotherapeutic agents or apoptosis inducers are unaffected by this vitamin. Interestingly, these anti-chemotherapeutic effects of alpha-tocopherol appear to be unrelated to its antioxidant properties since a variety of other antioxidants were completely neutral toward KI-induced cell cycle arrest and cell death. In conclusion, our data suggest that dietary alpha-tocopherol could limit KI effects on tumour cells, and, by extent, that this could result in a reduction of the clinical efficacy of anti-cancer treatments based on KI molecules.	[Pedeboscq, Stephane; Rey, Christophe; De Giorgi, Francesca; Ichas, Francois; Lartigue, Lydia] Univ Bordeaux 2, Inst Bergonie, INSERM, VINCO U916, F-33076 Bordeaux, France; [Pedeboscq, Stephane] CHU Bordeaux, Hop St Andre, Serv Pharm, Bordeaux, France; [Petit, Muriel; De Giorgi, Francesca; Ichas, Francois] Fluofarma, Pessac, France; [Harpey, Catherine] Inst Rech Servier, F-92150 Suresnes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; CHU Bordeaux; Servier; Institut de Recherches Internationales Servier	Pedeboscq, S (corresponding author), Univ Bordeaux 2, Inst Bergonie, INSERM, VINCO U916, F-33076 Bordeaux, France.	lartigue-faustin@bergonie.org	lartigue, lydia/I-9548-2014; Ichas, François/ABD-8277-2020	Ichas, François/0000-0001-8184-5248; De Giorgi, Francesca/0000-0003-4850-3582	National Agency of Research (ANR); French National Institute for Medical Research (INSERM); Region of Aquitaine; French Ministry of Research; Institute Bergonie; Association for Cancer Research; Ligue Contre le Cancer; Canceropole Grand Sud-Ouest	National Agency of Research (ANR)(French National Research Agency (ANR)); French National Institute for Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region of Aquitaine(Region Nouvelle-Aquitaine); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institute Bergonie; Association for Cancer Research; Ligue Contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand Sud-Ouest	The authors were supported by grants from the National Agency of Research (ANR), the French National Institute for Medical Research (INSERM), the Region of Aquitaine, the French Ministry of Research, the Institute Bergonie, the Association for Cancer Research, the Ligue Contre le Cancer and the Canceropole Grand Sud-Ouest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlemeyer B, 2000, NEUROCHEM INT, V36, P1, DOI 10.1016/S0197-0186(99)00101-1; Aratri E, 1999, FEBS LETT, V447, P91, DOI 10.1016/S0014-5793(99)00277-X; AZZI A, 1993, MOL ASPECTS MED, V14, P265, DOI 10.1016/0098-2997(93)90014-5; Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003; Bjelakovic G, 2004, LANCET, V364, P1219, DOI 10.1016/S0140-6736(04)17138-9; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Cachia O, 1998, J BIOL CHEM, V273, P32801, DOI 10.1074/jbc.273.49.32801; CHATELAIN E, 1993, BIOCHIM BIOPHYS ACTA, V1176, P83, DOI 10.1016/0167-4889(93)90181-N; Coyoy A, 2008, FREE RADICAL BIO MED, V45, P1056, DOI 10.1016/j.freeradbiomed.2008.06.027; Devaraj S, 1996, J CLIN INVEST, V98, P756, DOI 10.1172/JCI118848; Devaraj S, 1997, ARTERIOSCL THROM VAS, V17, P2273, DOI 10.1161/01.ATV.17.10.2273; Devaraj S, 1999, ARTERIOSCL THROM VAS, V19, P1125, DOI 10.1161/01.ATV.19.4.1125; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; Gescher A, 1998, GEN PHARMACOL, V31, P721, DOI 10.1016/S0306-3623(98)00069-X; Gulcin I, 2005, CHEM PHARM BULL, V53, P281, DOI 10.1248/cpb.53.281; ISHIZAKI Y, 1993, J CELL BIOL, V121, P899, DOI 10.1083/jcb.121.4.899; JARVIS WD, 1994, CANCER RES, V54, P1707; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Keaney JF, 1999, FASEB J, V13, P965, DOI 10.1096/fasebj.13.9.965; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martin-Nizard F, 1998, J Cardiovasc Risk, V5, P339, DOI 10.1097/00043798-199810000-00010; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; Monnerat C, 2004, ANN ONCOL, V15, P316, DOI 10.1093/annonc/mdh052; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pratico D, 1998, NAT MED, V4, P1189, DOI 10.1038/2685; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Ricciarelli R, 2001, FASEB J, V15, P2314, DOI 10.1096/fj.01-0258rev; Schembri L, 2009, ANAL CHEM, V81, P9590, DOI 10.1021/ac9015227; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Sigounas G, 1997, NUTR CANCER, V28, P30, DOI 10.1080/01635589709514549; Sordet O, 2004, J BIOL CHEM, V279, P50499, DOI 10.1074/jbc.M410277200; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Sylvester PW, 2007, VITAM HORM, V76, P329, DOI 10.1016/S0083-6729(07)76012-0; Tada H, 1997, METABOLISM, V46, P779, DOI 10.1016/S0026-0495(97)90122-0; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Temkin V, 2007, IMMUNOL REV, V220, P8, DOI 10.1111/j.1600-065X.2007.00560.x; Upston JM, 1999, FASEB J, V13, P977, DOI 10.1096/fasebj.13.9.977; Vignot S, 2008, B CANCER, V95, P683, DOI 10.1684/bdc.2008.0665; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Yano M, 2000, J NUTR, V130, P1095, DOI 10.1093/jn/130.5.1095	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36811	10.1371/journal.pone.0036811	http://dx.doi.org/10.1371/journal.pone.0036811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590613	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335500030
J	van Velthoven, MHMMT; Car, LT; Car, J; Atun, R				van Velthoven, Michelle H. M. M. T.; Car, Lorainne Tudor; Car, Josip; Atun, Rifat			Telephone Consultation for Improving Health of People Living with or at Risk of HIV: A Systematic Review	PLOS ONE			English	Review							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED RURAL PERSONS; MEDICATION ADHERENCE; SMOKING-CESSATION; RANDOMIZED-TRIAL; HOME COLLECTION; INTERVENTION; CARE; HIV/AIDS; DEPRESSION	Background: Low cost, effective interventions are needed to deal with the major global burden of HIV/AIDS. Telephone consultation offers the potential to improve health of people living with HIV/AIDS cost-effectively and to reduce the burden on affected people and health systems. The aim of this systematic review was to assess the effectiveness of telephone consultation for HIV/AIDS care. Methods: We undertook a comprehensive search of peer-reviewed and grey literature. Two authors independently screened citations, extracted data and assessed the quality of randomized controlled trials which compared telephone interventions with control groups for HIV/AIDS care. Telephone interventions were voice calls with landlines or mobile phones. We present a narrative overview of the results as the obtained trials were highly heterogeneous in design and therefore the data could not be pooled for statistical analysis. Results: The search yielded 3321 citations. Of these, nine studies involving 1162 participants met the inclusion criteria. The telephone was used for giving HIV test results (one trial) and for delivering behavioural interventions aimed at improving mental health (four trials), reducing sexual transmission risk (one trial), improving medication adherence (two trials) and smoking cessation (one trial). Limited effectiveness of the intervention was found in the trial giving HIV test results, in one trial supporting medication adherence and in one trial for smoking cessation by telephone. Conclusions: We found some evidence of the benefits of interventions delivered by telephone for the health of people living with HIV or at risk of HIV. However, only limited conclusions can be drawn as we only found nine studies for five different interventions and they mainly took place in the United States. Nevertheless, given the high penetration of low-cost mobile phones in countries with high HIV endemicity, more evidence is needed on how telephone consultation can aid in the delivery of HIV prevention, treatment and care.	[van Velthoven, Michelle H. M. M. T.; Car, Lorainne Tudor; Car, Josip] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Global eHlth Unit, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	Imperial College London; Imperial College London	van Velthoven, MHMMT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, Global eHlth Unit, London, England.	josip.car@imperial.ac.uk	Atun, Rifat/AAH-5537-2021; Car, Josip/H-6755-2015; van Velthoven, Michelle Helena/AAA-6819-2019; Car, Lorainne Tudor/E-1205-2017	Car, Josip/0000-0001-8969-371X; van Velthoven, Michelle Helena/0000-0003-1245-8759; Car, Lorainne Tudor/0000-0001-8414-7664; Atun, Rifat/0000-0002-1531-5983	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme; NIHR Biomedical Research Centre scheme; Imperial Centre for Patient Safety and Service Quality	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre scheme(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality	The Department of Primary Care & Public Health at Imperial College London is grateful for support from the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC) Scheme, the NIHR Biomedical Research Centre scheme, and the Imperial Centre for Patient Safety and Service Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; [Anonymous], 2009, ENDNOTEX4; [Anonymous], 2011, AIDS TAK LONG TERM V; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Bartholow BN, 2006, COMPARISON CONSUMER; Bos AER, 2004, PATIENT EDUC COUNS, V54, P201, DOI 10.1016/S0738-3991(03)00214-3; Bunn F, 2005, BRIT J GEN PRACT, V55, P956; Bunn F, 2004, TELEPHONE CONSULTATI; Car J, 2004, QUAL SAF HEALTH CARE, V13, P2, DOI 10.1136/qshc.2003.009241; Car J, 2003, BMJ-BRIT MED J, V326, P966, DOI 10.1136/bmj.326.7396.966; Chiou PY, 2004, AIDS PATIENT CARE ST, V18, P539, DOI 10.1089/1087291042222992; Collier AC, 2005, J INFECT DIS, V192, P1398, DOI 10.1086/466526; Cook PF, 2009, J ASSOC NURSE AIDS C, V20, P316, DOI 10.1016/j.jana.2009.02.008; Cosio D, 2008, TELEPHONE DELIVERED; Cosio D, 2010, SEX TRANSM DIS, V37, P140, DOI 10.1097/OLQ.0b013e3181c18975; Cox HL, 2006, AIDS 2006 16 INT AID; Dale J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006903.pub2; Eaton AH, 1995, IMMUNOLOGICAL PSYCHO; Ellen JM, 2002, J ADOLESCENT HEALTH, V31, P26, DOI 10.1016/S1054-139X(01)00404-9; Fife BL, 2008, J ASSOC NURSE AIDS C, V19, P75, DOI 10.1016/j.jana.2007.11.002; Fischl MA, 2003, J INFECT DIS, V188, P625, DOI 10.1086/377311; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Frank AP, 1997, ARCH INTERN MED, V157, P309, DOI 10.1001/archinte.157.3.309; Heckman TG, 2004, HEALTH PSYCHOL, V23, P94, DOI 10.1037/0278-6133.23.1.94; Heckman TG, 2007, AIDS BEHAV, V11, P5, DOI 10.1007/s10461-006-9111-9; Heckman TG, 2006, ANN BEHAV MED, V32, P27, DOI 10.1207/s15324796abm3201_4; Herman DS, 2006, J CLIN PSYCHOL MED S, V13, P81, DOI 10.1007/s10880-005-9002-7; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; ITU-D, 2011, WORLD 2011 ICT FACTS; Konkle-Parker DJ, 2010, PATIENT EDUC COUNS, V78, P91, DOI 10.1016/j.pec.2009.04.010; Konkle-Parker DJ, 2002, 14 INT AIDS C; Kwong J, 2010, J ASSOC NURSE AIDS C, V21, P3, DOI 10.1016/j.jana.2009.03.007; Lucy JR, 1995, FULL THEOL SEM SCH P; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Mckinstry LA, 2007, SEX TRANSM DIS, V34, P796, DOI 10.1097/01.olq.000261726.56859.5a; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Mohr DC, 2008, CLIN PSYCHOL-SCI PR, V15, P243, DOI 10.1111/j.1468-2850.2008.00134.x; Morrison RE, 1998, AIDS PATIENT CARE ST, V12, P131, DOI 10.1089/apc.1998.12.131; Muko K, 2009, 5 IAS C HIV PATH TRE; Nahvi S, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.3_supp.14; Picciano JF, 2001, AIDS BEHAV, V5, P251, DOI DOI 10.1023/A:1011392610578; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Puskin DS, 2010, TELEMED J E-HEALTH, V16, P96, DOI 10.1089/tmj.2009.0182; Quinones C, 2004, 15 INT AIDS C; Ransom D, 2007, TELEPHONE DELIVERED; Ransom D, 2008, PSYCHIAT SERV, V59, P871, DOI 10.1176/ps.2008.59.8.871; Reynolds NR, 2008, JAIDS-J ACQ IMM DEF, V47, P62, DOI 10.1097/QAI.0b013e3181582d54; Reynolds NR, 2004, CURR HIV RES, V2, P207, DOI 10.2174/1570162043351309; Reynolds NR, 2003, AIDS CARE, V15, P117, DOI 10.1080/0954012021000039815; Reynolds NR, 2008, AIDS 2008 17 INT AID; Roffman R. A., 1997, AIDS BEHAV, V1, P137; Roffman R, 2007, AIDS BEHAV, V11, P3, DOI 10.1007/s10461-006-9176-5; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Skrajner MJ, 2009, HIV AIDS-RES PALLIAT, V1, P23; Smeaton LM, 2001, CONTROL CLIN TRIALS, V22, P142, DOI 10.1016/S0197-2456(00)00126-4; Spielberg F, 2000, AIDS, V14, P1819, DOI 10.1097/00002030-200008180-00018; Stead LF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002850.pub2; Stein MD, 2007, AIDS BEHAV, V11, P15, DOI 10.1007/s10461-006-9131-5; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; Tsu RC, 2002, J ADOLESCENT HEALTH, V30, P154, DOI 10.1016/S1054-139X(01)00340-8; Ullrich A, 2011, LANCET, V377, P639, DOI 10.1016/S0140-6736(11)60233-X; UNAIDS, 2011, GLOB HIV AIDS RESP E; UNAIDS, 2011, UNAIDS DAT TABL; UNAIDS, 2002, HIV AIDS COUNS JUST; Vidrine DJ, 2006, NICOTINE TOB RES, V8, pS103, DOI 10.1080/14622200601039451; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Waegemann CP, 2010, TELEMED J E-HEALTH, V16, P23, DOI 10.1089/tmj.2010.9990; Wang HH, 2010, J CLIN NURS, V19, P380, DOI 10.1111/j.1365-2702.2009.03048.x; Wewers M E, 2000, J Assoc Nurses AIDS Care, V11, P37, DOI 10.1016/S1055-3290(06)60353-1; WHA, 2005, WHA58 28 EHEALTH 9 P; Whittaker R, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006611.pub2, 10.1002/14651858.CD006611.pub3]; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wu AW, 1997, QUAL LIFE RES, V6, P3, DOI 10.1023/A:1026471020698	77	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e36105	10.1371/journal.pone.0036105	http://dx.doi.org/10.1371/journal.pone.0036105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UQ	22615751	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341200006
J	Kirov, A; Duarte, M; Guay, J; Karolak, M; Yan, C; Oxburgh, L; Prudovsky, I				Kirov, Aleksandr; Duarte, Maria; Guay, Justin; Karolak, Michele; Yan, Cong; Oxburgh, Leif; Prudovsky, Igor			Transgenic Expression of Nonclassically Secreted FGF Suppresses Kidney Repair	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-I; PROTEIN EXPRESSION; GENE; MACROPHAGES; RELEASE; TAURINE; INJURY; CELLS; FIBROBLAST-GROWTH-FACTOR-1	FGF1 is a signal peptide-less nonclassically released growth factor that is involved in angiogenesis, tissue repair, inflammation, and carcinogenesis. The effects of nonclassical FGF export in vivo are not sufficiently studied. We produced transgenic mice expressing FGF1 in endothelial cells (EC), which allowed the detection of FGF1 export to the vasculature, and studied the efficiency of postischemic kidney repair in these animals. Although FGF1 transgenic mice had a normal phenotype with unperturbed kidney structure, they showed a severely inhibited kidney repair after unilateral ischemia/reperfusion. This was manifested by a strong decrease of postischemic kidney size and weight, whereas the undamaged contralateral kidney exhibited an enhanced compensatory size increase. In addition, the postischemic kidneys of transgenic mice were characterized by hyperplasia of interstitial cells, paucity of epithelial tubular structures, increase of the areas occupied by connective tissue, and neutrophil and macrophage infiltration. The continuous treatment of transgenic mice with the cell membrane stabilizer, taurine, inhibited nonclassical FGF1 export and significantly rescued postischemic kidney repair. It was also found that similar to EC, the transgenic expression of FGF1 in monocytes and macrophages suppresses kidney repair. We suggest that nonclassical export may be used as a target for the treatment of pathologies involving signal peptide-less FGFs.	[Kirov, Aleksandr; Duarte, Maria; Guay, Justin; Karolak, Michele; Oxburgh, Leif; Prudovsky, Igor] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Yan, Cong] Indiana Univ, Dept Pathol, Indianapolis, IN 46204 USA	Maine Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Kirov, A (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.	prudoi@mmc.org	Duarte, Fátima/H-5177-2013; Prudovsky, Igor/GVU-1521-2022	Duarte, Fátima/0000-0002-2223-7784; Oxburgh, Leif/0000-0002-2825-7663	National Institutes of Health (NIH) [HL35627, DK078161, 8P20 GM103465, 8P30 GM103392]; Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627, R01HL067862, R01HL061803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465, P30GM103392] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study has been supported by a National Institutes of Health (NIH) grant HL35627 to IP and DK078161 to LO, and a grant from Maine Cancer Foundation to IP. The authors used the services of the Histopathology Core supported by NIH grant 8P20 GM103465 (D. Wojchowski, PI), and Protein, Nucleic Acid and Cell Imaging Core, and Mouse Transgenic and In Vivo Imaging Core supported by NIH grant 8P30 GM103392 (R. Friesel, PI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Braun N, 2009, NEPHRON CLIN PRACT, V113, pC88, DOI 10.1159/000228540; Brown AC, 2011, DEVELOPMENT, V138, P5099, DOI 10.1242/dev.065995; Buehler A, 2002, CARDIOVASC RES, V55, P768, DOI 10.1016/S0008-6363(02)00494-7; Cancilla B, 2001, KIDNEY INT, V60, P147, DOI 10.1046/j.1523-1755.2001.00781.x; Cauchi J, 1996, CELL TISSUE RES, V285, P179, DOI 10.1007/s004410050635; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chesney RW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S4; Dorey K, 2010, DEVELOPMENT, V137, P3731, DOI 10.1242/dev.037689; Duarte M, 2006, BIOCHEM BIOPH RES CO, V350, P604, DOI 10.1016/j.bbrc.2006.09.107; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Erzurum VZ, 2003, J VASC SURG, V37, P1075, DOI 10.1067/mva.2003.177; Fallahzadeh MK, 2010, ARCH MED RES, V41, P59, DOI 10.1016/j.arcmed.2009.11.005; Gerber SD, 2009, DEV BIOL, V335, P106, DOI 10.1016/j.ydbio.2009.08.019; GRAZIANI I, 2006, BIOCH BIOPHYS RES CO; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Guz G, 2007, AMINO ACIDS, V32, P405, DOI 10.1007/s00726-006-0383-1; Hershey JC, 2003, CARDIOVASC RES, V59, P997, DOI 10.1016/S0008-6363(03)00522-4; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; ICHIMURA T, 1995, AM J PHYSIOL-RENAL, V269, pF653, DOI 10.1152/ajprenal.1995.269.5.F653; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; JACKSON A, 1992, P NATL ACAD SCI USA, V89, P10691, DOI 10.1073/pnas.89.22.10691; Kasama Tsuyoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P273, DOI 10.2174/1568010054022114; Khurana R, 2003, TRENDS CARDIOVAS MED, V13, P116, DOI 10.1016/S1050-1738(02)00259-1; Kirov A, 2012, J CELL BIOCHEM, V113, P956, DOI 10.1002/jcb.23425; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; KU PT, 1995, J CELL BIOCHEM, V58, P328, DOI 10.1002/jcb.240580307; Lasky JA, 2001, AM J MED SCI, V322, P213, DOI 10.1097/00000441-200110000-00012; Li L, 2010, SEMIN NEPHROL, V30, P268, DOI 10.1016/j.semnephrol.2010.03.005; Matsunaga S, 2009, J MOL CELL CARDIOL, V46, P663, DOI 10.1016/j.yjmcc.2009.01.015; Meij JTA, 2002, AM J PHYSIOL-HEART C, V282, pH547, DOI 10.1152/ajpheart.01019.2000; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Qiao J, 2001, MECH DEVELOP, V109, P123, DOI 10.1016/S0925-4773(01)00592-5; Rossini M, 2005, KIDNEY INT, V68, P2621, DOI 10.1111/j.1523-1755.2005.00734.x; Schumacher B, 1998, CIRCULATION, V97, P645, DOI 10.1161/01.CIR.97.7.645; Sellke FW, 1996, SURGERY, V120, P182, DOI 10.1016/S0039-6060(96)80286-8; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tomaszewski M, 2007, CIRCULATION, V116, P1915, DOI 10.1161/CIRCULATIONAHA.107.710293; Villanueva S, 2008, AM J PHYSIOL-REG I, V294, pR819, DOI 10.1152/ajpregu.00273.2007; Villanueva S, 2006, AM J PHYSIOL-REG I, V291, pR1677, DOI 10.1152/ajpregu.00023.2006; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yun YR, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/218142; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36485	10.1371/journal.pone.0036485	http://dx.doi.org/10.1371/journal.pone.0036485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606265	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400019
J	Krauss, P; Metzner, C; Lange, J; Lang, N; Fabry, B				Krauss, Patrick; Metzner, Claus; Lange, Janina; Lang, Nadine; Fabry, Ben			Parameter-Free Binarization and Skeletonization of Fiber Networks from Confocal Image Stacks	PLOS ONE			English	Article							MICROSCOPY; ALGORITHM; TOMOGRAMS	We present a method to reconstruct a disordered network of thin biopolymers, such as collagen gels, from three-dimensional (3D) image stacks recorded with a confocal microscope. The method is based on a template matching algorithm that simultaneously performs a binarization and skeletonization of the network. The size and intensity pattern of the template is automatically adapted to the input data so that the method is scale invariant and generic. Furthermore, the template matching threshold is iteratively optimized to ensure that the final skeletonized network obeys a universal property of voxelized random line networks, namely, solid-phase voxels have most likely three solid-phase neighbors in a 3 x 3 x 3 neighborhood. This optimization criterion makes our method free of user-defined parameters and the output exceptionally robust against imaging noise.	[Krauss, Patrick; Metzner, Claus; Lange, Janina; Lang, Nadine; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, Biophys Grp, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Krauss, P (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Biophys Grp, D-91054 Erlangen, Germany.	ben.fabry@biomed.uni-erlangen.de	Metzner, Claus/D-9707-2013; Fabry, Ben/AAT-5717-2020; Fabry, Ben/C-5496-2013	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Krauss, Patrick/0000-0002-6611-7733	German Research Foundation (DFG); Emerging Field Initiative of the University of Erlangen-Nuremberg	German Research Foundation (DFG)(German Research Foundation (DFG)); Emerging Field Initiative of the University of Erlangen-Nuremberg	The authors are grateful for financial support by the German Research Foundation (DFG) and the Emerging Field Initiative of the University of Erlangen-Nuremberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 1996, NEURAL NETWORKS; Gan G, 2007, ASA SIAM SER STAT AP, V20, P1, DOI 10.1137/1.9780898718348; Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065; Lang N, MANIPULATING EVALUAT; Lebbink MN, 2007, J STRUCT BIOL, V158, P327, DOI 10.1016/j.jsb.2006.12.001; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Ma CM, 1996, COMPUT VIS IMAGE UND, V64, P420, DOI 10.1006/cviu.1996.0069; Metzner C, 2011, ARXIV11101803; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Prohaska S, 2007, THESIS U POTSDAM; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Reniers D, 2009, THESIS EINDHOVEN U T; Rigort A, 2012, J STRUCT BIOL, V177, P135, DOI 10.1016/j.jsb.2011.08.012; Soille P., 1999, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-03939-7; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Wang T, 2007, NOTE FULLY PARALLEL; Weber B, 2011, J STRUCTURAL BIOL	17	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36575	10.1371/journal.pone.0036575	http://dx.doi.org/10.1371/journal.pone.0036575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606273	Green Published, gold			2022-12-27	WOS:000305339400024
J	Lo, MYM; Rival-Gervier, S; Pasceri, P; Ellis, J				Lo, Mandy Y. M.; Rival-Gervier, Sylvie; Pasceri, Peter; Ellis, James			Rapid Transcriptional Pulsing Dynamics of High Expressing Retroviral Transgenes in Embryonic Stem Cells	PLOS ONE			English	Article							LOCUS-CONTROL REGION; LIVING MAMMALIAN-CELLS; BETA-GLOBIN LOCUS; RNA-POLYMERASE-II; NUCLEAR PERIPHERY; HUMAN GENOME; GENE-EXPRESSION; MESSENGER-RNA; ACTIVE GENES; ACTIVATION	Single cell imaging studies suggest that transcription is not continuous and occurs as discrete pulses of gene activity. To study mechanisms by which retroviral transgenes can transcribe to high levels, we used the MS2 system to visualize transcriptional dynamics of high expressing proviral integration sites in embryonic stem (ES) cells. We established two ES cell lines each bearing a single copy, self-inactivating retroviral vector with a strong ubiquitous human EF1 alpha gene promoter directing expression of mRFP fused to an MS2-stem-loop array. Transfection of MS2-EGFP generated EGFP focal dots bound to the mRFP-MS2 stem loop mRNA. These transcription foci colocalized with the transgene integration site detected by immunoFISH. Live tracking of single cells for 20 minutes detected EGFP focal dots that displayed frequent and rapid fluctuations in transcription over periods as short as 25 seconds. Similarly rapid fluctuations were detected from focal doublet signals that colocalized with replicated proviral integration sites by immunoFISH, consistent with transcriptional pulses from sister chromatids. We concluded that retroviral transgenes experience rapid transcriptional pulses in clonal ES cell lines that exhibit high level expression. These events are directed by a constitutive housekeeping gene promoter and may provide precedence for rapid transcriptional pulsing at endogenous genes in mammalian stem cells.	[Lo, Mandy Y. M.; Rival-Gervier, Sylvie; Pasceri, Peter; Ellis, James] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Lo, Mandy Y. M.; Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rival-Gervier, Sylvie] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Lo, MYM (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jellis@sickkids.ca	Rival-Gervier, Sylvie/M-7649-2014; Ellis, James/F-4789-2011	Rival-Gervier, Sylvie/0000-0001-8266-8095; Ellis, James/0000-0002-4400-0091	Canadian Institutes of Health Research (CIHR) [MOP-111065, IG1-102956, RMF-92090]; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was funded by grants from the Canadian Institutes of Health Research (CIHR MOP-111065, IG1-102956 and RMF-92090) to JE, and a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship to MYML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Buzina A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000051; Chubb JR, 2010, CURR OPIN GENET DEV, V20, P478, DOI 10.1016/j.gde.2010.06.009; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Corry GN, 2005, BIOCHEM CELL BIOL, V83, P535, DOI 10.1139/O05-062; Dieudonne M, 2009, EMBO J, V28, P2231, DOI 10.1038/emboj.2009.141; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Ellis J, 1996, EMBO J, V15, P562, DOI 10.1002/j.1460-2075.1996.tb00388.x; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Maiuri P, 2011, EMBO REP, V12, P1280, DOI 10.1038/embor.2011.196; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Minoguchi S, 2008, STEM CELLS, V26, P1166, DOI 10.1634/stemcells.2007-1106; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramunas J, 2007, MOL THER, V15, P810, DOI 10.1038/sj.mt.6300073; RHODE BW, 1987, J VIROL, V61, P925, DOI 10.1128/JVI.61.3.925-927.1987; Roth SL, 2011, J VIROL, V85, P7393, DOI 10.1128/JVI.00635-11; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Skupsky R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000952; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37130	10.1371/journal.pone.0037130	http://dx.doi.org/10.1371/journal.pone.0037130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606340	Green Published, gold			2022-12-27	WOS:000305339400065
J	Molloy, K; Moore, DR; Sohoglu, E; Amitay, S				Molloy, Katharine; Moore, David R.; Sohoglu, Ediz; Amitay, Sygal			Less Is More: Latent Learning Is Maximized by Shorter Training Sessions in Auditory Perceptual Learning	PLOS ONE			English	Article							FREQUENCY DISCRIMINATION; TIME-COURSE; POWER-LAW; SLEEP; PERFORMANCE; ADAPTATION; SKILL; TASK; CONSOLIDATION; SPECIFICITY	Background: The time course and outcome of perceptual learning can be affected by the length and distribution of practice, but the training regimen parameters that govern these effects have received little systematic study in the auditory domain. We asked whether there was a minimum requirement on the number of trials within a training session for learning to occur, whether there was a maximum limit beyond which additional trials became ineffective, and whether multiple training sessions provided benefit over a single session. Methodology/Principal Findings: We investigated the efficacy of different regimens that varied in the distribution of practice across training sessions and in the overall amount of practice received on a frequency discrimination task. While learning was relatively robust to variations in regimen, the group with the shortest training sessions (similar to 8 min) had significantly faster learning in early stages of training than groups with longer sessions. In later stages, the group with the longest training sessions (>1 hr) showed slower learning than the other groups, suggesting overtraining. Between-session improvements were inversely correlated with performance; they were largest at the start of training and reduced as training progressed. In a second experiment we found no additional longer-term improvement in performance, retention, or transfer of learning for a group that trained over 4 sessions (similar to 4 hr in total) relative to a group that trained for a single session (similar to 1 hr). However, the mechanisms of learning differed; the single-session group continued to improve in the days following cessation of training, whereas the multi-session group showed no further improvement once training had ceased. Conclusions/Significance: Shorter training sessions were advantageous because they allowed for more latent, between-session and post-training learning to emerge. These findings suggest that efficient regimens should use short training sessions, and optimized spacing between sessions.	[Molloy, Katharine; Moore, David R.; Sohoglu, Ediz; Amitay, Sygal] Inst Hearing Res, MRC, Nottingham, England		Molloy, K (corresponding author), Inst Hearing Res, MRC, Nottingham, England.	sygal@ihr.mrc.ac.uk	Sohoglu, Ediz/B-7682-2013; Amitay, Sygal/D-7323-2012	Amitay, Sygal/0000-0001-9482-3435; Sohoglu, Ediz/0000-0002-0755-6445	Medical Research Council (MRC), United Kingdom; Medical Research Council [MC_U135097130] Funding Source: researchfish; MRC [MC_U135097130] Funding Source: UKRI	Medical Research Council (MRC), United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (MRC), United Kingdom, through intramural funding to the MRC Institute of Hearing Research. All authors were MRC employees at the time the research was conducted. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Amitay S, 2005, PERCEPT PSYCHOPHYS, V67, P691, DOI 10.3758/BF03193525; Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Amitay S., 2009, LEARN PERCEPT, V1, P59, DOI [10.1556/LP.1.2009.1.5, DOI 10.1556/LP.1.2009.1.5]; Amitay S, 2006, NAT NEUROSCI, V9, P1446, DOI 10.1038/nn1787; Anderson RB, 2001, MEM COGNITION, V29, P1061, DOI 10.3758/BF03195767; Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Atienza M, 2004, J COGNITIVE NEUROSCI, V16, P53, DOI 10.1162/089892904322755557; Banai K, 2010, NEUROSCIENCE, V165, P436, DOI 10.1016/j.neuroscience.2009.10.060; British Society of Audiology, 2004, REC PROC PUR TON AIR; Censor N, 2008, VISION RES, V48, P970, DOI 10.1016/j.visres.2008.01.016; Censor N, 2006, VISION RES, V46, P4071, DOI 10.1016/j.visres.2006.07.022; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Cohen J., 1988, CONCEPTS POWER ANAL; Demany L, 2002, J ACOUST SOC AM, V111, P1377, DOI 10.1121/1.1445791; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Dosher BA, 2007, PSYCHOL SCI, V18, P531, DOI 10.1111/j.1467-9280.2007.01934.x; Goedert KM, 2008, EXP BRAIN RES, V189, P189, DOI 10.1007/s00221-008-1414-9; Halliday LF, 2008, J ACOUST SOC AM, V123, P4393, DOI 10.1121/1.2890749; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Hussain Z, 2009, VISION RES, V49, P2624, DOI 10.1016/j.visres.2009.08.022; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; MOORE BCJ, 1973, J ACOUST SOC AM, V54, P610, DOI 10.1121/1.1913640; Ortiz JA, 2010, EXP BRAIN RES, V201, P441, DOI 10.1007/s00221-009-2053-5; Qu Z, 2010, NEUROPSYCHOLOGIA, V48, P1869, DOI 10.1016/j.neuropsychologia.2010.01.008; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Wechsler D, 1999, WASI WECHSLER ABBREV; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wright BA, 2007, EXP BRAIN RES, V180, P727, DOI 10.1007/s00221-007-0898-z; Wright BA, 2010, J NEUROSCI, V30, P12868, DOI 10.1523/JNEUROSCI.0487-10.2010; Wright BA, 2010, J NEUROSCI, V30, P11635, DOI 10.1523/JNEUROSCI.1441-10.2010	44	50	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36929	10.1371/journal.pone.0036929	http://dx.doi.org/10.1371/journal.pone.0036929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UF	22606309	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305339400042
J	Okada, H; Uezu, A; Soderblom, EJ; Moseley, MA; Gertler, FB; Soderling, SH				Okada, Hirokazu; Uezu, Akiyoshi; Soderblom, Erik J.; Moseley, M. Arthur, III; Gertler, Frank B.; Soderling, Scott H.			Peptide Array X-Linking (PAX): A New Peptide-Protein Identification Approach	PLOS ONE			English	Article							SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; TERMINAL SH3 DOMAIN; RECOGNITION DOMAINS; STATISTICAL-MODEL; COMPLEX; WAVE; CALMODULIN; ENA/VASP; MOTILITY	Many protein interaction domains bind short peptides based on canonical sequence consensus motifs. Here we report the development of a peptide array-based proteomics tool to identify proteins directly interacting with ligand peptides from cell lysates. Array-formatted bait peptides containing an amino acid-derived cross-linker are photo-induced to crosslink with interacting proteins from lysates of interest. Indirect associations are removed by high stringency washes under denaturing conditions. Covalently trapped proteins are subsequently identified by LC-MS/MS and screened by cluster analysis and domain scanning. We apply this methodology to peptides with different proline-containing consensus sequences and show successful identifications from brain lysates of known and novel proteins containing polyproline motif-binding domains such as EH, EVH1, SH3, WW domains. These results suggest the capacity of arrayed peptide ligands to capture and subsequently identify proteins by mass spectrometry is relatively broad and robust. Additionally, the approach is rapid and applicable to cell or tissue fractions from any source, making the approach a flexible tool for initial protein-protein interaction discovery.	[Okada, Hirokazu; Uezu, Akiyoshi; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Soderblom, Erik J.; Moseley, M. Arthur, III] Duke Univ, Sch Med, Inst Genome Sci & Policy, Prote Core Facil, Durham, NC USA; [Gertler, Frank B.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Duke University; Duke University; Massachusetts Institute of Technology (MIT)	Okada, H (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	s.soderling@cellbio.duke.edu		Okada, Hirokazu/0000-0002-1065-2470	National Institutes of Health [R21-CA-140030-01, R01-NS059957]; NATIONAL CANCER INSTITUTE [R21CA140030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R21-CA-140030-01 and R01-NS059957 (SHS). No additional external funding was used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GOUDREAU N, 1994, NAT STRUCT BIOL, V1, P898, DOI 10.1038/nsb1294-898; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; KAUER JC, 1986, J BIOL CHEM, V261, P695; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Nakagawa H, 2001, J CELL SCI, V114, P1555; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okada H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002189; ONEIL KT, 1989, J BIOL CHEM, V264, P14571; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rumpf J, 2008, EMBO J, V27, P558, DOI 10.1038/sj.emboj.7601980; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Sidhu SS, 2003, CURR OPIN CHEM BIOL, V7, P97, DOI 10.1016/S1367-5931(02)00011-x; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; TERASAWA H, 1994, NAT STRUCT BIOL, V1, P891, DOI 10.1038/nsb1294-891; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Yu JW, 2003, CURR OPIN CHEM BIOL, V7, P103, DOI 10.1016/S1367-5931(02)00008-X	50	14	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37035	10.1371/journal.pone.0037035	http://dx.doi.org/10.1371/journal.pone.0037035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606326	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400054
J	Weigand, AM; Pfenninger, M; Jochum, A; Klussmann-Kolb, A				Weigand, Alexander M.; Pfenninger, Markus; Jochum, Adrienne; Klussmann-Kolb, Annette			Alpine Crossroads or Origin of Genetic Diversity? Comparative Phylogeography of Two Sympatric Microgastropod Species	PLOS ONE			English	Article							POPULATION-GROWTH; POSTGLACIAL COLONIZATION; GLACIAL REFUGIA; PULMONATA; HYPOTHESES; HISTORY; SNAILS; DIFFERENTIATION; CONSEQUENCES; HITCHHIKING	The Alpine Region, constituting the Alps and the Dinaric Alps, has played a major role in the formation of current patterns of biodiversity either as a contact zone of postglacial expanding lineages or as the origin of genetic diversity. In our study, we tested these hypotheses for two widespread, sympatric microgastropod taxa - Carychium minimum O.F. Muller, 1774 and Carychium tridentatum (Risso, 1826) (Gastropoda, Eupulmonata, Carychiidae) - by using COI sequence data and species potential distribution models analyzed in a statistical phylogeographical framework. Additionally, we examined disjunct transatlantic populations of those taxa from the Azores and North America. In general, both Carychium taxa demonstrate a genetic structure composed of several differentiated haplotype lineages most likely resulting from allopatric diversification in isolated refugial areas during the Pleistocene glacial periods. However, the genetic structure of Carychium minimum is more pronounced, which can be attributed to ecological constraints relating to habitat proximity to permanent bodies of water. For most of the Carychium lineages, the broader Alpine Region was identified as the likely origin of genetic diversity. Several lineages are endemic to the broader Alpine Region whereas a single lineage per species underwent a postglacial expansion to (re) colonize previously unsuitable habitats, e. g. in Northern Europe. The source populations of those expanding lineages can be traced back to the Eastern and Western Alps. Consequently, we identify the Alpine Region as a significant 'hot-spot' for the formation of genetic diversity within European Carychium lineages. Passive dispersal via anthropogenic means best explains the presence of transatlantic European Carychium populations on the Azores and in North America. We conclude that passive (anthropogenic) transport could mislead the interpretation of observed phylogeographical patterns in general.	[Weigand, Alexander M.; Jochum, Adrienne; Klussmann-Kolb, Annette] Goethe Univ Frankfurt, Dept Phylogeny & Systemat, Frankfurt, Hesse, Germany; [Pfenninger, Markus] Senckenberg Gesell Nat Forsch, Biodivers & Climate Res Ctr, Mol Ecol Grp, Frankfurt, Hesse, Germany	Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN)	Weigand, AM (corresponding author), Goethe Univ Frankfurt, Dept Phylogeny & Systemat, Frankfurt, Hesse, Germany.	A.Weigand@bio.uni-frankfurt.de	Weigand, Alexander M./H-2087-2011; Klussmann-Kolb, Annette/H-2076-2011	Jochum, Adrienne/0000-0002-6624-6412; Weigand, Alexander/0000-0001-7587-6531	Biodiversity and Climate Research Centre from the LOEWE programme (Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts)	Biodiversity and Climate Research Centre from the LOEWE programme (Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts)	The Biodiversity and Climate Research Centre from the LOEWE programme (Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts) provided financial support for field trips and laboratory work (http://www.bik-f.de/root/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FAUN EUR FAUN EUR VE; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Balint Miklos, 2011, P189; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANK R A, 1985, Basteria, V49, P85; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; BOURGUIGNAT JR, 1864, MALACOLOGIE ALGERIE; Brawley SH, 2009, P NATL ACAD SCI USA, V106, P8239, DOI 10.1073/pnas.0812300106; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman JW, 2007, BIOL INVASIONS, V9, P737, DOI 10.1007/s10530-006-9073-x; Clapp WF, 1912, NAUTILUS, V26, P24; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cordellier M, 2009, MOL ECOL, V18, P534, DOI 10.1111/j.1365-294X.2008.04042.x; Cruzan MB, 2000, TRENDS ECOL EVOL, V15, P491, DOI 10.1016/S0169-5347(00)01998-4; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; DOLL W, 1982, ARCH MOLLUSKENKD, V112, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duda M, 2011, J MOLLUS STUD, V77, P30, DOI 10.1093/mollus/eyq037; Duda M, 2010, ECO MONT, V2, P5, DOI 10.1553/eco.mont-2-2s5; EGOROV R, 2007, TREASURE RUSSIAN SHE, V8, P13; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsyth R.G., 2004, LAND SNAILS BRIT COL; Forsyth Robert G., 2008, Check List, V4, P449; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2011, J INSECT CONSERV, V15, P469, DOI 10.1007/s10841-010-9349-4; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Grimm, 2009, IDENTIFYING LAND SNA; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Heller J, 2009, PENSOFT SERIES FAUNI, V83, P360; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horsak M., 2004, Malakologiai Tajekoztato, V22, P141; Horsak M, 2007, J MOLLUS STUD, V73, P53; HUBRICHT L, 1964, NATL SPELEOLOGICAL S, V26, P33; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jesse R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020734; Kirchner C, 1997, J MOLLUS STUD, V63, P479, DOI 10.1093/mollus/63.4.479; Leiss A, 1996, WISS MITT NIEDEROSTE, V9, P173; Lewis JJ, 2003, J CAVE KARST STUD, V65, P9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindroth C, 1957, FAUNAL CONNECTIONS E; Lozek V, 1957, ACTA SOC ZOOL BOHEMO, V21, P225; Maddison W.P., MESQUITE MODULAR SYS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Morton J. E., 1954, Proceedings of the Malacological Society of London, V31, P30; Mraz P, 2007, J BIOGEOGR, V34, P2100, DOI 10.1111/j.1365-2699.2007.01765.x; Muller OF, 1774, HAVNIAE LIPSIAE; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearce Timothy A., 2011, Tentacle, V19, P13; Peck S.B., 1990, Bulletin of the National Speleological Society, V51, P11; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pfenninger M, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-8; Pfenninger M, 2002, BIOL J LINN SOC, V76, P565, DOI 10.1046/j.1095-8312.2002.00080.x; Pfenninger M, 1997, VERHANDLUNGEN DER GESELLSCHAFT FUR OKOLOGIE, VOL 27, P469; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A, TRACER V1 5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Risso A., 1826, HIST NATURELLE PRINC, Vtroisieme, DOI DOI 10.5962/BHL.TITLE.58984; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROTH B, 1982, VELIGER, V24, P342; Ruiz Gregory M., 2003, P459; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ursenbacher S, 2010, CONSERV GENET, V11, P1265, DOI 10.1007/s10592-009-9956-3; VAGVOLGYI J, 1975, SYST ZOOL, V24, P465, DOI 10.2307/2412906; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; Watson H., 1953, Journal of Conchology London, V23, P306; Weigand AM, 2012, ORG DIVERS EVOL, V12, P377, DOI 10.1007/s13127-011-0070-2; Weigand Alexander M., 2010, Check List, V6, P517; Weigand AM, 2011, MOL ECOL RESOUR, V11, P255, DOI 10.1111/j.1755-0998.2010.02937.x; Zimmermann F., 1925, Zeitschrift fuer Induktive Abstammungs und Vererbungslehre Berlin, V37, P291, DOI 10.1007/BF01763340	104	16	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37089	10.1371/journal.pone.0037089	http://dx.doi.org/10.1371/journal.pone.0037089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606334	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400060
J	Haglund, F; Lu, M; Vukojevic, V; Nilsson, IL; Andreasson, A; Dzabic, M; Branstrom, R; Hoog, A; Juhlin, CC; Larsson, C				Haglund, Felix; Lu, Ming; Vukojevic, Vladana; Nilsson, Inga-Lena; Andreasson, Adam; Dzabic, Mensur; Branstrom, Robert; Hoog, Anders; Juhlin, C. Christofer; Larsson, Catharina			Prolactin Receptor in Primary Hyperparathyroidism - Expression, Functionality and Clinical Correlations	PLOS ONE			English	Article							BREAST-CANCER; CALCIUM HOMEOSTASIS; PARATHYROID-HORMONE; HUMAN-PREGNANCY; KNOCKOUT MICE; SERUM-CALCIUM; LACTATION; WOMEN; CELLS; GENE	Background: Primary hyperparathyroidism (PHPT) is an endocrine disorder most commonly affecting women, suggesting a role for female hormones and/or their receptors in parathyroid adenomas. We here investigated the prolactin receptor (PRLr) which is associated with tumours of the breast and other organs. Methodology/Principal Findings: PRLr expression was investigated in a panel of 37 patients with sporadic parathyroid tumours and its functionality in cultured parathyroid tumour cells. In comparison with other tissues and breast cancer cells, high levels of prolactin receptor gene (PRLR) transcripts were demonstrated in parathyroid tissues. PRLr products of 60/70 kDa were highly expressed in all parathyroid tumours. In addition varying levels of the 80 kDa PRLr isoform, with known proliferative activity, were demonstrated. In parathyroid tumours, PRLr immunoreactivity was observed in the cytoplasm (in all cases, n = 36), cytoplasmic granulae (n = 16), the plasma membrane (n = 12) or enlarged lysosomes (n = 4). In normal parathyroid rim (n = 28), PRLr was uniformly expressed in the cytoplasm and granulae. In in vitro studies of short-term cultured human parathyroid tumour cells, prolactin stimulation was associated with significant transcriptional changes in JAK/STAT, RIG-I like receptor and type II interferon signalling pathways as documented by gene expression profiling. Moreover, PRLR gene expression in parathyroid tumours was inversely correlated with the patients' plasma calcium levels. Conclusions: We demonstrate that the prolactin receptor is highly abundant in human parathyroid tissues and that PRLr isoforms expression and PRLr subcellular localisation are altered in parathyroid tumours. Responsiveness of PRLr to physiological levels of prolactin was observed in the form of increased PTH secretion and altered gene transcription with significant increase of RIG-I like receptor, JAK-STAT and Type II interferon signalling pathways. These data suggest a role of the prolactin receptor in parathyroid adenomas.	[Haglund, Felix; Lu, Ming; Nilsson, Inga-Lena; Andreasson, Adam; Branstrom, Robert; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Haglund, Felix; Vukojevic, Vladana; Andreasson, Adam; Dzabic, Mensur; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Dzabic, Mensur] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Hoog, Anders] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haglund, F (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Felix.Haglund@ki.se	Vukojevic, Vladana B/AAY-3144-2021; Stenman, Adam/AAI-3866-2021; Juhlin, Carl Christofer/C-1125-2016; Stenman, Adam/C-6131-2015	Stenman, Adam/0000-0003-3248-7629; Juhlin, Carl Christofer/0000-0002-5945-9081; Vukojevic, Vladana/0000-0003-0873-5653; Branstrom, Robert/0000-0001-6245-7223; Nilsson, Inga-Lena/0000-0002-8966-3729	The Swedish Cancer Foundation; Swedish Research Council; Gustav V Jubilee Foundation; Fredrik and Ingrid Thuring Foundation; AFA Insurance Foundation; Cancer Society of Stockholm; Stockholm County Council; Karolinska Institutet	The Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustav V Jubilee Foundation; Fredrik and Ingrid Thuring Foundation; AFA Insurance Foundation; Cancer Society of Stockholm; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The Swedish Cancer Foundation, the Swedish Research Council, the Gustav V Jubilee Foundation, the Fredrik and Ingrid Thuring Foundation, the AFA Insurance Foundation, the Cancer Society of Stockholm, Stockholm County Council, and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ND, 1979, J CLIN ENDOCR METAB, V49, P628, DOI 10.1210/jcem-49-4-628; Ajibade DV, 2010, ENDOCRINOLOGY, V151, P2974, DOI 10.1210/en.2010-0033; Bolanowski M, 2010, GYNECOL ENDOCRINOL, V26, P623, DOI 10.3109/09513591003686320; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Broome JT, 2011, ENDOCR PRACT, V17, P31, DOI 10.4158/EP10273.RA; Buteau H, 1998, MOL ENDOCRINOL, V12, P544, DOI 10.1210/me.12.4.544; Charoenphandhu N, 2010, TRENDS ENDOCRIN MET, V21, P395, DOI 10.1016/j.tem.2010.02.002; CHRISTENSSON T, 1976, ACTA MED SCAND, V200, P361; CHRISTIANSEN C, 1978, ACTA ENDOCRINOL-COP, V88, P528, DOI 10.1530/acta.0.0880528; Clement-Lacroix P, 1999, ENDOCRINOLOGY, V140, P96, DOI 10.1210/en.140.1.96; Clevenger Charles V, 2003, Breast Dis, V18, P75; Cole Adam R., 2008, V468, P45, DOI 10.1007/978-1-59745-249-6_4; CROSS NA, 1995, AM J CLIN NUTR, V61, P514, DOI 10.1093/ajcn/61.3.514; DeLellis R, 2004, PATHOLOGY GENETICS T; DeLellis RA, 2008, ARCH PATHOL LAB MED, V132, P1251, DOI 10.1043/1543-2165(2008)132[1251:PHACP]2.0.CO;2; DeLellis RA, 2011, MODERN PATHOL, V24, pS78, DOI 10.1038/modpathol.2010.132; Ding W, 2010, AFR J BIOTECHNOL, V9, P940; FAIRWEATHERTAIT S, 1995, AM J CLIN NUTR, V62, P1188, DOI 10.1093/ajcn/62.6.1188; Forsberg L, 2005, EUR J ENDOCRINOL, V152, P459, DOI 10.1530/eje.1.01864; Forsberg L, 2006, J BIOTECHNOL, V126, P582, DOI 10.1016/j.jbiotec.2006.05.020; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; GALLACHER SJ, 1994, EUR J ENDOCRINOL, V131, P369, DOI 10.1530/eje.0.1310369; Galsgaard ED, 2009, J ENDOCRINOL, V201, P115, DOI 10.1677/JOE-08-0479; GARFINKEL PE, 1973, LANCET, V2, P331; Harbaum L, 2010, MODERN PATHOL, V23, P961, DOI 10.1038/modpathol.2010.83; Howell V, 2004, MOL GENETICS HYPER B; Hu ZZ, 2001, J BIOL CHEM, V276, P41086, DOI 10.1074/jbc.M102109200; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Juhlin CC, 2009, INT J ONCOL, V34, P481, DOI 10.3892/ijo_00000173; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kedzia U, 2005, CANCER RES, V65, P8497, DOI 10.1158/0008-5472.CAN-04-3937; Kline JB, 2002, MOL ENDOCRINOL, V16, P2310, DOI 10.1210/me.2001-0033; KOVACS CS, 1995, J CLIN ENDOCR METAB, V80, P3036, DOI 10.1210/jc.80.10.3036; Lee SA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-72; Levina VV, 2009, CANCER RES, V69, P5226, DOI 10.1158/0008-5472.CAN-08-4652; Lu M, 2011, J ENDOCRINOL, V208, P31, DOI 10.1677/JOE-10-0123; Lundgren E, 2002, WORLD J SURG, V26, P931, DOI 10.1007/s00268-002-6621-0; MAGLIOLA L, 1984, AM J PHYSIOL, V247, pE675, DOI 10.1152/ajpendo.1984.247.5.E675; Nilsson IL, 2007, ENDOCR-RELAT CANCER, V14, P135, DOI 10.1677/erc.1.01261; O'Brien WT, 2009, BIOCHEM SOC T, V37, P1133, DOI 10.1042/BST0371133; PAHUJA DN, 1981, SCIENCE, V214, P1038, DOI 10.1126/science.7302575; Panidis D, 2005, CLIN CHEM, V51, P1691, DOI 10.1373/clinchem.2005.052761; Peirce SK, 2001, J ENDOCRINOL, V171, pR1, DOI 10.1677/joe.0.171R001; PITKIN RM, 1978, J CLIN ENDOCR METAB, V47, P626, DOI 10.1210/jcem-47-3-626; Plotnikov A, 2008, CANCER RES, V68, P1354, DOI 10.1158/0008-5472.CAN-07-6094; Rae-Venter B, 1981, Breast Cancer Res Treat, V1, P233, DOI 10.1007/BF01806263; Rastad J, 2001, J INTERN MED, V250, P43, DOI 10.1046/j.1365-2796.2001.00849.x; Ritchie LD, 1998, AM J CLIN NUTR, V67, P693, DOI 10.1093/ajcn/67.4.693; Rosen Jeffrey M, 2003, Breast Dis, V18, P3; Swaminathan G, 2008, J MAMMARY GLAND BIOL, V13, P81, DOI 10.1007/s10911-008-9068-6; Tan DY, 2011, CANCER LETT, V310, P101, DOI 10.1016/j.canlet.2011.06.014; Trott JF, 2003, J MOL ENDOCRINOL, V30, P31, DOI 10.1677/jme.0.0300031; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; VERHAEGHE J, 1992, J STEROID BIOCHEM, V41, P469, DOI 10.1016/0960-0760(92)90372-P; Vonderhaar BK, 1999, ENDOCR-RELAT CANCER, V6, P389, DOI 10.1677/erc.0.0060389; Wang Y, 2011, CANCER RES, V71, P371, DOI 10.1158/0008-5472.CAN-10-3221; Zapata CLV, 2004, AM J CLIN NUTR, V80, P417, DOI 10.1093/ajcn/80.2.417	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36448	10.1371/journal.pone.0036448	http://dx.doi.org/10.1371/journal.pone.0036448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606260	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338200028
J	Hensen, U; Meyer, T; Haas, J; Rex, R; Vriend, G; Grubmuller, H				Hensen, Ulf; Meyer, Tim; Haas, Juergen; Rex, Rene; Vriend, Gert; Grubmueller, Helmut			Exploring Protein Dynamics Space: The Dynasome as the Missing Link between Protein Structure and Function	PLOS ONE			English	Article							COMPARATIVE MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; DATABASE; SEQUENCE; RECOGNITION; DIVERGENCE; ALIGNMENT; DYNAMEOMICS; RESOLUTION; SIMILARITY	Proteins are usually described and classified according to amino acid sequence, structure or function. Here, we develop a minimally biased scheme to compare and classify proteins according to their internal mobility patterns. This approach is based on the notion that proteins not only fold into recurring structural motifs but might also be carrying out only a limited set of recurring mobility motifs. The complete set of these patterns, which we tentatively call the dynasome, spans a multidimensional space with axes, the dynasome descriptors, characterizing different aspects of protein dynamics. The unique dynamic fingerprint of each protein is represented as a vector in the dynasome space. The difference between any two vectors, consequently, gives a reliable measure of the difference between the corresponding protein dynamics. We characterize the properties of the dynasome by comparing the dynamics fingerprints obtained from molecular dynamics simulations of 112 proteins but our approach is, in principle, not restricted to any specific source of data of protein dynamics. We conclude that: 1. the dynasome consists of a continuum of proteins, rather than well separated classes. 2. For the majority of proteins we observe strong correlations between structure and dynamics. 3. Proteins with similar function carry out similar dynamics, which suggests a new method to improve protein function annotation based on protein dynamics.	[Hensen, Ulf; Meyer, Tim; Haas, Juergen; Rex, Rene; Grubmueller, Helmut] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Vriend, Gert] Radboud Univ Nijmegen, CMBI, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Hensen, U (corresponding author), Swiss Fed Inst Technol, D BSSE, Basel, Switzerland.	hgrubmu@gwdg.de	Meyer, Tim/ABC-1340-2020; Vriend, G./H-8112-2014	Meyer, Tim/0000-0002-0521-6711	BioRange programme of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; Klaus Tschira Foundation; EUROCORES-EuroSYNBIO [Pak 529]; NANOCELL [1590/2-1]	BioRange programme of the Netherlands Bioinformatics Centre; BSIK grant through the Netherlands Genomics Initiative; Klaus Tschira Foundation; EUROCORES-EuroSYNBIO; NANOCELL(European Commission)	This work has been funded by the BioRange programme of the Netherlands Bioinformatics Centre, which is supported by a BSIK grant through the Netherlands Genomics Initiative. Further funding by the Klaus Tschira Foundation (www.klaus-tschira-stiftung.de), and by the EUROCORES-EuroSYNBIO (Pak 529), "NANOCELL" (http://www.esf.org/activities/eurocores/running-programmes/eurosynbio.html), grant number 1590/2-1. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ACHARYA KR, 1995, P NATL ACAD SCI USA, V92, P2949, DOI 10.1073/pnas.92.7.2949; Ahmad S, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; ANFINSEN C, 1961, J BIOL CHEM, V236, P1361; [Anonymous], 2008, AMBER 10; ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BAN C, 1994, ACTA CRYSTALLOGR D, V50, P50, DOI 10.1107/S0907444993007991; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cox K, 2009, MOL MEMBR BIOL, V26, P205, DOI 10.1080/09687680902788967; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Erdin S, 2011, CURR OPIN STRUC BIOL, V21, P180, DOI 10.1016/j.sbi.2011.02.001; Haas J, WHAG GROMACS I UNPUB; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Holm L, 1997, STRUCTURE, V5, P165, DOI 10.1016/S0969-2126(97)00176-7; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hooft RWW, 1996, PROTEINS, V26, P363; Hooft RWW, 1996, COMPUT APPL BIOSCI, V12, P525; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hou JT, 2005, P NATL ACAD SCI USA, V102, P3651, DOI 10.1073/pnas.0409772102; Hubbard, 1993, NACCESS ATOMIC SOLVE; Jones DT, 1999, PROTEINS, P104; Jonsson AL, 2009, BIOPHYS J, V97, P2958, DOI 10.1016/j.bpj.2009.09.012; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; KITAO A, 1991, J COMPUT CHEM, V12, P359, DOI 10.1002/jcc.540120309; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lisewski AM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl788; Meyer T, 2010, STRUCTURE, V18, P1399, DOI 10.1016/j.str.2010.07.013; Meyer T, 2009, STRUCTURE, V17, P88, DOI 10.1016/j.str.2008.11.006; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Munz M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-188; Pang A, 2005, PROTEINS, V61, P809, DOI 10.1002/prot.20672; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; Pascual-Garcia A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000331; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; SAARINEN M, 1995, STRUCTURE, V3, P1097, DOI 10.1016/S0969-2126(01)00245-3; Sadowski MI, 2010, J STRUCT BIOL, V172, P244, DOI 10.1016/j.jsb.2010.07.016; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Seber GAF, 1984, CLUSTER ANAL MULTIVA; Shaw DE, 2009, ABSTR PAP AM CHEM S, V238; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Skolnick J, 2002, PROTEINS, V45, P149; Skolnick J, 2009, P NATL ACAD SCI USA, V106, P15690, DOI 10.1073/pnas.0907683106; SMITH JL, 1988, ACTA CRYSTALLOGR A, V44, P357, DOI 10.1107/S0108767388000303; Toofanny RD, 2010, BIOPHYS J, V98, P2671, DOI 10.1016/j.bpj.2010.02.048; TSUNASAWA S, 1989, J BIOL CHEM, V264, P3832; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; von Grotthuss M, 2008, NUCLEIC ACIDS RES, V36, pW303, DOI 10.1093/nar/gkn308; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zen A, 2008, PROTEIN SCI, V17, P918, DOI 10.1110/ps.073390208; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	77	67	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e33931	10.1371/journal.pone.0033931	http://dx.doi.org/10.1371/journal.pone.0033931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606222	Green Published, gold			2022-12-27	WOS:000305338200004
J	McLaughlin, B; Buendia, MA; Saborido, TP; Palubinsky, AM; Stankowski, JN; Stanwood, GD				McLaughlin, BethAnn; Buendia, Matthew A.; Saborido, Tommy P.; Palubinsky, Amy M.; Stankowski, Jeannette N.; Stanwood, Gregg D.			Haploinsufficiency of the E3 Ubiquitin Ligase C-Terminus of Heat Shock Cognate 70 Interacting Protein (CHIP) Produces Specific Behavioral Impairments	PLOS ONE			English	Article							OXIDATIVE STRESS; MOLECULAR CHAPERONES; MICE; PARKIN; DEGRADATION; GENE; TAU; IDENTIFICATION; DEFICITS; DISEASE	The multifunctional E3 ubiquitin ligase CHIP is an essential interacting partner of HSP70, which together promote the proteasomal degradation of client proteins. Acute CHIP overexpression provides neuroprotection against neurotoxic mitochondrial stress, glucocorticoids, and accumulation of toxic amyloid fragments, as well as genetic mutations in other E3 ligases, which have been shown to result in familial Parkinson's disease. These studies have created a great deal of interest in understanding CHIP activity, expression and modulation. While CHIP knockout mice have the potential to provide essential insights into the molecular control of cell fate and survival, the animals have been difficult to characterize in vivo due to severe phenotypic and behavioral dysfunction, which have thus far been poorly characterized. Therefore, in the present study we conducted a battery of neurobehavioral and physiological assays of adult CHIP heterozygotic (HET) mutant mice to provide a better understanding of the functional consequence of CHIP deficiency. We found that CHIP HET mice had normal body and brain weight, body temperature, muscle tone and breathing patterns, but do have a significant elevation in baseline heart rate. Meanwhile basic behavioral screens of sensory, motor, emotional and cognitive functions were normative. We observed no alterations in performance in the elevated plus maze, light-dark preference and tail suspension assays, or two simple cognitive tasks: novel object recognition and spontaneous alternation in a Y maze. Significant deficits were found, however, when CHIP HET mice performed wire hang, inverted screen, wire maneuver, and open field tasks. Taken together, our data indicate a clear subset of behaviors that are altered at baseline in CHIP deficient animals, which will further guide whole animal studies of the effects of CHIP dysregulation on cardiac function, brain circuitry and function, and responsiveness to environmental and cellular stress.	[McLaughlin, BethAnn] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA; [McLaughlin, BethAnn; Buendia, Matthew A.; Saborido, Tommy P.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [McLaughlin, BethAnn; Palubinsky, Amy M.; Stanwood, Gregg D.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Palubinsky, Amy M.; Stankowski, Jeannette N.] Vanderbilt Univ, Sch Med, Neurosci Grad Grp, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	McLaughlin, B (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37212 USA.	bethann.mclaughlin@vanderbilt.edu	Palubinsky, Amy/J-4310-2014; McLaughlin, BethAnn/D-9580-2012	McLaughlin, BethAnn/0000-0003-0228-6500; Stanwood, Gregg/0000-0001-6005-1203; Palubinsky, Amy/0000-0001-9285-6479	JB Marshall Neurovascular Therapeutics Program at Vanderbilt University; Vanderbilt Clinical Neuroscience Scholars Program; Vanderbilt Center for Molecular Neuroscience; Vanderbilt Kennedy Center; Vanderbilt Brain Institute;  [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050396] Funding Source: NIH RePORTER	JB Marshall Neurovascular Therapeutics Program at Vanderbilt University; Vanderbilt Clinical Neuroscience Scholars Program; Vanderbilt Center for Molecular Neuroscience; Vanderbilt Kennedy Center; Vanderbilt Brain Institute; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support was provided by a grant from the JB Marshall Neurovascular Therapeutics Program at Vanderbilt University (B.M.), the Vanderbilt Clinical Neuroscience Scholars Program (A.M.P.), the Vanderbilt Center for Molecular Neuroscience, the Vanderbilt Kennedy Center and the Vanderbilt Brain Institute (A.M.P.). Behavioral work was performed at the Vanderbilt Mouse Neurobehavioral Core, which is supported in part by P30HD15052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; Couppis MH, 2008, SYNAPSE, V62, P715, DOI 10.1002/syn.20545; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Han D, 2011, P NATL ACAD SCI USA; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Hovatta I, 2010, NEUROSCI RES, V68, P261, DOI 10.1016/j.neures.2010.08.007; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laviola G, 2009, NEUROSCI BIOBEHAV R, V33, P560, DOI 10.1016/j.neubiorev.2008.09.006; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; McLaughlin B, 2000, MOL BASIS NEUROLOGIC; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; O'Duffy AE, 2007, J CEREBR BLOOD F MET, V27, P655, DOI 10.1038/sj.jcbfm.9600380; Olsen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015085; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stankowski JN, 2011, ANTIOXID REDOX SIGN, V14, P1787, DOI 10.1089/ars.2010.3300; Stanwood GD, 2007, SYNAPSE, V61, P259, DOI 10.1002/syn.20364; Thompson BL, 2005, BEHAV BRAIN RES, V164, P107, DOI 10.1016/j.bbr.2005.06.010; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; von Coelln R, 2004, P NATL ACAD SCI USA, V101, P10744, DOI 10.1073/pnas.0401297101; WHITNEY G, 1970, BEHAV GENET, V1, P77, DOI 10.1007/BF01067373; Yao I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017317; Zeiger SLH, 2009, FREE RADICAL BIO MED, V47, P1422, DOI 10.1016/j.freeradbiomed.2009.08.011; Zhang GR, 2008, NEUROSCI LETT, V438, P371, DOI 10.1016/j.neulet.2008.04.075	52	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36340	10.1371/journal.pone.0036340	http://dx.doi.org/10.1371/journal.pone.0036340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606257	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200025
J	Nakamura, S; Oshima, M; Yuan, J; Saraya, A; Miyagi, S; Konuma, T; Yamazaki, S; Osawa, M; Nakauchi, H; Koseki, H; Iwama, A				Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Konuma, Takaaki; Yamazaki, Satoshi; Osawa, Mitsujiro; Nakauchi, Hiromitsu; Koseki, Haruhiko; Iwama, Atsushi			Bmi1 Confers Resistance to Oxidative Stress on Hematopoietic Stem Cells	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; SELF-RENEWAL; RADIORESISTANCE; DIFFERENTIATION; PATHWAYS; CAPACITY; DIVISION; LEVEL	Background: The polycomb-group (PcG) proteins function as general regulators of stem cells. We previously reported that retrovirus-mediated overexpression of Bmi1, a gene encoding a core component of polycomb repressive complex (PRC) 1, maintained self-renewing hematopoietic stem cells (HSCs) during long-term culture. However, the effects of overexpression of Bmi1 on HSCs in vivo remained to be precisely addressed. Methodology/Principal findings: In this study, we generated a mouse line where Bmi1 can be conditionally overexpressed under the control of the endogenous Rosa26 promoter in a hematopoietic cell-specific fashion (Tie2-Cre;R26Stop(FL)Bmi1). Although overexpression of Bmi1 did not significantly affect steady state hematopoiesis, it promoted expansion of functional HSCs during ex vivo culture and efficiently protected HSCs against loss of self-renewal capacity during serial transplantation. Overexpression of Bmi1 had no effect on DNA damage response triggered by ionizing radiation. In contrast, Tie2-Cre;R26Stop(FL)Bmi1 HSCs under oxidative stress maintained a multipotent state and generally tolerated oxidative stress better than the control. Unexpectedly, overexpression of Bmi1 had no impact on the level of intracellular reactive oxygen species (ROS). Conclusions/Significance: Our findings demonstrate that overexpression of Bmi1 confers resistance to stresses, particularly oxidative stress, onto HSCs. This thereby enhances their regenerative capacity and suggests that Bmi1 is located downstream of ROS signaling and negatively regulated by it.	[Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Konuma, Takaaki; Osawa, Mitsujiro; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Yokohama, Kanagawa, Japan; [Nakamura, Shunsuke; Oshima, Motohiko; Yuan, Jin; Saraya, Atsunori; Miyagi, Satoru; Osawa, Mitsujiro; Koseki, Haruhiko; Iwama, Atsushi] CREST, Japan Sci & Technol Agcy JST, Tokyo, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, Chiyoda Ku, Tokyo, Japan	Chiba University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Nakamura, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan.	aiwama@faculty.chiba-u.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Konuma, Takaaki/0000-0002-1953-8463	MEXT KAKENHI; Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; Japan Science and Technology Corporation (JST); Tokyo Biochemical Research Foundation; Astellas Foundation for Research on Metabolic Disorders	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Tokyo Biochemical Research Foundation; Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by MEXT KAKENHI and the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), a grant from the Tokyo Biochemical Research Foundation, and a grant from Astellas Foundation for Research on Metabolic Disorders. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fukamachi H, 2001, BIOCHEM BIOPH RES CO, V280, P1069, DOI 10.1006/bbrc.2001.4247; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Iwama A, 2005, INT J HEMATOL, V81, P294, DOI 10.1532/IJH97.05011; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Konuma T, 2010, DEV GROWTH DIFFER, V52, P505, DOI 10.1111/j.1440-169X.2010.01191.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mihara K, 2006, BLOOD, V107, P305, DOI 10.1182/blood-2005-06-2393; Negishi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012373; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Rizo A, 2009, BLOOD, V114, P1498, DOI 10.1182/blood-2009-03-209734; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Shima H, 2009, BIOCHEM BIOPH RES CO, V378, P467, DOI 10.1016/j.bbrc.2008.11.056; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Yahata T, 2011, BLOOD, V118, P2941, DOI 10.1182/blood-2011-01-330050; Zhou JB, 2011, BLOOD, V118, P2830, DOI 10.1182/blood-2010-07-294827	35	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36209	10.1371/journal.pone.0036209	http://dx.doi.org/10.1371/journal.pone.0036209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606246	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200017
J	Turroni, F; Peano, C; Pass, DA; Foroni, E; Severgnini, M; Claesson, MJ; Kerr, C; Hourihane, J; Murray, D; Fuligni, F; Gueimonde, M; Margolles, A; De Bellis, G; O'Toole, PW; van Sinderen, D; Marchesi, JR; Ventura, M				Turroni, Francesca; Peano, Clelia; Pass, Daniel A.; Foroni, Elena; Severgnini, Marco; Claesson, Marcus J.; Kerr, Colm; Hourihane, Jonathan; Murray, Deirdre; Fuligni, Fabio; Gueimonde, Miguel; Margolles, Abelardo; De Bellis, Gianluca; O'Toole, Paul W.; van Sinderen, Douwe; Marchesi, Julian R.; Ventura, Marco			Diversity of Bifidobacteria within the Infant Gut Microbiota	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; INTESTINAL BACTERIAL-COLONIZATION; PHYLOGENETIC MICROARRAY; GASTROINTESTINAL-TRACT; EFFECTIVE RECOVERY; FECAL SAMPLES; POPULATION; COMMUNITIES; MODULATION; SUCCESSION	Background: The human gastrointestinal tract (GIT) represents one of the most densely populated microbial ecosystems studied to date. Although this microbial consortium has been recognized to have a crucial impact on human health, its precise composition is still subject to intense investigation. Among the GIT microbiota, bifidobacteria represent an important commensal group, being among the first microbial colonizers of the gut. However, the prevalence and diversity of members of the genus Bifidobacterium in the infant intestinal microbiota has not yet been fully characterized, while some inconsistencies exist in literature regarding the abundance of this genus. Methods/Principal Findings: In the current report, we assessed the complexity of the infant intestinal bifidobacterial population by analysis of pyrosequencing data of PCR amplicons derived from two hypervariable regions of the 16 S rRNA gene. Eleven faecal samples were collected from healthy infants of different geographical origins (Italy, Spain or Ireland), feeding type (breast milk or formula) and mode of delivery (vaginal or caesarean delivery), while in four cases, faecal samples of corresponding mothers were also analyzed. Conclusions: In contrast to several previously published culture-independent studies, our analysis revealed a predominance of bifidobacteria in the infant gut as well as a profile of co-occurrence of bifidobacterial species in the infant's intestine.	[Turroni, Francesca; Foroni, Elena; Ventura, Marco] Univ Parma, Dept Genet Biol Microorganisms Anthropol & Evolut, Lab Probiogenom, I-43100 Parma, Italy; [Peano, Clelia; Severgnini, Marco; Fuligni, Fabio; De Bellis, Gianluca] CNR, Inst Biomed Technol, Milan, Italy; [Pass, Daniel A.; Marchesi, Julian R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Turroni, Francesca; Claesson, Marcus J.; O'Toole, Paul W.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Alimentary Pharmabiot Ctr, Cork, Ireland; [Turroni, Francesca; Claesson, Marcus J.; O'Toole, Paul W.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Dept Microbiol, Cork, Ireland; [Kerr, Colm; Hourihane, Jonathan; Murray, Deirdre] Natl Univ Ireland Univ Coll Cork, Dept Paediat & Child Hlth, Cork, Ireland; [Gueimonde, Miguel; Margolles, Abelardo] IPLA CSIC, Dept Microbiol & Bioquim Prod Lacteos, Villaviciosa, Asturias, Spain	University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Cardiff University; University College Cork; University College Cork; University College Cork; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Turroni, F (corresponding author), Univ Parma, Dept Genet Biol Microorganisms Anthropol & Evolut, Lab Probiogenom, I-43100 Parma, Italy.	marco.ventura@unipr.it	Van Sinderen, Douwe/A-6778-2015; ventura, marco/M-8230-2015; De Bellis, Gianluca/H-9725-2013; Gueimonde, Miguel/A-2106-2008; Turroni, Francesca/K-9660-2016; Gueimonde, Miguel/A-4239-2010; Peano, Clelia/C-4015-2018; Claesson, Marcus/K-7639-2015; O'Toole, Paul W/G-1593-2012; Marchesi, Julian/D-3731-2009; Marchesi, Julian/AAC-9021-2020; Claesson, Marcus/AAE-4145-2019; Margolles, Abelardo/H-3871-2012; Severgnini, Marco/F-5832-2013	Van Sinderen, Douwe/0000-0003-1823-7957; De Bellis, Gianluca/0000-0002-1622-4477; Gueimonde, Miguel/0000-0002-0192-901X; Turroni, Francesca/0000-0001-5363-0231; Peano, Clelia/0000-0001-7055-3629; Claesson, Marcus/0000-0002-5712-0623; O'Toole, Paul W/0000-0001-5377-0824; Marchesi, Julian/0000-0002-7994-5239; Claesson, Marcus/0000-0002-5712-0623; Margolles, Abelardo/0000-0003-2278-1816; Severgnini, Marco/0000-0001-8655-1206; Kerr, Colm/0000-0001-9976-8033; Ventura, Marco/0000-0002-4875-4560; Murray, Deirdre/0000-0002-2201-9912; Pass, Daniel/0000-0003-2799-8432	Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero"; Cariparma Bank Foundation; Spinner, Regione Emilia Romagna; FIRB-MIUR NG-LAB Research Program [RBLA03ER38_004]; FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan [02/CE/B124, 07/CE/B1368]; Royal Society; NERC [NBAF010005] Funding Source: UKRI; Natural Environment Research Council [NBAF010005] Funding Source: researchfish	Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero"; Cariparma Bank Foundation; Spinner, Regione Emilia Romagna(Regione Emilia Romagna); FIRB-MIUR NG-LAB Research Program(Ministry of Education, Universities and Research (MIUR)); FEMS Advanced Fellowship; IRCSET Embark postdoctoral fellowship; Science Foundation Ireland (SFI), through the Irish Government's National Development Plan(Science Foundation Ireland); Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was financially supported by the Italian Award for Outstanding Young Researcher scheme "Incentivazione alla mobilita di studiosi stranieri e italiani residenti all'estero" and by the Cariparma Bank Foundation to MV, by Spinner 2013, Regione Emilia Romagna and EF. This work was also financially supported by the FIRB-MIUR NG-LAB Research Program, Project RBLA03ER38_004 to GDB, by a FEMS Advanced Fellowship 2011 and an IRCSET Embark postdoctoral fellowship to FT. DvS and PO are members of The Alimentary Pharmabiotic Centre, which is a Centre for Science and Technology (CSET) funded by the Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (Grant no. 02/CE/B124 and 07/CE/B1368). The authors wish to thank The Royal Society for providing funds for the 48 core server used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Diamond J.M., 1975, P342; DiCello F, 1996, MINERVA BIOTECNOL, V8, P126; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fanaro S, 2003, ACTA PAEDIATR, V92, P634; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soergel D, 2012, ISME J, V1, P1; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Takahashi H, 2010, J PEDIATR GASTR NUTR, V51, P653, DOI 10.1097/MPG.0b013e3181f0e032; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turroni F, 2011, APPL ENVIRON MICROB, V77, P7408, DOI 10.1128/AEM.05336-11; Turroni F, 2011, GUT MICROBES, V2, P183, DOI 10.4161/gmic.2.3.16105; Turroni F, 2011, INT J FOOD MICROBIOL, V149, P37, DOI 10.1016/j.ijfoodmicro.2010.12.010; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Turroni F, 2009, ISME J, V3, P745, DOI 10.1038/ismej.2009.19; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Westerbeek EAM, 2006, CLIN NUTR, V25, P361, DOI 10.1016/j.clnu.2006.03.002; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	53	410	432	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36957	10.1371/journal.pone.0036957	http://dx.doi.org/10.1371/journal.pone.0036957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606315	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305338200059
J	Wang, Q; Na, B; Ou, JHJ; Pulliam, L; Yen, TSB				Wang, Qian; Na, Bing; Ou, Jing-hsiung James; Pulliam, Lynn; Yen, T. S. Benedict			Hepatitis B Virus Alters the Antioxidant System in Transgenic Mice and Sensitizes Hepatocytes to Fas Signaling	PLOS ONE			English	Article							PEROXIDASE-DEFICIENT MICE; NF-KAPPA-B; MEDIATED APOPTOSIS; OXIDATIVE STRESS; REACTIVE OXYGEN; GLUTATHIONE-PEROXIDASE; X-PROTEIN; SUPEROXIDE-DISMUTASE; KINASE ACTIVATION; HYDROGEN-PEROXIDE	Hepatitis B virus (HBV) is a major etiological factor of hepatocellular carcinoma (HCC). However, the precise pathogenetic mechanisms linking HBV infection and HCC remain uncertain. It has been reported that decreased antioxidant enzyme activities are associated with severe liver injury and hepatocarcinogenesis in mouse models. It is unclear if HBV can interfere with the activities of antioxidant enzymes. We established a HBV transgenic mouse line, which spontaneously developed HCC at 2 years of age. We studied the activities of the antioxidant enzymes in the liver of the HBV transgenic mice. Our results showed that the antioxidant enzymes glutathione peroxidase and superoxide dismutase 2 were down-regulated in HBV transgenic mice and correlated with JNK activation. HBV enhanced the Fas-mediated activation of caspase 6, caspase 8 and JNK without enhancing the activation of caspase 3 and hepatocellular apoptosis. As a proper redox balance is important for maintaining cellular homeostasis, these effects of HBV on the host antioxidant system and Fas-signaling may play an important role in HBV-induced hepatocarcinogenesis.	[Wang, Qian; Na, Bing; Yen, T. S. Benedict] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wang, Qian; Na, Bing; Yen, T. S. Benedict] VA Med Ctr, Pathol Serv 113B, San Francisco, CA USA; [Ou, Jing-hsiung James] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, VA Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Southern California; University of California System; University of California San Francisco	Wang, Q (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	lynn.pulliam@ucsf.edu			National Institutes of Health [RO1CA55578, P30DK26743, PO1CA123328]; NATIONAL CANCER INSTITUTE [R01CA055578, P01CA123328] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (RO1CA55578, P30DK26743 and PO1CA123328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bajt ML, 2002, ANTIOXID REDOX SIGN, V4, P733, DOI 10.1089/152308602760598873; Chang QS, 2009, J HEPATOL, V50, P323, DOI 10.1016/j.jhep.2008.07.037; Chen F, 2011, SEMIN CANCER BIOL, V21, P1, DOI 10.1016/j.semcancer.2011.01.003; Cheng WH, 2003, BIOCHEM J, V370, P927, DOI 10.1042/BJ20021870; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Diao JY, 2001, J BIOL CHEM, V276, P8328, DOI 10.1074/jbc.M006026200; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009; Huang TT, 2002, METHOD ENZYMOL, V349, P191, DOI 10.1016/S0076-6879(02)49335-4; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Jaeschke H, 1999, HEPATOLOGY, V29, P443, DOI 10.1002/hep.510290222; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Moriya K, 2001, CANCER RES, V61, P4365; Na B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026240; Nair J., 2009, MUTAT RES, V683, P23; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Pan JB, 2001, J GEN VIROL, V82, P171, DOI 10.1099/0022-1317-82-1-171; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tatone C, 2006, MOL HUM REPROD, V12, P655, DOI 10.1093/molehr/gal080; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	48	16	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36818	10.1371/journal.pone.0036818	http://dx.doi.org/10.1371/journal.pone.0036818			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606292	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200046
J	Celis-Morales, CA; Perez-Bravo, F; Ibanez, L; Salas, C; Bailey, MES; Gill, JMR				Celis-Morales, Carlos A.; Perez-Bravo, Francisco; Ibanez, Luis; Salas, Carlos; Bailey, Mark E. S.; Gill, Jason M. R.			Objective vs. Self-Reported Physical Activity and Sedentary Time: Effects of Measurement Method on Relationships with Risk Biomarkers	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ACTIVITY QUESTIONNAIRE; CARDIOVASCULAR-DISEASE; ENERGY-EXPENDITURE; SITTING TIME; LIFE-STYLE; OBESITY; MORTALITY; ADULTS; ACCELEROMETER	Purpose: Imprecise measurement of physical activity variables might attenuate estimates of the beneficial effects of activity on health-related outcomes. We aimed to compare the cardiometabolic risk factor dose-response relationships for physical activity and sedentary behaviour between accelerometer- and questionnaire-based activity measures. Methods: Physical activity and sedentary behaviour were assessed in 317 adults by 7-day accelerometry and International Physical Activity Questionnaire (IPAQ). Fasting blood was taken to determine insulin, glucose, triglyceride and total, LDL and HDL cholesterol concentrations and homeostasis model-estimated insulin resistance (HOMA(IR)). Waist circumference, BMI, body fat percentage and blood pressure were also measured. Results: For both accelerometer- derived sedentary time (<100 counts. min(-1)) and IPAQ-reported sitting time significant positive (negative for HDL cholesterol) relationships were observed with all measured risk factors - i.e. increased sedentary behaviour was associated with increased risk (all p <= 0.01). However, for HOMA(IR) and insulin the regression coefficients were >50% lower for the IPAQ-reported compared to the accelerometer-derived measure (p<0.0001 for both interactions). The relationships for moderate-to-vigorous physical activity (MVPA) and risk factors were less strong than those observed for sedentary behaviours, but significant negative relationships were observed for both accelerometer and IPAQ MVPA measures with glucose, and insulin and HOMA(IR) values (all p<0.05). For accelerometer-derived MVPA only, additional negative relationships were seen with triglyceride, total cholesterol and LDL cholesterol concentrations, BMI, waist circumference and percentage body fat, and a positive relationship was evident with HDL cholesterol (p=0.0002). Regression coefficients for HOMA(IR), insulin and triglyceride were 43-50% lower for the IPAQ-reported compared to the accelerometer-derived MVPA measure (all p <= 0.01). Conclusion: Using the IPAQ to determine sitting time and MVPA reveals some, but not all, relationships between these activity measures and metabolic and vascular disease risk factors. Using this self-report method to quantify activity can therefore underestimate the strength of some relationships with risk factors.	[Celis-Morales, Carlos A.; Gill, Jason M. R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Celis-Morales, Carlos A.; Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Perez-Bravo, Francisco] Univ Chile, Fac Med, Dept Nutr, Lab Nutr Genom, Santiago 7, Chile; [Ibanez, Luis] Ctr Nutr Metab & Phys Act CNEF, Concepcion, Chile; [Salas, Carlos] Univ Concepcion, Dept Phys Educ, Concepcion, Chile	University of Glasgow; University of Glasgow; Universidad de Chile; Universidad de Concepcion	Celis-Morales, CA (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk	Celis-Morales, Carlos/AAJ-5103-2020	Celis-Morales, Carlos/0000-0003-2612-3917; Bailey, Mark E. S./0000-0002-9788-2278	Government of Chile	Government of Chile	This work was supported by a scholarship to CACM from the Government of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza AA, 2011, MED SCI SPORT EXER, V43, P815, DOI 10.1249/MSS.0b013e3181fdfc32; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Celis-Morales CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024690; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Department of Health, 2011, START ACT STAY ACT R; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Hoffmeyer-Zlotnik JH, 1997, ADV CROSS NATL COMP, P97; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; National Socioeconomic Survey, 2006, POLL QUAL LIF HOUS; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Rosenberg DE, 2008, J PHYS ACT HEALTH, V5, pS30, DOI 10.1123/jpah.5.s1.s30; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000	34	330	333	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36345	10.1371/journal.pone.0036345	http://dx.doi.org/10.1371/journal.pone.0036345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590532	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305336100025
J	Haberer, JE; Kiwanuka, J; Nansera, D; Ragland, K; Mellins, C; Bangsberg, DR				Haberer, Jessica E.; Kiwanuka, Julius; Nansera, Denis; Ragland, Kathleen; Mellins, Claude; Bangsberg, David R.			Multiple Measures Reveal Antiretroviral Adherence Successes and Challenges in HIV-Infected Ugandan Children	PLOS ONE			English	Article							QUALITY-OF-LIFE; THERAPY ADHERENCE; VIRAL SUPPRESSION; SOUTH-AFRICA; SELF-REPORT; OUTCOMES; PARENTS; PREDICTORS; MANAGEMENT; REGIMENS	Background: Adherence to HIV antiretroviral therapy (ART) among children in developing settings is poorly understood. Methodology/Principal Findings: To understand the level, distribution, and correlates of ART adherence behavior, we prospectively determined monthly ART adherence through multiple measures and six-monthly HIV RNA levels among 121 Ugandan children aged 2-10 years for one year. Median adherence levels were 100% by three-day recall, 97.4% by 30-day visual analog scale, 97.3% by unannounced pill count/liquid formulation weights, and 96.3% by medication event monitors (MEMS). Interruptions in MEMS adherence of >= 48 hours were seen in 57.0% of children; 36.3% had detectable HIV RNA at one year. Only MEMS correlated significantly with HIV RNA levels (r = -0.25, p = 0.04). Multivariable regression found the following to be associated with <90% MEMS adherence: hospitalization of child (adjusted odds ratio [AOR] 3.0, 95% confidence interval [CI] 1.6-5.5; p = 0.001), liquid formulation use (AOR 1.4, 95% CI 1.0-2.0; p = 0.04), and caregiver's alcohol use (AOR 3.1, 95% CI 1.8-5.2; p < 0.0001). Child's use of co-trimoxazole (AOR 0.5, 95% CI 0.4-0.9; p = 0.009), caregiver's use of ART (AOR 0.6, 95% CI 0.4-0.9; p = 0.03), possible caregiver depression (AOR 0.6, 95% CI 0.4-0.8; p = 0.001), and caregiver feeling ashamed of child's HIV status (AOR 0.5, 95% CI 0.3-0.6; p < 0.0001) were protective against <90% MEMS adherence. Change in drug manufacturer (AOR 4.1, 95% CI 1.5-11.5; p = 0.009) and caregiver's alcohol use (AOR 5.5, 95% CI 2.8-10.7; p < 0.0001) were associated with >= 48-hour interruptions by MEMS, while second-line ART (AOR 0.3, 95% CI 0.1-0.99; p = 0.049) and increasing assets (AOR 0.7, 95% CI 0.6-0.9; p = 0.0007) were protective against these interruptions. Conclusions/Significance: Adherence success depends on a well-established medication taking routine, including caregiver support and adequate education on medication changes. Caregiver-reported depression and shame may reflect fear of poor outcomes, functioning as motivation for the child to adhere. Further research is needed to better understand and build on these key influential factors for adherence intervention development.	[Haberer, Jessica E.; Ragland, Kathleen; Bangsberg, David R.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Haberer, Jessica E.; Bangsberg, David R.] Harvard Univ, Sch Med, Boston, MA USA; [Kiwanuka, Julius; Nansera, Denis] Mbarara Univ Sci & Technol, Dept Paediat, Mbarara, Uganda; [Mellins, Claude] Columbia Univ, Dept Psychiat, New York, NY USA; [Mellins, Claude] Columbia Univ, Dept Sociomed Sci, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Columbia University; Columbia University	Haberer, JE (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.	jhaberer@partners.org	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	National Institute of Mental Health [R21MH 083306, K23MH087228, K24MH87227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH087228, R21MH083306, K24MH087227] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JEH and DRB received support from the National Institute of Mental Health (R21MH 083306 and K23MH087228; K24MH87227, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-265; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; BOZZETTE SA, 1995, NEW ENGL J MED, V332, P693, DOI 10.1056/NEJM199503163321101; Bunupuradah Torsak, 2006, AIDS Res Ther, V3, P30, DOI 10.1186/1742-6405-3-30; Bussmann H, 2011, AIDS RES HUM RETROV, V27, P365, DOI [10.1089/aid.2009.0299, 10.1089/aid.2010.0273]; Byakika-Tusiime J, 2009, AIDS BEHAV, V13, pS82, DOI 10.1007/s10461-009-9546-x; Cupsa A, 2000, ANN NY ACAD SCI, V918, P351; Silveira Vera Lúcia da, 2003, Braz J Infect Dis, V7, P194; Deschamps AE, 2006, JAIDS-J ACQ IMM DEF, V43, P247, DOI 10.1097/01.qai.0000246034.86135.89; Drotar D, 2009, J DEV BEHAV PEDIATR, V30, P574, DOI 10.1097/DBP.0b013e3181c3c3bb; Eley B, 2004, SAMJ S AFR MED J, V94, P643; Evans-Gilbert T, 2004, W INDIAN MED J, V53, P322; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE60, DOI 10.1097/QAI.0b013e3182303c7e; Fiese BH, 2005, J PEDIATR-US, V146, P171, DOI 10.1016/j.jpeds.2004.08.083; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Haberer Jessica, 2009, Curr HIV/AIDS Rep, V6, P194, DOI 10.1007/s11904-009-0026-8; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Jaspan HB, 2011, AIDS PATIENT CARE ST; Llibre JM, 2011, AIDS, V25, P1683, DOI 10.1097/QAD.0b013e3283499cd9; Marhefka SL, 2008, AIDS PATIENT CARE ST, V22, P637, DOI 10.1089/apc.2007.0110; Muller AD, 2008, PEDIATR INFECT DIS J, V27, P257, DOI 10.1097/INF.0b013e31815b1ad4; Muller AD, 2011, AIDS BEHAV, V15, P422, DOI 10.1007/s10461-010-9825-6; Muller AD, 2011, AIDS CARE, V23, P129, DOI 10.1080/09540121003758523; Myung P, 2007, AM J PUBLIC HEALTH, V97, P974, DOI 10.2105/AJPH.2005.083253; Nabukeera-Barungi N, 2007, ANN TROP PAEDIATR, V27, P123, DOI 10.1179/146532807X192499; National Paediatric ART Guidelines, 2008, NAT PAED ART GUID; Nyandiko WM, 2006, JAIDS-J ACQ IMM DEF, V43, P418, DOI 10.1097/01.qai.0000243122.52282.89; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Pediatric AIDS Clinical Trials Group, PED ADH QUEST MOD 1; Remien RH, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000298104.02356.b3; Rongkavilit C, 2010, AIDS PATIENT CARE ST, V24, P787, DOI 10.1089/apc.2010.0069; Safreed-Harmon K, 2007, CLIN INFECT DIS, V45, P669, DOI 10.1086/520784; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sutcliffe CG, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-54; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Wu AW, 1997, QUAL LIFE RES, V6, P531, DOI 10.1023/A:1018460132567	46	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36737	10.1371/journal.pone.0036737	http://dx.doi.org/10.1371/journal.pone.0036737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590600	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100057
J	Saunders, RJ; Paul, NA; Hu, Y; de Nys, R				Saunders, Richard J.; Paul, Nicholas A.; Hu, Yi; de Nys, Rocky			Sustainable Sources of Biomass for Bioremediation of Heavy Metals in Waste Water Derived from Coal-Fired Power Generation	PLOS ONE			English	Article							HYDRODICTYON-RETICULATUM; TROPHIC TRANSFER; BROWN-ALGAE; NEW-ZEALAND; BIOSORPTION; REMOVAL; BIOACCUMULATION; GROWTH; IONS; BIOAVAILABILITY	Biosorption of heavy metals using dried algal biomass has been extensively described but rarely implemented. We contend this is because available algal biomass is a valuable product with a ready market. Therefore, we considered an alternative and practical approach to algal bioremediation in which algae were cultured directly in the waste water stream. We cultured three species of algae with and without nutrient addition in water that was contaminated with heavy metals from an Ash Dam associated with coal-fired power generation and tested metal uptake and bioremediation potential. All species achieved high concentrations of heavy metals (to 8% dry mass). Two key elements, V and As, reached concentrations in the biomass of 1543 mg.kg(-1) DW and 137 mg.kg(-1) DW. Growth rates were reduced by more than half in neat Ash Dam water than when nutrients were supplied in excess. Growth rate and bioconcentration were positively correlated for most elements, but some elements (e.g. Cd, Zn) were concentrated more when growth rates were lower, indicating the potential to tailor bioremediation depending on the pollutant. The cosmopolitan nature of the macroalgae studied, and their ability to grow and concentrate a suite of heavy metals from industrial wastes, highlights a clear benefit in the practical application of waste water bioremediation.	[Saunders, Richard J.; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Saunders, Richard J.; Paul, Nicholas A.; de Nys, Rocky] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Hu, Yi] James Cook Univ, Adv Analyt Ctr, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Saunders, RJ (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	richard.saunders@jcu.edu.au	Paul, Nicholas/B-6496-2009; Saunders, Richard/F-4319-2012; Saunders, Richard/AAN-2427-2021; de Nys, Rocky/D-6741-2012	Saunders, Richard/0000-0001-9890-1998; de Nys, Rocky/0000-0003-3869-4928; Paul, Nicholas/0000-0002-9275-1535	Advanced Manufacturing Cooperative Research Centre; Australian Government's Cooperative Research Centre Scheme [2.3.2]	Advanced Manufacturing Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centre Scheme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	The project is supported by the Advanced Manufacturing Cooperative Research Centre, funded through the Australian Government's Cooperative Research Centre Scheme, grant number 2.3.2. The funders had no role in study design, data collection and analysis or preparation of the manuscript and have provided permission to publish.	Abu Al-Rub FA, 2004, PROCESS BIOCHEM, V39, P1767, DOI 10.1016/j.procbio.2003.08.002; Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006; ALBERTS JJ, 1985, WATER AIR SOIL POLL, V26, P111, DOI 10.1007/BF00292062; Batley GE, 2004, AUST J CHEM, V57, P903, DOI 10.1071/CH04095; Bird MI, 2011, BIORESOURCE IN PRESS; Boullemant A, 2009, ENVIRON SCI TECHNOL, V43, P3308, DOI 10.1021/es802832u; Chopin T., 2004, Bulletin of the Aquaculture Association of Canada, V104, P4; Chopin T., 2009, ENCY OCEAN SCI, P317, DOI DOI 10.1016/B978-012374473-9.00757-8; Cornelis G, 2008, APPL GEOCHEM, V23, P955, DOI 10.1016/j.apgeochem.2008.02.001; DAVIS LS, 1990, J PHYCOL, V26, P611, DOI 10.1111/j.0022-3646.1990.00611.x; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; de Silva PH, 2008, AQUACULTURE, V284, P74; DeForest DK, 2007, AQUAT TOXICOL, V84, P236, DOI 10.1016/j.aquatox.2007.02.022; Fei XG, 2004, HYDROBIOLOGIA, V512, P145, DOI 10.1023/B:HYDR.0000020320.68331.ce; FRANCKE JA, 1983, AQUAT BOT, V15, P375, DOI 10.1016/0304-3770(83)90005-0; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Geng WH, 2009, TALANTA, V79, P369, DOI 10.1016/j.talanta.2009.03.067; Ghimire KN, 2008, BIORESOURCE TECHNOL, V99, P32, DOI 10.1016/j.biortech.2006.11.057; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HAWES I, 1993, J APPL PHYCOL, V5, P437, DOI 10.1007/BF02182736; Hedouin L, 2008, MAR ENVIRON RES, V66, P438, DOI 10.1016/j.marenvres.2008.07.005; Hubbe MA, 2011, BIORESOURCES, V6, P2161; Israel A, 2005, AQUACULTURE, V249, P311, DOI 10.1016/j.aquaculture.2005.04.058; Jasonsmith JF, 2008, MAR FRESHWATER RES, V59, P1048, DOI 10.1071/MF08197; Kebede-Westhead E, 2006, J APPL PHYCOL, V18, P41, DOI 10.1007/s10811-005-9012-8; KUYUCAK N, 1988, BIOTECHNOL LETT, V10, P137, DOI 10.1007/BF01024641; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mehta SK, 2005, CRIT REV BIOTECHNOL, V25, P113, DOI 10.1080/07388550500248571; Mulbry WW, 2001, J APPL PHYCOL, V13, P301, DOI 10.1023/A:1017545116317; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Romero-Gonzalez ME, 2001, ENVIRON SCI TECHNOL, V35, P3025, DOI 10.1021/es991133r; Ruhl L, 2009, ENVIRON SCI TECHNOL, V43, P6326, DOI 10.1021/es900714p; RYTHER JH, 1972, BIOSCIENCE, V22, P144, DOI 10.2307/1296076; Senn DB, 2010, ENVIRON SCI TECHNOL, V44, P1630, DOI 10.1021/es902361j; Slaveykova VI, 2005, ENVIRON CHEM, V2, P9, DOI 10.1071/EN04076; Stengel DB, 2005, ESTUAR COAST SHELF S, V65, P687, DOI 10.1016/j.ecss.2005.07.003; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Sternberg SPK, 2002, BIORESOURCE TECHNOL, V81, P249, DOI 10.1016/S0960-8524(01)00131-6; Tang Q, 2011, MARINE ECOLOGY PROGR, P424; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Volland S, 2011, J PHYCOL, V47, P565, DOI 10.1111/j.1529-8817.2011.00988.x; Wells RDS, 1999, J AQUAT PLANT MANAGE, V37, P49; Yee N, 2011, ALGAKEY INTERACTIVE	43	49	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36470	10.1371/journal.pone.0036470	http://dx.doi.org/10.1371/journal.pone.0036470			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590550	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000305336100032
J	Song, IS; Lee, DY; Shin, MH; Kim, H; Ahn, YG; Park, I; Kim, KH; Kind, T; Shin, JG; Fiehn, O; Liu, KH				Song, Im-Sook; Lee, Do Yup; Shin, Min-Hye; Kim, Hyunmi; Ahn, Yun Gyong; Park, Inmyoung; Kim, Kyoung Heon; Kind, Tobias; Shin, Jae-Gook; Fiehn, Oliver; Liu, Kwang-Hyeon			Pharmacogenetics Meets Metabolomics: Discovery of Tryptophan as a New Endogenous OCT2 Substrate Related to Metformin Disposition	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; GENETIC-VARIANTS; FUNCTIONAL EXPRESSION; R-PACKAGE; KIDNEY; CLONING; METABONOMICS; RBOCT2	Genetic polymorphisms of the organic cation transporter 2 (OCT2), encoded by SLC22A2, have been investigated in association with metformin disposition. A functional decrease in transport function has been shown to be associated with the OCT2 variants. Using metabolomics, our study aims at a comprehensive monitoring of primary metabolite changes in order to understand biochemical alteration associated with OCT2 polymorphisms and discovery of potential endogenous metabolites related to the genetic variation of OCT2. Using GC-TOF MS based metabolite profiling, clear clustering of samples was observed in Partial Least Square Discriminant Analysis, showing that metabolic profiles were linked to the genetic variants of OCT2. Tryptophan and uridine presented the most significant alteration in SLC22A2-808TT homozygous and the SLC22A2-808G > T heterozygous variants relative to the reference. Particularly tryptophan showed gene-dose effects of transporter activity according to OCT2 genotypes and the greatest linear association with the pharmacokinetic parameters (Cl-renal, Cl-sec, Cl/F/kg, and Vd/F/kg) of metformin. An inhibition assay demonstrated the inhibitory effect of tryptophan on the uptake of 1-methyl-4-phenyl pyrinidium in a concentration dependent manner and subsequent uptake experiment revealed differential tryptophan-uptake rate in the oocytes expressing OCT2 reference and variant (808G > T). Our results collectively indicate tryptophan can serve as one of the endogenous substrate for the OCT2 as well as a biomarker candidate indicating the variability of the transport activity of OCT2.	[Song, Im-Sook; Kim, Hyunmi; Shin, Jae-Gook; Liu, Kwang-Hyeon] Inje Univ, Coll Med, Dept Pharmacol, Pusan, South Korea; [Song, Im-Sook; Kim, Hyunmi; Shin, Jae-Gook; Liu, Kwang-Hyeon] Inje Univ, Coll Med, PharmacoGenom Res Ctr, Pusan, South Korea; [Lee, Do Yup; Shin, Min-Hye; Ahn, Yun Gyong; Kind, Tobias; Fiehn, Oliver; Liu, Kwang-Hyeon] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Shin, Min-Hye; Kim, Kyoung Heon] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Ahn, Yun Gyong] Korea Basic Sci Inst, Seoul Ctr, Seoul, South Korea; [Park, Inmyoung] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Liu, Kwang-Hyeon] Kyungpook Natl Univ, Coll Pharm, Taegu, South Korea; [Liu, Kwang-Hyeon] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Taegu, South Korea	Inje University; Inje University; University of California System; University of California Davis; Korea University; Korea Basic Science Institute (KBSI); University of California System; University of California Davis; Kyungpook National University; Kyungpook National University	Song, IS (corresponding author), Inje Univ, Coll Med, Dept Pharmacol, Pusan, South Korea.	phshinjg@inje.ac.kr; ofiehn@ucdavis.edu; dstlkh@knu.ac.kr	Ahn, Yun Gyong/AAR-6614-2020; Kim, Kyoung Heon/F-1059-2013; Kind, Tobias/A-7553-2010	Ahn, Yun Gyong/0000-0003-4256-3824; Kim, Kyoung Heon/0000-0003-4600-8668; Kind, Tobias/0000-0002-1908-4916	Basic Science Research Program [2010-0021368]; Medical Research Center Program through the National Research Foundation of Korea [R13-2007-023-00000-0]; Ministry of Education, Science and Technology; Next-Generation Biogreen 21 Program Rural Development Administration, Republic of Korea [PJ008184]	Basic Science Research Program; Medical Research Center Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Next-Generation Biogreen 21 Program Rural Development Administration, Republic of Korea	This work was supported by Basic Science Research Program (Grants 2010-0021368) and Medical Research Center Program (R13-2007-023-00000-0) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, and by a grant from the Next-Generation Biogreen 21 Program (No. PJ008184), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt P, 2001, AM J PHYSIOL-RENAL, V281, pF454, DOI 10.1152/ajprenal.2001.281.3.F454; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Chen Y, 2009, PHARMACOGENET GENOM, V19, P497, DOI 10.1097/FPC.0b013e32832cc7e9; Choi MK, 2008, DRUG METAB PHARMACOK, V23, P243, DOI 10.2133/dmpk.23.243; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fujita T, 2006, J PHARM SCI-US, V95, P25, DOI 10.1002/jps.20536; Gieger C, 2008, PLOS GENET, V4; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kaewmokul S, 2003, AM J PHYSIOL-RENAL, V285, pF1149, DOI 10.1152/ajprenal.00112.2003; Kang HJ, 2007, DRUG METAB DISPOS, V35, P667, DOI 10.1124/dmd.106.013581; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Leabman MK, 2002, PHARMACOGENETICS, V12, P395, DOI 10.1097/00008571-200207000-00007; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Nakakariya M, 2009, AM J PHYSIOL-RENAL, V297, pF71, DOI 10.1152/ajprenal.90662.2008; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Okuda M, 1996, BIOCHEM BIOPH RES CO, V224, P500, DOI 10.1006/bbrc.1996.1056; PATERSON N, 1967, CLIN CHIM ACTA, V18, P57, DOI 10.1016/0009-8981(67)90245-8; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saude EJ, 2007, METABOLOMICS, V3, P439, DOI 10.1007/s11306-007-0091-1; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61; Song IS, 2008, XENOBIOTICA, V38, P1252, DOI [10.1080/00498250802130039, 10.1080/00498250802130039 ]; Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007; Zamora-Ros R, 2011, ANAL CHIMICA ACTA; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913; Zhang XH, 2002, AM J PHYSIOL-RENAL, V283, pF124, DOI 10.1152/ajprenal.00367.2001	37	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36637	10.1371/journal.pone.0036637	http://dx.doi.org/10.1371/journal.pone.0036637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590580	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335500022
J	Chinapaw, MJM; Yildirim, M; Altenburg, TM; Singh, AS; Kovacs, E; Molnar, D; Brug, J				Chinapaw, Mai J. M.; Yildirim, Mine; Altenburg, Teatske M.; Singh, Amika S.; Kovacs, Eva; Molnar, Denes; Brug, Johannes			Objective and Self-Rated Sedentary Time and Indicators of Metabolic Health in Dutch and Hungarian 10-12 Year Olds: The ENERGY-Project	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; OBESITY; CHILDHOOD; INACTIVITY; SCHOOLCHILDREN; RELIABILITY; OVERWEIGHT; ADULTHOOD	Background: The association between objectively assessed sedentary time and metabolic risk factors in childhood have rarely been studied. Therefore, we examined the independent relationship between objectively assessed and self-rated sedentary time and indicators of metabolic health in Dutch and Hungarian 10-12 year olds. Methodology/Principal Findings: We performed a cross-sectional survey in primary schools. Participants were Dutch and Hungarian girls (n = 73, aged 12.2 +/- 0.6 years, 18% overweight/obese) and boys (n = 69, aged 12.2 +/- 0.7 years, 38% overweight/obese). Sedentary time and physical activity were assessed by the Actigraph accelerometer. TV and PC time were assessed by self-report. Adiposity indicators included body weight, height, and waist circumference (WC). Fasting plasma glucose, C-peptide, total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol, and triglycerides were determined in capillary blood and summed into a metabolic risk score. Linear regression analyses were adjusted for physical activity, number of sedentary bouts and WC. Children spent on average 7.6 hours of their daily waking time in sedentary behavior and self-reported 116 +/- 64 min/day watching TV and 85 +/- 57 min/day using the computer. Comparing the 1st and 4th quartile of objectively assessed sedentary time, C-Peptide levels, WC and BMI were significantly higher in the most sedentary quartile, while the difference in metabolic risk score was borderline significant (p = 0.09). Comparing the 1st and 4th quartile of TV time, BMI was significantly higher in the most sedentary quartile, while the difference in WC score was borderline significant (p = 0.06). In the adjusted linear regression analysis we found no significant association of sedentary time with metabolic risk. Conclusions/Significance: Although BMI and WC were higher in the most sedentary versus the least sedentary children; we found no further evidence that more sedentary children were at increased metabolic risk.	[Chinapaw, Mai J. M.; Yildirim, Mine; Altenburg, Teatske M.] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Kovacs, Eva; Molnar, Denes] Univ Pecs, Dept Paediat, Pecs, Hungary; [Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Pecs; Vrije Universiteit Amsterdam	Chinapaw, MJM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	m.chinapaw@vumc.nl	Molnár, Dénes/AAB-6820-2022; Paw, Mai Chin A/N-1665-2019; Brug, Johannes/A-8242-2018; Singh, Amika/F-5033-2012; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; Brug, Johannes/0000-0002-1904-7349; Altenburg, Teatske/0000-0002-8764-5631	European Commission [FP7-HEALTH-2007-B]; World Cancer Research Fund (WCRF) [2008/65]	European Commission(European CommissionEuropean Commission Joint Research Centre); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF))	The ENERGY-project is funded by the Seventh Framework Programme (CORDIS FP7, http://cordis.europa.eu/fp7/home_en.html) of the European Commission, HEALTH (FP7-HEALTH-2007-B). The content of this article reflects only the authors' views and the European Community is not liable for any use that may be made of the information contained therein. The contribution of MY was funded by the World Cancer Research Fund (WCRF grant 2008/65 http://www.wcrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bokor S, 2008, INT J PEDIATR OBES, V3, P3, DOI 10.1080/17477160802404509; Brug J, 2012, PLOS ONE IN PRESS; Brug J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-276; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chinapaw MJM, 2011, OBES REV, V12, pE621, DOI 10.1111/j.1467-789X.2011.00865.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Fischer CC, 2012, PED EXERC S IN PRESS; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gootjes J, 2009, CLIN CHIM ACTA, V401, P152, DOI 10.1016/j.cca.2008.12.016; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rudolf MCJ, 2004, ARCH DIS CHILD, V89, P235, DOI 10.1136/adc.2002.020552; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Singh AS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-136; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Treuth MS, 2004, MED SCI SPORT EXER, V36, P1259, DOI 10.1249/01.MSS.0000074670.03001.98; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Yildirim M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-182; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005	32	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36657	10.1371/journal.pone.0036657	http://dx.doi.org/10.1371/journal.pone.0036657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586487	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000048
J	Sonkaria, S; Fuentes, G; Verma, C; Narang, R; Khare, V; Fischer, A; Faivre, D				Sonkaria, Sanjiv; Fuentes, Gloria; Verma, Chandra; Narang, Ram; Khare, Varsha; Fischer, Anna; Faivre, Damien			Insight into the Assembly Properties and Functional Organisation of the Magnetotactic Bacterial Actin-like Homolog, MamK	PLOS ONE			English	Article							F-ACTIN; POLYMERIZATION PROPERTIES; MECHANICAL-PROPERTIES; PROTEIN MAMK; FILAMENTS; MAGNETOSOMES; NUCLEOTIDES; SEQUENCE; FTSZ; MREB	Magnetotactic bacteria (MTB) synthesize magnetosomes, which are intracellular vesicles comprising a magnetic particle. A series of magnetosomes arrange themselves in chains to form a magnetic dipole that enables the cell to orient itself along the Earth's magnetic field. MamK, an actin-like homolog of MreB has been identified as a central component in this organisation. Gene deletion, fluorescence microscopy and in vitro studies have yielded mechanistic differences in the filament assembly of MamK with other bacterial cytoskeletal proteins within the cell. With little or no information on the structural and behavioural characteristics of MamK outside the cell, the mamK gene from Magnetospirillium gryphiswaldense was cloned and expressed to better understand the differences in the cytoskeletal properties with its bacterial homologues MreB and acitin. Despite the low sequence identity shared between MamK and MreB (22%) and actin (18%), the behaviour of MamK monitored by light scattering broadly mirrored that of its bacterial cousin MreB primarily in terms of its pH, salt, divalent metal-ion and temperature dependency. The broad size variability of MamK filaments revealed by light scattering studies was supported by transmission electron microscopy (TEM) imaging. Filament morphology however, indicated that MamK conformed to linearly orientated filaments that appeared to be distinctly dissimilar compared to MreB suggesting functional differences between these homologues. The presence of a nucleotide binding domain common to actin-like proteins was demonstrated by its ability to function both as an ATPase and GTPase. Circular dichroism and structural homology modelling showed that MamK adopts a protein fold that is consistent with the 'classical' actin family architecture but with notable structural differences within the smaller domains, the active site region and the overall surface electrostatic potential.	[Sonkaria, Sanjiv; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Fuentes, Gloria; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Narang, Ram] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, Potsdam, Germany; [Khare, Varsha] Max Planck Inst Colloids & Interfaces, Dept Colloid Chem, Potsdam, Germany; [Fischer, Anna] Tech Univ Berlin, Inst Chem, Berlin, Germany	Max Planck Society; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Max Planck Society; Max Planck Society; Technical University of Berlin	Sonkaria, S (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.	sanjiv.sonkaria@mpikg.mpg.de	Fischer, Anna/F-1810-2013; faivre, damien/D-3713-2009; fuentes, gloria/A-5018-2010; Khare, Varsha/A-1676-2010; Fischer, Anna/ABG-8100-2021; Fischer, Anna T. L./L-8830-2015	faivre, damien/0000-0001-6191-3389; fuentes, gloria/0000-0003-3676-9666; Fischer, Anna/0000-0003-4567-3009; Fischer, Anna T. L./0000-0003-4567-3009	Max Planck Society; German Science Foundation [FA 835/2, 1420]; European Research Council [256915-MB2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Max Planck Society, the German Science Foundation (Grant FA 835/2 within the priority programme 1420), and the European Research Council (Grant 256915-MB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; BETTACHE N, 1990, BIOCHEMISTRY-US, V29, P9085, DOI 10.1021/bi00490a028; Bombardier H, 1997, BIOCHEM BIOPH RES CO, V236, P798, DOI 10.1006/bbrc.1997.7052; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V17, P266; Claessens MMAE, 2008, P NATL ACAD SCI USA, V105, P8819, DOI 10.1073/pnas.0711149105; COMBEAU C, 1988, J BIOL CHEM, V263, P17429; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Ding Y, 2010, J BACTERIOL, V192, P1097, DOI 10.1128/JB.01292-09; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GERSHMAN LC, 1989, BIOCHIM BIOPHYS ACTA, V995, P109, DOI 10.1016/0167-4838(89)90068-X; Golaszewska HS, 1968, BIOCHIM BIOPHYS ACTA, V162, P581; Graumann PL, 2007, ANNU REV MICROBIOL, V61, P589, DOI 10.1146/annurev.micro.61.080706.093236; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; KASAI M, 1962, BIOCHIM BIOPHYS ACTA, V57, P22, DOI 10.1016/0006-3002(62)91073-9; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Lieleg O, 2009, SOFT MATTER, V5, P1796, DOI 10.1039/b814555p; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; OOSAWA F, 1975, THERMODYNAMICS POLYM, P41; Peer B, 1992, P NATL ACAD SCI USA, V89, P7290; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Popp D, 2010, J BIOL CHEM, V285, P15858, DOI 10.1074/jbc.M109.095901; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Sael L, 2008, PROTEINS, V73, P1, DOI 10.1002/prot.22141; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schirner K, 2009, MICROBIOL-SGM, V155, P3611, DOI 10.1099/mic.0.030692-0; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUCK D, 1981, P NATL ACAD SCI-BIOL, V78, P4319, DOI 10.1073/pnas.78.7.4319; TAKACS FP, 1964, J BACTERIOL, V87, P510, DOI 10.1128/JB.87.3.510-518.1964; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; Tilney LG, 2000, J CELL BIOL, V148, P87, DOI 10.1083/jcb.148.1.87; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Ullrich S, 2005, J BACTERIOL, V187, P7176, DOI 10.1128/JB.187.21.7176-7184.2005; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	50	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e34189	10.1371/journal.pone.0034189	http://dx.doi.org/10.1371/journal.pone.0034189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586444	Green Published, gold			2022-12-27	WOS:000305335000006
J	Baglioni, S; Cantini, G; Poli, G; Francalanci, M; Squecco, R; Di Franco, A; Borgogni, E; Frontera, S; Nesi, G; Liotta, F; Lucchese, M; Perigli, G; Francini, F; Forti, G; Serio, M; Luconi, M				Baglioni, Silvana; Cantini, Giulia; Poli, Giada; Francalanci, Michela; Squecco, Roberta; Di Franco, Alessandra; Borgogni, Elisa; Frontera, Salvatore; Nesi, Gabriella; Liotta, Francesco; Lucchese, Marcello; Perigli, Giuliano; Francini, Fabio; Forti, Gianni; Serio, Mario; Luconi, Michaela			Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in the Adipose Stem Cell	PLOS ONE			English	Article							REGIONAL DIFFERENCES; MULTIPOTENT CELLS; HUMAN ADIPOCYTES; IN-VITRO; TISSUE; INSULIN; EXPRESSION; BMI-1; DIFFERENTIATION; TRANSPLANTATION	Metabolic pathologies mainly originate from adipose tissue (AT) dysfunctions. AT differences are associated with fat-depot anatomic distribution in subcutaneous (SAT) and visceral omental (VAT) pads. We address the question whether the functional differences between the two compartments may be present early in the adipose stem cell (ASC) instead of being restricted to the mature adipocytes. Using a specific human ASC model, we evaluated proliferation/differentiation of ASC from abdominal SAT-(S-ASC) and VAT-(V-ASC) paired biopsies in parallel as well as the electrophysiological properties and functional activity of ASC and their in vitro-derived adipocytes. A dramatic difference in proliferation and adipogenic potential was observed between the two ASC populations, S-ASC having a growth rate and adipogenic potential significantly higher than V-ASC and giving rise to more functional and better organized adipocytes. To our knowledge, this is the first comprehensive electrophysiological analysis of ASC and derived-adipocytes, showing electrophysiological properties, such as membrane potential, capacitance and K+-current parameters which confirm the better functionality of S-ASC and their derived adipocytes. We document the greater ability of S-ASC-derived adipocytes to secrete adiponectin and their reduced susceptibility to lipolysis. These features may account for the metabolic differences observed between the SAT and VAT. Our findings suggest that VAT and SAT functional differences originate at the level of the adult ASC which maintains a memory of its fat pad of origin. Such stem cell differences may account for differential adipose depot susceptibility to the development of metabolic dysfunction and may represent a suitable target for specific therapeutic approaches.	[Baglioni, Silvana; Cantini, Giulia; Poli, Giada; Francalanci, Michela; Di Franco, Alessandra; Borgogni, Elisa; Frontera, Salvatore; Forti, Gianni; Serio, Mario; Luconi, Michaela] Univ Florence, Dept Clin Physiopathol, Endocrine Unit, Florence, Italy; [Squecco, Roberta; Francini, Fabio] Univ Florence, Dept Physiol Sci, Florence, Italy; [Nesi, Gabriella] Univ Florence, Dept Human Pathol & Oncol, Florence, Italy; [Liotta, Francesco] Univ Florence, Dept Internal Med, Florence, Italy; [Lucchese, Marcello] AOU Careggi, Florence, Italy; [Perigli, Giuliano] Univ Florence, Dept Gen Surg, Florence, Italy	University of Florence; University of Florence; University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Baglioni, S (corresponding author), Univ Florence, Dept Clin Physiopathol, Endocrine Unit, Florence, Italy.	m.luconi@dfc.unifi.it	Cantini, Giulia/K-7626-2016; Luconi, Michaela/W-9522-2019; Squecco, Roberta/K-8961-2019	Luconi, Michaela/0000-0001-5186-064X; CANTINI, GIULIA/0000-0002-9159-9199; francini, fabio/0000-0002-9255-1824	Ente Cassa di Risparmio di Firenze; Ente Cassa di Risparmio di Pistoia e Pescia	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Ente Cassa di Risparmio di Pistoia e Pescia	This study was supported by Ente Cassa di Risparmio di Firenze and the Ente Cassa di Risparmio di Pistoia e Pescia to M. Luconi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2010, EMBO J, V29, P3236, DOI 10.1038/emboj.2010.200; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Baglioni S, 2009, FASEB J, V23, P3494, DOI 10.1096/fj.08-126946; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Benvenuti S, 2006, EXP CELL RES, V312, P2592, DOI 10.1016/j.yexcr.2006.04.016; Blackiston DJ, 2009, CELL CYCLE, V8, P3527, DOI 10.4161/cc.8.21.9888; BOLINDER J, 1983, DIABETES, V32, P117, DOI 10.2337/diabetes.32.2.117; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hocking SL, 2008, DIABETOLOGIA, V51, P900, DOI 10.1007/s00125-008-0969-0; Hu H, 2009, J CELL PHYSIOL, V218, P427, DOI 10.1002/jcp.21617; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Lafontan M, 2003, TRENDS PHARMACOL SCI, V24, P276, DOI 10.1016/S0165-6147(03)00132-9; Laviola L, 2006, DIABETES, V55, P952, DOI 10.2337/diabetes.55.04.06.db05-1414; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; MAURIEGE P, 1987, EUR J CLIN INVEST, V17, P156, DOI 10.1111/j.1365-2362.1987.tb02395.x; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Nincheri P, 2009, CELL MOL LIFE SCI, V66, P1741, DOI 10.1007/s00018-009-9181-8; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ramirez-Ponce MP, 2003, J MEMBRANE BIOL, V196, P129, DOI 10.1007/s00232-003-0631-1; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Song LB, 2006, CANCER RES, V66, P6225, DOI 10.1158/0008-5472.CAN-06-0094; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Tanko LB, 2003, CIRCULATION, V107, P1626, DOI 10.1161/01.CIR.0000057974.74060.68; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tchkonia T, 2006, DIABETES, V55, P2571, DOI 10.2337/db06-0540; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Vilalta M, 2008, STEM CELLS DEV, V17, P993, DOI 10.1089/scd.2007.0201; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wang ZM, 2005, AM J CLIN NUTR, V81, P799, DOI 10.1093/ajcn/81.4.799; Zierath JR, 1998, DIABETOLOGIA, V41, P1343, DOI 10.1007/s001250051075	57	125	128	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36569	10.1371/journal.pone.0036569	http://dx.doi.org/10.1371/journal.pone.0036569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574183	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800080
J	Fernandez, O; Aguera, J; Izquierdo, G; Millan-Pascual, J; Torrenta, LRI; Oliva, P; Argente, J; Berdei, Y; Soler, JM; Carmona, O; Errea, JM; Farres, J				Fernandez, Oscar; Agueera, Javier; Izquierdo, Guillermo; Millan-Pascual, Javier; Ramio i Torrenta, Lluis; Oliva, Pedro; Argente, Javier; Berdei, Yasmina; Maria Soler, Jose; Carmona, Olga; Maria Errea, Jose; Farres, Jordi		Grp Adherence IFNb-1b Spain	Adherence to Interferon beta-1b Treatment in Patients with Multiple Sclerosis in Spain	PLOS ONE			English	Article							IMMUNOMODULATORY TREATMENTS; PHARMACY RECORDS; THERAPY; DRUG; PROGRESSION; DISABILITY; VALIDITY; BENEFIT	Background: Adherence to interferon beta-1b (INF beta-1b) therapy is essential to maximize the beneficial effects of treatment in multiple sclerosis (MS). For that reason, the main objectives of this study are to assess adherence to INF beta-1b in patients suffering from MS in Spain, and to identify the factors responsible for adherence in routine clinical practice. Methodology/Principal Findings: This was an observational, retrospective, cross-sectional study including 120 Spanish patients with MS under INF beta-1b treatment. Therapeutic adherence was assessed with Morisky-Green test and with the percentage of doses received. The proportion of adherent patients assessed by Morisky-Green test was 68.3%, being indicative of poor adherence. Nevertheless, the percentage of doses received, which was based on the number of injected medication, was 94.3%. The main reason for missing INF beta-1b injections was forgetting some of the administrations (64%). Therefore, interventions that diminish forgetfulness might have a positive effect in the proportion of adherent patients and in the percentage of doses received. In addition, age and comorbidities had a significant effect in the number of doses injected per month, and should be considered in the management of adherence in MS patients. Conclusion/Significance: Among all the available methods for assessing adherence, the overall consumption of the intended dose has to be considered when addressing adherence.	[Fernandez, Oscar] Hosp Univ Carlos Haya Malaga, Malaga, Spain; [Agueera, Javier] Hosp Univ Reina Sofia Cordoba, Cordoba, Spain; [Izquierdo, Guillermo] Hosp Virgen de la Macarena, Seville, Spain; [Millan-Pascual, Javier] Hosp La Mancha Ctr, Alcazar De San Juan, Spain; [Ramio i Torrenta, Lluis] Hosp Josep Trueta, Girona, Spain; [Oliva, Pedro] HUC Asturias, Oviedo, Spain; [Argente, Javier] Hosp Puerta del Mar, Cadiz, Spain; [Berdei, Yasmina] Hosp Salamanca, Salamanca, Spain; [Maria Soler, Jose] Hosp St Joan de Deu Manresa, Manresa, Spain; [Carmona, Olga] Hosp Figueres, Figueres, Spain; [Maria Errea, Jose] Hosp Barbastro, Barbastro, Spain; [Farres, Jordi] Bayer Hispania, Barcelona, Spain	Hospital Universitario Reina Sofia - Cordoba; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Bayer AG	Fernandez, O (corresponding author), Hosp Univ Carlos Haya Malaga, Malaga, Spain.	oscar.fernandez.sspa@juntadeandalucia.es	OLIVA-NACARINO, PEDRO/ABF-8090-2021; Aguera-Morales, Eduardo/Q-7167-2018; Aguera-Morales, Eduardo/AAN-3454-2020	Aguera-Morales, Eduardo/0000-0002-8604-2054; Aguera-Morales, Eduardo/0000-0002-8604-2054	Quimica Farmaceutica Bayer S.L.; RPS Research Iberica; Bayer-Schering; Biogen-Idec; Merck-Serono; TevA; Novartis; Sanofi-Aventis	Quimica Farmaceutica Bayer S.L.; RPS Research Iberica; Bayer-Schering(Bayer AG); Biogen-Idec(Biogen); Merck-Serono(Merck & Company); TevA(Teva Pharmaceutical Industries); Novartis(Novartis); Sanofi-Aventis(Sanofi-Aventis)	This study was supported by Quimica Farmaceutica Bayer S.L.and RPS Research Iberica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Quimica Farmaceutica Bayer S.L.and RPS Research Iberica. RPS Research Iberica helped in the statistical analysis. The corresponding author (Oscar Fernandez, MD, PhD) has received honoraria as consultant in advisory boards, and as chairmen or lecturer in meetings (Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis). He has also participated in clinical trials and other research projects sponsored by Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis. The author (Olga Carmona, MD, PhD) has received honoraria as consultant in advisory boards, and as a lecturer in meetings (Bayer-Schering; Biogen-Idec, Merck-Serono, TevA, Novartis and Sanofi-Aventis). She has also participated in clinical trials and other research projects sponsored by Bayer-Schering; Biogen-Idec, Merck-Serono, Teva, Novartis and Sanofi-Aventis. The remaining authors have declared that they have no conflict of interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2001, NEUROLOGY, V56, P1505; [Anonymous], 2008, NEURA PERSPECTIVES C, V8, P7; Applebee A, 2009, BIOL-TARGETS THER, V3, P257; Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Clerico M, 2007, J NEUROL SCI, V259, P104, DOI 10.1016/j.jns.2006.05.075; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Cunningham A, 2010, ACTA NEUROL SCAND, V121, P154, DOI 10.1111/j.1600-0404.2009.01285.x; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Francis G, 2001, NEUROLOGY, V56, P1628; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lau HS, 1997, J CLIN EPIDEMIOL, V50, P619, DOI 10.1016/S0895-4356(97)00040-1; Milanese C, 2003, J NEUROL NEUROSUR PS, V74, P1689, DOI 10.1136/jnnp.74.12.1689; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Patti F, 2010, PATIENT PREFER ADHER, V4, P1; Perez AM Garcia, 2000, MED FAMILIA, V1, P13; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Reynolds MW, 2010, CURR MED RES OPIN, V26, P663, DOI 10.1185/03007990903554257; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Ruggieri RM, 2003, NEUROL SCI, V24, P361, DOI 10.1007/s10072-003-0190-3; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Tremlett H, 2008, PHARMACOEPIDEM DR S, V17, P565, DOI 10.1002/pds.1593; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Wiendl H, 2008, J NEUROL, V255, P1449, DOI 10.1007/s00415-008-0061-1; World Health Organization, 2003, ADHERENCE LONG TERM	35	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35600	10.1371/journal.pone.0035600	http://dx.doi.org/10.1371/journal.pone.0035600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615737	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341300005
J	Pi, WF; Guo, XJ; Su, LP; Xu, WG				Pi, Weifeng; Guo, Xuejun; Su, Liping; Xu, Weiguo			BMP-2 Up-Regulates PTEN Expression and Induces Apoptosis of Pulmonary Artery Smooth Muscle Cells under Hypoxia	PLOS ONE			English	Article							PPAR-GAMMA; SKELETAL MYOBLASTS; IN-VITRO; HYPERTENSION; PROLIFERATION; ACTIVATION; ROSIGLITAZONE	Aim: To investigate the role of bone morphogenetic protein 2 (BMP-2) in regulation of phosphatase and tensin homologue deleted on chromosome ten (PTEN) and apoptosis of pulmonary artery smooth muscle cells (PASMCs) under hypoxia. Methods: Normal human PASMCs were cultured in growth medium (GM) and treated with BMP-2 from 5-80 ng/ml under hypoxia (5% CO2+94% N-2+1% O2) for 72 hours. Gene expression of PTEN, AKT-1 and AKT-2 were determined by quantitative RT-PCR (QRT-PCR). Protein expression levels of PTEN, AKT and phosph-AKT (pAKT) were determined. Apoptosis of PASMCs were determined by measuring activities of caspases-3, - 8 and - 9. siRNA-smad-4, bpV(HOpic) (PTEN inhibitor) and GW9662 (PPAR gamma antagonist) were used to determine the signalling pathways. Results: Proliferation of PASMCs showed dose dependence of BMP-2, the lowest proliferation rate was achieved at 60 ng/ml concentration under hypoxia (82.2 +/- 2.8%). BMP-2 increased PTEN gene expression level, while AKT-1 and AKT-2 did not change. Consistently, the PTEN protein expression also showed dose dependence of BMP-2. AKT activity significantly reduced in BMP-2 treated PASMCs. Increased activities of caspase-3, - 8 and - 9 of PASMCs were found after cultured with BMP-2. PTEN expression remained unchanged when Smad-4 expression was inhibited by siRNA-Smad-4. bpV(HOpic) and GW9662 (PPAR gamma inhibitor) inhibited PTEN protein expression and recovered PASMCs proliferation rate. Conclusion: BMP-2 increased PTEN expression under hypoxia in a dose dependent pattern. BMP-2 reduced AKT activity and increased caspase activity of PASMCs under hypoxia. The increased PTEN expression may be mediated through PPAR gamma signalling pathway, instead of BMP/Smad signalling pathway.	[Pi, Weifeng; Guo, Xuejun; Xu, Weiguo] Jiao Tong Univ, Sch Med, Dept Resp Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Su, Liping] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore	Shanghai Jiao Tong University; National University of Singapore	Pi, WF (corresponding author), Jiao Tong Univ, Sch Med, Dept Resp Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	guoxjz@yahoo.com.cn; xuweiguo@xinhuamed.com.cn						Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; McLaughlin VV, 2009, CIRCULATION, V119, P2250, DOI 10.1161/CIRCULATIONAHA.109.192230; Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198; RUBIN LJ, 1997, PRIMARY PULMONARY HY; Teresi RE, 2006, INT J CANCER, V118, P2390, DOI 10.1002/ijc.21799; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Ye L, 2009, DIABETOLOGIA, V52, P1925, DOI 10.1007/s00125-009-1421-9; Ye L, 2007, CIRCULATION, V116, pI113, DOI 10.1161/CIRCULATIONAHA.106.680124; Ye L, 2007, EXP BIOL MED, V232, P1477, DOI 10.3181/0706-RM-175; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhang W, 2006, CANCER BIOL THER, V5, P1008, DOI 10.4161/cbt.5.8.2887	19	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e35283	10.1371/journal.pone.0035283	http://dx.doi.org/10.1371/journal.pone.0035283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TM	22615735	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300002
J	Cipriani, S; Desjardins, CA; Burdett, TC; Xu, YH; Xu, K; Schwarzschild, MA				Cipriani, Sara; Desjardins, Cody A.; Burdett, Thomas C.; Xu, Yuehang; Xu, Kui; Schwarzschild, Michael A.			Urate and Its Transgenic Depletion Modulate Neuronal Vulnerability in a Cellular Model of Parkinson's Disease	PLOS ONE			English	Article							1-METHYL-4-PHENYLPYRIDINIUM ION MPP+; URIC-ACID LEVELS; EVOLUTIONARY IMPLICATIONS; MEMBRANE-PERMEABILITY; DOPAMINERGIC-NEURONS; GLUTAMATE TOXICITY; LIPID-PEROXIDATION; MOUSE ASTROCYTES; PC12 CELLS; OXIDASE	Urate is a major antioxidant as well as the enzymatic end product of purine metabolism in humans. Higher levels correlate with a reduced risk of developing Parkinson's disease (PD) and with a slower rate of PD progression. In this study we investigated the effects of modulating intracellular urate concentration on 1-methyl-4-phenyl-pyridinium (MPP+)-induced degeneration of dopaminergic neurons in cultures of mouse ventral mesencephalon prepared to contain low (neuron-enriched cultures) or high (neuron-glial cultures) percentage of astrocytes. Urate, added to the cultures 24 hours before and during treatment with MPP+, attenuated the loss of dopaminergic neurons in neuron-enriched cultures and fully prevented their loss and atrophy in neuron-astrocyte cultures. Exogenous urate was found to increase intracellular urate content in cortical neuronal cultures. To assess the effect of reducing cellular urate content on MPP+-induced toxicity, mesencephalic neurons were prepared from mice over-expressing urate oxidase (UOx). Transgenic UOx expression decreased endogenous urate content both in neurons and astrocytes. Dopaminergic neurons expressing UOx were more susceptible to MPP+ in mesencephalic neuron-enriched cultures and to a greater extent in mesencephalic neuron-astrocyte cultures. Our findings correlate intracellular urate content in dopaminergic neurons with their toxin resistance in a cellular model of PD and suggest a facilitative role for astrocytes in the neuroprotective effect of urate.	[Cipriani, Sara; Desjardins, Cody A.; Burdett, Thomas C.; Xu, Yuehang; Xu, Kui; Schwarzschild, Michael A.] Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Cipriani, S (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02114 USA.	scipriani@partners.org		Burdett, Thomas/0000-0001-7069-4122	United States National Institutes of Health [R21NS058324, K24NS060991]; US Department of Defense [W81XWH-11-1-0150]; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058324, K24NS060991] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding came from the United States National Institutes of Health http://www.nih.gov/(R21NS058324 and K24NS060991), US Department of Defense http://www.defense.gov/(W81XWH-11-1-0150), and the American Parkinson Disease Association http://www.apdaparkinson.org/userND/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andreadou E, 2009, CLIN NEUROL NEUROSUR, V111, P724, DOI 10.1016/j.clineuro.2009.06.012; Aoyama K, 2011, NEUROSCIENCE, V181, P206, DOI 10.1016/j.neuroscience.2011.02.047; ARDUINI A, 1992, ARCH BIOCHEM BIOPHYS, V294, P398, DOI 10.1016/0003-9861(92)90702-X; Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Chen PS, 2006, MOL PSYCHIATR, V11, P1116, DOI 10.1038/sj.mp.4001893; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Davis JW, 1996, AM J EPIDEMIOL, V144, P480, DOI 10.1093/oxfordjournals.aje.a008954; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Gess B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017139; Gomez FJ, 2011, J NEURAL TRANSM, V118, P421, DOI 10.1007/s00702-010-0489-1; GREEN CJ, 1986, CRYOBIOLOGY, V23, P358, DOI 10.1016/0011-2240(86)90040-4; Guerreiro S, 2009, J NEUROCHEM, V109, P1118, DOI 10.1111/j.1471-4159.2009.06040.x; Haberman F, 2007, NEUROMOL MED, V9, P315, DOI 10.1007/s12017-007-8010-1; HALDANE JBS, 1955, NATURE, V176, P169, DOI 10.1038/176169a0; Hazell AS, 1997, J NEUROCHEM, V68, P2216; Huang JJ, 2006, BRAIN RES, V1097, P52, DOI 10.1016/j.brainres.2006.04.047; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee CS, 2002, NEUROCHEM INT, V40, P361, DOI 10.1016/S0197-0186(01)00069-9; May JM, 2006, NEUROCHEM RES, V31, P785, DOI 10.1007/s11064-006-9077-z; MAYER RA, 1986, J NEUROCHEM, V47, P1073; MICHEL PP, 1992, BRAIN RES, V597, P233, DOI 10.1016/0006-8993(92)91479-X; MIZUNO Y, 1987, NEUROSCI LETT, V81, P204, DOI 10.1016/0304-3940(87)90366-1; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; OROWAN E, 1955, NATURE, V175, P683, DOI 10.1038/175683a0; Park TH, 2003, NEUROSCI RES, V46, P349, DOI 10.1016/S0168-0102(03)00097-X; PROCTOR P, 1970, NATURE, V228, P868, DOI 10.1038/228868a0; Scheers NM, 2011, BR J NUTR, V21, P1; Schmidt AP, 2009, BRIT J PHARMACOL, V156, P163, DOI 10.1111/j.1476-5381.2008.00025.x; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Schwarzschild MA, 2011, MOVEMENT DISORD, V26, P1864, DOI 10.1002/mds.23741; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Stinefelt B, 2005, ANN CLIN LAB SCI, V35, P37; THORN NA, 1991, ACTA PHYSIOL SCAND, V141, P97, DOI 10.1111/j.1748-1716.1991.tb09049.x; Truszkowski R, 1933, BIOCHEM J, V27, P612, DOI 10.1042/bj0270612; Uezono T, 2001, J NEURAL TRANSM, V108, P899, DOI 10.1007/s007020170011; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; VOLTERRA A, 1994, ANN NY ACAD SCI, V738, P153; Wang Li-jun, 2010, Zhonghua Yi Xue Za Zhi, V90, P1362; Wang TG, 2005, FASEB J, V19, P1134, DOI 10.1096/fj.04-2457fje; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Whiteman M, 2002, ANN NY ACAD SCI, V962, P242, DOI 10.1111/j.1749-6632.2002.tb04072.x; Wong SS, 1999, BRAIN RES, V836, P237, DOI 10.1016/S0006-8993(99)01661-3; WU EY, 1992, J PHARMACOL EXP THER, V262, P225; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; YELDANDI AV, 1991, GENE, V109, P281, DOI 10.1016/0378-1119(91)90622-I; Zhu TG, 2012, NEUROSCI LETT, V506, P175, DOI 10.1016/j.neulet.2011.10.075	56	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37331	10.1371/journal.pone.0037331	http://dx.doi.org/10.1371/journal.pone.0037331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606360	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400080
J	Jiang, BC; Zhao, W; Yuan, JP; Qian, YY; Sun, WJ; Zou, YX; Guo, CH; Chen, BX; Shao, CS; Gong, YQ				Jiang, Baichun; Zhao, Wei; Yuan, Jupeng; Qian, Yanyan; Sun, Wenjie; Zou, Yongxin; Guo, Chenhong; Chen, Bingxi; Shao, Changshun; Gong, Yaoqin			Lack of Cul4b, an E3 Ubiquitin Ligase Component, Leads to Embryonic Lethality and Abnormal Placental Development	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; CYCLIN-E; WD40-REPEAT PROTEINS; X-CHROMOSOME; S-PHASE; GENE; DEGRADATION; RECEPTOR; CELLS; PROLIFERATION	Cullin-RING ligases (CRLs) complexes participate in the regulation of diverse cellular processes, including cell cycle progression, transcription, signal transduction and development. Serving as the scaffold protein, cullins are crucial for the assembly of ligase complexes, which recognize and target various substrates for proteosomal degradation. Mutations in human CUL4B, one of the eight members in cullin family, are one of the major causes of X-linked mental retardation. We here report the generation and characterization of Cul4b knockout mice, in which exons 3 to 5 were deleted. In contrast to the survival to adulthood of human hemizygous males with CUL4B null mutation, Cul4b null mouse embryos show severe developmental arrest and usually die before embryonic day 9.5 (E9.5). Accumulation of cyclin E, a CRL (CUL4B) substrate, was observed in Cul4b null embryos. Cul4b heterozygotes were recovered at a reduced ratio and exhibited a severe developmental delay. The placentas in Cul4b heterozygotes were disorganized and were impaired in vascularization, which may contribute to the developmental delay. As in human CUL4B heterozygotes, Cul4b null cells were selected against in Cul4b heterozygotes, leading to various degrees of skewed X-inactivation in different tissues. Together, our results showed that CUL4B is indispensable for embryonic development in the mouse.	[Jiang, Baichun] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Jiang, BC (corresponding author), Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China.	changshun.shao@gmail.com; yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Basic Research Program of China [2011CB966200]; National Natural Science Foundation of China [30830065, 30900804, 81101522]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China [2011CB966200] and National Natural Science Foundation of China [30830065, 30900804 and 81101522]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Badura-Stronka M, 2010, CLIN GENET, V77, P141, DOI 10.1111/j.1399-0004.2009.01331.x; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gascoin-Lachambre G, 2010, PLACENTA, V31, P151, DOI 10.1016/j.placenta.2009.11.008; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Isidor B, 2010, AM J MED GENET A, V152A, P175, DOI 10.1002/ajmg.a.33152; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Kopanja D, 2011, DEV BIOL, V352, P278, DOI 10.1016/j.ydbio.2011.01.028; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li X, 2011, J BIOL CHEM, V286, P32344, DOI 10.1074/jbc.M111.249003; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Muers MR, 2007, AM J HUM GENET, V80, P1138, DOI 10.1086/518369; Nakagawa T, 2011, MOL CELL, V43, P381, DOI 10.1016/j.molcel.2011.05.033; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ravn K, 2012, CLIN GENET; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	40	54	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37070	10.1371/journal.pone.0037070	http://dx.doi.org/10.1371/journal.pone.0037070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606329	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400057
J	van der Werf-Eldering, MJ; Riemersma-van der Lek, RF; Burger, H; Holthausen, EAE; Aleman, A; Nolen, WA				van der Werf-Eldering, Marieke J.; Riemersma-van der Lek, Rixt F.; Burger, Huibert; Holthausen, Esther A. E.; Aleman, Andre; Nolen, Willem A.			Can Variation in Hypothalamic-Pituitary-Adrenal (HPA)-Axis Activity Explain the Relationship between Depression and Cognition in Bipolar Patients?	PLOS ONE			English	Article							CORTISOL AWAKENING RESPONSE; REPORT QIDS-SR; HIPPOCAMPAL ATROPHY; MAJOR DEPRESSION; QUICK INVENTORY; LABORATORY TEST; MOOD DISORDERS; HPA AXIS; SYMPTOMATOLOGY; MEMORY	Background: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is thought to be associated with more mood symptoms and worse cognitive functioning. This study examined whether variation in HPA axis activity underlies the association between mood symptoms and cognitive functioning. Methodology/Principal Findings: In 65 bipolar patients cognitive functioning was measured in domains of psychomotor speed, speed of information processing, attentional switching, verbal memory, visual memory, executive functioning and an overall mean score. Severity of depression was assessed by the Inventory of Depressive Symptomatology-self rating version. Saliva cortisol measurements were performed to calculate HPA axis indicators: cortisol awakening response, diurnal slope, the evening cortisol level and the cortisol suppression on the dexamethasone suppression test. Regression analyses of depressive symptoms and cognitive functioning on each HPA axis indicator were performed. In addition we calculated percentages explanation of the association between depressive symptoms and cognition by HPA axis indicators. Depressive symptoms were associated with dysfunction in psychomotor speed, attentional switching and the mean score, as well as with attenuation in diurnal slope value. No association was found between HPA axis activity and cognitive functioning and HPA axis activity did not explain the associations between depressive symptoms and cognition. Conclusions/Significance: As our study is the first one in this field specific for bipolar patients and changes in HPA-axis activity did not seem to explain the association between severity of depressive symptoms and cognitive functioning in bipolar patients, future studies are needed to evaluate other factors that might explain this relationship.	[van der Werf-Eldering, Marieke J.; Riemersma-van der Lek, Rixt F.; Burger, Huibert; Holthausen, Esther A. E.; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Burger, Huibert] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van der Werf-Eldering, MJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands.	m.j.van.der.werf@umcg.nl	Nolen, Willem A/E-9006-2014	Eldering, Marieke/0000-0002-7715-5946	AstraZeneca, The Netherlands; Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder; Netherlands Organization for Health Research and Development; European Union; Stanley Medical Research Institute; Eli Lilly; GlaxoSmithKline; Wyeth; Pfizer; Servier; Brystol-Myers Squibb	AstraZeneca, The Netherlands(Netherlands GovernmentAstraZeneca); Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Union(European Commission); Stanley Medical Research Institute; Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Wyeth(Wyeth); Pfizer(Pfizer); Servier(Servier); Brystol-Myers Squibb	MWE has received a Young Investigator's award from AstraZeneca, The Netherlands and a Lilly Travel Fellowship for 9th International Conference on Bipolar Disorder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. W. A. Nolen has received grants from the Netherlands Organization for Health Research and Development, the European Union, the Stanley Medical Research Institute, Astra Zeneca, Eli Lilly, GlaxoSmithKline and Wyeth; W. A. Nolen has received honoraria/speaker's fees from Astra Zeneca, Pfizer, Servier and Wyeth and has served in advisory boards for Astra Zeneca, Pfizer and Servier. R. F. Riemersma-van der Lek has received speaker's fees from Astra Zeneca. A. Aleman received an investigator-initiated unrestricted research grant from Brystol-Myers Squibb and speakers bureau honoraria from AstraZeneca, Brystol-Myers Squibb, GlaxoSmithKline and Janssen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors deny any conflicts of interest or commercial associations in connection with the submitted manuscript.	Aas M, 2011, PSYCHOL MED, V41, P463, DOI 10.1017/S0033291710001170; Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Beluche I, 2010, PSYCHOL MED, V40, P1039, DOI 10.1017/S0033291709991103; Bhattacharyya MR, 2008, J PSYCHOSOM RES, V65, P107, DOI 10.1016/j.jpsychores.2008.03.012; Brown ES, 2009, ANN NY ACAD SCI, V1179, P41, DOI 10.1111/j.1749-6632.2009.04981.x; Brown ES, 1999, NEUROPSYCHOPHARMACOL, V21, P474, DOI 10.1016/S0893-133X(99)00054-8; CARROLL BJ, 1981, ARCH GEN PSYCHIAT, V38, P15; Comijs HC, 2010, AM J GERIAT PSYCHIAT, V18, P42, DOI 10.1097/JGP.0b013e3181b970ae; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Deshauer D, 2003, CAN J PSYCHIAT, V48, P462, DOI 10.1177/070674370304800706; Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x; Gallagher P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005168.pub2; Grool AM, 2011, J NEUROL NEUROSUR PS, V82, P1093, DOI 10.1136/jnnp.2010.232413; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Jabben N, 2011, J PSYCHIATR RES, V45, P1208, DOI 10.1016/j.jpsychires.2011.03.010; KEEFE RSE, 1995, AM J PSYCHIAT, V152, P6; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kurtz MM, 2009, NEUROPSYCHOLOGY, V23, P551, DOI 10.1037/a0016277; Leverich GS, 2001, J AFFECT DISORDERS, V67, P33, DOI 10.1016/S0165-0327(01)00430-X; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; McQuade R, 2000, BRIT J PSYCHIAT, V177, P390, DOI 10.1192/bjp.177.5.390; Nelson HE., 1982, NATL ADULT READING T; Porter RJ, 2006, ACTA NEUROPSYCHIATR, V18, P193, DOI 10.1111/j.1601-5215.2006.00152.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Reppermund S, 2007, BIOL PSYCHIAT, V62, P400, DOI 10.1016/j.biopsych.2006.09.027; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Robinson LJ, 2006, J AFFECT DISORDERS, V93, P105, DOI 10.1016/j.jad.2006.02.016; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schwabe L, 2011, NEUROSCI BIOBEHAV RE; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Spijker AT, 2009, ANN NY ACAD SCI, V1179, P199, DOI 10.1111/j.1749-6632.2009.04985.x; SPSS Inc, 2008, STAT PACK SOC SCI SP; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Suppes T, 2001, J AFFECT DISORDERS, V67, P45, DOI 10.1016/S0165-0327(01)00432-3; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; van der Werf-Eldering MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013032; Vreeburg SA, 2009, PSYCHONEUROENDOCRINO, V34, P1109, DOI 10.1016/j.psyneuen.2009.04.024; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zobel AW, 2004, J PSYCHIATR RES, V38, P377, DOI 10.1016/j.jpsychires.2003.12.002	52	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37119	10.1371/journal.pone.0037119	http://dx.doi.org/10.1371/journal.pone.0037119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606339	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400064
J	Lambton, SL; Colloff, AD; Smith, RP; Caldow, GL; Scholes, SFE; Willoughby, K; Howie, F; Ellis-Iversen, J; David, G; Cook, AJC; Holliman, A				Lambton, Sarah L.; Colloff, Adrian D.; Smith, Richard P.; Caldow, George L.; Scholes, Sandra F. E.; Willoughby, Kim; Howie, Fiona; Ellis-Iversen, Johanne; David, Graham; Cook, Alasdair J. C.; Holliman, Andrew			Factors Associated with Bovine Neonatal Pancytopenia (BNP) in Calves: A Case-Control Study	PLOS ONE			English	Article							HEMORRHAGIC DIATHESIS; HEMOLYTIC-DISEASE; ANTIBODIES; NEWBORN	Bovine neonatal pancytopenia (BNP; previously known as idiopathic haemorrhagic diathesis and commonly known as bleeding calf syndrome) is a novel haemorrhagic disease of young calves which has emerged in a number of European countries during recent years. Data were retrospectively collected during June to November 2010 for 56 case calves diagnosed with BNP between 17 March and 7 June of the same year. These were compared with 58 control calves randomly recruited from herds with no history of BNP. Multivariable logistic regression analysis showed that increased odds of a calf being a BNP case were associated with its dam having received PregSure (R) BVD (Pfizer Animal Health) vaccination prior to the birth of the calf (odds ratio (OR) 40.78, p<0.001) and its herd of origin being located in Scotland (OR 9.71, p = 0.006). Decreased odds of a calf being a BNP case were associated with the calf having been kept outside (OR 0.11, p = 0.006). The longer that a cattle herd had been established on the farm was also associated with decreased odds of a calf in that herd being a BNP case (OR 0.97, p = 0.011).	[Lambton, Sarah L.; Smith, Richard P.; David, Graham; Cook, Alasdair J. C.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Colloff, Adrian D.] Anim Hlth & Vet Labs Agcy, Truro, Cornwall, England; [Caldow, George L.] Scottish Agr Coll Consulting, Vet Serv, St Boswells, Scottish Boarde, Scotland; [Scholes, Sandra F. E.] Anim Hlth & Vet Labs Agcy, Penicuik, Midlothian, Scotland; [Howie, Fiona] Scottish Agr Coll Consulting, Vet Serv, Penicuik, Midlothian, Scotland; [Willoughby, Kim] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Ellis-Iversen, Johanne] Dept Environm Food & Rural Affairs Defra, London, England; [Holliman, Andrew] Anim Hlth & Vet Labs Agcy, Penrith, Cumbria, England	Veterinary Laboratories Agency; Moredun Research Institute	Lambton, SL (corresponding author), Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England.	sarah.lambton@ahvla.gsi.gov.uk	Ellis-Iversen, Johanne/P-2185-2017; Cook, A/AAL-2872-2021; Smith, Richard/C-6765-2011	Ellis-Iversen, Johanne/0000-0002-6662-6853; Cook, A/0000-0002-3444-9493; Scholes, Sandra/0000-0003-3422-5956; Caldow, George/0000-0002-9084-0278; Lambton, Sarah/0000-0001-5802-3465	Department for Environment, Food and Rural Affairs as part of the implementation of the United Kingdom Veterinary Surveillance Strategy [ED0534]; Scottish Government; Scottish Government as part of its Public Good Veterinary and Advisory Services	Department for Environment, Food and Rural Affairs as part of the implementation of the United Kingdom Veterinary Surveillance Strategy; Scottish Government; Scottish Government as part of its Public Good Veterinary and Advisory Services	The study was funded by the Department for Environment, Food and Rural Affairs (Defra: www.defra.gov.uk) under project ED0534 as part of the implementation of the United Kingdom Veterinary Surveillance Strategy. The Moredun Research Institute is funded by the Scottish Government. Disease surveillance activities undertaken by Scottish Agricultural College Consulting: Veterinary Services are part-funded by the Scottish Government as part of its Public Good Veterinary and Advisory Services. The funders (Defra) explicitly defined the need for the study to explore causality of BNP, and their scientists joined the project team in discussions as to what study design could achieve this. At the end of the study, scientists working on behalf of the funders reviewed the manuscript and suggested additional analyses that could help to clarify some areas of uncertainty. Some of these analyses were carried out and are reported in the final draft.	Ballingall KT, 2011, VET IMMUNOL IMMUNOP, V141, P128, DOI 10.1016/j.vetimm.2011.01.017; Bastian M, 2011, VACCINE, V29, P5267, DOI 10.1016/j.vaccine.2011.05.012; Bell CR, 2010, VET REC, V167, P938, DOI 10.1136/vr.c4004; Blas N, 2000, WIN EPISCOPE 2 0; Bridger PS, 2011, VET IMMUNOL IMMUNOP, V141, P1, DOI 10.1016/j.vetimm.2011.01.001; BROWN CC, 2007, PATHOLOGY DOMESTIC A, V2, P140; Chen X, 2011, LOGISTIC REGRESSION; CORAPI WV, 1990, J AM VET MED ASSOC, V196, P590; DENNIS RA, 1970, J AM VET MED ASSOC, V156, P1861; Department for Environment Food and Rural Affairs, RAP AN DET AN REL RI; Deutskens F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-97; DIMMOCK CK, 1970, AUST VET J, V46, P44, DOI 10.1111/j.1751-0813.1970.tb05029.x; Ellis-Iversen J, 2009, P SAT S HAEM DIATH C; European Medicines Agency, 2010, OP FOLL ART 78 PROC; Friedrich A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-10; Kappe EC, 2010, BERL MUNCH TIERARZTL, V123, P31, DOI 10.2376/0005-9366-123-31; Krappmann K, 2011, VET J, V190, P225, DOI 10.1016/j.tvjl.2010.10.007; LANGFORD G, 1971, AUST VET J, V47, P1, DOI 10.1111/j.1751-0813.1971.tb09192.x; NEWMAN MJ, 1980, J REPROD FERTIL, V60, P237, DOI 10.1530/jrf.0.0600237; Pardon B, 2010, TRANSBOUND EMERG DIS, V57, P135, DOI 10.1111/j.1865-1682.2010.01098.x; Pardon B, 2011, VET IMMUNOL IMMUNOP, V141, P293, DOI 10.1016/j.vetimm.2011.02.017; Sanchez-Miguel C, 2010, VET REC, V166, P664, DOI 10.1136/vr.c2690; Scholes SFE, 2009, P SAT S HAEM DIATH C; Scottish Agricultural College Veterinary Services, 2009, VET REC, V165, P39; Veterinary Laboratories Agency, 2009, VET REC, V165, P304; Veterinary Medicines Directorate, 2010, SUSP ADV EV 2010; Willoughby K, 2010, VET REC, V166, P436, DOI 10.1136/vr.c1685	27	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e34183	10.1371/journal.pone.0034183	http://dx.doi.org/10.1371/journal.pone.0034183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606224	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200006
J	Pichler, G; Jack, A; Wolf, P; Hake, SB				Pichler, Garwin; Jack, Antonia; Wolf, Patricia; Hake, Sandra B.			Versatile Toolbox for High Throughput Biochemical and Functional Studies with Fluorescent Fusion Proteins	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; CPG BINDING DOMAIN; DNA-REPAIR SITES; HISTONE H3; MASS-SPECTROMETRY; LIVING CELLS; REPLICATION; METHYLTRANSFERASE; RECRUITMENT; MECP2	Fluorescent fusion proteins are widely used to study protein localization and interaction dynamics in living cells. However, to fully characterize proteins and to understand their function it is crucial to determine biochemical characteristics such as enzymatic activity and binding specificity. Here we demonstrate an easy, reliable and versatile medium/high-throughput method to study biochemical and functional characteristics of fluorescent fusion proteins. Using a new system based on 96-well micro plates comprising an immobilized GFP-binding protein (GFP-mulitTrap), we performed fast and efficient one-step purification of different GFP- and YFP-fusion proteins from crude cell lysate. After immobilization we determined highly reproducible binding ratios of cellular expressed GFP-fusion proteins to histone-tail peptides, DNA or selected RFP-fusion proteins. In particular, we found Cbx1 preferentially binding to di-and trimethylated H3K9 that is abolished by phosphorylation of the adjacent serine. DNA binding assays showed, that the MBD domain of MeCP2 discriminates between fully methylated over unmethylated DNA and protein-protein interactions studies demonstrate, that the PBD domain of Dnmt1 is essential for binding to PCNA. Moreover, using an ELISA-based approach, we detected endogenous PCNA and histone H3 bound at GFP-fusions. In addition, we quantified the level of H3K4me2 on nucleosomes containing different histone variants. In summary, we present an innovative medium/high-throughput approach to analyse binding specificities of fluroescently labeled fusion proteins and to detect endogenous interacting factors in a fast and reliable manner in vitro.	[Pichler, Garwin; Wolf, Patricia] Univ Munich, Dept Biol 2, Munich, Germany; [Jack, Antonia; Hake, Sandra B.] Univ Munich, CIPSM, Dept Mol Biol, Adolf Butenandt Inst, Munich, Germany	University of Munich; University of Munich	Pichler, G (corresponding author), Univ Munich, Dept Biol 2, Munich, Germany.	pichler@bio.lmu.de	Pichler, Garwin/J-2773-2014	Pichler, Garwin/0000-0001-6096-0570	International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); CIPSM; DFG	International Doctorate Program NanoBioTechnology (IDK-NBT); International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); CIPSM; DFG(German Research Foundation (DFG))	GP was supported by the International Doctorate Program NanoBioTechnology (IDK-NBT, http://www.cens.de/doctorate-program/) and GP and AJ by the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, https://www.imprs-ls.de/). PW is a fellow of the Graduate School Life Science Munich (LSM, http://www.lsm.bio.lmu.de/). SBH was supported by CIPSM (http://www.cipsm.de/en/index.html) and the DFG (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan K, 2005, CURR OPIN CHEM BIOL, V9, P538, DOI 10.1016/j.cbpa.2005.08.021; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Hiragami-Hamada K, 2011, MOL CELL BIOL, V31, P1186, DOI 10.1128/MCB.01012-10; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mortusewicz O, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-81; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Pichler G, 2011, J CELL BIOCHEM, V112, P2585, DOI 10.1002/jcb.23185; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Viens A, 2006, MOL CELL BIOL, V26, P5325, DOI 10.1128/MCB.00584-06; Walther TC, 2010, J CELL BIOL, V190, P491, DOI 10.1083/jcb.201004052; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36967	10.1371/journal.pone.0036967	http://dx.doi.org/10.1371/journal.pone.0036967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606318	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200060
J	He, HB; Wang, HB; Fang, CX; Lin, ZH; Yu, ZM; Lin, WX				He, Hai Bin; Wang, Hai Bin; Fang, Chang Xun; Lin, Zhi Hua; Yu, Zheng Ming; Lin, Wen Xiong			Separation of Allelopathy from Resource Competition Using Rice/Barnyardgrass Mixed-Cultures	PLOS ONE			English	Article							PHENOLIC-ACIDS; RICE; INTERFERENCE; NITROGEN	Plant-plant interference is the combined effect of allelopathy, resource competition, and many other factors. Separating allelopathy from resource competition is almost impossible in natural systems but it is important to evaluate the relative contribution of each of the two mechanisms on plant interference. Research on allelopathy in natural and cultivated plant communities has been hindered in the absence of a reliable method that can separate allelopathic effect from resource competition. In this paper, the interactions between allelopathic rice accession PI312777, non-allelopathic rice accession Lemont and barnyardgrass were explored respectively by using a target (rice)-neighbor (barnyardgrass) mixed-culture in hydroponic system. The relative competitive intensity (RCI), the relative neighbor effect (RNE) and the competitive ratio (CR) were used to quantify the intensity of competition between each of the two different potentially allelopathic rice accessions and barnyardgrass. Use of hydroponic culture system enabled us to exclude any uncontrolled factors that might operate in the soil and we were able to separate allelopathy from resource competition between each rice accession and barnyardgrass. The RCI and RNE values showed that the plant-plant interaction was positive (facilitation) for PI312777 but that was negative (competition) for Lemont and barnyardgrass in rice/barnyardgrass mixed-cultures. The CR values showed that one PI312777 plant was more competitive than 2 barnyardgrass plants. The allelopathic effects of PI312777 were much more intense than the resource competition in rice/barnyardgrass mixed cultures. The reverse was true for Lemont. These results demonstrate that the allelopathic effect of PI312777 was predominant in rice/barnyardgrass mixed-cultures. The most significant result of our study is the discovery of an experimental design, target-neighbor mixed-culture in combination with competition indices, can successfully separate allelopathic effects from competition.	[He, Hai Bin] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [He, Hai Bin; Wang, Hai Bin; Fang, Chang Xun; Lin, Zhi Hua; Yu, Zheng Ming; Lin, Wen Xiong] Fujian Agr & Forestry Univ, Sch Life Sci, Agroecol Inst, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	He, HB (corresponding author), Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	wenxiong181@163.com		Yu, Zhenming/0000-0002-8077-5791	National Natural Science Foundation of China [31070447]; Key Program of Ecology, Fujian Province, China [0608507, 0b08b005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Ecology, Fujian Province, China	This work was supported by grants from the National Natural Science Foundation of China (31070447) and the Key Program of Ecology, Fujian Province (0608507, 0b08b005), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi HH, 2007, J CHEM ECOL, V33, P1089, DOI 10.1007/s10886-007-9286-1; Blum U, 1999, CRIT REV PLANT SCI, V18, P673, DOI 10.1016/S0735-2689(99)00396-2; Courtois B, 1998, ALL RIC P WORKSH ALL, P57; Dilday R.H., 1998, ALLELOPATHY RICE, P7; Dilday R.H., 1991, P SUST AGR GREAT PLA, P193; EINHELLIG FA, 1995, ACS SYM SER, V582, P96; Fang CX, 2010, PLANT GROWTH REGUL, V61, P277, DOI 10.1007/s10725-010-9475-8; Fang CX, 2009, PLANT GROWTH REGUL, V57, P163, DOI 10.1007/s10725-008-9333-0; FISCHER NH, 1994, J CHEM ECOL, V20, P1355, DOI 10.1007/BF02059812; GRACE JB, 1995, ECOLOGY, V76, P305, DOI 10.2307/1940651; GRAF B, 1992, AGR SYST, V40, P345, DOI 10.1016/0308-521X(92)90046-Q; He HB, 2006, ALLELOPATHY J, V18, P247; Inderjit, 1997, BOT REV, V63, P221, DOI 10.1007/BF02857949; Inderjit, 2002, PHYSIOL PLANTARUM, V114, P422; International Allelopathy Society, 1996, CONST DRAWN 1 WORLD; Jensen LB, 2001, AGRON J, V93, P21, DOI 10.2134/agronj2001.93121x; Kato-Noguchi H, 2001, BIOL PLANTARUM, V44, P635, DOI 10.1023/A:1013731828945; Kato-Noguchi H, 2011, J PLANT PHYSIOL, V168, P1016, DOI 10.1016/j.jplph.2010.12.021; Kim KU, 2000, RICE ALLELOPATHY; KIM KW, 2000, RICE ALLELOPATHY, P83; MACIAS FA, 1995, ACS SYM SER, V582, P310; Macias FA, 2006, STEROIDS, V71, P603, DOI 10.1016/j.steroids.2006.03.001; Mallik A., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P3; Markham JH, 1996, FUNCT ECOL, V10, P548; Mattice J.D., 1998, ALLELOPATHY RICE, P81; MULLER CH, 1966, B TORREY BOT CLUB, V93, P332, DOI 10.2307/2483447; NILSSON MC, 1994, OECOLOGIA, V98, P1, DOI 10.1007/BF00326083; Olofsdotter M, 2002, PLANT BREEDING, V121, P1, DOI 10.1046/j.1439-0523.2002.00662.x; Olofsdotter M., 1998, ALLELOPATHY RICE, P1; PUTNAM AR, 1978, ANNU REV PHYTOPATHOL, V16, P431, DOI 10.1146/annurev.py.16.090178.002243; PUTNAM AR, 1974, SCIENCE, V185, P370, DOI 10.1126/science.185.4148.370; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; Rice EL, 1984, ALLELOPATHY; Seal AN, 2004, J CHEM ECOL, V30, P1647, DOI 10.1023/B:JOEC.0000042074.96036.14; Song BQ, 2008, J CHEM ECOL, V34, P688, DOI 10.1007/s10886-008-9455-x; Strandberg B., 2000, 315 NERI; Tang Q., 2007, DPS DATA PROCESSING; THIJS H, 1994, ECOLOGY, V75, P1959, DOI 10.2307/1941600; Vergara BS, 1979, FARMERS PRIMER GROWI; Weidenhamer JD, 1996, AGRON J, V88, P866, DOI 10.2134/agronj1996.00021962003600060005x; WEIDENHAMER JD, 1989, J APPL ECOL, V26, P613, DOI 10.2307/2404086; Weidenhamer JD, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P85, DOI 10.1007/1-4020-4280-9_4; Weston L. A., 2005, Proceedings of the 4th World Congress on Allelopathy, "Establishing the Scientific Base", Wagga Wagga, New South Wales, Australia, 21-26 August 2005, P15; WILLEY RW, 1980, EXP AGR, V16, P117, DOI 10.1017/S0014479700010802; Xu Gao-feng, 2010, Zhongguo Shuidao Kexue, V24, P62, DOI 10.3969/j.issn.1001-7216.2010.01.11	45	35	47	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37201	10.1371/journal.pone.0037201	http://dx.doi.org/10.1371/journal.pone.0037201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590655	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400064
J	Matrkova, J; Remes, V				Matrkova, Jana; Remes, Vladimir			Environmental and Genetic Effects on Pigment-Based vs. Structural Component of Yellow Feather Colouration	PLOS ONE			English	Article							TIT PARUS-MAJOR; NESTLING BLUE TITS; CAROTENOID-BASED COLORATION; SIGNAL DIFFERENT ASPECTS; GREAT TIT; PLUMAGE COLORATION; CONDITION-DEPENDENCE; CYANISTES-CAERULEUS; SEXUAL SELECTION; DIET QUALITY	Background: Carotenoid plumage is of widespread use in bird communication. Carotenoid-based feather colouration has recently been shown to be dependent on both pigment concentration and feather structure. If these two components are determined differently, one plumage patch may potentially convey different aspects of individual quality. Methodology/Principal Findings: We evaluated the effects of genetic and environmental factors on carotenoid-based yellow breast colouration of Great Tit (Parus major) nestlings. By partial cross-fostering, we separated the genetic and prenatal vs. post-natal parental effects on both the structural and the pigment-based component of carotenoid-based plumage colouration. We also simultaneously manipulated the post-hatching environment by brood size manipulation. The structural component of nestling colouration reflected features of female colouration. On the other hand, the pigment-based component was more affected by rearing conditions presumably representing food quality. While the structural component was related to both origin- and environment-related factors, the pigment-based component seemed to be environment-dependent only. These results support the notion that pigment-based and structural components of feather colouration are determined differently. Conclusions/Significance: Chromatic and achromatic components of carotenoid-based feather colouration reflected different aspects of individual quality and history, and thus may potentially form a multicomponent signal.	[Matrkova, Jana] Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic; Palacky Univ, Ornithol Lab, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc	Matrkova, J (corresponding author), Palacky Univ, Dept Zool, CR-77147 Olomouc, Czech Republic.	jana.matrkova@seznam.cz	Remeš, Vladimír/B-6842-2016		Czech Ministry of Education [MSM6198959212]; Palacky University [IGA Prf_2012_021]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Palacky University	This work was supported by Czech Ministry of Education (grant no. MSM6198959212; http://www.msmt.cz) and Palacky University (grant no. IGA Prf_2012_021; http://www.upol.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Arnold KE, 2010, BIOL J LINN SOC, V99, P708, DOI 10.1111/j.1095-8312.2010.01377.x; Arriero E, 2006, NATURWISSENSCHAFTEN, V93, P173, DOI 10.1007/s00114-006-0090-5; Biard C, 2005, OECOLOGIA, V144, P32, DOI 10.1007/s00442-005-0048-x; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; Biard C, 2007, J EVOLUTION BIOL, V20, P326, DOI 10.1111/j.1420-9101.2006.01194.x; Bitton PP, 2008, J AVIAN BIOL, V39, P446, DOI 10.1111/j.2008.0908-8857.04283.x; Blount Jonathan D., 2008, V4, P213, DOI 10.1007/978-3-7643-7499-0_11; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; del Cerro S, 2010, OECOLOGIA, V162, P825, DOI 10.1007/s00442-009-1510-y; Delhey K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011582; Delhey Kaspar, 2010, BMC Ecology, V10, P13, DOI 10.1186/1472-6785-10-13; Eeva T, 1998, FUNCT ECOL, V12, P607, DOI 10.1046/j.1365-2435.1998.00221.x; Eeva T, 2009, J AVIAN BIOL, V40, P491, DOI 10.1111/j.1600-048X.2008.04535.x; Eeva T, 2008, ECOHEALTH, V5, P328, DOI 10.1007/s10393-008-0184-y; Espmark Y., 2000, ANIMAL SIGNALS SIGNA; Evans SR, 2012, AM NAT, V179, P79, DOI 10.1086/663198; Evans SR, 2010, BIOL J LINN SOC, V101, P777, DOI 10.1111/j.1095-8312.2010.01548.x; Ferns PN, 2008, IBIS, V150, P152; Fitze PS, 2006, J EVOLUTION BIOL, V19, P618, DOI 10.1111/j.1420-9101.2005.01008.x; Fitze PS, 2003, OECOLOGIA, V137, P148, DOI 10.1007/s00442-003-1323-3; Fitze PS, 2003, EVOLUTION, V57, P144; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; Galvan I, 2008, J AVIAN BIOL, V39, P277, DOI 10.1111/j.0908-8857.2008.04273.x; Galvan I, 2009, ACTA ORNITHOL, V44, P139, DOI 10.3161/000164509X482722; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Grafen A., 2002, MODERN STAT LIFE SCI; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; Hadfield JD, 2007, J EVOLUTION BIOL, V20, P549, DOI 10.1111/j.1420-9101.2006.01262.x; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hill G. E., 2002, RED BIRD BROWN BAG F; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Horak P, 2000, NATURWISSENSCHAFTEN, V87, P460, DOI 10.1007/s001140050759; Isaksson C, 2008, P ROY SOC B-BIOL SCI, V275, P309, DOI 10.1098/rspb.2007.1474; Isaksson C, 2006, BEHAV ECOL SOCIOBIOL, V60, P556, DOI 10.1007/s00265-006-0200-6; Isaksson C, 2008, BIOL J LINN SOC, V95, P758, DOI 10.1111/j.1095-8312.2008.01033.x; Jacot A, 2007, BEHAV ECOL, V18, P34, DOI 10.1093/beheco/arl054; Jacot A, 2010, AM NAT, V176, P55, DOI 10.1086/653000; Jenni L., 1994, BIOL MOULT BIRDS; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Larcombe SD, 2010, NATURWISSENSCHAFTEN, V97, P903, DOI 10.1007/s00114-010-0708-5; Matysiokova B, 2011, J ORNITHOL, V152, P337, DOI 10.1007/s10336-010-0594-9; Matysiokova B, 2010, ETHOLOGY, V116, P596, DOI 10.1111/j.1439-0310.2010.01776.x; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Olson VA, 2005, J EVOLUTION BIOL, V18, P1534, DOI 10.1111/j.1420-9101.2005.00940.x; Peters A, 2011, J EVOLUTION BIOL, V24, P976, DOI 10.1111/j.1420-9101.2011.02229.x; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Prum RO, 2006, BIRD COLORATION, V1, P295; Quesada J, 2009, BEHAVIOUR, V146, P1235, DOI 10.1163/156853909X420017; Quesada J, 2006, J AVIAN BIOL, V37, P609, DOI 10.1111/j.0908-8857.2006.03636.x; Remes V, 2011, J AVIAN BIOL, V42, P387, DOI 10.1111/j.1600-048X.2011.05402.x; Remes V, 2011, BEHAV ECOL SOCIOBIOL, V65, P1257, DOI 10.1007/s00265-011-1139-9; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Senar JC, 2002, P ROY SOC B-BIOL SCI, V269, P257, DOI 10.1098/rspb.2001.1882; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2009, J R SOC INTERFACE, V6, pS221, DOI 10.1098/rsif.2008.0459.focus; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siefferman L, 2005, EVOLUTION, V59, P1819, DOI 10.1111/j.0014-3820.2005.tb01828.x; Siitari H, 2007, AM NAT, V169, pS81, DOI 10.1086/510140; Sillanpaa S, 2009, ACTA OECOL, V35, P805, DOI 10.1016/j.actao.2009.08.006; SLAGSVOLD T, 1985, J ZOOL, V206, P321; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Tanner M, 2008, BEHAV ECOL, V19, P369, DOI 10.1093/beheco/arm142; Tschirren B, 2003, J EVOLUTION BIOL, V16, P91, DOI 10.1046/j.1420-9101.2003.00483.x; Tschirren B, 2005, OECOLOGIA, V143, P477, DOI 10.1007/s00442-004-1812-z	77	12	12	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36640	10.1371/journal.pone.0036640	http://dx.doi.org/10.1371/journal.pone.0036640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590581	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400024
J	Bazile, V; Moran, JA; Le Moguedec, G; Marshall, DJ; Gaume, L				Bazile, Vincent; Moran, Jonathan A.; Le Moguedec, Gilles; Marshall, David J.; Gaume, Laurence			A Carnivorous Plant Fed by Its Ant Symbiont: A Unique Multi-Faceted Nutritional Mutualism	PLOS ONE			English	Article							PITCHER PLANT; NEPENTHES-BICALCARATA; ASSIMILATORY ORGANS; FOLIAR REFLECTANCE; HOST-PLANT; NITROGEN; PREY; ABSORPTION; EVOLUTION; MODEL	Scarcity of essential nutrients has led plants to evolve alternative nutritional strategies, such as myrmecotrophy (ant-waste-derived nutrition) and carnivory (invertebrate predation). The carnivorous plant Nepenthes bicalcarata grows in the Bornean peatswamp forests and is believed to have a mutualistic relationship with its symbiotic ant Camponotus schmitzi. However, the benefits provided by the ant have not been quantified. We tested the hypothesis of a nutritional mutualism, using foliar isotopic and reflectance analyses and by comparing fitness-related traits between ant-inhabited and uninhabited plants. Plants inhabited by C. schmitzi produced more leaves of greater area and nitrogen content than unoccupied plants. The ants were estimated to provide a 200% increase in foliar nitrogen to adult plants. Inhabited plants also produced more and larger pitchers containing higher prey biomass. C. schmitzi-occupied pitchers differed qualitatively in containing C. schmitzi wastes and captured large ants and flying insects. Pitcher abortion rates were lower in inhabited plants partly because of herbivore deterrence as herbivory-aborted buds decreased with ant occupation rate. Lower abortion was also attributed to ant nutritional service. The ants had higher delta N-15 values than any tested prey, and foliar delta N-15 increased with ant occupation rate, confirming their predatory behaviour and demonstrating their direct contribution to the plant-recycled N. We estimated that N. bicalcarata derives on average 42% of its foliar N from C. schmitzi wastes, (76% in highly-occupied plants). According to the Structure Independent Pigment Index, plants without C. schmitzi were nutrient stressed compared to both occupied plants, and pitcher-lacking plants. This attests to the physiological cost of pitcher production and poor nutrient assimilation in the absence of the symbiont. Hence C. schmitzi contributes crucially to the nutrition of N. bicalcarata, via protection of assimilatory organs, enhancement of prey capture, and myrmecotrophy. This combination of carnivory and myrmecotrophy represents an outstanding strategy of nutrient sequestration.	[Bazile, Vincent; Le Moguedec, Gilles; Gaume, Laurence] Univ Montpellier 2, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Le Moguedec, Gilles] INRA, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Gaume, Laurence] CNRS, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France; [Moran, Jonathan A.] Royal Rd Univ, Sch Environm & Sustainabil, Victoria, BC, Canada; [Marshall, David J.] Univ Brunei Darussalam, Dept Biol, Gadong, Brunei	CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University Brunei Darussalam	Bazile, V (corresponding author), Univ Montpellier 2, UMR AMAP Bot & Bioinformat Architecture Plantes, Montpellier, France.	Vincent.Bazile@cirad.fr		Marshall, David/0000-0003-3771-5950	Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE	Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE	The work was supported by Centre National de la Recherche Scientifique (CNRS) through the PEPS/INEE-2010 grant devoted to the "CarniBiop" project supervised by LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2003, OIKOS, V1, P1989; [Anonymous], 2001, FLORA MALESIANA 1; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; BEATTIE A, 1989, TRENDS ECOL EVOL, V4, P172, DOI 10.1016/0169-5347(89)90122-5; Beaver R.A., 1983, P129; Beccari O, 1885, PLANTES FOURMIS ARCH; BENZING DH, 1991, ANT - PLANT INTERACTIONS, P353; BENZING DH, 1987, TRENDS ECOL EVOL, V2, P364, DOI 10.1016/0169-5347(87)90137-6; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Bonhomme V, 2011, NEW PHYTOL, V191, P545, DOI 10.1111/j.1469-8137.2011.03696.x; Bonhomme V, 2011, J TROP ECOL, V27, P15, DOI 10.1017/S0266467410000532; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; Clarke C., 1998, Sandakania, P27; Clarke C., 1997, NEPENTHES OF BORNEO; CLARKE CM, 1993, ECOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-2311.1993.tb01074.x; CLARKE CM, 1995, J TROP ECOL, V11, P589, DOI 10.1017/S0266467400009160; COMBES C, 1995, PARASITISM ECOLOGY E; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Defossez E, 2011, P ROY SOC B-BIOL SCI, V278, P1419, DOI 10.1098/rspb.2010.1884; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Ellis AG, 1996, OECOLOGIA, V106, P478, DOI 10.1007/BF00329705; Ellison AM, 2006, PLANT BIOLOGY, V8, P740, DOI 10.1055/s-2006-923956; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Ellison AM, 2002, P NATL ACAD SCI USA, V99, P4409, DOI 10.1073/pnas.022057199; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Gamon JA, 1997, OECOLOGIA, V112, P492, DOI 10.1007/s004420050337; Gaume L, 2004, ARTHROPOD STRUCT DEV, V33, P103, DOI 10.1016/j.asd.2003.11.005; Gaume L, 1998, P ROY SOC B-BIOL SCI, V265, P569, DOI 10.1098/rspb.1998.0332; Gaume L, 2009, ANN BOT-LONDON, V104, P1281, DOI 10.1093/aob/mcp238; Gaume L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001185; GAY H, 1993, BIOL J LINN SOC, V50, P221, DOI 10.1111/j.1095-8312.1993.tb00928.x; Grafe TU, 2011, BIOL LETTERS, V7, P436, DOI 10.1098/rsbl.2010.1141; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; JACQUEMOUD S, 1990, REMOTE SENS ENVIRON, V34, P75, DOI 10.1016/0034-4257(90)90100-Z; Juniper B. E., 1989, CARNIVOROUS PLANTS; Leroy C, 2011, J ECOL, V99, P583, DOI 10.1111/j.1365-2745.2010.01763.x; McKey Doyle, 2005, P386, DOI 10.1017/CBO9780511541971.017; McPherson S.R., 2009, PITCHER PLANTS OLD W, V1-2; Merbach Marlis A., 2007, Ecotropica-Bonn, V13, P45; Merbach Marlis A., 1999, Ecotropica, V5, P45; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moon DC, 2010, OECOLOGIA, V164, P185, DOI 10.1007/s00442-010-1670-9; Moran JA, 2003, INT J PLANT SCI, V164, P635, DOI 10.1086/375422; Moran JA, 2001, ANN BOT-LONDON, V88, P307, DOI 10.1006/anbo.2001.1460; Moran JA, 1998, INT J PLANT SCI, V159, P996; Moran JA, 2000, TREE PHYSIOL, V20, P1113; Moran JA, 2010, J EXP BOT, V61, P1365, DOI 10.1093/jxb/erq004; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Osunkoya OO, 2008, ANN BOT-LONDON, V102, P845, DOI 10.1093/aob/mcn162; Osunkoya OO, 2007, ANN BOT-LONDON, V99, P895, DOI 10.1093/aob/mcm023; Pavlovic A, 2009, ANN BOT-LONDON, V104, P307, DOI 10.1093/aob/mcp121; PENUELAS J, 1995, PHOTOSYNTHETICA, V31, P221; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; RICKSON FR, 1979, AM J BOT, V66, P87, DOI 10.2307/2442629; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RICOGRAY V, 1989, AM J BOT, V76, P603, DOI 10.2307/2444355; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Shaerer G., 1988, STABLE ISOTOPES ECOL, V68, P342; Solano PJ, 2004, BIOL J LINN SOC, V83, P433, DOI 10.1111/j.1095-8312.2004.00381.x; THOMPSON JN, 1981, BIOL J LINN SOC, V16, P147, DOI 10.1111/j.1095-8312.1981.tb01647.x; Thornham DG, 2011, FUNCTIONAL ECOLOGY; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0	63	38	38	4	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36179	10.1371/journal.pone.0036179	http://dx.doi.org/10.1371/journal.pone.0036179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590524	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100020
J	Mundia, MM; Demers, RW; Chow, ML; Perieteanu, AA; Dawson, JF				Mundia, Maureen M.; Demers, Ryan W.; Chow, Melissa L.; Perieteanu, Alexandru A.; Dawson, John F.			Subdomain Location of Mutations in Cardiac Actin Correlate with Type of Functional Change	PLOS ONE			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; TETRAMETHYLRHODAMINE-LABELED ACTIN; DNASE-I; DILATED CARDIOMYOPATHY; THERMAL-DENATURATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ATP HYDROLYSIS; GENE-MUTATIONS; STATE	Determining the molecular mechanisms that lead to the development of heart failure will help us gain better insight into the most costly health problem in the Western world. To understand the roles that the actin protein plays in the development of heart failure, we have taken a systematic approach toward characterizing human cardiac actin mutants that have been associated with either hypertrophic or dilated cardiomyopathy. Seven known cardiac actin mutants were expressed in a baculovirus system, and their intrinsic properties were studied. In general, the changes to the properties of the actin proteins themselves were subtle. The R312H variant exhibited reduced stability, with a T-m of 53.6 degrees C compared to 56.8 degrees C for WT actin, accompanied with increased polymerization critical concentration and Pi release rate, and a marked increase in nucleotide release rates. Substitution of methionine for leucine at amino acid 305 showed no impact on the increase in Pi release was observed. Increases to both the Tm and DNase-I inhibition activity suggested interactions between E99K actin molecules under monomer-promoting conditions. Y166C actin had a higher critical concentration protein correlated with the molecular effects; in general, mutations in subdomain 3 affected the stability of the ACTC protein or affect the polymerization of actin filaments, while mutations in subdomains 1 and 4 more likely affect protein-protein interactions.	[Mundia, Maureen M.; Demers, Ryan W.; Chow, Melissa L.; Perieteanu, Alexandru A.; Dawson, John F.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Mundia, MM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jdawso01@uoguelph.ca	Dawson, John/HDM-6702-2022		Heart and Stroke Foundation of Canada [NA 6469]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	JFD was supported by a Grant-in-aid from the Heart and Stroke Foundation of Canada (#NA 6469, www.heartandstroke.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler GM, 2005, J MOL BIOL, V353, P385, DOI 10.1016/j.jmb.2005.07.062; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Conchaudron AP, 2006, J BIOL CHEM, V281, P24036, DOI 10.1074/jbc.M602747200; CONTAXIS CC, 1977, CAN J BIOCHEM CELL B, V55, P325, DOI 10.1139/o77-045; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; DRUMMOND DR, 1992, EUR J BIOCHEM, V209, P171, DOI 10.1111/j.1432-1033.1992.tb17274.x; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaski JP, 2009, CIRC-CARDIOVASC GENE, V2, P436, DOI 10.1161/CIRCGENETICS.108.821314; Kudryashov DS, 2010, J BIOL CHEM, V285, P25591, DOI 10.1074/jbc.M110.123869; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; LE BIHAN T, 1993, BIOCHEM BIOPH RES CO, V194, P1065, DOI 10.1006/bbrc.1993.1930; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Morrison SS, 2007, ANAL BIOCHEM, V364, P159, DOI 10.1016/j.ab.2007.02.027; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Olson TM, 2000, J MOL CELL CARDIOL, V32, P1687, DOI 10.1006/jmcc.2000.1204; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Perieteanu AA, 2008, BIOCHEMISTRY-US, V47, P9688, DOI 10.1021/bi800421u; Perrot A, 2007, EUR J HEART FAIL, V9, P4, DOI 10.1016/j.ejheart.2006.04.010; Rutkevich LA, 2006, CAN J PHYSIOL PHARM, V84, P111, DOI 10.1139/Y05-140; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Saeki K, 2000, BIOCHEMISTRY-US, V39, P1324, DOI 10.1021/bi991297k; Schrodinger L., 2020, PYMOL; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Song WH, 2011, J BIOL CHEM, V286, P27582, DOI 10.1074/jbc.M111.252320; Song WH, 2010, J MOL CELL CARDIOL, V49, P380, DOI 10.1016/j.yjmcc.2010.05.009; STRZELECKAGOLASZEWSKA H, 1995, BIOCHEM J, V307, P527, DOI 10.1042/bj3070527; Vang S, 2005, FEBS J, V272, P2037, DOI 10.1111/j.1742-4658.2005.04630.x; WERTMAN KF, 1992, GENETICS, V132, P337; Wong WNW, 2001, J MUSCLE RES CELL M, V22, P665, DOI 10.1023/A:1016354308436; Yates SP, 2007, ARCH BIOCHEM BIOPHYS, V466, P58, DOI 10.1016/j.abb.2007.07.018; Yates SP, 2009, BIOCHEM CELL BIOL, V87, P853, DOI [10.1139/O09-039, 10.1139/o09-039]	40	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36821	10.1371/journal.pone.0036821	http://dx.doi.org/10.1371/journal.pone.0036821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590617	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500031
J	Wiede, F; Chew, SH; van Vliet, C; Poulton, IJ; Kyparissoudis, K; Sasmono, T; Loh, K; Tremblay, ML; Godfrey, DI; Sims, NA; Tiganis, T				Wiede, Florian; Chew, Sock Hui; van Vliet, Catherine; Poulton, Ingrid J.; Kyparissoudis, Konstantinos; Sasmono, Tedjo; Loh, Kim; Tremblay, Michel L.; Godfrey, Dale I.; Sims, Natalie A.; Tiganis, Tony			Strain-Dependent Differences in Bone Development, Myeloid Hyperplasia, Morbidity and Mortality in Ptpn2-Deficient Mice	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GROWTH-FACTOR RECEPTOR; TC-PTP; NEGATIVE REGULATOR; MARROW MICROENVIRONMENT; EMBRYONIC LETHALITY; SIGNALING PATHWAY; DEFICIENT MICE; EGF RECEPTOR; STEM-CELLS	Single nucleotide polymorphisms in the gene encoding the protein tyrosine phosphatase TCPTP (encoded by PTPN2) have been linked with the development of autoimmunity. Here we have used Cre/LoxP recombination to generate Ptpn2(ex2-/ex2-) mice with a global deficiency in TCPTP on a C57BL/6 background and compared the phenotype of these mice to Ptpn2(-/-) mice (BALB/c-129SJ) generated previously by homologous recombination and backcrossed onto the BALB/c background. Ptpn2(ex2-/ex2-) mice exhibited growth retardation and a median survival of 32 days, as compared to 21 days for Ptpn2(-/-) (BALB/c) mice, but the overt signs of morbidity (hunched posture, piloerection, decreased mobility and diarrhoea) evident in Ptpn2(-/-) (BALB/c) mice were not detected in Ptpn2(ex2-/ex2-) mice. At 14 days of age, bone development was delayed in Ptpn2(-/-) (BALB/c) mice. This was associated with increased trabecular bone mass and decreased bone remodeling, a phenotype that was not evident in Ptpn2(ex2-/ex2-) mice. Ptpn2(ex2-/ex2-) mice had defects in erythropoiesis and B cell development as evident in Ptpn2(-/-) (BALB/c) mice, but not splenomegaly and did not exhibit an accumulation of myeloid cells in the spleen as seen in Ptpn2(-/-) (BALB/c) mice. Moreover, thymic atrophy, another feature of Ptpn2(-/-) (BALB/c) mice, was delayed in PPtpn2(ex2-/ex2-) mice and preceded by an increase in thymocyte positive selection and a concomitant increase in lymph node T cells. Backcrossing Ptpn2(-/-) (BALB/c) mice onto the C57BL/6 background largely recapitulated the phenotype of PPtpn2(ex2-/ex2-) mice. Taken together these results reaffirm TCPTP's important role in lymphocyte development and indicate that the effects on morbidity, mortality, bone development and the myeloid compartment are straindependent.	[Wiede, Florian; Chew, Sock Hui; van Vliet, Catherine; Sasmono, Tedjo; Loh, Kim; Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Poulton, Ingrid J.; Sims, Natalie A.] St Vincents Inst Med Res, Melbourne, Vic, Australia; [Kyparissoudis, Konstantinos; Godfrey, Dale I.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Tremblay, Michel L.] McGill Univ, McGill Canc Ctr, Montreal, PQ, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada	Monash University; St. Vincent's Institute of Medical Research; University of Melbourne; McGill University; McGill University	Wiede, F (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	Tony.Tiganis@monash.edu	Sims, Natalie Ann/A-7192-2012; Sasmono, Tedjo/H-5680-2016; Tiganis, Tony/AAV-3495-2020	Sims, Natalie Ann/0000-0003-1421-8468; Sasmono, Tedjo/0000-0003-0986-2590; Tiganis, Tony/0000-0002-8065-9942; Loh, Kim/0000-0003-3781-1926; Wiede, Florian/0000-0001-5145-7180; Godfrey, Dale/0000-0002-3009-5472	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (www.nhmrc.gov.au) to T.T., NA.S. & D.I.G.; N.A.S., T.T. and D.I.G. are NHMRC Research Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aoki N, 2002, MOL ENDOCRINOL, V16, P58, DOI 10.1210/me.16.1.58; Bonyadi M, 1997, NAT GENET, V15, P207, DOI 10.1038/ng0297-207; Bourdeau A, 2007, BLOOD, V109, P4220, DOI 10.1182/blood-2006-08-044370; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Doody KM, 2012, ARTHRITIS RHEUM-US, V64, P752, DOI 10.1002/art.33399; Fayad R, 2005, EUR J IMMUNOL, V35, P2304, DOI 10.1002/eji.200526062; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Heinonen KM, 2004, BLOOD; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Kleppe M, 2010, NAT GENET, V42, P530, DOI 10.1038/ng.587; Klingler-Hoffmann M, 2001, J BIOL CHEM, V276, P46313, DOI 10.1074/jbc.M106571200; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Lee CF, 2009, WORLD J GASTROENTERO, V15, P356, DOI 10.3748/wjg.15.356; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Samitas K, 2010, ARCH IMMUNOL THER EX, V58, P209, DOI 10.1007/s00005-010-0073-2; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Shimizu T, 2004, EXP HEMATOL, V32, P1057, DOI 10.1016/j.exphem.2004.07.024; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Simoncic PD, 2006, MOL CELL BIOL, V26, P4149, DOI 10.1128/MCB.01932-05; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tiganis T, 1999, J BIOL CHEM, V274, P27768, DOI 10.1074/jbc.274.39.27768; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wiede F, 2011, J CLIN INVEST, V121, P4758, DOI 10.1172/JCI59492; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Zee T, 2012, MOL CELL BIOL, V32, P1080, DOI 10.1128/MCB.06279-11	49	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36703	10.1371/journal.pone.0036703	http://dx.doi.org/10.1371/journal.pone.0036703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590589	gold, Green Published			2022-12-27	WOS:000305335500024
J	Albert, MV; Kording, K; Herrmann, M; Jayaraman, A				Albert, Mark V.; Kording, Konrad; Herrmann, Megan; Jayaraman, Arun			Fall Classification by Machine Learning Using Mobile Phones	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; FEAR; PREVENTION; INJURY; WOMEN	Fall prevention is a critical component of health care; falls are a common source of injury in the elderly and are associated with significant levels of mortality and morbidity. Automatically detecting falls can allow rapid response to potential emergencies; in addition, knowing the cause or manner of a fall can be beneficial for prevention studies or a more tailored emergency response. The purpose of this study is to demonstrate techniques to not only reliably detect a fall but also to automatically classify the type. We asked 15 subjects to simulate four different types of falls-left and right lateral, forward trips, and backward slips-while wearing mobile phones and previously validated, dedicated accelerometers. Nine subjects also wore the devices for ten days, to provide data for comparison with the simulated falls. We applied five machine learning classifiers to a large time-series feature set to detect falls. Support vector machines and regularized logistic regression were able to identify a fall with 98% accuracy and classify the type of fall with 99% accuracy. This work demonstrates how current machine learning approaches can simplify data collection for prevention in fall-related research as well as improve rapid response to potential injuries due to falls.	[Albert, Mark V.; Kording, Konrad] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA; [Albert, Mark V.; Kording, Konrad; Jayaraman, Arun] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Ctr Bion Med, Chicago, IL 60611 USA; [Herrmann, Megan; Jayaraman, Arun] Northwestern Univ, Rehabil Inst Chicago, Max Nader Ctr Rehabil Technol & Outcomes Res, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab	Albert, MV (corresponding author), Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL 60611 USA.	mark@mva.me	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499	National Institutes of Health [P01NS044393, R01NS063399]; Max Nader Center at the Rehabilitation Institute of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, P01NS044393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Nader Center at the Rehabilitation Institute of Chicago; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institutes of Health (P01NS044393, R01NS063399) and the Max Nader Center at the Rehabilitation Institute of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieber G, 2009, LECT NOTES COMPUT SC, V5615, P289, DOI 10.1007/978-3-642-02710-9_32; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2011, IEEE ENG MED BIO, P4449, DOI 10.1109/IEMBS.2011.6091103; Brezmes T, 2009, LECT NOTES COMPUT SC, V5518, P796, DOI 10.1007/978-3-642-02481-8_120; Campbell AJ, 1999, AGE AGEING, V28, P513, DOI 10.1093/ageing/28.6.513; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delbaere K, 2004, AGE AGEING, V33, P368, DOI 10.1093/ageing/afh106; Fernandes HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020290; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Gyorbiro N, 2009, MOBILE NETW APPL, V14, P82, DOI 10.1007/s11036-008-0112-y; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kwapisz JR., 2011, ACM SIGKDD EXPLORATI, V12, P74, DOI [10.1145/1964897.1964918, DOI 10.1145/1964897.1964918]; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Liu Y, 2011, IEEE ENG MED BIO, P1499, DOI 10.1109/IEMBS.2011.6090342; Hidalgo JLT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-910; Lutrek M., 2009, INFORMATICA, V33, P205; Mann R, 2006, AGE AGEING, V35, P143, DOI 10.1093/ageing/afj013; Peek-Asa C, 2003, EPIDEMIOL REV, V25, P77, DOI 10.1093/epirev/mxg006; RYYNANEN OP, 1992, Z GERONTOL, V25, P278; Sadigh S, 2004, J COMMUN HEALTH, V29, P129, DOI 10.1023/B:JOHE.0000016717.22032.03; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Seguin R, 2003, AM J PREV MED, V25, P141, DOI 10.1016/S0749-3797(03)00177-6; Sixsmith A, 2004, IEEE PERVAS COMPUT, V3, P42, DOI 10.1109/MPRV.2004.1316817; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Tideiksaar R, 1998, FALLING OLD AGE PREV; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Tolkiehn M, 2011, IEEE ENG MED BIO, P369, DOI 10.1109/IEMBS.2011.6090120; U.S. Census Bureau, 2010, POP DAT PUBL WEB SIT; Vellas BJ, 1997, AGE AGEING, V26, P189, DOI 10.1093/ageing/26.3.189; Wang Y, 2009, MOBISYS'09: PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P179, DOI 10.1016/B978-044306732-7.50020-9; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	33	146	148	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36556	10.1371/journal.pone.0036556	http://dx.doi.org/10.1371/journal.pone.0036556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TC	22586477	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000038
J	Sun, M; Gao, L; Liu, Y; Zhao, YQ; Wang, XQ; Pan, YQ; Ning, T; Cai, H; Yang, HJ; Zhai, WW; Ke, Y				Sun, Min; Gao, Lei; Liu, Ying; Zhao, Yiqiang; Wang, Xueqian; Pan, Yaqi; Ning, Tao; Cai, Hong; Yang, Haijun; Zhai, Weiwei; Ke, Yang			Whole Genome Sequencing and Evolutionary Analysis of Human Papillomavirus Type 16 in Central China	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CERVICAL-CANCER PATIENTS; LONG CONTROL REGION; AMINO-ACID SITES; VARIANT ANALYSIS; E6 VARIANTS; L1 GENES; NUCLEOTIDE SUBSTITUTION; NATURAL VARIANTS; PHYSICAL STATE	Human papillomavirus type 16 plays a critical role in the neoplastic transformation of cervical cancers. Molecular variants of HPV16 existing in different ethnic groups have shown substantial phenotypic differences in pathogenicity, immunogenicity and tumorigenicity. In this study, we sequenced the entire HPV16 genome of 76 isolates originated from Anyang, central China. Phylogenetic analysis of these sequences identified two major variants of HPV16 in the Anyang area, namely the European prototype (E(p)) and the European Asian type (E(As)). These two variants show a high degree of divergence between groups, and the E(p) comprised higher genetic diversity than the E(As). Analysis with two measurements of genetic diversity indicated that viral population size was relatively stable in this area in the past. Codon based likelihood models revealed strong statistical support for adaptive evolution acting on the E6 gene. Bayesian analysis identified several important amino acid positions that may be driving adaptive selection in the HPV 16 population, including R10G, D25E, L83V, and E113D in the E6 gene. We hypothesize that the positive selection at these codons might be a contributing factor responsible for the phenotypic differences in carcinogenesis and immunogenicity among cervical cancers in China based on the potential roles of these molecular variants reported in other studies.	[Sun, Min; Gao, Lei; Liu, Ying; Zhao, Yiqiang; Wang, Xueqian; Pan, Yaqi; Ning, Tao; Cai, Hong; Ke, Yang] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Ctr Computat Biol, Beijing, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Yang, Haijun] Anyang Canc Hosp, Anyang, Henan, Peoples R China	Peking University; Chinese Academy of Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, M (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing 100871, Peoples R China.	weiweizhai@big.ac.cn; keyang@bjmu.edu.cn		Zhai, Weiwei/0000-0001-7938-0226	Natural Science Foundation of China [30872937, 30930102, 31000957, 91131011]; National Ministry of Science and Technology [2011CB504301, 2012CB316505, 2006AA2Z467]; Charity Project of National Ministry of Health [200902002]; Natural Science Foundation of Beijing [7100001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Science and Technology; Charity Project of National Ministry of Health; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work is supported in part by Natural Science Foundation of China 30872937, 30930102, 31000957 and 91131011, "973" Project of National Ministry of Science and Technology Grant 2011CB504301, 2012CB316505, "863" Key Projects of National Ministry of Science and Technology Grant 2006AA2Z467, Charity Project of National Ministry of Health 200902002, and Natural Science Foundation of Beijing 7100001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2000, BRIT J CANCER, V83, P307, DOI 10.1054/bjoc.2000.1247; [Anonymous], 2007, IARC MON EV CARC RIS; Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Bernard HU, 2008, ORIGIN AND EVOLUTION OF VIRUSES, 2ND EDITION, P417, DOI 10.1016/B978-0-12-374153-0.00018-7; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Blakaj DM, 2009, FRONT BIOSCI-LANDMRK, V14, P900, DOI 10.2741/3285; Bravo IG, 2004, J VIROL, V78, P13613, DOI 10.1128/JVI.78.24.13613-13626.2004; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; Chan PKS, 2002, J INFECT DIS, V186, P696, DOI 10.1086/342048; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Choo KB, 2000, J MED VIROL, V61, P298, DOI 10.1002/1096-9071(200007)61:3&lt;298::AID-JMV3&gt;3.0.CO;2-Y; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; Souza PSD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-246; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Ding TA, 2010, INT J GYNECOL CANCER, V20, P1391, DOI 10.1111/IGC.0b013e3181eced04; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; Giannoudis A, 2001, BRIT J CANCER, V84, P1058, DOI 10.1054/bjoc.2001.1695; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Hu Y, 2011, REPROD SCI, V18, P406, DOI 10.1177/1933719110387830; Hudelist G, 2004, GYNECOL ONCOL, V92, P873, DOI 10.1016/j.ygyno.2003.11.035; JONES RE, 1990, J BIOL CHEM, V265, P12782; Kang S, 2005, INT J GYNECOL CANCER, V15, P107, DOI 10.1111/j.1048-891x.2005.15010.x; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; MacCallum C, 2006, PLOS BIOL, V4, P293, DOI 10.1371/journal.pbio.0040087; Masterson PJ, 1998, J VIROL, V72, P7407, DOI 10.1128/JVI.72.9.7407-7419.1998; Matsumoto K, 2003, INT J CANCER, V106, P919, DOI 10.1002/ijc.11332; Matsumoto K, 2000, CANCER LETT, V156, P159, DOI 10.1016/S0304-3835(00)00457-2; Meyers G, 1997, HUMAN PAPILLOMAVIRUS; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Picconi MA, 2003, J MED VIROL, V69, P546, DOI 10.1002/jmv.10343; Qiu AD, 2007, GYNECOL ONCOL, V104, P77, DOI 10.1016/j.ygyno.2006.07.016; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Shang QL, 2011, J CLIN MICROBIOL, V49, P2656, DOI 10.1128/JCM.02203-10; Sharp PM, 2002, CELL, V108, P305, DOI 10.1016/S0092-8674(02)00639-6; SLATKIN M, 1991, GENETICS, V129, P555; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephen AL, 2000, INT J CANCER, V86, P695, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;695::AID-IJC15&gt;3.0.CO;2-C; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Sun ZR, 2011, INT J GYNECOL CANCER, V21, P551, DOI 10.1097/IGC.0b013e3182112023; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; TAJIMA F, 1989, GENETICS, V123, P585; Vaeteewoottacharn K, 2003, ANTICANCER RES, V23, P1927; van Duin M, 2000, J GEN VIROL, V81, P317, DOI 10.1099/0022-1317-81-2-317; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wu YP, 2006, J GEN VIROL, V87, P1181, DOI 10.1099/vir.0.81649-0; Xi LF, 2002, CANCER EPIDEM BIOMAR, V11, P343; Xiong Guang-Wu, 2010, Yichuan, V32, P339, DOI 10.3724/SP.J.1005.2010.00339; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971	78	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36577	10.1371/journal.pone.0036577	http://dx.doi.org/10.1371/journal.pone.0036577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574185	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800082
J	Vinnemeier, CD; Schwarz, NG; Sarpong, N; Loag, W; Acquah, S; Nkrumah, B; Huenger, F; Adu-Sarkodie, Y; May, J				Vinnemeier, Christof David; Schwarz, Norbert Georg; Sarpong, Nimako; Loag, Wibke; Acquah, Samuel; Nkrumah, Bernard; Huenger, Frank; Adu-Sarkodie, Yaw; May, Juergen			Predictive Value of Fever and Palmar Pallor for P. falciparum Parasitaemia in Children from an Endemic Area	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; CLINICAL ALGORITHM; INTEGRATED MANAGEMENT; CHILDHOOD ILLNESS; AFRICAN CHILDREN; SEVERE ANEMIA; MALARIA; TRANSMISSION; ACCURACY; FEATURES	Introduction: Although the incidence of Plasmodium falciparum malaria in some parts of sub-Saharan Africa is reported to decline and other conditions, causing similar symptoms as clinical malaria are gaining in relevance, presumptive antimalarial treatment is still common. This study traced for age-dependent signs and symptoms predictive for P. falciparum parasitaemia. Methods: In total, 5447 visits of 3641 patients between 2-60 months of age who attended an outpatient department (OPD) of a rural hospital in the Ashanti Region, Ghana, were analysed. All Children were examined by a paediatrician and a full blood count and thick smear were done. A Classification and Regression Tree (CART) model was used to generate a clinical decision tree to predict malarial parasitaemia a7nd predictive values of all symptoms were calculated. Results: Malarial parasitaemia was detected in children between 2-12 months and between 12-60 months of age with a prevalence of 13.8% and 30.6%, respectively. The CART-model revealed age-dependent differences in the ability of the variables to predict parasitaemia. While palmar pallor was the most important symptom in children between 2-12 months, a report of fever and an elevated body temperature of >= 37.5 degrees C gained in relevance in children between 12-60 months. The variable palmar pallor was significantly (p<0.001) associated with lower haemoglobin levels in children of all ages. Compared to the Integrated Management of Childhood Illness (IMCI) algorithm the CART-model had much lower sensitivities, but higher specificities and positive predictive values for a malarial parasitaemia. Conclusions: Use of age-derived algorithms increases the specificity of the prediction for P. falciparum parasitaemia. The predictive value of palmar pallor should be underlined in health worker training. Due to a lack of sensitivity neither the best algorithm nor palmar pallor as a single sign are eligible for decision-making and cannot replace presumptive treatment or laboratory diagnosis.	[Vinnemeier, Christof David; Schwarz, Norbert Georg; Loag, Wibke; May, Juergen] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Sarpong, Nimako; Acquah, Samuel; Nkrumah, Bernard; Huenger, Frank] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Huenger, Frank] Inst Transfus Med, Lab Med & Med Microbiol, Dortmund, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology	Vinnemeier, CD (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	vinnemeier@bni-hamburg.de	Schwarz, Norbert G/C-8797-2012	Schwarz, Norbert G/0000-0002-8387-2837; Acquah, Samuel/0000-0002-3896-2665; May, Jurgen/0000-0001-7831-8420	Swiss foundation	Swiss foundation(Swiss National Science Foundation (SNSF))	The study was supported by Swiss foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; Bojang KA, 2000, TROP MED INT HEALTH, V5, P231, DOI 10.1046/j.1365-3156.2000.00538.x; Bonner K, MALAR J, V10, P73; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-166; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Ceesay SJ, PLOS ONE, V5; Chalco Juan P, 2005, BMC Pediatr, V5, P46, DOI 10.1186/1471-2431-5-46; Chandramohan D, 2001, TROP MED INT HEALTH, V6, P505, DOI 10.1046/j.1365-3156.2001.00739.x; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Gay-Andrieu F, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-10; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hopkins H, 2008, J INFECT DIS, V197, P510, DOI 10.1086/526502; Kalantri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008545; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; Muhe L, 1999, ARCH DIS CHILD, V81, P216, DOI 10.1136/adc.81.3.216; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5; Redd SC, 1996, LANCET, V347, P223, DOI 10.1016/S0140-6736(96)90404-3; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ronald LA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-105; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Schellenberg JA, 2004, HEALTH POLICY PLANN, V19, P1, DOI 10.1093/heapol/czh001; Speybroeck N, 2011, INT J PUBLIC HLTH; STROBACH RS, 1988, ARCH INTERN MED, V148, P831, DOI 10.1001/archinte.148.4.831; UNICEF, UNICEF PROGR CHILDR; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P113; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, WHO GLOB MAL PARTN R; WHO, 1999, WHO MAT NEWB CHILD A; WHO, 2004, WHO IMCI DOC EXP PRO; WHO, 2005, WHO CHILD AD HLTH DE; Ye Y, 2007, ANN TROP MED PARASIT, V101, P297, DOI 10.1179/136485907X176391	42	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36678	10.1371/journal.pone.0036678	http://dx.doi.org/10.1371/journal.pone.0036678			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574213	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800110
J	Brown, JE; Krodel, M; Pazos, M; Lai, C; Prieto, AL				Brown, Jessica E.; Krodel, Meredith; Pazos, Mauricio; Lai, Cary; Prieto, Anne L.			Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells	PLOS ONE			English	Article							ARREST-SPECIFIC GENE; TYROSINE KINASE TYRO3; SURVIVAL ACTIVITIES; TAM RECEPTORS; GROWTH-FACTOR; PI3 KINASE; PROTEIN-S; GAS6; PATHWAY; TRANSDUCTION	The dysregulation of receptor protein tyrosine kinase (RPTK) function can result in changes in cell proliferation, cell growth and metastasis leading to malignant transformation. Among RPTKs, the TAM receptor family composed of three members Tyro3, Axl, and Mer has been recognized to have a prominent role in cell transformation. In this study we analyzed the consequences of Tyro3 overexpression on cell proliferation, activation of signaling pathways and its functional interactions with Axl. Overexpression of Tyro3 in the Rat2 cell line that expresses Axl, but not Mer or Tyro3, resulted in a 5 fold increase in cell proliferation. This increase was partially blocked by inhibitors of the mitogen-activated protein kinase (MAPK) signaling pathway but not by inhibitors of the phosphatidylinositol 3-kinase (PI(3) K) signaling pathway. Consistent with these findings, an increase in ERK1/2 phosphorylation was detected with Tyro3 but not with Axl overexpression. In contrast, activation of Axl stimulated the PI(3) K pathway, which was mitigated by co-expression of Tyro3. The overexpression of Tyro3 enhanced Gas6-mediated Axl phosphorylation, which was not detected upon overexpression of a "kinase dead" form of Tyro3 (kdTyro3). In addition, the overexpression of Axl induced kdTyro3 phosphorylation. Co-immunoprecipitation experiments confirmed that the Axl and Tyro3 receptors are closely associated. These findings show that overexpression of Tyro3 in the presence of Axl promotes cell proliferation, and that co-expression of Axl and Tyro3 can affect the outcome of Gas6-initiated signaling. Furthermore, they demonstrate a functional interaction between the members of the TAM receptor family which can shed light on the molecular mechanisms underlying the functional consequences of TAM receptor activation in cell transformation, neural function, immune function, and reproductive function among others.	[Brown, Jessica E.; Krodel, Meredith; Pazos, Mauricio; Lai, Cary; Prieto, Anne L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Brown, Jessica E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA	Indiana University System; Indiana University Bloomington; Medical College of Wisconsin	Brown, JE (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	aprieto@indiana.edu			National Institutes of Health [NS37471, NS32367]; NSF [NSF0136383]; Indiana University FRSP award; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc, Indianapolis, IN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Indiana University FRSP award; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc, Indianapolis, IN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Institutes of Health grant NS37471 (ALP) and NS32367 (CL), by NSF grant NSF0136383 (ALP), by an Indiana University FRSP award (ALP) and the Indiana METACyt Initiative of Indiana University, funded through a major grant from the Lilly Endowment, Inc, Indianapolis, IN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1999, MOL ENDOCRINOL, V13, P191, DOI 10.1210/me.13.2.191; Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Arai H, 2008, VITAM HORM, V78, P375, DOI 10.1016/S0083-6729(07)00015-5; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bellido-Martin L, 2008, VITAM HORM, V78, P185, DOI 10.1016/S0083-6729(07)00009-X; Besser D, 1999, MOL CELL BIOL, V19, P1401; Binder MD, 2009, NEUROSIGNALS, V17, P277, DOI 10.1159/000231894; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Emaduddin M, 1999, BIOCHEM J, V341, P523, DOI 10.1042/0264-6021:3410523; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Goruppi S, 1996, ONCOGENE, V12, P471; Hafizi S, 2005, FASEB J, V19, P971, DOI 10.1096/fj.04-2532fje; Hafizi S, 2002, BIOCHEM BIOPH RES CO, V299, P793, DOI 10.1016/S0006-291X(02)02718-3; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Heldin CH, 2001, STEM CELLS, V19, P295, DOI 10.1634/stemcells.19-4-295; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Katagiri M, 2001, J BIOL CHEM, V276, P7376, DOI 10.1074/jbc.M007393200; LAI C, 1994, ONCOGENE, V9, P2567; Lan ZD, 2000, BLOOD, V95, P633, DOI 10.1182/blood.V95.2.633; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li RH, 1996, J NEUROSCI, V16, P2012; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loges S, 2010, BLOOD, V115, P2264, DOI 10.1182/blood-2009-06-228684; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nakano T, 1996, FEBS LETT, V387, P78, DOI 10.1016/0014-5793(96)00395-X; Nakano T, 1997, BIOCHEM J, V323, P387, DOI 10.1042/bj3230387; Natarajan Kanchana, 2006, V332, P51; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pierce A, 2008, MOL ENDOCRINOL, V22, P2481, DOI 10.1210/me.2008-0169; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shiozawa Y, 2010, NEOPLASIA, V12, P116, DOI 10.1593/neo.91384; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; TAYLOR ICA, 1995, J BIOL CHEM, V270, P6872, DOI 10.1074/jbc.270.12.6872; Tjwa M, 2009, CURR OPIN LIPIDOL, V20, P386, DOI 10.1097/MOL.0b013e328330982e; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Weinger JG, 2008, J NEUROCHEM, V106, P134, DOI 10.1111/j.1471-4159.2008.05343.x; Wu H, 2008, MOL REPROD DEV, V75, P1775, DOI 10.1002/mrd.20917; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Yanagita M, 1999, J AM SOC NEPHROL, V10, P2503; Zhong ZH, 2010, J NEUROSCI, V30, P15521, DOI 10.1523/JNEUROSCI.4437-10.2010; Zhu ST, 2009, P NATL ACAD SCI USA, V106, P17025, DOI 10.1073/pnas.0909292106; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	61	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36800	10.1371/journal.pone.0036800	http://dx.doi.org/10.1371/journal.pone.0036800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606290	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400034
J	Gaudreault, N; Kumar, N; Olivas, VR; Eberle, D; Rapp, JH; Raffai, RL				Gaudreault, Nathalie; Kumar, Nikit; Olivas, Victor R.; Eberle, Delphine; Rapp, Joseph H.; Raffai, Robert L.			Macrophage-Specific ApoE Gene Repair Reduces Diet-Induced Hyperlipidemia and Atherosclerosis in Hypomorphic Apoe Mice	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; HUMAN APOLIPOPROTEIN-E; E-DEFICIENT MICE; REMNANT LIPOPROTEIN CLEARANCE; SEVERE HYPERCHOLESTEROLEMIA; LIVER-TRANSPLANTATION; CHOLESTEROL EFFLUX; EXPRESSION; IRRADIATION; PHENOTYPES	Background: Apolipoprotein (apo) E is best known for its ability to lower plasma cholesterol and protect against atherosclerosis. Although the liver is the major source of plasma apoE, extra-hepatic sources of apoE, including from macrophages, account for up to 10% of plasma apoE levels. This study examined the contribution of macrophage-derived apoE expression levels in diet-induced hyperlipidemia and atherosclerosis. Methodology/Principal Findings: Hypomorphic apoE (Apoe(h/h)) mice expressing wildtype mouse apoE at similar to 2-5% of physiological levels in all tissues were derived by gene targeting in embryonic stem cells. Cre-mediated gene repair of the Apoe(h/h) allele in Apoe(h/h)LysM-Cre mice raised apoE expression levels by 26 fold in freshly isolated peritoneal macrophages, restoring it to 37% of levels seen in wildtype mice. Chow-fed Apoe(h/h)LysM-Cre and Apoe(h/h) mice displayed similar plasma apoE and cholesterol levels (55.53=2.90 mg/dl versus 62.70=2.77 mg/dl, n = 12). When fed a high-cholesterol diet (HCD) for 16 weeks, Apoe(h/h)LysM-Cre mice displayed a 3-fold increase in plasma apoE and a concomitant 32% decrease in plasma cholesterol when compared to Apoe(h/h) mice (602.20 +/- 22.30 mg/dl versus 888.80=24.99 mg/dl, n = 7). On HCD, Apoe(h/h)LysM-Cre mice showed increased apoE immunoreactivity in lesional macrophages and liver-associated Kupffer cells but not hepatocytes. In addition, Apoe(h/h)LysM-Cre mice developed 35% less atherosclerotic lesions in the aortic root than Apoe(h/h) mice (167x10(3) = 16x10(3) mu m(2) versus 259x10(3)+/- 56x10(3) mu m(2), n = 7). This difference in atherosclerosis lesions size was proportional to the observed reduction in plasma cholesterol. Conclusions/Significance: Macrophage-derived apoE raises plasma apoE levels in response to diet-induced hyperlipidemia and by such reduces atherosclerosis proportionally to the extent to which it lowers plasma cholesterol levels.	[Gaudreault, Nathalie; Kumar, Nikit; Olivas, Victor R.; Eberle, Delphine; Rapp, Joseph H.; Raffai, Robert L.] Univ Calif San Francisco, VA Med Ctr, Dept Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Gaudreault, N (corresponding author), Univ Calif San Francisco, VA Med Ctr, Dept Surg, San Francisco, CA 94143 USA.	robert.raffai@ucsfmedctr.org	EBERLE, Delphine/R-5551-2018	EBERLE, Delphine/0000-0003-2211-6146; Kumar, Nikit/0000-0003-3673-2302	National Institutes of Health [HL089871, 5I01BX000532]; Foundation for Accelerated Vascular Research; Department of Surgery at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Accelerated Vascular Research; Department of Surgery at UCSF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Institutes of Health HL089871, and a Merit Review grant 5I01BX000532 to RLR, which were administered by the Northern California Institute for Research and Education, and with resources of the Veterans Affairs Medical Center, San Francisco, California. This work was also supported by the Foundation for Accelerated Vascular Research, and funds from the Department of Surgery at UCSF to RLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; Boisvert WA, 1999, J LIPID RES, V40, P806; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; DE AK, 1978, STRAHLENTHER ONKOL, V154, P134; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gustafsson M, 2004, CURR OPIN LIPIDOL, V15, P505, DOI 10.1097/00041433-200410000-00003; Hasty AH, 1999, J LIPID RES, V40, P1529; Hasty AH, 1999, CIRCULATION, V99, P2571, DOI 10.1161/01.CIR.99.19.2571; JI ZS, 1993, J BIOL CHEM, V268, P10160; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; LIN CT, 1986, J CLIN INVEST, V78, P947, DOI 10.1172/JCI112685; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAZZONE T, 1994, J LIPID RES, V35, P1345; O'Brien KD, 1998, CIRCULATION, V98, P519, DOI 10.1161/01.CIR.98.6.519; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Raffai RL, 2003, J BIOL CHEM, V278, P11670, DOI 10.1074/jbc.M212873200; Raffai RL, 2002, J BIOL CHEM, V277, P11064, DOI 10.1074/jbc.M111222200; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; ROSENFELD ME, 1993, ARTERIOSCLER THROMB, V13, P1382, DOI 10.1161/01.ATV.13.9.1382; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Shi WB, 2004, BIOCHEM BIOPH RES CO, V317, P223, DOI 10.1016/j.bbrc.2004.03.037; Shi WB, 2002, ARTERIOSCL THROM VAS, V22, P650, DOI 10.1161/01.ATV.0000013388.03553.31; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; Tsukamoto K, 1997, J CLIN INVEST, V100, P107, DOI 10.1172/JCI119501; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Yu KCW, 2000, J LIPID RES, V41, P1715; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhu YH, 1998, P NATL ACAD SCI USA, V95, P7585, DOI 10.1073/pnas.95.13.7585	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35816	10.1371/journal.pone.0035816	http://dx.doi.org/10.1371/journal.pone.0035816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606237	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400007
J	Hack, K; Reilly, L; Palmer, C; Read, KD; Norval, S; Kime, R; Booth, K; Foerster, J				Hack, Katrin; Reilly, Louise; Palmer, Colin; Read, Kevin D.; Norval, Suzanne; Kime, Robert; Booth, Kally; Foerster, John			Skin-Targeted Inhibition of PPAR beta/delta by Selective Antagonists to Treat PPAR beta/delta - Mediated Psoriasis-Like Skin Disease In Vivo	PLOS ONE			English	Article							DELTA ANTAGONIST; GAMMA AGONISTS; IDENTIFICATION; EXPRESSION; GSK3787; CELLS; ACID	We have previously shown that peroxisome proliferator activating receptor beta/delta (PPAR beta/delta is overexpressed in psoriasis. PPAR beta/delta is not present in adult epidermis of mice. Targeted expression of PPAR beta/delta and activation by a selective synthetic agonist is sufficient to induce an inflammatory skin disease resembling psoriasis. Several signalling pathways dysregulated in psoriasis are replicated in this model, suggesting that PPAR beta/delta activation contributes to psoriasis pathogenesis. Thus, inhibition of PPAR beta/delta might harbour therapeutical potential. Since PPAR beta/delta has pleiotropic functions in metabolism, skin-targeted inhibition offer the potential of reducing systemic adverse effects. Here, we report that three selective PPAR beta/delta antagonists, GSK0660, compound 3 h, and GSK3787 can be formulated for topical application to the skin and that their skin concentration can be accurately quantified using ultra-high performance liquid chromatography (UPLC)/mass spectrometry. These antagonists show efficacy in our transgenic mouse model in reducing psoriasis - like changes triggered by activation of PPAR beta/delta. PPAR beta/delta antagonists GSK0660 and compound 3 do not exhibit systemic drug accumulation after prolonged application to the skin, nor do they induce inflammatory or irritant changes. Significantly, the irreversible PPAR beta/delta antagonist (GSK3787) retains efficacy when applied topically only three times per week which could be of practical clinical usefulness. Our data suggest that topical inhibition of PPAR beta/delta to treat psoriasis may warrant further exploration.	[Hack, Katrin; Reilly, Louise; Palmer, Colin] Univ Dundee, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland; [Foerster, John] Univ Dundee, Dept Dermatol, Coll Med Dent & Nursing, Dundee, Scotland; [Foerster, John] Univ Dundee, Educ Div, Coll Med Dent & Nursing, Dundee, Scotland; [Booth, Kally] Univ Dundee, Coll Med Dent & Nursing, Biol Resource Unit, Sch Med, Dundee, Scotland; [Read, Kevin D.; Norval, Suzanne; Kime, Robert] Univ Dundee, Coll Life Sci, Biol Chem & Drug Discovery Unit, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Hack, K (corresponding author), Univ Dundee, Med Res Inst, Coll Med Dent & Nursing, Dundee, Scotland.	j.foerster@dundee.ac.uk	Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560; Hack, Katrin/0000-0003-2246-5856; Reilly, Louise/0000-0002-2224-1708	Medical Research Council UK (MRC DPFS award) [G900864]; MRC [MC_G0900864] Funding Source: UKRI; Medical Research Council [MC_G0900864] Funding Source: researchfish	Medical Research Council UK (MRC DPFS award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK (MRC DPFS award ref. no. G900864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Barish GD, 2008, P NATL ACAD SCI USA, V105, P4271, DOI 10.1073/pnas.0711875105; Bongartz T, 2005, RHEUMATOLOGY, V44, P126, DOI 10.1093/rheumatology/keh423; de Lange P, 2008, PPAR RES, V2008, DOI 10.1155/2008/172676; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Hall JM, 2007, MOL ENDOCRINOL, V21, P1756, DOI 10.1210/me.2007-0060; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Kasuga J, 2009, BIOORG MED CHEM LETT, V19, P6595, DOI 10.1016/j.bmcl.2009.10.021; Kobayashi N, 1998, CHEM PHARM BULL, V46, P1833; Kuenzli S, 2003, DERMATOLOGY, V206, P252, DOI 10.1159/000068897; Malhotra S, 2005, EXPERT OPIN PHARMACO, V6, P1455, DOI 10.1517/14656566.6.9.1455; Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1238, DOI 10.1093/gerona/60.10.1238; Naldi L, 2005, J INVEST DERMATOL, V125, P61, DOI 10.1111/j.0022-202X.2005.23681.x; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Palkar PS, 2010, MOL PHARMACOL, V78, P419, DOI 10.1124/mol.110.065508; PIQUERAS L, 2006, ARTERIOSCLER THROMB; Pollock CB, 2010, PPAR RES, V2010, DOI 10.1155/2010/571783; Romanowska M, 2007, J INVEST DERMATOL; Romanowska M, 2008, J INVEST DERMATOL, V128, P110, DOI 10.1038/sj.jid.5700943; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Sommer DM, 2006, ARCH DERMATOL RES, V298, P321, DOI 10.1007/s00403-006-0703-z; Sterry W, 2005, E SCHERING RES FDN W, V50, P193; Sun L, 2008, CHINESE MED J-PEKING, V121, P2305, DOI 10.1097/00029330-200811020-00017; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Wang LH, 2004, IMMUNITY, V20, P205, DOI 10.1016/S1074-7613(04)00030-5; WOOLLARD PM, 1986, BIOCHEM BIOPH RES CO, V136, P169, DOI 10.1016/0006-291X(86)90891-0; Zaveri NT, 2009, CANCER BIOL THER, V8, P1252, DOI 10.4161/cbt.8.13.8691; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	31	28	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37097	10.1371/journal.pone.0037097	http://dx.doi.org/10.1371/journal.pone.0037097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606335	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400061
J	Carretie, L; Rios, M; Perianez, JA; Kessel, D; Alvarez-Linera, J				Carretie, Luis; Rios, Marcos; Perianez, Jose A.; Kessel, Dominique; Alvarez-Linera, Juan			The Role of Low and High Spatial Frequencies in Exogenous Attention to Biologically Salient Stimuli	PLOS ONE			English	Article							TOP-DOWN FACILITATION; HUMAN BRAIN; TALAIRACH ATLAS; TIME-COURSE; PRIORITY; EMOTION; NETWORK; SYSTEM; SHIFTS	Exogenous attention can be understood as an adaptive tool that permits the detection and processing of biologically salient events even when the individual is engaged in a resource-consuming task. Indirect data suggest that the spatial frequency of stimulation may be a crucial element in this process. Behavioral and neural data (both functional and structural) were analyzed for 36 participants engaged in a digit categorization task in which distracters were presented. Distracters were biologically salient or anodyne images, and had three spatial frequency formats: intact, low spatial frequencies only, and high spatial frequencies only. Behavior confirmed enhanced exogenous attention to biologically salient distracters. The activity in the right and left intraparietal sulci and the right middle frontal gyrus was associated with this behavioral pattern and was greater in response to salient than to neutral distracters, the three areas presenting strong correlations to each other. Importantly, the enhanced response of this network to biologically salient distracters with respect to neutral distracters relied on low spatial frequencies to a significantly greater extent than on high spatial frequencies. Structural analyses suggested the involvement of internal capsule, superior longitudinal fasciculus and corpus callosum in this network. Results confirm that exogenous attention is preferentially captured by biologically salient information, and suggest that the architecture and function underlying this process are low spatial frequency-biased.	[Carretie, Luis; Kessel, Dominique] Univ Autonoma Madrid, Fac Psicol, Madrid, Spain; [Rios, Marcos] Univ Nacl Educ Distancia, Fac Psicol, E-28040 Madrid, Spain; [Rios, Marcos; Perianez, Jose A.; Alvarez-Linera, Juan] Fdn CIEN Reina Sofia, Unidad Invest Proyecto Alzheimer, Madrid, Spain; [Perianez, Jose A.] Univ Complutense Madrid, Fac Psicol, Madrid, Spain; [Alvarez-Linera, Juan] Hosp Ruber Int, Dept Radiol, Madrid, Spain	Autonomous University of Madrid; Universidad Nacional de Educacion a Distancia (UNED); Complutense University of Madrid	Carretie, L (corresponding author), Univ Autonoma Madrid, Fac Psicol, Madrid, Spain.	carretie@uam.es	Periañez, Jose Antonio/AAI-3988-2021; Kessel, Dominique/B-5256-2012; Carretié, Luis/B-7290-2008; Rios-Lago, Marcos/C-9568-2012	Kessel, Dominique/0000-0001-8275-9923; Carretié, Luis/0000-0001-7375-6739; Rios-Lago, Marcos/0000-0003-0187-5047; Perianez, Jose A./0000-0003-4310-4021	Ministerio de Ciencia e Innovacion (MICINN) of Spain [PSI2008-03688]	Ministerio de Ciencia e Innovacion (MICINN) of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the grant PSI2008-03688 from the Ministerio de Ciencia e Innovacion (MICINN) of Spain (www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alorda C, 2007, NEUROPSYCHOLOGIA, V45, P3223, DOI 10.1016/j.neuropsychologia.2007.06.017; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Anderson EJ, 2011, CEREBRAL CO IN PRESS; Bar M, 2003, J COGNITIVE NEUROSCI, V15, P600, DOI 10.1162/089892903321662976; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brett M, 2001, NEUROIMAGE, V13, pS85; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Calvo MG, 2009, COGN AFFECT BEHAV NE, V9, P398, DOI 10.3758/CABN.9.4.398; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carretie L, 2007, NEUROPSYCHOLOGIA, V45, P1187, DOI 10.1016/j.neuropsychologia.2006.10.013; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Delplanque S, 2007, J NEUROSCI METH, V165, P144, DOI 10.1016/j.jneumeth.2007.05.030; Doallo S, 2006, NEUROREPORT, V17, P1797, DOI 10.1097/01.wnr.0000246325.51191.39; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Grosbras MN, 2005, HUM BRAIN MAPP, V25, P140, DOI 10.1002/hbm.20145; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hodsoll J, 2009, CEREB CORTEX, V19, P106, DOI 10.1093/cercor/bhn070; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lang P. J., 2005, INT AFFECTIVE PICTUR; Laycock R, 2008, NEUROSCI BIOBEHAV R, V32, P1409, DOI 10.1016/j.neubiorev.2008.04.008; Leigh J, 2006, NEUROLOGY EYE MOVEME; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mori S., 2005, MRI ATLAS HUMAN WHIT; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Muri RM, 2011, OXFORD HDB EYE MOVEM, P399; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Olesen PJ, 2003, COGNITIVE BRAIN RES, V18, P48, DOI 10.1016/j.cogbrainres.2003.09.003; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P410, DOI 10.1017/CBO9780511546396.018; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Sullivan EV, 2010, NEUROPSYCHOLOGIA, V48, P4155, DOI 10.1016/j.neuropsychologia.2010.10.023; Tanaka M, 2011, OXFORD HDB EYE MOVEM, P235; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Zaidel E, 2003, PARALLEL BRAIN COGNI, P1; Zenon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002219	50	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37082	10.1371/journal.pone.0037082	http://dx.doi.org/10.1371/journal.pone.0037082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590649	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400058
J	Chen, HB; Zheng, Z; Huang, Y; Guo, KF; Lu, JX; Zhang, L; Yu, HY; Bao, YQ; Jia, WP				Chen, Haibing; Zheng, Zhi; Huang, Yan; Guo, Kaifeng; Lu, Junxi; Zhang, Lei; Yu, Haoyong; Bao, Yuqian; Jia, Weiping			A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; NEPHROPATHY; PREVALENCE; ALBUMINURIA; POPULATION; PROGRESSION; MORTALITY; LESIONS; MARKER	Objective: To test the hypothesis that a microalbuminuria (MA) threshold can help predict the risk for the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM)_ patients. Design: We conducted a cross-sectional study of 4739 subjects with T2DM and a prospective study of 297 subjects with T2DM in China respectively. Methods: Clinical and laboratory data were collected and biologic risk factors associated with any DR were analysed. Results: In the cross-sectional study, we found that MA was an independent risk factor for DR development; further, when the patients were divided into MA deciles, odds ratio (ORs) of DR for the patients in the sixth MA decile (10.7 mg/24 h) was 1.579-fold (1.161-2.147) compared to that for patients in the first MA decile. Furthermore, the OR of DR increased with a gradual increase in MA levels. Similarly, in the prospective study, during a mean follow-up of 4.5 years, we found that 51 patients (29.0%) of the 176 subjects with high MA level (10.7-30 mg/24 h) developed DR, while 17 patients (14.1%) of the 121 subjects with lower MA (<10.7 mg/24 h) developed DR, and the relative risk ratio of the development of DR is 2.13(95% CI, 1.58-3.62, P<0.001). Conclusion: These data suggest that an MA threshold can predict the risk for the development of DR in type 2 diabetes mellitus, although it is still within the traditionally established normal range.	[Chen, Haibing; Huang, Yan; Guo, Kaifeng; Lu, Junxi; Zhang, Lei; Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Shanghai Key Lab Diabet Mellitus, Dept Endocrinol & Metab, Shanghai Diabet Inst,Affiliated Peoples Hosp 6,Sh, Shanghai 200030, Peoples R China; [Zheng, Zhi] Shanghai Jiao Tong Univ, Dept Ophthalmol, Peoples Hosp Shanghai 1, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, HB (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Diabet Mellitus, Dept Endocrinol & Metab, Shanghai Diabet Inst,Affiliated Peoples Hosp 6,Sh, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012	Zhang, Xinyuan/0000-0002-3372-0798	Research Fund for the National Natural Science Funding of China [81070649, 81070739]; National Key Basic Research Program [2010CB535006]	Research Fund for the National Natural Science Funding of China; National Key Basic Research Program(National Basic Research Program of China)	This work was supported by grants from the Research Fund for the National Natural Science Funding of China (No. 81070649 and 81070739) and the National Key Basic Research Program (2010CB535006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Cheung N, 2008, J AM COLL CARDIOL, V51, P1573, DOI 10.1016/j.jacc.2007.11.076; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Comper WD, 2004, KIDNEY INT, V65, P1850, DOI 10.1111/j.1523-1755.2004.00585.x; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Deckert T, 1996, BRIT MED J, V312, P871; Forsblom CM, 1998, DIABETES CARE, V21, P1932, DOI 10.2337/diacare.21.11.1932; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Girach A, 2006, J DIABETES COMPLICAT, V20, P228, DOI 10.1016/j.jdiacomp.2006.03.001; Grauslund J, 2008, DIABETOLOGIA, V51, P583, DOI 10.1007/s00125-008-0953-8; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; KNOWLER WC, 1980, NEW ENGL J MED, V302, P645, DOI 10.1056/NEJM198003203021201; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Macky TA, 2011, OPHTHALMIC RES, V45, P73, DOI 10.1159/000314876; Manaviat Masoud R, 2004, BMC Ophthalmol, V4, P9, DOI 10.1186/1471-2415-4-9; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Murussi M, 2007, DIABETIC MED, V24, P1136, DOI 10.1111/j.1464-5491.2007.02209.x; Namperumalsamy P, 2009, BRIT J OPHTHALMOL, V93, P429, DOI 10.1136/bjo.2008.147934; Pedro RA, 2010, OPHTHAL EPIDEMIOL, V17, P251, DOI 10.3109/09286586.2010.498661; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Taylor HR, 2001, BRIT J OPHTHALMOL, V85, P261, DOI 10.1136/bjo.85.3.261; Thomas GN, 2004, DIABETOLOGIA, V47, P1528, DOI 10.1007/s00125-004-1490-8; West SK, 2002, AM J OPHTHALMOL, V134, P390, DOI 10.1016/S0002-9394(02)01595-7; Wong J, 2008, DIABETES CARE, V31, P1985, DOI 10.2337/dc08-0580; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; 2007, AM J KIDNEY DIS, V49, pS12; 2000, NEW ENGL J MED, V342, P381	32	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36718	10.1371/journal.pone.0036718	http://dx.doi.org/10.1371/journal.pone.0036718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590593	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400029
J	Chapman, EJ; Greenham, K; Castillejo, C; Sartor, R; Bialy, A; Sun, TP; Estelle, M				Chapman, Elisabeth J.; Greenham, Kathleen; Castillejo, Cristina; Sartor, Ryan; Bialy, Agniezska; Sun, Taiping; Estelle, Mark			Hypocotyl Transcriptome Reveals Auxin Regulation of Growth-Promoting Genes through GA-Dependent and -Independent Pathways	PLOS ONE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; LATERAL ROOT-FORMATION; OF-FUNCTION MUTATION; INTERACTING FACTOR 4; BOX PROTEIN TIR1; ARABIDOPSIS-THALIANA; SHADE AVOIDANCE; COINCIDENCE MECHANISM; DIFFERENTIAL GROWTH; PLANT DEVELOPMENT	Many processes critical to plant growth and development are regulated by the hormone auxin. Auxin responses are initiated through activation of a transcriptional response mediated by the TIR1/AFB family of F-box protein auxin receptors as well as the AUX/IAA and ARF families of transcriptional regulators. However, there is little information on how auxin regulates a specific cellular response. To begin to address this question, we have focused on auxin regulation of cell expansion in the Arabidopsis hypocotyl. We show that auxin-mediated hypocotyl elongation is dependent upon the TIR1/AFB family of auxin receptors and degradation of AUX/IAA repressors. We also use microarray studies of elongating hypocotyls to show that a number of growth-associated processes are activated by auxin including gibberellin biosynthesis, cell wall reorganization and biogenesis, and others. Our studies indicate that GA biosynthesis is required for normal response to auxin in the hypocotyl but that the overall transcriptional auxin output consists of PIF-dependent and - independent genes. We propose that auxin acts independently from and interdependently with PIF and GA pathways to regulate expression of growth-associated genes in cell expansion.	[Chapman, Elisabeth J.; Greenham, Kathleen; Castillejo, Cristina; Sartor, Ryan; Bialy, Agniezska] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Sun, Taiping] Duke Univ, Dept Biol, Durham, NC USA; [Estelle, Mark] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Duke University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Chapman, EJ (corresponding author), Forage Genet Int, W Salem, WI USA.	mestelle@ucsd.edu	CASTILLEJO, CRISTINA/R-6802-2018; Estelle, Mark/ABD-6742-2021	CASTILLEJO, CRISTINA/0000-0003-2596-8790; Greenham, Kathleen/0000-0001-7681-5263	National Institute of Health Institute of General Medicine [GM 43644]; Department of Energy [De-FG02-02ER15312]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100051, R01GM043644] Funding Source: NIH RePORTER	National Institute of Health Institute of General Medicine; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health Institute of General Medicine (GM 43644) and the Department of Energy (De-FG02-02ER15312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Berleth T, 2004, CURR OPIN PLANT BIOL, V7, P553, DOI 10.1016/j.pbi.2004.07.016; Beuchat J, 2010, NEW PHYTOL, V188, P23, DOI 10.1111/j.1469-8137.2010.03387.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chapman EJ, 2009, ANNU REV GENET, V43, P265, DOI 10.1146/annurev-genet-102108-134148; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; Desgagne-Penix I, 2008, J EXP BOT, V59, P2057, DOI 10.1093/jxb/ern063; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fox J., 2019, R COMPANION APPL REG, V.; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Gallego-Bartolome J, 2011, PLANT PHYSIOL, V156, P1819, DOI 10.1104/pp.111.173971; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Greenham K, 2011, CURR BIOL, V21, P520, DOI 10.1016/j.cub.2011.02.029; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hu Y, 2006, PLANT J, V47, P1, DOI 10.1111/j.1365-313X.2006.02750.x; Hu YX, 2003, PLANT CELL, V15, P1951, DOI 10.1105/tpc.013557; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Jamet E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-505; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kunihiro A, 2011, PLANT CELL PHYSIOL, V52, P1315, DOI 10.1093/pcp/pcr076; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Leyser O, 2010, PLANT PHYSIOL, V154, P501, DOI 10.1104/pp.110.161323; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li Y, 2003, CURR OPIN PLANT BIOL, V6, P603, DOI 10.1016/j.pbi.2003.09.003; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Lucyshyn D, 2009, CURR BIOL, V19, pR265, DOI 10.1016/j.cub.2009.01.051; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nemhauser JL, 2004, PLOS BIOL, V2, P1460, DOI 10.1371/journal.pbio.0020258; Niwa Y, 2009, PLANT CELL PHYSIOL, V50, P838, DOI 10.1093/pcp/pcp028; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nozue K, 2011, PLANT PHYSIOL, V156, P357, DOI 10.1104/pp.111.172684; O'Neill DP, 2010, PLANTA, V232, P1141, DOI 10.1007/s00425-010-1248-0; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Paponov IA, 2008, MOL PLANT, V1, P321, DOI 10.1093/mp/ssm021; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Roig-Villanova I, 2007, EMBO J, V26, P4756, DOI 10.1038/sj.emboj.7601890; Ross JJ, 2000, PLANT J, V21, P547, DOI 10.1046/j.1365-313x.2000.00702.x; Ross JJ, 2001, J PLANT GROWTH REGUL, V20, P346, DOI 10.1007/s003440010034; Ross JJ, 2011, PHYSIOL PLANTARUM, V141, P299, DOI 10.1111/j.1399-3054.2011.01444.x; Sato A, 2008, PHYSIOL PLANTARUM, V133, P397, DOI 10.1111/j.1399-3054.2008.01055.x; Savaldi-Goldstein S, 2008, P NATL ACAD SCI USA, V105, P15190, DOI 10.1073/pnas.0806324105; SCOTT TK, 1972, ANN REV PLANT PHYSIO, V23, P235, DOI 10.1146/annurev.pp.23.060172.001315; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stavang JA, 2009, PLANT J, V60, P589, DOI 10.1111/j.1365-313X.2009.03983.x; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; TIMPTE C, 1994, GENETICS, V138, P1239; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Tromas A, 2010, CR BIOL, V333, P297, DOI 10.1016/j.crvi.2010.01.005; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; ULMASOV T, 1995, PLANT CELL, V7, P1611, DOI 10.1105/tpc.7.10.1611; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Voesenek LACJ, 2003, ANN BOT-LONDON, V91, P205, DOI 10.1093/aob/mcf116; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Watahiki MK, 1997, PLANT PHYSIOL, V115, P419, DOI 10.1104/pp.115.2.419; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Yamada M, 2009, PLANT PHYSIOL, V151, P168, DOI 10.1104/pp.109.138859; Yang XQ, 2004, PLANT J, V40, P772, DOI 10.1111/j.1365-313X.2004.02254.x; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402	106	102	108	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36210	10.1371/journal.pone.0036210	http://dx.doi.org/10.1371/journal.pone.0036210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590525	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100021
J	Hu, ZH; Zhou, J; Xu, XF; Li, ZW; Zhou, L; Wu, J; Zhang, M; Zheng, SS				Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen			Salvage Liver Transplantation Is a Reasonable Option for Selected Patients Who Have Recurrent Hepatocellular Carcinoma after Liver Resection	PLOS ONE			English	Article							LIVING DONOR; CIRRHOTIC-PATIENTS; STRATEGY; HEPATECTOMY; SURVIVAL; OUTCOMES; PATTERN; SINGLE	Background: Salvage liver transplantation (SLT) has been reported as being feasible for patients who develop recurrent hepatocellular carcinoma (HCC) after primary liver resection, but this finding remains controversial. We retrospectively studied the clinical characteristics of SLT recipients and conducted a comparison between SLT recipients and primary liver transplantation (PLT) recipients. Methodology and Principal Findings: A retrospective study examined data from the China Liver Transplant Registry (CLTR) for 6,975 transplants performed from January 1999 to December 2009. A total of 6,087 patients underwent PLT and 888 patients underwent SLT for recurrence. Living donor liver transplantation (LDLT) was performed in 389 patients, while 6,586 patients underwent deceased donor liver transplantation (DDLT). Kaplan-Meier curves were used to compare survival rates. The 1-year, 3-year, and 5-year overall survival of SLT recipients was similar to that of PLT recipients: 73.00%, 51.77%, and 45.84% vs. 74.49%, 55.10%, and 48.81%, respectively (P = 0.260). The 1-year, 3-year and 5-year disease-free survival of SLT recipients was inferior to that of PLT recipients: 64.79%, 45.57%, and 37.78% vs. 66.39%, 50.39%, and 43.50%, respectively (P = 0.048). Similar survival results were observed for SLT and PLT within both the LDLT and DDLT recipients. Within the SLT group, the 1-year, 3-year, and 5-year overall survival for LDLT and DDLT recipients was similar: 93.33%, 74.67%, and 74.67% vs. 80.13%, 62.10%, and 54.18% (P = 0.281), as was the disease-free survival: 84.85%, 62.85%, and 62.85% vs. 70.54%, 53.94%, and 43.57% (P = 0.462). Conclusions: Our study demonstrates that for selected patients, SLT has similar survival to that of PLT, indicating that SLT is acceptable for patients with recurrent HCC after liver resection. Given the limited organ donor pool, salvage LDLT might be considered as a possible treatment.	[Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Zhenhua; Zhou, Jie; Xu, Xiaofeng; Li, Zhiwei; Zhou, Lin; Wu, Jian; Zhang, Min; Zheng, Shusen] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Organ Transplantat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Hu, ZH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National Basic Research Program of China (973 Program) [2009CB522403]; National Natural Science Foundation of China [30730085]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB522403) and National Natural Science Foundation of China (No. 30730085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2003, ANN SURG, V238, P508, DOI 10.1097/01.sla.0000090449.87109.44; Belghiti J, 2007, LIVER TRANSPLANT, V13, P636, DOI 10.1002/lt.21023; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120; Del Gaudio M, 2008, AM J TRANSPLANT, V8, P1177, DOI 10.1111/j.1600-6143.2008.02229.x; Dmitrewski J, 1998, J Hepatobiliary Pancreat Surg, V5, P18, DOI 10.1007/PL00009945; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Eguchi S, 2009, J GASTROENTEROL, V44, P624, DOI 10.1007/s00535-009-0043-9; Facciuto ME, 2008, ANN SURG ONCOL, V15, P1383, DOI 10.1245/s10434-008-9851-z; Fan ST, 2000, J GASTROEN HEPATOL, V15, pE181, DOI 10.1046/j.1440-1746.2000.02119.x; Figueras J, 2000, J AM COLL SURGEONS, V190, P580, DOI 10.1016/S1072-7515(00)00251-9; Hwang S, 2005, LIVER TRANSPLANT, V11, P1265, DOI 10.1002/lt.20549; Hwang S, 2007, LIVER TRANSPLANT, V13, P741, DOI 10.1002/lt.21157; Laurent A, 2009, J HEPATO-BILIARY-PAN, V16, P310, DOI 10.1007/s00534-009-0063-0; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Majno PE, 2000, HEPATOLOGY, V31, P899, DOI 10.1053/he.2000.5763; Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX; Margarit C, 2005, LIVER TRANSPLANT, V11, P1242, DOI 10.1002/lt.20398; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; Mor E, 1998, ANN INTERN MED, V129, P643, DOI 10.7326/0003-4819-129-8-199810150-00013; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Sarasin FP, 2001, HEPATOLOGY, V33, P1073, DOI 10.1053/jhep.2001.23311; Strong RW, 2000, SEMIN SURG ONCOL, V19, P189, DOI 10.1002/1098-2388(200009)19:2<189::AID-SSU10>3.0.CO;2-U; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Vennarecci G, 2007, TRANSPL P, V39, P1857, DOI 10.1016/j.transproceed.2007.05.073; Yao FY, 2003, LIVER TRANSPLANT, V9, P684, DOI 10.1053/jlts.2003.50147; Zheng SS, 2008, TRANSPLANTATION, V85, P1726, DOI 10.1097/TP.0b013e31816b67e4	29	21	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36587	10.1371/journal.pone.0036587	http://dx.doi.org/10.1371/journal.pone.0036587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574187	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800084
J	Khatau, SB; Kusuma, S; Hanjaya-Putra, D; Mali, P; Cheng, LZ; Lee, JSH; Gerecht, S; Wirtz, D				Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Mali, Prashant; Cheng, Linzhao; Lee, Jerry S. H.; Gerecht, Sharon; Wirtz, Denis			The Differential Formation of the LINC-Mediated Perinuclear Actin Cap in Pluripotent and Somatic Cells	PLOS ONE			English	Article							OUTER NUCLEAR-MEMBRANE; EMBRYONIC STEM-CELLS; ENVELOPE; PROTEIN; SUN; LOCALIZATION; KASH; REQUIREMENTS; EXPRESSION; NESPRIN-3	The actin filament cytoskeleton mediates cell motility and adhesion in somatic cells. However, whether the function and organization of the actin network are fundamentally different in pluripotent stem cells is unknown. Here we show that while conventional actin stress fibers at the basal surface of cells are present before and after onset of differentiation of mouse (mESCs) and human embryonic stem cells (hESCs), actin stress fibers of the actin cap, which wrap around the nucleus, are completely absent from undifferentiated mESCs and hESCs and their formation strongly correlates with differentiation. Similarly, the perinuclear actin cap is absent from human induced pluripotent stem cells (hiPSCs), while it is organized in the parental lung fibroblasts from which these hiPSCs are derived and in a wide range of human somatic cells, including lung, embryonic, and foreskin fibroblasts and endothelial cells. During differentiation, the formation of the actin cap follows the expression and proper localization of nuclear lamin A/C and associated linkers of nucleus and cytoskeleton (LINC) complexes at the nuclear envelope, which physically couple the actin cap to the apical surface of the nucleus. The differentiation of hESCs is accompanied by the progressive formation of a perinuclear actin cap while induced pluripotency is accompanied by the specific elimination of the actin cap, and that, through lamin A/C and LINC complexes, this actin cap is involved in progressively shaping the nucleus of hESCs undergoing differentiation. While, the localization of lamin A/C at the nuclear envelope is required for perinuclear actin cap formation, it is not sufficient to control nuclear shape.	[Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Lee, Jerry S. H.; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Khatau, Shyam B.; Kusuma, Sravanti; Hanjaya-Putra, Donny; Gerecht, Sharon; Wirtz, Denis] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA; [Kusuma, Sravanti; Mali, Prashant] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Cheng, Linzhao] Johns Hopkins Sch Med, Inst Cell Engn, Baltimore, MD USA; [Cheng, Linzhao] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Lee, Jerry S. H.] NCI, Ctr Strateg Sci Initiat, Off Director, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Khatau, SB (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Lee, Jerry/K-4553-2014; Lee, Jerry S.H./AAL-1072-2021; Gerecht, Sharon/A-3388-2010; Lee, Jerry/A-3189-2008; Hanjaya-Putra, Donny/P-1611-2017	Lee, Jerry S.H./0000-0003-1515-0952; Lee, Jerry/0000-0003-1515-0952; Hanjaya-Putra, Donny/0000-0002-3039-9206	National Institutes of Health [R01GM075305, U54CA143868, RC2HL101582]; March of Dimes Basil O'Conner Scholar Award; National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology; NATIONAL CANCER INSTITUTE [U54CA143868] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Basil O'Conner Scholar Award; National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM075305 and U54CA143868 (to DW), RC2HL101582 (to LC), and March of Dimes Basil O'Conner Scholar Award (to SG). SBK was partially supported by a National Science Foundation graduate training program in the Johns Hopkins Institute for NanoBioTechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Celedon A, 2011, BIOPHYS J, V101, P1880, DOI 10.1016/j.bpj.2011.09.008; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Gay O, 2011, P NATL ACAD SCI USA, V108, P11464, DOI 10.1073/pnas.1104211108; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Khatau SB, 2010, NUCLEUS-PHILA, V1, P337, DOI 10.4161/nucl.1.4.12331; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Malone C, 2003, CELL MOTIL CYTOSKEL, V54, P168; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Panorchan P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041906; Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2001, DEVELOPMENT, V128, P5039; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Technau M, 2008, FLY, V2, P82, DOI 10.4161/fly.6288; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhen YY, 2002, J CELL SCI, V115, P3207	37	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36689	10.1371/journal.pone.0036689	http://dx.doi.org/10.1371/journal.pone.0036689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574215	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800112
J	Zhang, YR; Zhao, YQ; Huang, JF				Zhang, Yu-Ru; Zhao, Yu-Qi; Huang, Jing-Fei			Retinoid-Binding Proteins: Similar Protein Architectures Bind Similar Ligands via Completely Different Ways	PLOS ONE			English	Article							ACID; COMPLEX; IDENTIFICATION; SUMMARIES; ALIGNMENT; RECEPTOR; DATABASE; FAMILY; PDBSUM; SITE	Background: Retinoids are a class of compounds that are chemically related to vitamin A, which is an essential nutrient that plays a key role in vision, cell growth and differentiation. In vivo, retinoids must bind with specific proteins to perform their necessary functions. Plasma retinol-binding protein (RBP) and epididymal retinoic acid binding protein (ERABP) carry retinoids in bodily fluids, while cellular retinol-binding proteins (CRBPs) and cellular retinoic acid-binding proteins (CRABPs) carry retinoids within cells. Interestingly, although all of these transport proteins possess similar structures, the modes of binding for the different retinoid ligands with their carrier proteins are different. Methodology/Principal Findings: In this work, we analyzed the various retinoid transport mechanisms using structure and sequence comparisons, binding site analyses and molecular dynamics simulations. Our results show that in the same family of proteins and subcellular location, the orientation of a retinoid molecule within a binding protein is same, whereas when different families of proteins are considered, the orientation of the bound retinoid is completely different. In addition, none of the amino acid residues involved in ligand binding is conserved between the transport proteins. However, for each specific binding protein, the amino acids involved in the ligand binding are conserved. The results of this study allow us to propose a possible transport model for retinoids. Conclusions/Significance: Our results reveal the differences in the binding modes between the different retinoid-binding proteins.	[Zhang, Yu-Ru; Zhao, Yu-Qi; Huang, Jing-Fei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Zhang, Yu-Ru; Zhao, Yu-Qi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Huang, Jing-Fei] Chinese Univ Hongkong, Joint Res Ctr Bioresources & Human Dis Mech, Kunming Inst Zool, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese University of Hong Kong	Zhang, YR (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	huangjf@mail.kiz.ac.cn	Zhao, Yuqi/L-5639-2016	Zhao, Yuqi/0000-0003-0730-5854; Zhao, Yuqi/0000-0002-4256-4512	National Program on Key Basic Research Project (973 Program) [2009CB941302]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work have supported by the National Program on Key Basic Research Project (973 Program)(Grant No. 2009CB941302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; BASS NM, 1993, MOL CELL BIOCHEM, V123, P191, DOI 10.1007/BF01076492; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Calderone V, 2003, J MOL BIOL, V329, P841, DOI 10.1016/S0022-2836(03)00468-6; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; DONOVAN M, 1995, J STEROID BIOCHEM, V53, P459, DOI 10.1016/0960-0760(95)00092-E; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Franzoni L, 2002, J BIOL CHEM, V277, P21983, DOI 10.1074/jbc.M201994200; Grune T, 2010, J NUTR, V140, p2268S, DOI 10.3945/jn.109.119024; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Holland LZ, 2007, NATURE, V447, P153, DOI 10.1038/447153a; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2010, METHODS MOL BIOL, V652, P341, DOI 10.1007/978-1-60327-325-1_20; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Lu JY, 2003, J MOL BIOL, V330, P799, DOI 10.1016/S0022-2836(03)00629-6; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; NEWCOMER ME, 1995, FASEB J, V9, P229, DOI 10.1096/fasebj.9.2.7781925; NEWCOMER ME, 1993, STRUCTURE, V1, P7, DOI 10.1016/0969-2126(93)90004-Z; Redondo C, 2008, FASEB J, V22, P1043, DOI 10.1096/fj.07-8939com; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; STUMP DG, 1991, J BIOL CHEM, V266, P4622; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; ZANOTTI G, 1993, J MOL BIOL, V230, P613, DOI 10.1006/jmbi.1993.1173; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8	33	24	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36772	10.1371/journal.pone.0036772	http://dx.doi.org/10.1371/journal.pone.0036772			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574224	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800121
J	Cong, R; Wu, B; Qiu, YY; Wang, L				Cong, Rui; Wu, Bin; Qiu, Yuanying; Wang, Long			Evolution of Cooperation Driven by Reputation-Based Migration	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; EMERGENCE; MOBILITY	How cooperation emerges and is stabilized has been a puzzling problem to biologists and sociologists since Darwin. One of the possible answers to this problem lies in the mobility patterns. These mobility patterns in previous works are either random-like or driven by payoff-related properties such as fitness, aspiration, or expectation. Here we address another force which drives us to move from place to place: reputation. To this end, we propose a reputation-based model to explore the effect of migration on cooperation in the contest of the prisoner's dilemma. In this model, individuals earn their reputation scores through previous cooperative behaviors. An individual tends to migrate to a new place if he has a neighborhood of low reputation. We show that cooperation is promoted for relatively large population density and not very large temptation to defect. A higher mobility sensitivity to reputation is always better for cooperation. A longer reputation memory favors cooperation, provided that the corresponding mobility sensitivity to reputation is strong enough. The microscopic perception of the effect of this mechanism is also given. Our results may shed some light on the role played by migration in the emergence and persistence of cooperation.	[Cong, Rui; Qiu, Yuanying; Wang, Long] Xidian Univ, MOE Key Lab Elect Equipment Struct Design, Sch Mechanoelect Engn, Xian, Peoples R China; [Wu, Bin; Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Ctr Syst & Control, Beijing 100871, Peoples R China	Xidian University; Peking University	Cong, R (corresponding author), Xidian Univ, MOE Key Lab Elect Equipment Struct Design, Sch Mechanoelect Engn, Xian, Peoples R China.	congrui0000@126.com; bin.wu@evolbio.mpg.de	Wang, Long/A-7798-2010; Gao, Y./GWZ-3665-2022; Cong, Rui/H-7022-2016	Wang, Long/0000-0001-5600-8157; Cong, Rui/0000-0003-4159-9681	National Natural Science Foundation of China (NSFC) [51175397, 61020106005, 10972002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (NSFC) under Grant No. 51175397, No. 61020106005, and No. 10972002 (http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 2008, ESSAYS PEDAGOGY; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Cheng HY, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123014; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gonzalez MC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088702; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Lin H, 2011, CHAOS SOLITON FRACT, V44, P153, DOI 10.1016/j.chaos.2011.01.004; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2004, J THEOR BIOL, V231, P107, DOI 10.1016/j.jtbi.2004.06.005; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2006, EUROPHYS LETT, V75, P841, DOI 10.1209/epl/i2006-10217-3; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066101; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Saavedra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013475; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Sicardi EA, 2009, J THEOR BIOL, V256, P240, DOI 10.1016/j.jtbi.2008.09.022; Sigmund K., 1993, GAMES LIFE EXPLORATI; SMITH JM, 1976, Q REV BIOL, V51, P277, DOI 10.1086/409311; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Traulsen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000270; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Vainstein MH, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051905; Volstorf J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018945; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wu B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046111; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Wu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027669; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Yu WJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026105; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026724	55	85	88	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e35776	10.1371/journal.pone.0035776	http://dx.doi.org/10.1371/journal.pone.0035776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22615739	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341300006
J	Akagi, J; Khoshmanesh, K; Evans, B; Hall, CJ; Crosier, KE; Cooper, JM; Crosier, PS; Wlodkowic, D				Akagi, Jin; Khoshmanesh, Khashayar; Evans, Barbara; Hall, Chris J.; Crosier, Kathryn E.; Cooper, Jonathan M.; Crosier, Philip S.; Wlodkowic, Donald			Miniaturized Embryo Array for Automated Trapping, Immobilization and Microperfusion of Zebrafish Embryos	PLOS ONE			English	Article							VIVO DRUG DISCOVERY; TRANSGENIC ZEBRAFISH; THROUGHPUT; INHIBITOR; ELEGANS; MODELS	Zebrafish (Danio rerio) has recently emerged as a powerful experimental model in drug discovery and environmental toxicology. Drug discovery screens performed on zebrafish embryos mirror with a high level of accuracy the tests usually performed on mammalian animal models, and fish embryo toxicity assay (FET) is one of the most promising alternative approaches to acute ecotoxicity testing with adult fish. Notwithstanding this, automated in-situ analysis of zebrafish embryos is still deeply in its infancy. This is mostly due to the inherent limitations of conventional techniques and the fact that metazoan organisms are not easily susceptible to laboratory automation. In this work, we describe the development of an innovative miniaturized chip-based device for the in-situ analysis of zebrafish embryos. We present evidence that automatic, hydrodynamic positioning, trapping and long-term immobilization of single embryos inside the microfluidic chips can be combined with time-lapse imaging to provide real-time developmental analysis. Our platform, fabricated using biocompatible polymer molding technology, enables rapid trapping of embryos in low shear stress zones, uniform drug microperfusion and high-resolution imaging without the need of manual embryo handling at various developmental stages. The device provides a highly controllable fluidic microenvironment and post-analysis eleuthero-embryo stage recovery. Throughout the incubation, the position of individual embryos is registered. Importantly, we also for first time show that microfluidic embryo array technology can be effectively used for the analysis of anti-angiogenic compounds using transgenic zebrafish line (fli1a:EGFP). The work provides a new rationale for rapid and automated manipulation and analysis of developing zebrafish embryos at a large scale.	[Akagi, Jin; Khoshmanesh, Khashayar; Evans, Barbara; Wlodkowic, Donald] Univ Auckland, Sch Chem Sci, BioMEMS Res Grp, Auckland 1, New Zealand; [Khoshmanesh, Khashayar] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia; [Hall, Chris J.; Crosier, Kathryn E.; Crosier, Philip S.] Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Cooper, Jonathan M.] Univ Glasgow, Sch Engn, Glasgow, Lanark, Scotland; [Wlodkowic, Donald] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	University of Auckland; Royal Melbourne Institute of Technology (RMIT); University of Auckland; University of Glasgow; Royal Melbourne Institute of Technology (RMIT)	Akagi, J (corresponding author), Univ Auckland, Sch Chem Sci, BioMEMS Res Grp, Auckland 1, New Zealand.	d.wlodkowic@auckland.ac.nz	Wlodkowic, Donald/F-2431-2010; Wlodkowic, Donald/P-4124-2019; Cooper, Jonathan/E-9000-2010; Cooper, Jonathan/GLS-9195-2022	Wlodkowic, Donald/0000-0002-0780-3362; Wlodkowic, Donald/0000-0002-0780-3362; Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Khoshmanesh, Khashayar/0000-0001-6036-7371; Hall, Chris/0000-0001-6473-7720	Faculty Research and Development Fund, University of Auckland, New Zealand; Australia Endeavour Awards, Department of Education, Employment and Workplace Relations, Australia; Ministry of Science AMP; Innovation New Zealand; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Scottish Funding Council UK under the RASOR (Radical Solutions for Researching the proteome) Program; Biotechnology and Biological Sciences Research Council [BB/C511572/1] Funding Source: researchfish	Faculty Research and Development Fund, University of Auckland, New Zealand; Australia Endeavour Awards, Department of Education, Employment and Workplace Relations, Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Ministry of Science AMP; Innovation New Zealand; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Scottish Funding Council UK under the RASOR (Radical Solutions for Researching the proteome) Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Grant sponsor: Supported by Faculty Research and Development Fund, University of Auckland, New Zealand (JA, KK, BE, DW); The Australia Endeavour Awards, Department of Education, Employment and Workplace Relations, Australia (KK); Ministry of Science & Innovation New Zealand (CJH, KEC, PSC); and Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC) and Scottish Funding Council UK, funded under the RASOR (Radical Solutions for Researching the proteome) Program (JMC, DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchanan CM, 2012, CLIN SCI, V122, P449, DOI 10.1042/CS20110412; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Evensen L, 2010, CURR PHARM DESIGN, V16, P3958, DOI 10.2174/138161210794455030; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; Funfak A, 2007, LAB CHIP, V7, P1132, DOI 10.1039/b701116d; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Khoshmanesh K, 2011, ELECTROPHORESIS, V32, P3129, DOI 10.1002/elps.201100160; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobel S, 2010, LAB CHIP, V10, P857, DOI 10.1039/b918055a; Lammer E, 2009, TOXICOL IN VITRO, V23, P1436, DOI 10.1016/j.tiv.2009.05.014; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lucchetta EM, 2006, LAB CHIP, V6, P185, DOI 10.1039/b516119c; Nakamura K, 2006, CANCER RES, V66, P9134, DOI 10.1158/0008-5472.CAN-05-4290; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Pulak R, 2002, GENET ENG NEWS, V22, P32; Pulak Rock, 2006, V351, P275; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Son SU, 2009, LAB CHIP, V9, P2398, DOI 10.1039/b906257b; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; Tanyeri M, 2011, LAB CHIP, V11, P1786, DOI [10.1039/c01c00709a, 10.1039/c0lc00709a]; Vogt A, 2009, DEV DYNAM, V238, P656, DOI 10.1002/dvdy.21892; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; Wlodkowic D, 2011, CYTOM PART A, V79A, P799, DOI 10.1002/cyto.a.21070; Wlodkowic D, 2009, ANAL CHEM, V81, P9828, DOI 10.1021/ac902010s; Wlodkowic D, 2009, ANAL CHEM, V81, P5517, DOI 10.1021/ac9008463; Yang F, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3605509; Yin HB, 2007, ANAL CHEM, V79, P7139, DOI 10.1021/ac071146k; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	36	63	64	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36630	10.1371/journal.pone.0036630	http://dx.doi.org/10.1371/journal.pone.0036630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606275	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400026
J	Boutant, M; Ramos, OHP; Lecoeur, C; Vaillant, E; Philippe, J; Zhang, PL; Perilhou, A; Valcarcel, B; Sebert, S; Jarvelin, MR; Balkau, B; Scott, D; Froguel, P; Vaxillaire, M; Vasseur-Cognet, M				Boutant, Marie; Ramos, Oscar Henrique Pereira; Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Zhang, Pili; Perilhou, Anais; Valcarcel, Beatriz; Sebert, Sylvain; Jarvelin, Mario-Ritta; Balkau, Beverley; Scott, Donald; Froguel, Philippe; Vaxillaire, Martine; Vasseur-Cognet, Mireille			Glucose-Dependent Regulation of NR2F2 Promoter and Influence of SNP-rs3743462 on Whole Body Insulin Sensitivity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES RISK; COUP-TFII; FASTING GLUCOSE; DESIR; LOCI; HOMEOSTASIS; EXPRESSION; IMPACT; GENE	Background: The Nuclear Receptor 2F2 (NR2F2/COUP-TFII) heterozygous knockout mice display low basal insulinemia and enhanced insulin sensitivity. We previously established that insulin represses NR2F2 gene expression in pancreatic beta-cells. The cis-regulatory region of the NR2F2 promoter is unknown and its influence on metabolism in humans is poorly understood. The present study aimed to identify the regulatory regions that control NR2F2 gene transcription and to evaluate the effect of NR2F2 promoter variation on glucose homeostasis in humans. Methodology/Principal Findings: Regulation of the NR2F2 promoter was assessed using gene reporter assays, ChIP and gelshift experiments. The effects of variation at SNP rs3743462 in NR2F2 on quantitative metabolic traits were studied in two European prospective cohorts. We identified a minimal promoter region that down-regulates NR2F2 expression by attenuating HNF4 alpha activation in response to high glucose concentrations. Subjects of the French DESIR population, who carried thers3743462T-to-C polymorphism, located in the distal glucose-responsive promoter, displayed lower basal insulin levels and lower HOMA-IR index. The C-allele at rs3743462 was associated with increased NR2F2 binding and decreased NR2F2 gene expression. Conclusions/Significance: The rs3743462 polymorphism affects glucose-responsive NR2F2 promoter regulation and thereby may influence whole-body insulin sensitivity, suggesting a role of NR2F2 in the control of glucose homeostasis in humans.	[Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] Cochin Inst, Dept Endocrinol Metab & Canc, CNRS, UMR 8104, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] INSERM, U1016, Paris, France; [Boutant, Marie; Ramos, Oscar Henrique Pereira; Perilhou, Anais; Vasseur-Cognet, Mireille] Univ Paris 05, Paris, France; [Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Froguel, Philippe; Vaxillaire, Martine] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Lecoeur, Cecile; Vaillant, Emmanuel; Philippe, Julien; Froguel, Philippe; Vaxillaire, Martine] Lille Nord France Univ, Lille, France; [Zhang, Pili; Scott, Donald] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA USA; [Valcarcel, Beatriz; Sebert, Sylvain; Jarvelin, Mario-Ritta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Fac Med, London, England; [Balkau, Beverley] INSERM, U1018, Ctr Rech Epidemiol & Sante Populat, Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, Villejuif, France; [Sebert, Sylvain; Jarvelin, Mario-Ritta] Univ Oulu, Inst Hlth Sci, Bioctr Oulu, Oulu, Finland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Genom Common Dis, Sch Publ Hlth, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Oulu; Imperial College London	Boutant, M (corresponding author), Cochin Inst, Dept Endocrinol Metab & Canc, CNRS, UMR 8104, Paris, France.	mireille.vasseur@inserm.fr	Ramos, Oscar HP/E-1862-2013; Philippe, Julien/R-5183-2019; FROGUEL, Philippe/O-6799-2017; Vasseur, Mireille/L-6958-2017	Ramos, Oscar HP/0000-0002-5788-4500; FROGUEL, Philippe/0000-0003-2972-0784; Vasseur, Mireille/0000-0001-6963-4114; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Philippe, Julien/0000-0003-1906-7259; Sebert, Sylvain/0000-0001-6681-6983	European Foundation for the Study of Diabetes; program partner Merck Sharp Dohme; Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 'Axe Cardio-Diabete'); National de la Recherche Scientifique (CNRS); INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofiaventis; INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche; Topcon; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project [HEALTH-F4-2007-201413]; Medical Research Council, UK [G0500539]; Ministere del'Enseignement Superieur et de la Recherche; Association pour la Recherche sur le Cancer; Ile-de-France [CODDIM2008]; Merck Sharp Dohme; MRC [G1002084] Funding Source: UKRI; Medical Research Council [G0801056B, G1002084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	European Foundation for the Study of Diabetes; program partner Merck Sharp Dohme; Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 'Axe Cardio-Diabete')(Region Hauts-de-France); National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofiaventis(Sanofi-Aventis); INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche(Roche Holding); Topcon; NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministere del'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ile-de-France; Merck Sharp Dohme(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the European Foundation for the Study of Diabetes and the program partner Merck Sharp & Dohme 2010 to M. V.-C., from the Contrat de Projets Etat-Region Nord-Pas-De-Calais (CPER 2007-2013 'Axe Cardio-Diabete') to M. V. and P. F., and Centre National de la Recherche Scientifique (CNRS). The D.E.S.I.R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma, and Sanofiaventis, and by INSERM (Reseauxen Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR 2008), the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Societe Francophone du Diabete, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, and Topcon. Additional support came from the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643); NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01); NIH/NIMH (5R01MH63706:02); ENGAGE project and grant agreement HEALTH-F4-2007-201413; and the Medical Research Council, UK (studentship grant G0500539). M. B. is the recipient of doctoral fellowships from the Ministere del'Enseignement Superieur et de la Recherche and Association pour la Recherche sur le Cancer. O.H.P.R. was the recipient of a 12-month post-doctoral fellowship from Ile-de-France CODDIM2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest: This work was supported by grants from Merck Sharp & Dohme. The D. E. S. I. R. study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma, and Sanofiaventis, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, and Topcon. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Boutant M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030847; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sabra-Makke L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013464; Skilton MR, 2011, ATHEROSCLEROSIS, V216, P471, DOI 10.1016/j.atherosclerosis.2011.02.032; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soosaar A, 1996, FEBS LETT, V391, P95, DOI 10.1016/0014-5793(96)00711-9; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang P, 2002, MECH DEVELOP, V119, P109, DOI 10.1016/S0925-4773(02)00286-1; Zhang P, 2010, MOL ENDOCRINOL, V24, P1274, DOI 10.1210/me.2009-0437	26	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35810	10.1371/journal.pone.0035810	http://dx.doi.org/10.1371/journal.pone.0035810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606236	Green Published, gold, Green Accepted			2022-12-27	WOS:000305339400006
J	Ahmed, SF; Klena, JD; Mostafa, M; Dogantemur, J; Middleton, T; Hanson, J; Sebeny, PJ				Ahmed, Salwa F.; Klena, John D.; Mostafa, Manal; Dogantemur, Jessica; Middleton, Tracy; Hanson, James; Sebeny, Peter J.			Viral Gastroenteritis Associated with Genogroup II Norovirus among US Military Personnel in Turkey, 2009	PLOS ONE			English	Article							UNITED-STATES; OUTBREAKS; EPIDEMIOLOGY; MARINES; VIRUSES; ILLNESS; ASSAY	The present study demonstrates that multiple NoV genotypes belonging to genogroup II contributed to an acute gastroenteritis outbreak at a US military facility in Turkey that was associated with significant negative operational impact. Norovirus (NoV) is an important pathogen associated with acute gastroenteritis among military populations. We describe the genotypes of NoV outbreak occurred at a United States military facility in Turkey. Stool samples were collected from 37 out of 97 patients presenting to the clinic on base with acute gastroenteritis and evaluated for bacterial and viral pathogens. NoV genogroup II (GII) was identified by RT-PCR in 43% (16/37) stool samples. Phylogenetic analysis of a 260 base pair fragment of the NoV capsid gene from ten stool samples indicated the circulation of multiple and rare genotypes of GII NoV during the outbreak. We detected four GII.8 isolates, three GII.15, two GII.9 and a sole GII.10 NoV. Viral sequences could be grouped into four clusters, three of which have not been previously reported in Turkey. The fact that current NoV outbreak was caused by rare genotypes highlights the importance of norovirus strain typing. While NoV genogroup II is recognized as causative agent of outbreak, circulation of current genotypes has been rarely observed in large number of outbreaks.	[Ahmed, Salwa F.; Klena, John D.; Mostafa, Manal; Sebeny, Peter J.] United States Naval Med Res Unit 3, Cairo, Egypt; [Dogantemur, Jessica; Middleton, Tracy; Hanson, James] Incirlik Air Base, Incirlik, Turkey	Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Ahmed, SF (corresponding author), United States Naval Med Res Unit 3, Cairo, Egypt.	salwa.fouad.eg@med.navy.mil			Military Infectious Disease Research Program (MIDRP) - The Epidemiology and Management of Diarrhea Among Deployed US Forces [D0105_09_N3]	Military Infectious Disease Research Program (MIDRP) - The Epidemiology and Management of Diarrhea Among Deployed US Forces	This work was supported by the Military Infectious Disease Research Program (MIDRP) proposal D0105_09_N3 - The Epidemiology and Management of Diarrhea Among Deployed US Forces to CENTCOM and EUCOM theaters of operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Altindis M, 2009, SCAND J INFECT DIS, V41, P685, DOI 10.1080/00365540903071342; [Anonymous], [No title captured]; [Anonymous], REAL WORLD SPRING 20; Bailey M S, 2008, J R Army Med Corps, V154, P156; CLSI Clinical Laboratory Standars Institute, 2009, M100S1993 CLSI; Costantini V, 2010, J CLIN MICROBIOL, V48, P2770, DOI 10.1128/JCM.00654-10; Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Gallimore C I, 2003, Commun Dis Public Health, V6, P285; Goodgame Richard, 2007, Curr Infect Dis Rep, V9, P102, DOI 10.1007/s11908-007-0004-5; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Koo HL, 2010, DISCOV MED, V10, P61; Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08; Lopman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006671; Mans J, 2010, J CLIN VIROL, V49, P258, DOI 10.1016/j.jcv.2010.08.011; Matson DO, 2005, CLIN INFECT DIS, V40, P526, DOI 10.1086/427508; Mattison K, 2009, J CLIN MICROBIOL, V47, P3927, DOI 10.1128/JCM.00497-09; McCarthy M, 2000, J INFECT DIS, V181, pS387, DOI 10.1086/315582; Nada RA, 2010, DIAGN MICR INFEC DIS, V67, P134, DOI 10.1016/j.diagmicrobio.2010.01.011; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501; Vega E, 2011, EMERG INFECT DIS, V17, P1516, DOI 10.3201/eid1708.110025; Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001; Vinje J, 2000, ARCH VIROL, V145, P223, DOI 10.1007/s007050050020	35	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35791	10.1371/journal.pone.0035791	http://dx.doi.org/10.1371/journal.pone.0035791			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606235	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338200013
J	Chappell, JM; Iqbal, A; Abbott, D				Chappell, James M.; Iqbal, Azhar; Abbott, Derek			N-Player Quantum Games in an EPR Setting	PLOS ONE			English	Article							BELL INEQUALITIES; HILBERT-SPACE; MINORITY GAME; STRATEGIES; ENTANGLEMENT; MULTIPLAYER; INFORMATION; ADVANTAGE; STATES	The N-player quantum games are analyzed that use an Einstein-Podolsky-Rosen (EPR) experiment, as the underlying physical setup. In this setup, a player's strategies are not unitary transformations as in alternate quantum game-theoretic frameworks, but a classical choice between two directions along which spin or polarization measurements are made. The players' strategies thus remain identical to their strategies in the mixed-strategy version of the classical game. In the EPR setting the quantum game reduces itself to the corresponding classical game when the shared quantum state reaches zero entanglement. We find the relations for the probability distribution for N-qubit GHZ and W-type states, subject to general measurement directions, from which the expressions for the players' payoffs and mixed Nash equilibrium are determined. Players' N x N payoff matrices are then defined using linear functions so that common two-player games can be easily extended to the N-player case and permit analytic expressions for the Nash equilibrium. As a specific example, we solve the Prisoners' Dilemma game for general N >= 2. We find a new property for the game that for an even number of players the payoffs at the Nash equilibrium are equal, whereas for an odd number of players the cooperating players receive higher payoffs. By dispensing with the standard unitary transformations on state vectors in Hilbert space and using instead rotors and multivectors, based on Clifford's geometric algebra (GA), it is shown how the N-player case becomes tractable. The new mathematical approach presented here has wide implications in the areas of quantum information and quantum complexity, as it opens up a powerful way to tractably analyze N-partite qubit interactions.	[Chappell, James M.; Iqbal, Azhar; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.m.chappell@adelaide.edu.au	Abbott, Derek/E-8352-2011; Iqbal, Azhar/E-8749-2011	Abbott, Derek/0000-0002-0945-2674; Iqbal, Azhar/0000-0002-5221-9384				Aharon N, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052310; Ahmed A, 2008, ARXIV08081391; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bell J. S., 1964, PHYSICS, V1, P195, DOI [10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bell J. S., 2004, SPEAKABLE UNSPEAKABL, V2nd, DOI DOI 10.1017/CBO9780511815676; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Benjamin SC, 2000, PHYS REV A, V64, P5; Binmore K., 2007, GAME THEORY VERY SHO, V173; Blaquiere A., 1980, DYNAMICAL SYSTEMS MI, P33, DOI 10.1007/978-3-7091-4330-8_2; Bleiler SA, 2008, ARXIV08081389; Bohm D., 1951, QUANTUM THEORY; Boyer M, 2004, ARXIVQUANTPH048090; Broom M, 1997, B MATH BIOL, V59; Cereceda JL, 2000, FOUND PHYS LETT, V13, P427, DOI 10.1023/A:1007828731477; Chappell JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029015; Chappell JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021623; Chappell JM, 2010, PHYS LETT A, V374, P4104, DOI 10.1016/j.physleta.2010.08.024; Chappell JM, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.054801; Chen Q, 2004, PHYS LETT A, V327, P98, DOI 10.1016/j.physleta.2004.05.012; Cheon T, 2006, PHYS LETT A, V348, P147, DOI 10.1016/j.physleta.2005.08.066; Cheon T, 2006, AIP CONF PROC, V864, P254, DOI 10.1063/1.2400897; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Sabbata V., 2007, GEOMETRIC ALGEBRA AP; Doran C., 2003, GEOMETRIC ALGEBRA PH, DOI DOI 10.1017/CBO9780511807497; Dorst L., 2002, APPL GEOMETRIC ALGEB; Du JF, 2002, PHYS LETT A, V302, P229, DOI 10.1016/S0375-9601(02)01144-1; Du JF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137902; Du JF, 2002, CHINESE PHYS LETT, V19, P1221, DOI 10.1088/0256-307X/19/9/301; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Eisert J, 1999, PHYS REV LETT, V83, P3077, DOI 10.1103/PhysRevLett.83.3077; Flitney AP, 2002, FLUCT NOISE LETT, V2, pR175, DOI 10.1142/S0219477502000981; Flitney AP, 2007, PHYS LETT A, V363, P381, DOI 10.1016/j.physleta.2006.11.044; Flitney AP, 2007, PHYS LETT A, V362, P132, DOI 10.1016/j.physleta.2006.10.007; Flitney AP, 2009, PHYS LETT A, V373, P521, DOI 10.1016/j.physleta.2008.12.003; Flitney AP, 2005, J PHYS A-MATH GEN, V38, P449, DOI 10.1088/0305-4470/38/2/011; Flitney AP, 2003, P ROY SOC A-MATH PHY, V459, P2463, DOI 10.1098/rspa.2003.1136; Guo H, 2008, DECIS SUPPORT SYST, V46, P318, DOI 10.1016/j.dss.2008.07.001; Han YJ, 2002, PHYS LETT A, V295, P61, DOI 10.1016/S0375-9601(02)00168-8; Havel TF, 2002, QUANTUM INFORMATION, V305, P81; HESTENES D, 1984, CLIFFORD ALGEBRA GEO, V5; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Ichikawa T, 2007, ANN PHYS-NEW YORK, V322, P531, DOI 10.1016/j.aop.2006.05.001; Ichikawa T, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/13/135303; Iqbal A, 2005, J PHYS A-MATH GEN, V38, P9551, DOI 10.1088/0305-4470/38/43/009; Iqbal A, 2004, J PHYS A-MATH GEN, V37, P5873, DOI 10.1088/0305-4470/37/22/012; Iqbal A, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.052328; Iqbal A, 2002, PHYS LETT A, V293, P103, DOI 10.1016/S0375-9601(02)00003-8; Iqbal A, 2001, PHYS LETT A, V280, P249, DOI 10.1016/S0375-9601(01)00082-2; Iqbal A, 2007, SPIE, V6802, P1, DOI [10.1117/12.774374, DOI 10.1117/12.774374]; Iqbal A, 2009, PHYS LETT A, V373, P2537, DOI 10.1016/j.physleta.2009.05.020; Iqbal A, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.014803; Iqbal A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061122; Iqbal A, 2008, PHYS LETT A, V372, P6564, DOI 10.1016/j.physleta.2008.09.026; Ji M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036113; Johnson NF, 2000, PHYS REV A, V63, P1; Li Q, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/44/445303; Marinatto L, 2000, PHYS LETT A, V272, P291, DOI 10.1016/S0375-9601(00)00441-2; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Mendes RV, 2005, QUANTUM INF PROCESS, V4, P1, DOI 10.1007/s11128-005-3192-7; MERMIN ND, 1990, AM J PHYS, V58, P731, DOI 10.1119/1.16503; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Meyer DA, 1999, PHYS REV LETT, V82, P1052, DOI 10.1103/PhysRevLett.82.1052; Nawaz A, 2004, J PHYS A-MATH GEN, V37, P11457, DOI 10.1088/0305-4470/37/47/014; Nielsen MA., 2002, QUANTUM COMPUTATION; Ozdemir SK, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/2/043; Ozdemir SK, 2004, PHYS LETT A, V325, P104, DOI 10.1016/j.physleta.2004.03.042; Peres Asher., 1993, QUANTUM THEORY CONCE, V57; Piotrowski EW, 2003, INT J THEOR PHYS, V42, P1089, DOI 10.1023/A:1025443111388; Piotrowski EW, 2002, PHYSICA A, V312, P208, DOI 10.1016/S0378-4371(02)00842-7; Ramzan M, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/5/055307; Rasmusen E., 2007, GAMES INFORM INTRO G; Shimamura J, 2004, INT J QUANTUM INF, V2, P79, DOI 10.1142/S0219749904000092; Shimamura J, 2004, PHYS LETT A, V328, P20, DOI 10.1016/j.physleta.2004.06.006; Vaidman L, 1999, FOUND PHYS, V29, P755, DOI 10.1023/A:1018826607583; van Enk SJ, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.024306; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Wiesner S., 1983, SIGACT News, V15, P78, DOI 10.1145/1008908.1008920	77	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36404	10.1371/journal.pone.0036404	http://dx.doi.org/10.1371/journal.pone.0036404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606258	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338200026
J	Grabenhenrich, L; Hompes, S; Gough, H; Rueff, F; Scherer, K; Pfohler, C; Treudler, R; Mahler, V; Hawranek, T; Nemat, K; Koehli, A; Keil, T; Worm, M				Grabenhenrich, Linus; Hompes, Stephanie; Gough, Hannah; Rueff, Franziska; Scherer, Kathrin; Pfoehler, Claudia; Treudler, Regina; Mahler, Vera; Hawranek, Thomas; Nemat, Katja; Koehli, Alice; Keil, Thomas; Worm, Margitta			Implementation of Anaphylaxis Management Guidelines: A Register-Based Study	PLOS ONE			English	Article							ALLERGIC REACTIONS; EPIDEMIOLOGY; IMMUNOLOGY; COMMUNITY	Background: Anaphylaxis management guidelines recommend the use of intramuscular adrenaline in severe reactions, complemented by antihistamines and corticoids; secondary prevention includes allergen avoidance and provision of self-applicable first aid drugs. Gaps between recommendations and their implementation have been reported, but only in confined settings. Hence, we analysed nation-wide data on the management of anaphylaxis, evaluating the implementation of guidelines. Methods: Within the anaphylaxis registry, allergy referral centres across Germany, Austria and Switzerland provided data on severe anaphylaxis cases. Based on patient records, details on reaction circumstances, diagnostic workup and treatment were collected via online questionnaire. Report of anaphylaxis through emergency physicians allowed for validation of registry data. Results: 2114 severe anaphylaxis patients from 58 centres were included. 8% received adrenaline intravenously, 4% intramuscularly; 50% antihistamines, and 51% corticoids. Validation data indicated moderate underreporting of first aid drugs in the Registry. 20% received specific instructions at the time of the reaction; 81% were provided with prophylactic first aid drugs at any time. Conclusion: There is a distinct discrepancy between current anaphylaxis management guidelines and their implementation. To improve patient care, a revised approach for medical education and training on the management of severe anaphylaxis is warranted.	[Grabenhenrich, Linus; Gough, Hannah; Keil, Thomas] Charite, Med Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Worm, Margitta] Charite, Med Ctr Berlin, Dept Dermatol, Anaphylaxis Res, D-13353 Berlin, Germany; [Rueff, Franziska] Univ Munich, Dept Dermatol & Allergol, Munich, Germany; [Scherer, Kathrin] Univ Basel Hosp, Allergy Unit, Dept Dermatol, CH-4031 Basel, Switzerland; [Pfoehler, Claudia] Saarland Univ Hosp, Dept Dermatol, Div Allergy, Homburg, Germany; [Treudler, Regina] Univ Leipzig, Div Allergy, Dept Dermatol Venerol & Allergy, Leipzig, Germany; [Mahler, Vera] Univ Hosp Erlangen, Dept Allergy, Div Allergy, Erlangen, Germany; [Hawranek, Thomas] Paracelsus Private Med Univ Salzburg, Dept Dermatol, Dept Allergy, Salzburg, Austria; [Nemat, Katja] Univ Hosp Carl Gustav Carus, Childrens Hosp, Dept Pneumol & Allergol, Allergen Lab, Dresden, Germany; [Koehli, Alice] Univ Childrens Hosp Zurich, Div Allergol, Zurich, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Basel; Universitatsklinikum des Saarlandes; Leipzig University; University of Erlangen Nuremberg; Paracelsus Private Medical University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University Children's Hospital Zurich	Grabenhenrich, L (corresponding author), Charite, Med Ctr Berlin, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany.	margitta.worm@charite.de		Worm, Margitta/0000-0002-3449-1245; Grabenhenrich, Linus/0000-0002-9300-6625; Scherer, Kathrin/0000-0002-5235-2556	Allergopharma, Reinbek, Germany; ALK-Abello, Wedel, Germany; German Federal Office for Consumer Protection and Food Safety; Allergopharma; ALK-Abello	Allergopharma, Reinbek, Germany; ALK-Abello, Wedel, Germany; German Federal Office for Consumer Protection and Food Safety; Allergopharma; ALK-Abello	This work was supported by unrestricted grants from Allergopharma, Reinbek, Germany, ALK-Abello, Wedel, Germany and the German Federal Office for Consumer Protection and Food Safety. The funders had no role in the design, management, data collection, analysis or interpretation of the data or in the writing of the manuscript or the decision to submit for publication.; This work was supported by unrestricted grants from Allergopharma and ALK-Abello. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alrasbi M, 2007, ALLERGY, V62, P838, DOI 10.1111/j.1398-9995.2007.01434.x; Alves B, 2001, ARCH DIS CHILD, V85, P349; Choo KJL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007596.pub2; Decker WW, 2008, J ALLERGY CLIN IMMUN, V122, P1161, DOI 10.1016/j.jaci.2008.09.043; Estelle F, 2006, J ALLERGY CLIN IMMUN, V117, P367, DOI 10.1016/j.jaci.2005.12.002; Estelle F, 2001, J ALLERGY CLIN IMMUN, V108, P871, DOI 10.1067/mai.2001.119409; Gaeta TJ, 2007, ANN ALLERG ASTHMA IM, V98, P360, DOI 10.1016/S1081-1206(10)60883-6; Grouhi M, 1999, J ALLERGY CLIN IMMUN, V104, P190, DOI 10.1016/S0091-6749(99)70134-X; Gupta R, 2003, BRIT MED J, V327, P1142, DOI 10.1136/bmj.327.7424.1142; Haymore BR, 2005, ALLERGY ASTHMA PROC, V26, P361; Hompes S, 2011, PEDIAT ALLERGY IMMUN; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kastner M, 2010, ALLERGY, V65, P435, DOI 10.1111/j.1398-9995.2009.02294.x; Lieberman P, 2006, ANN ALLERG ASTHMA IM, V97, P596, DOI 10.1016/S1081-1206(10)61086-1; McLean-Tooke APC, 2003, BMJ-BRIT MED J, V327, P1332, DOI 10.1136/bmj.327.7427.1332; Mehl A, 2005, ALLERGY, V60, P1440, DOI 10.1111/j.1398-9995.2005.00909.x; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Ring J, 1999, CLIN REV ALLERG IMMU, V17, P387, DOI 10.1007/BF02737644; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Sheikh A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006160.pub2; Sheikh A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006312.pub2; Simons FER, 2008, J ALLERGY CLIN IMMUN, V122, P1166, DOI 10.1016/j.jaci.2008.10.019; Soar J, 2008, RESUSCITATION, V77, P157, DOI 10.1016/j.resuscitation.2008.02.001; Worm M, 2010, ALLERGY, V65, P671, DOI 10.1111/j.1398-9995.2010.02332.x	24	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e35778	10.1371/journal.pone.0035778	http://dx.doi.org/10.1371/journal.pone.0035778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590513	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336400008
J	Stockwell, MP; Clulow, J; Mahony, MJ				Stockwell, Michelle Pirrie; Clulow, John; Mahony, Michael Joseph			Sodium Chloride Inhibits the Growth and Infective Capacity of the Amphibian Chytrid Fungus and Increases Host Survival Rates	PLOS ONE			English	Article							PATHOGEN BATRACHOCHYTRIUM-DENDROBATIDIS; HYDROGEN-PEROXIDE; EMERGING DISEASE; CHYTRIDIOMYCOSIS; MORTALITY; DECLINES; BACTERIA; SAPROLEGNIOSIS; BIODIVERSITY; AUSTRALIA	The amphibian chytrid fungus Batrachochytrium dendrobatidis is a recently emerged pathogen that causes the infectious disease chytridiomycosis and has been implicated as a contributing factor in the global amphibian decline. Since its discovery, research has been focused on developing various methods of mitigating the impact of chytridiomycosis on amphibian hosts but little attention has been given to the role of antifungal agents that could be added to the host's environment. Sodium chloride is a known antifungal agent used routinely in the aquaculture industry and this study investigates its potential for use as a disease management tool in amphibian conservation. The effect of 0-5 ppt NaCl on the growth, motility and survival of the chytrid fungus when grown in culture media and its effect on the growth, infection load and survivorship of infected Peron's tree frogs (Litoria peronii) in captivity, was investigated. The results reveal that these concentrations do not negatively affect the survival of the host or the pathogen. However, concentrations greater than 3 ppt significantly reduced the growth and motility of the chytrid fungus compared to 0 ppt. Concentrations of 1-4 ppt NaCl were also associated with significantly lower host infection loads while infected hosts exposed to 3 and 4 ppt NaCl were found to have significantly higher survival rates. These results support the potential for NaCl to be used as an environmentally distributed antifungal agent for the prevention of chytridiomycosis in susceptible amphibian hosts. However, further research is required to identify any negative effects of salt exposure on both target and non-target organisms prior to implementation.	[Stockwell, Michelle Pirrie; Clulow, John; Mahony, Michael Joseph] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Stockwell, MP (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	michelle.stockwell@newcastle.edu.au		Clulow, John/0000-0001-8991-1449	Kooragang Wetland Rehabilitation Project	Kooragang Wetland Rehabilitation Project	Work was funded by the Kooragang Wetland Rehabilitation Project: http://www.hcr.cma.nsw.gov.au/kooragang/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bd-Maps (n.d.), GLOB BD MAPP PROJ; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; BERGER L, 1999, DECLINES DISAPPEARAN; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Blomberg A., 1993, STRESS TOLERANCE FUN, P209; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Gleason FH, 2006, MYCOL RES, V110, P869, DOI 10.1016/j.mycres.2006.04.002; Halse SA, 2003, AUST J BOT, V51, P673, DOI 10.1071/BT02113; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7; Li MH, 1996, J WORLD AQUACULT SOC, V27, P1, DOI 10.1111/j.1749-7345.1996.tb00587.x; Martel A, 2010, MED MYCOLOGY; McConnell TH, 2007, NATURE DIS; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; McKenzie NL, 2003, AUST J BOT, V51, P725, DOI 10.1071/BT02116; Mifsud C, 2008, AQUAC RES, V39, P1175, DOI 10.1111/j.1365-2109.2008.01981.x; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Schreier TM, 1996, AQUACULTURE, V140, P323, DOI 10.1016/0044-8486(95)01182-X; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sparling Donald W., 2010, P105; SPEARE R, 2005, CHYTRIDIOMYCOSIS STA; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stockwell M, 2011, THESIS U NEWCASTLE; Stockwell MP, 2010, ANIM CONSERV, V13, P62, DOI 10.1111/j.1469-1795.2010.00407.x; Stockwell MP, 2010, DIS AQUAT ORGAN, V88, P177, DOI 10.3354/dao02165; Stockwell M. P., 2008, Australian Zoologist, V34, P379; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamukai K, 2010, J VET MED SCI; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; WATERSTRAT PR, 1995, PROG FISH CULT, V57, P287, DOI 10.1577/1548-8640(1995)057&lt;0287:CCEOFH&gt;2.3.CO;2; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Wright Kevin M., 2001, P309	53	39	39	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36942	10.1371/journal.pone.0036942	http://dx.doi.org/10.1371/journal.pone.0036942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590639	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336400049
J	Ye, W; Chen, Y; Wang, W; Yu, QF; Li, YX; Zhang, J; Chen, HF				Ye, Wei; Chen, Yue; Wang, Wei; Yu, Qingfen; Li, Yixue; Zhang, Jian; Chen, Hai-Feng			Insight into the Stability of Cross-beta Amyloid Fibril from VEALYL Short Peptide with Molecular Dynamics Simulation	PLOS ONE			English	Article							STRUCTURAL STABILITY; FOLDING SIMULATIONS; FORMING PEPTIDE; PRION PROTEIN; EARLY STEPS; AGGREGATION; OLIGOMERS; MECHANISM; BINDING; POLYMORPHISM	Amyloid fibrils are found in many fatal neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, type II diabetes, and prion disease. The VEALYL short peptide from insulin has been confirmed to aggregate amyloid-like fibrils. However, the aggregation mechanism of amyloid fibril is poorly understood. Here, we utilized molecular dynamics simulation to analyse the stability of VEALYL hexamer. The statistical results indicate that hydrophobic residues play key roles in stabilizing VEALYL hexamer. Single point and two linkage mutants confirmed that Val1, Leu4, and Tyr5 of VEALYL are key residues. The consistency of the results for the VEALYL oligomer suggests that the intermediate states might be trimer (3-0) and pentamer(3-2). These results can help us to obtain an insight into the aggregation mechanism of amyloid fibril. These methods can be used to study the stability of amyloid fibril from other short peptides.	[Ye, Wei; Chen, Yue; Wang, Wei; Yu, Qingfen; Chen, Hai-Feng] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Yixue; Chen, Hai-Feng] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Ye, W (corresponding author), Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Dept Bioinformat & Biostat, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	yxli@scbit.org; jian.zhang@sjtu.edu.cn; haifengchen@sjtu.edu.cn	Chen, Haifeng/AAT-7444-2020; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Ye, Wei/0000-0001-6268-2703	 [2012CB721003];  [2012AA020403];  [YG2010MS67];  [10ZR1414500];  [10PJD010];  [10PJ1406800];  [12ZZ023]	; ; ; ; ; ; 	2012CB721003 http://www.most.gov.cn/; 2012AA020403 http://www.most.gov.cn/; YG2010MS67 http://www.sjtu.edu.cn/10ZR1414500; http://www.stcsm.gov.cn/; 10PJD010 http://www.stcsm.gov.cn/; 10PJ1406800 http://www.stcsm.gov.cn/; 12ZZ023 http://www.shdrc.gov.cn The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berryman JT, 2011, BIOPHYS J, V100, P2234, DOI 10.1016/j.bpj.2011.02.060; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Boucher G, 2006, PROTEINS, V65, P877, DOI 10.1002/prot.21134; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CASE DA, 2004, AMBER 8; Chebaro Y, 2009, PROTEINS, V75, P442, DOI 10.1002/prot.22254; Chen HF, 2008, J CHEM THEORY COMPUT, V4, P1360, DOI 10.1021/ct800030s; Chen HF, 2007, J AM CHEM SOC, V129, P2930, DOI 10.1021/ja0678774; Chen HF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006516; Chen HF, 2009, COMPUT BIOL CHEM, V33, P41, DOI 10.1016/j.compbiolchem.2008.07.023; Chen J, 2010, J AM CHEM SOC, V132, P17015, DOI 10.1021/ja107552s; Chen Y, 2010, BIOPOLYMERS, V93, P578, DOI 10.1002/bip.21405; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Connelly L, 2012, J PHYS CHEM B, V116, P1728, DOI 10.1021/jp2108126; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Day R, 2005, P NATL ACAD SCI USA, V102, P13445, DOI 10.1073/pnas.0501773102; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Derreumaux P, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408414; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Gnanakaran S, 2006, J AM CHEM SOC, V128, P2158, DOI 10.1021/ja0548337; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Kent A, 2008, J PHYS CHEM B, V112, P6175, DOI 10.1021/jp077099h; Lin YF, 2010, BIOPOLYMERS, V94, P269, DOI 10.1002/bip.21322; Lipfert J, 2005, J MOL BIOL, V349, P648, DOI 10.1016/j.jmb.2005.03.083; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Lwin TZ, 2006, PROTEIN SCI, V15, P2642, DOI 10.1110/ps.062438006; Masman MF, 2009, J PHYS CHEM B, V113, P11710, DOI 10.1021/jp901057w; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Nguyen HD, 2004, P NATL ACAD SCI USA, V101, P16180, DOI 10.1073/pnas.0407273101; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Qin F, 2012, PHYS CHEM CHEM PHYS, V14, P538, DOI 10.1039/c1cp22610j; Qin F, 2011, PHYS CHEM CHEM PHYS, V13, P1407, DOI 10.1039/c0cp00701c; Qin F, 2010, RNA, V16, P1053, DOI 10.1261/rna.2008110; Qin F, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3224126; Reddy G, 2010, P NATL ACAD SCI USA, V107, P21459, DOI 10.1073/pnas.1008616107; Rychaert J.P., 1977, COMPUT PHYS, V23, P327; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Toschi F, 2009, J PHYS CHEM B, V113, P369, DOI 10.1021/jp807896g; Wang J, 2008, BIOPHYS J, V95, P5037, DOI 10.1529/biophysj.108.131672; Wu C, 2011, BIOPHYS J, V100, P1316, DOI 10.1016/j.bpj.2011.01.058; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2006, BIOPHYS J, V91, P824, DOI 10.1529/biophysj.106.083246	49	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36382	10.1371/journal.pone.0036382	http://dx.doi.org/10.1371/journal.pone.0036382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590535	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400011
J	Zhou, WS; Dowell, DR; Huckabee, MM; Newcomb, DC; Boswell, MG; Goleniewska, K; Lotz, MT; Toki, S; Yin, HY; Yao, SY; Natarajan, C; Wu, PS; Sriram, S; Breyer, RM; FitzGerald, GA; Peebles, RS				Zhou, Weisong; Dowell, Dustin R.; Huckabee, Matthew M.; Newcomb, Dawn C.; Boswell, Madison G.; Goleniewska, Kasia; Lotz, Matthew T.; Toki, Shinji; Yin, Huiyong; Yao, Songyi; Natarajan, Chandramohan; Wu, Pingsheng; Sriram, Subramaniam; Breyer, Richard M.; FitzGerald, Garret A.; Peebles, R. Stokes, Jr.			Prostaglandin I-2 Signaling Drives Th17 Differentiation and Exacerbates Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; CD4 T-CELLS; CYTOKINE PRODUCTION; DENDRITIC CELLS; HOST-DEFENSE; INFLAMMATION; IL-17; RECEPTOR; LINEAGE; T(H)17	Background: Prostaglandin I-2 (PGI(2)), a lipid mediator currently used in treatment of human disease, is a critical regulator of adaptive immune responses. Although PGI(2) signaling suppressed Th1 and Th2 immune responses, the role of PGI(2) in Th17 differentiation is not known. Methodology/Principal Findings: In mouse CD4(+)CD62L(+) naive T cell culture, the PGI(2) analogs iloprost and cicaprost increased IL-17A and IL-22 protein production and Th17 differentiation in vitro. This effect was augmented by IL-23 and was dependent on PGI(2) receptor IP signaling. In mouse bone marrow-derived CD11c(+) dendritic cells (BMDCs), PGI(2) analogs increased the ratio of IL-23/IL-12, which is correlated with increased ability of BMDCs to stimulate naive T cells for IL-17A production. Moreover, IP knockout mice had delayed onset of a Th17-associated neurological disease, experimental autoimmune encephalomyelitis (EAE), and reduced infiltration of IL-17A-expressing mononuclear cells in the spinal cords compared to wild type mice. These results suggest that PGI(2) promotes in vivo Th17 responses. Conclusion: The preferential stimulation of Th17 differentiation by IP signaling may have important clinical implications as PGI(2) and its analogs are commonly used to treat human pulmonary hypertension.	[Zhou, Weisong; Dowell, Dustin R.; Huckabee, Matthew M.; Newcomb, Dawn C.; Boswell, Madison G.; Goleniewska, Kasia; Lotz, Matthew T.; Toki, Shinji; Wu, Pingsheng; Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Yao, Songyi; Natarajan, Chandramohan; Sriram, Subramaniam] Vanderbilt Univ, Sch Med, Dept Med, Div Neurol, Nashville, TN 37212 USA; [Yin, Huiyong] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Breyer, Richard M.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol, Nashville, TN 37212 USA; [FitzGerald, Garret A.] Univ Penn, Dept Med & Pharmacol, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pennsylvania	Zhou, WS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA.	weisong.zhou@vanderbilt.edu			National Institute of Health [R56 AI076411, R01 AI 070672, R01 AI 059108, GM 015431, F32 HL091653]; Veteran Affairs [1I01BX000624]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070672, R56AI076411, R01AI059108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000624] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by National Institute of Health grants R56 AI076411, R01 AI 070672, R01 AI 059108, GM 015431, F32 HL091653 and Veteran Affairs grant 1I01BX000624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley SP, 2009, AM J PHYSIOL-HEART C, V296, pH1617, DOI 10.1152/ajpheart.01226.2008; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; DANIEL VC, 1994, J CHROMATOGR B, V653, P117, DOI 10.1016/0378-4347(93)E0432-P; Galie N, 2001, CLIN CHEST MED, V22, P529, DOI 10.1016/S0272-5231(05)70289-6; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hashimoto K, 2004, J VIROL, V78, P10303, DOI 10.1128/JVI.78.19.10303-10309.2004; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Idzko M, 2007, J CLIN INVEST, V117, P464, DOI 10.1172/JCI28949; Iniguez Miguel A., 2008, Archives of Physiology and Biochemistry, V114, P201, DOI [10.1080/13813450802180882, 10.1080/13813450802180882 ]; Jaffar Z, 2002, J IMMUNOL, V169, P5997, DOI 10.4049/jimmunol.169.10.5997; Jaffar Z, 2007, J IMMUNOL, V179, P6193, DOI 10.4049/jimmunol.179.9.6193; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Li H, 2011, AM J RESP CRIT CARE, V184, P37, DOI 10.1164/rccm.201010-1637OC; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Momcilovic M, 2008, NEUROSCI LETT, V447, P148, DOI 10.1016/j.neulet.2008.09.082; Nagao K, 2003, AM J RESP CELL MOL, V29, P314, DOI 10.1165/rcmb.2003-0035OC; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhou WS, 2007, J LEUKOCYTE BIOL, V81, P809, DOI 10.1189/jlb.0606375; Zhou WS, 2007, J IMMUNOL, V178, P702, DOI 10.4049/jimmunol.178.2.702	41	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e33518	10.1371/journal.pone.0033518	http://dx.doi.org/10.1371/journal.pone.0033518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590492	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336400002
J	Lisziewicz, J; Bakare, N; Calarota, SA; Banhegyi, D; Szlavik, J; Ujhelyi, E; Toke, ER; Molnar, L; Lisziewicz, Z; Autran, B; Lori, F				Lisziewicz, Julianna; Bakare, Nyasha; Calarota, Sandra A.; Banhegyi, Denes; Szlavik, Janos; Ujhelyi, Eszter; Toke, Eniko R.; Molnar, Levente; Lisziewicz, Zsolt; Autran, Brigitte; Lori, Franco			Single DermaVir Immunization: Dose-Dependent Expansion of Precursor/Memory T Cells against All HIV Antigens in HIV-1 Infected Individuals	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; ANTIRETROVIRAL THERAPY; CENTRAL MEMORY; VIREMIA; INTENSIFICATION; CORRELATE; VACCINE; PRIME; MODEL; GAG	Background: The GIHU004 study was designed to evaluate the safety and immunogenicity of three doses of DermaVir immunization in HIV-infected subjects on fully suppressive combination antiretroviral therapy (cART). Methodology/Principal Findings: This first-in-human dose escalation study was conducted with three topical DermaVir doses targeted to epidermal Langerhans cells to express fifteen HIV antigens in draining lymph nodes: 0.1 mg DNA targeted to two, 0.4 mg and 0.8 mg DNA targeted to four lymph nodes. Particularly, in the medium dose cohort 0.1 mg DNA was targeted per draining lymph node via similar to 8 million Langerhans cells located in 80 cm(2) epidermis area. The 28-days study with 48-week safety follow-up evaluated HIV-specific T cell responses against Gag p17, Gag p24 and Gag p15, Tat and Rev antigens. DermaVir-associated side effects were mild, transient and not dose-dependent. Boosting of HIV-specific effector CD4(+) and CD8(+) T cells expressing IFN-gamma and IL-2 was detected against several antigens in every subject of the medium dose cohort. The striking result was the dose-dependent expansion of HIV-specific precursor/memory T cells with high proliferation capacity. In low, medium and high dose cohorts this HIV-specific T cell population increased by 325-, 136,202 and 50,759 counts after 4 weeks, and by 3,899, 9,878 and 18,382 counts after one year, respectively, compared to baseline. Conclusions/Significance: Single immunization with the DermaVir candidate therapeutic vaccine was safe and immunogenic in HIV-infected individuals. Based on the potent induction of Gag, Tat and Rev-specific memory T cells, especially in the medium dose cohort, we speculate that DermaVir boost T cell responses specific to all the 15 HIV antigens expressed from the single DNA. For durable immune reactivity repeated DermaVir immunization might be required since the frequency of DermaVir-boosted HIV-specific memory T cells decreased during the 48-week follow up.	[Lisziewicz, Julianna; Toke, Eniko R.; Molnar, Levente; Lisziewicz, Zsolt] Genet Immun, Budapest, Hungary; [Lisziewicz, Julianna; Toke, Eniko R.; Molnar, Levente; Lisziewicz, Zsolt] Genet Immun Inc, Mclean, VA USA; [Bakare, Nyasha; Calarota, Sandra A.; Lori, Franco] Res Inst Genet & Human Therapy, Cambridge, MA USA; [Banhegyi, Denes; Szlavik, Janos; Ujhelyi, Eszter] Szent Laszlo Hosp, Budapest, Hungary; [Autran, Brigitte] Ctr Hosp Univ Pitie Salpetriere, Lab Immunol Cellulaire, Paris, France	Szent Laszlo Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Lisziewicz, J (corresponding author), Genet Immun, Budapest, Hungary.	lisziewj@geneticimmunity.com		Lisziewicz, Julianna/0000-0002-3349-4495; Molnar, Levente/0000-0003-2107-7878; Toke, Eniko Rita/0000-0001-9692-4010	Division of AIDS, National Insitute of Allergy and Infectious Diseases, National Institutes of Health (United States of America); European Union [MEXCCT2003513834]; Hungarian National Office for Research and Technology [DermaVirHIKC05, DVCLIN01]; Commercial funder Genetic Immunity, LLC	Division of AIDS, National Insitute of Allergy and Infectious Diseases, National Institutes of Health (United States of America); European Union(European Commission); Hungarian National Office for Research and Technology(National Office for Research and Technology); Commercial funder Genetic Immunity, LLC	Funding provided by the Division of AIDS, National Insitute of Allergy and Infectious Diseases, National Institutes of Health (United States of America); the European Union FP6 (MEXCCT2003513834) Marie Curie Excellence Chair Programme; and the Hungarian National Office for Research and Technology (DermaVirHIKC05; DVCLIN01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Study sponsored by Commercial funder Genetic Immunity, LLC; JL, NB, ZL and FL are employees of or hold shares in Genetic Immunity Inc. There are several patent applications to protect DermaVir product and technology - JL, FL, ET from Genetic Immunity could benefit. DermaVir is a immunotherapeutic product candidate in development by Genetic Immunity. There are no other patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Calarota SA, 2008, J IMMUNOL, V180, P5907, DOI 10.4049/jimmunol.180.9.5907; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Chapuis AG, 2011, BLOOD, V117, P5391, DOI 10.1182/blood-2010-11-320226; Cristillo AD, 2007, VIROLOGY, V366, P197, DOI 10.1016/j.virol.2007.04.012; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; Gandhi RT, 2011, PLOS MED, V7, P1; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hatano H, 2011, J INFECT DIS, V203, P960, DOI 10.1093/infdis/jiq138; Holzmann S, 2004, J INVEST DERMATOL, V122, P1165, DOI 10.1111/j.0022-202X.2004.22520.x; Jansen CA, 2006, BLOOD, V107, P1427, DOI 10.1182/blood-2005-07-2907; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; Lisziewicz J, 2005, AIDS, V19, P35, DOI 10.1097/00002030-200501030-00004; Lisziewicz J, 2005, J INVEST DERMATOL, V124, P160, DOI 10.1111/j.0022-202X.2004.23535.x; Lisziewicz J, 2001, J VIROL, V75, P7621, DOI 10.1128/JVI.75.16.7621-7628.2001; Lorincz O, 2012, NANOMED-NANOTECHNOL, V8, P497, DOI 10.1016/j.nano.2011.07.013; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Natz E, 2012, GENE VACCINES, P127, DOI 10.1007/978-3-7091-0439-2_6; Notermans DW, 2000, AIDS RES HUM RETROV, V16, P1507, DOI 10.1089/088922200750006038; Ondondo BO, 2006, EUR J IMMUNOL, V36, P2585, DOI 10.1002/eji.200636508; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schellens IMM, 2008, PLOS ONE, V3, P1; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Somogyi E, 2011, VACCINE, V29, P744, DOI 10.1016/j.vaccine.2010.11.019; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Toke ER, 2010, INT J PHARMACEUT, V392, P261, DOI 10.1016/j.ijpharm.2010.03.048	33	56	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35416	10.1371/journal.pone.0035416	http://dx.doi.org/10.1371/journal.pone.0035416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590502	Green Published, gold			2022-12-27	WOS:000305336100008
J	Ohara, K; Enomoto, A; Kato, T; Hashimoto, T; Isotani-Sakakibara, M; Asai, N; Ishida-Takagishi, M; Weng, L; Nakayama, M; Watanabe, T; Kato, K; Kaibuchi, K; Murakumo, Y; Hirooka, Y; Goto, H; Takahashi, M				Ohara, Kei; Enomoto, Atsushi; Kato, Takuya; Hashimoto, Takahiko; Isotani-Sakakibara, Mayu; Asai, Naoya; Ishida-Takagishi, Maki; Weng, Liang; Nakayama, Masanori; Watanabe, Takashi; Kato, Katsuhiro; Kaibuchi, Kozo; Murakumo, Yoshiki; Hirooka, Yoshiki; Goto, Hidemi; Takahashi, Masahide			Involvement of Girdin in the Determination of Cell Polarity during Cell Migration	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; G-ALPHA-I; TIGHT JUNCTION; PAR PROTEINS; COMPLEX; AKT; ACTIVATION; CANCER; ROLES; GIV	Cell migration is a critical cellular process that determines embryonic development and the progression of human diseases. Therefore, cell- or context-specific mechanisms by which multiple promigratory proteins differentially regulate cell migration must be analyzed in detail. Girdin (girders of actin filaments) (also termed GIV,G alpha-interacting vesicle associated protein) is an actin-binding protein that regulates migration of various cells such as endothelial cells, smooth muscle cells, neuroblasts, and cancer cells. Here we show that Girdin regulates the establishment of cell polarity, the deregulation of which may result in the disruption of directional cell migration. We found that Girdin interacts with Par-3, a scaffolding protein that is a component of the Par protein complex that has an established role in determining cell polarity. RNA interference-mediated depletion of Girdin leads to impaired polarization of fibroblasts and mammary epithelial cells in a way similar to that observed in Par-3-depleted cells. Accordingly, the expression of Par- 3 mutants unable to interact with Girdin abrogates cell polarization in fibroblasts. Further biochemical analysis suggests that Girdin is present in the Par protein complex that includes Par-3, Par-6, and atypical protein kinase C. Considering previous reports showing the role of Girdin in the directional migration of neuroblasts, network formation of endothelial cells, and cancer invasion, these data may provide a specific mechanism by which Girdin regulates cell movement in biological contexts that require directional cell movement.	[Ohara, Kei; Enomoto, Atsushi; Kato, Takuya; Hashimoto, Takahiko; Isotani-Sakakibara, Mayu; Asai, Naoya; Ishida-Takagishi, Maki; Weng, Liang; Murakumo, Yoshiki; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan; [Ohara, Kei; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol, Nagoya, Aichi 4648601, Japan; [Enomoto, Atsushi; Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Mol Pathol, Nagoya, Aichi 4648601, Japan; [Nakayama, Masanori; Watanabe, Takashi; Kato, Katsuhiro; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ Hosp, Dept Endoscopy, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Ohara, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan.	enomoto@iar.nagoya-u.ac.jp; mtakaha@med.nagoya-u.ac.jp	TAKAHASHI, Masahide/I-7244-2014; Weng, Liang/B-8451-2016; Kaibuchi, Kozo/M-4887-2014; ASAI, Naoya/I-7377-2014; Hirooka, Yoshiki/I-7351-2014; Takahashi, Masahide/AAN-4770-2020; Kato, Katsuhiro/AAV-8356-2020; Enomoto, Atsushi/I-7272-2014	Kaibuchi, Kozo/0000-0003-0714-1992; Hirooka, Yoshiki/0000-0001-9639-7425; Takahashi, Masahide/0000-0002-2803-2683; Enomoto, Atsushi/0000-0002-9206-6116; Weng, Liang/0000-0001-7058-8274; Watanabe, Takashi/0000-0002-9015-5246; Takagishi, Maki/0000-0002-6745-3982	Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology (SCF); Naito Foundation;  [23249020];  [22117005]; Grants-in-Aid for Scientific Research [23249020, 22117005] Funding Source: KAKEN	Program for Improvement of Research Environment for Young Researchers; Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Global Center of Excellence (GCOE) Research, Scientific Research (A) (23249020), a Grant-in-Aid for Scientific Research on Innovative Areas (22117005) (to MT), the Program for Improvement of Research Environment for Young Researchers, Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to AE), and the Naito Foundation (to AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Aranda V, 2008, ONCOGENE, V27, P6878, DOI 10.1038/onc.2008.340; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Brajenovic M, 2004, J BIOL CHEM, V279, P12804, DOI 10.1074/jbc.M312171200; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kunnev D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-318; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Nakayama M, 2008, DEV CELL, V14, P205, DOI 10.1016/j.devcel.2007.11.021; Nance J, 2011, DEVELOPMENT, V138, P799, DOI 10.1242/dev.053538; Natsume A, 2012, ONCOGENE IN PRESS; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Wang Y, 2011, J NEUROSCI, V31, P8109, DOI 10.1523/JNEUROSCI.1130-11.2011; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Zen K, 2009, ONCOGENE, V28, P2910, DOI 10.1038/onc.2009.148	63	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36681	10.1371/journal.pone.0036681	http://dx.doi.org/10.1371/journal.pone.0036681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574214	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800111
J	Bar-Kochva, I; Breznitz, Z				Bar-Kochva, Irit; Breznitz, Zvia			Does the Reading of Different Orthographies Produce Distinct Brain Activity Patterns? An ERP Study	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; TIME-COURSE; PHONEME CONVERSION; LEXICAL DECISION; HEBREW; P300; PSYCHOPHYSIOLOGY; LATERALIZATION; TRANSLATION; PERCEPTION	Orthographies vary in the degree of transparency of spelling-sound correspondence. These range from shallow orthographies with transparent grapheme-phoneme relations, to deep orthographies, in which these relations are opaque. Only a few studies have examined whether orthographic depth is reflected in brain activity. In these studies a between-language design was applied, making it difficult to isolate the aspect of orthographic depth. In the present work this question was examined using a within-subject-and-language investigation. The participants were speakers of Hebrew, as they are skilled in reading two forms of script transcribing the same oral language. One form is the shallow pointed script (with diacritics), and the other is the deep unpointed script (without diacritics). Event-related potentials (ERPs) were recorded while skilled readers carried out a lexical decision task in the two forms of script. A visual non-orthographic task controlled for the visual difference between the scripts (resulting from the addition of diacritics to the pointed script only). At an early visual-perceptual stage of processing (similar to 165 ms after target onset), the pointed script evoked larger amplitudes with longer latencies than the unpointed script at occipital-temporal sites. However, these effects were not restricted to orthographic processing, and may therefore have reflected, at least in part, the visual load imposed by the diacritics. Nevertheless, the results implied that distinct orthographic processing may have also contributed to these effects. At later stages (similar to 340 ms after target onset) the unpointed script elicited larger amplitudes than the pointed one with earlier latencies. As this latency has been linked to orthographic-linguistic processing and to the classification of stimuli, it is suggested that these differences are associated with distinct lexical processing of a shallow and a deep orthography.	[Bar-Kochva, Irit; Breznitz, Zvia] Univ Haifa, Dept Learning Disabil, Edmond J Safra Brain Res Ctr, Study Learning Disabil, IL-31999 Haifa, Israel	University of Haifa	Bar-Kochva, I (corresponding author), Univ Haifa, Dept Learning Disabil, Edmond J Safra Brain Res Ctr, Study Learning Disabil, IL-31999 Haifa, Israel.	ibarkoch@campus.haifa.ac.il		Bar-Kochva, Irit/0000-0003-4895-3225	Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This study was supported by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balgur R., 1968, BASIC WORD LIST ELEM; BENTIN S, 1989, J EXP PSYCHOL LEARN, V15, P61; BENTIN S, 1987, MEM COGNITION, V15, P13, DOI 10.3758/BF03197708; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Deutsch A, 1999, LANG COGNITIVE PROC, V14, P393, DOI 10.1080/016909699386284; FROST R, 1995, J EXP PSYCHOL LEARN, V21, P398, DOI 10.1037/0278-7393.21.2.398; Frost R, 2005, J EXP PSYCHOL LEARN, V31, P1293, DOI 10.1037/0278-7393.31.6.1293; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; Frost R, 1994, EXP PSYCHOL LEARN ME, V20, P116; Frost R, 2009, WORD FREQUENCY DATAB; Frost R, 2005, BL HBK DEV PSYCHOL, P272, DOI 10.1002/9780470757642.ch15; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Katz L., 1992, ADV PSYCHOL, V94, P67, DOI [10.1016/S0166-4115(08)62789-2, DOI 10.1016/S0166-4115(08)62789-2]; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KORIAT A, 1984, ATTENTION PERFORM, V10, P227; KORIAT A, 1985, BRIT J PSYCHOL, V76, P161, DOI 10.1111/j.2044-8295.1985.tb01939.x; KORIAT A, 1985, MEM COGNITION, V13, P37, DOI 10.3758/BF03198441; Kovelman I, 2008, J COGNITIVE NEUROSCI, V20, P153, DOI 10.1162/jocn.2008.20011; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck S.J., 2005, INTRO EVENT RELATED; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2008, J COGNITIVE NEUROSCI, V20, P1878, DOI 10.1162/jocn.2008.20125; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; NAVON D, 1981, J VERB LEARN VERB BE, V20, P97, DOI 10.1016/S0022-5371(81)90334-0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Proverbio AM, 2004, J COGNITIVE NEUROSCI, V16, P301, DOI 10.1162/089892904322984580; Proverbio AM, 2003, BRAIN LANG, V87, P412, DOI 10.1016/S0093-934X(03)00139-1; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Sauseng P, 2004, COGNITIVE BRAIN RES, V20, P529, DOI 10.1016/j.cogbrainres.2004.04.008; Schneider W., 2002, E PRIME USERS GUIDE; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Shani M., 2006, ALEF AD TAF A Z DIAG; Shatil E., 1997, ONE MINUTE TEST WORD; SHIMRON J, 1982, READ RES QUART, V17, P210, DOI 10.2307/747484; Shimron J., 2006, READING HEBREW LANGU; Simon GG, 2004, INT J NEUROSCI, V114, P1401, DOI 10.1080/00207450490476057; Simon G, 2006, BRAIN RES, V1104, P141, DOI 10.1016/j.brainres.2006.05.071; Smolka E, 2006, COGN NEUROPSYCHOL, V23, P972, DOI 10.1080/02643290600654855; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wechsler D., 1997, WAIS 3 ADULT INTELLI; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	49	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2012	7	5							e36030	10.1371/journal.pone.0036030	http://dx.doi.org/10.1371/journal.pone.0036030			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TM	22615746	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336300005
J	Dwivedi, V; Anandan, EM; Mony, RS; Muraleedharan, TS; Valiathan, MS; Mutsuddi, M; Lakhotia, SC				Dwivedi, Vibha; Anandan, E. M.; Mony, Rajesh S.; Muraleedharan, T. S.; Valiathan, M. S.; Mutsuddi, Mousumi; Lakhotia, Subhash C.			In Vivo Effects Of Traditional Ayurvedic Formulations in Drosophila melanogaster Model Relate with Therapeutic Applications	PLOS ONE			English	Article							HEAT-SHOCK; STARVATION RESISTANCE; HNRNP PROTEIN; RNA; MERCURY; TRANSCRIPTS; STRESS; GENE; EVOLUTIONARY; MECHANISMS	Background: Ayurveda represents the traditional medicine system of India. Since mechanistic details of therapy in terms of current biology are not available in Ayurvedic literature, modern scientific studies are necessary to understand its major concepts and procedures. It is necessary to examine effects of the whole Ayurvedic formulations rather than their "active" components as is done in most current studies. Methods: We tested two different categories of formulations, a Rasayana (Amalaki Rasayana or AR, an herbal derivative) and a Bhasma (Rasa-Sindoor or RS, an organo-metallic derivative of mercury), for effects on longevity, development, fecundity, stress-tolerance, and heterogeneous nuclear ribonucleoprotein (hnRNP) levels of Drosophila melanogaster using at least 200 larvae or flies for each assay. Results: A 0.5% (weight/volume) supplement of AR or RS affected life-history and other physiological traits in distinct ways. While the size of salivary glands, hnRNP levels in larval tissues, and thermotolerance of larvae/adult flies improved significantly following feeding either of the two formulations, the median life span and starvation resistance improved only with AR. Feeding on AR or RS supplemented food improved fecundity differently. Feeding of larvae and adults with AR increased the fecundity while the same with RS had opposite effect. On the contrary, feeding larvae on normal food and adults on AR supplement had no effect on fecundity but a comparable regime of feeding on RS-supplemented food improved fecundity. RS feeding did not cause heavy metal toxicity. Conclusions: The present study with two Ayurvedic formulations reveals formulation-specific effects on several parameters of the fly's life, which seem to generally agree with their recommended human usages in Ayurvedic practices. Thus, Drosophila, with its very rich genetic tools and well-worked-out developmental pathways promises to be a very good model for examining the cellular and molecular bases of the effects of different Ayurvedic formulations.	[Dwivedi, Vibha; Lakhotia, Subhash C.] Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India; [Anandan, E. M.; Mony, Rajesh S.; Muraleedharan, T. S.] Arya Vaidya Sala, Kottakkal, India; [Valiathan, M. S.] Manipal Univ, Manipal, India; [Mutsuddi, Mousumi] Banaras Hindu Univ, Dept Mol & Human Genet, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Manipal Academy of Higher Education (MAHE); Banaras Hindu University (BHU)	Dwivedi, V (corresponding author), Banaras Hindu Univ, Dept Zool, Cytogenet Lab, Varanasi 221005, Uttar Pradesh, India.	lakhotia@bhu.ac.in	Lakhotia, Subhash C/D-2058-2011	Lakhotia, Subhash C/0000-0003-1842-8411	Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects [Prn.SA/ADV/Ayurveda/6/2006]; UGC Center of Advanced Studies in Zoology Junior Research Fellowship	Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects; UGC Center of Advanced Studies in Zoology Junior Research Fellowship	This work was supported by a research grant from the Office of the Principal Scientific Advisor to the Government of India, under the coordinated "Science & Ayurveda" projects (Grant no. Prn.SA/ADV/Ayurveda/6/2006). VD is recipient of a UGC Center of Advanced Studies in Zoology Junior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERO SA, 1993, MOL CELL BIOL, V13, P5323, DOI 10.1128/MCB.13.9.5323; Ashburner M, 1972, Results Probl Cell Differ, V4, P101; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Blanchette M, 2009, MOL CELL, V33, P438, DOI 10.1016/j.molcel.2009.01.022; BOFFETTA P, 1993, SCAND J WORK ENV HEA, V19, P1; Borah S, 2009, P NATL ACAD SCI USA, V106, P2577, DOI 10.1073/pnas.0812826106; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Chatterjee UR, 2011, INT J BIOL MACROMOL, V49, P637, DOI 10.1016/j.ijbiomac.2011.06.024; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Govindarajan R, 2005, J ETHNOPHARMACOL, V99, P165, DOI 10.1016/j.jep.2005.02.035; Guzzi G, 2008, TOXICOLOGY, V244, P1, DOI 10.1016/j.tox.2007.11.002; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hao XM, 2007, CELL STRESS CHAPERON, V12, P364, DOI 10.1379/CSC-308.1; HAYNES SR, 1991, NUCLEIC ACIDS RES, V19, P25; HUEY RB, 1992, FUNCT ECOL, V6, P489, DOI 10.2307/2389288; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Khan KH, 2009, BOT RES INT, V2, P218; Krishnaveni Mani, 2010, Journal of Basic and Clinical Physiology and Pharmacology, V21, P93; Kristensen TN, 2003, J GENET, V82, P89, DOI 10.1007/BF02715811; Lakhotia S C, 2010, J Ayurveda Integr Med, V1, P171, DOI 10.4103/0975-9476.72607; Lakhotia SC, 1998, CHROMOSOMA, V107, P127, DOI 10.1007/s004120050288; Lakhotia SC, 1999, CURR SCI INDIA, V77, P553; Lakhotia SC, 2012, CHROMOSOMA, V121, P49, DOI 10.1007/s00412-011-0341-x; Lakhotia SC, 2011, J BIOSCIENCES, V36, P399, DOI 10.1007/s12038-011-9078-1; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Liu J, 2008, EXP BIOL MED, V233, P810, DOI 10.3181/0712-MR-336; Mallik M, 2010, J GENET, V89, P497, DOI 10.1007/s12041-010-0072-4; Miller A., 1950, BIOL DROSOPHILA, P420; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Murthy KRS, 2000, ASHTANGA HRIDAYA; Norry FM, 2009, J INSECT PHYSIOL, V55, P1050, DOI 10.1016/j.jinsphys.2009.07.009; Patel NG, 1986, ART SCI; Poltanov EA, 2009, PHYTOTHER RES, V23, P1309, DOI 10.1002/ptr.2775; Prasad B. R. Guru, 2011, Munis Entomology & Zoology, V6, P785; Prasad NG, 2003, J GENET, V82, P45, DOI 10.1007/BF02715881; Prasanth KV, 2000, J CELL SCI, V113, P3485; Priyadarshini S, 2010, J Ayurveda Integr Med, V1, P114, DOI 10.4103/0975-9476.65085; Restifo LL, 2005, MENT RETARD DEV D R, V11, P286, DOI 10.1002/mrdd.20083; ROY SA, 1977, INDIAN J EXP BIOL, V15, P794; Sarkar PK, 2010, J SCI IND RES INDIA, V69, P901; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Sharma P V, 1999, SUSHRUTA SAMHITA; Sharma P V, 1994, CHARAKA SAMHITA; Sharma S., 1979, RASTARANGINI; Singh R. H., 2003, HOLISTIC PRINCIPLES; Singh SK, 2009, INDIAN J TRADIT KNOW, V8, P346; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Swain U, 2011, MECH AGEING DEV; Tapadia MG, 1997, CHROMOSOME RES, V5, P359, DOI 10.1023/A:1018440224177; Valiathan MS, 2006, CURR SCI INDIA, V90, P5; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; Wayne ML, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-57; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Zhimulev I. F., 2009, ENCY LIFE SCI ELS; Zhou XR, 2011, J ETHNOPHARMACOL, V135, P110, DOI 10.1016/j.jep.2011.02.032; Zu K, 1998, RNA, V4, P1585, DOI 10.1017/S135583829898102X; Zu K, 1996, MOL BIOL CELL, V7, P1059, DOI 10.1091/mbc.7.7.1059	62	43	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37113	10.1371/journal.pone.0037113	http://dx.doi.org/10.1371/journal.pone.0037113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606337	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400062
J	Lee, JS; Hur, MW; Lee, SK; Choi, WI; Kwon, YG; Yun, CO				Lee, Jung-Sun; Hur, Man-Wook; Lee, Seong Kyung; Choi, Won-Il; Kwon, Young-Guen; Yun, Chae-Ok			A Novel sLRP6E1E2 Inhibits Canonical Wnt Signaling, Epithelial-to-Mesenchymal Transition, and Induces Mitochondria-Dependent Apoptosis in Lung Cancer	PLOS ONE			English	Article							REPLICATION-COMPETENT ADENOVIRUS; TUMOR-GROWTH; ONCOLYTIC ADENOVIRUS; WNT3A-INDUCED PROLIFERATION; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODY; COLON-CARCINOMA; EXPRESSION; ACTIVATION; CELLS	Aberrant activation of the Wnt pathway contributes to human cancer progression. Antagonists that interfere with Wnt ligand/receptor interactions can be useful in cancer treatments. In this study, we evaluated the therapeutic potential of a soluble Wnt receptor decoy in cancer gene therapy. We designed a Wnt antagonist sLRP6E1E2, and generated a replication-incompetent adenovirus (Ad), dE1-k35/sLRP6E1E2, and a replication-competent oncolytic Ad, RdB-k35/sLRP6E1E2, both expressing sLRP6E1E2. sLRP6E1E2 prevented Wnt-mediated stabilization of cytoplasmic beta-catenin, decreased Wnt/beta-catenin signaling and cell proliferation via the mitogen-activated protein kinase, and phosphatidylinositol 3-kinase pathways. sLRP6E1E2 induced apoptosis, cytochrome c release, and increased cleavage of PARP and caspase-3. sLRP6E1E2 suppressed growth of the human lung tumor xenograft, and reduced motility and invasion of cancer cells. In addition, sLRP6E1E2 upregulated expression of epithelial marker genes, while sLRP6E1E2 downregulated mesenchymal marker genes. Taken together, sLRP6E1E2, by inhibiting interaction between Wnt and its receptor, suppressed Wnt-induced cell proliferation and epithelial-to-mesenchymal transition.	[Lee, Jung-Sun; Lee, Seong Kyung; Choi, Won-Il] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Jung-Sun; Lee, Seong Kyung] Yonsei Univ, Coll Med, Inst Canc Res, Yonsei Canc Ctr, Seoul, South Korea; [Hur, Man-Wook; Choi, Won-Il] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kwon, Young-Guen] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem & Mol Biol, Seoul 120749, South Korea; [Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Hanyang University	Lee, JS (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Brain Korea Project Med Sci 21, Seoul, South Korea.	chaeok@hanyang.ac.kr		Yun, Chae-Ok/0000-0002-9466-4531; CHOI, WONIL/0000-0002-4837-0436	Ministry of Knowledge Economy [10030051]; Korea Science and Engineering Foundation [2009K001644, 2010-0029220]; Korea Food and Drug Administration [KFDA-10172-332]; Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea	Ministry of Knowledge Economy(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Food and Drug Administration(Food & Drug Administration (KFDA), Republic of Korea); Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea	This work was supported by grants from the Ministry of Knowledge Economy (10030051, Dr. C-O Yun), the Korea Science and Engineering Foundation (2009K001644, 2010-0029220, Dr. C-O Yun), and the Korea Food and Drug Administration (KFDA-10172-332 to Dr. C-O Yun). Jung-Sun Lee is a graduate student sponsored by the Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Broxterman HJ, 2007, DRUG RESIST UPDATE, V10, P182, DOI 10.1016/j.drup.2007.07.001; Burstein HJ, 1999, NEW ENGL J MED, V340, P1733, DOI 10.1056/NEJM199906033402206; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dennis S, 1999, J CELL SCI, V112, P3815; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holcombe RF, 2002, J CLIN PATHOL-MOL PA, V55, P220, DOI 10.1136/mp.55.4.220; Kim J, 2007, HUM GENE THER, V18, P773, DOI 10.1089/hum.2006.167; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kurihara T, 2000, J CLIN INVEST, V106, P763, DOI 10.1172/JCI9180; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; Liu JR, 2002, CANCER RES, V62, P924; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Nishio M, 1996, J CLIN ONCOL, V14, P497, DOI 10.1200/JCO.1996.14.2.497; Nishio M, 1997, CLIN CANCER RES, V3, P1051; NUSSE R, 1990, MOL CELL BIOL, V10, P4170, DOI 10.1128/MCB.10.8.4170; Saito Y, 2006, CANCER GENE THER, V13, P242, DOI 10.1038/sj.cgt.7700902; SATO H, 1992, ONCOGENE, V7, P77; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Vincan E, 2005, DIFFERENTIATION, V73, P142, DOI 10.1111/j.1432-0436.2005.00015.x; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang LL, 2003, CANCER RES, V63, P831; Yoo JY, 2008, GENE THER, V15, P635, DOI 10.1038/gt.2008.3; Yoo JY, 2007, MOL THER, V15, P295, DOI 10.1038/sj.mt.6300023; Yoon AR, 2006, HUM GENE THER, V17, P379, DOI 10.1089/hum.2006.17.379; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Yun CO, 2005, CANCER GENE THER, V12, P61, DOI 10.1038/sj.cgt.7700769; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zhou ZC, 2003, MOL CANCER THER, V2, P1313; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	43	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36520	10.1371/journal.pone.0036520	http://dx.doi.org/10.1371/journal.pone.0036520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606268	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339400022
J	Bordeaux, JM; Cheng, H; Welsh, AW; Haffty, BG; Lannin, DR; Wu, XY; Su, N; Ma, XJ; Luo, YL; Rimm, DL				Bordeaux, Jennifer M.; Cheng, Huan; Welsh, Allison W.; Haffty, Bruce G.; Lannin, Donald R.; Wu, Xingyong; Su, Nan; Ma, Xiao-Jun; Luo, Yuling; Rimm, David L.			Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen	PLOS ONE			English	Article							GENE-EXPRESSION; THERAPY; MARKERS; BENEFIT; ASSAY	Purpose: Quantification of mRNA has historically been done by reverse transcription polymerase chain reaction (RT-PCR). Recently, a robust method of detection of mRNA utilizing in situ hybridization has been described that is linear and shows high specificity with low background. Here we describe the use of the AQUA method of quantitative immunofluorescence (QIF) for measuring mRNA in situ using ESR1 (the estrogen receptor alpha gene) in breast cancer to determine its predictive value compared to Estrogen Receptor alpha (ER) protein. Methods: Messenger RNA for ER (ESR1) and Ubiquitin C (UbC) were visualized using RNAscope probes and levels were quantified by quantitative in situ hybridization (qISH) on two Yale breast cancer cohorts on tissue microarrays. ESR1 levels were compared to ER protein levels measured by QIF using the SP1 antibody. Results: ESR1 mRNA is reproducibly and specifically measurable by qISH on tissue collected from 1993 or later. ESR1 levels were correlated to ER protein levels in a non-linear manner on two Yale cohorts. High levels of ESR1 were found to be predictive of response to tamoxifin. Conclusion: Quantification of mRNA using qISH may allow assessment of large cohorts with minimal formalin fixed, paraffin embedded tissue. Exploratory data using this method suggests that measurement of ESR1 mRNA levels may be predictive of response to endocrine therapy in a manner that is different from the predictive value of ER.	[Bordeaux, Jennifer M.; Cheng, Huan; Welsh, Allison W.; Haffty, Bruce G.; Lannin, Donald R.; Rimm, David L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Wu, Xingyong; Su, Nan; Ma, Xiao-Jun; Luo, Yuling] Adv Cell Diagnost, Hayward, CA USA	Yale University	Bordeaux, JM (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	david.rimm@yale.edu	su, nan/GRS-5213-2022	Rimm, David/0000-0001-5820-4397	United States Department of Defense Predoctoral Fellowship [W81XWH-08-1-0404]; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	United States Department of Defense Predoctoral Fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding came from a United States Department of Defense Predoctoral Fellowship W81XWH-08-1-0404 to JMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Lacroix M, 2001, BREAST CANCER RES TR, V67, P263, DOI 10.1023/A:1017946810277; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Masand RP, 2011, HEAD NECK PATHOL, V5, P108, DOI 10.1007/s12105-011-0245-3; Mook Stella, 2007, Cancer Genomics & Proteomics, V4, P147; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pusztai L, 2003, CLIN CANCER RES, V9, P2406; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Ukpo OC, 2011, AM J SURG PATHOL, V35, P1343, DOI 10.1097/PAS.0b013e318220e59d; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Welsh A, 2011, CLIN CANC RES; Welsh AW, 2011, J CLIN ONCOL, V29, P2978, DOI 10.1200/JCO.2010.32.9706	20	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36559	10.1371/journal.pone.0036559	http://dx.doi.org/10.1371/journal.pone.0036559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606272	gold, Green Published			2022-12-27	WOS:000305338200034
J	Legge, ELG; Spetch, ML; Cenkner, A; Bulitko, V; Anderson, C; Brown, M; Heth, D				Legge, Eric L. G.; Spetch, Marcia L.; Cenkner, Andrew; Bulitko, Vadim; Anderson, Craig; Brown, Matthew; Heth, Donald			Not All Locations Are Created Equal: Exploring How Adults Hide and Search for Objects	PLOS ONE			English	Article							WESTERN SCRUB-JAYS; REAL; STRATEGIES	Little is known about the strategies people use to effectively hide objects from others, or to search for objects others have hidden. The present research extends a recent investigation of people's hiding and searching strategies in a simple room with 9 cache location. In the present studies, people hid and searched for three objects under more than 70 floor tiles in complex real and virtual rooms. Experiment 1 replicated several finding of Talbot et al within the more complex real and virtual environments. Specifically, people traveled further from origin and selected more dispersed locations when hiding than when searching. Experiments 2 and 3 showed that: 1) people were attracted to an area of darkness when searching and avoided locations close to a window when hiding, 2) when search attempts were limited to three choices, people searched farther from origin and dispersed their locations more when hiding than when searching, and 3) informing people that they would need to recover their hidden objects altered their hiding behavior and increased recovery accuracy. Across all experiments, consistencies in location preferences emerged, with more preference for the middle of the room during hiding and more preference for corners of the room during searching. Even though the same people participated in both the hiding and searching tasks, it appears that people use different strategies to select hiding places than to search for objects hidden by others.	[Legge, Eric L. G.; Spetch, Marcia L.; Anderson, Craig; Heth, Donald] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Cenkner, Andrew; Bulitko, Vadim] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Brown, Matthew] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Legge, ELG (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.	elegge@ualberta.ca		Legge, Eric/0000-0003-1560-5152	National Science and Engineering Research Council of Canada (NSERC) Discovery grant [38861]; NSERC Discovery grant; NSERC Equipment grant [38954]; NSERC Alexander Graham Bell Canada Graduate Scholarship - Doctoral grant; association of Academic Staff grant from the University of Alberta; NSERC CGS Grant	National Science and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Equipment grant; NSERC Alexander Graham Bell Canada Graduate Scholarship - Doctoral grant; association of Academic Staff grant from the University of Alberta; NSERC CGS Grant	Funding provided by National Science and Engineering Research Council of Canada (NSERC) Discovery grant #38861 (to MLS), NSERC Discovery grant (to VB), NSERC Equipment grant #38954 (to MLS), NSERC Alexander Graham Bell Canada Graduate Scholarship - Doctoral grant (to ELGL) and association of Academic Staff grant from the University of Alberta (to DH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NSERC Discovery Grant Website: http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp. NSERC Equipment Grant Website: http://www.nserc-crsng.gc.ca/Professors-Professeurs/RTII-OIRI/RTI-OIR_eng.asp. NSERC CGS Grant Website: http://www.nserc-crsng.gc.ca/students-etudiants/pg-cs/bellandpostgrad-belletsuperieures_eng.asp.	[Anonymous], 2004, HALF LIF; BENEDIKT ML, 1979, ENVIRON PLANN B, V6, P47, DOI 10.1068/b060047; Buechner SJ, 2009, P 31 ANN C COGN SCI, P1066; Cenkner A, 2011, P 7 ART INT INT DIG, P128; CORNELL EH, 1986, CHILD DEV, V57, P603; CORNELL EH, 1983, J EXP CHILD PSYCHOL, V35, P93, DOI 10.1016/0022-0965(83)90072-3; Daily JM, 2004, P ROY SOC B-BIOL SCI, V271, pS387, DOI 10.1098/rsbl.2004.0190; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Dally JM, 2010, EUR J DEV PSYCHOL, V7, P17, DOI 10.1080/17405620802571711; Elazary L, 2010, VISION RES, V50, P1338, DOI 10.1016/j.visres.2010.01.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Kelly DM, 2007, COMP COGN BEHAV REV, V2, P111, DOI 10.3819/ccbr.2008.20007; Montello D. R., 1993, Spatial Information Theory. A Theoretical Basis for GIS. European Conference, COSIT '93 Proceedings, P312; Nichols-Whitehead P, 2001, J COGN DEV, V2, P367, DOI 10.1207/S15327647JCD0204_2; Smilek D, 2009, ATTEN PERCEPT PSYCHO, V71, P1793, DOI 10.3758/APP.71.8.1793; Sturz BR, 2009, ANIM COGN, V12, P237, DOI 10.1007/s10071-008-0182-z; Talbot KJ, 2009, LEARN MOTIV, V40, P221, DOI 10.1016/j.lmot.2009.01.003; Valve Corporation, 2004, SOURC ENG CURR BUILD; WELLMAN HM, 1979, DEV PSYCHOL, V15, P530, DOI 10.1037/0012-1649.15.5.530; WELLMAN HM, 1984, CHILD DEV, V55, P472; Wolfe JM, 2011, TRENDS COGN SCI, V15, P77, DOI 10.1016/j.tics.2010.12.001	23	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36993	10.1371/journal.pone.0036993	http://dx.doi.org/10.1371/journal.pone.0036993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606324	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200061
J	Liang, SN; Lan, BL				Liang, Shiuan-Ni; Lan, Boon Leong			Statistical Predictions for the Dynamics of a Low-Speed System: Newtonian versus Special-Relativistic Mechanics	PLOS ONE			English	Article							KICKED PENDULUM; STANDARD MAP; CHAOS	The Newtonian and special-relativistic statistical predictions for the mean, standard deviation and probability density function of the position and momentum are compared for the periodically-delta-kicked particle at low speed. Contrary to expectation, we find that the statistical predictions, which are calculated from the same parameters and initial Gaussian ensemble of trajectories, do not always agree if the initial ensemble is sufficiently well-localized in phase space. Moreover, the breakdown of agreement is very fast if the trajectories in the ensemble are chaotic, but very slow if the trajectories in the ensemble are non-chaotic. The breakdown of agreement implies that special-relativistic mechanics must be used, instead of the standard practice of using Newtonian mechanics, to correctly calculate the statistical predictions for the dynamics of a low-speed system.	[Liang, Shiuan-Ni; Lan, Boon Leong] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia	Monash University; Monash University Sunway	Liang, SN (corresponding author), Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia.	lan.boon.leong@monash.edu		Liang, Shiuan-Ni/0000-0001-9953-339X	Fundamental Research Grant Scheme [FRGS/2/2010/ST/MUSM/02/1]	Fundamental Research Grant Scheme	This work was supported by a Fundamental Research Grant Scheme, FRGS/2/2010/ST/MUSM/02/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell D., 1987, LOS ALAMOS SCI, V15, P228; Casati G., 1979, Stochastic Behaviour in Classical and Quantum Hamiltonian Systems. Volta Memorial Conference, P334; CHERNIKOV AA, 1989, PHYS REV A, V40, P4072, DOI 10.1103/PhysRevA.40.4072; CHIRIKOV BV, 1979, PHYS REP, V52, P263, DOI 10.1016/0370-1573(79)90023-1; Ciubotariu C, 2002, CHAOS SOLITON FRACT, V13, P1253, DOI 10.1016/S0960-0779(01)00122-9; FOX RF, 1994, PHYS REV E, V49, P3683, DOI 10.1103/PhysRevE.49.3683; French A. P., 1968, SPECIAL RELATIVITY; Hartle J.B., 2003, GRAVITY INTRO EINSTE; Lan BL, 2009, TOPICS ON CHAOTIC SYSTEMS, P199, DOI 10.1142/9789814271349_0023; LAN BL, 1994, PHYS REV E, V50, P764, DOI 10.1103/PhysRevE.50.764; Lan BL, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036201; Lan BL, 2010, COMMUN NONLINEAR SCI, V15, P2497, DOI 10.1016/j.cnsns.2009.10.008; Lan BL, 2009, CHAOS SOLITON FRACT, V42, P534, DOI 10.1016/j.chaos.2009.01.021; Lan BL, 2006, CHAOS, V16, DOI 10.1063/1.2218379; Liang SN, 2011, RESULTS PHYS, V1, P36, DOI 10.1016/j.rinp.2011.10.001; Liang SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034720; McComb W. D., 1999, DYNAMICS RELATIVITY; NOMURA Y, 1992, PHYS REV A, V45, P1103, DOI 10.1103/PhysRevA.45.1103; Pospelov M, 2004, PHYS TODAY, V57, P40, DOI 10.1063/1.1784301	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36430	10.1371/journal.pone.0036430	http://dx.doi.org/10.1371/journal.pone.0036430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606259	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200027
J	Nishimura, Y; Kamikawa, R; Hashimoto, T; Inagaki, Y				Nishimura, Yuki; Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji			Separate Origins of Group I Introns in Two Mitochondrial Genes of the Katablepharid Leucocryptos marina	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; PHYLOGENETIC ANALYSES; SEQUENCE; GENOME; INVASION; MOBILITY; DATABASE; MODELS; EXONS	Mitochondria are descendants of the endosymbiotic alpha-proteobacterium most likely engulfed by the ancestral eukaryotic cells, and the proto-mitochondrial genome should have been severely streamlined in terms of both genome size and gene repertoire. In addition, mitochondrial (mt) sequence data indicated that frequent intron gain/loss events contributed to shaping the modern mt genome organizations, resulting in the homologous introns being shared between two distantly related mt genomes. Unfortunately, the bulk of mt sequence data currently available are of phylogenetically restricted lineages, i.e., metazoans, fungi, and land plants, and are insufficient to elucidate the entire picture of intron evolution in mt genomes. In this work, we sequenced a 12 kbp-fragment of the mt genome of the katablepharid Leucocryptos marina. Among nine protein-coding genes included in the mt genome fragment, the genes encoding cytochrome b and cytochrome c oxidase subunit I (cob and cox1) were interrupted by group I introns. We further identified that the cob and cox1 introns host open reading frames for homing endonucleases (HEs) belonging to distantly related superfamilies. Phylogenetic analyses recovered an affinity between the HE in the Leucocryptos cob intron and two green algal HEs, and that between the HE in the Leucocryptos cox1 intron and a fungal HE, suggesting that the Leucocryptos cob and cox1 introns possess distinct evolutionary origins. Although the current intron (and intronic HE) data are insufficient to infer how the homologous introns were distributed to distantly related mt genomes, the results presented here successfully expanded the evolutionary dynamism of group I introns in mt genomes.	[Nishimura, Yuki; Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kamikawa, Ryoma; Hashimoto, Tetsuo; Inagaki, Yuji] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Nishimura, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yuji@ccs.tsukuba.ac.jp		Nishimura, Yuki/0000-0002-7990-1316; Inagaki, Yuji/0000-0003-0101-8483	Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists [210528]; JSPS grant [21370031]; grants from the Ministry of Education, Culture, Sports, Science and Technology [23117006, 23117005]; Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists; JSPS grant; grants from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RK was a research fellow supported by the Japanese Society for the Promotion of Sciences (JSPS) for Young Scientists (no. 210528). This work was supported by a JSPS grant awarded to YI (no. 21370031), and grants from the Ministry of Education, Culture, Sports, Science and Technology awarded to YI and TH (nos. 23117006 and 23117005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Auer B, 2001, FRESHWATER BIOL, V46, P959, DOI 10.1046/j.1365-2427.2001.00730.x; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Inagaki Y, 1998, J MOL EVOL, V47, P378, DOI 10.1007/PL00006395; Johansen S, 1997, MOL MICROBIOL, V24, P737, DOI 10.1046/j.1365-2958.1997.3921743.x; Kamikawa R, 2009, PHYCOL RES, V57, P1, DOI 10.1111/j.1440-1835.2008.00511.x; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Korab-Laskowska M, 1998, NUCLEIC ACIDS RES, V26, P138, DOI 10.1093/nar/26.1.138; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Masuda I, 2011, HARMFUL ALGAE, V10, P130, DOI 10.1016/j.hal.2010.08.004; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Okamoto N, 2005, PROTIST, V156, P163, DOI 10.1016/j.protis.2004.12.003; Puerta MVS, 2004, DNA RES, V11, P1, DOI 10.1093/dnares/11.1.1; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Sanchez-Puerta MV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-277; Sandegren L, 2004, J BIOL CHEM, V279, P22218, DOI 10.1074/jbc.M400929200; Sellem CH, 1996, GENETICS, V143, P777; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37307	10.1371/journal.pone.0037307	http://dx.doi.org/10.1371/journal.pone.0037307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606358	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200069
J	Sow, A; Sidibe, I; Bengaly, Z; Bance, AZ; Sawadogo, GJ; Solano, P; Vreysen, MJB; Lancelot, R; Bouyer, J				Sow, Adama; Sidibe, Issa; Bengaly, Zakaria; Bance, Augustin Z.; Sawadogo, Germain J.; Solano, Philippe; Vreysen, Marc J. B.; Lancelot, Renaud; Bouyer, Jeremy			Irradiated Male Tsetse from a 40-Year-Old Colony Are Still Competitive in a Riparian Forest in Burkina Faso	PLOS ONE			English	Article							GLOSSINA-PALPALIS-GAMBIENSIS; AFRICAN ANIMAL TRYPANOSOMOSIS; ISOMETAMIDIUM CHLORIDE TREATMENT; DIPTERA GLOSSINIDAE; INTEGRATED CAMPAIGN; FUSCIPES FUSCIPES; RIVERINE TSETSE; FLIES; RELEASE; CATTLE	Background: Tsetse flies are the cyclical vectors of African trypanosomosis that constitute a major constraint to development in Africa. Their control is an important component of the integrated management of these diseases, and among the techniques available, the sterile insect technique (SIT) is the sole that is efficient at low densities. The government of Burkina Faso has embarked on a tsetse eradication programme in the framework of the PATTEC, where SIT is an important component. The project plans to use flies from a Glossina palpalis gambiensis colony that has been maintained for about 40 years at the Centre International de Recherche-Developpement sur l'Elevage en zone Subhumide (CIRDES). It was thus necessary to test the competitiveness of the sterile males originating from this colony. Methodology/Principal Findings: During the period January-February 2010, 16,000 sterile male G. p. gambiensis were released along a tributary of the Mouhoun river. The study revealed that with a mean sterile to wild male ratio of 1.16 (s.d. 0.38), the abortion rate of the wild female flies was significantly higher than before (p = 0.026) and after (p = 0.019) the release period. The estimated competitiveness of the sterile males (Fried index) was 0.07 (s.d. 0.02), indicating that a sterile to wild male ratio of 14.4 would be necessary to obtain nearly complete induced sterility in the female population. The aggregation patterns of sterile and wild male flies were similar. The survival rate of the released sterile male flies was similar to that observed in 1983-1985 for the same colony. Conclusions/Significance: We conclude that gamma sterilised male G. p. gambiensis derived from the CIRDES colony have a competitiveness that is comparable to their competitiveness obtained 35 years ago and can still be used for an area-wide integrated pest management campaign with a sterile insect component in Burkina Faso.	[Sow, Adama; Sidibe, Issa; Bengaly, Zakaria; Bance, Augustin Z.; Solano, Philippe] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Sow, Adama; Sidibe, Issa] PATTEC, Projet Creat Zones Liberees Durablement Tse Tse &, Bobo Dioulasso, Burkina Faso; [Sow, Adama; Sawadogo, Germain J.] Ecole Inter Etats Sci & Med Vet EISMV, Dakar, Senegal; [Solano, Philippe] INTERTRYP, IRD, UMR IRD CIRAD 177, Montpellier, France; [Vreysen, Marc J. B.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Lancelot, Renaud; Bouyer, Jeremy] Inst Senegalais Rech Agr, Lab Natl Elevage & Rech Vet, Dakar, Senegal; [Bouyer, Jeremy] Ctr Cooperat Int Rech Agron Dev CIRAD, Montpellier, France	CIRAD; Institut de Recherche pour le Developpement (IRD); International Atomic Energy Agency; CIRAD	Sow, A (corresponding author), Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso.	bouyer@cirad.fr	Bouyer, Jérémy/AAK-7370-2020; Lancelot, Renaud/HGE-1086-2022; solano, philippe/B-2328-2010	Bouyer, Jérémy/0000-0002-1913-416X; Lancelot, Renaud/0000-0002-5826-5242; solano, philippe/0000-0002-4351-3506	Institute of Tropical Medicine Anvers; Pan African Tsetse; Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso	Institute of Tropical Medicine Anvers; Pan African Tsetse; Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso	This work was carried out with the financial support of Institute of Tropical Medicine Anvers and Pan African Tsetse and Trypanosomosis Eradication-Projet de Creation de Zones Liberees Durablement de Tse-tse et de Trypanosomoses, Burkina Faso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abila PP, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.13; BARCLAY HJ, 1992, RES POPUL ECOL, V34, P131, DOI 10.1007/BF02513526; Bauer B, 1999, TROP ANIM HEALTH PRO, V31, P89, DOI 10.1023/A:1005115707181; BAUER B, 1995, TROP MED PARASITOL, V46, P183; BAUMHOVER AH, 1955, J ECON ENTOMOL, V48, P462, DOI 10.1093/jee/48.4.462; Bouyer J, 2008, MED VET ENTOMOL, V22, P140, DOI 10.1111/j.1365-2915.2008.00727.x; Bouyer J, 2005, MED VET ENTOMOL, V19, P372, DOI 10.1111/j.1365-2915.2005.00584.x; Bouyer J, 2009, MOL ECOL, V18, P2787, DOI 10.1111/j.1365-294X.2009.04233.x; Bouyer J, 2009, VET PARASITOL, V161, P187, DOI 10.1016/j.vetpar.2009.01.018; Bouyer J., 2010, INFECT PARASITIC DIS, P1936; Bouyer J, 2006, VET RES, V37, P633, DOI 10.1051/vetres:2006025; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; Bouyer J, 2010, INFECT GENET EVOL, V10, P321, DOI 10.1016/j.meegid.2009.12.009; Budd L.T., 1999, DFID FUNDED TSETSE T; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Challier A., 1965, Bulletin de la Societe de Pathologie Exotique, V58, P250; CHALLIER A, 1982, INSECT SCI APPL, V3, P97, DOI 10.1017/S1742758400005725; CLAIR M, 1976, REV ELEV MED VET PAY, V29, P341, DOI 10.19182/remvt.8002; Cuisance D, 1973, Rev Elev Med Vet Pays Trop, V26, P169; CUISANCE D, 1984, REV ELEV MED VET PAY, V37, P449; Dagnachew Shimelis, 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P151; Delespaux V, 2008, TRENDS PARASITOL, V24, P236, DOI 10.1016/j.pt.2008.02.006; Dyck V.A., 2006, STERILE INSECT TECHN; ESNAULT O, 2007, ETUDE STRUCTURATION, DOI DOI 10.1111/J.1365-2915.2010.00938.X; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Hargrove JW, 2000, B ENTOMOL RES, V90, P201, DOI 10.1017/S0007485300000328; Hargrove JW, 2003, B ENTOMOL RES, V93, P203, DOI 10.1079/BER2003234; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Kagbadouno MS, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-18; Kgori PM, 2006, ACTA TROP, V99, P184, DOI 10.1016/j.actatropica.2006.07.007; Klassen W, 2003, J AM MOSQUITO CONTR, V19, P94; KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kone N, 2011, MED VET ENTOMOL, V25, P156, DOI 10.1111/j.1365-2915.2010.00938.x; Kone N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001217; Kristjanson PM, 1999, AGR SYST, V59, P79, DOI 10.1016/S0308-521X(98)00086-9; Laveissiere C., 2000, GLOSSINES VECTRICES; MUTIKA GN, 2012, ENTOMOL EXP IN PRESS; Novy J. E., 1991, World Animal Review, P18; POLITZAR H, 1984, INSECT SCI APPL, V5, P439, DOI 10.1017/S1742758400008791; Pollock J.N., 1982, TRAINING MANUAL TSET, V1; Rowlands GJ, 2000, MED VET ENTOMOL, P15; Schlather M, 2004, J R STAT SOC B, V66, P79, DOI 10.1046/j.1369-7412.2003.05343.x; Shaw APM, 2005, TRYPANOSOMIASES, P369, DOI 10.1079/9780851994758.0369; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Sow A., 2010, Bulletin of Animal Health and Production in Africa, V58, P95; Swallow BM., 1999, IMPACTS TRYPANOSOMIA; TAKKEN W, 1986, B ENTOMOL RES, V76, P275, DOI 10.1017/S0007485300014747; TAZE Y, 1977, REV ELEV MED VET PAY, V30, P269, DOI 10.19182/remvt.8083; Van den Bossche P, 2006, J MED ENTOMOL, V43, P564, DOI 10.1603/0022-2585(2006)43[564:EOICTO]2.0.CO;2; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; VANDERVLOEDT AMV, 1980, INSECT SCI APPL, V1, P105, DOI 10.1017/S1742758400000229; Vargas-Teran M., 1991, World Animal Review, P28; VARGASTERAN M, 1994, PARASITOL TODAY, V10, P119, DOI 10.1016/0169-4758(94)90014-0; Vreysen M J, 2001, Med Trop (Mars), V61, P397; Vreysen M. J. B., 2007, AREA WIDE CONTROL IN; Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Vreysen MJB, 1996, INT J RADIAT BIOL, V69, P67, DOI 10.1080/095530096146192; WILLIAMSON DL, 1983, B ENTOMOL RES, V73, P267, DOI 10.1017/S0007485300008853	61	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e37124	10.1371/journal.pone.0037124	http://dx.doi.org/10.1371/journal.pone.0037124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590652	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400061
J	Bouzigon, E; Monier, F; Boussaha, M; Le Moual, N; Huyvaert, H; Matran, R; Letort, S; Bousquet, J; Pin, I; Lathrop, M; Kauffmann, F; Demenais, F; Nadif, R				Bouzigon, Emmanuelle; Monier, Florent; Boussaha, Mekki; Le Moual, Nicole; Huyvaert, Helene; Matran, Regis; Letort, Sebastien; Bousquet, Jean; Pin, Isabelle; Lathrop, Mark; Kauffmann, Francine; Demenais, Florence; Nadif, Rachel		EGEA Cooperative Grp	Associations between Nitric Oxide Synthase Genes and Exhaled NO-Related Phenotypes according to Asthma Status	PLOS ONE			English	Article							BRONCHIAL HYPERRESPONSIVENESS; ATOPY; EOSINOPHILS; ENVIRONMENT; GENOTYPE; GENETICS; CHILDREN; PATHWAY; BREATH; COPD	Background: The nitric oxide (NO) pathway is involved in asthma, and eosinophils participate in the regulation of the NO pool in pulmonary tissues. We investigated associations between single nucleotide polymorphisms (SNPs) of NO synthase genes (NOS) and biological NO-related phenotypes measured in two compartments (exhaled breath condensate and plasma) and blood eosinophil counts. Methodology: SNPs (N=121) belonging to NOS1, NOS2 and NOS3 genes were genotyped in 1277 adults from the French Epidemiological study on the Genetics and Environment of Asthma (EGEA). Association analyses were conducted on four quantitative phenotypes: the exhaled fraction of NO (FENO), plasma and exhaled breath condensate (EBC) nitrite-nitrate levels (NO2-NO3) and blood eosinophils in asthmatics and non-asthmatics separately. Genetic heterogeneity of these phenotypes between asthmatics and non-asthmatics was also investigated. Principal Findings: In non-asthmatics, after correction for multiple comparisons, we found significant associations of Fe-NO levels with three SNPs in NOS3 and NOS2 (P <= 0.002), and of EBC NO2-NO3 level with NOS2 (P=0.002). In asthmatics, a single significant association was detected between FENO levels and one SNP in NOS3 (P=0.004). Moreover, there was significant heterogeneity of NOS3 SNP effect on Fe-NO between asthmatics and non-asthmatics (P=0.0002 to 0.005). No significant association was found between any SNP and NO2-NO3 plasma levels or blood eosinophil counts. Conclusions: Variants in NO synthase genes influence Fe-NO and EBC NO2-NO3 levels in adults. These genetic determinants differ according to asthma status. Significant associations were only detected for exhaled phenotypes, highlighting the critical relevance to have access to specific phenotypes measured in relevant biological fluid.	[Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Lathrop, Mark; Demenais, Florence] INSERM, U946, Paris, France; [Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Demenais, Florence] Univ Paris Diderot, Sorbonne Paris Cite, Inst Univ Hematol, Paris, France; [Bouzigon, Emmanuelle; Boussaha, Mekki; Letort, Sebastien; Demenais, Florence] CEPH, Fdn Jean Dausset, Paris, France; [Monier, Florent; Le Moual, Nicole; Bousquet, Jean; Kauffmann, Francine; Nadif, Rachel] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Villejuif, France; [Monier, Florent; Le Moual, Nicole; Bousquet, Jean; Kauffmann, Francine; Nadif, Rachel] INSERM, U1018, Environm Epidemiol Team, Villejuif, France; [Monier, Florent; Le Moual, Nicole; Kauffmann, Francine; Nadif, Rachel] Univ Paris 11, UMRS 1018, Villejuif, France; [Huyvaert, Helene; Matran, Regis] Univ Lille Nord, Lille, France; [Huyvaert, Helene; Matran, Regis] CHU Lille, F-59037 Lille, France; [Bousquet, Jean] CHU Arnaud Villeneuve, Montpellier, France; [Pin, Isabelle] INSERM, U823, Inst Albert Bonniot, Grenoble, France; [Pin, Isabelle] Univ Grenoble 1, Grenoble, France; [Pin, Isabelle] CHU Grenoble, F-38043 Grenoble, France; [Lathrop, Mark] Ctr Natl Genotypage, Commissariat Energie Atom, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Bouzigon, E (corresponding author), INSERM, U946, Paris, France.	rachel.nadif@inserm.fr	Le Moual, Nicole/GNP-5114-2022; Dizier, Marie-Hélène/K-8463-2018; Demenais, Florence/G-3298-2013; Nadif, Rachel/R-2876-2016; Bousquet, Jean/O-4221-2019; PIN, Isabelle/N-3020-2013; Bouzigon, Emmanuelle/L-2766-2017; Le Moual, Nicole/R-8976-2016	Le Moual, Nicole/0000-0002-2723-5569; Dizier, Marie-Hélène/0000-0001-8460-7667; Demenais, Florence/0000-0001-8361-0936; Nadif, Rachel/0000-0003-4938-9339; Bouzigon, Emmanuelle/0000-0001-5756-4286; Le Moual, Nicole/0000-0002-2723-5569; boussaha, mekki/0000-0002-5432-4604	PHRC-Paris; PHRC-Grenoble [ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS, ANR-CES-2009]; Region Nord Pas-de-Calais; Merck Sharp Dohme (MSD); GA2LEN project; Global Allergy and Asthma European Network; GABRIEL; European Community from the European Commission [018996]; EGEA; CIC-Inserm of Necker, Grenoble; CIC-Inserm of Necker, Marseille	PHRC-Paris; PHRC-Grenoble; Region Nord Pas-de-Calais(Region Hauts-de-France); Merck Sharp Dohme (MSD)(Merck & Company); GA2LEN project; Global Allergy and Asthma European Network; GABRIEL; European Community from the European Commission; EGEA; CIC-Inserm of Necker, Grenoble; CIC-Inserm of Necker, Marseille	This research is funded in part by PHRC-Paris, PHRC-Grenoble, ANR 05-SEST-020-02/05-9-97, ANR-06-CEBS, ANR-CES-2009, Region Nord Pas-de-Calais, Merck Sharp & Dohme (MSD), the GA2LEN project, Global Allergy and Asthma European Network and GABRIEL, a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community (contract 018996 from the European Commission). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FD received a grant of (sic)720 000 in November 2002 for the follow-up and genetic studies of the EGEA cohort. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; The authors thank all those who participated to the setting of the study and on the various aspects of the examinations involved: interviewers, technicians for lung function testing and skin prick tests, blood sampling, IgE determinations, coders, those involved in quality control, data and sample management and all those who supervised the study in all centers. The authors are grateful to the three CIC-Inserm of Necker, Grenoble and Marseille who supported the study and in which subjects were examined. They are also grateful to the three biobanks in Lille (CIC-Inserm), Evry (Centre National du Genotypage) and at Annemasse (Etablissement francais du sang) where biological samples are stored. They are indebted to all the individuals who participated without whom that study would not have been possible. The authors thank Anna-Carin Olin and Fredrick Nyberg for having supplied the results of the ADONIX study cohort that were in press in the meantime of the review of this manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; [Anonymous], 2006, AM J RESP CRIT CARE, V173, P811; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Batra J, 2007, THORAX, V62, P16, DOI 10.1136/thx.2006.057935; Dahgam S, 2012, J MED GENET, V49, P200, DOI 10.1136/jmedgenet-2011-100584; delPozo V, 1997, J IMMUNOL, V158, P859; Dweik RA, 2005, THORAX, V60, P265, DOI 10.1136/thx.2004.038471; Dweik RA, 2011, OFFICIAL ATS CLIN PR; Fitzpatrick AM, 2009, J ALLERGY CLIN IMMUN, V124, P990, DOI 10.1016/j.jaci.2009.08.039; Ghosh S, 2011, BBA-GEN SUBJECTS, V1810, P1008, DOI 10.1016/j.bbagen.2011.06.009; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Hunt J, 2007, IMMUNOL ALLERGY CLIN, V27, P587, DOI 10.1016/j.iac.2007.09.001; Iijima H, 2001, AM J RESP CRIT CARE, V163, P1233, DOI 10.1164/ajrccm.163.5.2003145; Kauffmann F, 1999, CLIN EXP ALLERGY, V29, P17; Kauffmann F, 1997, AM J RESP CRIT CARE, V156, pS123, DOI 10.1164/ajrccm.156.4.12tac9; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Lundberg JO, 2010, NITRIC OXIDE-BIOL CH, V22, P61, DOI 10.1016/j.niox.2009.11.004; Malerba M, 2008, CHEST, V134, P733, DOI 10.1378/chest.08-0763; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Nadif R, 2010, ANN ALLERG ASTHMA IM, V104, P385, DOI 10.1016/j.anai.2010.03.013; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Queto T, 2010, AM J RESP CRIT CARE, V181, P429, DOI 10.1164/rccm.200905-0800OC; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Taylor DR, 2009, THORAX, V64, P261, DOI 10.1136/thx.2008.098640; van's Gravesande Karin Storm, 2003, American Journal of Respiratory and Critical Care Medicine, V168, P228, DOI 10.1164/rccm.200212-1491BC; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004; Wechsler ME, 2000, AM J RESP CRIT CARE, V162, P2043, DOI 10.1164/ajrccm.162.6.2003089; Weitzberg E, 2010, ANESTHESIOLOGY, V113, P1460, DOI 10.1097/ALN.0b013e3181fcf3cc	36	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36672	10.1371/journal.pone.0036672	http://dx.doi.org/10.1371/journal.pone.0036672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590587	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100052
J	Genead, R; Fischer, H; Hussain, A; Jaksch, M; Andersson, AB; Ljung, K; Bulatovic, I; Franco-Cereceda, A; Elsheikh, E; Corbascio, M; Smith, CIE; Sylven, C; Grinnemo, KH				Genead, Rami; Fischer, Helene; Hussain, Alamdar; Jaksch, Marie; Andersson, Agneta B.; Ljung, Karin; Bulatovic, Ivana; Franco-Cereceda, Anders; Elsheikh, Elzafir; Corbascio, Matthias; Smith, C. I. Edvard; Sylven, Christer; Grinnemo, Karl-Henrik			Ischemia-Reperfusion Injury and Pregnancy Initiate Time-Dependent and Robust Signs of Up-Regulation of Cardiac Progenitor Cells	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; STEM-CELLS; MAST-CELLS; MYOCARDIAL REGENERATION; MAMMALIAN HEART; SMOOTH-MUSCLE; FACTOR-I; DIFFERENTIATION; MULTIPOTENT; INFARCTION	To explore how cardiac regeneration and cell turnover adapts to disease, different forms of stress were studied for their effects on the cardiac progenitor cell markers c-Kit and Isl1, the early cardiomyocyte marker Nkx2.5, and mast cells. Adult female rats were examined during pregnancy, after myocardial infarction and ischemia-reperfusion injury with/out insulin like growth factor-1(IGF-1) and hepatocyte growth factor (HGF). Different cardiac sub-domains were analyzed at one and two weeks post-intervention, both at the mRNA and protein levels. While pregnancy and myocardial infarction up-regulated Nkx2.5 and c-Kit (adjusted for mast cell activation), ischemia-reperfusion injury induced the strongest up-regulation which occurred globally throughout the entire heart and not just around the site of injury. This response seems to be partly mediated by increased endogenous production of IGF-1 and HGF. Contrary to c-Kit, Isl1 was not up-regulated by pregnancy or myocardial infarction while ischemia-reperfusion injury induced not a global but a focal up-regulation in the outflow tract and also in the peri-ischemic region, correlating with the up-regulation of endogenous IGF-1. The addition of IGF-1 and HGF did boost the endogenous expression of IGF and HGF correlating to focal up-regulation of Isl1. c-Kit expression was not further influenced by the exogenous growth factors. This indicates that there is a spatial mismatch between on one hand c-Kit and Nkx2.5 expression and on the other hand Isl1 expression. In conclusion, ischemia-reperfusion injury was the strongest stimulus with both global and focal cardiomyocyte progenitor cell marker up-regulations, correlating to the endogenous up-regulation of the growth factors IGF-1 and HGF. Also pregnancy induced a general up-regulation of c-Kit and early Nkx2.5+ cardiomyocytes throughout the heart. Utilization of these pathways could provide new strategies for the treatment of cardiac disease.	[Genead, Rami; Andersson, Agneta B.; Elsheikh, Elzafir; Sylven, Christer] Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden; [Fischer, Helene] Karolinska Inst, Dept Physiol, S-10401 Stockholm, Sweden; [Hussain, Alamdar; Smith, C. I. Edvard] Karolinska Inst, Dept Lab Med, Clin Res Ctr, Stockholm, Sweden; [Hussain, Alamdar] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Jaksch, Marie; Ljung, Karin; Bulatovic, Ivana; Franco-Cereceda, Anders; Corbascio, Matthias; Grinnemo, Karl-Henrik] Karolinska Univ Hosp, Div Cardiothorac Surg & Anaesthesiol, Dept Mol Med & Surg, Karolinska Inst, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; COMSATS University Islamabad (CUI); Karolinska Institutet; Karolinska University Hospital	Genead, R (corresponding author), Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden.	rami.genead@ki.se		Grinnemo, Karl-Henrik/0000-0001-6717-3393; SMITH, C. I. Edvard/0000-0003-1907-3392; Grinnemo, Karl-Henrik/0000-0002-6100-6209	Swedish Research Council; Heart and Lung Foundation; Karolinska Institutets Fonder; Signhild Engqvist Foundation; Mats Kleberg Stiftelse; Egyptian ministry of higher education	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutets Fonder(Karolinska Institutet); Signhild Engqvist Foundation; Mats Kleberg Stiftelse; Egyptian ministry of higher education(Science and Technology Development Fund (STDF))	This study was supported by grants from the Swedish Research Council, the Heart and Lung Foundation, the "Karolinska Institutets Fonder'', the Signhild Engqvist Foundation, the Mats Kleberg Stiftelse and the Egyptian ministry of higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghestanian M, 1997, BLOOD, V90, P4438; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BRODSKY VY, 1994, VIRCHOWS ARCH, V424, P429; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Ellison GM, 2011, J AM COLL CARDIOL; Frangogiannis NG, 1998, CIRCULATION, V98, P699, DOI 10.1161/01.CIR.98.7.699; Frangogiannis Nikolaos G, 2006, Methods Mol Biol, V315, P91; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Guo JL, 2009, INT J EXP PATHOL, V90, P355, DOI 10.1111/j.1365-2613.2009.00659.x; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; ITO BR, 1993, AM J PHYSIOL, V264, pH1346, DOI 10.1152/ajpheart.1993.264.5.H1346; Kara RJ, 2012, CIRC RES, V110, P82, DOI 10.1161/CIRCRESAHA.111.249037; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; PFITZER P, 1971, VIRCHOWS ARCH B, V9, P180; Pouly J, 2008, J THORAC CARDIOV SUR, V135, P673, DOI 10.1016/j.jtcvs.2007.10.024; Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097; Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Suleiman MS, 2007, PHARMACOL THERAPEUT, V114, P278, DOI 10.1016/j.pharmthera.2007.03.001; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Tomita N, 2003, CIRCULATION, V107, P1411, DOI 10.1161/01.CIR.0000055331.41937.AA; Tomita Y, 2005, J CELL BIOL, V170, P1135, DOI 10.1083/jcb.200504061; Torella Daniele, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P53, DOI 10.2174/187152508783329984; Torella Daniele, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS8, DOI 10.1038/ncpcardio0409; Virgen-Ortiz A, 2009, J PHYSIOL SCI, V59, P391, DOI 10.1007/s12576-009-0047-5; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou Y, 2010, J HISTOCHEM CYTOCHEM, V58, P309, DOI 10.1369/jhc.2009.955146	45	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36804	10.1371/journal.pone.0036804	http://dx.doi.org/10.1371/journal.pone.0036804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590612	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100062
J	Hou, JM; Wang, LW				Hou, Junmei; Wang, Liewei			FKBP5 as a Selection Biomarker for Gemcitabine and Akt Inhibitors in Treatment of Pancreatic Cancer	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; GENOME-WIDE ASSOCIATION; PROTEIN-KINASE; RESPONSE BIOMARKERS; PI3K/AKT PATHWAY; DRUG RESPONSE; PHOSPHORYLATION; CHEMOTHERAPY; GROWTH; TRIAL	We have recently shown that the immunophilin FKBP5 (also known as FKBP51) is a scaffolding protein that can enhance PHLPP-AKT interaction and facilitate PHLPP-mediated dephosphorylation of Akt Ser473, negatively regulating Akt activation in vitro. Therefore, FKBP5 might function as a tumor suppressor, and levels of FKBP5 would affect cell response to chemotherapy. In the current study, we have taken a step forward by using a pancreatic cancer xenograft mice model to show that down regulation of FKBP5 in shFKBP5 xenograft mice promotes tumor growth and resistance to gemcitabine, a phenomenon consistent with our previous findings in pancreatic cell lines. In addition, we also found that inhibitors targeting the Akt pathway, including PI3K inhibitor, Akt inhibitor and mTOR inhibitor had a different effect on sensitization to gemcitabine and other chemotherapeutic agents in cell lines, with a specific Akt inhibitor, triciribine, having the greatest sensitization effect. We then tested the hypothesis that addition of triciribine can sensitize gemcitabine treatment, especially in shFKBP5 pancreatic cancer xenograft mice. We found that combination treatment with gemcitabine and triciribine has a better effect on tumor inhibition than either drug alone (p<0.005) and that the inhibition effect is more significant in shFKBP5 xenograft mice than wt mice (p<0.05). These effects were correlated with level of Akt 473 phosphorylation as well as proliferation rate, as indicated by Ki67 staining in xenograft tumor tissues. These results provide evidence in support of future clinical trials designed to tailor therapy based on our observations.	[Hou, Junmei; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA	Mayo Clinic	Hou, JM (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Div Clin Pharmacol, Rochester, MN 55905 USA.	wang.liewei@mayo.edu			U.S. National Institutes of Health [K22 CA130828, R01 CA138461, P50 CA102701, U19 GM61388]; NATIONAL CANCER INSTITUTE [P50CA102701, K22CA130828, R01CA138461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. National Institutes of Health grants K22 CA130828, R01 CA138461, P50 CA102701, and U19 GM61388 (The Pharmacogenomics Research Network). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; El-Rayes Basil F, 2003, Clin Adv Hematol Oncol, V1, P430; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Farnell MB, 2005, SURGERY, V138, P618, DOI 10.1016/j.surg.2005.06.044; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Li L, 2008, CANCER RES, V68, P7050, DOI 10.1158/0008-5472.CAN-08-0405; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007765; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Pino Simona M, 2004, Curr Oncol Rep, V6, P199, DOI 10.1007/s11912-004-0050-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Wang H, 1999, P NATL ACAD SCI USA, V96, P13989, DOI 10.1073/pnas.96.24.13989; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/00000658-200209000-00012; Zhang Z, 2003, P NATL ACAD SCI USA, V100, P11636, DOI 10.1073/pnas.1934692100	35	33	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36252	10.1371/journal.pone.0036252	http://dx.doi.org/10.1371/journal.pone.0036252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590527	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100023
J	Hansen, BF; Glendorf, T; Hegelund, AC; Lundby, A; Lutzen, A; Slaaby, R; Stidsen, CE				Hansen, Bo F.; Glendorf, Tine; Hegelund, Anne C.; Lundby, Anders; Lutzen, Anne; Slaaby, Rita; Stidsen, Carsten Enggaard			Molecular Characterisation of Long-Acting Insulin Analogues in Comparison with Human Insulin, IGF-1 and Insulin X10	PLOS ONE			English	Article							FACTOR-I-RECEPTOR; INCREASED MITOGENIC POTENCY; GROWTH-FACTOR RECEPTOR; SMOOTH-MUSCLE-CELLS; MONOCLONAL-ANTIBODIES; HYBRID RECEPTORS; CANCER-RISK; BINDING; GLARGINE; MALIGNANCIES	Aims/Hypothesis: There is controversy with respect to molecular characteristics of insulin analogues. We report a series of experiments forming a comprehensive characterisation of the long acting insulin analogues, glargine and detemir, in comparison with human insulin, IGF-1, and the super-mitogenic insulin, X10. Methods: We measured binding of ligands to membrane-bound and solubilised receptors, receptor activation and mitogenicity in a number of cell types. Results: Detemir and glargine each displayed a balanced affinity for insulin receptor (IR) isoforms A and B. This was also true for X10, whereas IGF-1 had a higher affinity for IR-A than IR-B. X10 and glargine both exhibited a higher relative IGF-1R than IR binding affinity, whereas detemir displayed an IGF-1R:IR binding ratio of <= 1. Ligands with high relative IGF-1R affinity also had high affinity for IR/IGF-1R hybrid receptors. In general, the relative binding affinities of the analogues were reflected in their ability to phosphorylate the IR and IGF-1R. Detailed analysis revealed that X10, in contrast to the other ligands, seemed to evoke a preferential phosphorylation of juxtamembrane and kinase domain phosphorylation sites of the IR. Sustained phosphorylation was only observed from the IR after stimulation with X10, and after stimulation with IGF-1 from the IGF-1R. Both X10 and glargine showed an increased mitogenic potency compared to human insulin in cells expressing many IGF-1Rs, whereas only X10 showed increased mitogenicity in cells expressing many IRs. Conclusions: Detailed analysis of receptor binding, activation and in vitro mitogenicity indicated no molecular safety concern with detemir.	[Hansen, Bo F.; Glendorf, Tine; Hegelund, Anne C.; Lundby, Anders; Lutzen, Anne; Slaaby, Rita; Stidsen, Carsten Enggaard] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark	Novo Nordisk	Hansen, BF (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	bfh@novonordisk.com						Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; BORNFELDT KE, 1991, DIABETOLOGIA, V34, P307, DOI 10.1007/BF00405001; Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; European Pharmacopoeia, 2008, STAT AN RES BIOL ASS; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Glendorf T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020288; Hansen BF, 2008, HORM METAB RES, V40, P431, DOI 10.1055/s-2008-1062740; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 1996, BIOCHEM J, V315, P271; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Kazda C, 2010, DIABETES-METAB RES, V26, P145, DOI 10.1002/dmrr.1072; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Pollak M, 2010, INT J CLIN PRACT, V64, P628, DOI 10.1111/j.1742-1241.2010.02354.x; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Shukla A, 2009, ENDOCR-RELAT CANCER, V16, P429, DOI 10.1677/ERC-08-0240; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sorensen AR, 2010, DIABETES OBES METAB, V12, P665, DOI 10.1111/j.1463-1326.2010.01206.x; Varewijck AJ, 2010, GROWTH HORM IGF RES, V20, P427, DOI 10.1016/j.ghir.2010.10.002; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Yehezkel E, 2010, DIABETOLOGIA, V53, P2667, DOI 10.1007/s00125-010-1899-1	35	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e34274	10.1371/journal.pone.0034274	http://dx.doi.org/10.1371/journal.pone.0034274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	22590494	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335500001
J	Cuthill, JH; Charleston, M				Cuthill, Jennifer Hoyal; Charleston, Michael			Phylogenetic Codivergence Supports Coevolution of Mimetic Heliconius Butterflies	PLOS ONE			English	Article							MULLERIAN MIMICRY; POPULATION-SIZE; MUELLERIAN MIMICRY; RACE FORMATION; EVOLUTION; TREES; DIVERSITY; INFERENCE; DYNAMICS; PATTERNS	The unpalatable and warning-patterned butterflies Heliconius erato and Heliconius melpomene provide the best studied example of mutualistic Mullerian mimicry, thought-but rarely demonstrated-to promote coevolution. Some of the strongest available evidence for coevolution comes from phylogenetic codivergence, the parallel divergence of ecologically associated lineages. Early evolutionary reconstructions suggested codivergence between mimetic populations of H. erato and H. melpomene, and this was initially hailed as one of the most striking known cases of coevolution. However, subsequent molecular phylogenetic analyses found discrepancies in phylogenetic branching patterns and timing (topological and temporal incongruence) that argued against codivergence. We present the first explicit cophylogenetic test of codivergence between mimetic populations of H. erato and H. melpomene, and re-examine the timing of these radiations. We find statistically significant topological congruence between multilocus coalescent population phylogenies of H. erato and H. melpomene. Cophylogenetic historical reconstructions support repeated codivergence of mimetic populations, from the base of the sampled radiations. Pairwise distance correlation tests, based on our coalescent analyses plus recently published AFLP and wing colour pattern gene data, also suggest that the phylogenies of H. erato and H. melpomene show significant topological congruence. Divergence time estimates, based on a Bayesian coalescent model, suggest that the evolutionary radiations of H. erato and H. melpomene occurred over the same time period, and are compatible with a series of temporally congruent codivergence events. Our results suggest that differences in within-species genetic divergence are the result of a greater overall effective population size for H. erato relative to H. melpomene and do not imply incongruence in the timing of their phylogenetic radiations. Repeated codivergence between Mullerian co-mimics, predicted to exert mutual selection pressures, strongly suggests coevolution. Our results therefore support a history of reciprocal coevolution between Mullerian co-mimics characterised by phylogenetic codivergence and parallel phenotypic change.	[Cuthill, Jennifer Hoyal; Charleston, Michael] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia	University of Sydney	Cuthill, JH (corresponding author), Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia.	jenhc@it.usyd.edu.au	Charleston, Michael A/O-4903-2017	Charleston, Michael A/0000-0001-8385-341X; Hoyal Cuthill, Jennifer/0000-0002-3139-9750	Australian Research Council [DP1094891]	Australian Research Council(Australian Research Council)	This research was supported by a Discovery Project grant (number DP1094891) from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arias CF, 2008, MOL ECOL, V17, P4699, DOI 10.1111/j.1365-294X.2008.03934.x; Bates H.W., 1862, T LINN SOC LOND, V23, P495; Baxter SW, 2010, PLOS GENET, V6, P1; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; Beltran M, 2007, BIOL J LINN SOC, V92, P221, DOI 10.1111/j.1095-8312.2007.00830.x; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Ceccarelli FS, 2007, J EVOLUTION BIOL, V20, P286, DOI 10.1111/j.1420-9101.2006.01199.x; CHAI P, 1986, BIOL J LINN SOC, V29, P161, DOI 10.1111/j.1095-8312.1986.tb01772.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Conow C, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-16; Counterman BA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000796; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eckert AJ, 2008, MOL PHYLOGENET EVOL, V49, P832, DOI 10.1016/j.ympev.2008.09.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eltringham H, 1916, T ENTOMOLOGICAL SOC, V1916, P101; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Flanagan NS, 2004, P NATL ACAD SCI USA, V101, P9704, DOI 10.1073/pnas.0306243101; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Futuyma DJ, 1986, EVOL BIOL; Futyma DJ, 1983, COEVOLUTION, P1; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gilbert L.E., 1983, P263; Gilbert L.E., 1984, Symposia of the Royal Entomological Society of London, P41; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 1997, GENETICS, V145, P833; Hines HM, 2011, P NATL ACAD SCI USA, V108, P19666, DOI 10.1073/pnas.1110096108; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Knapp S, 2003, SCIENCE, V300, P71, DOI 10.1126/science.1083007; Kronforst MR, 2008, P ROY SOC B-BIOL SCI, V275, P493, DOI 10.1098/rspb.2007.1378; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lamas G, 2004, ATLAS NEOTROPICAL 4A, V5A; Maddison W.P., MESQUITE MODULAR SYS; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1996, CURR BIOL, V6, P937, DOI 10.1016/S0960-9822(02)00631-0; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; MULLER F., 1879, T ENTOMOL SOC LOND, V1879, pxx; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Pinheiro CEG, 2003, BIOTROPICA, V35, P356, DOI 10.1646/02128; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quek SP, 2010, P NATL ACAD SCI USA, V107, P7365, DOI 10.1073/pnas.0911572107; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Simonsen TJ, 2011, CLADISTICS, V27, P113, DOI 10.1111/j.1096-0031.2010.00326.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson JD., 1994, COEVOLUTIONARY PROCE; THOMPSON JN, 1989, TRENDS ECOL EVOL, V4, P179, DOI 10.1016/0169-5347(89)90125-0; TURNER JRG, 1987, ECOL ENTOMOL, V12, P81, DOI 10.1111/j.1365-2311.1987.tb00987.x; Wakeley J, 1997, GENETICS, V145, P847; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wright S, 1931, GENETICS, V16, P0097; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071	68	34	34	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36464	10.1371/journal.pone.0036464	http://dx.doi.org/10.1371/journal.pone.0036464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586474	Green Submitted, gold, Green Published			2022-12-27	WOS:000305335000036
J	Guzman-Aranguez, A; Woodward, AM; Pintor, J; Argueso, P				Guzman-Aranguez, Ana; Woodward, Ashley M.; Pintor, Jesus; Argueeso, Pablo			Targeted Disruption of Core 1 beta 1,3-galactosyltransferase (C1galt1) Induces Apical Endocytic Trafficking in Human Corneal Keratinocytes	PLOS ONE			English	Article							EPITHELIAL-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; MEDIATED ENDOCYTOSIS; RAT HEPATOCYTES; O-GLYCANS; IN-VITRO; SURFACE; MEMBRANE; MUCIN; INFECTION	Background: Exposed mucosal surfaces limit constitutive endocytosis under physiological conditions to prevent uptake of macromolecules and pathogens and, therefore, cellular damage. It is now accepted that cell surface mucins, a group of high molecular weight glycoproteins on the epithelial glycocalyx, defined by their extensive O-glycosylation, play a major role in maintaining barrier function in these surfaces, but the precise mechanisms are unclear. Methodology/Principal Findings: In this work, we utilized a stable tetracycline-inducible RNA interfering system targeting the core 1 beta 1,3-galactosyltransferase (C1galt1 or T-synthase), a critical galactosyltransferase required for the synthesis of core 1 O-glycans, to explore the role of mucin-type carbohydrates in apical endocytic trafficking in human corneal keratinocytes. Using cell surface biotinylation and subcellular fractionation, we found increased accumulation of plasma membrane protein in endosomes after C1galt1 depletion. Confocal laser scanning microscopy and fluorometry revealed increased translocation of negatively charged fluorescent nanospheres after C1galt1 knockdown sustained by an active transport process and largely independent of apical intercellular junctions. Internalization of nanospheres could be blocked by dynasore, nocodazole, chlorpromazine, and hyperosmotic sucrose, suggesting a mechanism for clathrin-coated pit budding and vesicular trafficking. This possibility was supported by experiments showing nanosphere colocalization with clathrin heavy chain in the cytoplasm. Conclusions/Significance: Together, the data suggest that core 1 O-glycans contribute to maintenance of apical barrier function on exposed mucosal surfaces by preventing clathrin-mediated endocytosis.	[Guzman-Aranguez, Ana; Pintor, Jesus] Univ Complutense Madrid, Escuela Univ Opt, Dept Bioquim & Biol Mol, Madrid, Spain; [Guzman-Aranguez, Ana; Woodward, Ashley M.; Argueeso, Pablo] Harvard Univ, Sch Med, Schepens Eye Res Inst, Dept Ophthalmol, Boston, MA USA	Complutense University of Madrid; Harvard University; Harvard Medical School; Schepens Eye Research Institute	Guzman-Aranguez, A (corresponding author), Univ Complutense Madrid, Escuela Univ Opt, Dept Bioquim & Biol Mol, Madrid, Spain.	pablo.argueso@schepens.harvard.edu	guzman, ana/Y-8286-2019	Guzman-Aranguez, Ana/0000-0001-6722-2044; Argueso, Pablo/0000-0001-7321-9503	National Eye Institute of the United States National Institutes of Health [R01 EY014847]; NATIONAL EYE INSTITUTE [R01EY014847] Funding Source: NIH RePORTER	National Eye Institute of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by National Eye Institute of the United States National Institutes of Health, Grant #R01 EY014847 to PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Baribaud F, 1999, J VIROL, V73, P7899, DOI 10.1128/JVI.73.9.7899-7902.1999; Chen CL, 2009, J CELL SCI, V122, P1863, DOI 10.1242/jcs.038729; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kardon R, 1999, INVEST OPHTH VIS SCI, V40, P1328; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; Komatsu M, 1997, J BIOL CHEM, V272, P33245, DOI 10.1074/jbc.272.52.33245; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; MADARA JL, 1990, AM J PATHOL, V137, P1273; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Ryeom SW, 2000, MOL BIOL CELL, V11, P1687, DOI 10.1091/mbc.11.5.1687; SCARMATO P, 1986, BIOL CELL, V56, P255, DOI 10.1111/j.1768-322X.1986.tb00457.x; Shah A, 2010, MOL VIS, V16, P2476; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Sumiyoshi M, 2008, INVEST OPHTH VIS SCI, V49, P197, DOI 10.1167/iovs.07-1038; Sundaram S, 2009, FASEB J, V23, P3752, DOI 10.1096/fj.09-129825; THOFT RA, 1975, EXP EYE RES, V21, P409, DOI 10.1016/0014-4835(75)90123-2; Ulloa F, 2003, J BIOL CHEM, V278, P12374, DOI 10.1074/jbc.M211909200; van der Bijl Pieter, 2004, Current Drug Delivery, V1, P129; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Yamamoto N, 2005, INVEST OPHTH VIS SCI, V46, P1348, DOI 10.1167/iovs.04-0542	39	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36628	10.1371/journal.pone.0036628	http://dx.doi.org/10.1371/journal.pone.0036628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574202	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800099
J	Coggill, P; Bateman, A				Coggill, Penny; Bateman, Alex			The YARHG Domain: An Extracellular Domain in Search of a Function	PLOS ONE			English	Article							PROTEIN; SEQUENCE; PROTEOLYSIS; PEPTIDASE; FAMILIES; COMPLEX	We have identified a new bacterial protein domain that we hypothesise binds to peptidoglycan. This domain is called the YARHG domain after the most highly conserved sequence-segment. The domain is found in the extracellular space and is likely to be composed of four alpha-helices. The domain is found associated with protein kinase domains, suggesting it is associated with signalling in some bacteria. The domain is also found associated with three different families of peptidases. The large number of different domains that are found associated with YARHG suggests that it is a useful functional module that nature has recombined multiple times.	[Coggill, Penny; Bateman, Alex] Wellcome Trust Sanger Inst, Hinxton, England	Wellcome Trust Sanger Institute	Coggill, P (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	pcc@sanger.ac.uk	Bateman, Alex/H-2861-2019	Bateman, Alex/0000-0002-6982-4660	Wellcome Trust [WT098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust [grant number WT098051]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bidle KA, 2010, ENVIRON MICROBIOL, V12, P1161, DOI 10.1111/j.1462-2920.2010.02157.x; BORK P, 1995, TRENDS BIOCHEM SCI, V20, P104, DOI 10.1016/S0968-0004(00)88974-4; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Das S, 2000, ADV PROTEIN CHEM, V54, P159, DOI 10.1016/S0065-3233(00)54006-6; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ehrmann M, 2004, ANNU REV GENET, V38, P709, DOI 10.1146/annurev.genet.38.072902.093416; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kapatral V, 2003, GENOME RES, V13, P1180, DOI 10.1101/gr.566003; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; KORNITZER D, 1991, J BACTERIOL, V173, P2944, DOI 10.1128/JB.173.9.2944-2953.1991; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Marcotte Cynthia J Verjovsky, 2002, Appl Bioinformatics, V1, P93; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Whisstock JC, 1999, TRENDS BIOCHEM SCI, V24, P132, DOI 10.1016/S0968-0004(99)01366-3; Wolin MJ, 2008, INT J SYST EVOL MICR, V58, P742, DOI 10.1099/ijs.0.65850-0; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Zupicich J, 2001, GENOME BIOL, V2	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2012	7	5							e35575	10.1371/journal.pone.0035575	http://dx.doi.org/10.1371/journal.pone.0035575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UQ	22615736	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341200002
J	Loh, KC; Leong, WI; Carlson, ME; Oskouian, B; Kumar, A; Fyrst, H; Zhang, M; Proia, RL; Hoffman, EP; Saba, JD				Loh, Kenneth C.; Leong, Weng-In; Carlson, Morgan E.; Oskouian, Babak; Kumar, Ashok; Fyrst, Henrik; Zhang, Meng; Proia, Richard L.; Hoffman, Eric P.; Saba, Julie D.			Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SPHINGOSINE 1-PHOSPHATE LYASE; ISCHEMIA-REPERFUSION INJURY; PROTEIN-COUPLED RECEPTOR; DEFICIENT MDX MICE; SKELETAL-MUSCLE; STEM-CELL; S1P LYASE; MYOGENIC DIFFERENTIATION; LYMPHOCYTE SEQUESTRATION	Sphingosine-1-phosphate (S1P) activates a widely expressed family of G protein-coupled receptors, serves as a muscle trophic factor and activates muscle stem cells called satellite cells (SCs) through unknown mechanisms. Here we show that muscle injury induces dynamic changes in S1P signaling and metabolism in vivo. These changes include early and profound induction of the gene encoding the S1P biosynthetic enzyme SphK1, followed by induction of the catabolic enzyme sphingosine phosphate lyase (SPL) 3 days later. These changes correlate with a transient increase in circulating S1P levels after muscle injury. We show a specific requirement for SphK1 to support efficient muscle regeneration and SC proliferation and differentiation. Mdx mice, which serve as a model for muscular dystrophy (MD), were found to be S1P-deficient and exhibited muscle SPL upregulation, suggesting that S1P catabolism is enhanced in dystrophic muscle. Pharmacological SPL inhibition increased muscle S1P levels, improved mdx muscle regeneration and enhanced SC proliferation via S1P receptor 2 (S1PR2)-dependent inhibition of Rac1, thereby activating Signal Transducer and Activator of Transcription 3 (STAT3), a central player in inflammatory signaling. STAT3 activation resulted in p21 and p27 downregulation in a S1PR2-dependent fashion in myoblasts. Our findings suggest that S1P promotes SC progression through the cell cycle by repression of cell cycle inhibitors via S1PR2/STAT3-dependent signaling and that SPL inhibition may provide a therapeutic strategy for MD.	[Loh, Kenneth C.; Leong, Weng-In; Carlson, Morgan E.; Oskouian, Babak; Kumar, Ashok; Fyrst, Henrik; Zhang, Meng; Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA; [Hoffman, Eric P.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's National Health System	Loh, KC (corresponding author), Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.	jsaba@chori.org	Proia, Richard L/A-7908-2012	Hoffman, Eric/0000-0001-6470-5139; Proia, Richard/0000-0003-0456-1270	National Institutes of Health [GM66954, CA77528, 5T32CA009041, NIH 5R24HD050846-06, CIRM TG2-01164]; Muscular Dystrophy Association USA; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077528, T32CA009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association USA(Muscular Dystrophy Association); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM66954 and CA77528 (JDS), 5T32CA009041 (WIL), NIH 5R24HD050846-06 (EPH) and CIRM TG2-01164 (KCL), and grants from the Muscular Dystrophy Association USA (EPH and JDS). This research was supported in part by the Intramural Research Programs of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (RLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Aguilar Ana, 2012, Adv Biol Regul, V52, P17; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Bagdanoff JT, 2010, J MED CHEM, V53, P8650, DOI 10.1021/jm101183p; Bandhuvula P, 2011, AM J PHYSIOL-HEART C, V300, pH1753, DOI 10.1152/ajpheart.00946.2010; Baranowski M, 2011, ACTA PHYSIOL, V203, P373, DOI 10.1111/j.1748-1716.2011.02322.x; Berry SE, 2007, REGEN MED, V2, P275, DOI 10.2217/17460751.2.3.275; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Dogra C, 2008, MOL CELL BIOCHEM, V312, P17, DOI 10.1007/s11010-008-9716-6; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Evans NP, 2009, PM&R, V1, P755, DOI 10.1016/j.pmrj.2009.04.010; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; Formigli L, 2009, J CELL SCI, V122, P1322, DOI 10.1242/jcs.035402; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; Heslop L, 2000, J CELL SCI, V113, P2299; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ieronimakis N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010920; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kumar A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.3; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Meacci E, 2010, CELL MOL LIFE SCI, V67, P4269, DOI 10.1007/s00018-010-0442-3; Medlin MD, 2010, ARTERIOSCL THROM VAS, V30, P1779, DOI 10.1161/ATVBAHA.110.209395; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Mounier R, 2011, CURR TOP DEV BIOL, V96, P121, DOI 10.1016/B978-0-12-385940-2.00005-X; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Nagata Y, 2006, J CELL BIOL, V174, P245, DOI 10.1083/jcb.200605028; Nincheri P, 2010, CELL SIGNAL, V22, P1688, DOI 10.1016/j.cellsig.2010.06.009; Nosi D, 2004, CELLS TISSUES ORGANS, V178, P129, DOI 10.1159/000082243; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pellegrin Stephanie, 2008, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1408s38; PINNEY DF, 1989, ENVIRON HEALTH PERSP, V80, P221, DOI 10.2307/3430747; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Rapizzi E, 2008, MOL CELL BIOCHEM, V314, P193, DOI 10.1007/s11010-008-9780-y; Rapizzi E, 2009, CELL MOL LIFE SCI, V66, P3207, DOI 10.1007/s00018-009-0106-3; Raptis L, 2011, EXP CELL RES, V317, P1787, DOI 10.1016/j.yexcr.2011.05.008; Sabbadini RA, 1999, ITAL J NEUROL SCI, V20, P423; Sassoli C, 2011, J CELL MOL MED, V15, P2498, DOI 10.1111/j.1582-4934.2010.01250.x; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Sekine Y, 2011, PROSTATE, V71, P690, DOI 10.1002/pros.21285; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Simon AR, 2000, SCIENCE, V290, P144, DOI 10.1126/science.290.5489.144; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Spangenburg EE, 2006, CYTOKINE, V34, P125, DOI 10.1016/j.cyto.2006.05.001; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; SULLARDS MC, 2001, SCI STKE, V67, P1; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trenerry Marissa K., 2011, BMC Physiology, V11, P6, DOI 10.1186/1472-6793-11-6; Vessey DA, 2006, MED SCI MONITOR, V12, pBR318; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; White JD, 2001, MUSCLE NERVE, V24, P695, DOI 10.1002/mus.1057; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Yu XQ, 2010, XENOBIOTICA, V40, P350, DOI 10.3109/00498251003611376; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zanin M, 2008, AM J PHYSIOL-CELL PH, V294, pC36, DOI 10.1152/ajpcell.00164.2007; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhao YT, 2011, AM J RESP CELL MOL, V45, P426, DOI 10.1165/rcmb.2010-0422OC	80	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37218	10.1371/journal.pone.0037218	http://dx.doi.org/10.1371/journal.pone.0037218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606352	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339400076
J	Dunstan, PK; Althaus, F; Williams, A; Bax, NJ				Dunstan, Piers K.; Althaus, Franziska; Williams, Alan; Bax, Nicholas J.			Characterising and Predicting Benthic Biodiversity for Conservation Planning in Deepwater Environments	PLOS ONE			English	Article							SEAMOUNT; HABITAT; DIVERSITY; PATTERNS; TASMANIA; ENDEMISM; ECOLOGY; SECTION; SLOPE	Understanding patterns of biodiversity in deep sea systems is increasingly important because human activities are extending further into these areas. However, obtaining data is difficult, limiting the ability of science to inform management decisions. We have used three different methods of quantifying biodiversity to describe patterns of biodiversity in an area that includes two marine reserves in deep water off southern Australia. We used biological data collected during a recent survey, combined with extensive physical data to model, predict and map three different attributes of biodiversity: distributions of common species, beta diversity and rank abundance distributions (RAD). The distribution of each of eight common species was unique, although all the species respond to a depth-correlated physical gradient. Changes in composition (beta diversity) were large, even between sites with very similar environmental conditions. Composition at any one site was highly uncertain, and the suite of species changed dramatically both across and down slope. In contrast, the distributions of the RAD components of biodiversity (community abundance, richness, and evenness) were relatively smooth across the study area, suggesting that assemblage structure (i.e. the distribution of abundances of species) is limited, irrespective of species composition. Seamounts had similar biodiversity based on metrics of species presence, beta diversity, total abundance, richness and evenness to the adjacent continental slope in the same depth ranges. These analyses suggest that conservation objectives need to clearly identify which aspects of biodiversity are valued, and employ an appropriate suite of methods to address these aspects, to ensure that conservation goals are met.	[Dunstan, Piers K.; Althaus, Franziska; Williams, Alan; Bax, Nicholas J.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Marine Labs, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dunstan, PK (corresponding author), Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Marine Labs, Hobart, Tas, Australia.	Piers.Dunstan@csiro.au	Williams, Alan/C-6999-2012; Dunstan, Piers K/B-7309-2016; Althaus, Franziska/B-6873-2015; Bax, Nicholas J/A-2321-2012; Althaus, Franziska/E-4660-2017	Williams, Alan/0000-0002-2867-7713; Dunstan, Piers K/0000-0002-2568-5945; Bax, Nicholas J/0000-0002-9697-4963; Althaus, Franziska/0000-0002-5336-4612	The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship; Australian Government Department of Water, Environment, Heritage and the Arts; Australia's Marine National Facility; Commonwealth Environment Facilities (CERF), programme; Australian Government initiative	The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship; Australian Government Department of Water, Environment, Heritage and the Arts(Australian Government); Australia's Marine National Facility; Commonwealth Environment Facilities (CERF), programme; Australian Government initiative(Australian Government)	Funding for the surveys was provided by The Commonwealth Scientific and Industrial Research Organisation Wealth from Oceans Flagship, and the Australian Government Department of Water, Environment, Heritage and the Arts, with support from Australia's Marine National Facility. The authors are supported through the Commonwealth Environment Facilities (CERF), programme, an Australian Government initiative, and in particular by the CERF Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Clark M. R., 2007, SEAMOUNTS ECOLOGY FI, P413, DOI 10.1002/9780470691953.; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Davies AJ, 2008, DEEP-SEA RES PT I, V55, P1048, DOI 10.1016/j.dsr.2008.04.010; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Dunn JR, 2002, DEEP-SEA RES PT I, V49, P591, DOI 10.1016/S0967-0637(01)00069-3; Dunstan PK, 2011, ECOGRAPHY, V34, P798, DOI 10.1111/j.1600-0587.2010.06552.x; Dunstan PK, 2011, ECOL MODEL, V222, P955, DOI 10.1016/j.ecolmodel.2010.11.030; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Foster SD, 2010, BIOMETRICS, V66, P186, DOI 10.1111/j.1541-0420.2009.01263.x; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; GA Australian Bathymetry and topography grid, 2009, GA AUSTR BATH TOP GR; Glover AG, 2003, ENVIRON CONSERV, V30, P219, DOI 10.1017/S0376892903000225; Hall-Spencer J, 2002, P ROY SOC B-BIOL SCI, V269, P507, DOI 10.1098/rspb.2001.1910; Hein JR, 2010, OCEANOGRAPHY, V23, P184, DOI 10.5670/oceanog.2010.70; Howell KL, 2010, MAR ECOL-EVOL PERSP, V31, P52, DOI 10.1111/j.1439-0485.2010.00368.x; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Koslow JA, 2001, MAR ECOL PROG SER, V213, P111, DOI 10.3354/meps213111; Leathwick JR, 2011, FRESHWATER BIOL, V56, P21, DOI 10.1111/j.1365-2427.2010.02414.x; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P1, DOI 10.1111/j.1439-0485.2009.00358.x; Lewis M, 1999, DEEP-SEA RES PT I, V46, P1101, DOI 10.1016/S0967-0637(98)00107-1; Li J., 2008, GEOSCI AUST, V53, P137; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; McCartney MS, 1982, J MAR RES, V40, P427; McClain CR, 2010, MAR ECOL-EVOL PERSP, V31, P14, DOI 10.1111/j.1439-0485.2010.00367.x; McEnnulty FR, RECORDS W A IN PRESS; Morell V, 2007, SCIENCE, V318, P181; O'Hara TD, 2007, GLOBAL ECOL BIOGEOGR, V16, P720, DOI 10.1111/j.1466-8238.2007.00329.x; Parslow J, 1996, TASMANIAN SLOPE TROP; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; Rintoul SR, 1999, DEEP-SEA RES PT I, V46, P1417, DOI 10.1016/S0967-0637(99)00013-8; Rintoul SR, 2001, J GEOPHYS RES-OCEANS, V106, P2815, DOI 10.1029/2000JC900107; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P226, DOI 10.1111/j.1439-0485.2010.00400.x; Samadi S, 2006, MAR BIOL, V149, P1463, DOI 10.1007/s00227-006-0306-4; Schlacher TA, 2010, MAR ECOL-EVOL PERSP, V31, P200, DOI 10.1111/j.1439-0485.2009.00286.x; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Williams A, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2010.00385.x; Williams A, 2009, ICES J MAR SCI, V66, P214, DOI 10.1093/icesjms/fsn189; WOA, 2005, WORLD OC ATL 2005	45	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36558	10.1371/journal.pone.0036558	http://dx.doi.org/10.1371/journal.pone.0036558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606271	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200033
J	Koch, AJ; Holaska, JM				Koch, Adam J.; Holaska, James M.			Loss of Emerin Alters Myogenic Signaling and miRNA Expression in Mouse Myogenic Progenitors	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; TRANSFORMING-GROWTH-FACTOR; NUCLEAR-MEMBRANE PROTEIN; SKELETAL-MUSCLE CELLS; MYOBLAST DIFFERENTIATION; STEM-CELLS; FACTOR-I; SATELLITE CELLS; MYOD PATHWAYS; FACTOR-BETA	Emerin is an integral membrane protein of the inner nuclear membrane. Mutations in emerin cause X-linked Emery-Dreifuss muscular dystrophy (EDMD), a disease characterized by skeletal muscle wasting and dilated cardiomyopathy. Current evidence suggests the muscle wasting phenotype of EDMD is caused by defective myogenic progenitor cell differentiation and impaired muscle regeneration. We obtained genome-wide expression data for both mRNA and micro-RNA (miRNA) in wildtype and emerin-null mouse myogenic progenitor cells. We report here that emerin-null myogenic progenitors exhibit differential expression of multiple signaling pathway components required for normal muscle development and regeneration. Components of the Wnt, IGF-1, TGF-beta, and Notch signaling pathways are misexpressed in emerin-null myogenic progenitors at both the mRNA and protein levels. We also report significant perturbations in the expression and activation of p38/Mapk14 in emerin-null myogenic progenitors, showing that perturbed expression of Wnt, IGF-1, TGF-beta, and Notch signaling components disrupts normal downstream myogenic signaling in these cells. Collectively, these data support the hypothesis that emerin is essential for proper myogenic signaling in myogenic progenitors, which is necessary for myogenic differentiation and muscle regeneration.	[Koch, Adam J.; Holaska, James M.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Holaska, James M.] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; [Holaska, James M.] Univ Chicago, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Koch, AJ (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.	jholaska@uchicago.edu		Holaska, James/0000-0003-0273-9995	Ellison Medical Foundation; American Heart Association; Schweppe Foundation; National Institutes of Health [T32 GM007197, T32 HL007381]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); Schweppe Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants to JMH from the Ellison Medical Foundation (www.ellisonfoundation.org), the American Heart Association (www.heart.org), and the Schweppe Foundation. AJK was partially supported by National Institutes of Health Grants T32 GM007197 and T32 HL007381. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; D'Angelo M, 2006, CELL MOL LIFE SCI; Dechat T, 2010, NUCL LAMINS COLD SPR, P1; Dedeic Z, 2011, J CELL SCI, V124, P1691, DOI 10.1242/jcs.080259; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; EDWALL D, 1989, ENDOCRINOLOGY, V124, P820, DOI 10.1210/endo-124-2-820; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Engert J, 1996, J CELL BIOL; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Gagan J, 2011, J BIOL CHEM, P1; Gardner S, 2011, MOLECULAR; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heron-Milhavet L, 2010, J CELL PHYSIOL, V225, P1, DOI 10.1002/jcp.22218; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; JENNISCHE E, 1987, ACTA PHYSIOL SCAND, V130, P327, DOI 10.1111/j.1748-1716.1987.tb08144.x; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; LEVINOVITZ A, 1992, MOL ENDOCRINOL, V6, P1227, DOI 10.1210/me.6.8.1227; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Lovett FA, 2010, ENDOCRINOLOGY, V151, P4368, DOI 10.1210/en.2010-0209; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; MORGAN JE, 1994, DEV BIOL, V162, P486, DOI 10.1006/dbio.1994.1103; Mozzetta C, 2011, CELL CYCLE GEORGETOW, P10; Muchir A, 2007, CURR NEUROL NEUROSCI, V7, P78, DOI 10.1007/s11910-007-0025-3; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Nagano A, 1996, NAT GENET; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Olguin HC, 2011, MARKING TEMPO MYOGEN; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; ROSENTHAL SM, 1995, P NATL ACAD SCI USA, V92, P10307, DOI 10.1073/pnas.92.22.10307; Schabort EJ, 2009, EXP CELL RES, V315, P373, DOI 10.1016/j.yexcr.2008.10.037; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Vlcek S, 2007, SCIENCEDIRECT CURREN; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	61	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37262	10.1371/journal.pone.0037262	http://dx.doi.org/10.1371/journal.pone.0037262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606356	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200068
J	Nelson, DE; Dong, QF; Van der Pol, B; Toh, E; Fan, BC; Katz, BP; Mi, DM; Rong, RC; Weinstock, GM; Sodergren, E; Fortenberry, JD				Nelson, David E.; Dong, Qunfeng; Van der Pol, Barbara; Toh, Evelyn; Fan, Baochang; Katz, Barry P.; Mi, Deming; Rong, Ruichen; Weinstock, George M.; Sodergren, Erica; Fortenberry, J. Dennis			Bacterial Communities of the Coronal Sulcus and Distal Urethra of Adolescent Males	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; NEISSERIA-GONORRHOEAE; HYDROGEN-PEROXIDE; MALE CIRCUMCISION; VAGINOSIS; RISK; MICROBIOME; DIVERSITY; INFECTION; PATHOGENS	Lactobacillus-dominated vaginal microbiotas are associated with reproductive health and STI resistance in women, whereas altered microbiotas are associated with bacterial vaginosis (BV), STI risk and poor reproductive outcomes. Putative vaginal taxa have been observed in male first-catch urine, urethral swab and coronal sulcus (CS) specimens but the significance of these observations is unclear. We used 16 S rRNA sequencing to characterize the microbiota of the CS and urine collected from 18 adolescent men over three consecutive months. CS microbiotas of most participants were more stable than their urine microbiotas and the composition of CS microbiotas were strongly influenced by circumcision. BV-associated taxa, including Atopobium, Megasphaera, Mobiluncus, Prevotella and Gemella, were detected in CS specimens from sexually experienced and inexperienced participants. In contrast, urine primarily contained taxa that were not abundant in CS specimens. Lactobacilllus and Streptococcus were major urine taxa but their abundance was inversely correlated. In contrast, Sneathia, Mycoplasma and Ureaplasma were only found in urine from sexually active participants. Thus, the CS and urine support stable and distinct bacterial communities. Finally, our results suggest that the penis and the urethra can be colonized by a variety of BV-associated taxa and that some of these colonizations result from partnered sexual activity.	[Nelson, David E.; Toh, Evelyn; Fan, Baochang] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Dong, Qunfeng; Rong, Ruichen] Univ N Texas, Dept Biol Sci, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Van der Pol, Barbara] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Katz, Barry P.; Mi, Deming] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Weinstock, George M.; Sodergren, Erica] Washington Univ St Louis Sch Med, Dept Genet, St Louis, MO USA	Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Washington University (WUSTL)	Nelson, DE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	nelsonde@indiana.edu; jfortenb@iupui.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Van Der Pol, Barbara/0000-0003-3064-8564; Toh, Evelyn/0000-0003-2932-4060	National Institutes of Health [NIH UH2 DK083980, NIH RC2 HG005806]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants NIH UH2 DK083980 to JDF and NIH RC2 HG005806 to DN and QD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atassi F, 2010, FEMS MICROBIOL LETT, V304, P29, DOI 10.1111/j.1574-6968.2009.01887.x; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; CAMERON DW, 1989, LANCET, V2, P403; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donders GGG, 2003, AM J OBSTET GYNECOL, V189, P1433, DOI 10.1067/S0002-9378(03)00653-7; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Group. JCHMPDGW, 2012, EV 16 S RDNA BAS COM; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Lee JW, 2009, PEDIATR NEPHROL, V24, P135, DOI 10.1007/s00467-008-0974-z; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mehta SD, 2009, J INFECT DIS, V200, P370, DOI 10.1086/600074; Mirmonsef P, 2011, AM J REPROD IMMUNOL, V65, P190, DOI 10.1111/j.1600-0897.2010.00943.x; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rajendhran J, 2010, MICROBIOL RES; RAVEL J, 2010, P NATL ACAD SCI US; Schwebke JR, 2007, AM J OBSTET GYNECOL, V196, P517, DOI 10.1016/j.ajog.2007.02.048; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Spurbeck RR, 2008, INFECT IMMUN, V76, P3124, DOI 10.1128/IAI.00101-08; Starnbach MN, 2008, NAT REV IMMUNOL, V8, P313, DOI 10.1038/nri2272; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Witkin SS, 2007, CLIN INFECT DIS, V44, P554, DOI 10.1086/511045	42	123	130	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36298	10.1371/journal.pone.0036298	http://dx.doi.org/10.1371/journal.pone.0036298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606251	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338200021
J	Wang, ZY; Feng, Y; Bardessy, N; Wong, KK; Liu, XY; Ji, HB				Wang, Zuoyun; Feng, Yan; Bardessy, Nabeel; Wong, Kwok-Kin; Liu, Xin-Yuan; Ji, Hongbin			Temporal Dissection of K-ras(G12D) Mutant In Vitro and In Vivo Using a Regulatable K-ras(G12D) Mouse Allele	PLOS ONE			English	Article							LUNG-CANCER PROGRESSION; K-RAS; INDUCED APOPTOSIS; P53 RESTORATION; ACTIVATION; CELLS; MICE; MYC; INHIBITORS; EXPRESSION	Animal models which allow the temporal regulation of gene activities are valuable for dissecting gene function in tumorigenesis. Here we have constructed a conditional inducible estrogen receptor-K-ras(G12D) (ER-K-ras(G12D)) knock-in mice allele that allows us to temporally switch on or off the activity of K-ras oncogenic mutant through tamoxifen administration. In vitro studies using mice embryonic fibroblast (MEF) showed that a dose of tamoxifen at 0.05 mu M works optimally for activation of ER-K-ras(G12D) independent of the gender status. Furthermore, tamoxifen-inducible activation of K-ras(G12D) promotes cell proliferation, anchor-independent growth, transformation as well as invasion, potentially via activation of downstream MAPK pathway and cell cycle progression. Continuous activation of K-ras(G12D) in vivo by tamoxifen treatment is sufficient to drive the neoplastic transformation of normal lung epithelial cells in mice. Tamoxifen withdrawal after the tumor formation results in apoptosis and tumor regression in mouse lungs. Taken together, these data have convincingly demonstrated that K-ras mutant is essential for neoplastic transformation and this animal model may provide an ideal platform for further detailed characterization of the role of K-ras oncogenic mutant during different stages of lung tumorigenesis.	[Wang, Zuoyun; Feng, Yan; Liu, Xin-Yuan; Ji, Hongbin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Bardessy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Wong, Kwok-Kin] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Wang, ZY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	kwong1@partners.org; xyliu@sibs.ac.cn; hbji@sibs.ac.cn	Liu, Xinyuan/HDM-5505-2022	wong, kwok kin/0000-0001-6323-235X	National Basic Research Program of China [2012CB910800, 2010CB912102]; National Natural Science Foundation of China [30971461]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010023] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Basic Research Program of China (2012CB910800 and 2010CB912102), the National Natural Science Foundation of China (30971461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Ambesi A, 2005, CANCER RES, V65, P148; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Blagosklonny MV, 2002, INT J CANCER, V98, P161, DOI 10.1002/ijc.10158; BOS JL, 1989, CANCER RES, V49, P4682; BRIAND P, 1986, ANTICANCER RES, V6, P85; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Finch AJ, 2009, MOL CELL BIOL, V29, P5306, DOI 10.1128/MCB.01745-08; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fujimoto K, 2006, DRUG METAB DISPOS, V34, P1495, DOI 10.1124/dmd.106.010009; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Junttila MR, NATURE, V468, P567; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Kohno T, 2008, CARCINOGENESIS; Konopleva M, 2005, CANCER RES, V65, P9962, DOI 10.1158/0008-5472.CAN-05-1068; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Mahgoub N, 1998, GENE CHROMOSOME CANC, V21, P270, DOI 10.1002/(SICI)1098-2264(199803)21:3<270::AID-GCC14>3.0.CO;2-T; Marchetti A, 2009, NEOPLASIA, V11, P1084, DOI 10.1593/neo.09814; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Mukhopadhyay A, 2011, J INVEST DERMATOL, V131, P311, DOI 10.1038/jid.2010.296; OSBORNE CK, 1985, CANCER RES, V45, P584; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Quinlan MP, 2008, MOL CELL BIOL; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; Sasaki H, 2007, ONCOL REP, V18, P623; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Tarutani M, 2003, CANCER RES, V63, P319; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wells V, 2007, ONCOGENE, V26, P7709, DOI 10.1038/sj.onc.1210580; Westra WH, 1996, CANCER RES, V56, P2224; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Yu DN, 2007, BLOOD, V109, P4936, DOI 10.1182/blood-2006-10-050294	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e37308	10.1371/journal.pone.0037308	http://dx.doi.org/10.1371/journal.pone.0037308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606359	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338200070
J	Thein, M; Bonde, M; Bunikis, I; Denker, K; Sickmann, A; Bergstrom, S; Benz, R				Thein, Marcus; Bonde, Mari; Bunikis, Ignas; Denker, Katrin; Sickmann, Albert; Bergstroem, Sven; Benz, Roland			DipA, a Pore-Forming Protein in the Outer Membrane of Lyme Disease Spirochetes Exhibits Specificity for the Permeation of Dicarboxylates	PLOS ONE			English	Article							LIPID BILAYER-MEMBRANES; FRACTURE ELECTRON-MICROSCOPY; BORRELIA-BURGDORFERI; ESCHERICHIA-COLI; BINDING-SITE; INSERTIONAL INACTIVATION; MITOCHONDRIAL PORIN; POLYACRYLAMIDE GELS; TREPONEMA-PALLIDUM; MOLECULAR ANALYSIS	Lyme disease Borreliae are highly dependent on the uptake of nutrients provided by their hosts. Our study describes the identification of a 36 kDa protein that functions as putative dicarboxylate-specific porin in the outer membrane of Lyme disease Borrelia. The protein was purified by hydroxyapatite chromatography from Borrelia burgdorferi B31 and designated as DipA, for dicarboxylate-specific porin A. DipA was partially sequenced, and corresponding genes were identified in the genomes of B. burgdorferi B31, Borrelia garinii PBi and Borrelia afzelii PKo. DipA exhibits high homology to the Oms38 porins of relapsing fever Borreliae. B. burgdorferi DipA was characterized using the black lipid bilayer assay. The protein has a single-channel conductance of 50 pS in 1 M KCl, is slightly selective for anions with a permeability ratio for cations over anions of 0.57 in KCl and is not voltage-dependent. The channel could be partly blocked by different di- and tricarboxylic anions. Particular high stability constants up to about 28,000 l/mol (in 0.1 M KCl) were obtained among the 11 tested anions for oxaloacetate, 2-oxoglutarate and citrate. The results imply that DipA forms a porin specific for dicarboxylates which may play an important role for the uptake of specific nutrients in different Borrelia species.	[Thein, Marcus; Denker, Katrin; Sickmann, Albert; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany; [Bonde, Mari; Bunikis, Ignas; Bergstroem, Sven] Umea Univ, Dept Mol Biol, Umea, Sweden; [Sickmann, Albert] Leibniz Inst Analyt Wissensch ISAS, Dept Bioanalyt, Dortmund, Germany; [Benz, Roland] Univ Bremen, Sch Sci & Engn, D-28359 Bremen, Germany	German Research Foundation (DFG); University of Wurzburg; Umea University; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Bremen	Thein, M (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, Wurzburg, Germany.	r.benz@jacobs-university.de	Sickmann, Albert/A-1010-2011	Sickmann, Albert/0000-0002-2388-5265; Benz, Roland/0000-0002-9510-9265	Stint (Swedish Foundation for International Cooperation in Research and Higher Education); DAAD (German Academic Exchange Service); Deutsche Forschungsgemeinschaft [BE865/15]; Swedish Research Council; German Research Foundation (DFG); University of Wuerzburg	Stint (Swedish Foundation for International Cooperation in Research and Higher Education); DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by Stint (Swedish Foundation for International Cooperation in Research and Higher Education) and DAAD (German Academic Exchange Service), Deutsche Forschungsgemeinschaft (project BE865/15), and the Swedish Research Council. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Andersen C, 2003, J BIOL CHEM, V278, P24269, DOI 10.1074/jbc.M213087200; ASBRINK E, 1984, ACTA DERM-VENEREOL, V64, P291; Bagos PG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-29; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barcena-Uribarri I, 2010, BBA-BIOMEMBRANES, V1798, P1197, DOI 10.1016/j.bbamem.2010.02.011; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BENZ R, 1988, EUR J BIOCHEM, V176, P699, DOI 10.1111/j.1432-1033.1988.tb14333.x; Benz R., 2001, MICROBIAL TRANSPORT, P227; Benz R., 1994, BACTERIAL CELL WALL, P397; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BERNARDINI ML, 1993, INFECT IMMUN, V61, P3625, DOI 10.1128/IAI.61.9.3625-3635.1993; BLEDSOE HA, 1994, J BACTERIOL, V176, P7447, DOI 10.1128/JB.176.24.7447-7455.1994; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; BUNIKIS J, 1995, FEMS MICROBIOL LETT, V131, P139, DOI 10.1111/j.1574-6968.1995.tb07768.x; BURGDORFER W, 1984, YALE J BIOL MED, V57, P515; CAPORALE DA, 1994, MOL BIOL EVOL, V11, P51; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Charbit A, 2003, FRONT BIOSCI, V8, pS265, DOI 10.2741/1046; Cox DL, 2001, MICROBIOL-SGM, V147, P1161, DOI 10.1099/00221287-147-5-1161; Cox DL, 1996, P NATL ACAD SCI USA, V93, P7973, DOI 10.1073/pnas.93.15.7973; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Delcour AH, 2002, J MOL MICROB BIOTECH, V4, P1; deSilva AM, 1997, J CLIN INVEST, V99, P377, DOI 10.1172/JCI119169; Ding W, 2000, J MOL BIOL, V302, P1153, DOI 10.1006/jmbi.2000.4119; EIFFERT H, 1991, MED MICROBIOL IMMUN, V180, P229, DOI 10.1007/BF00202557; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FREITAG H, 1982, FEBS LETT, V145, P72, DOI 10.1016/0014-5793(82)81209-X; Gromiha MM, 2004, J COMPUT CHEM, V25, P762, DOI 10.1002/jcc.10386; HANCOCK REW, 1986, BIOCHIM BIOPHYS ACTA, V860, P699, DOI 10.1016/0005-2736(86)90569-9; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JOHNSON RC, 1977, ANNU REV MICROBIOL, V31, P89, DOI 10.1146/annurev.mi.31.100177.000513; Kubo A, 2001, MICROBIOL-SGM, V147, P3135, DOI 10.1099/00221287-147-11-3135; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKEY JH, 1989, EUR J BIOCHEM, V186, P303, DOI 10.1111/j.1432-1033.1989.tb15209.x; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; LUDWIG O, 1986, BIOCHIM BIOPHYS ACTA, V860, P268, DOI 10.1016/0005-2736(86)90523-7; MAGNARELLI LA, 1989, J INFECT DIS, V159, P43, DOI 10.1093/infdis/159.1.43; MAIER C, 1988, J BIOL CHEM, V263, P2493; Mirzabekov Tajib A., 1996, Biophysical Journal, V70, pA205; Mulay V, 2007, J BACTERIOL, V189, P2063, DOI 10.1128/JB.01239-06; Nadelman RB, 1998, LANCET, V352, P557, DOI 10.1016/S0140-6736(98)01146-5; Nilsson CL, 2002, J AM SOC MASS SPECTR, V13, P295, DOI 10.1016/S1044-0305(01)00365-8; Noppa L, 2001, INFECT IMMUN, V69, P3323, DOI 10.1128/IAI.69.5.3323-3334.2001; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Ostberg Y, 2002, J BACTERIOL, V184, P6811, DOI 10.1128/JB.184.24.6811-6819.2002; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinne M, 2007, FEMS MICROBIOL LETT, V266, P241, DOI 10.1111/j.1574-6968.2006.00529.x; PROBERT WS, 1995, INFECT IMMUN, V63, P1933, DOI 10.1128/IAI.63.5.1933-1939.1995; RADOLF JD, 1995, INFECT IMMUN, V63, P2154, DOI 10.1128/IAI.63.6.2154-2163.1995; RADOLF JD, 1994, J BACTERIOL, V176, P21, DOI 10.1128/JB.176.1.21-31.1994; Ras NM, 1996, INT J SYST BACTERIOL, V46, P859; Reumann S, 1998, EUR J BIOCHEM, V251, P359, DOI 10.1046/j.1432-1327.1998.2510359.x; Sadziene A, 1996, INFECTION, V24, P195, DOI 10.1007/BF01713339; SADZIENE A, 1992, J EXP MED, V176, P799, DOI 10.1084/jem.176.3.799; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Sallmann FR, 1999, J BIOL CHEM, V274, P16107, DOI 10.1074/jbc.274.23.16107; Schindler J, 2008, J PROTEOME RES, V7, P432, DOI 10.1021/pr0704736; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Schwan TG, 1996, INFECT AGENT DIS, V5, P167; SEN K, 1988, J BIOL CHEM, V263, P1182; Shang ES, 1998, INFECT IMMUN, V66, P1082, DOI 10.1128/IAI.66.3.1082-1091.1998; Skare JT, 1996, J BACTERIOL, V178, P4909, DOI 10.1128/jb.178.16.4909-4918.1996; SKARE JT, 1995, J CLIN INVEST, V96, P2380, DOI 10.1172/JCI118295; Skare JT, 1997, INFECT IMMUN, V65, P3654, DOI 10.1128/IAI.65.9.3654-3661.1997; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Srivastava SY, 2008, J BACTERIOL, V190, P3429, DOI 10.1128/JB.00085-08; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; WALKER EM, 1991, J BACTERIOL, V173, P5585, DOI 10.1128/jb.173.17.5585-5588.1991; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wilske B, 2003, VECTOR-BORNE ZOONOT, V3, P215, DOI 10.1089/153036603322662200; Yu SL, 1998, J BIOMED SCI, V5, P370, DOI 10.1159/000025351	91	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36523	10.1371/journal.pone.0036523	http://dx.doi.org/10.1371/journal.pone.0036523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590556	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400021
J	D'Ausilio, A; Badino, L; Li, Y; Tokay, S; Craighero, L; Canto, R; Aloimonos, Y; Fadiga, L				D'Ausilio, Alessandro; Badino, Leonardo; Li, Yi; Tokay, Sera; Craighero, Laila; Canto, Rosario; Aloimonos, Yiannis; Fadiga, Luciano			Leadership in Orchestra Emerges from the Causal Relationships of Movement Kinematics	PLOS ONE			English	Article							MIRROR NEURONS; MODELS	Non-verbal communication enables efficient transfer of information among people. In this context, classic orchestras are a remarkable instance of interaction and communication aimed at a common aesthetic goal: musicians train for years in order to acquire and share a non-linguistic framework for sensorimotor communication. To this end, we recorded violinists' and conductors' movement kinematics during execution of Mozart pieces, searching for causal relationships among musicians by using the Granger Causality method (GC). We show that the increase of conductor-to-musicians influence, together with the reduction of musician-to-musician coordination (an index of successful leadership) goes in parallel with quality of execution, as assessed by musical experts' judgments. Rigorous quantification of sensorimotor communication efficacy has always been complicated and affected by rather vague qualitative methodologies. Here we propose that the analysis of motor behavior provides a potentially interesting tool to approach the rather intangible concept of aesthetic quality of music and visual communication efficacy.	[D'Ausilio, Alessandro; Badino, Leonardo; Canto, Rosario; Fadiga, Luciano] Ist Italiano Tecnol, Genoa, Italy; [Li, Yi; Aloimonos, Yiannis] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Tokay, Sera] Sisli Symphony Orchestra, Istanbul, Turkey; [Tokay, Sera] Philarmonie Chambre Tokay, Paris, France; [Craighero, Laila; Canto, Rosario; Fadiga, Luciano] Univ Ferrara, DSBTA, I-44100 Ferrara, Italy	Istituto Italiano di Tecnologia - IIT; University System of Maryland; University of Maryland College Park; University of Ferrara	D'Ausilio, A (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	luciano.fadiga@iit.it	D'Ausilio, Alessandro/A-3997-2010; Aloimonos, Yiannis/AAI-2969-2020; Fadiga, Luciano/AAC-7404-2022; D'Ausilio, Alessandro/M-6688-2019; Craighero, Laila/F-3408-2015	D'Ausilio, Alessandro/0000-0003-1472-6200; Aloimonos, Yiannis/0000-0002-8152-4281; D'Ausilio, Alessandro/0000-0003-1472-6200; Craighero, Laila/0000-0002-5400-8732; fadiga, luciano/0000-0001-5691-5080	European Union (EU) [250026, 215843]	European Union (EU)(CGIAREuropean Commission)	This work has been supported by European Union (EU) FP7 grant SIEMPRE (project number: 250026), awarded to L.F., and EU FP7 grant POETICON (project number: 215843) to L.F. and Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; de Boor C., 2001, APPL MATH SCI, V27; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hurley S, 2008, BEHAV BRAIN SCI, V31, P1, DOI 10.1017/S0140525X07003123; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2007, FUNCT NEUROL, V22, P205; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sommerville JA, 2006, PSYCHON B REV, V13, P179, DOI 10.3758/BF03193831; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; ZEKI S, 1994, BRAIN, V117, P607, DOI 10.1093/brain/117.3.607; Zeki S, 2001, SCIENCE, V293, P51, DOI 10.1126/science.1062331	28	81	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35757	10.1371/journal.pone.0035757	http://dx.doi.org/10.1371/journal.pone.0035757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TK	22590511	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100011
J	Kamphuis, T; Meijerhof, T; Stegmann, T; Lederhofer, J; Wilschut, J; de Haan, A				Kamphuis, Tobias; Meijerhof, Tjarko; Stegmann, Toon; Lederhofer, Julia; Wilschut, Jan; de Haan, Aalzen			Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice	PLOS ONE			English	Article							INFECTION; DISEASE; IMMUNIZATION; RESPONSES; GLYCOPROTEIN; ANTIBODIES; CHILDREN; INFANTS; ADULTS; TLR4	Respiratory Syncytial Virus (RSV) is a major cause of viral brochiolitis in infants and young children and is also a significant problem in elderly and immuno-compromised adults. To date there is no efficacious and safe RSV vaccine, partially because of the outcome of a clinical trial in the 1960s with a formalin-inactivated RSV vaccine (FI-RSV). This vaccine caused enhanced respiratory disease upon exposure to the live virus, leading to increased morbidity and the death of two children. Subsequent analyses of this incident showed that FI-RSV induces a Th2-skewed immune response together with poorly neutralizing antibodies. As a new approach, we used reconstituted RSV viral envelopes, i.e. virosomes, with incorporated monophosphoryl lipid A (MPLA) adjuvant to enhance immunogenicity and to skew the immune response towards a Th1 phenotype. Incorporation of MPLA stimulated the overall immunogenicity of the virosomes compared to non-adjuvanted virosomes in mice. Intramuscular administration of the vaccine led to the induction of RSV-specific IgG2a levels similar to those induced by inoculation of the animals with live RSV. These antibodies were able to neutralize RSV in vitro. Furthermore, MPLA-adjuvanted RSV virosomes induced high amounts of IFN gamma and low amounts of IL5 in both spleens and lungs of immunized and subsequently challenged animals, compared to levels of these cytokines in animals vaccinated with FI-RSV, indicating a Th1-skewed response. Mice vaccinated with RSV-MPLA virosomes were protected from live RSV challenge, clearing the inoculated virus without showing signs of lung pathology. Taken together, these data demonstrate that RSV-MPLA virosomes represent a safe and efficacious vaccine candidate which warrants further evaluation.	[Kamphuis, Tobias; Meijerhof, Tjarko; Stegmann, Toon; Lederhofer, Julia; Wilschut, Jan; de Haan, Aalzen] Univ Groningen, Dept Med Microbiol, Mol Virol Sect, Univ Med Ctr Groningen, Groningen, Netherlands; [Stegmann, Toon] Mymetics BV, Leiden, Netherlands	University of Groningen	Kamphuis, T (corresponding author), Univ Groningen, Dept Med Microbiol, Mol Virol Sect, Univ Med Ctr Groningen, Groningen, Netherlands.	t.kamphuis@umcg.nl		Lederhofer, Julia/0000-0001-9096-9701	Consortium of Top Institute Pharma, the Netherlands [T4-214]	Consortium of Top Institute Pharma, the Netherlands	This work was supported by Consortium T4-214 of Top Institute Pharma, the Netherlands. The funders had no role in study design, data collection and analysis or preparation of the manuscript. The manuscript was evaluated and subsequently approved for publication by TI Pharma.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Boukhvalova MS, 2006, VACCINE, V24, P5027, DOI 10.1016/j.vaccine.2006.03.064; Budimir N, 2010, VACCINE, V28, P8280, DOI 10.1016/j.vaccine.2010.10.007; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crommelin D, 2010, NAT REV DRUG DISCOV, V9, P99, DOI 10.1038/nrd3087; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; Falsey AR, 2006, CLIN INFECT DIS, V42, P518, DOI 10.1086/499955; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; FULGINITI VA, 1969, AM J EPIDEMIOL, V89, P435, DOI 10.1093/oxfordjournals.aje.a120956; Garcon N, 2011, VACCINE, V29, P4453, DOI 10.1016/j.vaccine.2011.04.046; Garcon N, 2011, EXPERT OPIN BIOL TH, V11, P667, DOI 10.1517/14712598.2011.573624; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Groothuis JR, 2011, ADV THER, V28, P110, DOI 10.1007/s12325-010-0101-y; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hampp C, 2011, ARCH PEDIAT ADOL MED, V165, P498, DOI 10.1001/archpediatrics.2010.298; Heer AK, 2007, J IMMUNOL, V178, P2182, DOI 10.4049/jimmunol.178.4.2182; JOHNSON RS, 1990, J BIOL CHEM, V265, P8108; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KIM H, 1969, AM J; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Moghaddam A, 2006, NAT MED, V12, P905, DOI 10.1038/nm1456; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Netea MG, 2005, ANTIMICROB AGENTS CH, V49, P3991, DOI 10.1128/AAC.49.10.3991-3996.2005; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Polack FP, 2004, PEDIATR INFECT DIS J, V23, pS65, DOI 10.1097/01.inf.0000108194.71892.95; Prince GA, 2001, VACCINE, V19, P2048, DOI 10.1016/S0264-410X(00)00417-5; Prince GA, 2001, J GEN VIROL, V82, P2881, DOI 10.1099/0022-1317-82-12-2881; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; WELLIVER RC, 1984, J IMMUNOL, V133, P1925; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501	44	61	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36812	10.1371/journal.pone.0036812	http://dx.doi.org/10.1371/journal.pone.0036812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590614	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336100063
J	Ospina, S; Rusch, GM; Pezo, D; Casanoves, F; Sinclair, FL				Ospina, Sonia; Rusch, Graciela M.; Pezo, Danilo; Casanoves, Fernando; Sinclair, Fergus L.			More Stable Productivity of Semi Natural Grasslands than Sown Pastures in a Seasonally Dry Climate	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SILVOPASTORAL SYSTEMS; PLANT DIVERSITY; NORTH-AMERICAN; PRECIPITATION; BIODIVERSITY; VARIABILITY; SAVANNAS; RAINFALL; BIOMASS	In the Neotropics the predominant pathway to intensify productivity is generally thought to be to convert grasslands to sown pastures, mostly in monoculture. This article examines how above-ground net primary productivity (ANPP) in semi-natural grasslands and sown pastures in Central America respond to rainfall by: (i) assessing the relationships between ANPP and accumulated rainfall and indices of rainfall distribution, (ii) evaluating the variability of ANPP between and within seasons, and (iii) estimating the temporal stability of ANPP. We conducted sequential biomass harvests during 12 periods of 22 days and related those to rainfall. There were significant relationships between ANPP and cumulative rainfall in 22-day periods for both vegetation types and a model including a linear and quadratic term explained 74% of the variation in the data. There was also a significant correlation between ANPP and the number of rainfall events for both vegetation types. Sown pastures had higher ANPP increments per unit rainfall and higher ANPP at the peak of the rainy season than semi-natural grasslands. In contrast, semi-natural grasslands showed higher ANPP early in the dry season. The temporal stability of ANPP was higher in semi-natural grasslands than in the sown pastures in the dry season and over a whole annual cycle. Our results reveal that, contrary to conventional thinking amongst pasture scientists, there appears to be no increase in ANPP arising from replacing semi-natural grasslands with sown pastures under prevailing pasture management practices in seasonally dry climates, while the temporal distribution of ANPP is more even in semi-natural grasslands. Neither sown pastures nor semi-natural grasslands are productive towards the end of the dry season, indicating the potential importance of the widespread practice of retaining tree cover in pastures.	[Ospina, Sonia] Ctr Res Sustainable Agr Prod Syst, Area Sustainable Livestock, Cali, Colombia; [Rusch, Graciela M.] Norwegian Inst Nat Res, Dept Terr Ecol, N-7004 Trondheim, Norway; [Pezo, Danilo] Trop Agr Res & Higher Educ Ctr, Livestock & Environm Program, Turrialba, Costa Rica; [Casanoves, Fernando] Trop Agr Res & Higher Educ Ctr, Biometr Unit, Turrialba, Costa Rica; [Sinclair, Fergus L.] Bangor Univ, Coll Nat Sci, Bangor, Gwynedd, Wales; [Sinclair, Fergus L.] World Agroforestry Ctr, Nairobi, Kenya	Norwegian Institute Nature Research; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; Bangor University; CGIAR; World Agroforestry (ICRAF)	Ospina, S (corresponding author), Ctr Res Sustainable Agr Prod Syst, Area Sustainable Livestock, Cali, Colombia.	sospina@cipav.org.co	Casanoves, Fernando/I-3588-2016	Casanoves, Fernando/0000-0001-8765-9382; Rusch, Graciela/0000-0003-3769-8345	Norwegian Institute for Nature Research; Tropical Agricultural Research and Higher Education Center (CATIE); University of Oslo - SUM; Norwegian Agency for Development Cooperation; "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project; Norwegian Ministry of Foreign Affairs; Research Council of Norway; Norwegian Agency for Development Cooperation (Norad); Pastures in Central America project	Norwegian Institute for Nature Research(Bioforsk); Tropical Agricultural Research and Higher Education Center (CATIE); University of Oslo - SUM; Norwegian Agency for Development Cooperation; "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project; Norwegian Ministry of Foreign Affairs; Research Council of Norway(Research Council of Norway); Norwegian Agency for Development Cooperation (Norad)(CGIAR); Pastures in Central America project	This study was funded in part by the Pastures in Central America project, a collaboration by the Norwegian Institute for Nature Research, the Tropical Agricultural Research and Higher Education Center (CATIE) and the University of Oslo - SUM funded by the Norwegian Agency for Development Cooperation. Additional support was provided by the "Multi-stake holders participatory development of sustainable land use alternatives for degraded pasturelands in Central America" project, led by CATIE and funded by the Norwegian Ministry of Foreign Affairs, and by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Andreas Nieuwenhuyse, for his assistance with the characterization of soils, as well as to Eddie and Norman Salazar for their support with the design of a database for this study. We also thank: Evaristo Lanuza, Otilio Castro, Eddie Gonzalez, Santiago Espino, Adolfo Roque, Adolfo Zeledon, Vicente Moreno, Rosalio Bermudez, Luis Rocha and their families for allowing us to work in their farms. The research was funded by the Norwegian Agency for Development Cooperation (Norad) and the Research Council of Norway.	Altesor A, 2005, PLANT ECOL, V179, P83, DOI 10.1007/s11258-004-5800-5; Andrade HJ, 2008, PLANT SOIL, V308, P11, DOI 10.1007/s11104-008-9600-x; Baeza S, 2010, APPL VEG SCI, V13, P72, DOI 10.1111/j.1654-109X.2009.01051.x; Baruch Z, 2005, FLORA, V200, P49, DOI 10.1016/j.flora.2004.06.001; Baruch Z, 1996, PLANT SOIL, V181, P175, DOI 10.1007/BF00012051; Bullock S.H., 1995, SEASONALLY DRY TROPI; Cajas-Giron YS, 2001, AGROFOREST SYST, V53, P215, DOI 10.1023/A:1013384706085; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Camberlin P, 2009, THEOR APPL CLIMATOL, V98, P237, DOI 10.1007/s00704-009-0113-1; Chidumayo EN, 2003, J TROP ECOL, V19, P407, DOI 10.1017/S0266467403003456; de Bello F, 2009, AGR ECOSYST ENVIRON, V131, P303, DOI 10.1016/j.agee.2009.02.002; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Dias-Filho M.B., 2007, DEGRADACAO PASTAGENS, Vfourth.; Dias-Filho MB, 2005, DEGRADACAO PASTAGNES; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fahey T. J., 2007, Principles and standards for measuring primary production, P3; FISHER MJ, 1994, NATURE, V371, P236, DOI 10.1038/371236a0; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Garnier E, 2007, ANN BOT-LONDON, V99, P967, DOI 10.1093/aob/mcl215; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guenni O, 2004, PLANT SOIL, V258, P249, DOI 10.1023/B:PLSO.0000016555.53797.58; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Holdridge LR, 2000, ECOLOGIA BASADA ZONA; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2006, OECOLOGIA, V149, P456, DOI 10.1007/s00442-006-0468-2; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loik ME, 2004, OECOLOGIA, V141, P269, DOI 10.1007/s00442-004-1570-y; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Maass MJ, 1995, SEASONALLY DRY TROPI, P399; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; Moron V, 2007, J CLIMATE, V20, P5244, DOI 10.1175/2007JCLI1623.1; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pieters A, 1997, J RANGE MANAGE, V50, P268, DOI 10.2307/4003728; Poorter H., 2007, FUNCTIONAL PLANT ECO, P67, DOI DOI 10.1201/9781420007626; Rivas L, POTENTIAL EC IMPACT; Sala OE, 2000, METHODS IN ECOSYSTEM SCIENCE, P31; Sarmiento G, 1984, ECOLOGY NEOTROPICAL; Sarmiento G, 1999, ECOLOGICAL SOCIOECON, P295; Savadogo P, 2007, AGR ECOSYST ENVIRON, V118, P80, DOI 10.1016/j.agee.2006.05.002; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Simpson P, 1996, NEW ZEAL J AGR RES, V39, P601, DOI 10.1080/00288233.1996.9513219; Snyman HA, 2009, AGR ECOSYST ENVIRON, V131, P247, DOI 10.1016/j.agee.2009.01.023; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Team R. D. C, 2011, R LANG ENV STAT COMP; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614	51	23	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35555	10.1371/journal.pone.0035555	http://dx.doi.org/10.1371/journal.pone.0035555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590506	gold, Green Published			2022-12-27	WOS:000305336100010
J	Osvath, M; Karvonen, E				Osvath, Mathias; Karvonen, Elin			Spontaneous Innovation for Future Deception in a Male Chimpanzee	PLOS ONE			English	Article							MENTAL TIME-TRAVEL; WESTERN SCRUB-JAYS; TACTICAL DECEPTION; ANIMALS; FORESIGHT; EVOLUTION; COGNITION; MEMORY; RAVENS; FOOD	Background: The ability to invent means to deceive others, where the deception lies in the perceptually or contextually detached future, appears to require the coordination of sophisticated cognitive skills toward a single goal. Meanwhile innovation for a current situation has been observed in a wide range of species. Planning, on the one hand, and the social cognition required for deception on the other, have been linked to one another, both from a co-evolutionary and a neuroanatomical perspective. Innovation and deception have also been suggested to be connected in their nature of relying on novelty. Methodology/Principal Findings: We report on systematic observations suggesting innovation for future deception by a captive male chimpanzee (Pan troglodytes). As an extension of previously described behaviour - caching projectiles for later throwing at zoo visitors - the chimpanzee, again in advance, manufactured concealments from hay, as well as used naturally occurring concealments. All were placed near the visitors' observation area, allowing the chimpanzee to make throws before the crowd could back off. We observed what was likely the first instance of this innovation. Further observations showed that the creation of future-oriented concealments became the significantly preferred strategy. What is more, the chimpanzee appeared consistently to combine two deceptive strategies: hiding projectiles and inhibiting dominance display behaviour. Conclusions/Significance: The findings suggest that chimpanzees can represent the future behaviours of others while those others are not present, as well as take actions in the current situation towards such potential future behaviours. Importantly, the behaviour of the chimpanzee produced a future event, rather than merely prepared for an event that had been reliably re-occurring in the past. These findings might indicate that the chimpanzee recombined episodic memories in perceptual simulations.	[Osvath, Mathias] Lund Univ, Dept Cognit Sci, Lund, Sweden; [Karvonen, Elin] Lund Univ, Primate Res Stn Furuvik, Furuvik, Sweden	Lund University; Lund University	Osvath, M (corresponding author), Lund Univ, Dept Cognit Sci, Lund, Sweden.	mathias.osvath@lucs.lu.se			Swedish Science Foundation [2009-2332]	Swedish Science Foundation	The work was supported by the Swedish Science Foundation, grant number 2009-2332. Link: http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett L, 2003, TRENDS COGN SCI, V7, P494, DOI 10.1016/j.tics.2003.09.005; Boyer P, 2008, TRENDS COGN SCI, V12, P219, DOI 10.1016/j.tics.2008.03.003; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Bugnyar T, 2004, ANIM COGN, V7, P69, DOI 10.1007/s10071-003-0189-4; Bugnyar T, 2006, ANIM COGN, V9, P369, DOI 10.1007/s10071-006-0035-6; Byrne R.W., 1990, Primate Report, P1; Byrne Richard W., 2003, P237; BYRNE RW, 1985, ANIM BEHAV, V33, P669, DOI 10.1016/S0003-3472(85)80093-2; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Clayton NS, 2008, ANIM BEHAV, V76, pE9, DOI 10.1016/j.anbehav.2008.06.020; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 2003, TRENDS COGN SCI, V7, P436, DOI 10.1016/j.tics.2003.08.003; Correia SPC, 2007, CURR BIOL, V17, P856, DOI 10.1016/j.cub.2007.03.063; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; de Waal Frans B.M., 1992, Evolutionary Anthropology, V1, P86, DOI 10.1002/evan.1360010306; Dufour V, 2008, BEHAV PROCESS, V79, P19, DOI 10.1016/j.beproc.2008.04.003; Humphrey N., 1992, HIST MIND; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Lee P.C., 1991, P39; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lurz RW, 2011, BRADFORD BOOKS, P1; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Osvath M, 2010, TRENDS COGN SCI, V14, P51, DOI 10.1016/j.tics.2009.11.007; Osvath M, 2008, ANIM COGN, V11, P661, DOI 10.1007/s10071-008-0157-0; Osvath M, 2010, ANIM COGN, V13, P777, DOI 10.1007/s10071-010-0336-7; Osvath M, 2009, CURR BIOL, V19, pR190, DOI 10.1016/j.cub.2009.01.010; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raby CR, 2007, NATURE, V445, P919, DOI 10.1038/nature05575; Raby CR, 2009, BEHAV PROCESS, V80, P314, DOI 10.1016/j.beproc.2008.12.005; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Roberts WA, 2010, TRENDS COGN SCI, V14, P52, DOI 10.1016/j.tics.2009.11.009; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Suddendorf T, 2003, TRENDS COGN SCI, V7, P437, DOI 10.1016/j.tics.2003.08.010; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; Suddendorf T, 2008, ANIM BEHAV, V75, pE1, DOI 10.1016/j.anbehav.2008.01.006; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suddendorf T, 2010, BEHAV BRAIN RES, V215, P292, DOI 10.1016/j.bbr.2009.11.044; Suddendorf T, 2010, WIRES COGN SCI, V1, P99, DOI 10.1002/wcs.23; Suddendorf T, 2009, ANIM COGN, V12, P751, DOI 10.1007/s10071-009-0253-9; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E., 1972, ORG MEMORY, P423; WHITEN A, 1988, BEHAV BRAIN SCI, V11, P233, DOI 10.1017/S0140525X00049682	48	43	44	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36782	10.1371/journal.pone.0036782	http://dx.doi.org/10.1371/journal.pone.0036782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590606	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336100060
J	Weng, MK; Zimmer, B; Poltl, D; Broeg, MP; Ivanova, V; Gaspar, JA; Sachinidis, A; Wullner, U; Waldmann, T; Leist, M				Weng, Matthias K.; Zimmer, Bastian; Poeltl, Dominik; Broeg, Marc P.; Ivanova, Violeta; Gaspar, John A.; Sachinidis, Agapios; Wuellner, Ullrich; Waldmann, Tanja; Leist, Marcel			Extensive Transcriptional Regulation of Chromatin Modifiers during Human Neurodevelopment	PLOS ONE			English	Article							STEM-CELLS; NEURONAL DIFFERENTIATION; EPIGENETIC ALTERATIONS; REMODELING COMPLEX; GENE FAMILY; HISTONE H3; PLURIPOTENT; EXPRESSION; METHYLATION; NUCLEOSOME	Epigenetic changes, including histone modifications or chromatin remodeling are regulated by a large number of human genes. We developed a strategy to study the coordinate regulation of such genes, and to compare different cell populations or tissues. A set of 150 genes, comprising different classes of epigenetic modifiers was compiled. This new tool was used initially to characterize changes during the differentiation of human embryonic stem cells (hESC) to central nervous system neuroectoderm progenitors (NEP). qPCR analysis showed that more than 60% of the examined transcripts were regulated, and >10% of them had a >5-fold increased expression. For comparison, we differentiated hESC to neural crest progenitors (NCP), a distinct peripheral nervous system progenitor population. Some epigenetic modifiers were regulated into the same direction in NEP and NCP, but also distinct differences were observed. For instance, the remodeling ATPase SMARCA2 was up-regulated >30-fold in NCP, while it remained unchanged in NEP; up-regulation of the ATP-dependent chromatin remodeler CHD7 was increased in NEP, while it was down-regulated in NCP. To compare the neural precursor profiles with those of mature neurons, we analyzed the epigenetic modifiers in human cortical tissue. This resulted in the identification of 30 regulations shared between all cell types, such as the histone methyltransferase SETD7. We also identified new markers for post-mitotic neurons, like the arginine methyl transferase PRMT8 and the methyl transferase EZH1. Our findings suggest a hitherto unexpected extent of regulation, and a cell type-dependent specificity of epigenetic modifiers in neurodifferentiation.	[Weng, Matthias K.; Zimmer, Bastian; Poeltl, Dominik; Waldmann, Tanja; Leist, Marcel] Univ Konstanz, Doerenkamp Zbinden Dept Vitro Toxicol, Constance, Germany; [Weng, Matthias K.; Poeltl, Dominik; Ivanova, Violeta] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Weng, Matthias K.; Poeltl, Dominik; Ivanova, Violeta] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Broeg, Marc P.] Univ Konstanz, Dept Comp Graph & Media Design, Constance, Germany; [Ivanova, Violeta] Univ Konstanz, Dept Bioinformat & Informat Min, Constance, Germany; [Ivanova, Violeta] Univ Konstanz, Grad Sch Comp & Informat Sci, Constance, Germany; [Gaspar, John A.; Sachinidis, Agapios] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Wuellner, Ullrich] Bonn Univ Hosp, Dept Neurol, Bonn, Germany	University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz; University of Konstanz; University of Cologne; University of Bonn	Weng, MK (corresponding author), Univ Konstanz, Doerenkamp Zbinden Dept Vitro Toxicol, Constance, Germany.	tanja.waldmann@uni-konstanz.de	Waldmann, Tanja/A-5145-2010; Wüllner, Ullrich/R-6790-2019; Sachinidis, Agapios/AAM-7988-2020; Sachinidis, Agapios/AAD-4178-2020; Leist, Marcel/D-2133-2010	Waldmann, Tanja/0000-0001-9276-1592; Leist, Marcel/0000-0002-3778-8693; Zimmer, Bastian/0000-0003-0004-4890	German Research Foundation (DFG) [GRK1331/2]; Doerenkamp-Zbinden Foundation, Konstanz Research School Chemical Biology (KoRS-CB), graduate school for computer and information science at Konstanz University; European Union [FP7-201619]	German Research Foundation (DFG)(German Research Foundation (DFG)); Doerenkamp-Zbinden Foundation, Konstanz Research School Chemical Biology (KoRS-CB), graduate school for computer and information science at Konstanz University; European Union(European Commission)	This work was supported by the German Research Foundation (DFG, GRK1331/2), the Doerenkamp-Zbinden Foundation, Konstanz Research School Chemical Biology (KoRS-CB), graduate school for computer and information science at Konstanz University and the ESNATS project of the European Union (FP7-201619). The funders had no role in study design, data collection and analysis.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; CHAMBERS SM, 2009, NAT BIOTECHNOL; Chambers SM, 2011, METHODS MOL BIOL, V793, P87, DOI 10.1007/978-1-61779-328-8_6; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Falsig J, 2004, J IMMUNOL, V173, P2762, DOI 10.4049/jimmunol.173.4.2762; Fulton DL, 2011, NUCLEIC ACIDS RES, V39, P7974, DOI 10.1093/nar/gkr326; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hermanson E, 2006, J NEUROCHEM, V97, P1403, DOI 10.1111/j.1471-4159.2006.03829.x; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu HD, 2008, J NEUROSCI RES, V86, P537, DOI 10.1002/jnr.21521; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minard ME, 2009, GENESIS, V47, P559, DOI 10.1002/dvg.20534; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Nishihara E, 2007, BRAIN RES, V1135, P22, DOI 10.1016/j.brainres.2006.12.026; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Sen N, 2011, P NATL ACAD SCI USA, V108, P20178, DOI 10.1073/pnas.1117820108; Shur I, 2005, J MOL BIOL, V352, P646, DOI 10.1016/j.jmb.2005.06.049; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thomas T, 2000, DEVELOPMENT, V127, P2537; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Umlauf David, 2004, Methods Mol Biol, V287, P99; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang QW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-286; Zimmer B, 2011, CELL DEATH DIFFER, V18, P383, DOI 10.1038/cdd.2010.109	59	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36708	10.1371/journal.pone.0036708	http://dx.doi.org/10.1371/journal.pone.0036708			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590590	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336100053
J	Brion, F; Le Page, Y; Piccini, B; Cardoso, O; Tong, SK; Chung, BC; Kah, O				Brion, Francois; Le Page, Yann; Piccini, Benjamin; Cardoso, Olivier; Tong, Sok-Keng; Chung, Bon-chu; Kah, Olivier			Screening Estrogenic Activities of Chemicals or Mixtures In Vivo Using Transgenic (cyp19a1b-GFP) Zebrafish Embryos	PLOS ONE			English	Article							BRAIN AROMATASE; ANDROGEN RECEPTOR; FATHEAD MINNOW; EXPRESSION; BINDING; GENE; WILDLIFE; 5-ALPHA-REDUCTASE; XENOESTROGENS; METABOLITES	The tg(cyp19a1b-GFP) transgenic zebrafish expresses GFP (green fluorescent protein) under the control of the cyp19a1b gene, encoding brain aromatase. This gene has two major characteristics: (i) it is only expressed in radial glial progenitors in the brain of fish and (ii) it is exquisitely sensitive to estrogens. Based on these properties, we demonstrate that natural or synthetic hormones (alone or in binary mixture), including androgens or progestagens, and industrial chemicals induce a concentration-dependent GFP expression in radial glial progenitors. As GFP expression can be quantified by in vivo imaging, this model presents a very powerful tool to screen and characterize compounds potentially acting as estrogen mimics either directly or after metabolization by the zebrafish embryo. This study also shows that radial glial cells that act as stem cells are direct targets for a large panel of endocrine disruptors, calling for more attention regarding the impact of environmental estrogens and/or certain pharmaceuticals on brain development. Altogether these data identify this in vivo bioassay as an interesting alternative to detect estrogen mimics in hazard and risk assessment perspective.	[Brion, Francois; Piccini, Benjamin; Cardoso, Olivier] Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo, Direct Risques Chron, Verneuil En Halatte, France; [Le Page, Yann; Kah, Olivier] Univ Rennes 1, Inst Rech Sante Environm & Travail IRSET, INSERM, BIOSIT,U1085, Rennes, France; [Tong, Sok-Keng; Chung, Bon-chu] Acad Sinica, Taiwan Inst Mol Biol, Taipei 115, Taiwan	Institut National de l'Environnement Industriel et des Risques (INERIS); Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Academia Sinica - Taiwan	Brion, F (corresponding author), Inst Natl Environm Ind & Risques INERIS, Unite Ecotoxicol Vitro & Vivo, Direct Risques Chron, Verneuil En Halatte, France.	olivier.kah@univ-rennes1.fr	kah, olivier/K-7624-2012; Le Page, yann/K-2868-2015; Tong, Sok-Keng/Y-6513-2019; BRION, Francois/Q-8713-2018	Le Page, yann/0000-0002-7194-8267; BRION, Francois/0000-0003-2341-4196; Tong, Sok Keng/0000-0002-8504-9473; Chung, Bon-chu/0000-0002-8612-0219	ANR NEED [CES-2008-11]; NEMO; NSC Taiwan-CNRS France exchange program	ANR NEED(French National Research Agency (ANR)); NEMO; NSC Taiwan-CNRS France exchange program	The ANR NEED (CES-2008-11) (to O.K. and F.B.), the Post-Grenelle grant NEMO (to F. B. and O.K.) and a NSC Taiwan-CNRS France exchange program (to B. C.C. and O.K.) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Bauer ERS, 2000, APMIS, V108, P838, DOI 10.1111/j.1600-0463.2000.tb00007.x; BERENBAUM MC, 1985, J THEOR BIOL, V114, P413, DOI 10.1016/S0022-5193(85)80176-4; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOTELLA J, 1995, J STEROID BIOCHEM, V55, P77, DOI 10.1016/0960-0760(95)00156-T; Brinton RD, 2009, TRENDS PHARMACOL SCI, V30, P212, DOI 10.1016/j.tips.2008.12.006; Chen H, 2010, AQUAT TOXICOL, V96, P53, DOI 10.1016/j.aquatox.2009.09.015; Cheshenko K, 2007, TOXICOL SCI, V96, P255, DOI 10.1093/toxsci/kfm003; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Cosnefroy A, 2009, TOXICOL IN VITRO, V23, P1450, DOI 10.1016/j.tiv.2009.07.003; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; Diotel N, 2011, EUR J NEUROSCI, V34, P45, DOI 10.1111/j.1460-9568.2011.07731.x; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Garcia-Becerra R, 2002, J STEROID BIOCHEM, V82, P333, DOI 10.1016/S0960-0760(02)00192-9; Gorelick DA, 2011, ENDOCRINOLOGY, V152, P2690, DOI 10.1210/en.2010-1257; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Larrea F, 2001, ENDOCRINOLOGY, V142, P3791, DOI 10.1210/en.142.9.3791; Le Page Y, 2006, ENVIRON HEALTH PERSP, V114, P752, DOI 10.1289/ehp.8141; Le Page Y, 2008, MOL REPROD DEV, V75, P1549, DOI 10.1002/mrd.20892; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Lephart ED, 1996, BRAIN RES REV, V22, P1; Martinez-Cerdeno V, 2006, EUR J NEUROSCI, V24, P3475, DOI 10.1111/j.1460-9568.2006.05239.x; McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924; Menuet A, 2005, J COMP NEUROL, V485, P304, DOI 10.1002/cne.20497; Menuet A, 2002, BIOL REPROD, V66, P1881, DOI 10.1095/biolreprod66.6.1881; Miyashita M, 2004, CHEMOSPHERE, V54, P1273, DOI 10.1016/j.chemosphere.2003.10.035; Mouriec K, 2009, DEV DYNAM, V238, P2641, DOI 10.1002/dvdy.22069; Mouriec K, 2009, BIOL REPROD, V80, P889, DOI 10.1095/biolreprod.108.073643; Mueller SO, 2004, ANAL BIOANAL CHEM, V378, P582, DOI 10.1007/s00216-003-2238-x; OECD, 2006, DRAFT REP PREV INT V, P185; PASMANIK M, 1988, ENDOCRINOLOGY, V122, P1349, DOI 10.1210/endo-122-4-1349; PASMANIK M, 1985, GEN COMP ENDOCR, V60, P244, DOI 10.1016/0016-6480(85)90320-X; Pellegrini E, 2007, J COMP NEUROL, V501, P150, DOI 10.1002/cne.21222; Pillon A, 2005, ENVIRON HEALTH PERSP, V113, P278, DOI 10.1289/ehp.7522; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Sassi-Messai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004935; Schwartz P, 2010, SCI TOTAL ENVIRON, V409, P326, DOI 10.1016/j.scitotenv.2010.10.017; Sugiyama N, 2009, MOL PSYCHIATR, V14, P223, DOI 10.1038/mp.2008.118; Sugiyama N, 2010, TRENDS ENDOCRIN MET, V21, P545, DOI 10.1016/j.tem.2010.05.001; Thorpe KL, 2007, AQUAT TOXICOL, V85, P176, DOI 10.1016/j.aquatox.2007.08.012; Tong SK, 2009, GENESIS, V47, P67, DOI 10.1002/dvg.20459; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Vosges M, 2010, AQUAT TOXICOL, V99, P479, DOI 10.1016/j.aquatox.2010.06.009; Wang L, 2003, P NATL ACAD SCI USA, V100, P703, DOI 10.1073/pnas.242735799; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Wilson VS, 2007, ENVIRON TOXICOL CHEM, V26, P1793, DOI 10.1897/06-593R.1; Zeman F, 2008, THESIS U MONTPELLIER, P164; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	50	136	142	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36069	10.1371/journal.pone.0036069	http://dx.doi.org/10.1371/journal.pone.0036069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586461	Green Submitted, Green Published, gold			2022-12-27	WOS:000305335000023
J	Peyroche, G; Saveanu, C; Dauplais, M; Lazard, M; Beuneu, F; Decourty, L; Malabat, C; Jacquier, A; Blanquet, S; Plateau, P				Peyroche, Gerald; Saveanu, Cosmin; Dauplais, Marc; Lazard, Myriam; Beuneu, Francois; Decourty, Laurence; Malabat, Christophe; Jacquier, Alain; Blanquet, Sylvain; Plateau, Pierre			Sodium Selenide Toxicity Is Mediated by O-2-Dependent DNA Breaks	PLOS ONE			English	Article							5-(DIETHOXYPHOSPHORYL)-5-METHYL-1-PYRROLINE N-OXIDE; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; HOMOLOGOUS RECOMBINATION; GLUTATHIONE REDUCTASE; HYDROGEN-SULFIDE; GENES; YEAST; DAMAGE	Hydrogen selenide is a recurrent metabolite of selenium compounds. However, few experiments studied the direct link between this toxic agent and cell death. To address this question, we first screened a systematic collection of Saccharomyces cerevisiae haploid knockout strains for sensitivity to sodium selenide, a donor for hydrogen selenide (H2Se/HSe-/Se2-). Among the genes whose deletion caused hypresensitivity, homologous recombination and DNA damage checkpoint genes were over-represented, suggesting that DNA double-strand breaks are a dominant cause of hydrogen selenide toxicity. Consistent with this hypothesis, treatment of S. cerevisiae cells with sodium selenide triggered G2/M checkpoint activation and induced in vivo chromosome fragmentation. In vitro, sodium selenide directly induced DNA phosphodiester-bond breaks via an O-2-dependent reaction. The reaction was inhibited by mannitol, a hydroxyl radical quencher, but not by superoxide dismutase or catalase, strongly suggesting the involvement of hydroxyl radicals and ruling out participations of superoxide anions or hydrogen peroxide. The (OH)-O-center dot signature could indeed be detected by electron spin resonance upon exposure of a solution of sodium selenide to O-2. Finally we showed that, in vivo, toxicity strictly depended on the presence of O-2. Therefore, by combining genome-wide and biochemical approaches, we demonstrated that, in yeast cells, hydrogen selenide induces toxic DNA breaks through an O-2-dependent radical-based mechanism.	[Peyroche, Gerald; Dauplais, Marc; Lazard, Myriam; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Saveanu, Cosmin; Decourty, Laurence; Malabat, Christophe; Jacquier, Alain] Inst Pasteur, CNRS, Unite Genet Interact Macromol, URA2171, Paris, France; [Beuneu, Francois] Ecole Polytech, CNRS, Lab Solides Irradies, CEA,UMR7642, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; CNRS - Institute of Physics (INP)	Peyroche, G (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu	Saveanu, Cosmin/Q-1251-2019; Saveanu, Cosmin/K-6494-2015	Saveanu, Cosmin/0000-0002-1677-7936; Saveanu, Cosmin/0000-0002-1677-7936; JACQUIER, ALAIN/0000-0001-5707-9184; Malabat, Christophe/0000-0003-2551-2355; Lazard, Myriam/0000-0002-7154-1352	CNRS; Ecole polytechnique; Ministere de l'Education Nationale; French Agence Nationale de la Recherche [ANR-08-JCJC-0019-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole polytechnique; Ministere de l'Education Nationale; French Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was funded by the CNRS, the Ecole polytechnique, the Ministere de l'Education Nationale (to GP) and the French Agence Nationale de la Recherche (ANR-08-JCJC-0019-01, GENO-GIM, to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; ANJARIA KB, 1988, MUTAT RES, V204, P605, DOI 10.1016/0165-1218(88)90063-8; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Game JC, 2003, RADIAT RES, V160, P14, DOI 10.1667/RR3019; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hanway D, 2002, P NATL ACAD SCI USA, V99, P10605, DOI 10.1073/pnas.152264899; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; HSIEH HS, 1975, BIOCHEMISTRY-US, V14, P1632, DOI 10.1021/bi00679a014; Imura N., 1989, SE BIOL MED, P70, DOI [10.1007/978-3-642-74421-1_14, DOI 10.1007/978-3-642-74421-1_14]; Izquierdo A, 2010, MICROBIOL-SGM, V156, P2608, DOI 10.1099/mic.0.039719-0; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; KITAHARA J, 1995, GENETIC RESPONSE TO METALS, P121; KITAHARA J, 1993, JPN J TOX ENV HEALTH, V39, pP5; Ledesma MC, 2011, MOL MED, V17, P134, DOI 10.2119/molmed.2010.00136; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Letavayova L, 2008, MUTAT RES-GEN TOX EN, V652, P198, DOI 10.1016/j.mrgentox.2008.03.001; Letavayova L, 2008, MUTAT RES-FUND MOL M, V638, P1, DOI 10.1016/j.mrfmmm.2007.08.009; Lewinska A, 2008, FUNGAL GENET BIOL, V45, P1182, DOI 10.1016/j.fgb.2008.05.011; LIN Y, 1993, BIOCHEM PHARMACOL, V45, P429, DOI 10.1016/0006-2952(93)90080-G; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Manikova D, 2010, MUTAGENESIS, V25, P155, DOI 10.1093/mutage/gep056; Mazon G, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.006; Muecke R, 2010, INTEGR CANCER THER, V9, P136, DOI 10.1177/1534735410367648; NASHEF AS, 1977, ANAL BIOCHEM, V79, P394, DOI 10.1016/0003-2697(77)90413-4; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; NUTTALL KL, 1984, INORG CHIM A-BIOINOR, V91, P243, DOI 10.1016/S0020-1693(00)81844-7; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Pietri S, 1998, EUR J BIOCHEM, V254, P256, DOI 10.1046/j.1432-1327.1998.2540256.x; Pinson B, 2000, MOL MICROBIOL, V36, P679, DOI 10.1046/j.1365-2958.2000.01890.x; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Seitomer E, 2008, MOL NUTR FOOD RES, V52, P1305, DOI 10.1002/mnfr.200700347; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shen HM, 2000, FREE RADICAL BIO MED, V28, P1115, DOI 10.1016/S0891-5849(00)00206-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tapley DW, 1999, BIOL BULL, V196, P52, DOI 10.2307/1543166; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; van Attikum H, 2007, EMBO J, V26, P4113, DOI 10.1038/sj.emboj.7601835; WERES O, 1985, CORROSION, V41, P307, DOI 10.5006/1.3582010; Wu M, 2010, J BIOL CHEM, V285, P12055, DOI 10.1074/jbc.M109.088781	45	47	49	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36343	10.1371/journal.pone.0036343	http://dx.doi.org/10.1371/journal.pone.0036343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586468	gold, Green Published			2022-12-27	WOS:000305335000030
J	Zhang, YQ; Zhang, Y; Bone, RN; Cui, WX; Peng, JB; Siegal, GP; Wang, HJ; Wu, HJ				Zhang, Yanqing; Zhang, Yuan; Bone, Robert N.; Cui, Wanxing; Peng, Ji-Bin; Siegal, Gene P.; Wang, Hongjun; Wu, Hongju			Regeneration of Pancreatic Non-beta Endocrine Cells in Adult Mice following a Single Diabetes-Inducing Dose of Streptozotocin	PLOS ONE			English	Article							NEONATAL-RAT; PRECURSOR CELLS; ALPHA-CELLS; IN-VITRO; INSULIN; ISLETS; GLUCAGON; GROWTH; ONSET; PDX-1	The non-beta endocrine cells in pancreatic islets play an essential counterpart and regulatory role to the insulin-producing beta-cells in the regulation of blood-glucose homeostasis. While significant progress has been made towards the understanding of beta-cell regeneration in adults, very little is known about the regeneration of the non-b endocrine cells such as glucagon-producing alpha-cells and somatostatin producing delta-cells. Previous studies have noted the increase of alpha-cell composition in diabetes patients and in animal models. It is thus our hypothesis that non-beta-cells such as a-cells and delta-cells in adults can regenerate, and that the regeneration accelerates in diabetic conditions. To test this hypothesis, we examined islet cell composition in a streptozotocin ( STZ)-induced diabetes mouse model in detail. Our data showed the number of alpha-cells in each islet increased following STZ-mediated beta-cell destruction, peaked at Day 6, which was about 3 times that of normal islets. In addition, we found delta-cell numbers doubled by Day 6 following STZ treatment. These data suggest alpha-and delta-cell regeneration occurred rapidly following a single diabetes-inducing dose of STZ in mice. Using in vivo BrdU labeling techniques, we demonstrated alpha- and delta-cell regeneration involved cell proliferation. Co-staining of the islets with the proliferating cell marker Ki67 showed alpha- and delta-cells could replicate, suggesting self-duplication played a role in their regeneration. Furthermore, Pdx1(+)/Insulin(-) cells were detected following STZ treatment, indicating the involvement of endocrine progenitor cells in the regeneration of these non-beta cells. This is further confirmed by the detection of Pdx1(+)/glucagon(+) cells and Pdx1(+)/somatostatin(+) cells following STZ treatment. Taken together, our study demonstrated adult alpha-and delta-cells could regenerate, and both self-duplication and regeneration from endocrine precursor cells were involved in their regeneration.	[Zhang, Yanqing; Wu, Hongju] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Zhang, Yuan; Peng, Ji-Bin] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bone, Robert N.; Siegal, Gene P.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Cui, Wanxing] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Siegal, Gene P.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Wang, Hongjun] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Zhang, Yanqing] Guangzhou Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yanqing; Wu, Hongju] Tulane Univ, Dept Med, New Orleans, LA 70118 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical University of South Carolina; Guangzhou Medical University; Tulane University	Zhang, YQ (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA.	hwu3@tulane.edu	Wang, Hongjun/AAA-1319-2021; Siegal, Gene/A-8653-2009	Siegal, Gene/0000-0003-3857-3368; Bone, Robert/0000-0003-3222-8918	Juvenile Diabetes Research Foundation [27-2009-378]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK081463]; American Heart Association Greater Southeast Affiliate [09GRNT2160024]; National Institutes of Health [R01DK072154]; CoBRE core facility; Histology Research Laboratory in Tulane University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072154, R01DK081463] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Greater Southeast Affiliate(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CoBRE core facility; Histology Research Laboratory in Tulane University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Juvenile Diabetes Research Foundation grant 27-2009-378 and the National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK081463. J-B. Peng was supported by grants 09GRNT2160024 from the American Heart Association Greater Southeast Affiliate and R01DK072154 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Edward Phillips and Shawn Williams in the UAB High Resolution Imaging Facility for their excellent technical assistance with microscopic imaging. They are also thankful for the technical support from the Center for Metabolic Bone Disease Core Laboratory and the Animal Physiology Core in the Diabetes Research and Training Center at UAB. Finally, the authors want to thank the CoBRE core facility and Histology Research Laboratory in Tulane University for their kind support.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; BONNERWEIR S, 1981, DIABETES, V30, P64, DOI 10.2337/diabetes.30.1.64; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chen XJ, 2009, TRANSPLANTATION, V88, P496, DOI 10.1097/TP.0b013e3181b0d2ee; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; DALESSIO DA, 1989, J CLIN INVEST, V84, P857, DOI 10.1172/JCI114246; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Iki K, 2007, J HISTOCHEM CYTOCHEM, V55, P111, DOI 10.1369/jhc.6A7024.2006; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; MANDARINO L, 1981, NATURE, V291, P76, DOI 10.1038/291076a0; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; OReilly LA, 1997, DIABETES, V46, P599, DOI 10.2337/diabetes.46.4.599; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pechhold K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004827; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; SAMOLS E, 1986, CLIN ENDOCRINOL META, V15, P33, DOI 10.1016/S0300-595X(86)80041-X; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Strowski MZ, 2000, ENDOCRINOLOGY, V141, P111, DOI 10.1210/en.141.1.111; TEITELMAN G, 1993, DEVELOPMENT, V118, P1031; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735	44	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36675	10.1371/journal.pone.0036675	http://dx.doi.org/10.1371/journal.pone.0036675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586489	Green Published, gold, Green Submitted			2022-12-27	WOS:000305335000050
J	Broos, N; Schmaal, L; Wiskerke, J; Kostelijk, L; Lam, T; Stoop, N; Weierink, L; Ham, J; de Geus, EJC; Schoffelmeer, ANM; van den Brink, W; Veltman, DJ; de Vries, TJ; Pattij, T; Goudriaan, AE				Broos, Nienke; Schmaal, Lianne; Wiskerke, Joost; Kostelijk, Lennard; Lam, Thomas; Stoop, Nicky; Weierink, Lonneke; Ham, Jannemieke; de Geus, Eco J. C.; Schoffelmeer, Anton N. M.; van den Brink, Wim; Veltman, Dick J.; de Vries, Taco J.; Pattij, Tommy; Goudriaan, Anna E.			The Relationship between Impulsive Choice and Impulsive Action: A Cross-Species Translational Study	PLOS ONE			English	Article							REACTION-TIME-TASK; SUBSTANCE-USE DISORDERS; DELAYED MEMORY TASKS; RESPONSE-INHIBITION; REFLECTION-IMPULSIVITY; DECISION-MAKING; DISTINCT FORMS; D-AMPHETAMINE; BEHAVIOR; RATS	Maladaptive impulsivity is a core symptom in various psychiatric disorders. However, there is only limited evidence available on whether different measures of impulsivity represent largely unrelated aspects or a unitary construct. In a cross-species translational study, thirty rats were trained in impulsive choice (delayed reward task) and impulsive action (five-choice serial reaction time task) paradigms. The correlation between those measures was assessed during baseline performance and after pharmacological manipulations with the psychostimulant amphetamine and the norepinephrine reuptake inhibitor atomoxetine. In parallel, to validate the animal data, 101 human subjects performed analogous measures of impulsive choice (delay discounting task, DDT) and impulsive action (immediate and delayed memory task, IMT/DMT). Moreover, all subjects completed the Stop Signal Task (SST, as an additional measure of impulsive action) and filled out the Barratt impulsiveness scale (BIS-11). Correlations between DDT and IMT/DMT were determined and a principal component analysis was performed on all human measures of impulsivity. In both rats and humans measures of impulsive choice and impulsive action did not correlate. In rats the within-subject pharmacological effects of amphetamine and atomoxetine did not correlate between tasks, suggesting distinct underlying neural correlates. Furthermore, in humans, principal component analysis identified three independent factors: (1) self-reported impulsivity (BIS-11); (2) impulsive action (IMT/DMT and SST); (3) impulsive choice (DDT). This is the first study directly comparing aspects of impulsivity using a cross-species translational approach. The present data reveal the non-unitary nature of impulsivity on a behavioral and pharmacological level. Collectively, this warrants a stronger focus on the relative contribution of distinct forms of impulsivity in psychopathology.	[Broos, Nienke; Wiskerke, Joost; Stoop, Nicky; Weierink, Lonneke; Ham, Jannemieke; Schoffelmeer, Anton N. M.; de Vries, Taco J.; Pattij, Tommy] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Schmaal, Lianne; Kostelijk, Lennard; Lam, Thomas; van den Brink, Wim; Goudriaan, Anna E.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Broos, N (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	t.pattij@vumc.nl	De Vries, Taco J/B-2831-2014; Stoop, Nicky/GPG-0589-2022; Wiskerke, Joost/L-5271-2017; de Geus, Eco J.C./M-9318-2015	Wiskerke, Joost/0000-0001-5029-341X; de Geus, Eco J.C./0000-0001-6022-2666; Pattij, Tommy/0000-0002-0079-7385; Schmaal, Lianne/0000-0001-9822-048X; De Vries, Taco/0000-0002-0340-4946	Netherlands Organization for Scientific Research (ZonMW) [3116003]	Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This study was financially supported by a grant from the Netherlands Organization for Scientific Research (ZonMW grant no. 3116003/www.ZonMW.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarendse PJJ, 2012, PSYCHOPHARMACOLOGY, V219, P313, DOI 10.1007/s00213-011-2576-x; Bickel WK, 2009, J NEUROSCI, V29, P8839, DOI 10.1523/JNEUROSCI.5319-08.2009; Blondeau C, 2007, BIOL PSYCHIAT, V61, P1340, DOI 10.1016/j.biopsych.2006.06.030; Broos N, 2012, NEUROPSYCHO IN PRESS; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; Chamberlain SR, 2011, BIOL PSYCHIAT, V69, P1192, DOI 10.1016/j.biopsych.2010.08.019; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; COLE BJ, 1987, PSYCHOPHARMACOLOGY, V91, P458, DOI 10.1007/BF00216011; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Dougherty DM, 2003, J CHILD PSYCHOL PSYC, V44, P1145, DOI 10.1111/1469-7610.00197; Dougherty DM, 2002, BEHAV RES METH INS C, V34, P391, DOI 10.3758/BF03195467; Dougherty DM, 2009, ADDICT DISORD TREAT, V8, P61, DOI 10.1097/ADT.0b013e318172e488; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; KAGAN J, 1966, J ABNORM PSYCHOL, V71, P17, DOI 10.1037/h0022886; Killeen PR, 2009, PSYCHOL REV, V116, P602, DOI 10.1037/a0016414; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Lane S.D., 2003, ADDICT DISORD TREAT, V2, P33, DOI [DOI 10.1097/00132576-200302020-00001, 10.1097/00132576-200302020-00001]; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; MacKillop J, 2009, DRUG ALCOHOL DEPEN, V104, P197, DOI 10.1016/j.drugalcdep.2009.04.020; Mathias CW, 2002, PERCEPT MOTOR SKILL, V95, P559, DOI 10.2466/PMS.95.5.559-569; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Paterson NE, 2011, NEUROSCI RES, V69, P41, DOI 10.1016/j.neures.2010.10.001; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Perkins KA, 2008, PSYCHOPHARMACOLOGY, V200, P529, DOI 10.1007/s00213-008-1231-7; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Reynolds B, 2008, EXP CLIN PSYCHOPHARM, V16, P124, DOI 10.1037/1064-1297.16.2.124; Robinson ESJ, 2009, BEHAV BRAIN RES, V196, P310, DOI 10.1016/j.bbr.2008.09.021; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Scheres A, 2001, J CHILD PSYCHOL PSYC, V42, P347, DOI 10.1111/1469-7610.00728; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Swann AC, 2009, J PSYCHIATR RES, V43, P1057, DOI 10.1016/j.jpsychires.2009.03.003; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Van den Bergh F, 2006, BEHAV BRAIN RES, V175, P75, DOI 10.1016/j.bbr.2006.08.003; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; van Gaalen MM, 2006, BIOL PSYCHIAT, V60, P66, DOI 10.1016/j.biopsych.2005.06.005; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; Wiskerke J, 2011, J NEUROSCI, V31, P262, DOI 10.1523/JNEUROSCI.4794-10.2011	55	168	170	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36781	10.1371/journal.pone.0036781	http://dx.doi.org/10.1371/journal.pone.0036781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574225	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800122
J	Rubio-Diaz, S; Perez-Perez, JM; Gonzalez-Bayon, R; Munoz-Viana, R; Borrega, N; Mouille, G; Hernandez-Romero, D; Robles, P; Hofte, H; Ponce, MR; Micol, JL				Rubio-Diaz, Silvia; Perez-Perez, Jose Manuel; Gonzalez-Bayon, Rebeca; Munoz-Viana, Rafael; Borrega, Nero; Mouille, Gregory; Hernandez-Romero, Diana; Robles, Pedro; Hoefte, Herman; Ponce, Maria Rosa; Micol, Jose Luis			Cell Expansion-Mediated Organ Growth Is Affected by Mutations in Three EXIGUA Genes	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CELLULOSE SYNTHESIS; LEAF MORPHOGENESIS; SIZE CONTROL; MUTANTS; IDENTIFICATION; PLANT; PROLIFERATION; REVEALS; ENCODES	Organ growth depends on two distinct, yet integrated, processes: cell proliferation and post-mitotic cell expansion. Although the regulatory networks of plant cell proliferation during organ growth have begun to be unveiled, the mechanisms regulating post-mitotic cell growth remain mostly unknown. Here, we report the characterization of three EXIGUA (EXI) genes that encode different subunits of the cellulose synthase complex specifically required for secondary cell wall formation. Despite this highly specific role of EXI genes, all the cells within the leaf, even those that do not have secondary walls, display small sizes in the exi mutants. In addition, we found a positive correlation between cell size and the DNA ploidy levels in exi mutant leaves, suggesting that both processes share some regulatory components. Our results are consistent with the hypothesis that the collapsed xylem vessels of the exi mutants hamper water transport throughout the plant, which, in turn, limits the turgor pressure levels required for normal post-mitotic cell expansion during leaf growth.	[Rubio-Diaz, Silvia; Perez-Perez, Jose Manuel; Gonzalez-Bayon, Rebeca; Munoz-Viana, Rafael; Hernandez-Romero, Diana; Robles, Pedro; Ponce, Maria Rosa; Micol, Jose Luis] Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain; [Borrega, Nero; Mouille, Gregory; Hoefte, Herman] INRA, Ctr Versailles Grignon, Inst Natl Rech Agron AgroParisTech, Inst Jean Pierre Bourgin,UMR1318, F-78026 Versailles, France	Universidad Miguel Hernandez de Elche; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rubio-Diaz, S (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Campus de Elche, Alicante, Spain.	jlmicol@umh.es	Micol, José Luis/B-4832-2010; Perez-Perez, Jose Manuel/B-4247-2011; Gonzalez-Bayon, Rebeca/I-4605-2012; Ponce, María Rosa/C-8203-2014; Robles, Pedro/L-5104-2014	Micol, José Luis/0000-0002-0396-1750; Perez-Perez, Jose Manuel/0000-0003-2848-4919; Ponce, María Rosa/0000-0003-0770-4230; Robles, Pedro/0000-0002-4539-5435; Gonzalez-Bayon, Rebeca/0000-0002-9939-0795; Mouille, Gregory/0000-0002-5493-754X	Ministerio de Ciencia e Innovacion of Spain [BFU2011-22825, CSD2007-00057 (TRANSPLANTA)]; Generalitat Valenciana [PROMETEO/2009/112]; European Commission [LSHG-CT-2006-037704 (AGRON-OMICS)]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain [BFU2011-22825 and CSD2007-00057 (TRANSPLANTA) grants, awarded to JLM], the Generalitat Valenciana (PROMETEO/2009/112, to JLM) and the European Commission [LSHG-CT-2006-037704 (AGRON-OMICS), to JLM and HH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Berna G, 1999, GENETICS, V152, P729; Bogre L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-226; Bosca S, 2006, PLANT PHYSIOL, V142, P1353, DOI 10.1104/pp.106.087700; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Brux A, 2008, PLANT CELL, V20, P1088, DOI 10.1105/tpc.108.058362; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Chu ZQ, 2007, PLANT PHYSIOL, V143, P213, DOI 10.1104/pp.106.088393; Cochard H, 2004, PLANT PHYSIOL, V134, P401, DOI 10.1104/pp.103.028357; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Faix O., 1992, METHODS LIGNIN CHEM, P83, DOI DOI 10.1007/978-3-642-74065-7_7; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; Fujikura U, 2007, PLANT CELL PHYSIOL, V48, P278, DOI 10.1093/pcp/pcm002; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Gille S, 2011, PLANT CELL, V23, P4041, DOI 10.1105/tpc.111.091728; Gonzalez N, 2007, PLANT J, V51, P642, DOI 10.1111/j.1365-313X.2007.03167.x; Gonzalez-Bayon R, 2006, J EXP BOT, V57, P3019, DOI 10.1093/jxb/erl063; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Hamann T, 2009, PLANT J, V57, P1015, DOI 10.1111/j.1365-313X.2008.03744.x; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; Horiguchi G, 2006, J PLANT RES, V119, P37, DOI 10.1007/s10265-005-0232-4; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kohorn BD, 2006, PLANT J, V46, P307, DOI 10.1111/j.1365-313X.2006.02695.x; Lefebvre V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016645; Liang YK, 2010, PLANT J, V64, P679, DOI 10.1111/j.1365-313X.2010.04362.x; Perez-Perez JM, 2009, INT J DEV BIOL, V53, P1623, DOI 10.1387/ijdb.072534jp; Perez-Perez JM, 2009, TRENDS GENET, V25, P368, DOI 10.1016/j.tig.2009.06.004; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Micol JL, 2009, CURR OPIN PLANT BIOL, V12, P9, DOI 10.1016/j.pbi.2008.11.001; Mouille G, 2003, PLANT J, V35, P393, DOI 10.1046/j.1365-313X.2003.01807.x; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Piazza P, 2005, NEW PHYTOL, V167, P693, DOI 10.1111/j.1469-8137.2005.01466.x; Ponce M. Rosa, 2006, V323, P105; Ponce MR, 1999, MOL GEN GENET, V261, P408, DOI 10.1007/s004380050982; Ponce MR, 1998, PLANT J, V14, P497, DOI 10.1046/j.1365-313X.1998.00146.x; Reiter WD, 1997, PLANT J, V12, P335, DOI 10.1046/j.1365-313X.1997.12020335.x; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Sauter A, 2001, J EXP BOT, V52, P1991, DOI 10.1093/jexbot/52.363.1991; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Shimotohno A, 2006, PLANT J, V47, P701, DOI 10.1111/j.1365-313X.2006.02820.x; Skirycz A, 2011, J PROTEOME RES, V10, P1018, DOI 10.1021/pr100785n; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Zhong RQ, 2003, PLANT PHYSIOL, V132, P786, DOI 10.1104/pp.102.019331; ZIMMERMANN U, 1978, ANNU REV PLANT PHYS, V29, P121, DOI 10.1146/annurev.pp.29.060178.001005	71	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36500	10.1371/journal.pone.0036500	http://dx.doi.org/10.1371/journal.pone.0036500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22586475	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800069
J	Yang, JK; Chen, FY; Yan, XX; Miao, LH; Dai, JH				Yang, Jiang-Ke; Chen, Fang-Yuan; Yan, Xiang-Xiang; Miao, Li-Hong; Dai, Jiang-Hong			A Simple and Accurate Two-Step Long DNA Sequences Synthesis Strategy to Improve Heterologous Gene Expression in Pichia	PLOS ONE			English	Article							HIGH-FIDELITY; PCR; OLIGONUCLEOTIDES; OPTIMIZATION; DESIGN	In vitro gene chemical synthesis is a powerful tool to improve the expression of gene in heterologous system. In this study, a two-step gene synthesis strategy that combines an assembly PCR and an overlap extension PCR (AOE) was developed. In this strategy, the chemically synthesized oligonucleotides were assembled into several 200-500 bp fragments with 20-25 bp overlap at each end by assembly PCR, and then an overlap extension PCR was conducted to assemble all these fragments into a full length DNA sequence. Using this method, we de novo designed and optimized the codon of Rhizopus oryzae lipase gene ROL (810 bp) and Aspergillus niger phytase gene phyA (1404 bp). Compared with the original ROL gene and phyA gene, the codon-optimized genes expressed at a significantly higher level in yeasts after methanol induction. We believe this AOE method to be of special interest as it is simple, accurate and has no limitation with respect to the size of the gene to be synthesized. Combined with de novo design, this method allows the rapid synthesis of a gene optimized for expression in the system of choice and production of sufficient biological material for molecular characterization and biotechnological application.	[Yang, Jiang-Ke; Chen, Fang-Yuan; Miao, Li-Hong; Dai, Jiang-Hong] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China; [Yan, Xiang-Xiang] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China.	jiangke.yang@gmail.com			Human Resource Foundation of Wuhan Polytechnic University; Key Project of Chinese Ministry of Education [212118]; Chinese High Technology Research and Development Program [2007AA05Z417]	Human Resource Foundation of Wuhan Polytechnic University; Key Project of Chinese Ministry of Education(Ministry of Education, China); Chinese High Technology Research and Development Program	This work was granted by Human Resource Foundation of Wuhan Polytechnic University, the Key Project of Chinese Ministry of Education.(No. 212118) and Chinese High Technology Research and Development Program (No. 2007AA05Z417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL KL, 1970, NATURE, V227, P27, DOI 10.1038/227027a0; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; Gao XX, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng143; Gizzi G, 2008, J AOAC INT, V91, P259; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jayaraj S, 2005, NUCLEIC ACIDS RES, V33, P3011, DOI 10.1093/nar/gki614; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; SANDHU GS, 1992, BIOTECHNIQUES, V12, P14; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	21	38	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36607	10.1371/journal.pone.0036607	http://dx.doi.org/10.1371/journal.pone.0036607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574193	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800090
J	Scerbo, P; Girardot, F; Vivien, C; Markov, GV; Luxardi, G; Demeneix, B; Kodjabachian, L; Coen, L				Scerbo, Pierluigi; Girardot, Fabrice; Vivien, Celine; Markov, Gabriel V.; Luxardi, Guillaume; Demeneix, Barbara; Kodjabachian, Laurent; Coen, Laurent			Ventx Factors Function as Nanog-Like Guardians of Developmental Potential in Xenopus	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; DORSOVENTRAL AXIS FORMATION; HOMEOBOX GENE; PLURIPOTENCY FACTORS; SIGNALING PATHWAY; FATE DECISIONS; GROUND-STATE; ES CELLS; IN-VIVO; EXPRESSION	Vertebrate development requires progressive commitment of embryonic cells into specific lineages through a continuum of signals that play off differentiation versus multipotency. In mammals, Nanog is a key transcription factor that maintains cellular pluripotency by controlling competence to respond to differentiation cues. Nanog orthologs are known in most vertebrates examined to date, but absent from the Anuran amphibian Xenopus. Interestingly, in silico analyses and literature scanning reveal that basal vertebrate ventral homeobox (ventxs) and mammalian Nanog factors share extensive structural, evolutionary and functional properties. Here, we reassess the role of ventx activity in Xenopus laevis embryos and demonstrate that they play an unanticipated role as guardians of high developmental potential during early development. Joint over-expression of Xenopus ventx1.2 and ventx2.1-b (ventx1/2) counteracts lineage commitment towards both dorsal and ventral fates and prevents msx1-induced ventralization. Furthermore, ventx1/2 inactivation leads to down-regulation of the multipotency marker oct91 and to premature differentiation of blastula cells. Finally, supporting the key role of ventx1/2 in the control of developmental potential during development, mouse Nanog (mNanog) expression specifically rescues embryonic axis formation in ventx1/2 deficient embryos. We conclude that during Xenopus development ventx1/2 activity, reminiscent of that of Nanog in mammalian embryos, controls the switch of early embryonic cells from uncommitted to committed states.	[Scerbo, Pierluigi; Girardot, Fabrice; Vivien, Celine; Markov, Gabriel V.; Demeneix, Barbara; Coen, Laurent] Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris, France; [Scerbo, Pierluigi; Luxardi, Guillaume; Kodjabachian, Laurent] Aix Marseille Univ, Inst Biol Dev Marseille Luminy, Marseille, France; [Vivien, Celine] WatchFrog SA, Evry, France; [Markov, Gabriel V.] Univ Lyon, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Lyon, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Scerbo, P (corresponding author), Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris, France.	coen@mnhn.fr	Markov, Gabriel V./Y-5043-2019; Girardot, Fabrice/B-7587-2012; Vivien, Celine/AAJ-8066-2020	Markov, Gabriel V./0000-0002-8566-7482; Girardot, Fabrice/0000-0002-0916-877X; Kodjabachian, Laurent/0000-0002-4000-612X; Scerbo, Pierluigi/0000-0002-3360-4367	Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships; Fondation pour la Recherche Medicale (FRM) PhD fellowships; Association pour la Recherche sur le Cancer (ARC) PhD fellowship; EU [018652 CRESCENDO]; Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat (PNRPE) [0007065]; l'Agence Nationale de la Recherche (ANR)	Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships; Fondation pour la Recherche Medicale (FRM) PhD fellowships; Association pour la Recherche sur le Cancer (ARC) PhD fellowship; EU(European Commission); Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat (PNRPE); l'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Ministere de l'Enseignement Superieur et de la Recherche PhD fellowships to PS, GVM and GL; by Fondation pour la Recherche Medicale (FRM: http://www.frm.org) PhD fellowships to PS and GVM; by an Association pour la Recherche sur le Cancer (ARC: http://www.recherche-cancer.net) PhD fellowship to GL; by EU contract no. 018652 CRESCENDO; by Programme National de Recherche sur les Perturbateurs Endocriniens of Ministere de L'Ecologie et du Developpement Durable Contrat 2009 no0007065 (PNRPE: http://www.pnrpe.fr/) and by l'Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2010, EMBO J, V29, P3236, DOI 10.1038/emboj.2010.200; Ault KT, 1996, P NATL ACAD SCI USA, V93, P6415, DOI 10.1073/pnas.93.13.6415; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Blythe SA, 2010, DEV CELL, V19, P220, DOI 10.1016/j.devcel.2010.07.007; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camp E, 2009, STEM CELLS, V27, P2081, DOI 10.1002/stem.133; Canon S, 2006, DEV DYNAM, V235, P2889, DOI 10.1002/dvdy.20927; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chenoweth JG, 2010, DEV GROWTH DIFFER, V52, P293, DOI 10.1111/j.1440-169X.2010.01171.x; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clark AT, 2007, STEM CELL REV, V3, P49, DOI 10.1007/s12015-007-0002-x; Davis RL, 2000, DEVELOPMENT, V127, P255; Dixon JE, 2010, DEVELOPMENT, V137, P2973, DOI 10.1242/dev.049262; Domingo C, 2000, DEV BIOL, V225, P226, DOI 10.1006/dbio.2000.9769; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Flores MVC, 2008, NAT CELL BIOL, V10, P346, DOI 10.1038/ncb1697; Frankenberg S, 2010, DEV BIOL, V337, P162, DOI 10.1016/j.ydbio.2009.10.017; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Imai Y, 2001, DEVELOPMENT, V128, P2407; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2008, J EXP ZOOL PART B, V310B, P492, DOI 10.1002/jez.b.21222; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Koziol MJ, 2007, CURR BIOL, V17, P801, DOI 10.1016/j.cub.2007.03.062; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Kumano G, 1999, DEVELOPMENT, V126, P5327; Lane MC, 2006, DEV BIOL, V296, P12, DOI 10.1016/j.ydbio.2006.04.447; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maeda R, 1997, DEVELOPMENT, V124, P2553; Maki N, 2009, DEV DYNAM, V238, P1613, DOI 10.1002/dvdy.21959; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Niwa H, 2008, EVOL DEV, V10, P671, DOI 10.1111/j.1525-142X.2008.00280.x; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Papalopulu N, 1996, DEV BIOL, V174, P104, DOI 10.1006/dbio.1996.0055; Polli M, 2002, DEVELOPMENT, V129, P2917; Rankin SA, 2011, DEV BIOL, V351, P297, DOI 10.1016/j.ydbio.2010.11.037; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schuff M, 2011, STEM CELLS DEV; Shapira E, 1999, MECH DEVELOP, V86, P99, DOI 10.1016/S0925-4773(99)00120-3; Shapira E, 2000, MECH DEVELOP, V90, P77, DOI 10.1016/S0925-4773(99)00283-X; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Skirkanich J, 2011, DEV BIOL, V357, P478, DOI 10.1016/j.ydbio.2011.06.010; SLACK JMW, 1984, PHILOS T R SOC B, V307, P331, DOI 10.1098/rstb.1984.0135; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takeda M, 2000, COMP BIOCHEM PHYS B, V126, P157, DOI 10.1016/S0305-0491(00)00194-2; Theunissen TW, 2011, DEVELOPMENT, V138, P4853, DOI 10.1242/dev.068775; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Vivien C, 2012, J BIOL CHEM; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Zhu ZL, 2002, DEV CELL, V3, P557, DOI 10.1016/S1534-5807(02)00270-8	77	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e36855	10.1371/journal.pone.0036855	http://dx.doi.org/10.1371/journal.pone.0036855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606298	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400038
J	Swales, N; Martens, GA; Bonne, S; Heremans, Y; Borup, R; Van de Casteele, M; Ling, ZD; Pipeleers, D; Ravassard, P; Nielsen, F; Ferrer, J; Heimberg, H				Swales, Nathalie; Martens, Geert A.; Bonne, Stefan; Heremans, Yves; Borup, Rehannah; Van de Casteele, Mark; Ling, Zhidong; Pipeleers, Daniel; Ravassard, Philippe; Nielsen, Finn; Ferrer, Jorge; Heimberg, Harry			Plasticity of Adult Human Pancreatic Duct Cells by Neurogenin3-Mediated Reprogramming	PLOS ONE			English	Article							ISLET DIFFERENTIATION PROGRAM; ENDOCRINE PROGENITOR CELLS; BETA-CELLS; EXPRESSION; GENES; DISTINCT; REVEALS; MYT1	Aims/Hypothesis: Duct cells isolated from adult human pancreas can be reprogrammed to express islet beta cell genes by adenoviral transduction of the developmental transcription factor neurogenin3 (Ngn3). In this study we aimed to fully characterize the extent of this reprogramming and intended to improve it. Methods: The extent of the Ngn3-mediated duct-to-endocrine cell reprogramming was measured employing genome wide mRNA profiling. By modulation of the Delta-Notch signaling or addition of pancreatic endocrine transcription factors Myt1, MafA and Pdx1 we intended to improve the reprogramming. Results: Ngn3 stimulates duct cells to express a focused set of genes that are characteristic for islet endocrine cells and/or neural tissues. This neuro-endocrine shift however, is incomplete with less than 10% of full duct-to-endocrine reprogramming achieved. Transduction of exogenous Ngn3 activates endogenous Ngn3 suggesting auto-activation of this gene. Furthermore, pancreatic endocrine reprogramming of human duct cells can be moderately enhanced by inhibition of Delta-Notch signaling as well as by co-expressing the transcription factor Myt1, but not MafA and Pdx1. Conclusions/Interpretation: The results provide further insight into the plasticity of adult human duct cells and suggest measurable routes to enhance Ngn3-mediated in vitro reprogramming protocols for regenerative beta cell therapy in diabetes.	[Swales, Nathalie; Martens, Geert A.; Bonne, Stefan; Heremans, Yves; Van de Casteele, Mark; Ling, Zhidong; Pipeleers, Daniel; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Borup, Rehannah; Nielsen, Finn] Rigshosp, Microarray Facil, DK-2100 Copenhagen, Denmark; [Ravassard, Philippe] Univ Paris 06, CNRS UMR7225, Inst Cerveau & Moelle, Ctr Rech, Paris, France; [Ferrer, Jorge] Inst Invest Biomed August Pi & Sunyer, Genom Programming Beta Cells Lab, Barcelona, Spain	Vrije Universiteit Brussel; Rigshospitalet; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Swales, N (corresponding author), Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium.	harry.heimberg@vub.ac.be	Martens, Geert A./F-6920-2015; Nielsen, Finn Cilius/AAA-4926-2020; Martens, Geert/ABA-6297-2020; Ferrer, Jorge/A-3176-2012	Martens, Geert A./0000-0003-1208-6289; Martens, Geert/0000-0003-1208-6289; Ferrer, Jorge/0000-0002-5959-5729; Heimberg, Harry/0000-0003-1954-7375; Van De Casteele, mark/0000-0002-8594-9260; Pipeleers, Daniel/0000-0002-6440-2485; ravassard, philippe/0000-0002-0393-9262	VUB Research Council; Research Foundation - Flanders (FWO); European Union Sixth Framework Program [LSHB-CT-2005-512145]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)	VUB Research Council; Research Foundation - Flanders (FWO)(FWO); European Union Sixth Framework Program(European Commission); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Financial support was from the VUB Research Council (HH), the Research Foundation - Flanders (FWO; http://www.fwo.be/) (HH, SB), the European Union Sixth Framework Program (http://ec.europa.eu/research/fp6/index_en.cfm; LSHB-CT-2005-512145) (ZL, DP and HH) and the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT; http://www.iwt.be) (NS and HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnfelt-Ronne J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-63; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; BOUWENS L, 1994, HISTOCHEMISTRY, V101, P209, DOI 10.1007/BF00269546; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heimberg H, 2000, DIABETES, V49, P571, DOI 10.2337/diabetes.49.4.571; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; KerrConte J, 1996, DIABETES, V45, P1108, DOI 10.2337/diabetes.45.8.1108; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; Lee J, 2003, DEV BIOL, V253, P84, DOI 10.1006/dbio.2002.0868; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lipsett MA, 2006, DIABETOLOGIA, V49, P2910, DOI 10.1007/s00125-006-0428-8; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Noguchi H, 2006, CELL TRANSPLANT, V15, P929, DOI 10.3727/000000006783981431; Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028; Oliveros J. C., INTERACTIVE TOOL COM; Rescan C, 2005, LAB INVEST, V85, P65, DOI 10.1038/labinvest.3700204; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Simon-Areces J, J COMP NEUROL, V518; Smith SB, 2004, MOL ENDOCRINOL, V18, P142, DOI 10.1210/me.2003-0037; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Watada H, 2003, J BIOL CHEM, V278, P17130, DOI 10.1074/jbc.M213196200; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e37055	10.1371/journal.pone.0037055	http://dx.doi.org/10.1371/journal.pone.0037055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22606327	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339400055
J	Baureder, M; Hederstedt, L				Baureder, Michael; Hederstedt, Lars			Genes Important for Catalase Activity in Enterococcus faecalis	PLOS ONE			English	Article							CYTOCHROME BD BIOSYNTHESIS; GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STREPTOCOCCUS-PYOGENES; BIOFILM FORMATION; NADH PEROXIDASE; IDENTIFICATION; TRANSPORTER; EXPRESSION	Little in general is known about how heme proteins are assembled from their constituents in cells. The Gram-positive bacterium Enterococcus faecalis cannot synthesize heme and does not depend on it for growth. However, when supplied with heme in the growth medium the cells can synthesize two heme proteins; catalase (KatA) and cytochrome bd (CydAB). To identify novel factors important for catalase biogenesis libraries of E. faecalis gene insertion mutants were generated using two different types of transposons. The libraries of mutants were screened for clones deficient in catalase activity using a colony zymogram staining procedure. Analysis of obtained clones identified, in addition to katA (encoding the catalase enzyme protein), nine genes distributed over five different chromosomal loci. No factors with a dedicated essential role in catalase biogenesis or heme trafficking were revealed, but the results indicate the RNA degradosome (srmB, rnjA), an ABC-type oligopeptide transporter (oppBC), a two-component signal transducer (etaR), and NADH peroxidase (npr) as being important for expression of catalase activity in E. faecalis. It is demonstrated that catalase biogenesis in E. faecalis is independent of the CydABCD proteins and that a conserved proline residue in the N-terminal region of KatA is important for catalase assembly.	[Baureder, Michael; Hederstedt, Lars] Lund Univ, Microbiol Grp, Dept Biol, Lund, Sweden	Lund University	Baureder, M (corresponding author), Lund Univ, Microbiol Grp, Dept Biol, Lund, Sweden.	Michael.Baureder@biol.lu.se		Hederstedt, Lars/0000-0002-6650-6296; Baureder, Michael/0000-0003-0810-4341	Swedish Research Council [621-2010-5672]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grant 621-2010-5672 from the Swedish Research Council (http://www.vr.se/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugrysheva JV, 2010, MOL MICROBIOL, V75, P731, DOI 10.1111/j.1365-2958.2009.07012.x; Condon C, 2010, RNA BIOL, V7, P316, DOI 10.4161/rna.7.3.11913; Cotter PD, 1999, J BACTERIOL, V181, P6840, DOI 10.1128/JB.181.21.6840-6843.1999; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Fernandez A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000860; Flint A, 2012, J BACTERIOL, V194, P334, DOI 10.1128/JB.05740-11; Frankenberg L, 2002, J BACTERIOL, V184, P6351, DOI 10.1128/JB.184.22.6351-6356.2002; Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10; GEORGIOU CD, 1987, J BACTERIOL, V169, P2107, DOI 10.1128/jb.169.5.2107-2112.1987; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hakansson KO, 2004, ACTA CRYSTALLOGR D, V60, P1374, DOI 10.1107/S0907444904012004; HANKER JS, 1975, J CLIN MICROBIOL, V2, P463; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kristich CJ, 2008, APPL ENVIRON MICROB, V74, P3377, DOI 10.1128/AEM.02665-07; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Le Breton Y, 2003, ENVIRON MICROBIOL, V5, P329, DOI 10.1046/j.1462-2920.2003.00405.x; Lechardeur D, 2012, J BIOL CHEM, V287, P4752, DOI 10.1074/jbc.M111.297531; Lechardeur D, 2010, J BIOL CHEM, V285, P16032, DOI 10.1074/jbc.M109.024505; Letoffe S, 2006, P NATL ACAD SCI USA, V103, P12891, DOI 10.1073/pnas.0605440103; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Mader U, 2008, MOL MICROBIOL, V70, P183, DOI 10.1111/j.1365-2958.2008.06400.x; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; POOLE RK, 1993, MOL MICROBIOL, V10, P421, DOI 10.1111/j.1365-2958.1993.tb02673.x; ROSS RP, 1991, J MOL BIOL, V221, P857, DOI 10.1016/0022-2836(91)80180-3; Roux CM, 2011, J BACTERIOL, V193, P5520, DOI 10.1128/JB.05485-11; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Winstedt L, 2000, J BACTERIOL, V182, P3863, DOI 10.1128/JB.182.13.3863-3866.2000; Winstedt L, 1998, J BACTERIOL, V180, P6571, DOI 10.1128/JB.180.24.6571-6580.1998; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	31	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 10	2012	7	5							e36725	10.1371/journal.pone.0036725	http://dx.doi.org/10.1371/journal.pone.0036725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TN	22590595	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336400030
J	Oles, K; Gudowska-Nowak, E; Kleczkowski, A				Oles, Katarzyna; Gudowska-Nowak, Ewa; Kleczkowski, Adam			Understanding Disease Control: Influence of Epidemiological and Economic Factors	PLOS ONE			English	Article							CONTROL STRATEGIES; EPIDEMICS; LANDSCAPE; SPREAD; IMPACT; MODELS	We present a model of disease transmission on a regular and small world network and compare different control options. Comparison is based on a total cost of epidemic, including cost of palliative treatment of ill individuals and preventive cost aimed at vaccination or culling of susceptible individuals. Disease is characterized by pre-symptomatic phase, which makes detection and control difficult. Three general strategies emerge: global preventive treatment, local treatment within a neighborhood of certain size and only palliative treatment with no prevention. While the choice between the strategies depends on a relative cost of palliative and preventive treatment, the details of the local strategy and, in particular, the size of the optimal treatment neighborhood depend on the epidemiological factors. The required extent of prevention is proportional to the size of the infection neighborhood, but depends on time till detection and time till treatment in a non-nonlinear (power) law. The optimal size of control neighborhood is also highly sensitive to the relative cost, particularly for inefficient detection and control application. These results have important consequences for design of prevention strategies aiming at emerging diseases for which parameters are not nessecerly known in advance.	[Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland; [Oles, Katarzyna; Gudowska-Nowak, Ewa] Jagiellonian Univ, M Smoluchowski Inst Phys, Krakow, Poland; [Oles, Katarzyna; Kleczkowski, Adam] Univ Stirling, Dept Comp Sci & Math, Stirling FK9 4LA, Scotland	Jagiellonian University; Jagiellonian University; University of Stirling	Oles, K (corresponding author), Jagiellonian Univ, M Kac Complex Syst Res Ctr, Krakow, Poland.	kas@cs.stir.ac.uk	Gudowska-Nowak, Ewa/A-7622-2014; Oles, Katarzyna/AAH-1828-2021; Kleczkowski, Adam/B-2016-2009	Gudowska-Nowak, Ewa/0000-0001-5604-094X; Oles, Katarzyna/0000-0001-6821-9904; Kleczkowski, Adam/0000-0003-1384-4352	European Regional Development Fund [MPD/2009/6]; Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Development Fund; European Science Foundation (ESF)	European Regional Development Fund(European Commission); Jagiellonian University International Ph.D. Studies in Physics of Complex Systems; European Development Fund; European Science Foundation (ESF)(European Science Foundation (ESF))	Project operated within the Foundation for Polish Science International Ph.D. Projects Programme co-financed by the European Regional Development Fund covering, under the agreement no. MPD/2009/6, the Jagiellonian University International Ph.D. Studies in Physics of Complex Systems. The project was carried out within the MPD programme "Physics of Complex Systems" of the Foundation for Polish Science and cofinanced by the European Development Fund in the framework of the "Innovative Economy Programme" and within the framework of "Exploring the Physics of Small Devices (EPSD)" of European Science Foundation (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barrett S, 2003, J EUR ECON ASSOC, V1, P591, DOI 10.1162/154247603322391224; BOCCARA N, 1994, J PHYS A-MATH GEN, V27, P1585, DOI 10.1088/0305-4470/27/5/022; Dybiec B, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066145; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Gastner MT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016117; Gersovitz M, 2004, ECON J, V114, P1, DOI 10.1046/j.0013-0133.2003.0174.x; Gilligan CA, 2007, J R SOC INTERFACE, V4, P925, DOI 10.1098/rsif.2007.1019; Gottwald TR, 2001, PHYTOPATHOLOGY, V91, P30, DOI 10.1094/PHYTO.2001.91.1.30; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Kleczkowski A, 2006, PHYSICS0608141 ARXIV; Kleczkowski A, 2012, J R SOC INTERFACE, V9, P158, DOI 10.1098/rsif.2011.0216; Klein E, 2007, ENVIRON DEV ECON, V12, P707, DOI 10.1017/S1355770X0700383X; Mbah MLN, 2010, J THEOR BIOL, V262, P757, DOI 10.1016/j.jtbi.2009.11.001; Newman M.E.J., 2010, NETWORKS INTRO; Rowthorn RE, 2009, J R SOC INTERFACE, V6, P1135, DOI 10.1098/rsif.2008.0402; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Taraskin S N, 2005, Phys Rev E Stat Nonlin Soft Matter Phys, V72, P016111; Vernon MC, 2009, P ROY SOC B-BIOL SCI, V276, P469, DOI 10.1098/rspb.2008.1009	23	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e36026	10.1371/journal.pone.0036026	http://dx.doi.org/10.1371/journal.pone.0036026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590517	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305336100015
J	Raska, P; Iversen, E; Chen, A; Chen, ZH; Fridley, BL; Permuth-Wey, J; Tsai, YY; Vierkant, RA; Goode, EL; Risch, H; Schildkraut, JM; Sellers, TA; Barnholtz-Sloan, J				Raska, Paola; Iversen, Edwin; Chen, Ann; Chen, Zhihua; Fridley, Brooke L.; Permuth-Wey, Jennifer; Tsai, Ya-Yu; Vierkant, Robert A.; Goode, Ellen L.; Risch, Harvey; Schildkraut, Joellen M.; Sellers, Thomas A.; Barnholtz-Sloan, Jill			European American Stratification in Ovarian Cancer Case Control Data: The Utility of Genome-Wide Data for Inferring Ancestry	PLOS ONE			English	Article							HUMAN-POPULATION STRUCTURE; ASSOCIATION; LOCI	We investigated the ability of several principal components analysis (PCA)-based strategies to detect and control for population stratification using data from a multi-center study of epithelial ovarian cancer among women of European-American ethnicity. These include a correction based on an ancestry informative markers (AIMs) panel designed to capture European ancestral variation and corrections utilizing un-thinned genome-wide SNP data; case-control samples were drawn from four geographically distinct North-American sites. The AIMs-only and genome-wide first principal components (PC1) both corresponded to the previously described North or Northwest-Southeast axis of European variation. We found that the genome-wide PCA captured this primary dimension of variation more precisely and identified additional axes of genome-wide variation of relevance to epithelial ovarian cancer. Associations evident between the genome-wide PCs and study site corroborate North American immigration history and suggest that undiscovered dimensions of variation lie within Northern Europe. The structure captured by the genome-wide PCA was also found within control individuals and did not reflect the case-control variation present in the data. The genome-wide PCA highlighted three regions of local LD, corresponding to the lactase (LCT) gene on chromosome 2, the human leukocyte antigen system (HLA) on chromosome 6 and to a common inversion polymorphism on chromosome 8. These features did not compromise the efficacy of PCs from this analysis for ancestry control. This study concludes that although AIMs panels are a cost-effective way of capturing population structure, genome-wide data should preferably be used when available.	[Raska, Paola] Case Sch Med, Dept Epidemiol & Biostat, Cleveland, OH USA; [Raska, Paola; Barnholtz-Sloan, Jill] Case Sch Med, Case Comprehens Canc Ctr, Cleveland, OH USA; [Iversen, Edwin] Duke Univ, Dept Stat Sci, Durham, NC USA; [Chen, Ann] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Chen, Zhihua] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL USA; [Fridley, Brooke L.; Vierkant, Robert A.; Goode, Ellen L.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Permuth-Wey, Jennifer; Tsai, Ya-Yu; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Genet & Epidemiol, Risk Assessment Detect & Intervent Program, Tampa, FL USA; [Risch, Harvey] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Schildkraut, Joellen M.] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA	Case Western Reserve University; Case Western Reserve University; Duke University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; Yale University; Duke University	Raska, P (corresponding author), Case Sch Med, Dept Epidemiol & Biostat, Cleveland, OH USA.	pxo11@case.edu	Vierkant, Robert/AAP-4927-2020; Barnholtz-Sloan, Jill/A-4817-2011; Fridley, Brooke L/D-8315-2015	Vierkant, Robert/0000-0001-6242-5221; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Fridley, Brooke L/0000-0001-7739-7956	Mayo Foundation; American Cancer Society [CRTG-00-196-01-CCE]; Department of Defense [DAMD-17-98-1-8659]; Canadian Cancer Society; National Institutes of Health [R01-CA-63682, R01-CA-63678]; National Cancer Institute [P30-CA-15083];  [R01-CA-114343];  [R01-CA114343-S1];  [R01-CA-122443];  [P50-CA-136393];  [R01-CA-76016];  [R01-CA-106414]; NATIONAL CANCER INSTITUTE [R01CA106414, P30CA015083, P30CA076292, P50CA136393, R01CA122443, R01CA076016, R01CA063678, R01CA063682, R01CA114343] Funding Source: NIH RePORTER	Mayo Foundation; American Cancer Society(American Cancer Society); Department of Defense(United States Department of Defense); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The genotyping for stage 1 was supported by R01-CA-114343 and R01-CA114343-S1. The MAY0 study is supported by R01-CA-122443 and P50-CA-136393 and funding from the Mayo Foundation. The NCO study is supported by R01-CA-76016. The TBO study is supported by R01-CA-106414, the American Cancer Society (CRTG-00-196-01-CCE), and the Advanced Cancer Detection Center Grant, Department of Defense (DAMD-17-98-1-8659). The TOR study is supported by grants from the Canadian Cancer Society and the National Institutes of Health (R01-CA-63682 and R01-CA-63678). The Mayo Clinic Genotyping Shared Resource is supported by the National Cancer Institute (P30-CA-15083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, WERE MAJOR WAVES IMM; [Anonymous], IMMIGRATIONINUSHISTO; [Anonymous], PRINCIPALCOMPONENTAN; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Broman KW, 2003, COMMON LONG HUMAN IN, P237; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Drineas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011892; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Paschou P, 2008, PLOS GENET, V4, P13; Permuth-Wey J, 2011, CANC EPIDEMIOLOGY BI; Price AL, 2008, PLOS GENET, V4, P9; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seldin MF, 2008, PLOS GENET, V4, P3; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tiwari HK, 2008, HUM HERED, V66, P67, DOI 10.1159/000119107; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2008, AM J HUM GENET, V82, P352, DOI 10.1016/j.ajhg.2007.10.009; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758; Zou F, 2010, HUM HERED, V70, P9, DOI 10.1159/000288706	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2012	7	5							e35235	10.1371/journal.pone.0035235	http://dx.doi.org/10.1371/journal.pone.0035235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TK	22590501	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336100007
J	Cardoso, FL; Kittel, A; Veszelka, S; Palmela, I; Toth, A; Brites, D; Deli, MA; Brito, MA				Cardoso, Filipa L.; Kittel, Agnes; Veszelka, Szilvia; Palmela, Ines; Toth, Andrea; Brites, Dora; Deli, Maria A.; Brito, Maria A.			Exposure to Lipopolysaccharide and/or Unconjugated Bilirubin Impair the Integrity and Function of Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; P-GLYCOPROTEIN; IN-VITRO; GLUTAMATE RELEASE; OXIDATIVE STRESS; BARRIER FUNCTION; TIGHT JUNCTIONS; DOWN-REGULATION; REDOX STATUS	Background: Sepsis and jaundice are common conditions in newborns that can lead to brain damage. Though lipopolysaccharide (LPS) is known to alter the integrity of the blood-brain barrier (BBB), little is known on the effects of unconjugated bilirubin (UCB) and even less on the joint effects of UCB and LPS on brain microvascular endothelial cells (BMEC). Methodology/Principal Findings: Monolayers of primary rat BMEC were treated with 1 mu g/ml LPS and/or 50 mu M UCB, in the presence of 100 mM human serum albumin, for 4 or 24 h. Co-cultures of BMEC with astroglial cells, a more complex BBB model, were used in selected experiments. LPS led to apoptosis and UCB induced both apoptotic and necrotic-like cell death. LPS and UCB led to inhibition of P-glycoprotein and activation of matrix metalloproteinases-2 and -9 in mono-cultures. Transmission electron microscopy evidenced apoptotic bodies, as well as damaged mitochondria and rough endoplasmic reticulum in BMEC by either insult. Shorter cell contacts and increased caveolae-like invaginations were noticeable in LPS-treated cells and loss of intercellular junctions was observed upon treatment with UCB. Both compounds triggered impairment of endothelial permeability and transendothelial electrical resistance both in mono-and co-cultures. The functional changes were confirmed by alterations in immunostaining for junctional proteins beta-catenin, ZO-1 and claudin-5. Enlargement of intercellular spaces, and redistribution of junctional proteins were found in BMEC after exposure to LPS and UCB. Conclusions: LPS and/or UCB exert direct toxic effects on BMEC, with distinct temporal profiles and mechanisms of action. Therefore, the impairment of brain endothelial integrity upon exposure to these neurotoxins may favor their access to the brain, thus increasing the risk of injury and requiring adequate clinical management of sepsis and jaundice in the neonatal period.	[Cardoso, Filipa L.; Palmela, Ines; Brites, Dora; Brito, Maria A.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal; [Kittel, Agnes] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Veszelka, Szilvia; Toth, Andrea; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Mol Neurobiol Lab, H-6701 Szeged, Hungary; [Brites, Dora; Brito, Maria A.] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1699 Lisbon, Portugal	Universidade de Lisboa; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Universidade de Lisboa	Cardoso, FL (corresponding author), Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci, P-1699 Lisbon, Portugal.	abrito@ff.ul.pt	Brites, Dora/AGY-4537-2022; Toth, Andrea E. E/T-1226-2018; Deli, Mária A./I-2885-2019; Brites, Dora/AAW-2001-2021; brito, maria/HDO-2541-2022; Brites, Dora/M-8293-2013; brito, maria/M-8278-2013; iMed.ULisboa, NeuronGliaBiol/B-5403-2014	Brites, Dora/0000-0002-3024-9777; Toth, Andrea E. E/0000-0001-6122-919X; Deli, Mária A./0000-0001-6084-6524; Brites, Dora/0000-0002-3024-9777; Brites, Dora/0000-0002-3024-9777; brito, maria/0000-0002-8493-4649; Cardoso, Filipa Lourenco/0000-0002-4391-1336; Veszelka, Szilvia/0000-0001-8864-1184	Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal [PTDC/SAU-FCF/68819/2006]	Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by grant PTDC/SAU-FCF/68819/2006 of the Fundacaopara a Ciencia e a Tecnologia (FCT), Lisbon, Portugal. No competing financial interests exist. The funder (FCT, http://alfa.fct.mctes.pt) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors CE, 2003, PEDIATRICS, V111, P1110, DOI 10.1542/peds.111.5.1110; Akin E, 2002, BRAIN RES, V931, P168, DOI 10.1016/S0006-8993(02)02276-X; Akrout N, 2009, CURR NEUROPHARMACOL, V7, P296, DOI 10.2174/157015909790031175; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bachschmid M, 2003, FASEB J, V17, P914, DOI 10.1096/fj.02-0530fje; Barbieri SS, 2007, FASEB J, V21, P1831, DOI 10.1096/fj.06-7557com; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Bohm F, 1995, PHOTOCHEM PHOTOBIOL, V62, P980; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brites D, 2012, NEONATAL JAUNDICE; Brito M. A., 2001, THESIS U LISBON; Brito MA, 2004, BRAIN RES, V1026, P33, DOI 10.1016/j.brainres.2004.07.063; Brito MA, 2001, ARCH BIOCHEM BIOPHYS, V387, P57, DOI 10.1006/abbi.2000.2210; Brito MA, 2011, J CHILD NEUROL; Brito MA, 2008, NEUROTOXICOLOGY, V29, P259, DOI 10.1016/j.neuro.2007.11.002; Brito MA, 2008, NEUROBIOL DIS, V29, P30, DOI 10.1016/j.nbd.2007.07.023; Brito MA, 2010, MOL MED, V16, P372, DOI 10.2119/molmed.2009.00152; Brito Maria Alexandra, 2006, P1; Calabria AR, 2008, J CEREBR BLOOD F MET, V28, P135, DOI 10.1038/sj.jcbfm.9600518; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Cepinskas G, 2008, AM J PHYSIOL-GASTR L, V294, pG184, DOI 10.1152/ajpgi.00348.2007; Choi YK, 2008, BMB REP, V41, P345, DOI 10.5483/BMBRep.2008.41.5.345; Colgan OC, 2008, BRAIN RES, V1193, P84, DOI 10.1016/j.brainres.2007.11.072; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Descamps L, 2003, GLIA, V42, P46, DOI 10.1002/glia.10205; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Ding M, 2007, J PHARM PHARMACOL, V59, P1027, DOI 10.1211/jpp.59.7.0016; Dohgu S, 2008, EXP NEUROL, V210, P740, DOI 10.1016/j.expneurol.2007.12.028; Dore S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445; Falcao AS, 2005, NEUROBIOL DIS, V20, P199, DOI 10.1016/j.nbd.2005.03.001; Fernandes A, 2006, J NEUROCHEM, V96, P1667, DOI 10.1111/j.1471-4159.2006.03680.x; Fernandes A, 2004, J NEUROIMMUNOL, V153, P64, DOI 10.1016/j.jneuroim.2004.04.007; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fernandes A, 2009, DEV NEUROBIOL, V69, P568, DOI 10.1002/dneu.20727; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Gesuete R, 2011, STROKE, V42, P1445, DOI 10.1161/STROKEAHA.110.603266; Gordo AC, 2006, J NEUROSCI RES, V84, P194, DOI 10.1002/jnr.20857; Gualazzi MG, 2007, THESIS U BOLOGNE; Hanko E, 2003, PEDIATR RES, V54, P441, DOI 10.1203/01.PDR.0000085169.87948.B6; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; He F, 2011, NEUROSCIENCE, V188, P35, DOI 10.1016/j.neuroscience.2011.04.025; Hoheisel D, 1998, BIOCHEM BIOPH RES CO, V244, P312, DOI 10.1006/bbrc.1997.8051; Karahashi H, 2009, J IMMUNOL, V182, P7280, DOI 10.4049/jimmunol.0801376; Kim HG, 2000, BIOCHEM BIOPH RES CO, V269, P401; Kis B, 1999, EUR J PHARMACOL, V368, P35, DOI 10.1016/S0014-2999(99)00024-2; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Kittel A, 1999, J HISTOCHEM CYTOCHEM, V47, P393, DOI 10.1177/002215549904700313; Kittel A, 2007, INT J DEV NEUROSCI, V25, P275, DOI 10.1016/j.ijdevneu.2007.05.007; Kondo T, 1996, NEUROSCI LETT, V208, P101, DOI 10.1016/0304-3940(96)12555-6; Lee SW, 2011, MOL MED REP, V4, P145, DOI 10.3892/mmr.2010.389; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu HC, 2004, J NEUROIMMUNOL, V146, P13, DOI 10.1016/j.jneuroim.2003.09.016; Maghzal GJ, 2009, J BIOL CHEM, V284, P29251, DOI 10.1074/jbc.M109.037119; Maisels J, 2009, PEDIATRICS, V124, P1193, DOI 10.1542/peds.2009-0329; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; Mariano C, 2011, EUR J CELL BIOL, V90, P787, DOI 10.1016/j.ejcb.2011.06.005; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Nagyoszi P, 2010, NEUROCHEM INT, V57, P556, DOI 10.1016/j.neuint.2010.07.002; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Palmela I, 2011, CURR NEUROVASC RES, V8, P153, DOI 10.2174/156720211795495358; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Phillips PG, 2004, AM J PHYSIOL-LUNG C, V286, pL1055, DOI 10.1152/ajplung.00262.2003; Raimondi F, 2006, PEDIATR RES, V60, P30, DOI 10.1203/01.pdr.0000220344.09034.63; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Roca L, 2006, PEDIATR RES, V60, P724, DOI 10.1203/01.pdr.0000245992.89965.94; Rodrigues CMP, 2002, J HEPATOL, V36, P335, DOI 10.1016/S0168-8278(01)00279-3; Salkeni MA, 2009, J NEUROIMMUNE PHARM, V4, P276, DOI 10.1007/s11481-008-9138-y; Sequeira D, 2007, PEDIATR CRIT CARE ME, V8, P570, DOI 10.1097/01.PCC.0000288716.63685.1B; Shioiri T, 2009, BBA-MOL BASIS DIS, V1792, P1011, DOI 10.1016/j.bbadis.2009.06.006; Silva RFM, 2006, TOXICOL LETT, V163, P1, DOI 10.1016/j.toxlet.2005.09.033; Silva SL, 2011, J NEUROCHEM, V117, P412, DOI 10.1111/j.1471-4159.2011.07200.x; Silva SL, 2010, NEUROBIOL DIS, V40, P663, DOI 10.1016/j.nbd.2010.08.010; Singh AK, 2004, TOXICOLOGY, V201, P197, DOI 10.1016/j.tox.2004.04.015; Singh AK, 2007, TOXICOL MECH METHOD, V17, P331, DOI 10.1080/15376510601077029; Tien YC, 2010, J ETHNOPHARMACOL, V130, P505, DOI 10.1016/j.jep.2010.05.038; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tomita M, 2010, INT J PHARMACEUT, V392, P35, DOI 10.1016/j.ijpharm.2010.03.019; Toth Andrea, 2011, Recent Pat CNS Drug Discov, V6, P107; Vaz AR, 2010, J NEUROCHEM, V112, P56, DOI 10.1111/j.1471-4159.2009.06429.x; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Wang XY, 2004, J SURG RES, V122, P274, DOI 10.1016/j.jss.2004.07.008; Watchko JF, 1998, PEDIATR RES, V44, P763, DOI 10.1203/00006450-199811000-00020; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Wu LL, 2011, CRIT CARE MED, V39, P2087, DOI 10.1097/CCM.0b013e31821cb40e; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yesilova Z, 2008, J GASTROEN HEPATOL, V23, P1556, DOI 10.1111/j.1440-1746.2008.05388.x; Zeissig S, 2004, GUT, V53, P1295, DOI 10.1136/gut.2003.036632; Zhong Y, 2012, J NEUROSCI, V32, P143, DOI 10.1523/JNEUROSCI.4266-11.2012	93	78	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35919	10.1371/journal.pone.0035919	http://dx.doi.org/10.1371/journal.pone.0035919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586454	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000016
J	Dubey, MK; Ubhayasekera, W; Sandgren, M; Jensen, DF; Karlsson, M				Dubey, Mukesh K.; Ubhayasekera, Wimal; Sandgren, Mats; Jensen, Dan Funck; Karlsson, Magnus			Disruption of the Eng18B ENGase Gene in the Fungal Biocontrol Agent Trichoderm atroviride Affetcs Growth Conidation and Antagonistic Ability	PLOS ONE			English	Article							BETA-N-ACETYLGLUCOSAMINIDASE; DEPENDENT PROTEIN-KINASE; MOLECULAR-CLONING; CHITINASES; OLIGOSACCHARIDES; BASIDIOMYCETE; PURIFICATION; SPECIFICITY; EVOLUTION; REVEALS	The recently identified phylogenetic subgroup B5 of fungal glycoside hydrolase family 18 genes encodes enzymes with mannosyl glycoprotein endo-N-acetyl-b-D-glucosaminidase (ENGase)-type activity. Intracellular ENGase activity is associated with the endoplasmic reticulum associated protein degradation pathway (ERAD) of misfolded glycoproteins, although the biological relevance in filamentous fungi is not known. Trichoderma atroviride is a mycoparasitic fungus that is used for biological control of plant pathogenic fungi. The present work is a functional study of the T. atroviride B5-group gene Eng18B, with emphasis on its role in fungal growth and antagonism. A homology model of T. atroviride Eng18B structure predicts a typical glycoside hydrolase family 18 (ab) 8 barrel architecture. Gene expression analysis shows that Eng18B is induced in dual cultures with the fungal plant pathogens Botrytis cinerea and Rhizoctonia solani, although a basal expression is observed in all growth conditions tested. Eng18B disruption strains had significantly reduced growth rates but higher conidiation rates compared to the wild-type strain. However, growth rates on abiotic stress media were significantly higher in Eng18B disruption strains compared to the wild-type strain. No difference in spore germination, germ-tube morphology or in hyphal branching was detected. Disruption strains produced less biomass in liquid cultures than the wild-type strain when grown with chitin as the sole carbon source. In addition, we determined that Eng18B is required for the antagonistic ability of T. atroviride against the grey mould fungus B. cinerea in dual cultures and that this reduction in antagonistic ability is partly connected to a secreted factor. The phenotypes were recovered by re-introduction of an intact Eng18B gene fragment in mutant strains. A putative role of Eng18B ENGase activity in the endoplasmic reticulum associated protein degradation pathway of endogenous glycoproteins in T. atroviride is discussed in relation to the observed phenotypes.	[Dubey, Mukesh K.; Jensen, Dan Funck; Karlsson, Magnus] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Ubhayasekera, Wimal] Lund Univ, MAX Lab, Lund, Sweden; [Ubhayasekera, Wimal] Univ Copenhagen, Inst Med Chem, Copenhagen, Denmark; [Sandgren, Mats] Swedish Univ Agr Sci, Dept Mol Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Lund University; University of Copenhagen; Swedish University of Agricultural Sciences	Dubey, MK (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, Uppsala BioCtr, Box 7026, S-75007 Uppsala, Sweden.	magnus.karlsson@slu.se	Karlsson, Magnus/P-6556-2014; Jensen, Dan/G-9041-2012	Karlsson, Magnus/0000-0001-6098-138X; Jensen, Dan/0000-0002-8855-5283; Sandgren, Mats/0000-0002-2358-4534	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [229-2009-1530]; Carl Trygger Foundation [CTS08:189]; Royal Swedish Academy of Sciences; Danish Agency for Science, Technology and Innovation; DANSCATT	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Carl Trygger Foundation; Royal Swedish Academy of Sciences; Danish Agency for Science, Technology and Innovation; DANSCATT	This work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS, grant number 229-2009-1530), the Carl Trygger Foundation (grant number CTS08:189), the Royal Swedish Academy of Sciences, the Danish Agency for Science, Technology and Innovation and DANSCATT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; Bartnicki-Garcia S, 1968, ANNU REV MICROBIOL, V22, P97; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; CUEVA R, 1990, FEMS MICROBIOL LETT, V69, P153, DOI 10.1016/0378-1097(90)90430-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Hamaguchi T, 2010, GLYCOBIOLOGY, V20, P420, DOI 10.1093/glycob/cwp188; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Ihrmark K, 2010, EVOL BIOINFORM, V6, P1; Ilmen M, 1996, MOL GEN GENET, V251, P451, DOI 10.1007/s004380050189; Inglis GD, 2002, CAN J MICROBIOL, V48, P60, DOI 10.1139/W01-130; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karlsson M, 2008, EVOL BIOINFORM, V4, P47; Karlsson M, 2009, J MOL MICROB BIOTECH, V16, P208, DOI 10.1159/000151220; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuack U., 2006, FUNGAL GENET NEWSL, V53, P9, DOI DOI 10.4148/1941-4765.1106; Lee TS, 2008, EVOL BIOINFORM, V4, P7; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nygren CMR, 2008, NEW PHYTOL, V180, P875, DOI 10.1111/j.1469-8137.2008.02618.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; Seidl V, 2005, FEBS J, V272, P5923, DOI 10.1111/j.1742-4658.2005.04994.x; Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433; Shimizu K, 2001, GENETICS, V157, P591; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Utermark J, 2008, NATURE PROTOCOLS ONL; Vogel H.J., 1956, MICROB GENET B, V13, P42; Xu RQ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-4; Yang Z, 2011, J STRUCT BIOL	50	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36152	10.1371/journal.pone.0036152	http://dx.doi.org/10.1371/journal.pone.0036152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586463	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305335000025
J	Ridley, EV; Wong, ACN; Westmiller, S; Douglas, AE				Ridley, Emma V.; Wong, Adam C-N.; Westmiller, Stephanie; Douglas, Angela E.			Impact of the Resident Microbiota on the Nutritional Phenotype of Drosophila melanogaster	PLOS ONE			English	Article							GUT-MICROBIOTA; LIFE-SPAN; LACTOBACILLUS-PLANTARUM; HEALTHY-SUBJECTS; BLOOD-GLUCOSE; BACTERIA; INSULIN; HOMEOSTASIS; COLONIZATION; MECHANISMS	Background: Animals are chronically infected by benign and beneficial microorganisms that generally promote animal health through their effects on the nutrition, immune function and other physiological systems of the host. Insight into the host-microbial interactions can be obtained by comparing the traits of animals experimentally deprived of their microbiota and untreated animals. Drosophila melanogaster is an experimentally tractable system to study host-microbial interactions. Methodology/Principal Findings: The nutritional significance of the microbiota was investigated in D. melanogaster bearing unmanipulated microbiota, demonstrated by 454 sequencing of 16S rRNA amplicons to be dominated by the alpha-proteobacterium Acetobacter, and experimentally deprived of the microbiota by egg dechorionation (conventional and axenic flies, respectively). In axenic flies, larval development rate was depressed with no effect on adult size relative to conventional flies, indicating that the microbiota promotes larval growth rates. Female fecundity did not differ significantly between conventional and axenic flies, but axenic flies had significantly reduced metabolic rate and altered carbohydrate allocation, including elevated glucose levels. Conclusions/Significance: We have shown that elimination of the resident microbiota extends larval development and perturbs energy homeostasis and carbohydrate allocation patterns of of D. melanogaster. Our results indicate that the resident microbiota promotes host nutrition and interacts with the regulation of host metabolism.	[Ridley, Emma V.; Douglas, Angela E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Ridley, Emma V.; Wong, Adam C-N.; Westmiller, Stephanie; Douglas, Angela E.] Cornell Univ, Dept Entomol, Ithaca, NY 10021 USA	University of York - UK; Cornell University	Ridley, EV (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	aes326@cornell.edu			NIH [1R01GM095372-01]; Biotechnology and Biological Sciences Research Council; Sarkaria Institute of Insect Physiology and Toxicology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095372] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sarkaria Institute of Insect Physiology and Toxicology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by NIH award 1R01GM095372-01 (http://www.nih.gov/), Studentship award of Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/), and The Sarkaria Institute of Insect Physiology and Toxicology (no website). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2005, DROSOPHILA LAB HDB; BAKULA M, 1969, J INVERTEBR PATHOL, V14, P365, DOI 10.1016/0022-2011(69)90163-3; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; BRIGHENTI F, 1995, EUR J CLIN NUTR, V49, P242; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Chapman R. F., 1999, INSECTS STRUCTURE FU; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Faith JJ, 2010, ISME J, V4, P1094, DOI 10.1038/ismej.2010.110; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Johnston CS, 2010, ANN NUTR METAB, V56, P74, DOI 10.1159/000272133; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kunin V, 2010, OPEN J, V1, P1; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Matzkin LM, 2011, J NUTR, V141, P1127, DOI 10.3945/jn.111.138438; McFall-Ngai M, 2007, NATURE, V445, P153, DOI 10.1038/445153a; Morales-Jimenez J, 2009, MICROB ECOL, V58, P879, DOI 10.1007/s00248-009-9548-2; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; NUNNEY L, 1990, ECOLOGY, V71, P1904, DOI 10.2307/1937598; Ogawa N, 2000, J NUTR, V130, P507, DOI 10.1093/jn/130.3.507; Ostman EM, 2002, J CEREAL SCI, V36, P339, DOI 10.1006/jcrs.2002.0469; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Stump CS, 2003, PNAS, V100, P7998; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	44	164	169	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e36765	10.1371/journal.pone.0036765	http://dx.doi.org/10.1371/journal.pone.0036765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586494	Green Published, Green Submitted, gold			2022-12-27	WOS:000305335000055
J	Storchi, R; Zippo, AG; Caramenti, GC; Valente, M; Biella, GEM				Storchi, Riccardo; Zippo, Antonio G.; Caramenti, Gian Carlo; Valente, Maurizio; Biella, Gabriele E. M.			Predicting Spike Occurrence and Neuronal Responsiveness from LFPs in Primary Somatosensory Cortex	PLOS ONE			English	Article							CONNECTIVITY; INTEGRATION; POTENTIALS; TRAINS; FMRI	Local Field Potentials (LFPs) integrate multiple neuronal events like synaptic inputs and intracellular potentials. LFP spatiotemporal features are particularly relevant in view of their applications both in research (e. g. for understanding brain rhythms, inter-areal neural communication and neronal coding) and in the clinics (e. g. for improving invasive Brain-Machine Interface devices). However the relation between LFPs and spikes is complex and not fully understood. As spikes represent the fundamental currency of neuronal communication this gap in knowledge strongly limits our comprehension of neuronal phenomena underlying LFPs. We investigated the LFP-spike relation during tactile stimulation in primary somatosensory (S-I) cortex in the rat. First we quantified how reliably LFPs and spikes code for a stimulus occurrence. Then we used the information obtained from our analyses to design a predictive model for spike occurrence based on LFP inputs. The model was endowed with a flexible meta-structure whose exact form, both in parameters and structure, was estimated by using a multi-objective optimization strategy. Our method provided a set of nonlinear simple equations that maximized the match between models and true neurons in terms of spike timings and Peri Stimulus Time Histograms. We found that both LFPs and spikes can code for stimulus occurrence with millisecond precision, showing, however, high variability. Spike patterns were predicted significantly above chance for 75% of the neurons analysed. Crucially, the level of prediction accuracy depended on the reliability in coding for the stimulus occurrence. The best predictions were obtained when both spikes and LFPs were highly responsive to the stimuli. Spike reliability is known to depend on neuron intrinsic properties (i.e. on channel noise) and on spontaneous local network fluctuations. Our results suggest that the latter, measured through the LFP response variability, play a dominant role.	[Storchi, Riccardo; Zippo, Antonio G.; Valente, Maurizio; Biella, Gabriele E. M.] Inst Mol Bioimaging & Physiol IBFM, Milan, Italy; [Caramenti, Gian Carlo] Inst Biomed Technol ITB, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Storchi, R (corresponding author), Inst Mol Bioimaging & Physiol IBFM, Milan, Italy.	gabriele.biella@ibfm.cnr.it	Zippo, Antonio Giuliano/AAF-8781-2020; Caramenti, Gian Carlo/AAH-9027-2021; Zippo, Antonio G./O-7313-2017	Zippo, Antonio Giuliano/0000-0001-8421-7554; Zippo, Antonio G./0000-0001-8421-7554; Storchi, Riccardo/0000-0002-3656-7514; Biella, Gabriele/0000-0001-8451-249X				Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; [Anonymous], DUEM; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Besserve M, 2010, J COMPUT NEUROSCI, V29, P547, DOI 10.1007/s10827-010-0236-5; Bonacina L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.023408; Canolty RT, 2010, P NATL ACAD SCI USA, V107, P17356, DOI 10.1073/pnas.1008306107; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Deb K, 2000, IEEE T EVOLUTIONARY, V6, P181, DOI DOI 10.1109/4235.996017; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Denker M, 2011, CEREB CORTEX, V21, P2681, DOI 10.1093/cercor/bhr040; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Foffani G, 2008, J NEUROPHYSIOL, V100, P268, DOI 10.1152/jn.01015.2007; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galindo-Leon EE, 2010, J COMPUT NEUROSCI, V29, P581, DOI 10.1007/s10827-010-0221-z; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; Gollub C, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013019; Hwang EJ, 2011, J NEUROPHYSIOL, V105, P1850, DOI 10.1152/jn.00802.2010; Jin Y., 2006, MULTIOBJECTIVE MACHI; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Knowles J, 2008, MULTIOBJECTIVE PROBL, P155; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Kumar CA, 2010, INT J SOFT COMPUTING, V5, P83; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luccioli S, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.041902; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pedersen GK, 2006, P 8 ANN C GEN EV COM; Pesaran B, 2009, NEURON, V61, P1, DOI 10.1016/j.neuron.2008.12.019; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Saravanan R, 2008, J INTELL ROBOT SYST, V52, P45, DOI 10.1007/s10846-008-9202-0; Saravanan R, 2008, INT J ADV MANUF TECH, V41, P1483; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Watson C, 2006, RAT BRAIN STEREOTAXI; Zanos TP, 2011, J NEUROPHYSIOL, V105, P474, DOI 10.1152/jn.00642.2010	46	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35850	10.1371/journal.pone.0035850	http://dx.doi.org/10.1371/journal.pone.0035850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586452	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335000014
J	Malik, SZ; Lewis, M; Isaacs, A; Haskins, M; Van Winkle, T; Vite, CH; Watson, DJ				Malik, Saafan Z.; Lewis, Melissa; Isaacs, Alison; Haskins, Mark; Van Winkle, Thomas; Vite, Charles H.; Watson, Deborah J.			Identification of the Rostral Migratory Stream in the Canine and Feline Brain	PLOS ONE			English	Article							NEURAL PROGENITOR CELLS; SUBVENTRICULAR ZONE; STEM-CELLS; OLFACTORY-BULB; PET DOGS; TRANSPLANTATION; DIFFERENTIATION; GLIOBLASTOMA; NEURONS; MODELS	In the adult rodent brain, neural progenitor cells migrate from the subventricular zone of the lateral ventricle towards the olfactory bulb in a track known as the rostral migratory stream (RMS). To facilitate the study of neural progenitor cells and stem cell therapy in large animal models of CNS disease, we now report the location and characteristics of the normal canine and feline RMS. The RMS was found in Nissl-stained sagittal sections of adult canine and feline brains as a prominent, dense, continuous cellular track beginning at the base of the anterior horn of the lateral ventricle, curving around the head of the caudate nucleus and continuing laterally and ventrally to the olfactory peduncle before entering the olfactory tract and bulb. To determine if cells in the RMS were proliferating, the thymidine analog 5-bromo-2-deoxyuridine (BrdU) was administered and detected by immunostaining. BrdU-immunoreactive cells were present throughout this track. The RMS was also immunoreactive for markers of proliferating cells, progenitor cells and immature neurons (Ki-67 and doublecortin), but not for NeuN, a marker of mature neurons. Luxol fast blue and CNPase staining indicated that myelin is closely apposed to the RMS along much of its length and may provide guidance cues for the migrating cells. Identification and characterization of the RMS in canine and feline brain will facilitate studies of neural progenitor cell biology and migration in large animal models of neurologic disease.	[Malik, Saafan Z.; Isaacs, Alison; Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Lewis, Melissa; Haskins, Mark; Vite, Charles H.] Univ Penn, Dept Clin Studies, Philadelphia, PA 19104 USA; [Haskins, Mark; Van Winkle, Thomas] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Malik, SZ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	djw3@mail.med.upenn.edu		Lewis, Melissa J/0000-0001-6643-191X	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health [DK54481, DK25759, RR02512]; Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054481, R01DK025759] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	University of Pennsylvania Department of Neurosurgery funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ara Parseghian Medical Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by University of Pennsylvania Department of Neurosurgery funds (DW), National Institutes of Health DK54481, DK25759 and RR02512 (MH), and the Ara Parseghian Medical Research Foundation (CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2006, J NEUROSCI METH, V150, P41, DOI 10.1016/j.jneumeth.2005.05.024; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; Berman A.L., 1968, BRAIN STEM CAT CYTOA; Berman AL, 1982, THALAMUS BASAL TELEN; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Chandler K, 2006, VET J, V172, P207, DOI 10.1016/j.tvjl.2005.07.001; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fitzgerald TC, 1961, VET MED, V56, P38; Gil-Perotin S, 2009, J COMP NEUROL, V514, P533, DOI 10.1002/cne.22026; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; Jenkins T, 1972, FUNCATIONAL MAMMALIA; Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792; Klassen H, 2007, VET OPHTHALMOL, V10, P245, DOI 10.1111/j.1463-5224.2007.00547.x; Koestner A, 1999, HISTOLOGIC CLASSIFIC; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipsitz D, 2003, VET PATHOL, V40, P659, DOI 10.1354/vp.40-6-659; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Rosomoff HL, 1996, CRIT CARE MED, V24, pS48; Rossignol S, 2002, PROG BRAIN RES, V137, P151; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Smitka M, 2009, NEUROSCIENCE, V162, P482, DOI 10.1016/j.neuroscience.2009.04.058; Snyder JM, 2006, J VET INTERN MED, V20, P669, DOI 10.1892/0891-6640(2006)20[669:CIPNC]2.0.CO;2; Stoica G, 2004, VET PATHOL, V41, P10, DOI 10.1354/vp.41-1-10; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Thomson SAM, 2005, VET PATHOL, V42, P550, DOI 10.1354/vp.42-5-550; Trojanowski JQ, 2008, ALZHEIMERS DEMENT, V4, P1, DOI 10.1016/j.jalz.2007.09.007; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vite C H, 2006, BRAUNDS CLIN NEUROLO; Walton RM, 2008, J NEUROPATH EXP NEUR, V67, P954, DOI 10.1097/NEN.0b013e3181875b2f; Walton RM, 2008, J NEUROSCI METH, V169, P158, DOI 10.1016/j.jneumeth.2007.12.011; Wang L, 2007, NEUROSCI RES, V59, P327, DOI 10.1016/j.neures.2007.08.011; Waters DJ, 2006, SCI AM, V295, P94, DOI 10.1038/scientificamerican1206-94; WATSON DJ, 2002, VIRAL VECTORS GENE T, P383	43	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e36016	10.1371/journal.pone.0036016	http://dx.doi.org/10.1371/journal.pone.0036016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22606243	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338200016
J	Zhang, XN; Jaramillo, M; Singh, S; Kumta, P; Banerjee, I				Zhang, Xinan; Jaramillo, Maria; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita			Analysis of Regulatory Network Involved in Mechanical Induction of Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-3-BETA; ENRICHED TRANSCRIPTION FACTORS; GENE-EXPRESSION DATA; LIVER DEVELOPMENT; HOMEOBOX GENE; ENDODERM; COMMITMENT; BINDING	Embryonic stem cells are conventionally differentiated by modulating specific growth factors in the cell culture media. Recently the effect of cellular mechanical microenvironment in inducing phenotype specific differentiation has attracted considerable attention. We have shown the possibility of inducing endoderm differentiation by culturing the stem cells on fibrin substrates of specific stiffness [1]. Here, we analyze the regulatory network involved in such mechanically induced endoderm differentiation under two different experimental configurations of 2-dimensional and 3-dimensional culture, respectively. Mouse embryonic stem cells are differentiated on an array of substrates of varying mechanical properties and analyzed for relevant endoderm markers. The experimental data set is further analyzed for identification of co-regulated transcription factors across different substrate conditions using the technique of bi-clustering. Overlapped bi-clusters are identified following an optimization formulation, which is solved using an evolutionary algorithm. While typically such analysis is performed at the mean value of expression data across experimental repeats, the variability of stem cell systems reduces the confidence on such analysis of mean data. Bootstrapping technique is thus integrated with the bi-clustering algorithm to determine sets of robust bi-clusters, which is found to differ significantly from corresponding bi-clusters at the mean data value. Analysis of robust bi-clusters reveals an overall similar network interaction as has been reported for chemically induced endoderm or endodermal organs but with differences in patterning between 2-dimensional and 3-dimensional culture. Such analysis sheds light on the pathway of stem cell differentiation indicating the prospect of the two culture configurations for further maturation.	[Zhang, Xinan] Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China; [Zhang, Xinan; Singh, Satish; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Jaramillo, Maria; Kumta, Prashant; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Kumta, Prashant] Univ Pittsburgh, Ctr Complex Engn Multifunct Mat, Pittsburgh, PA USA	Central China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, XN (corresponding author), Cent China Normal Univ, Sch Math & Stat, Wuhan, Peoples R China.	ipb1@pitt.edu			National Institutes of Health [DP2 116520]; Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oak Ridge Associated Universities; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors acknowledge support from National Institutes of Health New Innovator Award DP2 116520 and Oak Ridge Associated Universities Ralph Powe Junior Faculty Enhancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2006, NEUROCOMPUTING, V69, P1882, DOI 10.1016/j.neucom.2006.02.018; Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; Banerjee I, 2006, COMBUST FLAME, V144, P619, DOI 10.1016/j.combustflame.2005.10.001; Banerjee I, 2003, CHEM ENG SCI, V58, P4537, DOI 10.1016/S0009-2509(03)00343-9; Banerjee I, 2010, BIOINFORMATICS, V26, P1332, DOI 10.1093/bioinformatics/btq139; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bieniasz LK, 2006, ANAL CHEM, V78, P8430, DOI 10.1021/ac061167z; Cao L, 2011, DIFFERENTIATION, V81, P1, DOI 10.1016/j.diff.2010.09.182; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; COCKELL M, 1995, MOL CELL BIOL, V15, P1933; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Denson LA, 2000, GENE, V246, P311, DOI 10.1016/S0378-1119(00)00082-2; Denton AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-294; Divina F, 2006, IEEE T KNOWL DATA EN, V18, P590, DOI 10.1109/TKDE.2006.74; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Goldberg D.E., 1989, GENETIC ALGORITHMS S; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; HERBST RS, 1991, NEW BIOL, V3, P289; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Jaramillo M, 2011, INDUCING ENDODERM DI; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Lopez-Sanchez C, 2009, INT J DEV BIOL, V53, P1445, DOI 10.1387/ijdb.072417cl; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Orling J, 1977, NEDERL AKAD WETENSCH, V39, P8; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; STINE R, 1989, SOCIOL METHOD RES, V18, P243, DOI 10.1177/0049124189018002003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang H, 2002, P 2002 ACM SIGMOD IN, P418; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yang E, 2007, BIOINFORMATICS, V23, P2306, DOI 10.1093/bioinformatics/btm335	40	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35700	10.1371/journal.pone.0035700	http://dx.doi.org/10.1371/journal.pone.0035700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558203	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305336000049
J	Gamble, T; Greenbaum, E; Jackman, TR; Russell, AP; Bauer, AM				Gamble, Tony; Greenbaum, Eli; Jackman, Todd R.; Russell, Anthony P.; Bauer, Aaron M.			Repeated Origin and Loss of Adhesive Toepads in Geckos	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; EVOLUTION; LIKELIHOOD; GEKKOTA; GEKKONIDAE; ECOLOGY; LIZARDS; SYSTEM; CLADE	Geckos are well known for their extraordinary clinging abilities and many species easily scale vertical or even inverted surfaces. This ability is enabled by a complex digital adhesive mechanism (adhesive toepads) that employs van der Waals based adhesion, augmented by frictional forces. Numerous morphological traits and behaviors have evolved to facilitate deployment of the adhesive mechanism, maximize adhesive force and enable release from the substrate. The complex digital morphologies that result allow geckos to interact with their environment in a novel fashion quite differently from most other lizards. Details of toepad morphology suggest multiple gains and losses of the adhesive mechanism, but lack of a comprehensive phylogeny has hindered efforts to determine how frequently adhesive toepads have been gained and lost. Here we present a multigene phylogeny of geckos, including 107 of 118 recognized genera, and determine that adhesive toepads have been gained and lost multiple times, and remarkably, with approximately equal frequency. The most likely hypothesis suggests that adhesive toepads evolved 11 times and were lost nine times. The overall external morphology of the toepad is strikingly similar in many lineages in which it is independently derived, but lineage-specific differences are evident, particularly regarding internal anatomy, with unique morphological patterns defining each independent derivation.	[Gamble, Tony] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Gamble, Tony] Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA; [Greenbaum, Eli; Jackman, Todd R.; Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Russell, Anthony P.] Univ Dept Calgary, Dept Biol Sci, Calgary, AB, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Villanova University	Gamble, T (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	aaron.bauer@villanova.edu	Gamble, Tony/AAT-4463-2020; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; Young, Bridget/A-2184-2014	Gamble, Tony/0000-0002-0204-8003; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Snowdon, Claire/0000-0002-9133-5476; Young, Bridget/0000-0001-6041-9901; Jackman, Todd/0000-0002-5391-8136	National science Foundation [DEB 0515909, DEB 0844523]; Natural Sciences and Engineering Research Council of Canada [9745-2008]; Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish	National science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by grants DEB 0515909 and DEB 0844523 from the National science Foundation (www.nsf.gov) and by Discovery Grant 9745-2008 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2003, J MORPHOL, V256, P134, DOI 10.1002/jmor.10076; Aristotle, 1910, HIST ANIMALS; Arnold EN, 2008, ZOOTAXA, P62, DOI 10.11646/zootaxa.1847.1.5; Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Bauer Aaron M., 1999, African Journal of Herpetology, V48, P53, DOI 10.1080/21564574.1999.9651072; Bauer Aaron M., 1997, Proceedings of the California Academy of Sciences, V49, P447; Bauer AM, 2005, J ZOOL, V265, P327, DOI 10.1017/S0952836904006259; Bauer AM, 1987, CAN J ZOOL, V66, P1583; FITZINGER L. J., 1843, SYSTEMA REPTILIUM AM; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Fujita MK, 2011, MOL PHYLOGENET EVOL, V58, P71, DOI 10.1016/j.ympev.2010.10.014; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Gamble T, 2008, J BIOGEOGR, V35, P88, DOI 10.1111/j.1365-2699.2007.01770.x; Gamble T, 2011, ZOOL J LINN SOC-LOND, V163, P1244, DOI 10.1111/j.1096-3642.2011.00741.x; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Gould SJ, 2002, STRUCTURE EVOLUTIONA; GREEN DM, 1981, COPEIA, P790, DOI 10.2307/1444179; Haldane JB., 1990, CAUSES EVOLUTION; Han D, 2004, BIOL J LINN SOC, V83, P353, DOI 10.1111/j.1095-8312.2004.00393.x; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jackman TR, 2008, MOL PHYLOGENET EVOL, V46, P74, DOI 10.1016/j.ympev.2007.10.018; Johnson MK, 2009, J ANAT, V214, P937, DOI 10.1111/j.1469-7580.2009.01075.x; Johnson MK, 2005, CAN J ZOOL, V83, P1511, DOI 10.1139/Z05-112; Kim S, 2008, IEEE T ROBOT, V24, P65, DOI 10.1109/TRO.2007.909786; KLUGE AG, 1983, COPEIA, P465, DOI 10.2307/1444392; Kopp A, 2009, EVOLUTION, V63, P2771, DOI 10.1111/j.1558-5646.2009.00761.x; Lamb T, 2006, P ROY SOC B-BIOL SCI, V273, P855, DOI 10.1098/rspb.2005.3390; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Loveridge Arthur, 1947, BULL MUS CAMP ZOOL HARVARD UNIV, V98, P1; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Maddison W.P., 2008, MESQUITE MODULAR SYS; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Maderson P. F. A., 1970, Forma Functio, V1970, P179; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105; MAHENDRA BENI CHARAN, 1941, PROC INDIAN ACAD SCI SECT B, V13, P288; Nielsen SV, 2011, MOL PHYLOGENET EVOL, V59, P1, DOI 10.1016/j.ympev.2010.12.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliver PM, 2012, MOL PHYLOGENET EVOL, V63, P255, DOI 10.1016/j.ympev.2011.12.013; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peattie AM, 2008, ANAT REC, V291, P869, DOI 10.1002/ar.20706; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Pianka ER, 2005, BIOESSAYS, V27, P647, DOI 10.1002/bies.20237; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2013, TRACER VERSION 1 6; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell A.P., 1976, Linnean Soc Symp Ser, V3, P217; Russell Anthony P., 2009, Functional Properties of Bio-Inspired Surfaces Characterization and Technological Applications, P103, DOI 10.1142/9789812837028_0005; Russell AP, 2007, J ADHES SCI TECHNOL, V21, P1119, DOI 10.1163/156856107782328371; Russell Anthony P., 2002, Bulletin of the Natural History Museum Zoology Series, V68, P113; Russell AP, 2009, P R SOC B, V276, P3705, DOI 10.1098/rspb.2009.0946; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1979, COPEIA, P1, DOI 10.2307/1443723; RUSSELL AP, 1988, J MORPHOL, V197, P221, DOI 10.1002/jmor.1051970208; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P, 2010, ZOOTAXA, P59, DOI 10.11646/zootaxa.2334.1.3; UNDERWOOD GARTH, 1954, PROC ZOOL SOC LONDON, V124, P469; VANZOLINI P E, 1968, Arquivos de Zoologia do Estado de Sao Paulo, V17, P85; Vermeij GJ, 2006, P NATL ACAD SCI USA, V103, P1804, DOI 10.1073/pnas.0508724103; Vidal N, 2009, CR BIOL, V332, P129, DOI 10.1016/j.crvi.2008.07.010; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Vitt LJ, 2005, P NATL ACAD SCI USA, V102, P7877, DOI 10.1073/pnas.0501104102; von Dassow G, 1999, J EXP ZOOL, V285, P307, DOI 10.1002/(SICI)1097-010X(19991215)285:4<307::AID-JEZ2>3.3.CO;2-M; Wagner GP, 1996, AM ZOOL, V36, P36; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Webster NB, 2009, ACTA ZOOL-STOCKHOLM, V90, P18, DOI 10.1111/j.1463-6395.2008.00324.x; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	88	258	266	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2012	7	6							e39429	10.1371/journal.pone.0039429	http://dx.doi.org/10.1371/journal.pone.0039429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	966GL	22586456	Green Published, Green Submitted, gold			2022-12-27	WOS:000305825800033
J	Shema, H; Bar-Ilan, J; Thelwall, M				Shema, Hadas; Bar-Ilan, Judit; Thelwall, Mike			Research Blogs and the Discussion of Scholarly Information	PLOS ONE			English	Article							WEB	The research blog has become a popular mechanism for the quick discussion of scholarly information. However, unlike peer-reviewed journals, the characteristics of this form of scientific discourse are not well understood, for example in terms of the spread of blogger levels of education, gender and institutional affiliations. In this paper we fill this gap by analyzing a sample of blog posts discussing science via an aggregator called ResearchBlogging.org (RB). ResearchBlogging.org aggregates posts based on peer-reviewed research and allows bloggers to cite their sources in a scholarly manner. We studied the bloggers, blog posts and referenced journals of bloggers who posted at least 20 items. We found that RB bloggers show a preference for papers from high-impact journals and blog mostly about research in the life and behavioral sciences. The most frequently referenced journal sources in the sample were: Science, Nature, PNAS and PLoS One. Most of the bloggers in our sample had active Twitter accounts connected with their blogs, and at least 90% of these accounts connect to at least one other RB-related Twitter account. The average RB blogger in our sample is male, either a graduate student or has been awarded a PhD and blogs under his own name.	[Shema, Hadas; Bar-Ilan, Judit] Bar Ilan Univ, Dept Informat Sci, Ramat Gan, Israel; [Thelwall, Mike] Wolverhampton Univ, Sch Technol, Stat Cybermetr Res Grp, Wolverhampton WV1 1DJ, W Midlands, England	Bar Ilan University; University of Wolverhampton	Shema, H (corresponding author), Bar Ilan Univ, Dept Informat Sci, Ramat Gan, Israel.	dassysh@gmail.com	Zaitchik, Benjamin/B-9461-2013; Bar-Ilan, Judit/B-3452-2009; Thelwall, Mike/C-1449-2013	Bar-Ilan, Judit/0000-0002-8796-5248; Thelwall, Mike/0000-0001-6065-205X; Zaitchik, Benjamin/0000-0002-0698-0658; Novoplansky, Ariel/0000-0003-0988-786X; Shema, Hadas/0000-0003-0536-1772	European Union grant by the 7th Framework Programme; Academic Careers Understood through Measurement and Norms (ACUMEN) project [266632]	European Union grant by the 7th Framework Programme; Academic Careers Understood through Measurement and Norms (ACUMEN) project	This work was supported by a European Union grant by the 7th Framework Programme. It is part of the Academic Careers Understood through Measurement and Norms (ACUMEN) project (contract 266632) (http://research-acumen.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2010, ANNOUNCING PLOS BLOG; Amsen E, 2006, HYPOTHESIS, P10; [Anonymous], 2006, USES BLOGS; [Anonymous], 2010, CBC NEWS; Ashlin A, 2006, SCIENCE, V312, P201, DOI 10.1126/science.1124197; Batts SA, 2008, PLOS BIOL, V6, P1837, DOI 10.1371/journal.pbio.0060240; BLACKWELL PK, 1981, P AM SOC INFORM SCI, V18, P215; Bonetta L, 2007, CELL, V129, P443, DOI 10.1016/j.cell.2007.04.032; Conrad P, 1999, PUBLIC UNDERST SCI, V8, P285, DOI 10.1088/0963-6625/8/4/302; Cronin B., 1984, CITATION PROCESS ROL; Garfield E, 1979, CITATION INDEXING IT; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Glott R., 2010, WIKIPEDIA SURVEY OVE; Goldstein A. M., 2009, EVOLUTION ED OUTREAC, V2, P548, DOI DOI 10.1007/S12052-009-0149-9; Groth P., 2010, P WEBSCI10 EXT FRONT; Jha A., 2010, GUARDIAN; Kjellberg S., 2010, 1 MONDAY, V15; Kouper I, 2010, JCOM-J SCI COMMUN, V9; Kousha K, 2007, J AM SOC INF SCI TEC, V58, P1631, DOI 10.1002/asi.20649; Kovic I, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1118; Lam SK, 2011, WIKISYM 11 MOUNT VIE; Marcus A, 2011, NATURE, V480, P449, DOI 10.1038/480449a; Mason B, 2010, MEET NEW WIRED SCI A; Merton R.E., SOCIOLOGY SCI THEORE; Munger D, 2010, RETHINKING TOPIC TAG; Munger D, 2010, SEED MAGAZINE; National Science Foundation Division of Science Resources Statistics, 2010, HIGHER ED SCI ENG; National Science Foundation Division of Science Resources Statistics, 2010, 11306 NSF DIV SCI RE; PRIEM J., 2011, METR 2011 S INF SCI; Priem J, 2010, ALT METRICS MANIFEST; Priem J, 2010, P 73 ASIS T ANN M PI; Redfield RJ, 2011, SCIENCE, V332, DOI [10.1126/science.1201304, 10.1126/science.1201482]; Saunders T, 2011, OBESITY PANACEA; Scheer R, 2011, SCIENTIFICAMERICAN; Science Foundation Division of Science Resources Statistics, 2010, SCI ENG IND 2010; Shema H, 2010, MEDIA, V6, P46; Smith M., 2010, NODEXL FREE OPEN NET; Sneyd E, 2010, GUARDIAN LAUNCHES SC; Twitter, 2011, ON HUNDR MILL VOIC; Vaughan L, 2005, J AM SOC INF SCI TEC, V56, P1075, DOI 10.1002/asi.20199; Vaughan L, 2003, J AM SOC INF SCI TEC, V54, P1313, DOI 10.1002/asi.10338; Wolfe-Simon F., 2010, SCIENCE; Wouters P., 1999, THESIS U AMSTERDAM A; Zivkovic B, 2011, ARSENICLIFE LINK COL	44	110	110	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2012	7	5							e35869	10.1371/journal.pone.0035869	http://dx.doi.org/10.1371/journal.pone.0035869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TW	22499177	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338200014
J	Liu, SY; Lin, JQ; Wu, HL; Wang, CC; Huang, SJ; Luo, YF; Sun, JH; Zhou, JX; Yan, SJ; He, JG; Wang, J; He, ZM				Liu, Si-Yang; Lin, Jian-Qing; Wu, Hong-Long; Wang, Cheng-Cheng; Huang, Shu-Jia; Luo, Yan-Feng; Sun, Ji-Hua; Zhou, Jian-Xiang; Yan, Shu-Jing; He, Jian-Guo; Wang, Jun; He, Zhu-Mei			Bisulfite Sequencing Reveals That Aspergillus flavus Holds a Hollow in DNA Methylation	PLOS ONE			English	Article							INDUCED POINT MUTATION; CYTOSINE METHYLTRANSFERASE HOMOLOG; SECONDARY METABOLISM; AFLATOXIN; CONTAINS; RIP; HETEROCHROMATIN; IDENTIFICATION; 5-AZACYTIDINE; ELEMENTS	Aspergillus flavus first gained scientific attention for its production of aflatoxin. The underlying regulation of aflatoxin biosynthesis has been serving as a theoretical model for biosynthesis of other microbial secondary metabolites. Nevertheless, for several decades, the DNA methylation status, one of the important epigenomic modifications involved in gene regulation, in A. flavus remains to be controversial. Here, we applied bisulfite sequencing in conjunction with a biological replicate strategy to investigate the DNA methylation profiling of A. flavus genome. Both the bisulfite sequencing data and the methylome comparisons with other fungi confirm that the DNA methylation level of this fungus is negligible. Further investigation into the DNA methyltransferase of Aspergillus uncovers its close relationship with RID-like enzymes as well as its divergence with the methyltransferase of species with validated DNA methylation. The lack of repeat contents of the A. flavus' genome and the high RIP-index of the small amount of remanent repeat potentially support our speculation that DNA methylation may be absent in A. flavus or that it may possess de novo DNA methylation which occurs very transiently during the obscure sexual stage of this fungal species. This work contributes to our understanding on the DNA methylation status of A. flavus, as well as reinforces our views on the DNA methylation in fungal species. In addition, our strategy of applying bisulfite sequencing to DNA methylation detection in species with low DNA methylation may serve as a reference for later scientific investigations in other hypomethylated species.	[Liu, Si-Yang; Lin, Jian-Qing; Wang, Cheng-Cheng; Luo, Yan-Feng; Zhou, Jian-Xiang; He, Jian-Guo; He, Zhu-Mei] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Si-Yang; Wu, Hong-Long; Huang, Shu-Jia; Sun, Ji-Hua; Yan, Shu-Jing; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Liu, SY (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, Key Lab Gene Engn, Minist Educ,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn; wangj@genomics.org.cn; lsshezm@mail.sysu.edu.cn	贺, 竹梅/GVS-1592-2022; Huang, Shujia/GXG-8583-2022; Wang, Jun/A-7261-2013; Liu, Siyang/M-6127-2014; Lin, Jianqing/GYU-6251-2022; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Huang, Shujia/0000-0003-2100-2534; Liu, Siyang/0000-0001-6780-9419; Nettleton, Dan/0000-0002-6045-1036; Wang, Jun/0000-0002-2113-5874; Yeh, Cheng-Ting/0000-0002-1392-2018; Wang, Jun/0000-0002-8540-8931; Schnable, Patrick/0000-0001-9169-5204	National Natural Science Foundation of China [30870024, 31170044]; Natural Science Foundation of Guangdong Province of China [9151027501000113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (grant no. 30870024 and grant no. 31170044), Natural Science Foundation of Guangdong Province of China (grant no. 9151027501000113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, no additional external funding received for this study.	ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Aziz NH, 1997, NAHRUNG, V41, P150, DOI 10.1002/food.19970410307; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bestor TH, 1999, GENETICA, V107, P289, DOI 10.1023/A:1003990818251; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Cichewicz RH, 2010, NAT PROD REP, V27, P11, DOI 10.1039/b920860g; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Clutterbuck AJ, 2011, FUNGAL GENET BIOL, V48, P306, DOI 10.1016/j.fgb.2010.09.002; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Doiron KMJ, 1999, MUTAT RES-FUND MOL M, V429, P37, DOI 10.1016/S0027-5107(99)00099-8; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Gowher H, 2001, FEMS MICROBIOL LETT, V205, P151, DOI 10.1111/j.1574-6968.2001.tb10939.x; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hayatsu Hikoya, 2006, Nucleic Acids Symp Ser (Oxf), P69, DOI 10.1093/nass/nrl034; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Lee DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002531; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; MAGILL JM, 1989, DEV GENET, V10, P63, DOI 10.1002/dvg.1020100202; Margolin BS, 1998, GENETICS, V149, P1787; Montiel MD, 2006, FUNGAL GENET BIOL, V43, P439, DOI 10.1016/j.fgb.2006.01.011; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rountree MR, 2010, HEREDITY, V105, P38, DOI 10.1038/hdy.2010.44; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SELKER EU, 1990, ANNU REV GENET, V24, P579, DOI 10.1146/annurev.ge.24.120190.003051; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TAMAME M, 1983, MOL CELL BIOL, V3, P2287, DOI 10.1128/MCB.3.12.2287; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Xiang H, 2010, NAT BIOTECHNOL, V28, P516, DOI 10.1038/nbt.1626; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	49	121	129	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30349	10.1371/journal.pone.0030349	http://dx.doi.org/10.1371/journal.pone.0030349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22586469	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100036
J	Gamble, C; Nadel, S; Snape, D; McKay, A; Hickey, H; Williamson, P; Glennie, L; Snowdon, C; Young, B				Gamble, Carrol; Nadel, Simon; Snape, Dee; McKay, Andrew; Hickey, Helen; Williamson, Paula; Glennie, Linda; Snowdon, Claire; Young, Bridget			What Parents of Children Who Have Received Emergency Care Think about Deferring Consent in Randomised Trials of Emergency Treatments: Postal Survey	PLOS ONE			English	Article								Objective: To investigate parents' views about deferred consent to inform management of trial disclosure after a child's death. Methods: A postal questionnaire survey was sent to members of the Meningitis Research Foundation UK charity, whose child had suffered from bacterial meningitis or meningococcal septicaemia within the previous 5 years. Main outcome measures were acceptability of deferred consent; timing of requesting consent; and the management of disclosure of the trial after a child's death. Results: 220 families were sent questionnaires of whom 63 (29%) were bereaved. 68 families responded (31%), of whom 19 (28%) were bereaved. The majority (67%) was willing for their child to be involved in the trial without the trial being explained to them beforehand; 70% wanted to be informed about the trial as soon as their child's condition had stabilised. In the event of a child's death before the trial could be discussed the majority of bereaved parents (66% 12/18) anticipated wanting to be told about the trial at some time. This compared with 37% (18/49) of non-bereaved families (p = 0.06). Parents' free text responses indicated that the word 'trial' held strongly negative connotations. A few parents regarded gaps in the evidence base about emergency treatments as indicating staff lacked expertise to care for a critically ill child. Bereaved parents' free text responses indicated the importance of individualised management of disclosure about a trial following a child's death. Discussion: Deferred consent is acceptable to the majority of respondents. Parents whose children had recovered differed in their views compared to bereaved parents. Most bereaved parents would want to be informed about the trial in the aftermath of a child's death, although a minority strongly opposed such disclosure. Distinction should be drawn between the views of bereaved and non-bereaved parents when considering the acceptability of different consent processes.	[Gamble, Carrol; McKay, Andrew; Hickey, Helen; Williamson, Paula] Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England; [Nadel, Simon] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England; [Glennie, Linda] Meningitis Res Fdn, Bristol, Avon, England; [Snowdon, Claire] London Sch Hyg & Trop Med, London WC1, England	University of Liverpool; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Gamble, C (corresponding author), Univ Liverpool, Clin Trials Res Ctr, Liverpool L69 3BX, Merseyside, England.	c.gamble@liv.ac.uk	Gamble, Tony/AAT-4463-2020; Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; Young, Bridget/A-2184-2014	Gamble, Tony/0000-0002-0204-8003; Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Snowdon, Claire/0000-0002-9133-5476; Young, Bridget/0000-0001-6041-9901; Jackman, Todd/0000-0002-5391-8136	MRC North West Hub Trials Methodology Research; Imperial College Healthcare Trust BRC (Biomedical Research Centre); Medical Research Council [G0800792] Funding Source: researchfish; National Institute for Health Research [05/516/08] Funding Source: researchfish	MRC North West Hub Trials Methodology Research; Imperial College Healthcare Trust BRC (Biomedical Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge MRC North West Hub Trials Methodology Research for supporting contributions from Paula Williamson, Bridget Young, and Carrol Gamble, and the Imperial College Healthcare Trust BRC (Biomedical Research Centre) for support of Simon Nadel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, OFFICIAL J EUROPEA L, VL 121, P0034; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Culbert A, 2005, J MED ETHICS, V31, P721, DOI 10.1136/jme.2004.011247; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; Morrison CA, 2009, J SURG RES, V157, P115, DOI 10.1016/j.jss.2009.03.051; National Collaborating Centre for Women's and Children's Health (UK), 2010, NICE CLIN GUID; Nichol G, 2006, RESUSCITATION, V70, P360, DOI 10.1016/j.resuscitation.2006.01.020; Shilling V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021604; Smyth RL, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6756; Spencer L., 2003, QUALITY QUALITATIVE; Stephenson T, 2006, BRIT J CLIN PHARMACO, V61, P716, DOI 10.1111/j.1365-2125.2006.02676.x; 1996, FED REG, V61, P51498	16	258	266	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2012	7	5							e35982	10.1371/journal.pone.0035982	http://dx.doi.org/10.1371/journal.pone.0035982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TC	22586456	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000305335000018
J	Zhang, X; Tiewsiri, K; Kain, W; Huang, LH; Wang, P				Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping			Resistance of Trichoplusia ni to Bacillus thuringiensis Toxin Cry1Ac Is Independent of Alteration of the Cadherin-Like Receptor for Cry Toxins	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; HELIOTHIS-VIRESCENS; INSECT RESISTANCE; CABBAGE-LOOPER; MANDUCA-SEXTA; BT TOXINS; BINDING; MEMBRANE; PROTEIN; MECHANISM	Alteration of binding sites for Bacillus thuringiensis (Bt) toxins in insect midgut is the major mechanism of high-level resistance to Bt toxins in insects. The midgut cadherin is known to be a major binding protein for Bt Cry1A toxins and linkage of Bt-resistance to cadherin gene mutations has been identified in lepidopterans. The resistance to Bt toxin Cry1Ac evolved in greenhouse populations of Trichoplusia ni has been identified to be associated with the down-regulation of an aminopeptidase N (APN1) gene by a trans-regulatory mechanism and the resistance gene has been mapped to the locus of an ABC transporter (ABCC2) gene. However, whether cadherin is also involved with Cry1Ac-resistance in T. ni requires to be understood. Here we report that the Cry1Ac-resistance in T. ni is independent of alteration of the cadherin. The T. ni cadherin cDNA was cloned and the cadherin sequence showed characteristic features known to cadherins from Lepidoptera. Various T. ni cadherin gene alleles were identified and genetic linkage analysis of the cadherin alleles with Cry1Ac-resistance showed no association of the cadherin gene with the Cry1Ac-resistance in T. ni. Analysis of cadherin transcripts showed no quantitative difference between the susceptible and Cry1Ac-resistant T. ni larvae. Quantitative proteomic analysis of midgut BBMV proteins by iTRAQ-2D-LC-MS/MS determined that there was no quantitative difference in cadherin content between the susceptible and the resistant larvae and the cadherin only accounted for 0.0014% (mol%) of the midgut BBMV proteins, which is 1/300 of APN1 in molar ratio. The cadherin from both the susceptible and resistant larvae showed as a 200-kDa Cry1Ac-binding protein by toxin overlay binding analysis, and nano-LC-MS/MS analysis of the 200-kDa cadherin determined that there is no quantitative difference between the susceptible and resistant larvae. Results from this study indicate that the Cry1Ac-resistance in T. ni is independent of cadherin alteration.	[Zhang, Xin; Tiewsiri, Kasorn; Kain, Wendy; Huang, Lihua; Wang, Ping] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA	Cornell University	Zhang, X (corresponding author), Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA.	pingwang@cornell.edu			Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2008-35302-18806]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive from the USDA National Institute of Food and Agriculture; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Agriculture and Food Research Initiative Competitive Grant no. 2008-35302-18806 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bell RA., 1981, USDA TECH B, P599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Bravo A, 2002, BBA-BIOMEMBRANES, V1562, P63, DOI 10.1016/S0005-2736(02)00360-7; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flannagan RD, 2005, INSECT BIOCHEM MOLEC, V35, P33, DOI 10.1016/j.ibmb.2004.10.001; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; Huang FN, 2007, J ECON ENTOMOL, V100, P164, DOI 10.1603/0022-0493(2007)100[164:SBLCRT]2.0.CO;2; Ibrahim Mohamed A, 2010, Bioeng Bugs, V1, P31, DOI 10.4161/bbug.1.1.10519; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1999, FEBS LETT, V460, P385, DOI 10.1016/S0014-5793(99)01327-7; Oppert B, 1999, ARCH INSECT BIOCHEM, V42, P1, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;1::AID-ARCH2&gt;3.0.CO;2-#; Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Redding Alyssa M., 2006, Briefings in Functional Genomics & Proteomics, V5, P133, DOI 10.1093/bfgp/ell025; RINALDINI L M, 1954, J Physiol, V123, P20; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; Tabashnik Bruce E, 2011, Nat Biotechnol, V29, P1128, DOI 10.1038/nbt.1988; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2007, APPL ENVIRON MICROB, V73, P1199, DOI 10.1128/AEM.01834-06; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	62	308	314	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2012	7	5							e35991	10.1371/journal.pone.0035991	http://dx.doi.org/10.1371/journal.pone.0035991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UF	22558203	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339400010
J	Brown, JC; Huedo-Medina, TB; Pescatello, LS; Ryan, SM; Pescatello, SM; Moker, E; LaCroix, JM; Ferrer, RA; Johnson, BT				Brown, Justin C.; Huedo-Medina, Tania B.; Pescatello, Linda S.; Ryan, Stacey M.; Pescatello, Shannon M.; Moker, Emily; LaCroix, Jessica M.; Ferrer, Rebecca A.; Johnson, Blair T.			The Efficacy of Exercise in Reducing Depressive Symptoms among Cancer Survivors: A Meta-Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER; PHYSICAL-ACTIVITY; REHABILITATION PROGRAM; CLINICAL DEPRESSION; AEROBIC EXERCISE; META-REGRESSION; WOMEN; FATIGUE	Introduction: The purpose of this meta-analysis was to examine the efficacy of exercise to reduce depressive symptoms among cancer survivors. In addition, we examined the extent to which exercise dose and clinical characteristics of cancer survivors influence the relationship between exercise and reductions in depressive symptoms. Methods: We conducted a systematic search identifying randomized controlled trials of exercise interventions among adult cancer survivors, examining depressive symptoms as an outcome. We calculated effect sizes for each study and performed weighted multiple regression moderator analysis. Results: We identified 40 exercise interventions including 2,929 cancer survivors. Diverse groups of cancer survivors were examined in seven exercise interventions; breast cancer survivors were examined in 26; prostate cancer, leukemia, and lymphoma were examined in two; and colorectal cancer in one. Cancer survivors who completed an exercise intervention reduced depression more than controls, d(+) = 20.13 (95% CI: -0.26, -0.01). Increases in weekly volume of aerobic exercise reduced depressive symptoms in dose-response fashion (beta = -0.24, p = 0.03), a pattern evident only in higher quality trials. Exercise reduced depressive symptoms most when exercise sessions were supervised (beta = -0.26, p = 0.01) and when cancer survivors were between 47-62 yr (beta = 0.27, p = 0.01). Conclusion: Exercise training provides a small overall reduction in depressive symptoms among cancer survivors but one that increased in dose-response fashion with weekly volume of aerobic exercise in high quality trials. Depressive symptoms were reduced to the greatest degree among breast cancer survivors, among cancer survivors aged between 47-62 yr, or when exercise sessions were supervised.	[Brown, Justin C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Brown, Justin C.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Huedo-Medina, Tania B.; Pescatello, Linda S.; Moker, Emily; LaCroix, Jessica M.; Johnson, Blair T.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Storrs, CT USA; [Ryan, Stacey M.] Univ Texas MD Anderson Canc Ctr, Dept Phys Therapy, Houston, TX 77030 USA; [Pescatello, Shannon M.] Western New England Coll, Dept Psychol, Springfield, MA USA; [Ferrer, Rebecca A.] NCI, Rockville, MD USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Connecticut; University of Texas System; UTMD Anderson Cancer Center; Western New England University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brown, JC (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	brownjus@mail.med.upenn.edu	Brown, Jennifer Valeska Elli/C-6947-2019	Brown, Jennifer Valeska Elli/0000-0003-0943-5177; Byrne, Thirimon Moe/0000-0002-2827-9715	University of Connecticut Research Advisory Council Foundation [433527]	University of Connecticut Research Advisory Council Foundation	Funding was provided by the University of Connecticut Research Advisory Council Foundation grant no. 433527 (PIs: Blair T. Johnson and Linda S. Pescatello). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Becker B. J., 2000, HDB APPL MULTIVARIAT, P499, DOI [DOI 10.1016/B978-012691360-6/50018-5, 10.1016/B978-012691360-6/50018-5]; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERGLUND G, 1994, EUR J CANCER, V30A, P1744, DOI 10.1016/0959-8049(94)00330-8; Brosse AL, 2002, SPORTS MED, V32, P741, DOI 10.2165/00007256-200232120-00001; Brown JC, 2011, CANCER EPIDEM BIOMAR, V20, P123, DOI 10.1158/1055-9965.EPI-10-0988; Burnham TR, 2002, MED SCI SPORT EXER, V34, P1863, DOI 10.1097/00005768-200212000-00001; Cadmus LA, 2009, PSYCHO-ONCOLOGY, V18, P343, DOI 10.1002/pon.1525; Chandwani Kavita D, 2010, J Soc Integr Oncol, V8, P43; Chang PH, 2008, J PAIN SYMPTOM MANAG, V35, P524, DOI 10.1016/j.jpainsymman.2007.06.013; Clark AM, 2010, EUR J CARDIOV PREV R, V17, P261, DOI 10.1097/HJR.0b013e32833090ef; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L, 2004, CANCER-AM CANCER SOC, V100, P2253, DOI 10.1002/cncr.20236; Conn VS, 2010, ANN BEHAV MED, V39, P128, DOI 10.1007/s12160-010-9172-x; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Courneya KS, 2009, J CLIN ONCOL, V27, P4605, DOI 10.1200/JCO.2008.20.0634; Courneya KS, 2003, EUR J CANCER CARE, V12, P347, DOI 10.1046/j.1365-2354.2003.00437.x; Courneya KS, 2003, PSYCHO-ONCOLOGY, V12, P357, DOI 10.1002/pon.658; Coventry PA, 2007, J PSYCHOSOM RES, V63, P551, DOI 10.1016/j.jpsychores.2007.08.002; Craft L, 2011, CANC EPIDEMIOL BIOMA; Culos-Reed SN, 2006, PSYCHO-ONCOLOGY, V15, P891, DOI 10.1002/pon.1021; Culos-Reed SN, 2010, SUPPORT CARE CANCER, V18, P591, DOI 10.1007/s00520-009-0694-3; Daley AJ, 2007, J CLIN ONCOL, V25, P1713, DOI 10.1200/JCO.2006.09.5083; Danhauer SC, 2009, PSYCHO-ONCOLOGY, V18, P360, DOI 10.1002/pon.1503; Demark-Wahnefried W, 2008, CLIN BREAST CANCER, V8, P70, DOI 10.3816/CBC.2008.n.005; Dimeo FC, 1999, CANCER, V85, P2273, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO;2-B; Dodd MJ, 2010, CANCER NURS, V33, P245, DOI 10.1097/NCC.0b013e3181ddc58c; Drown JS, 2005, REHABIL ONCOL, V23, P11, DOI 10.1097/01893697-200523010-00004; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eyigor S, 2010, EUR J PHYS REHAB MED, V46, P481; Ferrer RA, 2011, ANN BEHAV MED, V41, P32, DOI 10.1007/s12160-010-9225-1; GILBAR O, 1989, J PSYCHOSOM RES, V33, P1, DOI 10.1016/0022-3999(89)90100-1; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; Hedges L. V., 1985, STAT METHODS META AN, DOI [DOI 10.1016/B978-0-08-057065-5.50005-1, 10.2307/1164953, DOI 10.2307/1164953]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holland JC, 2010, J NATL COMPR CANC NE, V8, P448, DOI 10.6004/jnccn.2010.0034; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jarden M, 2009, J PAIN SYMPTOM MANAG, V38, P174, DOI 10.1016/j.jpainsymman.2008.09.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson BT, 2011, RES SYN METHOD; Jones LW, 2010, LANCET ONCOL, V11, P914, DOI 10.1016/S1470-2045(10)70184-4; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Latka RN, 2009, J CANCER SURVIV, V3, P148, DOI 10.1007/s11764-009-0088-z; LEBOVITS AH, 1990, CANCER, V65, P17, DOI 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I; Lee SA, 2010, CLIN REHABIL, V24, P600, DOI 10.1177/0269215510362324; Lipsey MW, 2001, PRACTICAL METAANALYS, P247; Maher CG, 2003, PHYS THER, V83, P713, DOI 10.1093/ptj/83.8.713; Mao JJ, 2007, J AM BOARD FAM MED, V20, P434, DOI 10.3122/jabfm.2007.05.060225; McClure MK, 2010, AM J OCCUP THER, V64, P59, DOI 10.5014/ajot.64.1.59; Mock V, 1994, Oncol Nurs Forum, V21, P899; Mock V, 1997, Oncol Nurs Forum, V24, P991; Monga U, 2007, ARCH PHYS MED REHAB, V88, P1416, DOI 10.1016/j.apmr.2007.08.110; MOR V, 1994, CANCER-AM CANCER SOC, V74, P2118, DOI 10.1002/1097-0142(19941001)74:7+<2118::AID-CNCR2820741720>3.0.CO;2-N; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Newport DJ, 1998, J PSYCHOSOM RES, V45, P215, DOI 10.1016/S0022-3999(98)00011-7; North T C, 1990, Exerc Sport Sci Rev, V18, P379; O'Brien Kelly, 2010, Cochrane Database Syst Rev, pCD001796, DOI 10.1002/14651858.CD001796.pub3; Ohira T, 2006, CANCER-AM CANCER SOC, V106, P2076, DOI 10.1002/cncr.21829; Papakostas GI, 2008, J CLIN PSYCHIAT, V69, P1287, DOI 10.4088/JCP.v69n0812; Pasquini Massimo, 2007, Clin Pract Epidemiol Ment Health, V3, P2, DOI 10.1186/1745-0179-3-2; Patel SR, 2004, THESIS; Payne JK, 2008, ONCOL NURS FORUM, V35, P635, DOI 10.1188/08.ONF.635-642; Perna FM, 2010, INT J SPORT EXERC PS, V8, P36, DOI 10.1080/1612197X.2010.9671932; Pinto BM, 2003, PSYCHO-ONCOLOGY, V12, P118, DOI 10.1002/pon.618; Raghavendra RM, 2009, INTEGR CANCER THER, V8, P37, DOI 10.1177/1534735409331456; Rausch SM, 2007, THESIS; REDDON JR, 1985, J PSYCHOPATHOL BEHAV, V7, P243, DOI 10.1007/BF00960756; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Salkind M R, 1969, J R Coll Gen Pract, V18, P267; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Spence RR, 2011, EUR J CANCER CARE, V20, P257, DOI 10.1111/j.1365-2354.2010.01214.x; SUTHERLAND HJ, 1988, CANCER NURS, V11, P303; Targ EF, 2002, GEN HOSP PSYCHIAT, V24, P238, DOI 10.1016/S0163-8343(02)00191-3; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thompson WR, ACSMS GUIDELINES EXE; Thorsen L, 2005, J CLIN ONCOL, V23, P2378, DOI 10.1200/JCO.2005.04.106; Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005; Vito NL, 2007, THESIS; Watson M, 1999, LANCET, V354, P1331, DOI 10.1016/S0140-6736(98)11392-2; Whitehead S, 2009, QUAL HEALTH RES, V19, P894, DOI 10.1177/1049732309337523; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	216	222	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e30955	10.1371/journal.pone.0030955	http://dx.doi.org/10.1371/journal.pone.0030955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	911GB	22586491	gold, Green Published			2022-12-27	WOS:000301704200049
J	Williams, LJ; Dunlop, JP; Abdi, H				Williams, Lynne J.; Dunlop, Joseph P.; Abdi, Herve			Effect of Age on Variability in the Production of Text-Based Global Inferences	PLOS ONE			English	Article							INTRAINDIVIDUAL VARIABILITY; INDIVIDUAL VARIABILITY; MEMORY PERFORMANCE; OLD-AGE; BOOTSTRAP; DISCOURSE; SPEED; GIST; RECOGNITION; CONFIDENCE	As we age, our differences in cognitive skills become more visible, an effect especially true for memory and problem solving skills (i.e., fluid intelligence). However, by contrast with fluid intelligence, few studies have examined variability in measures that rely on one's world knowledge (i.e., crystallized intelligence). The current study investigated whether age increased the variability in text based global inference generation-a measure of crystallized intelligence. Global inference generation requires the integration of textual information and world knowledge and can be expressed as a gist or lesson. Variability in generating two global inferences for a single text was examined in young-old (62 to 69 years), middle-old (70 to 76 years) and old-old (77 to 94 years) adults. The older two groups showed greater variability, with the middle elderly group being most variable. These findings suggest that variability may be a characteristic of both fluid and crystallized intelligence in aging.	[Williams, Lynne J.] Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada; [Dunlop, Joseph P.; Abdi, Herve] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Texas System; University of Texas Dallas	Williams, LJ (corresponding author), Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada.	lwilliams@research.baycrest.org; herve@utdallas.edu	Williams, Lynne/P-4799-2019; Beutels, Philippe/A-1919-2010; Hens, Niel/M-4445-2017	Williams, Lynne/0000-0001-6790-1362; Abdi, Herve/0000-0002-9522-1978; Chao, Dennis/0000-0002-8253-6321; Beutels, Philippe/0000-0001-5034-3595; Hens, Niel/0000-0003-1881-0637; Willem, Lander/0000-0002-9210-1196	NIGMS NIH HHS [U01-GM070749, U01 GM070749] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdi H, 2007, ENCY MEASUREMENT STA, V2, P651; Abdi H., 2010, ENCY RES DESIGN, P655; Abdi H., 2007, ENCY MEASUREMENT STA, P270; Abdi H, 1985, B PSYCHOL, V38, P633; Abdi H, 2010, ENCY RES DESIGN, P267; Abdi H, 1990, CUMFID, V16, P99; Abdi H, 2012, WILEY INTERDISCIP RE, V4, P124, DOI 10.1002/wics.198; Abdi H, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/634165; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; Adam S, 2007, EC STAT, V403, P83; ADAMS C, 1990, J GERONTOL, V45, pP17, DOI 10.1093/geronj/45.1.P17; ADAMS C, 1991, PSYCHOL AGING, V6, P323, DOI 10.1037/0882-7974.6.3.323; Allaire JC, 2005, PSYCHOL AGING, V20, P390, DOI 10.1037/0882-7974.20.3.390; Anstey Kaarin J, 2004, Aust Fam Physician, V33, P783; Benzecri Jean-Paul, 1973, ANAL DONNEES, V2; Benzecri Jean-Paul, 1973, ANAL DONNEES, V1; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503; Blasius J, 2006, STAT SOC BEHAV SCI, P3; Bonsang E, DOES RETIREMENT AFFE; Brose A, 2010, RES HUM DEV, V7, P61, DOI 10.1080/15427600903578177; Burke Deborah M., 2006, LIFESPAN COGNITION M, P193; Carnes P, 1988, PROVERBIA FABULA ESS; Caskie GIL, 1999, GER SOC AM C; Chastaing M, 1980, J PSYCHOL NORMALE PA, V77, P31; Chesneau S, 2007, PSYCHOL NEUROPSYCHIA, V5, P47, DOI 10.1684/pnv.2007.0037; Chi YY, 2011, WILEY INTERDISCIPLIN, V4, P35; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; Clausen S.E., 1998, APPL CORRES ANAL INT, V121; Daly DL, 1963, INTELLIGENCE, P33; DIXON RA, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P77; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Dolby-Stahl SK, 1980, FOLKLORE 2 CONTINENT, P160; DORFMAN MH, 1994, DISCOURSE PROCESS, V17, P105, DOI 10.1080/01638539409544861; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FISKE DW, 1957, EDUC PSYCHOL MEAS, V17, P317, DOI 10.1177/001316445701700301; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; GAUDREAULT R, 1994, SEMIOTICA, V99, P297, DOI 10.1515/semi.1994.99.3-4.297; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; Greenacre M., 2007, CORRES ANAL PRACTICE; Greenacre Michael, 1984, THEORY APPL CORRES A; Gutchess AH, 2012, NEUROIMAGE, V59, P3418, DOI 10.1016/j.neuroimage.2011.11.078; HAMM VP, 1992, PSYCHOL AGING, V7, P56, DOI 10.1037/0882-7974.7.1.56; Hanauer DI, 2000, DISCOURSE PROCESS, V30, P107, DOI 10.1207/S15326950DP3002_02; HART R. P., 1988, CLIN NEUROPSYCHOL, V2, P49, DOI [10.1080/13854048808520085, DOI 10.1080/13854048808520085]; HERTZOG C, 1992, BRAIN LANG, V42, P248, DOI 10.1016/0093-934X(92)90100-S; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hosokawa A, 2006, JPN PSYCHOL RES, V48, P77, DOI 10.1111/j.1468-5884.2006.00308.x; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF, 2005, MEASURING MIND SPEED; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024; Jamet MC, 1988, LINGUE MONDO, V53, P79; Kintsch W, 1998, COMPREHENSION PARADI; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34; Le Roux B., 2010, MULTIPLE CORRES ANAL; Lebart L, 2006, JOURNEES INT ANAL ST, V8; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; Lindenberger U, 1997, PSYCHOL AGING, V12, P410, DOI 10.1037/0882-7974.12.3.410; LINDENBERGER U, 1993, PSYCHOL AGING, V8, P207, DOI 10.1037/0882-7974.8.2.207; Luszcz MA, 2004, GERONTOLOGY, V50, P5, DOI 10.1159/000074381; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; MAGLIANO JP, 1991, POETICS, V20, P193, DOI 10.1016/0304-422X(91)90007-C; Martin M, 2004, GERONTOLOGY, V50, P7, DOI 10.1159/000074382; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; Meyer BI, 1987, ANN REV GERONTOLOGY, V7; Miller MB, 2007, INT J PSYCHOPHYSIOL, V63, P205, DOI 10.1016/j.ijpsycho.2006.03.019; Nesselroade J. R., 2004, RES HUMAN DEV, V1, P9, DOI [DOI 10.1080/15427609.2004.9683328, 10.1207/s15427617rhd0101&2_3]; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; Olness G, 2000, THESIS U TEXAS DALLA; Papenberg G, 2011, NEUROPSYCHOLOGIA, V49, P1879, DOI 10.1016/j.neuropsychologia.2011.03.013; Park D. C., 1999, COGNITIVE AGING PRIM; Pinkham AE, J ABNORMAL IN PRESS, P121; Radvansky GA, 2001, PSYCHOL AGING, V16, P145, DOI 10.1037//0882-7974.16.1.145; Ram N, 2005, PSYCHOL AGING, V20, P623, DOI 10.1037/0882-7974.20.4.623; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REYNA VF, 1994, DEV PSYCHOL, V30, P178, DOI 10.1037/0012-1649.30.2.178; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salthouse TA, 1998, PSYCHOL AGING, V13, P445, DOI 10.1037/0882-7974.13.3.445; Salthouse TA, 2001, PSYCHOL AGING, V16, P251, DOI 10.1037//0882-7974.16.2.251; Saporta G, 2006, STAT SOC BEHAV SCI, P371; Schank RC., 1977, SCRIPTS PLANS GOALS; SEIFERT CM, 1985, J MEM LANG, V24, P405, DOI 10.1016/0749-596X(85)90037-3; Shammi P, 1998, AGING NEUROPSYCHOL C, V5, P1, DOI 10.1076/anec.5.1.1.23; SIEGLER RS, 1994, CURR DIR PSYCHOL SCI, V3, P1, DOI 10.1111/1467-8721.ep10769817; Sims DG, 1975, J ACADEMY REHABILITA, V8, P70; Smith M., 1915, J ENGLISH GERMANIC P, V14, P519; Solomon P R, 1998, Fam Med, V30, P265; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Stahl C, 2008, J EXP PSYCHOL LEARN, V34, P570, DOI 10.1037/0278-7393.34.3.570; Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.2.453; Ulatowska HK, 2005, BRAIN LANG, V95, P109, DOI 10.1016/j.bandl.2005.07.059; Ulatowska HK, 1998, APHASIOLOGY, V12, P619, DOI 10.1080/02687039808249562; Ulatowska HK, 2000, APHASIOLOGY, V14, P227, DOI 10.1080/026870300401450; van Dijk T., 1983, STRATEGIES DISCOURSE; van Dijk T. A., 1977, COGNITIVE PROCESS, P03; van Dijk TA, 1980, MACROSTRUCTURES; Wechsler D., 1998, WECHSLER ADULT INTEL; Wechsler D, 1998, WECHSLER MEMORY SCAL; Williams LJ, 2010, J SPEECH LANG HEAR R, V53, P1372, DOI 10.1044/1092-4388(2010/08-0141); Zelinski E. M., 1988, LANGUAGE MEMORY AGIN, P117	111	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36161	10.1371/journal.pone.0036161	http://dx.doi.org/10.1371/journal.pone.0036161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TF	22590523	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335500008
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500028
